data_1dmz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1dmz _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 698' ' ' ASP . 0.5 OUTLIER -150.92 -40.8 0.12 Allowed 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.045 0.926 . . . . 0.0 108.795 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 594' ' ' ILE . 16.1 tp -130.69 119.59 22.63 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.335 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 88.7 m -102.66 118.3 36.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.141 -0.974 . . . . 0.0 109.434 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.401 HD12 ' CD1' ' A' ' 594' ' ' ILE . 15.3 mt -91.16 112.02 23.74 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.433 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -114.24 101.56 54.18 Favored Pre-proline 0 C--N 1.302 -1.473 0 C-N-CA 118.131 -1.428 . . . . 0.0 112.843 -177.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.146 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.2 Cg_endo -79.6 144.24 17.51 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 N-CA-C 105.788 -2.428 . . . . 0.0 105.788 174.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.69 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -123.48 -178.3 0.64 Allowed Pre-proline 0 N--CA 1.498 1.927 0 C-N-CA 118.214 -1.394 . . . . 0.0 114.082 -175.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.69 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.5 Cg_endo -67.6 -31.81 32.39 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 124.272 1.67 . . . . 0.0 111.375 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.79 -30.72 67.8 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.449 ' CB ' ' N ' ' A' ' 691' ' ' GLY . 4.0 p -97.43 153.41 18.13 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.529 ' CG1' HG12 ' A' ' 690' ' ' ILE . 4.7 pt -56.69 -17.15 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 109.637 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.541 HG13 HG12 ' A' ' 613' ' ' ILE . 7.0 mm -99.61 114.96 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.318 -0.864 . . . . 0.0 108.7 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.525 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -126.12 73.0 1.33 Allowed 'General case' 0 N--CA 1.508 2.443 0 O-C-N 120.653 -1.28 . . . . 0.0 110.587 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.146 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 49.6 mt-10 -143.04 174.7 10.45 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.489 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.32 126.34 40.59 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.589 -1.319 . . . . 0.0 109.752 176.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 1.1 mt -110.7 156.0 21.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 0.0 109.28 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -125.2 110.04 13.59 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.427 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 578' ' ' LEU . 29.3 mt -80.28 108.39 13.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.406 ' O ' ' C ' ' A' ' 596' ' ' GLN . 3.8 mt-30 -70.99 120.67 16.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.507 -0.746 . . . . 0.0 111.261 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.538 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 11.6 mm-40 37.77 33.72 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.409 0.624 . . . . 0.0 111.035 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . 80.15 65.07 1.78 Allowed Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.492 HG11 HG22 ' A' ' 594' ' ' ILE . 10.9 p -79.69 105.07 8.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -121.72 150.9 56.43 Favored Pre-proline 0 C--N 1.28 -2.454 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.694 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.459 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.6 Cg_endo -86.68 157.46 51.63 Favored 'Cis proline' 0 C--N 1.308 -1.602 0 C-N-CA 121.075 -2.469 . . . . 0.0 109.511 0.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.484 ' CD2' ' HB2' ' A' ' 611' ' ' CYS . 3.0 t80 -106.25 116.11 31.37 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.547 ' O ' ' HB3' ' A' ' 609' ' ' CYS . 60.6 m-85 -87.89 144.33 26.63 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.311 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.609 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.8 mt -141.02 142.12 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.742 -0.599 . . . . 0.0 110.602 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.774 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 170.37 -159.05 31.27 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.912 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -71.37 -47.24 57.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.819 -0.812 . . . . 0.0 110.957 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.88 126.97 31.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 110.808 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.536 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.2 OUTLIER -56.76 -15.54 4.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.832 . . . . 0.0 110.439 179.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -45.73 -35.94 4.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.251 -0.906 . . . . 0.0 109.125 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 602' ' ' PHE . 1.3 m -62.78 136.65 57.97 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -49.86 -25.51 3.22 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.307 -0.87 . . . . 0.0 109.628 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.609 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 2.1 t -109.03 143.57 38.16 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.536 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -110.48 128.55 55.67 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 122.198 0.999 . . . . 0.0 113.101 -178.256 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.541 HG12 HG13 ' A' ' 588' ' ' ILE . 13.0 mt -142.39 108.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -89.68 102.46 15.15 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 117.838 -1.545 . . . . 0.0 107.796 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.808 ' HB3' ' CB ' ' A' ' 618' ' ' LEU . 9.9 t0 -139.93 106.39 5.31 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.57 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -38.67 -65.86 0.32 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.579 -0.701 . . . . 0.0 112.747 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.72 -16.51 64.29 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.117 -0.99 . . . . 0.0 112.455 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.808 ' CB ' ' HB3' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -73.19 129.44 38.05 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.0 -1.062 . . . . 0.0 110.87 -179.035 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.8 160.89 24.94 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.287 -0.883 . . . . 0.0 110.818 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.774 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.7 mtt180 -64.43 -46.94 81.03 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.294 -0.879 . . . . 0.0 109.474 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.475 ' O ' ' C ' ' A' ' 622' ' ' HIS . 9.3 m -95.37 2.58 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.402 -0.811 . . . . 0.0 109.577 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.6 t60 -25.41 -45.94 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.263 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 621' ' ' VAL . 0.7 OUTLIER -136.49 145.68 45.41 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.453 -1.299 . . . . 0.0 111.283 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.543 ' HA ' HG13 ' A' ' 603' ' ' ILE . 2.1 p90 -145.52 144.15 30.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.544 -0.723 . . . . 0.0 110.09 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 12.3 mt -103.28 121.42 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 9.4 t80 -114.52 154.87 27.48 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.397 -0.814 . . . . 0.0 109.861 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 5.2 ttmt -120.17 136.84 54.48 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.49 0.662 . . . . 0.0 110.583 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.471 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -138.93 163.57 31.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.628 -0.67 . . . . 0.0 110.357 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -78.11 127.64 32.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.241 -0.912 . . . . 0.0 108.728 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.529 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.6 t60 . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 110.769 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 5.3 mp . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 24.4 m-20 -119.24 124.76 47.52 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.007 -1.058 . . . . 0.0 111.386 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.425 ' OD2' ' CE1' ' A' ' 630' ' ' HIS . 7.9 t0 -112.87 155.93 23.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.481 -0.762 . . . . 0.0 110.027 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 13.2 pt -107.08 134.71 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.252 -0.905 . . . . 0.0 109.943 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.694 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.4 m95 -119.05 124.01 45.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.649 -0.657 . . . . 0.0 111.233 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.439 ' CE1' HD13 ' A' ' 678' ' ' ILE . 12.5 t80 -83.37 114.95 21.79 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 8.2 t -108.67 109.17 20.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.051 -1.031 . . . . 0.0 111.423 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.599 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 9.4 t60 -75.28 160.72 30.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.43 -0.794 . . . . 0.0 110.057 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -152.52 -29.72 0.15 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.355 -0.841 . . . . 0.0 113.187 -178.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.599 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -79.28 135.48 15.48 Favored Glycine 0 N--CA 1.502 3.047 0 C-N-CA 117.866 -2.111 . . . . 0.0 110.212 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 654' ' ' THR . . . . . 0.448 ' O ' HG13 ' A' ' 656' ' ' VAL . 5.8 m -36.87 -24.56 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.511 ' O ' HG22 ' A' ' 656' ' ' VAL . 2.4 t-20 -59.12 -2.22 0.25 Allowed 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.471 -1.393 . . . . 0.0 113.179 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 655' ' ' ASN . 0.9 OUTLIER 63.92 146.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.453 -0.779 . . . . 0.0 110.702 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -97.7 153.38 18.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.76 -0.587 . . . . 0.0 110.246 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.474 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 10.2 m-85 -138.45 125.4 21.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.324 -0.86 . . . . 0.0 110.057 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 661' ' ' ASN . 0.1 OUTLIER -134.52 121.16 20.61 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.318 -0.864 . . . . 0.0 109.908 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 6.5 m120 55.16 -86.29 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.479 -0.763 . . . . 0.0 110.437 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 659' ' ' LEU . 5.8 t30 -143.32 14.05 1.81 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.096 -1.003 . . . . 0.0 110.602 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -102.29 118.16 36.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.135 -0.978 . . . . 0.0 110.383 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . 0.434 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 0.0 OUTLIER -85.04 139.01 32.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.366 -0.834 . . . . 0.0 110.004 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.446 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 3.5 mtp -120.25 -179.54 3.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 0.0 110.616 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.462 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 7.0 pt -120.18 -161.0 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.41 -0.806 . . . . 0.0 110.093 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -84.96 72.03 10.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.345 -0.847 . . . . 0.0 110.748 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 134.2 59.54 0.07 OUTLIER Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.6 OUTLIER -124.31 149.89 46.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.155 -1.203 . . . . 0.0 110.318 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.463 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 11.9 tttt -108.79 133.67 52.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.493 -0.754 . . . . 0.0 109.016 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.483 ' HD1' ' HA ' ' A' ' 716' ' ' VAL . 11.9 t80 -138.01 146.42 43.06 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.485 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.694 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.9 OUTLIER -72.69 144.66 47.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.461 -0.774 . . . . 0.0 110.267 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.43 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 1.3 mt -111.71 104.56 12.92 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.676 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -84.62 161.28 20.2 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -56.85 143.94 35.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.119 . . . . 0.0 109.569 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.67 47.27 50.01 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.664 -2.174 . . . . 0.0 107.664 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.31 89.91 3.54 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.836 -0.803 . . . . 0.0 110.473 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.914 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 7.1 tt0 -93.29 106.85 18.76 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.44 ' CG2' ' HG ' ' A' ' 659' ' ' LEU . 3.3 pt -111.1 137.32 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.346 0.593 . . . . 0.0 111.473 -177.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.29 109.96 22.53 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.525 -0.734 . . . . 0.0 109.091 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.426 ' CD1' ' CD1' ' A' ' 613' ' ' ILE . 89.9 mt -74.35 -29.51 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.404 -0.81 . . . . 0.0 110.26 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 689' ' ' VAL . 3.0 mt -143.0 133.26 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 109.851 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -138.42 111.79 8.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.572 -0.705 . . . . 0.0 110.108 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -129.12 117.54 21.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -66.69 -33.28 75.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.437 -0.789 . . . . 0.0 110.726 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -55.98 -43.52 77.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.395 -0.816 . . . . 0.0 111.08 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.05 12.14 11.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 110.706 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.31 23.69 2.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.159 -0.963 . . . . 0.0 110.41 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.5 ' CE2' ' HA ' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -72.81 74.39 1.13 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 0.0 109.53 179.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 681' ' ' ILE . 14.6 p -105.56 136.96 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.43 -0.794 . . . . 0.0 110.895 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.529 HG12 ' CG1' ' A' ' 587' ' ' ILE . 18.2 mt -108.38 163.77 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.347 -0.846 . . . . 0.0 108.928 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.449 ' N ' ' CB ' ' A' ' 586' ' ' SER . . . -170.84 123.62 1.06 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.914 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 11.4 m-85 -120.16 137.34 54.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.53 -0.982 . . . . 0.0 109.589 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 21.2 tptt -100.52 114.21 27.65 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 110.515 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 1.2 t -85.62 118.78 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.373 -0.829 . . . . 0.0 109.001 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -130.08 104.75 7.51 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.925 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 10.9 mt -85.49 104.4 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 110.037 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -77.27 -43.15 34.37 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.54 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -111.02 140.94 45.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.712 -0.618 . . . . 0.0 110.316 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 699' ' ' THR . 2.0 p -114.94 96.45 5.71 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 4.6 p -81.93 92.94 6.82 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.507 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 47.6 42.97 20.96 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.407 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 2.0 tp -85.79 148.78 25.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.45 -1.029 . . . . 0.0 110.337 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.538 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 5.1 p90 -49.47 -25.48 2.65 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.505 -0.747 . . . . 0.0 110.288 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.538 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.6 t30 . . . . . 0 C--N 1.301 -1.507 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.411 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 7.7 mmm-85 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.274 0.559 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.6 m -107.71 152.58 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.844 . . . . 0.0 109.406 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.483 ' HA ' ' HD1' ' A' ' 670' ' ' PHE . 49.6 t -96.24 133.37 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 110.735 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.43 162.14 14.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.514 -0.742 . . . . 0.0 109.56 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -97.37 149.49 22.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 0.0 110.511 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -80.94 129.07 34.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.434 -0.791 . . . . 0.0 110.015 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.2 p -103.42 -176.39 3.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.393 -0.817 . . . . 0.0 110.19 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.31 -28.79 30.23 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.397 -0.814 . . . . 0.0 110.113 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.11 -51.69 62.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.849 . . . . 0.0 109.897 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -64.02 -47.58 79.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.997 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.61 -32.73 52.36 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.322 -0.861 . . . . 0.0 110.076 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.45 -36.15 78.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.414 -0.804 . . . . 0.0 110.101 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 38.6 mt -58.55 -46.59 86.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.365 -0.834 . . . . 0.0 110.296 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.8 p -71.42 -20.75 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.225 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -53.41 -45.31 69.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.24 -0.913 . . . . 0.0 108.81 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.8 104.44 11.34 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.218 1.009 . . . . 0.0 109.006 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.415 ' OXT' ' CD2' ' A' ' 602' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--N 1.274 -2.692 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.281 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.572 0.701 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.54 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 8.5 t80 -95.83 -43.28 7.93 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.92 0.867 . . . . 0.0 109.392 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.5 ' HB2' ' CD2' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -126.97 136.98 53.0 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.043 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 88.4 m -113.43 117.26 31.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.14 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 2.6 mt -92.69 112.11 23.95 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 2.1 mmtt -112.81 102.18 54.18 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 118.255 -1.378 . . . . 0.0 113.24 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.084 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 45.0 Cg_endo -79.58 142.01 16.0 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 N-CA-C 105.32 -2.608 . . . . 0.0 105.32 173.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.727 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -119.16 -176.2 0.37 Allowed Pre-proline 0 N--CA 1.496 1.847 0 C-N-CA 118.16 -1.416 . . . . 0.0 113.896 -175.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.727 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.1 Cg_endo -66.82 -32.41 36.76 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 124.274 1.671 . . . . 0.0 112.033 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -59.08 -29.68 67.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.785 -1.197 . . . . 0.0 108.525 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.595 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 66.7 p -96.5 150.24 20.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.857 -0.527 . . . . 0.0 109.833 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.537 ' CG2' HD13 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -54.76 -20.31 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.146 -0.971 . . . . 0.0 109.028 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.665 HD11 ' HA ' ' A' ' 613' ' ' ILE . 9.2 mm -93.65 115.06 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.483 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -125.46 72.31 1.26 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 109.865 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.084 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 58.3 mm-40 -145.15 175.85 9.95 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.623 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.52 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.47 126.02 39.65 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.986 -1.071 . . . . 0.0 109.052 176.327 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 1.2 mp -109.79 154.08 23.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 0.0 109.745 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -125.53 110.05 13.41 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.502 -0.749 . . . . 0.0 110.989 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.416 HG21 ' HB ' ' A' ' 598' ' ' VAL . 1.9 mt -80.91 109.86 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.151 -0.968 . . . . 0.0 108.675 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -53.06 165.89 0.27 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.672 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.54 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 5.2 mt-30 -65.1 68.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.421 -0.799 . . . . 0.0 109.87 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 138.57 21.87 0.43 Allowed Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.567 -1.302 . . . . 0.0 110.789 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.446 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -85.92 101.53 10.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 O-C-N 120.732 -1.452 . . . . 0.0 107.176 178.449 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 627' ' ' LYS . 13.8 t-20 -144.99 134.05 11.17 Favored Pre-proline 0 C--N 1.284 -2.266 0 CA-C-N 114.777 -1.102 . . . . 0.0 110.21 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.556 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 51.0 Cg_endo -91.99 164.01 26.78 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 123.222 -1.574 . . . . 0.0 108.784 -2.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.505 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 4.1 t80 -104.48 116.11 31.53 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.556 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 36.4 m-85 -83.16 144.2 29.98 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.541 -0.724 . . . . 0.0 110.436 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.529 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 3.3 mt -142.67 141.77 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.66 -0.65 . . . . 0.0 110.045 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.749 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 168.75 -160.97 34.63 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.925 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 14.5 tpt180 -71.13 -43.52 67.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.713 -0.875 . . . . 0.0 111.189 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.431 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -78.3 126.51 30.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 110.872 -179.227 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.439 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.9 tt0 -54.04 -18.33 3.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.141 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.06 -31.32 0.9 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.255 -0.903 . . . . 0.0 109.142 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.5 m -69.89 130.77 43.15 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.505 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -44.83 -28.59 0.66 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.267 -0.895 . . . . 0.0 109.904 179.514 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.529 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 2.4 t -105.19 143.49 33.29 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.439 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.1 OUTLIER -109.19 128.19 54.83 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.286 -0.966 . . . . 0.0 112.859 -178.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.665 ' HA ' HD11 ' A' ' 588' ' ' ILE . 12.1 mt -141.79 108.06 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -91.73 103.79 16.32 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.228 -1.389 . . . . 0.0 108.396 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 2.6 m-20 -138.81 106.02 5.49 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.363 -1.289 . . . . 0.0 108.839 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -45.69 -42.17 11.31 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.546 -0.721 . . . . 0.0 111.948 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 27.2 mtm-85 -83.12 -17.14 44.11 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.074 -1.016 . . . . 0.0 111.269 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.485 ' CD2' ' HA2' ' A' ' 604' ' ' GLY . 0.8 OUTLIER -77.85 140.54 39.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.271 -0.893 . . . . 0.0 110.826 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 619' ' ' SER . . . . . 0.434 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.84 161.45 28.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.322 -0.861 . . . . 0.0 110.694 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.749 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 13.3 ttp180 -64.09 -45.79 87.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.328 -0.858 . . . . 0.0 109.255 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.466 ' O ' ' C ' ' A' ' 622' ' ' HIS . 2.8 t -95.52 2.07 9.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.84 0.829 . . . . 0.0 109.475 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.2 t60 -27.18 -46.69 0.03 OUTLIER 'General case' 0 C--O 1.196 -1.762 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.549 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.8 OUTLIER -137.59 145.69 43.12 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 118.025 -1.47 . . . . 0.0 111.857 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.516 ' HA ' HG13 ' A' ' 603' ' ' ILE . 13.1 p90 -146.68 142.64 28.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.595 -0.691 . . . . 0.0 109.9 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 60.3 mt -102.61 117.97 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.407 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 8.6 t80 -114.53 154.72 27.76 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.767 0.794 . . . . 0.0 110.017 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 5.4 ttmt -120.18 137.48 54.16 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.597 0.713 . . . . 0.0 110.737 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.407 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.44 163.94 29.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.516 -0.74 . . . . 0.0 110.092 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.6 OUTLIER -77.25 117.79 19.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.158 -0.964 . . . . 0.0 108.704 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.526 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.7 t60 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 121.647 0.737 . . . . 0.0 110.701 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.44 ' HB2' ' N ' ' A' ' 703' ' ' PHE . 5.1 mp . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.2 m-20 -110.02 124.22 51.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.007 -1.058 . . . . 0.0 110.908 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 628' ' ' LYS . 24.0 t0 -110.02 151.11 27.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.425 -0.797 . . . . 0.0 109.944 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 11.1 pt -105.66 132.0 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.338 -0.851 . . . . 0.0 109.898 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.624 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.7 m95 -119.03 119.25 33.72 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.87 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.508 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 1.1 t80 -80.96 114.08 19.6 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 668' ' ' THR . 62.9 m -108.37 108.66 19.72 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.506 -0.877 . . . . 0.0 111.206 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.558 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 17.8 t60 -73.24 169.16 17.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.499 -0.75 . . . . 0.0 109.992 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -159.58 -29.87 0.06 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.292 -0.88 . . . . 0.0 113.118 -178.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.558 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -79.7 140.43 22.55 Favored Glycine 0 N--CA 1.502 3.035 0 O-C-N 119.453 -2.029 . . . . 0.0 110.406 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 654' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 656' ' ' VAL . 22.7 m -47.1 -22.2 0.33 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.479 ' O ' ' CB ' ' A' ' 656' ' ' VAL . 1.0 OUTLIER -58.51 -4.27 0.38 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.601 -1.312 . . . . 0.0 112.444 -178.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.486 ' C ' ' CE1' ' A' ' 651' ' ' HIS . 0.4 OUTLIER 79.52 167.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 CA-C-O 121.878 0.847 . . . . 0.0 110.814 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.526 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -128.93 151.13 50.0 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.612 -179.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -138.48 126.59 22.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.174 -0.954 . . . . 0.0 110.946 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.505 ' CD2' ' CD2' ' A' ' 670' ' ' PHE . 14.7 tp -124.49 107.35 10.98 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.256 -0.903 . . . . 0.0 109.576 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 63.2 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.51 -0.743 . . . . 0.0 110.042 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 659' ' ' LEU . 3.2 m-20 -154.5 23.91 0.47 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 110.172 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.46 116.94 29.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.176 -0.953 . . . . 0.0 110.373 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.76 139.08 43.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 110.001 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.427 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 47.2 mtp -122.6 157.84 31.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.345 -0.847 . . . . 0.0 110.234 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.411 ' CG1' HG23 ' A' ' 668' ' ' THR . 16.2 pt -98.8 -157.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.0 109.829 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -86.12 119.63 26.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.288 -0.883 . . . . 0.0 110.43 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 81.03 52.83 4.15 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -114.85 148.49 38.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.991 -1.299 . . . . 0.0 110.274 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.444 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -109.04 138.68 45.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.566 -0.709 . . . . 0.0 109.345 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.505 ' CD2' ' CD2' ' A' ' 659' ' ' LEU . 0.6 OUTLIER -144.59 145.21 31.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 111.288 -178.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.624 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -70.15 147.69 49.59 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.433 -0.792 . . . . 0.0 110.604 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.508 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 10.7 mt -118.02 114.67 23.49 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.413 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -95.1 147.91 22.93 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.41 ' HB3' HD12 ' A' ' 696' ' ' ILE . 23.1 p-10 -46.3 143.02 2.64 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.133 -0.98 . . . . 0.0 110.532 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.66 47.33 41.58 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 107.611 -2.196 . . . . 0.0 107.611 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.52 93.87 4.73 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.885 -0.774 . . . . 0.0 110.07 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.873 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.1 tm-20 -93.86 107.58 19.45 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.444 ' CG2' ' CD1' ' A' ' 659' ' ' LEU . 28.2 pt -107.43 137.91 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.602 -0.686 . . . . 0.0 111.811 -178.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -98.76 110.81 23.35 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.428 ' CG2' ' NE2' ' A' ' 622' ' ' HIS . 72.4 mt -75.01 -19.86 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.886 . . . . 0.0 110.839 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.508 ' HB ' HG12 ' A' ' 690' ' ' ILE . 8.4 mt -142.9 136.47 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.16 -0.962 . . . . 0.0 110.52 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -137.65 108.96 6.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.455 -0.778 . . . . 0.0 109.899 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 686' ' ' ASN . 0.3 OUTLIER -120.96 117.68 27.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -45.13 78.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.459 -0.776 . . . . 0.0 111.115 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.64 -43.63 15.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.241 -0.912 . . . . 0.0 111.361 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 683' ' ' ASP . 97.5 m-20 -83.19 -8.67 59.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.136 -0.978 . . . . 0.0 110.601 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.5 tptt 56.25 19.66 4.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.225 -0.922 . . . . 0.0 110.778 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.43 78.76 1.03 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.175 -0.953 . . . . 0.0 109.144 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 41.0 t -101.79 141.32 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.381 -0.824 . . . . 0.0 110.912 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.595 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 41.6 mm -126.32 163.94 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -172.48 124.98 1.12 Allowed Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.367 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.873 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.5 m-85 -120.23 138.06 53.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.59 -0.947 . . . . 0.0 108.828 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -105.1 117.95 35.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.841 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.12 122.28 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.542 -0.724 . . . . 0.0 109.241 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -130.24 104.54 7.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.516 -0.74 . . . . 0.0 110.289 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.41 HD12 ' HB3' ' A' ' 674' ' ' ASP . 71.8 mt -76.51 104.35 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 109.571 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.11 -42.85 59.43 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.609 -0.836 . . . . 0.0 108.889 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.8 OUTLIER -111.01 141.3 44.67 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.698 0.761 . . . . 0.0 110.747 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 44.5 p -115.38 96.06 5.47 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 7.2 t -136.16 136.31 39.92 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.262 0.554 . . . . 0.0 110.587 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.04 26.52 27.76 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.41 HD12 ' CZ ' ' A' ' 577' ' ' PHE . 4.1 tp -105.26 138.19 41.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.358 -1.084 . . . . 0.0 110.469 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.574 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 3.0 p90 -53.83 -23.75 13.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.404 -0.81 . . . . 0.0 110.045 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.574 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.1 t30 . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.424 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.821 0 CA-C-O 121.257 0.551 . . . . 0.0 111.782 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.424 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 31.5 m -107.78 151.01 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.431 -0.793 . . . . 0.0 109.382 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.427 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 65.0 t -93.12 117.8 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 0.0 110.489 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.8 mp -89.88 162.51 15.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.38 -0.825 . . . . 0.0 109.734 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.98 146.24 28.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.215 -0.928 . . . . 0.0 110.167 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -79.88 137.38 36.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.223 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.8 p -110.16 -176.79 3.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.416 -0.802 . . . . 0.0 110.353 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.61 -28.92 35.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.432 -0.792 . . . . 0.0 110.153 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -66.21 -50.16 64.79 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.448 -0.782 . . . . 0.0 110.043 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.444 ' HA ' HD21 ' A' ' 726' ' ' LEU . 14.6 mt-10 -63.71 -47.68 80.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.36 -0.838 . . . . 0.0 110.123 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . 0.415 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 3.0 tmmm? -62.46 -31.9 72.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.471 -0.768 . . . . 0.0 110.946 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.07 -50.74 69.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.217 -0.927 . . . . 0.0 112.041 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.444 HD21 ' HA ' ' A' ' 723' ' ' GLU . 0.7 OUTLIER -72.72 -35.93 67.67 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.907 -1.121 . . . . 0.0 111.516 -178.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . 0.445 ' CG2' ' CG1' ' A' ' 621' ' ' VAL . 9.3 p -79.08 -15.18 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.828 -1.17 . . . . 0.0 110.37 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -41.98 69.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.944 . . . . 0.0 108.685 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.44 103.32 10.32 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 122.253 1.025 . . . . 0.0 108.963 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.423 ' HA ' ' CE2' ' A' ' 602' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.272 -2.78 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.269 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 32.2 ttp-105 . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 121.591 0.71 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.571 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 9.8 t80 -111.6 -40.23 4.39 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 122.061 0.934 . . . . 0.0 109.288 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 0.9 OUTLIER -124.5 119.69 29.86 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.787 -179.126 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 62.3 m -99.15 115.45 29.09 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.989 -1.069 . . . . 0.0 109.005 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.409 ' N ' ' CD2' ' A' ' 580' ' ' LEU . 1.6 mm? -89.98 111.76 22.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.401 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 1.1 mmtt -112.04 101.49 51.86 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 118.026 -1.47 . . . . 0.0 112.478 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.057 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.9 Cg_endo -80.17 144.58 16.67 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 N-CA-C 106.45 -2.173 . . . . 0.0 106.45 174.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.72 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -121.56 -174.31 0.3 Allowed Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.765 -176.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.72 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.1 Cg_endo -66.09 -31.17 46.2 Favored 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 124.289 1.679 . . . . 0.0 110.086 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -59.13 -25.28 63.73 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 13.4 t -95.19 150.58 20.06 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 614' ' ' GLU . 5.3 tp -55.58 -21.47 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.289 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 612' ' ' LYS . 1.6 tp -110.17 117.92 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.522 -0.736 . . . . 0.0 109.903 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.445 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -110.58 79.89 1.25 Allowed 'General case' 0 N--CA 1.508 2.429 0 O-C-N 120.359 -1.463 . . . . 0.0 108.938 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.057 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.6 mt-10 -143.02 175.55 9.77 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.787 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.537 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.66 125.56 40.35 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.097 -1.002 . . . . 0.0 109.127 176.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.418 HD11 ' HA ' ' A' ' 611' ' ' CYS . 65.9 mt -110.17 156.08 21.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 109.592 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -124.85 110.56 14.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.856 . . . . 0.0 111.683 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.489 HG21 ' HB ' ' A' ' 598' ' ' VAL . 21.1 mt -82.33 110.38 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 597' ' ' GLY . 2.3 mt-30 -53.98 179.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.213 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.571 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -58.03 69.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.455 -0.778 . . . . 0.0 111.138 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 106.07 43.84 1.46 Allowed Glycine 0 N--CA 1.485 1.915 0 C-N-CA 119.699 -1.239 . . . . 0.0 110.591 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.56 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 0.5 OUTLIER -79.05 104.57 7.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -141.53 138.27 17.25 Favored Pre-proline 0 C--N 1.28 -2.442 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.004 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.612 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.1 Cg_endo -90.54 161.1 31.99 Favored 'Cis proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.273 -1.97 . . . . 0.0 109.38 -1.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.545 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 5.3 t80 -107.28 116.6 32.22 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.669 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 60.7 m-85 -90.08 145.93 24.7 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 111.047 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.639 HG12 ' CB ' ' A' ' 611' ' ' CYS . 2.4 mt -140.5 141.02 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.554 -0.716 . . . . 0.0 110.239 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.684 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 178.1 -161.14 27.86 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.867 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -75.71 -32.45 60.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.754 -0.85 . . . . 0.0 110.087 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.43 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -86.3 127.46 34.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.417 -0.802 . . . . 0.0 110.623 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.5 tm-20 -59.41 -13.73 9.57 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.972 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -46.44 -36.19 6.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.426 -0.796 . . . . 0.0 110.24 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.669 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 62.2 m -71.26 152.7 43.04 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.545 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.1 m120 -59.17 -13.63 7.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.415 -0.803 . . . . 0.0 110.48 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.639 ' CB ' HG12 ' A' ' 603' ' ' ILE . 6.9 t -120.43 144.22 48.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.433 -0.792 . . . . 0.0 109.942 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.613 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -113.37 130.95 56.16 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 122.032 0.92 . . . . 0.0 112.901 -178.43 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.584 ' HA ' ' HB ' ' A' ' 588' ' ' ILE . 7.9 mt -146.63 109.96 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.44 ' O ' HG12 ' A' ' 587' ' ' ILE . 3.3 mm-40 -85.58 102.44 13.54 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 117.806 -1.558 . . . . 0.0 108.547 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 4.3 m-20 -139.05 106.13 5.46 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.728 178.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -45.4 -44.51 12.06 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.42 -0.8 . . . . 0.0 111.925 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.86 -16.75 43.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.126 -0.984 . . . . 0.0 112.023 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 1.3 tp -76.55 130.35 37.77 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.95 -1.093 . . . . 0.0 110.898 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 619' ' ' SER . . . . . 0.487 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.2 m -68.81 161.2 29.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.43 -0.794 . . . . 0.0 110.467 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.684 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -63.61 -45.75 88.89 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.189 -0.944 . . . . 0.0 109.204 179.577 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.472 ' O ' ' C ' ' A' ' 622' ' ' HIS . 16.4 m -94.8 2.12 9.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 121.386 -0.821 . . . . 0.0 109.481 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.74 ' O ' ' N ' ' A' ' 652' ' ' THR . 3.8 t60 -28.47 -48.27 0.06 Allowed 'General case' 0 C--O 1.192 -1.946 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.946 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.434 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.8 OUTLIER -137.13 145.5 43.91 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.375 -1.33 . . . . 0.0 110.901 179.065 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.593 ' HA ' HG13 ' A' ' 603' ' ' ILE . 24.2 p90 -146.37 151.18 37.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.493 -0.754 . . . . 0.0 110.419 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 15.7 mt -103.13 120.95 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 8.0 t80 -116.45 154.23 30.7 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.39 -0.818 . . . . 0.0 109.828 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 8.3 ttmt -120.22 136.98 54.46 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.444 0.64 . . . . 0.0 110.368 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.427 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.03 163.97 28.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.64 -0.663 . . . . 0.0 110.389 -179.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 629' ' ' ARG . 0.3 OUTLIER -77.6 115.65 17.53 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.507 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.2 t60 . . . . . 0 N--CA 1.488 1.461 0 O-C-N 121.542 -0.724 . . . . 0.0 110.561 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 630' ' ' HIS . 5.1 mp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.5 OUTLIER -115.46 124.63 51.61 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.846 -1.159 . . . . 0.0 111.386 -179.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.414 ' OD2' ' CE1' ' A' ' 630' ' ' HIS . 24.0 t0 -113.5 156.4 23.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.386 -0.821 . . . . 0.0 110.129 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.424 HD13 HD11 ' A' ' 578' ' ' LEU . 11.2 pt -109.67 129.85 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.26 -0.9 . . . . 0.0 110.142 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.638 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 91.6 m95 -119.86 128.53 53.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.621 -0.675 . . . . 0.0 111.199 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.506 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 9.3 t80 -88.17 114.87 25.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 668' ' ' THR . 14.4 m -108.01 106.03 16.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 111.781 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.524 ' CD2' ' N ' ' A' ' 652' ' ' THR . 13.1 t60 -65.95 159.07 26.51 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.482 -0.761 . . . . 0.0 109.975 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.74 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.03 -28.79 0.2 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.471 -0.768 . . . . 0.0 112.84 -179.228 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.521 ' HA3' ' CG ' ' A' ' 622' ' ' HIS . . . -79.26 -163.89 26.79 Favored Glycine 0 N--CA 1.496 2.688 0 O-C-N 119.337 -2.102 . . . . 0.0 109.885 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 654' ' ' THR . . . . . 0.435 ' O ' HG12 ' A' ' 656' ' ' VAL . 21.3 m -94.08 -19.12 21.12 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.096 -1.238 . . . . 0.0 114.095 -176.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.539 ' O ' HG21 ' A' ' 656' ' ' VAL . 24.7 m120 -61.01 -2.83 0.65 Allowed 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.597 -1.315 . . . . 0.0 112.629 -178.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 655' ' ' ASN . 0.8 OUTLIER 62.68 145.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.58 -0.7 . . . . 0.0 109.847 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.456 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -95.09 151.29 19.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.601 -0.687 . . . . 0.0 111.071 -178.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.464 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 37.5 m-85 -134.45 126.22 29.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.595 -0.691 . . . . 0.0 109.569 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 661' ' ' ASN . 53.8 tp -130.93 111.89 12.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.198 -0.939 . . . . 0.0 110.098 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.83 -79.43 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.594 -0.691 . . . . 0.0 110.027 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 659' ' ' LEU . 25.5 p30 -148.74 23.92 0.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 110.128 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.74 119.68 39.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 110.253 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -84.97 134.92 34.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.889 . . . . 0.0 110.045 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.439 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 2.8 mtp -116.3 -166.2 1.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.647 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.412 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 7.9 pt -139.94 -154.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.447 -0.783 . . . . 0.0 110.291 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 652' ' ' THR . 44.2 tt0 -86.31 91.71 8.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.376 -0.828 . . . . 0.0 110.699 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.5 54.62 0.54 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.6 OUTLIER -119.07 145.53 45.83 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.06 -1.259 . . . . 0.0 110.001 179.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -108.34 138.72 44.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.454 -0.779 . . . . 0.0 109.247 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.494 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 0.5 OUTLIER -144.62 142.88 30.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.027 -1.045 . . . . 0.0 111.518 -178.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.638 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -70.89 147.5 48.74 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.524 -0.735 . . . . 0.0 110.773 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.506 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 14.6 mt -120.3 114.67 22.21 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.386 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 676' ' ' ASP . 17.2 mt-30 -84.5 -177.16 6.54 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -78.24 139.06 38.92 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.778 -1.201 . . . . 0.0 109.315 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 73.25 47.9 21.37 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.451 -2.259 . . . . 0.0 107.451 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 2.1 t0 -105.55 97.77 7.56 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.847 -0.796 . . . . 0.0 110.337 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.867 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.47 107.03 18.93 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.447 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 1.5 mp -105.01 138.01 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.531 -0.731 . . . . 0.0 111.57 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -100.39 114.58 28.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.747 -0.596 . . . . 0.0 109.639 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 76.7 mt -79.35 -24.09 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.926 . . . . 0.0 110.933 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.476 ' HB ' HG12 ' A' ' 690' ' ' ILE . 7.2 mt -141.57 141.15 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.148 -0.97 . . . . 0.0 110.389 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -138.09 109.59 6.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.89 . . . . 0.0 110.11 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.44 118.04 24.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.331 -0.856 . . . . 0.0 110.005 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -46.85 76.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.306 -0.871 . . . . 0.0 110.963 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -84.65 -43.47 14.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.345 -0.847 . . . . 0.0 110.939 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.33 -11.1 60.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.249 -0.907 . . . . 0.0 110.556 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.1 mttt 52.46 24.86 3.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.17 -0.956 . . . . 0.0 110.388 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.88 73.76 7.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.434 -0.792 . . . . 0.0 109.896 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 586' ' ' SER . 34.8 m -101.92 135.87 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 110.322 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.476 HG12 ' HB ' ' A' ' 681' ' ' ILE . 19.3 mm -114.05 164.44 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.535 -0.728 . . . . 0.0 109.505 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -174.43 123.33 0.95 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.527 -1.32 . . . . 0.0 110.446 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.867 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.3 m-85 -120.04 137.74 53.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.534 -0.98 . . . . 0.0 108.581 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -102.56 114.54 28.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.871 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -81.31 113.24 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -121.56 104.3 9.54 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.695 -0.628 . . . . 0.0 109.914 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.408 HG12 ' HG ' ' A' ' 578' ' ' LEU . 63.1 mt -79.13 104.58 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 109.51 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.88 -42.76 48.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.328 -0.857 . . . . 0.0 108.826 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 577' ' ' PHE . 1.2 m-20 -110.84 142.45 42.84 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.397 0.618 . . . . 0.0 110.336 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 42.9 p -114.18 95.78 5.47 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.44 -133.57 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.027 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . 0.426 ' O ' ' CD2' ' A' ' 644' ' ' LEU . . . -93.49 35.04 4.29 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 1.0 OUTLIER -60.77 149.98 33.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.617 -0.931 . . . . 0.0 110.172 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 704' ' ' ASN . 4.1 p90 -49.63 -24.56 2.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.362 -0.836 . . . . 0.0 110.402 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 703' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.494 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 121.381 0.61 . . . . 0.0 112.225 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.408 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 34.9 m -107.59 151.59 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.453 -0.779 . . . . 0.0 109.454 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.439 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 86.6 t -97.04 122.77 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 110.564 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.5 mp -93.8 162.16 14.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.52 -0.737 . . . . 0.0 109.822 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.33 151.09 21.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.875 . . . . 0.0 110.068 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -80.31 142.83 34.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.807 . . . . 0.0 110.343 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 12.8 p -117.16 -176.27 2.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.399 -0.813 . . . . 0.0 110.143 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.53 -28.8 33.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.355 -0.84 . . . . 0.0 110.224 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -68.15 -47.65 67.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.0 109.984 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.8 -48.05 78.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -0.796 . . . . 0.0 110.023 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -54.03 -32.49 54.55 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.364 -0.835 . . . . 0.0 110.069 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -68.11 -36.38 79.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.487 -0.758 . . . . 0.0 110.383 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 37.8 mt -59.8 -46.55 88.85 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.262 -0.899 . . . . 0.0 110.195 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.5 p -72.34 -19.46 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.087 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -53.5 -44.73 69.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.865 . . . . 0.0 108.904 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.54 103.48 10.45 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 122.215 1.007 . . . . 0.0 109.262 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.409 ' O ' ' CD2' ' A' ' 602' ' ' PHE . 3.5 mt . . . . . 0 C--N 1.274 -2.696 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.518 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 121.613 0.72 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.587 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 9.8 t80 -124.8 -39.69 2.25 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 122.063 0.935 . . . . 0.0 109.427 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.473 ' HG ' HG12 ' A' ' 696' ' ' ILE . 0.4 OUTLIER -131.6 120.23 22.56 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.26 -178.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 4.4 m -93.95 120.19 33.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.0 109.093 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 4.6 mt -87.05 112.38 21.81 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.522 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -111.1 100.48 47.06 Favored Pre-proline 0 C--N 1.301 -1.505 0 C-N-CA 118.197 -1.401 . . . . 0.0 112.989 -176.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.083 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 55.6 Cg_endo -87.88 141.23 5.25 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 N-CA-C 106.342 -2.214 . . . . 0.0 106.342 174.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.728 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -120.52 -173.71 0.27 Allowed Pre-proline 0 C--N 1.294 -1.815 0 C-N-CA 118.57 -1.252 . . . . 0.0 112.575 -177.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.728 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.2 Cg_endo -66.42 -30.71 43.86 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 O-C-N 124.212 1.638 . . . . 0.0 110.279 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -59.2 -24.45 63.12 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 17.6 t -95.35 153.32 17.74 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 614' ' ' GLU . 4.9 tp -57.42 -19.69 11.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.178 -0.951 . . . . 0.0 109.298 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.622 HG12 ' O ' ' A' ' 612' ' ' LYS . 1.5 tp -113.17 118.08 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 110.117 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.496 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -111.24 81.65 1.47 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.483 -1.386 . . . . 0.0 108.634 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.083 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.5 mt-10 -143.11 175.68 9.68 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.883 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.522 ' HB3' ' CD ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.62 122.88 36.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.018 -1.051 . . . . 0.0 109.17 176.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.66 155.05 20.59 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -125.69 110.26 13.56 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.433 -0.792 . . . . 0.0 111.304 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.453 HG22 ' HB ' ' A' ' 598' ' ' VAL . 9.9 mt -81.37 109.56 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.7 OUTLIER -53.14 168.97 0.12 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.609 -0.837 . . . . 0.0 109.054 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.587 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 6.0 mt-30 -61.58 70.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.391 -0.818 . . . . 0.0 110.432 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 124.69 30.44 0.97 Allowed Glycine 0 N--CA 1.487 2.044 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.78 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.485 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 1.2 t -79.9 102.73 6.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -143.95 135.5 12.8 Favored Pre-proline 0 C--N 1.282 -2.358 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.885 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.631 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.1 Cg_endo -90.91 162.12 30.45 Favored 'Cis proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.747 -1.772 . . . . 0.0 109.15 -1.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.501 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 6.3 t80 -106.41 116.69 32.36 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.711 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 58.3 m-85 -88.62 146.24 25.22 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.406 -0.808 . . . . 0.0 111.182 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.597 HG12 ' CB ' ' A' ' 611' ' ' CYS . 2.4 mt -140.85 140.48 33.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.648 -0.657 . . . . 0.0 110.18 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.672 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 177.18 -162.63 30.86 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.924 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -74.0 -35.06 64.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.794 -0.827 . . . . 0.0 110.248 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.16 127.37 34.24 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.394 -0.817 . . . . 0.0 110.585 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.445 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 42.8 tt0 -58.75 -12.89 4.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.291 -0.881 . . . . 0.0 109.993 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.18 -36.86 4.05 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.421 -0.8 . . . . 0.0 110.079 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.711 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 79.6 m -71.68 154.48 41.34 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.284 -0.885 . . . . 0.0 109.926 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.501 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -61.53 -12.06 13.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.511 -0.743 . . . . 0.0 110.396 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.597 ' CB ' HG12 ' A' ' 603' ' ' ILE . 6.9 t -119.84 143.74 47.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.531 -0.731 . . . . 0.0 109.559 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.622 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -113.32 130.22 56.32 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.055 0.931 . . . . 0.0 112.993 -178.237 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.572 ' HA ' ' HB ' ' A' ' 588' ' ' ILE . 7.3 mt -146.57 109.75 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 177.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.437 ' O ' HG12 ' A' ' 587' ' ' ILE . 2.2 mt-10 -85.68 102.47 13.63 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 117.704 -1.598 . . . . 0.0 108.538 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 4.9 m-20 -139.42 106.08 5.36 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.869 178.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . 0.41 ' OD1' ' CZ ' ' A' ' 688' ' ' PHE . 29.5 p-10 -47.45 -41.33 20.17 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.453 -0.779 . . . . 0.0 111.648 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -84.19 -16.99 41.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.089 -1.007 . . . . 0.0 111.8 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 1.3 tp -78.27 130.84 36.7 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.082 -1.012 . . . . 0.0 110.816 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 619' ' ' SER . . . . . 0.474 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 2.2 t -70.75 159.4 34.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.362 -0.836 . . . . 0.0 110.53 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.672 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 35.7 ttp180 -61.55 -45.66 93.21 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.26 -0.9 . . . . 0.0 109.344 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.482 ' O ' ' C ' ' A' ' 622' ' ' HIS . 15.8 m -94.74 1.95 9.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.389 -0.82 . . . . 0.0 109.613 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.9 t60 -28.1 -48.18 0.05 OUTLIER 'General case' 0 C--O 1.192 -1.962 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.833 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.414 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.7 OUTLIER -137.03 145.58 44.22 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.406 -1.318 . . . . 0.0 110.753 178.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.527 ' CZ ' ' CB ' ' A' ' 650' ' ' CYS . 12.4 p90 -145.3 148.75 33.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.532 -0.73 . . . . 0.0 110.306 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.501 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 24.5 mt -103.9 121.1 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 7.5 t80 -114.95 154.44 28.75 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.694 0.759 . . . . 0.0 109.484 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.01 137.09 54.29 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.548 0.689 . . . . 0.0 110.587 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.427 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -137.62 163.6 30.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.712 -0.617 . . . . 0.0 110.152 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 629' ' ' ARG . 1.0 OUTLIER -77.93 115.48 17.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.188 -0.945 . . . . 0.0 108.889 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.507 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.4 t60 . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.536 -0.728 . . . . 0.0 110.615 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.465 ' HB2' ' CA ' ' A' ' 703' ' ' PHE . 5.1 mp . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.19 124.4 50.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.859 -1.151 . . . . 0.0 111.08 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -110.26 150.56 28.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.443 -0.785 . . . . 0.0 109.847 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . . . . . . . . . 11.3 pt -106.56 131.66 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.304 -0.873 . . . . 0.0 109.85 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.494 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 95.2 m95 -119.47 123.05 43.11 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.649 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.468 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 9.7 t80 -88.83 114.35 25.36 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.527 ' CB ' ' CZ ' ' A' ' 624' ' ' PHE . 1.0 OUTLIER -108.12 102.66 11.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.078 -1.014 . . . . 0.0 111.697 -178.246 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.496 ' CD2' ' N ' ' A' ' 652' ' ' THR . 13.1 t60 -62.07 157.46 18.89 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.471 -0.768 . . . . 0.0 109.77 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -149.14 -29.75 0.26 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.469 -0.769 . . . . 0.0 112.702 -179.113 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.531 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.68 -164.05 25.42 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 117.72 -2.181 . . . . 0.0 109.498 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 654' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 656' ' ' VAL . 25.0 m -97.65 -18.22 19.02 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.858 -1.378 . . . . 0.0 113.821 -176.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.458 ' CB ' HG12 ' A' ' 681' ' ' ILE . 22.8 m120 -58.35 -4.25 0.36 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.681 -1.262 . . . . 0.0 112.497 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.451 ' C ' ' CE1' ' A' ' 651' ' ' HIS . 3.1 t 70.21 148.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.609 -0.682 . . . . 0.0 110.169 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.433 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -105.82 143.82 33.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.508 -0.745 . . . . 0.0 110.741 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.426 ' CE1' ' HG2' ' A' ' 663' ' ' ARG . 74.7 m-85 -135.22 126.2 27.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.43 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.479 ' CD1' HG23 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -124.11 114.32 19.53 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.373 -0.829 . . . . 0.0 109.789 179.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 659' ' ' LEU . 14.0 t-20 59.27 -78.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.549 -0.72 . . . . 0.0 110.499 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 659' ' ' LEU . 10.7 t30 -147.86 27.27 0.98 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.077 -1.014 . . . . 0.0 110.33 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.71 139.36 49.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 0.0 110.269 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . 0.426 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 8.5 tmm_? -103.52 129.48 50.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.339 -0.85 . . . . 0.0 110.107 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.428 ' CB ' ' OG ' ' A' ' 657' ' ' SER . 4.3 mtp -112.1 -165.7 1.01 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 110.325 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.41 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 1.6 pt -141.54 -158.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.375 -0.828 . . . . 0.0 110.091 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -82.06 93.24 6.96 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.286 -0.884 . . . . 0.0 110.524 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 106.84 53.21 0.71 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.2 OUTLIER -120.51 147.62 44.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.11 -1.23 . . . . 0.0 110.078 179.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -108.32 144.04 36.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 0.0 109.196 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.48 ' CE1' ' O ' ' A' ' 715' ' ' VAL . 0.6 OUTLIER -144.65 147.11 32.69 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.508 -178.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.494 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.68 131.5 45.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.465 -0.772 . . . . 0.0 109.705 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.468 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 6.3 mt -104.61 97.68 7.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 111.173 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -84.86 146.64 27.2 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -46.11 151.78 0.46 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.222 -0.924 . . . . 0.0 110.612 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 65.36 49.11 62.82 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.04 92.52 4.11 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.763 -0.845 . . . . 0.0 110.611 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.812 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -92.93 106.91 18.8 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.171 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.479 HG23 ' CD1' ' A' ' 659' ' ' LEU . 1.0 OUTLIER -116.56 137.78 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.6 -0.687 . . . . 0.0 111.865 -176.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.45 111.54 23.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.586 -0.696 . . . . 0.0 109.675 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 81.0 mt -74.08 -19.57 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.302 -0.874 . . . . 0.0 110.465 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.477 ' HB ' HG12 ' A' ' 690' ' ' ILE . 12.7 mt -141.81 137.67 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.028 -1.045 . . . . 0.0 110.286 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -137.43 110.41 7.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.131 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -129.25 118.38 22.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.784 . . . . 0.0 109.844 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.6 -44.84 85.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.375 -0.828 . . . . 0.0 110.884 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -84.11 -43.42 15.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.324 -0.86 . . . . 0.0 110.924 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -17.69 60.57 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.263 -0.898 . . . . 0.0 110.456 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.6 tttt 60.53 14.66 5.03 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.193 -0.942 . . . . 0.0 110.887 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.41 ' CZ ' ' OD1' ' A' ' 616' ' ' ASN . 0.3 OUTLIER -72.06 78.69 0.93 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.039 -1.038 . . . . 0.0 108.975 179.189 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 586' ' ' SER . 96.3 t -101.59 130.98 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.496 -0.752 . . . . 0.0 110.706 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.477 HG12 ' HB ' ' A' ' 681' ' ' ILE . 18.0 mm -114.94 164.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -173.27 116.13 0.59 Allowed Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.446 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.812 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.4 m-85 -119.7 137.13 54.11 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 581' ' ' LYS . 5.8 ttmm -110.77 114.14 27.26 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 110.305 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.49 126.85 36.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.758 -0.777 . . . . 0.0 108.95 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.67 104.41 7.41 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.192 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.473 HG12 ' HG ' ' A' ' 578' ' ' LEU . 83.6 mt -79.47 103.6 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 109.559 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.27 -41.01 58.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.387 -0.821 . . . . 0.0 108.844 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 1.3 m-20 -110.34 140.2 44.76 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.678 0.751 . . . . 0.0 110.655 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 36.0 p -115.98 96.17 5.46 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 30.2 m -133.09 133.18 42.63 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.814 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 50.32 30.11 17.66 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 7.2 tp -103.91 138.92 39.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.545 -0.974 . . . . 0.0 110.717 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 2.6 p90 -53.28 -23.87 10.1 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.418 -0.801 . . . . 0.0 109.988 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.578 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.2 t30 . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.442 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.349 0.595 . . . . 0.0 111.869 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.48 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 26.9 m -107.58 150.01 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.481 -0.762 . . . . 0.0 109.069 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.424 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 58.3 t -96.73 133.12 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.186 -0.946 . . . . 0.0 111.109 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.8 mp -105.08 162.64 13.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.656 -0.653 . . . . 0.0 109.598 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.35 145.37 28.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.17 -0.956 . . . . 0.0 110.291 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.82 152.09 29.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.355 -0.841 . . . . 0.0 110.259 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 38.6 p -121.14 -176.25 3.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.42 -0.8 . . . . 0.0 110.359 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.36 -29.08 32.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.361 -0.837 . . . . 0.0 110.105 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -51.0 68.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.353 -0.842 . . . . 0.0 109.579 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -64.65 -45.25 87.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.463 -0.773 . . . . 0.0 109.734 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . 0.406 ' O ' ' CG1' ' A' ' 727' ' ' VAL . 0.4 OUTLIER -54.71 -32.73 59.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.344 -0.848 . . . . 0.0 109.837 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -36.11 78.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.399 -0.813 . . . . 0.0 110.227 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 34.1 mt -58.76 -46.16 88.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.298 -0.877 . . . . 0.0 110.228 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . 0.406 ' CG1' ' O ' ' A' ' 724' ' ' LYS . 7.2 p -71.76 -20.34 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.546 -0.721 . . . . 0.0 110.087 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.78 -45.84 70.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 108.845 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.71 104.26 11.18 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.206 1.003 . . . . 0.0 109.025 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--N 1.274 -2.71 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.432 -179.933 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 121.584 0.707 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.589 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 0.9 OUTLIER -113.85 -41.62 3.54 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 122.052 0.93 . . . . 0.0 109.36 -179.316 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.478 ' HB2' ' CE1' ' A' ' 577' ' ' PHE . 14.2 tp -126.1 119.87 28.7 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.529 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 55.9 m -96.88 117.3 30.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.759 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 7.6 mt -91.98 112.18 24.01 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.534 ' O ' ' CD1' ' A' ' 583' ' ' LEU . 0.7 OUTLIER -116.07 104.58 52.15 Favored Pre-proline 0 C--N 1.299 -1.617 0 C-N-CA 118.379 -1.328 . . . . 0.0 113.289 -177.066 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.126 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 40.8 Cg_endo -77.86 145.04 22.24 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 N-CA-C 105.968 -2.358 . . . . 0.0 105.968 174.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.715 ' N ' ' CD1' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -122.14 176.73 1.86 Allowed Pre-proline 0 N--CA 1.496 1.826 0 C-N-CA 118.197 -1.401 . . . . 0.0 113.599 -176.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.67 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 37.8 Cg_endo -66.36 -35.42 31.36 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.905 1.737 . . . . 0.0 111.848 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.43 -26.38 63.23 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.507 ' OG ' ' HA ' ' A' ' 690' ' ' ILE . 1.9 t -95.57 151.84 18.97 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.062 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.523 HG22 HD12 ' A' ' 588' ' ' ILE . 7.5 mm -57.35 -18.63 9.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 108.993 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.595 HG13 HG12 ' A' ' 613' ' ' ILE . 3.1 mm -99.67 115.55 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.472 -0.768 . . . . 0.0 109.218 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.476 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.86 71.42 1.04 Allowed 'General case' 0 N--CA 1.509 2.512 0 O-C-N 120.672 -1.268 . . . . 0.0 109.888 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.126 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 45.3 mt-10 -143.75 175.37 10.04 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.354 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.467 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.25 126.66 39.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.79 -1.194 . . . . 0.0 109.978 176.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 1.1 mt -111.41 156.17 22.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.329 -0.857 . . . . 0.0 109.391 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -125.19 110.6 14.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 111.835 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.455 ' N ' ' O ' ' A' ' 578' ' ' LEU . 24.8 mt -81.29 110.9 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 597' ' ' GLY . 2.3 mt-30 -54.67 179.25 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.979 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.589 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -59.08 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.505 -0.747 . . . . 0.0 111.217 -179.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 115.15 41.71 0.81 Allowed Glycine 0 N--CA 1.485 1.962 0 C-N-CA 119.496 -1.335 . . . . 0.0 111.019 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.47 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 1.2 t -79.01 103.75 6.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 627' ' ' LYS . 5.2 t30 -141.4 136.41 15.67 Favored Pre-proline 0 C--N 1.283 -2.314 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.258 -178.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.524 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.4 Cg_endo -90.44 161.28 32.53 Favored 'Cis proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.41 -1.913 . . . . 0.0 109.366 -1.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.532 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 2.9 t80 -107.03 116.26 31.62 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.533 ' HB3' ' SG ' ' A' ' 609' ' ' CYS . 58.8 m-85 -87.48 143.74 27.07 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 110.162 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.537 HG13 ' HA ' ' A' ' 624' ' ' PHE . 3.6 mt -140.56 142.16 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.782 -0.574 . . . . 0.0 110.345 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.773 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 166.14 -165.22 38.04 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.617 -1.278 . . . . 0.0 111.131 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 10.1 tpt180 -60.67 -55.55 31.97 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.854 -0.791 . . . . 0.0 111.879 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.43 126.15 28.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 111.499 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.436 ' HB2' ' HD2' ' A' ' 612' ' ' LYS . 42.3 tt0 -52.67 -19.05 2.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.418 -0.801 . . . . 0.0 110.046 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 607' ' ' GLU . 0.9 OUTLIER -42.36 -35.39 1.0 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.399 -0.813 . . . . 0.0 109.092 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' ' 602' ' ' PHE . 1.3 m -64.92 133.76 52.52 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.532 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -45.72 -28.16 0.97 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.389 -0.82 . . . . 0.0 109.544 179.336 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.518 ' CB ' HG12 ' A' ' 603' ' ' ILE . 2.4 t -107.6 143.53 35.92 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.463 ' O ' ' CG2' ' A' ' 588' ' ' ILE . 0.3 OUTLIER -107.7 129.0 55.06 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.078 -1.014 . . . . 0.0 113.178 -178.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.595 HG12 HG13 ' A' ' 588' ' ' ILE . 13.5 mt -143.5 109.5 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.8 103.6 15.55 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 117.865 -1.534 . . . . 0.0 109.535 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 0.2 OUTLIER -139.38 106.93 5.57 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.965 177.414 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -41.33 -41.65 2.0 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.611 -0.681 . . . . 0.0 111.993 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -83.84 -17.69 40.08 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.064 -1.023 . . . . 0.0 111.502 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -80.16 130.4 35.21 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.212 -0.93 . . . . 0.0 110.691 -179.189 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 619' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -66.78 160.84 24.99 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.254 -0.904 . . . . 0.0 111.169 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.773 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -64.74 -47.04 79.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.233 -0.917 . . . . 0.0 109.746 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.476 ' O ' ' C ' ' A' ' 622' ' ' HIS . 3.7 m -95.32 2.4 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.247 -0.908 . . . . 0.0 109.316 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.735 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.8 t60 -25.36 -46.43 0.02 OUTLIER 'General case' 0 C--O 1.193 -1.897 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.267 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.437 ' N ' ' O ' ' A' ' 621' ' ' VAL . 0.8 OUTLIER -136.92 146.33 45.34 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 118.32 -1.352 . . . . 0.0 111.336 179.121 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.537 ' HA ' HG13 ' A' ' 603' ' ' ILE . 14.7 p90 -145.86 143.77 29.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.563 -0.71 . . . . 0.0 109.997 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 10.7 mt -102.85 118.2 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 5.0 t80 -113.39 155.07 25.89 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.572 0.701 . . . . 0.0 109.544 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 5.6 ttmt -119.67 137.16 54.07 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.617 0.723 . . . . 0.0 110.773 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.436 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.49 164.16 28.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.741 -0.6 . . . . 0.0 110.167 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.3 tpt180 -77.75 118.97 20.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.128 -0.983 . . . . 0.0 109.043 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.532 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.7 t60 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.566 -0.709 . . . . 0.0 110.719 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.501 ' HB2' ' N ' ' A' ' 703' ' ' PHE . 5.0 mp . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.7 m-20 -108.1 124.38 50.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.98 -1.075 . . . . 0.0 111.264 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 628' ' ' LYS . 29.5 t70 -110.11 141.05 43.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.452 -0.78 . . . . 0.0 109.803 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 22.6 pt -95.97 132.44 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.243 -0.911 . . . . 0.0 110.105 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.504 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 95.5 m95 -119.07 122.12 41.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.616 -0.678 . . . . 0.0 111.179 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.487 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 11.9 t80 -85.21 115.69 23.13 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 624' ' ' PHE . 22.5 m -108.11 102.9 12.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.186 -0.946 . . . . 0.0 111.582 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' A' ' 652' ' ' THR . 12.2 t60 -63.89 159.28 20.09 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.442 -0.786 . . . . 0.0 109.93 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.735 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.44 -29.55 0.18 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.435 -0.791 . . . . 0.0 112.757 -179.196 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.563 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.29 -165.59 30.28 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 117.857 -2.116 . . . . 0.0 109.937 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 654' ' ' THR . . . . . 0.453 ' O ' HG13 ' A' ' 656' ' ' VAL . 26.0 m -93.6 -18.87 21.72 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.064 -1.256 . . . . 0.0 114.025 -176.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.544 ' O ' HG21 ' A' ' 656' ' ' VAL . 19.4 m120 -60.04 -2.56 0.44 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.663 -1.273 . . . . 0.0 112.564 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.544 HG21 ' O ' ' A' ' 655' ' ' ASN . 0.8 OUTLIER 63.11 142.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 121.583 0.706 . . . . 0.0 110.173 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 664' ' ' MET . 0.0 OUTLIER -94.52 150.49 20.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.691 -0.631 . . . . 0.0 110.729 -179.034 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.483 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 20.2 m-85 -135.05 126.4 28.38 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.332 -0.855 . . . . 0.0 110.437 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.503 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.0 OUTLIER -134.2 120.8 20.5 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.21 -0.931 . . . . 0.0 109.926 179.251 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 56.3 -85.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.569 -0.707 . . . . 0.0 110.521 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 659' ' ' LEU . 55.6 t30 -148.17 25.46 1.0 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.221 -0.924 . . . . 0.0 110.247 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -119.34 117.52 28.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 0.0 110.447 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . 0.415 ' CG ' ' CE1' ' A' ' 658' ' ' TYR . 2.7 tmm_? -87.24 138.33 31.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.374 -0.829 . . . . 0.0 109.983 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.494 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 0.3 OUTLIER -112.83 -152.68 0.51 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.278 -0.889 . . . . 0.0 109.969 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 1.1 pp -143.4 -165.96 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.241 -0.912 . . . . 0.0 110.706 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -76.58 83.99 3.25 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.483 -0.761 . . . . 0.0 110.412 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 117.88 53.15 0.31 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -122.92 149.17 44.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.098 -1.236 . . . . 0.0 110.08 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 717' ' ' LEU . 3.8 tttt -108.64 146.34 33.54 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.502 -0.749 . . . . 0.0 109.472 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.458 ' CD1' HG23 ' A' ' 716' ' ' VAL . 9.7 t80 -145.17 147.82 32.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.12 -0.988 . . . . 0.0 112.404 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.504 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.12 131.8 45.56 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.599 -0.688 . . . . 0.0 109.535 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.487 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 7.2 mt -105.88 104.95 14.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.049 -1.032 . . . . 0.0 111.227 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -91.73 146.75 23.52 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.558 -0.714 . . . . 0.0 109.127 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -43.94 147.84 0.45 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.139 -0.975 . . . . 0.0 110.397 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 66.31 48.1 66.46 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 107.587 -2.205 . . . . 0.0 107.587 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.27 90.15 3.23 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.798 -0.825 . . . . 0.0 110.787 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.945 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 3.2 tt0 -93.46 107.03 18.94 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.533 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 1.8 pt -105.49 136.87 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.861 -0.524 . . . . 0.0 110.972 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 25.2 mttt -95.31 110.32 22.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.569 -0.707 . . . . 0.0 109.637 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.416 ' CG2' ' NE2' ' A' ' 622' ' ' HIS . 63.4 mt -76.72 -22.77 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 110.074 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.448 HG21 HD13 ' A' ' 690' ' ' ILE . 15.0 tt -143.39 137.92 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.241 -0.912 . . . . 0.0 110.284 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -138.07 112.78 8.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.203 -0.936 . . . . 0.0 110.701 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.93 117.19 28.15 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.233 -0.917 . . . . 0.0 109.753 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -67.57 -47.6 69.3 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.423 -0.798 . . . . 0.0 111.475 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.23 -43.47 13.74 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.307 -0.871 . . . . 0.0 111.225 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.01 -7.07 51.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.211 -0.93 . . . . 0.0 110.914 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.95 24.15 3.24 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.152 -0.968 . . . . 0.0 110.038 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.03 95.98 10.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.44 -0.787 . . . . 0.0 109.681 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 587' ' ' ILE . 31.5 m -125.79 142.36 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 111.059 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.507 ' HA ' ' OG ' ' A' ' 586' ' ' SER . 12.2 mt -123.81 164.06 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -175.38 142.94 6.42 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.439 -1.362 . . . . 0.0 110.376 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.945 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 17.0 m-85 -129.14 137.6 51.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.503 -0.998 . . . . 0.0 109.865 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -98.45 113.66 25.74 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.219 -0.925 . . . . 0.0 109.682 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -82.66 121.48 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.361 -0.837 . . . . 0.0 109.074 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.05 104.62 7.44 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.581 -0.699 . . . . 0.0 110.237 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 60.2 mt -81.12 104.17 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.325 -0.86 . . . . 0.0 109.552 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -75.57 -42.1 53.02 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.377 -0.827 . . . . 0.0 108.996 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.462 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.1 m-20 -110.66 141.3 44.09 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.637 0.732 . . . . 0.0 110.521 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 21.9 p -114.99 96.04 5.5 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 16.1 p -128.12 131.99 48.97 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.235 0.54 . . . . 0.0 110.707 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 51.86 32.37 33.56 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.412 HD13 ' CZ ' ' A' ' 577' ' ' PHE . 4.1 tp -108.09 138.37 44.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.45 -1.029 . . . . 0.0 110.717 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.571 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 3.1 p90 -54.92 -24.03 21.67 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.71 . . . . 0.0 109.921 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.571 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.2 t30 . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.447 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.355 0.598 . . . . 0.0 111.616 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.4 m -107.69 153.33 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.465 -0.772 . . . . 0.0 109.3 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.458 HG23 ' CD1' ' A' ' 670' ' ' PHE . 58.1 t -98.39 133.11 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.935 . . . . 0.0 110.797 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 669' ' ' LYS . 4.0 mp -102.44 156.63 17.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.509 -0.744 . . . . 0.0 109.569 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.13 154.11 17.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.192 -0.942 . . . . 0.0 110.489 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -87.27 146.2 26.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.389 -0.82 . . . . 0.0 110.345 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 10.5 p -121.21 -176.12 3.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.343 -0.848 . . . . 0.0 110.309 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.2 -28.84 28.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.416 -0.802 . . . . 0.0 110.097 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.58 -47.49 75.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.356 -0.84 . . . . 0.0 109.552 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -63.85 -48.01 78.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.394 -0.816 . . . . 0.0 109.772 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . 0.407 ' O ' ' CG1' ' A' ' 727' ' ' VAL . 12.2 tttt -53.77 -32.37 52.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.333 -0.854 . . . . 0.0 110.065 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.21 -36.24 79.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -0.827 . . . . 0.0 110.21 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 32.9 mt -59.52 -46.53 88.58 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.273 -0.892 . . . . 0.0 110.325 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 724' ' ' LYS . 8.5 p -70.79 -18.92 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.142 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.91 -43.74 69.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.214 -0.929 . . . . 0.0 108.824 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.59 103.52 10.48 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 122.281 1.039 . . . . 0.0 109.177 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.411 ' O ' ' CD2' ' A' ' 602' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.274 -2.712 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.365 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 121.44 0.638 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.2 OUTLIER -106.49 -40.09 5.68 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.92 0.867 . . . . 0.0 109.545 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 9.7 tt -117.95 119.86 36.09 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.713 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 86.1 m -98.4 116.55 30.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.291 -0.881 . . . . 0.0 109.074 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.405 ' CD1' ' CD1' ' A' ' 625' ' ' ILE . 2.4 mt -90.78 112.16 23.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.408 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 2.4 mmtt -112.81 101.89 53.74 Favored Pre-proline 0 C--N 1.3 -1.548 0 C-N-CA 118.153 -1.419 . . . . 0.0 112.737 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.051 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.0 Cg_endo -79.55 144.97 18.14 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 N-CA-C 106.454 -2.172 . . . . 0.0 106.454 174.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.722 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.62 -173.54 0.28 Allowed Pre-proline 0 N--CA 1.494 1.74 0 C-N-CA 118.651 -1.22 . . . . 0.0 112.791 -176.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.722 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.2 Cg_endo -66.55 -28.3 45.4 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 124.113 1.586 . . . . 0.0 110.176 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.31 -28.4 66.76 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 46.7 p -95.43 153.57 17.63 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.441 HG12 ' O ' ' A' ' 614' ' ' GLU . 5.7 tp -57.07 -16.38 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.831 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 612' ' ' LYS . 1.2 tp -113.98 117.73 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.219 -0.925 . . . . 0.0 110.231 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.42 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -110.95 80.82 1.34 Allowed 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.219 -1.551 . . . . 0.0 109.209 179.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.051 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 33.8 mm-40 -142.24 175.81 9.47 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.823 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.541 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.66 125.48 40.18 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.138 -0.976 . . . . 0.0 109.096 176.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 611' ' ' CYS . 61.5 mt -111.39 156.07 22.16 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.369 -0.832 . . . . 0.0 109.987 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -125.25 111.05 14.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.356 -0.84 . . . . 0.0 111.802 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 39.9 mt -82.31 110.61 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.51 ' O ' ' C ' ' A' ' 596' ' ' GLN . 21.2 mm100 -69.39 114.9 8.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.499 -0.751 . . . . 0.0 112.794 -177.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.51 ' C ' ' O ' ' A' ' 595' ' ' GLN . 0.0 OUTLIER 14.6 56.77 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 178.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 106.98 46.65 1.08 Allowed Glycine 0 N--CA 1.486 1.988 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.845 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.488 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 1.0 OUTLIER -79.4 104.66 7.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 177.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -140.41 137.9 18.27 Favored Pre-proline 0 C--N 1.28 -2.421 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.103 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.519 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.7 Cg_endo -90.01 160.18 34.22 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.009 -2.08 . . . . 0.0 109.581 -0.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.538 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 4.5 t80 -107.29 116.73 32.44 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.705 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 52.3 m-85 -91.23 145.77 24.39 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.207 -0.933 . . . . 0.0 110.817 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.599 HG12 ' CB ' ' A' ' 611' ' ' CYS . 2.2 mt -139.68 141.17 35.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.491 -0.755 . . . . 0.0 110.436 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.727 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 174.17 -167.12 39.44 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.431 -1.366 . . . . 0.0 111.362 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 6.7 mmm-85 -64.34 -40.61 96.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.919 -0.754 . . . . 0.0 110.834 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.23 127.81 34.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.396 -0.815 . . . . 0.0 111.446 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -57.67 -14.88 6.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -0.84 . . . . 0.0 109.854 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -44.23 -36.97 2.94 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.413 -0.804 . . . . 0.0 110.092 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.705 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 74.8 m -71.42 151.85 43.64 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.385 -0.822 . . . . 0.0 109.575 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.535 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -57.78 -14.5 5.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.432 -0.792 . . . . 0.0 110.508 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.599 ' CB ' HG12 ' A' ' 603' ' ' ILE . 7.0 t -120.4 143.66 48.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.546 -0.721 . . . . 0.0 109.692 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.593 ' O ' HG12 ' A' ' 588' ' ' ILE . 1.7 ttpm? -111.82 130.68 55.73 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.053 0.93 . . . . 0.0 112.769 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.558 ' HA ' ' HB ' ' A' ' 588' ' ' ILE . 4.8 mt -146.55 110.58 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.441 ' O ' HG12 ' A' ' 587' ' ' ILE . 1.2 mt-10 -93.64 102.34 14.51 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 117.73 -1.588 . . . . 0.0 109.306 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.535 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 1.1 m-20 -138.39 105.85 5.55 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.184 177.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 615' ' ' ASP . 1.7 t30 -35.9 -48.28 0.56 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.632 -0.668 . . . . 0.0 112.583 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -83.55 -17.44 41.79 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.969 -1.082 . . . . 0.0 111.963 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -72.71 125.39 27.4 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.95 -1.094 . . . . 0.0 110.697 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 619' ' ' SER . . . . . 0.474 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -67.0 161.15 24.95 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.372 -0.83 . . . . 0.0 111.031 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.727 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -64.16 -45.56 87.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.243 -0.91 . . . . 0.0 109.223 179.35 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.467 ' O ' ' C ' ' A' ' 622' ' ' HIS . 12.4 m -94.86 2.3 9.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.386 -0.821 . . . . 0.0 109.336 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.9 t60 -29.09 -46.74 0.05 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.988 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.5 OUTLIER -136.46 145.24 44.97 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 118.514 -1.274 . . . . 0.0 110.777 179.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.539 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 4.1 p90 -145.57 144.05 30.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.55 -0.719 . . . . 0.0 110.116 178.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 76.0 mt -103.31 120.4 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.441 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 3.7 t80 -114.46 155.1 27.0 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.618 0.723 . . . . 0.0 109.666 -178.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.402 ' CE ' ' HA2' ' A' ' 597' ' ' GLY . 5.1 ttmt -118.01 137.45 52.87 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 121.639 0.733 . . . . 0.0 110.337 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.441 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -136.11 164.33 28.27 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.707 -0.62 . . . . 0.0 110.757 -179.121 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.0 tpt180 -77.52 117.26 18.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 108.677 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.51 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 5.6 t60 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.591 0.71 . . . . 0.0 110.941 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 703' ' ' PHE . 4.2 mt . . . . . 0 N--CA 1.486 1.325 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.7 OUTLIER -115.04 124.53 51.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.877 -1.139 . . . . 0.0 111.476 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 628' ' ' LYS . 12.6 t0 -108.18 156.67 19.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.524 -0.735 . . . . 0.0 109.871 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.456 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 14.6 pt -104.85 131.72 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.314 -0.866 . . . . 0.0 110.174 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.52 ' CE3' HD11 ' A' ' 671' ' ' LEU . 97.9 m95 -118.56 121.0 39.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.684 -0.635 . . . . 0.0 110.937 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.526 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 8.8 t80 -80.82 114.82 19.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 108.67 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.539 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 8.8 t -107.6 109.02 20.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.189 -0.944 . . . . 0.0 111.432 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.605 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 10.5 t60 -75.04 160.18 30.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.0 109.979 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -150.69 -32.4 0.17 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.394 -0.816 . . . . 0.0 112.868 -178.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.605 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -79.38 130.35 9.8 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 117.897 -2.097 . . . . 0.0 109.976 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 654' ' ' THR . . . . . 0.433 ' C ' ' H ' ' A' ' 656' ' ' VAL . 14.5 m -36.01 -23.42 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 115.383 1.624 . . . . 0.0 115.383 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.474 ' O ' ' HB ' ' A' ' 656' ' ' VAL . 4.5 t-20 -54.97 -4.51 0.07 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.336 -1.478 . . . . 0.0 113.197 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 655' ' ' ASN . 4.3 t 75.31 150.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 121.592 -0.692 . . . . 0.0 110.984 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.548 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -111.66 151.9 28.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.577 -0.702 . . . . 0.0 110.347 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -138.39 126.47 22.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 109.863 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.515 ' CD2' ' CD2' ' A' ' 670' ' ' PHE . 19.4 tp -128.11 110.24 12.28 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.869 . . . . 0.0 110.161 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.67 -72.9 0.05 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.637 -0.664 . . . . 0.0 109.985 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 659' ' ' LEU . 4.9 m-80 -153.82 19.36 0.52 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.354 -0.841 . . . . 0.0 110.435 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -116.95 116.92 28.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.031 -1.043 . . . . 0.0 110.501 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.97 141.6 32.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 109.579 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.42 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 0.8 OUTLIER -115.2 -169.17 1.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 110.681 -179.214 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.453 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 1.1 pt -120.3 -165.62 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.41 -0.806 . . . . 0.0 110.068 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -84.22 73.02 10.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.36 -0.838 . . . . 0.0 110.569 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 130.47 54.47 0.1 OUTLIER Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -121.77 151.28 40.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -1.187 . . . . 0.0 110.106 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.437 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 7.2 tttt -109.04 139.69 43.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.486 -0.759 . . . . 0.0 109.411 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.515 ' CD2' ' CD2' ' A' ' 659' ' ' LEU . 0.6 OUTLIER -144.36 146.59 32.64 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.299 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.52 HD11 ' CE3' ' A' ' 648' ' ' TRP . 12.7 tp -70.56 146.16 50.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.32 -0.862 . . . . 0.0 111.227 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.526 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 7.7 mt -118.93 102.15 8.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 110.585 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -84.53 160.61 20.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.458 -0.777 . . . . 0.0 109.204 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -52.25 149.31 5.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.008 -1.057 . . . . 0.0 110.289 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 63.75 50.14 63.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.8 94.9 5.23 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.715 -0.874 . . . . 0.0 111.098 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.882 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -94.64 106.83 18.83 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.414 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.463 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 17.6 pt -106.78 135.8 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.474 -0.766 . . . . 0.0 111.328 -178.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -98.52 109.57 22.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.369 -0.832 . . . . 0.0 109.146 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.414 ' CD1' ' CD1' ' A' ' 613' ' ' ILE . 89.7 mt -74.86 -42.19 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.39 -0.819 . . . . 0.0 110.537 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.48 ' CD1' ' HB2' ' A' ' 618' ' ' LEU . 3.1 mt -130.75 132.95 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.202 -0.936 . . . . 0.0 110.347 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -138.75 112.04 8.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.571 -0.706 . . . . 0.0 109.904 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -129.94 117.91 20.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 110.248 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -29.73 69.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.466 -0.771 . . . . 0.0 110.721 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -55.69 -43.36 76.33 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.365 -0.835 . . . . 0.0 111.031 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 688' ' ' PHE . 2.1 t30 -137.26 36.0 2.52 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.192 -0.942 . . . . 0.0 110.256 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . 0.509 ' O ' ' C ' ' A' ' 688' ' ' PHE . 0.8 OUTLIER 65.54 -67.82 0.13 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.77 -0.581 . . . . 0.0 109.856 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.509 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.1 OUTLIER 28.72 52.67 0.07 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.244 0.545 . . . . 0.0 111.346 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 586' ' ' SER . 91.6 t -101.76 142.64 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 110.674 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.411 HD11 ' HB ' ' A' ' 587' ' ' ILE . 44.5 mm -120.0 165.32 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 179.79 121.37 0.72 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.052 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.882 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.8 m-85 -119.9 136.6 54.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.54 -0.977 . . . . 0.0 108.978 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.78 114.28 27.93 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.216 -0.927 . . . . 0.0 110.511 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -82.97 120.62 34.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -127.08 104.5 8.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.753 -0.592 . . . . 0.0 110.077 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 65.4 mt -84.35 103.63 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.665 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -80.99 -42.97 20.34 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.9 OUTLIER -110.81 140.27 45.38 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.483 0.659 . . . . 0.0 110.271 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 12.1 p -114.9 96.13 5.56 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 35.7 m -117.94 121.67 41.28 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.208 0.528 . . . . 0.0 110.607 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 52.41 45.5 58.65 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.443 ' O ' HD11 ' A' ' 644' ' ' LEU . 3.7 mt -115.38 132.81 56.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.439 -1.036 . . . . 0.0 110.728 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.627 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 3.1 p90 -47.43 -24.71 0.87 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.568 0.699 . . . . 0.0 110.47 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.627 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.458 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 1.3 mmm-85 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.259 0.552 . . . . 0.0 111.893 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.444 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 35.5 m -108.31 151.13 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.455 -0.778 . . . . 0.0 109.583 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.42 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 87.5 t -98.44 127.47 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.266 -0.896 . . . . 0.0 110.758 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.22 145.74 41.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.58 -0.7 . . . . 0.0 109.347 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.95 149.62 35.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.159 -0.963 . . . . 0.0 110.693 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -81.03 154.29 26.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.419 -0.801 . . . . 0.0 110.278 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 11.5 p -108.38 -176.61 3.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.331 -0.856 . . . . 0.0 110.677 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.51 -29.42 36.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.415 -0.803 . . . . 0.0 110.157 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . 0.45 ' O ' HD13 ' A' ' 726' ' ' LEU . 11.1 tp10 -60.72 -52.48 64.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.499 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -63.89 -42.72 97.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 0.0 109.378 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -54.12 -32.21 54.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.341 -0.85 . . . . 0.0 109.552 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.26 -38.45 78.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.471 -0.768 . . . . 0.0 110.399 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 722' ' ' GLU . 11.0 mp -55.75 -47.83 76.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.245 -0.909 . . . . 0.0 110.521 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.65 -22.22 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.226 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -51.44 65.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 108.912 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.84 104.98 11.87 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.171 0.986 . . . . 0.0 109.062 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 2.0 mt . . . . . 0 C--N 1.275 -2.657 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.444 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.599 0.714 . . . . 0.0 109.661 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.532 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 6.7 t80 -98.09 -41.7 7.81 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.867 0.841 . . . . 0.0 109.678 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.455 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 48.5 tp -129.39 119.77 24.41 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.272 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 89.2 m -94.89 116.43 28.7 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.701 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 7.4 mt -89.91 111.34 22.36 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 583' ' ' LEU . 0.4 OUTLIER -114.08 102.77 55.09 Favored Pre-proline 0 C--N 1.298 -1.638 0 C-N-CA 118.116 -1.434 . . . . 0.0 112.463 -177.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.094 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.8 Cg_endo -79.63 143.97 17.26 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 N-CA-C 107.134 -1.91 . . . . 0.0 107.134 174.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 1.013 ' HB2' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -128.06 -173.98 0.34 Allowed Pre-proline 0 C--N 1.3 -1.585 0 C-N-CA 118.958 -1.097 . . . . 0.0 112.381 -177.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 1.013 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 35.3 Cg_endo -60.5 -33.43 93.88 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.819 1.431 . . . . 0.0 111.556 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . 0.512 ' HB2' HD21 ' A' ' 583' ' ' LEU . 4.3 m-20 -59.73 -23.99 63.65 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.695 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 19.1 t -95.73 151.45 19.36 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.478 HG21 ' OD1' ' A' ' 615' ' ' ASP . 7.8 tp -62.34 -17.09 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.026 -1.046 . . . . 0.0 109.647 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.572 HG12 ' O ' ' A' ' 612' ' ' LYS . 1.2 tp -108.21 122.72 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.318 -0.864 . . . . 0.0 110.187 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 586' ' ' SER . 23.6 mp0 -110.07 79.8 1.25 Allowed 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.463 -1.398 . . . . 0.0 109.399 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.094 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 27.2 mt-10 -144.71 175.45 10.16 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.643 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.52 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.13 124.77 35.57 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.138 -0.976 . . . . 0.0 108.889 175.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 2.1 mt -109.53 155.73 21.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.918 . . . . 0.0 109.565 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -125.26 110.25 13.81 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.373 -0.829 . . . . 0.0 111.346 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.462 HG22 ' HB ' ' A' ' 598' ' ' VAL . 2.0 mt -81.61 109.21 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.2 OUTLIER -56.15 165.07 1.08 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.446 -179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.532 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -63.17 70.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.54 -0.725 . . . . 0.0 110.065 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 137.79 21.83 0.48 Allowed Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.819 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.462 ' HB ' HG22 ' A' ' 594' ' ' ILE . 0.9 OUTLIER -84.29 101.67 9.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 O-C-N 120.764 -1.433 . . . . 0.0 107.21 178.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -145.46 132.57 10.1 Favored Pre-proline 0 C--N 1.283 -2.312 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.869 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.631 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 53.9 Cg_endo -91.71 163.5 27.77 Favored 'Cis proline' 0 C--N 1.311 -1.409 0 C-N-CA 123.31 -1.538 . . . . 0.0 109.045 -2.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.521 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 7.9 t80 -105.11 116.91 32.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.657 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 70.0 m-85 -86.34 146.15 26.6 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.416 -0.803 . . . . 0.0 111.406 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.575 HG12 ' CB ' ' A' ' 611' ' ' CYS . 2.9 mt -141.68 140.69 30.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.703 -0.623 . . . . 0.0 109.895 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.72 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 175.25 -161.41 30.59 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.298 -1.429 . . . . 0.0 111.436 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.408 ' CG ' ' O ' ' A' ' 615' ' ' ASP . 5.9 mmm-85 -69.7 -44.65 69.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.973 -0.722 . . . . 0.0 110.82 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.06 128.22 33.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.454 -0.779 . . . . 0.0 110.981 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.451 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 1.6 pt-20 -58.54 -12.79 4.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.429 -0.794 . . . . 0.0 109.657 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -45.25 -36.07 3.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.483 -0.761 . . . . 0.0 110.155 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.657 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 81.8 m -71.44 154.26 41.66 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 121.184 -0.947 . . . . 0.0 109.601 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.521 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -58.98 -14.0 8.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.443 -0.785 . . . . 0.0 110.14 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.575 ' CB ' HG12 ' A' ' 603' ' ' ILE . 6.1 t -120.18 143.94 47.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.492 -0.755 . . . . 0.0 110.033 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.572 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -110.63 129.7 55.75 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 121.992 0.901 . . . . 0.0 112.562 -178.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.53 ' HA ' ' HB ' ' A' ' 588' ' ' ILE . 4.3 mt -146.82 111.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -93.05 102.76 15.1 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 117.69 -1.604 . . . . 0.0 109.095 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 3.2 m-20 -138.26 105.29 5.43 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.505 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -42.81 -41.43 3.24 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.412 -0.805 . . . . 0.0 111.881 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.97 -16.88 42.47 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.137 -0.977 . . . . 0.0 111.739 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.52 ' CD2' ' HA2' ' A' ' 604' ' ' GLY . 0.7 OUTLIER -80.75 134.75 35.87 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.121 -0.987 . . . . 0.0 111.319 -178.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 619' ' ' SER . . . . . 0.463 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.42 162.83 28.02 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.466 -0.771 . . . . 0.0 111.025 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.72 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 34.2 ttp180 -64.36 -46.77 81.98 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.348 -0.845 . . . . 0.0 109.738 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.483 ' O ' ' C ' ' A' ' 622' ' ' HIS . 13.8 m -94.67 2.43 9.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.209 -0.932 . . . . 0.0 109.059 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.764 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.4 t60 -28.59 -47.85 0.05 Allowed 'General case' 0 C--O 1.192 -1.954 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.751 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.8 OUTLIER -137.21 145.16 43.32 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 118.311 -1.356 . . . . 0.0 111.166 179.049 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 6.5 p90 -145.86 150.4 36.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.573 -0.704 . . . . 0.0 110.339 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 19.0 mt -103.41 119.56 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 7.0 t80 -112.61 155.4 24.47 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.482 -0.761 . . . . 0.0 109.351 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 0.8 OUTLIER -119.61 136.06 54.54 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.852 0.834 . . . . 0.0 111.183 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.43 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -140.51 163.54 32.56 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.515 ' HD2' ' O ' ' A' ' 630' ' ' HIS . 0.0 OUTLIER -78.18 133.98 37.7 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.966 -1.084 . . . . 0.0 109.439 -179.492 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.515 ' O ' ' HD2' ' A' ' 629' ' ' ARG . 1.2 t60 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.368 -0.832 . . . . 0.0 111.247 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.45 ' CB ' ' N ' ' A' ' 703' ' ' PHE . 4.9 mp . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.6 OUTLIER -108.63 124.96 51.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.067 -1.021 . . . . 0.0 110.728 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -121.36 135.51 55.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.355 -0.841 . . . . 0.0 110.509 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 25.4 pt -92.69 135.28 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.272 -0.893 . . . . 0.0 110.075 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.63 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.6 m95 -119.62 121.93 40.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.604 -0.685 . . . . 0.0 111.306 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.502 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 14.0 t80 -80.78 115.54 20.33 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 9.8 t -107.22 108.45 19.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 111.64 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.516 ' CD2' ' N ' ' A' ' 652' ' ' THR . 12.5 t60 -70.72 158.66 35.88 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.461 -0.774 . . . . 0.0 109.761 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.764 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -149.86 -29.58 0.23 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.43 -0.794 . . . . 0.0 112.441 -179.077 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.542 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.45 -167.59 31.86 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 117.642 -2.218 . . . . 0.0 109.17 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 27.6 m -95.62 -17.44 21.34 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.014 -1.286 . . . . 0.0 113.751 -176.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.495 ' CB ' HG12 ' A' ' 681' ' ' ILE . 16.7 m120 -59.48 -4.01 0.54 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.775 -1.203 . . . . 0.0 112.683 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.462 ' C ' ' CE1' ' A' ' 651' ' ' HIS . 3.4 t 71.52 148.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-O 121.494 0.664 . . . . 0.0 110.604 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.436 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -106.83 143.09 35.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.721 -0.612 . . . . 0.0 110.068 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.456 ' CE1' ' CG ' ' A' ' 663' ' ' ARG . 36.6 m-85 -136.0 126.74 27.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.211 -0.93 . . . . 0.0 110.701 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.448 ' HG ' ' CG2' ' A' ' 678' ' ' ILE . 0.1 OUTLIER -130.02 119.04 22.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.392 -0.817 . . . . 0.0 109.787 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 56.89 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.388 -0.82 . . . . 0.0 110.429 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 659' ' ' LEU . 3.6 t-20 -138.07 5.73 2.57 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.017 -1.052 . . . . 0.0 110.984 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -96.28 132.99 41.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.032 -1.043 . . . . 0.0 110.566 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . 0.456 ' CG ' ' CE1' ' A' ' 658' ' ' TYR . 4.6 tmm_? -99.47 138.69 36.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.448 -0.783 . . . . 0.0 109.872 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.427 ' CB ' ' OG ' ' A' ' 657' ' ' SER . 3.6 mtp -117.41 -165.99 1.14 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.229 -0.92 . . . . 0.0 110.716 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.419 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 2.5 pt -141.86 -158.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.354 -0.842 . . . . 0.0 110.171 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -82.85 92.05 7.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.2 -0.938 . . . . 0.0 110.759 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 109.65 49.74 0.73 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.2 OUTLIER -118.52 148.39 42.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.06 -1.259 . . . . 0.0 109.943 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.416 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 7.6 tttt -108.5 138.88 44.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.441 -0.787 . . . . 0.0 109.088 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.479 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 5.2 t80 -144.25 147.19 33.25 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.104 -0.997 . . . . 0.0 112.032 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.63 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -69.76 147.49 50.41 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.554 -0.717 . . . . 0.0 111.583 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.502 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 7.8 mt -122.81 99.2 6.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.322 -0.861 . . . . 0.0 111.444 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 674' ' ' ASP . 94.2 mt-30 -84.65 141.26 30.75 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 673' ' ' GLN . 0.3 OUTLIER -38.34 151.51 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.354 -0.842 . . . . 0.0 110.815 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 64.9 49.59 62.35 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 107.358 -2.297 . . . . 0.0 107.358 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . 0.419 ' HB2' ' CG1' ' A' ' 694' ' ' VAL . 0.3 OUTLIER -115.81 92.43 3.9 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.871 -0.782 . . . . 0.0 110.774 -178.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.935 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.2 OUTLIER -93.93 106.98 18.93 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.448 ' CG2' ' HG ' ' A' ' 659' ' ' LEU . 1.2 pt -106.84 137.31 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.369 0.604 . . . . 0.0 111.404 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' A' ' 679' ' ' LYS . 2.9 ptmm? -97.17 110.44 22.99 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.488 -0.757 . . . . 0.0 109.418 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 68.5 mt -80.09 -22.65 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.373 -0.829 . . . . 0.0 110.692 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.495 HG12 ' CB ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER -134.64 135.17 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.163 -0.961 . . . . 0.0 109.998 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -138.0 109.13 6.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.934 . . . . 0.0 110.562 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.16 118.23 21.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.281 -0.887 . . . . 0.0 109.666 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.95 -32.53 74.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.334 -0.854 . . . . 0.0 111.215 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -84.23 -43.71 14.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.092 -1.005 . . . . 0.0 111.504 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . 0.443 ' HB3' ' CD1' ' A' ' 688' ' ' PHE . 88.4 m-20 -73.88 -19.83 60.59 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.137 -0.977 . . . . 0.0 110.798 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.53 22.09 4.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.168 -0.958 . . . . 0.0 110.46 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.697 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.7 OUTLIER -114.24 83.8 1.94 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.26 1.029 . . . . 0.0 109.472 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.695 ' O ' ' HA ' ' A' ' 586' ' ' SER . 14.9 m -101.04 143.17 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.075 -1.016 . . . . 0.0 110.553 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.475 ' CD1' ' CG2' ' A' ' 587' ' ' ILE . 47.7 mm -85.19 165.13 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.554 -0.716 . . . . 0.0 109.975 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -176.8 117.06 0.58 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.935 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.6 m-85 -121.46 137.26 54.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 109.945 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.96 113.95 25.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.282 -0.886 . . . . 0.0 109.98 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 676' ' ' ASP . 0.5 OUTLIER -83.65 123.7 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.364 -0.835 . . . . 0.0 109.254 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.39 108.52 10.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.85 -0.531 . . . . 0.0 110.408 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 81.0 mt -86.37 104.42 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.887 . . . . 0.0 109.826 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -77.4 -41.39 40.18 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.421 -0.8 . . . . 0.0 109.453 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.461 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 5.2 m-20 -110.22 140.97 43.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.479 -0.763 . . . . 0.0 110.735 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 15.7 p -115.88 96.27 5.51 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 82.5 m -108.7 114.71 28.74 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 121.752 -0.592 . . . . 0.0 110.738 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 49.46 36.37 23.58 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.445 HD11 ' CE1' ' A' ' 577' ' ' PHE . 5.2 tp -98.41 141.18 31.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.613 -0.933 . . . . 0.0 110.195 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.534 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 3.6 p90 -51.75 -24.92 6.5 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.395 -0.816 . . . . 0.0 109.756 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.534 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.479 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 121.723 0.773 . . . . 0.0 109.356 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 36.0 m -105.25 168.7 2.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.666 -0.646 . . . . 0.0 109.63 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.412 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 52.7 t -71.34 128.48 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.326 -0.859 . . . . 0.0 111.139 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.62 162.3 13.63 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -98.64 154.39 17.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.981 -1.074 . . . . 0.0 110.467 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.69 145.08 33.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.54 -0.725 . . . . 0.0 110.403 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 34.3 p -121.07 -176.8 3.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 110.093 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.78 -32.21 63.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.292 -0.88 . . . . 0.0 110.448 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -64.49 -52.3 58.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.386 -0.822 . . . . 0.0 110.22 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.42 -40.3 95.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.328 -0.857 . . . . 0.0 110.051 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -56.93 -35.11 68.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.311 -0.868 . . . . 0.0 109.945 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 728' ' ' LYS . 0.9 OUTLIER -67.7 -35.79 79.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.472 -0.768 . . . . 0.0 109.994 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 50.3 mt -57.06 -46.39 82.52 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.333 -0.854 . . . . 0.0 110.336 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.2 p -76.28 -24.33 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.613 -0.68 . . . . 0.0 110.914 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 725' ' ' ASP . 0.7 OUTLIER -53.32 -45.18 68.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.055 -1.028 . . . . 0.0 108.956 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -116.67 103.81 10.74 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 122.197 0.999 . . . . 0.0 109.057 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.401 ' O ' ' CE2' ' A' ' 602' ' ' PHE . 2.2 mt . . . . . 0 C--N 1.274 -2.708 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.375 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.572 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.1 OUTLIER -120.96 -39.69 2.69 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.843 0.83 . . . . 0.0 109.415 -179.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 8.5 tt -120.31 119.52 33.38 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.326 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 71.2 m -99.44 118.89 37.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 109.52 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 5.8 mt -91.37 111.97 23.68 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.485 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.79 101.82 54.2 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 118.075 -1.45 . . . . 0.0 112.736 -177.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.064 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 44.2 Cg_endo -79.75 145.78 18.31 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 N-CA-C 106.784 -2.045 . . . . 0.0 106.784 174.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.709 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.33 -174.37 0.31 Allowed Pre-proline 0 N--CA 1.494 1.753 0 C-N-CA 118.81 -1.156 . . . . 0.0 112.763 -177.104 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.709 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.9 Cg_endo -66.79 -28.73 43.15 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 124.111 1.585 . . . . 0.0 110.319 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -59.4 -28.35 66.83 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 53.7 p -95.45 153.73 17.55 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.535 ' HB ' HD11 ' A' ' 690' ' ' ILE . 3.8 tp -54.76 -16.98 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.333 -0.855 . . . . 0.0 109.944 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.648 HG12 ' O ' ' A' ' 612' ' ' LYS . 1.6 tp -116.3 119.34 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.265 -0.897 . . . . 0.0 110.575 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -112.39 80.73 1.37 Allowed 'General case' 0 N--CA 1.509 2.498 0 O-C-N 120.444 -1.41 . . . . 0.0 109.143 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.064 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 6.7 mm-40 -142.57 175.78 9.53 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.625 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.537 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.92 125.85 40.37 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.083 -1.011 . . . . 0.0 109.456 176.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 17.4 mt -111.17 156.02 22.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.405 -0.809 . . . . 0.0 109.649 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -125.23 111.12 14.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.378 -0.826 . . . . 0.0 111.836 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 45.9 mt -80.42 110.81 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 596' ' ' GLN . 2.0 mt-30 -70.71 109.47 4.95 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.52 ' HA ' ' HB3' ' A' ' 577' ' ' PHE . 0.5 OUTLIER 20.43 53.89 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 178.333 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . 109.96 44.62 1.01 Allowed Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.603 -1.284 . . . . 0.0 111.03 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.508 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 1.0 OUTLIER -79.63 103.85 7.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 177.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.2 OUTLIER -140.97 140.52 21.55 Favored Pre-proline 0 C--N 1.281 -2.371 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.639 -178.703 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.554 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.2 Cg_endo -88.79 160.82 40.67 Favored 'Cis proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.721 -2.199 . . . . 0.0 109.07 -0.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.556 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -106.56 116.82 32.58 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.679 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 58.1 m-85 -91.25 145.86 24.31 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.39 -0.818 . . . . 0.0 111.037 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.606 HG12 ' CB ' ' A' ' 611' ' ' CYS . 2.2 mt -140.02 141.05 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.33 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.7 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 175.33 -165.85 37.04 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.356 -1.402 . . . . 0.0 111.321 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 13.2 tpt180 -66.69 -38.81 87.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.956 -0.732 . . . . 0.0 110.777 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.459 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -84.22 126.8 33.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.398 -0.814 . . . . 0.0 110.748 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.42 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -59.3 -12.68 6.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 110.009 179.125 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.32 -36.97 6.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.882 . . . . 0.0 110.036 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.679 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 75.3 m -68.93 153.65 43.42 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 121.265 -0.897 . . . . 0.0 109.773 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.556 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -58.63 -14.78 9.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.485 -0.76 . . . . 0.0 110.238 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.606 ' CB ' HG12 ' A' ' 603' ' ' ILE . 6.6 t -119.95 143.46 47.99 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.582 -0.699 . . . . 0.0 109.528 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.648 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -110.23 130.88 55.47 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 122.054 0.93 . . . . 0.0 112.856 -178.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.556 ' HA ' ' HB ' ' A' ' 588' ' ' ILE . 3.9 mt -147.15 110.39 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.411 ' O ' HG12 ' A' ' 587' ' ' ILE . 2.7 tt0 -92.31 102.98 15.48 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 117.666 -1.614 . . . . 0.0 109.277 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 1.0 OUTLIER -139.55 106.15 5.34 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.692 177.322 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -42.94 -43.68 4.25 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.485 -0.76 . . . . 0.0 111.962 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -83.53 -17.13 42.89 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.144 -0.973 . . . . 0.0 111.729 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.496 ' CD2' ' HA2' ' A' ' 604' ' ' GLY . 0.8 OUTLIER -78.01 134.65 37.77 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.07 -1.019 . . . . 0.0 110.694 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 619' ' ' SER . . . . . 0.457 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.1 m -73.37 161.14 30.79 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.337 -0.852 . . . . 0.0 110.915 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.7 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 43.6 mtm180 -64.2 -45.63 87.47 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.235 -0.916 . . . . 0.0 109.309 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.469 ' O ' ' C ' ' A' ' 622' ' ' HIS . 15.7 m -94.66 2.0 9.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.83 0.824 . . . . 0.0 109.402 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.6 t60 -28.28 -46.91 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.771 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.5 OUTLIER -136.17 144.93 45.26 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.523 178.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 6.3 p90 -145.7 143.65 29.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.485 -0.759 . . . . 0.0 110.229 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.478 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 76.8 mt -103.43 117.66 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 8.3 t80 -110.95 155.0 23.32 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.853 0.835 . . . . 0.0 110.234 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.424 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 3.1 tppp? -118.96 137.13 53.71 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 121.372 0.606 . . . . 0.0 109.735 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.0 OUTLIER -133.88 163.82 28.65 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.566 -0.709 . . . . 0.0 111.038 -179.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.46 ' HD2' ' O ' ' A' ' 644' ' ' LEU . 2.5 tpt180 -77.66 116.2 18.02 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.366 -0.834 . . . . 0.0 108.929 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 8.5 t60 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.651 0.738 . . . . 0.0 110.649 -179.131 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.537 ' HB2' ' N ' ' A' ' 703' ' ' PHE . 4.6 mp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 628' ' ' LYS . 41.6 m-20 -112.22 124.72 53.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.873 -1.142 . . . . 0.0 111.325 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 628' ' ' LYS . 5.6 t0 -98.34 156.57 16.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.482 -0.761 . . . . 0.0 109.647 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 12.7 pt -106.25 130.18 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.278 -0.889 . . . . 0.0 110.38 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.711 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.6 m95 -117.84 124.38 48.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.841 -0.537 . . . . 0.0 111.194 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.455 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 7.1 t80 -83.91 114.47 21.7 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 17.4 t -109.71 106.1 15.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.061 -1.024 . . . . 0.0 112.112 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.549 ' CD2' ' N ' ' A' ' 652' ' ' THR . 14.4 t60 -67.54 162.55 23.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.454 -0.778 . . . . 0.0 109.854 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -154.47 -30.98 0.11 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.304 -0.872 . . . . 0.0 112.509 -179.244 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.553 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.62 -168.57 34.18 Favored Glycine 0 N--CA 1.497 2.712 0 C-N-CA 117.82 -2.133 . . . . 0.0 109.766 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 654' ' ' THR . . . . . 0.468 ' O ' HG12 ' A' ' 656' ' ' VAL . 11.1 m -89.71 -18.78 25.74 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.088 -1.242 . . . . 0.0 114.217 -176.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.579 ' O ' HG23 ' A' ' 656' ' ' VAL . 24.4 m120 -59.32 -3.03 0.36 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.605 -1.309 . . . . 0.0 112.728 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 62.52 142.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.549 -0.719 . . . . 0.0 110.164 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.482 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -96.95 151.8 19.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.589 -0.695 . . . . 0.0 110.554 -179.168 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.481 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 12.6 m-85 -138.02 125.46 21.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.363 -0.836 . . . . 0.0 110.175 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.496 HD11 ' CD1' ' A' ' 670' ' ' PHE . 1.7 mt -129.4 110.15 11.66 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.382 -0.824 . . . . 0.0 109.83 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 59.02 -80.67 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.428 -0.795 . . . . 0.0 110.37 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 659' ' ' LEU . 7.6 p-10 -144.64 13.73 1.54 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 110.94 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -100.16 116.74 32.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.017 -1.052 . . . . 0.0 110.225 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -81.46 136.14 35.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.348 -0.845 . . . . 0.0 109.676 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.435 ' CG ' ' CG2' ' A' ' 716' ' ' VAL . 1.6 mtp -119.07 -167.39 1.38 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 0.0 110.223 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.432 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 11.2 pt -146.74 -162.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -75.68 79.4 2.65 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.342 -0.849 . . . . 0.0 111.272 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.93 58.07 0.21 Allowed Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.833 -1.175 . . . . 0.0 110.678 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 1.2 p -123.9 145.58 49.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.994 -1.298 . . . . 0.0 110.074 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 650' ' ' CYS . 8.0 tttt -108.52 136.94 47.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.398 -0.814 . . . . 0.0 109.205 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.496 ' CD1' HD11 ' A' ' 659' ' ' LEU . 8.1 t80 -144.45 146.81 32.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.163 -0.96 . . . . 0.0 111.49 -178.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.711 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.9 OUTLIER -72.17 145.88 47.77 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.413 -0.804 . . . . 0.0 111.628 -179.374 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.458 ' CD2' HD13 ' A' ' 659' ' ' LEU . 6.2 mt -115.55 112.94 22.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.228 -0.92 . . . . 0.0 111.318 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -84.53 -177.03 6.5 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.55 149.7 42.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.982 -1.074 . . . . 0.0 109.711 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 59.68 50.26 69.61 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.2 94.74 5.89 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.74 0.781 . . . . 0.0 110.643 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.896 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 5.9 tt0 -93.49 107.42 19.27 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.486 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 1.9 mp -104.15 137.15 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.642 -0.661 . . . . 0.0 111.88 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -99.58 109.89 22.37 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 74.9 mt -79.52 -19.89 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.352 -0.842 . . . . 0.0 111.076 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.437 HG12 ' CB ' ' A' ' 655' ' ' ASN . 8.4 mt -141.6 141.33 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.967 -1.083 . . . . 0.0 110.762 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -137.79 108.77 6.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.43 -0.794 . . . . 0.0 109.965 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.96 118.43 29.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.268 -0.895 . . . . 0.0 110.161 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -66.33 -46.87 75.36 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.364 -0.835 . . . . 0.0 110.963 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -84.93 -43.43 14.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.258 -0.901 . . . . 0.0 111.2 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . 0.462 ' O ' ' N ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -91.23 0.39 57.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.262 -0.899 . . . . 0.0 111.004 -179.353 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . 0.537 ' O ' ' C ' ' A' ' 688' ' ' PHE . 0.0 OUTLIER 65.49 -67.73 0.13 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.42 -0.8 . . . . 0.0 109.777 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.537 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.1 OUTLIER 24.52 61.0 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.369 0.604 . . . . 0.0 111.317 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 586' ' ' SER . 59.8 t -101.97 142.46 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.422 -0.799 . . . . 0.0 110.718 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.535 HD11 ' HB ' ' A' ' 587' ' ' ILE . 40.4 mm -122.64 165.38 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -176.35 121.01 0.78 Allowed Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.896 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 10.6 m-85 -119.62 136.51 54.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.526 -0.985 . . . . 0.0 108.798 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -98.77 114.32 26.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 110.898 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.432 ' O ' ' CG1' ' A' ' 694' ' ' VAL . 1.2 t -84.78 114.0 24.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -122.37 104.34 9.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.733 -0.604 . . . . 0.0 109.826 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 83.3 mt -88.71 103.28 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.33 -0.856 . . . . 0.0 109.679 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.0 -41.75 22.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 0.0 108.927 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.7 OUTLIER -109.92 141.29 42.87 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.391 0.615 . . . . 0.0 109.629 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 16.3 p -113.29 95.8 5.56 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 40.7 m -129.65 134.62 47.78 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.87 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 57.72 29.35 61.28 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.83 128.07 56.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.503 -0.998 . . . . 0.0 110.24 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.537 ' N ' ' HB2' ' A' ' 644' ' ' LEU . 3.5 p90 -50.44 -24.01 2.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.481 -0.762 . . . . 0.0 110.753 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.508 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.433 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 3.5 mmm-85 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.223 0.535 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 32.0 m -108.04 152.25 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.533 -0.729 . . . . 0.0 109.522 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.435 ' CG2' ' CG ' ' A' ' 664' ' ' MET . 14.6 p -104.21 133.29 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.725 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.0 mp -104.01 162.76 12.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.416 -0.803 . . . . 0.0 110.001 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -93.33 154.27 18.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.223 -0.923 . . . . 0.0 110.163 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -79.61 148.02 31.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.36 -0.838 . . . . 0.0 110.358 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 11.9 p -121.07 -176.37 3.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.381 -0.824 . . . . 0.0 110.359 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.49 -29.0 33.89 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.332 -0.855 . . . . 0.0 110.093 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.8 -51.32 65.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.461 -0.774 . . . . 0.0 109.745 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -64.06 -43.64 94.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.45 -0.781 . . . . 0.0 109.937 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . 0.414 ' O ' ' CG1' ' A' ' 727' ' ' VAL . 16.1 tttt -56.41 -32.86 65.24 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.35 -0.843 . . . . 0.0 110.06 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -68.78 -36.31 78.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.387 -0.821 . . . . 0.0 110.364 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 37.8 mt -60.02 -46.32 89.9 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.362 -0.836 . . . . 0.0 110.439 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' A' ' 724' ' ' LYS . 7.1 p -69.15 -19.67 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.04 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.53 -50.8 69.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 108.877 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -116.85 105.29 12.2 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 122.132 0.968 . . . . 0.0 109.122 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.415 ' O ' ' CE2' ' A' ' 602' ' ' PHE . 4.5 mt . . . . . 0 C--N 1.274 -2.68 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.472 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 14.0 ttp-105 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 121.707 0.765 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.52 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 3.0 t80 -92.47 -43.52 9.14 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.913 0.863 . . . . 0.0 109.475 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.511 ' HB2' ' CD2' ' A' ' 577' ' ' PHE . 5.4 tp -125.1 119.7 29.36 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.628 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 36.2 m -96.75 118.66 33.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.53 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 3.3 mt -94.72 112.3 24.04 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.1 OUTLIER -111.97 104.18 55.83 Favored Pre-proline 0 C--N 1.3 -1.563 0 C-N-CA 118.467 -1.293 . . . . 0.0 112.935 -177.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.097 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.7 Cg_endo -76.81 142.46 22.59 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 N-CA-C 105.72 -2.454 . . . . 0.0 105.72 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 1.012 ' HB2' ' HD2' ' A' ' 584' ' ' PRO . 0.1 OUTLIER -126.78 -175.28 0.41 Allowed Pre-proline 0 N--CA 1.499 1.982 0 C-N-CA 118.416 -1.314 . . . . 0.0 113.806 -176.052 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 1.012 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 37.7 Cg_endo -65.75 -33.43 44.17 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.961 1.506 . . . . 0.0 111.381 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.08 -30.34 68.01 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.598 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 84.2 p -97.59 153.77 17.97 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.505 ' CG2' HD13 ' A' ' 588' ' ' ILE . 0.2 OUTLIER -61.6 -11.06 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.935 . . . . 0.0 109.839 178.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.725 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 8.5 mm -98.54 116.95 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.351 -0.843 . . . . 0.0 109.779 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 586' ' ' SER . 17.8 mp0 -118.67 70.32 0.82 Allowed 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.491 -1.38 . . . . 0.0 109.932 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.097 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 18.0 mt-10 -144.31 175.44 10.09 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.014 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.473 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.61 125.57 36.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.995 -1.066 . . . . 0.0 109.04 176.371 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 611' ' ' CYS . 46.5 mt -111.63 155.05 23.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 109.828 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.402 ' OE1' ' N ' ' A' ' 593' ' ' GLU . 16.3 mp0 -126.27 110.59 13.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.835 . . . . 0.0 111.461 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 3.5 mt -77.94 109.52 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.06 -1.025 . . . . 0.0 108.32 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -53.61 161.22 1.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.451 -0.781 . . . . 0.0 109.766 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.52 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.3 OUTLIER -48.94 79.05 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.706 -0.621 . . . . 0.0 111.551 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 107.41 34.93 2.78 Favored Glycine 0 N--CA 1.486 1.995 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.844 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.461 ' HB ' HG22 ' A' ' 594' ' ' ILE . 1.0 OUTLIER -79.77 103.05 6.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 627' ' ' LYS . 6.4 t30 -143.01 135.25 13.3 Favored Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.023 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.609 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.0 Cg_endo -91.08 161.9 29.67 Favored 'Cis proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.781 -1.758 . . . . 0.0 108.987 -1.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.498 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -106.62 116.2 31.52 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.609 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 63.6 m-85 -83.02 143.63 30.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 0.0 110.288 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.557 HG12 ' CB ' ' A' ' 611' ' ' CYS . 3.9 mt -142.93 142.08 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.563 -0.711 . . . . 0.0 110.224 -178.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.779 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 165.42 -161.2 34.67 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.339 -1.41 . . . . 0.0 111.4 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.401 ' N ' HD23 ' A' ' 618' ' ' LEU . 3.4 mmm-85 -63.74 -53.87 44.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.78 -0.835 . . . . 0.0 111.834 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.446 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -71.59 124.73 25.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 111.239 -178.592 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.482 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.1 OUTLIER -54.07 -17.67 2.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 0.0 109.813 178.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -45.18 -30.99 1.29 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 0.0 109.272 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 602' ' ' PHE . 1.7 m -68.6 133.81 49.05 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.498 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -45.08 -26.93 0.51 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.318 -0.864 . . . . 0.0 109.759 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.557 ' CB ' HG12 ' A' ' 603' ' ' ILE . 13.0 t -106.23 143.61 34.1 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -108.91 125.15 51.71 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.253 1.025 . . . . 0.0 113.161 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.725 ' HA ' ' CD1' ' A' ' 588' ' ' ILE . 18.3 mt -143.13 108.31 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.433 ' H ' ' CD1' ' A' ' 588' ' ' ILE . 3.8 mt-10 -97.77 104.41 16.43 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 118.302 -1.359 . . . . 0.0 109.25 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.556 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 1.0 OUTLIER -137.99 106.19 5.75 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.238 177.439 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -42.49 -39.48 2.27 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.485 -0.759 . . . . 0.0 111.678 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.67 -17.8 40.2 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.152 -0.968 . . . . 0.0 111.303 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.556 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -79.3 140.45 37.56 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.177 -0.952 . . . . 0.0 110.562 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 619' ' ' SER . . . . . 0.406 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.82 161.02 29.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.372 -0.83 . . . . 0.0 110.718 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.779 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 9.8 ttp180 -63.6 -45.65 89.4 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.25 -0.906 . . . . 0.0 109.173 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 622' ' ' HIS . 7.7 t -95.98 1.92 10.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.483 -0.761 . . . . 0.0 109.931 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.751 ' O ' ' N ' ' A' ' 652' ' ' THR . 9.2 t60 -27.49 -41.82 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.078 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 621' ' ' VAL . 0.7 OUTLIER -136.76 145.0 44.07 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 118.228 -1.389 . . . . 0.0 110.861 179.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.551 ' CE2' ' CB ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -147.63 140.75 25.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.579 -0.7 . . . . 0.0 109.992 178.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -103.21 136.88 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.231 -0.918 . . . . 0.0 109.327 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.525 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 7.6 t80 -128.97 155.83 44.75 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.503 -0.748 . . . . 0.0 109.636 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.439 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 1.2 tppp? -119.02 136.93 53.87 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.404 0.621 . . . . 0.0 110.622 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.424 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -140.32 163.82 31.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.627 -0.67 . . . . 0.0 110.709 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.529 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -78.39 128.61 33.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.377 -0.827 . . . . 0.0 109.411 -179.733 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.537 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.5 t60 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.421 -0.799 . . . . 0.0 110.845 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.482 ' HB2' ' CA ' ' A' ' 703' ' ' PHE . 5.2 mp . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.8 OUTLIER -121.56 124.6 44.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.083 -1.01 . . . . 0.0 111.186 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.415 ' OD2' ' ND1' ' A' ' 630' ' ' HIS . 3.2 t0 -114.11 149.0 36.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.383 -0.823 . . . . 0.0 109.7 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 5.4 pt -94.76 136.81 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.211 -0.93 . . . . 0.0 110.194 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.556 ' CH2' ' CD1' ' A' ' 671' ' ' LEU . 95.7 m95 -119.39 121.37 39.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.653 -0.654 . . . . 0.0 110.525 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.455 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 5.2 t80 -80.53 117.95 21.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.138 -0.977 . . . . 0.0 108.6 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 668' ' ' THR . 4.3 m -107.84 102.57 11.77 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.422 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.501 ' CD2' ' N ' ' A' ' 652' ' ' THR . 27.0 t60 -64.47 163.58 13.1 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.29 -0.881 . . . . 0.0 109.503 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.751 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -151.9 -28.78 0.17 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.551 ' N ' ' HA ' ' A' ' 622' ' ' HIS . . . -79.16 -169.27 36.94 Favored Glycine 0 N--CA 1.496 2.665 0 O-C-N 119.204 -2.185 . . . . 0.0 109.856 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 12.6 m -94.06 -18.62 21.64 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.178 -1.189 . . . . 0.0 113.9 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 656' ' ' VAL . 29.8 m120 -61.86 -4.26 1.48 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.625 -1.297 . . . . 0.0 111.896 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.482 ' CB ' ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 78.21 169.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 121.919 0.866 . . . . 0.0 110.607 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.477 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -125.35 149.44 48.11 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.436 -179.222 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.415 ' CZ ' ' HG3' ' A' ' 663' ' ' ARG . 2.9 m-85 -138.58 126.7 22.71 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.313 -0.867 . . . . 0.0 110.657 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 661' ' ' ASN . 24.8 tp -125.67 107.63 10.76 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.359 -0.838 . . . . 0.0 109.914 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 27.2 t30 64.73 -68.09 0.11 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.648 -0.658 . . . . 0.0 110.412 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.8 OUTLIER -158.86 24.68 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 110.164 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.31 132.87 56.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -0.937 . . . . 0.0 110.425 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . 0.415 ' HG3' ' CZ ' ' A' ' 658' ' ' TYR . 5.4 ttt180 -95.12 130.14 41.94 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.467 -0.77 . . . . 0.0 110.28 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.415 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 2.4 mtp -110.05 -164.58 0.94 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.409 -0.807 . . . . 0.0 110.056 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.404 ' CG1' ' CG2' ' A' ' 668' ' ' THR . 1.8 pt -140.21 -163.24 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 110.213 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -77.5 93.64 4.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.333 -0.854 . . . . 0.0 110.653 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.42 53.58 0.87 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.557 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -118.24 147.74 43.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.183 -1.186 . . . . 0.0 109.911 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -108.38 139.5 43.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.538 -0.726 . . . . 0.0 109.53 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.466 ' CE2' HD22 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -144.47 142.87 30.57 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.093 -179.226 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.556 ' CD1' ' CH2' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.87 147.01 50.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.519 -0.738 . . . . 0.0 110.753 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.455 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 26.1 mt -118.08 131.33 56.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.356 -0.84 . . . . 0.0 111.277 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 674' ' ' ASP . 61.6 mt-30 -113.19 143.17 44.84 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 673' ' ' GLN . 3.7 p-10 -41.03 144.91 0.24 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.184 -0.947 . . . . 0.0 110.748 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.48 49.39 44.92 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.7 97.43 6.97 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.788 0.804 . . . . 0.0 110.616 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.684 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.82 107.01 18.95 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.492 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 35.3 pt -108.38 136.84 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.48 -0.763 . . . . 0.0 111.56 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.73 110.29 22.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.514 -0.741 . . . . 0.0 109.253 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.469 ' CG2' ' CD2' ' A' ' 622' ' ' HIS . 70.8 mt -76.74 -26.41 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.335 -0.853 . . . . 0.0 110.191 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 618' ' ' LEU . 4.4 mt -143.29 133.84 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 109.961 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -137.61 114.61 10.73 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.359 -0.838 . . . . 0.0 110.329 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.51 118.33 23.79 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.318 -0.864 . . . . 0.0 110.028 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -65.94 -42.76 89.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.393 -0.817 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -83.73 -43.34 15.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.332 -0.855 . . . . 0.0 110.844 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -80.31 -12.05 59.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.283 -0.886 . . . . 0.0 110.663 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 57.16 18.77 4.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.13 -0.981 . . . . 0.0 110.5 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.404 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -77.52 76.21 4.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.161 179.213 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 586' ' ' SER . 60.5 t -101.86 137.23 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.458 -0.776 . . . . 0.0 110.941 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.453 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 49.0 mm -118.73 164.43 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -178.02 124.94 0.96 Allowed Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.496 -1.335 . . . . 0.0 110.196 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.684 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 13.4 m-85 -120.43 137.76 54.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.591 -0.946 . . . . 0.0 109.132 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.4 113.95 26.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.157 -0.964 . . . . 0.0 109.985 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 1.1 t -83.06 118.16 30.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.481 -0.762 . . . . 0.0 109.151 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -128.8 104.6 7.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.65 -0.657 . . . . 0.0 110.097 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 69.1 mt -81.86 104.69 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.46 -0.775 . . . . 0.0 109.832 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.48 -42.52 35.5 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.439 -0.788 . . . . 0.0 108.875 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.5 ' O ' ' CD1' ' A' ' 577' ' ' PHE . 3.9 m-20 -110.84 141.49 44.14 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.463 0.649 . . . . 0.0 110.68 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 9.0 p -114.04 96.2 5.69 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.8 m -94.65 100.03 12.05 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.261 0.553 . . . . 0.0 111.735 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 45.9 34.48 5.64 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.471 HD11 ' CE1' ' A' ' 577' ' ' PHE . 1.1 tp -84.47 150.22 25.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -1.12 . . . . 0.0 110.043 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.561 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 2.6 p90 -51.49 -24.44 5.11 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.314 -0.866 . . . . 0.0 110.038 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.561 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.6 t30 . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.423 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 121.54 0.686 . . . . 0.0 110.094 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 34.2 m -106.57 153.07 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.65 -0.656 . . . . 0.0 109.69 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.415 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 84.1 t -85.06 133.32 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.22 -0.925 . . . . 0.0 110.916 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.6 mt -105.39 162.38 13.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.555 -0.716 . . . . 0.0 109.6 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -101.24 153.53 19.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.167 -0.958 . . . . 0.0 110.292 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -85.35 151.03 24.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.347 -0.846 . . . . 0.0 110.263 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 19.0 p -121.33 -176.66 3.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.329 -0.857 . . . . 0.0 110.47 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.68 -29.81 40.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.45 -0.781 . . . . 0.0 110.119 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . 0.423 ' O ' HD11 ' A' ' 726' ' ' LEU . 3.6 tt0 -63.49 -52.29 61.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.673 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.38 -38.18 90.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.427 -0.795 . . . . 0.0 109.496 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . 0.425 ' O ' ' CG1' ' A' ' 727' ' ' VAL . 11.8 tttt -57.76 -32.27 67.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.421 -0.799 . . . . 0.0 109.833 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.69 -40.33 80.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.259 -0.901 . . . . 0.0 110.409 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.423 HD11 ' O ' ' A' ' 722' ' ' GLU . 11.0 mp -55.91 -47.02 78.22 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.223 -0.923 . . . . 0.0 110.843 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . 0.425 ' CG1' ' O ' ' A' ' 724' ' ' LYS . 7.2 p -69.23 -18.05 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.486 -0.759 . . . . 0.0 110.232 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.37 -43.96 68.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 108.854 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -116.96 104.32 11.16 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 122.254 1.026 . . . . 0.0 109.221 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.413 ' O ' ' CD2' ' A' ' 602' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--N 1.275 -2.664 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.402 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.6 ' CD2' ' O ' ' A' ' 698' ' ' ASP . 0.7 OUTLIER -110.01 -41.0 4.58 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.831 0.824 . . . . 0.0 109.832 -179.1 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.478 ' HB2' ' CD1' ' A' ' 577' ' ' PHE . 17.4 tp -121.17 127.68 51.76 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.448 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 94.1 m -111.38 117.97 34.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 6.1 mt -90.71 112.25 23.94 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.417 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 1.2 mmtt -113.54 101.05 53.24 Favored Pre-proline 0 C--N 1.303 -1.442 0 C-N-CA 118.02 -1.472 . . . . 0.0 112.611 -178.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.129 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.5 Cg_endo -78.79 145.44 20.12 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 N-CA-C 106.232 -2.257 . . . . 0.0 106.232 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.706 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -123.54 -176.76 0.46 Allowed Pre-proline 0 N--CA 1.498 1.931 0 C-N-CA 118.251 -1.38 . . . . 0.0 114.094 -175.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.706 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.6 Cg_endo -67.84 -34.0 25.3 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.825 1.683 . . . . 0.0 111.953 -178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -58.31 -29.69 66.08 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.772 -1.205 . . . . 0.0 107.931 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.475 ' HB3' ' N ' ' A' ' 691' ' ' GLY . 4.3 p -96.25 150.66 20.3 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.507 ' CG2' HD11 ' A' ' 588' ' ' ILE . 0.1 OUTLIER -55.64 -17.79 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 0.0 109.467 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.625 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 9.1 mm -100.03 114.87 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.539 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -126.01 74.59 1.44 Allowed 'General case' 0 N--CA 1.51 2.569 0 O-C-N 120.581 -1.325 . . . . 0.0 110.423 -179.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.129 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.2 mt-10 -143.31 175.9 9.55 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.506 -0.77 . . . . 0.0 108.993 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.496 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.3 127.04 42.01 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.761 -1.212 . . . . 0.0 109.476 176.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.417 ' CD1' ' SG ' ' A' ' 611' ' ' CYS . 67.2 mt -111.32 156.21 21.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.419 -0.801 . . . . 0.0 109.628 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -124.46 110.77 14.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 111.423 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.44 ' N ' ' O ' ' A' ' 578' ' ' LEU . 31.3 mt -81.01 109.04 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.534 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -66.89 118.17 10.0 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.533 -0.729 . . . . 0.0 111.955 -177.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.554 ' HA ' ' HB3' ' A' ' 577' ' ' PHE . 6.8 tp-100 13.32 61.99 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 95.61 50.75 1.94 Allowed Glycine 0 N--CA 1.487 2.04 0 C-N-CA 119.931 -1.128 . . . . 0.0 110.585 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 0.6 OUTLIER -79.49 105.09 8.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.01 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.4 OUTLIER -140.26 142.0 28.22 Favored Pre-proline 0 C--N 1.28 -2.417 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.79 -178.462 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.458 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.5 Cg_endo -88.91 159.12 39.19 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.564 -2.265 . . . . 0.0 109.001 -0.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.536 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.1 t80 -106.53 116.24 31.58 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.785 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 39.6 m-85 -91.43 146.01 24.16 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 110.757 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.577 HG12 ' CB ' ' A' ' 611' ' ' CYS . 2.7 mt -139.91 141.08 34.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.48 -0.763 . . . . 0.0 110.618 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.733 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 173.24 -164.88 36.86 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.51 -1.329 . . . . 0.0 111.186 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 8.5 mmm-85 -66.66 -41.0 88.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.892 -0.769 . . . . 0.0 110.866 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.4 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -83.12 132.04 35.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -0.848 . . . . 0.0 111.218 -178.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.538 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.7 OUTLIER -61.24 -13.04 15.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.413 -0.804 . . . . 0.0 109.858 178.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.45 -37.4 5.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.3 -0.875 . . . . 0.0 109.858 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.785 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 64.4 m -71.23 148.79 46.9 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.403 -0.811 . . . . 0.0 109.613 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.536 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -56.0 -16.68 5.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.482 -0.761 . . . . 0.0 110.655 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.577 ' CB ' HG12 ' A' ' 603' ' ' ILE . 10.5 t -115.67 143.34 45.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.439 -0.788 . . . . 0.0 109.542 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.538 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -112.82 121.28 44.22 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.169 -0.957 . . . . 0.0 112.689 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.625 ' HA ' ' CD1' ' A' ' 588' ' ' ILE . 18.5 mt -141.73 108.25 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.4 ' N ' HD13 ' A' ' 588' ' ' ILE . 3.8 tm-20 -90.64 103.89 16.53 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.625 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 618' ' ' LEU . 1.5 m-20 -138.25 105.78 5.57 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.675 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -39.55 -52.34 2.17 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.755 -0.59 . . . . 0.0 112.256 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -75.12 -16.49 60.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.09 -1.006 . . . . 0.0 111.364 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.493 ' CD2' ' HA2' ' A' ' 604' ' ' GLY . 0.8 OUTLIER -80.0 132.67 36.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.215 -0.928 . . . . 0.0 111.134 -178.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 619' ' ' SER . . . . . 0.494 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -74.77 162.39 28.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.489 -0.757 . . . . 0.0 110.812 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.733 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.3 OUTLIER -64.19 -46.06 85.59 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.288 -0.883 . . . . 0.0 109.389 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.469 ' O ' ' C ' ' A' ' 622' ' ' HIS . 16.2 m -94.6 2.25 9.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.216 -0.927 . . . . 0.0 109.179 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.754 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.4 t60 -28.66 -47.44 0.05 Allowed 'General case' 0 C--O 1.192 -1.953 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.051 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.6 OUTLIER -137.44 145.12 42.75 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.398 -1.321 . . . . 0.0 111.02 179.046 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.538 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 3.6 p90 -145.95 144.81 30.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.589 -0.694 . . . . 0.0 110.212 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.52 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 11.3 mt -103.5 118.05 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 7.7 t80 -111.55 154.62 24.52 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.774 0.797 . . . . 0.0 109.819 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 3.7 ttmt -120.07 136.67 54.5 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 121.464 0.65 . . . . 0.0 110.31 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.453 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.82 163.72 28.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.617 -0.677 . . . . 0.0 110.343 -179.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.8 tpt180 -77.72 115.28 17.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.516 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 3.0 t60 . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.497 -0.752 . . . . 0.0 110.574 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.462 ' HB2' ' N ' ' A' ' 703' ' ' PHE . 5.3 mp . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.4 m-20 -114.95 124.34 51.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.965 -1.084 . . . . 0.0 111.115 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -107.08 156.12 19.11 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.537 -0.727 . . . . 0.0 109.82 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 13.8 pt -110.7 131.45 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.623 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.4 m95 -119.11 121.95 40.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.654 -0.654 . . . . 0.0 111.369 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.508 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 8.7 t80 -80.95 114.84 20.1 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.538 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 7.5 t -107.12 110.3 22.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.207 -0.933 . . . . 0.0 111.731 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.518 ' CD2' ' N ' ' A' ' 652' ' ' THR . 18.5 t60 -72.66 162.67 29.19 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.476 -0.765 . . . . 0.0 109.833 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.754 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -155.11 -30.84 0.1 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.458 -0.776 . . . . 0.0 112.205 -179.114 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.54 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.08 -165.23 29.11 Favored Glycine 0 N--CA 1.496 2.665 0 C-N-CA 117.966 -2.064 . . . . 0.0 109.739 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 654' ' ' THR . . . . . 0.448 ' O ' HG11 ' A' ' 656' ' ' VAL . 14.5 m -93.55 -18.9 21.73 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.007 -1.29 . . . . 0.0 114.012 -176.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.543 ' O ' HG21 ' A' ' 656' ' ' VAL . 86.6 m-20 -59.81 -2.56 0.4 Allowed 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.746 -1.221 . . . . 0.0 112.727 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.543 HG21 ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 63.36 146.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 121.57 0.7 . . . . 0.0 110.305 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.461 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -98.27 141.99 30.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.69 -0.631 . . . . 0.0 110.605 -178.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.459 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 11.1 m-85 -129.75 126.17 37.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 110.364 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.481 ' CD1' HG21 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -132.6 114.89 14.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.356 -0.84 . . . . 0.0 110.047 179.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 56.54 -84.69 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.434 -0.791 . . . . 0.0 110.475 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.6 m120 -143.52 20.3 1.86 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.058 -1.026 . . . . 0.0 110.353 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -111.2 118.48 36.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.283 -0.886 . . . . 0.0 110.239 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -86.67 139.81 30.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 110.184 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.43 ' CB ' ' OG ' ' A' ' 657' ' ' SER . 4.5 mtp -117.27 -167.29 1.29 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.866 . . . . 0.0 110.124 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.414 ' CG1' ' CG2' ' A' ' 668' ' ' THR . 1.5 pt -137.24 -158.49 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.253 -0.905 . . . . 0.0 110.426 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -83.11 90.2 7.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.336 -0.853 . . . . 0.0 110.547 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 651' ' ' HIS . . . 110.12 52.53 0.6 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.2 OUTLIER -119.8 148.89 42.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.145 -1.209 . . . . 0.0 110.177 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.426 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 9.5 tttt -108.59 139.02 43.95 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.437 ' CD1' HG21 ' A' ' 716' ' ' VAL . 13.4 t80 -142.54 146.38 34.58 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.154 -0.966 . . . . 0.0 111.615 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.623 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -73.33 146.82 44.97 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.59 -0.694 . . . . 0.0 110.502 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.508 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 12.1 mt -119.39 115.35 23.93 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.559 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -87.39 -177.41 5.92 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -78.31 142.97 37.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 109.432 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.93 46.71 43.16 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 107.678 -2.169 . . . . 0.0 107.678 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -101.15 91.51 4.57 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.817 -0.813 . . . . 0.0 110.396 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.796 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -93.09 106.91 18.8 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.481 HG21 ' CD1' ' A' ' 659' ' ' LEU . 1.3 pt -114.17 137.8 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.7 -0.625 . . . . 0.0 111.55 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -95.68 112.76 24.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.553 -0.717 . . . . 0.0 109.418 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 64.5 mt -76.14 -20.9 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.927 . . . . 0.0 110.438 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.412 HD12 ' ND2' ' A' ' 655' ' ' ASN . 8.8 mt -141.55 133.66 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.075 -1.016 . . . . 0.0 110.721 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -137.86 108.86 6.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.48 -0.762 . . . . 0.0 109.943 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . 0.403 ' CB ' ' HB2' ' A' ' 686' ' ' ASN . 45.3 m-20 -125.66 118.38 25.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 110.088 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -65.87 -38.64 89.32 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.461 -0.774 . . . . 0.0 110.983 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -84.04 -43.54 15.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.272 -0.892 . . . . 0.0 111.076 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . 0.403 ' HB2' ' CB ' ' A' ' 683' ' ' ASP . 50.9 m-80 -81.81 -12.35 58.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.129 -0.982 . . . . 0.0 110.69 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.8 tttp 56.25 20.43 4.56 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.145 -0.972 . . . . 0.0 110.439 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.88 85.37 2.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.144 -0.972 . . . . 0.0 109.347 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 586' ' ' SER . 2.9 t -101.73 135.91 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.442 -0.786 . . . . 0.0 110.656 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.437 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 40.5 mm -123.44 163.63 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.475 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . -174.76 124.67 1.03 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.525 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.796 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.9 m-85 -120.44 138.01 54.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.559 -0.965 . . . . 0.0 108.736 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.5 114.59 28.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 110.976 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.96 112.97 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -116.3 104.66 11.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.495 -0.753 . . . . 0.0 110.456 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.468 HG23 HD12 ' A' ' 696' ' ' ILE . 78.8 mt -84.11 103.81 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -0.828 . . . . 0.0 109.517 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -81.94 -42.27 19.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 108.889 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.6 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.2 m-20 -110.55 142.29 42.55 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.401 0.62 . . . . 0.0 110.145 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 35.6 p -115.97 95.92 5.34 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 2.7 m -131.92 139.24 48.67 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.351 -0.539 . . . . 0.0 110.282 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.15 28.79 34.83 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.494 ' CD2' ' CZ ' ' A' ' 577' ' ' PHE . 0.2 OUTLIER -107.89 131.29 54.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.587 -0.949 . . . . 0.0 110.563 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 4.0 p90 -52.25 -23.7 6.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.42 -0.8 . . . . 0.0 109.806 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.563 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.424 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 2.8 mmm-85 . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.335 0.588 . . . . 0.0 111.345 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 32.6 m -107.73 153.07 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.412 -0.805 . . . . 0.0 109.433 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.437 HG21 ' CD1' ' A' ' 670' ' ' PHE . 59.8 t -95.1 133.25 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 110.648 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.5 mt -104.83 162.26 13.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.488 -0.757 . . . . 0.0 109.765 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.78 153.43 19.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 110.246 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.85 122.29 26.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.4 -0.813 . . . . 0.0 110.249 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 27.8 p -95.92 -176.53 3.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.432 -0.792 . . . . 0.0 110.162 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.55 -28.99 34.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.293 -0.88 . . . . 0.0 110.188 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -69.01 -46.57 67.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.373 -0.829 . . . . 0.0 109.983 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.75 -50.26 69.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.383 -0.823 . . . . 0.0 110.043 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -53.71 -32.7 52.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.36 -0.837 . . . . 0.0 109.909 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 728' ' ' LYS . 28.7 t70 -66.18 -35.86 81.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.497 -0.752 . . . . 0.0 110.129 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 37.5 mt -61.16 -46.32 90.99 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.277 -0.89 . . . . 0.0 110.083 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.72 -24.26 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.601 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 725' ' ' ASP . 0.6 OUTLIER -53.94 -46.06 71.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.116 -0.99 . . . . 0.0 108.902 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -116.83 104.0 10.88 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.219 1.009 . . . . 0.0 109.011 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.274 -2.701 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.336 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.688 0.756 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -102.92 -42.57 5.79 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 122.044 0.926 . . . . 0.0 109.286 -179.287 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 9.7 tt -120.47 131.67 54.85 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.611 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 32.6 m -109.18 118.27 36.29 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.961 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 13.2 mt -93.17 112.28 24.17 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.453 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.3 OUTLIER -114.99 103.6 54.6 Favored Pre-proline 0 C--N 1.302 -1.488 0 C-N-CA 118.326 -1.35 . . . . 0.0 113.387 -176.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.078 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 45.6 Cg_endo -78.58 140.66 16.99 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 N-CA-C 105.045 -2.713 . . . . 0.0 105.045 174.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.742 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -121.55 -175.05 0.33 Allowed Pre-proline 0 N--CA 1.496 1.863 0 C-N-CA 118.044 -1.462 . . . . 0.0 113.779 -176.118 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.742 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.4 Cg_endo -66.11 -33.75 39.6 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 O-C-N 124.198 1.631 . . . . 0.0 111.969 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.74 -29.48 66.76 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.709 -1.196 . . . . 0.0 107.856 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.573 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 27.1 p -96.39 153.28 17.91 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.533 ' CG2' HD12 ' A' ' 588' ' ' ILE . 0.4 OUTLIER -59.92 -15.73 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.184 -0.948 . . . . 0.0 109.127 178.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.657 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 7.8 mm -95.03 115.83 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.437 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -121.74 70.23 0.95 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.55 -1.344 . . . . 0.0 109.372 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.078 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 33.8 tt0 -144.34 174.08 11.22 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.698 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.49 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.87 127.53 40.39 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.937 -1.102 . . . . 0.0 109.365 176.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 1.1 mp -111.5 153.78 25.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.183 -0.948 . . . . 0.0 110.073 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -125.74 112.46 16.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.537 -0.727 . . . . 0.0 111.185 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.454 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 69.6 mt -78.88 109.52 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.087 -1.008 . . . . 0.0 108.71 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.589 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -63.49 100.31 0.25 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.59 -0.694 . . . . 0.0 110.948 -178.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.589 ' C ' ' O ' ' A' ' 595' ' ' GLN . 0.8 OUTLIER -0.21 75.9 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 179.422 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 128.84 10.04 3.3 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.365 -1.397 . . . . 0.0 110.973 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.402 ' HB ' ' CG2' ' A' ' 594' ' ' ILE . 1.5 t -82.77 100.67 6.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 O-C-N 120.6 -1.529 . . . . 0.0 107.632 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.2 OUTLIER -144.61 135.88 12.58 Favored Pre-proline 0 C--N 1.282 -2.36 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.69 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 53.3 Cg_endo -90.42 164.46 32.58 Favored 'Cis proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.78 -1.758 . . . . 0.0 108.918 -1.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.523 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 3.3 t80 -103.27 115.93 31.49 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.511 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 44.9 m-85 -81.38 143.6 32.05 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 110.342 -178.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.551 HG12 ' CB ' ' A' ' 611' ' ' CYS . 3.6 mt -142.88 142.12 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.667 -0.646 . . . . 0.0 110.291 -178.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.756 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 169.16 -161.46 35.07 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.778 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -72.61 -35.43 67.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.677 -0.896 . . . . 0.0 111.006 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.0 123.69 29.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.846 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.509 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 7.5 tt0 -53.23 -19.26 2.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.328 -0.857 . . . . 0.0 110.052 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -45.1 -31.11 1.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.367 -0.833 . . . . 0.0 109.043 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 602' ' ' PHE . 1.3 m -69.76 131.44 44.53 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.523 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -44.96 -27.89 0.6 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.34 -0.85 . . . . 0.0 110.027 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.551 ' CB ' HG12 ' A' ' 603' ' ' ILE . 2.0 t -107.27 143.52 35.39 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.509 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -110.46 128.01 55.4 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 119.102 -1.039 . . . . 0.0 112.963 -178.404 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.657 ' HA ' ' CD1' ' A' ' 588' ' ' ILE . 19.8 mt -142.19 107.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.12 103.18 15.82 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.108 -1.437 . . . . 0.0 108.651 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.478 ' HB2' ' HB3' ' A' ' 618' ' ' LEU . 1.1 m-20 -139.55 106.06 5.32 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.602 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -41.13 -57.0 2.19 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.545 -0.722 . . . . 0.0 112.253 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -72.57 -16.85 61.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.169 -0.957 . . . . 0.0 111.975 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -76.23 122.22 24.05 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.025 -1.047 . . . . 0.0 110.71 -179.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 619' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -58.54 159.86 6.04 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.466 -0.772 . . . . 0.0 110.942 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.756 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 14.3 mtt-85 -64.27 -45.2 89.13 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.354 -0.841 . . . . 0.0 109.493 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.461 ' O ' ' C ' ' A' ' 622' ' ' HIS . 11.8 t -95.4 1.7 10.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 121.93 0.871 . . . . 0.0 109.338 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.736 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.8 t60 -27.43 -46.69 0.03 OUTLIER 'General case' 0 C--O 1.195 -1.808 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.594 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.432 ' O ' ' HB ' ' A' ' 603' ' ' ILE . 1.0 OUTLIER -137.92 146.18 42.97 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 117.953 -1.499 . . . . 0.0 112.06 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 2.4 p90 -145.92 145.67 30.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.701 -0.624 . . . . 0.0 109.819 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 625' ' ' ILE . 88.2 mt -103.56 117.56 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 10.1 t80 -110.28 154.2 23.78 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.429 -0.794 . . . . 0.0 109.874 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 13.5 ttmt -120.33 136.84 54.56 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.55 0.69 . . . . 0.0 110.373 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.1 OUTLIER -134.66 164.22 28.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.702 -0.624 . . . . 0.0 109.892 -179.489 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -77.1 121.25 23.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.059 -1.026 . . . . 0.0 108.871 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.52 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 6.0 t60 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.707 0.765 . . . . 0.0 111.05 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.474 ' HB2' ' CA ' ' A' ' 703' ' ' PHE . 5.0 mp . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.9 m-20 -112.2 124.17 51.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.044 -1.035 . . . . 0.0 111.367 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 628' ' ' LYS . 21.1 t0 -105.1 156.46 18.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.555 -0.715 . . . . 0.0 109.584 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.448 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 18.5 pt -110.11 129.95 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.233 -0.917 . . . . 0.0 110.32 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.637 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.0 m95 -118.86 120.34 37.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.75 -0.594 . . . . 0.0 110.968 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.447 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 8.0 t80 -80.61 114.44 19.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.963 . . . . 0.0 108.474 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.0 OUTLIER -105.25 107.4 18.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.342 -0.849 . . . . 0.0 111.322 -178.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.515 ' CE1' ' C ' ' A' ' 656' ' ' VAL . 17.8 t60 -68.44 159.87 30.8 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.429 -0.794 . . . . 0.0 109.961 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.736 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -149.86 -31.02 0.22 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.437 -0.79 . . . . 0.0 112.879 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.537 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.57 -165.13 27.42 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 117.741 -2.171 . . . . 0.0 109.61 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 654' ' ' THR . . . . . 0.412 ' C ' ' H ' ' A' ' 656' ' ' VAL . 15.1 m -98.66 -17.65 18.48 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.976 -1.308 . . . . 0.0 113.552 -176.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 656' ' ' VAL . 18.0 m120 -59.73 -4.43 0.68 Allowed 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.786 -1.196 . . . . 0.0 112.328 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.515 ' C ' ' CE1' ' A' ' 651' ' ' HIS . 0.4 OUTLIER 77.7 166.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-O 121.939 0.876 . . . . 0.0 110.247 -179.539 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.457 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -125.61 141.41 52.04 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.474 -179.035 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -127.91 125.72 40.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.932 . . . . 0.0 110.715 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 661' ' ' ASN . 0.1 OUTLIER -114.67 106.23 13.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.224 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 659' ' ' LEU . 17.2 m120 56.35 -79.25 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.548 -0.72 . . . . 0.0 110.295 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.539 ' N ' ' O ' ' A' ' 659' ' ' LEU . 21.4 t-20 -140.19 20.28 2.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 0.0 110.548 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -110.68 137.06 48.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.165 -0.959 . . . . 0.0 110.437 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -93.76 141.39 28.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.397 -0.814 . . . . 0.0 110.005 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.476 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 90.6 mtp -126.07 -168.19 1.82 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.355 -0.84 . . . . 0.0 110.056 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.413 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 4.1 pt -144.09 -160.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.159 -0.963 . . . . 0.0 110.953 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -76.07 111.09 11.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.745 . . . . 0.0 110.748 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 86.12 48.87 4.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -114.19 146.1 40.81 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.051 -1.264 . . . . 0.0 109.863 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -108.24 138.91 43.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.561 -0.712 . . . . 0.0 109.488 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.506 ' CD1' ' HG ' ' A' ' 659' ' ' LEU . 2.8 t80 -144.64 146.25 32.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 111.329 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.637 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -72.55 147.01 46.35 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.468 -0.77 . . . . 0.0 110.89 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.447 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 10.6 mt -118.07 101.43 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.396 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -84.81 157.19 21.04 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -52.69 148.37 7.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.933 -1.104 . . . . 0.0 109.925 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 67.95 48.52 53.81 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . 0.425 ' HB2' ' CG1' ' A' ' 694' ' ' VAL . 0.3 OUTLIER -108.55 92.43 4.05 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.846 -0.796 . . . . 0.0 110.602 -178.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.878 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.0 OUTLIER -93.85 107.2 19.11 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.449 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.473 HD12 HG21 ' A' ' 678' ' ' ILE . 24.7 pt -111.85 138.07 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.667 -0.646 . . . . 0.0 111.537 -177.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -100.37 111.75 24.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.517 -0.74 . . . . 0.0 109.647 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 65.8 mt -80.01 -29.3 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 0.0 110.249 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.466 HG23 HG12 ' A' ' 690' ' ' ILE . 0.4 OUTLIER -128.61 133.59 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.25 -0.906 . . . . 0.0 109.817 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -138.17 111.75 8.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.467 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.68 117.63 25.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.89 . . . . 0.0 109.667 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -46.98 75.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.326 -0.859 . . . . 0.0 110.834 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -84.89 -43.21 14.3 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 110.776 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -71.51 -9.15 57.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.249 -0.907 . . . . 0.0 110.706 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.34 22.3 6.2 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.105 -0.997 . . . . 0.0 110.344 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.65 104.17 16.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 109.873 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 13.7 m -126.72 140.77 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.397 -0.814 . . . . 0.0 110.829 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.573 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 38.8 mm -117.47 163.6 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.456 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -173.28 123.05 0.96 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.878 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 11.3 m-85 -120.19 137.41 54.2 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.566 -0.961 . . . . 0.0 109.145 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -102.07 113.87 27.5 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.156 -0.965 . . . . 0.0 110.156 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 676' ' ' ASP . 0.9 OUTLIER -84.67 119.3 33.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.036 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -130.06 104.67 7.47 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.372 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 46.3 mt -79.17 103.86 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -0.885 . . . . 0.0 109.6 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.92 -43.07 46.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.363 -0.836 . . . . 0.0 108.805 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 1.2 m-20 -110.53 141.54 43.54 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.442 0.639 . . . . 0.0 110.135 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 21.4 p -114.22 95.94 5.54 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 50.2 m -131.66 133.78 45.26 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.378 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.74 25.86 30.7 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.419 HD12 ' CE1' ' A' ' 577' ' ' PHE . 4.8 tp -105.55 134.75 48.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.389 -1.065 . . . . 0.0 110.438 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 2.9 p90 -52.69 -23.69 7.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.521 -0.737 . . . . 0.0 110.403 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.59 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.424 ' HA ' ' HD2' ' A' ' 714' ' ' ARG . 12.7 mmm-85 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.385 0.612 . . . . 0.0 111.629 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.4 m -107.7 152.58 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.563 -0.711 . . . . 0.0 109.418 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.476 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 44.1 t -92.94 121.15 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.576 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.8 mp -91.44 162.49 14.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.437 -0.789 . . . . 0.0 109.55 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -98.05 153.65 18.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.103 -0.998 . . . . 0.0 110.665 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.47 142.61 27.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.488 -0.757 . . . . 0.0 109.963 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 37.6 p -121.18 -178.36 3.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.317 -0.865 . . . . 0.0 110.575 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.4 -36.3 66.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.459 -0.776 . . . . 0.0 110.244 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -57.54 -52.16 66.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.381 -0.825 . . . . 0.0 109.963 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.456 ' HA ' HD21 ' A' ' 726' ' ' LEU . 74.5 mm-40 -63.54 -46.21 87.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.34 -0.85 . . . . 0.0 109.771 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . 0.424 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 10.1 tttt -62.64 -31.94 72.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.39 -0.819 . . . . 0.0 110.775 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.56 -50.48 71.17 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -0.934 . . . . 0.0 112.051 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.456 HD21 ' HA ' ' A' ' 723' ' ' GLU . 0.4 OUTLIER -72.35 -36.55 68.82 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.825 -1.172 . . . . 0.0 111.269 -178.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . 0.432 HG21 ' CG1' ' A' ' 621' ' ' VAL . 8.3 p -79.4 -18.25 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.868 -1.145 . . . . 0.0 110.416 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -43.21 66.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.176 -0.953 . . . . 0.0 108.814 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.45 103.27 10.28 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 122.211 1.005 . . . . 0.0 109.034 178.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 1.5 mt . . . . . 0 C--N 1.273 -2.727 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.231 -179.801 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.418 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.5 ttm105 . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 121.575 0.702 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.505 ' HA ' ' HB2' ' A' ' 698' ' ' ASP . 0.0 OUTLIER -97.08 -43.24 7.49 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.89 0.852 . . . . 0.0 109.124 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.481 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 7.7 tp -126.68 139.74 52.93 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.188 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 87.2 m -121.83 119.52 31.88 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 8.6 mt -95.56 112.38 24.11 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.1 OUTLIER -110.72 103.46 54.5 Favored Pre-proline 0 C--N 1.301 -1.538 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.732 -177.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.054 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.3 Cg_endo -76.22 140.99 22.76 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 N-CA-C 105.737 -2.447 . . . . 0.0 105.737 174.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.752 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -127.48 -173.14 0.29 Allowed Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 118.187 -1.405 . . . . 0.0 113.338 -176.164 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.752 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 37.9 Cg_endo -64.68 -36.34 42.06 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 124.263 1.665 . . . . 0.0 111.116 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -58.52 -28.87 65.84 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.621 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 47.9 t -96.47 152.76 18.3 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.502 ' CG2' HD13 ' A' ' 588' ' ' ILE . 0.8 OUTLIER -64.56 -11.61 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.904 -1.123 . . . . 0.0 109.205 178.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.688 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 7.9 mm -97.21 117.05 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.484 -0.76 . . . . 0.0 109.401 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.621 ' NE2' ' O ' ' A' ' 586' ' ' SER . 21.1 mp0 -117.55 68.65 0.76 Allowed 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.462 -1.398 . . . . 0.0 109.743 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.054 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 2.6 mm-40 -143.35 175.78 9.66 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.607 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.519 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.97 125.42 35.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.071 -1.018 . . . . 0.0 109.585 176.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.485 ' N ' ' CD2' ' A' ' 592' ' ' LEU . 1.6 mm? -106.8 151.15 25.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 108.963 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.418 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.2 mp0 -124.77 110.27 14.12 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.555 -0.716 . . . . 0.0 110.872 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 4.8 mt -83.78 109.19 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.181 -0.949 . . . . 0.0 109.156 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.617 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.2 OUTLIER -64.97 137.14 57.55 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.735 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.449 ' CA ' ' HB3' ' A' ' 577' ' ' PHE . 2.4 pt20 -44.45 84.37 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.507 -0.746 . . . . 0.0 110.782 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 137.67 3.85 1.99 Allowed Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.647 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.453 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -79.97 101.97 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 120.745 -1.444 . . . . 0.0 107.27 178.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 627' ' ' LYS . 49.0 t-20 -145.47 133.33 10.49 Favored Pre-proline 0 C--N 1.282 -2.367 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.85 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.612 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 51.1 Cg_endo -93.29 163.79 22.61 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 123.258 -1.559 . . . . 0.0 109.127 -2.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.603 ' HB3' ' CG2' ' A' ' 625' ' ' ILE . 3.9 t80 -104.96 116.03 31.28 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.612 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 34.8 m-85 -85.42 144.86 27.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.373 -0.829 . . . . 0.0 110.256 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.489 HG21 ' CD1' ' A' ' 613' ' ' ILE . 4.5 mt -140.52 142.34 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.512 -0.742 . . . . 0.0 110.201 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.772 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 164.96 -163.53 36.48 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.368 -1.396 . . . . 0.0 111.306 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 8.6 tpt180 -62.87 -55.81 22.86 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.78 -0.836 . . . . 0.0 111.772 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.444 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -72.18 126.9 30.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 111.492 -178.283 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.45 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -51.64 -19.25 1.46 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.072 178.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 607' ' ' GLU . 27.1 t0 -42.27 -32.16 0.47 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.484 -0.76 . . . . 0.0 109.01 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.3 m -69.86 129.59 39.95 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.601 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.1 m120 -44.55 -28.12 0.55 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.217 -0.927 . . . . 0.0 109.973 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.495 ' HB2' ' CD2' ' A' ' 601' ' ' PHE . 3.8 t -105.21 143.57 33.2 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.45 ' HD2' ' CB ' ' A' ' 607' ' ' GLU . 1.1 ttpm? -106.53 128.35 54.04 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.059 -1.057 . . . . 0.0 113.467 -178.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.688 ' HA ' ' CD1' ' A' ' 588' ' ' ILE . 24.2 mt -143.29 107.71 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.465 ' H ' ' CD1' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -97.86 104.73 16.78 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.238 -1.385 . . . . 0.0 109.306 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 1.3 m-20 -138.3 106.42 5.73 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.173 177.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . 0.417 ' HA ' ' NH1' ' A' ' 605' ' ' ARG . 1.4 m120 -41.12 -41.56 1.79 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.669 -0.644 . . . . 0.0 111.932 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.61 -21.61 32.49 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.093 -1.004 . . . . 0.0 111.272 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -73.84 131.96 42.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.191 -0.943 . . . . 0.0 110.702 -179.531 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 619' ' ' SER . . . . . 0.429 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -68.09 158.39 33.12 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.356 -0.84 . . . . 0.0 110.725 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.772 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 15.2 ttp180 -62.24 -45.24 94.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.225 -0.922 . . . . 0.0 109.211 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 622' ' ' HIS . 4.4 t -95.28 2.08 9.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.75 0.786 . . . . 0.0 109.593 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.75 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.0 t60 -29.63 -42.91 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.854 -178.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.9 OUTLIER -137.19 144.8 43.06 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 117.789 -1.564 . . . . 0.0 111.429 179.114 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.623 ' CE2' ' HB3' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -147.57 126.58 12.83 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.62 -0.675 . . . . 0.0 109.533 178.222 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.603 ' CG2' ' HB3' ' A' ' 601' ' ' PHE . 2.4 tt -104.08 118.16 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.362 -0.836 . . . . 0.0 108.869 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.623 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 17.5 p90 -122.83 155.2 37.08 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.758 0.789 . . . . 0.0 110.715 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 5.3 ttmt -99.55 136.68 39.13 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.939 0.876 . . . . 0.0 110.891 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.7 OUTLIER -131.11 163.09 28.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.648 -0.658 . . . . 0.0 109.934 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 6.6 tpt180 -78.0 115.06 17.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.041 -1.037 . . . . 0.0 109.257 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 703' ' ' PHE . 6.6 t60 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.528 0.68 . . . . 0.0 110.866 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 703' ' ' PHE . 1.1 mp . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.3 OUTLIER -120.85 123.85 43.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.126 -0.984 . . . . 0.0 110.813 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.484 ' O ' ' CD1' ' A' ' 648' ' ' TRP . 10.3 t0 -101.93 132.2 47.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.417 -0.802 . . . . 0.0 109.211 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 6.4 pt -80.97 129.3 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.114 -0.992 . . . . 0.0 109.972 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.515 ' CZ3' HD21 ' A' ' 671' ' ' LEU . 87.8 m95 -116.15 122.56 45.43 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.526 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.472 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 6.8 t80 -82.05 113.12 19.71 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.1 OUTLIER -107.41 102.87 12.12 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.284 -0.967 . . . . 0.0 111.127 -178.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.504 ' CE1' ' C ' ' A' ' 656' ' ' VAL . 11.1 t60 -61.71 154.93 24.04 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.408 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.75 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -146.14 -25.22 0.44 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.568 ' N ' ' HA ' ' A' ' 622' ' ' HIS . . . -77.94 -171.12 36.94 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 117.992 -2.052 . . . . 0.0 109.119 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 27.1 m -95.56 -16.52 22.08 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.013 -1.287 . . . . 0.0 113.285 -176.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 656' ' ' VAL . 3.0 t-20 -62.33 -4.47 1.84 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.007 -1.058 . . . . 0.0 112.596 -178.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.504 ' C ' ' CE1' ' A' ' 651' ' ' HIS . 0.4 OUTLIER 78.62 166.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 CA-C-O 121.987 0.898 . . . . 0.0 110.464 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.443 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -124.99 152.13 44.61 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.435 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -138.34 126.91 23.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.252 -0.905 . . . . 0.0 110.437 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.506 ' CD2' ' CD1' ' A' ' 670' ' ' PHE . 43.5 tp -128.5 114.16 16.42 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 110.027 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 41.9 t30 56.43 -80.93 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.615 -0.678 . . . . 0.0 110.349 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 659' ' ' LEU . 46.1 p-10 -142.52 11.62 1.9 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.042 -1.037 . . . . 0.0 110.767 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -105.5 133.5 50.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.98 -1.075 . . . . 0.0 110.798 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -93.11 142.14 27.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.48 -0.762 . . . . 0.0 109.802 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.412 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 4.4 mtp -121.03 -166.88 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -0.954 . . . . 0.0 110.617 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.419 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 2.7 pt -141.27 -164.26 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.443 -0.786 . . . . 0.0 110.19 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -78.32 86.73 4.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.34 -0.85 . . . . 0.0 110.62 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.74 52.61 0.43 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.2 OUTLIER -119.32 147.19 44.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.226 -1.161 . . . . 0.0 110.009 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.471 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 1.7 tttt -108.76 148.13 30.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.739 . . . . 0.0 109.361 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.506 ' CD1' ' CD2' ' A' ' 659' ' ' LEU . 1.2 t80 -145.72 147.44 31.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.139 -0.975 . . . . 0.0 111.901 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.515 HD21 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.48 132.82 47.64 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.405 -0.809 . . . . 0.0 109.647 179.19 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.472 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 2.7 mt -113.22 104.91 12.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.022 -1.049 . . . . 0.0 111.106 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 53.5 mm-40 -90.79 -177.1 4.88 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -76.28 144.11 40.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.12 . . . . 0.0 109.761 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 69.41 48.35 45.32 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.24 99.4 7.19 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.808 -0.819 . . . . 0.0 109.995 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.89 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.85 113.4 25.42 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.427 ' CG1' ' CD1' ' A' ' 659' ' ' LEU . 1.5 mp -104.82 137.43 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.582 -0.699 . . . . 0.0 111.594 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -99.25 117.14 33.05 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 680' ' ' ILE . 79.9 mt -87.7 -27.92 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.221 -0.924 . . . . 0.0 111.145 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 618' ' ' LEU . 1.5 mt -143.23 133.43 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 0.0 111.078 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 14.0 t90 -138.2 109.0 6.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.629 -0.669 . . . . 0.0 109.568 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.15 117.92 28.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.085 -1.009 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -66.63 -29.8 69.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.418 -0.801 . . . . 0.0 110.775 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -43.32 76.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.34 -0.85 . . . . 0.0 110.924 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 688' ' ' PHE . 10.9 t-20 -139.37 34.61 2.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.242 -0.912 . . . . 0.0 110.072 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . 0.49 ' O ' ' C ' ' A' ' 688' ' ' PHE . 0.0 OUTLIER 66.26 -67.02 0.16 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.705 -0.622 . . . . 0.0 109.703 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.2 OUTLIER 30.76 56.85 0.22 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.34 0.591 . . . . 0.0 111.11 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 586' ' ' SER . 41.6 t -101.67 141.52 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.43 -0.794 . . . . 0.0 110.714 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.441 ' CD1' ' CG2' ' A' ' 587' ' ' ILE . 47.9 mm -118.21 163.94 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.49 -0.756 . . . . 0.0 109.207 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.446 ' N ' ' OG ' ' A' ' 586' ' ' SER . . . -177.26 126.92 1.14 Allowed Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.19 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.89 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 12.9 m-85 -120.14 137.87 53.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.668 -0.901 . . . . 0.0 108.776 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.99 114.3 26.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.11 -0.994 . . . . 0.0 110.387 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 675' ' ' GLY . 0.9 OUTLIER -85.37 120.31 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.523 -0.736 . . . . 0.0 109.37 179.56 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -126.59 114.6 18.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.672 -0.642 . . . . 0.0 110.209 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.424 HD12 HG21 ' A' ' 696' ' ' ILE . 88.5 mt -92.1 104.55 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.353 -0.842 . . . . 0.0 110.19 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.45 -43.73 18.46 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.505 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 4.2 m-20 -110.58 143.59 40.75 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.346 0.593 . . . . 0.0 109.929 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 39.7 p -112.51 95.71 5.59 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 11.1 p -135.01 133.15 39.13 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.844 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 62.67 28.85 72.21 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.451 ' CD2' ' CE1' ' A' ' 577' ' ' PHE . 0.3 OUTLIER -111.4 129.85 55.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.426 -1.043 . . . . 0.0 110.099 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.537 ' CZ ' ' CG ' ' A' ' 704' ' ' ASN . 10.5 p90 -49.09 -24.58 1.67 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.434 -0.791 . . . . 0.0 110.403 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.537 ' CG ' ' CZ ' ' A' ' 703' ' ' PHE . 35.5 p-10 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.817 0.818 . . . . 0.0 110.347 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 670' ' ' PHE . 9.7 mmm180 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.383 0.611 . . . . 0.0 111.778 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 34.2 m -107.94 159.72 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.457 -0.777 . . . . 0.0 109.528 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.442 ' CG2' ' CE2' ' A' ' 670' ' ' PHE . 47.6 t -104.24 133.47 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.116 -0.99 . . . . 0.0 110.856 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.57 162.99 13.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.551 -0.718 . . . . 0.0 109.655 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -103.82 143.32 32.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.196 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -85.98 154.37 21.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.354 -0.841 . . . . 0.0 110.385 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 15.9 p -115.95 -176.63 2.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 0.0 110.426 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.58 -32.41 50.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.422 -0.799 . . . . 0.0 110.296 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -60.66 -52.25 65.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.337 -0.852 . . . . 0.0 109.772 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.484 ' O ' ' HG ' ' A' ' 726' ' ' LEU . 5.6 mt-10 -64.68 -37.98 89.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.499 -0.751 . . . . 0.0 109.755 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -32.38 73.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.333 -0.854 . . . . 0.0 110.58 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.46 -50.91 49.02 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.245 -0.909 . . . . 0.0 111.766 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.503 ' CD1' ' CE2' ' A' ' 624' ' ' PHE . 0.6 OUTLIER -62.22 -42.22 99.11 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.949 -1.094 . . . . 0.0 110.935 -179.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . 0.419 ' CG2' ' CG1' ' A' ' 621' ' ' VAL . 7.2 p -76.67 -17.04 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.877 -1.14 . . . . 0.0 110.349 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -53.67 -43.32 68.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.202 -0.936 . . . . 0.0 108.856 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -116.52 103.78 10.76 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.249 1.024 . . . . 0.0 109.021 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.438 ' HA ' ' CE2' ' A' ' 602' ' ' PHE . 1.3 mt . . . . . 0 C--N 1.273 -2.743 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.362 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 121.499 0.666 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.557 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 0.8 OUTLIER -91.35 -40.92 11.19 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.76 0.79 . . . . 0.0 109.216 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.523 ' HB2' ' CD2' ' A' ' 577' ' ' PHE . 3.5 tt -135.63 142.76 45.26 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.597 0.713 . . . . 0.0 111.561 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 95.6 m -118.53 123.65 45.6 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.4 HD12 ' CD1' ' A' ' 594' ' ' ILE . 9.6 mt -93.16 112.41 24.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.438 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 2.9 mmtt -113.77 102.34 54.71 Favored Pre-proline 0 C--N 1.302 -1.497 0 C-N-CA 118.223 -1.391 . . . . 0.0 112.835 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.082 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.5 Cg_endo -81.15 141.1 12.76 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 N-CA-C 105.808 -2.42 . . . . 0.0 105.808 174.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.753 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -120.29 -174.86 0.31 Allowed Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 118.128 -1.429 . . . . 0.0 113.512 -176.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.753 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 37.7 Cg_endo -63.86 -36.23 51.67 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 124.269 1.668 . . . . 0.0 111.657 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.63 -27.32 64.62 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 33.0 t -96.04 148.48 22.62 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.541 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.488 ' HB ' HD13 ' A' ' 690' ' ' ILE . 0.8 OUTLIER -56.68 -18.71 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.991 -1.068 . . . . 0.0 109.178 178.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.738 HG12 ' HA ' ' A' ' 613' ' ' ILE . 4.1 mp -94.72 116.38 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.458 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -120.67 67.2 0.85 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.545 -1.347 . . . . 0.0 108.864 -179.493 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.082 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 15.5 tp10 -145.0 175.14 10.45 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.243 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.497 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.19 124.24 38.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.085 -1.009 . . . . 0.0 109.447 176.626 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 611' ' ' CYS . 1.1 mt -103.04 155.72 18.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.455 -0.778 . . . . 0.0 109.173 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -125.25 110.3 13.88 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.393 -0.817 . . . . 0.0 111.177 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.471 HG22 HG11 ' A' ' 598' ' ' VAL . 26.4 mt -80.08 108.31 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.4 OUTLIER -68.0 116.73 8.97 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.437 -0.79 . . . . 0.0 111.106 -178.29 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.557 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.1 OUTLIER 38.57 32.41 0.05 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.255 0.55 . . . . 0.0 111.188 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.422 ' HA2' ' CG2' ' A' ' 594' ' ' ILE . . . 83.73 63.7 1.67 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.471 HG11 HG22 ' A' ' 594' ' ' ILE . 9.8 p -79.47 105.15 8.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 O-C-N 121.039 -1.271 . . . . 0.0 107.583 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.414 ' CB ' ' HB3' ' A' ' 627' ' ' LYS . 3.9 p-10 -121.79 151.13 57.07 Favored Pre-proline 0 C--N 1.279 -2.466 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.649 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.463 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.7 Cg_endo -86.24 156.8 54.58 Favored 'Cis proline' 0 C--N 1.307 -1.618 0 C-N-CA 120.933 -2.528 . . . . 0.0 109.475 0.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.507 ' CD2' ' HB2' ' A' ' 611' ' ' CYS . 4.8 t80 -105.66 115.39 30.16 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.533 ' O ' ' HB3' ' A' ' 609' ' ' CYS . 50.2 m-85 -86.14 143.68 27.89 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.431 -178.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.555 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 4.1 mt -140.68 141.75 31.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.894 -0.504 . . . . 0.0 110.013 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.777 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 165.42 -162.3 35.66 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.361 -1.399 . . . . 0.0 111.13 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.433 ' N ' HD23 ' A' ' 618' ' ' LEU . 5.9 mmm-85 -61.26 -58.48 8.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.89 -0.771 . . . . 0.0 111.804 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.03 124.27 22.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 111.251 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.533 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 11.8 pt-20 -54.16 -16.98 2.35 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.922 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -44.88 -36.44 3.31 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.37 -0.831 . . . . 0.0 109.074 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 602' ' ' PHE . 1.3 m -59.63 136.63 58.05 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.479 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -47.42 -26.77 1.43 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.209 -0.932 . . . . 0.0 109.414 179.165 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.555 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 3.0 t -109.48 143.02 39.66 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.533 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -103.1 126.62 50.36 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.497 -0.881 . . . . 0.0 112.447 -178.559 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.738 ' HA ' HG12 ' A' ' 588' ' ' ILE . 5.3 mt -143.19 109.64 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.401 ' O ' ' CG2' ' A' ' 587' ' ' ILE . 2.1 tp10 -97.26 103.04 14.94 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 117.99 -1.484 . . . . 0.0 108.357 178.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 618' ' ' LEU . 4.3 m-20 -137.7 105.73 5.69 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.417 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -42.36 -51.66 4.81 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.599 -0.688 . . . . 0.0 112.181 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -74.77 -16.7 60.71 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.182 -0.949 . . . . 0.0 111.602 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.532 ' CD2' ' HA2' ' A' ' 604' ' ' GLY . 0.5 OUTLIER -80.23 143.58 33.62 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.155 -0.965 . . . . 0.0 111.071 -179.062 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 619' ' ' SER . . . . . 0.434 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -79.85 162.88 24.79 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.414 -0.803 . . . . 0.0 110.681 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.777 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.4 mpt_? -64.32 -46.76 82.11 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.145 -0.972 . . . . 0.0 109.936 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.466 ' O ' ' C ' ' A' ' 622' ' ' HIS . 5.2 m -95.75 2.14 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.235 -0.916 . . . . 0.0 109.42 178.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.725 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.2 t60 -25.28 -47.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.409 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.444 ' O ' ' HB ' ' A' ' 603' ' ' ILE . 1.0 OUTLIER -136.82 146.41 45.63 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 118.206 -1.397 . . . . 0.0 111.497 179.523 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.542 ' HA ' HG13 ' A' ' 603' ' ' ILE . 3.6 p90 -145.82 146.58 31.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.622 -0.674 . . . . 0.0 110.073 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 19.8 mt -103.55 117.46 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.444 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 10.9 t80 -111.78 154.61 24.8 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 109.956 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 2.8 ttmt -120.3 136.6 54.63 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 121.556 0.694 . . . . 0.0 110.434 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.444 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.53 164.81 26.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.648 -0.658 . . . . 0.0 109.949 -179.589 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.1 OUTLIER -77.12 115.01 16.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 109.03 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.527 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.8 t-160 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.585 -0.697 . . . . 0.0 110.998 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 5.0 mp . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.3 OUTLIER -118.0 124.26 47.74 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.975 -1.078 . . . . 0.0 111.412 -179.426 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.429 ' HB2' ' ND1' ' A' ' 630' ' ' HIS . 28.7 t0 -111.18 155.65 22.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.443 -0.786 . . . . 0.0 109.92 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 21.8 pt -108.81 128.79 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.21 -0.931 . . . . 0.0 109.748 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.506 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 95.6 m95 -115.48 119.95 37.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.678 -0.639 . . . . 0.0 111.595 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.522 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 11.5 t80 -83.31 114.13 21.19 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.0 OUTLIER -108.86 103.28 12.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.154 -0.966 . . . . 0.0 111.353 -178.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.53 ' CD2' ' N ' ' A' ' 652' ' ' THR . 8.9 t60 -63.04 156.75 23.87 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.513 -0.742 . . . . 0.0 109.895 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.725 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -148.19 -29.11 0.31 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.395 -0.816 . . . . 0.0 112.875 -179.206 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.531 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.85 -163.66 25.15 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 117.864 -2.112 . . . . 0.0 109.473 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 654' ' ' THR . . . . . 0.407 ' C ' ' H ' ' A' ' 656' ' ' VAL . 19.3 m -99.3 -17.84 17.86 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.02 -1.282 . . . . 0.0 113.709 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.445 ' O ' ' CB ' ' A' ' 656' ' ' VAL . 8.7 m120 -59.16 -3.77 0.43 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 120.667 -1.27 . . . . 0.0 112.492 -178.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.464 ' C ' ' CE1' ' A' ' 651' ' ' HIS . 2.9 t 71.52 147.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.626 -0.671 . . . . 0.0 110.207 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.437 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -102.74 141.64 35.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.517 -0.739 . . . . 0.0 111.145 -178.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.414 ' CE1' ' HG2' ' A' ' 663' ' ' ARG . 95.3 m-85 -129.46 126.61 39.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.552 -0.718 . . . . 0.0 109.724 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.546 HD21 ' CD1' ' A' ' 670' ' ' PHE . 31.3 tp -130.85 111.83 12.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.222 -0.924 . . . . 0.0 110.107 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 56.31 -82.2 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.565 -0.709 . . . . 0.0 110.167 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 659' ' ' LEU . 17.1 m-80 -141.89 17.77 2.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 110.131 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . 0.421 ' HB3' ' CE2' ' A' ' 670' ' ' PHE . 0.8 OUTLIER -109.45 127.12 54.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.494 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . 0.414 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 0.0 OUTLIER -93.22 141.15 28.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.417 -0.802 . . . . 0.0 109.794 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.433 ' CB ' ' OG ' ' A' ' 657' ' ' SER . 3.0 mtp -122.79 -167.65 1.62 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.372 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.404 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 3.0 pt -139.82 -160.96 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.399 -0.813 . . . . 0.0 110.239 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -79.76 95.51 6.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.283 -0.886 . . . . 0.0 110.668 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 104.31 51.6 0.92 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -118.18 145.36 45.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.103 -1.233 . . . . 0.0 109.993 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.77 141.62 39.05 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.546 ' CD1' HD21 ' A' ' 659' ' ' LEU . 3.7 t80 -145.36 148.21 33.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.106 -0.996 . . . . 0.0 112.299 -177.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.506 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.53 130.91 44.24 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.443 -0.786 . . . . 0.0 109.893 179.514 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.522 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 4.3 mt -107.44 105.01 14.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.907 -1.121 . . . . 0.0 111.226 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -87.51 165.36 15.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.476 -0.765 . . . . 0.0 109.052 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -62.74 157.42 21.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.127 -0.983 . . . . 0.0 109.923 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 59.88 51.52 58.46 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 107.765 -2.134 . . . . 0.0 107.765 -178.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.09 96.34 5.76 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.786 -0.832 . . . . 0.0 110.868 -178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.886 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.6 tt0 -94.46 107.98 19.93 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.432 ' CG2' ' CD1' ' A' ' 659' ' ' LEU . 35.5 pt -107.59 138.38 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.598 -0.689 . . . . 0.0 112.331 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -100.06 112.79 25.09 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.418 HD13 ' CD1' ' A' ' 613' ' ' ILE . 56.8 mt -81.63 -33.81 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.26 -0.9 . . . . 0.0 111.504 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.463 HG22 HG12 ' A' ' 690' ' ' ILE . 14.1 tt -133.85 136.15 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.938 -1.101 . . . . 0.0 110.213 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -137.59 116.48 12.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.316 -0.865 . . . . 0.0 110.462 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -127.94 117.6 22.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.84 -30.19 70.3 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.466 -0.771 . . . . 0.0 111.015 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -55.65 -43.45 76.28 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.301 -0.874 . . . . 0.0 110.872 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 687' ' ' LYS . 6.9 m-80 -136.62 32.35 2.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 110.002 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 688' ' ' PHE . 5.8 mttm 64.21 -67.0 0.11 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.915 -0.49 . . . . 0.0 110.09 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.478 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.1 OUTLIER 33.42 55.48 0.5 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.3 0.571 . . . . 0.0 110.965 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.3 142.19 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.414 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.542 ' CD1' HD11 ' A' ' 588' ' ' ILE . 31.2 mm -117.83 164.2 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.473 -0.767 . . . . 0.0 109.333 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -170.96 124.71 1.14 Allowed Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.058 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.886 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 14.3 m-85 -119.19 137.25 53.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.625 -0.926 . . . . 0.0 108.654 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -101.13 113.95 27.46 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 110.753 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 675' ' ' GLY . 0.8 OUTLIER -83.84 121.51 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -129.26 105.81 8.4 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.623 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 577' ' ' PHE . 82.1 mt -85.73 105.95 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.449 -0.782 . . . . 0.0 109.614 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.28 -44.13 13.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.428 -0.795 . . . . 0.0 108.889 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.432 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 9.9 m-20 -111.26 142.35 43.59 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.401 0.62 . . . . 0.0 110.229 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 699' ' ' THR . 2.0 p -114.19 96.15 5.65 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 7.2 t -86.26 95.96 9.79 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.334 0.588 . . . . 0.0 111.216 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 47.43 36.77 11.69 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.404 HD11 ' CE1' ' A' ' 577' ' ' PHE . 1.7 tp -84.41 149.96 25.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.392 -1.063 . . . . 0.0 110.336 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 2.5 p90 -53.5 -23.2 9.67 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.384 -0.823 . . . . 0.0 109.939 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.552 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.8 t30 . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 714' ' ' ARG . 5.2 mmm-85 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.368 0.604 . . . . 0.0 111.354 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.77 151.75 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.475 -0.765 . . . . 0.0 109.279 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.422 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 61.6 t -92.3 118.58 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 110.512 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.3 mp -90.22 161.8 15.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.546 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.12 153.99 17.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -0.93 . . . . 0.0 110.244 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -79.93 145.8 32.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.472 -0.768 . . . . 0.0 110.181 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 20.3 p -121.13 -176.89 3.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.309 -0.87 . . . . 0.0 110.362 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.7 67.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.376 -0.827 . . . . 0.0 110.456 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.32 -52.46 64.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.352 -0.842 . . . . 0.0 110.001 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.8 -42.47 85.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -0.873 . . . . 0.0 109.929 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . 0.413 ' O ' ' CG1' ' A' ' 727' ' ' VAL . 12.2 ttmm -56.69 -32.83 65.84 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.319 -0.863 . . . . 0.0 109.756 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.8 -36.21 77.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.399 -0.813 . . . . 0.0 110.09 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 33.4 mt -58.18 -46.63 85.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.404 -0.81 . . . . 0.0 110.446 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . 0.413 ' CG1' ' O ' ' A' ' 724' ' ' LYS . 7.9 p -69.88 -19.57 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.065 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -54.44 -48.49 71.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -0.894 . . . . 0.0 108.79 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.81 104.98 11.88 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 122.229 1.014 . . . . 0.0 108.923 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.427 HD22 ' CG ' ' A' ' 602' ' ' PHE . 0.7 OUTLIER . . . . . 0 C--N 1.275 -2.657 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.377 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.483 1.206 0 CA-C-O 121.62 0.724 . . . . 0.0 109.253 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.545 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 3.7 t80 -123.56 -41.47 2.27 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 122.074 0.94 . . . . 0.0 109.215 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 594' ' ' ILE . 22.1 tp -123.83 140.76 52.67 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.285 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 88.1 m -123.51 116.98 24.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.705 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.436 ' N ' ' CD2' ' A' ' 580' ' ' LEU . 1.9 mm? -90.37 111.74 23.08 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.416 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 2.5 mmtt -112.89 101.26 52.91 Favored Pre-proline 0 C--N 1.299 -1.594 0 C-N-CA 117.987 -1.485 . . . . 0.0 112.657 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.119 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.1 Cg_endo -80.87 140.72 12.95 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 N-CA-C 105.428 -2.566 . . . . 0.0 105.428 174.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.718 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -118.86 -176.95 0.41 Allowed Pre-proline 0 N--CA 1.495 1.793 0 C-N-CA 118.177 -1.409 . . . . 0.0 113.567 -176.232 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.718 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.3 Cg_endo -66.56 -31.3 41.63 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 O-C-N 124.342 1.706 . . . . 0.0 111.83 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -59.0 -29.89 67.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.798 -1.189 . . . . 0.0 108.124 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.541 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 54.4 p -96.44 153.29 17.91 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.914 -0.491 . . . . 0.0 109.724 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.527 ' CG2' HD11 ' A' ' 588' ' ' ILE . 0.1 OUTLIER -57.0 -18.95 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.16 -0.963 . . . . 0.0 109.101 178.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.647 HD12 ' HA ' ' A' ' 613' ' ' ILE . 10.0 mm -95.96 115.38 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.474 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -124.47 71.37 1.14 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 120.601 -1.312 . . . . 0.0 110.099 -178.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.119 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 18.9 mt-10 -145.12 174.97 10.6 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.579 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.495 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.79 127.23 41.57 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.841 -1.162 . . . . 0.0 109.393 176.483 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 1.2 mp -111.39 155.73 22.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 109.747 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -124.96 110.41 14.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.481 -0.762 . . . . 0.0 111.406 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.476 HG23 ' HB ' ' A' ' 598' ' ' VAL . 3.0 mt -80.85 110.49 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.7 OUTLIER -51.48 172.83 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.634 -0.666 . . . . 0.0 110.052 -179.815 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.545 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 5.6 mt-30 -64.36 66.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.476 -0.765 . . . . 0.0 110.555 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 128.72 30.65 0.69 Allowed Glycine 0 N--CA 1.486 2.01 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.806 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.476 ' HB ' HG23 ' A' ' 594' ' ' ILE . 0.9 OUTLIER -81.34 102.81 7.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.486 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 11.8 t-20 -143.3 134.54 12.66 Favored Pre-proline 0 C--N 1.284 -2.265 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.89 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.624 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 55.9 Cg_endo -91.48 162.52 28.47 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.958 -1.684 . . . . 0.0 109.192 -1.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.53 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 3.8 t80 -106.25 116.35 31.79 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.624 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 73.0 m-85 -86.47 144.08 27.44 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.269 -0.894 . . . . 0.0 110.538 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.578 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 3.0 mt -141.64 141.46 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.73 -0.606 . . . . 0.0 110.148 -178.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.754 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 163.94 -163.09 35.67 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.45 -1.357 . . . . 0.0 111.12 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.418 ' N ' HD23 ' A' ' 618' ' ' LEU . 1.1 mmm-85 -62.46 -53.11 59.73 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.832 -0.805 . . . . 0.0 111.491 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 3.1 p -68.22 121.14 15.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 111.04 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.6 mt-10 -54.2 -17.4 2.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.641 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -47.36 -30.23 3.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.426 -0.796 . . . . 0.0 109.032 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 602' ' ' PHE . 1.6 m -65.88 130.48 43.42 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.53 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -43.97 -29.57 0.6 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.381 -0.824 . . . . 0.0 109.524 179.433 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.578 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 2.3 t -106.01 143.37 34.24 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.511 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -108.52 128.59 54.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.079 -1.013 . . . . 0.0 113.093 -178.144 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.647 ' HA ' HD12 ' A' ' 588' ' ' ILE . 8.8 mt -142.21 108.87 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -98.33 104.07 16.08 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.221 -1.392 . . . . 0.0 109.517 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.577 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 0.2 OUTLIER -138.78 106.69 5.67 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.165 177.181 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -39.25 -43.79 1.17 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.65 -0.656 . . . . 0.0 112.123 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.01 -17.71 39.53 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.118 -0.988 . . . . 0.0 111.847 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -75.47 131.37 40.09 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.103 -0.998 . . . . 0.0 110.882 -179.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 619' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 622' ' ' HIS . 10.0 t -65.34 159.08 24.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.335 -0.853 . . . . 0.0 110.837 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.754 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.9 mpp_? -64.76 -45.3 86.99 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.181 -0.949 . . . . 0.0 109.518 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.486 ' O ' ' C ' ' A' ' 622' ' ' HIS . 17.3 t -95.35 2.06 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 121.739 0.78 . . . . 0.0 109.721 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.734 ' O ' ' N ' ' A' ' 652' ' ' THR . 6.1 t60 -24.55 -46.82 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.542 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.444 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.8 OUTLIER -138.19 146.1 42.29 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 118.283 -1.367 . . . . 0.0 112.038 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.551 ' HA ' HG13 ' A' ' 603' ' ' ILE . 1.9 p90 -146.13 144.25 29.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.454 -0.779 . . . . 0.0 109.981 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 26.8 mt -102.66 123.1 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.423 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 2.3 t80 -118.26 154.33 32.44 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.351 -0.843 . . . . 0.0 109.516 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 9.0 tttt -120.46 136.27 54.8 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.657 0.741 . . . . 0.0 110.786 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.423 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -126.35 163.66 22.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.715 -0.615 . . . . 0.0 109.676 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.474 ' C ' ' CD ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -78.67 123.1 26.79 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.157 -0.964 . . . . 0.0 108.894 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.3 t-160 . . . . . 0 N--CA 1.486 1.328 0 O-C-N 121.331 -0.856 . . . . 0.0 110.538 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.639 ' HG ' ' HA ' ' A' ' 703' ' ' PHE . 3.4 mm? . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.9 m-20 -130.41 133.24 46.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.906 -1.122 . . . . 0.0 111.148 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.438 ' CG ' ' HE1' ' A' ' 648' ' ' TRP . 3.2 p30 -115.59 152.73 32.53 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.404 -0.81 . . . . 0.0 110.954 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 6.2 pt -111.2 130.89 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.264 -0.897 . . . . 0.0 109.868 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.552 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 94.2 m95 -119.04 140.06 50.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.611 -0.681 . . . . 0.0 110.89 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.443 ' HB3' HD11 ' A' ' 672' ' ' LEU . 4.3 t80 -97.97 114.34 26.43 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.547 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 24.8 t -104.22 102.32 12.03 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.23 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.544 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 24.9 t60 -67.59 164.68 18.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.443 -0.786 . . . . 0.0 109.543 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.734 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -155.28 -31.31 0.1 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.213 -0.93 . . . . 0.0 113.257 -178.83 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.558 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.25 132.88 11.83 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 117.937 -2.077 . . . . 0.0 110.427 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 654' ' ' THR . . . . . 0.433 ' C ' ' H ' ' A' ' 656' ' ' VAL . 23.8 m -37.71 -24.46 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -177.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 656' ' ' VAL . 7.9 m120 -57.7 -4.72 0.3 Allowed 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.266 -1.521 . . . . 0.0 112.407 -178.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.495 ' O ' ' CE1' ' A' ' 651' ' ' HIS . 0.4 OUTLIER 76.77 168.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 CA-C-O 121.83 0.824 . . . . 0.0 110.256 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.502 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -127.5 154.76 44.73 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.601 -179.01 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -137.92 126.36 23.37 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.163 -0.96 . . . . 0.0 110.83 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.49 ' CD2' ' CD2' ' A' ' 670' ' ' PHE . 22.2 tp -122.05 107.32 12.07 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.391 -0.818 . . . . 0.0 109.84 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.3 t30 63.2 -73.45 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.545 -0.722 . . . . 0.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 659' ' ' LEU . 37.1 m-20 -153.9 22.51 0.51 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.348 -0.845 . . . . 0.0 110.389 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.38 116.86 28.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.149 -0.969 . . . . 0.0 110.37 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -80.54 139.67 36.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.421 -0.8 . . . . 0.0 109.908 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.474 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 37.7 mtp -118.2 -161.74 0.85 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.869 . . . . 0.0 110.094 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.403 ' CG1' ' CG2' ' A' ' 668' ' ' THR . 3.7 pt -133.02 -160.87 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 109.725 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -81.39 117.33 21.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.343 -0.848 . . . . 0.0 110.26 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 82.49 50.73 4.63 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -115.27 146.34 41.58 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.109 -1.23 . . . . 0.0 110.111 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.408 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 2.7 ttpt -108.77 141.99 39.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.524 -0.735 . . . . 0.0 109.853 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.49 ' CD2' ' CD2' ' A' ' 659' ' ' LEU . 0.4 OUTLIER -144.61 141.0 29.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 110.898 -179.067 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.552 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -70.05 146.35 51.05 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.285 -0.885 . . . . 0.0 110.682 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 649' ' ' TYR . 3.9 mp -111.45 149.05 31.83 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.924 0.868 . . . . 0.0 111.632 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . 0.467 ' O ' ' C ' ' A' ' 674' ' ' ASP . 15.3 mt-30 -127.0 136.59 52.45 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 673' ' ' GLN . 0.0 OUTLIER -37.93 129.22 1.21 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.967 -1.083 . . . . 0.0 110.276 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 83.88 44.05 6.93 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.97 90.48 4.19 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.948 -0.737 . . . . 0.0 110.463 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.805 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.8 tt0 -94.21 107.74 19.65 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.451 ' CG2' ' CD1' ' A' ' 659' ' ' LEU . 41.5 pt -113.06 138.5 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.49 -0.757 . . . . 0.0 111.829 -178.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 15.9 mttp -94.47 110.53 22.32 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.45 ' CG2' ' CD2' ' A' ' 622' ' ' HIS . 69.9 mt -73.88 -30.95 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.348 -0.845 . . . . 0.0 110.801 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 618' ' ' LEU . 6.0 mt -143.0 137.38 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.018 -1.051 . . . . 0.0 110.876 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 6.6 t90 -137.93 108.98 6.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.559 -0.713 . . . . 0.0 109.795 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -114.34 118.12 32.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.096 -1.003 . . . . 0.0 110.598 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -66.52 -30.01 70.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.495 -0.753 . . . . 0.0 110.806 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -55.88 -43.71 77.44 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.397 -0.815 . . . . 0.0 111.078 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 688' ' ' PHE . 2.1 m-20 -141.26 34.96 1.69 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.92 . . . . 0.0 110.066 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . 0.477 ' O ' ' C ' ' A' ' 688' ' ' PHE . 0.2 OUTLIER 66.54 -67.71 0.15 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.737 -0.602 . . . . 0.0 110.003 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.477 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.5 OUTLIER 33.69 59.92 0.52 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.684 -0.635 . . . . 0.0 110.7 179.718 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 586' ' ' SER . 34.2 m -102.06 142.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 111.352 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.541 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 43.1 mm -113.43 163.56 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.465 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -173.31 118.71 0.72 Allowed Glycine 0 N--CA 1.491 2.314 0 C-N-CA 118.948 -1.596 . . . . 0.0 110.618 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.805 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 13.7 m-85 -120.5 138.02 54.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.613 -0.934 . . . . 0.0 108.784 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -108.64 114.52 28.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 0.0 110.763 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 1.2 t -76.52 119.68 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.382 -0.824 . . . . 0.0 108.924 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.71 104.61 7.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.672 -0.642 . . . . 0.0 110.023 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 62.5 mt -86.68 107.7 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 109.714 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -78.3 -41.14 34.69 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.405 -0.81 . . . . 0.0 109.077 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.443 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.3 m-20 -110.81 140.86 44.87 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.579 0.704 . . . . 0.0 110.682 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 14.5 p -115.16 96.0 5.47 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 22.2 m -113.58 129.64 56.52 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.853 -0.53 . . . . 0.0 110.797 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 50.76 37.9 35.73 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.418 HD22 ' CZ ' ' A' ' 577' ' ' PHE . 5.0 tp -109.94 125.43 52.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.461 -1.023 . . . . 0.0 110.653 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.639 ' HA ' ' HG ' ' A' ' 644' ' ' LEU . 10.8 p90 -50.55 -27.4 6.63 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.901 0.858 . . . . 0.0 109.566 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.55 ' HB3' ' CZ ' ' A' ' 703' ' ' PHE . 6.6 t30 . . . . . 0 C--N 1.303 -1.423 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.43 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 6.0 mmm-85 . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.849 0.833 . . . . 0.0 112.254 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 11.2 m -106.96 151.76 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.474 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 60.4 t -86.2 133.15 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.85 . . . . 0.0 110.939 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.0 mt -103.65 162.15 13.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.54 -0.725 . . . . 0.0 109.552 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.01 154.15 18.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 110.259 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -79.94 134.19 36.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 0.0 110.168 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 63.1 p -106.18 -176.3 3.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.413 -0.804 . . . . 0.0 110.3 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.26 -28.86 29.78 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.282 -0.886 . . . . 0.0 110.018 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -65.93 -47.92 73.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.416 -0.802 . . . . 0.0 109.785 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -63.93 -47.86 78.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.417 -0.802 . . . . 0.0 109.956 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . 0.407 ' O ' ' CG1' ' A' ' 727' ' ' VAL . 12.0 tttm -52.42 -33.71 45.1 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.422 -0.799 . . . . 0.0 109.85 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -69.16 -36.12 77.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.471 -0.768 . . . . 0.0 110.251 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.421 HD13 ' CE1' ' A' ' 624' ' ' PHE . 56.2 mt -56.25 -47.53 78.34 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.312 -0.867 . . . . 0.0 110.619 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 724' ' ' LYS . 6.3 p -69.67 -17.67 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.154 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -54.27 -45.82 72.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 0.0 108.836 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.1 104.76 11.55 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.225 1.012 . . . . 0.0 109.209 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.414 ' OXT' ' CD2' ' A' ' 602' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.274 -2.714 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.365 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.417 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 2.6 ttm180 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 121.612 0.72 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.49 ' HB3' ' CA ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -93.32 -44.09 8.47 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.809 0.814 . . . . 0.0 109.116 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.479 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 9.9 tt -125.48 142.2 51.63 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.275 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 87.0 m -122.38 121.97 37.93 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 14.1 mt -95.15 112.5 24.2 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.464 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.49 103.66 55.57 Favored Pre-proline 0 C--N 1.302 -1.485 0 C-N-CA 118.464 -1.294 . . . . 0.0 113.21 -177.272 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.059 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 44.1 Cg_endo -78.5 137.24 14.54 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 N-CA-C 105.274 -2.625 . . . . 0.0 105.274 174.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.79 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -125.88 -171.9 0.24 Allowed Pre-proline 0 C--N 1.295 -1.786 0 C-N-CA 118.138 -1.425 . . . . 0.0 113.405 -176.104 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.79 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 36.7 Cg_endo -61.67 -35.4 80.57 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 124.129 1.594 . . . . 0.0 111.951 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -58.69 -29.75 66.86 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.459 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 24.6 t -96.54 148.09 23.18 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.499 HG13 HD13 ' A' ' 588' ' ' ILE . 1.4 pt -62.96 -18.21 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.244 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.679 HG13 HG12 ' A' ' 613' ' ' ILE . 4.3 mm -83.27 116.2 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.459 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -119.76 69.52 0.84 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.432 -1.417 . . . . 0.0 109.348 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.059 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 24.8 tt0 -144.61 174.35 11.04 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.637 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.5 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.2 125.01 36.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.971 -1.08 . . . . 0.0 109.011 176.342 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.98 155.04 19.76 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.31 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.417 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.6 OUTLIER -125.48 110.54 14.02 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.478 -0.764 . . . . 0.0 111.287 -179.016 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 3.2 mt -84.16 109.27 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.157 -0.965 . . . . 0.0 109.007 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.2 OUTLIER -64.74 140.41 58.86 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.048 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.49 ' CA ' ' HB3' ' A' ' 577' ' ' PHE . 2.2 pt20 -46.56 85.47 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.486 -0.759 . . . . 0.0 110.783 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 135.44 5.21 2.35 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.722 -1.227 . . . . 0.0 110.483 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.432 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -80.21 101.66 5.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 O-C-N 120.788 -1.419 . . . . 0.0 107.421 178.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 627' ' ' LYS . 21.6 t-20 -145.42 132.52 10.1 Favored Pre-proline 0 C--N 1.282 -2.352 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.065 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.529 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 50.8 Cg_endo -92.87 164.13 23.88 Favored 'Cis proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.38 -1.508 . . . . 0.0 108.747 -2.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.517 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 5.4 t80 -104.39 116.14 31.61 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.529 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 35.9 m-85 -82.96 143.91 30.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.435 -0.79 . . . . 0.0 110.616 -178.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.542 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 3.6 mt -141.99 141.57 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.659 -0.651 . . . . 0.0 109.952 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.728 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 163.8 -163.8 36.02 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.395 -1.383 . . . . 0.0 111.24 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.474 ' N ' HD23 ' A' ' 618' ' ' LEU . 4.8 mmm-85 -60.33 -57.7 11.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.921 -0.752 . . . . 0.0 111.862 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.45 125.07 25.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 111.209 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.455 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 4.3 pt-20 -54.08 -17.61 2.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.888 . . . . 0.0 109.735 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.49 -32.58 1.44 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.457 -0.777 . . . . 0.0 108.951 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.3 m -65.9 130.37 43.03 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.517 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -43.3 -29.42 0.41 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.333 -0.854 . . . . 0.0 109.893 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.542 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 2.9 t -104.73 143.11 33.55 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -107.91 126.48 52.73 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 122.279 1.038 . . . . 0.0 113.363 -178.077 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.679 HG12 HG13 ' A' ' 588' ' ' ILE . 22.9 mt -143.9 108.57 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.49 ' O ' HD13 ' A' ' 587' ' ' ILE . 1.5 pt-20 -96.0 104.2 16.13 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 118.197 -1.401 . . . . 0.0 108.718 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.479 ' CB ' ' CB ' ' A' ' 618' ' ' LEU . 1.3 m-20 -136.41 105.81 6.08 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.587 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . 0.402 ' OD1' ' CE2' ' A' ' 688' ' ' PHE . 16.2 p-10 -44.64 -40.41 5.83 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.657 -0.652 . . . . 0.0 111.734 -179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.4 -17.38 42.4 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.101 -0.999 . . . . 0.0 111.032 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.511 ' CD2' ' HA2' ' A' ' 604' ' ' GLY . 0.6 OUTLIER -81.03 139.25 35.86 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.305 -0.872 . . . . 0.0 110.555 -179.499 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 619' ' ' SER . . . . . 0.426 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.0 OUTLIER -73.95 158.87 33.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.392 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.728 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.2 mpt_? -63.31 -43.15 98.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.2 -0.938 . . . . 0.0 109.191 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.459 ' CG1' ' CG2' ' A' ' 727' ' ' VAL . 18.8 t -95.82 1.57 10.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.921 0.867 . . . . 0.0 109.693 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.747 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.2 t60 -28.1 -45.37 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.884 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.459 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.8 OUTLIER -137.46 145.88 43.62 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 117.959 -1.496 . . . . 0.0 112.191 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 4.5 p90 -146.35 142.05 27.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.605 -0.685 . . . . 0.0 110.088 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 73.8 mt -102.99 117.61 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.421 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 4.1 t80 -112.86 155.46 24.63 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.769 0.795 . . . . 0.0 110.17 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.44 ' O ' ' ND2' ' A' ' 599' ' ' ASN . 21.9 ttmt -119.34 137.92 53.39 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 121.525 0.679 . . . . 0.0 110.487 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.421 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -132.75 163.92 27.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.58 -0.7 . . . . 0.0 110.753 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.4 tpt85 -77.51 112.3 14.14 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.523 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.2 t60 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.722 . . . . 0.0 110.887 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.513 ' HB2' ' CA ' ' A' ' 703' ' ' PHE . 5.3 mp . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.2 OUTLIER -118.39 123.96 46.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.097 -1.002 . . . . 0.0 110.905 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -105.4 156.54 18.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.433 -0.792 . . . . 0.0 109.742 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 18.1 pt -106.65 129.37 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.342 -0.849 . . . . 0.0 110.423 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.515 ' CE3' HD13 ' A' ' 671' ' ' LEU . 97.9 m95 -116.63 121.12 40.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.718 -0.614 . . . . 0.0 110.791 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.521 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 13.9 t80 -80.61 116.13 20.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 108.469 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 13.8 t -109.0 107.01 17.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 0.0 111.767 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.542 ' CB ' ' OG ' ' A' ' 657' ' ' SER . 11.9 t60 -70.51 161.67 30.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.568 -0.707 . . . . 0.0 109.812 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.747 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.94 -30.24 0.16 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.329 -0.857 . . . . 0.0 112.562 -179.191 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.585 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.13 -167.71 33.93 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 117.853 -2.118 . . . . 0.0 109.901 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 654' ' ' THR . . . . . 0.46 ' O ' HG13 ' A' ' 656' ' ' VAL . 5.6 m -89.6 -19.28 25.13 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -176.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.578 ' O ' HG22 ' A' ' 656' ' ' VAL . 89.7 m-20 -59.75 -2.86 0.42 Allowed 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.686 -1.258 . . . . 0.0 112.924 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 62.11 143.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.575 -0.703 . . . . 0.0 110.293 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.542 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -95.98 142.99 27.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.621 -0.675 . . . . 0.0 110.462 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.448 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 10.8 m-85 -129.03 126.13 38.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.923 . . . . 0.0 110.526 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.496 ' CD1' HG23 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -134.55 114.35 12.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.331 -0.856 . . . . 0.0 110.001 179.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.02 -85.79 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.439 -0.788 . . . . 0.0 110.494 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.6 p-10 -143.67 19.28 1.84 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.11 -0.994 . . . . 0.0 110.409 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.84 118.36 36.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.313 -0.867 . . . . 0.0 110.177 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.05 136.44 35.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.466 -0.772 . . . . 0.0 110.044 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.464 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 8.1 mmm -115.61 -168.2 1.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 0.0 109.997 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.413 ' CG1' ' CG2' ' A' ' 668' ' ' THR . 1.1 pt -143.38 -165.81 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.22 -0.925 . . . . 0.0 110.494 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -77.64 78.42 4.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.574 -0.704 . . . . 0.0 110.473 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.42 53.79 0.23 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -122.24 148.15 45.33 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.056 -1.261 . . . . 0.0 109.928 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 650' ' ' CYS . 2.8 tttt -108.4 138.75 44.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.524 -0.735 . . . . 0.0 109.574 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.461 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 0.7 OUTLIER -144.53 146.42 32.37 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.664 -178.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.515 HD13 ' CE3' ' A' ' 648' ' ' TRP . 13.5 tp -71.29 146.19 49.06 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.429 -0.794 . . . . 0.0 110.898 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.521 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 9.0 mt -117.78 107.74 14.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.415 -0.803 . . . . 0.0 111.06 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -84.86 153.41 22.92 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -50.42 141.97 11.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.072 -1.018 . . . . 0.0 109.947 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 71.87 45.97 39.98 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.94 90.49 3.32 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.855 -0.791 . . . . 0.0 110.198 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.797 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 5.3 tt0 -93.45 107.41 19.25 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.496 HG23 ' CD1' ' A' ' 659' ' ' LEU . 1.1 pt -111.44 137.77 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 121.446 0.641 . . . . 0.0 111.551 -177.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -95.13 110.83 22.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.486 -0.759 . . . . 0.0 109.258 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 57.0 mt -75.02 -23.92 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.232 -0.918 . . . . 0.0 110.517 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.422 HD13 ' HB2' ' A' ' 618' ' ' LEU . 7.1 mt -140.49 139.09 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.195 -0.941 . . . . 0.0 110.276 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -137.69 109.51 7.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.365 -0.834 . . . . 0.0 110.401 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.29 117.7 28.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.328 -0.858 . . . . 0.0 109.975 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -47.19 72.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.291 -0.881 . . . . 0.0 111.037 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -84.84 -43.56 14.04 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.259 -0.9 . . . . 0.0 110.849 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.63 -12.07 61.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.576 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm 52.14 25.36 3.22 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.242 -0.911 . . . . 0.0 110.314 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.448 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -93.06 79.43 4.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.374 -0.829 . . . . 0.0 109.764 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.41 ' O ' HG21 ' A' ' 689' ' ' VAL . 27.3 m -103.55 142.33 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.391 -0.818 . . . . 0.0 110.673 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.46 ' CD1' HG12 ' A' ' 587' ' ' ILE . 30.0 mm -116.6 164.34 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.456 -0.778 . . . . 0.0 109.03 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -173.58 124.19 1.03 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.316 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.797 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 15.0 m-85 -120.2 138.6 53.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.647 -0.913 . . . . 0.0 108.857 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -103.3 114.01 27.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.057 -1.027 . . . . 0.0 110.582 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -82.81 113.49 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -120.37 104.34 9.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.464 -0.772 . . . . 0.0 110.444 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 577' ' ' PHE . 87.6 mt -83.54 103.99 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 109.276 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -83.51 -45.29 13.75 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.482 -0.761 . . . . 0.0 109.211 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.447 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 4.8 m-20 -111.62 140.98 45.78 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.777 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 5.6 p -114.66 96.17 5.61 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 70.3 m -78.65 -92.64 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.883 -0.511 . . . . 0.0 110.84 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . -114.09 44.28 1.53 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.6 tp -90.72 145.72 24.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.587 -0.949 . . . . 0.0 110.436 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 2.5 p90 -53.35 -23.04 8.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.531 -0.731 . . . . 0.0 110.636 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.555 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.3 t30 . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.461 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 4.1 mmm-85 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.36 0.6 . . . . 0.0 111.945 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.412 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 27.7 m -107.89 151.77 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.447 -0.783 . . . . 0.0 109.431 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 78.9 t -89.31 133.42 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.185 -0.947 . . . . 0.0 110.498 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.9 mp -107.77 162.35 14.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 109.954 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.97 147.5 26.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 110.273 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -80.02 152.82 29.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.31 -0.869 . . . . 0.0 110.301 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 75.6 p -121.08 -177.54 3.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.273 -0.892 . . . . 0.0 110.364 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.99 -35.72 67.1 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.422 -0.799 . . . . 0.0 110.146 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . 0.421 ' O ' ' CD2' ' A' ' 726' ' ' LEU . 0.7 OUTLIER -65.36 -44.93 86.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 0.0 110.022 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.53 ' HA ' HD22 ' A' ' 726' ' ' LEU . 7.1 mt-10 -63.02 -48.73 77.51 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.441 -0.787 . . . . 0.0 109.984 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . 0.403 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 22.4 mtpp -63.04 -32.23 73.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.398 -0.813 . . . . 0.0 111.072 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -61.56 -50.81 71.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.247 -0.908 . . . . 0.0 112.46 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.53 HD22 ' HA ' ' A' ' 723' ' ' GLU . 0.4 OUTLIER -68.43 -32.73 72.97 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.732 -1.23 . . . . 0.0 110.803 -179.062 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . 0.459 ' CG2' ' CG1' ' A' ' 621' ' ' VAL . 12.6 p -83.87 -18.48 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.054 . . . . 0.0 110.073 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -53.34 -45.37 69.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 108.889 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.5 103.53 10.52 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.193 0.997 . . . . 0.0 109.021 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.422 HD23 ' CG ' ' A' ' 602' ' ' PHE . 1.6 mt . . . . . 0 C--N 1.273 -2.746 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.415 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 121.687 0.756 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.544 ' HB3' ' CA ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -91.02 -43.79 9.72 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.96 0.886 . . . . 0.0 108.898 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 9.0 tt -121.43 125.33 46.65 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.086 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 25.2 m -103.6 116.63 32.71 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.422 ' HG ' ' CD2' ' A' ' 578' ' ' LEU . 5.4 mt -91.49 112.25 24.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.558 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.1 OUTLIER -114.65 104.26 54.44 Favored Pre-proline 0 C--N 1.298 -1.645 0 C-N-CA 118.386 -1.326 . . . . 0.0 113.128 -177.268 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.103 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.4 Cg_endo -76.33 142.1 23.63 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 N-CA-C 105.221 -2.646 . . . . 0.0 105.221 174.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.747 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -125.97 -173.91 0.32 Allowed Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 117.916 -1.514 . . . . 0.0 113.87 -175.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.747 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.2 Cg_endo -66.41 -34.17 35.34 Favored 'Trans proline' 0 N--CA 1.487 1.142 0 O-C-N 124.169 1.615 . . . . 0.0 111.322 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.88 -30.63 67.91 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.61 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 88.9 p -97.74 153.49 18.23 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.518 ' CG2' HD12 ' A' ' 588' ' ' ILE . 1.0 OUTLIER -62.41 -9.75 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.982 -1.074 . . . . 0.0 109.969 179.21 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.566 HD13 ' HA ' ' A' ' 613' ' ' ILE . 10.1 mm -97.85 116.36 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.274 -0.891 . . . . 0.0 109.626 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.61 ' NE2' ' O ' ' A' ' 586' ' ' SER . 16.3 mp0 -118.53 71.87 0.85 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.659 -1.276 . . . . 0.0 109.713 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.103 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 42.5 mt-10 -144.48 174.63 10.77 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.941 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.558 ' HB3' ' HG2' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.54 128.27 40.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.005 -1.06 . . . . 0.0 109.487 176.483 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.485 ' N ' ' CD2' ' A' ' 592' ' ' LEU . 1.8 mm? -111.2 152.26 27.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.976 . . . . 0.0 109.343 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -124.7 110.77 14.79 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.517 -0.74 . . . . 0.0 110.578 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 40.6 mt -82.18 109.12 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.072 -1.018 . . . . 0.0 109.272 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -62.46 110.38 1.66 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.423 -0.798 . . . . 0.0 108.963 179.454 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.551 ' C ' ' O ' ' A' ' 595' ' ' GLN . 1.9 pt20 -19.11 85.4 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 121.396 0.617 . . . . 0.0 112.03 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 124.98 10.27 4.82 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.366 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.542 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -83.96 102.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-O 123.112 1.434 . . . . 0.0 107.57 178.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.2 OUTLIER -144.52 138.78 14.91 Favored Pre-proline 0 C--N 1.281 -2.384 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.808 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.569 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 51.9 Cg_endo -90.94 163.44 30.41 Favored 'Cis proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.564 -1.848 . . . . 0.0 108.817 -1.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.58 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 4.1 t80 -104.42 116.0 31.35 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.569 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 33.0 m-85 -83.82 144.17 29.45 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.478 -0.764 . . . . 0.0 110.303 -178.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.519 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 3.7 mt -142.19 142.12 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.653 -0.655 . . . . 0.0 110.036 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.759 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 168.43 -162.97 36.76 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.807 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 13.7 tpt180 -70.36 -42.4 71.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.768 -0.842 . . . . 0.0 110.863 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.83 123.34 26.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.742 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.436 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 14.3 tt0 -53.34 -17.77 2.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 110.247 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.47 -31.49 1.77 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.316 -0.865 . . . . 0.0 108.967 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.481 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.5 m -68.05 132.74 47.8 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.58 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.0 OUTLIER -46.77 -26.65 0.99 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.292 -0.88 . . . . 0.0 109.945 179.555 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.519 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 3.3 t -106.97 143.55 34.89 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.436 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -109.45 127.88 54.74 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 119.288 -0.965 . . . . 0.0 113.17 -178.363 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.566 ' HA ' HD13 ' A' ' 588' ' ' ILE . 29.3 mt -142.63 108.49 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -90.46 103.54 16.21 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 118.124 -1.43 . . . . 0.0 108.484 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 0.7 OUTLIER -139.15 106.11 5.43 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.692 178.163 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -43.68 -44.65 6.58 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.548 -0.72 . . . . 0.0 112.077 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.53 -17.33 42.2 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.168 -0.958 . . . . 0.0 111.855 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -76.46 122.31 24.35 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.037 -1.039 . . . . 0.0 110.506 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 619' ' ' SER . . . . . 0.408 ' CB ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -57.84 158.99 5.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.306 -0.871 . . . . 0.0 110.927 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.759 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -64.09 -45.17 89.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.222 -0.924 . . . . 0.0 109.366 179.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 622' ' ' HIS . 4.3 t -95.33 1.78 10.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.892 0.853 . . . . 0.0 109.347 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.733 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.4 t60 -28.37 -46.38 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.645 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.8 OUTLIER -137.04 145.86 44.53 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 117.985 -1.486 . . . . 0.0 112.08 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.531 ' CZ ' ' CB ' ' A' ' 650' ' ' CYS . 9.7 p90 -145.91 139.63 26.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.791 -0.568 . . . . 0.0 109.554 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.415 HD11 ' CD1' ' A' ' 580' ' ' LEU . 82.7 mt -102.83 117.72 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.435 ' CE1' ' O ' ' A' ' 627' ' ' LYS . 6.6 t80 -109.97 154.75 22.7 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.734 0.778 . . . . 0.0 109.914 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.435 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 11.1 ttmt -118.47 136.12 53.98 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.573 0.702 . . . . 0.0 110.1 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.7 OUTLIER -129.75 163.54 25.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.659 -0.651 . . . . 0.0 110.238 -179.193 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.5 tpt180 -78.22 121.81 24.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.073 -1.017 . . . . 0.0 108.75 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.522 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 4.8 t60 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.416 -0.803 . . . . 0.0 110.656 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 5.3 mp . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.8 m-20 -119.08 124.22 46.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.088 -1.007 . . . . 0.0 111.241 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 628' ' ' LYS . 18.2 t0 -101.84 156.18 17.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.597 -0.689 . . . . 0.0 109.57 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.446 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 11.7 pt -109.87 128.84 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.187 -0.945 . . . . 0.0 110.3 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.603 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 97.0 m95 -117.8 123.16 45.28 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.137 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.443 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 8.9 t80 -81.11 117.01 21.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.531 ' CB ' ' CZ ' ' A' ' 624' ' ' PHE . 89.0 m -109.14 103.3 12.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.972 . . . . 0.0 111.818 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.529 ' CD2' ' N ' ' A' ' 652' ' ' THR . 13.3 t60 -66.73 159.23 28.3 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.402 -0.811 . . . . 0.0 109.781 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.733 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -152.13 -28.85 0.17 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.38 -0.825 . . . . 0.0 113.008 -179.295 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.526 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.47 -167.91 32.51 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 117.678 -2.201 . . . . 0.0 109.535 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 654' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 656' ' ' VAL . 26.2 m -93.35 -18.76 22.03 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.964 -1.315 . . . . 0.0 113.818 -176.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 656' ' ' VAL . 23.9 m120 -59.43 -4.27 0.57 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.669 -1.27 . . . . 0.0 112.359 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.46 ' C ' ' CE1' ' A' ' 651' ' ' HIS . 3.1 t 69.76 147.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.655 -0.653 . . . . 0.0 110.343 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.489 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -101.69 149.42 24.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.698 -0.626 . . . . 0.0 110.686 -179.012 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -136.83 126.37 25.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 110.441 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.436 ' CD2' ' CG2' ' A' ' 678' ' ' ILE . 1.0 OUTLIER -128.13 106.72 9.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.394 -0.816 . . . . 0.0 109.79 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.0 t30 63.52 -74.22 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.525 -0.735 . . . . 0.0 110.593 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 659' ' ' LEU . 10.7 m120 -153.1 23.95 0.55 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.208 -0.933 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.67 120.99 43.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.304 -0.873 . . . . 0.0 110.238 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.65 131.07 34.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.412 -0.805 . . . . 0.0 110.002 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.411 ' CB ' ' OG ' ' A' ' 657' ' ' SER . 2.7 mtp -111.17 -165.25 0.97 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.413 -0.804 . . . . 0.0 110.424 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.404 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 2.1 pt -137.44 -164.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.378 -0.826 . . . . 0.0 110.324 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -80.79 82.35 6.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.374 -0.829 . . . . 0.0 110.522 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 120.43 55.59 0.24 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.2 OUTLIER -121.97 147.05 46.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.192 -1.181 . . . . 0.0 109.986 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.439 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 2.8 tttm -108.61 140.21 42.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.61 -0.681 . . . . 0.0 109.188 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.47 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 0.4 OUTLIER -144.31 142.89 30.71 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.101 -1.0 . . . . 0.0 111.418 -178.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.603 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.96 146.72 50.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.428 -0.795 . . . . 0.0 110.47 179.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.443 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 12.2 mt -119.08 108.98 15.38 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.148 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -84.8 -176.98 6.46 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -73.03 141.85 47.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.192 -0.942 . . . . 0.0 109.538 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.33 47.48 43.43 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 107.596 -2.201 . . . . 0.0 107.596 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.28 91.81 4.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.956 -0.732 . . . . 0.0 110.302 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.974 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 2.4 tt0 -93.61 108.33 20.06 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.436 ' CG2' ' CD2' ' A' ' 659' ' ' LEU . 11.8 pt -105.69 137.66 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.644 -0.66 . . . . 0.0 111.868 -177.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -99.92 110.5 22.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.563 -0.711 . . . . 0.0 109.341 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 66.3 mt -81.92 -34.01 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.297 -0.877 . . . . 0.0 110.586 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.429 ' HB ' ' CG1' ' A' ' 690' ' ' ILE . 0.1 OUTLIER -126.9 136.12 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.325 -0.859 . . . . 0.0 109.587 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -137.66 118.64 14.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.249 -0.907 . . . . 0.0 110.659 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.99 117.83 20.67 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.282 -0.886 . . . . 0.0 110.055 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -47.36 71.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.412 -0.805 . . . . 0.0 111.408 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -84.72 -43.49 14.24 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.213 -0.929 . . . . 0.0 111.079 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.6 -7.69 55.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.308 -0.87 . . . . 0.0 110.742 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.93 19.51 3.64 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.117 -0.989 . . . . 0.0 110.364 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.83 86.86 5.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.242 -0.911 . . . . 0.0 109.102 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 681' ' ' ILE . 9.3 p -116.61 141.83 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.41 -0.806 . . . . 0.0 110.572 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.567 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 42.9 mm -118.95 164.35 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.338 -0.851 . . . . 0.0 109.653 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.459 ' N ' ' CB ' ' A' ' 586' ' ' SER . . . -175.31 126.09 1.14 Allowed Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.974 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 10.1 m-85 -119.5 137.3 53.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.56 -0.965 . . . . 0.0 108.674 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 12.4 tptt -97.91 113.8 25.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.225 -0.922 . . . . 0.0 110.459 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -85.27 112.53 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.42 104.67 9.23 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.168 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 577' ' ' PHE . 57.3 mt -79.54 103.21 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.376 -0.827 . . . . 0.0 109.576 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.2 -45.25 20.25 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 3.4 m-20 -111.12 141.56 44.47 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.735 -0.603 . . . . 0.0 109.895 178.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 20.6 p -113.95 95.79 5.49 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.96 133.52 52.99 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.026 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.41 26.05 28.93 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.426 HD21 ' CE1' ' A' ' 577' ' ' PHE . 0.2 OUTLIER -102.85 124.88 49.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.569 -0.96 . . . . 0.0 109.976 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.625 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 4.4 p90 -48.09 -24.56 1.14 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.384 -0.822 . . . . 0.0 110.197 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.625 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--N 1.303 -1.442 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.47 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.287 0.565 . . . . 0.0 111.626 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.451 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 31.4 m -107.83 150.85 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 109.509 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.409 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 61.6 t -97.52 133.07 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.215 -0.928 . . . . 0.0 110.643 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.3 mp -110.12 162.51 14.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.498 -0.751 . . . . 0.0 109.85 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.18 145.32 28.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.195 -0.941 . . . . 0.0 110.17 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -80.64 150.21 29.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.33 -0.856 . . . . 0.0 110.18 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 17.0 p -113.73 -176.7 2.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.322 -0.861 . . . . 0.0 110.397 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.92 -32.99 55.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.385 -0.822 . . . . 0.0 110.364 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . 0.432 ' O ' ' CD2' ' A' ' 726' ' ' LEU . 2.7 tt0 -66.59 -46.74 74.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.353 -0.842 . . . . 0.0 109.977 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . 0.457 ' HA ' HD21 ' A' ' 726' ' ' LEU . 0.5 OUTLIER -62.78 -48.39 79.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.481 -0.762 . . . . 0.0 109.903 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . 0.401 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 8.5 tttp -62.96 -31.61 72.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.447 -0.783 . . . . 0.0 110.468 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.48 -50.45 73.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.372 -0.83 . . . . 0.0 112.238 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.457 HD21 ' HA ' ' A' ' 723' ' ' GLU . 0.3 OUTLIER -72.32 -36.32 68.83 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.921 -1.112 . . . . 0.0 111.415 -178.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . 0.434 ' CG2' ' CG1' ' A' ' 621' ' ' VAL . 7.2 p -81.31 -17.85 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.881 -1.137 . . . . 0.0 110.441 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -47.46 75.26 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.107 -0.996 . . . . 0.0 108.866 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.37 103.92 10.94 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.335 1.064 . . . . 0.0 109.01 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.419 HD21 ' CG ' ' A' ' 602' ' ' PHE . 1.8 mt . . . . . 0 C--N 1.273 -2.729 0 CA-C-O 117.984 -1.007 . . . . 0.0 110.366 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.57 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.2 OUTLIER -102.65 -40.23 6.71 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.915 0.864 . . . . 0.0 109.502 -179.253 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 9.8 tt -116.7 124.5 49.84 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.246 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 25.5 m -108.58 116.88 32.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -0.852 . . . . 0.0 109.944 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.418 ' CD1' ' CD1' ' A' ' 625' ' ' ILE . 1.8 mt -95.71 112.83 24.46 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.62 104.58 55.67 Favored Pre-proline 0 C--N 1.299 -1.612 0 C-N-CA 118.496 -1.282 . . . . 0.0 113.071 -177.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.035 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 44.8 Cg_endo -76.09 142.02 24.24 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 N-CA-C 106.295 -2.233 . . . . 0.0 106.295 175.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 1.057 ' HB2' ' HD2' ' A' ' 584' ' ' PRO . 0.2 OUTLIER -127.59 -171.69 0.24 Allowed Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 120.991 -1.068 . . . . 0.0 112.743 -176.276 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 1.057 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 36.4 Cg_endo -61.86 -31.29 85.0 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.859 1.452 . . . . 0.0 110.631 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -59.34 -26.62 65.2 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.481 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 19.1 t -96.56 153.38 17.88 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.526 HG21 ' HB2' ' A' ' 615' ' ' ASP . 13.8 tt -62.94 -15.89 16.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.703 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.69 ' HB ' ' HA ' ' A' ' 613' ' ' ILE . 1.0 OUTLIER -109.72 120.95 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.415 -0.803 . . . . 0.0 110.533 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 586' ' ' SER . 24.9 mp0 -107.25 79.94 1.36 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.578 -1.326 . . . . 0.0 108.728 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.035 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.6 mm-40 -141.52 176.61 8.75 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.36 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.552 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.38 127.21 42.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.31 -0.869 . . . . 0.0 108.859 176.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.45 HD11 ' HD3' ' A' ' 582' ' ' PRO . 0.6 OUTLIER -104.0 148.87 25.71 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.149 -0.97 . . . . 0.0 110.147 -179.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -124.68 109.99 13.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.488 -0.757 . . . . 0.0 110.658 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 44.2 mt -86.0 112.47 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 108.493 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.525 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -67.07 104.98 1.54 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.678 -0.638 . . . . 0.0 112.522 -177.67 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.525 ' C ' ' O ' ' A' ' 595' ' ' GLN . 0.0 OUTLIER 16.84 57.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 178.341 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 113.3 39.61 1.11 Allowed Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.592 -1.29 . . . . 0.0 111.197 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.497 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 1.2 t -79.82 103.58 6.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.3 OUTLIER -141.37 140.16 20.21 Favored Pre-proline 0 C--N 1.282 -2.339 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.499 -178.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.446 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.2 Cg_endo -88.61 161.06 41.71 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.728 -2.197 . . . . 0.0 108.88 -0.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.1 t80 -106.35 116.17 31.47 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.695 ' C ' ' HB2' ' A' ' 609' ' ' CYS . 32.1 m-85 -92.35 144.59 25.23 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.29 -0.881 . . . . 0.0 110.702 -178.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.533 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -135.68 142.47 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.644 -0.66 . . . . 0.0 110.079 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 170.82 -168.67 41.77 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.737 -1.221 . . . . 0.0 110.783 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 13.9 mmm-85 -70.0 -44.95 68.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.69 -0.888 . . . . 0.0 110.673 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.495 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -75.01 119.63 19.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 110.125 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 608' ' ' ASP . 12.8 pt-20 -48.53 -18.9 0.28 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.316 -0.865 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 607' ' ' GLU . 0.9 OUTLIER -42.48 -37.87 1.75 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.321 -0.862 . . . . 0.0 109.318 179.101 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.695 ' HB2' ' C ' ' A' ' 602' ' ' PHE . 23.0 p -68.73 128.21 35.82 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.535 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -43.66 -24.6 0.13 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.562 -0.711 . . . . 0.0 111.897 -178.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.549 ' O ' ' SG ' ' A' ' 609' ' ' CYS . 9.0 t -108.57 142.64 38.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.351 -0.843 . . . . 0.0 109.593 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.493 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -113.53 130.61 56.31 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.909 -1.119 . . . . 0.0 112.584 -178.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.69 ' HA ' ' HB ' ' A' ' 588' ' ' ILE . 13.7 tt -145.09 109.26 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.426 ' O ' ' CG2' ' A' ' 587' ' ' ILE . 6.2 mm-40 -84.48 100.98 11.7 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 116.844 -1.942 . . . . 0.0 108.087 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.697 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 27.7 t0 -139.96 105.01 4.99 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.335 177.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.48 -67.96 0.18 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.506 -0.746 . . . . 0.0 112.746 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -16.58 25.62 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.174 -0.954 . . . . 0.0 111.839 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.697 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -72.84 124.32 25.16 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.077 -1.014 . . . . 0.0 111.02 -179.006 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 619' ' ' SER . . . . . 0.477 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -69.8 161.71 29.29 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.384 -0.823 . . . . 0.0 110.639 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.64 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 31.9 mtm105 -63.88 -45.17 90.58 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 122.087 0.946 . . . . 0.0 109.126 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.471 ' O ' ' C ' ' A' ' 622' ' ' HIS . 21.8 m -95.77 2.29 9.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 121.639 0.733 . . . . 0.0 109.422 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.755 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.3 t60 -29.86 -47.97 0.08 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.937 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.5 OUTLIER -136.82 144.93 43.92 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 118.492 -1.283 . . . . 0.0 110.964 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.529 ' CZ ' ' CB ' ' A' ' 650' ' ' CYS . 8.4 p90 -145.87 141.44 27.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.506 -0.746 . . . . 0.0 110.053 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 71.5 mt -103.41 118.7 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 9.0 t80 -108.89 154.98 21.36 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.533 -0.729 . . . . 0.0 109.463 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.409 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 8.4 tttt -119.25 136.62 54.14 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.571 0.701 . . . . 0.0 110.379 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.455 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.23 163.97 29.15 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.749 -0.595 . . . . 0.0 110.421 -179.219 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.0 OUTLIER -77.78 124.97 28.64 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.564 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.897 0.856 . . . . 0.0 111.312 -177.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.525 ' HB2' ' CA ' ' A' ' 703' ' ' PHE . 5.1 mp . . . . . 0 N--CA 1.486 1.344 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.92 124.07 51.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.991 -1.068 . . . . 0.0 111.054 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -109.22 156.07 20.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.454 -0.779 . . . . 0.0 110.043 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 11.2 pt -111.06 128.92 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.271 -0.893 . . . . 0.0 109.633 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.491 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 99.0 m95 -114.29 120.09 39.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.724 -0.61 . . . . 0.0 111.539 -178.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.477 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 18.5 t80 -82.17 114.09 20.45 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.529 ' CB ' ' CZ ' ' A' ' 624' ' ' PHE . 62.2 m -109.54 102.27 11.14 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.145 -0.972 . . . . 0.0 111.399 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.613 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 12.1 t60 -69.0 160.39 31.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.461 -0.775 . . . . 0.0 109.918 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.755 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.37 -31.09 0.17 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.424 -0.797 . . . . 0.0 113.112 -178.888 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.613 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -78.53 134.91 14.77 Favored Glycine 0 N--CA 1.502 3.087 0 C-N-CA 117.801 -2.143 . . . . 0.0 110.253 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 654' ' ' THR . . . . . 0.448 ' O ' HG12 ' A' ' 656' ' ' VAL . 26.7 m -34.45 -24.87 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -177.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.532 ' O ' HG22 ' A' ' 656' ' ' VAL . 10.0 m120 -59.23 -3.02 0.34 Allowed 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.346 -1.472 . . . . 0.0 113.123 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 655' ' ' ASN . 0.8 OUTLIER 62.14 145.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.509 -0.745 . . . . 0.0 110.259 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.535 ' OG ' ' HB2' ' A' ' 664' ' ' MET . 0.0 OUTLIER -93.98 151.36 19.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.555 -0.716 . . . . 0.0 110.495 -179.199 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.454 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 14.5 m-85 -135.1 125.78 27.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 109.929 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.434 ' HG ' ' CG2' ' A' ' 678' ' ' ILE . 0.1 OUTLIER -134.56 113.94 12.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.25 -0.907 . . . . 0.0 110.18 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 54.19 -88.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.482 -0.761 . . . . 0.0 110.773 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.3 m120 -136.71 18.25 3.07 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.066 -1.021 . . . . 0.0 110.509 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -111.85 116.77 31.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.924 . . . . 0.0 110.444 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -94.08 138.19 32.43 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.475 -0.765 . . . . 0.0 109.815 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.535 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 0.0 OUTLIER -117.08 -159.44 0.73 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.893 . . . . 0.0 109.884 -179.722 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 1.7 pt -133.43 -171.69 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.246 -0.909 . . . . 0.0 110.372 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -74.27 70.06 1.62 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.351 -0.843 . . . . 0.0 110.452 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 133.13 55.77 0.08 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -123.09 150.57 43.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.255 -1.144 . . . . 0.0 110.307 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.41 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.1 ttpm? -108.84 146.66 33.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.579 -0.701 . . . . 0.0 109.178 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.458 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 3.5 t80 -145.05 146.28 31.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 111.915 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.491 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.68 130.55 42.66 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.546 -0.721 . . . . 0.0 109.497 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.477 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 1.7 mt -104.61 118.75 37.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.081 -1.012 . . . . 0.0 111.26 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 674' ' ' ASP . 78.4 mt-30 -106.94 138.99 42.06 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 673' ' ' GLN . 6.2 p-10 -36.69 146.19 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.268 -0.895 . . . . 0.0 110.921 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 73.13 48.76 18.6 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . 0.401 ' OD2' ' N ' ' A' ' 673' ' ' GLN . 0.4 OUTLIER -106.77 92.54 4.14 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.839 -0.8 . . . . 0.0 110.883 -178.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.25 106.49 18.45 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.023 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.453 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 5.0 pt -115.25 135.61 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.541 -0.724 . . . . 0.0 111.715 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.39 110.57 22.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.518 -0.739 . . . . 0.0 109.106 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.436 ' CG2' ' NE2' ' A' ' 622' ' ' HIS . 72.1 mt -72.4 -46.18 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.369 -0.832 . . . . 0.0 110.19 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.455 HG12 ' CB ' ' A' ' 655' ' ' ASN . 9.8 mt -126.81 133.59 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -0.845 . . . . 0.0 109.874 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -137.67 113.09 9.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 110.391 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -130.35 118.12 20.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.307 -0.87 . . . . 0.0 110.057 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -46.13 78.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.427 -0.796 . . . . 0.0 110.998 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.26 -43.02 82.91 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.31 -0.869 . . . . 0.0 110.75 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -90.47 -2.49 57.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.253 -0.904 . . . . 0.0 110.824 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.21 21.22 2.96 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.127 -0.983 . . . . 0.0 110.531 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.26 78.73 4.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.891 . . . . 0.0 109.084 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 39.5 t -101.69 131.47 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.557 -0.715 . . . . 0.0 110.682 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.438 HD13 HG22 ' A' ' 690' ' ' ILE . 49.7 mm -112.0 164.25 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.343 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 179.95 116.33 0.51 Allowed Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.417 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.658 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 12.1 m-85 -119.5 137.32 53.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.251 -1.146 . . . . 0.0 108.484 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -107.98 114.75 28.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 111.209 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.33 123.68 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.455 -0.778 . . . . 0.0 109.021 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -129.95 104.82 7.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.542 -0.724 . . . . 0.0 110.119 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 71.7 mt -84.35 103.95 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.366 -0.834 . . . . 0.0 109.851 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -81.78 -42.9 19.08 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.6 OUTLIER -110.7 140.29 45.21 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.682 -0.637 . . . . 0.0 110.249 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 6.6 p -114.7 96.09 5.56 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 4.6 p -97.07 105.42 17.56 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.298 0.57 . . . . 0.0 111.144 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 49.42 27.53 8.31 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.24 147.02 29.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.387 -1.066 . . . . 0.0 110.28 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.564 ' CD2' ' CE1' ' A' ' 630' ' ' HIS . 2.5 p90 -52.62 -23.55 6.73 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.43 -0.794 . . . . 0.0 110.292 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.555 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.6 t30 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.458 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 3.4 mmm-85 . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 121.434 0.635 . . . . 0.0 110.584 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 27.7 m -106.09 149.26 9.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 89.3 t -78.63 133.12 30.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 111.041 -178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.35 162.2 13.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.519 -0.738 . . . . 0.0 109.782 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -100.11 152.95 19.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.943 . . . . 0.0 110.135 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -79.87 154.18 28.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.83 . . . . 0.0 110.263 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.6 p -120.29 -176.99 3.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.35 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.09 -28.95 56.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.318 -0.864 . . . . 0.0 110.241 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . 0.429 ' O ' HD13 ' A' ' 726' ' ' LEU . 0.0 OUTLIER -68.22 -52.51 33.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.49 -0.756 . . . . 0.0 110.077 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -63.44 -37.75 88.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.352 -0.843 . . . . 0.0 109.771 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -58.44 -32.47 68.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.408 -0.807 . . . . 0.0 109.816 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.0 -39.21 79.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.459 -0.775 . . . . 0.0 110.341 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . 0.429 HD13 ' O ' ' A' ' 722' ' ' GLU . 10.9 mp -55.75 -47.55 76.78 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.308 -0.87 . . . . 0.0 110.638 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.98 -22.16 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.069 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -54.73 -50.37 68.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 109.048 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -116.53 103.46 10.44 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 122.241 1.02 . . . . 0.0 109.341 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.273 -2.736 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.212 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 121.653 0.74 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.517 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 4.7 t80 -98.71 -42.77 7.07 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.953 0.882 . . . . 0.0 109.516 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 696' ' ' ILE . 49.6 tp -123.3 120.35 32.83 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.606 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 85.5 m -101.17 116.81 33.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.401 HD11 HD12 ' A' ' 625' ' ' ILE . 4.3 mt -88.45 112.58 23.11 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.07 101.56 54.54 Favored Pre-proline 0 C--N 1.301 -1.505 0 C-N-CA 117.911 -1.516 . . . . 0.0 113.01 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.156 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.1 Cg_endo -82.13 145.18 13.68 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 N-CA-C 106.017 -2.34 . . . . 0.0 106.017 173.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.684 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.33 -178.73 0.66 Allowed Pre-proline 0 N--CA 1.498 1.971 0 C-N-CA 118.207 -1.397 . . . . 0.0 114.166 -176.373 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.684 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.1 Cg_endo -67.6 -28.54 37.73 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 124.322 1.696 . . . . 0.0 111.965 -178.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -58.6 -30.96 67.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.681 -1.262 . . . . 0.0 107.609 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.483 ' HB3' ' N ' ' A' ' 691' ' ' GLY . 3.3 p -97.88 153.85 18.04 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.528 ' CG2' HD13 ' A' ' 588' ' ' ILE . 0.4 OUTLIER -57.17 -16.09 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.97 -1.081 . . . . 0.0 109.437 179.255 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.645 HD11 ' HA ' ' A' ' 613' ' ' ILE . 9.9 mm -97.1 114.59 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.285 -0.884 . . . . 0.0 108.739 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.531 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -126.75 73.96 1.44 Allowed 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.583 -1.323 . . . . 0.0 110.014 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.156 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 66.4 mm-40 -143.95 174.46 10.82 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.198 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.429 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.6 125.91 39.17 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.794 -1.191 . . . . 0.0 109.565 176.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.34 155.43 21.21 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.284 -0.885 . . . . 0.0 109.626 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -125.02 109.99 13.63 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.363 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 4.4 mt -81.98 109.65 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -53.01 174.47 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.504 -0.747 . . . . 0.0 109.952 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.517 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -62.0 65.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.47 -0.769 . . . . 0.0 110.854 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 125.62 34.16 0.67 Allowed Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.938 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.472 ' HB ' HG22 ' A' ' 594' ' ' ILE . 1.2 t -79.62 103.17 6.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.4 t30 -143.18 134.68 12.82 Favored Pre-proline 0 C--N 1.283 -2.315 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.172 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.5 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 55.8 Cg_endo -91.47 161.35 28.16 Favored 'Cis proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.614 -1.828 . . . . 0.0 109.158 -1.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 611' ' ' CYS . 5.8 t80 -107.08 116.65 32.3 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.725 ' C ' ' HB2' ' A' ' 609' ' ' CYS . 60.8 m-85 -89.63 144.98 25.57 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.375 -0.828 . . . . 0.0 110.786 -178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.541 HG12 ' CB ' ' A' ' 611' ' ' CYS . 3.2 mt -138.17 142.24 36.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.634 -0.666 . . . . 0.0 109.702 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 174.67 -161.24 30.84 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.415 -1.374 . . . . 0.0 111.111 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -76.26 -44.3 37.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.847 -0.796 . . . . 0.0 110.479 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.5 123.27 27.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.277 -0.889 . . . . 0.0 110.413 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 608' ' ' ASP . 10.1 pt-20 -48.18 -18.98 0.24 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.385 -0.822 . . . . 0.0 111.058 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 607' ' ' GLU . 2.2 t0 -40.76 -37.27 0.73 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.375 -0.828 . . . . 0.0 109.653 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.725 ' HB2' ' C ' ' A' ' 602' ' ' PHE . 18.0 p -73.43 133.6 43.76 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.473 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -44.58 -23.08 0.1 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.558 -0.713 . . . . 0.0 111.959 -178.691 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.541 ' CB ' HG12 ' A' ' 603' ' ' ILE . 10.7 t -110.08 143.63 39.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.316 -0.865 . . . . 0.0 109.743 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.7 125.61 52.09 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.003 -1.061 . . . . 0.0 113.122 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.645 ' HA ' HD11 ' A' ' 588' ' ' ILE . 10.7 mt -142.59 108.84 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -89.52 103.49 16.13 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 118.045 -1.462 . . . . 0.0 109.207 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 1.1 m-20 -139.37 106.45 5.46 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.348 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -43.15 -43.25 4.47 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.602 -0.686 . . . . 0.0 112.048 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -83.88 -17.52 40.57 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.017 -1.052 . . . . 0.0 111.905 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -77.27 133.96 38.68 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.056 -1.028 . . . . 0.0 110.834 -179.153 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 619' ' ' SER . . . . . 0.462 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.5 m -75.92 159.82 30.52 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.367 -0.833 . . . . 0.0 111.225 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.596 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 19.4 ttm105 -62.62 -44.48 96.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.361 -0.837 . . . . 0.0 109.219 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.464 ' O ' ' C ' ' A' ' 622' ' ' HIS . 27.4 m -94.65 1.81 9.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 121.761 0.791 . . . . 0.0 109.358 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.8 t60 -30.81 -48.22 0.11 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.718 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.5 OUTLIER -136.5 144.89 44.56 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.579 -1.249 . . . . 0.0 110.826 178.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.502 ' HA ' HG13 ' A' ' 603' ' ' ILE . 17.1 p90 -146.29 145.84 30.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.543 -0.723 . . . . 0.0 110.163 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 8.7 mt -103.2 122.37 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.413 ' HB2' ' HE2' ' A' ' 624' ' ' PHE . 3.5 t80 -117.63 154.9 30.79 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.543 -0.723 . . . . 0.0 109.462 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 10.1 tttt -119.72 136.19 54.53 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.77 0.795 . . . . 0.0 111.023 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.72 163.5 28.86 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -78.3 126.3 30.59 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.818 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 7.0 t60 . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.399 -0.813 . . . . 0.0 110.749 -179.039 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.606 ' CD1' ' O ' ' A' ' 701' ' ' GLY . 3.0 mm? . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.54 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 4.5 m-20 -130.19 132.53 46.06 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.035 -1.041 . . . . 0.0 111.306 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -127.26 143.24 51.28 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.229 -0.92 . . . . 0.0 110.538 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 12.7 pt -96.96 134.45 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.261 -0.9 . . . . 0.0 109.926 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.675 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.3 m95 -119.18 120.87 38.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.571 -0.706 . . . . 0.0 111.313 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.451 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 4.0 t80 -80.84 114.25 19.59 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 624' ' ' PHE . 38.5 m -108.57 108.62 19.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 111.117 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.587 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 12.1 t60 -74.21 161.7 29.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.572 -0.705 . . . . 0.0 110.362 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -151.11 -31.57 0.17 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.587 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -79.41 130.89 10.18 Favored Glycine 0 N--CA 1.501 2.983 0 O-C-N 119.232 -2.167 . . . . 0.0 110.342 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 654' ' ' THR . . . . . 0.433 ' C ' ' H ' ' A' ' 656' ' ' VAL . 11.4 m -36.54 -24.24 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -177.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 656' ' ' VAL . 4.1 t-20 -56.01 -4.74 0.13 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.325 -1.484 . . . . 0.0 112.775 -178.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.504 ' O ' ' CE1' ' A' ' 651' ' ' HIS . 0.4 OUTLIER 77.69 166.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 CA-C-O 122.043 0.925 . . . . 0.0 110.734 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.479 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -126.84 150.9 48.99 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.045 -178.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -135.75 126.4 27.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.396 -0.815 . . . . 0.0 110.23 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.478 ' HG ' HG21 ' A' ' 678' ' ' ILE . 0.4 OUTLIER -127.36 108.95 11.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.305 -0.872 . . . . 0.0 109.679 179.487 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.9 m120 58.79 -81.34 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.426 -0.796 . . . . 0.0 110.195 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.9 OUTLIER -143.78 22.66 1.78 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.069 -1.019 . . . . 0.0 110.439 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -116.57 128.17 55.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.195 -0.941 . . . . 0.0 110.395 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -91.46 141.32 28.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.393 -0.817 . . . . 0.0 110.176 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.405 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 3.5 mtp -120.28 -172.96 2.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.401 -0.812 . . . . 0.0 110.208 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.424 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 1.1 pp -126.09 -169.94 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -0.87 . . . . 0.0 110.24 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -76.8 72.44 3.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.334 -0.854 . . . . 0.0 110.748 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 129.12 55.65 0.1 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -122.17 151.76 40.64 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.281 -1.129 . . . . 0.0 110.296 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.452 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -108.85 139.03 44.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.264 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.455 ' CD1' ' CD1' ' A' ' 659' ' ' LEU . 8.5 t80 -143.56 146.36 33.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 111.268 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.675 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -73.88 146.98 43.66 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.614 -0.679 . . . . 0.0 110.778 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.451 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 10.2 mt -115.71 114.34 24.7 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.285 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -97.04 148.76 22.67 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.0 135.19 25.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.044 -1.035 . . . . 0.0 110.087 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 83.77 45.57 6.34 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 107.686 -2.166 . . . . 0.0 107.686 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.85 93.5 4.53 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.802 -0.822 . . . . 0.0 110.444 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.815 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 4.6 tt0 -93.35 107.47 19.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.478 HG21 ' HG ' ' A' ' 659' ' ' LEU . 4.1 pt -112.43 138.04 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.564 -0.71 . . . . 0.0 112.38 -176.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.22 113.58 26.76 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 85.0 mt -76.83 -30.66 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.172 -0.955 . . . . 0.0 110.51 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 618' ' ' LEU . 4.0 mt -138.64 134.93 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.269 -0.894 . . . . 0.0 110.047 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -137.38 108.84 6.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.539 -0.726 . . . . 0.0 110.104 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.59 118.39 33.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.32 -0.862 . . . . 0.0 110.221 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.04 -46.64 77.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.425 -0.797 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -84.6 -43.37 14.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.32 -0.863 . . . . 0.0 110.763 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -76.21 -10.09 59.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.333 -0.854 . . . . 0.0 110.662 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.76 20.2 4.95 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.111 -0.993 . . . . 0.0 110.433 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.3 75.15 9.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -0.885 . . . . 0.0 109.354 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 10.8 p -103.16 131.65 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.387 -0.821 . . . . 0.0 111.054 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.429 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 36.3 mm -113.3 163.67 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.429 -0.795 . . . . 0.0 109.168 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.483 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . -167.79 120.29 0.89 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.198 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.815 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 7.7 m-85 -120.41 137.78 54.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.519 -0.989 . . . . 0.0 109.115 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -110.36 114.77 28.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.404 -0.81 . . . . 0.0 110.757 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.41 ' O ' ' CG1' ' A' ' 694' ' ' VAL . 0.8 OUTLIER -75.67 119.97 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.478 -0.763 . . . . 0.0 109.084 179.227 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -129.68 103.95 7.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.438 -0.789 . . . . 0.0 110.143 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 60.0 mt -86.97 111.4 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -0.799 . . . . 0.0 109.734 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -81.28 -43.26 19.41 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.491 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.5 m-20 -111.65 140.56 46.18 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.555 0.693 . . . . 0.0 110.61 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 699' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 700' ' ' THR . 25.0 p -115.62 96.77 5.78 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 700' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 699' ' ' THR . 9.0 t -60.0 -147.52 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.138 0.494 . . . . 0.0 110.248 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 644' ' ' LEU . . . -67.86 -1.17 16.79 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.431 HD13 ' CE2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.03 144.46 2.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.287 -1.125 . . . . 0.0 111.15 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.533 ' HB3' ' CB ' ' A' ' 644' ' ' LEU . 50.7 p90 -53.53 -27.62 26.85 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.137 0.97 . . . . 0.0 108.803 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.489 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 24.4 t30 . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 15.9 mmm-85 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.286 0.565 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.0 m -107.74 152.48 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.441 -0.787 . . . . 0.0 109.494 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.428 HG23 ' CD2' ' A' ' 670' ' ' PHE . 57.7 t -89.4 121.5 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.16 -0.962 . . . . 0.0 110.543 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.1 mp -96.1 161.89 13.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.426 -0.796 . . . . 0.0 109.846 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.68 153.66 17.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.375 -0.828 . . . . 0.0 109.841 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -87.16 125.06 33.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.318 -0.864 . . . . 0.0 110.38 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 39.7 p -93.15 -176.31 4.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.376 -0.828 . . . . 0.0 110.124 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.44 -28.91 32.75 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.326 -0.859 . . . . 0.0 110.207 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.1 -52.17 63.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.377 -0.827 . . . . 0.0 109.858 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -48.65 75.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 0.0 109.975 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . 0.404 ' O ' ' CG1' ' A' ' 727' ' ' VAL . 5.7 tttp -53.74 -32.17 51.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.386 -0.822 . . . . 0.0 110.123 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.28 -36.17 78.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.87 . . . . 0.0 110.242 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 42.1 mt -59.46 -46.33 89.09 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.346 -0.846 . . . . 0.0 110.245 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . 0.404 ' CG2' ' HB ' ' A' ' 621' ' ' VAL . 7.1 p -71.77 -22.2 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.145 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.26 -47.69 68.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.895 . . . . 0.0 108.937 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -116.87 104.28 11.15 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.151 0.977 . . . . 0.0 109.235 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.274 -2.69 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.252 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . 0.409 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 121.692 0.758 . . . . 0.0 109.515 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.502 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 3.4 t80 -106.29 -43.17 4.86 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.974 0.892 . . . . 0.0 109.46 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.439 ' HB2' ' CD1' ' A' ' 577' ' ' PHE . 31.4 tp -120.66 142.42 49.47 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.968 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 42.5 m -125.76 116.87 22.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.503 -0.748 . . . . 0.0 109.39 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 3.5 mt -95.13 112.08 23.83 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.404 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 1.6 mmtt -108.62 102.78 49.05 Favored Pre-proline 0 C--N 1.3 -1.586 0 C-N-CA 118.4 -1.32 . . . . 0.0 112.408 -177.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.062 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.8 Cg_endo -79.08 142.69 17.35 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 N-CA-C 106.547 -2.136 . . . . 0.0 106.547 175.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.782 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -128.05 -171.08 0.23 Allowed Pre-proline 0 C--N 1.297 -1.693 0 C-N-CA 118.501 -1.279 . . . . 0.0 112.79 -177.056 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.782 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 37.2 Cg_endo -63.58 -35.09 61.32 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 124.068 1.562 . . . . 0.0 110.815 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.99 -28.73 66.63 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.585 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 46.0 t -96.53 153.45 17.84 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.439 HG21 ' CD1' ' A' ' 690' ' ' ILE . 6.1 tp -63.53 -12.98 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.384 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.771 ' CG1' ' HA ' ' A' ' 613' ' ' ILE . 31.3 mm -100.97 120.29 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.369 -0.832 . . . . 0.0 109.838 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . 0.585 ' NE2' ' O ' ' A' ' 586' ' ' SER . 23.6 mp0 -115.98 68.27 0.72 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.55 -1.344 . . . . 0.0 109.307 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.062 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.5 mm-40 -143.97 176.85 8.98 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.593 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.502 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.19 125.77 41.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.194 -0.941 . . . . 0.0 108.859 176.576 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 1.9 mt -106.51 153.78 21.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.362 -0.836 . . . . 0.0 109.661 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.409 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 6.5 mp0 -125.99 110.12 13.22 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.308 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.507 HG22 ' HB ' ' A' ' 598' ' ' VAL . 1.7 mt -84.18 109.58 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.124 -0.985 . . . . 0.0 108.353 178.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.8 OUTLIER -51.66 172.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.655 -0.653 . . . . 0.0 109.869 -179.622 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.502 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 4.2 mt-30 -66.55 65.31 0.05 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.477 -0.764 . . . . 0.0 110.086 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 135.09 27.19 0.48 Allowed Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.611 -1.28 . . . . 0.0 110.988 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.507 ' HB ' HG22 ' A' ' 594' ' ' ILE . 0.9 OUTLIER -80.08 102.23 5.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.392 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 627' ' ' LYS . 14.2 t-20 -144.3 133.45 11.33 Favored Pre-proline 0 C--N 1.282 -2.341 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.367 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.655 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 55.2 Cg_endo -91.96 162.86 26.92 Favored 'Cis proline' 0 C--N 1.311 -1.442 0 C-N-CA 123.086 -1.631 . . . . 0.0 108.891 -2.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.528 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 5.5 t80 -105.97 116.42 31.91 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.655 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 73.8 m-85 -84.96 144.83 28.07 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.323 -0.861 . . . . 0.0 110.977 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.8 mt -142.19 141.62 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.724 -0.61 . . . . 0.0 110.291 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.802 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 167.88 -167.58 40.16 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.331 -1.414 . . . . 0.0 111.306 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 8.0 tpt180 -63.01 -36.34 83.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.889 -0.771 . . . . 0.0 111.774 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.22 121.62 28.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.043 -1.036 . . . . 0.0 111.246 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.548 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 7.0 tm-20 -53.11 -19.06 2.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 110.02 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.55 -30.24 2.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.347 -0.846 . . . . 0.0 109.292 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 602' ' ' PHE . 4.7 m -69.06 136.37 52.25 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.489 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -47.82 -25.09 1.16 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.276 -0.89 . . . . 0.0 110.056 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.552 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 4.0 t -110.52 143.32 41.06 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.599 ' O ' HG13 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -106.93 127.23 53.26 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.099 -1.001 . . . . 0.0 112.682 -178.694 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.771 ' HA ' ' CG1' ' A' ' 588' ' ' ILE . 2.3 mt -144.01 108.99 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 605' ' ' ARG . 3.1 tt0 -97.79 104.48 16.51 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.302 -1.359 . . . . 0.0 108.916 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.542 ' HA ' ' CZ ' ' A' ' 688' ' ' PHE . 6.1 m-20 -138.41 106.1 5.61 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.531 177.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -43.32 -42.3 4.44 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.671 -0.643 . . . . 0.0 111.953 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -83.09 -17.16 44.08 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.096 -1.002 . . . . 0.0 111.098 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.493 ' CD2' ' HA2' ' A' ' 604' ' ' GLY . 0.5 OUTLIER -79.74 140.4 36.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.25 -0.906 . . . . 0.0 110.677 -179.335 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 619' ' ' SER . . . . . 0.418 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.89 161.83 28.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.274 -0.891 . . . . 0.0 110.794 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.802 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -64.22 -45.24 89.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.337 -0.852 . . . . 0.0 109.534 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.469 ' O ' ' C ' ' A' ' 622' ' ' HIS . 11.5 t -95.76 2.22 9.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.383 -0.823 . . . . 0.0 109.405 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.8 t60 -26.05 -47.12 0.02 OUTLIER 'General case' 0 C--O 1.194 -1.831 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.46 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.8 OUTLIER -137.69 146.09 43.38 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 118.049 -1.46 . . . . 0.0 111.955 179.528 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.536 ' HA ' HG13 ' A' ' 603' ' ' ILE . 2.0 p90 -145.3 148.91 33.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.6 -0.688 . . . . 0.0 109.984 177.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 13.8 mt -103.72 124.41 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 6.0 t80 -117.32 155.24 29.87 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.481 -0.762 . . . . 0.0 109.386 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 4.3 tppt? -119.73 137.06 54.17 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.604 0.716 . . . . 0.0 110.896 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -139.09 163.07 33.39 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.719 -0.613 . . . . 0.0 109.641 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -78.5 121.24 24.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.974 -1.079 . . . . 0.0 109.314 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.522 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.0 t60 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 111.07 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.568 ' CD1' ' HA ' ' A' ' 703' ' ' PHE . 2.9 mt . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.0 OUTLIER -112.83 124.9 53.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.963 -1.085 . . . . 0.0 111.061 -179.592 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.416 ' OD2' ' CZ2' ' A' ' 648' ' ' TRP . 37.6 t0 -112.72 143.63 43.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 0.0 110.188 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 8.5 pt -99.39 132.36 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.259 -0.9 . . . . 0.0 109.663 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.611 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.2 m95 -118.12 142.95 46.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.527 -0.733 . . . . 0.0 110.918 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.474 ' N ' ' CD1' ' A' ' 672' ' ' LEU . 27.0 t80 -103.24 114.81 29.39 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.5 OUTLIER -104.06 102.63 12.38 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.641 -178.531 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.526 ' CD2' ' N ' ' A' ' 652' ' ' THR . 8.7 t60 -64.2 156.63 28.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.345 -0.847 . . . . 0.0 109.294 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -149.55 -28.22 0.26 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.364 -0.835 . . . . 0.0 112.543 -179.122 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.579 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.51 -163.82 27.26 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 117.943 -2.075 . . . . 0.0 109.724 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 654' ' ' THR . . . . . 0.448 ' O ' HG13 ' A' ' 656' ' ' VAL . 25.2 m -96.93 -17.99 19.76 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.961 -1.317 . . . . 0.0 113.921 -176.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.579 ' O ' HG22 ' A' ' 656' ' ' VAL . 20.3 m120 -59.6 -2.96 0.4 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.774 -1.204 . . . . 0.0 112.591 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 63.38 138.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-O 121.69 0.757 . . . . 0.0 110.161 -179.332 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.449 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -91.48 142.73 27.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.653 -0.655 . . . . 0.0 110.685 -178.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.466 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 6.1 m-85 -132.42 126.55 33.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.354 -0.841 . . . . 0.0 110.496 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.479 ' CD1' HG21 ' A' ' 678' ' ' ILE . 0.0 OUTLIER -130.97 115.38 16.42 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.366 -0.834 . . . . 0.0 109.955 179.515 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.08 -81.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.391 -0.818 . . . . 0.0 110.343 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.7 OUTLIER -148.36 26.87 0.94 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.0 110.157 179.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -111.21 133.52 53.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.234 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . 0.407 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 6.5 tmm_? -98.71 126.66 44.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.372 -0.83 . . . . 0.0 110.102 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.449 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 4.4 mtp -108.06 -167.73 1.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 110.345 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.415 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 1.7 pt -138.43 -164.22 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.352 -0.842 . . . . 0.0 110.279 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 652' ' ' THR . 51.5 tt0 -79.81 82.27 5.93 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.49 -0.756 . . . . 0.0 110.505 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.07 52.19 0.24 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.3 OUTLIER -121.15 148.3 44.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.018 -1.284 . . . . 0.0 110.111 179.678 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 650' ' ' CYS . 1.3 ttpm? -108.31 141.34 40.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.492 -0.755 . . . . 0.0 109.456 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.44 ' CE1' ' O ' ' A' ' 715' ' ' VAL . 0.5 OUTLIER -144.42 146.72 32.65 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.49 -178.828 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.611 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -71.31 147.17 48.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.511 -0.743 . . . . 0.0 111.197 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.474 ' CD1' ' N ' ' A' ' 649' ' ' TYR . 3.0 mp -113.45 104.98 12.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.637 -0.664 . . . . 0.0 111.5 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -88.47 151.04 22.81 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -48.22 143.83 4.3 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.162 -0.961 . . . . 0.0 110.377 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.96 46.29 52.83 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 107.841 -2.104 . . . . 0.0 107.841 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . 0.425 ' CB ' ' HB ' ' A' ' 694' ' ' VAL . 0.2 OUTLIER -100.38 88.94 3.8 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.795 -0.826 . . . . 0.0 110.512 -179.14 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.777 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -93.41 107.08 18.98 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.397 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.479 HG21 ' CD1' ' A' ' 659' ' ' LEU . 1.8 pt -115.12 137.95 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.631 -0.668 . . . . 0.0 111.737 -176.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 7.2 mttp -96.89 111.23 23.52 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . 0.412 ' CD1' ' CD1' ' A' ' 613' ' ' ILE . 73.1 mt -77.32 -11.76 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.299 -0.875 . . . . 0.0 110.64 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.484 HG21 ' O ' ' A' ' 688' ' ' PHE . 14.4 tt -143.2 133.87 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.074 -1.016 . . . . 0.0 110.158 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -138.11 111.69 8.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.149 -0.969 . . . . 0.0 110.738 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.3 117.15 19.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.233 -0.917 . . . . 0.0 109.86 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -46.93 72.71 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.361 -0.837 . . . . 0.0 110.954 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -66.94 -38.82 86.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.219 -0.925 . . . . 0.0 109.947 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . 0.58 ' O ' ' C ' ' A' ' 687' ' ' LYS . 1.5 m-80 -122.07 84.27 2.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.586 -0.696 . . . . 0.0 109.551 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . 0.58 ' C ' ' O ' ' A' ' 686' ' ' ASN . 23.4 mmtp -19.74 -82.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 122.054 -0.404 . . . . 0.0 111.335 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.542 ' CZ ' ' HA ' ' A' ' 615' ' ' ASP . 1.3 t80 33.8 73.41 0.07 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.504 -0.747 . . . . 0.0 110.099 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 586' ' ' SER . 58.6 t -112.21 143.14 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.459 -0.775 . . . . 0.0 111.49 -178.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.466 HG12 ' CG2' ' A' ' 681' ' ' ILE . 16.1 mm -103.46 164.65 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.453 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -177.12 115.8 0.52 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.001 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.777 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 12.8 m-85 -119.92 137.49 54.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -1.042 . . . . 0.0 109.138 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -101.5 114.75 29.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 110.593 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . 0.425 ' HB ' ' CB ' ' A' ' 676' ' ' ASP . 1.2 t -82.43 121.48 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.578 -0.701 . . . . 0.0 109.169 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.12 104.83 7.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.711 -0.618 . . . . 0.0 110.172 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 19.9 mt -80.91 104.43 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 0.0 109.935 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -72.78 -43.08 63.25 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.306 -0.872 . . . . 0.0 108.973 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.452 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 6.5 m-20 -110.68 140.75 44.76 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.618 0.723 . . . . 0.0 110.741 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 28.6 p -115.43 96.06 5.47 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 39.3 p -126.5 131.63 51.58 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.642 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 51.15 35.85 34.6 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . 0.45 ' O ' HD13 ' A' ' 644' ' ' LEU . 5.3 tp -108.99 132.96 53.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.451 -1.029 . . . . 0.0 111.036 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.615 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 3.3 p90 -48.47 -25.02 1.47 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.644 0.735 . . . . 0.0 110.301 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.615 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.1 t30 . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.425 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.269 0.557 . . . . 0.0 111.389 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.44 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 31.9 m -107.25 150.1 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 109.214 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.449 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 85.1 t -95.45 133.16 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 110.729 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.2 mp -108.86 162.34 14.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.42 -0.8 . . . . 0.0 110.094 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.17 154.61 17.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.36 -0.838 . . . . 0.0 110.1 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.62 148.02 31.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.304 -0.872 . . . . 0.0 110.406 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 11.1 p -121.35 -176.2 3.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.379 -0.826 . . . . 0.0 110.384 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.44 -29.2 34.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.369 -0.832 . . . . 0.0 110.002 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -66.05 -45.45 81.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.421 -0.799 . . . . 0.0 109.523 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.95 -46.91 79.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.47 -0.769 . . . . 0.0 109.62 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . 0.403 ' O ' ' CG1' ' A' ' 727' ' ' VAL . 9.1 tttt -53.53 -32.64 51.37 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.427 -0.795 . . . . 0.0 109.746 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.59 -35.94 78.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.527 -0.733 . . . . 0.0 110.33 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 34.4 mt -58.92 -46.84 86.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.274 -0.891 . . . . 0.0 110.305 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . 0.403 ' CG1' ' O ' ' A' ' 724' ' ' LYS . 7.5 p -70.8 -19.87 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.557 -0.715 . . . . 0.0 110.264 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.0 -43.51 66.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.265 -0.897 . . . . 0.0 108.956 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.94 103.52 10.37 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 122.222 1.01 . . . . 0.0 109.191 177.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.4 ' O ' ' CD2' ' A' ' 602' ' ' PHE . 1.2 mt . . . . . 0 C--N 1.273 -2.74 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.344 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.751 0.786 . . . . 1.95 109.387 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 577' ' ' PHE . . . . . 0.581 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -115.5 -42.1 3.18 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.053 0.93 . . . . 1.35 109.241 -179.178 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.581 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 9.4 tt -120.45 128.79 53.49 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.872 -0.603 . . . . 1.85 110.749 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 61.7 m -104.36 116.83 32.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 1.01 109.704 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 580' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 592' ' ' LEU . 4.1 mt -92.11 112.6 24.6 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.843 -1.169 . . . . 1.63 107.843 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 581' ' ' LYS . . . . . 0.443 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 1.0 OUTLIER -113.5 102.77 55.18 Favored Pre-proline 0 C--N 1.301 -1.502 0 C-N-CA 118.337 -1.345 . . . . 1.43 112.565 -178.089 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 582' ' ' PRO . . . . . 1.067 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.7 Cg_endo -77.49 143.11 21.47 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 N-CA-C 105.83 -2.411 . . . . 0.28 105.83 174.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 583' ' ' LEU . . . . . 0.705 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.41 -177.53 0.52 Allowed Pre-proline 0 N--CA 1.497 1.909 0 C-N-CA 118.181 -1.408 . . . . 1.73 113.848 -176.233 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 584' ' ' PRO . . . . . 0.705 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.6 Cg_endo -66.96 -34.83 28.24 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 124.253 1.659 . . . . 0.59 111.75 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -58.25 -29.32 65.68 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.173 -1.417 . . . . 1.42 107.173 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 586' ' ' SER . . . . . 0.53 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 3.0 t -95.92 150.8 20.04 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.396 -0.964 . . . . 1.31 108.396 177.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 587' ' ' ILE . . . . . 0.521 ' CG2' HD13 ' A' ' 588' ' ' ILE . 0.5 OUTLIER -57.52 -15.98 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.994 -1.066 . . . . 1.78 109.428 179.457 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 588' ' ' ILE . . . . . 0.725 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 8.1 mm -98.49 114.67 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.388 -0.82 . . . . 2.21 109.153 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.65 69.29 0.97 Allowed 'General case' 0 N--CA 1.507 2.395 0 O-C-N 120.711 -1.243 . . . . 1.7 109.512 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . 1.067 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 27.6 mt-10 -142.74 176.04 9.35 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.132 -0.94 . . . . 2.13 109.004 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.518 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.73 123.67 35.92 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.791 -1.193 . . . . 0.85 109.926 177.382 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 580' ' ' LEU . 1.8 mt -112.07 155.52 23.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.457 -0.777 . . . . 1.85 109.37 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -126.99 113.87 17.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 1.67 111.501 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 594' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 4.1 mt -72.13 109.36 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.98 -1.075 . . . . 1.17 108.31 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 595' ' ' GLN . . . . . 0.557 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -61.52 107.95 0.88 Allowed 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.601 -0.687 . . . . 1.92 110.738 -178.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 596' ' ' GLN . . . . . 0.557 ' C ' ' O ' ' A' ' 595' ' ' GLN . 3.5 tt0 -11.52 87.29 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.298 0.571 . . . . 1.86 112.253 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 597' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 105.87 22.1 8.2 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.668 -1.373 . . . . 1.37 109.668 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 598' ' ' VAL . . . . . 0.484 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 1.2 t -82.28 103.59 9.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 107.074 -1.454 . . . . 1.23 107.074 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 599' ' ' ASN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 627' ' ' LYS . 7.9 t30 -143.17 134.2 12.57 Favored Pre-proline 0 C--N 1.281 -2.403 0 CA-C-N 114.549 -1.205 . . . . 1.52 110.19 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 600' ' ' PRO . . . . . 0.648 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 54.9 Cg_endo -91.56 162.26 28.1 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.804 -1.748 . . . . 0.38 109.334 -1.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 601' ' ' PHE . . . . . 0.586 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 5.1 t80 -106.28 117.21 33.45 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.363 -1.347 . . . . 0.32 107.363 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 602' ' ' PHE . . . . . 0.653 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 56.3 m-85 -88.71 146.04 25.29 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.378 -0.826 . . . . 0.64 110.939 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 603' ' ' ILE . . . . . 0.579 HG12 ' CB ' ' A' ' 611' ' ' CYS . 2.9 mt -141.76 139.72 31.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.965 -0.694 . . . . 1.07 109.962 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 604' ' ' GLY . . . . . 0.696 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 174.82 -166.81 38.74 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.505 -1.331 . . . . 0.26 110.977 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 605' ' ' ARG . . . . . 0.426 ' HD2' ' HA ' ' A' ' 614' ' ' GLU . 14.8 tpt180 -65.4 -38.83 91.14 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.858 -0.79 . . . . 1.87 110.591 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 606' ' ' SER . . . . . 0.413 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 1.0 OUTLIER -81.04 122.32 27.16 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.323 -0.861 . . . . 1.16 110.862 -179.351 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 607' ' ' GLU . . . . . 0.509 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.1 OUTLIER -57.73 -15.2 7.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 2.39 109.79 178.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.09 -36.19 5.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.502 -0.749 . . . . 1.72 110.068 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 609' ' ' CYS . . . . . 0.653 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 73.6 m -67.41 152.71 45.21 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.552 -0.859 . . . . 1.26 109.451 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 610' ' ' ASN . . . . . 0.535 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.2 OUTLIER -57.06 -14.35 3.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.46 -0.775 . . . . 1.87 110.473 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 611' ' ' CYS . . . . . 0.579 ' CB ' HG12 ' A' ' 603' ' ' ILE . 8.7 t -120.08 144.21 47.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.398 -0.814 . . . . 0.91 109.804 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 612' ' ' LYS . . . . . 0.509 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -110.46 120.06 41.21 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 122.158 0.98 . . . . 2.66 113.29 -178.117 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 613' ' ' ILE . . . . . 0.725 ' HA ' ' CD1' ' A' ' 588' ' ' ILE . 14.1 mt -142.8 107.92 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 107.36 -1.348 . . . . 1.21 107.36 176.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 614' ' ' GLU . . . . . 0.435 ' H ' ' CD1' ' A' ' 588' ' ' ILE . 6.0 tt0 -92.45 104.4 16.73 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.98 1.371 . . . . 2.28 109.664 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 615' ' ' ASP . . . . . 0.557 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 1.8 m-20 -138.4 106.06 5.61 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.074 -1.421 . . . . 1.39 107.971 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -39.65 -44.27 1.48 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.617 -0.677 . . . . 2.23 112.131 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.78 -17.32 41.52 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.093 -1.005 . . . . 3.46 111.672 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -78.04 119.28 21.24 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.019 -1.051 . . . . 1.16 110.768 -179.137 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 619' ' ' SER . . . . . 0.453 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -59.18 159.86 7.04 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.4 -0.813 . . . . 1.36 110.809 179.852 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 620' ' ' ARG . . . . . 0.696 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -63.91 -45.39 89.53 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.32 -0.862 . . . . 2.83 109.183 179.521 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 621' ' ' VAL . . . . . 0.466 ' O ' ' C ' ' A' ' 622' ' ' HIS . 10.5 m -95.06 1.84 9.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.355 -0.84 . . . . 1.75 109.469 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 6.3 t60 -28.87 -46.79 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.622 -0.717 . . . . 0.25 110.875 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 623' ' ' CYS . . . . . 0.426 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.6 OUTLIER -136.45 145.77 45.58 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.45 -1.3 . . . . 0.91 110.777 178.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 624' ' ' PHE . . . . . 0.558 ' HA ' HG13 ' A' ' 603' ' ' ILE . 3.1 p90 -144.72 149.58 35.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.458 -0.776 . . . . 0.75 110.219 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 625' ' ' ILE . . . . . 0.586 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 69.2 mt -104.54 121.75 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.765 -0.828 . . . . 1.32 108.765 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 626' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 4.5 t80 -115.27 153.96 29.95 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.52 -0.737 . . . . 1.17 109.439 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 627' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 1.2 ttmt -120.12 137.08 54.35 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.578 0.704 . . . . 1.63 110.501 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 628' ' ' LYS . . . . . 0.42 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.57 163.32 29.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.594 -0.691 . . . . 2.49 110.321 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 629' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.5 OUTLIER -78.32 115.08 17.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.95 . . . . 2.64 108.74 179.82 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 630' ' ' HIS . . . . . 0.538 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.9 t60 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.505 -0.747 . . . . 0.78 110.846 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 644' ' ' LEU . . . . . 0.481 ' HB2' ' CA ' ' A' ' 703' ' ' PHE . 5.0 mp . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 108.97 -0.752 . . . . 1.86 108.97 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -112.54 123.97 51.48 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.974 -1.079 . . . . 1.54 111.276 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 646' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 628' ' ' LYS . 26.5 t70 -109.57 146.8 34.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.513 -0.742 . . . . 1.2 109.665 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 647' ' ' ILE . . . . . 0.46 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 12.5 pt -102.49 130.66 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.279 -0.888 . . . . 1.11 110.039 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 648' ' ' TRP . . . . . 0.606 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 91.3 m95 -118.58 119.71 35.31 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.092 -0.643 . . . . 0.35 110.754 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.459 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 3.8 t80 -80.93 114.69 19.98 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.366 -0.975 . . . . 0.97 108.366 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 650' ' ' CYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.1 OUTLIER -106.35 114.29 28.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.909 . . . . 1.51 111.564 -178.608 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.527 ' CE1' ' C ' ' A' ' 656' ' ' VAL . 17.2 t60 -74.04 159.92 32.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.451 -0.781 . . . . 0.36 109.975 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -149.96 -30.59 0.22 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.403 -0.81 . . . . 1.1 112.968 -179.158 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 653' ' ' GLY . . . . . 0.562 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.03 -167.73 30.93 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 117.579 -2.248 . . . . 0.72 109.416 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 24.3 m -94.94 -17.85 21.62 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.968 -1.313 . . . . 1.16 113.91 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 655' ' ' ASN . . . . . 0.458 ' O ' ' CB ' ' A' ' 656' ' ' VAL . 30.5 m120 -60.85 -4.29 0.96 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.774 -1.204 . . . . 1.79 112.398 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . 0.527 ' C ' ' CE1' ' A' ' 651' ' ' HIS . 0.4 OUTLIER 75.45 166.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-O 121.95 0.881 . . . . 2.06 110.648 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 657' ' ' SER . . . . . 0.42 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -123.73 145.51 48.96 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.162 -0.615 . . . . 0.41 110.585 -178.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.434 ' CE1' ' CG ' ' A' ' 663' ' ' ARG . 15.7 m-85 -135.64 126.32 27.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.272 -0.893 . . . . 1.39 110.615 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.51 ' CD1' HG21 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -128.2 109.85 11.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.273 -0.892 . . . . 2.0 109.927 179.231 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.77 -80.34 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.484 -0.76 . . . . 2.02 110.358 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 661' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.4 m-20 -146.13 25.21 1.27 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.25 -0.906 . . . . 2.88 110.307 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.03 117.95 30.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.284 -0.885 . . . . 1.86 110.285 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 663' ' ' ARG . . . . . 0.434 ' CG ' ' CE1' ' A' ' 658' ' ' TYR . 3.0 tmm_? -84.39 141.06 31.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 3.05 110.098 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 664' ' ' MET . . . . . 0.418 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 3.5 mtp -118.89 -166.12 1.21 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.279 -0.888 . . . . 1.1 110.294 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 665' ' ' ILE . . . . . 0.418 ' CG1' ' CG2' ' A' ' 668' ' ' THR . 1.4 pt -138.34 -160.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.225 -0.922 . . . . 1.22 110.365 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -81.65 90.43 6.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.398 -0.814 . . . . 1.05 110.564 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.07 50.43 0.68 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.021 -1.232 . . . . 0.43 110.021 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 668' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -117.61 149.43 40.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.113 -1.227 . . . . 1.05 110.13 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.42 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 10.8 tttt -108.39 141.01 40.87 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.985 -0.746 . . . . 1.3 108.985 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 670' ' ' PHE . . . . . 0.439 ' CD1' HG23 ' A' ' 716' ' ' VAL . 13.5 t80 -143.96 146.29 32.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.148 -0.97 . . . . 1.73 111.665 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 671' ' ' LEU . . . . . 0.606 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -73.08 147.26 45.14 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.626 -0.671 . . . . 1.98 110.621 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 672' ' ' LEU . . . . . 0.459 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 12.8 mt -118.56 112.83 20.39 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.672 -0.811 . . . . 1.55 111.306 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -90.25 -177.43 5.12 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.044 -0.725 . . . . 1.28 109.044 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -76.26 142.83 41.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.138 -0.976 . . . . 1.21 109.691 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.34 47.2 59.48 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 107.788 -2.125 . . . . 0.3 107.788 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.45 91.93 4.92 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.748 -0.854 . . . . 1.33 110.491 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.908 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.3 tt0 -93.16 107.42 19.23 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.76 -1.2 . . . . 1.79 107.76 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 678' ' ' ILE . . . . . 0.51 HG21 ' CD1' ' A' ' 659' ' ' LEU . 1.4 pt -111.73 137.74 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.419 0.628 . . . . 1.58 111.667 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -98.95 111.01 23.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.515 -0.741 . . . . 2.9 109.4 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 72.8 mt -75.35 -24.11 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 1.04 110.352 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 681' ' ' ILE . . . . . 0.471 ' CD1' ' HB2' ' A' ' 618' ' ' LEU . 3.6 mt -143.02 136.15 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -0.942 . . . . 1.84 110.394 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -137.49 108.91 6.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.435 -0.79 . . . . 1.24 110.109 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.36 118.36 29.27 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.265 -0.897 . . . . 1.43 110.221 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -65.99 -46.35 78.31 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.423 -0.798 . . . . 2.71 110.887 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -80.4 -43.31 21.25 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.252 -0.905 . . . . 2.46 110.68 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.74 -13.8 58.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.306 -0.871 . . . . 2.85 110.471 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 57.23 18.95 4.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.221 -0.925 . . . . 3.12 110.56 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 688' ' ' PHE . . . . . 0.414 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -74.66 77.98 2.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 1.88 109.034 179.252 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.63 136.15 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.82 . . . . 2.04 110.881 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 690' ' ' ILE . . . . . 0.447 ' CD1' ' CG2' ' A' ' 587' ' ' ILE . 47.1 mm -117.5 163.26 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.738 -0.838 . . . . 1.49 108.738 178.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 691' ' ' GLY . . . . . 0.53 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -172.98 125.39 1.14 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.511 -1.328 . . . . 0.29 109.932 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 692' ' ' PHE . . . . . 0.908 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 6.9 m-85 -120.63 137.71 54.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.603 -0.939 . . . . 0.32 109.484 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -100.67 113.71 26.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.13 -0.981 . . . . 2.84 110.031 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 1.2 t -85.45 115.03 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.365 -0.835 . . . . 1.11 108.884 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -122.55 103.92 9.02 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.136 -0.626 . . . . 1.66 109.923 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 74.0 mt -77.23 103.95 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.4 -0.812 . . . . 1.14 109.113 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.21 -43.51 28.26 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.355 -0.841 . . . . 1.14 108.808 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 698' ' ' ASP . . . . . 0.42 ' O ' ' HD1' ' A' ' 577' ' ' PHE . 8.0 m-20 -111.33 141.81 44.38 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.543 0.687 . . . . 1.19 110.612 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 27.1 p -115.27 96.1 5.5 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.164 -1.421 . . . . 1.13 107.164 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 6.7 m -127.43 132.63 50.04 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.305 0.574 . . . . 2.15 111.077 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 50.4 25.99 9.19 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.135 -1.186 . . . . 1.33 110.135 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.23 134.87 44.81 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.283 -1.128 . . . . 1.84 110.239 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 703' ' ' PHE . . . . . 0.623 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 3.4 p90 -49.47 -24.28 1.96 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.627 -0.67 . . . . 0.86 110.673 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 704' ' ' ASN . . . . . 0.623 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 O-C-N 121.531 -0.731 . . . . 0.99 109.031 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 714' ' ' ARG . . . . . 0.412 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.238 0.542 . . . . 1.6 111.691 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.86 153.1 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.553 -0.717 . . . . 1.26 109.522 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 716' ' ' VAL . . . . . 0.439 HG23 ' CD1' ' A' ' 670' ' ' PHE . 48.1 t -96.52 133.33 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.121 -0.987 . . . . 1.3 110.581 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.9 mp -109.5 162.66 14.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.478 -0.764 . . . . 1.46 109.94 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -99.16 149.05 23.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.971 . . . . 2.93 110.045 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.92 150.13 30.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.829 . . . . 2.45 110.248 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 21.8 p -116.42 -176.48 2.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 1.19 110.277 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.58 -28.96 35.07 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.337 -0.852 . . . . 1.23 110.163 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.63 -47.88 71.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.385 -0.822 . . . . 2.33 109.779 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -64.21 -48.61 75.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.417 -0.802 . . . . 1.95 110.056 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -52.61 -33.19 45.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.389 -0.819 . . . . 2.93 109.795 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -68.39 -35.91 78.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.528 -0.732 . . . . 1.6 109.911 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 42.7 mt -55.95 -46.54 78.54 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.395 -0.816 . . . . 1.79 110.018 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.01 -21.01 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.606 -0.683 . . . . 1.67 110.351 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -52.9 -43.09 65.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.238 -0.914 . . . . 2.96 108.857 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -116.8 103.67 10.56 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.292 1.044 . . . . 3.07 109.138 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 730' ' ' LEU . . . . . 0.41 ' O ' ' CE2' ' A' ' 602' ' ' PHE . 4.3 mt . . . . . 0 C--N 1.274 -2.687 0 CA-C-O 118.017 -0.992 . . . . 1.25 110.38 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.412 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -82.84 -10.51 58.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.368 -1.077 . . . . 0.0 110.622 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 165.2 38.64 0.02 OUTLIER Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.49 151.82 19.06 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.317 -1.108 . . . . 0.0 109.102 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.54 ' CD2' ' O ' ' A' ' 698' ' ' ASP . 0.5 OUTLIER -150.92 -40.8 0.12 Allowed 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.045 0.926 . . . . 0.0 108.795 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 594' ' ' ILE . 16.1 tp -130.69 119.59 22.63 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.335 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 88.7 m -102.66 118.3 36.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.141 -0.974 . . . . 0.0 109.434 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.401 HD12 ' CD1' ' A' ' 594' ' ' ILE . 15.3 mt -91.16 112.02 23.74 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.433 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -114.24 101.56 54.18 Favored Pre-proline 0 C--N 1.302 -1.473 0 C-N-CA 118.131 -1.428 . . . . 0.0 112.843 -177.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.146 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.2 Cg_endo -79.6 144.24 17.51 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 N-CA-C 105.788 -2.428 . . . . 0.0 105.788 174.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.69 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -123.48 -178.3 0.64 Allowed Pre-proline 0 N--CA 1.498 1.927 0 C-N-CA 118.214 -1.394 . . . . 0.0 114.082 -175.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.69 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.5 Cg_endo -67.6 -31.81 32.39 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 124.272 1.67 . . . . 0.0 111.375 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.79 -30.72 67.8 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.449 ' CB ' ' N ' ' A' ' 691' ' ' GLY . 4.0 p -97.43 153.41 18.13 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.529 ' CG1' HG12 ' A' ' 690' ' ' ILE . 4.7 pt -56.69 -17.15 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 109.637 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.541 HG13 HG12 ' A' ' 613' ' ' ILE . 7.0 mm -99.61 114.96 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.318 -0.864 . . . . 0.0 108.7 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.525 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -126.12 73.0 1.33 Allowed 'General case' 0 N--CA 1.508 2.443 0 O-C-N 120.653 -1.28 . . . . 0.0 110.587 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.146 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 49.6 mt-10 -143.04 174.7 10.45 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.489 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.32 126.34 40.59 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.589 -1.319 . . . . 0.0 109.752 176.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 1.1 mt -110.7 156.0 21.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 0.0 109.28 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -125.2 110.04 13.59 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.427 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 578' ' ' LEU . 29.3 mt -80.28 108.39 13.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.406 ' O ' ' C ' ' A' ' 596' ' ' GLN . 3.8 mt-30 -70.99 120.67 16.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.507 -0.746 . . . . 0.0 111.261 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.538 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 11.6 mm-40 37.77 33.72 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.409 0.624 . . . . 0.0 111.035 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . 80.15 65.07 1.78 Allowed Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.492 HG11 HG22 ' A' ' 594' ' ' ILE . 10.9 p -79.69 105.07 8.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -121.72 150.9 56.43 Favored Pre-proline 0 C--N 1.28 -2.454 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.694 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.459 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.6 Cg_endo -86.68 157.46 51.63 Favored 'Cis proline' 0 C--N 1.308 -1.602 0 C-N-CA 121.075 -2.469 . . . . 0.0 109.511 0.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.484 ' CD2' ' HB2' ' A' ' 611' ' ' CYS . 3.0 t80 -106.25 116.11 31.37 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.547 ' O ' ' HB3' ' A' ' 609' ' ' CYS . 60.6 m-85 -87.89 144.33 26.63 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.311 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.609 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.8 mt -141.02 142.12 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.742 -0.599 . . . . 0.0 110.602 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.774 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 170.37 -159.05 31.27 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.912 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -71.37 -47.24 57.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.819 -0.812 . . . . 0.0 110.957 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.88 126.97 31.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 110.808 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.536 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.2 OUTLIER -56.76 -15.54 4.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.832 . . . . 0.0 110.439 179.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -45.73 -35.94 4.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.251 -0.906 . . . . 0.0 109.125 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 602' ' ' PHE . 1.3 m -62.78 136.65 57.97 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -49.86 -25.51 3.22 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.307 -0.87 . . . . 0.0 109.628 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.609 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 2.1 t -109.03 143.57 38.16 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.536 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -110.48 128.55 55.67 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 122.198 0.999 . . . . 0.0 113.101 -178.256 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.541 HG12 HG13 ' A' ' 588' ' ' ILE . 13.0 mt -142.39 108.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -89.68 102.46 15.15 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 117.838 -1.545 . . . . 0.0 107.796 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.808 ' HB3' ' CB ' ' A' ' 618' ' ' LEU . 9.9 t0 -139.93 106.39 5.31 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.57 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -38.67 -65.86 0.32 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.579 -0.701 . . . . 0.0 112.747 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.72 -16.51 64.29 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.117 -0.99 . . . . 0.0 112.455 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.808 ' CB ' ' HB3' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -73.19 129.44 38.05 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.0 -1.062 . . . . 0.0 110.87 -179.035 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 619' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.8 160.89 24.94 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.287 -0.883 . . . . 0.0 110.818 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.774 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.7 mtt180 -64.43 -46.94 81.03 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.294 -0.879 . . . . 0.0 109.474 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.475 ' O ' ' C ' ' A' ' 622' ' ' HIS . 9.3 m -95.37 2.58 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.402 -0.811 . . . . 0.0 109.577 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.6 t60 -25.41 -45.94 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.263 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.443 ' N ' ' O ' ' A' ' 621' ' ' VAL . 0.7 OUTLIER -136.49 145.68 45.41 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.453 -1.299 . . . . 0.0 111.283 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.543 ' HA ' HG13 ' A' ' 603' ' ' ILE . 2.1 p90 -145.52 144.15 30.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.544 -0.723 . . . . 0.0 110.09 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 12.3 mt -103.28 121.42 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 9.4 t80 -114.52 154.87 27.48 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.397 -0.814 . . . . 0.0 109.861 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 5.2 ttmt -120.17 136.84 54.48 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.49 0.662 . . . . 0.0 110.583 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.471 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -138.93 163.57 31.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.628 -0.67 . . . . 0.0 110.357 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -78.11 127.64 32.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.241 -0.912 . . . . 0.0 108.728 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.529 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.6 t60 -57.79 124.07 17.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 110.769 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -79.85 113.92 18.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.793 -0.567 . . . . 0.0 110.47 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 14.6 p -123.82 174.64 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.431 -0.793 . . . . 0.0 110.321 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -99.3 -169.17 30.42 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.56 137.91 58.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.273 -1.134 . . . . 0.0 109.979 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.93 84.77 1.25 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.386 -0.821 . . . . 0.0 110.703 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 26.8 mtt -63.21 126.24 26.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.416 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.61 -145.67 0.38 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.414 -0.804 . . . . 0.0 109.603 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -115.33 101.29 8.79 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.114 -0.991 . . . . 0.0 109.147 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 91.8 p -137.61 151.38 70.76 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.905 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.64 -151.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.588 1.31 . . . . 0.0 109.6 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 52.73 24.92 3.45 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.38 -0.825 . . . . 0.0 110.821 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -73.17 60.31 0.57 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.191 -0.943 . . . . 0.0 110.175 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 62.48 114.63 0.01 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 5.3 mp -141.99 -152.71 0.42 Allowed 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 24.4 m-20 -119.24 124.76 47.52 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.007 -1.058 . . . . 0.0 111.386 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.425 ' OD2' ' CE1' ' A' ' 630' ' ' HIS . 7.9 t0 -112.87 155.93 23.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.481 -0.762 . . . . 0.0 110.027 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 13.2 pt -107.08 134.71 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.252 -0.905 . . . . 0.0 109.943 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.694 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.4 m95 -119.05 124.01 45.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.649 -0.657 . . . . 0.0 111.233 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.439 ' CE1' HD13 ' A' ' 678' ' ' ILE . 12.5 t80 -83.37 114.95 21.79 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.535 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 8.2 t -108.67 109.17 20.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.051 -1.031 . . . . 0.0 111.423 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.599 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 9.4 t60 -75.28 160.72 30.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.43 -0.794 . . . . 0.0 110.057 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -152.52 -29.72 0.15 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.355 -0.841 . . . . 0.0 113.187 -178.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.599 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -79.28 135.48 15.48 Favored Glycine 0 N--CA 1.502 3.047 0 C-N-CA 117.866 -2.111 . . . . 0.0 110.212 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 654' ' ' THR . . . . . 0.448 ' O ' HG13 ' A' ' 656' ' ' VAL . 5.8 m -36.87 -24.56 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.511 ' O ' HG22 ' A' ' 656' ' ' VAL . 2.4 t-20 -59.12 -2.22 0.25 Allowed 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.471 -1.393 . . . . 0.0 113.179 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 655' ' ' ASN . 0.9 OUTLIER 63.92 146.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.453 -0.779 . . . . 0.0 110.702 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.527 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -97.7 153.38 18.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.76 -0.587 . . . . 0.0 110.246 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.474 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 10.2 m-85 -138.45 125.4 21.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.324 -0.86 . . . . 0.0 110.057 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' A' ' 661' ' ' ASN . 0.1 OUTLIER -134.52 121.16 20.61 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.318 -0.864 . . . . 0.0 109.908 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 6.5 m120 55.16 -86.29 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.479 -0.763 . . . . 0.0 110.437 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 659' ' ' LEU . 5.8 t30 -143.32 14.05 1.81 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.096 -1.003 . . . . 0.0 110.602 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -102.29 118.16 36.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.135 -0.978 . . . . 0.0 110.383 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . 0.434 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 0.0 OUTLIER -85.04 139.01 32.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.366 -0.834 . . . . 0.0 110.004 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.446 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 3.5 mtp -120.25 -179.54 3.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 0.0 110.616 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.462 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 7.0 pt -120.18 -161.0 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.41 -0.806 . . . . 0.0 110.093 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -84.96 72.03 10.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.345 -0.847 . . . . 0.0 110.748 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 134.2 59.54 0.07 OUTLIER Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.6 OUTLIER -124.31 149.89 46.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.155 -1.203 . . . . 0.0 110.318 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.463 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 11.9 tttt -108.79 133.67 52.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.493 -0.754 . . . . 0.0 109.016 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.483 ' HD1' ' HA ' ' A' ' 716' ' ' VAL . 11.9 t80 -138.01 146.42 43.06 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.485 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.694 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.9 OUTLIER -72.69 144.66 47.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.461 -0.774 . . . . 0.0 110.267 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.43 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 1.3 mt -111.71 104.56 12.92 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.676 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.551 ' NE2' ' HA3' ' A' ' 708' ' ' GLY . 17.1 mt-30 -84.62 161.28 20.2 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 706' ' ' GLY . 8.2 p-10 -56.85 143.94 35.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.119 . . . . 0.0 109.569 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.67 47.27 50.01 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.664 -2.174 . . . . 0.0 107.664 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.31 89.91 3.54 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.836 -0.803 . . . . 0.0 110.473 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.914 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 7.1 tt0 -93.29 106.85 18.76 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.44 ' CG2' ' HG ' ' A' ' 659' ' ' LEU . 3.3 pt -111.1 137.32 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.346 0.593 . . . . 0.0 111.473 -177.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.29 109.96 22.53 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.525 -0.734 . . . . 0.0 109.091 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.426 ' CD1' ' CD1' ' A' ' 613' ' ' ILE . 89.9 mt -74.35 -29.51 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.404 -0.81 . . . . 0.0 110.26 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 689' ' ' VAL . 3.0 mt -143.0 133.26 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 109.851 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -138.42 111.79 8.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.572 -0.705 . . . . 0.0 110.108 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -129.12 117.54 21.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -66.69 -33.28 75.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.437 -0.789 . . . . 0.0 110.726 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -55.98 -43.52 77.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.395 -0.816 . . . . 0.0 111.08 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.05 12.14 11.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 110.706 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.31 23.69 2.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.159 -0.963 . . . . 0.0 110.41 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.5 ' CE2' ' HA ' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -72.81 74.39 1.13 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 0.0 109.53 179.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 681' ' ' ILE . 14.6 p -105.56 136.96 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.43 -0.794 . . . . 0.0 110.895 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.529 HG12 ' CG1' ' A' ' 587' ' ' ILE . 18.2 mt -108.38 163.77 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.347 -0.846 . . . . 0.0 108.928 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.449 ' N ' ' CB ' ' A' ' 586' ' ' SER . . . -170.84 123.62 1.06 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.914 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 11.4 m-85 -120.16 137.34 54.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.53 -0.982 . . . . 0.0 109.589 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 21.2 tptt -100.52 114.21 27.65 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 110.515 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 1.2 t -85.62 118.78 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.373 -0.829 . . . . 0.0 109.001 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -130.08 104.75 7.51 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.925 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.489 ' CD1' ' HA3' ' A' ' 706' ' ' GLY . 10.9 mt -85.49 104.4 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 110.037 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -77.27 -43.15 34.37 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.54 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -111.02 140.94 45.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.712 -0.618 . . . . 0.0 110.316 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 699' ' ' THR . 2.0 p -114.94 96.45 5.71 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 4.6 p -81.93 92.94 6.82 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.507 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 47.6 42.97 20.96 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.407 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 2.0 tp -85.79 148.78 25.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.45 -1.029 . . . . 0.0 110.337 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.538 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 5.1 p90 -49.47 -25.48 2.65 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.505 -0.747 . . . . 0.0 110.288 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.538 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.6 t30 -157.88 168.94 25.76 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.467 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 13.5 pt-20 -51.29 -23.47 3.6 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.09 -1.006 . . . . 0.0 110.073 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.489 ' HA3' ' CD1' ' A' ' 696' ' ' ILE . . . 121.71 6.52 8.57 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.034 -1.627 . . . . 0.0 109.034 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 708' ' ' GLY . 0.3 OUTLIER -89.59 10.01 24.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.447 -1.031 . . . . 0.0 111.157 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.551 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 49.73 100.85 0.01 OUTLIER Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.41 ' HE1' ' CE2' ' A' ' 703' ' ' PHE . 0.0 OUTLIER -138.84 40.44 2.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -1.184 . . . . 0.0 110.391 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.49 -173.31 3.53 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.296 -0.878 . . . . 0.0 110.338 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -57.47 -53.51 57.34 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.341 -0.849 . . . . 0.0 110.933 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -63.41 141.68 58.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.21 -0.931 . . . . 0.0 110.146 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -111.48 95.92 5.8 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.349 -0.844 . . . . 0.0 109.454 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.411 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 7.7 mmm-85 46.88 70.98 0.35 Allowed 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.274 0.559 . . . . 0.0 111.225 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.6 m -107.71 152.58 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.844 . . . . 0.0 109.406 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.483 ' HA ' ' HD1' ' A' ' 670' ' ' PHE . 49.6 t -96.24 133.37 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 110.735 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.43 162.14 14.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.514 -0.742 . . . . 0.0 109.56 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -97.37 149.49 22.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 0.0 110.511 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -80.94 129.07 34.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.434 -0.791 . . . . 0.0 110.015 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.2 p -103.42 -176.39 3.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.393 -0.817 . . . . 0.0 110.19 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.31 -28.79 30.23 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.397 -0.814 . . . . 0.0 110.113 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.11 -51.69 62.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.849 . . . . 0.0 109.897 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -64.02 -47.58 79.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.997 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.61 -32.73 52.36 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.322 -0.861 . . . . 0.0 110.076 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.45 -36.15 78.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.414 -0.804 . . . . 0.0 110.101 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 38.6 mt -58.55 -46.59 86.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.365 -0.834 . . . . 0.0 110.296 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.8 p -71.42 -20.75 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.225 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -53.41 -45.31 69.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.24 -0.913 . . . . 0.0 108.81 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.8 104.44 11.34 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.218 1.009 . . . . 0.0 109.006 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.415 ' OXT' ' CD2' ' A' ' 602' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--N 1.274 -2.692 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.281 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.7 -10.21 59.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -1.098 . . . . 0.0 110.529 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 126.16 -19.07 6.48 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -92.77 114.36 26.89 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.213 -1.169 . . . . 0.0 109.54 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.54 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 8.5 t80 -95.83 -43.28 7.93 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.92 0.867 . . . . 0.0 109.392 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.5 ' HB2' ' CD2' ' A' ' 577' ' ' PHE . 0.5 OUTLIER -126.97 136.98 53.0 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.043 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 88.4 m -113.43 117.26 31.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.14 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 2.6 mt -92.69 112.11 23.95 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 2.1 mmtt -112.81 102.18 54.18 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 118.255 -1.378 . . . . 0.0 113.24 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.084 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 45.0 Cg_endo -79.58 142.01 16.0 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 N-CA-C 105.32 -2.608 . . . . 0.0 105.32 173.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.727 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -119.16 -176.2 0.37 Allowed Pre-proline 0 N--CA 1.496 1.847 0 C-N-CA 118.16 -1.416 . . . . 0.0 113.896 -175.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.727 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.1 Cg_endo -66.82 -32.41 36.76 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 124.274 1.671 . . . . 0.0 112.033 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -59.08 -29.68 67.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.785 -1.197 . . . . 0.0 108.525 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.595 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 66.7 p -96.5 150.24 20.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.857 -0.527 . . . . 0.0 109.833 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.537 ' CG2' HD13 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -54.76 -20.31 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.146 -0.971 . . . . 0.0 109.028 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.665 HD11 ' HA ' ' A' ' 613' ' ' ILE . 9.2 mm -93.65 115.06 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.483 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -125.46 72.31 1.26 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 109.865 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.084 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 58.3 mm-40 -145.15 175.85 9.95 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.623 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.52 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.47 126.02 39.65 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.986 -1.071 . . . . 0.0 109.052 176.327 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 1.2 mp -109.79 154.08 23.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 0.0 109.745 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -125.53 110.05 13.41 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.502 -0.749 . . . . 0.0 110.989 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.416 HG21 ' HB ' ' A' ' 598' ' ' VAL . 1.9 mt -80.91 109.86 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.151 -0.968 . . . . 0.0 108.675 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -53.06 165.89 0.27 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.672 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.54 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 5.2 mt-30 -65.1 68.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.421 -0.799 . . . . 0.0 109.87 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 138.57 21.87 0.43 Allowed Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.567 -1.302 . . . . 0.0 110.789 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.446 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -85.92 101.53 10.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 O-C-N 120.732 -1.452 . . . . 0.0 107.176 178.449 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 627' ' ' LYS . 13.8 t-20 -144.99 134.05 11.17 Favored Pre-proline 0 C--N 1.284 -2.266 0 CA-C-N 114.777 -1.102 . . . . 0.0 110.21 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.556 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 51.0 Cg_endo -91.99 164.01 26.78 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 123.222 -1.574 . . . . 0.0 108.784 -2.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.505 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 4.1 t80 -104.48 116.11 31.53 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.556 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 36.4 m-85 -83.16 144.2 29.98 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.541 -0.724 . . . . 0.0 110.436 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.529 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 3.3 mt -142.67 141.77 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.66 -0.65 . . . . 0.0 110.045 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.749 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 168.75 -160.97 34.63 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.925 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 14.5 tpt180 -71.13 -43.52 67.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.713 -0.875 . . . . 0.0 111.189 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.431 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -78.3 126.51 30.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 110.872 -179.227 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.439 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.9 tt0 -54.04 -18.33 3.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.141 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.06 -31.32 0.9 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.255 -0.903 . . . . 0.0 109.142 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.5 m -69.89 130.77 43.15 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.505 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -44.83 -28.59 0.66 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.267 -0.895 . . . . 0.0 109.904 179.514 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.529 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 2.4 t -105.19 143.49 33.29 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.439 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.1 OUTLIER -109.19 128.19 54.83 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.286 -0.966 . . . . 0.0 112.859 -178.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.665 ' HA ' HD11 ' A' ' 588' ' ' ILE . 12.1 mt -141.79 108.06 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -91.73 103.79 16.32 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.228 -1.389 . . . . 0.0 108.396 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 2.6 m-20 -138.81 106.02 5.49 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.363 -1.289 . . . . 0.0 108.839 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -45.69 -42.17 11.31 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.546 -0.721 . . . . 0.0 111.948 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 27.2 mtm-85 -83.12 -17.14 44.11 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.074 -1.016 . . . . 0.0 111.269 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.485 ' CD2' ' HA2' ' A' ' 604' ' ' GLY . 0.8 OUTLIER -77.85 140.54 39.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.271 -0.893 . . . . 0.0 110.826 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.434 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.84 161.45 28.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.322 -0.861 . . . . 0.0 110.694 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.749 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 13.3 ttp180 -64.09 -45.79 87.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.328 -0.858 . . . . 0.0 109.255 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.466 ' O ' ' C ' ' A' ' 622' ' ' HIS . 2.8 t -95.52 2.07 9.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.84 0.829 . . . . 0.0 109.475 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.2 t60 -27.18 -46.69 0.03 OUTLIER 'General case' 0 C--O 1.196 -1.762 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.549 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.8 OUTLIER -137.59 145.69 43.12 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 118.025 -1.47 . . . . 0.0 111.857 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.516 ' HA ' HG13 ' A' ' 603' ' ' ILE . 13.1 p90 -146.68 142.64 28.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.595 -0.691 . . . . 0.0 109.9 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 60.3 mt -102.61 117.97 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.407 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 8.6 t80 -114.53 154.72 27.76 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.767 0.794 . . . . 0.0 110.017 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 5.4 ttmt -120.18 137.48 54.16 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.597 0.713 . . . . 0.0 110.737 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.407 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.44 163.94 29.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.516 -0.74 . . . . 0.0 110.092 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.6 OUTLIER -77.25 117.79 19.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.158 -0.964 . . . . 0.0 108.704 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.526 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.7 t60 -58.23 124.47 19.56 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.647 0.737 . . . . 0.0 110.701 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -114.01 112.91 24.03 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.765 -0.584 . . . . 0.0 110.259 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 57.7 t -86.92 167.56 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.417 -0.802 . . . . 0.0 110.178 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -59.38 174.1 3.9 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -55.53 129.61 39.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.294 -1.121 . . . . 0.0 110.232 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 85.6 p -105.99 93.36 4.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 110.608 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.6 36.79 1.45 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.348 -0.845 . . . . 0.0 109.722 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.24 -151.65 0.19 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.538 -0.726 . . . . 0.0 109.911 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -116.07 102.97 10.1 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.195 -0.941 . . . . 0.0 109.036 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 48.5 p -134.72 150.44 73.48 Favored Pre-proline 0 C--N 1.293 -1.85 0 O-C-N 121.883 -0.511 . . . . 0.0 110.191 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . 0.409 ' O ' ' CB ' ' A' ' 641' ' ' ALA . 50.0 Cg_endo -70.36 -151.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.77 1.405 . . . . 0.0 110.012 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.42 ' O ' ' CD1' ' A' ' 644' ' ' LEU . . . 68.21 -61.58 0.39 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.651 -0.656 . . . . 0.0 110.669 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 52.05 -159.76 0.11 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.118 -0.989 . . . . 0.0 109.93 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -114.79 130.59 9.29 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.44 ' HB2' ' N ' ' A' ' 703' ' ' PHE . 5.1 mp -142.58 -151.35 0.35 Allowed 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.959 -0.73 . . . . 0.0 109.326 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.2 m-20 -110.02 124.22 51.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.007 -1.058 . . . . 0.0 110.908 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 628' ' ' LYS . 24.0 t0 -110.02 151.11 27.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.425 -0.797 . . . . 0.0 109.944 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 11.1 pt -105.66 132.0 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.338 -0.851 . . . . 0.0 109.898 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.624 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.7 m95 -119.03 119.25 33.72 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.87 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.508 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 1.1 t80 -80.96 114.08 19.6 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 668' ' ' THR . 62.9 m -108.37 108.66 19.72 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.506 -0.877 . . . . 0.0 111.206 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.558 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 17.8 t60 -73.24 169.16 17.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.499 -0.75 . . . . 0.0 109.992 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -159.58 -29.87 0.06 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.292 -0.88 . . . . 0.0 113.118 -178.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.558 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -79.7 140.43 22.55 Favored Glycine 0 N--CA 1.502 3.035 0 O-C-N 119.453 -2.029 . . . . 0.0 110.406 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 654' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 656' ' ' VAL . 22.7 m -47.1 -22.2 0.33 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.479 ' O ' ' CB ' ' A' ' 656' ' ' VAL . 1.0 OUTLIER -58.51 -4.27 0.38 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.601 -1.312 . . . . 0.0 112.444 -178.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.486 ' C ' ' CE1' ' A' ' 651' ' ' HIS . 0.4 OUTLIER 79.52 167.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 CA-C-O 121.878 0.847 . . . . 0.0 110.814 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.526 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -128.93 151.13 50.0 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.612 -179.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -138.48 126.59 22.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.174 -0.954 . . . . 0.0 110.946 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.505 ' CD2' ' CD2' ' A' ' 670' ' ' PHE . 14.7 tp -124.49 107.35 10.98 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.256 -0.903 . . . . 0.0 109.576 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 63.2 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.51 -0.743 . . . . 0.0 110.042 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 659' ' ' LEU . 3.2 m-20 -154.5 23.91 0.47 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 110.172 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.46 116.94 29.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.176 -0.953 . . . . 0.0 110.373 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.76 139.08 43.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 110.001 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.427 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 47.2 mtp -122.6 157.84 31.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.345 -0.847 . . . . 0.0 110.234 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.411 ' CG1' HG23 ' A' ' 668' ' ' THR . 16.2 pt -98.8 -157.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.0 109.829 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -86.12 119.63 26.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.288 -0.883 . . . . 0.0 110.43 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 81.03 52.83 4.15 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -114.85 148.49 38.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.991 -1.299 . . . . 0.0 110.274 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.444 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -109.04 138.68 45.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.566 -0.709 . . . . 0.0 109.345 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.505 ' CD2' ' CD2' ' A' ' 659' ' ' LEU . 0.6 OUTLIER -144.59 145.21 31.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 111.288 -178.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.624 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -70.15 147.69 49.59 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.433 -0.792 . . . . 0.0 110.604 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.508 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 10.7 mt -118.02 114.67 23.49 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.413 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.429 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 87.4 mt-30 -95.1 147.91 22.93 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 706' ' ' GLY . 23.1 p-10 -46.3 143.02 2.64 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.133 -0.98 . . . . 0.0 110.532 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.66 47.33 41.58 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 107.611 -2.196 . . . . 0.0 107.611 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.52 93.87 4.73 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.885 -0.774 . . . . 0.0 110.07 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.873 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.1 tm-20 -93.86 107.58 19.45 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.444 ' CG2' ' CD1' ' A' ' 659' ' ' LEU . 28.2 pt -107.43 137.91 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.602 -0.686 . . . . 0.0 111.811 -178.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -98.76 110.81 23.35 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.428 ' CG2' ' NE2' ' A' ' 622' ' ' HIS . 72.4 mt -75.01 -19.86 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.886 . . . . 0.0 110.839 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.508 ' HB ' HG12 ' A' ' 690' ' ' ILE . 8.4 mt -142.9 136.47 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.16 -0.962 . . . . 0.0 110.52 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -137.65 108.96 6.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.455 -0.778 . . . . 0.0 109.899 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 686' ' ' ASN . 0.3 OUTLIER -120.96 117.68 27.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -45.13 78.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.459 -0.776 . . . . 0.0 111.115 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.64 -43.63 15.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.241 -0.912 . . . . 0.0 111.361 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 683' ' ' ASP . 97.5 m-20 -83.19 -8.67 59.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.136 -0.978 . . . . 0.0 110.601 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.5 tptt 56.25 19.66 4.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.225 -0.922 . . . . 0.0 110.778 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.43 78.76 1.03 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.175 -0.953 . . . . 0.0 109.144 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 41.0 t -101.79 141.32 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.381 -0.824 . . . . 0.0 110.912 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.595 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 41.6 mm -126.32 163.94 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -172.48 124.98 1.12 Allowed Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.367 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.873 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.5 m-85 -120.23 138.06 53.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.59 -0.947 . . . . 0.0 108.828 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -105.1 117.95 35.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.841 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.12 122.28 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.542 -0.724 . . . . 0.0 109.241 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -130.24 104.54 7.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.516 -0.74 . . . . 0.0 110.289 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.41 HD12 ' HB3' ' A' ' 674' ' ' ASP . 71.8 mt -76.51 104.35 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 109.571 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.11 -42.85 59.43 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.609 -0.836 . . . . 0.0 108.889 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.8 OUTLIER -111.01 141.3 44.67 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.698 0.761 . . . . 0.0 110.747 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 44.5 p -115.38 96.06 5.47 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 7.2 t -136.16 136.31 39.92 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.262 0.554 . . . . 0.0 110.587 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.04 26.52 27.76 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.41 HD12 ' CZ ' ' A' ' 577' ' ' PHE . 4.1 tp -105.26 138.19 41.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.358 -1.084 . . . . 0.0 110.469 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.574 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 3.0 p90 -53.83 -23.75 13.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.404 -0.81 . . . . 0.0 110.045 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.574 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.1 t30 -170.76 157.26 5.5 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.509 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 16.4 pt-20 -50.92 -26.98 6.59 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.25 -0.906 . . . . 0.0 110.575 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 122.57 15.05 4.15 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.76 9.07 10.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.025 -1.279 . . . . 0.0 111.264 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.565 ' O ' ' HG3' ' A' ' 709' ' ' MET . . . 91.34 -79.16 1.33 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.565 ' HG3' ' O ' ' A' ' 708' ' ' GLY . 0.9 OUTLIER 26.59 66.84 0.06 Allowed 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.94 -0.741 . . . . 0.0 112.158 -179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.8 159.96 41.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 110.243 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -60.04 -54.46 45.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.315 -0.866 . . . . 0.0 110.198 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.72 149.05 47.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.366 -0.834 . . . . 0.0 109.903 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 714' ' ' ARG . 2.6 tt0 -110.59 95.33 5.49 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.212 -0.93 . . . . 0.0 109.316 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.424 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.0 OUTLIER 36.06 76.1 0.05 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.782 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.424 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 31.5 m -107.78 151.01 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.431 -0.793 . . . . 0.0 109.382 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.427 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 65.0 t -93.12 117.8 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 0.0 110.489 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.8 mp -89.88 162.51 15.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.38 -0.825 . . . . 0.0 109.734 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.98 146.24 28.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.215 -0.928 . . . . 0.0 110.167 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -79.88 137.38 36.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.223 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.8 p -110.16 -176.79 3.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.416 -0.802 . . . . 0.0 110.353 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.61 -28.92 35.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.432 -0.792 . . . . 0.0 110.153 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -66.21 -50.16 64.79 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.448 -0.782 . . . . 0.0 110.043 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.444 ' HA ' HD21 ' A' ' 726' ' ' LEU . 14.6 mt-10 -63.71 -47.68 80.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.36 -0.838 . . . . 0.0 110.123 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . 0.415 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 3.0 tmmm? -62.46 -31.9 72.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.471 -0.768 . . . . 0.0 110.946 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.07 -50.74 69.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.217 -0.927 . . . . 0.0 112.041 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.444 HD21 ' HA ' ' A' ' 723' ' ' GLU . 0.7 OUTLIER -72.72 -35.93 67.67 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.907 -1.121 . . . . 0.0 111.516 -178.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . 0.445 ' CG2' ' CG1' ' A' ' 621' ' ' VAL . 9.3 p -79.08 -15.18 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.828 -1.17 . . . . 0.0 110.37 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -41.98 69.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.944 . . . . 0.0 108.685 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.44 103.32 10.32 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 122.253 1.025 . . . . 0.0 108.963 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.423 ' HA ' ' CE2' ' A' ' 602' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.272 -2.78 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.269 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.24 -10.14 58.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.345 -1.091 . . . . 0.0 110.601 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 166.76 66.27 0.03 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 32.2 ttp-105 -92.68 123.61 36.09 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.5 -1.0 . . . . 0.0 109.484 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.571 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 9.8 t80 -111.6 -40.23 4.39 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 122.061 0.934 . . . . 0.0 109.288 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 0.9 OUTLIER -124.5 119.69 29.86 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.787 -179.126 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 62.3 m -99.15 115.45 29.09 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.989 -1.069 . . . . 0.0 109.005 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.409 ' N ' ' CD2' ' A' ' 580' ' ' LEU . 1.6 mm? -89.98 111.76 22.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.401 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 1.1 mmtt -112.04 101.49 51.86 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 118.026 -1.47 . . . . 0.0 112.478 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.057 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.9 Cg_endo -80.17 144.58 16.67 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 N-CA-C 106.45 -2.173 . . . . 0.0 106.45 174.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.72 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -121.56 -174.31 0.3 Allowed Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.765 -176.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.72 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.1 Cg_endo -66.09 -31.17 46.2 Favored 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 124.289 1.679 . . . . 0.0 110.086 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -59.13 -25.28 63.73 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 13.4 t -95.19 150.58 20.06 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 614' ' ' GLU . 5.3 tp -55.58 -21.47 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.289 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 612' ' ' LYS . 1.6 tp -110.17 117.92 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.522 -0.736 . . . . 0.0 109.903 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.445 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -110.58 79.89 1.25 Allowed 'General case' 0 N--CA 1.508 2.429 0 O-C-N 120.359 -1.463 . . . . 0.0 108.938 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.057 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.6 mt-10 -143.02 175.55 9.77 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.787 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.537 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.66 125.56 40.35 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.097 -1.002 . . . . 0.0 109.127 176.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.418 HD11 ' HA ' ' A' ' 611' ' ' CYS . 65.9 mt -110.17 156.08 21.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 109.592 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -124.85 110.56 14.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.856 . . . . 0.0 111.683 -178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.489 HG21 ' HB ' ' A' ' 598' ' ' VAL . 21.1 mt -82.33 110.38 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 597' ' ' GLY . 2.3 mt-30 -53.98 179.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.213 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.571 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -58.03 69.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.455 -0.778 . . . . 0.0 111.138 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 106.07 43.84 1.46 Allowed Glycine 0 N--CA 1.485 1.915 0 C-N-CA 119.699 -1.239 . . . . 0.0 110.591 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.56 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 0.5 OUTLIER -79.05 104.57 7.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -141.53 138.27 17.25 Favored Pre-proline 0 C--N 1.28 -2.442 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.004 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.612 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.1 Cg_endo -90.54 161.1 31.99 Favored 'Cis proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.273 -1.97 . . . . 0.0 109.38 -1.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.545 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 5.3 t80 -107.28 116.6 32.22 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.669 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 60.7 m-85 -90.08 145.93 24.7 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 111.047 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.639 HG12 ' CB ' ' A' ' 611' ' ' CYS . 2.4 mt -140.5 141.02 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.554 -0.716 . . . . 0.0 110.239 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.684 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 178.1 -161.14 27.86 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.867 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -75.71 -32.45 60.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.754 -0.85 . . . . 0.0 110.087 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.43 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -86.3 127.46 34.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.417 -0.802 . . . . 0.0 110.623 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.5 tm-20 -59.41 -13.73 9.57 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.972 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -46.44 -36.19 6.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.426 -0.796 . . . . 0.0 110.24 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.669 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 62.2 m -71.26 152.7 43.04 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.545 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.1 m120 -59.17 -13.63 7.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.415 -0.803 . . . . 0.0 110.48 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.639 ' CB ' HG12 ' A' ' 603' ' ' ILE . 6.9 t -120.43 144.22 48.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.433 -0.792 . . . . 0.0 109.942 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.613 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -113.37 130.95 56.16 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 122.032 0.92 . . . . 0.0 112.901 -178.43 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.584 ' HA ' ' HB ' ' A' ' 588' ' ' ILE . 7.9 mt -146.63 109.96 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.44 ' O ' HG12 ' A' ' 587' ' ' ILE . 3.3 mm-40 -85.58 102.44 13.54 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 117.806 -1.558 . . . . 0.0 108.547 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 4.3 m-20 -139.05 106.13 5.46 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.728 178.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -45.4 -44.51 12.06 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.42 -0.8 . . . . 0.0 111.925 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.86 -16.75 43.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.126 -0.984 . . . . 0.0 112.023 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 1.3 tp -76.55 130.35 37.77 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.95 -1.093 . . . . 0.0 110.898 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.487 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.2 m -68.81 161.2 29.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.43 -0.794 . . . . 0.0 110.467 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.684 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -63.61 -45.75 88.89 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.189 -0.944 . . . . 0.0 109.204 179.577 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.472 ' O ' ' C ' ' A' ' 622' ' ' HIS . 16.4 m -94.8 2.12 9.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 121.386 -0.821 . . . . 0.0 109.481 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.74 ' O ' ' N ' ' A' ' 652' ' ' THR . 3.8 t60 -28.47 -48.27 0.06 Allowed 'General case' 0 C--O 1.192 -1.946 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.946 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.434 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.8 OUTLIER -137.13 145.5 43.91 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.375 -1.33 . . . . 0.0 110.901 179.065 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.593 ' HA ' HG13 ' A' ' 603' ' ' ILE . 24.2 p90 -146.37 151.18 37.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.493 -0.754 . . . . 0.0 110.419 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 15.7 mt -103.13 120.95 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 8.0 t80 -116.45 154.23 30.7 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.39 -0.818 . . . . 0.0 109.828 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 8.3 ttmt -120.22 136.98 54.46 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.444 0.64 . . . . 0.0 110.368 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.427 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.03 163.97 28.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.64 -0.663 . . . . 0.0 110.389 -179.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 629' ' ' ARG . 0.3 OUTLIER -77.6 115.65 17.53 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.507 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.2 t60 -58.04 124.46 19.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.542 -0.724 . . . . 0.0 110.561 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -125.16 103.81 8.18 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.386 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . 0.4 ' CG2' ' N ' ' A' ' 633' ' ' GLY . 7.5 p -73.15 170.98 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.561 -0.712 . . . . 0.0 110.089 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . 0.4 ' N ' ' CG2' ' A' ' 632' ' ' VAL . . . -60.25 -165.25 0.2 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.54 133.36 55.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.287 -1.125 . . . . 0.0 110.279 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.87 63.48 3.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.312 -0.867 . . . . 0.0 110.358 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -58.65 125.93 25.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 109.705 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 64.61 -145.35 0.26 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.428 -0.795 . . . . 0.0 109.901 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -115.44 103.05 10.39 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.08 -1.013 . . . . 0.0 109.16 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 5.2 p -120.78 151.33 54.4 Favored Pre-proline 0 C--N 1.292 -1.899 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.029 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 641' ' ' ALA . 48.7 Cg_endo -69.72 -151.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.732 1.385 . . . . 0.0 110.088 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.41 ' O ' ' CD1' ' A' ' 644' ' ' LEU . . . 68.88 -62.02 0.4 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.662 -0.649 . . . . 0.0 110.642 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.97 -155.35 0.16 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.073 -1.017 . . . . 0.0 110.183 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -119.95 129.72 8.09 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 630' ' ' HIS . 5.1 mp -142.77 -146.23 0.18 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 122.088 -0.654 . . . . 0.0 109.363 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.5 OUTLIER -115.46 124.63 51.61 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.846 -1.159 . . . . 0.0 111.386 -179.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.414 ' OD2' ' CE1' ' A' ' 630' ' ' HIS . 24.0 t0 -113.5 156.4 23.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.386 -0.821 . . . . 0.0 110.129 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.424 HD13 HD11 ' A' ' 578' ' ' LEU . 11.2 pt -109.67 129.85 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.26 -0.9 . . . . 0.0 110.142 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.638 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 91.6 m95 -119.86 128.53 53.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.621 -0.675 . . . . 0.0 111.199 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.506 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 9.3 t80 -88.17 114.87 25.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 668' ' ' THR . 14.4 m -108.01 106.03 16.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 111.781 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.524 ' CD2' ' N ' ' A' ' 652' ' ' THR . 13.1 t60 -65.95 159.07 26.51 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.482 -0.761 . . . . 0.0 109.975 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.74 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.03 -28.79 0.2 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.471 -0.768 . . . . 0.0 112.84 -179.228 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.521 ' HA3' ' CG ' ' A' ' 622' ' ' HIS . . . -79.26 -163.89 26.79 Favored Glycine 0 N--CA 1.496 2.688 0 O-C-N 119.337 -2.102 . . . . 0.0 109.885 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 654' ' ' THR . . . . . 0.435 ' O ' HG12 ' A' ' 656' ' ' VAL . 21.3 m -94.08 -19.12 21.12 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.096 -1.238 . . . . 0.0 114.095 -176.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.539 ' O ' HG21 ' A' ' 656' ' ' VAL . 24.7 m120 -61.01 -2.83 0.65 Allowed 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.597 -1.315 . . . . 0.0 112.629 -178.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 655' ' ' ASN . 0.8 OUTLIER 62.68 145.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.58 -0.7 . . . . 0.0 109.847 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.456 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -95.09 151.29 19.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.601 -0.687 . . . . 0.0 111.071 -178.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.464 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 37.5 m-85 -134.45 126.22 29.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.595 -0.691 . . . . 0.0 109.569 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 661' ' ' ASN . 53.8 tp -130.93 111.89 12.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.198 -0.939 . . . . 0.0 110.098 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.83 -79.43 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.594 -0.691 . . . . 0.0 110.027 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 659' ' ' LEU . 25.5 p30 -148.74 23.92 0.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 110.128 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.74 119.68 39.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 110.253 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -84.97 134.92 34.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.889 . . . . 0.0 110.045 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.439 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 2.8 mtp -116.3 -166.2 1.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.647 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.412 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 7.9 pt -139.94 -154.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.447 -0.783 . . . . 0.0 110.291 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 652' ' ' THR . 44.2 tt0 -86.31 91.71 8.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.376 -0.828 . . . . 0.0 110.699 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.5 54.62 0.54 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.6 OUTLIER -119.07 145.53 45.83 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.06 -1.259 . . . . 0.0 110.001 179.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -108.34 138.72 44.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.454 -0.779 . . . . 0.0 109.247 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.494 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 0.5 OUTLIER -144.62 142.88 30.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.027 -1.045 . . . . 0.0 111.518 -178.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.638 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -70.89 147.5 48.74 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.524 -0.735 . . . . 0.0 110.773 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.506 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 14.6 mt -120.3 114.67 22.21 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.386 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 17.2 mt-30 -84.5 -177.16 6.54 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 706' ' ' GLY . 2.2 p30 -78.24 139.06 38.92 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.778 -1.201 . . . . 0.0 109.315 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 73.25 47.9 21.37 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.451 -2.259 . . . . 0.0 107.451 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 673' ' ' GLN . 2.1 t0 -105.55 97.77 7.56 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.847 -0.796 . . . . 0.0 110.337 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.867 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.47 107.03 18.93 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.447 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 1.5 mp -105.01 138.01 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.531 -0.731 . . . . 0.0 111.57 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -100.39 114.58 28.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.747 -0.596 . . . . 0.0 109.639 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 76.7 mt -79.35 -24.09 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.926 . . . . 0.0 110.933 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.476 ' HB ' HG12 ' A' ' 690' ' ' ILE . 7.2 mt -141.57 141.15 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.148 -0.97 . . . . 0.0 110.389 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -138.09 109.59 6.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.89 . . . . 0.0 110.11 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.44 118.04 24.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.331 -0.856 . . . . 0.0 110.005 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -46.85 76.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.306 -0.871 . . . . 0.0 110.963 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -84.65 -43.47 14.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.345 -0.847 . . . . 0.0 110.939 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.33 -11.1 60.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.249 -0.907 . . . . 0.0 110.556 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.1 mttt 52.46 24.86 3.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.17 -0.956 . . . . 0.0 110.388 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.88 73.76 7.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.434 -0.792 . . . . 0.0 109.896 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 586' ' ' SER . 34.8 m -101.92 135.87 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 110.322 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.476 HG12 ' HB ' ' A' ' 681' ' ' ILE . 19.3 mm -114.05 164.44 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.535 -0.728 . . . . 0.0 109.505 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -174.43 123.33 0.95 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.527 -1.32 . . . . 0.0 110.446 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.867 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.3 m-85 -120.04 137.74 53.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.534 -0.98 . . . . 0.0 108.581 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -102.56 114.54 28.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.871 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -81.31 113.24 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -121.56 104.3 9.54 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.695 -0.628 . . . . 0.0 109.914 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.51 ' CD1' ' HA3' ' A' ' 706' ' ' GLY . 63.1 mt -79.13 104.58 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 109.51 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.88 -42.76 48.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.328 -0.857 . . . . 0.0 108.826 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 577' ' ' PHE . 1.2 m-20 -110.84 142.45 42.84 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.397 0.618 . . . . 0.0 110.336 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 42.9 p -114.18 95.78 5.47 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.44 -133.57 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.027 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.426 ' O ' ' CD2' ' A' ' 644' ' ' LEU . . . -93.49 35.04 4.29 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' A' ' 704' ' ' ASN . 1.0 OUTLIER -60.77 149.98 33.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.617 -0.931 . . . . 0.0 110.172 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 704' ' ' ASN . 4.1 p90 -49.63 -24.56 2.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.362 -0.836 . . . . 0.0 110.402 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 703' ' ' PHE . 1.0 OUTLIER -158.06 170.8 21.48 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.228 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.466 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 16.3 pt-20 -51.19 -23.6 3.5 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.961 -1.087 . . . . 0.0 110.309 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 123.77 4.55 7.98 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 24.8 tp -89.9 11.66 19.7 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.325 -1.103 . . . . 0.0 110.941 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.497 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 77.81 -137.99 20.86 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 6.7 ptp -161.1 -174.46 4.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -1.079 . . . . 0.0 110.031 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.53 34.35 4.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 110.674 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.77 -41.48 5.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.447 -0.783 . . . . 0.0 109.268 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -114.09 149.11 36.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.653 -0.655 . . . . 0.0 109.331 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . 0.509 ' O ' ' C ' ' A' ' 714' ' ' ARG . 2.1 mt-30 -109.86 95.52 5.65 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.21 -0.931 . . . . 0.0 109.481 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.509 ' C ' ' O ' ' A' ' 713' ' ' GLN . 0.1 OUTLIER 22.04 82.62 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.225 179.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.408 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 34.9 m -107.59 151.59 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.453 -0.779 . . . . 0.0 109.454 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.439 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 86.6 t -97.04 122.77 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 110.564 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.5 mp -93.8 162.16 14.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.52 -0.737 . . . . 0.0 109.822 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.33 151.09 21.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.875 . . . . 0.0 110.068 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -80.31 142.83 34.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.807 . . . . 0.0 110.343 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 12.8 p -117.16 -176.27 2.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.399 -0.813 . . . . 0.0 110.143 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.53 -28.8 33.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.355 -0.84 . . . . 0.0 110.224 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -68.15 -47.65 67.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.0 109.984 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.8 -48.05 78.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -0.796 . . . . 0.0 110.023 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -54.03 -32.49 54.55 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.364 -0.835 . . . . 0.0 110.069 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -68.11 -36.38 79.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.487 -0.758 . . . . 0.0 110.383 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 37.8 mt -59.8 -46.55 88.85 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.262 -0.899 . . . . 0.0 110.195 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.5 p -72.34 -19.46 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.087 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -53.5 -44.73 69.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.865 . . . . 0.0 108.904 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.54 103.48 10.45 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 122.215 1.007 . . . . 0.0 109.262 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.409 ' O ' ' CD2' ' A' ' 602' ' ' PHE . 3.5 mt . . . . . 0 C--N 1.274 -2.696 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.518 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -84.14 -10.19 57.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.406 -1.055 . . . . 0.0 110.687 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 67.19 37.02 90.93 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -93.55 135.33 34.92 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.407 -1.055 . . . . 0.0 109.261 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.587 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 9.8 t80 -124.8 -39.69 2.25 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 122.063 0.935 . . . . 0.0 109.427 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.473 ' HG ' HG12 ' A' ' 696' ' ' ILE . 0.4 OUTLIER -131.6 120.23 22.56 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.26 -178.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 4.4 m -93.95 120.19 33.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.0 109.093 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 4.6 mt -87.05 112.38 21.81 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.522 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -111.1 100.48 47.06 Favored Pre-proline 0 C--N 1.301 -1.505 0 C-N-CA 118.197 -1.401 . . . . 0.0 112.989 -176.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.083 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 55.6 Cg_endo -87.88 141.23 5.25 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 N-CA-C 106.342 -2.214 . . . . 0.0 106.342 174.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.728 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -120.52 -173.71 0.27 Allowed Pre-proline 0 C--N 1.294 -1.815 0 C-N-CA 118.57 -1.252 . . . . 0.0 112.575 -177.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.728 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.2 Cg_endo -66.42 -30.71 43.86 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 O-C-N 124.212 1.638 . . . . 0.0 110.279 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -59.2 -24.45 63.12 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 17.6 t -95.35 153.32 17.74 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 614' ' ' GLU . 4.9 tp -57.42 -19.69 11.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.178 -0.951 . . . . 0.0 109.298 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.622 HG12 ' O ' ' A' ' 612' ' ' LYS . 1.5 tp -113.17 118.08 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 110.117 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.496 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -111.24 81.65 1.47 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.483 -1.386 . . . . 0.0 108.634 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.083 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.5 mt-10 -143.11 175.68 9.68 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.883 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.522 ' HB3' ' CD ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.62 122.88 36.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.018 -1.051 . . . . 0.0 109.17 176.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.66 155.05 20.59 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -125.69 110.26 13.56 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.433 -0.792 . . . . 0.0 111.304 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.453 HG22 ' HB ' ' A' ' 598' ' ' VAL . 9.9 mt -81.37 109.56 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.7 OUTLIER -53.14 168.97 0.12 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.609 -0.837 . . . . 0.0 109.054 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.587 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 6.0 mt-30 -61.58 70.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.391 -0.818 . . . . 0.0 110.432 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 124.69 30.44 0.97 Allowed Glycine 0 N--CA 1.487 2.044 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.78 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.485 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 1.2 t -79.9 102.73 6.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -143.95 135.5 12.8 Favored Pre-proline 0 C--N 1.282 -2.358 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.885 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.631 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.1 Cg_endo -90.91 162.12 30.45 Favored 'Cis proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.747 -1.772 . . . . 0.0 109.15 -1.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.501 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 6.3 t80 -106.41 116.69 32.36 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.711 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 58.3 m-85 -88.62 146.24 25.22 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.406 -0.808 . . . . 0.0 111.182 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.597 HG12 ' CB ' ' A' ' 611' ' ' CYS . 2.4 mt -140.85 140.48 33.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.648 -0.657 . . . . 0.0 110.18 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.672 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 177.18 -162.63 30.86 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.924 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -74.0 -35.06 64.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.794 -0.827 . . . . 0.0 110.248 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.16 127.37 34.24 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.394 -0.817 . . . . 0.0 110.585 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.445 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 42.8 tt0 -58.75 -12.89 4.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.291 -0.881 . . . . 0.0 109.993 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.18 -36.86 4.05 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.421 -0.8 . . . . 0.0 110.079 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.711 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 79.6 m -71.68 154.48 41.34 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.284 -0.885 . . . . 0.0 109.926 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.501 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -61.53 -12.06 13.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.511 -0.743 . . . . 0.0 110.396 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.597 ' CB ' HG12 ' A' ' 603' ' ' ILE . 6.9 t -119.84 143.74 47.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.531 -0.731 . . . . 0.0 109.559 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.622 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -113.32 130.22 56.32 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.055 0.931 . . . . 0.0 112.993 -178.237 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.572 ' HA ' ' HB ' ' A' ' 588' ' ' ILE . 7.3 mt -146.57 109.75 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 177.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.437 ' O ' HG12 ' A' ' 587' ' ' ILE . 2.2 mt-10 -85.68 102.47 13.63 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 117.704 -1.598 . . . . 0.0 108.538 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 4.9 m-20 -139.42 106.08 5.36 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.869 178.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . 0.41 ' OD1' ' CZ ' ' A' ' 688' ' ' PHE . 29.5 p-10 -47.45 -41.33 20.17 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.453 -0.779 . . . . 0.0 111.648 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -84.19 -16.99 41.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.089 -1.007 . . . . 0.0 111.8 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 1.3 tp -78.27 130.84 36.7 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.082 -1.012 . . . . 0.0 110.816 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.474 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 2.2 t -70.75 159.4 34.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.362 -0.836 . . . . 0.0 110.53 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.672 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 35.7 ttp180 -61.55 -45.66 93.21 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.26 -0.9 . . . . 0.0 109.344 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.482 ' O ' ' C ' ' A' ' 622' ' ' HIS . 15.8 m -94.74 1.95 9.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.389 -0.82 . . . . 0.0 109.613 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.9 t60 -28.1 -48.18 0.05 OUTLIER 'General case' 0 C--O 1.192 -1.962 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.833 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.414 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.7 OUTLIER -137.03 145.58 44.22 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.406 -1.318 . . . . 0.0 110.753 178.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.527 ' CZ ' ' CB ' ' A' ' 650' ' ' CYS . 12.4 p90 -145.3 148.75 33.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.532 -0.73 . . . . 0.0 110.306 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.501 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 24.5 mt -103.9 121.1 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 7.5 t80 -114.95 154.44 28.75 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.694 0.759 . . . . 0.0 109.484 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.01 137.09 54.29 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.548 0.689 . . . . 0.0 110.587 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.427 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -137.62 163.6 30.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.712 -0.617 . . . . 0.0 110.152 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 629' ' ' ARG . 1.0 OUTLIER -77.93 115.48 17.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.188 -0.945 . . . . 0.0 108.889 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.507 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.4 t60 -58.62 124.77 20.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.536 -0.728 . . . . 0.0 110.615 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -111.64 111.72 22.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.678 -0.639 . . . . 0.0 110.325 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . 0.401 ' CG2' ' N ' ' A' ' 633' ' ' GLY . 7.7 p -69.72 169.78 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.341 -0.849 . . . . 0.0 109.945 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . 0.401 ' N ' ' CG2' ' A' ' 632' ' ' VAL . . . -126.11 155.68 19.36 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt 52.07 62.5 2.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.383 -1.069 . . . . 0.0 110.466 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 89.3 p -103.25 46.93 0.9 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 0.0 110.236 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 38.3 mtt -92.49 43.31 1.13 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.426 -0.796 . . . . 0.0 109.894 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -172.21 -147.77 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.49 -0.757 . . . . 0.0 109.751 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -115.41 102.34 9.74 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.177 -0.952 . . . . 0.0 108.8 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 59.8 p -136.4 151.49 73.19 Favored Pre-proline 0 C--N 1.292 -1.911 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.193 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . 0.41 ' O ' ' CB ' ' A' ' 641' ' ' ALA . 48.6 Cg_endo -69.4 -151.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.691 1.364 . . . . 0.0 110.013 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 640' ' ' PRO . . . 68.35 -62.8 0.36 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.617 -0.677 . . . . 0.0 110.481 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.92 -154.48 0.15 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.211 -0.931 . . . . 0.0 110.051 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -120.03 125.91 6.48 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.465 ' HB2' ' CA ' ' A' ' 703' ' ' PHE . 5.1 mp -142.41 -148.22 0.23 Allowed 'General case' 0 C--N 1.293 -1.865 0 O-C-N 122.046 -0.679 . . . . 0.0 109.207 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.19 124.4 50.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.859 -1.151 . . . . 0.0 111.08 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -110.26 150.56 28.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.443 -0.785 . . . . 0.0 109.847 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . . . . . . . . . 11.3 pt -106.56 131.66 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.304 -0.873 . . . . 0.0 109.85 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.494 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 95.2 m95 -119.47 123.05 43.11 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.649 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.468 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 9.7 t80 -88.83 114.35 25.36 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.527 ' CB ' ' CZ ' ' A' ' 624' ' ' PHE . 1.0 OUTLIER -108.12 102.66 11.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.078 -1.014 . . . . 0.0 111.697 -178.246 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.496 ' CD2' ' N ' ' A' ' 652' ' ' THR . 13.1 t60 -62.07 157.46 18.89 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.471 -0.768 . . . . 0.0 109.77 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -149.14 -29.75 0.26 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.469 -0.769 . . . . 0.0 112.702 -179.113 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.531 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.68 -164.05 25.42 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 117.72 -2.181 . . . . 0.0 109.498 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 654' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 656' ' ' VAL . 25.0 m -97.65 -18.22 19.02 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.858 -1.378 . . . . 0.0 113.821 -176.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.458 ' CB ' HG12 ' A' ' 681' ' ' ILE . 22.8 m120 -58.35 -4.25 0.36 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.681 -1.262 . . . . 0.0 112.497 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.451 ' C ' ' CE1' ' A' ' 651' ' ' HIS . 3.1 t 70.21 148.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.609 -0.682 . . . . 0.0 110.169 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.433 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -105.82 143.82 33.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.508 -0.745 . . . . 0.0 110.741 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.426 ' CE1' ' HG2' ' A' ' 663' ' ' ARG . 74.7 m-85 -135.22 126.2 27.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.43 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.479 ' CD1' HG23 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -124.11 114.32 19.53 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.373 -0.829 . . . . 0.0 109.789 179.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 659' ' ' LEU . 14.0 t-20 59.27 -78.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.549 -0.72 . . . . 0.0 110.499 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 659' ' ' LEU . 10.7 t30 -147.86 27.27 0.98 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.077 -1.014 . . . . 0.0 110.33 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.71 139.36 49.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 0.0 110.269 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . 0.426 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 8.5 tmm_? -103.52 129.48 50.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.339 -0.85 . . . . 0.0 110.107 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.428 ' CB ' ' OG ' ' A' ' 657' ' ' SER . 4.3 mtp -112.1 -165.7 1.01 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 110.325 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.41 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 1.6 pt -141.54 -158.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.375 -0.828 . . . . 0.0 110.091 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -82.06 93.24 6.96 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.286 -0.884 . . . . 0.0 110.524 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 106.84 53.21 0.71 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.2 OUTLIER -120.51 147.62 44.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.11 -1.23 . . . . 0.0 110.078 179.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -108.32 144.04 36.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 0.0 109.196 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.48 ' CE1' ' O ' ' A' ' 715' ' ' VAL . 0.6 OUTLIER -144.65 147.11 32.69 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.508 -178.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.494 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.68 131.5 45.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.465 -0.772 . . . . 0.0 109.705 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.468 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 6.3 mt -104.61 97.68 7.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 111.173 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.411 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 87.9 mt-30 -84.86 146.64 27.2 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 706' ' ' GLY . 20.0 p-10 -46.11 151.78 0.46 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.222 -0.924 . . . . 0.0 110.612 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 65.36 49.11 62.82 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.04 92.52 4.11 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.763 -0.845 . . . . 0.0 110.611 -178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.812 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -92.93 106.91 18.8 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.171 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.479 HG23 ' CD1' ' A' ' 659' ' ' LEU . 1.0 OUTLIER -116.56 137.78 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.6 -0.687 . . . . 0.0 111.865 -176.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.45 111.54 23.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.586 -0.696 . . . . 0.0 109.675 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 81.0 mt -74.08 -19.57 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.302 -0.874 . . . . 0.0 110.465 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.477 ' HB ' HG12 ' A' ' 690' ' ' ILE . 12.7 mt -141.81 137.67 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.028 -1.045 . . . . 0.0 110.286 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -137.43 110.41 7.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.131 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -129.25 118.38 22.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.784 . . . . 0.0 109.844 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.6 -44.84 85.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.375 -0.828 . . . . 0.0 110.884 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -84.11 -43.42 15.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.324 -0.86 . . . . 0.0 110.924 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -17.69 60.57 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.263 -0.898 . . . . 0.0 110.456 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.6 tttt 60.53 14.66 5.03 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.193 -0.942 . . . . 0.0 110.887 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.41 ' CZ ' ' OD1' ' A' ' 616' ' ' ASN . 0.3 OUTLIER -72.06 78.69 0.93 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.039 -1.038 . . . . 0.0 108.975 179.189 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 586' ' ' SER . 96.3 t -101.59 130.98 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.496 -0.752 . . . . 0.0 110.706 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.477 HG12 ' HB ' ' A' ' 681' ' ' ILE . 18.0 mm -114.94 164.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -173.27 116.13 0.59 Allowed Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.446 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.812 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.4 m-85 -119.7 137.13 54.11 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 581' ' ' LYS . 5.8 ttmm -110.77 114.14 27.26 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 110.305 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.49 126.85 36.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.758 -0.777 . . . . 0.0 108.95 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.67 104.41 7.41 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.192 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.473 HG12 ' HG ' ' A' ' 578' ' ' LEU . 83.6 mt -79.47 103.6 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 109.559 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.27 -41.01 58.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.387 -0.821 . . . . 0.0 108.844 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 1.3 m-20 -110.34 140.2 44.76 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.678 0.751 . . . . 0.0 110.655 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 36.0 p -115.98 96.17 5.46 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 30.2 m -133.09 133.18 42.63 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.814 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 50.32 30.11 17.66 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 7.2 tp -103.91 138.92 39.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.545 -0.974 . . . . 0.0 110.717 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.578 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 2.6 p90 -53.28 -23.87 10.1 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.418 -0.801 . . . . 0.0 109.988 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.578 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.2 t30 -174.52 155.05 2.18 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.456 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 14.6 pt-20 -51.24 -25.14 5.15 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.18 -0.95 . . . . 0.0 110.825 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 124.32 13.12 4.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.4 ' N ' HD22 ' A' ' 704' ' ' ASN . 0.4 OUTLIER -82.64 9.19 10.01 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.001 -1.293 . . . . 0.0 111.502 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.584 ' O ' ' HG3' ' A' ' 709' ' ' MET . . . 96.71 -63.74 1.08 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.584 ' HG3' ' O ' ' A' ' 708' ' ' GLY . 0.8 OUTLIER 40.65 39.39 0.75 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.743 -0.857 . . . . 0.0 111.714 -179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.16 136.11 43.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.172 -0.955 . . . . 0.0 110.623 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -57.4 -35.48 70.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.42 -0.8 . . . . 0.0 110.006 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -63.83 149.15 47.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.447 -0.783 . . . . 0.0 109.73 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -110.31 95.34 5.51 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.248 -0.907 . . . . 0.0 109.471 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.442 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.5 OUTLIER 39.23 82.97 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.349 0.595 . . . . 0.0 111.869 179.401 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.48 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 26.9 m -107.58 150.01 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.481 -0.762 . . . . 0.0 109.069 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.424 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 58.3 t -96.73 133.12 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.186 -0.946 . . . . 0.0 111.109 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.8 mp -105.08 162.64 13.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.656 -0.653 . . . . 0.0 109.598 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.35 145.37 28.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.17 -0.956 . . . . 0.0 110.291 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.82 152.09 29.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.355 -0.841 . . . . 0.0 110.259 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 38.6 p -121.14 -176.25 3.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.42 -0.8 . . . . 0.0 110.359 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.36 -29.08 32.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.361 -0.837 . . . . 0.0 110.105 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -51.0 68.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.353 -0.842 . . . . 0.0 109.579 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -64.65 -45.25 87.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.463 -0.773 . . . . 0.0 109.734 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . 0.406 ' O ' ' CG1' ' A' ' 727' ' ' VAL . 0.4 OUTLIER -54.71 -32.73 59.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.344 -0.848 . . . . 0.0 109.837 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -36.11 78.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.399 -0.813 . . . . 0.0 110.227 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 34.1 mt -58.76 -46.16 88.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.298 -0.877 . . . . 0.0 110.228 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . 0.406 ' CG1' ' O ' ' A' ' 724' ' ' LYS . 7.2 p -71.76 -20.34 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.546 -0.721 . . . . 0.0 110.087 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.78 -45.84 70.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 108.845 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.71 104.26 11.18 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.206 1.003 . . . . 0.0 109.025 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--N 1.274 -2.71 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.432 -179.933 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.55 -10.28 58.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.342 -1.093 . . . . 0.0 110.626 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 78.96 12.42 84.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -92.77 126.25 37.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.291 -1.123 . . . . 0.0 109.284 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.589 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 0.9 OUTLIER -113.85 -41.62 3.54 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 122.052 0.93 . . . . 0.0 109.36 -179.316 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.478 ' HB2' ' CE1' ' A' ' 577' ' ' PHE . 14.2 tp -126.1 119.87 28.7 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.529 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 55.9 m -96.88 117.3 30.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.759 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 7.6 mt -91.98 112.18 24.01 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.534 ' O ' ' CD1' ' A' ' 583' ' ' LEU . 0.7 OUTLIER -116.07 104.58 52.15 Favored Pre-proline 0 C--N 1.299 -1.617 0 C-N-CA 118.379 -1.328 . . . . 0.0 113.289 -177.066 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.126 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 40.8 Cg_endo -77.86 145.04 22.24 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 N-CA-C 105.968 -2.358 . . . . 0.0 105.968 174.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.715 ' N ' ' CD1' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -122.14 176.73 1.86 Allowed Pre-proline 0 N--CA 1.496 1.826 0 C-N-CA 118.197 -1.401 . . . . 0.0 113.599 -176.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.67 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 37.8 Cg_endo -66.36 -35.42 31.36 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.905 1.737 . . . . 0.0 111.848 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.43 -26.38 63.23 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.507 ' OG ' ' HA ' ' A' ' 690' ' ' ILE . 1.9 t -95.57 151.84 18.97 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.062 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.523 HG22 HD12 ' A' ' 588' ' ' ILE . 7.5 mm -57.35 -18.63 9.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 108.993 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.595 HG13 HG12 ' A' ' 613' ' ' ILE . 3.1 mm -99.67 115.55 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.472 -0.768 . . . . 0.0 109.218 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.476 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.86 71.42 1.04 Allowed 'General case' 0 N--CA 1.509 2.512 0 O-C-N 120.672 -1.268 . . . . 0.0 109.888 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.126 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 45.3 mt-10 -143.75 175.37 10.04 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.354 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.467 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.25 126.66 39.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.79 -1.194 . . . . 0.0 109.978 176.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 1.1 mt -111.41 156.17 22.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.329 -0.857 . . . . 0.0 109.391 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -125.19 110.6 14.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 111.835 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.455 ' N ' ' O ' ' A' ' 578' ' ' LEU . 24.8 mt -81.29 110.9 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 597' ' ' GLY . 2.3 mt-30 -54.67 179.25 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.979 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.589 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -59.08 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.505 -0.747 . . . . 0.0 111.217 -179.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 115.15 41.71 0.81 Allowed Glycine 0 N--CA 1.485 1.962 0 C-N-CA 119.496 -1.335 . . . . 0.0 111.019 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.47 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 1.2 t -79.01 103.75 6.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 627' ' ' LYS . 5.2 t30 -141.4 136.41 15.67 Favored Pre-proline 0 C--N 1.283 -2.314 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.258 -178.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.524 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.4 Cg_endo -90.44 161.28 32.53 Favored 'Cis proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.41 -1.913 . . . . 0.0 109.366 -1.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.532 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 2.9 t80 -107.03 116.26 31.62 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.533 ' HB3' ' SG ' ' A' ' 609' ' ' CYS . 58.8 m-85 -87.48 143.74 27.07 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 110.162 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.537 HG13 ' HA ' ' A' ' 624' ' ' PHE . 3.6 mt -140.56 142.16 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.782 -0.574 . . . . 0.0 110.345 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.773 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 166.14 -165.22 38.04 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.617 -1.278 . . . . 0.0 111.131 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.542 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 10.1 tpt180 -60.67 -55.55 31.97 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.854 -0.791 . . . . 0.0 111.879 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.43 126.15 28.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 111.499 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.436 ' HB2' ' HD2' ' A' ' 612' ' ' LYS . 42.3 tt0 -52.67 -19.05 2.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.418 -0.801 . . . . 0.0 110.046 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 607' ' ' GLU . 0.9 OUTLIER -42.36 -35.39 1.0 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.399 -0.813 . . . . 0.0 109.092 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' ' 602' ' ' PHE . 1.3 m -64.92 133.76 52.52 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.532 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -45.72 -28.16 0.97 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.389 -0.82 . . . . 0.0 109.544 179.336 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.518 ' CB ' HG12 ' A' ' 603' ' ' ILE . 2.4 t -107.6 143.53 35.92 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.463 ' O ' ' CG2' ' A' ' 588' ' ' ILE . 0.3 OUTLIER -107.7 129.0 55.06 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.078 -1.014 . . . . 0.0 113.178 -178.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.595 HG12 HG13 ' A' ' 588' ' ' ILE . 13.5 mt -143.5 109.5 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.8 103.6 15.55 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 117.865 -1.534 . . . . 0.0 109.535 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 0.2 OUTLIER -139.38 106.93 5.57 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.965 177.414 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -41.33 -41.65 2.0 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.611 -0.681 . . . . 0.0 111.993 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -83.84 -17.69 40.08 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.064 -1.023 . . . . 0.0 111.502 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -80.16 130.4 35.21 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.212 -0.93 . . . . 0.0 110.691 -179.189 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.412 ' CB ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -66.78 160.84 24.99 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.254 -0.904 . . . . 0.0 111.169 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.773 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -64.74 -47.04 79.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.233 -0.917 . . . . 0.0 109.746 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.476 ' O ' ' C ' ' A' ' 622' ' ' HIS . 3.7 m -95.32 2.4 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.247 -0.908 . . . . 0.0 109.316 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.735 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.8 t60 -25.36 -46.43 0.02 OUTLIER 'General case' 0 C--O 1.193 -1.897 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.267 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.437 ' N ' ' O ' ' A' ' 621' ' ' VAL . 0.8 OUTLIER -136.92 146.33 45.34 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 118.32 -1.352 . . . . 0.0 111.336 179.121 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.537 ' HA ' HG13 ' A' ' 603' ' ' ILE . 14.7 p90 -145.86 143.77 29.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.563 -0.71 . . . . 0.0 109.997 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 10.7 mt -102.85 118.2 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 5.0 t80 -113.39 155.07 25.89 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.572 0.701 . . . . 0.0 109.544 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 5.6 ttmt -119.67 137.16 54.07 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.617 0.723 . . . . 0.0 110.773 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.436 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.49 164.16 28.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.741 -0.6 . . . . 0.0 110.167 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.3 tpt180 -77.75 118.97 20.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.128 -0.983 . . . . 0.0 109.043 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.532 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.7 t60 -58.43 124.45 19.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.566 -0.709 . . . . 0.0 110.719 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -98.35 125.35 43.45 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.689 -0.632 . . . . 0.0 110.279 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 52.3 t -83.63 161.8 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.315 -0.866 . . . . 0.0 110.223 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -79.9 -165.22 30.99 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.91 88.98 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.33 -1.1 . . . . 0.0 110.205 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 635' ' ' SER . . . . . 0.409 ' HA ' ' CZ ' ' A' ' 637' ' ' TYR . 9.4 p -101.58 83.68 2.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 0.0 110.451 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -95.8 36.81 1.25 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.341 -0.85 . . . . 0.0 109.821 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . 0.409 ' CZ ' ' HA ' ' A' ' 635' ' ' SER . 3.3 p90 -148.59 -153.11 0.47 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.586 -0.696 . . . . 0.0 109.506 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -115.21 102.83 10.26 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.109 -0.994 . . . . 0.0 109.134 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 75.8 p -136.24 152.15 74.68 Favored Pre-proline 0 C--N 1.293 -1.882 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.014 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 641' ' ' ALA . 44.9 Cg_endo -67.91 -150.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.803 1.422 . . . . 0.0 109.821 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.425 ' O ' ' CD1' ' A' ' 644' ' ' LEU . . . 68.21 -62.74 0.35 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.626 -0.671 . . . . 0.0 110.326 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.75 -162.57 0.06 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.243 -0.911 . . . . 0.0 110.313 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -111.99 129.89 9.33 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.501 ' HB2' ' N ' ' A' ' 703' ' ' PHE . 5.0 mp -143.91 -150.59 0.32 Allowed 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.7 m-20 -108.1 124.38 50.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.98 -1.075 . . . . 0.0 111.264 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 628' ' ' LYS . 29.5 t70 -110.11 141.05 43.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.452 -0.78 . . . . 0.0 109.803 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 22.6 pt -95.97 132.44 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.243 -0.911 . . . . 0.0 110.105 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.504 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 95.5 m95 -119.07 122.12 41.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.616 -0.678 . . . . 0.0 111.179 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.487 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 11.9 t80 -85.21 115.69 23.13 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 624' ' ' PHE . 22.5 m -108.11 102.9 12.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.186 -0.946 . . . . 0.0 111.582 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' A' ' 652' ' ' THR . 12.2 t60 -63.89 159.28 20.09 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.442 -0.786 . . . . 0.0 109.93 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.735 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.44 -29.55 0.18 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.435 -0.791 . . . . 0.0 112.757 -179.196 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.563 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.29 -165.59 30.28 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 117.857 -2.116 . . . . 0.0 109.937 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 654' ' ' THR . . . . . 0.453 ' O ' HG13 ' A' ' 656' ' ' VAL . 26.0 m -93.6 -18.87 21.72 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.064 -1.256 . . . . 0.0 114.025 -176.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.544 ' O ' HG21 ' A' ' 656' ' ' VAL . 19.4 m120 -60.04 -2.56 0.44 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.663 -1.273 . . . . 0.0 112.564 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.544 HG21 ' O ' ' A' ' 655' ' ' ASN . 0.8 OUTLIER 63.11 142.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 121.583 0.706 . . . . 0.0 110.173 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 664' ' ' MET . 0.0 OUTLIER -94.52 150.49 20.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.691 -0.631 . . . . 0.0 110.729 -179.034 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.483 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 20.2 m-85 -135.05 126.4 28.38 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.332 -0.855 . . . . 0.0 110.437 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.503 ' HG ' HG23 ' A' ' 678' ' ' ILE . 0.0 OUTLIER -134.2 120.8 20.5 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.21 -0.931 . . . . 0.0 109.926 179.251 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 56.3 -85.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.569 -0.707 . . . . 0.0 110.521 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 659' ' ' LEU . 55.6 t30 -148.17 25.46 1.0 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.221 -0.924 . . . . 0.0 110.247 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -119.34 117.52 28.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 0.0 110.447 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . 0.415 ' CG ' ' CE1' ' A' ' 658' ' ' TYR . 2.7 tmm_? -87.24 138.33 31.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.374 -0.829 . . . . 0.0 109.983 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.494 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 0.3 OUTLIER -112.83 -152.68 0.51 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.278 -0.889 . . . . 0.0 109.969 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 1.1 pp -143.4 -165.96 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.241 -0.912 . . . . 0.0 110.706 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -76.58 83.99 3.25 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.483 -0.761 . . . . 0.0 110.412 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 117.88 53.15 0.31 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -122.92 149.17 44.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.098 -1.236 . . . . 0.0 110.08 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 717' ' ' LEU . 3.8 tttt -108.64 146.34 33.54 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.502 -0.749 . . . . 0.0 109.472 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.458 ' CD1' HG23 ' A' ' 716' ' ' VAL . 9.7 t80 -145.17 147.82 32.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.12 -0.988 . . . . 0.0 112.404 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.504 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.12 131.8 45.56 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.599 -0.688 . . . . 0.0 109.535 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.487 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 7.2 mt -105.88 104.95 14.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.049 -1.032 . . . . 0.0 111.227 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.435 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 87.6 mt-30 -91.73 146.75 23.52 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.558 -0.714 . . . . 0.0 109.127 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 706' ' ' GLY . 8.7 p-10 -43.94 147.84 0.45 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.139 -0.975 . . . . 0.0 110.397 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 66.31 48.1 66.46 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 107.587 -2.205 . . . . 0.0 107.587 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.27 90.15 3.23 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.798 -0.825 . . . . 0.0 110.787 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.945 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 3.2 tt0 -93.46 107.03 18.94 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.533 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 1.8 pt -105.49 136.87 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.861 -0.524 . . . . 0.0 110.972 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 25.2 mttt -95.31 110.32 22.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.569 -0.707 . . . . 0.0 109.637 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.416 ' CG2' ' NE2' ' A' ' 622' ' ' HIS . 63.4 mt -76.72 -22.77 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 110.074 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.448 HG21 HD13 ' A' ' 690' ' ' ILE . 15.0 tt -143.39 137.92 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.241 -0.912 . . . . 0.0 110.284 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -138.07 112.78 8.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.203 -0.936 . . . . 0.0 110.701 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.93 117.19 28.15 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.233 -0.917 . . . . 0.0 109.753 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -67.57 -47.6 69.3 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.423 -0.798 . . . . 0.0 111.475 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.23 -43.47 13.74 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.307 -0.871 . . . . 0.0 111.225 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.01 -7.07 51.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.211 -0.93 . . . . 0.0 110.914 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.95 24.15 3.24 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.152 -0.968 . . . . 0.0 110.038 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.03 95.98 10.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.44 -0.787 . . . . 0.0 109.681 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 587' ' ' ILE . 31.5 m -125.79 142.36 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 111.059 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.507 ' HA ' ' OG ' ' A' ' 586' ' ' SER . 12.2 mt -123.81 164.06 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -175.38 142.94 6.42 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.439 -1.362 . . . . 0.0 110.376 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.945 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 17.0 m-85 -129.14 137.6 51.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.503 -0.998 . . . . 0.0 109.865 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -98.45 113.66 25.74 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.219 -0.925 . . . . 0.0 109.682 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -82.66 121.48 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.361 -0.837 . . . . 0.0 109.074 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.05 104.62 7.44 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.581 -0.699 . . . . 0.0 110.237 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 60.2 mt -81.12 104.17 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.325 -0.86 . . . . 0.0 109.552 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -75.57 -42.1 53.02 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.377 -0.827 . . . . 0.0 108.996 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.462 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.1 m-20 -110.66 141.3 44.09 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.637 0.732 . . . . 0.0 110.521 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 21.9 p -114.99 96.04 5.5 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 16.1 p -128.12 131.99 48.97 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.235 0.54 . . . . 0.0 110.707 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 51.86 32.37 33.56 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.412 HD13 ' CZ ' ' A' ' 577' ' ' PHE . 4.1 tp -108.09 138.37 44.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.45 -1.029 . . . . 0.0 110.717 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.571 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 3.1 p90 -54.92 -24.03 21.67 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.71 . . . . 0.0 109.921 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.571 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.2 t30 -172.37 157.01 3.95 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.475 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 13.0 pt-20 -51.11 -24.36 3.95 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.11 -0.994 . . . . 0.0 110.546 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 118.66 15.74 5.73 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 1.1 tp -82.76 9.13 10.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.03 -1.277 . . . . 0.0 111.431 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.538 ' O ' ' HG3' ' A' ' 709' ' ' MET . . . 92.08 -76.92 1.31 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.538 ' HG3' ' O ' ' A' ' 708' ' ' GLY . 0.5 OUTLIER 25.22 88.75 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.914 -0.757 . . . . 0.0 112.079 -179.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -163.59 178.89 7.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 0.0 110.362 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -80.57 -54.16 5.91 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.367 -0.833 . . . . 0.0 109.688 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.81 149.03 47.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.456 -0.778 . . . . 0.0 109.826 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.59 95.51 5.61 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.237 -0.915 . . . . 0.0 109.393 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.447 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 0.3 OUTLIER 40.11 76.7 0.06 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.355 0.598 . . . . 0.0 111.616 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.4 m -107.69 153.33 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.465 -0.772 . . . . 0.0 109.3 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.458 HG23 ' CD1' ' A' ' 670' ' ' PHE . 58.1 t -98.39 133.11 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.935 . . . . 0.0 110.797 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 669' ' ' LYS . 4.0 mp -102.44 156.63 17.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.509 -0.744 . . . . 0.0 109.569 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.13 154.11 17.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.192 -0.942 . . . . 0.0 110.489 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -87.27 146.2 26.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.389 -0.82 . . . . 0.0 110.345 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 10.5 p -121.21 -176.12 3.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.343 -0.848 . . . . 0.0 110.309 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.2 -28.84 28.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.416 -0.802 . . . . 0.0 110.097 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.58 -47.49 75.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.356 -0.84 . . . . 0.0 109.552 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -63.85 -48.01 78.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.394 -0.816 . . . . 0.0 109.772 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . 0.407 ' O ' ' CG1' ' A' ' 727' ' ' VAL . 12.2 tttt -53.77 -32.37 52.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.333 -0.854 . . . . 0.0 110.065 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.21 -36.24 79.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -0.827 . . . . 0.0 110.21 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 32.9 mt -59.52 -46.53 88.58 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.273 -0.892 . . . . 0.0 110.325 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 724' ' ' LYS . 8.5 p -70.79 -18.92 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.142 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.91 -43.74 69.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.214 -0.929 . . . . 0.0 108.824 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.59 103.52 10.48 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 122.281 1.039 . . . . 0.0 109.177 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.411 ' O ' ' CD2' ' A' ' 602' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.274 -2.712 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.365 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -83.82 2.77 36.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.366 -1.079 . . . . 0.0 110.696 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 139.38 -16.34 3.16 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -92.26 115.71 28.32 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.302 -1.117 . . . . 0.0 109.516 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.616 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.2 OUTLIER -106.49 -40.09 5.68 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.92 0.867 . . . . 0.0 109.545 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.616 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 9.7 tt -117.95 119.86 36.09 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.713 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 86.1 m -98.4 116.55 30.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.291 -0.881 . . . . 0.0 109.074 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.405 ' CD1' ' CD1' ' A' ' 625' ' ' ILE . 2.4 mt -90.78 112.16 23.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.408 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 2.4 mmtt -112.81 101.89 53.74 Favored Pre-proline 0 C--N 1.3 -1.548 0 C-N-CA 118.153 -1.419 . . . . 0.0 112.737 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.051 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.0 Cg_endo -79.55 144.97 18.14 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 N-CA-C 106.454 -2.172 . . . . 0.0 106.454 174.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.722 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.62 -173.54 0.28 Allowed Pre-proline 0 N--CA 1.494 1.74 0 C-N-CA 118.651 -1.22 . . . . 0.0 112.791 -176.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.722 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.2 Cg_endo -66.55 -28.3 45.4 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 124.113 1.586 . . . . 0.0 110.176 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.31 -28.4 66.76 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 46.7 p -95.43 153.57 17.63 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.441 HG12 ' O ' ' A' ' 614' ' ' GLU . 5.7 tp -57.07 -16.38 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.831 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 612' ' ' LYS . 1.2 tp -113.98 117.73 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.219 -0.925 . . . . 0.0 110.231 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.42 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -110.95 80.82 1.34 Allowed 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.219 -1.551 . . . . 0.0 109.209 179.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.051 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 33.8 mm-40 -142.24 175.81 9.47 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.823 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.541 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.66 125.48 40.18 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.138 -0.976 . . . . 0.0 109.096 176.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 611' ' ' CYS . 61.5 mt -111.39 156.07 22.16 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.369 -0.832 . . . . 0.0 109.987 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -125.25 111.05 14.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.356 -0.84 . . . . 0.0 111.802 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 39.9 mt -82.31 110.61 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.51 ' O ' ' C ' ' A' ' 596' ' ' GLN . 21.2 mm100 -69.39 114.9 8.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.499 -0.751 . . . . 0.0 112.794 -177.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.51 ' C ' ' O ' ' A' ' 595' ' ' GLN . 0.0 OUTLIER 14.6 56.77 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 178.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 106.98 46.65 1.08 Allowed Glycine 0 N--CA 1.486 1.988 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.845 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.488 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 1.0 OUTLIER -79.4 104.66 7.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 177.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -140.41 137.9 18.27 Favored Pre-proline 0 C--N 1.28 -2.421 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.103 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.519 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.7 Cg_endo -90.01 160.18 34.22 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.009 -2.08 . . . . 0.0 109.581 -0.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.538 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 4.5 t80 -107.29 116.73 32.44 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.705 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 52.3 m-85 -91.23 145.77 24.39 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.207 -0.933 . . . . 0.0 110.817 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.599 HG12 ' CB ' ' A' ' 611' ' ' CYS . 2.2 mt -139.68 141.17 35.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.491 -0.755 . . . . 0.0 110.436 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.727 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 174.17 -167.12 39.44 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.431 -1.366 . . . . 0.0 111.362 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 6.7 mmm-85 -64.34 -40.61 96.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.919 -0.754 . . . . 0.0 110.834 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.23 127.81 34.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.396 -0.815 . . . . 0.0 111.446 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -57.67 -14.88 6.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -0.84 . . . . 0.0 109.854 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -44.23 -36.97 2.94 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.413 -0.804 . . . . 0.0 110.092 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.705 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 74.8 m -71.42 151.85 43.64 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.385 -0.822 . . . . 0.0 109.575 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.535 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -57.78 -14.5 5.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.432 -0.792 . . . . 0.0 110.508 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.599 ' CB ' HG12 ' A' ' 603' ' ' ILE . 7.0 t -120.4 143.66 48.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.546 -0.721 . . . . 0.0 109.692 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.593 ' O ' HG12 ' A' ' 588' ' ' ILE . 1.7 ttpm? -111.82 130.68 55.73 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.053 0.93 . . . . 0.0 112.769 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.558 ' HA ' ' HB ' ' A' ' 588' ' ' ILE . 4.8 mt -146.55 110.58 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.441 ' O ' HG12 ' A' ' 587' ' ' ILE . 1.2 mt-10 -93.64 102.34 14.51 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 117.73 -1.588 . . . . 0.0 109.306 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.535 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 1.1 m-20 -138.39 105.85 5.55 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.184 177.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 615' ' ' ASP . 1.7 t30 -35.9 -48.28 0.56 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.632 -0.668 . . . . 0.0 112.583 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -83.55 -17.44 41.79 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.969 -1.082 . . . . 0.0 111.963 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -72.71 125.39 27.4 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.95 -1.094 . . . . 0.0 110.697 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.474 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -67.0 161.15 24.95 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.372 -0.83 . . . . 0.0 111.031 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.727 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -64.16 -45.56 87.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.243 -0.91 . . . . 0.0 109.223 179.35 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.467 ' O ' ' C ' ' A' ' 622' ' ' HIS . 12.4 m -94.86 2.3 9.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.386 -0.821 . . . . 0.0 109.336 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.9 t60 -29.09 -46.74 0.05 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.988 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.5 OUTLIER -136.46 145.24 44.97 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 118.514 -1.274 . . . . 0.0 110.777 179.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.539 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 4.1 p90 -145.57 144.05 30.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.55 -0.719 . . . . 0.0 110.116 178.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 76.0 mt -103.31 120.4 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.441 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 3.7 t80 -114.46 155.1 27.0 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.618 0.723 . . . . 0.0 109.666 -178.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.402 ' CE ' ' HA2' ' A' ' 597' ' ' GLY . 5.1 ttmt -118.01 137.45 52.87 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 121.639 0.733 . . . . 0.0 110.337 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.441 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -136.11 164.33 28.27 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.707 -0.62 . . . . 0.0 110.757 -179.121 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.0 tpt180 -77.52 117.26 18.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 108.677 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.51 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 5.6 t60 -58.57 124.55 20.05 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.591 0.71 . . . . 0.0 110.941 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -95.31 83.63 3.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.664 -0.648 . . . . 0.0 110.018 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 7.5 p -56.55 170.18 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.493 -0.754 . . . . 0.0 110.522 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -59.67 -168.89 0.32 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -59.17 133.56 56.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.308 -1.113 . . . . 0.0 110.238 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 74.4 p -95.55 40.32 1.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.376 -0.828 . . . . 0.0 110.405 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 17.3 mtt -89.87 48.17 1.55 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.382 -0.824 . . . . 0.0 109.873 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -172.89 -152.02 0.06 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.431 -0.793 . . . . 0.0 109.525 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -115.63 101.63 9.02 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.179 -0.95 . . . . 0.0 108.804 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 5.4 p -137.09 151.36 71.76 Favored Pre-proline 0 C--N 1.293 -1.868 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.087 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 642' ' ' GLN . 49.6 Cg_endo -70.86 -154.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.705 1.371 . . . . 0.0 109.944 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 65.77 -62.86 0.23 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.781 -0.575 . . . . 0.0 110.77 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 640' ' ' PRO . 23.3 tt0 52.69 32.06 11.33 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.084 -1.01 . . . . 0.0 110.169 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . 0.405 ' O ' ' HG ' ' A' ' 644' ' ' LEU . . . 69.38 119.18 0.03 OUTLIER Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 703' ' ' PHE . 4.2 mt -139.55 -157.31 0.76 Allowed 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.7 OUTLIER -115.04 124.53 51.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.877 -1.139 . . . . 0.0 111.476 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 628' ' ' LYS . 12.6 t0 -108.18 156.67 19.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.524 -0.735 . . . . 0.0 109.871 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.456 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 14.6 pt -104.85 131.72 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.314 -0.866 . . . . 0.0 110.174 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.52 ' CE3' HD11 ' A' ' 671' ' ' LEU . 97.9 m95 -118.56 121.0 39.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.684 -0.635 . . . . 0.0 110.937 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.526 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 8.8 t80 -80.82 114.82 19.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 108.67 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.539 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 8.8 t -107.6 109.02 20.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.189 -0.944 . . . . 0.0 111.432 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.605 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 10.5 t60 -75.04 160.18 30.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.0 109.979 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -150.69 -32.4 0.17 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.394 -0.816 . . . . 0.0 112.868 -178.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.605 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -79.38 130.35 9.8 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 117.897 -2.097 . . . . 0.0 109.976 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 654' ' ' THR . . . . . 0.433 ' C ' ' H ' ' A' ' 656' ' ' VAL . 14.5 m -36.01 -23.42 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 115.383 1.624 . . . . 0.0 115.383 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.474 ' O ' ' HB ' ' A' ' 656' ' ' VAL . 4.5 t-20 -54.97 -4.51 0.07 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.336 -1.478 . . . . 0.0 113.197 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 655' ' ' ASN . 4.3 t 75.31 150.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 121.592 -0.692 . . . . 0.0 110.984 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.548 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -111.66 151.9 28.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.577 -0.702 . . . . 0.0 110.347 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -138.39 126.47 22.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 109.863 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.515 ' CD2' ' CD2' ' A' ' 670' ' ' PHE . 19.4 tp -128.11 110.24 12.28 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.869 . . . . 0.0 110.161 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.67 -72.9 0.05 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.637 -0.664 . . . . 0.0 109.985 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 659' ' ' LEU . 4.9 m-80 -153.82 19.36 0.52 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.354 -0.841 . . . . 0.0 110.435 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -116.95 116.92 28.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.031 -1.043 . . . . 0.0 110.501 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.97 141.6 32.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 109.579 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.42 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 0.8 OUTLIER -115.2 -169.17 1.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 110.681 -179.214 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.453 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 1.1 pt -120.3 -165.62 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.41 -0.806 . . . . 0.0 110.068 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -84.22 73.02 10.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.36 -0.838 . . . . 0.0 110.569 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 130.47 54.47 0.1 OUTLIER Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -121.77 151.28 40.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -1.187 . . . . 0.0 110.106 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.437 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 7.2 tttt -109.04 139.69 43.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.486 -0.759 . . . . 0.0 109.411 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.515 ' CD2' ' CD2' ' A' ' 659' ' ' LEU . 0.6 OUTLIER -144.36 146.59 32.64 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.299 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.52 HD11 ' CE3' ' A' ' 648' ' ' TRP . 12.7 tp -70.56 146.16 50.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.32 -0.862 . . . . 0.0 111.227 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.526 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 7.7 mt -118.93 102.15 8.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 110.585 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.403 ' NE2' ' CA ' ' A' ' 708' ' ' GLY . 71.9 mt-30 -84.53 160.61 20.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.458 -0.777 . . . . 0.0 109.204 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 706' ' ' GLY . 21.4 p-10 -52.25 149.31 5.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.008 -1.057 . . . . 0.0 110.289 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 63.75 50.14 63.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.8 94.9 5.23 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.715 -0.874 . . . . 0.0 111.098 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.882 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -94.64 106.83 18.83 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.414 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.463 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 17.6 pt -106.78 135.8 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.474 -0.766 . . . . 0.0 111.328 -178.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -98.52 109.57 22.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.369 -0.832 . . . . 0.0 109.146 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.414 ' CD1' ' CD1' ' A' ' 613' ' ' ILE . 89.7 mt -74.86 -42.19 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.39 -0.819 . . . . 0.0 110.537 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.48 ' CD1' ' HB2' ' A' ' 618' ' ' LEU . 3.1 mt -130.75 132.95 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.202 -0.936 . . . . 0.0 110.347 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -138.75 112.04 8.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.571 -0.706 . . . . 0.0 109.904 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -129.94 117.91 20.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 110.248 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -29.73 69.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.466 -0.771 . . . . 0.0 110.721 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -55.69 -43.36 76.33 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.365 -0.835 . . . . 0.0 111.031 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 688' ' ' PHE . 2.1 t30 -137.26 36.0 2.52 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.192 -0.942 . . . . 0.0 110.256 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.509 ' O ' ' C ' ' A' ' 688' ' ' PHE . 0.8 OUTLIER 65.54 -67.82 0.13 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.77 -0.581 . . . . 0.0 109.856 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.509 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.1 OUTLIER 28.72 52.67 0.07 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.244 0.545 . . . . 0.0 111.346 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 586' ' ' SER . 91.6 t -101.76 142.64 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 110.674 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.411 HD11 ' HB ' ' A' ' 587' ' ' ILE . 44.5 mm -120.0 165.32 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 179.79 121.37 0.72 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.052 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.882 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.8 m-85 -119.9 136.6 54.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.54 -0.977 . . . . 0.0 108.978 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.78 114.28 27.93 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.216 -0.927 . . . . 0.0 110.511 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -82.97 120.62 34.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -127.08 104.5 8.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.753 -0.592 . . . . 0.0 110.077 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.403 ' CD1' ' O ' ' A' ' 705' ' ' GLU . 65.4 mt -84.35 103.63 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.665 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -80.99 -42.97 20.34 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.9 OUTLIER -110.81 140.27 45.38 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.483 0.659 . . . . 0.0 110.271 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 12.1 p -114.9 96.13 5.56 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 35.7 m -117.94 121.67 41.28 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.208 0.528 . . . . 0.0 110.607 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 52.41 45.5 58.65 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.443 ' O ' HD11 ' A' ' 644' ' ' LEU . 3.7 mt -115.38 132.81 56.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.439 -1.036 . . . . 0.0 110.728 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.627 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 3.1 p90 -47.43 -24.71 0.87 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.568 0.699 . . . . 0.0 110.47 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.627 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER -170.8 155.0 4.53 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.093 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.469 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 11.7 pt-20 -51.15 -26.78 7.24 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.194 -0.941 . . . . 0.0 110.398 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 119.71 18.47 4.38 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.06 9.28 10.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.071 -1.252 . . . . 0.0 111.74 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.403 ' CA ' ' NE2' ' A' ' 673' ' ' GLN . . . 69.39 84.21 0.15 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.408 ' O ' ' CG ' ' A' ' 709' ' ' MET . 0.2 OUTLIER -117.35 101.89 8.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.421 -1.046 . . . . 0.0 110.403 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -175.87 153.47 1.37 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.02 -1.05 . . . . 0.0 110.499 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -42.08 97.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.359 -0.838 . . . . 0.0 109.663 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.65 149.04 47.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.454 -0.779 . . . . 0.0 109.559 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -110.4 95.32 5.5 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.172 -0.955 . . . . 0.0 109.697 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.458 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 1.3 mmm-85 38.32 84.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.893 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.444 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 35.5 m -108.31 151.13 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.455 -0.778 . . . . 0.0 109.583 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.42 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 87.5 t -98.44 127.47 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.266 -0.896 . . . . 0.0 110.758 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.22 145.74 41.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.58 -0.7 . . . . 0.0 109.347 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.95 149.62 35.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.159 -0.963 . . . . 0.0 110.693 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -81.03 154.29 26.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.419 -0.801 . . . . 0.0 110.278 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 11.5 p -108.38 -176.61 3.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.331 -0.856 . . . . 0.0 110.677 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.51 -29.42 36.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.415 -0.803 . . . . 0.0 110.157 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . 0.45 ' O ' HD13 ' A' ' 726' ' ' LEU . 11.1 tp10 -60.72 -52.48 64.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.499 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -63.89 -42.72 97.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 0.0 109.378 179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -54.12 -32.21 54.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.341 -0.85 . . . . 0.0 109.552 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.26 -38.45 78.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.471 -0.768 . . . . 0.0 110.399 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 722' ' ' GLU . 11.0 mp -55.75 -47.83 76.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.245 -0.909 . . . . 0.0 110.521 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.65 -22.22 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.226 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -51.44 65.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 108.912 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.84 104.98 11.87 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.171 0.986 . . . . 0.0 109.062 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 2.0 mt . . . . . 0 C--N 1.275 -2.657 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.444 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -83.18 -10.36 58.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.395 -1.062 . . . . 0.0 110.619 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 126.41 -30.68 4.21 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.59 114.39 26.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.325 -1.103 . . . . 0.0 109.661 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.532 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 6.7 t80 -98.09 -41.7 7.81 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.867 0.841 . . . . 0.0 109.678 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.455 ' HB3' ' HB ' ' A' ' 594' ' ' ILE . 48.5 tp -129.39 119.77 24.41 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.272 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 89.2 m -94.89 116.43 28.7 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.701 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 7.4 mt -89.91 111.34 22.36 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 583' ' ' LEU . 0.4 OUTLIER -114.08 102.77 55.09 Favored Pre-proline 0 C--N 1.298 -1.638 0 C-N-CA 118.116 -1.434 . . . . 0.0 112.463 -177.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.094 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.8 Cg_endo -79.63 143.97 17.26 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 N-CA-C 107.134 -1.91 . . . . 0.0 107.134 174.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 1.013 ' HB2' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -128.06 -173.98 0.34 Allowed Pre-proline 0 C--N 1.3 -1.585 0 C-N-CA 118.958 -1.097 . . . . 0.0 112.381 -177.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 1.013 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 35.3 Cg_endo -60.5 -33.43 93.88 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.819 1.431 . . . . 0.0 111.556 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . 0.512 ' HB2' HD21 ' A' ' 583' ' ' LEU . 4.3 m-20 -59.73 -23.99 63.65 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.695 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 19.1 t -95.73 151.45 19.36 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.478 HG21 ' OD1' ' A' ' 615' ' ' ASP . 7.8 tp -62.34 -17.09 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.026 -1.046 . . . . 0.0 109.647 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.572 HG12 ' O ' ' A' ' 612' ' ' LYS . 1.2 tp -108.21 122.72 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.318 -0.864 . . . . 0.0 110.187 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 586' ' ' SER . 23.6 mp0 -110.07 79.8 1.25 Allowed 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.463 -1.398 . . . . 0.0 109.399 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.094 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 27.2 mt-10 -144.71 175.45 10.16 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.643 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.52 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.13 124.77 35.57 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.138 -0.976 . . . . 0.0 108.889 175.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 2.1 mt -109.53 155.73 21.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.918 . . . . 0.0 109.565 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -125.26 110.25 13.81 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.373 -0.829 . . . . 0.0 111.346 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.462 HG22 ' HB ' ' A' ' 598' ' ' VAL . 2.0 mt -81.61 109.21 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.2 OUTLIER -56.15 165.07 1.08 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.446 -179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.532 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -63.17 70.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.54 -0.725 . . . . 0.0 110.065 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 137.79 21.83 0.48 Allowed Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.819 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.462 ' HB ' HG22 ' A' ' 594' ' ' ILE . 0.9 OUTLIER -84.29 101.67 9.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 O-C-N 120.764 -1.433 . . . . 0.0 107.21 178.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -145.46 132.57 10.1 Favored Pre-proline 0 C--N 1.283 -2.312 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.869 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.631 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 53.9 Cg_endo -91.71 163.5 27.77 Favored 'Cis proline' 0 C--N 1.311 -1.409 0 C-N-CA 123.31 -1.538 . . . . 0.0 109.045 -2.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.521 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 7.9 t80 -105.11 116.91 32.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.657 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 70.0 m-85 -86.34 146.15 26.6 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.416 -0.803 . . . . 0.0 111.406 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.575 HG12 ' CB ' ' A' ' 611' ' ' CYS . 2.9 mt -141.68 140.69 30.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.703 -0.623 . . . . 0.0 109.895 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.72 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 175.25 -161.41 30.59 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.298 -1.429 . . . . 0.0 111.436 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.408 ' CG ' ' O ' ' A' ' 615' ' ' ASP . 5.9 mmm-85 -69.7 -44.65 69.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.973 -0.722 . . . . 0.0 110.82 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.06 128.22 33.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.454 -0.779 . . . . 0.0 110.981 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.451 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 1.6 pt-20 -58.54 -12.79 4.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.429 -0.794 . . . . 0.0 109.657 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -45.25 -36.07 3.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.483 -0.761 . . . . 0.0 110.155 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.657 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 81.8 m -71.44 154.26 41.66 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 121.184 -0.947 . . . . 0.0 109.601 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.521 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -58.98 -14.0 8.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.443 -0.785 . . . . 0.0 110.14 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.575 ' CB ' HG12 ' A' ' 603' ' ' ILE . 6.1 t -120.18 143.94 47.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.492 -0.755 . . . . 0.0 110.033 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.572 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -110.63 129.7 55.75 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 121.992 0.901 . . . . 0.0 112.562 -178.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.53 ' HA ' ' HB ' ' A' ' 588' ' ' ILE . 4.3 mt -146.82 111.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -93.05 102.76 15.1 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 117.69 -1.604 . . . . 0.0 109.095 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 3.2 m-20 -138.26 105.29 5.43 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.505 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -42.81 -41.43 3.24 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.412 -0.805 . . . . 0.0 111.881 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.97 -16.88 42.47 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.137 -0.977 . . . . 0.0 111.739 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.52 ' CD2' ' HA2' ' A' ' 604' ' ' GLY . 0.7 OUTLIER -80.75 134.75 35.87 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.121 -0.987 . . . . 0.0 111.319 -178.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.463 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.42 162.83 28.02 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.466 -0.771 . . . . 0.0 111.025 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.72 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 34.2 ttp180 -64.36 -46.77 81.98 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.348 -0.845 . . . . 0.0 109.738 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.483 ' O ' ' C ' ' A' ' 622' ' ' HIS . 13.8 m -94.67 2.43 9.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.209 -0.932 . . . . 0.0 109.059 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.764 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.4 t60 -28.59 -47.85 0.05 Allowed 'General case' 0 C--O 1.192 -1.954 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.751 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.435 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.8 OUTLIER -137.21 145.16 43.32 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 118.311 -1.356 . . . . 0.0 111.166 179.049 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.596 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 6.5 p90 -145.86 150.4 36.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.573 -0.704 . . . . 0.0 110.339 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 19.0 mt -103.41 119.56 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.43 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 7.0 t80 -112.61 155.4 24.47 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.482 -0.761 . . . . 0.0 109.351 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 0.8 OUTLIER -119.61 136.06 54.54 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.852 0.834 . . . . 0.0 111.183 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.43 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -140.51 163.54 32.56 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.515 ' HD2' ' O ' ' A' ' 630' ' ' HIS . 0.0 OUTLIER -78.18 133.98 37.7 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.966 -1.084 . . . . 0.0 109.439 -179.492 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.515 ' O ' ' HD2' ' A' ' 629' ' ' ARG . 1.2 t60 -58.4 123.66 16.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.368 -0.832 . . . . 0.0 111.247 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -75.21 108.38 7.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.636 -0.665 . . . . 0.0 110.487 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . 0.425 HG21 ' N ' ' A' ' 633' ' ' GLY . 7.1 p -109.17 168.27 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.392 -0.817 . . . . 0.0 110.087 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . 0.425 ' N ' HG21 ' A' ' 632' ' ' VAL . . . -110.98 -157.78 15.07 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -59.66 139.5 57.17 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.39 -1.065 . . . . 0.0 110.173 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.39 85.61 3.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.259 -0.901 . . . . 0.0 110.289 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.09 125.35 22.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.873 . . . . 0.0 109.649 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 64.53 -144.78 0.26 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.464 -0.772 . . . . 0.0 109.853 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -115.4 103.02 10.37 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.137 -0.977 . . . . 0.0 109.314 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 13.0 p -135.9 151.36 73.81 Favored Pre-proline 0 C--N 1.294 -1.838 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.737 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.28 -153.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.673 1.354 . . . . 0.0 110.094 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.406 ' O ' HG22 ' A' ' 632' ' ' VAL . . . 54.48 20.69 2.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.56 -0.712 . . . . 0.0 110.913 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.99 60.97 0.55 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.103 -0.998 . . . . 0.0 109.837 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 62.26 117.71 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.45 ' CB ' ' N ' ' A' ' 703' ' ' PHE . 4.9 mp -140.84 -146.9 0.2 Allowed 'General case' 0 C--N 1.29 -1.985 0 O-C-N 122.076 -0.661 . . . . 0.0 109.422 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.6 OUTLIER -108.63 124.96 51.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.067 -1.021 . . . . 0.0 110.728 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -121.36 135.51 55.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.355 -0.841 . . . . 0.0 110.509 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 25.4 pt -92.69 135.28 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.272 -0.893 . . . . 0.0 110.075 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.63 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.6 m95 -119.62 121.93 40.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.604 -0.685 . . . . 0.0 111.306 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.502 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 14.0 t80 -80.78 115.54 20.33 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.596 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 9.8 t -107.22 108.45 19.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 111.64 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.516 ' CD2' ' N ' ' A' ' 652' ' ' THR . 12.5 t60 -70.72 158.66 35.88 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.461 -0.774 . . . . 0.0 109.761 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.764 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -149.86 -29.58 0.23 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.43 -0.794 . . . . 0.0 112.441 -179.077 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.542 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.45 -167.59 31.86 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 117.642 -2.218 . . . . 0.0 109.17 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 27.6 m -95.62 -17.44 21.34 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.014 -1.286 . . . . 0.0 113.751 -176.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.495 ' CB ' HG12 ' A' ' 681' ' ' ILE . 16.7 m120 -59.48 -4.01 0.54 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.775 -1.203 . . . . 0.0 112.683 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.462 ' C ' ' CE1' ' A' ' 651' ' ' HIS . 3.4 t 71.52 148.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-O 121.494 0.664 . . . . 0.0 110.604 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.436 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -106.83 143.09 35.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.721 -0.612 . . . . 0.0 110.068 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.456 ' CE1' ' CG ' ' A' ' 663' ' ' ARG . 36.6 m-85 -136.0 126.74 27.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.211 -0.93 . . . . 0.0 110.701 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.448 ' HG ' ' CG2' ' A' ' 678' ' ' ILE . 0.1 OUTLIER -130.02 119.04 22.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.392 -0.817 . . . . 0.0 109.787 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 56.89 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.388 -0.82 . . . . 0.0 110.429 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 659' ' ' LEU . 3.6 t-20 -138.07 5.73 2.57 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.017 -1.052 . . . . 0.0 110.984 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -96.28 132.99 41.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.032 -1.043 . . . . 0.0 110.566 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . 0.456 ' CG ' ' CE1' ' A' ' 658' ' ' TYR . 4.6 tmm_? -99.47 138.69 36.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.448 -0.783 . . . . 0.0 109.872 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.427 ' CB ' ' OG ' ' A' ' 657' ' ' SER . 3.6 mtp -117.41 -165.99 1.14 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.229 -0.92 . . . . 0.0 110.716 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.419 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 2.5 pt -141.86 -158.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.354 -0.842 . . . . 0.0 110.171 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -82.85 92.05 7.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.2 -0.938 . . . . 0.0 110.759 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 109.65 49.74 0.73 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.2 OUTLIER -118.52 148.39 42.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.06 -1.259 . . . . 0.0 109.943 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.416 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 7.6 tttt -108.5 138.88 44.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.441 -0.787 . . . . 0.0 109.088 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.479 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 5.2 t80 -144.25 147.19 33.25 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.104 -0.997 . . . . 0.0 112.032 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.63 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -69.76 147.49 50.41 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.554 -0.717 . . . . 0.0 111.583 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.502 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 7.8 mt -122.81 99.2 6.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.322 -0.861 . . . . 0.0 111.444 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 674' ' ' ASP . 94.2 mt-30 -84.65 141.26 30.75 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 706' ' ' GLY . 0.3 OUTLIER -38.34 151.51 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.354 -0.842 . . . . 0.0 110.815 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 64.9 49.59 62.35 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 107.358 -2.297 . . . . 0.0 107.358 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . 0.419 ' HB2' ' CG1' ' A' ' 694' ' ' VAL . 0.3 OUTLIER -115.81 92.43 3.9 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.871 -0.782 . . . . 0.0 110.774 -178.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.935 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.2 OUTLIER -93.93 106.98 18.93 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.448 ' CG2' ' HG ' ' A' ' 659' ' ' LEU . 1.2 pt -106.84 137.31 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.369 0.604 . . . . 0.0 111.404 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' A' ' 679' ' ' LYS . 2.9 ptmm? -97.17 110.44 22.99 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.488 -0.757 . . . . 0.0 109.418 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 68.5 mt -80.09 -22.65 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.373 -0.829 . . . . 0.0 110.692 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.495 HG12 ' CB ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER -134.64 135.17 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.163 -0.961 . . . . 0.0 109.998 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -138.0 109.13 6.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.934 . . . . 0.0 110.562 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.16 118.23 21.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.281 -0.887 . . . . 0.0 109.666 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.95 -32.53 74.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.334 -0.854 . . . . 0.0 111.215 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -84.23 -43.71 14.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.092 -1.005 . . . . 0.0 111.504 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . 0.443 ' HB3' ' CD1' ' A' ' 688' ' ' PHE . 88.4 m-20 -73.88 -19.83 60.59 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.137 -0.977 . . . . 0.0 110.798 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.53 22.09 4.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.168 -0.958 . . . . 0.0 110.46 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.697 ' CG ' ' O ' ' A' ' 688' ' ' PHE . 0.7 OUTLIER -114.24 83.8 1.94 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.26 1.029 . . . . 0.0 109.472 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.695 ' O ' ' HA ' ' A' ' 586' ' ' SER . 14.9 m -101.04 143.17 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.075 -1.016 . . . . 0.0 110.553 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.475 ' CD1' ' CG2' ' A' ' 587' ' ' ILE . 47.7 mm -85.19 165.13 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.554 -0.716 . . . . 0.0 109.975 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -176.8 117.06 0.58 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.935 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.6 m-85 -121.46 137.26 54.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 109.945 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.96 113.95 25.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.282 -0.886 . . . . 0.0 109.98 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 676' ' ' ASP . 0.5 OUTLIER -83.65 123.7 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.364 -0.835 . . . . 0.0 109.254 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.39 108.52 10.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.85 -0.531 . . . . 0.0 110.408 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.419 ' CD1' ' O ' ' A' ' 705' ' ' GLU . 81.0 mt -86.37 104.42 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.887 . . . . 0.0 109.826 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -77.4 -41.39 40.18 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.421 -0.8 . . . . 0.0 109.453 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.461 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 5.2 m-20 -110.22 140.97 43.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.479 -0.763 . . . . 0.0 110.735 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 15.7 p -115.88 96.27 5.51 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 82.5 m -108.7 114.71 28.74 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 121.752 -0.592 . . . . 0.0 110.738 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 49.46 36.37 23.58 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.445 HD11 ' CE1' ' A' ' 577' ' ' PHE . 5.2 tp -98.41 141.18 31.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.613 -0.933 . . . . 0.0 110.195 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.534 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 3.6 p90 -51.75 -24.92 6.5 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.395 -0.816 . . . . 0.0 109.756 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.534 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.8 OUTLIER -176.92 155.64 1.25 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.255 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.451 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 11.1 pt-20 -51.41 -22.86 3.27 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.114 -0.991 . . . . 0.0 110.456 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 115.04 16.66 7.18 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 3.3 tp -85.17 8.76 17.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -1.204 . . . . 0.0 111.871 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.412 ' CA ' ' NE2' ' A' ' 673' ' ' GLN . . . 45.95 73.81 0.27 Allowed Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.542 ' O ' ' HG ' ' A' ' 710' ' ' LEU . 0.0 OUTLIER -81.27 177.29 9.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.255 -1.144 . . . . 0.0 110.577 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 709' ' ' MET . 0.3 OUTLIER 40.99 -159.41 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.416 0.627 . . . . 0.0 111.703 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -91.83 71.87 5.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.526 -0.734 . . . . 0.0 109.145 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.02 148.18 48.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.439 -0.788 . . . . 0.0 110.566 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -111.07 97.32 6.72 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.479 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -116.98 88.9 3.0 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.723 0.773 . . . . 0.0 109.356 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 36.0 m -105.25 168.7 2.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.666 -0.646 . . . . 0.0 109.63 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.412 ' HA ' ' CD2' ' A' ' 670' ' ' PHE . 52.7 t -71.34 128.48 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.326 -0.859 . . . . 0.0 111.139 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.62 162.3 13.63 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -98.64 154.39 17.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.981 -1.074 . . . . 0.0 110.467 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.69 145.08 33.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.54 -0.725 . . . . 0.0 110.403 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 34.3 p -121.07 -176.8 3.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 110.093 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.78 -32.21 63.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.292 -0.88 . . . . 0.0 110.448 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -64.49 -52.3 58.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.386 -0.822 . . . . 0.0 110.22 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.42 -40.3 95.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.328 -0.857 . . . . 0.0 110.051 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -56.93 -35.11 68.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.311 -0.868 . . . . 0.0 109.945 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 728' ' ' LYS . 0.9 OUTLIER -67.7 -35.79 79.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.472 -0.768 . . . . 0.0 109.994 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 50.3 mt -57.06 -46.39 82.52 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.333 -0.854 . . . . 0.0 110.336 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.2 p -76.28 -24.33 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.613 -0.68 . . . . 0.0 110.914 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 725' ' ' ASP . 0.7 OUTLIER -53.32 -45.18 68.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.055 -1.028 . . . . 0.0 108.956 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -116.67 103.81 10.74 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 122.197 0.999 . . . . 0.0 109.057 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.401 ' O ' ' CE2' ' A' ' 602' ' ' PHE . 2.2 mt . . . . . 0 C--N 1.274 -2.708 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.375 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.399 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -82.83 1.61 38.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.34 -1.094 . . . . 0.0 110.656 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 105.03 7.34 38.43 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -94.28 124.42 38.29 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.222 -1.164 . . . . 0.0 109.296 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.572 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.1 OUTLIER -120.96 -39.69 2.69 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.843 0.83 . . . . 0.0 109.415 -179.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 8.5 tt -120.31 119.52 33.38 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.326 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 71.2 m -99.44 118.89 37.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 109.52 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 5.8 mt -91.37 111.97 23.68 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.485 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.79 101.82 54.2 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 118.075 -1.45 . . . . 0.0 112.736 -177.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.064 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 44.2 Cg_endo -79.75 145.78 18.31 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 N-CA-C 106.784 -2.045 . . . . 0.0 106.784 174.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.709 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.33 -174.37 0.31 Allowed Pre-proline 0 N--CA 1.494 1.753 0 C-N-CA 118.81 -1.156 . . . . 0.0 112.763 -177.104 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.709 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.9 Cg_endo -66.79 -28.73 43.15 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 124.111 1.585 . . . . 0.0 110.319 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -59.4 -28.35 66.83 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 53.7 p -95.45 153.73 17.55 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.535 ' HB ' HD11 ' A' ' 690' ' ' ILE . 3.8 tp -54.76 -16.98 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.333 -0.855 . . . . 0.0 109.944 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.648 HG12 ' O ' ' A' ' 612' ' ' LYS . 1.6 tp -116.3 119.34 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.265 -0.897 . . . . 0.0 110.575 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -112.39 80.73 1.37 Allowed 'General case' 0 N--CA 1.509 2.498 0 O-C-N 120.444 -1.41 . . . . 0.0 109.143 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.064 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 6.7 mm-40 -142.57 175.78 9.53 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.625 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.537 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.92 125.85 40.37 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.083 -1.011 . . . . 0.0 109.456 176.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 17.4 mt -111.17 156.02 22.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.405 -0.809 . . . . 0.0 109.649 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -125.23 111.12 14.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.378 -0.826 . . . . 0.0 111.836 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 45.9 mt -80.42 110.81 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 596' ' ' GLN . 2.0 mt-30 -70.71 109.47 4.95 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.52 ' HA ' ' HB3' ' A' ' 577' ' ' PHE . 0.5 OUTLIER 20.43 53.89 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 178.333 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . 109.96 44.62 1.01 Allowed Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.603 -1.284 . . . . 0.0 111.03 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.508 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 1.0 OUTLIER -79.63 103.85 7.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 177.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.2 OUTLIER -140.97 140.52 21.55 Favored Pre-proline 0 C--N 1.281 -2.371 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.639 -178.703 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.554 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.2 Cg_endo -88.79 160.82 40.67 Favored 'Cis proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.721 -2.199 . . . . 0.0 109.07 -0.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.556 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -106.56 116.82 32.58 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.679 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 58.1 m-85 -91.25 145.86 24.31 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.39 -0.818 . . . . 0.0 111.037 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.606 HG12 ' CB ' ' A' ' 611' ' ' CYS . 2.2 mt -140.02 141.05 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.33 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.7 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 175.33 -165.85 37.04 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.356 -1.402 . . . . 0.0 111.321 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 13.2 tpt180 -66.69 -38.81 87.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.956 -0.732 . . . . 0.0 110.777 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.459 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -84.22 126.8 33.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.398 -0.814 . . . . 0.0 110.748 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.42 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -59.3 -12.68 6.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 110.009 179.125 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.32 -36.97 6.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.882 . . . . 0.0 110.036 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.679 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 75.3 m -68.93 153.65 43.42 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 121.265 -0.897 . . . . 0.0 109.773 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.556 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -58.63 -14.78 9.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.485 -0.76 . . . . 0.0 110.238 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.606 ' CB ' HG12 ' A' ' 603' ' ' ILE . 6.6 t -119.95 143.46 47.99 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.582 -0.699 . . . . 0.0 109.528 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.648 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -110.23 130.88 55.47 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 122.054 0.93 . . . . 0.0 112.856 -178.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.556 ' HA ' ' HB ' ' A' ' 588' ' ' ILE . 3.9 mt -147.15 110.39 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.411 ' O ' HG12 ' A' ' 587' ' ' ILE . 2.7 tt0 -92.31 102.98 15.48 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 117.666 -1.614 . . . . 0.0 109.277 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 1.0 OUTLIER -139.55 106.15 5.34 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.692 177.322 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -42.94 -43.68 4.25 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.485 -0.76 . . . . 0.0 111.962 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -83.53 -17.13 42.89 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.144 -0.973 . . . . 0.0 111.729 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.496 ' CD2' ' HA2' ' A' ' 604' ' ' GLY . 0.8 OUTLIER -78.01 134.65 37.77 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.07 -1.019 . . . . 0.0 110.694 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.457 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.1 m -73.37 161.14 30.79 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.337 -0.852 . . . . 0.0 110.915 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.7 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 43.6 mtm180 -64.2 -45.63 87.47 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.235 -0.916 . . . . 0.0 109.309 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.469 ' O ' ' C ' ' A' ' 622' ' ' HIS . 15.7 m -94.66 2.0 9.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.83 0.824 . . . . 0.0 109.402 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.6 t60 -28.28 -46.91 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.771 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.445 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.5 OUTLIER -136.17 144.93 45.26 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.523 178.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 6.3 p90 -145.7 143.65 29.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.485 -0.759 . . . . 0.0 110.229 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.478 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 76.8 mt -103.43 117.66 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 8.3 t80 -110.95 155.0 23.32 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.853 0.835 . . . . 0.0 110.234 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.424 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 3.1 tppp? -118.96 137.13 53.71 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 121.372 0.606 . . . . 0.0 109.735 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.0 OUTLIER -133.88 163.82 28.65 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.566 -0.709 . . . . 0.0 111.038 -179.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.46 ' HD2' ' O ' ' A' ' 644' ' ' LEU . 2.5 tpt180 -77.66 116.2 18.02 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.366 -0.834 . . . . 0.0 108.929 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -57.93 124.63 19.9 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.651 0.738 . . . . 0.0 110.649 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -60.11 124.3 19.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.683 -0.635 . . . . 0.0 110.537 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . 0.4 ' HA ' ' HB3' ' A' ' 642' ' ' GLN . 8.2 p -113.27 171.81 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.416 -0.803 . . . . 0.0 110.24 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . 68.24 150.66 0.27 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.16 35.62 17.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.336 -1.096 . . . . 0.0 110.455 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.0 83.46 1.76 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.45 -0.781 . . . . 0.0 110.085 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 636' ' ' MET . . . . . 0.424 ' O ' ' O ' ' A' ' 637' ' ' TYR . 13.4 mmt 53.48 -135.95 1.42 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.162 -0.961 . . . . 0.0 109.318 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 636' ' ' MET . 2.6 p90 -57.87 -160.31 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.413 -0.804 . . . . 0.0 109.743 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -115.58 101.63 9.04 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 120.773 -1.204 . . . . 0.0 109.691 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 639' ' ' SER . . . . . 0.422 ' HB3' ' CE1' ' A' ' 637' ' ' TYR . 4.4 p -137.81 145.44 48.43 Favored Pre-proline 0 C--N 1.293 -1.871 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.022 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . 0.589 ' O ' ' CB ' ' A' ' 641' ' ' ALA . 49.6 Cg_endo -70.05 -150.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.637 1.335 . . . . 0.0 109.319 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.589 ' CB ' ' O ' ' A' ' 640' ' ' PRO . . . 82.47 -49.12 0.19 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.708 -0.62 . . . . 0.0 110.893 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . 0.4 ' HB3' ' HA ' ' A' ' 632' ' ' VAL . 4.8 mt-30 -74.81 134.43 41.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.889 -1.132 . . . . 0.0 110.195 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 135.25 -3.04 3.98 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.537 ' HB2' ' N ' ' A' ' 703' ' ' PHE . 4.6 mp -105.67 -154.45 0.51 Allowed 'General case' 0 C--N 1.283 -2.322 0 O-C-N 122.09 -0.653 . . . . 0.0 109.546 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 628' ' ' LYS . 41.6 m-20 -112.22 124.72 53.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.873 -1.142 . . . . 0.0 111.325 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 628' ' ' LYS . 5.6 t0 -98.34 156.57 16.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.482 -0.761 . . . . 0.0 109.647 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 12.7 pt -106.25 130.18 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.278 -0.889 . . . . 0.0 110.38 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.711 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.6 m95 -117.84 124.38 48.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.841 -0.537 . . . . 0.0 111.194 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.455 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 7.1 t80 -83.91 114.47 21.7 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 17.4 t -109.71 106.1 15.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.061 -1.024 . . . . 0.0 112.112 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.549 ' CD2' ' N ' ' A' ' 652' ' ' THR . 14.4 t60 -67.54 162.55 23.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.454 -0.778 . . . . 0.0 109.854 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -154.47 -30.98 0.11 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.304 -0.872 . . . . 0.0 112.509 -179.244 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.553 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.62 -168.57 34.18 Favored Glycine 0 N--CA 1.497 2.712 0 C-N-CA 117.82 -2.133 . . . . 0.0 109.766 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 654' ' ' THR . . . . . 0.468 ' O ' HG12 ' A' ' 656' ' ' VAL . 11.1 m -89.71 -18.78 25.74 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.088 -1.242 . . . . 0.0 114.217 -176.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.579 ' O ' HG23 ' A' ' 656' ' ' VAL . 24.4 m120 -59.32 -3.03 0.36 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.605 -1.309 . . . . 0.0 112.728 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 62.52 142.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.549 -0.719 . . . . 0.0 110.164 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.482 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -96.95 151.8 19.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.589 -0.695 . . . . 0.0 110.554 -179.168 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.481 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 12.6 m-85 -138.02 125.46 21.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.363 -0.836 . . . . 0.0 110.175 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.496 HD11 ' CD1' ' A' ' 670' ' ' PHE . 1.7 mt -129.4 110.15 11.66 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.382 -0.824 . . . . 0.0 109.83 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 59.02 -80.67 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.428 -0.795 . . . . 0.0 110.37 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 659' ' ' LEU . 7.6 p-10 -144.64 13.73 1.54 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 110.94 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -100.16 116.74 32.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.017 -1.052 . . . . 0.0 110.225 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -81.46 136.14 35.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.348 -0.845 . . . . 0.0 109.676 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.435 ' CG ' ' CG2' ' A' ' 716' ' ' VAL . 1.6 mtp -119.07 -167.39 1.38 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 0.0 110.223 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.432 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 11.2 pt -146.74 -162.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -75.68 79.4 2.65 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.342 -0.849 . . . . 0.0 111.272 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.93 58.07 0.21 Allowed Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.833 -1.175 . . . . 0.0 110.678 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 1.2 p -123.9 145.58 49.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.994 -1.298 . . . . 0.0 110.074 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 650' ' ' CYS . 8.0 tttt -108.52 136.94 47.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.398 -0.814 . . . . 0.0 109.205 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.496 ' CD1' HD11 ' A' ' 659' ' ' LEU . 8.1 t80 -144.45 146.81 32.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.163 -0.96 . . . . 0.0 111.49 -178.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.711 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.9 OUTLIER -72.17 145.88 47.77 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.413 -0.804 . . . . 0.0 111.628 -179.374 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.458 ' CD2' HD13 ' A' ' 659' ' ' LEU . 6.2 mt -115.55 112.94 22.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.228 -0.92 . . . . 0.0 111.318 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 15.3 mt-30 -84.53 -177.03 6.5 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 706' ' ' GLY . 0.0 OUTLIER -73.55 149.7 42.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.982 -1.074 . . . . 0.0 109.711 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 59.68 50.26 69.61 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.2 94.74 5.89 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.74 0.781 . . . . 0.0 110.643 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.896 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 5.9 tt0 -93.49 107.42 19.27 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.486 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 1.9 mp -104.15 137.15 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.642 -0.661 . . . . 0.0 111.88 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -99.58 109.89 22.37 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 74.9 mt -79.52 -19.89 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.352 -0.842 . . . . 0.0 111.076 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.437 HG12 ' CB ' ' A' ' 655' ' ' ASN . 8.4 mt -141.6 141.33 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.967 -1.083 . . . . 0.0 110.762 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -137.79 108.77 6.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.43 -0.794 . . . . 0.0 109.965 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.96 118.43 29.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.268 -0.895 . . . . 0.0 110.161 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -66.33 -46.87 75.36 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.364 -0.835 . . . . 0.0 110.963 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -84.93 -43.43 14.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.258 -0.901 . . . . 0.0 111.2 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . 0.462 ' O ' ' N ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -91.23 0.39 57.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.262 -0.899 . . . . 0.0 111.004 -179.353 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.537 ' O ' ' C ' ' A' ' 688' ' ' PHE . 0.0 OUTLIER 65.49 -67.73 0.13 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.42 -0.8 . . . . 0.0 109.777 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.537 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.1 OUTLIER 24.52 61.0 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.369 0.604 . . . . 0.0 111.317 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 586' ' ' SER . 59.8 t -101.97 142.46 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.422 -0.799 . . . . 0.0 110.718 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.535 HD11 ' HB ' ' A' ' 587' ' ' ILE . 40.4 mm -122.64 165.38 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -176.35 121.01 0.78 Allowed Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.896 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 10.6 m-85 -119.62 136.51 54.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.526 -0.985 . . . . 0.0 108.798 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -98.77 114.32 26.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 110.898 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.432 ' O ' ' CG1' ' A' ' 694' ' ' VAL . 1.2 t -84.78 114.0 24.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -122.37 104.34 9.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.733 -0.604 . . . . 0.0 109.826 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.522 ' CD1' ' HA3' ' A' ' 706' ' ' GLY . 83.3 mt -88.71 103.28 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.33 -0.856 . . . . 0.0 109.679 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.0 -41.75 22.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 0.0 108.927 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.7 OUTLIER -109.92 141.29 42.87 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.391 0.615 . . . . 0.0 109.629 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 16.3 p -113.29 95.8 5.56 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 40.7 m -129.65 134.62 47.78 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.87 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 57.72 29.35 61.28 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.83 128.07 56.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.503 -0.998 . . . . 0.0 110.24 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.537 ' N ' ' HB2' ' A' ' 644' ' ' LEU . 3.5 p90 -50.44 -24.01 2.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.481 -0.762 . . . . 0.0 110.753 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.522 ' OD1' ' HG2' ' A' ' 705' ' ' GLU . 0.9 OUTLIER -157.93 171.37 20.38 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -178.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.522 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 16.6 pt-20 -51.33 -22.83 3.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.068 -1.02 . . . . 0.0 110.295 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 120.83 5.75 9.71 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.515 ' O ' ' CD1' ' A' ' 707' ' ' LEU . 0.8 OUTLIER -90.21 10.36 24.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.351 -1.088 . . . . 0.0 110.669 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.485 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 61.84 162.02 0.21 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.64 110.2 0.07 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.371 -1.076 . . . . 0.0 110.231 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -175.06 165.48 3.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.225 -0.922 . . . . 0.0 110.368 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.08 -44.05 95.06 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.351 -0.843 . . . . 0.0 109.895 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -63.78 149.38 46.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.43 -0.794 . . . . 0.0 109.685 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.32 95.72 5.86 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.295 -0.878 . . . . 0.0 109.349 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.433 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 3.5 mmm-85 46.47 82.27 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.262 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 32.0 m -108.04 152.25 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.533 -0.729 . . . . 0.0 109.522 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.435 ' CG2' ' CG ' ' A' ' 664' ' ' MET . 14.6 p -104.21 133.29 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.725 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.0 mp -104.01 162.76 12.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.416 -0.803 . . . . 0.0 110.001 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -93.33 154.27 18.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.223 -0.923 . . . . 0.0 110.163 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -79.61 148.02 31.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.36 -0.838 . . . . 0.0 110.358 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 11.9 p -121.07 -176.37 3.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.381 -0.824 . . . . 0.0 110.359 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.49 -29.0 33.89 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.332 -0.855 . . . . 0.0 110.093 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.8 -51.32 65.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.461 -0.774 . . . . 0.0 109.745 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -64.06 -43.64 94.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.45 -0.781 . . . . 0.0 109.937 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . 0.414 ' O ' ' CG1' ' A' ' 727' ' ' VAL . 16.1 tttt -56.41 -32.86 65.24 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.35 -0.843 . . . . 0.0 110.06 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -68.78 -36.31 78.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.387 -0.821 . . . . 0.0 110.364 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 37.8 mt -60.02 -46.32 89.9 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.362 -0.836 . . . . 0.0 110.439 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' A' ' 724' ' ' LYS . 7.1 p -69.15 -19.67 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.04 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.53 -50.8 69.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 108.877 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -116.85 105.29 12.2 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 122.132 0.968 . . . . 0.0 109.122 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.415 ' O ' ' CE2' ' A' ' 602' ' ' PHE . 4.5 mt . . . . . 0 C--N 1.274 -2.68 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.472 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.97 -10.25 58.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.286 -1.126 . . . . 0.0 110.608 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . -134.8 23.21 3.57 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 14.0 ttp-105 -92.04 114.1 26.55 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.265 -1.138 . . . . 0.0 109.202 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.52 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 3.0 t80 -92.47 -43.52 9.14 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.913 0.863 . . . . 0.0 109.475 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.511 ' HB2' ' CD2' ' A' ' 577' ' ' PHE . 5.4 tp -125.1 119.7 29.36 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.628 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 36.2 m -96.75 118.66 33.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.53 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 3.3 mt -94.72 112.3 24.04 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.1 OUTLIER -111.97 104.18 55.83 Favored Pre-proline 0 C--N 1.3 -1.563 0 C-N-CA 118.467 -1.293 . . . . 0.0 112.935 -177.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.097 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.7 Cg_endo -76.81 142.46 22.59 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 N-CA-C 105.72 -2.454 . . . . 0.0 105.72 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 1.012 ' HB2' ' HD2' ' A' ' 584' ' ' PRO . 0.1 OUTLIER -126.78 -175.28 0.41 Allowed Pre-proline 0 N--CA 1.499 1.982 0 C-N-CA 118.416 -1.314 . . . . 0.0 113.806 -176.052 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 1.012 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 37.7 Cg_endo -65.75 -33.43 44.17 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.961 1.506 . . . . 0.0 111.381 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.08 -30.34 68.01 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.598 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 84.2 p -97.59 153.77 17.97 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.505 ' CG2' HD13 ' A' ' 588' ' ' ILE . 0.2 OUTLIER -61.6 -11.06 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.935 . . . . 0.0 109.839 178.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.725 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 8.5 mm -98.54 116.95 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.351 -0.843 . . . . 0.0 109.779 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 586' ' ' SER . 17.8 mp0 -118.67 70.32 0.82 Allowed 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.491 -1.38 . . . . 0.0 109.932 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.097 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 18.0 mt-10 -144.31 175.44 10.09 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.014 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.473 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.61 125.57 36.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.995 -1.066 . . . . 0.0 109.04 176.371 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 611' ' ' CYS . 46.5 mt -111.63 155.05 23.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 109.828 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.402 ' OE1' ' N ' ' A' ' 593' ' ' GLU . 16.3 mp0 -126.27 110.59 13.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.835 . . . . 0.0 111.461 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 3.5 mt -77.94 109.52 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.06 -1.025 . . . . 0.0 108.32 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -53.61 161.22 1.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.451 -0.781 . . . . 0.0 109.766 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.52 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.3 OUTLIER -48.94 79.05 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.706 -0.621 . . . . 0.0 111.551 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 107.41 34.93 2.78 Favored Glycine 0 N--CA 1.486 1.995 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.844 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.461 ' HB ' HG22 ' A' ' 594' ' ' ILE . 1.0 OUTLIER -79.77 103.05 6.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 627' ' ' LYS . 6.4 t30 -143.01 135.25 13.3 Favored Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.023 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.609 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.0 Cg_endo -91.08 161.9 29.67 Favored 'Cis proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.781 -1.758 . . . . 0.0 108.987 -1.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.498 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -106.62 116.2 31.52 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.609 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 63.6 m-85 -83.02 143.63 30.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 0.0 110.288 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.557 HG12 ' CB ' ' A' ' 611' ' ' CYS . 3.9 mt -142.93 142.08 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.563 -0.711 . . . . 0.0 110.224 -178.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.779 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 165.42 -161.2 34.67 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.339 -1.41 . . . . 0.0 111.4 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.401 ' N ' HD23 ' A' ' 618' ' ' LEU . 3.4 mmm-85 -63.74 -53.87 44.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.78 -0.835 . . . . 0.0 111.834 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.446 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -71.59 124.73 25.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 111.239 -178.592 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.482 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.1 OUTLIER -54.07 -17.67 2.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 0.0 109.813 178.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -45.18 -30.99 1.29 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 0.0 109.272 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 602' ' ' PHE . 1.7 m -68.6 133.81 49.05 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.498 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -45.08 -26.93 0.51 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.318 -0.864 . . . . 0.0 109.759 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.557 ' CB ' HG12 ' A' ' 603' ' ' ILE . 13.0 t -106.23 143.61 34.1 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -108.91 125.15 51.71 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.253 1.025 . . . . 0.0 113.161 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.725 ' HA ' ' CD1' ' A' ' 588' ' ' ILE . 18.3 mt -143.13 108.31 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.433 ' H ' ' CD1' ' A' ' 588' ' ' ILE . 3.8 mt-10 -97.77 104.41 16.43 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 118.302 -1.359 . . . . 0.0 109.25 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.556 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 1.0 OUTLIER -137.99 106.19 5.75 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.238 177.439 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -42.49 -39.48 2.27 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.485 -0.759 . . . . 0.0 111.678 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.67 -17.8 40.2 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.152 -0.968 . . . . 0.0 111.303 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.556 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -79.3 140.45 37.56 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.177 -0.952 . . . . 0.0 110.562 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.406 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.82 161.02 29.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.372 -0.83 . . . . 0.0 110.718 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.779 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 9.8 ttp180 -63.6 -45.65 89.4 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.25 -0.906 . . . . 0.0 109.173 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 622' ' ' HIS . 7.7 t -95.98 1.92 10.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.483 -0.761 . . . . 0.0 109.931 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.751 ' O ' ' N ' ' A' ' 652' ' ' THR . 9.2 t60 -27.49 -41.82 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.078 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.438 ' N ' ' O ' ' A' ' 621' ' ' VAL . 0.7 OUTLIER -136.76 145.0 44.07 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 118.228 -1.389 . . . . 0.0 110.861 179.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.551 ' CE2' ' CB ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -147.63 140.75 25.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.579 -0.7 . . . . 0.0 109.992 178.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -103.21 136.88 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.231 -0.918 . . . . 0.0 109.327 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.525 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 7.6 t80 -128.97 155.83 44.75 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.503 -0.748 . . . . 0.0 109.636 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.439 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 1.2 tppp? -119.02 136.93 53.87 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.404 0.621 . . . . 0.0 110.622 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.424 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -140.32 163.82 31.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.627 -0.67 . . . . 0.0 110.709 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.529 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -78.39 128.61 33.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.377 -0.827 . . . . 0.0 109.411 -179.733 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.537 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.5 t60 -58.56 124.72 20.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.421 -0.799 . . . . 0.0 110.845 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -78.61 107.47 11.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.62 -0.675 . . . . 0.0 110.499 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 9.1 p -122.1 172.37 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.445 -0.784 . . . . 0.0 110.491 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -87.41 -168.65 44.88 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -63.45 168.28 4.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.254 -1.144 . . . . 0.0 110.042 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.78 77.34 1.58 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.275 -0.89 . . . . 0.0 110.496 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 7.9 ptm -61.26 126.21 26.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 109.676 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 1.5 t80 63.15 -145.17 0.35 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.882 . . . . 0.0 109.87 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 638' ' ' GLU . 3.5 pt-20 -115.51 102.24 9.62 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.227 1.013 . . . . 0.0 109.393 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 62.7 p -136.78 151.33 72.25 Favored Pre-proline 0 C--N 1.294 -1.847 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.799 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.43 -154.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.661 1.348 . . . . 0.0 109.734 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.41 ' HA ' HD13 ' A' ' 644' ' ' LEU . . . 47.66 26.47 0.86 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.642 -0.661 . . . . 0.0 110.915 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -74.44 60.49 0.86 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.216 -0.927 . . . . 0.0 110.125 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 62.04 116.11 0.01 OUTLIER Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.482 ' HB2' ' CA ' ' A' ' 703' ' ' PHE . 5.2 mp -141.52 -151.87 0.38 Allowed 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.8 OUTLIER -121.56 124.6 44.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.083 -1.01 . . . . 0.0 111.186 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.415 ' OD2' ' ND1' ' A' ' 630' ' ' HIS . 3.2 t0 -114.11 149.0 36.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.383 -0.823 . . . . 0.0 109.7 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 5.4 pt -94.76 136.81 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.211 -0.93 . . . . 0.0 110.194 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.556 ' CH2' ' CD1' ' A' ' 671' ' ' LEU . 95.7 m95 -119.39 121.37 39.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.653 -0.654 . . . . 0.0 110.525 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.455 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 5.2 t80 -80.53 117.95 21.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.138 -0.977 . . . . 0.0 108.6 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 668' ' ' THR . 4.3 m -107.84 102.57 11.77 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.422 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.501 ' CD2' ' N ' ' A' ' 652' ' ' THR . 27.0 t60 -64.47 163.58 13.1 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.29 -0.881 . . . . 0.0 109.503 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.751 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -151.9 -28.78 0.17 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.551 ' N ' ' HA ' ' A' ' 622' ' ' HIS . . . -79.16 -169.27 36.94 Favored Glycine 0 N--CA 1.496 2.665 0 O-C-N 119.204 -2.185 . . . . 0.0 109.856 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 12.6 m -94.06 -18.62 21.64 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.178 -1.189 . . . . 0.0 113.9 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 656' ' ' VAL . 29.8 m120 -61.86 -4.26 1.48 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.625 -1.297 . . . . 0.0 111.896 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.482 ' CB ' ' O ' ' A' ' 655' ' ' ASN . 0.4 OUTLIER 78.21 169.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 121.919 0.866 . . . . 0.0 110.607 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.477 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -125.35 149.44 48.11 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.436 -179.222 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.415 ' CZ ' ' HG3' ' A' ' 663' ' ' ARG . 2.9 m-85 -138.58 126.7 22.71 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.313 -0.867 . . . . 0.0 110.657 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 661' ' ' ASN . 24.8 tp -125.67 107.63 10.76 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.359 -0.838 . . . . 0.0 109.914 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 27.2 t30 64.73 -68.09 0.11 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.648 -0.658 . . . . 0.0 110.412 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.8 OUTLIER -158.86 24.68 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 110.164 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.31 132.87 56.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -0.937 . . . . 0.0 110.425 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . 0.415 ' HG3' ' CZ ' ' A' ' 658' ' ' TYR . 5.4 ttt180 -95.12 130.14 41.94 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.467 -0.77 . . . . 0.0 110.28 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.415 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 2.4 mtp -110.05 -164.58 0.94 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.409 -0.807 . . . . 0.0 110.056 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.404 ' CG1' ' CG2' ' A' ' 668' ' ' THR . 1.8 pt -140.21 -163.24 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 110.213 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -77.5 93.64 4.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.333 -0.854 . . . . 0.0 110.653 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.42 53.58 0.87 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.557 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -118.24 147.74 43.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.183 -1.186 . . . . 0.0 109.911 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -108.38 139.5 43.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.538 -0.726 . . . . 0.0 109.53 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.466 ' CE2' HD22 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -144.47 142.87 30.57 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.093 -179.226 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.556 ' CD1' ' CH2' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.87 147.01 50.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.519 -0.738 . . . . 0.0 110.753 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.455 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 26.1 mt -118.08 131.33 56.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.356 -0.84 . . . . 0.0 111.277 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.459 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 61.6 mt-30 -113.19 143.17 44.84 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 706' ' ' GLY . 3.7 p-10 -41.03 144.91 0.24 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.184 -0.947 . . . . 0.0 110.748 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.48 49.39 44.92 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.7 97.43 6.97 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.788 0.804 . . . . 0.0 110.616 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.684 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.82 107.01 18.95 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.492 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 35.3 pt -108.38 136.84 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.48 -0.763 . . . . 0.0 111.56 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.73 110.29 22.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.514 -0.741 . . . . 0.0 109.253 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.469 ' CG2' ' CD2' ' A' ' 622' ' ' HIS . 70.8 mt -76.74 -26.41 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.335 -0.853 . . . . 0.0 110.191 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 618' ' ' LEU . 4.4 mt -143.29 133.84 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 109.961 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -137.61 114.61 10.73 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.359 -0.838 . . . . 0.0 110.329 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.51 118.33 23.79 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.318 -0.864 . . . . 0.0 110.028 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -65.94 -42.76 89.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.393 -0.817 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -83.73 -43.34 15.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.332 -0.855 . . . . 0.0 110.844 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -80.31 -12.05 59.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.283 -0.886 . . . . 0.0 110.663 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 57.16 18.77 4.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.13 -0.981 . . . . 0.0 110.5 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.404 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -77.52 76.21 4.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.161 179.213 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 586' ' ' SER . 60.5 t -101.86 137.23 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.458 -0.776 . . . . 0.0 110.941 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.453 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 49.0 mm -118.73 164.43 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -178.02 124.94 0.96 Allowed Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.496 -1.335 . . . . 0.0 110.196 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.684 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 13.4 m-85 -120.43 137.76 54.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.591 -0.946 . . . . 0.0 109.132 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.4 113.95 26.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.157 -0.964 . . . . 0.0 109.985 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 1.1 t -83.06 118.16 30.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.481 -0.762 . . . . 0.0 109.151 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -128.8 104.6 7.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.65 -0.657 . . . . 0.0 110.097 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.433 ' CD1' ' O ' ' A' ' 705' ' ' GLU . 69.1 mt -81.86 104.69 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.46 -0.775 . . . . 0.0 109.832 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.48 -42.52 35.5 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.439 -0.788 . . . . 0.0 108.875 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.5 ' O ' ' CD1' ' A' ' 577' ' ' PHE . 3.9 m-20 -110.84 141.49 44.14 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.463 0.649 . . . . 0.0 110.68 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 9.0 p -114.04 96.2 5.69 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.8 m -94.65 100.03 12.05 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.261 0.553 . . . . 0.0 111.735 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 45.9 34.48 5.64 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.471 HD11 ' CE1' ' A' ' 577' ' ' PHE . 1.1 tp -84.47 150.22 25.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -1.12 . . . . 0.0 110.043 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.561 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 2.6 p90 -51.49 -24.44 5.11 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.314 -0.866 . . . . 0.0 110.038 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.561 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.6 t30 -175.03 153.26 1.6 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.439 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 12.4 pt-20 -51.21 -24.95 4.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.23 -0.919 . . . . 0.0 110.45 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 116.91 19.08 5.36 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 3.8 tp -88.14 9.63 22.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -1.199 . . . . 0.0 111.643 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.419 ' CA ' ' NE2' ' A' ' 673' ' ' GLN . . . 61.97 49.16 78.21 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.482 ' HE3' ' CD2' ' A' ' 703' ' ' PHE . 0.3 OUTLIER -51.65 176.75 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.383 -1.069 . . . . 0.0 111.021 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 709' ' ' MET . 0.4 OUTLIER 40.66 -157.68 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.384 0.612 . . . . 0.0 111.863 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -92.88 74.88 4.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.584 -0.697 . . . . 0.0 109.726 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.87 148.13 48.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.574 -0.704 . . . . 0.0 110.424 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -111.61 96.9 6.36 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.514 -0.741 . . . . 0.0 109.005 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.423 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.7 OUTLIER -70.91 70.33 0.49 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.54 0.686 . . . . 0.0 110.094 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 34.2 m -106.57 153.07 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.65 -0.656 . . . . 0.0 109.69 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.415 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 84.1 t -85.06 133.32 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.22 -0.925 . . . . 0.0 110.916 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.6 mt -105.39 162.38 13.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.555 -0.716 . . . . 0.0 109.6 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -101.24 153.53 19.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.167 -0.958 . . . . 0.0 110.292 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -85.35 151.03 24.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.347 -0.846 . . . . 0.0 110.263 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 19.0 p -121.33 -176.66 3.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.329 -0.857 . . . . 0.0 110.47 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.68 -29.81 40.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.45 -0.781 . . . . 0.0 110.119 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . 0.423 ' O ' HD11 ' A' ' 726' ' ' LEU . 3.6 tt0 -63.49 -52.29 61.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.673 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.38 -38.18 90.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.427 -0.795 . . . . 0.0 109.496 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . 0.425 ' O ' ' CG1' ' A' ' 727' ' ' VAL . 11.8 tttt -57.76 -32.27 67.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.421 -0.799 . . . . 0.0 109.833 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.69 -40.33 80.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.259 -0.901 . . . . 0.0 110.409 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.423 HD11 ' O ' ' A' ' 722' ' ' GLU . 11.0 mp -55.91 -47.02 78.22 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.223 -0.923 . . . . 0.0 110.843 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . 0.425 ' CG1' ' O ' ' A' ' 724' ' ' LYS . 7.2 p -69.23 -18.05 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.486 -0.759 . . . . 0.0 110.232 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.37 -43.96 68.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 108.854 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -116.96 104.32 11.16 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 122.254 1.026 . . . . 0.0 109.221 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.413 ' O ' ' CD2' ' A' ' 602' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--N 1.275 -2.664 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.402 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -82.9 -10.4 58.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -1.115 . . . . 0.0 110.503 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 596' ' ' GLN . . . 84.1 27.39 37.34 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -93.31 118.03 30.78 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.204 -1.174 . . . . 0.0 109.239 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.6 ' CD2' ' O ' ' A' ' 698' ' ' ASP . 0.7 OUTLIER -110.01 -41.0 4.58 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.831 0.824 . . . . 0.0 109.832 -179.1 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.478 ' HB2' ' CD1' ' A' ' 577' ' ' PHE . 17.4 tp -121.17 127.68 51.76 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.448 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 94.1 m -111.38 117.97 34.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 6.1 mt -90.71 112.25 23.94 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.417 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 1.2 mmtt -113.54 101.05 53.24 Favored Pre-proline 0 C--N 1.303 -1.442 0 C-N-CA 118.02 -1.472 . . . . 0.0 112.611 -178.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.129 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.5 Cg_endo -78.79 145.44 20.12 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 N-CA-C 106.232 -2.257 . . . . 0.0 106.232 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.706 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -123.54 -176.76 0.46 Allowed Pre-proline 0 N--CA 1.498 1.931 0 C-N-CA 118.251 -1.38 . . . . 0.0 114.094 -175.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.706 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.6 Cg_endo -67.84 -34.0 25.3 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.825 1.683 . . . . 0.0 111.953 -178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -58.31 -29.69 66.08 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.772 -1.205 . . . . 0.0 107.931 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.475 ' HB3' ' N ' ' A' ' 691' ' ' GLY . 4.3 p -96.25 150.66 20.3 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.507 ' CG2' HD11 ' A' ' 588' ' ' ILE . 0.1 OUTLIER -55.64 -17.79 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 0.0 109.467 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.625 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 9.1 mm -100.03 114.87 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.539 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -126.01 74.59 1.44 Allowed 'General case' 0 N--CA 1.51 2.569 0 O-C-N 120.581 -1.325 . . . . 0.0 110.423 -179.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.129 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.2 mt-10 -143.31 175.9 9.55 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.506 -0.77 . . . . 0.0 108.993 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.496 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.3 127.04 42.01 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.761 -1.212 . . . . 0.0 109.476 176.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.417 ' CD1' ' SG ' ' A' ' 611' ' ' CYS . 67.2 mt -111.32 156.21 21.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.419 -0.801 . . . . 0.0 109.628 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -124.46 110.77 14.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 111.423 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.44 ' N ' ' O ' ' A' ' 578' ' ' LEU . 31.3 mt -81.01 109.04 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.534 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -66.89 118.17 10.0 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.533 -0.729 . . . . 0.0 111.955 -177.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.554 ' HA ' ' HB3' ' A' ' 577' ' ' PHE . 6.8 tp-100 13.32 61.99 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 95.61 50.75 1.94 Allowed Glycine 0 N--CA 1.487 2.04 0 C-N-CA 119.931 -1.128 . . . . 0.0 110.585 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 0.6 OUTLIER -79.49 105.09 8.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.01 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.4 OUTLIER -140.26 142.0 28.22 Favored Pre-proline 0 C--N 1.28 -2.417 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.79 -178.462 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.458 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.5 Cg_endo -88.91 159.12 39.19 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.564 -2.265 . . . . 0.0 109.001 -0.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.536 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.1 t80 -106.53 116.24 31.58 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.785 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 39.6 m-85 -91.43 146.01 24.16 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 110.757 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.577 HG12 ' CB ' ' A' ' 611' ' ' CYS . 2.7 mt -139.91 141.08 34.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.48 -0.763 . . . . 0.0 110.618 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.733 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 173.24 -164.88 36.86 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.51 -1.329 . . . . 0.0 111.186 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 8.5 mmm-85 -66.66 -41.0 88.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.892 -0.769 . . . . 0.0 110.866 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.4 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -83.12 132.04 35.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -0.848 . . . . 0.0 111.218 -178.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.538 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.7 OUTLIER -61.24 -13.04 15.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.413 -0.804 . . . . 0.0 109.858 178.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.45 -37.4 5.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.3 -0.875 . . . . 0.0 109.858 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.785 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 64.4 m -71.23 148.79 46.9 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.403 -0.811 . . . . 0.0 109.613 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.536 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -56.0 -16.68 5.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.482 -0.761 . . . . 0.0 110.655 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.577 ' CB ' HG12 ' A' ' 603' ' ' ILE . 10.5 t -115.67 143.34 45.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.439 -0.788 . . . . 0.0 109.542 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.538 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -112.82 121.28 44.22 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.169 -0.957 . . . . 0.0 112.689 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.625 ' HA ' ' CD1' ' A' ' 588' ' ' ILE . 18.5 mt -141.73 108.25 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.4 ' N ' HD13 ' A' ' 588' ' ' ILE . 3.8 tm-20 -90.64 103.89 16.53 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.625 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 618' ' ' LEU . 1.5 m-20 -138.25 105.78 5.57 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.675 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -39.55 -52.34 2.17 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.755 -0.59 . . . . 0.0 112.256 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -75.12 -16.49 60.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.09 -1.006 . . . . 0.0 111.364 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.493 ' CD2' ' HA2' ' A' ' 604' ' ' GLY . 0.8 OUTLIER -80.0 132.67 36.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.215 -0.928 . . . . 0.0 111.134 -178.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.494 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -74.77 162.39 28.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.489 -0.757 . . . . 0.0 110.812 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.733 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.3 OUTLIER -64.19 -46.06 85.59 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.288 -0.883 . . . . 0.0 109.389 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.469 ' O ' ' C ' ' A' ' 622' ' ' HIS . 16.2 m -94.6 2.25 9.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.216 -0.927 . . . . 0.0 109.179 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.754 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.4 t60 -28.66 -47.44 0.05 Allowed 'General case' 0 C--O 1.192 -1.953 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.051 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.6 OUTLIER -137.44 145.12 42.75 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.398 -1.321 . . . . 0.0 111.02 179.046 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.538 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 3.6 p90 -145.95 144.81 30.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.589 -0.694 . . . . 0.0 110.212 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.52 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 11.3 mt -103.5 118.05 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 7.7 t80 -111.55 154.62 24.52 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.774 0.797 . . . . 0.0 109.819 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 3.7 ttmt -120.07 136.67 54.5 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 121.464 0.65 . . . . 0.0 110.31 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.453 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.82 163.72 28.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.617 -0.677 . . . . 0.0 110.343 -179.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 1.8 tpt180 -77.72 115.28 17.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.516 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 3.0 t60 -58.13 124.35 19.07 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.497 -0.752 . . . . 0.0 110.574 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -115.67 81.48 1.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.42 0.629 . . . . 0.0 110.466 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . 0.408 ' CG2' ' N ' ' A' ' 633' ' ' GLY . 7.3 p -61.46 171.76 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.457 -0.777 . . . . 0.0 109.875 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . 0.408 ' N ' ' CG2' ' A' ' 632' ' ' VAL . . . -53.12 176.09 0.2 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -53.26 142.03 22.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.223 -1.163 . . . . 0.0 110.35 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.07 60.74 1.47 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.291 -0.881 . . . . 0.0 110.297 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 636' ' ' MET . . . . . 0.41 ' O ' ' CB ' ' A' ' 637' ' ' TYR . 0.1 OUTLIER -61.97 125.94 25.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.749 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . 0.41 ' CB ' ' O ' ' A' ' 636' ' ' MET . 1.7 t80 65.79 -147.3 0.21 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.438 -0.789 . . . . 0.0 110.008 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -115.51 102.91 10.23 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.239 -0.913 . . . . 0.0 109.197 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 92.6 p -125.53 151.4 70.26 Favored Pre-proline 0 C--N 1.291 -1.943 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.994 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . 0.422 ' O ' ' CB ' ' A' ' 641' ' ' ALA . 47.6 Cg_endo -69.55 -151.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.741 1.39 . . . . 0.0 109.908 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 640' ' ' PRO . . . 68.53 -61.3 0.41 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.618 -0.676 . . . . 0.0 110.676 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 52.49 -158.09 0.14 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.128 -0.982 . . . . 0.0 109.851 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -117.31 129.35 8.29 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.462 ' HB2' ' N ' ' A' ' 703' ' ' PHE . 5.3 mp -141.44 -150.84 0.33 Allowed 'General case' 0 C--N 1.294 -1.84 0 O-C-N 122.072 -0.663 . . . . 0.0 109.297 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.4 m-20 -114.95 124.34 51.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.965 -1.084 . . . . 0.0 111.115 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -107.08 156.12 19.11 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.537 -0.727 . . . . 0.0 109.82 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 13.8 pt -110.7 131.45 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.623 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.4 m95 -119.11 121.95 40.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.654 -0.654 . . . . 0.0 111.369 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.508 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 8.7 t80 -80.95 114.84 20.1 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.538 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 7.5 t -107.12 110.3 22.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.207 -0.933 . . . . 0.0 111.731 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.518 ' CD2' ' N ' ' A' ' 652' ' ' THR . 18.5 t60 -72.66 162.67 29.19 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.476 -0.765 . . . . 0.0 109.833 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.754 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -155.11 -30.84 0.1 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.458 -0.776 . . . . 0.0 112.205 -179.114 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.54 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.08 -165.23 29.11 Favored Glycine 0 N--CA 1.496 2.665 0 C-N-CA 117.966 -2.064 . . . . 0.0 109.739 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 654' ' ' THR . . . . . 0.448 ' O ' HG11 ' A' ' 656' ' ' VAL . 14.5 m -93.55 -18.9 21.73 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.007 -1.29 . . . . 0.0 114.012 -176.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.543 ' O ' HG21 ' A' ' 656' ' ' VAL . 86.6 m-20 -59.81 -2.56 0.4 Allowed 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.746 -1.221 . . . . 0.0 112.727 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.543 HG21 ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 63.36 146.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 121.57 0.7 . . . . 0.0 110.305 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.461 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -98.27 141.99 30.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.69 -0.631 . . . . 0.0 110.605 -178.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.459 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 11.1 m-85 -129.75 126.17 37.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 110.364 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.481 ' CD1' HG21 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -132.6 114.89 14.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.356 -0.84 . . . . 0.0 110.047 179.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 56.54 -84.69 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.434 -0.791 . . . . 0.0 110.475 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.6 m120 -143.52 20.3 1.86 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.058 -1.026 . . . . 0.0 110.353 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -111.2 118.48 36.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.283 -0.886 . . . . 0.0 110.239 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -86.67 139.81 30.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 110.184 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.43 ' CB ' ' OG ' ' A' ' 657' ' ' SER . 4.5 mtp -117.27 -167.29 1.29 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.866 . . . . 0.0 110.124 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.414 ' CG1' ' CG2' ' A' ' 668' ' ' THR . 1.5 pt -137.24 -158.49 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.253 -0.905 . . . . 0.0 110.426 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -83.11 90.2 7.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.336 -0.853 . . . . 0.0 110.547 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 651' ' ' HIS . . . 110.12 52.53 0.6 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.2 OUTLIER -119.8 148.89 42.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.145 -1.209 . . . . 0.0 110.177 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.426 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 9.5 tttt -108.59 139.02 43.95 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.437 ' CD1' HG21 ' A' ' 716' ' ' VAL . 13.4 t80 -142.54 146.38 34.58 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.154 -0.966 . . . . 0.0 111.615 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.623 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -73.33 146.82 44.97 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.59 -0.694 . . . . 0.0 110.502 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.508 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 12.1 mt -119.39 115.35 23.93 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.559 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.457 ' CA ' ' O ' ' A' ' 706' ' ' GLY . 60.1 mt-30 -87.39 -177.41 5.92 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 706' ' ' GLY . 21.8 p-10 -78.31 142.97 37.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 109.432 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.93 46.71 43.16 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 107.678 -2.169 . . . . 0.0 107.678 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -101.15 91.51 4.57 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.817 -0.813 . . . . 0.0 110.396 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.796 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -93.09 106.91 18.8 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.481 HG21 ' CD1' ' A' ' 659' ' ' LEU . 1.3 pt -114.17 137.8 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.7 -0.625 . . . . 0.0 111.55 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -95.68 112.76 24.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.553 -0.717 . . . . 0.0 109.418 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 64.5 mt -76.14 -20.9 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.927 . . . . 0.0 110.438 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.412 HD12 ' ND2' ' A' ' 655' ' ' ASN . 8.8 mt -141.55 133.66 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.075 -1.016 . . . . 0.0 110.721 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -137.86 108.86 6.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.48 -0.762 . . . . 0.0 109.943 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . 0.403 ' CB ' ' HB2' ' A' ' 686' ' ' ASN . 45.3 m-20 -125.66 118.38 25.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 110.088 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -65.87 -38.64 89.32 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.461 -0.774 . . . . 0.0 110.983 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -84.04 -43.54 15.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.272 -0.892 . . . . 0.0 111.076 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . 0.403 ' HB2' ' CB ' ' A' ' 683' ' ' ASP . 50.9 m-80 -81.81 -12.35 58.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.129 -0.982 . . . . 0.0 110.69 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 2.8 tttp 56.25 20.43 4.56 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.145 -0.972 . . . . 0.0 110.439 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.88 85.37 2.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.144 -0.972 . . . . 0.0 109.347 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 586' ' ' SER . 2.9 t -101.73 135.91 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.442 -0.786 . . . . 0.0 110.656 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.437 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 40.5 mm -123.44 163.63 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.475 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . -174.76 124.67 1.03 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.525 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.796 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.9 m-85 -120.44 138.01 54.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.559 -0.965 . . . . 0.0 108.736 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.5 114.59 28.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 110.976 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.96 112.97 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -116.3 104.66 11.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.495 -0.753 . . . . 0.0 110.456 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.468 HG23 HD12 ' A' ' 696' ' ' ILE . 78.8 mt -84.11 103.81 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -0.828 . . . . 0.0 109.517 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -81.94 -42.27 19.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 108.889 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.6 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.2 m-20 -110.55 142.29 42.55 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.401 0.62 . . . . 0.0 110.145 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 35.6 p -115.97 95.92 5.34 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 2.7 m -131.92 139.24 48.67 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.351 -0.539 . . . . 0.0 110.282 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.15 28.79 34.83 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.494 ' CD2' ' CZ ' ' A' ' 577' ' ' PHE . 0.2 OUTLIER -107.89 131.29 54.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.587 -0.949 . . . . 0.0 110.563 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 4.0 p90 -52.25 -23.7 6.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.42 -0.8 . . . . 0.0 109.806 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.563 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.9 OUTLIER -163.13 163.41 25.72 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.021 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.55 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 16.0 pt-20 -51.15 -27.8 9.5 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.115 -0.991 . . . . 0.0 110.174 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 123.55 13.41 4.26 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 708' ' ' GLY . 0.2 OUTLIER -87.19 8.19 25.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.762 -1.434 . . . . 0.0 111.188 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.426 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 37.42 97.7 0.01 OUTLIER Glycine 0 N--CA 1.502 3.067 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.19 43.01 1.66 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.131 -1.217 . . . . 0.0 110.41 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.78 -168.21 1.9 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.392 -0.818 . . . . 0.0 110.449 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -59.78 -56.56 20.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.41 -0.806 . . . . 0.0 110.511 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -63.61 144.24 57.17 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.324 -0.86 . . . . 0.0 110.061 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -111.6 95.75 5.69 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.35 -0.844 . . . . 0.0 109.525 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.424 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 2.8 mmm-85 43.43 77.03 0.07 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.335 0.588 . . . . 0.0 111.345 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 32.6 m -107.73 153.07 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.412 -0.805 . . . . 0.0 109.433 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.437 HG21 ' CD1' ' A' ' 670' ' ' PHE . 59.8 t -95.1 133.25 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 110.648 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.5 mt -104.83 162.26 13.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.488 -0.757 . . . . 0.0 109.765 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.78 153.43 19.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 110.246 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.85 122.29 26.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.4 -0.813 . . . . 0.0 110.249 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 27.8 p -95.92 -176.53 3.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.432 -0.792 . . . . 0.0 110.162 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.55 -28.99 34.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.293 -0.88 . . . . 0.0 110.188 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -69.01 -46.57 67.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.373 -0.829 . . . . 0.0 109.983 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.75 -50.26 69.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.383 -0.823 . . . . 0.0 110.043 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -53.71 -32.7 52.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.36 -0.837 . . . . 0.0 109.909 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 728' ' ' LYS . 28.7 t70 -66.18 -35.86 81.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.497 -0.752 . . . . 0.0 110.129 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 37.5 mt -61.16 -46.32 90.99 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.277 -0.89 . . . . 0.0 110.083 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.72 -24.26 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.601 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 725' ' ' ASP . 0.6 OUTLIER -53.94 -46.06 71.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.116 -0.99 . . . . 0.0 108.902 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -116.83 104.0 10.88 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.219 1.009 . . . . 0.0 109.011 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.274 -2.701 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.336 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -82.88 -10.1 58.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -1.104 . . . . 0.0 110.534 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 144.02 62.59 0.02 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -91.16 116.7 29.02 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.347 -1.09 . . . . 0.0 109.319 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -102.92 -42.57 5.79 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 122.044 0.926 . . . . 0.0 109.286 -179.287 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 9.7 tt -120.47 131.67 54.85 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.611 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 32.6 m -109.18 118.27 36.29 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.961 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 13.2 mt -93.17 112.28 24.17 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.453 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.3 OUTLIER -114.99 103.6 54.6 Favored Pre-proline 0 C--N 1.302 -1.488 0 C-N-CA 118.326 -1.35 . . . . 0.0 113.387 -176.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.078 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 45.6 Cg_endo -78.58 140.66 16.99 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 N-CA-C 105.045 -2.713 . . . . 0.0 105.045 174.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.742 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -121.55 -175.05 0.33 Allowed Pre-proline 0 N--CA 1.496 1.863 0 C-N-CA 118.044 -1.462 . . . . 0.0 113.779 -176.118 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.742 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.4 Cg_endo -66.11 -33.75 39.6 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 O-C-N 124.198 1.631 . . . . 0.0 111.969 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.74 -29.48 66.76 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.709 -1.196 . . . . 0.0 107.856 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.573 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 27.1 p -96.39 153.28 17.91 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.533 ' CG2' HD12 ' A' ' 588' ' ' ILE . 0.4 OUTLIER -59.92 -15.73 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.184 -0.948 . . . . 0.0 109.127 178.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.657 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 7.8 mm -95.03 115.83 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.437 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -121.74 70.23 0.95 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.55 -1.344 . . . . 0.0 109.372 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.078 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 33.8 tt0 -144.34 174.08 11.22 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.698 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.49 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.87 127.53 40.39 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.937 -1.102 . . . . 0.0 109.365 176.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 1.1 mp -111.5 153.78 25.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.183 -0.948 . . . . 0.0 110.073 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -125.74 112.46 16.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.537 -0.727 . . . . 0.0 111.185 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.454 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 69.6 mt -78.88 109.52 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.087 -1.008 . . . . 0.0 108.71 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.589 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -63.49 100.31 0.25 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.59 -0.694 . . . . 0.0 110.948 -178.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.589 ' C ' ' O ' ' A' ' 595' ' ' GLN . 0.8 OUTLIER -0.21 75.9 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 179.422 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 128.84 10.04 3.3 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.365 -1.397 . . . . 0.0 110.973 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.402 ' HB ' ' CG2' ' A' ' 594' ' ' ILE . 1.5 t -82.77 100.67 6.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 O-C-N 120.6 -1.529 . . . . 0.0 107.632 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.2 OUTLIER -144.61 135.88 12.58 Favored Pre-proline 0 C--N 1.282 -2.36 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.69 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 53.3 Cg_endo -90.42 164.46 32.58 Favored 'Cis proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.78 -1.758 . . . . 0.0 108.918 -1.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.523 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 3.3 t80 -103.27 115.93 31.49 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.511 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 44.9 m-85 -81.38 143.6 32.05 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 110.342 -178.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.551 HG12 ' CB ' ' A' ' 611' ' ' CYS . 3.6 mt -142.88 142.12 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.667 -0.646 . . . . 0.0 110.291 -178.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.756 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 169.16 -161.46 35.07 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.778 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -72.61 -35.43 67.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.677 -0.896 . . . . 0.0 111.006 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.0 123.69 29.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.846 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.509 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 7.5 tt0 -53.23 -19.26 2.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.328 -0.857 . . . . 0.0 110.052 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -45.1 -31.11 1.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.367 -0.833 . . . . 0.0 109.043 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 602' ' ' PHE . 1.3 m -69.76 131.44 44.53 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.523 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -44.96 -27.89 0.6 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.34 -0.85 . . . . 0.0 110.027 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.551 ' CB ' HG12 ' A' ' 603' ' ' ILE . 2.0 t -107.27 143.52 35.39 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.509 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -110.46 128.01 55.4 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 119.102 -1.039 . . . . 0.0 112.963 -178.404 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.657 ' HA ' ' CD1' ' A' ' 588' ' ' ILE . 19.8 mt -142.19 107.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.12 103.18 15.82 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.108 -1.437 . . . . 0.0 108.651 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.478 ' HB2' ' HB3' ' A' ' 618' ' ' LEU . 1.1 m-20 -139.55 106.06 5.32 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.602 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -41.13 -57.0 2.19 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.545 -0.722 . . . . 0.0 112.253 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -72.57 -16.85 61.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.169 -0.957 . . . . 0.0 111.975 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -76.23 122.22 24.05 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.025 -1.047 . . . . 0.0 110.71 -179.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -58.54 159.86 6.04 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.466 -0.772 . . . . 0.0 110.942 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.756 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 14.3 mtt-85 -64.27 -45.2 89.13 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.354 -0.841 . . . . 0.0 109.493 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.461 ' O ' ' C ' ' A' ' 622' ' ' HIS . 11.8 t -95.4 1.7 10.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 121.93 0.871 . . . . 0.0 109.338 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.736 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.8 t60 -27.43 -46.69 0.03 OUTLIER 'General case' 0 C--O 1.195 -1.808 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.594 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.432 ' O ' ' HB ' ' A' ' 603' ' ' ILE . 1.0 OUTLIER -137.92 146.18 42.97 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 117.953 -1.499 . . . . 0.0 112.06 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 2.4 p90 -145.92 145.67 30.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.701 -0.624 . . . . 0.0 109.819 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 625' ' ' ILE . 88.2 mt -103.56 117.56 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 10.1 t80 -110.28 154.2 23.78 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.429 -0.794 . . . . 0.0 109.874 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 13.5 ttmt -120.33 136.84 54.56 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.55 0.69 . . . . 0.0 110.373 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.1 OUTLIER -134.66 164.22 28.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.702 -0.624 . . . . 0.0 109.892 -179.489 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -77.1 121.25 23.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.059 -1.026 . . . . 0.0 108.871 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.52 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 6.0 t60 -58.55 124.5 19.85 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.707 0.765 . . . . 0.0 111.05 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -77.68 104.43 8.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.706 -0.621 . . . . 0.0 110.095 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 1.6 p -103.95 -167.53 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.333 -0.855 . . . . 0.0 110.019 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -97.38 174.3 29.52 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.07 144.0 57.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.375 -1.074 . . . . 0.0 110.145 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 85.6 p -116.83 87.77 2.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 110.219 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 9.3 mmt -93.2 40.67 1.07 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.337 -0.852 . . . . 0.0 109.979 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -171.74 -147.68 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.536 -0.728 . . . . 0.0 109.234 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -115.23 99.97 7.8 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.167 -0.958 . . . . 0.0 108.925 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 29.8 p -138.87 151.19 67.83 Favored Pre-proline 0 C--N 1.294 -1.817 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.596 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -72.19 -157.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.583 1.307 . . . . 0.0 109.513 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 38.52 31.84 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.993 -0.442 . . . . 0.0 111.658 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -72.13 61.3 0.44 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.015 -1.053 . . . . 0.0 110.198 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 62.33 118.29 0.01 OUTLIER Glycine 0 N--CA 1.487 2.068 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.474 ' HB2' ' CA ' ' A' ' 703' ' ' PHE . 5.0 mp -141.89 -153.65 0.47 Allowed 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.9 m-20 -112.2 124.17 51.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.044 -1.035 . . . . 0.0 111.367 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 628' ' ' LYS . 21.1 t0 -105.1 156.46 18.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.555 -0.715 . . . . 0.0 109.584 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.448 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 18.5 pt -110.11 129.95 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.233 -0.917 . . . . 0.0 110.32 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.637 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.0 m95 -118.86 120.34 37.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.75 -0.594 . . . . 0.0 110.968 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.447 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 8.0 t80 -80.61 114.44 19.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.963 . . . . 0.0 108.474 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.0 OUTLIER -105.25 107.4 18.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.342 -0.849 . . . . 0.0 111.322 -178.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.515 ' CE1' ' C ' ' A' ' 656' ' ' VAL . 17.8 t60 -68.44 159.87 30.8 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.429 -0.794 . . . . 0.0 109.961 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.736 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -149.86 -31.02 0.22 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.437 -0.79 . . . . 0.0 112.879 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.537 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.57 -165.13 27.42 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 117.741 -2.171 . . . . 0.0 109.61 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 654' ' ' THR . . . . . 0.412 ' C ' ' H ' ' A' ' 656' ' ' VAL . 15.1 m -98.66 -17.65 18.48 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.976 -1.308 . . . . 0.0 113.552 -176.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 656' ' ' VAL . 18.0 m120 -59.73 -4.43 0.68 Allowed 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.786 -1.196 . . . . 0.0 112.328 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.515 ' C ' ' CE1' ' A' ' 651' ' ' HIS . 0.4 OUTLIER 77.7 166.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-O 121.939 0.876 . . . . 0.0 110.247 -179.539 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.457 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -125.61 141.41 52.04 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.474 -179.035 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -127.91 125.72 40.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.932 . . . . 0.0 110.715 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 661' ' ' ASN . 0.1 OUTLIER -114.67 106.23 13.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.224 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 659' ' ' LEU . 17.2 m120 56.35 -79.25 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.548 -0.72 . . . . 0.0 110.295 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.539 ' N ' ' O ' ' A' ' 659' ' ' LEU . 21.4 t-20 -140.19 20.28 2.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 0.0 110.548 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -110.68 137.06 48.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.165 -0.959 . . . . 0.0 110.437 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -93.76 141.39 28.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.397 -0.814 . . . . 0.0 110.005 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.476 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 90.6 mtp -126.07 -168.19 1.82 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.355 -0.84 . . . . 0.0 110.056 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.413 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 4.1 pt -144.09 -160.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.159 -0.963 . . . . 0.0 110.953 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -76.07 111.09 11.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.745 . . . . 0.0 110.748 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 86.12 48.87 4.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -114.19 146.1 40.81 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.051 -1.264 . . . . 0.0 109.863 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -108.24 138.91 43.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.561 -0.712 . . . . 0.0 109.488 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.506 ' CD1' ' HG ' ' A' ' 659' ' ' LEU . 2.8 t80 -144.64 146.25 32.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 111.329 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.637 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -72.55 147.01 46.35 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.468 -0.77 . . . . 0.0 110.89 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.447 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 10.6 mt -118.07 101.43 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.396 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -84.81 157.19 21.04 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 706' ' ' GLY . 21.0 p-10 -52.69 148.37 7.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.933 -1.104 . . . . 0.0 109.925 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 67.95 48.52 53.81 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . 0.425 ' HB2' ' CG1' ' A' ' 694' ' ' VAL . 0.3 OUTLIER -108.55 92.43 4.05 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.846 -0.796 . . . . 0.0 110.602 -178.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.878 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.0 OUTLIER -93.85 107.2 19.11 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.449 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.473 HD12 HG21 ' A' ' 678' ' ' ILE . 24.7 pt -111.85 138.07 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.667 -0.646 . . . . 0.0 111.537 -177.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -100.37 111.75 24.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.517 -0.74 . . . . 0.0 109.647 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 65.8 mt -80.01 -29.3 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 0.0 110.249 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.466 HG23 HG12 ' A' ' 690' ' ' ILE . 0.4 OUTLIER -128.61 133.59 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.25 -0.906 . . . . 0.0 109.817 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -138.17 111.75 8.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.467 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.68 117.63 25.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.89 . . . . 0.0 109.667 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -46.98 75.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.326 -0.859 . . . . 0.0 110.834 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -84.89 -43.21 14.3 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 110.776 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -71.51 -9.15 57.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.249 -0.907 . . . . 0.0 110.706 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.34 22.3 6.2 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.105 -0.997 . . . . 0.0 110.344 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.65 104.17 16.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 109.873 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 13.7 m -126.72 140.77 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.397 -0.814 . . . . 0.0 110.829 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.573 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 38.8 mm -117.47 163.6 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.456 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -173.28 123.05 0.96 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.878 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 11.3 m-85 -120.19 137.41 54.2 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.566 -0.961 . . . . 0.0 109.145 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -102.07 113.87 27.5 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.156 -0.965 . . . . 0.0 110.156 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 676' ' ' ASP . 0.9 OUTLIER -84.67 119.3 33.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.036 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -130.06 104.67 7.47 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.372 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.414 ' CD1' ' O ' ' A' ' 705' ' ' GLU . 46.3 mt -79.17 103.86 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -0.885 . . . . 0.0 109.6 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.92 -43.07 46.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.363 -0.836 . . . . 0.0 108.805 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 1.2 m-20 -110.53 141.54 43.54 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.442 0.639 . . . . 0.0 110.135 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 21.4 p -114.22 95.94 5.54 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 50.2 m -131.66 133.78 45.26 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.378 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.74 25.86 30.7 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.419 HD12 ' CE1' ' A' ' 577' ' ' PHE . 4.8 tp -105.55 134.75 48.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.389 -1.065 . . . . 0.0 110.438 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 2.9 p90 -52.69 -23.69 7.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.521 -0.737 . . . . 0.0 110.403 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.59 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.9 OUTLIER -169.73 158.41 7.51 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -178.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.545 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 15.7 pt-20 -51.5 -26.33 8.16 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.179 -0.951 . . . . 0.0 110.589 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 122.76 12.72 4.87 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.64 9.9 10.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.996 -1.296 . . . . 0.0 111.19 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 101.19 -94.6 1.27 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 15.3 ttp 54.64 80.76 0.12 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.347 -1.09 . . . . 0.0 110.646 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -169.47 155.95 6.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.325 -0.859 . . . . 0.0 110.279 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.45 -51.84 52.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.283 -0.885 . . . . 0.0 110.191 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -63.73 149.0 47.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.268 -0.895 . . . . 0.0 109.885 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -110.47 95.29 5.48 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.145 -0.972 . . . . 0.0 109.52 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.424 ' HA ' ' HD2' ' A' ' 714' ' ' ARG . 12.7 mmm-85 40.07 77.13 0.06 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.385 0.612 . . . . 0.0 111.629 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.4 m -107.7 152.58 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.563 -0.711 . . . . 0.0 109.418 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.476 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 44.1 t -92.94 121.15 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.576 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.8 mp -91.44 162.49 14.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.437 -0.789 . . . . 0.0 109.55 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -98.05 153.65 18.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.103 -0.998 . . . . 0.0 110.665 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.47 142.61 27.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.488 -0.757 . . . . 0.0 109.963 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 37.6 p -121.18 -178.36 3.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.317 -0.865 . . . . 0.0 110.575 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.4 -36.3 66.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.459 -0.776 . . . . 0.0 110.244 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -57.54 -52.16 66.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.381 -0.825 . . . . 0.0 109.963 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.456 ' HA ' HD21 ' A' ' 726' ' ' LEU . 74.5 mm-40 -63.54 -46.21 87.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.34 -0.85 . . . . 0.0 109.771 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . 0.424 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 10.1 tttt -62.64 -31.94 72.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.39 -0.819 . . . . 0.0 110.775 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.56 -50.48 71.17 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -0.934 . . . . 0.0 112.051 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.456 HD21 ' HA ' ' A' ' 723' ' ' GLU . 0.4 OUTLIER -72.35 -36.55 68.82 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.825 -1.172 . . . . 0.0 111.269 -178.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . 0.432 HG21 ' CG1' ' A' ' 621' ' ' VAL . 8.3 p -79.4 -18.25 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.868 -1.145 . . . . 0.0 110.416 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -43.21 66.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.176 -0.953 . . . . 0.0 108.814 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.45 103.27 10.28 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 122.211 1.005 . . . . 0.0 109.034 178.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 1.5 mt . . . . . 0 C--N 1.273 -2.727 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.231 -179.801 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.424 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -83.21 -10.09 58.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.393 -1.063 . . . . 0.0 110.633 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . -172.92 53.82 0.16 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.418 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.5 ttm105 -92.67 113.94 26.35 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.412 -1.052 . . . . 0.0 109.603 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.505 ' HA ' ' HB2' ' A' ' 698' ' ' ASP . 0.0 OUTLIER -97.08 -43.24 7.49 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.89 0.852 . . . . 0.0 109.124 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.481 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 7.7 tp -126.68 139.74 52.93 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.188 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 87.2 m -121.83 119.52 31.88 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 8.6 mt -95.56 112.38 24.11 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.1 OUTLIER -110.72 103.46 54.5 Favored Pre-proline 0 C--N 1.301 -1.538 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.732 -177.547 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.054 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.3 Cg_endo -76.22 140.99 22.76 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 N-CA-C 105.737 -2.447 . . . . 0.0 105.737 174.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.752 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -127.48 -173.14 0.29 Allowed Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 118.187 -1.405 . . . . 0.0 113.338 -176.164 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.752 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 37.9 Cg_endo -64.68 -36.34 42.06 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 124.263 1.665 . . . . 0.0 111.116 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -58.52 -28.87 65.84 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.621 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 47.9 t -96.47 152.76 18.3 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.502 ' CG2' HD13 ' A' ' 588' ' ' ILE . 0.8 OUTLIER -64.56 -11.61 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.904 -1.123 . . . . 0.0 109.205 178.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.688 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 7.9 mm -97.21 117.05 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.484 -0.76 . . . . 0.0 109.401 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.621 ' NE2' ' O ' ' A' ' 586' ' ' SER . 21.1 mp0 -117.55 68.65 0.76 Allowed 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.462 -1.398 . . . . 0.0 109.743 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.054 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 2.6 mm-40 -143.35 175.78 9.66 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.607 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.519 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.97 125.42 35.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.071 -1.018 . . . . 0.0 109.585 176.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.485 ' N ' ' CD2' ' A' ' 592' ' ' LEU . 1.6 mm? -106.8 151.15 25.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 108.963 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.418 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.2 mp0 -124.77 110.27 14.12 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.555 -0.716 . . . . 0.0 110.872 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 4.8 mt -83.78 109.19 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.181 -0.949 . . . . 0.0 109.156 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.617 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.2 OUTLIER -64.97 137.14 57.55 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.735 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.449 ' CA ' ' HB3' ' A' ' 577' ' ' PHE . 2.4 pt20 -44.45 84.37 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.507 -0.746 . . . . 0.0 110.782 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 137.67 3.85 1.99 Allowed Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.647 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.453 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -79.97 101.97 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 120.745 -1.444 . . . . 0.0 107.27 178.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 627' ' ' LYS . 49.0 t-20 -145.47 133.33 10.49 Favored Pre-proline 0 C--N 1.282 -2.367 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.85 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.612 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 51.1 Cg_endo -93.29 163.79 22.61 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 123.258 -1.559 . . . . 0.0 109.127 -2.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.603 ' HB3' ' CG2' ' A' ' 625' ' ' ILE . 3.9 t80 -104.96 116.03 31.28 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.612 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 34.8 m-85 -85.42 144.86 27.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.373 -0.829 . . . . 0.0 110.256 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.489 HG21 ' CD1' ' A' ' 613' ' ' ILE . 4.5 mt -140.52 142.34 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.512 -0.742 . . . . 0.0 110.201 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.772 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 164.96 -163.53 36.48 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.368 -1.396 . . . . 0.0 111.306 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 8.6 tpt180 -62.87 -55.81 22.86 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.78 -0.836 . . . . 0.0 111.772 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.444 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -72.18 126.9 30.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 111.492 -178.283 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.45 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -51.64 -19.25 1.46 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.072 178.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 607' ' ' GLU . 27.1 t0 -42.27 -32.16 0.47 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.484 -0.76 . . . . 0.0 109.01 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.3 m -69.86 129.59 39.95 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.601 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.1 m120 -44.55 -28.12 0.55 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.217 -0.927 . . . . 0.0 109.973 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.495 ' HB2' ' CD2' ' A' ' 601' ' ' PHE . 3.8 t -105.21 143.57 33.2 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.45 ' HD2' ' CB ' ' A' ' 607' ' ' GLU . 1.1 ttpm? -106.53 128.35 54.04 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.059 -1.057 . . . . 0.0 113.467 -178.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.688 ' HA ' ' CD1' ' A' ' 588' ' ' ILE . 24.2 mt -143.29 107.71 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.465 ' H ' ' CD1' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -97.86 104.73 16.78 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.238 -1.385 . . . . 0.0 109.306 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 1.3 m-20 -138.3 106.42 5.73 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.173 177.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . 0.417 ' HA ' ' NH1' ' A' ' 605' ' ' ARG . 1.4 m120 -41.12 -41.56 1.79 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.669 -0.644 . . . . 0.0 111.932 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.61 -21.61 32.49 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.093 -1.004 . . . . 0.0 111.272 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -73.84 131.96 42.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.191 -0.943 . . . . 0.0 110.702 -179.531 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.429 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -68.09 158.39 33.12 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.356 -0.84 . . . . 0.0 110.725 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.772 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 15.2 ttp180 -62.24 -45.24 94.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.225 -0.922 . . . . 0.0 109.211 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 622' ' ' HIS . 4.4 t -95.28 2.08 9.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.75 0.786 . . . . 0.0 109.593 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.75 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.0 t60 -29.63 -42.91 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.854 -178.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.9 OUTLIER -137.19 144.8 43.06 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 117.789 -1.564 . . . . 0.0 111.429 179.114 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.623 ' CE2' ' HB3' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -147.57 126.58 12.83 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.62 -0.675 . . . . 0.0 109.533 178.222 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.603 ' CG2' ' HB3' ' A' ' 601' ' ' PHE . 2.4 tt -104.08 118.16 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.362 -0.836 . . . . 0.0 108.869 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.623 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 17.5 p90 -122.83 155.2 37.08 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.758 0.789 . . . . 0.0 110.715 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 5.3 ttmt -99.55 136.68 39.13 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.939 0.876 . . . . 0.0 110.891 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.7 OUTLIER -131.11 163.09 28.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.648 -0.658 . . . . 0.0 109.934 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 6.6 tpt180 -78.0 115.06 17.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.041 -1.037 . . . . 0.0 109.257 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 703' ' ' PHE . 6.6 t60 -58.52 124.68 20.43 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.528 0.68 . . . . 0.0 110.866 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -85.94 86.82 7.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.727 -0.608 . . . . 0.0 109.974 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -78.74 -164.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.409 -0.807 . . . . 0.0 110.161 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -72.47 174.64 44.7 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.47 156.31 16.44 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.37 -1.076 . . . . 0.0 110.16 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 59.6 p -106.65 43.46 1.15 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.0 110.306 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.13 40.01 1.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.359 -0.838 . . . . 0.0 109.714 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -169.0 -150.71 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.597 -0.689 . . . . 0.0 109.515 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -115.55 101.6 9.02 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.204 -0.935 . . . . 0.0 109.022 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.26 151.29 71.3 Favored Pre-proline 0 C--N 1.294 -1.815 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.986 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 642' ' ' GLN . 49.9 Cg_endo -71.84 -156.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.614 1.323 . . . . 0.0 109.891 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.406 ' O ' ' CD1' ' A' ' 644' ' ' LEU . . . 63.01 -60.76 0.14 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.839 -0.538 . . . . 0.0 110.979 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 640' ' ' PRO . 30.2 mt-30 54.87 28.74 10.88 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.914 -1.116 . . . . 0.0 109.571 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 63.12 120.75 0.01 OUTLIER Glycine 0 N--CA 1.485 1.941 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 703' ' ' PHE . 1.1 mp -133.86 -150.61 0.41 Allowed 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.3 OUTLIER -120.85 123.85 43.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.126 -0.984 . . . . 0.0 110.813 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.484 ' O ' ' CD1' ' A' ' 648' ' ' TRP . 10.3 t0 -101.93 132.2 47.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.417 -0.802 . . . . 0.0 109.211 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 6.4 pt -80.97 129.3 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.114 -0.992 . . . . 0.0 109.972 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.515 ' CZ3' HD21 ' A' ' 671' ' ' LEU . 87.8 m95 -116.15 122.56 45.43 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.526 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.472 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 6.8 t80 -82.05 113.12 19.71 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.1 OUTLIER -107.41 102.87 12.12 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.284 -0.967 . . . . 0.0 111.127 -178.513 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.504 ' CE1' ' C ' ' A' ' 656' ' ' VAL . 11.1 t60 -61.71 154.93 24.04 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.408 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.75 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -146.14 -25.22 0.44 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.568 ' N ' ' HA ' ' A' ' 622' ' ' HIS . . . -77.94 -171.12 36.94 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 117.992 -2.052 . . . . 0.0 109.119 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 27.1 m -95.56 -16.52 22.08 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.013 -1.287 . . . . 0.0 113.285 -176.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 656' ' ' VAL . 3.0 t-20 -62.33 -4.47 1.84 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.007 -1.058 . . . . 0.0 112.596 -178.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.504 ' C ' ' CE1' ' A' ' 651' ' ' HIS . 0.4 OUTLIER 78.62 166.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 CA-C-O 121.987 0.898 . . . . 0.0 110.464 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.443 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -124.99 152.13 44.61 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.435 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -138.34 126.91 23.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.252 -0.905 . . . . 0.0 110.437 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.506 ' CD2' ' CD1' ' A' ' 670' ' ' PHE . 43.5 tp -128.5 114.16 16.42 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 110.027 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 41.9 t30 56.43 -80.93 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.615 -0.678 . . . . 0.0 110.349 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 659' ' ' LEU . 46.1 p-10 -142.52 11.62 1.9 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.042 -1.037 . . . . 0.0 110.767 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -105.5 133.5 50.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.98 -1.075 . . . . 0.0 110.798 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -93.11 142.14 27.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.48 -0.762 . . . . 0.0 109.802 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.412 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 4.4 mtp -121.03 -166.88 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -0.954 . . . . 0.0 110.617 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.419 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 2.7 pt -141.27 -164.26 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.443 -0.786 . . . . 0.0 110.19 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -78.32 86.73 4.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.34 -0.85 . . . . 0.0 110.62 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.74 52.61 0.43 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.2 OUTLIER -119.32 147.19 44.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.226 -1.161 . . . . 0.0 110.009 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.471 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 1.7 tttt -108.76 148.13 30.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.739 . . . . 0.0 109.361 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.506 ' CD1' ' CD2' ' A' ' 659' ' ' LEU . 1.2 t80 -145.72 147.44 31.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.139 -0.975 . . . . 0.0 111.901 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.515 HD21 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.48 132.82 47.64 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.405 -0.809 . . . . 0.0 109.647 179.19 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.472 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 2.7 mt -113.22 104.91 12.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.022 -1.049 . . . . 0.0 111.106 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 53.5 mm-40 -90.79 -177.1 4.88 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 706' ' ' GLY . 13.8 p-10 -76.28 144.11 40.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.12 . . . . 0.0 109.761 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 69.41 48.35 45.32 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.24 99.4 7.19 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.808 -0.819 . . . . 0.0 109.995 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.89 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.85 113.4 25.42 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.427 ' CG1' ' CD1' ' A' ' 659' ' ' LEU . 1.5 mp -104.82 137.43 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.582 -0.699 . . . . 0.0 111.594 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -99.25 117.14 33.05 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 680' ' ' ILE . 79.9 mt -87.7 -27.92 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.221 -0.924 . . . . 0.0 111.145 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 618' ' ' LEU . 1.5 mt -143.23 133.43 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 0.0 111.078 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 14.0 t90 -138.2 109.0 6.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.629 -0.669 . . . . 0.0 109.568 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.15 117.92 28.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.085 -1.009 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -66.63 -29.8 69.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.418 -0.801 . . . . 0.0 110.775 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -43.32 76.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.34 -0.85 . . . . 0.0 110.924 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 688' ' ' PHE . 10.9 t-20 -139.37 34.61 2.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.242 -0.912 . . . . 0.0 110.072 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.49 ' O ' ' C ' ' A' ' 688' ' ' PHE . 0.0 OUTLIER 66.26 -67.02 0.16 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.705 -0.622 . . . . 0.0 109.703 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.2 OUTLIER 30.76 56.85 0.22 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.34 0.591 . . . . 0.0 111.11 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 586' ' ' SER . 41.6 t -101.67 141.52 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.43 -0.794 . . . . 0.0 110.714 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.441 ' CD1' ' CG2' ' A' ' 587' ' ' ILE . 47.9 mm -118.21 163.94 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.49 -0.756 . . . . 0.0 109.207 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.446 ' N ' ' OG ' ' A' ' 586' ' ' SER . . . -177.26 126.92 1.14 Allowed Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.19 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.89 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 12.9 m-85 -120.14 137.87 53.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.668 -0.901 . . . . 0.0 108.776 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.99 114.3 26.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.11 -0.994 . . . . 0.0 110.387 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 675' ' ' GLY . 0.9 OUTLIER -85.37 120.31 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.523 -0.736 . . . . 0.0 109.37 179.56 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -126.59 114.6 18.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.672 -0.642 . . . . 0.0 110.209 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.424 HD12 HG21 ' A' ' 696' ' ' ILE . 88.5 mt -92.1 104.55 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.353 -0.842 . . . . 0.0 110.19 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.45 -43.73 18.46 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.505 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 4.2 m-20 -110.58 143.59 40.75 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.346 0.593 . . . . 0.0 109.929 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 39.7 p -112.51 95.71 5.59 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 11.1 p -135.01 133.15 39.13 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.844 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 62.67 28.85 72.21 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.451 ' CD2' ' CE1' ' A' ' 577' ' ' PHE . 0.3 OUTLIER -111.4 129.85 55.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.426 -1.043 . . . . 0.0 110.099 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.537 ' CZ ' ' CG ' ' A' ' 704' ' ' ASN . 10.5 p90 -49.09 -24.58 1.67 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.434 -0.791 . . . . 0.0 110.403 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.537 ' CG ' ' CZ ' ' A' ' 703' ' ' PHE . 35.5 p-10 -139.85 -157.71 0.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.817 0.818 . . . . 0.0 110.347 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 706' ' ' GLY . 16.7 pt-20 -84.01 -32.38 24.95 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.451 ' N ' ' HG3' ' A' ' 705' ' ' GLU . . . 127.92 15.06 2.41 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.94 9.58 34.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.123 -1.222 . . . . 0.0 111.32 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 65.29 89.0 0.05 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -103.97 96.87 6.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.406 -1.055 . . . . 0.0 110.18 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -171.65 161.93 6.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.302 -0.873 . . . . 0.0 110.307 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -81.01 -30.16 35.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.397 -0.814 . . . . 0.0 110.179 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -63.6 149.18 46.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.314 -0.866 . . . . 0.0 109.688 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -110.49 95.48 5.59 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.225 -0.922 . . . . 0.0 109.806 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 670' ' ' PHE . 9.7 mmm180 38.15 90.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.383 0.611 . . . . 0.0 111.778 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 34.2 m -107.94 159.72 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.457 -0.777 . . . . 0.0 109.528 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.442 ' CG2' ' CE2' ' A' ' 670' ' ' PHE . 47.6 t -104.24 133.47 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.116 -0.99 . . . . 0.0 110.856 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.57 162.99 13.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.551 -0.718 . . . . 0.0 109.655 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -103.82 143.32 32.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.196 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -85.98 154.37 21.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.354 -0.841 . . . . 0.0 110.385 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 15.9 p -115.95 -176.63 2.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 0.0 110.426 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.58 -32.41 50.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.422 -0.799 . . . . 0.0 110.296 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -60.66 -52.25 65.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.337 -0.852 . . . . 0.0 109.772 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.484 ' O ' ' HG ' ' A' ' 726' ' ' LEU . 5.6 mt-10 -64.68 -37.98 89.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.499 -0.751 . . . . 0.0 109.755 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -32.38 73.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.333 -0.854 . . . . 0.0 110.58 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.46 -50.91 49.02 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.245 -0.909 . . . . 0.0 111.766 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.503 ' CD1' ' CE2' ' A' ' 624' ' ' PHE . 0.6 OUTLIER -62.22 -42.22 99.11 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.949 -1.094 . . . . 0.0 110.935 -179.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . 0.419 ' CG2' ' CG1' ' A' ' 621' ' ' VAL . 7.2 p -76.67 -17.04 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.877 -1.14 . . . . 0.0 110.349 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -53.67 -43.32 68.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.202 -0.936 . . . . 0.0 108.856 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -116.52 103.78 10.76 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.249 1.024 . . . . 0.0 109.021 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.438 ' HA ' ' CE2' ' A' ' 602' ' ' PHE . 1.3 mt . . . . . 0 C--N 1.273 -2.743 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.362 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -91.92 6.14 47.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -1.123 . . . . 0.0 110.718 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . -150.51 54.45 0.48 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -93.05 114.46 27.0 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.371 -1.076 . . . . 0.0 109.512 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.557 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 0.8 OUTLIER -91.35 -40.92 11.19 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.76 0.79 . . . . 0.0 109.216 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.523 ' HB2' ' CD2' ' A' ' 577' ' ' PHE . 3.5 tt -135.63 142.76 45.26 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.597 0.713 . . . . 0.0 111.561 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 95.6 m -118.53 123.65 45.6 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.4 HD12 ' CD1' ' A' ' 594' ' ' ILE . 9.6 mt -93.16 112.41 24.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.438 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 2.9 mmtt -113.77 102.34 54.71 Favored Pre-proline 0 C--N 1.302 -1.497 0 C-N-CA 118.223 -1.391 . . . . 0.0 112.835 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.082 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.5 Cg_endo -81.15 141.1 12.76 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 N-CA-C 105.808 -2.42 . . . . 0.0 105.808 174.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.753 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -120.29 -174.86 0.31 Allowed Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 118.128 -1.429 . . . . 0.0 113.512 -176.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.753 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 37.7 Cg_endo -63.86 -36.23 51.67 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 124.269 1.668 . . . . 0.0 111.657 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.63 -27.32 64.62 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 586' ' ' SER . . . . . . . . . . . . . 33.0 t -96.04 148.48 22.62 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.541 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.488 ' HB ' HD13 ' A' ' 690' ' ' ILE . 0.8 OUTLIER -56.68 -18.71 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.991 -1.068 . . . . 0.0 109.178 178.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.738 HG12 ' HA ' ' A' ' 613' ' ' ILE . 4.1 mp -94.72 116.38 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.458 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -120.67 67.2 0.85 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.545 -1.347 . . . . 0.0 108.864 -179.493 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.082 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 15.5 tp10 -145.0 175.14 10.45 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.243 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.497 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.19 124.24 38.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.085 -1.009 . . . . 0.0 109.447 176.626 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 611' ' ' CYS . 1.1 mt -103.04 155.72 18.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.455 -0.778 . . . . 0.0 109.173 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -125.25 110.3 13.88 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.393 -0.817 . . . . 0.0 111.177 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.471 HG22 HG11 ' A' ' 598' ' ' VAL . 26.4 mt -80.08 108.31 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.4 OUTLIER -68.0 116.73 8.97 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.437 -0.79 . . . . 0.0 111.106 -178.29 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.557 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.1 OUTLIER 38.57 32.41 0.05 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.255 0.55 . . . . 0.0 111.188 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.422 ' HA2' ' CG2' ' A' ' 594' ' ' ILE . . . 83.73 63.7 1.67 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.471 HG11 HG22 ' A' ' 594' ' ' ILE . 9.8 p -79.47 105.15 8.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 O-C-N 121.039 -1.271 . . . . 0.0 107.583 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.414 ' CB ' ' HB3' ' A' ' 627' ' ' LYS . 3.9 p-10 -121.79 151.13 57.07 Favored Pre-proline 0 C--N 1.279 -2.466 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.649 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.463 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.7 Cg_endo -86.24 156.8 54.58 Favored 'Cis proline' 0 C--N 1.307 -1.618 0 C-N-CA 120.933 -2.528 . . . . 0.0 109.475 0.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.507 ' CD2' ' HB2' ' A' ' 611' ' ' CYS . 4.8 t80 -105.66 115.39 30.16 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.533 ' O ' ' HB3' ' A' ' 609' ' ' CYS . 50.2 m-85 -86.14 143.68 27.89 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.431 -178.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.555 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 4.1 mt -140.68 141.75 31.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.894 -0.504 . . . . 0.0 110.013 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.777 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 165.42 -162.3 35.66 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.361 -1.399 . . . . 0.0 111.13 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.433 ' N ' HD23 ' A' ' 618' ' ' LEU . 5.9 mmm-85 -61.26 -58.48 8.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.89 -0.771 . . . . 0.0 111.804 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.03 124.27 22.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 111.251 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.533 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 11.8 pt-20 -54.16 -16.98 2.35 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.922 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -44.88 -36.44 3.31 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.37 -0.831 . . . . 0.0 109.074 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 602' ' ' PHE . 1.3 m -59.63 136.63 58.05 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.479 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -47.42 -26.77 1.43 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.209 -0.932 . . . . 0.0 109.414 179.165 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.555 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 3.0 t -109.48 143.02 39.66 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.533 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -103.1 126.62 50.36 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.497 -0.881 . . . . 0.0 112.447 -178.559 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.738 ' HA ' HG12 ' A' ' 588' ' ' ILE . 5.3 mt -143.19 109.64 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.401 ' O ' ' CG2' ' A' ' 587' ' ' ILE . 2.1 tp10 -97.26 103.04 14.94 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 117.99 -1.484 . . . . 0.0 108.357 178.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 618' ' ' LEU . 4.3 m-20 -137.7 105.73 5.69 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.417 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -42.36 -51.66 4.81 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.599 -0.688 . . . . 0.0 112.181 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -74.77 -16.7 60.71 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.182 -0.949 . . . . 0.0 111.602 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.532 ' CD2' ' HA2' ' A' ' 604' ' ' GLY . 0.5 OUTLIER -80.23 143.58 33.62 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.155 -0.965 . . . . 0.0 111.071 -179.062 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.434 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -79.85 162.88 24.79 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.414 -0.803 . . . . 0.0 110.681 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.777 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.4 mpt_? -64.32 -46.76 82.11 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.145 -0.972 . . . . 0.0 109.936 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.466 ' O ' ' C ' ' A' ' 622' ' ' HIS . 5.2 m -95.75 2.14 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.235 -0.916 . . . . 0.0 109.42 178.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.725 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.2 t60 -25.28 -47.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.409 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.444 ' O ' ' HB ' ' A' ' 603' ' ' ILE . 1.0 OUTLIER -136.82 146.41 45.63 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 118.206 -1.397 . . . . 0.0 111.497 179.523 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.542 ' HA ' HG13 ' A' ' 603' ' ' ILE . 3.6 p90 -145.82 146.58 31.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.622 -0.674 . . . . 0.0 110.073 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 19.8 mt -103.55 117.46 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.444 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 10.9 t80 -111.78 154.61 24.8 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 109.956 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 2.8 ttmt -120.3 136.6 54.63 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 121.556 0.694 . . . . 0.0 110.434 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.444 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.53 164.81 26.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.648 -0.658 . . . . 0.0 109.949 -179.589 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.1 OUTLIER -77.12 115.01 16.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 109.03 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.527 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.8 t-160 -63.33 124.88 22.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.585 -0.697 . . . . 0.0 110.998 -179.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . 0.422 ' O ' ' CG1' ' A' ' 632' ' ' VAL . . . -79.58 122.67 26.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.646 -0.659 . . . . 0.0 109.793 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . 0.422 ' CG1' ' O ' ' A' ' 631' ' ' ALA . 1.6 p 44.8 -168.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.677 -0.639 . . . . 0.0 111.084 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . 131.75 -144.53 16.2 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -142.27 -173.24 3.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.306 -1.114 . . . . 0.0 110.229 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -169.38 135.29 1.59 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.328 -0.857 . . . . 0.0 110.51 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 636' ' ' MET . . . . . 0.424 ' O ' ' O ' ' A' ' 637' ' ' TYR . 0.8 OUTLIER 51.0 -134.76 1.55 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.248 -0.907 . . . . 0.0 110.158 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 636' ' ' MET . 0.1 OUTLIER -59.09 -154.34 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.496 -0.752 . . . . 0.0 109.741 179.522 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -78.9 98.02 6.22 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.775 -1.203 . . . . 0.0 108.108 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 10.0 p -139.44 152.52 69.25 Favored Pre-proline 0 C--N 1.289 -2.063 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.98 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.86 -150.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.584 1.307 . . . . 0.0 109.198 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . -163.41 105.81 0.99 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 109.623 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . 0.424 ' O ' ' O ' ' A' ' 643' ' ' GLY . 32.6 tt0 -77.82 48.9 0.73 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.376 -0.827 . . . . 0.0 110.839 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 642' ' ' GLN . . . 59.94 128.64 0.01 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 5.0 mp -140.39 -150.99 0.34 Allowed 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.828 -0.807 . . . . 0.0 109.141 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.3 OUTLIER -118.0 124.26 47.74 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.975 -1.078 . . . . 0.0 111.412 -179.426 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.429 ' HB2' ' ND1' ' A' ' 630' ' ' HIS . 28.7 t0 -111.18 155.65 22.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.443 -0.786 . . . . 0.0 109.92 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 21.8 pt -108.81 128.79 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.21 -0.931 . . . . 0.0 109.748 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.506 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 95.6 m95 -115.48 119.95 37.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.678 -0.639 . . . . 0.0 111.595 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.522 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 11.5 t80 -83.31 114.13 21.19 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.0 OUTLIER -108.86 103.28 12.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.154 -0.966 . . . . 0.0 111.353 -178.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.53 ' CD2' ' N ' ' A' ' 652' ' ' THR . 8.9 t60 -63.04 156.75 23.87 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.513 -0.742 . . . . 0.0 109.895 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.725 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -148.19 -29.11 0.31 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.395 -0.816 . . . . 0.0 112.875 -179.206 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.531 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.85 -163.66 25.15 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 117.864 -2.112 . . . . 0.0 109.473 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 654' ' ' THR . . . . . 0.407 ' C ' ' H ' ' A' ' 656' ' ' VAL . 19.3 m -99.3 -17.84 17.86 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.02 -1.282 . . . . 0.0 113.709 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.445 ' O ' ' CB ' ' A' ' 656' ' ' VAL . 8.7 m120 -59.16 -3.77 0.43 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 120.667 -1.27 . . . . 0.0 112.492 -178.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.464 ' C ' ' CE1' ' A' ' 651' ' ' HIS . 2.9 t 71.52 147.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.626 -0.671 . . . . 0.0 110.207 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.437 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -102.74 141.64 35.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.517 -0.739 . . . . 0.0 111.145 -178.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.414 ' CE1' ' HG2' ' A' ' 663' ' ' ARG . 95.3 m-85 -129.46 126.61 39.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.552 -0.718 . . . . 0.0 109.724 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.546 HD21 ' CD1' ' A' ' 670' ' ' PHE . 31.3 tp -130.85 111.83 12.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.222 -0.924 . . . . 0.0 110.107 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 56.31 -82.2 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.565 -0.709 . . . . 0.0 110.167 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 659' ' ' LEU . 17.1 m-80 -141.89 17.77 2.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 110.131 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . 0.421 ' HB3' ' CE2' ' A' ' 670' ' ' PHE . 0.8 OUTLIER -109.45 127.12 54.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.494 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . 0.414 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 0.0 OUTLIER -93.22 141.15 28.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.417 -0.802 . . . . 0.0 109.794 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.433 ' CB ' ' OG ' ' A' ' 657' ' ' SER . 3.0 mtp -122.79 -167.65 1.62 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.372 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.404 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 3.0 pt -139.82 -160.96 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.399 -0.813 . . . . 0.0 110.239 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -79.76 95.51 6.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.283 -0.886 . . . . 0.0 110.668 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 104.31 51.6 0.92 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -118.18 145.36 45.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.103 -1.233 . . . . 0.0 109.993 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.77 141.62 39.05 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.546 ' CD1' HD21 ' A' ' 659' ' ' LEU . 3.7 t80 -145.36 148.21 33.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.106 -0.996 . . . . 0.0 112.299 -177.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.506 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.53 130.91 44.24 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.443 -0.786 . . . . 0.0 109.893 179.514 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.522 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 4.3 mt -107.44 105.01 14.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.907 -1.121 . . . . 0.0 111.226 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -87.51 165.36 15.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.476 -0.765 . . . . 0.0 109.052 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 706' ' ' GLY . 14.4 p-10 -62.74 157.42 21.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.127 -0.983 . . . . 0.0 109.923 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 59.88 51.52 58.46 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 107.765 -2.134 . . . . 0.0 107.765 -178.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.09 96.34 5.76 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.786 -0.832 . . . . 0.0 110.868 -178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.886 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.6 tt0 -94.46 107.98 19.93 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.432 ' CG2' ' CD1' ' A' ' 659' ' ' LEU . 35.5 pt -107.59 138.38 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.598 -0.689 . . . . 0.0 112.331 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -100.06 112.79 25.09 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.418 HD13 ' CD1' ' A' ' 613' ' ' ILE . 56.8 mt -81.63 -33.81 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.26 -0.9 . . . . 0.0 111.504 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.463 HG22 HG12 ' A' ' 690' ' ' ILE . 14.1 tt -133.85 136.15 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.938 -1.101 . . . . 0.0 110.213 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -137.59 116.48 12.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.316 -0.865 . . . . 0.0 110.462 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -127.94 117.6 22.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.84 -30.19 70.3 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.466 -0.771 . . . . 0.0 111.015 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -55.65 -43.45 76.28 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.301 -0.874 . . . . 0.0 110.872 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 687' ' ' LYS . 6.9 m-80 -136.62 32.35 2.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 110.002 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 688' ' ' PHE . 5.8 mttm 64.21 -67.0 0.11 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.915 -0.49 . . . . 0.0 110.09 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.478 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.1 OUTLIER 33.42 55.48 0.5 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.3 0.571 . . . . 0.0 110.965 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.3 142.19 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.414 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.542 ' CD1' HD11 ' A' ' 588' ' ' ILE . 31.2 mm -117.83 164.2 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.473 -0.767 . . . . 0.0 109.333 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -170.96 124.71 1.14 Allowed Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.058 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.886 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 14.3 m-85 -119.19 137.25 53.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.625 -0.926 . . . . 0.0 108.654 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -101.13 113.95 27.46 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 110.753 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 675' ' ' GLY . 0.8 OUTLIER -83.84 121.51 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -129.26 105.81 8.4 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.623 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 577' ' ' PHE . 82.1 mt -85.73 105.95 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.449 -0.782 . . . . 0.0 109.614 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.28 -44.13 13.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.428 -0.795 . . . . 0.0 108.889 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.432 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 9.9 m-20 -111.26 142.35 43.59 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.401 0.62 . . . . 0.0 110.229 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 699' ' ' THR . 2.0 p -114.19 96.15 5.65 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 7.2 t -86.26 95.96 9.79 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.334 0.588 . . . . 0.0 111.216 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 47.43 36.77 11.69 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.404 HD11 ' CE1' ' A' ' 577' ' ' PHE . 1.7 tp -84.41 149.96 25.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.392 -1.063 . . . . 0.0 110.336 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 2.5 p90 -53.5 -23.2 9.67 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.384 -0.823 . . . . 0.0 109.939 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.552 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.8 t30 -172.12 154.96 3.54 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.454 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 16.9 pt-20 -50.98 -26.64 6.27 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.18 -0.95 . . . . 0.0 110.226 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 120.86 15.54 4.78 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 1.5 tp -83.34 9.61 10.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.099 -1.236 . . . . 0.0 111.385 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 106.31 -103.31 2.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.402 ' HE1' ' CD2' ' A' ' 703' ' ' PHE . 8.1 ttp 53.7 91.17 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.442 -1.034 . . . . 0.0 110.546 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -174.02 154.51 2.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.27 -0.894 . . . . 0.0 110.199 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -59.35 -57.71 11.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.273 -0.892 . . . . 0.0 109.834 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -63.86 149.35 47.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.514 -0.741 . . . . 0.0 109.642 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.17 95.62 5.7 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.149 -0.969 . . . . 0.0 109.274 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 714' ' ' ARG . 5.2 mmm-85 43.59 72.8 0.17 Allowed 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.368 0.604 . . . . 0.0 111.354 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.77 151.75 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.475 -0.765 . . . . 0.0 109.279 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.422 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 61.6 t -92.3 118.58 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 110.512 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.3 mp -90.22 161.8 15.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.546 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.12 153.99 17.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -0.93 . . . . 0.0 110.244 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -79.93 145.8 32.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.472 -0.768 . . . . 0.0 110.181 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 20.3 p -121.13 -176.89 3.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.309 -0.87 . . . . 0.0 110.362 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.7 67.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.376 -0.827 . . . . 0.0 110.456 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.32 -52.46 64.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.352 -0.842 . . . . 0.0 110.001 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -66.8 -42.47 85.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -0.873 . . . . 0.0 109.929 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . 0.413 ' O ' ' CG1' ' A' ' 727' ' ' VAL . 12.2 ttmm -56.69 -32.83 65.84 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.319 -0.863 . . . . 0.0 109.756 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.8 -36.21 77.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.399 -0.813 . . . . 0.0 110.09 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 33.4 mt -58.18 -46.63 85.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.404 -0.81 . . . . 0.0 110.446 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . 0.413 ' CG1' ' O ' ' A' ' 724' ' ' LYS . 7.9 p -69.88 -19.57 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.065 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -54.44 -48.49 71.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -0.894 . . . . 0.0 108.79 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.81 104.98 11.88 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 122.229 1.014 . . . . 0.0 108.923 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.427 HD22 ' CG ' ' A' ' 602' ' ' PHE . 0.7 OUTLIER . . . . . 0 C--N 1.275 -2.657 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.377 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.78 -10.15 59.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.4 -1.059 . . . . 0.0 110.401 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 167.21 65.62 0.03 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.77 129.59 38.64 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.385 -1.068 . . . . 0.0 109.253 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.545 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 3.7 t80 -123.56 -41.47 2.27 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 122.074 0.94 . . . . 0.0 109.215 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 594' ' ' ILE . 22.1 tp -123.83 140.76 52.67 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.285 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 88.1 m -123.51 116.98 24.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.705 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.436 ' N ' ' CD2' ' A' ' 580' ' ' LEU . 1.9 mm? -90.37 111.74 23.08 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.416 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 2.5 mmtt -112.89 101.26 52.91 Favored Pre-proline 0 C--N 1.299 -1.594 0 C-N-CA 117.987 -1.485 . . . . 0.0 112.657 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.119 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.1 Cg_endo -80.87 140.72 12.95 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 N-CA-C 105.428 -2.566 . . . . 0.0 105.428 174.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.718 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -118.86 -176.95 0.41 Allowed Pre-proline 0 N--CA 1.495 1.793 0 C-N-CA 118.177 -1.409 . . . . 0.0 113.567 -176.232 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.718 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.3 Cg_endo -66.56 -31.3 41.63 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 O-C-N 124.342 1.706 . . . . 0.0 111.83 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -59.0 -29.89 67.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.798 -1.189 . . . . 0.0 108.124 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.541 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 54.4 p -96.44 153.29 17.91 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.914 -0.491 . . . . 0.0 109.724 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.527 ' CG2' HD11 ' A' ' 588' ' ' ILE . 0.1 OUTLIER -57.0 -18.95 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.16 -0.963 . . . . 0.0 109.101 178.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.647 HD12 ' HA ' ' A' ' 613' ' ' ILE . 10.0 mm -95.96 115.38 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.474 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -124.47 71.37 1.14 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 120.601 -1.312 . . . . 0.0 110.099 -178.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.119 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 18.9 mt-10 -145.12 174.97 10.6 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.579 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.495 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.79 127.23 41.57 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.841 -1.162 . . . . 0.0 109.393 176.483 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 1.2 mp -111.39 155.73 22.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 109.747 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -124.96 110.41 14.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.481 -0.762 . . . . 0.0 111.406 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.476 HG23 ' HB ' ' A' ' 598' ' ' VAL . 3.0 mt -80.85 110.49 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.7 OUTLIER -51.48 172.83 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.634 -0.666 . . . . 0.0 110.052 -179.815 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.545 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 5.6 mt-30 -64.36 66.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.476 -0.765 . . . . 0.0 110.555 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 128.72 30.65 0.69 Allowed Glycine 0 N--CA 1.486 2.01 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.806 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.476 ' HB ' HG23 ' A' ' 594' ' ' ILE . 0.9 OUTLIER -81.34 102.81 7.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.486 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 11.8 t-20 -143.3 134.54 12.66 Favored Pre-proline 0 C--N 1.284 -2.265 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.89 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.624 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 55.9 Cg_endo -91.48 162.52 28.47 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.958 -1.684 . . . . 0.0 109.192 -1.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.53 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 3.8 t80 -106.25 116.35 31.79 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.624 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 73.0 m-85 -86.47 144.08 27.44 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.269 -0.894 . . . . 0.0 110.538 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.578 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 3.0 mt -141.64 141.46 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.73 -0.606 . . . . 0.0 110.148 -178.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.754 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 163.94 -163.09 35.67 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.45 -1.357 . . . . 0.0 111.12 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.418 ' N ' HD23 ' A' ' 618' ' ' LEU . 1.1 mmm-85 -62.46 -53.11 59.73 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.832 -0.805 . . . . 0.0 111.491 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 3.1 p -68.22 121.14 15.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 111.04 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.6 mt-10 -54.2 -17.4 2.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.641 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -47.36 -30.23 3.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.426 -0.796 . . . . 0.0 109.032 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 602' ' ' PHE . 1.6 m -65.88 130.48 43.42 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.53 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -43.97 -29.57 0.6 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.381 -0.824 . . . . 0.0 109.524 179.433 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.578 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 2.3 t -106.01 143.37 34.24 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.511 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -108.52 128.59 54.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.079 -1.013 . . . . 0.0 113.093 -178.144 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.647 ' HA ' HD12 ' A' ' 588' ' ' ILE . 8.8 mt -142.21 108.87 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -98.33 104.07 16.08 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.221 -1.392 . . . . 0.0 109.517 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.577 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 0.2 OUTLIER -138.78 106.69 5.67 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.165 177.181 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -39.25 -43.79 1.17 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.65 -0.656 . . . . 0.0 112.123 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.01 -17.71 39.53 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.118 -0.988 . . . . 0.0 111.847 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -75.47 131.37 40.09 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.103 -0.998 . . . . 0.0 110.882 -179.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 622' ' ' HIS . 10.0 t -65.34 159.08 24.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.335 -0.853 . . . . 0.0 110.837 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.754 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.9 mpp_? -64.76 -45.3 86.99 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.181 -0.949 . . . . 0.0 109.518 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.486 ' O ' ' C ' ' A' ' 622' ' ' HIS . 17.3 t -95.35 2.06 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 121.739 0.78 . . . . 0.0 109.721 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.734 ' O ' ' N ' ' A' ' 652' ' ' THR . 6.1 t60 -24.55 -46.82 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.542 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.444 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.8 OUTLIER -138.19 146.1 42.29 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 118.283 -1.367 . . . . 0.0 112.038 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.551 ' HA ' HG13 ' A' ' 603' ' ' ILE . 1.9 p90 -146.13 144.25 29.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.454 -0.779 . . . . 0.0 109.981 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 26.8 mt -102.66 123.1 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.423 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 2.3 t80 -118.26 154.33 32.44 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.351 -0.843 . . . . 0.0 109.516 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 9.0 tttt -120.46 136.27 54.8 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.657 0.741 . . . . 0.0 110.786 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.423 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -126.35 163.66 22.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.715 -0.615 . . . . 0.0 109.676 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.474 ' C ' ' CD ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -78.67 123.1 26.79 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.157 -0.964 . . . . 0.0 108.894 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.3 t-160 -75.21 122.93 24.4 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.331 -0.856 . . . . 0.0 110.538 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -130.64 75.1 1.63 Allowed 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.512 0.672 . . . . 0.0 109.883 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . 0.418 ' CG2' ' N ' ' A' ' 633' ' ' GLY . 5.6 p -57.72 169.09 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.565 -0.71 . . . . 0.0 110.474 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . 0.418 ' N ' ' CG2' ' A' ' 632' ' ' VAL . . . -121.49 -159.46 10.7 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 24.6 tttt 52.28 64.62 1.78 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.24 -1.153 . . . . 0.0 110.362 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 89.4 p -129.67 108.94 10.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.312 -0.867 . . . . 0.0 110.43 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 9.3 mmt -105.85 37.67 2.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.346 -0.846 . . . . 0.0 109.926 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -171.67 -152.78 0.08 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.504 -0.747 . . . . 0.0 110.002 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -116.37 102.75 9.8 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.291 -0.881 . . . . 0.0 108.913 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 78.3 p -136.47 151.73 73.52 Favored Pre-proline 0 C--N 1.293 -1.863 0 O-C-N 121.881 -0.512 . . . . 0.0 110.139 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . 0.417 ' O ' ' N ' ' A' ' 642' ' ' GLN . 46.1 Cg_endo -68.94 -151.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.756 1.398 . . . . 0.0 109.651 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' A' ' 640' ' ' PRO . . . 67.13 -61.05 0.35 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.607 -0.683 . . . . 0.0 110.553 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 640' ' ' PRO . 44.0 tt0 -62.83 83.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.368 -0.833 . . . . 0.0 110.548 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 133.03 5.94 2.94 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.958 -1.115 . . . . 0.0 111.046 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.639 ' HG ' ' HA ' ' A' ' 703' ' ' PHE . 3.4 mm? -82.17 -153.88 0.12 Allowed 'General case' 0 C--N 1.282 -2.363 0 O-C-N 121.948 -0.736 . . . . 0.0 109.792 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.9 m-20 -130.41 133.24 46.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.906 -1.122 . . . . 0.0 111.148 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.438 ' CG ' ' HE1' ' A' ' 648' ' ' TRP . 3.2 p30 -115.59 152.73 32.53 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.404 -0.81 . . . . 0.0 110.954 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 6.2 pt -111.2 130.89 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.264 -0.897 . . . . 0.0 109.868 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.552 ' CH2' ' HG ' ' A' ' 671' ' ' LEU . 94.2 m95 -119.04 140.06 50.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.611 -0.681 . . . . 0.0 110.89 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.443 ' HB3' HD11 ' A' ' 672' ' ' LEU . 4.3 t80 -97.97 114.34 26.43 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.547 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 24.8 t -104.22 102.32 12.03 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.23 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.544 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 24.9 t60 -67.59 164.68 18.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.443 -0.786 . . . . 0.0 109.543 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.734 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -155.28 -31.31 0.1 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.213 -0.93 . . . . 0.0 113.257 -178.83 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.558 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.25 132.88 11.83 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 117.937 -2.077 . . . . 0.0 110.427 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 654' ' ' THR . . . . . 0.433 ' C ' ' H ' ' A' ' 656' ' ' VAL . 23.8 m -37.71 -24.46 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -177.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 656' ' ' VAL . 7.9 m120 -57.7 -4.72 0.3 Allowed 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.266 -1.521 . . . . 0.0 112.407 -178.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.495 ' O ' ' CE1' ' A' ' 651' ' ' HIS . 0.4 OUTLIER 76.77 168.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 CA-C-O 121.83 0.824 . . . . 0.0 110.256 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.502 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -127.5 154.76 44.73 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.601 -179.01 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -137.92 126.36 23.37 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.163 -0.96 . . . . 0.0 110.83 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.49 ' CD2' ' CD2' ' A' ' 670' ' ' PHE . 22.2 tp -122.05 107.32 12.07 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.391 -0.818 . . . . 0.0 109.84 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.3 t30 63.2 -73.45 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.545 -0.722 . . . . 0.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 659' ' ' LEU . 37.1 m-20 -153.9 22.51 0.51 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.348 -0.845 . . . . 0.0 110.389 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.38 116.86 28.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.149 -0.969 . . . . 0.0 110.37 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -80.54 139.67 36.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.421 -0.8 . . . . 0.0 109.908 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.474 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 37.7 mtp -118.2 -161.74 0.85 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.869 . . . . 0.0 110.094 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.403 ' CG1' ' CG2' ' A' ' 668' ' ' THR . 3.7 pt -133.02 -160.87 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 109.725 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -81.39 117.33 21.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.343 -0.848 . . . . 0.0 110.26 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 82.49 50.73 4.63 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -115.27 146.34 41.58 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.109 -1.23 . . . . 0.0 110.111 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.408 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 2.7 ttpt -108.77 141.99 39.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.524 -0.735 . . . . 0.0 109.853 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.49 ' CD2' ' CD2' ' A' ' 659' ' ' LEU . 0.4 OUTLIER -144.61 141.0 29.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 110.898 -179.067 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.552 ' HG ' ' CH2' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -70.05 146.35 51.05 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.285 -0.885 . . . . 0.0 110.682 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 649' ' ' TYR . 3.9 mp -111.45 149.05 31.83 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.924 0.868 . . . . 0.0 111.632 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.586 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 15.3 mt-30 -127.0 136.59 52.45 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 673' ' ' GLN . 0.0 OUTLIER -37.93 129.22 1.21 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.967 -1.083 . . . . 0.0 110.276 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 83.88 44.05 6.93 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.97 90.48 4.19 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.948 -0.737 . . . . 0.0 110.463 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.805 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.8 tt0 -94.21 107.74 19.65 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.451 ' CG2' ' CD1' ' A' ' 659' ' ' LEU . 41.5 pt -113.06 138.5 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.49 -0.757 . . . . 0.0 111.829 -178.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 15.9 mttp -94.47 110.53 22.32 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.45 ' CG2' ' CD2' ' A' ' 622' ' ' HIS . 69.9 mt -73.88 -30.95 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.348 -0.845 . . . . 0.0 110.801 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 618' ' ' LEU . 6.0 mt -143.0 137.38 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.018 -1.051 . . . . 0.0 110.876 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 6.6 t90 -137.93 108.98 6.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.559 -0.713 . . . . 0.0 109.795 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -114.34 118.12 32.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.096 -1.003 . . . . 0.0 110.598 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -66.52 -30.01 70.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.495 -0.753 . . . . 0.0 110.806 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -55.88 -43.71 77.44 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.397 -0.815 . . . . 0.0 111.078 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 688' ' ' PHE . 2.1 m-20 -141.26 34.96 1.69 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.92 . . . . 0.0 110.066 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.477 ' O ' ' C ' ' A' ' 688' ' ' PHE . 0.2 OUTLIER 66.54 -67.71 0.15 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.737 -0.602 . . . . 0.0 110.003 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.477 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.5 OUTLIER 33.69 59.92 0.52 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.684 -0.635 . . . . 0.0 110.7 179.718 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 586' ' ' SER . 34.2 m -102.06 142.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 111.352 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.541 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 43.1 mm -113.43 163.56 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.465 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -173.31 118.71 0.72 Allowed Glycine 0 N--CA 1.491 2.314 0 C-N-CA 118.948 -1.596 . . . . 0.0 110.618 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.805 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 13.7 m-85 -120.5 138.02 54.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.613 -0.934 . . . . 0.0 108.784 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -108.64 114.52 28.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 0.0 110.763 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 1.2 t -76.52 119.68 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.382 -0.824 . . . . 0.0 108.924 179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.71 104.61 7.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.672 -0.642 . . . . 0.0 110.023 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.478 ' CD1' ' HA3' ' A' ' 706' ' ' GLY . 62.5 mt -86.68 107.7 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 109.714 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -78.3 -41.14 34.69 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.405 -0.81 . . . . 0.0 109.077 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.443 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 1.3 m-20 -110.81 140.86 44.87 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.579 0.704 . . . . 0.0 110.682 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 14.5 p -115.16 96.0 5.47 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 22.2 m -113.58 129.64 56.52 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.853 -0.53 . . . . 0.0 110.797 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 50.76 37.9 35.73 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.418 HD22 ' CZ ' ' A' ' 577' ' ' PHE . 5.0 tp -109.94 125.43 52.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.461 -1.023 . . . . 0.0 110.653 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.639 ' HA ' ' HG ' ' A' ' 644' ' ' LEU . 10.8 p90 -50.55 -27.4 6.63 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.901 0.858 . . . . 0.0 109.566 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.55 ' HB3' ' CZ ' ' A' ' 703' ' ' PHE . 6.6 t30 -148.25 170.33 18.12 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.452 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 12.8 pt-20 -52.73 -25.46 11.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 109.637 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 116.66 16.16 6.56 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 707' ' ' LEU . 45.8 tp -103.37 10.55 37.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.56 -0.965 . . . . 0.0 110.955 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.533 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 53.41 98.17 0.01 OUTLIER Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.421 ' HG3' ' ND2' ' A' ' 704' ' ' ASN . 0.0 OUTLIER -139.38 36.2 2.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.409 -1.054 . . . . 0.0 110.419 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.5 51.32 0.75 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.333 -0.854 . . . . 0.0 110.334 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 51.36 45.82 27.39 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.313 -0.867 . . . . 0.0 110.26 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -102.97 148.65 25.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.426 -0.796 . . . . 0.0 110.452 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . 0.64 ' O ' ' N ' ' A' ' 715' ' ' VAL . 0.3 OUTLIER -110.82 97.46 6.86 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.223 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.43 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 6.0 mmm-85 -29.58 79.47 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.849 0.833 . . . . 0.0 112.254 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.64 ' N ' ' O ' ' A' ' 713' ' ' GLN . 11.2 m -106.96 151.76 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.474 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 60.4 t -86.2 133.15 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.85 . . . . 0.0 110.939 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.0 mt -103.65 162.15 13.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.54 -0.725 . . . . 0.0 109.552 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.01 154.15 18.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 110.259 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -79.94 134.19 36.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 0.0 110.168 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 63.1 p -106.18 -176.3 3.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.413 -0.804 . . . . 0.0 110.3 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.26 -28.86 29.78 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.282 -0.886 . . . . 0.0 110.018 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -65.93 -47.92 73.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.416 -0.802 . . . . 0.0 109.785 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -63.93 -47.86 78.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.417 -0.802 . . . . 0.0 109.956 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . 0.407 ' O ' ' CG1' ' A' ' 727' ' ' VAL . 12.0 tttm -52.42 -33.71 45.1 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.422 -0.799 . . . . 0.0 109.85 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -69.16 -36.12 77.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.471 -0.768 . . . . 0.0 110.251 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.421 HD13 ' CE1' ' A' ' 624' ' ' PHE . 56.2 mt -56.25 -47.53 78.34 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.312 -0.867 . . . . 0.0 110.619 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 724' ' ' LYS . 6.3 p -69.67 -17.67 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.154 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -54.27 -45.82 72.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 0.0 108.836 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.1 104.76 11.55 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.225 1.012 . . . . 0.0 109.209 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.414 ' OXT' ' CD2' ' A' ' 602' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.274 -2.714 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.365 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -82.9 0.34 44.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -1.123 . . . . 0.0 110.676 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . -110.15 40.0 2.7 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.417 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 2.6 ttm180 -92.61 114.0 26.44 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.377 -1.072 . . . . 0.0 109.686 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.49 ' HB3' ' CA ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -93.32 -44.09 8.47 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.809 0.814 . . . . 0.0 109.116 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.479 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 9.9 tt -125.48 142.2 51.63 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.275 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 87.0 m -122.38 121.97 37.93 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 14.1 mt -95.15 112.5 24.2 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.464 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.49 103.66 55.57 Favored Pre-proline 0 C--N 1.302 -1.485 0 C-N-CA 118.464 -1.294 . . . . 0.0 113.21 -177.272 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.059 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 44.1 Cg_endo -78.5 137.24 14.54 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 N-CA-C 105.274 -2.625 . . . . 0.0 105.274 174.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.79 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -125.88 -171.9 0.24 Allowed Pre-proline 0 C--N 1.295 -1.786 0 C-N-CA 118.138 -1.425 . . . . 0.0 113.405 -176.104 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.79 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 36.7 Cg_endo -61.67 -35.4 80.57 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 124.129 1.594 . . . . 0.0 111.951 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -58.69 -29.75 66.86 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.459 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 24.6 t -96.54 148.09 23.18 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.499 HG13 HD13 ' A' ' 588' ' ' ILE . 1.4 pt -62.96 -18.21 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.244 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.679 HG13 HG12 ' A' ' 613' ' ' ILE . 4.3 mm -83.27 116.2 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.459 ' NE2' ' O ' ' A' ' 586' ' ' SER . 0.0 OUTLIER -119.76 69.52 0.84 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.432 -1.417 . . . . 0.0 109.348 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.059 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 24.8 tt0 -144.61 174.35 11.04 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.637 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.5 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.2 125.01 36.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.971 -1.08 . . . . 0.0 109.011 176.342 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.98 155.04 19.76 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.31 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.417 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.6 OUTLIER -125.48 110.54 14.02 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.478 -0.764 . . . . 0.0 111.287 -179.016 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 3.2 mt -84.16 109.27 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.157 -0.965 . . . . 0.0 109.007 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.2 OUTLIER -64.74 140.41 58.86 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.048 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.49 ' CA ' ' HB3' ' A' ' 577' ' ' PHE . 2.2 pt20 -46.56 85.47 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.486 -0.759 . . . . 0.0 110.783 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 135.44 5.21 2.35 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.722 -1.227 . . . . 0.0 110.483 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.432 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -80.21 101.66 5.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 O-C-N 120.788 -1.419 . . . . 0.0 107.421 178.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 627' ' ' LYS . 21.6 t-20 -145.42 132.52 10.1 Favored Pre-proline 0 C--N 1.282 -2.352 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.065 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.529 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 50.8 Cg_endo -92.87 164.13 23.88 Favored 'Cis proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.38 -1.508 . . . . 0.0 108.747 -2.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.517 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 5.4 t80 -104.39 116.14 31.61 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.529 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 35.9 m-85 -82.96 143.91 30.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.435 -0.79 . . . . 0.0 110.616 -178.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.542 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 3.6 mt -141.99 141.57 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.659 -0.651 . . . . 0.0 109.952 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.728 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 163.8 -163.8 36.02 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.395 -1.383 . . . . 0.0 111.24 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.474 ' N ' HD23 ' A' ' 618' ' ' LEU . 4.8 mmm-85 -60.33 -57.7 11.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.921 -0.752 . . . . 0.0 111.862 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.45 125.07 25.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 111.209 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.455 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 4.3 pt-20 -54.08 -17.61 2.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.888 . . . . 0.0 109.735 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.49 -32.58 1.44 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.457 -0.777 . . . . 0.0 108.951 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.3 m -65.9 130.37 43.03 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.517 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -43.3 -29.42 0.41 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.333 -0.854 . . . . 0.0 109.893 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.542 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 2.9 t -104.73 143.11 33.55 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -107.91 126.48 52.73 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 122.279 1.038 . . . . 0.0 113.363 -178.077 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.679 HG12 HG13 ' A' ' 588' ' ' ILE . 22.9 mt -143.9 108.57 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.49 ' O ' HD13 ' A' ' 587' ' ' ILE . 1.5 pt-20 -96.0 104.2 16.13 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 118.197 -1.401 . . . . 0.0 108.718 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.479 ' CB ' ' CB ' ' A' ' 618' ' ' LEU . 1.3 m-20 -136.41 105.81 6.08 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.587 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . 0.402 ' OD1' ' CE2' ' A' ' 688' ' ' PHE . 16.2 p-10 -44.64 -40.41 5.83 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.657 -0.652 . . . . 0.0 111.734 -179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.4 -17.38 42.4 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.101 -0.999 . . . . 0.0 111.032 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.511 ' CD2' ' HA2' ' A' ' 604' ' ' GLY . 0.6 OUTLIER -81.03 139.25 35.86 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.305 -0.872 . . . . 0.0 110.555 -179.499 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.426 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.0 OUTLIER -73.95 158.87 33.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.392 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.728 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.2 mpt_? -63.31 -43.15 98.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.2 -0.938 . . . . 0.0 109.191 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.459 ' CG1' ' CG2' ' A' ' 727' ' ' VAL . 18.8 t -95.82 1.57 10.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.921 0.867 . . . . 0.0 109.693 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.747 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.2 t60 -28.1 -45.37 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.884 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.459 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.8 OUTLIER -137.46 145.88 43.62 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 117.959 -1.496 . . . . 0.0 112.191 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.524 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 4.5 p90 -146.35 142.05 27.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.605 -0.685 . . . . 0.0 110.088 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 73.8 mt -102.99 117.61 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.421 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 4.1 t80 -112.86 155.46 24.63 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.769 0.795 . . . . 0.0 110.17 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.44 ' O ' ' ND2' ' A' ' 599' ' ' ASN . 21.9 ttmt -119.34 137.92 53.39 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 121.525 0.679 . . . . 0.0 110.487 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.421 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -132.75 163.92 27.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.58 -0.7 . . . . 0.0 110.753 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.4 tpt85 -77.51 112.3 14.14 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.523 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.2 t60 -58.16 124.24 18.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.722 . . . . 0.0 110.887 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -111.04 92.66 4.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.736 -0.602 . . . . 0.0 109.956 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . 0.4 ' CG2' ' N ' ' A' ' 633' ' ' GLY . 7.4 p -53.33 169.69 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.497 -0.752 . . . . 0.0 110.355 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . 0.4 ' N ' ' CG2' ' A' ' 632' ' ' VAL . . . -64.28 83.29 0.06 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp 51.44 -175.24 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.313 -1.11 . . . . 0.0 110.544 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 78.5 p -164.37 69.31 0.17 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.268 -0.895 . . . . 0.0 110.383 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.91 36.93 1.25 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.284 -0.885 . . . . 0.0 110.017 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -168.96 -149.15 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.494 -0.753 . . . . 0.0 109.889 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -115.89 102.96 10.15 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.274 -0.891 . . . . 0.0 109.148 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 84.9 p -135.62 151.34 74.24 Favored Pre-proline 0 C--N 1.292 -1.896 0 O-C-N 121.933 -0.479 . . . . 0.0 110.05 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.28 -153.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.666 1.351 . . . . 0.0 110.074 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.402 ' O ' ' CD1' ' A' ' 644' ' ' LEU . . . 66.54 -60.06 0.34 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.769 -0.582 . . . . 0.0 110.785 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 57.41 -161.29 0.22 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.028 -1.045 . . . . 0.0 109.92 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . -113.62 128.59 8.39 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.513 ' HB2' ' CA ' ' A' ' 703' ' ' PHE . 5.3 mp -142.09 -152.78 0.43 Allowed 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.2 OUTLIER -118.39 123.96 46.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.097 -1.002 . . . . 0.0 110.905 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -105.4 156.54 18.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.433 -0.792 . . . . 0.0 109.742 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 18.1 pt -106.65 129.37 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.342 -0.849 . . . . 0.0 110.423 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.515 ' CE3' HD13 ' A' ' 671' ' ' LEU . 97.9 m95 -116.63 121.12 40.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.718 -0.614 . . . . 0.0 110.791 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.521 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 13.9 t80 -80.61 116.13 20.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 108.469 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 13.8 t -109.0 107.01 17.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 0.0 111.767 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.542 ' CB ' ' OG ' ' A' ' 657' ' ' SER . 11.9 t60 -70.51 161.67 30.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.568 -0.707 . . . . 0.0 109.812 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.747 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.94 -30.24 0.16 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.329 -0.857 . . . . 0.0 112.562 -179.191 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.585 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.13 -167.71 33.93 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 117.853 -2.118 . . . . 0.0 109.901 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 654' ' ' THR . . . . . 0.46 ' O ' HG13 ' A' ' 656' ' ' VAL . 5.6 m -89.6 -19.28 25.13 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -176.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.578 ' O ' HG22 ' A' ' 656' ' ' VAL . 89.7 m-20 -59.75 -2.86 0.42 Allowed 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.686 -1.258 . . . . 0.0 112.924 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 62.11 143.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.575 -0.703 . . . . 0.0 110.293 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.542 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -95.98 142.99 27.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.621 -0.675 . . . . 0.0 110.462 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.448 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 10.8 m-85 -129.03 126.13 38.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.923 . . . . 0.0 110.526 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.496 ' CD1' HG23 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -134.55 114.35 12.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.331 -0.856 . . . . 0.0 110.001 179.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.02 -85.79 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.439 -0.788 . . . . 0.0 110.494 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.6 p-10 -143.67 19.28 1.84 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.11 -0.994 . . . . 0.0 110.409 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.84 118.36 36.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.313 -0.867 . . . . 0.0 110.177 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.05 136.44 35.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.466 -0.772 . . . . 0.0 110.044 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.464 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 8.1 mmm -115.61 -168.2 1.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 0.0 109.997 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.413 ' CG1' ' CG2' ' A' ' 668' ' ' THR . 1.1 pt -143.38 -165.81 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.22 -0.925 . . . . 0.0 110.494 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -77.64 78.42 4.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.574 -0.704 . . . . 0.0 110.473 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.42 53.79 0.23 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -122.24 148.15 45.33 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.056 -1.261 . . . . 0.0 109.928 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 650' ' ' CYS . 2.8 tttt -108.4 138.75 44.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.524 -0.735 . . . . 0.0 109.574 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.461 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 0.7 OUTLIER -144.53 146.42 32.37 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.664 -178.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.515 HD13 ' CE3' ' A' ' 648' ' ' TRP . 13.5 tp -71.29 146.19 49.06 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.429 -0.794 . . . . 0.0 110.898 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.521 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 9.0 mt -117.78 107.74 14.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.415 -0.803 . . . . 0.0 111.06 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.4 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 81.3 mt-30 -84.86 153.41 22.92 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 706' ' ' GLY . 11.2 p-10 -50.42 141.97 11.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.072 -1.018 . . . . 0.0 109.947 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 71.87 45.97 39.98 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.94 90.49 3.32 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.855 -0.791 . . . . 0.0 110.198 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.797 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 5.3 tt0 -93.45 107.41 19.25 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.496 HG23 ' CD1' ' A' ' 659' ' ' LEU . 1.1 pt -111.44 137.77 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 121.446 0.641 . . . . 0.0 111.551 -177.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -95.13 110.83 22.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.486 -0.759 . . . . 0.0 109.258 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 57.0 mt -75.02 -23.92 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.232 -0.918 . . . . 0.0 110.517 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.422 HD13 ' HB2' ' A' ' 618' ' ' LEU . 7.1 mt -140.49 139.09 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.195 -0.941 . . . . 0.0 110.276 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -137.69 109.51 7.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.365 -0.834 . . . . 0.0 110.401 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.29 117.7 28.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.328 -0.858 . . . . 0.0 109.975 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -47.19 72.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.291 -0.881 . . . . 0.0 111.037 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -84.84 -43.56 14.04 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.259 -0.9 . . . . 0.0 110.849 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.63 -12.07 61.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.576 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm 52.14 25.36 3.22 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.242 -0.911 . . . . 0.0 110.314 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.448 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -93.06 79.43 4.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.374 -0.829 . . . . 0.0 109.764 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.41 ' O ' HG21 ' A' ' 689' ' ' VAL . 27.3 m -103.55 142.33 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.391 -0.818 . . . . 0.0 110.673 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.46 ' CD1' HG12 ' A' ' 587' ' ' ILE . 30.0 mm -116.6 164.34 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.456 -0.778 . . . . 0.0 109.03 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -173.58 124.19 1.03 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.316 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.797 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 15.0 m-85 -120.2 138.6 53.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.647 -0.913 . . . . 0.0 108.857 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -103.3 114.01 27.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.057 -1.027 . . . . 0.0 110.582 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -82.81 113.49 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -120.37 104.34 9.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.464 -0.772 . . . . 0.0 110.444 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 577' ' ' PHE . 87.6 mt -83.54 103.99 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 109.276 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -83.51 -45.29 13.75 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.482 -0.761 . . . . 0.0 109.211 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.447 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 4.8 m-20 -111.62 140.98 45.78 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.777 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 5.6 p -114.66 96.17 5.61 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 70.3 m -78.65 -92.64 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.883 -0.511 . . . . 0.0 110.84 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . -114.09 44.28 1.53 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 1.6 tp -90.72 145.72 24.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.587 -0.949 . . . . 0.0 110.436 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.555 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 2.5 p90 -53.35 -23.04 8.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.531 -0.731 . . . . 0.0 110.636 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.555 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.3 t30 -169.73 156.88 6.64 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.483 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 16.4 pt-20 -51.12 -25.37 5.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.218 -0.926 . . . . 0.0 110.281 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 118.43 16.66 5.51 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.412 ' N ' HD22 ' A' ' 704' ' ' ASN . 1.5 tp -82.63 9.32 9.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.088 -1.242 . . . . 0.0 111.616 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 114.6 -97.67 0.84 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.426 ' O ' ' CE ' ' A' ' 709' ' ' MET . 2.0 ttp 55.45 91.52 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.368 -1.078 . . . . 0.0 110.118 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 176.54 135.05 0.06 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.305 -0.872 . . . . 0.0 110.431 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -42.18 93.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.304 -0.872 . . . . 0.0 109.635 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -68.26 149.57 49.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.533 -0.729 . . . . 0.0 109.665 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 714' ' ' ARG . 1.4 tp-100 -107.18 95.33 5.64 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.193 -0.942 . . . . 0.0 109.518 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.461 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 4.1 mmm-85 35.05 80.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.945 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.412 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 27.7 m -107.89 151.77 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.447 -0.783 . . . . 0.0 109.431 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 78.9 t -89.31 133.42 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.185 -0.947 . . . . 0.0 110.498 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.9 mp -107.77 162.35 14.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 109.954 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.97 147.5 26.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 110.273 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -80.02 152.82 29.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.31 -0.869 . . . . 0.0 110.301 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 75.6 p -121.08 -177.54 3.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.273 -0.892 . . . . 0.0 110.364 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.99 -35.72 67.1 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.422 -0.799 . . . . 0.0 110.146 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . 0.421 ' O ' ' CD2' ' A' ' 726' ' ' LEU . 0.7 OUTLIER -65.36 -44.93 86.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 0.0 110.022 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.53 ' HA ' HD22 ' A' ' 726' ' ' LEU . 7.1 mt-10 -63.02 -48.73 77.51 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.441 -0.787 . . . . 0.0 109.984 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . 0.403 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 22.4 mtpp -63.04 -32.23 73.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.398 -0.813 . . . . 0.0 111.072 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -61.56 -50.81 71.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.247 -0.908 . . . . 0.0 112.46 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.53 HD22 ' HA ' ' A' ' 723' ' ' GLU . 0.4 OUTLIER -68.43 -32.73 72.97 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.732 -1.23 . . . . 0.0 110.803 -179.062 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . 0.459 ' CG2' ' CG1' ' A' ' 621' ' ' VAL . 12.6 p -83.87 -18.48 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.054 . . . . 0.0 110.073 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -53.34 -45.37 69.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 108.889 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.5 103.53 10.52 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.193 0.997 . . . . 0.0 109.021 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.422 HD23 ' CG ' ' A' ' 602' ' ' PHE . 1.6 mt . . . . . 0 C--N 1.273 -2.746 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.415 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -82.8 -9.21 59.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.334 -1.098 . . . . 0.0 110.475 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 127.64 -13.48 6.5 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -92.03 114.07 26.51 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.193 -1.18 . . . . 0.0 109.557 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.544 ' HB3' ' CA ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -91.02 -43.79 9.72 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.96 0.886 . . . . 0.0 108.898 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 9.0 tt -121.43 125.33 46.65 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.086 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 25.2 m -103.6 116.63 32.71 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.422 ' HG ' ' CD2' ' A' ' 578' ' ' LEU . 5.4 mt -91.49 112.25 24.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.558 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.1 OUTLIER -114.65 104.26 54.44 Favored Pre-proline 0 C--N 1.298 -1.645 0 C-N-CA 118.386 -1.326 . . . . 0.0 113.128 -177.268 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.103 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.4 Cg_endo -76.33 142.1 23.63 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 N-CA-C 105.221 -2.646 . . . . 0.0 105.221 174.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.747 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -125.97 -173.91 0.32 Allowed Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 117.916 -1.514 . . . . 0.0 113.87 -175.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.747 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.2 Cg_endo -66.41 -34.17 35.34 Favored 'Trans proline' 0 N--CA 1.487 1.142 0 O-C-N 124.169 1.615 . . . . 0.0 111.322 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.88 -30.63 67.91 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.61 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 88.9 p -97.74 153.49 18.23 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.518 ' CG2' HD12 ' A' ' 588' ' ' ILE . 1.0 OUTLIER -62.41 -9.75 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.982 -1.074 . . . . 0.0 109.969 179.21 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.566 HD13 ' HA ' ' A' ' 613' ' ' ILE . 10.1 mm -97.85 116.36 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.274 -0.891 . . . . 0.0 109.626 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.61 ' NE2' ' O ' ' A' ' 586' ' ' SER . 16.3 mp0 -118.53 71.87 0.85 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.659 -1.276 . . . . 0.0 109.713 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.103 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 42.5 mt-10 -144.48 174.63 10.77 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.941 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.558 ' HB3' ' HG2' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.54 128.27 40.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.005 -1.06 . . . . 0.0 109.487 176.483 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.485 ' N ' ' CD2' ' A' ' 592' ' ' LEU . 1.8 mm? -111.2 152.26 27.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.976 . . . . 0.0 109.343 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -124.7 110.77 14.79 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.517 -0.74 . . . . 0.0 110.578 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.47 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 40.6 mt -82.18 109.12 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.072 -1.018 . . . . 0.0 109.272 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -62.46 110.38 1.66 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.423 -0.798 . . . . 0.0 108.963 179.454 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.551 ' C ' ' O ' ' A' ' 595' ' ' GLN . 1.9 pt20 -19.11 85.4 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 121.396 0.617 . . . . 0.0 112.03 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 124.98 10.27 4.82 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.366 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.542 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -83.96 102.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-O 123.112 1.434 . . . . 0.0 107.57 178.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.2 OUTLIER -144.52 138.78 14.91 Favored Pre-proline 0 C--N 1.281 -2.384 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.808 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.569 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 51.9 Cg_endo -90.94 163.44 30.41 Favored 'Cis proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.564 -1.848 . . . . 0.0 108.817 -1.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.58 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 4.1 t80 -104.42 116.0 31.35 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.569 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 33.0 m-85 -83.82 144.17 29.45 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.478 -0.764 . . . . 0.0 110.303 -178.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.519 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 3.7 mt -142.19 142.12 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.653 -0.655 . . . . 0.0 110.036 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.759 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 168.43 -162.97 36.76 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.807 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 13.7 tpt180 -70.36 -42.4 71.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.768 -0.842 . . . . 0.0 110.863 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.83 123.34 26.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.742 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.436 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 14.3 tt0 -53.34 -17.77 2.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 110.247 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.47 -31.49 1.77 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.316 -0.865 . . . . 0.0 108.967 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.481 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.5 m -68.05 132.74 47.8 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.58 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.0 OUTLIER -46.77 -26.65 0.99 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.292 -0.88 . . . . 0.0 109.945 179.555 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.519 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 3.3 t -106.97 143.55 34.89 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.436 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -109.45 127.88 54.74 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 119.288 -0.965 . . . . 0.0 113.17 -178.363 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.566 ' HA ' HD13 ' A' ' 588' ' ' ILE . 29.3 mt -142.63 108.49 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -90.46 103.54 16.21 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 118.124 -1.43 . . . . 0.0 108.484 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 0.7 OUTLIER -139.15 106.11 5.43 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.692 178.163 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -43.68 -44.65 6.58 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.548 -0.72 . . . . 0.0 112.077 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.53 -17.33 42.2 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.168 -0.958 . . . . 0.0 111.855 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -76.46 122.31 24.35 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.037 -1.039 . . . . 0.0 110.506 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.408 ' CB ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -57.84 158.99 5.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.306 -0.871 . . . . 0.0 110.927 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.759 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -64.09 -45.17 89.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.222 -0.924 . . . . 0.0 109.366 179.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.453 ' O ' ' C ' ' A' ' 622' ' ' HIS . 4.3 t -95.33 1.78 10.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.892 0.853 . . . . 0.0 109.347 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.733 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.4 t60 -28.37 -46.38 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.645 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.8 OUTLIER -137.04 145.86 44.53 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 117.985 -1.486 . . . . 0.0 112.08 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.531 ' CZ ' ' CB ' ' A' ' 650' ' ' CYS . 9.7 p90 -145.91 139.63 26.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.791 -0.568 . . . . 0.0 109.554 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.415 HD11 ' CD1' ' A' ' 580' ' ' LEU . 82.7 mt -102.83 117.72 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.435 ' CE1' ' O ' ' A' ' 627' ' ' LYS . 6.6 t80 -109.97 154.75 22.7 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.734 0.778 . . . . 0.0 109.914 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.435 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 11.1 ttmt -118.47 136.12 53.98 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.573 0.702 . . . . 0.0 110.1 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.7 OUTLIER -129.75 163.54 25.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.659 -0.651 . . . . 0.0 110.238 -179.193 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.5 tpt180 -78.22 121.81 24.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.073 -1.017 . . . . 0.0 108.75 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.522 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 4.8 t60 -57.99 124.29 18.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.416 -0.803 . . . . 0.0 110.656 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -64.74 125.75 25.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.757 -0.589 . . . . 0.0 110.195 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.92 -163.52 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.372 -0.83 . . . . 0.0 109.958 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -169.07 -158.58 13.13 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -61.42 105.93 0.58 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.348 -1.089 . . . . 0.0 110.076 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.77 161.69 27.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.338 -0.851 . . . . 0.0 110.715 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 636' ' ' MET . . . . . 0.431 ' O ' ' O ' ' A' ' 637' ' ' TYR . 41.3 mmm -65.68 -132.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.709 -0.62 . . . . 0.0 109.525 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 636' ' ' MET . 33.2 p90 -58.05 -155.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.41 -0.806 . . . . 0.0 110.094 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -78.45 100.96 7.07 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.836 -1.165 . . . . 0.0 108.549 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 639' ' ' SER . . . . . 0.412 ' HB3' ' CE1' ' A' ' 637' ' ' TYR . 22.6 p -136.71 151.95 73.53 Favored Pre-proline 0 C--N 1.286 -2.188 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.911 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . 0.401 ' HB2' ' H ' ' A' ' 641' ' ' ALA . 46.1 Cg_endo -68.25 -151.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.634 1.334 . . . . 0.0 109.74 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.401 ' H ' ' HB2' ' A' ' 640' ' ' PRO . . . 61.24 17.56 8.32 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.383 -0.823 . . . . 0.0 110.456 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -74.07 60.96 0.8 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.24 -0.913 . . . . 0.0 109.994 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 63.05 114.07 0.01 OUTLIER Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.522 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 5.3 mp -141.29 -152.15 0.39 Allowed 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.8 m-20 -119.08 124.22 46.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.088 -1.007 . . . . 0.0 111.241 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 628' ' ' LYS . 18.2 t0 -101.84 156.18 17.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.597 -0.689 . . . . 0.0 109.57 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.446 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 11.7 pt -109.87 128.84 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.187 -0.945 . . . . 0.0 110.3 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.603 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 97.0 m95 -117.8 123.16 45.28 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.137 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.443 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 8.9 t80 -81.11 117.01 21.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.531 ' CB ' ' CZ ' ' A' ' 624' ' ' PHE . 89.0 m -109.14 103.3 12.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.972 . . . . 0.0 111.818 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.529 ' CD2' ' N ' ' A' ' 652' ' ' THR . 13.3 t60 -66.73 159.23 28.3 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.402 -0.811 . . . . 0.0 109.781 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.733 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -152.13 -28.85 0.17 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.38 -0.825 . . . . 0.0 113.008 -179.295 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.526 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.47 -167.91 32.51 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 117.678 -2.201 . . . . 0.0 109.535 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 654' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 656' ' ' VAL . 26.2 m -93.35 -18.76 22.03 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.964 -1.315 . . . . 0.0 113.818 -176.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.425 ' O ' ' CB ' ' A' ' 656' ' ' VAL . 23.9 m120 -59.43 -4.27 0.57 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.669 -1.27 . . . . 0.0 112.359 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.46 ' C ' ' CE1' ' A' ' 651' ' ' HIS . 3.1 t 69.76 147.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.655 -0.653 . . . . 0.0 110.343 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.489 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -101.69 149.42 24.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.698 -0.626 . . . . 0.0 110.686 -179.012 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -136.83 126.37 25.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 110.441 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.436 ' CD2' ' CG2' ' A' ' 678' ' ' ILE . 1.0 OUTLIER -128.13 106.72 9.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.394 -0.816 . . . . 0.0 109.79 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.0 t30 63.52 -74.22 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.525 -0.735 . . . . 0.0 110.593 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 659' ' ' LEU . 10.7 m120 -153.1 23.95 0.55 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.208 -0.933 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.67 120.99 43.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.304 -0.873 . . . . 0.0 110.238 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.65 131.07 34.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.412 -0.805 . . . . 0.0 110.002 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.411 ' CB ' ' OG ' ' A' ' 657' ' ' SER . 2.7 mtp -111.17 -165.25 0.97 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.413 -0.804 . . . . 0.0 110.424 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.404 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 2.1 pt -137.44 -164.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.378 -0.826 . . . . 0.0 110.324 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -80.79 82.35 6.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.374 -0.829 . . . . 0.0 110.522 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 120.43 55.59 0.24 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.2 OUTLIER -121.97 147.05 46.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.192 -1.181 . . . . 0.0 109.986 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.439 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 2.8 tttm -108.61 140.21 42.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.61 -0.681 . . . . 0.0 109.188 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.47 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 0.4 OUTLIER -144.31 142.89 30.71 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.101 -1.0 . . . . 0.0 111.418 -178.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.603 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -69.96 146.72 50.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.428 -0.795 . . . . 0.0 110.47 179.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.443 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 12.2 mt -119.08 108.98 15.38 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.148 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.421 ' CA ' ' O ' ' A' ' 706' ' ' GLY . 62.7 mt-30 -84.8 -176.98 6.46 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 706' ' ' GLY . 16.6 p-10 -73.03 141.85 47.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.192 -0.942 . . . . 0.0 109.538 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.33 47.48 43.43 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 107.596 -2.201 . . . . 0.0 107.596 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.28 91.81 4.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.956 -0.732 . . . . 0.0 110.302 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.974 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 2.4 tt0 -93.61 108.33 20.06 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.436 ' CG2' ' CD2' ' A' ' 659' ' ' LEU . 11.8 pt -105.69 137.66 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.644 -0.66 . . . . 0.0 111.868 -177.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -99.92 110.5 22.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.563 -0.711 . . . . 0.0 109.341 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 66.3 mt -81.92 -34.01 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.297 -0.877 . . . . 0.0 110.586 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.429 ' HB ' ' CG1' ' A' ' 690' ' ' ILE . 0.1 OUTLIER -126.9 136.12 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.325 -0.859 . . . . 0.0 109.587 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -137.66 118.64 14.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.249 -0.907 . . . . 0.0 110.659 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.99 117.83 20.67 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.282 -0.886 . . . . 0.0 110.055 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -47.36 71.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.412 -0.805 . . . . 0.0 111.408 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -84.72 -43.49 14.24 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.213 -0.929 . . . . 0.0 111.079 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.6 -7.69 55.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.308 -0.87 . . . . 0.0 110.742 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.93 19.51 3.64 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.117 -0.989 . . . . 0.0 110.364 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.83 86.86 5.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.242 -0.911 . . . . 0.0 109.102 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 681' ' ' ILE . 9.3 p -116.61 141.83 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.41 -0.806 . . . . 0.0 110.572 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.567 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 42.9 mm -118.95 164.35 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.338 -0.851 . . . . 0.0 109.653 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.459 ' N ' ' CB ' ' A' ' 586' ' ' SER . . . -175.31 126.09 1.14 Allowed Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.974 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 10.1 m-85 -119.5 137.3 53.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.56 -0.965 . . . . 0.0 108.674 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 12.4 tptt -97.91 113.8 25.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.225 -0.922 . . . . 0.0 110.459 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -85.27 112.53 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.42 104.67 9.23 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.168 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 577' ' ' PHE . 57.3 mt -79.54 103.21 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.376 -0.827 . . . . 0.0 109.576 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.2 -45.25 20.25 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 3.4 m-20 -111.12 141.56 44.47 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.735 -0.603 . . . . 0.0 109.895 178.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 20.6 p -113.95 95.79 5.49 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.96 133.52 52.99 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.026 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.41 26.05 28.93 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.426 HD21 ' CE1' ' A' ' 577' ' ' PHE . 0.2 OUTLIER -102.85 124.88 49.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.569 -0.96 . . . . 0.0 109.976 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.625 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 4.4 p90 -48.09 -24.56 1.14 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.384 -0.822 . . . . 0.0 110.197 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.625 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.9 OUTLIER -165.86 160.21 16.69 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.174 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.504 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 12.5 pt-20 -50.98 -27.48 7.79 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.09 -1.006 . . . . 0.0 109.993 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 123.66 12.59 4.5 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.445 ' N ' HD22 ' A' ' 704' ' ' ASN . 3.5 tp -85.25 8.66 17.65 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.843 -1.386 . . . . 0.0 111.516 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.421 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 39.46 88.91 0.01 OUTLIER Glycine 0 N--CA 1.499 2.888 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.03 51.86 0.76 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -1.166 . . . . 0.0 110.199 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . 0.424 ' CD1' ' HB2' ' A' ' 712' ' ' GLU . 0.5 OUTLIER -106.5 -165.75 1.12 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.36 -0.837 . . . . 0.0 110.707 -179.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -91.36 -41.76 10.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.43 -0.794 . . . . 0.0 110.998 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . 0.424 ' HB2' ' CD1' ' A' ' 710' ' ' LEU . 10.9 mm-40 -63.24 148.52 47.93 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.116 -0.99 . . . . 0.0 109.793 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -110.87 95.6 5.65 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.316 -0.865 . . . . 0.0 109.72 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.47 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER 41.07 84.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.287 0.565 . . . . 0.0 111.626 179.239 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.451 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 31.4 m -107.83 150.85 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 109.509 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.409 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 61.6 t -97.52 133.07 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.215 -0.928 . . . . 0.0 110.643 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.3 mp -110.12 162.51 14.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.498 -0.751 . . . . 0.0 109.85 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.18 145.32 28.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.195 -0.941 . . . . 0.0 110.17 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -80.64 150.21 29.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.33 -0.856 . . . . 0.0 110.18 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 17.0 p -113.73 -176.7 2.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.322 -0.861 . . . . 0.0 110.397 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.92 -32.99 55.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.385 -0.822 . . . . 0.0 110.364 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . 0.432 ' O ' ' CD2' ' A' ' 726' ' ' LEU . 2.7 tt0 -66.59 -46.74 74.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.353 -0.842 . . . . 0.0 109.977 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . 0.457 ' HA ' HD21 ' A' ' 726' ' ' LEU . 0.5 OUTLIER -62.78 -48.39 79.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.481 -0.762 . . . . 0.0 109.903 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . 0.401 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 8.5 tttp -62.96 -31.61 72.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.447 -0.783 . . . . 0.0 110.468 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.48 -50.45 73.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.372 -0.83 . . . . 0.0 112.238 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.457 HD21 ' HA ' ' A' ' 723' ' ' GLU . 0.3 OUTLIER -72.32 -36.32 68.83 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.921 -1.112 . . . . 0.0 111.415 -178.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . 0.434 ' CG2' ' CG1' ' A' ' 621' ' ' VAL . 7.2 p -81.31 -17.85 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.881 -1.137 . . . . 0.0 110.441 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -47.46 75.26 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.107 -0.996 . . . . 0.0 108.866 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.37 103.92 10.94 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.335 1.064 . . . . 0.0 109.01 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.419 HD21 ' CG ' ' A' ' 602' ' ' PHE . 1.8 mt . . . . . 0 C--N 1.273 -2.729 0 CA-C-O 117.984 -1.007 . . . . 0.0 110.366 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -85.88 5.88 30.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -1.11 . . . . 0.0 110.723 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 108.9 42.78 1.27 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -85.09 114.8 22.5 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.339 -1.095 . . . . 0.0 109.022 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.57 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.2 OUTLIER -102.65 -40.23 6.71 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.915 0.864 . . . . 0.0 109.502 -179.253 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 577' ' ' PHE . 9.8 tt -116.7 124.5 49.84 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.246 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 25.5 m -108.58 116.88 32.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -0.852 . . . . 0.0 109.944 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.418 ' CD1' ' CD1' ' A' ' 625' ' ' ILE . 1.8 mt -95.71 112.83 24.46 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.62 104.58 55.67 Favored Pre-proline 0 C--N 1.299 -1.612 0 C-N-CA 118.496 -1.282 . . . . 0.0 113.071 -177.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.035 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 44.8 Cg_endo -76.09 142.02 24.24 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 N-CA-C 106.295 -2.233 . . . . 0.0 106.295 175.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 1.057 ' HB2' ' HD2' ' A' ' 584' ' ' PRO . 0.2 OUTLIER -127.59 -171.69 0.24 Allowed Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 120.991 -1.068 . . . . 0.0 112.743 -176.276 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 1.057 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 36.4 Cg_endo -61.86 -31.29 85.0 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.859 1.452 . . . . 0.0 110.631 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -59.34 -26.62 65.2 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.481 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 19.1 t -96.56 153.38 17.88 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.526 HG21 ' HB2' ' A' ' 615' ' ' ASP . 13.8 tt -62.94 -15.89 16.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.703 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.69 ' HB ' ' HA ' ' A' ' 613' ' ' ILE . 1.0 OUTLIER -109.72 120.95 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.415 -0.803 . . . . 0.0 110.533 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 586' ' ' SER . 24.9 mp0 -107.25 79.94 1.36 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.578 -1.326 . . . . 0.0 108.728 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.035 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.6 mm-40 -141.52 176.61 8.75 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.36 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.552 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.38 127.21 42.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.31 -0.869 . . . . 0.0 108.859 176.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.45 HD11 ' HD3' ' A' ' 582' ' ' PRO . 0.6 OUTLIER -104.0 148.87 25.71 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.149 -0.97 . . . . 0.0 110.147 -179.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -124.68 109.99 13.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.488 -0.757 . . . . 0.0 110.658 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 44.2 mt -86.0 112.47 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 108.493 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.525 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -67.07 104.98 1.54 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.678 -0.638 . . . . 0.0 112.522 -177.67 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.525 ' C ' ' O ' ' A' ' 595' ' ' GLN . 0.0 OUTLIER 16.84 57.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 178.341 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 113.3 39.61 1.11 Allowed Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.592 -1.29 . . . . 0.0 111.197 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.497 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 1.2 t -79.82 103.58 6.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.43 ' OD1' ' O ' ' A' ' 599' ' ' ASN . 0.3 OUTLIER -141.37 140.16 20.21 Favored Pre-proline 0 C--N 1.282 -2.339 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.499 -178.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.446 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.2 Cg_endo -88.61 161.06 41.71 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.728 -2.197 . . . . 0.0 108.88 -0.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.1 t80 -106.35 116.17 31.47 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.695 ' C ' ' HB2' ' A' ' 609' ' ' CYS . 32.1 m-85 -92.35 144.59 25.23 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.29 -0.881 . . . . 0.0 110.702 -178.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.533 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -135.68 142.47 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.644 -0.66 . . . . 0.0 110.079 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.64 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 170.82 -168.67 41.77 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.737 -1.221 . . . . 0.0 110.783 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 13.9 mmm-85 -70.0 -44.95 68.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.69 -0.888 . . . . 0.0 110.673 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.495 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -75.01 119.63 19.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 110.125 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 608' ' ' ASP . 12.8 pt-20 -48.53 -18.9 0.28 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.316 -0.865 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 607' ' ' GLU . 0.9 OUTLIER -42.48 -37.87 1.75 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.321 -0.862 . . . . 0.0 109.318 179.101 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.695 ' HB2' ' C ' ' A' ' 602' ' ' PHE . 23.0 p -68.73 128.21 35.82 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.535 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -43.66 -24.6 0.13 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.562 -0.711 . . . . 0.0 111.897 -178.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.549 ' O ' ' SG ' ' A' ' 609' ' ' CYS . 9.0 t -108.57 142.64 38.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.351 -0.843 . . . . 0.0 109.593 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.493 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -113.53 130.61 56.31 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.909 -1.119 . . . . 0.0 112.584 -178.785 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.69 ' HA ' ' HB ' ' A' ' 588' ' ' ILE . 13.7 tt -145.09 109.26 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.426 ' O ' ' CG2' ' A' ' 587' ' ' ILE . 6.2 mm-40 -84.48 100.98 11.7 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 116.844 -1.942 . . . . 0.0 108.087 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.697 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 27.7 t0 -139.96 105.01 4.99 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.335 177.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.48 -67.96 0.18 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.506 -0.746 . . . . 0.0 112.746 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -16.58 25.62 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.174 -0.954 . . . . 0.0 111.839 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.697 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -72.84 124.32 25.16 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.077 -1.014 . . . . 0.0 111.02 -179.006 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.477 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -69.8 161.71 29.29 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.384 -0.823 . . . . 0.0 110.639 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.64 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 31.9 mtm105 -63.88 -45.17 90.58 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 122.087 0.946 . . . . 0.0 109.126 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.471 ' O ' ' C ' ' A' ' 622' ' ' HIS . 21.8 m -95.77 2.29 9.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 121.639 0.733 . . . . 0.0 109.422 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.755 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.3 t60 -29.86 -47.97 0.08 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.937 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.5 OUTLIER -136.82 144.93 43.92 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 118.492 -1.283 . . . . 0.0 110.964 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.529 ' CZ ' ' CB ' ' A' ' 650' ' ' CYS . 8.4 p90 -145.87 141.44 27.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.506 -0.746 . . . . 0.0 110.053 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 71.5 mt -103.41 118.7 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 9.0 t80 -108.89 154.98 21.36 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.533 -0.729 . . . . 0.0 109.463 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.409 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 8.4 tttt -119.25 136.62 54.14 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.571 0.701 . . . . 0.0 110.379 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.455 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.23 163.97 29.15 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.749 -0.595 . . . . 0.0 110.421 -179.219 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.0 OUTLIER -77.78 124.97 28.64 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.564 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER -57.62 123.91 17.24 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.897 0.856 . . . . 0.0 111.312 -177.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -80.1 111.49 16.5 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.332 0.587 . . . . 0.0 110.633 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.7 170.52 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.396 -0.815 . . . . 0.0 110.166 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -94.24 -167.91 37.25 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.06 129.12 40.22 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.295 -1.121 . . . . 0.0 110.086 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.76 84.6 0.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.308 -0.87 . . . . 0.0 110.543 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 6.3 tpp -63.08 126.09 26.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.321 -0.862 . . . . 0.0 109.667 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.4 -144.5 0.4 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.954 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.14 102.22 9.7 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.162 -0.961 . . . . 0.0 109.15 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 27.9 p -136.91 151.74 72.81 Favored Pre-proline 0 C--N 1.293 -1.884 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.85 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.67 -153.1 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.614 1.323 . . . . 0.0 109.729 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 50.72 23.35 1.35 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.468 -0.77 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -74.34 61.73 0.92 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.132 -0.98 . . . . 0.0 110.153 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 62.28 114.76 0.01 OUTLIER Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.525 ' HB2' ' CA ' ' A' ' 703' ' ' PHE . 5.1 mp -142.07 -151.16 0.35 Allowed 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.92 124.07 51.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.991 -1.068 . . . . 0.0 111.054 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -109.22 156.07 20.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.454 -0.779 . . . . 0.0 110.043 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 11.2 pt -111.06 128.92 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.271 -0.893 . . . . 0.0 109.633 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.491 ' CH2' ' CD2' ' A' ' 671' ' ' LEU . 99.0 m95 -114.29 120.09 39.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.724 -0.61 . . . . 0.0 111.539 -178.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.477 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 18.5 t80 -82.17 114.09 20.45 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.529 ' CB ' ' CZ ' ' A' ' 624' ' ' PHE . 62.2 m -109.54 102.27 11.14 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.145 -0.972 . . . . 0.0 111.399 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.613 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 12.1 t60 -69.0 160.39 31.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.461 -0.775 . . . . 0.0 109.918 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.755 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.37 -31.09 0.17 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.424 -0.797 . . . . 0.0 113.112 -178.888 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.613 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -78.53 134.91 14.77 Favored Glycine 0 N--CA 1.502 3.087 0 C-N-CA 117.801 -2.143 . . . . 0.0 110.253 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 654' ' ' THR . . . . . 0.448 ' O ' HG12 ' A' ' 656' ' ' VAL . 26.7 m -34.45 -24.87 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -177.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.532 ' O ' HG22 ' A' ' 656' ' ' VAL . 10.0 m120 -59.23 -3.02 0.34 Allowed 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.346 -1.472 . . . . 0.0 113.123 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 655' ' ' ASN . 0.8 OUTLIER 62.14 145.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.509 -0.745 . . . . 0.0 110.259 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.535 ' OG ' ' HB2' ' A' ' 664' ' ' MET . 0.0 OUTLIER -93.98 151.36 19.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.555 -0.716 . . . . 0.0 110.495 -179.199 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.454 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 14.5 m-85 -135.1 125.78 27.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 109.929 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.434 ' HG ' ' CG2' ' A' ' 678' ' ' ILE . 0.1 OUTLIER -134.56 113.94 12.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.25 -0.907 . . . . 0.0 110.18 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 54.19 -88.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.482 -0.761 . . . . 0.0 110.773 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.3 m120 -136.71 18.25 3.07 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.066 -1.021 . . . . 0.0 110.509 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -111.85 116.77 31.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.924 . . . . 0.0 110.444 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -94.08 138.19 32.43 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.475 -0.765 . . . . 0.0 109.815 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.535 ' HB2' ' OG ' ' A' ' 657' ' ' SER . 0.0 OUTLIER -117.08 -159.44 0.73 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.893 . . . . 0.0 109.884 -179.722 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . . . . . . . . . 1.7 pt -133.43 -171.69 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.246 -0.909 . . . . 0.0 110.372 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -74.27 70.06 1.62 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.351 -0.843 . . . . 0.0 110.452 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 133.13 55.77 0.08 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -123.09 150.57 43.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.255 -1.144 . . . . 0.0 110.307 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.41 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.1 ttpm? -108.84 146.66 33.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.579 -0.701 . . . . 0.0 109.178 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.458 ' CZ ' ' HD2' ' A' ' 714' ' ' ARG . 3.5 t80 -145.05 146.28 31.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 111.915 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.491 ' CD2' ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.68 130.55 42.66 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.546 -0.721 . . . . 0.0 109.497 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.477 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 1.7 mt -104.61 118.75 37.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.081 -1.012 . . . . 0.0 111.26 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.467 ' NE2' ' HA2' ' A' ' 708' ' ' GLY . 78.4 mt-30 -106.94 138.99 42.06 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 706' ' ' GLY . 6.2 p-10 -36.69 146.19 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.268 -0.895 . . . . 0.0 110.921 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 73.13 48.76 18.6 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . 0.401 ' OD2' ' N ' ' A' ' 673' ' ' GLN . 0.4 OUTLIER -106.77 92.54 4.14 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.839 -0.8 . . . . 0.0 110.883 -178.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.658 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.25 106.49 18.45 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.023 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.453 ' O ' ' HA2' ' A' ' 691' ' ' GLY . 5.0 pt -115.25 135.61 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.541 -0.724 . . . . 0.0 111.715 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.39 110.57 22.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.518 -0.739 . . . . 0.0 109.106 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.436 ' CG2' ' NE2' ' A' ' 622' ' ' HIS . 72.1 mt -72.4 -46.18 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.369 -0.832 . . . . 0.0 110.19 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.455 HG12 ' CB ' ' A' ' 655' ' ' ASN . 9.8 mt -126.81 133.59 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -0.845 . . . . 0.0 109.874 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -137.67 113.09 9.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 110.391 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -130.35 118.12 20.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.307 -0.87 . . . . 0.0 110.057 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -46.13 78.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.427 -0.796 . . . . 0.0 110.998 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.26 -43.02 82.91 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.31 -0.869 . . . . 0.0 110.75 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -90.47 -2.49 57.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.253 -0.904 . . . . 0.0 110.824 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.21 21.22 2.96 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.127 -0.983 . . . . 0.0 110.531 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.26 78.73 4.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.891 . . . . 0.0 109.084 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 39.5 t -101.69 131.47 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.557 -0.715 . . . . 0.0 110.682 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.438 HD13 HG22 ' A' ' 690' ' ' ILE . 49.7 mm -112.0 164.25 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.343 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 179.95 116.33 0.51 Allowed Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.417 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.658 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 12.1 m-85 -119.5 137.32 53.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.251 -1.146 . . . . 0.0 108.484 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -107.98 114.75 28.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 111.209 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.33 123.68 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.455 -0.778 . . . . 0.0 109.021 179.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -129.95 104.82 7.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.542 -0.724 . . . . 0.0 110.119 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 71.7 mt -84.35 103.95 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.366 -0.834 . . . . 0.0 109.851 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -81.78 -42.9 19.08 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.6 OUTLIER -110.7 140.29 45.21 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.682 -0.637 . . . . 0.0 110.249 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 6.6 p -114.7 96.09 5.56 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 4.6 p -97.07 105.42 17.56 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.298 0.57 . . . . 0.0 111.144 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 49.42 27.53 8.31 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.24 147.02 29.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.387 -1.066 . . . . 0.0 110.28 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.564 ' CD2' ' CE1' ' A' ' 630' ' ' HIS . 2.5 p90 -52.62 -23.55 6.73 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.43 -0.794 . . . . 0.0 110.292 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.555 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.6 t30 -175.9 155.14 1.59 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.438 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 16.1 pt-20 -51.43 -23.36 3.81 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.094 -1.004 . . . . 0.0 110.579 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 118.77 13.4 6.68 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 1.5 tp -83.96 9.97 10.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.193 -1.181 . . . . 0.0 111.345 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.467 ' HA2' ' NE2' ' A' ' 673' ' ' GLN . . . 94.95 -44.61 2.17 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.434 ' O ' ' HG ' ' A' ' 710' ' ' LEU . 1.1 ttm 62.75 149.77 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.384 -1.068 . . . . 0.0 110.515 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 709' ' ' MET . 0.7 OUTLIER 37.73 -155.66 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 CA-C-O 121.337 0.589 . . . . 0.0 111.769 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -94.14 72.22 3.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.515 -0.741 . . . . 0.0 109.46 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.32 148.27 48.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.497 -0.752 . . . . 0.0 110.694 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 715' ' ' VAL . 11.7 mt-30 -111.17 97.82 7.07 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.458 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 3.4 mmm-85 -64.68 68.11 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.434 0.635 . . . . 0.0 110.584 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.477 ' N ' ' O ' ' A' ' 713' ' ' GLN . 27.7 m -106.09 149.26 9.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . . . . . . . . . 89.3 t -78.63 133.12 30.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 111.041 -178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.35 162.2 13.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.519 -0.738 . . . . 0.0 109.782 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -100.11 152.95 19.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.943 . . . . 0.0 110.135 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -79.87 154.18 28.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.83 . . . . 0.0 110.263 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.6 p -120.29 -176.99 3.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.35 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.09 -28.95 56.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.318 -0.864 . . . . 0.0 110.241 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . 0.429 ' O ' HD13 ' A' ' 726' ' ' LEU . 0.0 OUTLIER -68.22 -52.51 33.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.49 -0.756 . . . . 0.0 110.077 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -63.44 -37.75 88.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.352 -0.843 . . . . 0.0 109.771 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -58.44 -32.47 68.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.408 -0.807 . . . . 0.0 109.816 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.0 -39.21 79.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.459 -0.775 . . . . 0.0 110.341 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . 0.429 HD13 ' O ' ' A' ' 722' ' ' GLU . 10.9 mp -55.75 -47.55 76.78 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.308 -0.87 . . . . 0.0 110.638 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.98 -22.16 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.069 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -54.73 -50.37 68.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 109.048 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -116.53 103.46 10.44 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 122.241 1.02 . . . . 0.0 109.341 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.273 -2.736 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.212 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -82.84 -10.03 59.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -1.08 . . . . 0.0 110.569 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 122.52 1.32 10.04 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -92.31 114.71 27.34 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.219 -1.165 . . . . 0.0 109.556 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.517 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 4.7 t80 -98.71 -42.77 7.07 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.953 0.882 . . . . 0.0 109.516 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 696' ' ' ILE . 49.6 tp -123.3 120.35 32.83 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.606 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 85.5 m -101.17 116.81 33.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.401 HD11 HD12 ' A' ' 625' ' ' ILE . 4.3 mt -88.45 112.58 23.11 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.07 101.56 54.54 Favored Pre-proline 0 C--N 1.301 -1.505 0 C-N-CA 117.911 -1.516 . . . . 0.0 113.01 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.156 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.1 Cg_endo -82.13 145.18 13.68 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 N-CA-C 106.017 -2.34 . . . . 0.0 106.017 173.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.684 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.33 -178.73 0.66 Allowed Pre-proline 0 N--CA 1.498 1.971 0 C-N-CA 118.207 -1.397 . . . . 0.0 114.166 -176.373 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.684 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.1 Cg_endo -67.6 -28.54 37.73 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 124.322 1.696 . . . . 0.0 111.965 -178.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -58.6 -30.96 67.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.681 -1.262 . . . . 0.0 107.609 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.483 ' HB3' ' N ' ' A' ' 691' ' ' GLY . 3.3 p -97.88 153.85 18.04 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.528 ' CG2' HD13 ' A' ' 588' ' ' ILE . 0.4 OUTLIER -57.17 -16.09 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.97 -1.081 . . . . 0.0 109.437 179.255 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.645 HD11 ' HA ' ' A' ' 613' ' ' ILE . 9.9 mm -97.1 114.59 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.285 -0.884 . . . . 0.0 108.739 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.531 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -126.75 73.96 1.44 Allowed 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.583 -1.323 . . . . 0.0 110.014 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.156 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 66.4 mm-40 -143.95 174.46 10.82 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.198 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.429 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.6 125.91 39.17 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.794 -1.191 . . . . 0.0 109.565 176.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.34 155.43 21.21 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.284 -0.885 . . . . 0.0 109.626 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -125.02 109.99 13.63 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.363 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 4.4 mt -81.98 109.65 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -53.01 174.47 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.504 -0.747 . . . . 0.0 109.952 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.517 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -62.0 65.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.47 -0.769 . . . . 0.0 110.854 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 125.62 34.16 0.67 Allowed Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.938 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.472 ' HB ' HG22 ' A' ' 594' ' ' ILE . 1.2 t -79.62 103.17 6.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.4 t30 -143.18 134.68 12.82 Favored Pre-proline 0 C--N 1.283 -2.315 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.172 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.5 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 55.8 Cg_endo -91.47 161.35 28.16 Favored 'Cis proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.614 -1.828 . . . . 0.0 109.158 -1.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 611' ' ' CYS . 5.8 t80 -107.08 116.65 32.3 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.725 ' C ' ' HB2' ' A' ' 609' ' ' CYS . 60.8 m-85 -89.63 144.98 25.57 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.375 -0.828 . . . . 0.0 110.786 -178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.541 HG12 ' CB ' ' A' ' 611' ' ' CYS . 3.2 mt -138.17 142.24 36.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.634 -0.666 . . . . 0.0 109.702 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 174.67 -161.24 30.84 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.415 -1.374 . . . . 0.0 111.111 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -76.26 -44.3 37.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.847 -0.796 . . . . 0.0 110.479 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.5 123.27 27.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.277 -0.889 . . . . 0.0 110.413 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 608' ' ' ASP . 10.1 pt-20 -48.18 -18.98 0.24 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.385 -0.822 . . . . 0.0 111.058 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 607' ' ' GLU . 2.2 t0 -40.76 -37.27 0.73 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.375 -0.828 . . . . 0.0 109.653 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.725 ' HB2' ' C ' ' A' ' 602' ' ' PHE . 18.0 p -73.43 133.6 43.76 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.473 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -44.58 -23.08 0.1 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.558 -0.713 . . . . 0.0 111.959 -178.691 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.541 ' CB ' HG12 ' A' ' 603' ' ' ILE . 10.7 t -110.08 143.63 39.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.316 -0.865 . . . . 0.0 109.743 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.7 125.61 52.09 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.003 -1.061 . . . . 0.0 113.122 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.645 ' HA ' HD11 ' A' ' 588' ' ' ILE . 10.7 mt -142.59 108.84 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -89.52 103.49 16.13 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 118.045 -1.462 . . . . 0.0 109.207 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 1.1 m-20 -139.37 106.45 5.46 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.348 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -43.15 -43.25 4.47 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.602 -0.686 . . . . 0.0 112.048 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -83.88 -17.52 40.57 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.017 -1.052 . . . . 0.0 111.905 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -77.27 133.96 38.68 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.056 -1.028 . . . . 0.0 110.834 -179.153 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.462 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.5 m -75.92 159.82 30.52 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.367 -0.833 . . . . 0.0 111.225 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.596 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 19.4 ttm105 -62.62 -44.48 96.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.361 -0.837 . . . . 0.0 109.219 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.464 ' O ' ' C ' ' A' ' 622' ' ' HIS . 27.4 m -94.65 1.81 9.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 121.761 0.791 . . . . 0.0 109.358 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.8 t60 -30.81 -48.22 0.11 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.718 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.443 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.5 OUTLIER -136.5 144.89 44.56 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.579 -1.249 . . . . 0.0 110.826 178.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.502 ' HA ' HG13 ' A' ' 603' ' ' ILE . 17.1 p90 -146.29 145.84 30.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.543 -0.723 . . . . 0.0 110.163 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 8.7 mt -103.2 122.37 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.413 ' HB2' ' HE2' ' A' ' 624' ' ' PHE . 3.5 t80 -117.63 154.9 30.79 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.543 -0.723 . . . . 0.0 109.462 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 10.1 tttt -119.72 136.19 54.53 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.77 0.795 . . . . 0.0 111.023 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.72 163.5 28.86 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -78.3 126.3 30.59 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.818 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -65.06 125.1 23.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.399 -0.813 . . . . 0.0 110.749 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -119.41 140.14 50.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.594 -0.691 . . . . 0.0 110.327 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 14.6 p -118.39 174.09 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.366 -0.834 . . . . 0.0 110.172 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -108.9 113.79 3.85 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 10.4 tttt 56.17 102.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.39 -1.065 . . . . 0.0 110.584 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.33 95.19 9.56 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.364 -0.835 . . . . 0.0 110.105 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 4.5 ttm -63.4 125.08 22.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.38 -0.825 . . . . 0.0 109.968 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 1.5 t80 63.64 -144.8 0.32 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.363 -0.836 . . . . 0.0 110.26 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -113.26 102.8 10.69 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 122.013 0.911 . . . . 0.0 109.172 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 67.9 p -135.73 152.04 75.32 Favored Pre-proline 0 C--N 1.291 -1.95 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.695 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.95 -152.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.67 1.353 . . . . 0.0 109.856 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 52.85 22.43 2.36 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.371 -0.83 . . . . 0.0 110.636 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -105.61 57.83 0.67 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -0.898 . . . . 0.0 110.148 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 109.1 14.13 15.83 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.606 ' CD1' ' O ' ' A' ' 701' ' ' GLY . 3.0 mm? -65.87 -153.87 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.339 0 O-C-N 122.221 -0.576 . . . . 0.0 110.144 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.54 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 4.5 m-20 -130.19 132.53 46.06 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.035 -1.041 . . . . 0.0 111.306 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -127.26 143.24 51.28 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.229 -0.92 . . . . 0.0 110.538 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 12.7 pt -96.96 134.45 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.261 -0.9 . . . . 0.0 109.926 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.675 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.3 m95 -119.18 120.87 38.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.571 -0.706 . . . . 0.0 111.313 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.451 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 4.0 t80 -80.84 114.25 19.59 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 624' ' ' PHE . 38.5 m -108.57 108.62 19.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 111.117 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.587 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 12.1 t60 -74.21 161.7 29.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.572 -0.705 . . . . 0.0 110.362 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -151.11 -31.57 0.17 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.587 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -79.41 130.89 10.18 Favored Glycine 0 N--CA 1.501 2.983 0 O-C-N 119.232 -2.167 . . . . 0.0 110.342 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 654' ' ' THR . . . . . 0.433 ' C ' ' H ' ' A' ' 656' ' ' VAL . 11.4 m -36.54 -24.24 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -177.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 656' ' ' VAL . 4.1 t-20 -56.01 -4.74 0.13 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.325 -1.484 . . . . 0.0 112.775 -178.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.504 ' O ' ' CE1' ' A' ' 651' ' ' HIS . 0.4 OUTLIER 77.69 166.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 CA-C-O 122.043 0.925 . . . . 0.0 110.734 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.479 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -126.84 150.9 48.99 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.045 -178.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -135.75 126.4 27.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.396 -0.815 . . . . 0.0 110.23 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.478 ' HG ' HG21 ' A' ' 678' ' ' ILE . 0.4 OUTLIER -127.36 108.95 11.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.305 -0.872 . . . . 0.0 109.679 179.487 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.9 m120 58.79 -81.34 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.426 -0.796 . . . . 0.0 110.195 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.9 OUTLIER -143.78 22.66 1.78 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.069 -1.019 . . . . 0.0 110.439 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -116.57 128.17 55.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.195 -0.941 . . . . 0.0 110.395 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -91.46 141.32 28.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.393 -0.817 . . . . 0.0 110.176 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.405 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 3.5 mtp -120.28 -172.96 2.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.401 -0.812 . . . . 0.0 110.208 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.424 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 1.1 pp -126.09 -169.94 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -0.87 . . . . 0.0 110.24 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -76.8 72.44 3.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.334 -0.854 . . . . 0.0 110.748 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 129.12 55.65 0.1 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -122.17 151.76 40.64 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.281 -1.129 . . . . 0.0 110.296 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.452 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -108.85 139.03 44.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.264 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.455 ' CD1' ' CD1' ' A' ' 659' ' ' LEU . 8.5 t80 -143.56 146.36 33.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 111.268 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.675 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -73.88 146.98 43.66 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.614 -0.679 . . . . 0.0 110.778 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.451 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 10.2 mt -115.71 114.34 24.7 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.285 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 10.1 mt-30 -97.04 148.76 22.67 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.0 135.19 25.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.044 -1.035 . . . . 0.0 110.087 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 83.77 45.57 6.34 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 107.686 -2.166 . . . . 0.0 107.686 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.85 93.5 4.53 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.802 -0.822 . . . . 0.0 110.444 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.815 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 4.6 tt0 -93.35 107.47 19.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.478 HG21 ' HG ' ' A' ' 659' ' ' LEU . 4.1 pt -112.43 138.04 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.564 -0.71 . . . . 0.0 112.38 -176.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.22 113.58 26.76 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 85.0 mt -76.83 -30.66 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.172 -0.955 . . . . 0.0 110.51 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 618' ' ' LEU . 4.0 mt -138.64 134.93 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.269 -0.894 . . . . 0.0 110.047 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -137.38 108.84 6.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.539 -0.726 . . . . 0.0 110.104 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.59 118.39 33.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.32 -0.862 . . . . 0.0 110.221 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.04 -46.64 77.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.425 -0.797 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -84.6 -43.37 14.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.32 -0.863 . . . . 0.0 110.763 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -76.21 -10.09 59.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.333 -0.854 . . . . 0.0 110.662 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.76 20.2 4.95 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.111 -0.993 . . . . 0.0 110.433 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.3 75.15 9.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -0.885 . . . . 0.0 109.354 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 10.8 p -103.16 131.65 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.387 -0.821 . . . . 0.0 111.054 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.429 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 36.3 mm -113.3 163.67 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.429 -0.795 . . . . 0.0 109.168 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.483 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . -167.79 120.29 0.89 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.198 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.815 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 7.7 m-85 -120.41 137.78 54.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.519 -0.989 . . . . 0.0 109.115 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -110.36 114.77 28.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.404 -0.81 . . . . 0.0 110.757 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.41 ' O ' ' CG1' ' A' ' 694' ' ' VAL . 0.8 OUTLIER -75.67 119.97 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.478 -0.763 . . . . 0.0 109.084 179.227 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -129.68 103.95 7.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.438 -0.789 . . . . 0.0 110.143 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 60.0 mt -86.97 111.4 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -0.799 . . . . 0.0 109.734 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -81.28 -43.26 19.41 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.491 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.5 m-20 -111.65 140.56 46.18 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.555 0.693 . . . . 0.0 110.61 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 699' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 700' ' ' THR . 25.0 p -115.62 96.77 5.78 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 700' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 699' ' ' THR . 9.0 t -60.0 -147.52 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.138 0.494 . . . . 0.0 110.248 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 644' ' ' LEU . . . -67.86 -1.17 16.79 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.431 HD13 ' CE2' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -47.03 144.46 2.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.287 -1.125 . . . . 0.0 111.15 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.533 ' HB3' ' CB ' ' A' ' 644' ' ' LEU . 50.7 p90 -53.53 -27.62 26.85 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.137 0.97 . . . . 0.0 108.803 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.515 ' ND2' ' HG2' ' A' ' 705' ' ' GLU . 24.4 t30 -174.68 173.53 2.82 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.515 ' HG2' ' ND2' ' A' ' 704' ' ' ASN . 8.2 pt-20 -51.07 -40.93 59.48 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.098 -1.001 . . . . 0.0 110.191 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 149.83 37.92 0.04 OUTLIER Glycine 0 N--CA 1.498 2.796 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.971 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . 0.505 ' HB2' ' ND2' ' A' ' 704' ' ' ASN . 6.6 mp -86.0 9.24 17.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.043 -1.269 . . . . 0.0 111.448 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 64.88 -79.23 0.06 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.414 ' N ' ' O ' ' A' ' 707' ' ' LEU . 69.2 mtm 54.53 60.51 3.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.432 -1.04 . . . . 0.0 110.419 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.03 -160.78 1.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.358 -0.839 . . . . 0.0 110.136 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -65.08 -26.97 68.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.338 -0.851 . . . . 0.0 110.325 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -97.6 146.87 24.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.354 -0.841 . . . . 0.0 110.265 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -111.71 96.16 5.92 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.283 -0.886 . . . . 0.0 109.381 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 15.9 mmm-85 48.85 67.04 0.93 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.286 0.565 . . . . 0.0 110.865 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.0 m -107.74 152.48 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.441 -0.787 . . . . 0.0 109.494 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.428 HG23 ' CD2' ' A' ' 670' ' ' PHE . 57.7 t -89.4 121.5 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.16 -0.962 . . . . 0.0 110.543 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.1 mp -96.1 161.89 13.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.426 -0.796 . . . . 0.0 109.846 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.68 153.66 17.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.375 -0.828 . . . . 0.0 109.841 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -87.16 125.06 33.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.318 -0.864 . . . . 0.0 110.38 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 39.7 p -93.15 -176.31 4.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.376 -0.828 . . . . 0.0 110.124 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.44 -28.91 32.75 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.326 -0.859 . . . . 0.0 110.207 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.1 -52.17 63.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.377 -0.827 . . . . 0.0 109.858 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -48.65 75.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 0.0 109.975 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . 0.404 ' O ' ' CG1' ' A' ' 727' ' ' VAL . 5.7 tttp -53.74 -32.17 51.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.386 -0.822 . . . . 0.0 110.123 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.28 -36.17 78.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.87 . . . . 0.0 110.242 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 42.1 mt -59.46 -46.33 89.09 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.346 -0.846 . . . . 0.0 110.245 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . 0.404 ' CG2' ' HB ' ' A' ' 621' ' ' VAL . 7.1 p -71.77 -22.2 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.145 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.26 -47.69 68.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.895 . . . . 0.0 108.937 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -116.87 104.28 11.15 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.151 0.977 . . . . 0.0 109.235 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.274 -2.69 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.252 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -82.93 -9.99 59.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -1.074 . . . . 0.0 110.62 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 110.87 29.34 3.59 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . 0.409 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.1 OUTLIER -92.56 114.38 26.92 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.337 -1.096 . . . . 0.0 109.515 179.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.502 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 3.4 t80 -106.29 -43.17 4.86 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.974 0.892 . . . . 0.0 109.46 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.439 ' HB2' ' CD1' ' A' ' 577' ' ' PHE . 31.4 tp -120.66 142.42 49.47 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.968 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 42.5 m -125.76 116.87 22.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.503 -0.748 . . . . 0.0 109.39 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 3.5 mt -95.13 112.08 23.83 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.404 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 1.6 mmtt -108.62 102.78 49.05 Favored Pre-proline 0 C--N 1.3 -1.586 0 C-N-CA 118.4 -1.32 . . . . 0.0 112.408 -177.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.062 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.8 Cg_endo -79.08 142.69 17.35 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 N-CA-C 106.547 -2.136 . . . . 0.0 106.547 175.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.782 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -128.05 -171.08 0.23 Allowed Pre-proline 0 C--N 1.297 -1.693 0 C-N-CA 118.501 -1.279 . . . . 0.0 112.79 -177.056 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.782 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 37.2 Cg_endo -63.58 -35.09 61.32 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 124.068 1.562 . . . . 0.0 110.815 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.99 -28.73 66.63 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.585 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 46.0 t -96.53 153.45 17.84 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.439 HG21 ' CD1' ' A' ' 690' ' ' ILE . 6.1 tp -63.53 -12.98 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.384 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.771 ' CG1' ' HA ' ' A' ' 613' ' ' ILE . 31.3 mm -100.97 120.29 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.369 -0.832 . . . . 0.0 109.838 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . 0.585 ' NE2' ' O ' ' A' ' 586' ' ' SER . 23.6 mp0 -115.98 68.27 0.72 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.55 -1.344 . . . . 0.0 109.307 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.062 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.5 mm-40 -143.97 176.85 8.98 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.593 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.502 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.19 125.77 41.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.194 -0.941 . . . . 0.0 108.859 176.576 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 1.9 mt -106.51 153.78 21.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.362 -0.836 . . . . 0.0 109.661 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.409 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 6.5 mp0 -125.99 110.12 13.22 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.308 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.507 HG22 ' HB ' ' A' ' 598' ' ' VAL . 1.7 mt -84.18 109.58 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.124 -0.985 . . . . 0.0 108.353 178.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.8 OUTLIER -51.66 172.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.655 -0.653 . . . . 0.0 109.869 -179.622 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.502 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 4.2 mt-30 -66.55 65.31 0.05 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.477 -0.764 . . . . 0.0 110.086 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 135.09 27.19 0.48 Allowed Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.611 -1.28 . . . . 0.0 110.988 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.507 ' HB ' HG22 ' A' ' 594' ' ' ILE . 0.9 OUTLIER -80.08 102.23 5.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.392 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 627' ' ' LYS . 14.2 t-20 -144.3 133.45 11.33 Favored Pre-proline 0 C--N 1.282 -2.341 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.367 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.655 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 55.2 Cg_endo -91.96 162.86 26.92 Favored 'Cis proline' 0 C--N 1.311 -1.442 0 C-N-CA 123.086 -1.631 . . . . 0.0 108.891 -2.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.528 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 5.5 t80 -105.97 116.42 31.91 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.655 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 73.8 m-85 -84.96 144.83 28.07 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.323 -0.861 . . . . 0.0 110.977 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' ' 611' ' ' CYS . 2.8 mt -142.19 141.62 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.724 -0.61 . . . . 0.0 110.291 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.802 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 167.88 -167.58 40.16 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.331 -1.414 . . . . 0.0 111.306 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 8.0 tpt180 -63.01 -36.34 83.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.889 -0.771 . . . . 0.0 111.774 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.22 121.62 28.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.043 -1.036 . . . . 0.0 111.246 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.548 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 7.0 tm-20 -53.11 -19.06 2.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 110.02 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.55 -30.24 2.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.347 -0.846 . . . . 0.0 109.292 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 602' ' ' PHE . 4.7 m -69.06 136.37 52.25 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.489 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -47.82 -25.09 1.16 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.276 -0.89 . . . . 0.0 110.056 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.552 ' HB3' ' CG2' ' A' ' 603' ' ' ILE . 4.0 t -110.52 143.32 41.06 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.599 ' O ' HG13 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -106.93 127.23 53.26 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.099 -1.001 . . . . 0.0 112.682 -178.694 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.771 ' HA ' ' CG1' ' A' ' 588' ' ' ILE . 2.3 mt -144.01 108.99 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 605' ' ' ARG . 3.1 tt0 -97.79 104.48 16.51 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.302 -1.359 . . . . 0.0 108.916 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.542 ' HA ' ' CZ ' ' A' ' 688' ' ' PHE . 6.1 m-20 -138.41 106.1 5.61 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.531 177.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -43.32 -42.3 4.44 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.671 -0.643 . . . . 0.0 111.953 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -83.09 -17.16 44.08 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.096 -1.002 . . . . 0.0 111.098 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.493 ' CD2' ' HA2' ' A' ' 604' ' ' GLY . 0.5 OUTLIER -79.74 140.4 36.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.25 -0.906 . . . . 0.0 110.677 -179.335 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.418 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.89 161.83 28.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.274 -0.891 . . . . 0.0 110.794 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.802 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -64.22 -45.24 89.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.337 -0.852 . . . . 0.0 109.534 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.469 ' O ' ' C ' ' A' ' 622' ' ' HIS . 11.5 t -95.76 2.22 9.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.383 -0.823 . . . . 0.0 109.405 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.8 t60 -26.05 -47.12 0.02 OUTLIER 'General case' 0 C--O 1.194 -1.831 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.46 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.8 OUTLIER -137.69 146.09 43.38 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 118.049 -1.46 . . . . 0.0 111.955 179.528 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.536 ' HA ' HG13 ' A' ' 603' ' ' ILE . 2.0 p90 -145.3 148.91 33.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.6 -0.688 . . . . 0.0 109.984 177.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 13.8 mt -103.72 124.41 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 6.0 t80 -117.32 155.24 29.87 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.481 -0.762 . . . . 0.0 109.386 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 4.3 tppt? -119.73 137.06 54.17 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.604 0.716 . . . . 0.0 110.896 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -139.09 163.07 33.39 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.719 -0.613 . . . . 0.0 109.641 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -78.5 121.24 24.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.974 -1.079 . . . . 0.0 109.314 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.522 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.0 t60 -63.26 123.82 19.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 111.07 -178.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -96.63 98.17 9.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.615 -0.678 . . . . 0.0 109.941 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 6.3 p -57.34 168.29 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.41 -0.806 . . . . 0.0 110.323 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -75.2 89.63 0.8 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 51.3 -164.04 0.06 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.355 -1.085 . . . . 0.0 110.48 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 89.6 p -167.69 58.9 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.392 -0.817 . . . . 0.0 110.356 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 1.7 mtm -97.31 33.28 2.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.24 -0.912 . . . . 0.0 109.798 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -160.43 -154.94 0.4 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -115.61 101.85 9.23 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.062 -1.024 . . . . 0.0 108.975 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 77.8 p -136.98 151.43 72.11 Favored Pre-proline 0 C--N 1.294 -1.847 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.956 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . 0.412 ' O ' ' N ' ' A' ' 642' ' ' GLN . 48.5 Cg_endo -70.0 -152.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.664 1.349 . . . . 0.0 109.912 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . 0.411 ' HA ' ' CD1' ' A' ' 644' ' ' LEU . . . 66.77 -65.37 0.21 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.693 -0.63 . . . . 0.0 110.413 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 640' ' ' PRO . 8.4 tt0 48.93 31.28 3.15 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.28 -0.887 . . . . 0.0 110.325 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 70.01 120.6 0.04 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.568 ' CD1' ' HA ' ' A' ' 703' ' ' PHE . 2.9 mt -138.55 -150.72 0.35 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 122.185 -0.597 . . . . 0.0 109.393 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.0 OUTLIER -112.83 124.9 53.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.963 -1.085 . . . . 0.0 111.061 -179.592 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.416 ' OD2' ' CZ2' ' A' ' 648' ' ' TRP . 37.6 t0 -112.72 143.63 43.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 0.0 110.188 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 8.5 pt -99.39 132.36 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.259 -0.9 . . . . 0.0 109.663 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.611 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.2 m95 -118.12 142.95 46.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.527 -0.733 . . . . 0.0 110.918 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.474 ' N ' ' CD1' ' A' ' 672' ' ' LEU . 27.0 t80 -103.24 114.81 29.39 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.5 OUTLIER -104.06 102.63 12.38 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.641 -178.531 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.526 ' CD2' ' N ' ' A' ' 652' ' ' THR . 8.7 t60 -64.2 156.63 28.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.345 -0.847 . . . . 0.0 109.294 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -149.55 -28.22 0.26 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.364 -0.835 . . . . 0.0 112.543 -179.122 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.579 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.51 -163.82 27.26 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 117.943 -2.075 . . . . 0.0 109.724 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 654' ' ' THR . . . . . 0.448 ' O ' HG13 ' A' ' 656' ' ' VAL . 25.2 m -96.93 -17.99 19.76 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.961 -1.317 . . . . 0.0 113.921 -176.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.579 ' O ' HG22 ' A' ' 656' ' ' VAL . 20.3 m120 -59.6 -2.96 0.4 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.774 -1.204 . . . . 0.0 112.591 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 63.38 138.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-O 121.69 0.757 . . . . 0.0 110.161 -179.332 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.449 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -91.48 142.73 27.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.653 -0.655 . . . . 0.0 110.685 -178.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.466 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 6.1 m-85 -132.42 126.55 33.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.354 -0.841 . . . . 0.0 110.496 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.479 ' CD1' HG21 ' A' ' 678' ' ' ILE . 0.0 OUTLIER -130.97 115.38 16.42 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.366 -0.834 . . . . 0.0 109.955 179.515 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.08 -81.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.391 -0.818 . . . . 0.0 110.343 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.7 OUTLIER -148.36 26.87 0.94 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.0 110.157 179.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -111.21 133.52 53.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.234 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . 0.407 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 6.5 tmm_? -98.71 126.66 44.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.372 -0.83 . . . . 0.0 110.102 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.449 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 4.4 mtp -108.06 -167.73 1.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 110.345 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.415 ' O ' ' CD2' ' A' ' 651' ' ' HIS . 1.7 pt -138.43 -164.22 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.352 -0.842 . . . . 0.0 110.279 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 652' ' ' THR . 51.5 tt0 -79.81 82.27 5.93 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.49 -0.756 . . . . 0.0 110.505 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.07 52.19 0.24 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.3 OUTLIER -121.15 148.3 44.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.018 -1.284 . . . . 0.0 110.111 179.678 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 650' ' ' CYS . 1.3 ttpm? -108.31 141.34 40.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.492 -0.755 . . . . 0.0 109.456 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.44 ' CE1' ' O ' ' A' ' 715' ' ' VAL . 0.5 OUTLIER -144.42 146.72 32.65 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.49 -178.828 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.611 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -71.31 147.17 48.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.511 -0.743 . . . . 0.0 111.197 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.474 ' CD1' ' N ' ' A' ' 649' ' ' TYR . 3.0 mp -113.45 104.98 12.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.637 -0.664 . . . . 0.0 111.5 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.411 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 88.6 mt-30 -88.47 151.04 22.81 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 706' ' ' GLY . 2.8 p30 -48.22 143.83 4.3 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.162 -0.961 . . . . 0.0 110.377 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.96 46.29 52.83 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 107.841 -2.104 . . . . 0.0 107.841 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . 0.425 ' CB ' ' HB ' ' A' ' 694' ' ' VAL . 0.2 OUTLIER -100.38 88.94 3.8 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.795 -0.826 . . . . 0.0 110.512 -179.14 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.777 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -93.41 107.08 18.98 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.397 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.479 HG21 ' CD1' ' A' ' 659' ' ' LEU . 1.8 pt -115.12 137.95 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.631 -0.668 . . . . 0.0 111.737 -176.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 7.2 mttp -96.89 111.23 23.52 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . 0.412 ' CD1' ' CD1' ' A' ' 613' ' ' ILE . 73.1 mt -77.32 -11.76 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.299 -0.875 . . . . 0.0 110.64 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.484 HG21 ' O ' ' A' ' 688' ' ' PHE . 14.4 tt -143.2 133.87 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.074 -1.016 . . . . 0.0 110.158 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -138.11 111.69 8.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.149 -0.969 . . . . 0.0 110.738 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.3 117.15 19.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.233 -0.917 . . . . 0.0 109.86 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -46.93 72.71 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.361 -0.837 . . . . 0.0 110.954 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -66.94 -38.82 86.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.219 -0.925 . . . . 0.0 109.947 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . 0.58 ' O ' ' C ' ' A' ' 687' ' ' LYS . 1.5 m-80 -122.07 84.27 2.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.586 -0.696 . . . . 0.0 109.551 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . 0.58 ' C ' ' O ' ' A' ' 686' ' ' ASN . 23.4 mmtp -19.74 -82.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 122.054 -0.404 . . . . 0.0 111.335 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.542 ' CZ ' ' HA ' ' A' ' 615' ' ' ASP . 1.3 t80 33.8 73.41 0.07 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.504 -0.747 . . . . 0.0 110.099 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 586' ' ' SER . 58.6 t -112.21 143.14 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.459 -0.775 . . . . 0.0 111.49 -178.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.466 HG12 ' CG2' ' A' ' 681' ' ' ILE . 16.1 mm -103.46 164.65 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.453 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -177.12 115.8 0.52 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.001 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.777 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 12.8 m-85 -119.92 137.49 54.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -1.042 . . . . 0.0 109.138 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -101.5 114.75 29.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 110.593 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . 0.425 ' HB ' ' CB ' ' A' ' 676' ' ' ASP . 1.2 t -82.43 121.48 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.578 -0.701 . . . . 0.0 109.169 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.12 104.83 7.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.711 -0.618 . . . . 0.0 110.172 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 19.9 mt -80.91 104.43 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 0.0 109.935 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -72.78 -43.08 63.25 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.306 -0.872 . . . . 0.0 108.973 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.452 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 6.5 m-20 -110.68 140.75 44.76 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.618 0.723 . . . . 0.0 110.741 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 28.6 p -115.43 96.06 5.47 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 39.3 p -126.5 131.63 51.58 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.642 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 51.15 35.85 34.6 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . 0.45 ' O ' HD13 ' A' ' 644' ' ' LEU . 5.3 tp -108.99 132.96 53.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.451 -1.029 . . . . 0.0 111.036 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.615 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 3.3 p90 -48.47 -25.02 1.47 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.644 0.735 . . . . 0.0 110.301 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.615 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.1 t30 -173.46 154.72 2.65 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.439 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 15.9 pt-20 -51.02 -26.06 5.61 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.095 -1.003 . . . . 0.0 110.475 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 118.92 18.22 4.78 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.85 9.19 10.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.012 -1.287 . . . . 0.0 111.33 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 64.61 87.12 0.05 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.96 38.67 3.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.347 -1.09 . . . . 0.0 110.382 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.92 166.81 10.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.364 -0.835 . . . . 0.0 110.158 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -58.93 -52.87 63.89 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.308 -0.87 . . . . 0.0 110.16 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.8 148.68 48.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.496 -0.752 . . . . 0.0 109.917 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -110.9 95.71 5.72 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.232 -0.917 . . . . 0.0 109.283 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.425 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.1 OUTLIER 43.6 75.9 0.09 Allowed 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.269 0.557 . . . . 0.0 111.389 179.701 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.44 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 31.9 m -107.25 150.1 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 109.214 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.449 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 85.1 t -95.45 133.16 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 110.729 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.2 mp -108.86 162.34 14.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.42 -0.8 . . . . 0.0 110.094 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.17 154.61 17.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.36 -0.838 . . . . 0.0 110.1 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.62 148.02 31.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.304 -0.872 . . . . 0.0 110.406 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 11.1 p -121.35 -176.2 3.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.379 -0.826 . . . . 0.0 110.384 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.44 -29.2 34.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.369 -0.832 . . . . 0.0 110.002 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -66.05 -45.45 81.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.421 -0.799 . . . . 0.0 109.523 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.95 -46.91 79.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.47 -0.769 . . . . 0.0 109.62 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . 0.403 ' O ' ' CG1' ' A' ' 727' ' ' VAL . 9.1 tttt -53.53 -32.64 51.37 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.427 -0.795 . . . . 0.0 109.746 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.59 -35.94 78.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.527 -0.733 . . . . 0.0 110.33 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 34.4 mt -58.92 -46.84 86.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.274 -0.891 . . . . 0.0 110.305 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . 0.403 ' CG1' ' O ' ' A' ' 724' ' ' LYS . 7.5 p -70.8 -19.87 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.557 -0.715 . . . . 0.0 110.264 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.0 -43.51 66.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.265 -0.897 . . . . 0.0 108.956 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.94 103.52 10.37 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 122.222 1.01 . . . . 0.0 109.191 177.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.4 ' O ' ' CD2' ' A' ' 602' ' ' PHE . 1.2 mt . . . . . 0 C--N 1.273 -2.74 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.344 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.76 -1.336 . . . . 4.67 109.76 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.36 -10.3 59.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -1.214 . . . . 4.68 109.874 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . 0.629 ' O ' ' N ' ' A' ' 596' ' ' GLN . . . 132.53 -4.93 5.19 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 110.167 -1.173 . . . . 1.34 110.167 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -91.4 115.15 27.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.853 -1.38 . . . . 1.95 109.387 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 577' ' ' PHE . . . . . 0.581 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -115.5 -42.1 3.18 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.053 0.93 . . . . 1.35 109.241 -179.178 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.581 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 9.4 tt -120.45 128.79 53.49 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.872 -0.603 . . . . 1.85 110.749 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 61.7 m -104.36 116.83 32.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 1.01 109.704 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 580' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 592' ' ' LEU . 4.1 mt -92.11 112.6 24.6 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.843 -1.169 . . . . 1.63 107.843 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 581' ' ' LYS . . . . . 0.443 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 1.0 OUTLIER -113.5 102.77 55.18 Favored Pre-proline 0 C--N 1.301 -1.502 0 C-N-CA 118.337 -1.345 . . . . 1.43 112.565 -178.089 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 582' ' ' PRO . . . . . 1.067 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.7 Cg_endo -77.49 143.11 21.47 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 N-CA-C 105.83 -2.411 . . . . 0.28 105.83 174.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 583' ' ' LEU . . . . . 0.705 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.41 -177.53 0.52 Allowed Pre-proline 0 N--CA 1.497 1.909 0 C-N-CA 118.181 -1.408 . . . . 1.73 113.848 -176.233 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 584' ' ' PRO . . . . . 0.705 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.6 Cg_endo -66.96 -34.83 28.24 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 124.253 1.659 . . . . 0.59 111.75 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -58.25 -29.32 65.68 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.173 -1.417 . . . . 1.42 107.173 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 586' ' ' SER . . . . . 0.53 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 3.0 t -95.92 150.8 20.04 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.396 -0.964 . . . . 1.31 108.396 177.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 587' ' ' ILE . . . . . 0.521 ' CG2' HD13 ' A' ' 588' ' ' ILE . 0.5 OUTLIER -57.52 -15.98 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.994 -1.066 . . . . 1.78 109.428 179.457 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 588' ' ' ILE . . . . . 0.725 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 8.1 mm -98.49 114.67 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.388 -0.82 . . . . 2.21 109.153 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.65 69.29 0.97 Allowed 'General case' 0 N--CA 1.507 2.395 0 O-C-N 120.711 -1.243 . . . . 1.7 109.512 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . 1.067 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 27.6 mt-10 -142.74 176.04 9.35 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.132 -0.94 . . . . 2.13 109.004 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.518 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.73 123.67 35.92 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.791 -1.193 . . . . 0.85 109.926 177.382 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 580' ' ' LEU . 1.8 mt -112.07 155.52 23.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.457 -0.777 . . . . 1.85 109.37 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -126.99 113.87 17.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 1.67 111.501 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 594' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' A' ' 578' ' ' LEU . 4.1 mt -72.13 109.36 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.98 -1.075 . . . . 1.17 108.31 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 595' ' ' GLN . . . . . 0.58 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -61.52 107.95 0.88 Allowed 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.601 -0.687 . . . . 1.92 110.738 -178.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 596' ' ' GLN . . . . . 0.629 ' N ' ' O ' ' A' ' 575' ' ' GLY . 3.5 tt0 -11.52 87.29 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.298 0.571 . . . . 1.86 112.253 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 597' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 105.87 22.1 8.2 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.668 -1.373 . . . . 1.37 109.668 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 598' ' ' VAL . . . . . 0.484 ' O ' ' CG1' ' A' ' 598' ' ' VAL . 1.2 t -82.28 103.59 9.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 107.074 -1.454 . . . . 1.23 107.074 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 599' ' ' ASN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 627' ' ' LYS . 7.9 t30 -143.17 134.2 12.57 Favored Pre-proline 0 C--N 1.281 -2.403 0 CA-C-N 114.549 -1.205 . . . . 1.52 110.19 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 600' ' ' PRO . . . . . 0.648 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 54.9 Cg_endo -91.56 162.26 28.1 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.804 -1.748 . . . . 0.38 109.334 -1.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 601' ' ' PHE . . . . . 0.586 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 5.1 t80 -106.28 117.21 33.45 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.363 -1.347 . . . . 0.32 107.363 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 602' ' ' PHE . . . . . 0.653 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 56.3 m-85 -88.71 146.04 25.29 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.378 -0.826 . . . . 0.64 110.939 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 603' ' ' ILE . . . . . 0.579 HG12 ' CB ' ' A' ' 611' ' ' CYS . 2.9 mt -141.76 139.72 31.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.965 -0.694 . . . . 1.07 109.962 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.696 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 174.82 -166.81 38.74 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.505 -1.331 . . . . 0.26 110.977 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 605' ' ' ARG . . . . . 0.426 ' HD2' ' HA ' ' A' ' 614' ' ' GLU . 14.8 tpt180 -65.4 -38.83 91.14 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.858 -0.79 . . . . 1.87 110.591 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 606' ' ' SER . . . . . 0.413 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 1.0 OUTLIER -81.04 122.32 27.16 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.323 -0.861 . . . . 1.16 110.862 -179.351 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.509 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.1 OUTLIER -57.73 -15.2 7.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 2.39 109.79 178.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.09 -36.19 5.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.502 -0.749 . . . . 1.72 110.068 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 609' ' ' CYS . . . . . 0.653 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 73.6 m -67.41 152.71 45.21 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.552 -0.859 . . . . 1.26 109.451 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 610' ' ' ASN . . . . . 0.535 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.2 OUTLIER -57.06 -14.35 3.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.46 -0.775 . . . . 1.87 110.473 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 611' ' ' CYS . . . . . 0.579 ' CB ' HG12 ' A' ' 603' ' ' ILE . 8.7 t -120.08 144.21 47.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.398 -0.814 . . . . 0.91 109.804 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 612' ' ' LYS . . . . . 0.509 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -110.46 120.06 41.21 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 122.158 0.98 . . . . 2.66 113.29 -178.117 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 613' ' ' ILE . . . . . 0.725 ' HA ' ' CD1' ' A' ' 588' ' ' ILE . 14.1 mt -142.8 107.92 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 107.36 -1.348 . . . . 1.21 107.36 176.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 614' ' ' GLU . . . . . 0.435 ' H ' ' CD1' ' A' ' 588' ' ' ILE . 6.0 tt0 -92.45 104.4 16.73 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.98 1.371 . . . . 2.28 109.664 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 615' ' ' ASP . . . . . 0.557 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 1.8 m-20 -138.4 106.06 5.61 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.074 -1.421 . . . . 1.39 107.971 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -39.65 -44.27 1.48 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.617 -0.677 . . . . 2.23 112.131 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.78 -17.32 41.52 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.093 -1.005 . . . . 3.46 111.672 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.8 OUTLIER -78.04 119.28 21.24 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.019 -1.051 . . . . 1.16 110.768 -179.137 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 619' ' ' SER . . . . . 0.453 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -59.18 159.86 7.04 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.4 -0.813 . . . . 1.36 110.809 179.852 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 620' ' ' ARG . . . . . 0.696 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -63.91 -45.39 89.53 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.32 -0.862 . . . . 2.83 109.183 179.521 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 621' ' ' VAL . . . . . 0.466 ' O ' ' C ' ' A' ' 622' ' ' HIS . 10.5 m -95.06 1.84 9.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.355 -0.84 . . . . 1.75 109.469 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 6.3 t60 -28.87 -46.79 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.622 -0.717 . . . . 0.25 110.875 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . 0.426 ' O ' ' N ' ' A' ' 603' ' ' ILE . 0.6 OUTLIER -136.45 145.77 45.58 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.45 -1.3 . . . . 0.91 110.777 178.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 624' ' ' PHE . . . . . 0.558 ' HA ' HG13 ' A' ' 603' ' ' ILE . 3.1 p90 -144.72 149.58 35.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.458 -0.776 . . . . 0.75 110.219 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 625' ' ' ILE . . . . . 0.586 ' HB ' ' HB3' ' A' ' 601' ' ' PHE . 69.2 mt -104.54 121.75 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.765 -0.828 . . . . 1.32 108.765 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 626' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 4.5 t80 -115.27 153.96 29.95 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.52 -0.737 . . . . 1.17 109.439 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 627' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 1.2 ttmt -120.12 137.08 54.35 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.578 0.704 . . . . 1.63 110.501 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . 0.42 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.57 163.32 29.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.594 -0.691 . . . . 2.49 110.321 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 629' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.5 OUTLIER -78.32 115.08 17.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.95 . . . . 2.64 108.74 179.82 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 630' ' ' HIS . . . . . 0.538 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.9 t60 -58.7 124.52 20.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.505 -0.747 . . . . 0.78 110.846 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -93.2 102.98 15.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.673 -0.642 . . . . 1.59 110.016 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.23 170.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.395 -0.816 . . . . 2.45 110.403 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -91.72 58.69 2.93 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.89 -1.284 . . . . 3.01 109.89 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 72.3 tttt 57.49 107.41 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.412 -1.052 . . . . 6.58 110.646 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 79.6 p -90.91 94.49 9.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.91 . . . . 4.44 110.142 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 2.8 mtt -90.8 44.35 1.19 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.25 -0.907 . . . . 7.63 110.214 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.09 -151.87 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.826 -0.805 . . . . 7.67 108.826 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -108.86 98.87 8.29 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.99 -1.069 . . . . 5.16 108.311 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 25.0 p -139.57 152.04 67.82 Favored Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 115.799 -0.637 . . . . 3.0 109.839 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.43 -152.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.554 1.291 . . . . 2.8 108.988 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 50.03 24.81 1.47 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.417 -0.802 . . . . 1.95 110.997 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -68.8 64.62 0.12 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.274 -0.891 . . . . 3.98 110.152 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 62.4 110.44 0.01 OUTLIER Glycine 0 N--CA 1.487 2.061 0 N-CA-C 110.244 -1.142 . . . . 1.44 110.244 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 644' ' ' LEU . . . . . 0.481 ' HB2' ' CA ' ' A' ' 703' ' ' PHE . 5.0 mp -139.53 -153.77 0.48 Allowed 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.97 -0.752 . . . . 1.86 108.97 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -112.54 123.97 51.48 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.974 -1.079 . . . . 1.54 111.276 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 646' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 628' ' ' LYS . 26.5 t70 -109.57 146.8 34.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.513 -0.742 . . . . 1.2 109.665 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 647' ' ' ILE . . . . . 0.46 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 12.5 pt -102.49 130.66 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.279 -0.888 . . . . 1.11 110.039 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 648' ' ' TRP . . . . . 0.606 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 91.3 m95 -118.58 119.71 35.31 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.092 -0.643 . . . . 0.35 110.754 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.459 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 3.8 t80 -80.93 114.69 19.98 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.366 -0.975 . . . . 0.97 108.366 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 650' ' ' CYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.1 OUTLIER -106.35 114.29 28.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.909 . . . . 1.51 111.564 -178.608 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.527 ' CE1' ' C ' ' A' ' 656' ' ' VAL . 17.2 t60 -74.04 159.92 32.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.451 -0.781 . . . . 0.36 109.975 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -149.96 -30.59 0.22 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.403 -0.81 . . . . 1.1 112.968 -179.158 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 653' ' ' GLY . . . . . 0.562 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.03 -167.73 30.93 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 117.579 -2.248 . . . . 0.72 109.416 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 24.3 m -94.94 -17.85 21.62 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.968 -1.313 . . . . 1.16 113.91 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 655' ' ' ASN . . . . . 0.458 ' O ' ' CB ' ' A' ' 656' ' ' VAL . 30.5 m120 -60.85 -4.29 0.96 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.774 -1.204 . . . . 1.79 112.398 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.527 ' C ' ' CE1' ' A' ' 651' ' ' HIS . 0.4 OUTLIER 75.45 166.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-O 121.95 0.881 . . . . 2.06 110.648 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 657' ' ' SER . . . . . 0.42 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -123.73 145.51 48.96 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.162 -0.615 . . . . 0.41 110.585 -178.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.434 ' CE1' ' CG ' ' A' ' 663' ' ' ARG . 15.7 m-85 -135.64 126.32 27.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.272 -0.893 . . . . 1.39 110.615 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.51 ' CD1' HG21 ' A' ' 678' ' ' ILE . 0.2 OUTLIER -128.2 109.85 11.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.273 -0.892 . . . . 2.0 109.927 179.231 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.77 -80.34 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.484 -0.76 . . . . 2.02 110.358 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 661' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.4 m-20 -146.13 25.21 1.27 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.25 -0.906 . . . . 2.88 110.307 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.03 117.95 30.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.284 -0.885 . . . . 1.86 110.285 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 663' ' ' ARG . . . . . 0.434 ' CG ' ' CE1' ' A' ' 658' ' ' TYR . 3.0 tmm_? -84.39 141.06 31.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 3.05 110.098 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 664' ' ' MET . . . . . 0.418 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 3.5 mtp -118.89 -166.12 1.21 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.279 -0.888 . . . . 1.1 110.294 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 665' ' ' ILE . . . . . 0.418 ' CG1' ' CG2' ' A' ' 668' ' ' THR . 1.4 pt -138.34 -160.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.225 -0.922 . . . . 1.22 110.365 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -81.65 90.43 6.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.398 -0.814 . . . . 1.05 110.564 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.07 50.43 0.68 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.021 -1.232 . . . . 0.43 110.021 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 668' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -117.61 149.43 40.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.113 -1.227 . . . . 1.05 110.13 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.42 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 10.8 tttt -108.39 141.01 40.87 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.985 -0.746 . . . . 1.3 108.985 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . 0.439 ' CD1' HG23 ' A' ' 716' ' ' VAL . 13.5 t80 -143.96 146.29 32.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.148 -0.97 . . . . 1.73 111.665 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 671' ' ' LEU . . . . . 0.606 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -73.08 147.26 45.14 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.626 -0.671 . . . . 1.98 110.621 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 672' ' ' LEU . . . . . 0.459 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 12.8 mt -118.56 112.83 20.39 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.672 -0.811 . . . . 1.55 111.306 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 673' ' ' GLN . . . . . 0.428 ' NE2' ' HA3' ' A' ' 708' ' ' GLY . 75.2 mt-30 -90.25 -177.43 5.12 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.044 -0.725 . . . . 1.28 109.044 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 674' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 706' ' ' GLY . 14.9 p-10 -76.26 142.83 41.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.138 -0.976 . . . . 1.21 109.691 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.34 47.2 59.48 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 107.788 -2.125 . . . . 0.3 107.788 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.45 91.93 4.92 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.748 -0.854 . . . . 1.33 110.491 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.908 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.3 tt0 -93.16 107.42 19.23 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.76 -1.2 . . . . 1.79 107.76 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 678' ' ' ILE . . . . . 0.51 HG21 ' CD1' ' A' ' 659' ' ' LEU . 1.4 pt -111.73 137.74 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.419 0.628 . . . . 1.58 111.667 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -98.95 111.01 23.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.515 -0.741 . . . . 2.9 109.4 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 680' ' ' ILE . . . . . . . . . . . . . 72.8 mt -75.35 -24.11 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 1.04 110.352 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 681' ' ' ILE . . . . . 0.471 ' CD1' ' HB2' ' A' ' 618' ' ' LEU . 3.6 mt -143.02 136.15 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -0.942 . . . . 1.84 110.394 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -137.49 108.91 6.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.435 -0.79 . . . . 1.24 110.109 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.36 118.36 29.27 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.265 -0.897 . . . . 1.43 110.221 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -65.99 -46.35 78.31 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.423 -0.798 . . . . 2.71 110.887 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -80.4 -43.31 21.25 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.252 -0.905 . . . . 2.46 110.68 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.74 -13.8 58.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.306 -0.871 . . . . 2.85 110.471 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 57.23 18.95 4.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.221 -0.925 . . . . 3.12 110.56 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 688' ' ' PHE . . . . . 0.414 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -74.66 77.98 2.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 1.88 109.034 179.252 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 689' ' ' VAL . . . . . . . . . . . . . 43.5 t -101.63 136.15 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.82 . . . . 2.04 110.881 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 690' ' ' ILE . . . . . 0.447 ' CD1' ' CG2' ' A' ' 587' ' ' ILE . 47.1 mm -117.5 163.26 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.738 -0.838 . . . . 1.49 108.738 178.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 691' ' ' GLY . . . . . 0.53 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -172.98 125.39 1.14 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.511 -1.328 . . . . 0.29 109.932 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 692' ' ' PHE . . . . . 0.908 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 6.9 m-85 -120.63 137.71 54.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.603 -0.939 . . . . 0.32 109.484 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -100.67 113.71 26.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.13 -0.981 . . . . 2.84 110.031 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 694' ' ' VAL . . . . . . . . . . . . . 1.2 t -85.45 115.03 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.365 -0.835 . . . . 1.11 108.884 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -122.55 103.92 9.02 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.136 -0.626 . . . . 1.66 109.923 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 696' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 705' ' ' GLU . 74.0 mt -77.23 103.95 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.4 -0.812 . . . . 1.14 109.113 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.21 -43.51 28.26 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.355 -0.841 . . . . 1.14 108.808 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 698' ' ' ASP . . . . . 0.42 ' O ' ' HD1' ' A' ' 577' ' ' PHE . 8.0 m-20 -111.33 141.81 44.38 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.543 0.687 . . . . 1.19 110.612 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 27.1 p -115.27 96.1 5.5 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.164 -1.421 . . . . 1.13 107.164 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 6.7 m -127.43 132.63 50.04 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.305 0.574 . . . . 2.15 111.077 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 50.4 25.99 9.19 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.135 -1.186 . . . . 1.33 110.135 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 702' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.23 134.87 44.81 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.283 -1.128 . . . . 1.84 110.239 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 703' ' ' PHE . . . . . 0.623 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 3.4 p90 -49.47 -24.28 1.96 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.627 -0.67 . . . . 0.86 110.673 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 704' ' ' ASN . . . . . 0.623 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER -169.63 157.75 7.27 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.531 -0.731 . . . . 0.99 109.031 -178.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.535 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 15.4 pt-20 -51.48 -26.5 8.37 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.201 -0.937 . . . . 1.58 110.458 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 706' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 120.95 15.72 4.68 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.433 -1.467 . . . . 1.09 109.433 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 707' ' ' LEU . . . . . . . . . . . . . 1.6 tp -82.73 9.16 10.26 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.005 -1.291 . . . . 2.22 111.622 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 708' ' ' GLY . . . . . 0.428 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 66.61 43.56 91.82 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.866 -0.894 . . . . 2.05 110.866 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 709' ' ' MET . . . . . 0.417 ' HG2' ' CG ' ' A' ' 704' ' ' ASN . 0.0 OUTLIER -83.29 101.62 11.4 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.05 -1.264 . . . . 2.19 110.073 179.299 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -172.78 -170.11 0.64 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.064 -1.022 . . . . 3.78 110.347 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -90.9 -45.65 8.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.342 -0.849 . . . . 4.26 110.412 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -63.61 143.81 57.52 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.254 -0.904 . . . . 3.46 110.031 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -111.68 95.51 5.54 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.217 -0.927 . . . . 3.75 109.73 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 714' ' ' ARG . . . . . 0.412 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 0.8 OUTLIER 39.91 83.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.238 0.542 . . . . 1.6 111.691 179.346 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.86 153.1 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.553 -0.717 . . . . 1.26 109.522 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 716' ' ' VAL . . . . . 0.439 HG23 ' CD1' ' A' ' 670' ' ' PHE . 48.1 t -96.52 133.33 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.121 -0.987 . . . . 1.3 110.581 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.9 mp -109.5 162.66 14.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.478 -0.764 . . . . 1.46 109.94 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -99.16 149.05 23.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.971 . . . . 2.93 110.045 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.92 150.13 30.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.829 . . . . 2.45 110.248 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 21.8 p -116.42 -176.48 2.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 1.19 110.277 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.58 -28.96 35.07 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.337 -0.852 . . . . 1.23 110.163 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.63 -47.88 71.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.385 -0.822 . . . . 2.33 109.779 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -64.21 -48.61 75.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.417 -0.802 . . . . 1.95 110.056 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -52.61 -33.19 45.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.389 -0.819 . . . . 2.93 109.795 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -68.39 -35.91 78.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.528 -0.732 . . . . 1.6 109.911 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 42.7 mt -55.95 -46.54 78.54 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.395 -0.816 . . . . 1.79 110.018 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 727' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.01 -21.01 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.606 -0.683 . . . . 1.67 110.351 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -52.9 -43.09 65.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.238 -0.914 . . . . 2.96 108.857 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -116.8 103.67 10.56 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.292 1.044 . . . . 3.07 109.138 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 730' ' ' LEU . . . . . 0.41 ' O ' ' CE2' ' A' ' 602' ' ' PHE . 4.3 mt . . . . . 0 C--N 1.274 -2.687 0 CA-C-O 118.017 -0.992 . . . . 1.25 110.38 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.546 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 0.5 OUTLIER -150.92 -40.8 0.12 Allowed 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.045 0.926 . . . . 0.0 108.795 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.646 ' CD2' HD12 ' A' ' 594' ' ' ILE . 16.1 tp -130.69 119.59 22.63 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.335 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 88.7 m -102.66 118.3 36.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.141 -0.974 . . . . 0.0 109.434 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.636 HD11 HD12 ' A' ' 625' ' ' ILE . 15.3 mt -91.16 112.02 23.74 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.431 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -114.24 101.56 54.18 Favored Pre-proline 0 C--N 1.302 -1.473 0 C-N-CA 118.131 -1.428 . . . . 0.0 112.843 -177.663 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 1.131 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.2 Cg_endo -79.6 144.24 17.51 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 N-CA-C 105.788 -2.428 . . . . 0.0 105.788 174.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.709 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -123.48 -178.3 0.64 Allowed Pre-proline 0 N--CA 1.498 1.927 0 C-N-CA 118.214 -1.394 . . . . 0.0 114.082 -175.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.709 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.5 Cg_endo -67.6 -31.81 32.39 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 124.272 1.67 . . . . 0.0 111.375 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.79 -30.72 67.8 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.558 ' OG ' HD12 ' A' ' 583' ' ' LEU . 4.0 p -97.43 153.41 18.13 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.652 HD12 ' O ' ' A' ' 614' ' ' GLU . 4.7 pt -56.69 -17.15 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 109.637 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.759 HD12 ' HA ' ' A' ' 613' ' ' ILE . 7.0 mm -99.61 114.96 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.318 -0.864 . . . . 0.0 108.7 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.487 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 3.4 pm0 -126.12 73.0 1.33 Allowed 'General case' 0 N--CA 1.508 2.443 0 O-C-N 120.653 -1.28 . . . . 0.0 110.587 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 1.131 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 49.6 mt-10 -143.04 174.7 10.45 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.521 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.32 126.34 40.59 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.589 -1.319 . . . . 0.0 109.752 176.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.825 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.1 mt -110.7 156.0 21.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 0.0 109.28 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -125.2 110.04 13.59 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.427 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.646 HD12 ' CD2' ' A' ' 578' ' ' LEU . 29.3 mt -80.28 108.39 13.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.406 ' O ' ' C ' ' A' ' 596' ' ' GLN . 3.8 mt-30 -70.99 120.67 16.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.507 -0.746 . . . . 0.0 111.261 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.546 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 6.0 mm100 37.77 33.72 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.409 0.624 . . . . 0.0 111.035 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . 80.15 65.07 1.78 Allowed Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.654 ' O ' HG13 ' A' ' 598' ' ' VAL . 10.9 p -79.69 105.07 8.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.42 ' CB ' ' HB3' ' A' ' 627' ' ' LYS . 3.8 p-10 -121.72 150.9 56.43 Favored Pre-proline 0 C--N 1.28 -2.454 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.694 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.476 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.6 Cg_endo -86.68 157.46 51.63 Favored 'Cis proline' 0 C--N 1.308 -1.602 0 C-N-CA 121.075 -2.469 . . . . 0.0 109.511 0.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.481 ' CD2' ' HB2' ' A' ' 611' ' ' CYS . 3.0 t80 -106.25 116.11 31.37 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.561 ' HB3' ' SG ' ' A' ' 609' ' ' CYS . 60.6 m-85 -87.89 144.33 26.63 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.311 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.948 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.8 mt -141.02 142.12 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.742 -0.599 . . . . 0.0 110.602 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.784 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 170.37 -159.05 31.27 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.912 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 14.1 tpt180 -71.37 -47.24 57.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.819 -0.812 . . . . 0.0 110.957 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.88 126.97 31.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 110.808 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.554 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.2 OUTLIER -56.76 -15.54 4.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.832 . . . . 0.0 110.439 179.507 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -45.73 -35.94 4.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.251 -0.906 . . . . 0.0 109.125 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 602' ' ' PHE . 1.3 m -62.78 136.65 57.97 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.475 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -49.86 -25.51 3.22 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.307 -0.87 . . . . 0.0 109.628 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.948 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.1 t -109.03 143.57 38.16 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -110.48 128.55 55.67 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 122.198 0.999 . . . . 0.0 113.101 -178.256 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.759 ' HA ' HD12 ' A' ' 588' ' ' ILE . 13.0 mt -142.39 108.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.652 ' O ' HD12 ' A' ' 587' ' ' ILE . 1.4 tt0 -89.68 102.46 15.15 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 117.838 -1.545 . . . . 0.0 107.796 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.823 ' HB3' ' CB ' ' A' ' 618' ' ' LEU . 9.9 t0 -139.93 106.39 5.31 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.57 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -38.67 -65.86 0.32 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.579 -0.701 . . . . 0.0 112.747 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.72 -16.51 64.29 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.117 -0.99 . . . . 0.0 112.455 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.823 ' CB ' ' HB3' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -73.19 129.44 38.05 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.0 -1.062 . . . . 0.0 110.87 -179.035 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.405 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -66.8 160.89 24.94 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.287 -0.883 . . . . 0.0 110.818 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.784 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.7 mtt180 -64.43 -46.94 81.03 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.294 -0.879 . . . . 0.0 109.474 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.499 ' HB ' HG23 ' A' ' 727' ' ' VAL . 9.3 m -95.37 2.58 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.402 -0.811 . . . . 0.0 109.577 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.6 t60 -25.41 -45.94 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.263 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.84 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.7 OUTLIER -136.49 145.68 45.41 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.453 -1.299 . . . . 0.0 111.283 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 2.1 p90 -145.52 144.15 30.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.544 -0.723 . . . . 0.0 110.09 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.636 HD12 HD11 ' A' ' 580' ' ' LEU . 12.3 mt -103.28 121.42 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 9.4 t80 -114.52 154.87 27.48 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.397 -0.814 . . . . 0.0 109.861 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.432 ' HE2' HG23 ' A' ' 647' ' ' ILE . 5.2 ttmt -120.17 136.84 54.48 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.49 0.662 . . . . 0.0 110.583 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.469 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -138.93 163.57 31.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.628 -0.67 . . . . 0.0 110.357 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.0 OUTLIER -78.11 127.64 32.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.241 -0.912 . . . . 0.0 108.728 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.529 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.6 t60 . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 110.769 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.774 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.3 mp . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 24.4 m-20 -119.24 124.76 47.52 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.007 -1.058 . . . . 0.0 111.386 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.459 ' OD2' HD21 ' A' ' 671' ' ' LEU . 7.9 t0 -112.87 155.93 23.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.481 -0.762 . . . . 0.0 110.027 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.503 HD13 HD22 ' A' ' 578' ' ' LEU . 13.2 pt -107.08 134.71 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.252 -0.905 . . . . 0.0 109.943 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.71 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.4 m95 -119.05 124.01 45.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.649 -0.657 . . . . 0.0 111.233 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.623 ' HB2' HD11 ' A' ' 672' ' ' LEU . 12.5 t80 -83.37 114.95 21.79 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 8.2 t -108.67 109.17 20.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.051 -1.031 . . . . 0.0 111.423 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.599 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 9.4 t60 -75.28 160.72 30.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.43 -0.794 . . . . 0.0 110.057 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -152.52 -29.72 0.15 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.355 -0.841 . . . . 0.0 113.187 -178.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.599 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -79.28 135.48 15.48 Favored Glycine 0 N--CA 1.502 3.047 0 C-N-CA 117.866 -2.111 . . . . 0.0 110.212 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.8 m -36.87 -24.56 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.7 ' C ' HG13 ' A' ' 656' ' ' VAL . 2.4 t-20 -59.12 -2.22 0.25 Allowed 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.471 -1.393 . . . . 0.0 113.179 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.7 HG13 ' C ' ' A' ' 655' ' ' ASN . 0.9 OUTLIER 63.92 146.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.453 -0.779 . . . . 0.0 110.702 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.551 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -97.7 153.38 18.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.76 -0.587 . . . . 0.0 110.246 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.474 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 10.2 m-85 -138.45 125.4 21.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.324 -0.86 . . . . 0.0 110.057 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.662 HD11 HG21 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -134.52 121.16 20.61 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.318 -0.864 . . . . 0.0 109.908 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 6.5 m120 55.16 -86.29 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.479 -0.763 . . . . 0.0 110.437 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 659' ' ' LEU . 5.8 t30 -143.32 14.05 1.81 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.096 -1.003 . . . . 0.0 110.602 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -102.29 118.16 36.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.135 -0.978 . . . . 0.0 110.383 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.453 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 0.0 OUTLIER -85.04 139.01 32.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.366 -0.834 . . . . 0.0 110.004 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.468 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 3.5 mtp -120.25 -179.54 3.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 0.0 110.616 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.547 ' CG1' HG23 ' A' ' 668' ' ' THR . 7.0 pt -120.18 -161.0 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.41 -0.806 . . . . 0.0 110.093 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -84.96 72.03 10.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.345 -0.847 . . . . 0.0 110.748 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 134.2 59.54 0.07 OUTLIER Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.547 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.6 OUTLIER -124.31 149.89 46.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.155 -1.203 . . . . 0.0 110.318 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.492 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 11.9 tttt -108.79 133.67 52.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.493 -0.754 . . . . 0.0 109.016 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.527 ' CD1' HG22 ' A' ' 716' ' ' VAL . 11.9 t80 -138.01 146.42 43.06 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.485 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.71 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.9 OUTLIER -72.69 144.66 47.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.461 -0.774 . . . . 0.0 110.267 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 649' ' ' TYR . 1.3 mt -111.71 104.56 12.92 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.676 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -84.62 161.28 20.2 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -56.85 143.94 35.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.119 . . . . 0.0 109.569 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.67 47.27 50.01 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.664 -2.174 . . . . 0.0 107.664 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.416 ' HB2' ' CG1' ' A' ' 694' ' ' VAL . 0.1 OUTLIER -103.31 89.91 3.54 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.836 -0.803 . . . . 0.0 110.473 -179.108 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.933 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 7.1 tt0 -93.29 106.85 18.76 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.662 HG21 HD11 ' A' ' 659' ' ' LEU . 3.3 pt -111.1 137.32 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.346 0.593 . . . . 0.0 111.473 -177.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.415 ' HG2' ' HB2' ' A' ' 658' ' ' TYR . 0.0 OUTLIER -99.29 109.96 22.53 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.525 -0.734 . . . . 0.0 109.091 178.433 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.84 HD13 ' SG ' ' A' ' 623' ' ' CYS . 89.9 mt -74.35 -29.51 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.404 -0.81 . . . . 0.0 110.26 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.605 HG13 HD12 ' A' ' 618' ' ' LEU . 3.0 mt -143.0 133.26 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 109.851 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -138.42 111.79 8.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.572 -0.705 . . . . 0.0 110.108 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -129.12 117.54 21.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -66.69 -33.28 75.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.437 -0.789 . . . . 0.0 110.726 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -55.98 -43.52 77.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.395 -0.816 . . . . 0.0 111.08 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.05 12.14 11.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 110.706 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.31 23.69 2.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.159 -0.963 . . . . 0.0 110.41 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.55 ' CE2' ' HA ' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -72.81 74.39 1.13 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 0.0 109.53 179.743 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 681' ' ' ILE . 14.6 p -105.56 136.96 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.43 -0.794 . . . . 0.0 110.895 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.562 HG12 ' CG1' ' A' ' 587' ' ' ILE . 18.2 mt -108.38 163.77 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.347 -0.846 . . . . 0.0 108.928 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.449 ' N ' ' CB ' ' A' ' 586' ' ' SER . . . -170.84 123.62 1.06 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.933 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 11.4 m-85 -120.16 137.34 54.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.53 -0.982 . . . . 0.0 109.589 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 21.2 tptt -100.52 114.21 27.65 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 110.515 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.592 HG22 HD11 ' A' ' 578' ' ' LEU . 1.2 t -85.62 118.78 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.373 -0.829 . . . . 0.0 109.001 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -130.08 104.75 7.51 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.925 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 577' ' ' PHE . 10.9 mt -85.49 104.4 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 110.037 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -77.27 -43.15 34.37 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.54 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -111.02 140.94 45.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.712 -0.618 . . . . 0.0 110.316 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.406 ' O ' ' OG1' ' A' ' 699' ' ' THR . 2.0 p -114.94 96.45 5.71 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.423 HG21 ' CD ' ' A' ' 596' ' ' GLN . 4.6 p -81.93 92.94 6.82 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.507 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 47.6 42.97 20.96 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.614 ' O ' HD22 ' A' ' 644' ' ' LEU . 2.0 tp -85.79 148.78 25.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.45 -1.029 . . . . 0.0 110.337 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.774 ' HA ' HD13 ' A' ' 644' ' ' LEU . 5.1 p90 -49.47 -25.48 2.65 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.505 -0.747 . . . . 0.0 110.288 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.563 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.6 t30 . . . . . 0 C--N 1.301 -1.507 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.412 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 7.7 mmm-85 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.274 0.559 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.6 m -107.71 152.58 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.844 . . . . 0.0 109.406 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 670' ' ' PHE . 49.6 t -96.24 133.37 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 110.735 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.43 162.14 14.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.514 -0.742 . . . . 0.0 109.56 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -97.37 149.49 22.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 0.0 110.511 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -80.94 129.07 34.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.434 -0.791 . . . . 0.0 110.015 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.2 p -103.42 -176.39 3.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.393 -0.817 . . . . 0.0 110.19 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.31 -28.79 30.23 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.397 -0.814 . . . . 0.0 110.113 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.11 -51.69 62.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.849 . . . . 0.0 109.897 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -64.02 -47.58 79.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.997 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.532 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.0 OUTLIER -53.61 -32.73 52.36 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.322 -0.861 . . . . 0.0 110.076 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.45 -36.15 78.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.414 -0.804 . . . . 0.0 110.101 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 38.6 mt -58.55 -46.59 86.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.365 -0.834 . . . . 0.0 110.296 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 724' ' ' LYS . 7.8 p -71.42 -20.75 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.225 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -53.41 -45.31 69.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.24 -0.913 . . . . 0.0 108.81 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.8 104.44 11.34 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.218 1.009 . . . . 0.0 109.006 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.415 ' OXT' ' CD2' ' A' ' 602' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--N 1.274 -2.692 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.281 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.572 0.701 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.516 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 8.5 t80 -95.83 -43.28 7.93 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.92 0.867 . . . . 0.0 109.392 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.806 HD11 HD13 ' A' ' 647' ' ' ILE . 0.5 OUTLIER -126.97 136.98 53.0 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.043 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 88.4 m -113.43 117.26 31.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.14 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.598 HD12 HG13 ' A' ' 594' ' ' ILE . 2.6 mt -92.69 112.11 23.95 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.448 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 2.1 mmtt -112.81 102.18 54.18 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 118.255 -1.378 . . . . 0.0 113.24 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 1.08 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 45.0 Cg_endo -79.58 142.01 16.0 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 N-CA-C 105.32 -2.608 . . . . 0.0 105.32 173.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.746 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -119.16 -176.2 0.37 Allowed Pre-proline 0 N--CA 1.496 1.847 0 C-N-CA 118.16 -1.416 . . . . 0.0 113.896 -175.813 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.746 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.1 Cg_endo -66.82 -32.41 36.76 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 124.274 1.671 . . . . 0.0 112.033 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -59.08 -29.68 67.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.785 -1.197 . . . . 0.0 108.525 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.666 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 66.7 p -96.5 150.24 20.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.857 -0.527 . . . . 0.0 109.833 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.445 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -54.76 -20.31 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.146 -0.971 . . . . 0.0 109.028 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.865 HD12 ' HA ' ' A' ' 613' ' ' ILE . 9.2 mm -93.65 115.06 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.506 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -125.46 72.31 1.26 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 109.865 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 1.08 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 58.3 mm-40 -145.15 175.85 9.95 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.623 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.548 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.47 126.02 39.65 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.986 -1.071 . . . . 0.0 109.052 176.327 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.749 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.2 mp -109.79 154.08 23.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 0.0 109.745 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -125.53 110.05 13.41 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.502 -0.749 . . . . 0.0 110.989 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.598 HG13 HD12 ' A' ' 580' ' ' LEU . 1.9 mt -80.91 109.86 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.151 -0.968 . . . . 0.0 108.675 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.512 ' HB2' HG23 ' A' ' 598' ' ' VAL . 0.0 OUTLIER -53.06 165.89 0.27 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.672 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.516 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 5.2 mt-30 -65.1 68.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.421 -0.799 . . . . 0.0 109.87 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 138.57 21.87 0.43 Allowed Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.567 -1.302 . . . . 0.0 110.789 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -85.92 101.53 10.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 O-C-N 120.732 -1.452 . . . . 0.0 107.176 178.449 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 13.8 t-20 -144.99 134.05 11.17 Favored Pre-proline 0 C--N 1.284 -2.266 0 CA-C-N 114.777 -1.102 . . . . 0.0 110.21 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.571 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 51.0 Cg_endo -91.99 164.01 26.78 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 123.222 -1.574 . . . . 0.0 108.784 -2.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.504 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 4.1 t80 -104.48 116.11 31.53 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.668 ' HB3' HD23 ' A' ' 730' ' ' LEU . 36.4 m-85 -83.16 144.2 29.98 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.541 -0.724 . . . . 0.0 110.436 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.875 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.3 mt -142.67 141.77 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.66 -0.65 . . . . 0.0 110.045 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.797 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 168.75 -160.97 34.63 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.925 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 14.5 tpt180 -71.13 -43.52 67.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.713 -0.875 . . . . 0.0 111.189 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.466 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -78.3 126.51 30.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 110.872 -179.227 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.445 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.9 tt0 -54.04 -18.33 3.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.141 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.06 -31.32 0.9 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.255 -0.903 . . . . 0.0 109.142 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.5 m -69.89 130.77 43.15 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.504 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -44.83 -28.59 0.66 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.267 -0.895 . . . . 0.0 109.904 179.514 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.875 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.4 t -105.19 143.49 33.29 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.445 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.1 OUTLIER -109.19 128.19 54.83 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.286 -0.966 . . . . 0.0 112.859 -178.414 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.865 ' HA ' HD12 ' A' ' 588' ' ' ILE . 12.1 mt -141.79 108.06 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -91.73 103.79 16.32 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.228 -1.389 . . . . 0.0 108.396 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 2.6 m-20 -138.81 106.02 5.49 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.363 -1.289 . . . . 0.0 108.839 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -45.69 -42.17 11.31 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.546 -0.721 . . . . 0.0 111.948 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 27.2 mtm-85 -83.12 -17.14 44.11 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.074 -1.016 . . . . 0.0 111.269 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.797 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.8 OUTLIER -77.85 140.54 39.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.271 -0.893 . . . . 0.0 110.826 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.45 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.84 161.45 28.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.322 -0.861 . . . . 0.0 110.694 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.755 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 13.3 ttp180 -64.09 -45.79 87.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.328 -0.858 . . . . 0.0 109.255 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.586 HG11 HG22 ' A' ' 727' ' ' VAL . 2.8 t -95.52 2.07 9.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.84 0.829 . . . . 0.0 109.475 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.2 t60 -27.18 -46.69 0.03 OUTLIER 'General case' 0 C--O 1.196 -1.762 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.549 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.79 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.59 145.69 43.12 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 118.025 -1.47 . . . . 0.0 111.857 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.531 ' CZ ' ' HB2' ' A' ' 650' ' ' CYS . 13.1 p90 -146.68 142.64 28.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.595 -0.691 . . . . 0.0 109.9 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.538 HG13 HD11 ' A' ' 603' ' ' ILE . 60.3 mt -102.61 117.97 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.424 ' HB2' ' HE1' ' A' ' 624' ' ' PHE . 8.6 t80 -114.53 154.72 27.76 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.767 0.794 . . . . 0.0 110.017 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 5.4 ttmt -120.18 137.48 54.16 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.597 0.713 . . . . 0.0 110.737 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.413 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.44 163.94 29.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.516 -0.74 . . . . 0.0 110.092 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.6 OUTLIER -77.25 117.79 19.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.158 -0.964 . . . . 0.0 108.704 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.526 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.7 t60 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 121.647 0.737 . . . . 0.0 110.701 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 702' ' ' LEU . 5.1 mp . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.2 m-20 -110.02 124.22 51.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.007 -1.058 . . . . 0.0 110.908 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.698 ' OD2' HD21 ' A' ' 671' ' ' LEU . 24.0 t0 -110.02 151.11 27.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.425 -0.797 . . . . 0.0 109.944 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.806 HD13 HD11 ' A' ' 578' ' ' LEU . 11.1 pt -105.66 132.0 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.338 -0.851 . . . . 0.0 109.898 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.636 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.7 m95 -119.03 119.25 33.72 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.87 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.789 ' HB2' HD11 ' A' ' 672' ' ' LEU . 1.1 t80 -80.96 114.08 19.6 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 668' ' ' THR . 62.9 m -108.37 108.66 19.72 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.506 -0.877 . . . . 0.0 111.206 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.754 ' CE1' ' O ' ' A' ' 653' ' ' GLY . 7.1 t-80 -73.24 169.16 17.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.499 -0.75 . . . . 0.0 109.992 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -159.58 -29.87 0.06 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.292 -0.88 . . . . 0.0 113.118 -178.532 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.754 ' O ' ' CE1' ' A' ' 651' ' ' HIS . . . -79.7 140.43 22.55 Favored Glycine 0 N--CA 1.502 3.035 0 O-C-N 119.453 -2.029 . . . . 0.0 110.406 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 22.7 m -47.1 -22.2 0.33 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.732 ' CG ' HG23 ' A' ' 681' ' ' ILE . 0.1 OUTLIER -58.51 -4.27 0.38 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.601 -1.312 . . . . 0.0 112.444 -178.56 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.765 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 79.52 167.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 CA-C-O 121.878 0.847 . . . . 0.0 110.814 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.705 ' HB3' ' CD2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -128.93 151.13 50.0 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.612 -179.247 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -138.48 126.59 22.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.174 -0.954 . . . . 0.0 110.946 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.912 HD23 ' CD2' ' A' ' 670' ' ' PHE . 14.7 tp -124.49 107.35 10.98 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.256 -0.903 . . . . 0.0 109.576 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 63.2 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.51 -0.743 . . . . 0.0 110.042 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 659' ' ' LEU . 3.2 m-20 -154.5 23.91 0.47 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 110.172 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.46 116.94 29.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.176 -0.953 . . . . 0.0 110.373 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.76 139.08 43.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 110.001 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.765 ' O ' HG22 ' A' ' 656' ' ' VAL . 47.2 mtp -122.6 157.84 31.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.345 -0.847 . . . . 0.0 110.234 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.479 ' CG1' HG23 ' A' ' 668' ' ' THR . 16.2 pt -98.8 -157.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.0 109.829 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -86.12 119.63 26.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.288 -0.883 . . . . 0.0 110.43 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 81.03 52.83 4.15 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -114.85 148.49 38.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.991 -1.299 . . . . 0.0 110.274 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.464 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -109.04 138.68 45.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.566 -0.709 . . . . 0.0 109.345 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.912 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -144.59 145.21 31.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 111.288 -178.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.698 HD21 ' OD2' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -70.15 147.69 49.59 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.433 -0.792 . . . . 0.0 110.604 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.789 HD11 ' HB2' ' A' ' 649' ' ' TYR . 10.7 mt -118.02 114.67 23.49 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.413 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -95.1 147.91 22.93 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.474 ' HB3' HD12 ' A' ' 696' ' ' ILE . 23.1 p-10 -46.3 143.02 2.64 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.133 -0.98 . . . . 0.0 110.532 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.66 47.33 41.58 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 107.611 -2.196 . . . . 0.0 107.611 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.521 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.4 OUTLIER -109.52 93.87 4.73 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.885 -0.774 . . . . 0.0 110.07 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.904 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.1 tm-20 -93.86 107.58 19.45 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.766 HG22 HD13 ' A' ' 659' ' ' LEU . 28.2 pt -107.43 137.91 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.602 -0.686 . . . . 0.0 111.811 -178.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -98.76 110.81 23.35 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.79 HD13 ' SG ' ' A' ' 623' ' ' CYS . 72.4 mt -75.01 -19.86 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.886 . . . . 0.0 110.839 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.739 HD11 HD13 ' A' ' 618' ' ' LEU . 8.4 mt -142.9 136.47 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.16 -0.962 . . . . 0.0 110.52 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -137.65 108.96 6.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.455 -0.778 . . . . 0.0 109.899 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 683' ' ' ASP . . . . . 0.424 ' HB3' ' HB2' ' A' ' 686' ' ' ASN . 0.3 OUTLIER -120.96 117.68 27.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -45.13 78.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.459 -0.776 . . . . 0.0 111.115 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.64 -43.63 15.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.241 -0.912 . . . . 0.0 111.361 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 686' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 683' ' ' ASP . 97.5 m-20 -83.19 -8.67 59.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.136 -0.978 . . . . 0.0 110.601 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.5 tptt 56.25 19.66 4.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.225 -0.922 . . . . 0.0 110.778 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.43 78.76 1.03 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.175 -0.953 . . . . 0.0 109.144 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 586' ' ' SER . 41.0 t -101.79 141.32 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.381 -0.824 . . . . 0.0 110.912 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.666 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 41.6 mm -126.32 163.94 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.423 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . -172.48 124.98 1.12 Allowed Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.367 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.904 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.5 m-85 -120.23 138.06 53.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.59 -0.947 . . . . 0.0 108.828 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -105.1 117.95 35.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.841 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -87.12 122.28 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.542 -0.724 . . . . 0.0 109.241 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -130.24 104.54 7.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.516 -0.74 . . . . 0.0 110.289 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 674' ' ' ASP . 71.8 mt -76.51 104.35 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 109.571 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.11 -42.85 59.43 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.609 -0.836 . . . . 0.0 108.889 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.8 OUTLIER -111.01 141.3 44.67 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.698 0.761 . . . . 0.0 110.747 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 44.5 p -115.38 96.06 5.47 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 7.2 t -136.16 136.31 39.92 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.262 0.554 . . . . 0.0 110.587 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.04 26.52 27.76 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.83 ' O ' HD22 ' A' ' 644' ' ' LEU . 4.1 tp -105.26 138.19 41.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.358 -1.084 . . . . 0.0 110.469 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.828 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.0 p90 -53.83 -23.75 13.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.404 -0.81 . . . . 0.0 110.045 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.593 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.1 t30 . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.799 ' NH1' HD21 ' A' ' 659' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.821 0 CA-C-O 121.257 0.551 . . . . 0.0 111.782 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.424 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 31.5 m -107.78 151.01 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.431 -0.793 . . . . 0.0 109.382 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.538 HG13 ' HG2' ' A' ' 664' ' ' MET . 65.0 t -93.12 117.8 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 0.0 110.489 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.438 HD13 ' HD3' ' A' ' 669' ' ' LYS . 4.8 mp -89.88 162.51 15.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.38 -0.825 . . . . 0.0 109.734 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.98 146.24 28.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.215 -0.928 . . . . 0.0 110.167 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -79.88 137.38 36.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.223 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.8 p -110.16 -176.79 3.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.416 -0.802 . . . . 0.0 110.353 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.61 -28.92 35.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.432 -0.792 . . . . 0.0 110.153 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 722' ' ' GLU . . . . . 0.509 ' O ' HD23 ' A' ' 726' ' ' LEU . 3.9 tp10 -66.21 -50.16 64.79 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.448 -0.782 . . . . 0.0 110.043 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.704 ' O ' HG12 ' A' ' 727' ' ' VAL . 14.6 mt-10 -63.71 -47.68 80.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.36 -0.838 . . . . 0.0 110.123 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.467 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 3.0 tmmm? -62.46 -31.9 72.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.471 -0.768 . . . . 0.0 110.946 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.07 -50.74 69.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.217 -0.927 . . . . 0.0 112.041 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 722' ' ' GLU . 0.7 OUTLIER -72.72 -35.93 67.67 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.907 -1.121 . . . . 0.0 111.516 -178.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.704 HG12 ' O ' ' A' ' 723' ' ' GLU . 9.3 p -79.08 -15.18 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.828 -1.17 . . . . 0.0 110.37 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -41.98 69.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.944 . . . . 0.0 108.685 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.44 103.32 10.32 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 122.253 1.025 . . . . 0.0 108.963 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.668 HD23 ' HB3' ' A' ' 602' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.272 -2.78 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.269 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.412 ' HD3' ' HG2' ' A' ' 593' ' ' GLU . 32.2 ttp-105 . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 121.591 0.71 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.593 ' CZ ' HD13 ' A' ' 702' ' ' LEU . 9.8 t80 -111.6 -40.23 4.39 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 122.061 0.934 . . . . 0.0 109.288 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.003 HD11 HD13 ' A' ' 647' ' ' ILE . 0.9 OUTLIER -124.5 119.69 29.86 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.787 -179.126 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 62.3 m -99.15 115.45 29.09 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.989 -1.069 . . . . 0.0 109.005 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.491 HD21 HD12 ' A' ' 594' ' ' ILE . 1.6 mm? -89.98 111.76 22.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.408 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 1.1 mmtt -112.04 101.49 51.86 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 118.026 -1.47 . . . . 0.0 112.478 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 1.05 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.9 Cg_endo -80.17 144.58 16.67 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 N-CA-C 106.45 -2.173 . . . . 0.0 106.45 174.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.741 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -121.56 -174.31 0.3 Allowed Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.765 -176.792 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.741 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.1 Cg_endo -66.09 -31.17 46.2 Favored 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 124.289 1.679 . . . . 0.0 110.086 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.734 ' O ' HG23 ' A' ' 689' ' ' VAL . 70.2 m-20 -59.13 -25.28 63.73 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 13.4 t -95.19 150.58 20.06 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 614' ' ' GLU . 5.3 tp -55.58 -21.47 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.289 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.876 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.6 tp -110.17 117.92 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.522 -0.736 . . . . 0.0 109.903 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -110.58 79.89 1.25 Allowed 'General case' 0 N--CA 1.508 2.429 0 O-C-N 120.359 -1.463 . . . . 0.0 108.938 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 1.05 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.6 mt-10 -143.02 175.55 9.77 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.787 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.566 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.66 125.56 40.35 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.097 -1.002 . . . . 0.0 109.127 176.638 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 611' ' ' CYS . 65.9 mt -110.17 156.08 21.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 109.592 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.412 ' HG2' ' HD3' ' A' ' 576' ' ' ARG . 7.7 mp0 -124.85 110.56 14.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.856 . . . . 0.0 111.683 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.723 HG23 HG12 ' A' ' 598' ' ' VAL . 21.1 mt -82.33 110.38 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 597' ' ' GLY . 2.3 mt-30 -53.98 179.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.213 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.572 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -58.03 69.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.455 -0.778 . . . . 0.0 111.138 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 106.07 43.84 1.46 Allowed Glycine 0 N--CA 1.485 1.915 0 C-N-CA 119.699 -1.239 . . . . 0.0 110.591 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.723 HG12 HG23 ' A' ' 594' ' ' ILE . 0.5 OUTLIER -79.05 104.57 7.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.13 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 2.9 t30 -141.53 138.27 17.25 Favored Pre-proline 0 C--N 1.28 -2.442 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.004 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.637 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.1 Cg_endo -90.54 161.1 31.99 Favored 'Cis proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.273 -1.97 . . . . 0.0 109.38 -1.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.558 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 5.3 t80 -107.28 116.6 32.22 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.697 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 60.7 m-85 -90.08 145.93 24.7 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 111.047 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.704 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.4 mt -140.5 141.02 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.554 -0.716 . . . . 0.0 110.239 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.69 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 178.1 -161.14 27.86 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.867 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.424 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 15.0 tpt180 -75.71 -32.45 60.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.754 -0.85 . . . . 0.0 110.087 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.438 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -86.3 127.46 34.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.417 -0.802 . . . . 0.0 110.623 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.535 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.5 tm-20 -59.41 -13.73 9.57 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.972 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -46.44 -36.19 6.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.426 -0.796 . . . . 0.0 110.24 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.697 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 62.2 m -71.26 152.7 43.04 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.558 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.1 m120 -59.17 -13.63 7.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.415 -0.803 . . . . 0.0 110.48 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.704 ' SG ' HG23 ' A' ' 603' ' ' ILE . 6.9 t -120.43 144.22 48.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.433 -0.792 . . . . 0.0 109.942 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.613 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -113.37 130.95 56.16 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 122.032 0.92 . . . . 0.0 112.901 -178.43 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.655 HD11 ' CE1' ' A' ' 692' ' ' PHE . 7.9 mt -146.63 109.96 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.465 ' O ' HG12 ' A' ' 587' ' ' ILE . 3.3 mm-40 -85.58 102.44 13.54 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 117.806 -1.558 . . . . 0.0 108.547 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.592 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 4.3 m-20 -139.05 106.13 5.46 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.728 178.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -45.4 -44.51 12.06 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.42 -0.8 . . . . 0.0 111.925 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.86 -16.75 43.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.126 -0.984 . . . . 0.0 112.023 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.922 HD13 HD11 ' A' ' 681' ' ' ILE . 1.3 tp -76.55 130.35 37.77 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.95 -1.093 . . . . 0.0 110.898 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.511 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.2 m -68.81 161.2 29.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.43 -0.794 . . . . 0.0 110.467 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.69 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -63.61 -45.75 88.89 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.189 -0.944 . . . . 0.0 109.204 179.577 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.592 HG12 HD21 ' A' ' 730' ' ' LEU . 16.4 m -94.8 2.12 9.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 121.386 -0.821 . . . . 0.0 109.481 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.776 ' CE1' HD12 ' A' ' 618' ' ' LEU . 3.8 t60 -28.47 -48.27 0.06 Allowed 'General case' 0 C--O 1.192 -1.946 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.946 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.846 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.13 145.5 43.91 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.375 -1.33 . . . . 0.0 110.901 179.065 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.591 ' HA ' HG13 ' A' ' 603' ' ' ILE . 24.2 p90 -146.37 151.18 37.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.493 -0.754 . . . . 0.0 110.419 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.598 HG13 HD11 ' A' ' 603' ' ' ILE . 15.7 mt -103.13 120.95 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 8.0 t80 -116.45 154.23 30.7 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.39 -0.818 . . . . 0.0 109.828 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.519 ' HE2' HG23 ' A' ' 647' ' ' ILE . 8.3 ttmt -120.22 136.98 54.46 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.444 0.64 . . . . 0.0 110.368 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.03 163.97 28.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.64 -0.663 . . . . 0.0 110.389 -179.503 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -77.6 115.65 17.53 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.507 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.2 t60 . . . . . 0 N--CA 1.488 1.461 0 O-C-N 121.542 -0.724 . . . . 0.0 110.561 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.782 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.1 mp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.46 124.63 51.61 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.846 -1.159 . . . . 0.0 111.386 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.531 ' OD2' HD21 ' A' ' 671' ' ' LEU . 24.0 t0 -113.5 156.4 23.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.386 -0.821 . . . . 0.0 110.129 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 1.003 HD13 HD11 ' A' ' 578' ' ' LEU . 11.2 pt -109.67 129.85 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.26 -0.9 . . . . 0.0 110.142 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.652 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 91.6 m95 -119.86 128.53 53.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.621 -0.675 . . . . 0.0 111.199 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.865 ' HB2' HD11 ' A' ' 672' ' ' LEU . 9.3 t80 -88.17 114.87 25.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 668' ' ' THR . 14.4 m -108.01 106.03 16.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 111.781 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.641 ' HE1' ' O ' ' A' ' 653' ' ' GLY . 24.9 t-80 -65.95 159.07 26.51 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.482 -0.761 . . . . 0.0 109.975 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.74 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.03 -28.79 0.2 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.471 -0.768 . . . . 0.0 112.84 -179.228 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.641 ' O ' ' HE1' ' A' ' 651' ' ' HIS . . . -79.26 -163.89 26.79 Favored Glycine 0 N--CA 1.496 2.688 0 O-C-N 119.337 -2.102 . . . . 0.0 109.885 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 21.3 m -94.08 -19.12 21.12 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.096 -1.238 . . . . 0.0 114.095 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.717 ' HB3' HG23 ' A' ' 681' ' ' ILE . 24.7 m120 -61.01 -2.83 0.65 Allowed 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.597 -1.315 . . . . 0.0 112.629 -178.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.698 HG13 ' C ' ' A' ' 655' ' ' ASN . 0.8 OUTLIER 62.68 145.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.58 -0.7 . . . . 0.0 109.847 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.497 ' CB ' ' CD2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -95.09 151.29 19.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.601 -0.687 . . . . 0.0 111.071 -178.611 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.464 ' CZ ' ' CG2' ' A' ' 656' ' ' VAL . 37.5 m-85 -134.45 126.22 29.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.595 -0.691 . . . . 0.0 109.569 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.928 HD13 HG12 ' A' ' 678' ' ' ILE . 53.8 tp -130.93 111.89 12.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.198 -0.939 . . . . 0.0 110.098 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.83 -79.43 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.594 -0.691 . . . . 0.0 110.027 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 659' ' ' LEU . 25.5 p30 -148.74 23.92 0.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 110.128 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.74 119.68 39.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 110.253 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -84.97 134.92 34.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.889 . . . . 0.0 110.045 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.466 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 2.8 mtp -116.3 -166.2 1.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.647 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.5 ' CG1' HG23 ' A' ' 668' ' ' THR . 7.9 pt -139.94 -154.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.447 -0.783 . . . . 0.0 110.291 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 652' ' ' THR . 44.2 tt0 -86.31 91.71 8.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.376 -0.828 . . . . 0.0 110.699 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.5 54.62 0.54 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.6 OUTLIER -119.07 145.53 45.83 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.06 -1.259 . . . . 0.0 110.001 179.636 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.411 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 15.5 tttt -108.34 138.72 44.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.454 -0.779 . . . . 0.0 109.247 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.765 ' CE2' HD23 ' A' ' 659' ' ' LEU . 0.5 OUTLIER -144.62 142.88 30.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.027 -1.045 . . . . 0.0 111.518 -178.82 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.652 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -70.89 147.5 48.74 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.524 -0.735 . . . . 0.0 110.773 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.865 HD11 ' HB2' ' A' ' 649' ' ' TYR . 14.6 mt -120.3 114.67 22.21 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.386 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 673' ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' ' 676' ' ' ASP . 17.2 mt-30 -84.5 -177.16 6.54 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.403 ' HB3' HD12 ' A' ' 696' ' ' ILE . 2.2 p30 -78.24 139.06 38.92 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.778 -1.201 . . . . 0.0 109.315 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 73.25 47.9 21.37 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.451 -2.259 . . . . 0.0 107.451 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.868 ' OD1' HD11 ' A' ' 659' ' ' LEU . 2.1 t0 -105.55 97.77 7.56 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.847 -0.796 . . . . 0.0 110.337 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.895 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.47 107.03 18.93 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.928 HG12 HD13 ' A' ' 659' ' ' LEU . 1.5 mp -105.01 138.01 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.531 -0.731 . . . . 0.0 111.57 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -100.39 114.58 28.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.747 -0.596 . . . . 0.0 109.639 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.846 HD13 ' SG ' ' A' ' 623' ' ' CYS . 76.7 mt -79.35 -24.09 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.926 . . . . 0.0 110.933 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.922 HD11 HD13 ' A' ' 618' ' ' LEU . 7.2 mt -141.57 141.15 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.148 -0.97 . . . . 0.0 110.389 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -138.09 109.59 6.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.89 . . . . 0.0 110.11 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 683' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 686' ' ' ASN . 1.0 OUTLIER -125.44 118.04 24.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.331 -0.856 . . . . 0.0 110.005 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -46.85 76.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.306 -0.871 . . . . 0.0 110.963 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -84.65 -43.47 14.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.345 -0.847 . . . . 0.0 110.939 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 686' ' ' ASN . . . . . 0.4 ' CB ' ' HB3' ' A' ' 683' ' ' ASP . 0.6 OUTLIER -72.33 -11.1 60.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.249 -0.907 . . . . 0.0 110.556 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.1 mttt 52.46 24.86 3.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.17 -0.956 . . . . 0.0 110.388 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.88 73.76 7.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.434 -0.792 . . . . 0.0 109.896 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 585' ' ' ASP . 34.8 m -101.92 135.87 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 110.322 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.522 HG12 ' HB ' ' A' ' 681' ' ' ILE . 19.3 mm -114.05 164.44 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.535 -0.728 . . . . 0.0 109.505 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -174.43 123.33 0.95 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.527 -1.32 . . . . 0.0 110.446 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.895 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.3 m-85 -120.04 137.74 53.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.534 -0.98 . . . . 0.0 108.581 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -102.56 114.54 28.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.871 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 694' ' ' VAL . 1.0 OUTLIER -81.31 113.24 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.03 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -121.56 104.3 9.54 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.695 -0.628 . . . . 0.0 109.914 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.433 HG12 ' HG ' ' A' ' 578' ' ' LEU . 63.1 mt -79.13 104.58 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 109.51 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.88 -42.76 48.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.328 -0.857 . . . . 0.0 108.826 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 577' ' ' PHE . 1.2 m-20 -110.84 142.45 42.84 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.397 0.618 . . . . 0.0 110.336 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 42.9 p -114.18 95.78 5.47 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.44 -133.57 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.027 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.761 ' O ' HD23 ' A' ' 644' ' ' LEU . . . -93.49 35.04 4.29 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.593 HD13 ' CZ ' ' A' ' 577' ' ' PHE . 1.0 OUTLIER -60.77 149.98 33.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.617 -0.931 . . . . 0.0 110.172 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.782 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.1 p90 -49.63 -24.56 2.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.362 -0.836 . . . . 0.0 110.402 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.532 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.497 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 121.381 0.61 . . . . 0.0 112.225 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.408 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 34.9 m -107.59 151.59 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.453 -0.779 . . . . 0.0 109.454 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.466 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 86.6 t -97.04 122.77 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 110.564 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.5 mp -93.8 162.16 14.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.52 -0.737 . . . . 0.0 109.822 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.33 151.09 21.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.875 . . . . 0.0 110.068 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -80.31 142.83 34.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.807 . . . . 0.0 110.343 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 12.8 p -117.16 -176.27 2.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.399 -0.813 . . . . 0.0 110.143 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.53 -28.8 33.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.355 -0.84 . . . . 0.0 110.224 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -68.15 -47.65 67.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.0 109.984 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.8 -48.05 78.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -0.796 . . . . 0.0 110.023 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 727' ' ' VAL . 94.7 mttt -54.03 -32.49 54.55 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.364 -0.835 . . . . 0.0 110.069 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -68.11 -36.38 79.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.487 -0.758 . . . . 0.0 110.383 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 37.8 mt -59.8 -46.55 88.85 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.262 -0.899 . . . . 0.0 110.195 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.571 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.5 p -72.34 -19.46 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.087 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -53.5 -44.73 69.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.865 . . . . 0.0 108.904 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.54 103.48 10.45 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 122.215 1.007 . . . . 0.0 109.262 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.592 HD21 HG12 ' A' ' 621' ' ' VAL . 3.5 mt . . . . . 0 C--N 1.274 -2.696 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.518 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 121.613 0.72 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.563 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 9.8 t80 -124.8 -39.69 2.25 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 122.063 0.935 . . . . 0.0 109.427 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.723 HD11 HD13 ' A' ' 647' ' ' ILE . 0.4 OUTLIER -131.6 120.23 22.56 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.26 -178.586 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 4.4 m -93.95 120.19 33.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.0 109.093 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 1.058 HD11 HD12 ' A' ' 625' ' ' ILE . 4.6 mt -87.05 112.38 21.81 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.526 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -111.1 100.48 47.06 Favored Pre-proline 0 C--N 1.301 -1.505 0 C-N-CA 118.197 -1.401 . . . . 0.0 112.989 -176.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 1.09 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 55.6 Cg_endo -87.88 141.23 5.25 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 N-CA-C 106.342 -2.214 . . . . 0.0 106.342 174.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.75 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -120.52 -173.71 0.27 Allowed Pre-proline 0 C--N 1.294 -1.815 0 C-N-CA 118.57 -1.252 . . . . 0.0 112.575 -177.433 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.75 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.2 Cg_endo -66.42 -30.71 43.86 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 O-C-N 124.212 1.638 . . . . 0.0 110.279 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -59.2 -24.45 63.12 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 17.6 t -95.35 153.32 17.74 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 614' ' ' GLU . 4.9 tp -57.42 -19.69 11.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.178 -0.951 . . . . 0.0 109.298 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.841 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.5 tp -113.17 118.08 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 110.117 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 3.9 pm0 -111.24 81.65 1.47 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.483 -1.386 . . . . 0.0 108.634 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 1.09 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.5 mt-10 -143.11 175.68 9.68 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.883 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.526 ' HB3' ' CD ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.62 122.88 36.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.018 -1.051 . . . . 0.0 109.17 176.805 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.66 155.05 20.59 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -125.69 110.26 13.56 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.433 -0.792 . . . . 0.0 111.304 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.506 HG23 ' HB ' ' A' ' 598' ' ' VAL . 9.9 mt -81.37 109.56 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 597' ' ' GLY . 2.0 mp0 -53.14 168.97 0.12 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.609 -0.837 . . . . 0.0 109.054 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.563 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 6.0 mt-30 -61.58 70.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.391 -0.818 . . . . 0.0 110.432 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 124.69 30.44 0.97 Allowed Glycine 0 N--CA 1.487 2.044 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.78 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 598' ' ' VAL . 1.2 t -79.9 102.73 6.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.8 t30 -143.95 135.5 12.8 Favored Pre-proline 0 C--N 1.282 -2.358 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.885 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.655 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.1 Cg_endo -90.91 162.12 30.45 Favored 'Cis proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.747 -1.772 . . . . 0.0 109.15 -1.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.536 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 6.3 t80 -106.41 116.69 32.36 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.735 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 58.3 m-85 -88.62 146.24 25.22 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.406 -0.808 . . . . 0.0 111.182 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.72 HD11 HG13 ' A' ' 625' ' ' ILE . 2.4 mt -140.85 140.48 33.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.648 -0.657 . . . . 0.0 110.18 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.683 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 177.18 -162.63 30.86 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.924 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.412 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 14.2 tpt180 -74.0 -35.06 64.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.794 -0.827 . . . . 0.0 110.248 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.406 ' CB ' ' HD3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -85.16 127.37 34.24 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.394 -0.817 . . . . 0.0 110.585 -179.606 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 42.8 tt0 -58.75 -12.89 4.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.291 -0.881 . . . . 0.0 109.993 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.18 -36.86 4.05 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.421 -0.8 . . . . 0.0 110.079 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.735 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 79.6 m -71.68 154.48 41.34 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.284 -0.885 . . . . 0.0 109.926 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.521 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -61.53 -12.06 13.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.511 -0.743 . . . . 0.0 110.396 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.719 ' SG ' HG23 ' A' ' 603' ' ' ILE . 6.9 t -119.84 143.74 47.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.531 -0.731 . . . . 0.0 109.559 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.622 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -113.32 130.22 56.32 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.055 0.931 . . . . 0.0 112.993 -178.237 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.606 HD11 ' CE1' ' A' ' 692' ' ' PHE . 7.3 mt -146.57 109.75 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 177.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.46 ' O ' HG12 ' A' ' 587' ' ' ILE . 2.2 mt-10 -85.68 102.47 13.63 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 117.704 -1.598 . . . . 0.0 108.538 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.622 ' CG ' HD12 ' A' ' 681' ' ' ILE . 4.9 m-20 -139.42 106.08 5.36 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.869 178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 616' ' ' ASN . . . . . 0.41 ' OD1' ' CZ ' ' A' ' 688' ' ' PHE . 29.5 p-10 -47.45 -41.33 20.17 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.453 -0.779 . . . . 0.0 111.648 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -84.19 -16.99 41.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.089 -1.007 . . . . 0.0 111.8 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.866 HD13 HD11 ' A' ' 681' ' ' ILE . 1.3 tp -78.27 130.84 36.7 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.082 -1.012 . . . . 0.0 110.816 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.497 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 2.2 t -70.75 159.4 34.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.362 -0.836 . . . . 0.0 110.53 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.683 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 35.7 ttp180 -61.55 -45.66 93.21 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.26 -0.9 . . . . 0.0 109.344 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.595 ' HB ' HG23 ' A' ' 727' ' ' VAL . 15.8 m -94.74 1.95 9.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.389 -0.82 . . . . 0.0 109.613 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.9 t60 -28.1 -48.18 0.05 OUTLIER 'General case' 0 C--O 1.192 -1.962 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.833 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.816 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.7 OUTLIER -137.03 145.58 44.22 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.406 -1.318 . . . . 0.0 110.753 178.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.527 ' CZ ' ' CB ' ' A' ' 650' ' ' CYS . 12.4 p90 -145.3 148.75 33.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.532 -0.73 . . . . 0.0 110.306 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 1.058 HD12 HD11 ' A' ' 580' ' ' LEU . 24.5 mt -103.9 121.1 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 7.5 t80 -114.95 154.44 28.75 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.694 0.759 . . . . 0.0 109.484 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 0.2 OUTLIER -120.01 137.09 54.29 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.548 0.689 . . . . 0.0 110.587 -179.556 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -137.62 163.6 30.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.712 -0.617 . . . . 0.0 110.152 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.0 OUTLIER -77.93 115.48 17.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.188 -0.945 . . . . 0.0 108.889 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.507 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.4 t60 . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.536 -0.728 . . . . 0.0 110.615 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.812 HD22 ' O ' ' A' ' 702' ' ' LEU . 5.1 mp . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.19 124.4 50.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.859 -1.151 . . . . 0.0 111.08 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -110.26 150.56 28.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.443 -0.785 . . . . 0.0 109.847 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.723 HD13 HD11 ' A' ' 578' ' ' LEU . 11.3 pt -106.56 131.66 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.304 -0.873 . . . . 0.0 109.85 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.777 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 95.2 m95 -119.47 123.05 43.11 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.649 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.643 ' HB2' HD11 ' A' ' 672' ' ' LEU . 9.7 t80 -88.83 114.35 25.36 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 668' ' ' THR . 1.0 OUTLIER -108.12 102.66 11.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.078 -1.014 . . . . 0.0 111.697 -178.246 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.496 ' CD2' ' N ' ' A' ' 652' ' ' THR . 13.1 t60 -62.07 157.46 18.89 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.471 -0.768 . . . . 0.0 109.77 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -149.14 -29.75 0.26 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.469 -0.769 . . . . 0.0 112.702 -179.113 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.539 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.68 -164.05 25.42 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 117.72 -2.181 . . . . 0.0 109.498 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 25.0 m -97.65 -18.22 19.02 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.858 -1.378 . . . . 0.0 113.821 -176.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.594 ' HB3' HG23 ' A' ' 681' ' ' ILE . 22.8 m120 -58.35 -4.25 0.36 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.681 -1.262 . . . . 0.0 112.497 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.525 HG23 ' C ' ' A' ' 655' ' ' ASN . 3.1 t 70.21 148.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.609 -0.682 . . . . 0.0 110.169 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.434 ' CB ' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -105.82 143.82 33.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.508 -0.745 . . . . 0.0 110.741 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.445 ' CE1' ' HG2' ' A' ' 663' ' ' ARG . 74.7 m-85 -135.22 126.2 27.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.43 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.562 ' HG ' HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -124.11 114.32 19.53 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.373 -0.829 . . . . 0.0 109.789 179.411 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 659' ' ' LEU . 14.0 t-20 59.27 -78.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.549 -0.72 . . . . 0.0 110.499 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 659' ' ' LEU . 10.7 t30 -147.86 27.27 0.98 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.077 -1.014 . . . . 0.0 110.33 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.453 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.2 OUTLIER -113.71 139.36 49.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 0.0 110.269 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.445 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 8.5 tmm_? -103.52 129.48 50.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.339 -0.85 . . . . 0.0 110.107 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.557 ' HG2' HG13 ' A' ' 716' ' ' VAL . 4.3 mtp -112.1 -165.7 1.01 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 110.325 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.646 HG13 HG23 ' A' ' 668' ' ' THR . 1.6 pt -141.54 -158.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.375 -0.828 . . . . 0.0 110.091 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -82.06 93.24 6.96 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.286 -0.884 . . . . 0.0 110.524 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 106.84 53.21 0.71 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.646 HG23 HG13 ' A' ' 665' ' ' ILE . 0.2 OUTLIER -120.51 147.62 44.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.11 -1.23 . . . . 0.0 110.078 179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -108.32 144.04 36.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 0.0 109.196 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.48 ' CE1' ' O ' ' A' ' 715' ' ' VAL . 0.6 OUTLIER -144.65 147.11 32.69 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.508 -178.398 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.777 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.68 131.5 45.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.465 -0.772 . . . . 0.0 109.705 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.643 HD11 ' HB2' ' A' ' 649' ' ' TYR . 6.3 mt -104.61 97.68 7.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 111.173 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -84.86 146.64 27.2 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.415 ' HB3' HD12 ' A' ' 696' ' ' ILE . 20.0 p-10 -46.11 151.78 0.46 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.222 -0.924 . . . . 0.0 110.612 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 65.36 49.11 62.82 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.589 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.6 OUTLIER -107.04 92.52 4.11 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.763 -0.845 . . . . 0.0 110.611 -178.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.829 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -92.93 106.91 18.8 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.171 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.562 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.0 OUTLIER -116.56 137.78 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.6 -0.687 . . . . 0.0 111.865 -176.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.45 111.54 23.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.586 -0.696 . . . . 0.0 109.675 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.816 HD13 ' SG ' ' A' ' 623' ' ' CYS . 81.0 mt -74.08 -19.57 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.302 -0.874 . . . . 0.0 110.465 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.866 HD11 HD13 ' A' ' 618' ' ' LEU . 12.7 mt -141.81 137.67 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.028 -1.045 . . . . 0.0 110.286 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -137.43 110.41 7.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.131 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -129.25 118.38 22.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.784 . . . . 0.0 109.844 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.6 -44.84 85.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.375 -0.828 . . . . 0.0 110.884 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -84.11 -43.42 15.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.324 -0.86 . . . . 0.0 110.924 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -17.69 60.57 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.263 -0.898 . . . . 0.0 110.456 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.6 tttt 60.53 14.66 5.03 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.193 -0.942 . . . . 0.0 110.887 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.41 ' CZ ' ' OD1' ' A' ' 616' ' ' ASN . 0.3 OUTLIER -72.06 78.69 0.93 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.039 -1.038 . . . . 0.0 108.975 179.189 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 586' ' ' SER . 96.3 t -101.59 130.98 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.496 -0.752 . . . . 0.0 110.706 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.521 HG12 ' HB ' ' A' ' 681' ' ' ILE . 18.0 mm -114.94 164.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -173.27 116.13 0.59 Allowed Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.446 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.829 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.4 m-85 -119.7 137.13 54.11 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 693' ' ' LYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 581' ' ' LYS . 5.8 ttmm -110.77 114.14 27.26 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 110.305 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.636 HG22 ' CD2' ' A' ' 578' ' ' LEU . 0.5 OUTLIER -75.49 126.85 36.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.758 -0.777 . . . . 0.0 108.95 179.448 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.67 104.41 7.41 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.192 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.508 HG12 ' HG ' ' A' ' 578' ' ' LEU . 83.6 mt -79.47 103.6 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 109.559 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.27 -41.01 58.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.387 -0.821 . . . . 0.0 108.844 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 698' ' ' ASP . 1.3 m-20 -110.34 140.2 44.76 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.678 0.751 . . . . 0.0 110.655 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 36.0 p -115.98 96.17 5.46 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 30.2 m -133.09 133.18 42.63 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.814 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 50.32 30.11 17.66 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.812 ' O ' HD22 ' A' ' 644' ' ' LEU . 7.2 tp -103.91 138.92 39.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.545 -0.974 . . . . 0.0 110.717 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.805 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.6 p90 -53.28 -23.87 10.1 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.418 -0.801 . . . . 0.0 109.988 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.601 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.2 t30 . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.434 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.349 0.595 . . . . 0.0 111.869 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.48 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 26.9 m -107.58 150.01 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.481 -0.762 . . . . 0.0 109.069 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.557 HG13 ' HG2' ' A' ' 664' ' ' MET . 58.3 t -96.73 133.12 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.186 -0.946 . . . . 0.0 111.109 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.8 mp -105.08 162.64 13.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.656 -0.653 . . . . 0.0 109.598 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.35 145.37 28.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.17 -0.956 . . . . 0.0 110.291 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.82 152.09 29.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.355 -0.841 . . . . 0.0 110.259 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 38.6 p -121.14 -176.25 3.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.42 -0.8 . . . . 0.0 110.359 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.36 -29.08 32.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.361 -0.837 . . . . 0.0 110.105 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -51.0 68.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.353 -0.842 . . . . 0.0 109.579 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -64.65 -45.25 87.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.463 -0.773 . . . . 0.0 109.734 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.528 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.4 OUTLIER -54.71 -32.73 59.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.344 -0.848 . . . . 0.0 109.837 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -36.11 78.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.399 -0.813 . . . . 0.0 110.227 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 34.1 mt -58.76 -46.16 88.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.298 -0.877 . . . . 0.0 110.228 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.595 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.2 p -71.76 -20.34 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.546 -0.721 . . . . 0.0 110.087 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.78 -45.84 70.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 108.845 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.71 104.26 11.18 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.206 1.003 . . . . 0.0 109.025 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--N 1.274 -2.71 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.432 -179.933 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 121.584 0.707 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.575 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 0.9 OUTLIER -113.85 -41.62 3.54 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 122.052 0.93 . . . . 0.0 109.36 -179.316 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.707 ' CD2' HD12 ' A' ' 594' ' ' ILE . 14.2 tp -126.1 119.87 28.7 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.529 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 55.9 m -96.88 117.3 30.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.759 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.901 HD11 HD12 ' A' ' 625' ' ' ILE . 7.6 mt -91.98 112.18 24.01 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.534 ' O ' ' CD1' ' A' ' 583' ' ' LEU . 0.7 OUTLIER -116.07 104.58 52.15 Favored Pre-proline 0 C--N 1.299 -1.617 0 C-N-CA 118.379 -1.328 . . . . 0.0 113.289 -177.066 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 1.127 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 40.8 Cg_endo -77.86 145.04 22.24 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 N-CA-C 105.968 -2.358 . . . . 0.0 105.968 174.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.974 HD13 ' N ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -122.14 176.73 1.86 Allowed Pre-proline 0 N--CA 1.496 1.826 0 C-N-CA 118.197 -1.401 . . . . 0.0 113.599 -176.614 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.683 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 37.8 Cg_endo -66.36 -35.42 31.36 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.905 1.737 . . . . 0.0 111.848 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 689' ' ' VAL . 2.3 m-20 -58.43 -26.38 63.23 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.61 ' HB3' HD22 ' A' ' 583' ' ' LEU . 1.9 t -95.57 151.84 18.97 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.062 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.75 HG21 ' OD1' ' A' ' 615' ' ' ASP . 7.5 mm -57.35 -18.63 9.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 108.993 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.698 HD12 ' HA ' ' A' ' 613' ' ' ILE . 3.1 mm -99.67 115.55 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.472 -0.768 . . . . 0.0 109.218 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 2.5 pm0 -122.86 71.42 1.04 Allowed 'General case' 0 N--CA 1.509 2.512 0 O-C-N 120.672 -1.268 . . . . 0.0 109.888 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 1.127 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 45.3 mt-10 -143.75 175.37 10.04 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.354 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.498 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.25 126.66 39.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.79 -1.194 . . . . 0.0 109.978 176.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.831 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.1 mt -111.41 156.17 22.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.329 -0.857 . . . . 0.0 109.391 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -125.19 110.6 14.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 111.835 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.707 HD12 ' CD2' ' A' ' 578' ' ' LEU . 24.8 mt -81.29 110.9 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 597' ' ' GLY . 2.3 mt-30 -54.67 179.25 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.979 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.575 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -59.08 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.505 -0.747 . . . . 0.0 111.217 -179.492 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 115.15 41.71 0.81 Allowed Glycine 0 N--CA 1.485 1.962 0 C-N-CA 119.496 -1.335 . . . . 0.0 111.019 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.691 ' HB ' HG23 ' A' ' 594' ' ' ILE . 1.2 t -79.01 103.75 6.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 627' ' ' LYS . 5.2 t30 -141.4 136.41 15.67 Favored Pre-proline 0 C--N 1.283 -2.314 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.258 -178.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.545 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.4 Cg_endo -90.44 161.28 32.53 Favored 'Cis proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.41 -1.913 . . . . 0.0 109.366 -1.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.548 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 2.9 t80 -107.03 116.26 31.62 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.557 ' HB3' ' SG ' ' A' ' 609' ' ' CYS . 58.8 m-85 -87.48 143.74 27.07 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 110.162 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.834 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.6 mt -140.56 142.16 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.782 -0.574 . . . . 0.0 110.345 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.785 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 166.14 -165.22 38.04 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.617 -1.278 . . . . 0.0 111.131 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 10.1 tpt180 -60.67 -55.55 31.97 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.854 -0.791 . . . . 0.0 111.879 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.43 126.15 28.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 111.499 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.44 ' HB2' ' HD2' ' A' ' 612' ' ' LYS . 42.3 tt0 -52.67 -19.05 2.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.418 -0.801 . . . . 0.0 110.046 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 608' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 607' ' ' GLU . 0.9 OUTLIER -42.36 -35.39 1.0 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.399 -0.813 . . . . 0.0 109.092 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 602' ' ' PHE . 1.3 m -64.92 133.76 52.52 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.548 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 2.3 t-20 -45.72 -28.16 0.97 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.389 -0.82 . . . . 0.0 109.544 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.834 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.4 t -107.6 143.53 35.92 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.463 ' O ' ' CG2' ' A' ' 588' ' ' ILE . 0.3 OUTLIER -107.7 129.0 55.06 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.078 -1.014 . . . . 0.0 113.178 -178.168 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.772 ' CG2' HD13 ' A' ' 690' ' ' ILE . 13.5 mt -143.5 109.5 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.5 ' H ' HD12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -97.8 103.6 15.55 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 117.865 -1.534 . . . . 0.0 109.535 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.769 ' OD2' HD13 ' A' ' 681' ' ' ILE . 0.2 OUTLIER -139.38 106.93 5.57 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.965 177.414 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -41.33 -41.65 2.0 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.611 -0.681 . . . . 0.0 111.993 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -83.84 -17.69 40.08 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.064 -1.023 . . . . 0.0 111.502 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.728 HD22 HG22 ' A' ' 613' ' ' ILE . 0.6 OUTLIER -80.16 130.4 35.21 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.212 -0.93 . . . . 0.0 110.691 -179.189 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.415 ' CB ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -66.78 160.84 24.99 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.254 -0.904 . . . . 0.0 111.169 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.785 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -64.74 -47.04 79.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.233 -0.917 . . . . 0.0 109.746 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.476 ' O ' ' C ' ' A' ' 622' ' ' HIS . 3.7 m -95.32 2.4 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.247 -0.908 . . . . 0.0 109.316 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.735 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.8 t60 -25.36 -46.43 0.02 OUTLIER 'General case' 0 C--O 1.193 -1.897 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.267 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.806 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -136.92 146.33 45.34 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 118.32 -1.352 . . . . 0.0 111.336 179.121 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.546 ' HA ' HG13 ' A' ' 603' ' ' ILE . 14.7 p90 -145.86 143.77 29.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.563 -0.71 . . . . 0.0 109.997 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.901 HD12 HD11 ' A' ' 580' ' ' LEU . 10.7 mt -102.85 118.2 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 5.0 t80 -113.39 155.07 25.89 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.572 0.701 . . . . 0.0 109.544 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 5.6 ttmt -119.67 137.16 54.07 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.617 0.723 . . . . 0.0 110.773 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.49 164.16 28.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.741 -0.6 . . . . 0.0 110.167 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.3 tpt180 -77.75 118.97 20.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.128 -0.983 . . . . 0.0 109.043 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.532 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.7 t60 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.566 -0.709 . . . . 0.0 110.719 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.826 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.0 mp . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.7 m-20 -108.1 124.38 50.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.98 -1.075 . . . . 0.0 111.264 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 628' ' ' LYS . 29.5 t70 -110.11 141.05 43.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.452 -0.78 . . . . 0.0 109.803 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 22.6 pt -95.97 132.44 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.243 -0.911 . . . . 0.0 110.105 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.879 ' CH2' HD22 ' A' ' 671' ' ' LEU . 95.5 m95 -119.07 122.12 41.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.616 -0.678 . . . . 0.0 111.179 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.688 ' HB2' HD11 ' A' ' 672' ' ' LEU . 11.9 t80 -85.21 115.69 23.13 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 624' ' ' PHE . 22.5 m -108.11 102.9 12.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.186 -0.946 . . . . 0.0 111.582 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' A' ' 652' ' ' THR . 12.2 t60 -63.89 159.28 20.09 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.442 -0.786 . . . . 0.0 109.93 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.735 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.44 -29.55 0.18 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.435 -0.791 . . . . 0.0 112.757 -179.196 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.573 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.29 -165.59 30.28 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 117.857 -2.116 . . . . 0.0 109.937 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 26.0 m -93.6 -18.87 21.72 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.064 -1.256 . . . . 0.0 114.025 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.722 ' OD1' HD12 ' A' ' 681' ' ' ILE . 19.4 m120 -60.04 -2.56 0.44 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.663 -1.273 . . . . 0.0 112.564 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.684 HG13 ' C ' ' A' ' 655' ' ' ASN . 0.8 OUTLIER 63.11 142.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 121.583 0.706 . . . . 0.0 110.173 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.507 ' OG ' ' HB2' ' A' ' 664' ' ' MET . 0.0 OUTLIER -94.52 150.49 20.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.691 -0.631 . . . . 0.0 110.729 -179.034 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.483 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 20.2 m-85 -135.05 126.4 28.38 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.332 -0.855 . . . . 0.0 110.437 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.728 HD21 ' OD2' ' A' ' 676' ' ' ASP . 0.0 OUTLIER -134.2 120.8 20.5 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.21 -0.931 . . . . 0.0 109.926 179.251 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.0 m120 56.3 -85.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.569 -0.707 . . . . 0.0 110.521 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 659' ' ' LEU . 55.6 t30 -148.17 25.46 1.0 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.221 -0.924 . . . . 0.0 110.247 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -119.34 117.52 28.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 0.0 110.447 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.415 ' CG ' ' CE1' ' A' ' 658' ' ' TYR . 2.7 tmm_? -87.24 138.33 31.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.374 -0.829 . . . . 0.0 109.983 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.732 ' SD ' HG13 ' A' ' 716' ' ' VAL . 0.3 OUTLIER -112.83 -152.68 0.51 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.278 -0.889 . . . . 0.0 109.969 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.502 HG13 HG23 ' A' ' 668' ' ' THR . 1.1 pp -143.4 -165.96 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.241 -0.912 . . . . 0.0 110.706 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 652' ' ' THR . 22.0 tt0 -76.58 83.99 3.25 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.483 -0.761 . . . . 0.0 110.412 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 117.88 53.15 0.31 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -122.92 149.17 44.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.098 -1.236 . . . . 0.0 110.08 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 717' ' ' LEU . 3.8 tttt -108.64 146.34 33.54 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.502 -0.749 . . . . 0.0 109.472 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.553 ' CD2' HD22 ' A' ' 659' ' ' LEU . 9.7 t80 -145.17 147.82 32.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.12 -0.988 . . . . 0.0 112.404 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.879 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.12 131.8 45.56 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.599 -0.688 . . . . 0.0 109.535 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.742 HD23 ' OD2' ' A' ' 676' ' ' ASP . 7.2 mt -105.88 104.95 14.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.049 -1.032 . . . . 0.0 111.227 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -91.73 146.75 23.52 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.558 -0.714 . . . . 0.0 109.127 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -43.94 147.84 0.45 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.139 -0.975 . . . . 0.0 110.397 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 66.31 48.1 66.46 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 107.587 -2.205 . . . . 0.0 107.587 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.742 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.3 OUTLIER -110.27 90.15 3.23 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.798 -0.825 . . . . 0.0 110.787 -178.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.966 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 3.2 tt0 -93.46 107.03 18.94 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.658 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.8 pt -105.49 136.87 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.861 -0.524 . . . . 0.0 110.972 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 25.2 mttt -95.31 110.32 22.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.569 -0.707 . . . . 0.0 109.637 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.806 HD13 ' SG ' ' A' ' 623' ' ' CYS . 63.4 mt -76.72 -22.77 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 110.074 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.769 HD13 ' OD2' ' A' ' 615' ' ' ASP . 15.0 tt -143.39 137.92 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.241 -0.912 . . . . 0.0 110.284 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -138.07 112.78 8.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.203 -0.936 . . . . 0.0 110.701 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.93 117.19 28.15 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.233 -0.917 . . . . 0.0 109.753 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -67.57 -47.6 69.3 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.423 -0.798 . . . . 0.0 111.475 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.23 -43.47 13.74 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.307 -0.871 . . . . 0.0 111.225 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.01 -7.07 51.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.211 -0.93 . . . . 0.0 110.914 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.95 24.15 3.24 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.152 -0.968 . . . . 0.0 110.038 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.03 95.98 10.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.44 -0.787 . . . . 0.0 109.681 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 586' ' ' SER . 31.5 m -125.79 142.36 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 111.059 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.772 HD13 ' CG2' ' A' ' 613' ' ' ILE . 12.2 mt -123.81 164.06 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -175.38 142.94 6.42 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.439 -1.362 . . . . 0.0 110.376 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.966 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 17.0 m-85 -129.14 137.6 51.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.503 -0.998 . . . . 0.0 109.865 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -98.45 113.66 25.74 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.219 -0.925 . . . . 0.0 109.682 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.641 HG22 HD11 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -82.66 121.48 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.361 -0.837 . . . . 0.0 109.074 179.587 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.05 104.62 7.44 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.581 -0.699 . . . . 0.0 110.237 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 60.2 mt -81.12 104.17 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.325 -0.86 . . . . 0.0 109.552 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -75.57 -42.1 53.02 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.377 -0.827 . . . . 0.0 108.996 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.462 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.1 m-20 -110.66 141.3 44.09 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.637 0.732 . . . . 0.0 110.521 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 21.9 p -114.99 96.04 5.5 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 16.1 p -128.12 131.99 48.97 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.235 0.54 . . . . 0.0 110.707 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 51.86 32.37 33.56 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.823 ' O ' HD22 ' A' ' 644' ' ' LEU . 4.1 tp -108.09 138.37 44.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.45 -1.029 . . . . 0.0 110.717 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.826 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.1 p90 -54.92 -24.03 21.67 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.71 . . . . 0.0 109.921 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.588 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.2 t30 . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.447 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.355 0.598 . . . . 0.0 111.616 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 715' ' ' VAL . 35.4 m -107.69 153.33 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.465 -0.772 . . . . 0.0 109.3 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.732 HG13 ' SD ' ' A' ' 664' ' ' MET . 58.1 t -98.39 133.11 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.935 . . . . 0.0 110.797 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 669' ' ' LYS . 4.0 mp -102.44 156.63 17.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.509 -0.744 . . . . 0.0 109.569 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.13 154.11 17.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.192 -0.942 . . . . 0.0 110.489 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -87.27 146.2 26.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.389 -0.82 . . . . 0.0 110.345 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 10.5 p -121.21 -176.12 3.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.343 -0.848 . . . . 0.0 110.309 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.2 -28.84 28.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.416 -0.802 . . . . 0.0 110.097 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.58 -47.49 75.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.356 -0.84 . . . . 0.0 109.552 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -63.85 -48.01 78.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.394 -0.816 . . . . 0.0 109.772 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 727' ' ' VAL . 12.2 tttt -53.77 -32.37 52.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.333 -0.854 . . . . 0.0 110.065 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.21 -36.24 79.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -0.827 . . . . 0.0 110.21 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 32.9 mt -59.52 -46.53 88.58 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.273 -0.892 . . . . 0.0 110.325 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 724' ' ' LYS . 8.5 p -70.79 -18.92 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.142 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.91 -43.74 69.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.214 -0.929 . . . . 0.0 108.824 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.59 103.52 10.48 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 122.281 1.039 . . . . 0.0 109.177 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.411 ' O ' ' CD2' ' A' ' 602' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.274 -2.712 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.365 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 121.44 0.638 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.813 ' CE2' HD11 ' A' ' 702' ' ' LEU . 0.2 OUTLIER -106.49 -40.09 5.68 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.92 0.867 . . . . 0.0 109.545 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.979 HD22 HD12 ' A' ' 594' ' ' ILE . 9.7 tt -117.95 119.86 36.09 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.713 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 86.1 m -98.4 116.55 30.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.291 -0.881 . . . . 0.0 109.074 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.802 HD11 ' CD1' ' A' ' 625' ' ' ILE . 2.4 mt -90.78 112.16 23.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.415 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 2.4 mmtt -112.81 101.89 53.74 Favored Pre-proline 0 C--N 1.3 -1.548 0 C-N-CA 118.153 -1.419 . . . . 0.0 112.737 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 1.042 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.0 Cg_endo -79.55 144.97 18.14 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 N-CA-C 106.454 -2.172 . . . . 0.0 106.454 174.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.741 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.62 -173.54 0.28 Allowed Pre-proline 0 N--CA 1.494 1.74 0 C-N-CA 118.651 -1.22 . . . . 0.0 112.791 -176.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.741 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.2 Cg_endo -66.55 -28.3 45.4 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 124.113 1.586 . . . . 0.0 110.176 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.31 -28.4 66.76 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 46.7 p -95.43 153.57 17.63 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.584 ' H ' HD13 ' A' ' 690' ' ' ILE . 5.7 tp -57.07 -16.38 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.831 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.868 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.2 tp -113.98 117.73 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.219 -0.925 . . . . 0.0 110.231 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -110.95 80.82 1.34 Allowed 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.219 -1.551 . . . . 0.0 109.209 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 1.042 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 33.8 mm-40 -142.24 175.81 9.47 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.823 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.569 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.66 125.48 40.18 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.138 -0.976 . . . . 0.0 109.096 176.588 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 611' ' ' CYS . 61.5 mt -111.39 156.07 22.16 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.369 -0.832 . . . . 0.0 109.987 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -125.25 111.05 14.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.356 -0.84 . . . . 0.0 111.802 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.979 HD12 HD22 ' A' ' 578' ' ' LEU . 39.9 mt -82.31 110.61 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.51 ' O ' ' C ' ' A' ' 596' ' ' GLN . 21.2 mm100 -69.39 114.9 8.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.499 -0.751 . . . . 0.0 112.794 -177.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.51 ' C ' ' O ' ' A' ' 595' ' ' GLN . 0.0 OUTLIER 14.6 56.77 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 178.555 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 106.98 46.65 1.08 Allowed Glycine 0 N--CA 1.486 1.988 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.845 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.622 ' HB ' HG23 ' A' ' 594' ' ' ILE . 1.0 OUTLIER -79.4 104.66 7.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 177.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 2.8 t30 -140.41 137.9 18.27 Favored Pre-proline 0 C--N 1.28 -2.421 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.103 -178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.705 ' HB3' HD23 ' A' ' 726' ' ' LEU . 56.7 Cg_endo -90.01 160.18 34.22 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.009 -2.08 . . . . 0.0 109.581 -0.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 4.5 t80 -107.29 116.73 32.44 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.73 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 52.3 m-85 -91.23 145.77 24.39 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.207 -0.933 . . . . 0.0 110.817 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.699 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.2 mt -139.68 141.17 35.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.491 -0.755 . . . . 0.0 110.436 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 174.17 -167.12 39.44 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.431 -1.366 . . . . 0.0 111.362 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.447 ' HD2' ' HA ' ' A' ' 614' ' ' GLU . 6.7 mmm-85 -64.34 -40.61 96.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.919 -0.754 . . . . 0.0 110.834 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -84.23 127.81 34.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.396 -0.815 . . . . 0.0 111.446 -178.676 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.4 ' CG ' ' HD2' ' A' ' 612' ' ' LYS . 37.1 tt0 -57.67 -14.88 6.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -0.84 . . . . 0.0 109.854 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -44.23 -36.97 2.94 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.413 -0.804 . . . . 0.0 110.092 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.73 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 74.8 m -71.42 151.85 43.64 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.385 -0.822 . . . . 0.0 109.575 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.553 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -57.78 -14.5 5.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.432 -0.792 . . . . 0.0 110.508 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.699 ' SG ' HG23 ' A' ' 603' ' ' ILE . 7.0 t -120.4 143.66 48.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.546 -0.721 . . . . 0.0 109.692 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.59 ' O ' HG12 ' A' ' 588' ' ' ILE . 1.7 ttpm? -111.82 130.68 55.73 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.053 0.93 . . . . 0.0 112.769 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.651 HD11 ' CE1' ' A' ' 692' ' ' PHE . 4.8 mt -146.55 110.58 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.466 ' O ' HG12 ' A' ' 587' ' ' ILE . 1.2 mt-10 -93.64 102.34 14.51 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 117.73 -1.588 . . . . 0.0 109.306 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.726 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.1 m-20 -138.39 105.85 5.55 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.184 177.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 616' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 615' ' ' ASP . 1.7 t30 -35.9 -48.28 0.56 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.632 -0.668 . . . . 0.0 112.583 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -83.55 -17.44 41.79 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.969 -1.082 . . . . 0.0 111.963 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.641 HD22 HG22 ' A' ' 613' ' ' ILE . 0.6 OUTLIER -72.71 125.39 27.4 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.95 -1.094 . . . . 0.0 110.697 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -67.0 161.15 24.95 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.372 -0.83 . . . . 0.0 111.031 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.739 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -64.16 -45.56 87.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.243 -0.91 . . . . 0.0 109.223 179.35 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.59 ' HB ' HG23 ' A' ' 727' ' ' VAL . 12.4 m -94.86 2.3 9.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.386 -0.821 . . . . 0.0 109.336 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.9 t60 -29.09 -46.74 0.05 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.988 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.829 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -136.46 145.24 44.97 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 118.514 -1.274 . . . . 0.0 110.777 179.194 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 4.1 p90 -145.57 144.05 30.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.55 -0.719 . . . . 0.0 110.116 178.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.802 ' CD1' HD11 ' A' ' 580' ' ' LEU . 76.0 mt -103.31 120.4 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 3.7 t80 -114.46 155.1 27.0 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.618 0.723 . . . . 0.0 109.666 -178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 5.1 ttmt -118.01 137.45 52.87 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 121.639 0.733 . . . . 0.0 110.337 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.435 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -136.11 164.33 28.27 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.707 -0.62 . . . . 0.0 110.757 -179.121 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.0 tpt180 -77.52 117.26 18.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 108.677 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.51 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 5.6 t60 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.591 0.71 . . . . 0.0 110.941 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 4.2 mt . . . . . 0 N--CA 1.486 1.325 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.724 ' O ' HD23 ' A' ' 702' ' ' LEU . 0.7 OUTLIER -115.04 124.53 51.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.877 -1.139 . . . . 0.0 111.476 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.754 ' CG ' HD11 ' A' ' 671' ' ' LEU . 12.6 t0 -108.18 156.67 19.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.524 -0.735 . . . . 0.0 109.871 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.588 HD13 ' CD1' ' A' ' 578' ' ' LEU . 14.6 pt -104.85 131.72 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.314 -0.866 . . . . 0.0 110.174 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.742 ' CH2' HD13 ' A' ' 671' ' ' LEU . 97.9 m95 -118.56 121.0 39.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.684 -0.635 . . . . 0.0 110.937 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.6 ' HB2' HD11 ' A' ' 672' ' ' LEU . 8.8 t80 -80.82 114.82 19.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 108.67 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.555 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 8.8 t -107.6 109.02 20.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.189 -0.944 . . . . 0.0 111.432 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.81 ' CE1' ' O ' ' A' ' 653' ' ' GLY . 8.0 t-80 -75.04 160.18 30.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.0 109.979 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -150.69 -32.4 0.17 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.394 -0.816 . . . . 0.0 112.868 -178.904 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.81 ' O ' ' CE1' ' A' ' 651' ' ' HIS . . . -79.38 130.35 9.8 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 117.897 -2.097 . . . . 0.0 109.976 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 654' ' ' THR . . . . . 0.405 ' C ' ' H ' ' A' ' 656' ' ' VAL . 14.5 m -36.01 -23.42 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 115.383 1.624 . . . . 0.0 115.383 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.52 ' C ' HG23 ' A' ' 656' ' ' VAL . 4.5 t-20 -54.97 -4.51 0.07 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.336 -1.478 . . . . 0.0 113.197 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 664' ' ' MET . 4.3 t 75.31 150.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 121.592 -0.692 . . . . 0.0 110.984 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.627 ' HB3' ' CD2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -111.66 151.9 28.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.577 -0.702 . . . . 0.0 110.347 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -138.39 126.47 22.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 109.863 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 1.018 HD13 HG22 ' A' ' 678' ' ' ILE . 19.4 tp -128.11 110.24 12.28 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.869 . . . . 0.0 110.161 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.67 -72.9 0.05 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.637 -0.664 . . . . 0.0 109.985 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 659' ' ' LEU . 4.9 m-80 -153.82 19.36 0.52 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.354 -0.841 . . . . 0.0 110.435 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.425 ' ND2' HG23 ' A' ' 716' ' ' VAL . 9.6 t-20 -116.95 116.92 28.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.031 -1.043 . . . . 0.0 110.501 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.97 141.6 32.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 109.579 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.652 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.8 OUTLIER -115.2 -169.17 1.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 110.681 -179.214 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.646 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.1 pt -120.3 -165.62 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.41 -0.806 . . . . 0.0 110.068 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -84.22 73.02 10.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.36 -0.838 . . . . 0.0 110.569 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 130.47 54.47 0.1 OUTLIER Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.646 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.0 OUTLIER -121.77 151.28 40.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -1.187 . . . . 0.0 110.106 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.773 ' HE2' HD11 ' A' ' 717' ' ' LEU . 7.2 tttt -109.04 139.69 43.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.486 -0.759 . . . . 0.0 109.411 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.948 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -144.36 146.59 32.64 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.299 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.754 HD11 ' CG ' ' A' ' 646' ' ' ASP . 12.7 tp -70.56 146.16 50.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.32 -0.862 . . . . 0.0 111.227 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.6 HD11 ' HB2' ' A' ' 649' ' ' TYR . 7.7 mt -118.93 102.15 8.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 110.585 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -84.53 160.61 20.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.458 -0.777 . . . . 0.0 109.204 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.446 ' HB3' HD12 ' A' ' 696' ' ' ILE . 21.4 p-10 -52.25 149.31 5.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.008 -1.057 . . . . 0.0 110.289 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 63.75 50.14 63.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.441 ' HB3' HD22 ' A' ' 672' ' ' LEU . 0.2 OUTLIER -110.8 94.9 5.23 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.715 -0.874 . . . . 0.0 111.098 -178.648 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.891 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -94.64 106.83 18.83 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.414 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 1.018 HG22 HD13 ' A' ' 659' ' ' LEU . 17.6 pt -106.78 135.8 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.474 -0.766 . . . . 0.0 111.328 -178.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -98.52 109.57 22.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.369 -0.832 . . . . 0.0 109.146 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.829 HD13 ' SG ' ' A' ' 623' ' ' CYS . 89.7 mt -74.86 -42.19 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.39 -0.819 . . . . 0.0 110.537 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.635 HD12 ' HB2' ' A' ' 618' ' ' LEU . 3.1 mt -130.75 132.95 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.202 -0.936 . . . . 0.0 110.347 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -138.75 112.04 8.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.571 -0.706 . . . . 0.0 109.904 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -129.94 117.91 20.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 110.248 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -29.73 69.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.466 -0.771 . . . . 0.0 110.721 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -55.69 -43.36 76.33 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.365 -0.835 . . . . 0.0 111.031 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 686' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 688' ' ' PHE . 2.1 t30 -137.26 36.0 2.52 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.192 -0.942 . . . . 0.0 110.256 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 687' ' ' LYS . . . . . 0.756 ' O ' HG23 ' A' ' 689' ' ' VAL . 0.8 OUTLIER 65.54 -67.82 0.13 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.77 -0.581 . . . . 0.0 109.856 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.509 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.1 OUTLIER 28.72 52.67 0.07 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.244 0.545 . . . . 0.0 111.346 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 687' ' ' LYS . 91.6 t -101.76 142.64 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 110.674 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.726 HD11 ' OD2' ' A' ' 615' ' ' ASP . 44.5 mm -120.0 165.32 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 179.79 121.37 0.72 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.052 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.891 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.8 m-85 -119.9 136.6 54.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.54 -0.977 . . . . 0.0 108.978 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.78 114.28 27.93 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.216 -0.927 . . . . 0.0 110.511 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -82.97 120.62 34.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.151 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -127.08 104.5 8.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.753 -0.592 . . . . 0.0 110.077 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 674' ' ' ASP . 65.4 mt -84.35 103.63 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.665 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -80.99 -42.97 20.34 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.9 OUTLIER -110.81 140.27 45.38 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.483 0.659 . . . . 0.0 110.271 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 12.1 p -114.9 96.13 5.56 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 35.7 m -117.94 121.67 41.28 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.208 0.528 . . . . 0.0 110.607 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.509 ' C ' HD22 ' A' ' 644' ' ' LEU . . . 52.41 45.5 58.65 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.813 HD11 ' CE2' ' A' ' 577' ' ' PHE . 3.7 mt -115.38 132.81 56.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.439 -1.036 . . . . 0.0 110.728 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.645 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 3.1 p90 -47.43 -24.71 0.87 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.568 0.699 . . . . 0.0 110.47 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.645 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.731 ' NH1' HD21 ' A' ' 659' ' ' LEU . 1.3 mmm-85 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.259 0.552 . . . . 0.0 111.893 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.444 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 35.5 m -108.31 151.13 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.455 -0.778 . . . . 0.0 109.583 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.45 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 87.5 t -98.44 127.47 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.266 -0.896 . . . . 0.0 110.758 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.773 HD11 ' HE2' ' A' ' 669' ' ' LYS . 0.5 OUTLIER -114.22 145.74 41.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.58 -0.7 . . . . 0.0 109.347 179.057 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.95 149.62 35.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.159 -0.963 . . . . 0.0 110.693 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 719' ' ' GLN . . . . . 0.408 ' HB2' ' CB ' ' A' ' 723' ' ' GLU . 9.1 pt20 -81.03 154.29 26.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.419 -0.801 . . . . 0.0 110.278 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 11.5 p -108.38 -176.61 3.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.331 -0.856 . . . . 0.0 110.677 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.51 -29.42 36.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.415 -0.803 . . . . 0.0 110.157 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 722' ' ' GLU . . . . . 0.461 ' O ' HD13 ' A' ' 726' ' ' LEU . 11.1 tp10 -60.72 -52.48 64.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.499 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.408 ' CB ' ' HB2' ' A' ' 719' ' ' GLN . 3.3 mp0 -63.89 -42.72 97.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 0.0 109.378 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.521 ' O ' HG12 ' A' ' 727' ' ' VAL . 1.4 mmtm -54.12 -32.21 54.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.341 -0.85 . . . . 0.0 109.552 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.26 -38.45 78.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.471 -0.768 . . . . 0.0 110.399 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.705 HD23 ' HB3' ' A' ' 600' ' ' PRO . 11.0 mp -55.75 -47.83 76.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.245 -0.909 . . . . 0.0 110.521 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.59 HG23 ' HB ' ' A' ' 621' ' ' VAL . 8.1 p -69.65 -22.22 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.226 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -51.44 65.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 108.912 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.84 104.98 11.87 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.171 0.986 . . . . 0.0 109.062 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 2.0 mt . . . . . 0 C--N 1.275 -2.657 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.444 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.405 ' CZ ' ' HG2' ' A' ' 593' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.599 0.714 . . . . 0.0 109.661 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.504 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 6.7 t80 -98.09 -41.7 7.81 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.867 0.841 . . . . 0.0 109.678 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.846 HD23 HD12 ' A' ' 594' ' ' ILE . 48.5 tp -129.39 119.77 24.41 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.272 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 89.2 m -94.89 116.43 28.7 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.701 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 1.008 HD11 HD12 ' A' ' 625' ' ' ILE . 7.4 mt -89.91 111.34 22.36 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 583' ' ' LEU . 0.4 OUTLIER -114.08 102.77 55.09 Favored Pre-proline 0 C--N 1.298 -1.638 0 C-N-CA 118.116 -1.434 . . . . 0.0 112.463 -177.842 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 1.093 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.8 Cg_endo -79.63 143.97 17.26 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 N-CA-C 107.134 -1.91 . . . . 0.0 107.134 174.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 1.03 ' HB2' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -128.06 -173.98 0.34 Allowed Pre-proline 0 C--N 1.3 -1.585 0 C-N-CA 118.958 -1.097 . . . . 0.0 112.381 -177.239 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 1.03 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 35.3 Cg_endo -60.5 -33.43 93.88 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.819 1.431 . . . . 0.0 111.556 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 689' ' ' VAL . 4.3 m-20 -59.73 -23.99 63.65 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.734 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 19.1 t -95.73 151.45 19.36 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.804 HD13 ' HB2' ' A' ' 688' ' ' PHE . 7.8 tp -62.34 -17.09 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.026 -1.046 . . . . 0.0 109.647 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.957 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.2 tp -108.21 122.72 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.318 -0.864 . . . . 0.0 110.187 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 586' ' ' SER . 23.6 mp0 -110.07 79.8 1.25 Allowed 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.463 -1.398 . . . . 0.0 109.399 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 1.093 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 27.2 mt-10 -144.71 175.45 10.16 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.643 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.544 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.13 124.77 35.57 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.138 -0.976 . . . . 0.0 108.889 175.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.639 HD13 ' SG ' ' A' ' 611' ' ' CYS . 2.1 mt -109.53 155.73 21.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.918 . . . . 0.0 109.565 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.405 ' HG2' ' CZ ' ' A' ' 576' ' ' ARG . 3.1 mp0 -125.26 110.25 13.81 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.373 -0.829 . . . . 0.0 111.346 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.846 HD12 HD23 ' A' ' 578' ' ' LEU . 2.0 mt -81.61 109.21 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 597' ' ' GLY . 1.2 mp0 -56.15 165.07 1.08 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.446 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.504 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -63.17 70.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.54 -0.725 . . . . 0.0 110.065 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 137.79 21.83 0.48 Allowed Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.819 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.623 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -84.29 101.67 9.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 O-C-N 120.764 -1.433 . . . . 0.0 107.21 178.585 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 16.3 t-20 -145.46 132.57 10.1 Favored Pre-proline 0 C--N 1.283 -2.312 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.869 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.65 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 53.9 Cg_endo -91.71 163.5 27.77 Favored 'Cis proline' 0 C--N 1.311 -1.409 0 C-N-CA 123.31 -1.538 . . . . 0.0 109.045 -2.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.536 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 7.9 t80 -105.11 116.91 32.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.677 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 70.0 m-85 -86.34 146.15 26.6 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.416 -0.803 . . . . 0.0 111.406 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.686 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.9 mt -141.68 140.69 30.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.703 -0.623 . . . . 0.0 109.895 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.732 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 175.25 -161.41 30.59 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.298 -1.429 . . . . 0.0 111.436 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.408 ' CG ' ' O ' ' A' ' 615' ' ' ASP . 5.9 mmm-85 -69.7 -44.65 69.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.973 -0.722 . . . . 0.0 110.82 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.417 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -80.06 128.22 33.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.454 -0.779 . . . . 0.0 110.981 -178.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 1.6 pt-20 -58.54 -12.79 4.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.429 -0.794 . . . . 0.0 109.657 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 608' ' ' ASP . . . . . 0.452 ' OD2' HD13 ' A' ' 730' ' ' LEU . 15.7 t70 -45.25 -36.07 3.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.483 -0.761 . . . . 0.0 110.155 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.677 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 81.8 m -71.44 154.26 41.66 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 121.184 -0.947 . . . . 0.0 109.601 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.536 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 2.7 t-20 -58.98 -14.0 8.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.443 -0.785 . . . . 0.0 110.14 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.686 ' SG ' HG23 ' A' ' 603' ' ' ILE . 6.1 t -120.18 143.94 47.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.492 -0.755 . . . . 0.0 110.033 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.571 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -110.63 129.7 55.75 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 121.992 0.901 . . . . 0.0 112.562 -178.556 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.691 HD11 ' CE1' ' A' ' 692' ' ' PHE . 4.3 mt -146.82 111.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.49 ' O ' HG21 ' A' ' 587' ' ' ILE . 1.4 tt0 -93.05 102.76 15.1 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 117.69 -1.604 . . . . 0.0 109.095 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 3.2 m-20 -138.26 105.29 5.43 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.505 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -42.81 -41.43 3.24 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.412 -0.805 . . . . 0.0 111.881 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.97 -16.88 42.47 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.137 -0.977 . . . . 0.0 111.739 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.598 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.7 OUTLIER -80.75 134.75 35.87 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.121 -0.987 . . . . 0.0 111.319 -178.678 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.485 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.42 162.83 28.02 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.466 -0.771 . . . . 0.0 111.025 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.732 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 34.2 ttp180 -64.36 -46.77 81.98 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.348 -0.845 . . . . 0.0 109.738 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.569 ' HB ' HG23 ' A' ' 727' ' ' VAL . 13.8 m -94.67 2.43 9.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.209 -0.932 . . . . 0.0 109.059 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.764 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.4 t60 -28.59 -47.85 0.05 Allowed 'General case' 0 C--O 1.192 -1.954 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.751 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.845 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.21 145.16 43.32 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 118.311 -1.356 . . . . 0.0 111.166 179.049 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 6.5 p90 -145.86 150.4 36.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.573 -0.704 . . . . 0.0 110.339 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 1.008 HD12 HD11 ' A' ' 580' ' ' LEU . 19.0 mt -103.41 119.56 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 7.0 t80 -112.61 155.4 24.47 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.482 -0.761 . . . . 0.0 109.351 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 0.8 OUTLIER -119.61 136.06 54.54 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.852 0.834 . . . . 0.0 111.183 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.426 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -140.51 163.54 32.56 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 630' ' ' HIS . 0.0 OUTLIER -78.18 133.98 37.7 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.966 -1.084 . . . . 0.0 109.439 -179.492 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.517 ' O ' ' HD2' ' A' ' 629' ' ' ARG . 1.2 t60 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.368 -0.832 . . . . 0.0 111.247 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.76 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.9 mp . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.6 OUTLIER -108.63 124.96 51.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.067 -1.021 . . . . 0.0 110.728 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.736 ' OD2' HD21 ' A' ' 671' ' ' LEU . 17.5 t0 -121.36 135.51 55.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.355 -0.841 . . . . 0.0 110.509 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 25.4 pt -92.69 135.28 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.272 -0.893 . . . . 0.0 110.075 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.645 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.6 m95 -119.62 121.93 40.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.604 -0.685 . . . . 0.0 111.306 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.586 ' HB2' HD11 ' A' ' 672' ' ' LEU . 14.0 t80 -80.78 115.54 20.33 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 9.8 t -107.22 108.45 19.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 111.64 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.516 ' CD2' ' N ' ' A' ' 652' ' ' THR . 12.5 t60 -70.72 158.66 35.88 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.461 -0.774 . . . . 0.0 109.761 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.764 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -149.86 -29.58 0.23 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.43 -0.794 . . . . 0.0 112.441 -179.077 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.55 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.45 -167.59 31.86 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 117.642 -2.218 . . . . 0.0 109.17 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 27.6 m -95.62 -17.44 21.34 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.014 -1.286 . . . . 0.0 113.751 -176.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.516 ' C ' HG23 ' A' ' 656' ' ' VAL . 16.7 m120 -59.48 -4.01 0.54 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.775 -1.203 . . . . 0.0 112.683 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 664' ' ' MET . 3.4 t 71.52 148.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-O 121.494 0.664 . . . . 0.0 110.604 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.436 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -106.83 143.09 35.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.721 -0.612 . . . . 0.0 110.068 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.456 ' CE1' ' CG ' ' A' ' 663' ' ' ARG . 36.6 m-85 -136.0 126.74 27.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.211 -0.93 . . . . 0.0 110.701 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.581 ' HG ' HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -130.02 119.04 22.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.392 -0.817 . . . . 0.0 109.787 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 56.89 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.388 -0.82 . . . . 0.0 110.429 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 659' ' ' LEU . 3.6 t-20 -138.07 5.73 2.57 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.017 -1.052 . . . . 0.0 110.984 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -96.28 132.99 41.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.032 -1.043 . . . . 0.0 110.566 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.456 ' CG ' ' CE1' ' A' ' 658' ' ' TYR . 4.6 tmm_? -99.47 138.69 36.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.448 -0.783 . . . . 0.0 109.872 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.768 ' HG2' HG13 ' A' ' 716' ' ' VAL . 3.6 mtp -117.41 -165.99 1.14 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.229 -0.92 . . . . 0.0 110.716 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.588 HG13 HG23 ' A' ' 668' ' ' THR . 2.5 pt -141.86 -158.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.354 -0.842 . . . . 0.0 110.171 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -82.85 92.05 7.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.2 -0.938 . . . . 0.0 110.759 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 109.65 49.74 0.73 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.588 HG23 HG13 ' A' ' 665' ' ' ILE . 0.2 OUTLIER -118.52 148.39 42.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.06 -1.259 . . . . 0.0 109.943 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.45 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 7.6 tttt -108.5 138.88 44.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.441 -0.787 . . . . 0.0 109.088 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.51 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 5.2 t80 -144.25 147.19 33.25 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.104 -0.997 . . . . 0.0 112.032 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.736 HD21 ' OD2' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -69.76 147.49 50.41 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.554 -0.717 . . . . 0.0 111.583 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.663 HD23 ' OD2' ' A' ' 676' ' ' ASP . 7.8 mt -122.81 99.2 6.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.322 -0.861 . . . . 0.0 111.444 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 673' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 674' ' ' ASP . 94.2 mt-30 -84.65 141.26 30.75 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 673' ' ' GLN . 0.3 OUTLIER -38.34 151.51 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.354 -0.842 . . . . 0.0 110.815 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 64.9 49.59 62.35 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 107.358 -2.297 . . . . 0.0 107.358 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.663 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.3 OUTLIER -115.81 92.43 3.9 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.871 -0.782 . . . . 0.0 110.774 -178.631 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.966 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.2 OUTLIER -93.93 106.98 18.93 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.189 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.581 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.2 pt -106.84 137.31 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.369 0.604 . . . . 0.0 111.404 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.409 ' CG ' ' HB2' ' A' ' 658' ' ' TYR . 2.9 ptmm? -97.17 110.44 22.99 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.488 -0.757 . . . . 0.0 109.418 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.845 HD13 ' SG ' ' A' ' 623' ' ' CYS . 68.5 mt -80.09 -22.65 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.373 -0.829 . . . . 0.0 110.692 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.514 HG22 ' HA ' ' A' ' 689' ' ' VAL . 0.4 OUTLIER -134.64 135.17 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.163 -0.961 . . . . 0.0 109.998 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -138.0 109.13 6.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.934 . . . . 0.0 110.562 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 683' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 686' ' ' ASN . 0.7 OUTLIER -130.16 118.23 21.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.281 -0.887 . . . . 0.0 109.666 179.19 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.95 -32.53 74.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.334 -0.854 . . . . 0.0 111.215 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -84.23 -43.71 14.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.092 -1.005 . . . . 0.0 111.504 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 686' ' ' ASN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 688' ' ' PHE . 88.4 m-20 -73.88 -19.83 60.59 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.137 -0.977 . . . . 0.0 110.798 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.53 22.09 4.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.168 -0.958 . . . . 0.0 110.46 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.804 ' HB2' HD13 ' A' ' 587' ' ' ILE . 0.7 OUTLIER -114.24 83.8 1.94 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.26 1.029 . . . . 0.0 109.472 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' A' ' 586' ' ' SER . 14.9 m -101.04 143.17 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.075 -1.016 . . . . 0.0 110.553 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.734 ' CD1' HG22 ' A' ' 587' ' ' ILE . 47.7 mm -85.19 165.13 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.554 -0.716 . . . . 0.0 109.975 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.455 ' N ' HG22 ' A' ' 690' ' ' ILE . . . -176.8 117.06 0.58 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.966 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.6 m-85 -121.46 137.26 54.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 109.945 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.96 113.95 25.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.282 -0.886 . . . . 0.0 109.98 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.769 HG22 HD11 ' A' ' 578' ' ' LEU . 0.5 OUTLIER -83.65 123.7 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.364 -0.835 . . . . 0.0 109.254 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.39 108.52 10.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.85 -0.531 . . . . 0.0 110.408 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 81.0 mt -86.37 104.42 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.887 . . . . 0.0 109.826 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -77.4 -41.39 40.18 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.421 -0.8 . . . . 0.0 109.453 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.458 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 5.2 m-20 -110.22 140.97 43.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.479 -0.763 . . . . 0.0 110.735 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 15.7 p -115.88 96.27 5.51 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 82.5 m -108.7 114.71 28.74 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 121.752 -0.592 . . . . 0.0 110.738 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 49.46 36.37 23.58 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 704' ' ' ASN . 5.2 tp -98.41 141.18 31.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.613 -0.933 . . . . 0.0 110.195 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.76 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.6 p90 -51.75 -24.92 6.5 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.395 -0.816 . . . . 0.0 109.756 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.798 ' O ' HD23 ' A' ' 702' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.51 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 121.723 0.773 . . . . 0.0 109.356 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 36.0 m -105.25 168.7 2.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.666 -0.646 . . . . 0.0 109.63 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.768 HG13 ' HG2' ' A' ' 664' ' ' MET . 52.7 t -71.34 128.48 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.326 -0.859 . . . . 0.0 111.139 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.62 162.3 13.63 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -98.64 154.39 17.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.981 -1.074 . . . . 0.0 110.467 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 719' ' ' GLN . . . . . 0.428 ' HG3' ' HB3' ' A' ' 723' ' ' GLU . 0.4 OUTLIER -79.69 145.08 33.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.54 -0.725 . . . . 0.0 110.403 -179.69 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 34.3 p -121.07 -176.8 3.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 110.093 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.78 -32.21 63.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.292 -0.88 . . . . 0.0 110.448 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -64.49 -52.3 58.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.386 -0.822 . . . . 0.0 110.22 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.428 ' HB3' ' HG3' ' A' ' 719' ' ' GLN . 0.6 OUTLIER -64.42 -40.3 95.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.328 -0.857 . . . . 0.0 110.051 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.458 ' O ' HG12 ' A' ' 727' ' ' VAL . 18.3 ttpp -56.93 -35.11 68.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.311 -0.868 . . . . 0.0 109.945 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 725' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 728' ' ' LYS . 0.9 OUTLIER -67.7 -35.79 79.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.472 -0.768 . . . . 0.0 109.994 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.414 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 50.3 mt -57.06 -46.39 82.52 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.333 -0.854 . . . . 0.0 110.336 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.569 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.2 p -76.28 -24.33 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.613 -0.68 . . . . 0.0 110.914 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 728' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 725' ' ' ASP . 0.7 OUTLIER -53.32 -45.18 68.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.055 -1.028 . . . . 0.0 108.956 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -116.67 103.81 10.74 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 122.197 0.999 . . . . 0.0 109.057 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.452 HD13 ' OD2' ' A' ' 608' ' ' ASP . 2.2 mt . . . . . 0 C--N 1.274 -2.708 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.375 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.1 OUTLIER -120.96 -39.69 2.69 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.843 0.83 . . . . 0.0 109.415 -179.583 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.042 HD22 HD12 ' A' ' 594' ' ' ILE . 8.5 tt -120.31 119.52 33.38 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.326 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 71.2 m -99.44 118.89 37.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 109.52 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.658 HD11 HD12 ' A' ' 625' ' ' ILE . 5.8 mt -91.37 111.97 23.68 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.79 101.82 54.2 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 118.075 -1.45 . . . . 0.0 112.736 -177.77 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 1.047 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 44.2 Cg_endo -79.75 145.78 18.31 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 N-CA-C 106.784 -2.045 . . . . 0.0 106.784 174.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.73 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.33 -174.37 0.31 Allowed Pre-proline 0 N--CA 1.494 1.753 0 C-N-CA 118.81 -1.156 . . . . 0.0 112.763 -177.104 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.73 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.9 Cg_endo -66.79 -28.73 43.15 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 124.111 1.585 . . . . 0.0 110.319 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -59.4 -28.35 66.83 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 53.7 p -95.45 153.73 17.55 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.645 ' H ' HD13 ' A' ' 690' ' ' ILE . 3.8 tp -54.76 -16.98 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.333 -0.855 . . . . 0.0 109.944 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.86 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.6 tp -116.3 119.34 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.265 -0.897 . . . . 0.0 110.575 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.434 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 3.2 pm0 -112.39 80.73 1.37 Allowed 'General case' 0 N--CA 1.509 2.498 0 O-C-N 120.444 -1.41 . . . . 0.0 109.143 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 1.047 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 6.7 mm-40 -142.57 175.78 9.53 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.625 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.57 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.92 125.85 40.37 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.083 -1.011 . . . . 0.0 109.456 176.779 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 17.4 mt -111.17 156.02 22.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.405 -0.809 . . . . 0.0 109.649 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -125.23 111.12 14.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.378 -0.826 . . . . 0.0 111.836 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.042 HD12 HD22 ' A' ' 578' ' ' LEU . 45.9 mt -80.42 110.81 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 596' ' ' GLN . 2.0 mt-30 -70.71 109.47 4.95 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.493 ' HA ' ' CD1' ' A' ' 577' ' ' PHE . 0.5 OUTLIER 20.43 53.89 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 178.333 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . 109.96 44.62 1.01 Allowed Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.603 -1.284 . . . . 0.0 111.03 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 598' ' ' VAL . 1.0 OUTLIER -79.63 103.85 7.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 177.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.445 ' CB ' ' HB3' ' A' ' 627' ' ' LYS . 0.2 OUTLIER -140.97 140.52 21.55 Favored Pre-proline 0 C--N 1.281 -2.371 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.639 -178.703 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.574 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.2 Cg_endo -88.79 160.82 40.67 Favored 'Cis proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.721 -2.199 . . . . 0.0 109.07 -0.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -106.56 116.82 32.58 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.706 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 58.1 m-85 -91.25 145.86 24.31 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.39 -0.818 . . . . 0.0 111.037 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.724 HD11 HG13 ' A' ' 625' ' ' ILE . 2.2 mt -140.02 141.05 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.33 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.713 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 175.33 -165.85 37.04 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.356 -1.402 . . . . 0.0 111.321 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 13.2 tpt180 -66.69 -38.81 87.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.956 -0.732 . . . . 0.0 110.777 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.471 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -84.22 126.8 33.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.398 -0.814 . . . . 0.0 110.748 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.422 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -59.3 -12.68 6.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 110.009 179.125 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.32 -36.97 6.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.882 . . . . 0.0 110.036 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.706 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 75.3 m -68.93 153.65 43.42 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 121.265 -0.897 . . . . 0.0 109.773 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.572 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 3.1 t-20 -58.63 -14.78 9.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.485 -0.76 . . . . 0.0 110.238 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.699 ' SG ' HG23 ' A' ' 603' ' ' ILE . 6.6 t -119.95 143.46 47.99 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.582 -0.699 . . . . 0.0 109.528 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.65 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -110.23 130.88 55.47 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 122.054 0.93 . . . . 0.0 112.856 -178.268 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.669 HD11 ' CE1' ' A' ' 692' ' ' PHE . 3.9 mt -147.15 110.39 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.436 ' O ' HG12 ' A' ' 587' ' ' ILE . 2.7 tt0 -92.31 102.98 15.48 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 117.666 -1.614 . . . . 0.0 109.277 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.857 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.0 OUTLIER -139.55 106.15 5.34 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.692 177.322 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -42.94 -43.68 4.25 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.485 -0.76 . . . . 0.0 111.962 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -83.53 -17.13 42.89 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.144 -0.973 . . . . 0.0 111.729 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.947 HD13 HD11 ' A' ' 681' ' ' ILE . 0.8 OUTLIER -78.01 134.65 37.77 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.07 -1.019 . . . . 0.0 110.694 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.479 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.1 m -73.37 161.14 30.79 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.337 -0.852 . . . . 0.0 110.915 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.713 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 43.6 mtm180 -64.2 -45.63 87.47 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.235 -0.916 . . . . 0.0 109.309 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.708 ' HB ' HG23 ' A' ' 727' ' ' VAL . 15.7 m -94.66 2.0 9.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.83 0.824 . . . . 0.0 109.402 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.6 t60 -28.28 -46.91 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.771 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.823 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -136.17 144.93 45.26 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.523 178.86 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 6.3 p90 -145.7 143.65 29.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.485 -0.759 . . . . 0.0 110.229 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.724 HG13 HD11 ' A' ' 603' ' ' ILE . 76.8 mt -103.43 117.66 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 8.3 t80 -110.95 155.0 23.32 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.853 0.835 . . . . 0.0 110.234 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.445 ' HB3' ' CB ' ' A' ' 599' ' ' ASN . 3.1 tppp? -118.96 137.13 53.71 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 121.372 0.606 . . . . 0.0 109.735 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.0 OUTLIER -133.88 163.82 28.65 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.566 -0.709 . . . . 0.0 111.038 -179.11 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.494 ' HD2' ' O ' ' A' ' 644' ' ' LEU . 2.5 tpt180 -77.66 116.2 18.02 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.366 -0.834 . . . . 0.0 108.929 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 703' ' ' PHE . 8.5 t60 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.651 0.738 . . . . 0.0 110.649 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.662 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.6 mp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 628' ' ' LYS . 41.6 m-20 -112.22 124.72 53.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.873 -1.142 . . . . 0.0 111.325 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.494 ' OD1' HD21 ' A' ' 671' ' ' LEU . 5.6 t0 -98.34 156.57 16.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.482 -0.761 . . . . 0.0 109.647 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.49 HD13 HD12 ' A' ' 578' ' ' LEU . 12.7 pt -106.25 130.18 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.278 -0.889 . . . . 0.0 110.38 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.729 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.6 m95 -117.84 124.38 48.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.841 -0.537 . . . . 0.0 111.194 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.716 ' HB2' HD11 ' A' ' 672' ' ' LEU . 7.1 t80 -83.91 114.47 21.7 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 17.4 t -109.71 106.1 15.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.061 -1.024 . . . . 0.0 112.112 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.549 ' CD2' ' N ' ' A' ' 652' ' ' THR . 14.4 t60 -67.54 162.55 23.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.454 -0.778 . . . . 0.0 109.854 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -154.47 -30.98 0.11 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.304 -0.872 . . . . 0.0 112.509 -179.244 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.557 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.62 -168.57 34.18 Favored Glycine 0 N--CA 1.497 2.712 0 C-N-CA 117.82 -2.133 . . . . 0.0 109.766 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 11.1 m -89.71 -18.78 25.74 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.088 -1.242 . . . . 0.0 114.217 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.692 ' O ' HG22 ' A' ' 656' ' ' VAL . 24.4 m120 -59.32 -3.03 0.36 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.605 -1.309 . . . . 0.0 112.728 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 62.52 142.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.549 -0.719 . . . . 0.0 110.164 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.482 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -96.95 151.8 19.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.589 -0.695 . . . . 0.0 110.554 -179.168 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.481 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 12.6 m-85 -138.02 125.46 21.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.363 -0.836 . . . . 0.0 110.175 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.761 HD21 ' CG1' ' A' ' 678' ' ' ILE . 1.7 mt -129.4 110.15 11.66 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.382 -0.824 . . . . 0.0 109.83 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 59.02 -80.67 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.428 -0.795 . . . . 0.0 110.37 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 659' ' ' LEU . 7.6 p-10 -144.64 13.73 1.54 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 110.94 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -100.16 116.74 32.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.017 -1.052 . . . . 0.0 110.225 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -81.46 136.14 35.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.348 -0.845 . . . . 0.0 109.676 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.789 ' CG ' HG21 ' A' ' 716' ' ' VAL . 1.6 mtp -119.07 -167.39 1.38 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 0.0 110.223 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.536 HG13 HG23 ' A' ' 668' ' ' THR . 11.2 pt -146.74 -162.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 652' ' ' THR . 28.5 tt0 -75.68 79.4 2.65 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.342 -0.849 . . . . 0.0 111.272 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.93 58.07 0.21 Allowed Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.833 -1.175 . . . . 0.0 110.678 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 1.2 p -123.9 145.58 49.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.994 -1.298 . . . . 0.0 110.074 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -108.52 136.94 47.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.398 -0.814 . . . . 0.0 109.205 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 671' ' ' LEU . 8.1 t80 -144.45 146.81 32.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.163 -0.96 . . . . 0.0 111.49 -178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.729 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.9 OUTLIER -72.17 145.88 47.77 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.413 -0.804 . . . . 0.0 111.628 -179.374 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.716 HD11 ' HB2' ' A' ' 649' ' ' TYR . 6.2 mt -115.55 112.94 22.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.228 -0.92 . . . . 0.0 111.318 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 673' ' ' GLN . . . . . 0.498 ' O ' HG11 ' A' ' 694' ' ' VAL . 15.3 mt-30 -84.53 -177.03 6.5 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.55 149.7 42.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.982 -1.074 . . . . 0.0 109.711 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 59.68 50.26 69.61 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.2 94.74 5.89 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.74 0.781 . . . . 0.0 110.643 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.912 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 5.9 tt0 -93.49 107.42 19.27 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.761 ' CG1' HD21 ' A' ' 659' ' ' LEU . 1.9 mp -104.15 137.15 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.642 -0.661 . . . . 0.0 111.88 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -99.58 109.89 22.37 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.823 HD13 ' SG ' ' A' ' 623' ' ' CYS . 74.9 mt -79.52 -19.89 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.352 -0.842 . . . . 0.0 111.076 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.947 HD11 HD13 ' A' ' 618' ' ' LEU . 8.4 mt -141.6 141.33 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.967 -1.083 . . . . 0.0 110.762 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -137.79 108.77 6.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.43 -0.794 . . . . 0.0 109.965 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.96 118.43 29.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.268 -0.895 . . . . 0.0 110.161 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -66.33 -46.87 75.36 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.364 -0.835 . . . . 0.0 110.963 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -84.93 -43.43 14.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.258 -0.901 . . . . 0.0 111.2 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 686' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -91.23 0.39 57.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.262 -0.899 . . . . 0.0 111.004 -179.353 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 687' ' ' LYS . . . . . 0.626 ' O ' HG23 ' A' ' 689' ' ' VAL . 0.0 OUTLIER 65.49 -67.73 0.13 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.42 -0.8 . . . . 0.0 109.777 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.595 ' HD2' HG21 ' A' ' 681' ' ' ILE . 0.1 OUTLIER 24.52 61.0 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.369 0.604 . . . . 0.0 111.317 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 687' ' ' LYS . 59.8 t -101.97 142.46 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.422 -0.799 . . . . 0.0 110.718 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.857 HD11 ' OD2' ' A' ' 615' ' ' ASP . 40.4 mm -122.64 165.38 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -176.35 121.01 0.78 Allowed Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.912 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 10.6 m-85 -119.62 136.51 54.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.526 -0.985 . . . . 0.0 108.798 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -98.77 114.32 26.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 110.898 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 694' ' ' VAL . 1.2 t -84.78 114.0 24.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -122.37 104.34 9.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.733 -0.604 . . . . 0.0 109.826 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 83.3 mt -88.71 103.28 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.33 -0.856 . . . . 0.0 109.679 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.0 -41.75 22.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 0.0 108.927 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.7 OUTLIER -109.92 141.29 42.87 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.391 0.615 . . . . 0.0 109.629 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 16.3 p -113.29 95.8 5.56 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 40.7 m -129.65 134.62 47.78 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.87 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 57.72 29.35 61.28 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.596 ' O ' HD22 ' A' ' 644' ' ' LEU . 1.0 OUTLIER -113.83 128.07 56.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.503 -0.998 . . . . 0.0 110.24 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.662 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.5 p90 -50.44 -24.01 2.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.481 -0.762 . . . . 0.0 110.753 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.529 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.582 ' NH2' HD22 ' A' ' 659' ' ' LEU . 3.5 mmm-85 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.223 0.535 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 32.0 m -108.04 152.25 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.533 -0.729 . . . . 0.0 109.522 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.789 HG21 ' CG ' ' A' ' 664' ' ' MET . 14.6 p -104.21 133.29 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.725 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.0 mp -104.01 162.76 12.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.416 -0.803 . . . . 0.0 110.001 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -93.33 154.27 18.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.223 -0.923 . . . . 0.0 110.163 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -79.61 148.02 31.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.36 -0.838 . . . . 0.0 110.358 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 11.9 p -121.07 -176.37 3.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.381 -0.824 . . . . 0.0 110.359 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.49 -29.0 33.89 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.332 -0.855 . . . . 0.0 110.093 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.8 -51.32 65.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.461 -0.774 . . . . 0.0 109.745 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -64.06 -43.64 94.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.45 -0.781 . . . . 0.0 109.937 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.543 ' O ' HG12 ' A' ' 727' ' ' VAL . 16.1 tttt -56.41 -32.86 65.24 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.35 -0.843 . . . . 0.0 110.06 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -68.78 -36.31 78.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.387 -0.821 . . . . 0.0 110.364 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 37.8 mt -60.02 -46.32 89.9 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.362 -0.836 . . . . 0.0 110.439 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.708 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.1 p -69.15 -19.67 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.04 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.53 -50.8 69.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 108.877 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -116.85 105.29 12.2 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 122.132 0.968 . . . . 0.0 109.122 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.515 HD21 HG12 ' A' ' 621' ' ' VAL . 4.5 mt . . . . . 0 C--N 1.274 -2.68 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.472 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.413 ' HD3' ' HG2' ' A' ' 593' ' ' GLU . 14.0 ttp-105 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 121.707 0.765 . . . . 0.0 109.202 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.681 ' CZ ' HD13 ' A' ' 702' ' ' LEU . 3.0 t80 -92.47 -43.52 9.14 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.913 0.863 . . . . 0.0 109.475 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.079 HD23 HD12 ' A' ' 594' ' ' ILE . 5.4 tp -125.1 119.7 29.36 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.628 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 36.2 m -96.75 118.66 33.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.53 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.788 HD11 HD12 ' A' ' 625' ' ' ILE . 3.3 mt -94.72 112.3 24.04 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.563 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -111.97 104.18 55.83 Favored Pre-proline 0 C--N 1.3 -1.563 0 C-N-CA 118.467 -1.293 . . . . 0.0 112.935 -177.328 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 1.086 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.7 Cg_endo -76.81 142.46 22.59 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 N-CA-C 105.72 -2.454 . . . . 0.0 105.72 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 1.027 ' HB2' ' HD2' ' A' ' 584' ' ' PRO . 0.1 OUTLIER -126.78 -175.28 0.41 Allowed Pre-proline 0 N--CA 1.499 1.982 0 C-N-CA 118.416 -1.314 . . . . 0.0 113.806 -176.052 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 1.027 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 37.7 Cg_endo -65.75 -33.43 44.17 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.961 1.506 . . . . 0.0 111.381 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.08 -30.34 68.01 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.598 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 84.2 p -97.59 153.77 17.97 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.687 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.2 OUTLIER -61.6 -11.06 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.935 . . . . 0.0 109.839 178.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.766 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 8.5 mm -98.54 116.95 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.351 -0.843 . . . . 0.0 109.779 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 586' ' ' SER . 17.8 mp0 -118.67 70.32 0.82 Allowed 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.491 -1.38 . . . . 0.0 109.932 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 1.086 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 18.0 mt-10 -144.31 175.44 10.09 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.014 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.496 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.61 125.57 36.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.995 -1.066 . . . . 0.0 109.04 176.371 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.673 HD13 ' HA ' ' A' ' 611' ' ' CYS . 46.5 mt -111.63 155.05 23.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 109.828 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.413 ' HG2' ' HD3' ' A' ' 576' ' ' ARG . 16.3 mp0 -126.27 110.59 13.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.835 . . . . 0.0 111.461 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.079 HD12 HD23 ' A' ' 578' ' ' LEU . 3.5 mt -77.94 109.52 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.06 -1.025 . . . . 0.0 108.32 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -53.61 161.22 1.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.451 -0.781 . . . . 0.0 109.766 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.506 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.3 OUTLIER -48.94 79.05 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.706 -0.621 . . . . 0.0 111.551 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 107.41 34.93 2.78 Favored Glycine 0 N--CA 1.486 1.995 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.844 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.722 ' HB ' HG23 ' A' ' 594' ' ' ILE . 1.0 OUTLIER -79.77 103.05 6.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.383 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.4 t30 -143.01 135.25 13.3 Favored Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.023 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.633 ' HB3' HD23 ' A' ' 726' ' ' LEU . 56.0 Cg_endo -91.08 161.9 29.67 Favored 'Cis proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.781 -1.758 . . . . 0.0 108.987 -1.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.516 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -106.62 116.2 31.52 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.628 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 63.6 m-85 -83.02 143.63 30.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 0.0 110.288 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.775 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.9 mt -142.93 142.08 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.563 -0.711 . . . . 0.0 110.224 -178.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.787 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 165.42 -161.2 34.67 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.339 -1.41 . . . . 0.0 111.4 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.461 ' N ' HD23 ' A' ' 618' ' ' LEU . 3.4 mmm-85 -63.74 -53.87 44.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.78 -0.835 . . . . 0.0 111.834 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.481 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -71.59 124.73 25.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 111.239 -178.592 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.485 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.1 OUTLIER -54.07 -17.67 2.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 0.0 109.813 178.894 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -45.18 -30.99 1.29 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 0.0 109.272 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 602' ' ' PHE . 1.7 m -68.6 133.81 49.05 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.516 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 1.9 t-20 -45.08 -26.93 0.51 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.318 -0.864 . . . . 0.0 109.759 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.775 ' HB3' HG23 ' A' ' 603' ' ' ILE . 13.0 t -106.23 143.61 34.1 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.485 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -108.91 125.15 51.71 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.253 1.025 . . . . 0.0 113.161 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.766 ' HA ' ' CD1' ' A' ' 588' ' ' ILE . 18.3 mt -143.13 108.31 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.431 ' HA ' ' HD2' ' A' ' 605' ' ' ARG . 3.8 mt-10 -97.77 104.41 16.43 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 118.302 -1.359 . . . . 0.0 109.25 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.705 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.0 OUTLIER -137.99 106.19 5.75 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.238 177.439 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -42.49 -39.48 2.27 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.485 -0.759 . . . . 0.0 111.678 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.67 -17.8 40.2 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.152 -0.968 . . . . 0.0 111.303 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.751 HD12 HD11 ' A' ' 681' ' ' ILE . 0.7 OUTLIER -79.3 140.45 37.56 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.177 -0.952 . . . . 0.0 110.562 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.427 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.82 161.02 29.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.372 -0.83 . . . . 0.0 110.718 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.787 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 9.8 ttp180 -63.6 -45.65 89.4 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.25 -0.906 . . . . 0.0 109.173 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.873 HG11 HG23 ' A' ' 727' ' ' VAL . 7.7 t -95.98 1.92 10.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.483 -0.761 . . . . 0.0 109.931 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.751 ' O ' ' N ' ' A' ' 652' ' ' THR . 9.2 t60 -27.49 -41.82 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.078 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.739 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.7 OUTLIER -136.76 145.0 44.07 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 118.228 -1.389 . . . . 0.0 110.861 179.195 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.551 ' CE2' ' CB ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -147.63 140.75 25.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.579 -0.7 . . . . 0.0 109.992 178.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.788 HD12 HD11 ' A' ' 580' ' ' LEU . 0.6 OUTLIER -103.21 136.88 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.231 -0.918 . . . . 0.0 109.327 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.544 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 7.6 t80 -128.97 155.83 44.75 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.503 -0.748 . . . . 0.0 109.636 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.677 ' HE2' HG23 ' A' ' 647' ' ' ILE . 1.2 tppp? -119.02 136.93 53.87 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.404 0.621 . . . . 0.0 110.622 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.433 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -140.32 163.82 31.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.627 -0.67 . . . . 0.0 110.709 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -78.39 128.61 33.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.377 -0.827 . . . . 0.0 109.411 -179.733 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.537 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.5 t60 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.421 -0.799 . . . . 0.0 110.845 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.767 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.2 mp . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.8 OUTLIER -121.56 124.6 44.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.083 -1.01 . . . . 0.0 111.186 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.656 ' CG ' HD21 ' A' ' 671' ' ' LEU . 3.2 t0 -114.11 149.0 36.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.383 -0.823 . . . . 0.0 109.7 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.677 HG23 ' HE2' ' A' ' 627' ' ' LYS . 5.4 pt -94.76 136.81 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.211 -0.93 . . . . 0.0 110.194 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.601 ' CH2' HD12 ' A' ' 671' ' ' LEU . 95.7 m95 -119.39 121.37 39.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.653 -0.654 . . . . 0.0 110.525 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.94 ' HB2' HD11 ' A' ' 672' ' ' LEU . 5.2 t80 -80.53 117.95 21.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.138 -0.977 . . . . 0.0 108.6 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 668' ' ' THR . 4.3 m -107.84 102.57 11.77 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.422 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.667 ' HE1' ' O ' ' A' ' 653' ' ' GLY . 28.5 t-80 -64.47 163.58 13.1 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.29 -0.881 . . . . 0.0 109.503 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.751 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -151.9 -28.78 0.17 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.667 ' O ' ' HE1' ' A' ' 651' ' ' HIS . . . -79.16 -169.27 36.94 Favored Glycine 0 N--CA 1.496 2.665 0 O-C-N 119.204 -2.185 . . . . 0.0 109.856 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 12.6 m -94.06 -18.62 21.64 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.178 -1.189 . . . . 0.0 113.9 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.53 ' O ' HG12 ' A' ' 656' ' ' VAL . 29.8 m120 -61.86 -4.26 1.48 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.625 -1.297 . . . . 0.0 111.896 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 78.21 169.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 121.919 0.866 . . . . 0.0 110.607 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.582 ' HB3' ' CD2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -125.35 149.44 48.11 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.436 -179.222 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.416 ' CZ ' ' HG3' ' A' ' 663' ' ' ARG . 2.9 m-85 -138.58 126.7 22.71 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.313 -0.867 . . . . 0.0 110.657 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.825 HD23 ' CE2' ' A' ' 670' ' ' PHE . 24.8 tp -125.67 107.63 10.76 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.359 -0.838 . . . . 0.0 109.914 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 27.2 t30 64.73 -68.09 0.11 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.648 -0.658 . . . . 0.0 110.412 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.8 OUTLIER -158.86 24.68 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 110.164 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.31 132.87 56.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -0.937 . . . . 0.0 110.425 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 658' ' ' TYR . 5.4 ttt180 -95.12 130.14 41.94 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.467 -0.77 . . . . 0.0 110.28 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.692 ' HG2' HG13 ' A' ' 716' ' ' VAL . 2.4 mtp -110.05 -164.58 0.94 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.409 -0.807 . . . . 0.0 110.056 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.605 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.8 pt -140.21 -163.24 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 110.213 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -77.5 93.64 4.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.333 -0.854 . . . . 0.0 110.653 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.42 53.58 0.87 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.605 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.0 OUTLIER -118.24 147.74 43.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.183 -1.186 . . . . 0.0 109.911 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.422 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 2.7 tttm -108.38 139.5 43.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.538 -0.726 . . . . 0.0 109.53 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.825 ' CE2' HD23 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -144.47 142.87 30.57 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.093 -179.226 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.656 HD21 ' CG ' ' A' ' 646' ' ' ASP . 0.4 OUTLIER -69.87 147.01 50.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.519 -0.738 . . . . 0.0 110.753 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.94 HD11 ' HB2' ' A' ' 649' ' ' TYR . 26.1 mt -118.08 131.33 56.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.356 -0.84 . . . . 0.0 111.277 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 673' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 674' ' ' ASP . 61.6 mt-30 -113.19 143.17 44.84 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 673' ' ' GLN . 3.7 p-10 -41.03 144.91 0.24 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.184 -0.947 . . . . 0.0 110.748 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.48 49.39 44.92 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.687 ' OD2' HD11 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -109.7 97.43 6.97 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.788 0.804 . . . . 0.0 110.616 -178.846 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.706 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.82 107.01 18.95 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.721 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.757 HG22 HD13 ' A' ' 659' ' ' LEU . 35.3 pt -108.38 136.84 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.48 -0.763 . . . . 0.0 111.56 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.73 110.29 22.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.514 -0.741 . . . . 0.0 109.253 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.739 HD13 ' SG ' ' A' ' 623' ' ' CYS . 70.8 mt -76.74 -26.41 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.335 -0.853 . . . . 0.0 110.191 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.751 HD11 HD12 ' A' ' 618' ' ' LEU . 4.4 mt -143.29 133.84 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 109.961 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -137.61 114.61 10.73 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.359 -0.838 . . . . 0.0 110.329 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 683' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' A' ' 686' ' ' ASN . 0.2 OUTLIER -127.51 118.33 23.79 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.318 -0.864 . . . . 0.0 110.028 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -65.94 -42.76 89.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.393 -0.817 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -83.73 -43.34 15.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.332 -0.855 . . . . 0.0 110.844 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 686' ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 683' ' ' ASP . 1.9 t-20 -80.31 -12.05 59.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.283 -0.886 . . . . 0.0 110.663 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 57.16 18.77 4.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.13 -0.981 . . . . 0.0 110.5 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.404 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -77.52 76.21 4.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.161 179.213 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 681' ' ' ILE . 60.5 t -101.86 137.23 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.458 -0.776 . . . . 0.0 110.941 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.705 HD11 ' OD2' ' A' ' 615' ' ' ASP . 49.0 mm -118.73 164.43 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -178.02 124.94 0.96 Allowed Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.496 -1.335 . . . . 0.0 110.196 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.706 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 13.4 m-85 -120.43 137.76 54.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.591 -0.946 . . . . 0.0 109.132 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.4 113.95 26.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.157 -0.964 . . . . 0.0 109.985 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 694' ' ' VAL . 1.1 t -83.06 118.16 30.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.481 -0.762 . . . . 0.0 109.151 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -128.8 104.6 7.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.65 -0.657 . . . . 0.0 110.097 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.562 ' CG1' HD12 ' A' ' 578' ' ' LEU . 69.1 mt -81.86 104.69 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.46 -0.775 . . . . 0.0 109.832 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.48 -42.52 35.5 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.439 -0.788 . . . . 0.0 108.875 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.5 ' O ' ' CD1' ' A' ' 577' ' ' PHE . 3.9 m-20 -110.84 141.49 44.14 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.463 0.649 . . . . 0.0 110.68 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 9.0 p -114.04 96.2 5.69 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.8 m -94.65 100.03 12.05 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.261 0.553 . . . . 0.0 111.735 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 45.9 34.48 5.64 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.867 HD23 ' O ' ' A' ' 704' ' ' ASN . 1.1 tp -84.47 150.22 25.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -1.12 . . . . 0.0 110.043 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.767 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.6 p90 -51.49 -24.44 5.11 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.314 -0.866 . . . . 0.0 110.038 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.867 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.6 t30 . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.708 ' NH1' HD21 ' A' ' 659' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 121.54 0.686 . . . . 0.0 110.094 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 34.2 m -106.57 153.07 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.65 -0.656 . . . . 0.0 109.69 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.692 HG13 ' HG2' ' A' ' 664' ' ' MET . 84.1 t -85.06 133.32 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.22 -0.925 . . . . 0.0 110.916 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.6 mt -105.39 162.38 13.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.555 -0.716 . . . . 0.0 109.6 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -101.24 153.53 19.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.167 -0.958 . . . . 0.0 110.292 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -85.35 151.03 24.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.347 -0.846 . . . . 0.0 110.263 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 19.0 p -121.33 -176.66 3.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.329 -0.857 . . . . 0.0 110.47 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.68 -29.81 40.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.45 -0.781 . . . . 0.0 110.119 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 722' ' ' GLU . . . . . 0.434 ' O ' HD13 ' A' ' 726' ' ' LEU . 3.6 tt0 -63.49 -52.29 61.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.673 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.38 -38.18 90.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.427 -0.795 . . . . 0.0 109.496 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.477 ' O ' HG12 ' A' ' 727' ' ' VAL . 11.8 tttt -57.76 -32.27 67.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.421 -0.799 . . . . 0.0 109.833 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.69 -40.33 80.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.259 -0.901 . . . . 0.0 110.409 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.633 HD23 ' HB3' ' A' ' 600' ' ' PRO . 11.0 mp -55.91 -47.02 78.22 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.223 -0.923 . . . . 0.0 110.843 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.873 HG23 HG11 ' A' ' 621' ' ' VAL . 7.2 p -69.23 -18.05 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.486 -0.759 . . . . 0.0 110.232 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.37 -43.96 68.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 108.854 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -116.96 104.32 11.16 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 122.254 1.026 . . . . 0.0 109.221 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.413 ' O ' ' CD2' ' A' ' 602' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--N 1.275 -2.664 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.402 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.6 ' CD2' ' O ' ' A' ' 698' ' ' ASP . 0.7 OUTLIER -110.01 -41.0 4.58 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.831 0.824 . . . . 0.0 109.832 -179.1 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.69 ' CD2' HD12 ' A' ' 594' ' ' ILE . 17.4 tp -121.17 127.68 51.76 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.448 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 94.1 m -111.38 117.97 34.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 1.051 HD11 HD12 ' A' ' 625' ' ' ILE . 6.1 mt -90.71 112.25 23.94 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.424 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 1.2 mmtt -113.54 101.05 53.24 Favored Pre-proline 0 C--N 1.303 -1.442 0 C-N-CA 118.02 -1.472 . . . . 0.0 112.611 -178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 1.115 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.5 Cg_endo -78.79 145.44 20.12 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 N-CA-C 106.232 -2.257 . . . . 0.0 106.232 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.765 HD13 ' OD2' ' A' ' 585' ' ' ASP . 0.0 OUTLIER -123.54 -176.76 0.46 Allowed Pre-proline 0 N--CA 1.498 1.931 0 C-N-CA 118.251 -1.38 . . . . 0.0 114.094 -175.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.726 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.6 Cg_endo -67.84 -34.0 25.3 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.825 1.683 . . . . 0.0 111.953 -178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.765 ' OD2' HD13 ' A' ' 583' ' ' LEU . 1.8 p30 -58.31 -29.69 66.08 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.772 -1.205 . . . . 0.0 107.931 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.503 ' HB3' ' N ' ' A' ' 691' ' ' GLY . 4.3 p -96.25 150.66 20.3 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.585 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.1 OUTLIER -55.64 -17.79 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 0.0 109.467 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.765 HD12 ' HA ' ' A' ' 613' ' ' ILE . 9.1 mm -100.03 114.87 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 3.6 pm0 -126.01 74.59 1.44 Allowed 'General case' 0 N--CA 1.51 2.569 0 O-C-N 120.581 -1.325 . . . . 0.0 110.423 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 1.115 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.2 mt-10 -143.31 175.9 9.55 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.506 -0.77 . . . . 0.0 108.993 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.525 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.3 127.04 42.01 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.761 -1.212 . . . . 0.0 109.476 176.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 611' ' ' CYS . 67.2 mt -111.32 156.21 21.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.419 -0.801 . . . . 0.0 109.628 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -124.46 110.77 14.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 111.423 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.69 HD12 ' CD2' ' A' ' 578' ' ' LEU . 31.3 mt -81.01 109.04 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.534 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -66.89 118.17 10.0 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.533 -0.729 . . . . 0.0 111.955 -177.801 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.593 ' HA ' ' HB3' ' A' ' 577' ' ' PHE . 6.8 tp-100 13.32 61.99 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 95.61 50.75 1.94 Allowed Glycine 0 N--CA 1.487 2.04 0 C-N-CA 119.931 -1.128 . . . . 0.0 110.585 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.6 OUTLIER -79.49 105.09 8.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.01 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.4 OUTLIER -140.26 142.0 28.22 Favored Pre-proline 0 C--N 1.28 -2.417 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.79 -178.462 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.482 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.5 Cg_endo -88.91 159.12 39.19 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.564 -2.265 . . . . 0.0 109.001 -0.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.556 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 5.1 t80 -106.53 116.24 31.58 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.811 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 39.6 m-85 -91.43 146.01 24.16 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 110.757 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.743 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.7 mt -139.91 141.08 34.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.48 -0.763 . . . . 0.0 110.618 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.741 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 173.24 -164.88 36.86 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.51 -1.329 . . . . 0.0 111.186 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.431 ' HD2' ' HA ' ' A' ' 614' ' ' GLU . 8.5 mmm-85 -66.66 -41.0 88.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.892 -0.769 . . . . 0.0 110.866 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.411 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -83.12 132.04 35.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -0.848 . . . . 0.0 111.218 -178.801 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.542 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.7 OUTLIER -61.24 -13.04 15.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.413 -0.804 . . . . 0.0 109.858 178.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.45 -37.4 5.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.3 -0.875 . . . . 0.0 109.858 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.811 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 64.4 m -71.23 148.79 46.9 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.403 -0.811 . . . . 0.0 109.613 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.555 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -56.0 -16.68 5.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.482 -0.761 . . . . 0.0 110.655 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.743 ' SG ' HG23 ' A' ' 603' ' ' ILE . 10.5 t -115.67 143.34 45.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.439 -0.788 . . . . 0.0 109.542 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.542 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -112.82 121.28 44.22 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.169 -0.957 . . . . 0.0 112.689 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.765 ' HA ' HD12 ' A' ' 588' ' ' ILE . 18.5 mt -141.73 108.25 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.431 ' HA ' ' HD2' ' A' ' 605' ' ' ARG . 3.8 tm-20 -90.64 103.89 16.53 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.625 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.489 ' HB2' ' HB3' ' A' ' 618' ' ' LEU . 1.5 m-20 -138.25 105.78 5.57 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.675 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -39.55 -52.34 2.17 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.755 -0.59 . . . . 0.0 112.256 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -75.12 -16.49 60.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.09 -1.006 . . . . 0.0 111.364 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.906 HD13 HD11 ' A' ' 681' ' ' ILE . 0.8 OUTLIER -80.0 132.67 36.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.215 -0.928 . . . . 0.0 111.134 -178.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.518 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -74.77 162.39 28.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.489 -0.757 . . . . 0.0 110.812 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.741 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.3 OUTLIER -64.19 -46.06 85.59 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.288 -0.883 . . . . 0.0 109.389 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.687 ' HB ' HG23 ' A' ' 727' ' ' VAL . 16.2 m -94.6 2.25 9.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.216 -0.927 . . . . 0.0 109.179 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.754 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.4 t60 -28.66 -47.44 0.05 Allowed 'General case' 0 C--O 1.192 -1.953 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.051 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.698 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.6 OUTLIER -137.44 145.12 42.75 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.398 -1.321 . . . . 0.0 111.02 179.046 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 3.6 p90 -145.95 144.81 30.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.589 -0.694 . . . . 0.0 110.212 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 1.051 HD12 HD11 ' A' ' 580' ' ' LEU . 11.3 mt -103.5 118.05 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.45 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 7.7 t80 -111.55 154.62 24.52 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.774 0.797 . . . . 0.0 109.819 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.446 ' HB3' ' CB ' ' A' ' 599' ' ' ASN . 3.7 ttmt -120.07 136.67 54.5 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 121.464 0.65 . . . . 0.0 110.31 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.45 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.82 163.72 28.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.617 -0.677 . . . . 0.0 110.343 -179.487 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.8 tpt180 -77.72 115.28 17.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.516 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 3.0 t60 . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.497 -0.752 . . . . 0.0 110.574 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.844 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.3 mp . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.4 m-20 -114.95 124.34 51.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.965 -1.084 . . . . 0.0 111.115 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.739 ' OD2' HD21 ' A' ' 671' ' ' LEU . 14.7 t0 -107.08 156.12 19.11 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.537 -0.727 . . . . 0.0 109.82 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 13.8 pt -110.7 131.45 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.635 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.4 m95 -119.11 121.95 40.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.654 -0.654 . . . . 0.0 111.369 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.81 ' HB2' HD11 ' A' ' 672' ' ' LEU . 8.7 t80 -80.95 114.84 20.1 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 668' ' ' THR . 7.5 t -107.12 110.3 22.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.207 -0.933 . . . . 0.0 111.731 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.633 ' HE1' ' O ' ' A' ' 653' ' ' GLY . 39.6 t-80 -72.66 162.67 29.19 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.476 -0.765 . . . . 0.0 109.833 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.754 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -155.11 -30.84 0.1 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.458 -0.776 . . . . 0.0 112.205 -179.114 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.633 ' O ' ' HE1' ' A' ' 651' ' ' HIS . . . -79.08 -165.23 29.11 Favored Glycine 0 N--CA 1.496 2.665 0 C-N-CA 117.966 -2.064 . . . . 0.0 109.739 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 14.5 m -93.55 -18.9 21.73 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.007 -1.29 . . . . 0.0 114.012 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.711 ' O ' HG22 ' A' ' 656' ' ' VAL . 17.4 m120 -59.81 -2.56 0.4 Allowed 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.746 -1.221 . . . . 0.0 112.727 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.711 HG22 ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 63.36 146.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 121.57 0.7 . . . . 0.0 110.305 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.486 ' CB ' ' CD2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -98.27 141.99 30.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.69 -0.631 . . . . 0.0 110.605 -178.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.459 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 11.1 m-85 -129.75 126.17 37.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 110.364 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.603 HD11 HD21 ' A' ' 672' ' ' LEU . 0.1 OUTLIER -132.6 114.89 14.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.356 -0.84 . . . . 0.0 110.047 179.594 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 56.54 -84.69 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.434 -0.791 . . . . 0.0 110.475 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.6 m120 -143.52 20.3 1.86 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.058 -1.026 . . . . 0.0 110.353 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -111.2 118.48 36.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.283 -0.886 . . . . 0.0 110.239 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -86.67 139.81 30.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 110.184 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.585 ' HG2' HG13 ' A' ' 716' ' ' VAL . 4.5 mtp -117.27 -167.29 1.29 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.866 . . . . 0.0 110.124 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.638 HG13 HG23 ' A' ' 668' ' ' THR . 1.5 pt -137.24 -158.49 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.253 -0.905 . . . . 0.0 110.426 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 652' ' ' THR . 17.5 tt0 -83.11 90.2 7.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.336 -0.853 . . . . 0.0 110.547 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.12 52.53 0.6 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.638 HG23 HG13 ' A' ' 665' ' ' ILE . 0.2 OUTLIER -119.8 148.89 42.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.145 -1.209 . . . . 0.0 110.177 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.458 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 9.5 tttt -108.59 139.02 43.95 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.524 ' CD1' HG22 ' A' ' 716' ' ' VAL . 13.4 t80 -142.54 146.38 34.58 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.154 -0.966 . . . . 0.0 111.615 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.739 HD21 ' OD2' ' A' ' 646' ' ' ASP . 0.4 OUTLIER -73.33 146.82 44.97 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.59 -0.694 . . . . 0.0 110.502 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.81 HD11 ' HB2' ' A' ' 649' ' ' TYR . 12.1 mt -119.39 115.35 23.93 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.559 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -87.39 -177.41 5.92 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.412 ' HB3' HD12 ' A' ' 696' ' ' ILE . 21.8 p-10 -78.31 142.97 37.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 109.432 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.93 46.71 43.16 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 107.678 -2.169 . . . . 0.0 107.678 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.51 ' OD1' HD21 ' A' ' 659' ' ' LEU . 1.4 t0 -101.15 91.51 4.57 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.817 -0.813 . . . . 0.0 110.396 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.806 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -93.09 106.91 18.8 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.571 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.556 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.3 pt -114.17 137.8 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.7 -0.625 . . . . 0.0 111.55 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -95.68 112.76 24.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.553 -0.717 . . . . 0.0 109.418 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.698 HD13 ' SG ' ' A' ' 623' ' ' CYS . 64.5 mt -76.14 -20.9 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.927 . . . . 0.0 110.438 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.906 HD11 HD13 ' A' ' 618' ' ' LEU . 8.8 mt -141.55 133.66 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.075 -1.016 . . . . 0.0 110.721 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -137.86 108.86 6.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.48 -0.762 . . . . 0.0 109.943 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 683' ' ' ASP . . . . . 0.406 ' CB ' ' HB2' ' A' ' 686' ' ' ASN . 45.3 m-20 -125.66 118.38 25.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 110.088 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -65.87 -38.64 89.32 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.461 -0.774 . . . . 0.0 110.983 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -84.04 -43.54 15.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.272 -0.892 . . . . 0.0 111.076 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 686' ' ' ASN . . . . . 0.406 ' HB2' ' CB ' ' A' ' 683' ' ' ASP . 50.9 m-80 -81.81 -12.35 58.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.129 -0.982 . . . . 0.0 110.69 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 687' ' ' LYS . . . . . 0.471 ' O ' HG23 ' A' ' 689' ' ' VAL . 2.8 tttp 56.25 20.43 4.56 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.145 -0.972 . . . . 0.0 110.439 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.88 85.37 2.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.144 -0.972 . . . . 0.0 109.347 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 586' ' ' SER . 2.9 t -101.73 135.91 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.442 -0.786 . . . . 0.0 110.656 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.585 ' CD1' HG22 ' A' ' 587' ' ' ILE . 40.5 mm -123.44 163.63 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.503 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . -174.76 124.67 1.03 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.525 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.806 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.9 m-85 -120.44 138.01 54.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.559 -0.965 . . . . 0.0 108.736 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.5 114.59 28.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 110.976 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -80.96 112.97 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -116.3 104.66 11.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.495 -0.753 . . . . 0.0 110.456 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.412 HD12 ' HB3' ' A' ' 674' ' ' ASP . 78.8 mt -84.11 103.81 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -0.828 . . . . 0.0 109.517 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -81.94 -42.27 19.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 108.889 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.6 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.2 m-20 -110.55 142.29 42.55 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.401 0.62 . . . . 0.0 110.145 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 35.6 p -115.97 95.92 5.34 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 2.7 m -131.92 139.24 48.67 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.351 -0.539 . . . . 0.0 110.282 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.15 28.79 34.83 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.81 ' O ' HD22 ' A' ' 644' ' ' LEU . 0.2 OUTLIER -107.89 131.29 54.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.587 -0.949 . . . . 0.0 110.563 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.844 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.0 p90 -52.25 -23.7 6.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.42 -0.8 . . . . 0.0 109.806 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.585 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.422 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 2.8 mmm-85 . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.335 0.588 . . . . 0.0 111.345 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 32.6 m -107.73 153.07 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.412 -0.805 . . . . 0.0 109.433 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.585 HG13 ' HG2' ' A' ' 664' ' ' MET . 59.8 t -95.1 133.25 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 110.648 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.5 mt -104.83 162.26 13.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.488 -0.757 . . . . 0.0 109.765 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.78 153.43 19.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 110.246 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.85 122.29 26.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.4 -0.813 . . . . 0.0 110.249 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 27.8 p -95.92 -176.53 3.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.432 -0.792 . . . . 0.0 110.162 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.55 -28.99 34.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.293 -0.88 . . . . 0.0 110.188 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -69.01 -46.57 67.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.373 -0.829 . . . . 0.0 109.983 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.75 -50.26 69.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.383 -0.823 . . . . 0.0 110.043 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.46 ' O ' HG12 ' A' ' 727' ' ' VAL . 4.2 ttpt -53.71 -32.7 52.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.36 -0.837 . . . . 0.0 109.909 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 725' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 728' ' ' LYS . 28.7 t70 -66.18 -35.86 81.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.497 -0.752 . . . . 0.0 110.129 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 37.5 mt -61.16 -46.32 90.99 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.277 -0.89 . . . . 0.0 110.083 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.687 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.7 p -74.72 -24.26 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.601 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 728' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 725' ' ' ASP . 0.6 OUTLIER -53.94 -46.06 71.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.116 -0.99 . . . . 0.0 108.902 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -116.83 104.0 10.88 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.219 1.009 . . . . 0.0 109.011 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.599 HD21 ' SG ' ' A' ' 609' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--N 1.274 -2.701 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.336 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.419 ' HD2' ' CG ' ' A' ' 593' ' ' GLU . 41.0 ttp180 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.688 0.756 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -102.92 -42.57 5.79 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 122.044 0.926 . . . . 0.0 109.286 -179.287 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.061 HD22 HD12 ' A' ' 594' ' ' ILE . 9.7 tt -120.47 131.67 54.85 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.611 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.415 ' N ' HD23 ' A' ' 578' ' ' LEU . 32.6 m -109.18 118.27 36.29 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.961 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.618 HD11 HD11 ' A' ' 594' ' ' ILE . 13.2 mt -93.17 112.28 24.17 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.454 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.3 OUTLIER -114.99 103.6 54.6 Favored Pre-proline 0 C--N 1.302 -1.488 0 C-N-CA 118.326 -1.35 . . . . 0.0 113.387 -176.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 1.079 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 45.6 Cg_endo -78.58 140.66 16.99 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 N-CA-C 105.045 -2.713 . . . . 0.0 105.045 174.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.762 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -121.55 -175.05 0.33 Allowed Pre-proline 0 N--CA 1.496 1.863 0 C-N-CA 118.044 -1.462 . . . . 0.0 113.779 -176.118 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.762 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.4 Cg_endo -66.11 -33.75 39.6 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 O-C-N 124.198 1.631 . . . . 0.0 111.969 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.74 -29.48 66.76 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.709 -1.196 . . . . 0.0 107.856 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.638 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 27.1 p -96.39 153.28 17.91 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.57 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.4 OUTLIER -59.92 -15.73 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.184 -0.948 . . . . 0.0 109.127 178.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.778 HD12 ' HA ' ' A' ' 613' ' ' ILE . 7.8 mm -95.03 115.83 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.468 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -121.74 70.23 0.95 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.55 -1.344 . . . . 0.0 109.372 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 1.079 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 33.8 tt0 -144.34 174.08 11.22 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.698 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.517 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.87 127.53 40.39 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.937 -1.102 . . . . 0.0 109.365 176.454 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.774 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.1 mp -111.5 153.78 25.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.183 -0.948 . . . . 0.0 110.073 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.419 ' CG ' ' HD2' ' A' ' 576' ' ' ARG . 4.2 mp0 -125.74 112.46 16.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.537 -0.727 . . . . 0.0 111.185 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.061 HD12 HD22 ' A' ' 578' ' ' LEU . 69.6 mt -78.88 109.52 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.087 -1.008 . . . . 0.0 108.71 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.589 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -63.49 100.31 0.25 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.59 -0.694 . . . . 0.0 110.948 -178.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.589 ' C ' ' O ' ' A' ' 595' ' ' GLN . 0.8 OUTLIER -0.21 75.9 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 179.422 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 128.84 10.04 3.3 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.365 -1.397 . . . . 0.0 110.973 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.652 ' HB ' HG23 ' A' ' 594' ' ' ILE . 1.5 t -82.77 100.67 6.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 O-C-N 120.6 -1.529 . . . . 0.0 107.632 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.2 OUTLIER -144.61 135.88 12.58 Favored Pre-proline 0 C--N 1.282 -2.36 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.69 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.522 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 53.3 Cg_endo -90.42 164.46 32.58 Favored 'Cis proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.78 -1.758 . . . . 0.0 108.918 -1.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.543 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 3.3 t80 -103.27 115.93 31.49 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.616 ' CG ' HD23 ' A' ' 730' ' ' LEU . 44.9 m-85 -81.38 143.6 32.05 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 110.342 -178.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.888 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.6 mt -142.88 142.12 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.667 -0.646 . . . . 0.0 110.291 -178.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.76 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 169.16 -161.46 35.07 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.778 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.403 ' HD2' ' HA ' ' A' ' 614' ' ' GLU . 9.7 tpt180 -72.61 -35.43 67.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.677 -0.896 . . . . 0.0 111.006 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -83.0 123.69 29.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.846 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.523 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 7.5 tt0 -53.23 -19.26 2.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.328 -0.857 . . . . 0.0 110.052 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -45.1 -31.11 1.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.367 -0.833 . . . . 0.0 109.043 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.3 m -69.76 131.44 44.53 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.543 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 2.0 t-20 -44.96 -27.89 0.6 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.34 -0.85 . . . . 0.0 110.027 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.888 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.0 t -107.27 143.52 35.39 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.523 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -110.46 128.01 55.4 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 119.102 -1.039 . . . . 0.0 112.963 -178.404 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.778 ' HA ' HD12 ' A' ' 588' ' ' ILE . 19.8 mt -142.19 107.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 605' ' ' ARG . 0.1 OUTLIER -89.12 103.18 15.82 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.108 -1.437 . . . . 0.0 108.651 179.32 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.702 ' OD1' HD11 ' A' ' 690' ' ' ILE . 1.1 m-20 -139.55 106.06 5.32 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.602 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -41.13 -57.0 2.19 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.545 -0.722 . . . . 0.0 112.253 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 617' ' ' ARG . . . . . 0.404 ' HD2' ' CD1' ' A' ' 681' ' ' ILE . 7.5 ptp180 -72.57 -16.85 61.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.169 -0.957 . . . . 0.0 111.975 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.594 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.8 OUTLIER -76.23 122.22 24.05 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.025 -1.047 . . . . 0.0 110.71 -179.187 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -58.54 159.86 6.04 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.466 -0.772 . . . . 0.0 110.942 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.76 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 14.3 mtt-85 -64.27 -45.2 89.13 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.354 -0.841 . . . . 0.0 109.493 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.5 HG11 HG22 ' A' ' 727' ' ' VAL . 11.8 t -95.4 1.7 10.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 121.93 0.871 . . . . 0.0 109.338 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.736 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.8 t60 -27.43 -46.69 0.03 OUTLIER 'General case' 0 C--O 1.195 -1.808 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.594 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.788 ' SG ' HD13 ' A' ' 680' ' ' ILE . 1.0 OUTLIER -137.92 146.18 42.97 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 117.953 -1.499 . . . . 0.0 112.06 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 2.4 p90 -145.92 145.67 30.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.701 -0.624 . . . . 0.0 109.819 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.683 HG13 HD11 ' A' ' 603' ' ' ILE . 88.2 mt -103.56 117.56 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 10.1 t80 -110.28 154.2 23.78 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.429 -0.794 . . . . 0.0 109.874 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 13.5 ttmt -120.33 136.84 54.56 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.55 0.69 . . . . 0.0 110.373 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.459 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.1 OUTLIER -134.66 164.22 28.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.702 -0.624 . . . . 0.0 109.892 -179.489 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -77.1 121.25 23.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.059 -1.026 . . . . 0.0 108.871 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.52 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 6.0 t60 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.707 0.765 . . . . 0.0 111.05 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.84 HD22 ' O ' ' A' ' 702' ' ' LEU . 5.0 mp . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.9 m-20 -112.2 124.17 51.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.044 -1.035 . . . . 0.0 111.367 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.682 ' OD2' HD21 ' A' ' 671' ' ' LEU . 21.1 t0 -105.1 156.46 18.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.555 -0.715 . . . . 0.0 109.584 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.534 HD13 ' CD1' ' A' ' 578' ' ' LEU . 18.5 pt -110.11 129.95 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.233 -0.917 . . . . 0.0 110.32 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.651 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.0 m95 -118.86 120.34 37.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.75 -0.594 . . . . 0.0 110.968 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.685 ' HB2' HD11 ' A' ' 672' ' ' LEU . 8.0 t80 -80.61 114.44 19.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.963 . . . . 0.0 108.474 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.0 OUTLIER -105.25 107.4 18.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.342 -0.849 . . . . 0.0 111.322 -178.678 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.515 ' CE1' ' C ' ' A' ' 656' ' ' VAL . 17.8 t60 -68.44 159.87 30.8 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.429 -0.794 . . . . 0.0 109.961 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.736 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -149.86 -31.02 0.22 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.437 -0.79 . . . . 0.0 112.879 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.542 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.57 -165.13 27.42 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 117.741 -2.171 . . . . 0.0 109.61 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 15.1 m -98.66 -17.65 18.48 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.976 -1.308 . . . . 0.0 113.552 -176.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.539 ' O ' HG12 ' A' ' 656' ' ' VAL . 18.0 m120 -59.73 -4.43 0.68 Allowed 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.786 -1.196 . . . . 0.0 112.328 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 77.7 166.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-O 121.939 0.876 . . . . 0.0 110.247 -179.539 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.457 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -125.61 141.41 52.04 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.474 -179.035 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -127.91 125.72 40.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.932 . . . . 0.0 110.715 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.694 HD22 ' CG2' ' A' ' 678' ' ' ILE . 0.1 OUTLIER -114.67 106.23 13.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.224 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 659' ' ' LEU . 17.2 m120 56.35 -79.25 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.548 -0.72 . . . . 0.0 110.295 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.539 ' N ' ' O ' ' A' ' 659' ' ' LEU . 21.4 t-20 -140.19 20.28 2.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 0.0 110.548 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -110.68 137.06 48.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.165 -0.959 . . . . 0.0 110.437 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.425 ' O ' HG21 ' A' ' 716' ' ' VAL . 8.0 tmm_? -93.76 141.39 28.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.397 -0.814 . . . . 0.0 110.005 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.626 ' O ' HG22 ' A' ' 656' ' ' VAL . 90.6 mtp -126.07 -168.19 1.82 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.355 -0.84 . . . . 0.0 110.056 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.588 HG13 HG23 ' A' ' 668' ' ' THR . 4.1 pt -144.09 -160.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.159 -0.963 . . . . 0.0 110.953 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -76.07 111.09 11.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.745 . . . . 0.0 110.748 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 86.12 48.87 4.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -114.19 146.1 40.81 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.051 -1.264 . . . . 0.0 109.863 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.429 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 10.8 tttt -108.24 138.91 43.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.561 -0.712 . . . . 0.0 109.488 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.529 ' CD2' HG22 ' A' ' 716' ' ' VAL . 2.8 t80 -144.64 146.25 32.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 111.329 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.682 HD21 ' OD2' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -72.55 147.01 46.35 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.468 -0.77 . . . . 0.0 110.89 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.766 HD23 ' OD2' ' A' ' 676' ' ' ASP . 10.6 mt -118.07 101.43 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.396 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -84.81 157.19 21.04 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.456 ' HB3' HD12 ' A' ' 696' ' ' ILE . 21.0 p-10 -52.69 148.37 7.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.933 -1.104 . . . . 0.0 109.925 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 67.95 48.52 53.81 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.766 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.3 OUTLIER -108.55 92.43 4.05 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.846 -0.796 . . . . 0.0 110.602 -178.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.894 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.0 OUTLIER -93.85 107.2 19.11 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.449 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.694 ' CG2' HD22 ' A' ' 659' ' ' LEU . 24.7 pt -111.85 138.07 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.667 -0.646 . . . . 0.0 111.537 -177.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -100.37 111.75 24.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.517 -0.74 . . . . 0.0 109.647 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.788 HD13 ' SG ' ' A' ' 623' ' ' CYS . 65.8 mt -80.01 -29.3 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 0.0 110.249 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.55 HG22 HG12 ' A' ' 690' ' ' ILE . 0.4 OUTLIER -128.61 133.59 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.25 -0.906 . . . . 0.0 109.817 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -138.17 111.75 8.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.467 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.68 117.63 25.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.89 . . . . 0.0 109.667 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -46.98 75.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.326 -0.859 . . . . 0.0 110.834 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -84.89 -43.21 14.3 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 110.776 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -71.51 -9.15 57.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.249 -0.907 . . . . 0.0 110.706 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.34 22.3 6.2 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.105 -0.997 . . . . 0.0 110.344 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -87.65 104.17 16.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 109.873 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 586' ' ' SER . 13.7 m -126.72 140.77 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.397 -0.814 . . . . 0.0 110.829 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.702 HD11 ' OD1' ' A' ' 615' ' ' ASP . 38.8 mm -117.47 163.6 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.485 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -173.28 123.05 0.96 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.894 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 11.3 m-85 -120.19 137.41 54.2 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.566 -0.961 . . . . 0.0 109.145 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -102.07 113.87 27.5 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.156 -0.965 . . . . 0.0 110.156 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -84.67 119.3 33.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.036 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -130.06 104.67 7.47 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.372 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 674' ' ' ASP . 46.3 mt -79.17 103.86 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -0.885 . . . . 0.0 109.6 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.92 -43.07 46.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.363 -0.836 . . . . 0.0 108.805 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 1.2 m-20 -110.53 141.54 43.54 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.442 0.639 . . . . 0.0 110.135 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 21.4 p -114.22 95.94 5.54 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 50.2 m -131.66 133.78 45.26 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.378 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.74 25.86 30.7 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.84 ' O ' HD22 ' A' ' 644' ' ' LEU . 4.8 tp -105.55 134.75 48.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.389 -1.065 . . . . 0.0 110.438 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.835 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.9 p90 -52.69 -23.69 7.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.521 -0.737 . . . . 0.0 110.403 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.609 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.415 ' HD2' ' HA ' ' A' ' 714' ' ' ARG . 12.7 mmm-85 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.385 0.612 . . . . 0.0 111.629 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.4 m -107.7 152.58 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.563 -0.711 . . . . 0.0 109.418 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.529 HG22 ' CD2' ' A' ' 670' ' ' PHE . 44.1 t -92.94 121.15 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.576 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.8 mp -91.44 162.49 14.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.437 -0.789 . . . . 0.0 109.55 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -98.05 153.65 18.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.103 -0.998 . . . . 0.0 110.665 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 719' ' ' GLN . . . . . 0.4 ' HG2' ' HB2' ' A' ' 723' ' ' GLU . 0.2 OUTLIER -89.47 142.61 27.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.488 -0.757 . . . . 0.0 109.963 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 37.6 p -121.18 -178.36 3.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.317 -0.865 . . . . 0.0 110.575 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.4 -36.3 66.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.459 -0.776 . . . . 0.0 110.244 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 722' ' ' GLU . . . . . 0.539 ' O ' HD23 ' A' ' 726' ' ' LEU . 6.2 tt0 -57.54 -52.16 66.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.381 -0.825 . . . . 0.0 109.963 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.709 ' O ' HG12 ' A' ' 727' ' ' VAL . 74.5 mm-40 -63.54 -46.21 87.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.34 -0.85 . . . . 0.0 109.771 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.475 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 10.1 tttt -62.64 -31.94 72.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.39 -0.819 . . . . 0.0 110.775 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.56 -50.48 71.17 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -0.934 . . . . 0.0 112.051 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 722' ' ' GLU . 0.4 OUTLIER -72.35 -36.55 68.82 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.825 -1.172 . . . . 0.0 111.269 -178.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 723' ' ' GLU . 8.3 p -79.4 -18.25 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.868 -1.145 . . . . 0.0 110.416 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -43.21 66.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.176 -0.953 . . . . 0.0 108.814 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.45 103.27 10.28 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 122.211 1.005 . . . . 0.0 109.034 178.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.616 HD23 ' CG ' ' A' ' 602' ' ' PHE . 1.5 mt . . . . . 0 C--N 1.273 -2.727 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.231 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.423 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.5 ttm105 . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 121.575 0.702 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.592 ' CE1' HD21 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -97.08 -43.24 7.49 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.89 0.852 . . . . 0.0 109.124 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.778 HD23 HD12 ' A' ' 594' ' ' ILE . 7.7 tp -126.68 139.74 52.93 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.188 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 87.2 m -121.83 119.52 31.88 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 8.6 mt -95.56 112.38 24.11 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.511 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.1 OUTLIER -110.72 103.46 54.5 Favored Pre-proline 0 C--N 1.301 -1.538 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.732 -177.547 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 1.054 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.3 Cg_endo -76.22 140.99 22.76 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 N-CA-C 105.737 -2.447 . . . . 0.0 105.737 174.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.769 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -127.48 -173.14 0.29 Allowed Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 118.187 -1.405 . . . . 0.0 113.338 -176.164 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.769 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 37.9 Cg_endo -64.68 -36.34 42.06 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 124.263 1.665 . . . . 0.0 111.116 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -58.52 -28.87 65.84 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.621 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 47.9 t -96.47 152.76 18.3 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.715 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.8 OUTLIER -64.56 -11.61 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.904 -1.123 . . . . 0.0 109.205 178.89 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.729 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 7.9 mm -97.21 117.05 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.484 -0.76 . . . . 0.0 109.401 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.621 ' NE2' ' O ' ' A' ' 586' ' ' SER . 21.1 mp0 -117.55 68.65 0.76 Allowed 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.462 -1.398 . . . . 0.0 109.743 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 1.054 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 2.6 mm-40 -143.35 175.78 9.66 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.607 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.549 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.97 125.42 35.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.071 -1.018 . . . . 0.0 109.585 176.606 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.732 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.6 mm? -106.8 151.15 25.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 108.963 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.423 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.2 mp0 -124.77 110.27 14.12 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.555 -0.716 . . . . 0.0 110.872 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.778 HD12 HD23 ' A' ' 578' ' ' LEU . 4.8 mt -83.78 109.19 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.181 -0.949 . . . . 0.0 109.156 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.617 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.2 OUTLIER -64.97 137.14 57.55 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.735 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.467 ' CA ' ' HB3' ' A' ' 577' ' ' PHE . 2.4 pt20 -44.45 84.37 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.507 -0.746 . . . . 0.0 110.782 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 137.67 3.85 1.99 Allowed Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.647 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -79.97 101.97 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 120.745 -1.444 . . . . 0.0 107.27 178.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 627' ' ' LYS . 49.0 t-20 -145.47 133.33 10.49 Favored Pre-proline 0 C--N 1.282 -2.367 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.85 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.629 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 51.1 Cg_endo -93.29 163.79 22.61 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 123.258 -1.559 . . . . 0.0 109.127 -2.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.627 ' HB3' ' CG2' ' A' ' 625' ' ' ILE . 3.9 t80 -104.96 116.03 31.28 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.669 ' HB3' HD23 ' A' ' 730' ' ' LEU . 34.8 m-85 -85.42 144.86 27.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.373 -0.829 . . . . 0.0 110.256 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.84 HG23 ' HB3' ' A' ' 611' ' ' CYS . 4.5 mt -140.52 142.34 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.512 -0.742 . . . . 0.0 110.201 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.834 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 164.96 -163.53 36.48 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.368 -1.396 . . . . 0.0 111.306 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 8.6 tpt180 -62.87 -55.81 22.86 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.78 -0.836 . . . . 0.0 111.772 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.476 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -72.18 126.9 30.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 111.492 -178.283 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.467 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -51.64 -19.25 1.46 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.072 178.846 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 608' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 607' ' ' GLU . 27.1 t0 -42.27 -32.16 0.47 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.484 -0.76 . . . . 0.0 109.01 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.6 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.3 m -69.86 129.59 39.95 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.616 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.1 m120 -44.55 -28.12 0.55 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.217 -0.927 . . . . 0.0 109.973 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.84 ' HB3' HG23 ' A' ' 603' ' ' ILE . 3.8 t -105.21 143.57 33.2 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.467 ' HD2' ' CB ' ' A' ' 607' ' ' GLU . 1.1 ttpm? -106.53 128.35 54.04 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.059 -1.057 . . . . 0.0 113.467 -178.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.832 HD12 HG22 ' A' ' 603' ' ' ILE . 24.2 mt -143.29 107.71 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.459 ' H ' ' CD1' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -97.86 104.73 16.78 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.238 -1.385 . . . . 0.0 109.306 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.649 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.3 m-20 -138.3 106.42 5.73 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.173 177.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 616' ' ' ASN . . . . . 0.454 ' HA ' ' NH1' ' A' ' 605' ' ' ARG . 1.4 m120 -41.12 -41.56 1.79 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.669 -0.644 . . . . 0.0 111.932 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.61 -21.61 32.49 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.093 -1.004 . . . . 0.0 111.272 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.834 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.6 OUTLIER -73.84 131.96 42.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.191 -0.943 . . . . 0.0 110.702 -179.531 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.454 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -68.09 158.39 33.12 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.356 -0.84 . . . . 0.0 110.725 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.781 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 15.2 ttp180 -62.24 -45.24 94.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.225 -0.922 . . . . 0.0 109.211 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.504 HG22 HD21 ' A' ' 730' ' ' LEU . 4.4 t -95.28 2.08 9.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.75 0.786 . . . . 0.0 109.593 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.75 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.0 t60 -29.63 -42.91 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.854 -178.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.752 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.9 OUTLIER -137.19 144.8 43.06 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 117.789 -1.564 . . . . 0.0 111.429 179.114 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.651 ' CE2' ' HB3' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -147.57 126.58 12.83 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.62 -0.675 . . . . 0.0 109.533 178.222 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.627 ' CG2' ' HB3' ' A' ' 601' ' ' PHE . 2.4 tt -104.08 118.16 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.362 -0.836 . . . . 0.0 108.869 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.651 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 17.5 p90 -122.83 155.2 37.08 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.758 0.789 . . . . 0.0 110.715 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 5.3 ttmt -99.55 136.68 39.13 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.939 0.876 . . . . 0.0 110.891 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.7 OUTLIER -131.11 163.09 28.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.648 -0.658 . . . . 0.0 109.934 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 6.6 tpt180 -78.0 115.06 17.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.041 -1.037 . . . . 0.0 109.257 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 703' ' ' PHE . 6.6 t60 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.528 0.68 . . . . 0.0 110.866 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 1.1 mp . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 628' ' ' LYS . 0.3 OUTLIER -120.85 123.85 43.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.126 -0.984 . . . . 0.0 110.813 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.603 ' OD2' HD11 ' A' ' 671' ' ' LEU . 10.3 t0 -101.93 132.2 47.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.417 -0.802 . . . . 0.0 109.211 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.519 HD13 HD22 ' A' ' 578' ' ' LEU . 6.4 pt -80.97 129.3 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.114 -0.992 . . . . 0.0 109.972 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.804 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 87.8 m95 -116.15 122.56 45.43 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.526 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.909 ' HB2' HD11 ' A' ' 672' ' ' LEU . 6.8 t80 -82.05 113.12 19.71 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.1 OUTLIER -107.41 102.87 12.12 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.284 -0.967 . . . . 0.0 111.127 -178.513 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.504 ' CE1' ' C ' ' A' ' 656' ' ' VAL . 11.1 t60 -61.71 154.93 24.04 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.408 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.75 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -146.14 -25.22 0.44 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.857 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.624 ' N ' ' HA ' ' A' ' 622' ' ' HIS . . . -77.94 -171.12 36.94 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 117.992 -2.052 . . . . 0.0 109.119 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 27.1 m -95.56 -16.52 22.08 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.013 -1.287 . . . . 0.0 113.285 -176.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.569 ' O ' HG12 ' A' ' 656' ' ' VAL . 3.0 t-20 -62.33 -4.47 1.84 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.007 -1.058 . . . . 0.0 112.596 -178.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 78.62 166.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 CA-C-O 121.987 0.898 . . . . 0.0 110.464 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.443 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -124.99 152.13 44.61 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.435 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -138.34 126.91 23.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.252 -0.905 . . . . 0.0 110.437 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.927 HD21 ' NH1' ' A' ' 714' ' ' ARG . 43.5 tp -128.5 114.16 16.42 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 110.027 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 41.9 t30 56.43 -80.93 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.615 -0.678 . . . . 0.0 110.349 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 659' ' ' LEU . 46.1 p-10 -142.52 11.62 1.9 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.042 -1.037 . . . . 0.0 110.767 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -105.5 133.5 50.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.98 -1.075 . . . . 0.0 110.798 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -93.11 142.14 27.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.48 -0.762 . . . . 0.0 109.802 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.61 ' O ' HG22 ' A' ' 656' ' ' VAL . 4.4 mtp -121.03 -166.88 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -0.954 . . . . 0.0 110.617 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.635 ' CG1' HG23 ' A' ' 668' ' ' THR . 2.7 pt -141.27 -164.26 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.443 -0.786 . . . . 0.0 110.19 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -78.32 86.73 4.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.34 -0.85 . . . . 0.0 110.62 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.74 52.61 0.43 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.635 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.2 OUTLIER -119.32 147.19 44.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.226 -1.161 . . . . 0.0 110.009 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.477 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 1.7 tttt -108.76 148.13 30.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.739 . . . . 0.0 109.361 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.811 ' CD1' HD23 ' A' ' 659' ' ' LEU . 1.2 t80 -145.72 147.44 31.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.139 -0.975 . . . . 0.0 111.901 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.804 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.48 132.82 47.64 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.405 -0.809 . . . . 0.0 109.647 179.19 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.909 HD11 ' HB2' ' A' ' 649' ' ' TYR . 2.7 mt -113.22 104.91 12.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.022 -1.049 . . . . 0.0 111.106 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 673' ' ' GLN . . . . . 0.508 ' NE2' HD12 ' A' ' 671' ' ' LEU . 53.5 mm-40 -90.79 -177.1 4.88 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.474 ' HB3' HD12 ' A' ' 696' ' ' ILE . 13.8 p-10 -76.28 144.11 40.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.12 . . . . 0.0 109.761 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.41 48.35 45.32 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.24 99.4 7.19 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.808 -0.819 . . . . 0.0 109.995 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.914 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.85 113.4 25.42 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.862 HG12 HD13 ' A' ' 659' ' ' LEU . 1.5 mp -104.82 137.43 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.582 -0.699 . . . . 0.0 111.594 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -99.25 117.14 33.05 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.752 HD13 ' SG ' ' A' ' 623' ' ' CYS . 79.9 mt -87.7 -27.92 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.221 -0.924 . . . . 0.0 111.145 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.596 HG13 HD12 ' A' ' 618' ' ' LEU . 1.5 mt -143.23 133.43 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 0.0 111.078 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 14.0 t90 -138.2 109.0 6.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.629 -0.669 . . . . 0.0 109.568 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.15 117.92 28.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.085 -1.009 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -66.63 -29.8 69.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.418 -0.801 . . . . 0.0 110.775 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -43.32 76.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.34 -0.85 . . . . 0.0 110.924 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 686' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 688' ' ' PHE . 10.9 t-20 -139.37 34.61 2.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.242 -0.912 . . . . 0.0 110.072 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 687' ' ' LYS . . . . . 0.49 ' O ' ' C ' ' A' ' 688' ' ' PHE . 0.0 OUTLIER 66.26 -67.02 0.16 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.705 -0.622 . . . . 0.0 109.703 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.2 OUTLIER 30.76 56.85 0.22 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.34 0.591 . . . . 0.0 111.11 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 687' ' ' LYS . 41.6 t -101.67 141.52 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.43 -0.794 . . . . 0.0 110.714 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.715 ' CD1' HG22 ' A' ' 587' ' ' ILE . 47.9 mm -118.21 163.94 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.49 -0.756 . . . . 0.0 109.207 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.446 ' N ' ' OG ' ' A' ' 586' ' ' SER . . . -177.26 126.92 1.14 Allowed Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.19 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.914 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 12.9 m-85 -120.14 137.87 53.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.668 -0.901 . . . . 0.0 108.776 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.99 114.3 26.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.11 -0.994 . . . . 0.0 110.387 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.527 HG13 HD11 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -85.37 120.31 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.523 -0.736 . . . . 0.0 109.37 179.56 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -126.59 114.6 18.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.672 -0.642 . . . . 0.0 110.209 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.542 HG12 HD12 ' A' ' 578' ' ' LEU . 88.5 mt -92.1 104.55 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.353 -0.842 . . . . 0.0 110.19 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.45 -43.73 18.46 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.486 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 4.2 m-20 -110.58 143.59 40.75 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.346 0.593 . . . . 0.0 109.929 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 39.7 p -112.51 95.71 5.59 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 11.1 p -135.01 133.15 39.13 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.844 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 62.67 28.85 72.21 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.592 HD21 ' CE1' ' A' ' 577' ' ' PHE . 0.3 OUTLIER -111.4 129.85 55.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.426 -1.043 . . . . 0.0 110.099 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.537 ' CZ ' ' CG ' ' A' ' 704' ' ' ASN . 10.5 p90 -49.09 -24.58 1.67 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.434 -0.791 . . . . 0.0 110.403 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.537 ' CG ' ' CZ ' ' A' ' 703' ' ' PHE . 35.5 p-10 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.817 0.818 . . . . 0.0 110.347 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.927 ' NH1' HD21 ' A' ' 659' ' ' LEU . 9.7 mmm180 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.383 0.611 . . . . 0.0 111.778 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 34.2 m -107.94 159.72 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.457 -0.777 . . . . 0.0 109.528 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.726 HG22 ' CD2' ' A' ' 670' ' ' PHE . 47.6 t -104.24 133.47 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.116 -0.99 . . . . 0.0 110.856 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.57 162.99 13.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.551 -0.718 . . . . 0.0 109.655 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -103.82 143.32 32.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.196 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -85.98 154.37 21.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.354 -0.841 . . . . 0.0 110.385 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 15.9 p -115.95 -176.63 2.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 0.0 110.426 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.58 -32.41 50.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.422 -0.799 . . . . 0.0 110.296 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -60.66 -52.25 65.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.337 -0.852 . . . . 0.0 109.772 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.76 ' HA ' HD21 ' A' ' 726' ' ' LEU . 5.6 mt-10 -64.68 -37.98 89.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.499 -0.751 . . . . 0.0 109.755 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -32.38 73.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.333 -0.854 . . . . 0.0 110.58 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.46 -50.91 49.02 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.245 -0.909 . . . . 0.0 111.766 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.76 HD21 ' HA ' ' A' ' 723' ' ' GLU . 0.6 OUTLIER -62.22 -42.22 99.11 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.949 -1.094 . . . . 0.0 110.935 -179.207 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 723' ' ' GLU . 7.2 p -76.67 -17.04 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.877 -1.14 . . . . 0.0 110.349 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -53.67 -43.32 68.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.202 -0.936 . . . . 0.0 108.856 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -116.52 103.78 10.76 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.249 1.024 . . . . 0.0 109.021 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.669 HD23 ' HB3' ' A' ' 602' ' ' PHE . 1.3 mt . . . . . 0 C--N 1.273 -2.743 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.362 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 121.499 0.666 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.654 ' HE1' HD22 ' A' ' 702' ' ' LEU . 0.8 OUTLIER -91.35 -40.92 11.19 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.76 0.79 . . . . 0.0 109.216 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.84 HD21 HG22 ' A' ' 694' ' ' VAL . 3.5 tt -135.63 142.76 45.26 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.597 0.713 . . . . 0.0 111.561 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 95.6 m -118.53 123.65 45.6 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.991 HD11 HD12 ' A' ' 625' ' ' ILE . 9.6 mt -93.16 112.41 24.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.448 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 2.9 mmtt -113.77 102.34 54.71 Favored Pre-proline 0 C--N 1.302 -1.497 0 C-N-CA 118.223 -1.391 . . . . 0.0 112.835 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 1.072 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.5 Cg_endo -81.15 141.1 12.76 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 N-CA-C 105.808 -2.42 . . . . 0.0 105.808 174.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.773 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -120.29 -174.86 0.31 Allowed Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 118.128 -1.429 . . . . 0.0 113.512 -176.891 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.773 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 37.7 Cg_endo -63.86 -36.23 51.67 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 124.269 1.668 . . . . 0.0 111.657 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.63 -27.32 64.62 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.429 ' OG ' ' HA ' ' A' ' 690' ' ' ILE . 33.0 t -96.04 148.48 22.62 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.541 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.741 HG21 ' O ' ' A' ' 614' ' ' GLU . 0.8 OUTLIER -56.68 -18.71 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.991 -1.068 . . . . 0.0 109.178 178.814 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.937 ' CD1' HD12 ' A' ' 690' ' ' ILE . 4.1 mp -94.72 116.38 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.478 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -120.67 67.2 0.85 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.545 -1.347 . . . . 0.0 108.864 -179.493 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 1.072 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 15.5 tp10 -145.0 175.14 10.45 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.243 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.529 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.19 124.24 38.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.085 -1.009 . . . . 0.0 109.447 176.626 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.752 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.1 mt -103.04 155.72 18.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.455 -0.778 . . . . 0.0 109.173 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -125.25 110.3 13.88 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.393 -0.817 . . . . 0.0 111.177 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.803 HD12 HD22 ' A' ' 578' ' ' LEU . 26.4 mt -80.08 108.31 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.4 OUTLIER -68.0 116.73 8.97 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.437 -0.79 . . . . 0.0 111.106 -178.29 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.686 ' HG3' HG21 ' A' ' 700' ' ' THR . 0.1 OUTLIER 38.57 32.41 0.05 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.255 0.55 . . . . 0.0 111.188 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.414 ' HA2' ' CG2' ' A' ' 594' ' ' ILE . . . 83.73 63.7 1.67 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 598' ' ' VAL . 9.8 p -79.47 105.15 8.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 O-C-N 121.039 -1.271 . . . . 0.0 107.583 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.443 ' CB ' ' HB3' ' A' ' 627' ' ' LYS . 3.9 p-10 -121.79 151.13 57.07 Favored Pre-proline 0 C--N 1.279 -2.466 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.649 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.482 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.7 Cg_endo -86.24 156.8 54.58 Favored 'Cis proline' 0 C--N 1.307 -1.618 0 C-N-CA 120.933 -2.528 . . . . 0.0 109.475 0.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.508 ' CD2' ' HB2' ' A' ' 611' ' ' CYS . 4.8 t80 -105.66 115.39 30.16 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.54 ' HB3' ' SG ' ' A' ' 609' ' ' CYS . 50.2 m-85 -86.14 143.68 27.89 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.431 -178.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.926 HG23 ' HB3' ' A' ' 611' ' ' CYS . 4.1 mt -140.68 141.75 31.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.894 -0.504 . . . . 0.0 110.013 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.963 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 165.42 -162.3 35.66 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.361 -1.399 . . . . 0.0 111.13 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 5.9 mmm-85 -61.26 -58.48 8.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.89 -0.771 . . . . 0.0 111.804 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.03 124.27 22.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 111.251 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.538 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 11.8 pt-20 -54.16 -16.98 2.35 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.922 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -44.88 -36.44 3.31 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.37 -0.831 . . . . 0.0 109.074 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.54 ' SG ' ' HB3' ' A' ' 602' ' ' PHE . 1.3 m -59.63 136.63 58.05 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.491 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 1.8 t-20 -47.42 -26.77 1.43 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.209 -0.932 . . . . 0.0 109.414 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.926 ' HB3' HG23 ' A' ' 603' ' ' ILE . 3.0 t -109.48 143.02 39.66 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.538 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -103.1 126.62 50.36 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.497 -0.881 . . . . 0.0 112.447 -178.559 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.792 HG22 HD22 ' A' ' 618' ' ' LEU . 5.3 mt -143.19 109.64 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.741 ' O ' HG21 ' A' ' 587' ' ' ILE . 2.1 tp10 -97.26 103.04 14.94 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 117.99 -1.484 . . . . 0.0 108.357 178.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.534 ' HB2' ' HB3' ' A' ' 618' ' ' LEU . 4.3 m-20 -137.7 105.73 5.69 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.417 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -42.36 -51.66 4.81 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.599 -0.688 . . . . 0.0 112.181 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -74.77 -16.7 60.71 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.182 -0.949 . . . . 0.0 111.602 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.963 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.5 OUTLIER -80.23 143.58 33.62 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.155 -0.965 . . . . 0.0 111.071 -179.062 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.454 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -79.85 162.88 24.79 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.414 -0.803 . . . . 0.0 110.681 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.788 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.4 mpt_? -64.32 -46.76 82.11 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.145 -0.972 . . . . 0.0 109.936 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.557 ' HB ' HG23 ' A' ' 727' ' ' VAL . 5.2 m -95.75 2.14 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.235 -0.916 . . . . 0.0 109.42 178.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.725 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.2 t60 -25.28 -47.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.409 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.786 ' SG ' HD13 ' A' ' 680' ' ' ILE . 1.0 OUTLIER -136.82 146.41 45.63 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 118.206 -1.397 . . . . 0.0 111.497 179.523 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.555 ' HA ' HG13 ' A' ' 603' ' ' ILE . 3.6 p90 -145.82 146.58 31.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.622 -0.674 . . . . 0.0 110.073 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.991 HD12 HD11 ' A' ' 580' ' ' LEU . 19.8 mt -103.55 117.46 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.443 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 10.9 t80 -111.78 154.61 24.8 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 109.956 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.443 ' HB3' ' CB ' ' A' ' 599' ' ' ASN . 2.8 ttmt -120.3 136.6 54.63 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 121.556 0.694 . . . . 0.0 110.434 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.443 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.53 164.81 26.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.648 -0.658 . . . . 0.0 109.949 -179.589 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.1 OUTLIER -77.12 115.01 16.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 109.03 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.527 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.8 t-160 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.585 -0.697 . . . . 0.0 110.998 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.721 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.0 mp . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.3 OUTLIER -118.0 124.26 47.74 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.975 -1.078 . . . . 0.0 111.412 -179.426 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.475 ' OD2' HD11 ' A' ' 671' ' ' LEU . 28.7 t0 -111.18 155.65 22.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.443 -0.786 . . . . 0.0 109.92 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 21.8 pt -108.81 128.79 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.21 -0.931 . . . . 0.0 109.748 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.842 ' CH2' HD22 ' A' ' 671' ' ' LEU . 95.6 m95 -115.48 119.95 37.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.678 -0.639 . . . . 0.0 111.595 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.541 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 11.5 t80 -83.31 114.13 21.19 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.0 OUTLIER -108.86 103.28 12.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.154 -0.966 . . . . 0.0 111.353 -178.677 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.53 ' CD2' ' N ' ' A' ' 652' ' ' THR . 8.9 t60 -63.04 156.75 23.87 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.513 -0.742 . . . . 0.0 109.895 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.725 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -148.19 -29.11 0.31 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.395 -0.816 . . . . 0.0 112.875 -179.206 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.539 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.85 -163.66 25.15 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 117.864 -2.112 . . . . 0.0 109.473 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 19.3 m -99.3 -17.84 17.86 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.02 -1.282 . . . . 0.0 113.709 -176.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.551 ' C ' HG23 ' A' ' 656' ' ' VAL . 8.7 m120 -59.16 -3.77 0.43 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 120.667 -1.27 . . . . 0.0 112.492 -178.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.551 HG23 ' C ' ' A' ' 655' ' ' ASN . 2.9 t 71.52 147.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.626 -0.671 . . . . 0.0 110.207 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -102.74 141.64 35.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.517 -0.739 . . . . 0.0 111.145 -178.773 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.433 ' CE1' ' HG2' ' A' ' 663' ' ' ARG . 95.3 m-85 -129.46 126.61 39.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.552 -0.718 . . . . 0.0 109.724 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.772 HD23 ' CE1' ' A' ' 670' ' ' PHE . 31.3 tp -130.85 111.83 12.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.222 -0.924 . . . . 0.0 110.107 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 56.31 -82.2 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.565 -0.709 . . . . 0.0 110.167 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 659' ' ' LEU . 10.5 m120 -141.89 17.77 2.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 110.131 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.431 ' HB3' ' CE2' ' A' ' 670' ' ' PHE . 0.8 OUTLIER -109.45 127.12 54.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.494 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.433 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 0.0 OUTLIER -93.22 141.15 28.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.417 -0.802 . . . . 0.0 109.794 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.709 ' HG2' HG13 ' A' ' 716' ' ' VAL . 3.0 mtp -122.79 -167.65 1.62 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.372 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.606 HG13 HG23 ' A' ' 668' ' ' THR . 3.0 pt -139.82 -160.96 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.399 -0.813 . . . . 0.0 110.239 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -79.76 95.51 6.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.283 -0.886 . . . . 0.0 110.668 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 104.31 51.6 0.92 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.624 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -118.18 145.36 45.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.103 -1.233 . . . . 0.0 109.993 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.77 141.62 39.05 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.772 ' CE1' HD23 ' A' ' 659' ' ' LEU . 3.7 t80 -145.36 148.21 33.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.106 -0.996 . . . . 0.0 112.299 -177.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.842 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.53 130.91 44.24 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.443 -0.786 . . . . 0.0 109.893 179.514 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.541 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 4.3 mt -107.44 105.01 14.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.907 -1.121 . . . . 0.0 111.226 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 673' ' ' GLN . . . . . 0.453 ' O ' HG11 ' A' ' 694' ' ' VAL . 85.9 mt-30 -87.51 165.36 15.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.476 -0.765 . . . . 0.0 109.052 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.506 ' HB3' HD12 ' A' ' 696' ' ' ILE . 14.4 p-10 -62.74 157.42 21.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.127 -0.983 . . . . 0.0 109.923 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 675' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 59.88 51.52 58.46 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 107.765 -2.134 . . . . 0.0 107.765 -178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.512 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.5 OUTLIER -114.09 96.34 5.76 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.786 -0.832 . . . . 0.0 110.868 -178.644 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.913 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.6 tt0 -94.46 107.98 19.93 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.739 HG22 HD13 ' A' ' 659' ' ' LEU . 35.5 pt -107.59 138.38 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.598 -0.689 . . . . 0.0 112.331 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -100.06 112.79 25.09 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.786 HD13 ' SG ' ' A' ' 623' ' ' CYS . 56.8 mt -81.63 -33.81 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.26 -0.9 . . . . 0.0 111.504 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.68 HG22 ' CG1' ' A' ' 690' ' ' ILE . 14.1 tt -133.85 136.15 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.938 -1.101 . . . . 0.0 110.213 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -137.59 116.48 12.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.316 -0.865 . . . . 0.0 110.462 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -127.94 117.6 22.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.84 -30.19 70.3 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.466 -0.771 . . . . 0.0 111.015 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -55.65 -43.45 76.28 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.301 -0.874 . . . . 0.0 110.872 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 686' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 688' ' ' PHE . 5.3 m120 -136.62 32.35 2.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 110.002 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 687' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 688' ' ' PHE . 5.8 mttm 64.21 -67.0 0.11 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.915 -0.49 . . . . 0.0 110.09 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.494 ' N ' ' O ' ' A' ' 686' ' ' ASN . 0.1 OUTLIER 33.42 55.48 0.5 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.3 0.571 . . . . 0.0 110.965 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 687' ' ' LYS . 34.4 m -101.3 142.19 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.414 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.937 HD12 ' CD1' ' A' ' 588' ' ' ILE . 31.2 mm -117.83 164.2 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.473 -0.767 . . . . 0.0 109.333 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.43 ' N ' HG22 ' A' ' 690' ' ' ILE . . . -170.96 124.71 1.14 Allowed Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.058 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.913 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 14.3 m-85 -119.19 137.25 53.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.625 -0.926 . . . . 0.0 108.654 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -101.13 113.95 27.46 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 110.753 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.84 HG22 HD21 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -83.84 121.51 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.778 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -129.26 105.81 8.4 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.623 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.603 HG12 HD12 ' A' ' 578' ' ' LEU . 82.1 mt -85.73 105.95 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.449 -0.782 . . . . 0.0 109.614 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.28 -44.13 13.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.428 -0.795 . . . . 0.0 108.889 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -111.26 142.35 43.59 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.401 0.62 . . . . 0.0 110.229 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.0 p -114.19 96.15 5.65 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.686 HG21 ' HG3' ' A' ' 596' ' ' GLN . 7.2 t -86.26 95.96 9.79 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.334 0.588 . . . . 0.0 111.216 -178.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 47.43 36.77 11.69 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.884 HD23 ' O ' ' A' ' 704' ' ' ASN . 1.7 tp -84.41 149.96 25.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.392 -1.063 . . . . 0.0 110.336 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.721 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.5 p90 -53.5 -23.2 9.67 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.384 -0.823 . . . . 0.0 109.939 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.884 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.8 t30 . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.447 ' HA ' ' HD2' ' A' ' 714' ' ' ARG . 5.2 mmm-85 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.368 0.604 . . . . 0.0 111.354 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.77 151.75 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.475 -0.765 . . . . 0.0 109.279 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.709 HG13 ' HG2' ' A' ' 664' ' ' MET . 61.6 t -92.3 118.58 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 110.512 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.3 mp -90.22 161.8 15.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.546 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.12 153.99 17.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -0.93 . . . . 0.0 110.244 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 719' ' ' GLN . . . . . 0.407 ' HG3' ' CB ' ' A' ' 723' ' ' GLU . 33.0 tt0 -79.93 145.8 32.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.472 -0.768 . . . . 0.0 110.181 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 20.3 p -121.13 -176.89 3.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.309 -0.87 . . . . 0.0 110.362 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.7 67.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.376 -0.827 . . . . 0.0 110.456 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.32 -52.46 64.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.352 -0.842 . . . . 0.0 110.001 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.407 ' CB ' ' HG3' ' A' ' 719' ' ' GLN . 2.4 mp0 -66.8 -42.47 85.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -0.873 . . . . 0.0 109.929 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.563 ' O ' HG12 ' A' ' 727' ' ' VAL . 12.2 ttmm -56.69 -32.83 65.84 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.319 -0.863 . . . . 0.0 109.756 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.8 -36.21 77.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.399 -0.813 . . . . 0.0 110.09 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 33.4 mt -58.18 -46.63 85.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.404 -0.81 . . . . 0.0 110.446 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 724' ' ' LYS . 7.9 p -69.88 -19.57 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.065 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -54.44 -48.49 71.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -0.894 . . . . 0.0 108.79 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.81 104.98 11.88 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 122.229 1.014 . . . . 0.0 108.923 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.275 -2.657 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.377 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.483 1.206 0 CA-C-O 121.62 0.724 . . . . 0.0 109.253 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.519 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 3.7 t80 -123.56 -41.47 2.27 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 122.074 0.94 . . . . 0.0 109.215 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.643 HD23 HD12 ' A' ' 594' ' ' ILE . 22.1 tp -123.83 140.76 52.67 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.285 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.434 ' H ' HD12 ' A' ' 578' ' ' LEU . 88.1 m -123.51 116.98 24.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.705 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.661 HD11 ' CD1' ' A' ' 625' ' ' ILE . 1.9 mm? -90.37 111.74 23.08 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.426 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 2.5 mmtt -112.89 101.26 52.91 Favored Pre-proline 0 C--N 1.299 -1.594 0 C-N-CA 117.987 -1.485 . . . . 0.0 112.657 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 1.104 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.1 Cg_endo -80.87 140.72 12.95 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 N-CA-C 105.428 -2.566 . . . . 0.0 105.428 174.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.737 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -118.86 -176.95 0.41 Allowed Pre-proline 0 N--CA 1.495 1.793 0 C-N-CA 118.177 -1.409 . . . . 0.0 113.567 -176.232 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.737 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.3 Cg_endo -66.56 -31.3 41.63 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 O-C-N 124.342 1.706 . . . . 0.0 111.83 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -59.0 -29.89 67.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.798 -1.189 . . . . 0.0 108.124 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.599 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 54.4 p -96.44 153.29 17.91 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.914 -0.491 . . . . 0.0 109.724 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.644 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.1 OUTLIER -57.0 -18.95 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.16 -0.963 . . . . 0.0 109.101 178.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.873 HD12 ' HA ' ' A' ' 613' ' ' ILE . 10.0 mm -95.96 115.38 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.51 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -124.47 71.37 1.14 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 120.601 -1.312 . . . . 0.0 110.099 -178.527 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 1.104 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 18.9 mt-10 -145.12 174.97 10.6 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.579 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.526 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.79 127.23 41.57 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.841 -1.162 . . . . 0.0 109.393 176.483 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.837 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.2 mp -111.39 155.73 22.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 109.747 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -124.96 110.41 14.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.481 -0.762 . . . . 0.0 111.406 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.643 HD12 HD23 ' A' ' 578' ' ' LEU . 3.0 mt -80.85 110.49 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.525 ' HB2' HG23 ' A' ' 598' ' ' VAL . 2.0 mp0 -51.48 172.83 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.634 -0.666 . . . . 0.0 110.052 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.519 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 5.6 mt-30 -64.36 66.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.476 -0.765 . . . . 0.0 110.555 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 128.72 30.65 0.69 Allowed Glycine 0 N--CA 1.486 2.01 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.806 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -81.34 102.81 7.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.486 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 11.8 t-20 -143.3 134.54 12.66 Favored Pre-proline 0 C--N 1.284 -2.265 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.89 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.646 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 55.9 Cg_endo -91.48 162.52 28.47 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.958 -1.684 . . . . 0.0 109.192 -1.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.547 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 3.8 t80 -106.25 116.35 31.79 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.646 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 73.0 m-85 -86.47 144.08 27.44 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.269 -0.894 . . . . 0.0 110.538 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.913 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.0 mt -141.64 141.46 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.73 -0.606 . . . . 0.0 110.148 -178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.838 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 163.94 -163.09 35.67 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.45 -1.357 . . . . 0.0 111.12 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.466 ' N ' HD23 ' A' ' 618' ' ' LEU . 1.1 mmm-85 -62.46 -53.11 59.73 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.832 -0.805 . . . . 0.0 111.491 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 3.1 p -68.22 121.14 15.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 111.04 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.533 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.6 mt-10 -54.2 -17.4 2.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.641 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -47.36 -30.23 3.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.426 -0.796 . . . . 0.0 109.032 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 602' ' ' PHE . 1.6 m -65.88 130.48 43.42 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.547 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 1.9 t-20 -43.97 -29.57 0.6 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.381 -0.824 . . . . 0.0 109.524 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.913 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.3 t -106.01 143.37 34.24 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.533 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -108.52 128.59 54.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.079 -1.013 . . . . 0.0 113.093 -178.144 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.873 ' HA ' HD12 ' A' ' 588' ' ' ILE . 8.8 mt -142.21 108.87 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -98.33 104.07 16.08 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.221 -1.392 . . . . 0.0 109.517 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.829 ' OD2' HD11 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -138.78 106.69 5.67 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.165 177.181 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -39.25 -43.79 1.17 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.65 -0.656 . . . . 0.0 112.123 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.01 -17.71 39.53 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.118 -0.988 . . . . 0.0 111.847 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.838 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.6 OUTLIER -75.47 131.37 40.09 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.103 -0.998 . . . . 0.0 110.882 -179.15 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 622' ' ' HIS . 10.0 t -65.34 159.08 24.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.335 -0.853 . . . . 0.0 110.837 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.766 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.9 mpp_? -64.76 -45.3 86.99 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.181 -0.949 . . . . 0.0 109.518 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 1.064 HG11 HG23 ' A' ' 727' ' ' VAL . 17.3 t -95.35 2.06 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 121.739 0.78 . . . . 0.0 109.721 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.734 ' O ' ' N ' ' A' ' 652' ' ' THR . 6.1 t60 -24.55 -46.82 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.542 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.824 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -138.19 146.1 42.29 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 118.283 -1.367 . . . . 0.0 112.038 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 1.9 p90 -146.13 144.25 29.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.454 -0.779 . . . . 0.0 109.981 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.661 ' CD1' HD11 ' A' ' 580' ' ' LEU . 26.8 mt -102.66 123.1 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.434 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 2.3 t80 -118.26 154.33 32.44 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.351 -0.843 . . . . 0.0 109.516 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 9.0 tttt -120.46 136.27 54.8 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.657 0.741 . . . . 0.0 110.786 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -126.35 163.66 22.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.715 -0.615 . . . . 0.0 109.676 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.474 ' C ' ' CD ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -78.67 123.1 26.79 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.157 -0.964 . . . . 0.0 108.894 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.3 t-160 . . . . . 0 N--CA 1.486 1.328 0 O-C-N 121.331 -0.856 . . . . 0.0 110.538 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.602 ' HG ' ' HA ' ' A' ' 703' ' ' PHE . 3.4 mm? . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.9 m-20 -130.41 133.24 46.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.906 -1.122 . . . . 0.0 111.148 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.471 ' CG ' ' HE1' ' A' ' 648' ' ' TRP . 3.2 p30 -115.59 152.73 32.53 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.404 -0.81 . . . . 0.0 110.954 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 6.2 pt -111.2 130.89 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.264 -0.897 . . . . 0.0 109.868 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.62 ' CH2' HD12 ' A' ' 671' ' ' LEU . 94.2 m95 -119.04 140.06 50.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.611 -0.681 . . . . 0.0 110.89 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.949 ' CB ' HD11 ' A' ' 672' ' ' LEU . 4.3 t80 -97.97 114.34 26.43 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 24.8 t -104.22 102.32 12.03 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.23 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.744 ' CE1' ' O ' ' A' ' 653' ' ' GLY . 11.1 t-80 -67.59 164.68 18.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.443 -0.786 . . . . 0.0 109.543 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.734 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -155.28 -31.31 0.1 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.213 -0.93 . . . . 0.0 113.257 -178.83 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.744 ' O ' ' CE1' ' A' ' 651' ' ' HIS . . . -79.25 132.88 11.83 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 117.937 -2.077 . . . . 0.0 110.427 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 654' ' ' THR . . . . . 0.404 ' C ' ' H ' ' A' ' 656' ' ' VAL . 23.8 m -37.71 -24.46 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -177.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.533 ' O ' HG12 ' A' ' 656' ' ' VAL . 7.9 m120 -57.7 -4.72 0.3 Allowed 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.266 -1.521 . . . . 0.0 112.407 -178.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 76.77 168.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 CA-C-O 121.83 0.824 . . . . 0.0 110.256 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.698 ' HB3' ' CD2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -127.5 154.76 44.73 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.601 -179.01 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -137.92 126.36 23.37 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.163 -0.96 . . . . 0.0 110.83 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.789 HD23 ' CD2' ' A' ' 670' ' ' PHE . 22.2 tp -122.05 107.32 12.07 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.391 -0.818 . . . . 0.0 109.84 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.3 t30 63.2 -73.45 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.545 -0.722 . . . . 0.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 659' ' ' LEU . 37.1 m-20 -153.9 22.51 0.51 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.348 -0.845 . . . . 0.0 110.389 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.38 116.86 28.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.149 -0.969 . . . . 0.0 110.37 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -80.54 139.67 36.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.421 -0.8 . . . . 0.0 109.908 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.561 ' O ' HG22 ' A' ' 656' ' ' VAL . 37.7 mtp -118.2 -161.74 0.85 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.869 . . . . 0.0 110.094 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.538 ' CG1' HG23 ' A' ' 668' ' ' THR . 3.7 pt -133.02 -160.87 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 109.725 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -81.39 117.33 21.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.343 -0.848 . . . . 0.0 110.26 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 82.49 50.73 4.63 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.538 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.0 OUTLIER -115.27 146.34 41.58 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.109 -1.23 . . . . 0.0 110.111 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.442 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 2.7 ttpt -108.77 141.99 39.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.524 -0.735 . . . . 0.0 109.853 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.789 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -144.61 141.0 29.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 110.898 -179.067 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.62 HD12 ' CH2' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -70.05 146.35 51.05 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.285 -0.885 . . . . 0.0 110.682 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.949 HD11 ' CB ' ' A' ' 649' ' ' TYR . 3.9 mp -111.45 149.05 31.83 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.924 0.868 . . . . 0.0 111.632 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 673' ' ' GLN . . . . . 0.467 ' O ' ' C ' ' A' ' 674' ' ' ASP . 15.3 mt-30 -127.0 136.59 52.45 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 673' ' ' GLN . 0.0 OUTLIER -37.93 129.22 1.21 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.967 -1.083 . . . . 0.0 110.276 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 83.88 44.05 6.93 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.403 ' HB3' ' HB ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -100.97 90.48 4.19 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.948 -0.737 . . . . 0.0 110.463 -179.09 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.821 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.8 tt0 -94.21 107.74 19.65 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.653 HG22 ' HA ' ' A' ' 659' ' ' LEU . 41.5 pt -113.06 138.5 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.49 -0.757 . . . . 0.0 111.829 -178.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 15.9 mttp -94.47 110.53 22.32 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.824 HD13 ' SG ' ' A' ' 623' ' ' CYS . 69.9 mt -73.88 -30.95 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.348 -0.845 . . . . 0.0 110.801 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.693 ' CD1' HD12 ' A' ' 618' ' ' LEU . 6.0 mt -143.0 137.38 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.018 -1.051 . . . . 0.0 110.876 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 6.6 t90 -137.93 108.98 6.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.559 -0.713 . . . . 0.0 109.795 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 683' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 688' ' ' PHE . 1.2 t70 -114.34 118.12 32.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.096 -1.003 . . . . 0.0 110.598 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -66.52 -30.01 70.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.495 -0.753 . . . . 0.0 110.806 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -55.88 -43.71 77.44 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.397 -0.815 . . . . 0.0 111.078 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 686' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 688' ' ' PHE . 2.1 m-20 -141.26 34.96 1.69 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.92 . . . . 0.0 110.066 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 687' ' ' LYS . . . . . 0.477 ' O ' ' C ' ' A' ' 688' ' ' PHE . 0.2 OUTLIER 66.54 -67.71 0.15 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.737 -0.602 . . . . 0.0 110.003 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.477 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.5 OUTLIER 33.69 59.92 0.52 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.684 -0.635 . . . . 0.0 110.7 179.718 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 586' ' ' SER . 34.2 m -102.06 142.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 111.352 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.829 HD11 ' OD2' ' A' ' 615' ' ' ASP . 43.1 mm -113.43 163.56 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -173.31 118.71 0.72 Allowed Glycine 0 N--CA 1.491 2.314 0 C-N-CA 118.948 -1.596 . . . . 0.0 110.618 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.87 ' CZ ' HG21 ' A' ' 588' ' ' ILE . 13.7 m-85 -120.5 138.02 54.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.613 -0.934 . . . . 0.0 108.784 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -108.64 114.52 28.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 0.0 110.763 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.523 HG22 HD11 ' A' ' 578' ' ' LEU . 1.2 t -76.52 119.68 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.382 -0.824 . . . . 0.0 108.924 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.71 104.61 7.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.672 -0.642 . . . . 0.0 110.023 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 62.5 mt -86.68 107.7 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 109.714 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -78.3 -41.14 34.69 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.405 -0.81 . . . . 0.0 109.077 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.438 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.3 m-20 -110.81 140.86 44.87 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.579 0.704 . . . . 0.0 110.682 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 14.5 p -115.16 96.0 5.47 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 22.2 m -113.58 129.64 56.52 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.853 -0.53 . . . . 0.0 110.797 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.513 ' C ' HD12 ' A' ' 644' ' ' LEU . . . 50.76 37.9 35.73 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 704' ' ' ASN . 5.0 tp -109.94 125.43 52.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.461 -1.023 . . . . 0.0 110.653 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.602 ' HA ' ' HG ' ' A' ' 644' ' ' LEU . 10.8 p90 -50.55 -27.4 6.63 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.901 0.858 . . . . 0.0 109.566 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 703' ' ' PHE . 6.6 t30 . . . . . 0 C--N 1.303 -1.423 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.595 ' NH1' HD21 ' A' ' 659' ' ' LEU . 6.0 mmm-85 . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.849 0.833 . . . . 0.0 112.254 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 11.2 m -106.96 151.76 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.486 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 60.4 t -86.2 133.15 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.85 . . . . 0.0 110.939 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.0 mt -103.65 162.15 13.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.54 -0.725 . . . . 0.0 109.552 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.01 154.15 18.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 110.259 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -79.94 134.19 36.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 0.0 110.168 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 63.1 p -106.18 -176.3 3.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.413 -0.804 . . . . 0.0 110.3 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.26 -28.86 29.78 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.282 -0.886 . . . . 0.0 110.018 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -65.93 -47.92 73.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.416 -0.802 . . . . 0.0 109.785 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -63.93 -47.86 78.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.417 -0.802 . . . . 0.0 109.956 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.48 ' O ' HG12 ' A' ' 727' ' ' VAL . 12.0 tttm -52.42 -33.71 45.1 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.422 -0.799 . . . . 0.0 109.85 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -69.16 -36.12 77.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.471 -0.768 . . . . 0.0 110.251 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 56.2 mt -56.25 -47.53 78.34 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.312 -0.867 . . . . 0.0 110.619 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 1.064 HG23 HG11 ' A' ' 621' ' ' VAL . 6.3 p -69.67 -17.67 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.154 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -54.27 -45.82 72.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 0.0 108.836 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.1 104.76 11.55 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.225 1.012 . . . . 0.0 109.209 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.414 ' OXT' ' CD2' ' A' ' 602' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.274 -2.714 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.365 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.418 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 2.6 ttm180 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 121.612 0.72 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.512 ' HB3' ' CA ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -93.32 -44.09 8.47 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.809 0.814 . . . . 0.0 109.116 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.612 HD22 HD12 ' A' ' 594' ' ' ILE . 9.9 tt -125.48 142.2 51.63 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.275 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 579' ' ' THR . . . . . 0.421 ' N ' HD23 ' A' ' 578' ' ' LEU . 87.0 m -122.38 121.97 37.93 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.583 HD11 ' CD1' ' A' ' 625' ' ' ILE . 14.1 mt -95.15 112.5 24.2 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.49 103.66 55.57 Favored Pre-proline 0 C--N 1.302 -1.485 0 C-N-CA 118.464 -1.294 . . . . 0.0 113.21 -177.272 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 1.046 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 44.1 Cg_endo -78.5 137.24 14.54 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 N-CA-C 105.274 -2.625 . . . . 0.0 105.274 174.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.809 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -125.88 -171.9 0.24 Allowed Pre-proline 0 C--N 1.295 -1.786 0 C-N-CA 118.138 -1.425 . . . . 0.0 113.405 -176.104 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.809 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 36.7 Cg_endo -61.67 -35.4 80.57 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 124.129 1.594 . . . . 0.0 111.951 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.55 ' O ' HG23 ' A' ' 689' ' ' VAL . 45.3 m-20 -58.69 -29.75 66.86 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.494 ' OG ' ' HA ' ' A' ' 690' ' ' ILE . 24.6 t -96.54 148.09 23.18 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.563 ' CD1' HD11 ' A' ' 690' ' ' ILE . 1.4 pt -62.96 -18.21 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.244 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.711 HG13 HG12 ' A' ' 613' ' ' ILE . 4.3 mm -83.27 116.2 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.483 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -119.76 69.52 0.84 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.432 -1.417 . . . . 0.0 109.348 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 1.046 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 24.8 tt0 -144.61 174.35 11.04 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.637 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.526 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.2 125.01 36.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.971 -1.08 . . . . 0.0 109.011 176.342 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.778 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.1 mt -105.98 155.04 19.76 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.31 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.418 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.6 OUTLIER -125.48 110.54 14.02 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.478 -0.764 . . . . 0.0 111.287 -179.016 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.612 HD12 HD22 ' A' ' 578' ' ' LEU . 3.2 mt -84.16 109.27 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.157 -0.965 . . . . 0.0 109.007 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 597' ' ' GLY . 3.4 tp60 -64.74 140.41 58.86 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.512 ' CA ' ' HB3' ' A' ' 577' ' ' PHE . 12.0 pt20 -46.56 85.47 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.486 -0.759 . . . . 0.0 110.783 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 135.44 5.21 2.35 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.722 -1.227 . . . . 0.0 110.483 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -80.21 101.66 5.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 O-C-N 120.788 -1.419 . . . . 0.0 107.421 178.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 627' ' ' LYS . 21.6 t-20 -145.42 132.52 10.1 Favored Pre-proline 0 C--N 1.282 -2.352 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.065 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.542 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 50.8 Cg_endo -92.87 164.13 23.88 Favored 'Cis proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.38 -1.508 . . . . 0.0 108.747 -2.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.524 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.4 t80 -104.39 116.14 31.61 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.646 ' CG ' HD23 ' A' ' 730' ' ' LEU . 35.9 m-85 -82.96 143.91 30.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.435 -0.79 . . . . 0.0 110.616 -178.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.911 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.6 mt -141.99 141.57 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.659 -0.651 . . . . 0.0 109.952 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.85 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 163.8 -163.8 36.02 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.395 -1.383 . . . . 0.0 111.24 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.497 ' N ' HD23 ' A' ' 618' ' ' LEU . 4.8 mmm-85 -60.33 -57.7 11.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.921 -0.752 . . . . 0.0 111.862 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.45 125.07 25.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 111.209 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.46 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 4.3 pt-20 -54.08 -17.61 2.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.888 . . . . 0.0 109.735 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.49 -32.58 1.44 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.457 -0.777 . . . . 0.0 108.951 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.3 m -65.9 130.37 43.03 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.524 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -43.3 -29.42 0.41 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.333 -0.854 . . . . 0.0 109.893 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.911 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.9 t -104.73 143.11 33.55 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.46 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -107.91 126.48 52.73 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 122.279 1.038 . . . . 0.0 113.363 -178.077 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.711 HG12 HG13 ' A' ' 588' ' ' ILE . 22.9 mt -143.9 108.57 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 614' ' ' GLU . 1.5 pt-20 -96.0 104.2 16.13 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 118.197 -1.401 . . . . 0.0 108.718 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.548 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.3 m-20 -136.41 105.81 6.08 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.587 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 616' ' ' ASN . . . . . 0.402 ' OD1' ' CE2' ' A' ' 688' ' ' PHE . 16.2 p-10 -44.64 -40.41 5.83 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.657 -0.652 . . . . 0.0 111.734 -179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.4 -17.38 42.4 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.101 -0.999 . . . . 0.0 111.032 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.891 HD13 HD11 ' A' ' 681' ' ' ILE . 0.6 OUTLIER -81.03 139.25 35.86 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.305 -0.872 . . . . 0.0 110.555 -179.499 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.448 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.0 OUTLIER -73.95 158.87 33.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.392 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.735 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.2 mpt_? -63.31 -43.15 98.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.2 -0.938 . . . . 0.0 109.191 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.599 ' CG1' HG22 ' A' ' 727' ' ' VAL . 18.8 t -95.82 1.57 10.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.921 0.867 . . . . 0.0 109.693 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.747 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.2 t60 -28.1 -45.37 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.884 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.543 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.46 145.88 43.62 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 117.959 -1.496 . . . . 0.0 112.191 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.543 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 4.5 p90 -146.35 142.05 27.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.605 -0.685 . . . . 0.0 110.088 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.583 ' CD1' HD11 ' A' ' 580' ' ' LEU . 73.8 mt -102.99 117.61 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.431 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 4.1 t80 -112.86 155.46 24.63 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.769 0.795 . . . . 0.0 110.17 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.44 ' O ' ' ND2' ' A' ' 599' ' ' ASN . 21.9 ttmt -119.34 137.92 53.39 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 121.525 0.679 . . . . 0.0 110.487 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.0 OUTLIER -132.75 163.92 27.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.58 -0.7 . . . . 0.0 110.753 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.4 tpt85 -77.51 112.3 14.14 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.523 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.2 t60 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.722 . . . . 0.0 110.887 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.768 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.3 mp . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.2 OUTLIER -118.39 123.96 46.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.097 -1.002 . . . . 0.0 110.905 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.708 ' CG ' HD11 ' A' ' 671' ' ' LEU . 13.3 t0 -105.4 156.54 18.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.433 -0.792 . . . . 0.0 109.742 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 18.1 pt -106.65 129.37 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.342 -0.849 . . . . 0.0 110.423 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.763 ' CH2' HD13 ' A' ' 671' ' ' LEU . 97.9 m95 -116.63 121.12 40.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.718 -0.614 . . . . 0.0 110.791 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.65 ' HB2' HD11 ' A' ' 672' ' ' LEU . 13.9 t80 -80.61 116.13 20.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 108.469 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.543 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 13.8 t -109.0 107.01 17.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 0.0 111.767 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.708 ' HE1' ' O ' ' A' ' 653' ' ' GLY . 25.3 t-80 -70.51 161.67 30.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.568 -0.707 . . . . 0.0 109.812 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.747 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.94 -30.24 0.16 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.329 -0.857 . . . . 0.0 112.562 -179.191 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.708 ' O ' ' HE1' ' A' ' 651' ' ' HIS . . . -79.13 -167.71 33.93 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 117.853 -2.118 . . . . 0.0 109.901 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.6 m -89.6 -19.28 25.13 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.69 ' O ' HG22 ' A' ' 656' ' ' VAL . 18.6 m120 -59.75 -2.86 0.42 Allowed 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.686 -1.258 . . . . 0.0 112.924 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.69 HG22 ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 62.11 143.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.575 -0.703 . . . . 0.0 110.293 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.542 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -95.98 142.99 27.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.621 -0.675 . . . . 0.0 110.462 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.448 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 10.8 m-85 -129.03 126.13 38.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.923 . . . . 0.0 110.526 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.602 HD11 HG21 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -134.55 114.35 12.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.331 -0.856 . . . . 0.0 110.001 179.462 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.02 -85.79 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.439 -0.788 . . . . 0.0 110.494 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.6 p-10 -143.67 19.28 1.84 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.11 -0.994 . . . . 0.0 110.409 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 662' ' ' ASN . . . . . 0.59 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.4 OUTLIER -105.84 118.36 36.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.313 -0.867 . . . . 0.0 110.177 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.05 136.44 35.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.466 -0.772 . . . . 0.0 110.044 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.747 ' SD ' HG13 ' A' ' 716' ' ' VAL . 8.1 mmm -115.61 -168.2 1.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 0.0 109.997 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.639 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.1 pt -143.38 -165.81 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.22 -0.925 . . . . 0.0 110.494 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 652' ' ' THR . 17.2 tt0 -77.64 78.42 4.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.574 -0.704 . . . . 0.0 110.473 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.42 53.79 0.23 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.639 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.1 OUTLIER -122.24 148.15 45.33 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.056 -1.261 . . . . 0.0 109.928 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.44 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 2.8 tttt -108.4 138.75 44.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.524 -0.735 . . . . 0.0 109.574 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.464 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 0.7 OUTLIER -144.53 146.42 32.37 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.664 -178.697 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.763 HD13 ' CH2' ' A' ' 648' ' ' TRP . 13.5 tp -71.29 146.19 49.06 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.429 -0.794 . . . . 0.0 110.898 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 649' ' ' TYR . 9.0 mt -117.78 107.74 14.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.415 -0.803 . . . . 0.0 111.06 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -84.86 153.41 22.92 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -50.42 141.97 11.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.072 -1.018 . . . . 0.0 109.947 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 71.87 45.97 39.98 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.5 ' OD2' HD21 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -106.94 90.49 3.32 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.855 -0.791 . . . . 0.0 110.198 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.825 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 5.3 tt0 -93.45 107.41 19.25 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.602 HG21 HD11 ' A' ' 659' ' ' LEU . 1.1 pt -111.44 137.77 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 121.446 0.641 . . . . 0.0 111.551 -177.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -95.13 110.83 22.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.486 -0.759 . . . . 0.0 109.258 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.543 HD13 ' SG ' ' A' ' 623' ' ' CYS . 57.0 mt -75.02 -23.92 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.232 -0.918 . . . . 0.0 110.517 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.891 HD11 HD13 ' A' ' 618' ' ' LEU . 7.1 mt -140.49 139.09 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.195 -0.941 . . . . 0.0 110.276 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -137.69 109.51 7.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.365 -0.834 . . . . 0.0 110.401 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.29 117.7 28.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.328 -0.858 . . . . 0.0 109.975 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -47.19 72.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.291 -0.881 . . . . 0.0 111.037 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -84.84 -43.56 14.04 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.259 -0.9 . . . . 0.0 110.849 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.63 -12.07 61.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.576 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm 52.14 25.36 3.22 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.242 -0.911 . . . . 0.0 110.314 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.448 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -93.06 79.43 4.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.374 -0.829 . . . . 0.0 109.764 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 585' ' ' ASP . 27.3 m -103.55 142.33 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.391 -0.818 . . . . 0.0 110.673 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.563 HD11 ' CD1' ' A' ' 587' ' ' ILE . 30.0 mm -116.6 164.34 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.456 -0.778 . . . . 0.0 109.03 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 690' ' ' ILE . . . -173.58 124.19 1.03 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.316 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.825 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 15.0 m-85 -120.2 138.6 53.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.647 -0.913 . . . . 0.0 108.857 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -103.3 114.01 27.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.057 -1.027 . . . . 0.0 110.582 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.595 HG21 HD13 ' A' ' 672' ' ' LEU . 1.0 OUTLIER -82.81 113.49 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -120.37 104.34 9.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.464 -0.772 . . . . 0.0 110.444 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 577' ' ' PHE . 87.6 mt -83.54 103.99 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 109.276 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -83.51 -45.29 13.75 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.482 -0.761 . . . . 0.0 109.211 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.423 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 4.8 m-20 -111.62 140.98 45.78 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.777 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 5.6 p -114.66 96.17 5.61 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 701' ' ' GLY . 70.3 m -78.65 -92.64 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.883 -0.511 . . . . 0.0 110.84 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 700' ' ' THR . . . -114.09 44.28 1.53 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.724 ' O ' HD22 ' A' ' 644' ' ' LEU . 1.6 tp -90.72 145.72 24.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.587 -0.949 . . . . 0.0 110.436 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.768 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.5 p90 -53.35 -23.04 8.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.531 -0.731 . . . . 0.0 110.636 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.577 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.3 t30 . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.464 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 4.1 mmm-85 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.36 0.6 . . . . 0.0 111.945 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.412 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 27.7 m -107.89 151.77 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.447 -0.783 . . . . 0.0 109.431 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.747 HG13 ' SD ' ' A' ' 664' ' ' MET . 78.9 t -89.31 133.42 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.185 -0.947 . . . . 0.0 110.498 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.9 mp -107.77 162.35 14.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 109.954 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.97 147.5 26.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 110.273 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -80.02 152.82 29.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.31 -0.869 . . . . 0.0 110.301 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 75.6 p -121.08 -177.54 3.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.273 -0.892 . . . . 0.0 110.364 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.99 -35.72 67.1 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.422 -0.799 . . . . 0.0 110.146 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 722' ' ' GLU . . . . . 0.615 ' O ' HD23 ' A' ' 726' ' ' LEU . 0.7 OUTLIER -65.36 -44.93 86.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 0.0 110.022 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.49 ' HA ' HD21 ' A' ' 726' ' ' LEU . 7.1 mt-10 -63.02 -48.73 77.51 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.441 -0.787 . . . . 0.0 109.984 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.47 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 22.4 mtpp -63.04 -32.23 73.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.398 -0.813 . . . . 0.0 111.072 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -61.56 -50.81 71.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.247 -0.908 . . . . 0.0 112.46 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 722' ' ' GLU . 0.4 OUTLIER -68.43 -32.73 72.97 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.732 -1.23 . . . . 0.0 110.803 -179.062 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.599 HG22 ' CG1' ' A' ' 621' ' ' VAL . 12.6 p -83.87 -18.48 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.054 . . . . 0.0 110.073 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -53.34 -45.37 69.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 108.889 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.5 103.53 10.52 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.193 0.997 . . . . 0.0 109.021 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.646 HD23 ' CG ' ' A' ' 602' ' ' PHE . 1.6 mt . . . . . 0 C--N 1.273 -2.746 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.415 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 121.687 0.756 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.566 ' HB3' ' CA ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -91.02 -43.79 9.72 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.96 0.886 . . . . 0.0 108.898 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.909 HD22 HD12 ' A' ' 594' ' ' ILE . 9.0 tt -121.43 125.33 46.65 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.086 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 25.2 m -103.6 116.63 32.71 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.732 ' HG ' HD21 ' A' ' 578' ' ' LEU . 5.4 mt -91.49 112.25 24.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.578 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.1 OUTLIER -114.65 104.26 54.44 Favored Pre-proline 0 C--N 1.298 -1.645 0 C-N-CA 118.386 -1.326 . . . . 0.0 113.128 -177.268 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 1.085 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.4 Cg_endo -76.33 142.1 23.63 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 N-CA-C 105.221 -2.646 . . . . 0.0 105.221 174.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.765 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -125.97 -173.91 0.32 Allowed Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 117.916 -1.514 . . . . 0.0 113.87 -175.79 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.765 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.2 Cg_endo -66.41 -34.17 35.34 Favored 'Trans proline' 0 N--CA 1.487 1.142 0 O-C-N 124.169 1.615 . . . . 0.0 111.322 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.88 -30.63 67.91 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.636 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 88.9 p -97.74 153.49 18.23 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.544 HG22 ' CD1' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -62.41 -9.75 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.982 -1.074 . . . . 0.0 109.969 179.21 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.799 HD12 ' HA ' ' A' ' 613' ' ' ILE . 10.1 mm -97.85 116.36 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.274 -0.891 . . . . 0.0 109.626 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.61 ' NE2' ' O ' ' A' ' 586' ' ' SER . 16.3 mp0 -118.53 71.87 0.85 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.659 -1.276 . . . . 0.0 109.713 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 1.085 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 42.5 mt-10 -144.48 174.63 10.77 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.941 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.578 ' HB3' ' HG2' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.54 128.27 40.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.005 -1.06 . . . . 0.0 109.487 176.483 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.729 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.8 mm? -111.2 152.26 27.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.976 . . . . 0.0 109.343 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -124.7 110.77 14.79 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.517 -0.74 . . . . 0.0 110.578 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.909 HD12 HD22 ' A' ' 578' ' ' LEU . 40.6 mt -82.18 109.12 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.072 -1.018 . . . . 0.0 109.272 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.4 OUTLIER -62.46 110.38 1.66 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.423 -0.798 . . . . 0.0 108.963 179.454 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.566 ' CA ' ' HB3' ' A' ' 577' ' ' PHE . 10.1 pt20 -19.11 85.4 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 121.396 0.617 . . . . 0.0 112.03 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 124.98 10.27 4.82 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.366 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.697 HG12 HG23 ' A' ' 594' ' ' ILE . 0.9 OUTLIER -83.96 102.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-O 123.112 1.434 . . . . 0.0 107.57 178.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.2 OUTLIER -144.52 138.78 14.91 Favored Pre-proline 0 C--N 1.281 -2.384 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.808 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.582 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 51.9 Cg_endo -90.94 163.44 30.41 Favored 'Cis proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.564 -1.848 . . . . 0.0 108.817 -1.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.589 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 4.1 t80 -104.42 116.0 31.35 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.624 ' CG ' HD23 ' A' ' 730' ' ' LEU . 33.0 m-85 -83.82 144.17 29.45 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.478 -0.764 . . . . 0.0 110.303 -178.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.89 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.7 mt -142.19 142.12 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.653 -0.655 . . . . 0.0 110.036 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.764 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 168.43 -162.97 36.76 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.807 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 13.7 tpt180 -70.36 -42.4 71.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.768 -0.842 . . . . 0.0 110.863 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.83 123.34 26.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.742 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.446 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 14.3 tt0 -53.34 -17.77 2.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 110.247 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.47 -31.49 1.77 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.316 -0.865 . . . . 0.0 108.967 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.5 m -68.05 132.74 47.8 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.589 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.0 OUTLIER -46.77 -26.65 0.99 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.292 -0.88 . . . . 0.0 109.945 179.555 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.89 ' HB3' HG23 ' A' ' 603' ' ' ILE . 3.3 t -106.97 143.55 34.89 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.446 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -109.45 127.88 54.74 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 119.288 -0.965 . . . . 0.0 113.17 -178.363 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.799 ' HA ' HD12 ' A' ' 588' ' ' ILE . 29.3 mt -142.63 108.49 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.416 ' H ' HD12 ' A' ' 588' ' ' ILE . 4.5 tt0 -90.46 103.54 16.21 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 118.124 -1.43 . . . . 0.0 108.484 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 0.7 OUTLIER -139.15 106.11 5.43 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.692 178.163 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -43.68 -44.65 6.58 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.548 -0.72 . . . . 0.0 112.077 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.53 -17.33 42.2 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.168 -0.958 . . . . 0.0 111.855 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.598 HD11 HG21 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -76.46 122.31 24.35 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.037 -1.039 . . . . 0.0 110.506 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -57.84 158.99 5.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.306 -0.871 . . . . 0.0 110.927 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.764 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -64.09 -45.17 89.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.222 -0.924 . . . . 0.0 109.366 179.438 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.521 ' CG1' HG22 ' A' ' 727' ' ' VAL . 4.3 t -95.33 1.78 10.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.892 0.853 . . . . 0.0 109.347 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.733 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.4 t60 -28.37 -46.38 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.645 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.719 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.04 145.86 44.53 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 117.985 -1.486 . . . . 0.0 112.08 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.531 ' CZ ' ' CB ' ' A' ' 650' ' ' CYS . 9.7 p90 -145.91 139.63 26.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.791 -0.568 . . . . 0.0 109.554 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.708 ' CD1' HD11 ' A' ' 580' ' ' LEU . 82.7 mt -102.83 117.72 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.435 ' CE1' ' O ' ' A' ' 627' ' ' LYS . 6.6 t80 -109.97 154.75 22.7 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.734 0.778 . . . . 0.0 109.914 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.435 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 11.1 ttmt -118.47 136.12 53.98 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.573 0.702 . . . . 0.0 110.1 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.7 OUTLIER -129.75 163.54 25.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.659 -0.651 . . . . 0.0 110.238 -179.193 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.5 tpt180 -78.22 121.81 24.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.073 -1.017 . . . . 0.0 108.75 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.522 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 4.8 t60 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.416 -0.803 . . . . 0.0 110.656 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.852 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.3 mp . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.8 m-20 -119.08 124.22 46.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.088 -1.007 . . . . 0.0 111.241 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.697 ' OD2' HD21 ' A' ' 671' ' ' LEU . 18.2 t0 -101.84 156.18 17.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.597 -0.689 . . . . 0.0 109.57 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.446 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 11.7 pt -109.87 128.84 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.187 -0.945 . . . . 0.0 110.3 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.619 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 97.0 m95 -117.8 123.16 45.28 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.137 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.744 ' HB2' HD11 ' A' ' 672' ' ' LEU . 8.9 t80 -81.11 117.01 21.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 668' ' ' THR . 89.0 m -109.14 103.3 12.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.972 . . . . 0.0 111.818 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.529 ' CD2' ' N ' ' A' ' 652' ' ' THR . 13.3 t60 -66.73 159.23 28.3 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.402 -0.811 . . . . 0.0 109.781 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.733 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -152.13 -28.85 0.17 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.38 -0.825 . . . . 0.0 113.008 -179.295 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.534 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.47 -167.91 32.51 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 117.678 -2.201 . . . . 0.0 109.535 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 26.2 m -93.35 -18.76 22.03 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.964 -1.315 . . . . 0.0 113.818 -176.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.507 ' C ' HG23 ' A' ' 656' ' ' VAL . 23.9 m120 -59.43 -4.27 0.57 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.669 -1.27 . . . . 0.0 112.359 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.507 HG23 ' C ' ' A' ' 655' ' ' ASN . 3.1 t 69.76 147.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.655 -0.653 . . . . 0.0 110.343 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.507 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -101.69 149.42 24.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.698 -0.626 . . . . 0.0 110.686 -179.012 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -136.83 126.37 25.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 110.441 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.961 ' CD2' HG22 ' A' ' 678' ' ' ILE . 1.0 OUTLIER -128.13 106.72 9.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.394 -0.816 . . . . 0.0 109.79 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.405 ' O ' ' ND2' ' A' ' 661' ' ' ASN . 10.3 t-20 63.52 -74.22 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.525 -0.735 . . . . 0.0 110.593 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 659' ' ' LEU . 25.0 m-80 -153.1 23.95 0.55 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.208 -0.933 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.67 120.99 43.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.304 -0.873 . . . . 0.0 110.238 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.65 131.07 34.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.412 -0.805 . . . . 0.0 110.002 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.445 ' O ' HG13 ' A' ' 656' ' ' VAL . 2.7 mtp -111.17 -165.25 0.97 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.413 -0.804 . . . . 0.0 110.424 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.66 ' CG1' HG23 ' A' ' 668' ' ' THR . 2.1 pt -137.44 -164.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.378 -0.826 . . . . 0.0 110.324 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -80.79 82.35 6.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.374 -0.829 . . . . 0.0 110.522 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 120.43 55.59 0.24 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.66 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.2 OUTLIER -121.97 147.05 46.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.192 -1.181 . . . . 0.0 109.986 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.486 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 2.8 tttm -108.61 140.21 42.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.61 -0.681 . . . . 0.0 109.188 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.56 ' CD2' HD12 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -144.31 142.89 30.71 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.101 -1.0 . . . . 0.0 111.418 -178.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.697 HD21 ' OD2' ' A' ' 646' ' ' ASP . 0.4 OUTLIER -69.96 146.72 50.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.428 -0.795 . . . . 0.0 110.47 179.673 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.744 HD11 ' HB2' ' A' ' 649' ' ' TYR . 12.2 mt -119.08 108.98 15.38 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.148 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -84.8 -176.98 6.46 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -73.03 141.85 47.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.192 -0.942 . . . . 0.0 109.538 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.33 47.48 43.43 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 107.596 -2.201 . . . . 0.0 107.596 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.405 ' HB2' ' CG1' ' A' ' 694' ' ' VAL . 0.1 OUTLIER -103.28 91.81 4.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.956 -0.732 . . . . 0.0 110.302 -179.008 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.979 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 2.4 tt0 -93.61 108.33 20.06 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.961 HG22 ' CD2' ' A' ' 659' ' ' LEU . 11.8 pt -105.69 137.66 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.644 -0.66 . . . . 0.0 111.868 -177.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -99.92 110.5 22.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.563 -0.711 . . . . 0.0 109.341 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.719 HD13 ' SG ' ' A' ' 623' ' ' CYS . 66.3 mt -81.92 -34.01 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.297 -0.877 . . . . 0.0 110.586 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.585 HD12 ' HB2' ' A' ' 618' ' ' LEU . 0.1 OUTLIER -126.9 136.12 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.325 -0.859 . . . . 0.0 109.587 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -137.66 118.64 14.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.249 -0.907 . . . . 0.0 110.659 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.99 117.83 20.67 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.282 -0.886 . . . . 0.0 110.055 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -47.36 71.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.412 -0.805 . . . . 0.0 111.408 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -84.72 -43.49 14.24 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.213 -0.929 . . . . 0.0 111.079 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.6 -7.69 55.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.308 -0.87 . . . . 0.0 110.742 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.93 19.51 3.64 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.117 -0.989 . . . . 0.0 110.364 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.83 86.86 5.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.242 -0.911 . . . . 0.0 109.102 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 681' ' ' ILE . 9.3 p -116.61 141.83 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.41 -0.806 . . . . 0.0 110.572 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.636 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 42.9 mm -118.95 164.35 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.338 -0.851 . . . . 0.0 109.653 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.459 ' N ' ' CB ' ' A' ' 586' ' ' SER . . . -175.31 126.09 1.14 Allowed Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.979 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 10.1 m-85 -119.5 137.3 53.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.56 -0.965 . . . . 0.0 108.674 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 12.4 tptt -97.91 113.8 25.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.225 -0.922 . . . . 0.0 110.459 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -85.27 112.53 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.052 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.42 104.67 9.23 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.168 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 577' ' ' PHE . 57.3 mt -79.54 103.21 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.376 -0.827 . . . . 0.0 109.576 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.2 -45.25 20.25 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.457 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 3.4 m-20 -111.12 141.56 44.47 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.735 -0.603 . . . . 0.0 109.895 178.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 20.6 p -113.95 95.79 5.49 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.96 133.52 52.99 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.026 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.41 26.05 28.93 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.757 ' O ' HD22 ' A' ' 644' ' ' LEU . 0.2 OUTLIER -102.85 124.88 49.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.569 -0.96 . . . . 0.0 109.976 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.852 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.4 p90 -48.09 -24.56 1.14 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.384 -0.822 . . . . 0.0 110.197 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.643 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--N 1.303 -1.442 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.51 ' NH1' HD13 ' A' ' 659' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.287 0.565 . . . . 0.0 111.626 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.451 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 31.4 m -107.83 150.85 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 109.509 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.436 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 61.6 t -97.52 133.07 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.215 -0.928 . . . . 0.0 110.643 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.3 mp -110.12 162.51 14.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.498 -0.751 . . . . 0.0 109.85 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.18 145.32 28.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.195 -0.941 . . . . 0.0 110.17 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -80.64 150.21 29.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.33 -0.856 . . . . 0.0 110.18 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 17.0 p -113.73 -176.7 2.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.322 -0.861 . . . . 0.0 110.397 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.92 -32.99 55.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.385 -0.822 . . . . 0.0 110.364 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 722' ' ' GLU . . . . . 0.588 ' O ' HD23 ' A' ' 726' ' ' LEU . 2.7 tt0 -66.59 -46.74 74.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.353 -0.842 . . . . 0.0 109.977 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.609 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.5 OUTLIER -62.78 -48.39 79.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.481 -0.762 . . . . 0.0 109.903 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.452 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 8.5 tttp -62.96 -31.61 72.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.447 -0.783 . . . . 0.0 110.468 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.48 -50.45 73.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.372 -0.83 . . . . 0.0 112.238 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.588 HD23 ' O ' ' A' ' 722' ' ' GLU . 0.3 OUTLIER -72.32 -36.32 68.83 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.921 -1.112 . . . . 0.0 111.415 -178.738 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.609 HG12 ' O ' ' A' ' 723' ' ' GLU . 7.2 p -81.31 -17.85 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.881 -1.137 . . . . 0.0 110.441 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -47.46 75.26 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.107 -0.996 . . . . 0.0 108.866 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.37 103.92 10.94 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.335 1.064 . . . . 0.0 109.01 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.624 HD23 ' CG ' ' A' ' 602' ' ' PHE . 1.8 mt . . . . . 0 C--N 1.273 -2.729 0 CA-C-O 117.984 -1.007 . . . . 0.0 110.366 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.2 OUTLIER -102.65 -40.23 6.71 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.915 0.864 . . . . 0.0 109.502 -179.253 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 1.036 HD22 HD12 ' A' ' 594' ' ' ILE . 9.8 tt -116.7 124.5 49.84 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.246 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 25.5 m -108.58 116.88 32.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -0.852 . . . . 0.0 109.944 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.782 HD21 HG23 ' A' ' 694' ' ' VAL . 1.8 mt -95.71 112.83 24.46 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.497 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -109.62 104.58 55.67 Favored Pre-proline 0 C--N 1.299 -1.612 0 C-N-CA 118.496 -1.282 . . . . 0.0 113.071 -177.278 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 1.026 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 44.8 Cg_endo -76.09 142.02 24.24 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 N-CA-C 106.295 -2.233 . . . . 0.0 106.295 175.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 1.047 ' HB2' ' HD2' ' A' ' 584' ' ' PRO . 0.2 OUTLIER -127.59 -171.69 0.24 Allowed Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 120.991 -1.068 . . . . 0.0 112.743 -176.276 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 1.047 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 36.4 Cg_endo -61.86 -31.29 85.0 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.859 1.452 . . . . 0.0 110.631 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 585' ' ' ASP . . . . . 0.436 ' OD1' HD12 ' A' ' 583' ' ' LEU . 3.3 m-20 -59.34 -26.62 65.2 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.481 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 19.1 t -96.56 153.38 17.88 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.532 HD13 ' HA ' ' A' ' 615' ' ' ASP . 13.8 tt -62.94 -15.89 16.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.703 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.937 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.0 OUTLIER -109.72 120.95 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.415 -0.803 . . . . 0.0 110.533 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 586' ' ' SER . 24.9 mp0 -107.25 79.94 1.36 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.578 -1.326 . . . . 0.0 108.728 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 1.026 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.6 mm-40 -141.52 176.61 8.75 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.36 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.576 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.38 127.21 42.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.31 -0.869 . . . . 0.0 108.859 176.841 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.526 HD12 ' HB3' ' A' ' 580' ' ' LEU . 0.6 OUTLIER -104.0 148.87 25.71 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.149 -0.97 . . . . 0.0 110.147 -179.668 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -124.68 109.99 13.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.488 -0.757 . . . . 0.0 110.658 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 1.036 HD12 HD22 ' A' ' 578' ' ' LEU . 44.2 mt -86.0 112.47 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 108.493 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.525 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -67.07 104.98 1.54 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.678 -0.638 . . . . 0.0 112.522 -177.67 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.744 ' CD ' HG21 ' A' ' 700' ' ' THR . 0.0 OUTLIER 16.84 57.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 178.341 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 113.3 39.61 1.11 Allowed Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.592 -1.29 . . . . 0.0 111.197 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.644 HG12 ' O ' ' A' ' 598' ' ' VAL . 1.2 t -79.82 103.58 6.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.43 ' O ' ' OD1' ' A' ' 599' ' ' ASN . 0.3 OUTLIER -141.37 140.16 20.21 Favored Pre-proline 0 C--N 1.282 -2.339 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.499 -178.95 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.469 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.2 Cg_endo -88.61 161.06 41.71 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.728 -2.197 . . . . 0.0 108.88 -0.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.549 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.1 t80 -106.35 116.17 31.47 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.716 ' C ' ' HB2' ' A' ' 609' ' ' CYS . 32.1 m-85 -92.35 144.59 25.23 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.29 -0.881 . . . . 0.0 110.702 -178.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.834 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -135.68 142.47 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.644 -0.66 . . . . 0.0 110.079 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.649 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 170.82 -168.67 41.77 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.737 -1.221 . . . . 0.0 110.783 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 13.9 mmm-85 -70.0 -44.95 68.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.69 -0.888 . . . . 0.0 110.673 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.502 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -75.01 119.63 19.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 110.125 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 608' ' ' ASP . 12.8 pt-20 -48.53 -18.9 0.28 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.316 -0.865 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 608' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 607' ' ' GLU . 0.9 OUTLIER -42.48 -37.87 1.75 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.321 -0.862 . . . . 0.0 109.318 179.101 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.716 ' HB2' ' C ' ' A' ' 602' ' ' PHE . 23.0 p -68.73 128.21 35.82 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.549 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -43.66 -24.6 0.13 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.562 -0.711 . . . . 0.0 111.897 -178.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.834 ' HB3' HG23 ' A' ' 603' ' ' ILE . 9.0 t -108.57 142.64 38.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.351 -0.843 . . . . 0.0 109.593 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.515 ' C ' HD13 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -113.53 130.61 56.31 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.909 -1.119 . . . . 0.0 112.584 -178.785 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 613' ' ' ILE . 13.7 tt -145.09 109.26 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.451 ' O ' HD13 ' A' ' 587' ' ' ILE . 6.2 mm-40 -84.48 100.98 11.7 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 116.844 -1.942 . . . . 0.0 108.087 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.719 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 27.7 t0 -139.96 105.01 4.99 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.335 177.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.48 -67.96 0.18 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.506 -0.746 . . . . 0.0 112.746 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -16.58 25.62 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.174 -0.954 . . . . 0.0 111.839 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.719 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -72.84 124.32 25.16 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.077 -1.014 . . . . 0.0 111.02 -179.006 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.502 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -69.8 161.71 29.29 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.384 -0.823 . . . . 0.0 110.639 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.649 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 31.9 mtm105 -63.88 -45.17 90.58 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 122.087 0.946 . . . . 0.0 109.126 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.621 HG13 HD11 ' A' ' 730' ' ' LEU . 21.8 m -95.77 2.29 9.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 121.639 0.733 . . . . 0.0 109.422 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.755 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.3 t60 -29.86 -47.97 0.08 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.937 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.809 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -136.82 144.93 43.92 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 118.492 -1.283 . . . . 0.0 110.964 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.529 ' CZ ' ' CB ' ' A' ' 650' ' ' CYS . 8.4 p90 -145.87 141.44 27.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.506 -0.746 . . . . 0.0 110.053 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.6 HG13 HD11 ' A' ' 603' ' ' ILE . 71.5 mt -103.41 118.7 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 9.0 t80 -108.89 154.98 21.36 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.533 -0.729 . . . . 0.0 109.463 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.421 ' HB3' ' CB ' ' A' ' 599' ' ' ASN . 8.4 tttt -119.25 136.62 54.14 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.571 0.701 . . . . 0.0 110.379 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.453 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.23 163.97 29.15 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.749 -0.595 . . . . 0.0 110.421 -179.219 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.582 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.0 OUTLIER -77.78 124.97 28.64 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.564 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.897 0.856 . . . . 0.0 111.312 -177.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.719 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.1 mp . . . . . 0 N--CA 1.486 1.344 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.92 124.07 51.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.991 -1.068 . . . . 0.0 111.054 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -109.22 156.07 20.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.454 -0.779 . . . . 0.0 110.043 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.583 HD13 ' CD1' ' A' ' 578' ' ' LEU . 11.2 pt -111.06 128.92 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.271 -0.893 . . . . 0.0 109.633 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.977 ' CH2' HD22 ' A' ' 671' ' ' LEU . 99.0 m95 -114.29 120.09 39.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.724 -0.61 . . . . 0.0 111.539 -178.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.797 ' HB2' HD11 ' A' ' 672' ' ' LEU . 18.5 t80 -82.17 114.09 20.45 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.529 ' CB ' ' CZ ' ' A' ' 624' ' ' PHE . 62.2 m -109.54 102.27 11.14 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.145 -0.972 . . . . 0.0 111.399 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.613 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 12.1 t60 -69.0 160.39 31.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.461 -0.775 . . . . 0.0 109.918 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.755 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.37 -31.09 0.17 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.424 -0.797 . . . . 0.0 113.112 -178.888 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.613 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -78.53 134.91 14.77 Favored Glycine 0 N--CA 1.502 3.087 0 C-N-CA 117.801 -2.143 . . . . 0.0 110.253 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 26.7 m -34.45 -24.87 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -177.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.682 ' C ' HG13 ' A' ' 656' ' ' VAL . 10.0 m120 -59.23 -3.02 0.34 Allowed 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.346 -1.472 . . . . 0.0 113.123 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.682 HG13 ' C ' ' A' ' 655' ' ' ASN . 0.8 OUTLIER 62.14 145.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.509 -0.745 . . . . 0.0 110.259 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.55 ' OG ' ' HB2' ' A' ' 664' ' ' MET . 0.0 OUTLIER -93.98 151.36 19.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.555 -0.716 . . . . 0.0 110.495 -179.199 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.454 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 14.5 m-85 -135.1 125.78 27.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 109.929 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.614 ' CG ' HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -134.56 113.94 12.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.25 -0.907 . . . . 0.0 110.18 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 54.19 -88.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.482 -0.761 . . . . 0.0 110.773 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.3 m120 -136.71 18.25 3.07 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.066 -1.021 . . . . 0.0 110.509 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -111.85 116.77 31.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.924 . . . . 0.0 110.444 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -94.08 138.19 32.43 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.475 -0.765 . . . . 0.0 109.815 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.712 ' SD ' HG13 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -117.08 -159.44 0.73 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.893 . . . . 0.0 109.884 -179.722 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.662 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.7 pt -133.43 -171.69 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.246 -0.909 . . . . 0.0 110.372 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -74.27 70.06 1.62 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.351 -0.843 . . . . 0.0 110.452 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 133.13 55.77 0.08 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.662 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.0 OUTLIER -123.09 150.57 43.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.255 -1.144 . . . . 0.0 110.307 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.438 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 1.1 ttpm? -108.84 146.66 33.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.579 -0.701 . . . . 0.0 109.178 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.54 ' HD2' HD13 ' A' ' 659' ' ' LEU . 3.5 t80 -145.05 146.28 31.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 111.915 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.977 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.68 130.55 42.66 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.546 -0.721 . . . . 0.0 109.497 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.797 HD11 ' HB2' ' A' ' 649' ' ' TYR . 1.7 mt -104.61 118.75 37.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.081 -1.012 . . . . 0.0 111.26 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 673' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 674' ' ' ASP . 78.4 mt-30 -106.94 138.99 42.06 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 673' ' ' GLN . 6.2 p-10 -36.69 146.19 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.268 -0.895 . . . . 0.0 110.921 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 73.13 48.76 18.6 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.413 ' OD1' HD21 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -106.77 92.54 4.14 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.839 -0.8 . . . . 0.0 110.883 -178.738 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.25 106.49 18.45 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.023 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.614 HG22 ' CG ' ' A' ' 659' ' ' LEU . 5.0 pt -115.25 135.61 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.541 -0.724 . . . . 0.0 111.715 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.39 110.57 22.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.518 -0.739 . . . . 0.0 109.106 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.809 HD13 ' SG ' ' A' ' 623' ' ' CYS . 72.1 mt -72.4 -46.18 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.369 -0.832 . . . . 0.0 110.19 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.594 HD12 ' CG ' ' A' ' 615' ' ' ASP . 9.8 mt -126.81 133.59 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -0.845 . . . . 0.0 109.874 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -137.67 113.09 9.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 110.391 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -130.35 118.12 20.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.307 -0.87 . . . . 0.0 110.057 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -46.13 78.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.427 -0.796 . . . . 0.0 110.998 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.26 -43.02 82.91 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.31 -0.869 . . . . 0.0 110.75 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -90.47 -2.49 57.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.253 -0.904 . . . . 0.0 110.824 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.21 21.22 2.96 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.127 -0.983 . . . . 0.0 110.531 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.26 78.73 4.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.891 . . . . 0.0 109.084 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 586' ' ' SER . 39.5 t -101.69 131.47 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.557 -0.715 . . . . 0.0 110.682 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.647 ' CG2' HD11 ' A' ' 613' ' ' ILE . 49.7 mm -112.0 164.25 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.343 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 179.95 116.33 0.51 Allowed Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.417 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.916 ' CZ ' HG21 ' A' ' 588' ' ' ILE . 12.1 m-85 -119.5 137.32 53.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.251 -1.146 . . . . 0.0 108.484 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -107.98 114.75 28.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 111.209 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.782 HG23 HD21 ' A' ' 580' ' ' LEU . 0.8 OUTLIER -81.33 123.68 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.455 -0.778 . . . . 0.0 109.021 179.02 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -129.95 104.82 7.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.542 -0.724 . . . . 0.0 110.119 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 71.7 mt -84.35 103.95 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.366 -0.834 . . . . 0.0 109.851 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -81.78 -42.9 19.08 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.6 OUTLIER -110.7 140.29 45.21 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.682 -0.637 . . . . 0.0 110.249 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 6.6 p -114.7 96.09 5.56 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.744 HG21 ' CD ' ' A' ' 596' ' ' GLN . 4.6 p -97.07 105.42 17.56 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.298 0.57 . . . . 0.0 111.144 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 49.42 27.53 8.31 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.858 HD23 ' O ' ' A' ' 704' ' ' ASN . 0.5 OUTLIER -82.24 147.02 29.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.387 -1.066 . . . . 0.0 110.28 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.719 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.5 p90 -52.62 -23.55 6.73 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.43 -0.794 . . . . 0.0 110.292 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.858 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.6 t30 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.447 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 3.4 mmm-85 . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 121.434 0.635 . . . . 0.0 110.584 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 27.7 m -106.09 149.26 9.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.712 HG13 ' SD ' ' A' ' 664' ' ' MET . 89.3 t -78.63 133.12 30.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 111.041 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.35 162.2 13.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.519 -0.738 . . . . 0.0 109.782 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -100.11 152.95 19.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.943 . . . . 0.0 110.135 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -79.87 154.18 28.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.83 . . . . 0.0 110.263 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.6 p -120.29 -176.99 3.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.35 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.09 -28.95 56.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.318 -0.864 . . . . 0.0 110.241 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 722' ' ' GLU . . . . . 0.446 ' O ' HD13 ' A' ' 726' ' ' LEU . 0.0 OUTLIER -68.22 -52.51 33.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.49 -0.756 . . . . 0.0 110.077 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -63.44 -37.75 88.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.352 -0.843 . . . . 0.0 109.771 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.532 ' O ' HG12 ' A' ' 727' ' ' VAL . 13.1 tttm -58.44 -32.47 68.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.408 -0.807 . . . . 0.0 109.816 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.0 -39.21 79.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.459 -0.775 . . . . 0.0 110.341 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 722' ' ' GLU . 10.9 mp -55.75 -47.55 76.78 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.308 -0.87 . . . . 0.0 110.638 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 724' ' ' LYS . 8.8 p -69.98 -22.16 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.069 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -54.73 -50.37 68.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 109.048 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -116.53 103.46 10.44 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 122.241 1.02 . . . . 0.0 109.341 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.621 HD11 HG13 ' A' ' 621' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.273 -2.736 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.212 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 121.653 0.74 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.495 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 4.7 t80 -98.71 -42.77 7.07 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.953 0.882 . . . . 0.0 109.516 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.863 HD23 HD12 ' A' ' 594' ' ' ILE . 49.6 tp -123.3 120.35 32.83 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.606 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 85.5 m -101.17 116.81 33.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 1.045 HD11 HD12 ' A' ' 625' ' ' ILE . 4.3 mt -88.45 112.58 23.11 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 581' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.07 101.56 54.54 Favored Pre-proline 0 C--N 1.301 -1.505 0 C-N-CA 117.911 -1.516 . . . . 0.0 113.01 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 1.156 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.1 Cg_endo -82.13 145.18 13.68 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 N-CA-C 106.017 -2.34 . . . . 0.0 106.017 173.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.703 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.33 -178.73 0.66 Allowed Pre-proline 0 N--CA 1.498 1.971 0 C-N-CA 118.207 -1.397 . . . . 0.0 114.166 -176.373 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.703 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.1 Cg_endo -67.6 -28.54 37.73 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 124.322 1.696 . . . . 0.0 111.965 -178.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -58.6 -30.96 67.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.681 -1.262 . . . . 0.0 107.609 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.51 ' HB3' ' N ' ' A' ' 691' ' ' GLY . 3.3 p -97.88 153.85 18.04 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.457 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.4 OUTLIER -57.17 -16.09 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.97 -1.081 . . . . 0.0 109.437 179.255 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.856 HD12 ' HA ' ' A' ' 613' ' ' ILE . 9.9 mm -97.1 114.59 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.285 -0.884 . . . . 0.0 108.739 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 2.8 pm0 -126.75 73.96 1.44 Allowed 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.583 -1.323 . . . . 0.0 110.014 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 1.156 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 66.4 mm-40 -143.95 174.46 10.82 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.198 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.456 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.6 125.91 39.17 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.794 -1.191 . . . . 0.0 109.565 176.93 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.662 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.0 OUTLIER -109.34 155.43 21.21 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.284 -0.885 . . . . 0.0 109.626 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -125.02 109.99 13.63 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.363 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.863 HD12 HD23 ' A' ' 578' ' ' LEU . 4.4 mt -81.98 109.65 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.591 ' HB2' HG23 ' A' ' 598' ' ' VAL . 0.0 OUTLIER -53.01 174.47 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.504 -0.747 . . . . 0.0 109.952 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.495 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -62.0 65.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.47 -0.769 . . . . 0.0 110.854 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 125.62 34.16 0.67 Allowed Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.938 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 598' ' ' VAL . 1.2 t -79.62 103.17 6.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.4 t30 -143.18 134.68 12.82 Favored Pre-proline 0 C--N 1.283 -2.315 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.172 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.52 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 55.8 Cg_endo -91.47 161.35 28.16 Favored 'Cis proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.614 -1.828 . . . . 0.0 109.158 -1.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.487 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.8 t80 -107.08 116.65 32.3 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.745 ' C ' ' HB2' ' A' ' 609' ' ' CYS . 60.8 m-85 -89.63 144.98 25.57 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.375 -0.828 . . . . 0.0 110.786 -178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.831 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.2 mt -138.17 142.24 36.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.634 -0.666 . . . . 0.0 109.702 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 174.67 -161.24 30.84 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.415 -1.374 . . . . 0.0 111.111 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -76.26 -44.3 37.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.847 -0.796 . . . . 0.0 110.479 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.402 ' HB2' ' HG3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -80.5 123.27 27.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.277 -0.889 . . . . 0.0 110.413 -179.566 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 608' ' ' ASP . 10.1 pt-20 -48.18 -18.98 0.24 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.385 -0.822 . . . . 0.0 111.058 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 608' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 607' ' ' GLU . 2.2 t0 -40.76 -37.27 0.73 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.375 -0.828 . . . . 0.0 109.653 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.745 ' HB2' ' C ' ' A' ' 602' ' ' PHE . 18.0 p -73.43 133.6 43.76 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.487 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -44.58 -23.08 0.1 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.558 -0.713 . . . . 0.0 111.959 -178.691 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.831 ' HB3' HG23 ' A' ' 603' ' ' ILE . 10.7 t -110.08 143.63 39.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.316 -0.865 . . . . 0.0 109.743 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.7 125.61 52.09 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.003 -1.061 . . . . 0.0 113.122 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.856 ' HA ' HD12 ' A' ' 588' ' ' ILE . 10.7 mt -142.59 108.84 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -89.52 103.49 16.13 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 118.045 -1.462 . . . . 0.0 109.207 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.628 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 1.1 m-20 -139.37 106.45 5.46 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.348 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -43.15 -43.25 4.47 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.602 -0.686 . . . . 0.0 112.048 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -83.88 -17.52 40.57 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.017 -1.052 . . . . 0.0 111.905 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -77.27 133.96 38.68 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.056 -1.028 . . . . 0.0 110.834 -179.153 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.485 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.5 m -75.92 159.82 30.52 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.367 -0.833 . . . . 0.0 111.225 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.601 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 19.4 ttm105 -62.62 -44.48 96.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.361 -0.837 . . . . 0.0 109.219 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.756 ' HB ' HG23 ' A' ' 727' ' ' VAL . 27.4 m -94.65 1.81 9.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 121.761 0.791 . . . . 0.0 109.358 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.8 t60 -30.81 -48.22 0.11 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.718 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.827 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -136.5 144.89 44.56 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.579 -1.249 . . . . 0.0 110.826 178.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 650' ' ' CYS . 17.1 p90 -146.29 145.84 30.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.543 -0.723 . . . . 0.0 110.163 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 1.045 HD12 HD11 ' A' ' 580' ' ' LEU . 8.7 mt -103.2 122.37 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.432 ' HB2' ' HE2' ' A' ' 624' ' ' PHE . 3.5 t80 -117.63 154.9 30.79 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.543 -0.723 . . . . 0.0 109.462 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 10.1 tttt -119.72 136.19 54.53 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.77 0.795 . . . . 0.0 111.023 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.72 163.5 28.86 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.575 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -78.3 126.3 30.59 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.818 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 7.0 t60 . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.399 -0.813 . . . . 0.0 110.749 -179.039 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.751 HD12 ' N ' ' A' ' 703' ' ' PHE . 3.0 mm? . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.575 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 4.5 m-20 -130.19 132.53 46.06 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.035 -1.041 . . . . 0.0 111.306 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.588 ' OD1' HD21 ' A' ' 671' ' ' LEU . 2.2 t0 -127.26 143.24 51.28 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.229 -0.92 . . . . 0.0 110.538 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 12.7 pt -96.96 134.45 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.261 -0.9 . . . . 0.0 109.926 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.686 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.3 m95 -119.18 120.87 38.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.571 -0.706 . . . . 0.0 111.313 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.662 ' HB2' HD11 ' A' ' 672' ' ' LEU . 4.0 t80 -80.84 114.25 19.59 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 624' ' ' PHE . 38.5 m -108.57 108.62 19.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 111.117 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.791 ' CE1' ' O ' ' A' ' 653' ' ' GLY . 7.6 t-80 -74.21 161.7 29.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.572 -0.705 . . . . 0.0 110.362 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -151.11 -31.57 0.17 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.791 ' O ' ' CE1' ' A' ' 651' ' ' HIS . . . -79.41 130.89 10.18 Favored Glycine 0 N--CA 1.501 2.983 0 O-C-N 119.232 -2.167 . . . . 0.0 110.342 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 654' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 656' ' ' VAL . 11.4 m -36.54 -24.24 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -177.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.545 ' O ' HG12 ' A' ' 656' ' ' VAL . 4.1 t-20 -56.01 -4.74 0.13 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.325 -1.484 . . . . 0.0 112.775 -178.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 77.69 166.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 CA-C-O 122.043 0.925 . . . . 0.0 110.734 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.626 ' HB3' ' CD2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -126.84 150.9 48.99 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.045 -178.798 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -135.75 126.4 27.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.396 -0.815 . . . . 0.0 110.23 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.732 ' CD2' HG22 ' A' ' 678' ' ' ILE . 0.4 OUTLIER -127.36 108.95 11.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.305 -0.872 . . . . 0.0 109.679 179.487 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.9 m120 58.79 -81.34 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.426 -0.796 . . . . 0.0 110.195 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.9 OUTLIER -143.78 22.66 1.78 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.069 -1.019 . . . . 0.0 110.439 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -116.57 128.17 55.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.195 -0.941 . . . . 0.0 110.395 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -91.46 141.32 28.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.393 -0.817 . . . . 0.0 110.176 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.679 ' HG2' HG13 ' A' ' 716' ' ' VAL . 3.5 mtp -120.28 -172.96 2.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.401 -0.812 . . . . 0.0 110.208 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.567 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.1 pp -126.09 -169.94 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -0.87 . . . . 0.0 110.24 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -76.8 72.44 3.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.334 -0.854 . . . . 0.0 110.748 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 129.12 55.65 0.1 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.567 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.0 OUTLIER -122.17 151.76 40.64 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.281 -1.129 . . . . 0.0 110.296 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.597 ' HD3' HD13 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -108.85 139.03 44.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.264 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.657 ' CD1' HD13 ' A' ' 659' ' ' LEU . 8.5 t80 -143.56 146.36 33.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 111.268 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.686 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -73.88 146.98 43.66 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.614 -0.679 . . . . 0.0 110.778 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.761 HD13 HG21 ' A' ' 694' ' ' VAL . 10.2 mt -115.71 114.34 24.7 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.285 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -97.04 148.76 22.67 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.0 135.19 25.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.044 -1.035 . . . . 0.0 110.087 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 83.77 45.57 6.34 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 107.686 -2.166 . . . . 0.0 107.686 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.421 ' OD2' ' HA ' ' A' ' 672' ' ' LEU . 0.4 OUTLIER -109.85 93.5 4.53 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.802 -0.822 . . . . 0.0 110.444 -179.061 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.852 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 4.6 tt0 -93.35 107.47 19.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.732 HG22 ' CD2' ' A' ' 659' ' ' LEU . 4.1 pt -112.43 138.04 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.564 -0.71 . . . . 0.0 112.38 -176.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.22 113.58 26.76 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.827 HD13 ' SG ' ' A' ' 623' ' ' CYS . 85.0 mt -76.83 -30.66 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.172 -0.955 . . . . 0.0 110.51 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 618' ' ' LEU . 4.0 mt -138.64 134.93 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.269 -0.894 . . . . 0.0 110.047 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -137.38 108.84 6.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.539 -0.726 . . . . 0.0 110.104 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.59 118.39 33.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.32 -0.862 . . . . 0.0 110.221 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.04 -46.64 77.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.425 -0.797 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -84.6 -43.37 14.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.32 -0.863 . . . . 0.0 110.763 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -76.21 -10.09 59.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.333 -0.854 . . . . 0.0 110.662 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.76 20.2 4.95 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.111 -0.993 . . . . 0.0 110.433 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.407 ' CE2' ' HA ' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -82.3 75.15 9.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -0.885 . . . . 0.0 109.354 179.464 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 689' ' ' VAL . 10.8 p -103.16 131.65 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.387 -0.821 . . . . 0.0 111.054 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.566 HG23 HG12 ' A' ' 588' ' ' ILE . 36.3 mm -113.3 163.67 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.429 -0.795 . . . . 0.0 109.168 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.51 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . -167.79 120.29 0.89 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.198 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.852 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 7.7 m-85 -120.41 137.78 54.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.519 -0.989 . . . . 0.0 109.115 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -110.36 114.77 28.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.404 -0.81 . . . . 0.0 110.757 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.761 HG21 HD13 ' A' ' 672' ' ' LEU . 0.8 OUTLIER -75.67 119.97 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.478 -0.763 . . . . 0.0 109.084 179.227 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -129.68 103.95 7.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.438 -0.789 . . . . 0.0 110.143 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.551 ' CG1' HD13 ' A' ' 578' ' ' LEU . 60.0 mt -86.97 111.4 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -0.799 . . . . 0.0 109.734 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -81.28 -43.26 19.41 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.491 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.5 m-20 -111.65 140.56 46.18 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.555 0.693 . . . . 0.0 110.61 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 699' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 700' ' ' THR . 25.0 p -115.62 96.77 5.78 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 700' ' ' THR . . . . . 0.611 HG23 ' H ' ' A' ' 702' ' ' LEU . 9.0 t -60.0 -147.52 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.138 0.494 . . . . 0.0 110.248 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 644' ' ' LEU . . . -67.86 -1.17 16.79 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.611 ' H ' HG23 ' A' ' 700' ' ' THR . 0.0 OUTLIER -47.03 144.46 2.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.287 -1.125 . . . . 0.0 111.15 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.751 ' N ' HD12 ' A' ' 644' ' ' LEU . 50.7 p90 -53.53 -27.62 26.85 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.137 0.97 . . . . 0.0 108.803 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.507 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 24.4 t30 . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 15.9 mmm-85 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.286 0.565 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.0 m -107.74 152.48 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.441 -0.787 . . . . 0.0 109.494 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.679 HG13 ' HG2' ' A' ' 664' ' ' MET . 57.7 t -89.4 121.5 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.16 -0.962 . . . . 0.0 110.543 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.597 HD13 ' HD3' ' A' ' 669' ' ' LYS . 3.1 mp -96.1 161.89 13.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.426 -0.796 . . . . 0.0 109.846 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.68 153.66 17.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.375 -0.828 . . . . 0.0 109.841 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -87.16 125.06 33.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.318 -0.864 . . . . 0.0 110.38 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 39.7 p -93.15 -176.31 4.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.376 -0.828 . . . . 0.0 110.124 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.44 -28.91 32.75 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.326 -0.859 . . . . 0.0 110.207 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.1 -52.17 63.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.377 -0.827 . . . . 0.0 109.858 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -48.65 75.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 0.0 109.975 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.505 ' O ' HG12 ' A' ' 727' ' ' VAL . 5.7 tttp -53.74 -32.17 51.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.386 -0.822 . . . . 0.0 110.123 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.28 -36.17 78.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.87 . . . . 0.0 110.242 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 42.1 mt -59.46 -46.33 89.09 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.346 -0.846 . . . . 0.0 110.245 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.756 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.1 p -71.77 -22.2 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.145 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.26 -47.69 68.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.895 . . . . 0.0 108.937 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -116.87 104.28 11.15 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.151 0.977 . . . . 0.0 109.235 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.274 -2.69 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.252 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.419 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 121.692 0.758 . . . . 0.0 109.515 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.495 ' HB3' ' HA ' ' A' ' 596' ' ' GLN . 3.4 t80 -106.29 -43.17 4.86 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.974 0.892 . . . . 0.0 109.46 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.738 HD23 HD12 ' A' ' 594' ' ' ILE . 31.4 tp -120.66 142.42 49.47 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.968 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 42.5 m -125.76 116.87 22.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.503 -0.748 . . . . 0.0 109.39 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.596 HD11 ' CD1' ' A' ' 625' ' ' ILE . 3.5 mt -95.13 112.08 23.83 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.416 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 1.6 mmtt -108.62 102.78 49.05 Favored Pre-proline 0 C--N 1.3 -1.586 0 C-N-CA 118.4 -1.32 . . . . 0.0 112.408 -177.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 1.052 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.8 Cg_endo -79.08 142.69 17.35 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 N-CA-C 106.547 -2.136 . . . . 0.0 106.547 175.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.794 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -128.05 -171.08 0.23 Allowed Pre-proline 0 C--N 1.297 -1.693 0 C-N-CA 118.501 -1.279 . . . . 0.0 112.79 -177.056 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.794 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 37.2 Cg_endo -63.58 -35.09 61.32 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 124.068 1.562 . . . . 0.0 110.815 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.99 -28.73 66.63 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.585 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 46.0 t -96.53 153.45 17.84 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.753 HG22 ' CD1' ' A' ' 690' ' ' ILE . 6.1 tp -63.53 -12.98 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.384 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.783 ' CG1' ' HA ' ' A' ' 613' ' ' ILE . 31.3 mm -100.97 120.29 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.369 -0.832 . . . . 0.0 109.838 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 589' ' ' GLN . . . . . 0.585 ' NE2' ' O ' ' A' ' 586' ' ' SER . 23.6 mp0 -115.98 68.27 0.72 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.55 -1.344 . . . . 0.0 109.307 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 1.052 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.5 mm-40 -143.97 176.85 8.98 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.593 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.524 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.19 125.77 41.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.194 -0.941 . . . . 0.0 108.859 176.576 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.732 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.9 mt -106.51 153.78 21.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.362 -0.836 . . . . 0.0 109.661 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.419 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 6.5 mp0 -125.99 110.12 13.22 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.308 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.738 HD12 HD23 ' A' ' 578' ' ' LEU . 1.7 mt -84.18 109.58 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.124 -0.985 . . . . 0.0 108.353 178.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' A' ' 597' ' ' GLY . 1.9 mp0 -51.66 172.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.655 -0.653 . . . . 0.0 109.869 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.495 ' HA ' ' HB3' ' A' ' 577' ' ' PHE . 4.2 mt-30 -66.55 65.31 0.05 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.477 -0.764 . . . . 0.0 110.086 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 135.09 27.19 0.48 Allowed Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.611 -1.28 . . . . 0.0 110.988 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -80.08 102.23 5.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.392 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 627' ' ' LYS . 14.2 t-20 -144.3 133.45 11.33 Favored Pre-proline 0 C--N 1.282 -2.341 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.367 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.676 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 55.2 Cg_endo -91.96 162.86 26.92 Favored 'Cis proline' 0 C--N 1.311 -1.442 0 C-N-CA 123.086 -1.631 . . . . 0.0 108.891 -2.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.565 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 5.5 t80 -105.97 116.42 31.91 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.676 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 73.8 m-85 -84.96 144.83 28.07 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.323 -0.861 . . . . 0.0 110.977 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.88 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.8 mt -142.19 141.62 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.724 -0.61 . . . . 0.0 110.291 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.834 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 167.88 -167.58 40.16 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.331 -1.414 . . . . 0.0 111.306 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 8.0 tpt180 -63.01 -36.34 83.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.889 -0.771 . . . . 0.0 111.774 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.22 121.62 28.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.043 -1.036 . . . . 0.0 111.246 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.559 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 7.0 tm-20 -53.11 -19.06 2.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 110.02 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.55 -30.24 2.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.347 -0.846 . . . . 0.0 109.292 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 602' ' ' PHE . 4.7 m -69.06 136.37 52.25 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.496 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -47.82 -25.09 1.16 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.276 -0.89 . . . . 0.0 110.056 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.88 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.0 t -110.52 143.32 41.06 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.589 ' O ' HG13 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -106.93 127.23 53.26 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.099 -1.001 . . . . 0.0 112.682 -178.694 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.868 HG22 HD22 ' A' ' 618' ' ' LEU . 2.3 mt -144.01 108.99 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.536 ' H ' HD11 ' A' ' 588' ' ' ILE . 3.1 tt0 -97.79 104.48 16.51 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.302 -1.359 . . . . 0.0 108.916 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.573 ' HA ' ' CZ ' ' A' ' 688' ' ' PHE . 6.1 m-20 -138.41 106.1 5.61 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.531 177.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -43.32 -42.3 4.44 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.671 -0.643 . . . . 0.0 111.953 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -83.09 -17.16 44.08 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.096 -1.002 . . . . 0.0 111.098 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.868 HD22 HG22 ' A' ' 613' ' ' ILE . 0.5 OUTLIER -79.74 140.4 36.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.25 -0.906 . . . . 0.0 110.677 -179.335 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.435 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.89 161.83 28.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.274 -0.891 . . . . 0.0 110.794 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.809 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -64.22 -45.24 89.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.337 -0.852 . . . . 0.0 109.534 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 1.021 HG11 HG23 ' A' ' 727' ' ' VAL . 11.5 t -95.76 2.22 9.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.383 -0.823 . . . . 0.0 109.405 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.8 t60 -26.05 -47.12 0.02 OUTLIER 'General case' 0 C--O 1.194 -1.831 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.46 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.804 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.69 146.09 43.38 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 118.049 -1.46 . . . . 0.0 111.955 179.528 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.55 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 2.0 p90 -145.3 148.91 33.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.6 -0.688 . . . . 0.0 109.984 177.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.596 ' CD1' HD11 ' A' ' 580' ' ' LEU . 13.8 mt -103.72 124.41 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 6.0 t80 -117.32 155.24 29.87 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.481 -0.762 . . . . 0.0 109.386 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.49 ' NZ ' HG23 ' A' ' 647' ' ' ILE . 4.3 tppt? -119.73 137.06 54.17 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.604 0.716 . . . . 0.0 110.896 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.417 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -139.09 163.07 33.39 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.719 -0.613 . . . . 0.0 109.641 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -78.5 121.24 24.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.974 -1.079 . . . . 0.0 109.314 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.522 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.0 t60 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 111.07 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.588 ' CD1' ' HA ' ' A' ' 703' ' ' PHE . 2.9 mt . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.533 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.0 OUTLIER -112.83 124.9 53.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.963 -1.085 . . . . 0.0 111.061 -179.592 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.722 ' OD1' HD21 ' A' ' 671' ' ' LEU . 37.6 t0 -112.72 143.63 43.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 0.0 110.188 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.49 HG23 ' NZ ' ' A' ' 627' ' ' LYS . 8.5 pt -99.39 132.36 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.259 -0.9 . . . . 0.0 109.663 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.624 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.2 m95 -118.12 142.95 46.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.527 -0.733 . . . . 0.0 110.918 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.92 ' CB ' HD11 ' A' ' 672' ' ' LEU . 27.0 t80 -103.24 114.81 29.39 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.5 OUTLIER -104.06 102.63 12.38 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.641 -178.531 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.526 ' CD2' ' N ' ' A' ' 652' ' ' THR . 8.7 t60 -64.2 156.63 28.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.345 -0.847 . . . . 0.0 109.294 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -149.55 -28.22 0.26 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.364 -0.835 . . . . 0.0 112.543 -179.122 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.587 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.51 -163.82 27.26 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 117.943 -2.075 . . . . 0.0 109.724 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 25.2 m -96.93 -17.99 19.76 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.961 -1.317 . . . . 0.0 113.921 -176.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.691 ' C ' HG13 ' A' ' 656' ' ' VAL . 20.3 m120 -59.6 -2.96 0.4 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.774 -1.204 . . . . 0.0 112.591 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.691 HG13 ' C ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 63.38 138.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-O 121.69 0.757 . . . . 0.0 110.161 -179.332 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.449 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -91.48 142.73 27.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.653 -0.655 . . . . 0.0 110.685 -178.905 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.466 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 6.1 m-85 -132.42 126.55 33.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.354 -0.841 . . . . 0.0 110.496 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.694 HD21 ' OD2' ' A' ' 676' ' ' ASP . 0.0 OUTLIER -130.97 115.38 16.42 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.366 -0.834 . . . . 0.0 109.955 179.515 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.08 -81.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.391 -0.818 . . . . 0.0 110.343 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.4 OUTLIER -148.36 26.87 0.94 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.0 110.157 179.865 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -111.21 133.52 53.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.234 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.421 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 6.5 tmm_? -98.71 126.66 44.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.372 -0.83 . . . . 0.0 110.102 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.534 ' HG2' HG13 ' A' ' 716' ' ' VAL . 4.4 mtp -108.06 -167.73 1.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 110.345 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.637 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.7 pt -138.43 -164.22 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.352 -0.842 . . . . 0.0 110.279 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 666' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 652' ' ' THR . 51.5 tt0 -79.81 82.27 5.93 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.49 -0.756 . . . . 0.0 110.505 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.07 52.19 0.24 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.637 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.3 OUTLIER -121.15 148.3 44.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.018 -1.284 . . . . 0.0 110.111 179.678 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.42 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.3 ttpm? -108.31 141.34 40.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.492 -0.755 . . . . 0.0 109.456 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.451 ' HB2' ' CE ' ' A' ' 664' ' ' MET . 0.5 OUTLIER -144.42 146.72 32.65 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.49 -178.828 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.722 HD21 ' OD1' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -71.31 147.17 48.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.511 -0.743 . . . . 0.0 111.197 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.92 HD11 ' CB ' ' A' ' 649' ' ' TYR . 3.0 mp -113.45 104.98 12.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.637 -0.664 . . . . 0.0 111.5 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -88.47 151.04 22.81 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 674' ' ' ASP . . . . . 0.405 ' HB3' HD12 ' A' ' 696' ' ' ILE . 2.8 p30 -48.22 143.83 4.3 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.162 -0.961 . . . . 0.0 110.377 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.96 46.29 52.83 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 107.841 -2.104 . . . . 0.0 107.841 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.694 ' OD2' HD21 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -100.38 88.94 3.8 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.795 -0.826 . . . . 0.0 110.512 -179.14 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.788 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -93.41 107.08 18.98 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.397 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.627 HG21 HD11 ' A' ' 659' ' ' LEU . 1.8 pt -115.12 137.95 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.631 -0.668 . . . . 0.0 111.737 -176.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 679' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 7.2 mttp -96.89 111.23 23.52 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.804 HD13 ' SG ' ' A' ' 623' ' ' CYS . 73.1 mt -77.32 -11.76 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.299 -0.875 . . . . 0.0 110.64 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 688' ' ' PHE . 14.4 tt -143.2 133.87 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.074 -1.016 . . . . 0.0 110.158 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -138.11 111.69 8.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.149 -0.969 . . . . 0.0 110.738 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.3 117.15 19.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.233 -0.917 . . . . 0.0 109.86 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -46.93 72.71 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.361 -0.837 . . . . 0.0 110.954 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -66.94 -38.82 86.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.219 -0.925 . . . . 0.0 109.947 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 686' ' ' ASN . . . . . 0.58 ' O ' ' C ' ' A' ' 687' ' ' LYS . 1.5 m-80 -122.07 84.27 2.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.586 -0.696 . . . . 0.0 109.551 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 687' ' ' LYS . . . . . 0.58 ' C ' ' O ' ' A' ' 686' ' ' ASN . 23.4 mmtp -19.74 -82.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 122.054 -0.404 . . . . 0.0 111.335 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.573 ' CZ ' ' HA ' ' A' ' 615' ' ' ASP . 1.3 t80 33.8 73.41 0.07 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.504 -0.747 . . . . 0.0 110.099 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 586' ' ' SER . 58.6 t -112.21 143.14 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.459 -0.775 . . . . 0.0 111.49 -178.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.753 ' CD1' HG22 ' A' ' 587' ' ' ILE . 16.1 mm -103.46 164.65 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.443 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -177.12 115.8 0.52 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.001 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.788 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 12.8 m-85 -119.92 137.49 54.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -1.042 . . . . 0.0 109.138 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -101.5 114.75 29.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 110.593 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.653 HG22 HD11 ' A' ' 578' ' ' LEU . 1.2 t -82.43 121.48 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.578 -0.701 . . . . 0.0 109.169 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.12 104.83 7.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.711 -0.618 . . . . 0.0 110.172 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 696' ' ' ILE . . . . . 0.405 HD12 ' HB3' ' A' ' 674' ' ' ASP . 19.9 mt -80.91 104.43 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 0.0 109.935 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -72.78 -43.08 63.25 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.306 -0.872 . . . . 0.0 108.973 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.452 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 6.5 m-20 -110.68 140.75 44.76 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.618 0.723 . . . . 0.0 110.741 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 28.6 p -115.43 96.06 5.47 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 39.3 p -126.5 131.63 51.58 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.642 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 701' ' ' GLY . . . . . 0.426 ' C ' HD22 ' A' ' 644' ' ' LEU . . . 51.15 35.85 34.6 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 704' ' ' ASN . 5.3 tp -108.99 132.96 53.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.451 -1.029 . . . . 0.0 111.036 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.633 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 3.3 p90 -48.47 -25.02 1.47 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.644 0.735 . . . . 0.0 110.301 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.633 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.1 t30 . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.461 ' CZ ' HD23 ' A' ' 659' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.269 0.557 . . . . 0.0 111.389 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.44 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 31.9 m -107.25 150.1 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 109.214 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.534 HG13 ' HG2' ' A' ' 664' ' ' MET . 85.1 t -95.45 133.16 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 110.729 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.2 mp -108.86 162.34 14.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.42 -0.8 . . . . 0.0 110.094 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.17 154.61 17.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.36 -0.838 . . . . 0.0 110.1 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.62 148.02 31.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.304 -0.872 . . . . 0.0 110.406 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 11.1 p -121.35 -176.2 3.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.379 -0.826 . . . . 0.0 110.384 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.44 -29.2 34.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.369 -0.832 . . . . 0.0 110.002 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -66.05 -45.45 81.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.421 -0.799 . . . . 0.0 109.523 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.95 -46.91 79.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.47 -0.769 . . . . 0.0 109.62 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.492 ' O ' HG12 ' A' ' 727' ' ' VAL . 9.1 tttt -53.53 -32.64 51.37 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.427 -0.795 . . . . 0.0 109.746 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.59 -35.94 78.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.527 -0.733 . . . . 0.0 110.33 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 34.4 mt -58.92 -46.84 86.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.274 -0.891 . . . . 0.0 110.305 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 1.021 HG23 HG11 ' A' ' 621' ' ' VAL . 7.5 p -70.8 -19.87 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.557 -0.715 . . . . 0.0 110.264 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.0 -43.51 66.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.265 -0.897 . . . . 0.0 108.956 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.94 103.52 10.37 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 122.222 1.01 . . . . 0.0 109.191 177.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.4 ' O ' ' CD2' ' A' ' 602' ' ' PHE . 1.2 mt . . . . . 0 C--N 1.273 -2.74 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.344 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 576' ' ' ARG . . . . . 0.434 ' HD3' ' HB3' ' A' ' 593' ' ' GLU . 1.9 ttp180 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.751 0.786 . . . . 1.48 109.387 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 577' ' ' PHE . . . . . 0.608 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -115.5 -42.1 3.18 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.053 0.93 . . . . 1.03 109.241 -179.178 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.608 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 9.4 tt -120.45 128.79 53.49 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.872 -0.603 . . . . 1.1799999999999999 110.749 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 61.7 m -104.36 116.83 32.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 0.26000000000000001 109.704 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 580' ' ' LEU . . . . . 0.759 HD12 HG13 ' A' ' 594' ' ' ILE . 4.1 mt -92.11 112.6 24.6 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.843 -1.169 . . . . 0.89000000000000001 107.843 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 581' ' ' LYS . . . . . 0.441 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 1.0 OUTLIER -113.5 102.77 55.18 Favored Pre-proline 0 C--N 1.301 -1.502 0 C-N-CA 118.337 -1.345 . . . . 0.93000000000000005 112.565 -178.089 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 582' ' ' PRO . . . . . 1.06 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.7 Cg_endo -77.49 143.11 21.47 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 N-CA-C 105.83 -2.411 . . . . 0.25 105.83 174.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 583' ' ' LEU . . . . . 0.724 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.41 -177.53 0.52 Allowed Pre-proline 0 N--CA 1.497 1.909 0 C-N-CA 118.181 -1.408 . . . . 1.1000000000000001 113.848 -176.233 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 584' ' ' PRO . . . . . 0.724 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.6 Cg_endo -66.96 -34.83 28.24 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 124.253 1.659 . . . . 0.51000000000000001 111.75 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -58.25 -29.32 65.68 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.173 -1.417 . . . . 1.4199999999999999 107.173 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 586' ' ' SER . . . . . 0.532 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 3.0 t -95.92 150.8 20.04 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.396 -0.964 . . . . 1.1599999999999999 108.396 177.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 587' ' ' ILE . . . . . 0.67 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.5 OUTLIER -57.52 -15.98 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.994 -1.066 . . . . 1.29 109.428 179.457 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 588' ' ' ILE . . . . . 0.771 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 8.1 mm -98.49 114.67 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.388 -0.82 . . . . 1.6599999999999999 109.153 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -122.65 69.29 0.97 Allowed 'General case' 0 N--CA 1.507 2.395 0 O-C-N 120.711 -1.243 . . . . 1.29 109.512 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 590' ' ' GLU . . . . . 1.06 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 27.6 mt-10 -142.74 176.04 9.35 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.132 -0.94 . . . . 2.1299999999999999 109.004 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.551 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.73 123.67 35.92 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.791 -1.193 . . . . 0.22 109.926 177.382 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.547 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.8 mt -112.07 155.52 23.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.457 -0.777 . . . . 1.0800000000000001 109.37 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.434 ' HB3' ' HD3' ' A' ' 576' ' ' ARG . 10.5 mp0 -126.99 113.87 17.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 1.6699999999999999 111.501 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 594' ' ' ILE . . . . . 0.759 HG13 HD12 ' A' ' 580' ' ' LEU . 4.1 mt -72.13 109.36 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.98 -1.075 . . . . 0.46999999999999997 108.31 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 595' ' ' GLN . . . . . 0.557 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -61.52 107.95 0.88 Allowed 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.601 -0.687 . . . . 1.52 110.738 -178.943 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 596' ' ' GLN . . . . . 0.557 ' C ' ' O ' ' A' ' 595' ' ' GLN . 3.5 tt0 -11.52 87.29 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.298 0.571 . . . . 1.3400000000000001 112.253 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 597' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 105.87 22.1 8.2 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.668 -1.373 . . . . 1.0600000000000001 109.668 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 598' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 598' ' ' VAL . 1.2 t -82.28 103.59 9.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 107.074 -1.454 . . . . 0.53000000000000003 107.074 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 599' ' ' ASN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 627' ' ' LYS . 7.9 t30 -143.17 134.2 12.57 Favored Pre-proline 0 C--N 1.281 -2.403 0 CA-C-N 114.549 -1.205 . . . . 1.52 110.19 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 600' ' ' PRO . . . . . 0.668 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 54.9 Cg_endo -91.56 162.26 28.1 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.804 -1.748 . . . . 0.33000000000000002 109.334 -1.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 601' ' ' PHE . . . . . 0.625 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 5.1 t80 -106.28 117.21 33.45 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.363 -1.347 . . . . 0.28000000000000003 107.363 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 602' ' ' PHE . . . . . 0.681 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 56.3 m-85 -88.71 146.04 25.29 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.378 -0.826 . . . . 0.53000000000000003 110.939 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 603' ' ' ILE . . . . . 0.746 HD11 HG13 ' A' ' 625' ' ' ILE . 2.9 mt -141.76 139.72 31.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.965 -0.694 . . . . 0.28999999999999998 109.962 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 604' ' ' GLY . . . . . 0.708 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 174.82 -166.81 38.74 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.505 -1.331 . . . . 0.22 110.977 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 605' ' ' ARG . . . . . 0.482 ' HD2' ' HA ' ' A' ' 614' ' ' GLU . 14.8 tpt180 -65.4 -38.83 91.14 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.858 -0.79 . . . . 1.5600000000000001 110.591 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 606' ' ' SER . . . . . 0.412 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 1.0 OUTLIER -81.04 122.32 27.16 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.323 -0.861 . . . . 0.75 110.862 -179.351 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 607' ' ' GLU . . . . . 0.508 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.1 OUTLIER -57.73 -15.2 7.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 2.3900000000000001 109.79 178.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.09 -36.19 5.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.502 -0.749 . . . . 1.72 110.068 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 609' ' ' CYS . . . . . 0.681 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 73.6 m -67.41 152.71 45.21 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.552 -0.859 . . . . 0.98999999999999999 109.451 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 610' ' ' ASN . . . . . 0.566 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 1.5 t30 -57.06 -14.35 3.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.46 -0.775 . . . . 1.23 110.473 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 611' ' ' CYS . . . . . 0.711 ' HB3' HG23 ' A' ' 603' ' ' ILE . 8.7 t -120.08 144.21 47.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.398 -0.814 . . . . 0.34000000000000002 109.804 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 612' ' ' LYS . . . . . 0.508 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -110.46 120.06 41.21 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 122.158 0.98 . . . . 2.1699999999999999 113.29 -178.117 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 613' ' ' ILE . . . . . 0.771 ' HA ' ' CD1' ' A' ' 588' ' ' ILE . 14.1 mt -142.8 107.92 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 107.36 -1.348 . . . . 0.55000000000000004 107.36 176.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 614' ' ' GLU . . . . . 0.482 ' HA ' ' HD2' ' A' ' 605' ' ' ARG . 6.0 tt0 -92.45 104.4 16.73 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.98 1.371 . . . . 2.2799999999999998 109.664 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 615' ' ' ASP . . . . . 0.626 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.8 m-20 -138.4 106.06 5.61 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.074 -1.421 . . . . 1.3899999999999999 107.971 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -39.65 -44.27 1.48 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.617 -0.677 . . . . 1.8500000000000001 112.131 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.78 -17.32 41.52 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.093 -1.005 . . . . 2.9300000000000002 111.672 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.686 HD12 HD11 ' A' ' 681' ' ' ILE . 0.8 OUTLIER -78.04 119.28 21.24 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.019 -1.051 . . . . 0.40999999999999998 110.768 -179.137 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 619' ' ' SER . . . . . 0.476 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -59.18 159.86 7.04 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.4 -0.813 . . . . 0.91000000000000003 110.809 179.852 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 620' ' ' ARG . . . . . 0.708 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -63.91 -45.39 89.53 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.32 -0.862 . . . . 2.4199999999999999 109.183 179.521 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 621' ' ' VAL . . . . . 0.49 ' HB ' HG23 ' A' ' 727' ' ' VAL . 10.5 m -95.06 1.84 9.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.355 -0.84 . . . . 1.02 109.469 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 6.3 t60 -28.87 -46.79 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.622 -0.717 . . . . 0.22 110.875 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 623' ' ' CYS . . . . . 0.778 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.6 OUTLIER -136.45 145.77 45.58 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.45 -1.3 . . . . 0.19 110.777 178.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 624' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 3.1 p90 -144.72 149.58 35.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.458 -0.776 . . . . 0.53000000000000003 110.219 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 625' ' ' ILE . . . . . 0.746 HG13 HD11 ' A' ' 603' ' ' ILE . 69.2 mt -104.54 121.75 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.765 -0.828 . . . . 0.64000000000000001 108.765 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 626' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 4.5 t80 -115.27 153.96 29.95 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.52 -0.737 . . . . 0.92000000000000004 109.439 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 627' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 1.2 ttmt -120.12 137.08 54.35 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.578 0.704 . . . . 0.93999999999999995 110.501 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 628' ' ' LYS . . . . . 0.417 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.57 163.32 29.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.594 -0.691 . . . . 1.9399999999999999 110.321 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 629' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.5 OUTLIER -78.32 115.08 17.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.95 . . . . 2.1299999999999999 108.74 179.82 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 630' ' ' HIS . . . . . 0.538 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.9 t60 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.505 -0.747 . . . . 0.69999999999999996 110.846 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 644' ' ' LEU . . . . . 0.751 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.0 mp . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 108.97 -0.752 . . . . 1.23 108.97 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 645' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 13.2 m-20 -112.54 123.97 51.48 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.974 -1.079 . . . . 1.54 111.276 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 646' ' ' ASP . . . . . 0.535 ' OD2' HD21 ' A' ' 671' ' ' LEU . 26.5 t70 -109.57 146.8 34.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.513 -0.742 . . . . 1.2 109.665 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 647' ' ' ILE . . . . . 0.554 HD13 ' CD1' ' A' ' 578' ' ' LEU . 12.5 pt -102.49 130.66 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.279 -0.888 . . . . 0.28999999999999998 110.039 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 648' ' ' TRP . . . . . 0.616 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 91.3 m95 -118.58 119.71 35.31 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.092 -0.643 . . . . 0.32000000000000001 110.754 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.853 ' HB2' HD11 ' A' ' 672' ' ' LEU . 3.8 t80 -80.93 114.69 19.98 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.366 -0.975 . . . . 0.33000000000000002 108.366 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 650' ' ' CYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.1 OUTLIER -106.35 114.29 28.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.909 . . . . 1.1200000000000001 111.564 -178.608 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.706 ' HE1' ' O ' ' A' ' 653' ' ' GLY . 29.0 t-80 -74.04 159.92 32.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.451 -0.781 . . . . 0.23999999999999999 109.975 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -149.96 -30.59 0.22 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.403 -0.81 . . . . 0.31 112.968 -179.158 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 653' ' ' GLY . . . . . 0.706 ' O ' ' HE1' ' A' ' 651' ' ' HIS . . . -78.03 -167.73 30.93 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 117.579 -2.248 . . . . 0.71999999999999997 109.416 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 24.3 m -94.94 -17.85 21.62 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.968 -1.313 . . . . 0.54000000000000004 113.91 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 655' ' ' ASN . . . . . 0.535 ' O ' HG12 ' A' ' 656' ' ' VAL . 30.5 m120 -60.85 -4.29 0.96 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.774 -1.204 . . . . 1.79 112.398 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 75.45 166.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-O 121.95 0.881 . . . . 1.46 110.648 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 657' ' ' SER . . . . . 0.539 ' CB ' ' CD2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -123.73 145.51 48.96 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.162 -0.615 . . . . 0.28999999999999998 110.585 -178.921 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.434 ' CE1' ' CG ' ' A' ' 663' ' ' ARG . 15.7 m-85 -135.64 126.32 27.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.272 -0.893 . . . . 1.22 110.615 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.64 HD22 ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -128.2 109.85 11.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.273 -0.892 . . . . 1.28 109.927 179.231 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.77 -80.34 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.484 -0.76 . . . . 1.73 110.358 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 661' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.6 OUTLIER -146.13 25.21 1.27 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.25 -0.906 . . . . 2.1899999999999999 110.307 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.03 117.95 30.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.284 -0.885 . . . . 1.45 110.285 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 663' ' ' ARG . . . . . 0.434 ' CG ' ' CE1' ' A' ' 658' ' ' TYR . 3.0 tmm_? -84.39 141.06 31.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 2.4300000000000002 110.098 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 664' ' ' MET . . . . . 0.597 ' O ' HG22 ' A' ' 656' ' ' VAL . 3.5 mtp -118.89 -166.12 1.21 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.279 -0.888 . . . . 0.63 110.294 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 665' ' ' ILE . . . . . 0.624 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.4 pt -138.34 -160.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.225 -0.922 . . . . 0.5 110.365 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -81.65 90.43 6.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.398 -0.814 . . . . 0.75 110.564 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.07 50.43 0.68 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.021 -1.232 . . . . 0.28000000000000003 110.021 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 668' ' ' THR . . . . . 0.624 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.1 OUTLIER -117.61 149.43 40.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.113 -1.227 . . . . 0.29999999999999999 110.13 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.454 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 10.8 tttt -108.39 141.01 40.87 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.985 -0.746 . . . . 0.67000000000000004 108.985 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 670' ' ' PHE . . . . . 0.64 ' CD2' HD22 ' A' ' 659' ' ' LEU . 13.5 t80 -143.96 146.29 32.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.148 -0.97 . . . . 1.03 111.665 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 671' ' ' LEU . . . . . 0.616 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -73.08 147.26 45.14 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.626 -0.671 . . . . 1.3100000000000001 110.621 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 672' ' ' LEU . . . . . 0.853 HD11 ' HB2' ' A' ' 649' ' ' TYR . 12.8 mt -118.56 112.83 20.39 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.672 -0.811 . . . . 0.84999999999999998 111.306 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 673' ' ' GLN . . . . . 0.496 ' O ' HG11 ' A' ' 694' ' ' VAL . 75.2 mt-30 -90.25 -177.43 5.12 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.044 -0.725 . . . . 1.1599999999999999 109.044 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -76.26 142.83 41.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.138 -0.976 . . . . 1.21 109.691 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.34 47.2 59.48 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 107.788 -2.125 . . . . 0.29999999999999999 107.788 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 676' ' ' ASP . . . . . 0.61 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.5 OUTLIER -100.45 91.93 4.92 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.748 -0.854 . . . . 1.3300000000000001 110.491 -179.117 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.919 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.3 tt0 -93.16 107.42 19.23 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.76 -1.2 . . . . 1.79 107.76 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 678' ' ' ILE . . . . . 0.563 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.4 pt -111.73 137.74 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.419 0.628 . . . . 0.98999999999999999 111.667 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -98.95 111.01 23.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.515 -0.741 . . . . 2.4399999999999999 109.4 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 680' ' ' ILE . . . . . 0.778 HD13 ' SG ' ' A' ' 623' ' ' CYS . 72.8 mt -75.35 -24.11 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.23000000000000001 110.352 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 681' ' ' ILE . . . . . 0.686 HD11 HD12 ' A' ' 618' ' ' LEU . 3.6 mt -143.02 136.15 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -0.942 . . . . 1.3400000000000001 110.394 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -137.49 108.91 6.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.435 -0.79 . . . . 1.0700000000000001 110.109 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.36 118.36 29.27 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.265 -0.897 . . . . 1.4299999999999999 110.221 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -65.99 -46.35 78.31 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.423 -0.798 . . . . 2.21 110.887 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -80.4 -43.31 21.25 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.252 -0.905 . . . . 2.0499999999999998 110.68 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.74 -13.8 58.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.306 -0.871 . . . . 2.4100000000000001 110.471 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 57.23 18.95 4.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.221 -0.925 . . . . 2.6600000000000001 110.56 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 688' ' ' PHE . . . . . 0.414 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -74.66 77.98 2.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 1.3100000000000001 109.034 179.252 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 689' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 586' ' ' SER . 43.5 t -101.63 136.15 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.82 . . . . 1.3899999999999999 110.881 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 690' ' ' ILE . . . . . 0.67 ' CD1' HG22 ' A' ' 587' ' ' ILE . 47.1 mm -117.5 163.26 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.738 -0.838 . . . . 0.81000000000000005 108.738 178.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 691' ' ' GLY . . . . . 0.532 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -172.98 125.39 1.14 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.511 -1.328 . . . . 0.25 109.932 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 692' ' ' PHE . . . . . 0.919 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 6.9 m-85 -120.63 137.71 54.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.603 -0.939 . . . . 0.25 109.484 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -100.67 113.71 26.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.13 -0.981 . . . . 2.2400000000000002 110.031 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 694' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 694' ' ' VAL . 1.2 t -85.45 115.03 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.365 -0.835 . . . . 0.28000000000000003 108.884 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -122.55 103.92 9.02 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.136 -0.626 . . . . 1.6599999999999999 109.923 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 74.0 mt -77.23 103.95 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.4 -0.812 . . . . 0.37 109.113 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.21 -43.51 28.26 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.355 -0.841 . . . . 1.1399999999999999 108.808 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 698' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 8.0 m-20 -111.33 141.81 44.38 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.543 0.687 . . . . 1.1899999999999999 110.612 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 27.1 p -115.27 96.1 5.5 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.164 -1.421 . . . . 0.52000000000000002 107.164 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 6.7 m -127.43 132.63 50.04 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.305 0.574 . . . . 1.6000000000000001 111.077 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 50.4 25.99 9.19 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.135 -1.186 . . . . 1.3100000000000001 110.135 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 702' ' ' LEU . . . . . 0.739 ' O ' HD22 ' A' ' 644' ' ' LEU . 0.9 OUTLIER -102.23 134.87 44.81 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.283 -1.128 . . . . 1.22 110.239 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 703' ' ' PHE . . . . . 0.751 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.4 p90 -49.47 -24.28 1.96 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.627 -0.67 . . . . 0.76000000000000001 110.673 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 704' ' ' ASN . . . . . 0.643 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 O-C-N 121.531 -0.731 . . . . 0.98999999999999999 109.031 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 714' ' ' ARG . . . . . 0.41 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.238 0.542 . . . . 1.3799999999999999 111.691 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.86 153.1 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.553 -0.717 . . . . 0.63 109.522 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 716' ' ' VAL . . . . . 0.59 HG13 ' HG2' ' A' ' 664' ' ' MET . 48.1 t -96.52 133.33 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.121 -0.987 . . . . 0.58999999999999997 110.581 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 717' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 717' ' ' LEU . 4.9 mp -109.5 162.66 14.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.478 -0.764 . . . . 0.81999999999999995 109.94 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -99.16 149.05 23.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.971 . . . . 2.4300000000000002 110.045 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.92 150.13 30.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.829 . . . . 1.98 110.248 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 21.8 p -116.42 -176.48 2.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.55000000000000004 110.277 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.58 -28.96 35.07 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.337 -0.852 . . . . 0.57999999999999996 110.163 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.63 -47.88 71.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.385 -0.822 . . . . 2.3300000000000001 109.779 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 723' ' ' GLU . . . . . 0.583 ' OE1' HD12 ' A' ' 726' ' ' LEU . 12.3 mm-40 -64.21 -48.61 75.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.417 -0.802 . . . . 1.95 110.056 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 724' ' ' LYS . . . . . 0.49 ' O ' HG12 ' A' ' 727' ' ' VAL . 5.5 tttp -52.61 -33.19 45.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.389 -0.819 . . . . 2.3399999999999999 109.795 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 725' ' ' ASP . . . . . 0.406 ' HA ' ' HB2' ' A' ' 728' ' ' LYS . 3.6 t0 -68.39 -35.91 78.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.528 -0.732 . . . . 1.6000000000000001 109.911 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 726' ' ' LEU . . . . . 0.583 HD12 ' OE1' ' A' ' 723' ' ' GLU . 42.7 mt -55.95 -46.54 78.54 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.395 -0.816 . . . . 1.1000000000000001 110.018 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 727' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 724' ' ' LYS . 7.7 p -76.01 -21.01 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.606 -0.683 . . . . 1.1899999999999999 110.351 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 728' ' ' LYS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 725' ' ' ASP . 17.3 tttt -52.9 -43.09 65.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.238 -0.914 . . . . 2.5499999999999998 108.857 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -116.8 103.67 10.56 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.292 1.044 . . . . 2.5 109.138 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 730' ' ' LEU . . . . . 0.411 HD23 ' CG ' ' A' ' 602' ' ' PHE . 4.3 mt . . . . . 0 C--N 1.274 -2.687 0 CA-C-O 118.017 -0.992 . . . . 1.25 110.38 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.412 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -82.84 -10.51 58.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.368 -1.077 . . . . 0.0 110.622 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 165.2 38.64 0.02 OUTLIER Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.49 151.82 19.06 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.317 -1.108 . . . . 0.0 109.102 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.546 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 0.5 OUTLIER -150.92 -40.8 0.12 Allowed 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.045 0.926 . . . . 0.0 108.795 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.646 ' CD2' HD12 ' A' ' 594' ' ' ILE . 16.1 tp -130.69 119.59 22.63 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.335 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 88.7 m -102.66 118.3 36.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.141 -0.974 . . . . 0.0 109.434 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.636 HD11 HD12 ' A' ' 625' ' ' ILE . 15.3 mt -91.16 112.02 23.74 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.431 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -114.24 101.56 54.18 Favored Pre-proline 0 C--N 1.302 -1.473 0 C-N-CA 118.131 -1.428 . . . . 0.0 112.843 -177.663 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 1.131 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.2 Cg_endo -79.6 144.24 17.51 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 N-CA-C 105.788 -2.428 . . . . 0.0 105.788 174.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.709 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -123.48 -178.3 0.64 Allowed Pre-proline 0 N--CA 1.498 1.927 0 C-N-CA 118.214 -1.394 . . . . 0.0 114.082 -175.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.709 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.5 Cg_endo -67.6 -31.81 32.39 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 124.272 1.67 . . . . 0.0 111.375 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.79 -30.72 67.8 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.558 ' OG ' HD12 ' A' ' 583' ' ' LEU . 4.0 p -97.43 153.41 18.13 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.652 HD12 ' O ' ' A' ' 614' ' ' GLU . 4.7 pt -56.69 -17.15 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 109.637 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.759 HD12 ' HA ' ' A' ' 613' ' ' ILE . 7.0 mm -99.61 114.96 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.318 -0.864 . . . . 0.0 108.7 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.487 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 3.4 pm0 -126.12 73.0 1.33 Allowed 'General case' 0 N--CA 1.508 2.443 0 O-C-N 120.653 -1.28 . . . . 0.0 110.587 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 1.131 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 49.6 mt-10 -143.04 174.7 10.45 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.521 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.32 126.34 40.59 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.589 -1.319 . . . . 0.0 109.752 176.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.825 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.1 mt -110.7 156.0 21.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 0.0 109.28 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -125.2 110.04 13.59 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.427 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.646 HD12 ' CD2' ' A' ' 578' ' ' LEU . 29.3 mt -80.28 108.39 13.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 3.8 mt-30 -70.99 120.67 16.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.507 -0.746 . . . . 0.0 111.261 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.546 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 6.0 mm100 37.77 33.72 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.409 0.624 . . . . 0.0 111.035 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . 80.15 65.07 1.78 Allowed Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.654 ' O ' HG13 ' A' ' 598' ' ' VAL . 10.9 p -79.69 105.07 8.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.42 ' CB ' ' HB3' ' A' ' 627' ' ' LYS . 3.8 p-10 -121.72 150.9 56.43 Favored Pre-proline 0 C--N 1.28 -2.454 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.694 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.476 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.6 Cg_endo -86.68 157.46 51.63 Favored 'Cis proline' 0 C--N 1.308 -1.602 0 C-N-CA 121.075 -2.469 . . . . 0.0 109.511 0.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.481 ' CD2' ' HB2' ' A' ' 611' ' ' CYS . 3.0 t80 -106.25 116.11 31.37 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.561 ' HB3' ' SG ' ' A' ' 609' ' ' CYS . 60.6 m-85 -87.89 144.33 26.63 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.311 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.948 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.8 mt -141.02 142.12 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.742 -0.599 . . . . 0.0 110.602 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.784 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 170.37 -159.05 31.27 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.912 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 14.1 tpt180 -71.37 -47.24 57.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.819 -0.812 . . . . 0.0 110.957 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.88 126.97 31.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 110.808 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.554 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.2 OUTLIER -56.76 -15.54 4.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.832 . . . . 0.0 110.439 179.507 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -45.73 -35.94 4.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.251 -0.906 . . . . 0.0 109.125 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 602' ' ' PHE . 1.3 m -62.78 136.65 57.97 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.475 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -49.86 -25.51 3.22 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.307 -0.87 . . . . 0.0 109.628 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.948 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.1 t -109.03 143.57 38.16 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -110.48 128.55 55.67 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 122.198 0.999 . . . . 0.0 113.101 -178.256 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.759 ' HA ' HD12 ' A' ' 588' ' ' ILE . 13.0 mt -142.39 108.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.652 ' O ' HD12 ' A' ' 587' ' ' ILE . 1.4 tt0 -89.68 102.46 15.15 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 117.838 -1.545 . . . . 0.0 107.796 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.823 ' HB3' ' CB ' ' A' ' 618' ' ' LEU . 9.9 t0 -139.93 106.39 5.31 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.57 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -38.67 -65.86 0.32 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.579 -0.701 . . . . 0.0 112.747 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.72 -16.51 64.29 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.117 -0.99 . . . . 0.0 112.455 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.823 ' CB ' ' HB3' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -73.19 129.44 38.05 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.0 -1.062 . . . . 0.0 110.87 -179.035 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.405 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -66.8 160.89 24.94 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.287 -0.883 . . . . 0.0 110.818 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.784 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.7 mtt180 -64.43 -46.94 81.03 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.294 -0.879 . . . . 0.0 109.474 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.499 ' HB ' HG23 ' A' ' 727' ' ' VAL . 9.3 m -95.37 2.58 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.402 -0.811 . . . . 0.0 109.577 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.6 t60 -25.41 -45.94 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.263 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.84 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.7 OUTLIER -136.49 145.68 45.41 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.453 -1.299 . . . . 0.0 111.283 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 2.1 p90 -145.52 144.15 30.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.544 -0.723 . . . . 0.0 110.09 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.636 HD12 HD11 ' A' ' 580' ' ' LEU . 12.3 mt -103.28 121.42 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 9.4 t80 -114.52 154.87 27.48 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.397 -0.814 . . . . 0.0 109.861 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.432 ' HE2' HG23 ' A' ' 647' ' ' ILE . 5.2 ttmt -120.17 136.84 54.48 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.49 0.662 . . . . 0.0 110.583 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.469 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -138.93 163.57 31.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.628 -0.67 . . . . 0.0 110.357 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.0 OUTLIER -78.11 127.64 32.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.241 -0.912 . . . . 0.0 108.728 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.529 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.6 t60 -57.79 124.07 17.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 110.769 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -79.85 113.92 18.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.793 -0.567 . . . . 0.0 110.47 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.552 HG22 ' N ' ' A' ' 633' ' ' GLY . 14.6 p -123.82 174.64 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.431 -0.793 . . . . 0.0 110.321 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.552 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -99.3 -169.17 30.42 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.56 137.91 58.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.273 -1.134 . . . . 0.0 109.979 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.93 84.77 1.25 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.386 -0.821 . . . . 0.0 110.703 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 26.8 mtt -63.21 126.24 26.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.416 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.61 -145.67 0.38 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.414 -0.804 . . . . 0.0 109.603 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -115.33 101.29 8.79 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.114 -0.991 . . . . 0.0 109.147 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 91.8 p -137.61 151.38 70.76 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.905 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.64 -151.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.588 1.31 . . . . 0.0 109.6 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 52.73 24.92 3.45 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.38 -0.825 . . . . 0.0 110.821 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -73.17 60.31 0.57 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.191 -0.943 . . . . 0.0 110.175 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.702 ' C ' HD12 ' A' ' 644' ' ' LEU . . . 62.48 114.63 0.01 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.774 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.3 mp -141.99 -152.71 0.42 Allowed 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 24.4 m-20 -119.24 124.76 47.52 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.007 -1.058 . . . . 0.0 111.386 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.459 ' OD2' HD21 ' A' ' 671' ' ' LEU . 7.9 t0 -112.87 155.93 23.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.481 -0.762 . . . . 0.0 110.027 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.503 HD13 HD22 ' A' ' 578' ' ' LEU . 13.2 pt -107.08 134.71 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.252 -0.905 . . . . 0.0 109.943 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.71 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.4 m95 -119.05 124.01 45.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.649 -0.657 . . . . 0.0 111.233 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.623 ' HB2' HD11 ' A' ' 672' ' ' LEU . 12.5 t80 -83.37 114.95 21.79 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 8.2 t -108.67 109.17 20.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.051 -1.031 . . . . 0.0 111.423 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.599 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 9.4 t60 -75.28 160.72 30.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.43 -0.794 . . . . 0.0 110.057 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -152.52 -29.72 0.15 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.355 -0.841 . . . . 0.0 113.187 -178.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.599 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -79.28 135.48 15.48 Favored Glycine 0 N--CA 1.502 3.047 0 C-N-CA 117.866 -2.111 . . . . 0.0 110.212 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.8 m -36.87 -24.56 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.7 ' C ' HG13 ' A' ' 656' ' ' VAL . 2.4 t-20 -59.12 -2.22 0.25 Allowed 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.471 -1.393 . . . . 0.0 113.179 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.7 HG13 ' C ' ' A' ' 655' ' ' ASN . 0.9 OUTLIER 63.92 146.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.453 -0.779 . . . . 0.0 110.702 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.551 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -97.7 153.38 18.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.76 -0.587 . . . . 0.0 110.246 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.474 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 10.2 m-85 -138.45 125.4 21.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.324 -0.86 . . . . 0.0 110.057 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.662 HD11 HG21 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -134.52 121.16 20.61 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.318 -0.864 . . . . 0.0 109.908 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 6.5 m120 55.16 -86.29 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.479 -0.763 . . . . 0.0 110.437 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 659' ' ' LEU . 5.8 t30 -143.32 14.05 1.81 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.096 -1.003 . . . . 0.0 110.602 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -102.29 118.16 36.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.135 -0.978 . . . . 0.0 110.383 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.453 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 0.0 OUTLIER -85.04 139.01 32.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.366 -0.834 . . . . 0.0 110.004 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.468 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 3.5 mtp -120.25 -179.54 3.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 0.0 110.616 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.547 ' CG1' HG23 ' A' ' 668' ' ' THR . 7.0 pt -120.18 -161.0 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.41 -0.806 . . . . 0.0 110.093 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -84.96 72.03 10.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.345 -0.847 . . . . 0.0 110.748 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 134.2 59.54 0.07 OUTLIER Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.547 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.6 OUTLIER -124.31 149.89 46.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.155 -1.203 . . . . 0.0 110.318 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.492 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 11.9 tttt -108.79 133.67 52.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.493 -0.754 . . . . 0.0 109.016 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.527 ' CD1' HG22 ' A' ' 716' ' ' VAL . 11.9 t80 -138.01 146.42 43.06 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.485 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.71 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.9 OUTLIER -72.69 144.66 47.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.461 -0.774 . . . . 0.0 110.267 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 649' ' ' TYR . 1.3 mt -111.71 104.56 12.92 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.676 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.549 ' NE2' ' HA3' ' A' ' 708' ' ' GLY . 17.1 mt-30 -84.62 161.28 20.2 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.8 ' OD2' HD12 ' A' ' 707' ' ' LEU . 8.2 p-10 -56.85 143.94 35.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.119 . . . . 0.0 109.569 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.67 47.27 50.01 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.664 -2.174 . . . . 0.0 107.664 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.416 ' HB2' ' CG1' ' A' ' 694' ' ' VAL . 0.1 OUTLIER -103.31 89.91 3.54 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.836 -0.803 . . . . 0.0 110.473 -179.108 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.933 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 7.1 tt0 -93.29 106.85 18.76 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.662 HG21 HD11 ' A' ' 659' ' ' LEU . 3.3 pt -111.1 137.32 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.346 0.593 . . . . 0.0 111.473 -177.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.415 ' HG2' ' HB2' ' A' ' 658' ' ' TYR . 0.0 OUTLIER -99.29 109.96 22.53 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.525 -0.734 . . . . 0.0 109.091 178.433 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.84 HD13 ' SG ' ' A' ' 623' ' ' CYS . 89.9 mt -74.35 -29.51 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.404 -0.81 . . . . 0.0 110.26 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.605 HG13 HD12 ' A' ' 618' ' ' LEU . 3.0 mt -143.0 133.26 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 109.851 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -138.42 111.79 8.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.572 -0.705 . . . . 0.0 110.108 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -129.12 117.54 21.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -66.69 -33.28 75.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.437 -0.789 . . . . 0.0 110.726 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -55.98 -43.52 77.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.395 -0.816 . . . . 0.0 111.08 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.05 12.14 11.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 110.706 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.31 23.69 2.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.159 -0.963 . . . . 0.0 110.41 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.55 ' CE2' ' HA ' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -72.81 74.39 1.13 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 0.0 109.53 179.743 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 681' ' ' ILE . 14.6 p -105.56 136.96 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.43 -0.794 . . . . 0.0 110.895 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.562 HG12 ' CG1' ' A' ' 587' ' ' ILE . 18.2 mt -108.38 163.77 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.347 -0.846 . . . . 0.0 108.928 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.449 ' N ' ' CB ' ' A' ' 586' ' ' SER . . . -170.84 123.62 1.06 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.933 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 11.4 m-85 -120.16 137.34 54.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.53 -0.982 . . . . 0.0 109.589 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 21.2 tptt -100.52 114.21 27.65 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 110.515 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.592 HG22 HD11 ' A' ' 578' ' ' LEU . 1.2 t -85.62 118.78 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.373 -0.829 . . . . 0.0 109.001 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -130.08 104.75 7.51 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.925 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.784 HD13 ' HA3' ' A' ' 706' ' ' GLY . 10.9 mt -85.49 104.4 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 110.037 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -77.27 -43.15 34.37 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.54 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -111.02 140.94 45.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.712 -0.618 . . . . 0.0 110.316 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.406 ' O ' ' OG1' ' A' ' 699' ' ' THR . 2.0 p -114.94 96.45 5.71 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.423 HG21 ' CD ' ' A' ' 596' ' ' GLN . 4.6 p -81.93 92.94 6.82 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.507 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 47.6 42.97 20.96 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.614 ' O ' HD22 ' A' ' 644' ' ' LEU . 2.0 tp -85.79 148.78 25.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.45 -1.029 . . . . 0.0 110.337 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.774 ' HA ' HD13 ' A' ' 644' ' ' LEU . 5.1 p90 -49.47 -25.48 2.65 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.505 -0.747 . . . . 0.0 110.288 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.563 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.6 t30 -157.88 168.94 25.76 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.468 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 13.5 pt-20 -51.29 -23.47 3.6 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.09 -1.006 . . . . 0.0 110.073 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.784 ' HA3' HD13 ' A' ' 696' ' ' ILE . . . 121.71 6.52 8.57 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.034 -1.627 . . . . 0.0 109.034 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.8 HD12 ' OD2' ' A' ' 674' ' ' ASP . 0.3 OUTLIER -89.59 10.01 24.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.447 -1.031 . . . . 0.0 111.157 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.549 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 49.73 100.85 0.01 OUTLIER Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.84 40.44 2.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -1.184 . . . . 0.0 110.391 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.512 ' H ' HD23 ' A' ' 710' ' ' LEU . 0.5 OUTLIER -91.49 -173.31 3.53 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.296 -0.878 . . . . 0.0 110.338 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -57.47 -53.51 57.34 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.341 -0.849 . . . . 0.0 110.933 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.463 ' HB2' HD11 ' A' ' 710' ' ' LEU . 40.3 mt-10 -63.41 141.68 58.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.21 -0.931 . . . . 0.0 110.146 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -111.48 95.92 5.8 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.349 -0.844 . . . . 0.0 109.454 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.412 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 7.7 mmm-85 46.88 70.98 0.35 Allowed 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.274 0.559 . . . . 0.0 111.225 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.6 m -107.71 152.58 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.844 . . . . 0.0 109.406 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 670' ' ' PHE . 49.6 t -96.24 133.37 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 110.735 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.43 162.14 14.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.514 -0.742 . . . . 0.0 109.56 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -97.37 149.49 22.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 0.0 110.511 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -80.94 129.07 34.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.434 -0.791 . . . . 0.0 110.015 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.2 p -103.42 -176.39 3.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.393 -0.817 . . . . 0.0 110.19 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.31 -28.79 30.23 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.397 -0.814 . . . . 0.0 110.113 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.11 -51.69 62.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.849 . . . . 0.0 109.897 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -64.02 -47.58 79.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.997 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.532 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.0 OUTLIER -53.61 -32.73 52.36 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.322 -0.861 . . . . 0.0 110.076 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.45 -36.15 78.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.414 -0.804 . . . . 0.0 110.101 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 38.6 mt -58.55 -46.59 86.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.365 -0.834 . . . . 0.0 110.296 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 724' ' ' LYS . 7.8 p -71.42 -20.75 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.225 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -53.41 -45.31 69.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.24 -0.913 . . . . 0.0 108.81 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.8 104.44 11.34 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.218 1.009 . . . . 0.0 109.006 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.415 ' OXT' ' CD2' ' A' ' 602' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--N 1.274 -2.692 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.281 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.7 -10.21 59.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -1.098 . . . . 0.0 110.529 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 126.16 -19.07 6.48 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -92.77 114.36 26.89 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.213 -1.169 . . . . 0.0 109.54 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.516 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 8.5 t80 -95.83 -43.28 7.93 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.92 0.867 . . . . 0.0 109.392 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.806 HD11 HD13 ' A' ' 647' ' ' ILE . 0.5 OUTLIER -126.97 136.98 53.0 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.043 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 88.4 m -113.43 117.26 31.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.14 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.598 HD12 HG13 ' A' ' 594' ' ' ILE . 2.6 mt -92.69 112.11 23.95 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.448 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 2.1 mmtt -112.81 102.18 54.18 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 118.255 -1.378 . . . . 0.0 113.24 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 1.08 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 45.0 Cg_endo -79.58 142.01 16.0 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 N-CA-C 105.32 -2.608 . . . . 0.0 105.32 173.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.746 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -119.16 -176.2 0.37 Allowed Pre-proline 0 N--CA 1.496 1.847 0 C-N-CA 118.16 -1.416 . . . . 0.0 113.896 -175.813 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.746 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.1 Cg_endo -66.82 -32.41 36.76 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 124.274 1.671 . . . . 0.0 112.033 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -59.08 -29.68 67.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.785 -1.197 . . . . 0.0 108.525 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.666 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 66.7 p -96.5 150.24 20.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.857 -0.527 . . . . 0.0 109.833 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.445 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -54.76 -20.31 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.146 -0.971 . . . . 0.0 109.028 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.865 HD12 ' HA ' ' A' ' 613' ' ' ILE . 9.2 mm -93.65 115.06 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.506 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -125.46 72.31 1.26 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 109.865 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 1.08 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 58.3 mm-40 -145.15 175.85 9.95 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.623 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.548 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.47 126.02 39.65 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.986 -1.071 . . . . 0.0 109.052 176.327 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.749 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.2 mp -109.79 154.08 23.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 0.0 109.745 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -125.53 110.05 13.41 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.502 -0.749 . . . . 0.0 110.989 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.598 HG13 HD12 ' A' ' 580' ' ' LEU . 1.9 mt -80.91 109.86 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.151 -0.968 . . . . 0.0 108.675 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.512 ' HB2' HG23 ' A' ' 598' ' ' VAL . 0.0 OUTLIER -53.06 165.89 0.27 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.672 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.516 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 5.2 mt-30 -65.1 68.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.421 -0.799 . . . . 0.0 109.87 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 138.57 21.87 0.43 Allowed Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.567 -1.302 . . . . 0.0 110.789 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -85.92 101.53 10.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 O-C-N 120.732 -1.452 . . . . 0.0 107.176 178.449 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 13.8 t-20 -144.99 134.05 11.17 Favored Pre-proline 0 C--N 1.284 -2.266 0 CA-C-N 114.777 -1.102 . . . . 0.0 110.21 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.571 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 51.0 Cg_endo -91.99 164.01 26.78 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 123.222 -1.574 . . . . 0.0 108.784 -2.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.504 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 4.1 t80 -104.48 116.11 31.53 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.668 ' HB3' HD23 ' A' ' 730' ' ' LEU . 36.4 m-85 -83.16 144.2 29.98 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.541 -0.724 . . . . 0.0 110.436 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.875 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.3 mt -142.67 141.77 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.66 -0.65 . . . . 0.0 110.045 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.797 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 168.75 -160.97 34.63 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.925 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 14.5 tpt180 -71.13 -43.52 67.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.713 -0.875 . . . . 0.0 111.189 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.466 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -78.3 126.51 30.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 110.872 -179.227 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.445 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.9 tt0 -54.04 -18.33 3.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.141 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.06 -31.32 0.9 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.255 -0.903 . . . . 0.0 109.142 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.5 m -69.89 130.77 43.15 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.504 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -44.83 -28.59 0.66 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.267 -0.895 . . . . 0.0 109.904 179.514 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.875 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.4 t -105.19 143.49 33.29 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.445 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.1 OUTLIER -109.19 128.19 54.83 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.286 -0.966 . . . . 0.0 112.859 -178.414 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.865 ' HA ' HD12 ' A' ' 588' ' ' ILE . 12.1 mt -141.79 108.06 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -91.73 103.79 16.32 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.228 -1.389 . . . . 0.0 108.396 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 2.6 m-20 -138.81 106.02 5.49 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.363 -1.289 . . . . 0.0 108.839 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -45.69 -42.17 11.31 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.546 -0.721 . . . . 0.0 111.948 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 27.2 mtm-85 -83.12 -17.14 44.11 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.074 -1.016 . . . . 0.0 111.269 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.797 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.8 OUTLIER -77.85 140.54 39.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.271 -0.893 . . . . 0.0 110.826 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.45 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.84 161.45 28.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.322 -0.861 . . . . 0.0 110.694 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.755 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 13.3 ttp180 -64.09 -45.79 87.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.328 -0.858 . . . . 0.0 109.255 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.586 HG11 HG22 ' A' ' 727' ' ' VAL . 2.8 t -95.52 2.07 9.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.84 0.829 . . . . 0.0 109.475 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.2 t60 -27.18 -46.69 0.03 OUTLIER 'General case' 0 C--O 1.196 -1.762 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.549 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.79 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.59 145.69 43.12 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 118.025 -1.47 . . . . 0.0 111.857 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.531 ' CZ ' ' HB2' ' A' ' 650' ' ' CYS . 13.1 p90 -146.68 142.64 28.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.595 -0.691 . . . . 0.0 109.9 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.538 HG13 HD11 ' A' ' 603' ' ' ILE . 60.3 mt -102.61 117.97 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.424 ' HB2' ' HE1' ' A' ' 624' ' ' PHE . 8.6 t80 -114.53 154.72 27.76 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.767 0.794 . . . . 0.0 110.017 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 5.4 ttmt -120.18 137.48 54.16 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.597 0.713 . . . . 0.0 110.737 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.413 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.44 163.94 29.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.516 -0.74 . . . . 0.0 110.092 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.6 OUTLIER -77.25 117.79 19.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.158 -0.964 . . . . 0.0 108.704 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.526 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.7 t60 -58.23 124.47 19.56 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.647 0.737 . . . . 0.0 110.701 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -114.01 112.91 24.03 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.765 -0.584 . . . . 0.0 110.259 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 633' ' ' GLY . 57.7 t -86.92 167.56 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.417 -0.802 . . . . 0.0 110.178 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.484 ' N ' HG12 ' A' ' 632' ' ' VAL . . . -59.38 174.1 3.9 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -55.53 129.61 39.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.294 -1.121 . . . . 0.0 110.232 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 85.6 p -105.99 93.36 4.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 110.608 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.6 36.79 1.45 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.348 -0.845 . . . . 0.0 109.722 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.24 -151.65 0.19 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.538 -0.726 . . . . 0.0 109.911 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -116.07 102.97 10.1 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.195 -0.941 . . . . 0.0 109.036 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 48.5 p -134.72 150.44 73.48 Favored Pre-proline 0 C--N 1.293 -1.85 0 O-C-N 121.883 -0.511 . . . . 0.0 110.191 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.602 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 50.0 Cg_endo -70.36 -151.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.77 1.405 . . . . 0.0 110.012 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 68.21 -61.58 0.39 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.651 -0.656 . . . . 0.0 110.669 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 642' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 640' ' ' PRO . 84.3 mt-30 52.05 -159.76 0.11 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.118 -0.989 . . . . 0.0 109.93 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.668 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -114.79 130.59 9.29 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 702' ' ' LEU . 5.1 mp -142.58 -151.35 0.35 Allowed 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.959 -0.73 . . . . 0.0 109.326 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.2 m-20 -110.02 124.22 51.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.007 -1.058 . . . . 0.0 110.908 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.698 ' OD2' HD21 ' A' ' 671' ' ' LEU . 24.0 t0 -110.02 151.11 27.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.425 -0.797 . . . . 0.0 109.944 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.806 HD13 HD11 ' A' ' 578' ' ' LEU . 11.1 pt -105.66 132.0 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.338 -0.851 . . . . 0.0 109.898 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.636 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.7 m95 -119.03 119.25 33.72 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.87 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.789 ' HB2' HD11 ' A' ' 672' ' ' LEU . 1.1 t80 -80.96 114.08 19.6 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 668' ' ' THR . 62.9 m -108.37 108.66 19.72 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.506 -0.877 . . . . 0.0 111.206 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.754 ' CE1' ' O ' ' A' ' 653' ' ' GLY . 7.1 t-80 -73.24 169.16 17.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.499 -0.75 . . . . 0.0 109.992 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -159.58 -29.87 0.06 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.292 -0.88 . . . . 0.0 113.118 -178.532 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.754 ' O ' ' CE1' ' A' ' 651' ' ' HIS . . . -79.7 140.43 22.55 Favored Glycine 0 N--CA 1.502 3.035 0 O-C-N 119.453 -2.029 . . . . 0.0 110.406 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 22.7 m -47.1 -22.2 0.33 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.732 ' CG ' HG23 ' A' ' 681' ' ' ILE . 0.1 OUTLIER -58.51 -4.27 0.38 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.601 -1.312 . . . . 0.0 112.444 -178.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.765 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 79.52 167.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 CA-C-O 121.878 0.847 . . . . 0.0 110.814 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.705 ' HB3' ' CD2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -128.93 151.13 50.0 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.612 -179.247 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -138.48 126.59 22.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.174 -0.954 . . . . 0.0 110.946 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.912 HD23 ' CD2' ' A' ' 670' ' ' PHE . 14.7 tp -124.49 107.35 10.98 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.256 -0.903 . . . . 0.0 109.576 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 63.2 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.51 -0.743 . . . . 0.0 110.042 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 659' ' ' LEU . 3.2 m-20 -154.5 23.91 0.47 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 110.172 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.46 116.94 29.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.176 -0.953 . . . . 0.0 110.373 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.76 139.08 43.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 110.001 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.765 ' O ' HG22 ' A' ' 656' ' ' VAL . 47.2 mtp -122.6 157.84 31.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.345 -0.847 . . . . 0.0 110.234 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.479 ' CG1' HG23 ' A' ' 668' ' ' THR . 16.2 pt -98.8 -157.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.0 109.829 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -86.12 119.63 26.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.288 -0.883 . . . . 0.0 110.43 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 81.03 52.83 4.15 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -114.85 148.49 38.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.991 -1.299 . . . . 0.0 110.274 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.464 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -109.04 138.68 45.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.566 -0.709 . . . . 0.0 109.345 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.912 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -144.59 145.21 31.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 111.288 -178.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.698 HD21 ' OD2' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -70.15 147.69 49.59 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.433 -0.792 . . . . 0.0 110.604 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.789 HD11 ' HB2' ' A' ' 649' ' ' TYR . 10.7 mt -118.02 114.67 23.49 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.413 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.422 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 87.4 mt-30 -95.1 147.91 22.93 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.474 ' HB3' HD12 ' A' ' 696' ' ' ILE . 23.1 p-10 -46.3 143.02 2.64 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.133 -0.98 . . . . 0.0 110.532 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.66 47.33 41.58 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 107.611 -2.196 . . . . 0.0 107.611 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.521 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.4 OUTLIER -109.52 93.87 4.73 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.885 -0.774 . . . . 0.0 110.07 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.904 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.1 tm-20 -93.86 107.58 19.45 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.766 HG22 HD13 ' A' ' 659' ' ' LEU . 28.2 pt -107.43 137.91 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.602 -0.686 . . . . 0.0 111.811 -178.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -98.76 110.81 23.35 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.79 HD13 ' SG ' ' A' ' 623' ' ' CYS . 72.4 mt -75.01 -19.86 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.886 . . . . 0.0 110.839 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.739 HD11 HD13 ' A' ' 618' ' ' LEU . 8.4 mt -142.9 136.47 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.16 -0.962 . . . . 0.0 110.52 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -137.65 108.96 6.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.455 -0.778 . . . . 0.0 109.899 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.424 ' HB3' ' HB2' ' A' ' 686' ' ' ASN . 0.3 OUTLIER -120.96 117.68 27.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -45.13 78.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.459 -0.776 . . . . 0.0 111.115 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.64 -43.63 15.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.241 -0.912 . . . . 0.0 111.361 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 686' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 683' ' ' ASP . 97.5 m-20 -83.19 -8.67 59.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.136 -0.978 . . . . 0.0 110.601 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.5 tptt 56.25 19.66 4.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.225 -0.922 . . . . 0.0 110.778 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.43 78.76 1.03 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.175 -0.953 . . . . 0.0 109.144 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 586' ' ' SER . 41.0 t -101.79 141.32 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.381 -0.824 . . . . 0.0 110.912 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.666 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 41.6 mm -126.32 163.94 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.423 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . -172.48 124.98 1.12 Allowed Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.367 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.904 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.5 m-85 -120.23 138.06 53.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.59 -0.947 . . . . 0.0 108.828 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -105.1 117.95 35.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.841 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -87.12 122.28 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.542 -0.724 . . . . 0.0 109.241 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -130.24 104.54 7.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.516 -0.74 . . . . 0.0 110.289 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 674' ' ' ASP . 71.8 mt -76.51 104.35 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 109.571 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.11 -42.85 59.43 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.609 -0.836 . . . . 0.0 108.889 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.8 OUTLIER -111.01 141.3 44.67 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.698 0.761 . . . . 0.0 110.747 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 44.5 p -115.38 96.06 5.47 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 7.2 t -136.16 136.31 39.92 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.262 0.554 . . . . 0.0 110.587 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.04 26.52 27.76 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.83 ' O ' HD22 ' A' ' 644' ' ' LEU . 4.1 tp -105.26 138.19 41.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.358 -1.084 . . . . 0.0 110.469 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.828 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.0 p90 -53.83 -23.75 13.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.404 -0.81 . . . . 0.0 110.045 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.593 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.1 t30 -170.76 157.26 5.5 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.527 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 16.4 pt-20 -50.92 -26.98 6.59 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.25 -0.906 . . . . 0.0 110.575 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 122.57 15.05 4.15 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.431 ' N ' HD21 ' A' ' 704' ' ' ASN . 0.2 OUTLIER -82.76 9.07 10.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.025 -1.279 . . . . 0.0 111.264 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.645 ' C ' HD23 ' A' ' 710' ' ' LEU . . . 91.34 -79.16 1.33 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.581 ' HG3' ' O ' ' A' ' 708' ' ' GLY . 0.9 OUTLIER 26.59 66.84 0.06 Allowed 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.94 -0.741 . . . . 0.0 112.158 -179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.645 HD23 ' C ' ' A' ' 708' ' ' GLY . 0.6 OUTLIER -140.8 159.96 41.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 110.243 179.593 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -60.04 -54.46 45.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.315 -0.866 . . . . 0.0 110.198 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.72 149.05 47.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.366 -0.834 . . . . 0.0 109.903 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 713' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 714' ' ' ARG . 2.6 tt0 -110.59 95.33 5.49 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.212 -0.93 . . . . 0.0 109.316 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.799 ' NH1' HD21 ' A' ' 659' ' ' LEU . 0.0 OUTLIER 36.06 76.1 0.05 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.782 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.424 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 31.5 m -107.78 151.01 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.431 -0.793 . . . . 0.0 109.382 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.538 HG13 ' HG2' ' A' ' 664' ' ' MET . 65.0 t -93.12 117.8 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 0.0 110.489 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.438 HD13 ' HD3' ' A' ' 669' ' ' LYS . 4.8 mp -89.88 162.51 15.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.38 -0.825 . . . . 0.0 109.734 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.98 146.24 28.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.215 -0.928 . . . . 0.0 110.167 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -79.88 137.38 36.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.223 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.8 p -110.16 -176.79 3.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.416 -0.802 . . . . 0.0 110.353 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.61 -28.92 35.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.432 -0.792 . . . . 0.0 110.153 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 722' ' ' GLU . . . . . 0.509 ' O ' HD23 ' A' ' 726' ' ' LEU . 3.9 tp10 -66.21 -50.16 64.79 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.448 -0.782 . . . . 0.0 110.043 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.704 ' O ' HG12 ' A' ' 727' ' ' VAL . 14.6 mt-10 -63.71 -47.68 80.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.36 -0.838 . . . . 0.0 110.123 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.467 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 3.0 tmmm? -62.46 -31.9 72.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.471 -0.768 . . . . 0.0 110.946 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.07 -50.74 69.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.217 -0.927 . . . . 0.0 112.041 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 722' ' ' GLU . 0.7 OUTLIER -72.72 -35.93 67.67 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.907 -1.121 . . . . 0.0 111.516 -178.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.704 HG12 ' O ' ' A' ' 723' ' ' GLU . 9.3 p -79.08 -15.18 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.828 -1.17 . . . . 0.0 110.37 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -41.98 69.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.944 . . . . 0.0 108.685 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.44 103.32 10.32 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 122.253 1.025 . . . . 0.0 108.963 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.668 HD23 ' HB3' ' A' ' 602' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.272 -2.78 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.269 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.24 -10.14 58.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.345 -1.091 . . . . 0.0 110.601 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 166.76 66.27 0.03 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.412 ' HD3' ' HG2' ' A' ' 593' ' ' GLU . 32.2 ttp-105 -92.68 123.61 36.09 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.5 -1.0 . . . . 0.0 109.484 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.593 ' CZ ' HD13 ' A' ' 702' ' ' LEU . 9.8 t80 -111.6 -40.23 4.39 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 122.061 0.934 . . . . 0.0 109.288 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.003 HD11 HD13 ' A' ' 647' ' ' ILE . 0.9 OUTLIER -124.5 119.69 29.86 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.787 -179.126 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 62.3 m -99.15 115.45 29.09 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.989 -1.069 . . . . 0.0 109.005 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.491 HD21 HD12 ' A' ' 594' ' ' ILE . 1.6 mm? -89.98 111.76 22.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.408 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 1.1 mmtt -112.04 101.49 51.86 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 118.026 -1.47 . . . . 0.0 112.478 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 1.05 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.9 Cg_endo -80.17 144.58 16.67 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 N-CA-C 106.45 -2.173 . . . . 0.0 106.45 174.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.741 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -121.56 -174.31 0.3 Allowed Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.765 -176.792 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.741 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.1 Cg_endo -66.09 -31.17 46.2 Favored 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 124.289 1.679 . . . . 0.0 110.086 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.734 ' O ' HG23 ' A' ' 689' ' ' VAL . 70.2 m-20 -59.13 -25.28 63.73 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 13.4 t -95.19 150.58 20.06 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 614' ' ' GLU . 5.3 tp -55.58 -21.47 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.289 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.876 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.6 tp -110.17 117.92 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.522 -0.736 . . . . 0.0 109.903 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -110.58 79.89 1.25 Allowed 'General case' 0 N--CA 1.508 2.429 0 O-C-N 120.359 -1.463 . . . . 0.0 108.938 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 1.05 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.6 mt-10 -143.02 175.55 9.77 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.787 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.566 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.66 125.56 40.35 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.097 -1.002 . . . . 0.0 109.127 176.638 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 611' ' ' CYS . 65.9 mt -110.17 156.08 21.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 109.592 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.412 ' HG2' ' HD3' ' A' ' 576' ' ' ARG . 7.7 mp0 -124.85 110.56 14.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.856 . . . . 0.0 111.683 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.723 HG23 HG12 ' A' ' 598' ' ' VAL . 21.1 mt -82.33 110.38 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 597' ' ' GLY . 2.2 mt-30 -53.98 179.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.213 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.572 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -58.03 69.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.455 -0.778 . . . . 0.0 111.138 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 106.07 43.84 1.46 Allowed Glycine 0 N--CA 1.485 1.915 0 C-N-CA 119.699 -1.239 . . . . 0.0 110.591 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.723 HG12 HG23 ' A' ' 594' ' ' ILE . 0.5 OUTLIER -79.05 104.57 7.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.13 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 2.9 t30 -141.53 138.27 17.25 Favored Pre-proline 0 C--N 1.28 -2.442 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.004 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.637 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.1 Cg_endo -90.54 161.1 31.99 Favored 'Cis proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.273 -1.97 . . . . 0.0 109.38 -1.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.558 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 5.3 t80 -107.28 116.6 32.22 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.697 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 60.7 m-85 -90.08 145.93 24.7 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 111.047 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.704 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.4 mt -140.5 141.02 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.554 -0.716 . . . . 0.0 110.239 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.69 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 178.1 -161.14 27.86 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.867 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.424 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 15.0 tpt180 -75.71 -32.45 60.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.754 -0.85 . . . . 0.0 110.087 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.438 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -86.3 127.46 34.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.417 -0.802 . . . . 0.0 110.623 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.535 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.5 tm-20 -59.41 -13.73 9.57 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.972 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -46.44 -36.19 6.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.426 -0.796 . . . . 0.0 110.24 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.697 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 62.2 m -71.26 152.7 43.04 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.558 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.1 m120 -59.17 -13.63 7.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.415 -0.803 . . . . 0.0 110.48 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.704 ' SG ' HG23 ' A' ' 603' ' ' ILE . 6.9 t -120.43 144.22 48.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.433 -0.792 . . . . 0.0 109.942 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.613 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -113.37 130.95 56.16 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 122.032 0.92 . . . . 0.0 112.901 -178.43 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.655 HD11 ' CE1' ' A' ' 692' ' ' PHE . 7.9 mt -146.63 109.96 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.465 ' O ' HG12 ' A' ' 587' ' ' ILE . 3.3 mm-40 -85.58 102.44 13.54 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 117.806 -1.558 . . . . 0.0 108.547 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.592 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 4.3 m-20 -139.05 106.13 5.46 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.728 178.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -45.4 -44.51 12.06 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.42 -0.8 . . . . 0.0 111.925 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.86 -16.75 43.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.126 -0.984 . . . . 0.0 112.023 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.922 HD13 HD11 ' A' ' 681' ' ' ILE . 1.3 tp -76.55 130.35 37.77 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.95 -1.093 . . . . 0.0 110.898 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.511 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.2 m -68.81 161.2 29.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.43 -0.794 . . . . 0.0 110.467 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.69 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -63.61 -45.75 88.89 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.189 -0.944 . . . . 0.0 109.204 179.577 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.592 HG12 HD21 ' A' ' 730' ' ' LEU . 16.4 m -94.8 2.12 9.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 121.386 -0.821 . . . . 0.0 109.481 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.776 ' CE1' HD12 ' A' ' 618' ' ' LEU . 3.8 t60 -28.47 -48.27 0.06 Allowed 'General case' 0 C--O 1.192 -1.946 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.946 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.846 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.13 145.5 43.91 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.375 -1.33 . . . . 0.0 110.901 179.065 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.591 ' HA ' HG13 ' A' ' 603' ' ' ILE . 24.2 p90 -146.37 151.18 37.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.493 -0.754 . . . . 0.0 110.419 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.598 HG13 HD11 ' A' ' 603' ' ' ILE . 15.7 mt -103.13 120.95 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 8.0 t80 -116.45 154.23 30.7 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.39 -0.818 . . . . 0.0 109.828 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.519 ' HE2' HG23 ' A' ' 647' ' ' ILE . 8.3 ttmt -120.22 136.98 54.46 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.444 0.64 . . . . 0.0 110.368 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.03 163.97 28.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.64 -0.663 . . . . 0.0 110.389 -179.503 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -77.6 115.65 17.53 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.507 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.2 t60 -58.04 124.46 19.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.542 -0.724 . . . . 0.0 110.561 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -125.16 103.81 8.18 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.386 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.54 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.5 p -73.15 170.98 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.561 -0.712 . . . . 0.0 110.089 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.54 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -60.25 -165.25 0.2 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.54 133.36 55.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.287 -1.125 . . . . 0.0 110.279 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.87 63.48 3.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.312 -0.867 . . . . 0.0 110.358 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -58.65 125.93 25.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 109.705 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 64.61 -145.35 0.26 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.428 -0.795 . . . . 0.0 109.901 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -115.44 103.05 10.39 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.08 -1.013 . . . . 0.0 109.16 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 5.2 p -120.78 151.33 54.4 Favored Pre-proline 0 C--N 1.292 -1.899 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.029 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.621 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 48.7 Cg_endo -69.72 -151.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.732 1.385 . . . . 0.0 110.088 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 68.88 -62.02 0.4 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.662 -0.649 . . . . 0.0 110.642 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.97 -155.35 0.16 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.073 -1.017 . . . . 0.0 110.183 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.648 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -119.95 129.72 8.09 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.782 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.1 mp -142.77 -146.23 0.18 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 122.088 -0.654 . . . . 0.0 109.363 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.46 124.63 51.61 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.846 -1.159 . . . . 0.0 111.386 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.531 ' OD2' HD21 ' A' ' 671' ' ' LEU . 24.0 t0 -113.5 156.4 23.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.386 -0.821 . . . . 0.0 110.129 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 1.003 HD13 HD11 ' A' ' 578' ' ' LEU . 11.2 pt -109.67 129.85 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.26 -0.9 . . . . 0.0 110.142 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.652 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 91.6 m95 -119.86 128.53 53.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.621 -0.675 . . . . 0.0 111.199 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.865 ' HB2' HD11 ' A' ' 672' ' ' LEU . 9.3 t80 -88.17 114.87 25.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 668' ' ' THR . 14.4 m -108.01 106.03 16.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 111.781 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.641 ' HE1' ' O ' ' A' ' 653' ' ' GLY . 24.9 t-80 -65.95 159.07 26.51 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.482 -0.761 . . . . 0.0 109.975 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.74 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.03 -28.79 0.2 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.471 -0.768 . . . . 0.0 112.84 -179.228 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.641 ' O ' ' HE1' ' A' ' 651' ' ' HIS . . . -79.26 -163.89 26.79 Favored Glycine 0 N--CA 1.496 2.688 0 O-C-N 119.337 -2.102 . . . . 0.0 109.885 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 21.3 m -94.08 -19.12 21.12 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.096 -1.238 . . . . 0.0 114.095 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.717 ' HB3' HG23 ' A' ' 681' ' ' ILE . 24.7 m120 -61.01 -2.83 0.65 Allowed 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.597 -1.315 . . . . 0.0 112.629 -178.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.698 HG13 ' C ' ' A' ' 655' ' ' ASN . 0.8 OUTLIER 62.68 145.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.58 -0.7 . . . . 0.0 109.847 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.497 ' CB ' ' CD2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -95.09 151.29 19.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.601 -0.687 . . . . 0.0 111.071 -178.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.464 ' CZ ' ' CG2' ' A' ' 656' ' ' VAL . 37.5 m-85 -134.45 126.22 29.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.595 -0.691 . . . . 0.0 109.569 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.928 HD13 HG12 ' A' ' 678' ' ' ILE . 53.8 tp -130.93 111.89 12.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.198 -0.939 . . . . 0.0 110.098 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.83 -79.43 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.594 -0.691 . . . . 0.0 110.027 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 659' ' ' LEU . 25.5 p30 -148.74 23.92 0.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 110.128 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.74 119.68 39.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 110.253 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -84.97 134.92 34.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.889 . . . . 0.0 110.045 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.466 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 2.8 mtp -116.3 -166.2 1.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.647 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.5 ' CG1' HG23 ' A' ' 668' ' ' THR . 7.9 pt -139.94 -154.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.447 -0.783 . . . . 0.0 110.291 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 652' ' ' THR . 44.2 tt0 -86.31 91.71 8.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.376 -0.828 . . . . 0.0 110.699 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.5 54.62 0.54 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.6 OUTLIER -119.07 145.53 45.83 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.06 -1.259 . . . . 0.0 110.001 179.636 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.411 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 15.5 tttt -108.34 138.72 44.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.454 -0.779 . . . . 0.0 109.247 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.765 ' CE2' HD23 ' A' ' 659' ' ' LEU . 0.5 OUTLIER -144.62 142.88 30.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.027 -1.045 . . . . 0.0 111.518 -178.82 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.652 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -70.89 147.5 48.74 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.524 -0.735 . . . . 0.0 110.773 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.865 HD11 ' HB2' ' A' ' 649' ' ' TYR . 14.6 mt -120.3 114.67 22.21 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.386 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 17.2 mt-30 -84.5 -177.16 6.54 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 706' ' ' GLY . 2.2 p30 -78.24 139.06 38.92 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.778 -1.201 . . . . 0.0 109.315 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 73.25 47.9 21.37 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.451 -2.259 . . . . 0.0 107.451 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.868 ' OD1' HD11 ' A' ' 659' ' ' LEU . 2.1 t0 -105.55 97.77 7.56 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.847 -0.796 . . . . 0.0 110.337 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.895 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.47 107.03 18.93 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.928 HG12 HD13 ' A' ' 659' ' ' LEU . 1.5 mp -105.01 138.01 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.531 -0.731 . . . . 0.0 111.57 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -100.39 114.58 28.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.747 -0.596 . . . . 0.0 109.639 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.846 HD13 ' SG ' ' A' ' 623' ' ' CYS . 76.7 mt -79.35 -24.09 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.926 . . . . 0.0 110.933 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.922 HD11 HD13 ' A' ' 618' ' ' LEU . 7.2 mt -141.57 141.15 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.148 -0.97 . . . . 0.0 110.389 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -138.09 109.59 6.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.89 . . . . 0.0 110.11 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 686' ' ' ASN . 1.0 OUTLIER -125.44 118.04 24.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.331 -0.856 . . . . 0.0 110.005 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -46.85 76.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.306 -0.871 . . . . 0.0 110.963 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -84.65 -43.47 14.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.345 -0.847 . . . . 0.0 110.939 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 686' ' ' ASN . . . . . 0.4 ' CB ' ' HB3' ' A' ' 683' ' ' ASP . 0.6 OUTLIER -72.33 -11.1 60.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.249 -0.907 . . . . 0.0 110.556 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.1 mttt 52.46 24.86 3.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.17 -0.956 . . . . 0.0 110.388 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.88 73.76 7.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.434 -0.792 . . . . 0.0 109.896 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 585' ' ' ASP . 34.8 m -101.92 135.87 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 110.322 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.522 HG12 ' HB ' ' A' ' 681' ' ' ILE . 19.3 mm -114.05 164.44 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.535 -0.728 . . . . 0.0 109.505 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -174.43 123.33 0.95 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.527 -1.32 . . . . 0.0 110.446 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.895 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.3 m-85 -120.04 137.74 53.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.534 -0.98 . . . . 0.0 108.581 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -102.56 114.54 28.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.871 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 694' ' ' VAL . 1.0 OUTLIER -81.31 113.24 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.03 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -121.56 104.3 9.54 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.695 -0.628 . . . . 0.0 109.914 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.528 ' CD1' ' HA3' ' A' ' 706' ' ' GLY . 63.1 mt -79.13 104.58 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 109.51 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.88 -42.76 48.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.328 -0.857 . . . . 0.0 108.826 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 577' ' ' PHE . 1.2 m-20 -110.84 142.45 42.84 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.397 0.618 . . . . 0.0 110.336 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 42.9 p -114.18 95.78 5.47 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.44 -133.57 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.027 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.761 ' O ' HD23 ' A' ' 644' ' ' LEU . . . -93.49 35.04 4.29 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.593 HD13 ' CZ ' ' A' ' 577' ' ' PHE . 1.0 OUTLIER -60.77 149.98 33.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.617 -0.931 . . . . 0.0 110.172 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.782 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.1 p90 -49.63 -24.56 2.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.362 -0.836 . . . . 0.0 110.402 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.532 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER -158.06 170.8 21.48 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.228 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.466 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 16.3 pt-20 -51.19 -23.6 3.5 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.961 -1.087 . . . . 0.0 110.309 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 123.77 4.55 7.98 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.435 HD13 ' OD2' ' A' ' 674' ' ' ASP . 24.8 tp -89.9 11.66 19.7 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.325 -1.103 . . . . 0.0 110.941 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.502 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 77.81 -137.99 20.86 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 6.7 ptp -161.1 -174.46 4.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -1.079 . . . . 0.0 110.031 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.404 ' HA ' HD13 ' A' ' 710' ' ' LEU . 0.8 OUTLIER -112.53 34.35 4.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 110.674 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.77 -41.48 5.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.447 -0.783 . . . . 0.0 109.268 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -114.09 149.11 36.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.653 -0.655 . . . . 0.0 109.331 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 713' ' ' GLN . . . . . 0.509 ' O ' ' C ' ' A' ' 714' ' ' ARG . 2.1 mt-30 -109.86 95.52 5.65 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.21 -0.931 . . . . 0.0 109.481 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.509 ' C ' ' O ' ' A' ' 713' ' ' GLN . 0.1 OUTLIER 22.04 82.62 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.225 179.527 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.408 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 34.9 m -107.59 151.59 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.453 -0.779 . . . . 0.0 109.454 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.466 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 86.6 t -97.04 122.77 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 110.564 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.5 mp -93.8 162.16 14.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.52 -0.737 . . . . 0.0 109.822 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.33 151.09 21.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.875 . . . . 0.0 110.068 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -80.31 142.83 34.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.807 . . . . 0.0 110.343 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 12.8 p -117.16 -176.27 2.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.399 -0.813 . . . . 0.0 110.143 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.53 -28.8 33.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.355 -0.84 . . . . 0.0 110.224 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -68.15 -47.65 67.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.0 109.984 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.8 -48.05 78.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -0.796 . . . . 0.0 110.023 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 727' ' ' VAL . 94.7 mttt -54.03 -32.49 54.55 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.364 -0.835 . . . . 0.0 110.069 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -68.11 -36.38 79.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.487 -0.758 . . . . 0.0 110.383 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 37.8 mt -59.8 -46.55 88.85 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.262 -0.899 . . . . 0.0 110.195 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.571 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.5 p -72.34 -19.46 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.087 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -53.5 -44.73 69.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.865 . . . . 0.0 108.904 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.54 103.48 10.45 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 122.215 1.007 . . . . 0.0 109.262 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.592 HD21 HG12 ' A' ' 621' ' ' VAL . 3.5 mt . . . . . 0 C--N 1.274 -2.696 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.518 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.14 -10.19 57.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.406 -1.055 . . . . 0.0 110.687 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 67.19 37.02 90.93 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -93.55 135.33 34.92 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.407 -1.055 . . . . 0.0 109.261 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.563 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 9.8 t80 -124.8 -39.69 2.25 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 122.063 0.935 . . . . 0.0 109.427 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.723 HD11 HD13 ' A' ' 647' ' ' ILE . 0.4 OUTLIER -131.6 120.23 22.56 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.26 -178.586 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 4.4 m -93.95 120.19 33.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.0 109.093 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 1.058 HD11 HD12 ' A' ' 625' ' ' ILE . 4.6 mt -87.05 112.38 21.81 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.526 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -111.1 100.48 47.06 Favored Pre-proline 0 C--N 1.301 -1.505 0 C-N-CA 118.197 -1.401 . . . . 0.0 112.989 -176.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 1.09 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 55.6 Cg_endo -87.88 141.23 5.25 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 N-CA-C 106.342 -2.214 . . . . 0.0 106.342 174.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.75 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -120.52 -173.71 0.27 Allowed Pre-proline 0 C--N 1.294 -1.815 0 C-N-CA 118.57 -1.252 . . . . 0.0 112.575 -177.433 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.75 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.2 Cg_endo -66.42 -30.71 43.86 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 O-C-N 124.212 1.638 . . . . 0.0 110.279 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -59.2 -24.45 63.12 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 17.6 t -95.35 153.32 17.74 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 614' ' ' GLU . 4.9 tp -57.42 -19.69 11.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.178 -0.951 . . . . 0.0 109.298 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.841 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.5 tp -113.17 118.08 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 110.117 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 3.9 pm0 -111.24 81.65 1.47 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.483 -1.386 . . . . 0.0 108.634 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 1.09 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.5 mt-10 -143.11 175.68 9.68 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.883 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.526 ' HB3' ' CD ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.62 122.88 36.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.018 -1.051 . . . . 0.0 109.17 176.805 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.66 155.05 20.59 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -125.69 110.26 13.56 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.433 -0.792 . . . . 0.0 111.304 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.506 HG23 ' HB ' ' A' ' 598' ' ' VAL . 9.9 mt -81.37 109.56 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 597' ' ' GLY . 2.0 mp0 -53.14 168.97 0.12 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.609 -0.837 . . . . 0.0 109.054 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.563 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 6.0 mt-30 -61.58 70.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.391 -0.818 . . . . 0.0 110.432 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 124.69 30.44 0.97 Allowed Glycine 0 N--CA 1.487 2.044 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.78 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 598' ' ' VAL . 1.2 t -79.9 102.73 6.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.8 t30 -143.95 135.5 12.8 Favored Pre-proline 0 C--N 1.282 -2.358 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.885 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.655 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.1 Cg_endo -90.91 162.12 30.45 Favored 'Cis proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.747 -1.772 . . . . 0.0 109.15 -1.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.536 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 6.3 t80 -106.41 116.69 32.36 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.735 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 58.3 m-85 -88.62 146.24 25.22 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.406 -0.808 . . . . 0.0 111.182 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.72 HD11 HG13 ' A' ' 625' ' ' ILE . 2.4 mt -140.85 140.48 33.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.648 -0.657 . . . . 0.0 110.18 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.683 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 177.18 -162.63 30.86 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.924 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.412 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 14.2 tpt180 -74.0 -35.06 64.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.794 -0.827 . . . . 0.0 110.248 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.406 ' CB ' ' HD3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -85.16 127.37 34.24 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.394 -0.817 . . . . 0.0 110.585 -179.606 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 42.8 tt0 -58.75 -12.89 4.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.291 -0.881 . . . . 0.0 109.993 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.18 -36.86 4.05 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.421 -0.8 . . . . 0.0 110.079 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.735 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 79.6 m -71.68 154.48 41.34 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.284 -0.885 . . . . 0.0 109.926 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.521 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -61.53 -12.06 13.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.511 -0.743 . . . . 0.0 110.396 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.719 ' SG ' HG23 ' A' ' 603' ' ' ILE . 6.9 t -119.84 143.74 47.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.531 -0.731 . . . . 0.0 109.559 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.622 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -113.32 130.22 56.32 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.055 0.931 . . . . 0.0 112.993 -178.237 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.606 HD11 ' CE1' ' A' ' 692' ' ' PHE . 7.3 mt -146.57 109.75 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 177.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.46 ' O ' HG12 ' A' ' 587' ' ' ILE . 2.2 mt-10 -85.68 102.47 13.63 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 117.704 -1.598 . . . . 0.0 108.538 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.622 ' CG ' HD12 ' A' ' 681' ' ' ILE . 4.9 m-20 -139.42 106.08 5.36 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.869 178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 616' ' ' ASN . . . . . 0.41 ' OD1' ' CZ ' ' A' ' 688' ' ' PHE . 29.5 p-10 -47.45 -41.33 20.17 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.453 -0.779 . . . . 0.0 111.648 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -84.19 -16.99 41.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.089 -1.007 . . . . 0.0 111.8 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.866 HD13 HD11 ' A' ' 681' ' ' ILE . 1.3 tp -78.27 130.84 36.7 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.082 -1.012 . . . . 0.0 110.816 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.497 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 2.2 t -70.75 159.4 34.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.362 -0.836 . . . . 0.0 110.53 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.683 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 35.7 ttp180 -61.55 -45.66 93.21 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.26 -0.9 . . . . 0.0 109.344 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.595 ' HB ' HG23 ' A' ' 727' ' ' VAL . 15.8 m -94.74 1.95 9.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.389 -0.82 . . . . 0.0 109.613 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.9 t60 -28.1 -48.18 0.05 OUTLIER 'General case' 0 C--O 1.192 -1.962 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.833 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.816 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.7 OUTLIER -137.03 145.58 44.22 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.406 -1.318 . . . . 0.0 110.753 178.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.527 ' CZ ' ' CB ' ' A' ' 650' ' ' CYS . 12.4 p90 -145.3 148.75 33.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.532 -0.73 . . . . 0.0 110.306 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 1.058 HD12 HD11 ' A' ' 580' ' ' LEU . 24.5 mt -103.9 121.1 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 7.5 t80 -114.95 154.44 28.75 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.694 0.759 . . . . 0.0 109.484 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 0.2 OUTLIER -120.01 137.09 54.29 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.548 0.689 . . . . 0.0 110.587 -179.556 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -137.62 163.6 30.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.712 -0.617 . . . . 0.0 110.152 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.0 OUTLIER -77.93 115.48 17.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.188 -0.945 . . . . 0.0 108.889 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.507 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.4 t60 -58.62 124.77 20.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.536 -0.728 . . . . 0.0 110.615 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -111.64 111.72 22.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.678 -0.639 . . . . 0.0 110.325 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.545 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.7 p -69.72 169.78 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.341 -0.849 . . . . 0.0 109.945 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.545 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -126.11 155.68 19.36 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt 52.07 62.5 2.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.383 -1.069 . . . . 0.0 110.466 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 89.3 p -103.25 46.93 0.9 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 0.0 110.236 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 38.3 mtt -92.49 43.31 1.13 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.426 -0.796 . . . . 0.0 109.894 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -172.21 -147.77 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.49 -0.757 . . . . 0.0 109.751 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -115.41 102.34 9.74 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.177 -0.952 . . . . 0.0 108.8 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 59.8 p -136.4 151.49 73.19 Favored Pre-proline 0 C--N 1.292 -1.911 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.193 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.597 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 48.6 Cg_endo -69.4 -151.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.691 1.364 . . . . 0.0 110.013 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 68.35 -62.8 0.36 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.617 -0.677 . . . . 0.0 110.481 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.92 -154.48 0.15 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.211 -0.931 . . . . 0.0 110.051 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.656 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -120.03 125.91 6.48 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.812 HD22 ' O ' ' A' ' 702' ' ' LEU . 5.1 mp -142.41 -148.22 0.23 Allowed 'General case' 0 C--N 1.293 -1.865 0 O-C-N 122.046 -0.679 . . . . 0.0 109.207 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.19 124.4 50.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.859 -1.151 . . . . 0.0 111.08 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -110.26 150.56 28.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.443 -0.785 . . . . 0.0 109.847 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.723 HD13 HD11 ' A' ' 578' ' ' LEU . 11.3 pt -106.56 131.66 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.304 -0.873 . . . . 0.0 109.85 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.777 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 95.2 m95 -119.47 123.05 43.11 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.649 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.643 ' HB2' HD11 ' A' ' 672' ' ' LEU . 9.7 t80 -88.83 114.35 25.36 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 668' ' ' THR . 1.0 OUTLIER -108.12 102.66 11.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.078 -1.014 . . . . 0.0 111.697 -178.246 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.496 ' CD2' ' N ' ' A' ' 652' ' ' THR . 13.1 t60 -62.07 157.46 18.89 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.471 -0.768 . . . . 0.0 109.77 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -149.14 -29.75 0.26 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.469 -0.769 . . . . 0.0 112.702 -179.113 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.539 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.68 -164.05 25.42 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 117.72 -2.181 . . . . 0.0 109.498 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 25.0 m -97.65 -18.22 19.02 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.858 -1.378 . . . . 0.0 113.821 -176.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.594 ' HB3' HG23 ' A' ' 681' ' ' ILE . 22.8 m120 -58.35 -4.25 0.36 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.681 -1.262 . . . . 0.0 112.497 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.525 HG23 ' C ' ' A' ' 655' ' ' ASN . 3.1 t 70.21 148.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.609 -0.682 . . . . 0.0 110.169 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.434 ' CB ' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -105.82 143.82 33.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.508 -0.745 . . . . 0.0 110.741 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.445 ' CE1' ' HG2' ' A' ' 663' ' ' ARG . 74.7 m-85 -135.22 126.2 27.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.43 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.562 ' HG ' HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -124.11 114.32 19.53 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.373 -0.829 . . . . 0.0 109.789 179.411 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 659' ' ' LEU . 14.0 t-20 59.27 -78.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.549 -0.72 . . . . 0.0 110.499 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 659' ' ' LEU . 10.7 t30 -147.86 27.27 0.98 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.077 -1.014 . . . . 0.0 110.33 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.453 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.2 OUTLIER -113.71 139.36 49.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 0.0 110.269 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.445 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 8.5 tmm_? -103.52 129.48 50.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.339 -0.85 . . . . 0.0 110.107 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.557 ' HG2' HG13 ' A' ' 716' ' ' VAL . 4.3 mtp -112.1 -165.7 1.01 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 110.325 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.646 HG13 HG23 ' A' ' 668' ' ' THR . 1.6 pt -141.54 -158.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.375 -0.828 . . . . 0.0 110.091 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -82.06 93.24 6.96 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.286 -0.884 . . . . 0.0 110.524 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 106.84 53.21 0.71 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.646 HG23 HG13 ' A' ' 665' ' ' ILE . 0.2 OUTLIER -120.51 147.62 44.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.11 -1.23 . . . . 0.0 110.078 179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -108.32 144.04 36.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 0.0 109.196 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.48 ' CE1' ' O ' ' A' ' 715' ' ' VAL . 0.6 OUTLIER -144.65 147.11 32.69 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.508 -178.398 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.777 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.68 131.5 45.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.465 -0.772 . . . . 0.0 109.705 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.643 HD11 ' HB2' ' A' ' 649' ' ' TYR . 6.3 mt -104.61 97.68 7.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 111.173 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.406 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 87.9 mt-30 -84.86 146.64 27.2 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 706' ' ' GLY . 20.0 p-10 -46.11 151.78 0.46 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.222 -0.924 . . . . 0.0 110.612 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 65.36 49.11 62.82 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.589 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.6 OUTLIER -107.04 92.52 4.11 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.763 -0.845 . . . . 0.0 110.611 -178.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.829 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -92.93 106.91 18.8 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.171 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.562 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.0 OUTLIER -116.56 137.78 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.6 -0.687 . . . . 0.0 111.865 -176.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.45 111.54 23.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.586 -0.696 . . . . 0.0 109.675 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.816 HD13 ' SG ' ' A' ' 623' ' ' CYS . 81.0 mt -74.08 -19.57 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.302 -0.874 . . . . 0.0 110.465 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.866 HD11 HD13 ' A' ' 618' ' ' LEU . 12.7 mt -141.81 137.67 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.028 -1.045 . . . . 0.0 110.286 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -137.43 110.41 7.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.131 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -129.25 118.38 22.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.784 . . . . 0.0 109.844 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.6 -44.84 85.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.375 -0.828 . . . . 0.0 110.884 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -84.11 -43.42 15.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.324 -0.86 . . . . 0.0 110.924 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -17.69 60.57 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.263 -0.898 . . . . 0.0 110.456 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.6 tttt 60.53 14.66 5.03 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.193 -0.942 . . . . 0.0 110.887 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.41 ' CZ ' ' OD1' ' A' ' 616' ' ' ASN . 0.3 OUTLIER -72.06 78.69 0.93 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.039 -1.038 . . . . 0.0 108.975 179.189 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 586' ' ' SER . 96.3 t -101.59 130.98 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.496 -0.752 . . . . 0.0 110.706 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.521 HG12 ' HB ' ' A' ' 681' ' ' ILE . 18.0 mm -114.94 164.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -173.27 116.13 0.59 Allowed Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.446 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.829 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.4 m-85 -119.7 137.13 54.11 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 693' ' ' LYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 581' ' ' LYS . 5.8 ttmm -110.77 114.14 27.26 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 110.305 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.636 HG22 ' CD2' ' A' ' 578' ' ' LEU . 0.5 OUTLIER -75.49 126.85 36.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.758 -0.777 . . . . 0.0 108.95 179.448 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.67 104.41 7.41 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.192 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.508 HG12 ' HG ' ' A' ' 578' ' ' LEU . 83.6 mt -79.47 103.6 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 109.559 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.27 -41.01 58.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.387 -0.821 . . . . 0.0 108.844 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 1.3 m-20 -110.34 140.2 44.76 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.678 0.751 . . . . 0.0 110.655 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 36.0 p -115.98 96.17 5.46 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 30.2 m -133.09 133.18 42.63 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.814 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 50.32 30.11 17.66 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.812 ' O ' HD22 ' A' ' 644' ' ' LEU . 7.2 tp -103.91 138.92 39.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.545 -0.974 . . . . 0.0 110.717 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.805 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.6 p90 -53.28 -23.87 10.1 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.418 -0.801 . . . . 0.0 109.988 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.601 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.2 t30 -174.52 155.05 2.18 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.477 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 14.6 pt-20 -51.24 -25.14 5.15 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.18 -0.95 . . . . 0.0 110.825 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 124.32 13.12 4.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.45 ' N ' HD21 ' A' ' 704' ' ' ASN . 0.4 OUTLIER -82.64 9.19 10.01 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.001 -1.293 . . . . 0.0 111.502 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.607 ' O ' ' HG3' ' A' ' 709' ' ' MET . . . 96.71 -63.74 1.08 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.607 ' HG3' ' O ' ' A' ' 708' ' ' GLY . 0.8 OUTLIER 40.65 39.39 0.75 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.743 -0.857 . . . . 0.0 111.714 -179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.16 136.11 43.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.172 -0.955 . . . . 0.0 110.623 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -57.4 -35.48 70.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.42 -0.8 . . . . 0.0 110.006 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.585 ' OE1' HG11 ' A' ' 715' ' ' VAL . 17.4 mm-40 -63.83 149.15 47.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.447 -0.783 . . . . 0.0 109.73 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -110.31 95.34 5.51 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.248 -0.907 . . . . 0.0 109.471 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.434 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.5 OUTLIER 39.23 82.97 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.349 0.595 . . . . 0.0 111.869 179.401 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.585 HG11 ' OE1' ' A' ' 712' ' ' GLU . 26.9 m -107.58 150.01 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.481 -0.762 . . . . 0.0 109.069 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.557 HG13 ' HG2' ' A' ' 664' ' ' MET . 58.3 t -96.73 133.12 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.186 -0.946 . . . . 0.0 111.109 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.8 mp -105.08 162.64 13.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.656 -0.653 . . . . 0.0 109.598 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.35 145.37 28.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.17 -0.956 . . . . 0.0 110.291 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.82 152.09 29.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.355 -0.841 . . . . 0.0 110.259 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 38.6 p -121.14 -176.25 3.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.42 -0.8 . . . . 0.0 110.359 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.36 -29.08 32.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.361 -0.837 . . . . 0.0 110.105 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -51.0 68.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.353 -0.842 . . . . 0.0 109.579 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -64.65 -45.25 87.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.463 -0.773 . . . . 0.0 109.734 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.528 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.4 OUTLIER -54.71 -32.73 59.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.344 -0.848 . . . . 0.0 109.837 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -36.11 78.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.399 -0.813 . . . . 0.0 110.227 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 34.1 mt -58.76 -46.16 88.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.298 -0.877 . . . . 0.0 110.228 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.595 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.2 p -71.76 -20.34 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.546 -0.721 . . . . 0.0 110.087 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.78 -45.84 70.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 108.845 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.71 104.26 11.18 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.206 1.003 . . . . 0.0 109.025 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--N 1.274 -2.71 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.432 -179.933 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.55 -10.28 58.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.342 -1.093 . . . . 0.0 110.626 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 78.96 12.42 84.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -92.77 126.25 37.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.291 -1.123 . . . . 0.0 109.284 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.575 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 0.9 OUTLIER -113.85 -41.62 3.54 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 122.052 0.93 . . . . 0.0 109.36 -179.316 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.707 ' CD2' HD12 ' A' ' 594' ' ' ILE . 14.2 tp -126.1 119.87 28.7 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.529 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 55.9 m -96.88 117.3 30.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.759 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.901 HD11 HD12 ' A' ' 625' ' ' ILE . 7.6 mt -91.98 112.18 24.01 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.534 ' O ' ' CD1' ' A' ' 583' ' ' LEU . 0.7 OUTLIER -116.07 104.58 52.15 Favored Pre-proline 0 C--N 1.299 -1.617 0 C-N-CA 118.379 -1.328 . . . . 0.0 113.289 -177.066 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 1.127 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 40.8 Cg_endo -77.86 145.04 22.24 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 N-CA-C 105.968 -2.358 . . . . 0.0 105.968 174.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.974 HD13 ' N ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -122.14 176.73 1.86 Allowed Pre-proline 0 N--CA 1.496 1.826 0 C-N-CA 118.197 -1.401 . . . . 0.0 113.599 -176.614 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.683 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 37.8 Cg_endo -66.36 -35.42 31.36 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.905 1.737 . . . . 0.0 111.848 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 689' ' ' VAL . 2.3 m-20 -58.43 -26.38 63.23 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.61 ' HB3' HD22 ' A' ' 583' ' ' LEU . 1.9 t -95.57 151.84 18.97 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.062 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.75 HG21 ' OD1' ' A' ' 615' ' ' ASP . 7.5 mm -57.35 -18.63 9.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 108.993 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.698 HD12 ' HA ' ' A' ' 613' ' ' ILE . 3.1 mm -99.67 115.55 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.472 -0.768 . . . . 0.0 109.218 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 2.5 pm0 -122.86 71.42 1.04 Allowed 'General case' 0 N--CA 1.509 2.512 0 O-C-N 120.672 -1.268 . . . . 0.0 109.888 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 1.127 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 45.3 mt-10 -143.75 175.37 10.04 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.354 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.498 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.25 126.66 39.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.79 -1.194 . . . . 0.0 109.978 176.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.831 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.1 mt -111.41 156.17 22.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.329 -0.857 . . . . 0.0 109.391 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -125.19 110.6 14.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 111.835 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.707 HD12 ' CD2' ' A' ' 578' ' ' LEU . 24.8 mt -81.29 110.9 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 597' ' ' GLY . 2.6 mt-30 -54.67 179.25 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.979 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.575 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -59.08 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.505 -0.747 . . . . 0.0 111.217 -179.492 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 115.15 41.71 0.81 Allowed Glycine 0 N--CA 1.485 1.962 0 C-N-CA 119.496 -1.335 . . . . 0.0 111.019 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.691 ' HB ' HG23 ' A' ' 594' ' ' ILE . 1.2 t -79.01 103.75 6.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 627' ' ' LYS . 5.2 t30 -141.4 136.41 15.67 Favored Pre-proline 0 C--N 1.283 -2.314 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.258 -178.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.545 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.4 Cg_endo -90.44 161.28 32.53 Favored 'Cis proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.41 -1.913 . . . . 0.0 109.366 -1.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.548 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 2.9 t80 -107.03 116.26 31.62 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.557 ' HB3' ' SG ' ' A' ' 609' ' ' CYS . 58.8 m-85 -87.48 143.74 27.07 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 110.162 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.834 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.6 mt -140.56 142.16 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.782 -0.574 . . . . 0.0 110.345 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.785 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 166.14 -165.22 38.04 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.617 -1.278 . . . . 0.0 111.131 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 10.1 tpt180 -60.67 -55.55 31.97 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.854 -0.791 . . . . 0.0 111.879 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.43 126.15 28.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 111.499 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.44 ' HB2' ' HD2' ' A' ' 612' ' ' LYS . 42.3 tt0 -52.67 -19.05 2.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.418 -0.801 . . . . 0.0 110.046 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 608' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 607' ' ' GLU . 0.9 OUTLIER -42.36 -35.39 1.0 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.399 -0.813 . . . . 0.0 109.092 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 602' ' ' PHE . 1.3 m -64.92 133.76 52.52 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.548 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 2.3 t-20 -45.72 -28.16 0.97 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.389 -0.82 . . . . 0.0 109.544 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.834 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.4 t -107.6 143.53 35.92 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.463 ' O ' ' CG2' ' A' ' 588' ' ' ILE . 0.3 OUTLIER -107.7 129.0 55.06 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.078 -1.014 . . . . 0.0 113.178 -178.168 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.772 ' CG2' HD13 ' A' ' 690' ' ' ILE . 13.5 mt -143.5 109.5 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.5 ' H ' HD12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -97.8 103.6 15.55 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 117.865 -1.534 . . . . 0.0 109.535 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.769 ' OD2' HD13 ' A' ' 681' ' ' ILE . 0.2 OUTLIER -139.38 106.93 5.57 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.965 177.414 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -41.33 -41.65 2.0 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.611 -0.681 . . . . 0.0 111.993 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -83.84 -17.69 40.08 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.064 -1.023 . . . . 0.0 111.502 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.728 HD22 HG22 ' A' ' 613' ' ' ILE . 0.6 OUTLIER -80.16 130.4 35.21 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.212 -0.93 . . . . 0.0 110.691 -179.189 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.415 ' CB ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -66.78 160.84 24.99 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.254 -0.904 . . . . 0.0 111.169 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.785 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -64.74 -47.04 79.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.233 -0.917 . . . . 0.0 109.746 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.476 ' O ' ' C ' ' A' ' 622' ' ' HIS . 3.7 m -95.32 2.4 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.247 -0.908 . . . . 0.0 109.316 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.735 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.8 t60 -25.36 -46.43 0.02 OUTLIER 'General case' 0 C--O 1.193 -1.897 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.267 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.806 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -136.92 146.33 45.34 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 118.32 -1.352 . . . . 0.0 111.336 179.121 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.546 ' HA ' HG13 ' A' ' 603' ' ' ILE . 14.7 p90 -145.86 143.77 29.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.563 -0.71 . . . . 0.0 109.997 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.901 HD12 HD11 ' A' ' 580' ' ' LEU . 10.7 mt -102.85 118.2 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 5.0 t80 -113.39 155.07 25.89 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.572 0.701 . . . . 0.0 109.544 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 5.6 ttmt -119.67 137.16 54.07 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.617 0.723 . . . . 0.0 110.773 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.49 164.16 28.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.741 -0.6 . . . . 0.0 110.167 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.3 tpt180 -77.75 118.97 20.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.128 -0.983 . . . . 0.0 109.043 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.532 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.7 t60 -58.43 124.45 19.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.566 -0.709 . . . . 0.0 110.719 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -98.35 125.35 43.45 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.689 -0.632 . . . . 0.0 110.279 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 52.3 t -83.63 161.8 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.315 -0.866 . . . . 0.0 110.223 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -79.9 -165.22 30.99 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.91 88.98 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.33 -1.1 . . . . 0.0 110.205 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 635' ' ' SER . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 637' ' ' TYR . 9.4 p -101.58 83.68 2.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 0.0 110.451 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -95.8 36.81 1.25 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.341 -0.85 . . . . 0.0 109.821 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 637' ' ' TYR . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 635' ' ' SER . 3.3 p90 -148.59 -153.11 0.47 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.586 -0.696 . . . . 0.0 109.506 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -115.21 102.83 10.26 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.109 -0.994 . . . . 0.0 109.134 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 75.8 p -136.24 152.15 74.68 Favored Pre-proline 0 C--N 1.293 -1.882 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.014 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.608 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 44.9 Cg_endo -67.91 -150.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.803 1.422 . . . . 0.0 109.821 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 68.21 -62.74 0.35 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.626 -0.671 . . . . 0.0 110.326 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.75 -162.57 0.06 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.243 -0.911 . . . . 0.0 110.313 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.647 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -111.99 129.89 9.33 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.826 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.0 mp -143.91 -150.59 0.32 Allowed 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.7 m-20 -108.1 124.38 50.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.98 -1.075 . . . . 0.0 111.264 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 628' ' ' LYS . 29.5 t70 -110.11 141.05 43.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.452 -0.78 . . . . 0.0 109.803 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 22.6 pt -95.97 132.44 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.243 -0.911 . . . . 0.0 110.105 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.879 ' CH2' HD22 ' A' ' 671' ' ' LEU . 95.5 m95 -119.07 122.12 41.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.616 -0.678 . . . . 0.0 111.179 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.688 ' HB2' HD11 ' A' ' 672' ' ' LEU . 11.9 t80 -85.21 115.69 23.13 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 624' ' ' PHE . 22.5 m -108.11 102.9 12.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.186 -0.946 . . . . 0.0 111.582 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' A' ' 652' ' ' THR . 12.2 t60 -63.89 159.28 20.09 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.442 -0.786 . . . . 0.0 109.93 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.735 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.44 -29.55 0.18 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.435 -0.791 . . . . 0.0 112.757 -179.196 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.573 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.29 -165.59 30.28 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 117.857 -2.116 . . . . 0.0 109.937 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 26.0 m -93.6 -18.87 21.72 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.064 -1.256 . . . . 0.0 114.025 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.722 ' OD1' HD12 ' A' ' 681' ' ' ILE . 19.4 m120 -60.04 -2.56 0.44 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.663 -1.273 . . . . 0.0 112.564 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.684 HG13 ' C ' ' A' ' 655' ' ' ASN . 0.8 OUTLIER 63.11 142.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 121.583 0.706 . . . . 0.0 110.173 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.507 ' OG ' ' HB2' ' A' ' 664' ' ' MET . 0.0 OUTLIER -94.52 150.49 20.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.691 -0.631 . . . . 0.0 110.729 -179.034 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.483 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 20.2 m-85 -135.05 126.4 28.38 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.332 -0.855 . . . . 0.0 110.437 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.728 HD21 ' OD2' ' A' ' 676' ' ' ASP . 0.0 OUTLIER -134.2 120.8 20.5 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.21 -0.931 . . . . 0.0 109.926 179.251 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.0 m120 56.3 -85.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.569 -0.707 . . . . 0.0 110.521 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 659' ' ' LEU . 55.6 t30 -148.17 25.46 1.0 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.221 -0.924 . . . . 0.0 110.247 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -119.34 117.52 28.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 0.0 110.447 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.415 ' CG ' ' CE1' ' A' ' 658' ' ' TYR . 2.7 tmm_? -87.24 138.33 31.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.374 -0.829 . . . . 0.0 109.983 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.732 ' SD ' HG13 ' A' ' 716' ' ' VAL . 0.3 OUTLIER -112.83 -152.68 0.51 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.278 -0.889 . . . . 0.0 109.969 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.502 HG13 HG23 ' A' ' 668' ' ' THR . 1.1 pp -143.4 -165.96 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.241 -0.912 . . . . 0.0 110.706 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 652' ' ' THR . 22.0 tt0 -76.58 83.99 3.25 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.483 -0.761 . . . . 0.0 110.412 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 117.88 53.15 0.31 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -122.92 149.17 44.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.098 -1.236 . . . . 0.0 110.08 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 717' ' ' LEU . 3.8 tttt -108.64 146.34 33.54 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.502 -0.749 . . . . 0.0 109.472 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.553 ' CD2' HD22 ' A' ' 659' ' ' LEU . 9.7 t80 -145.17 147.82 32.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.12 -0.988 . . . . 0.0 112.404 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.879 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.12 131.8 45.56 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.599 -0.688 . . . . 0.0 109.535 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.742 HD23 ' OD2' ' A' ' 676' ' ' ASP . 7.2 mt -105.88 104.95 14.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.049 -1.032 . . . . 0.0 111.227 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 87.6 mt-30 -91.73 146.75 23.52 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.558 -0.714 . . . . 0.0 109.127 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.699 ' OD1' HD12 ' A' ' 707' ' ' LEU . 8.7 p-10 -43.94 147.84 0.45 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.139 -0.975 . . . . 0.0 110.397 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 66.31 48.1 66.46 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 107.587 -2.205 . . . . 0.0 107.587 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.742 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.3 OUTLIER -110.27 90.15 3.23 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.798 -0.825 . . . . 0.0 110.787 -178.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.966 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 3.2 tt0 -93.46 107.03 18.94 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.658 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.8 pt -105.49 136.87 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.861 -0.524 . . . . 0.0 110.972 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 25.2 mttt -95.31 110.32 22.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.569 -0.707 . . . . 0.0 109.637 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.806 HD13 ' SG ' ' A' ' 623' ' ' CYS . 63.4 mt -76.72 -22.77 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 110.074 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.769 HD13 ' OD2' ' A' ' 615' ' ' ASP . 15.0 tt -143.39 137.92 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.241 -0.912 . . . . 0.0 110.284 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -138.07 112.78 8.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.203 -0.936 . . . . 0.0 110.701 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.93 117.19 28.15 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.233 -0.917 . . . . 0.0 109.753 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -67.57 -47.6 69.3 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.423 -0.798 . . . . 0.0 111.475 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.23 -43.47 13.74 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.307 -0.871 . . . . 0.0 111.225 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.01 -7.07 51.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.211 -0.93 . . . . 0.0 110.914 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.95 24.15 3.24 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.152 -0.968 . . . . 0.0 110.038 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.03 95.98 10.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.44 -0.787 . . . . 0.0 109.681 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 586' ' ' SER . 31.5 m -125.79 142.36 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 111.059 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.772 HD13 ' CG2' ' A' ' 613' ' ' ILE . 12.2 mt -123.81 164.06 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -175.38 142.94 6.42 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.439 -1.362 . . . . 0.0 110.376 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.966 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 17.0 m-85 -129.14 137.6 51.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.503 -0.998 . . . . 0.0 109.865 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -98.45 113.66 25.74 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.219 -0.925 . . . . 0.0 109.682 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.641 HG22 HD11 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -82.66 121.48 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.361 -0.837 . . . . 0.0 109.074 179.587 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.05 104.62 7.44 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.581 -0.699 . . . . 0.0 110.237 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 60.2 mt -81.12 104.17 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.325 -0.86 . . . . 0.0 109.552 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -75.57 -42.1 53.02 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.377 -0.827 . . . . 0.0 108.996 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.462 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.1 m-20 -110.66 141.3 44.09 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.637 0.732 . . . . 0.0 110.521 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 21.9 p -114.99 96.04 5.5 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 16.1 p -128.12 131.99 48.97 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.235 0.54 . . . . 0.0 110.707 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 51.86 32.37 33.56 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.823 ' O ' HD22 ' A' ' 644' ' ' LEU . 4.1 tp -108.09 138.37 44.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.45 -1.029 . . . . 0.0 110.717 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.826 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.1 p90 -54.92 -24.03 21.67 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.71 . . . . 0.0 109.921 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.588 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.2 t30 -172.37 157.01 3.95 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.603 ' OE1' HD13 ' A' ' 707' ' ' LEU . 13.0 pt-20 -51.11 -24.36 3.95 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.11 -0.994 . . . . 0.0 110.546 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 118.66 15.74 5.73 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.699 HD12 ' OD1' ' A' ' 674' ' ' ASP . 1.1 tp -82.76 9.13 10.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.03 -1.277 . . . . 0.0 111.431 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.551 ' O ' ' HG3' ' A' ' 709' ' ' MET . . . 92.08 -76.92 1.31 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.551 ' HG3' ' O ' ' A' ' 708' ' ' GLY . 0.5 OUTLIER 25.22 88.75 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.914 -0.757 . . . . 0.0 112.079 -179.447 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.408 ' N ' HD23 ' A' ' 710' ' ' LEU . 1.0 OUTLIER -163.59 178.89 7.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 0.0 110.362 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -80.57 -54.16 5.91 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.367 -0.833 . . . . 0.0 109.688 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.81 149.03 47.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.456 -0.778 . . . . 0.0 109.826 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.59 95.51 5.61 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.237 -0.915 . . . . 0.0 109.393 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.447 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 0.3 OUTLIER 40.11 76.7 0.06 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.355 0.598 . . . . 0.0 111.616 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 715' ' ' VAL . 35.4 m -107.69 153.33 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.465 -0.772 . . . . 0.0 109.3 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.732 HG13 ' SD ' ' A' ' 664' ' ' MET . 58.1 t -98.39 133.11 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.935 . . . . 0.0 110.797 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 669' ' ' LYS . 4.0 mp -102.44 156.63 17.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.509 -0.744 . . . . 0.0 109.569 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.13 154.11 17.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.192 -0.942 . . . . 0.0 110.489 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -87.27 146.2 26.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.389 -0.82 . . . . 0.0 110.345 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 10.5 p -121.21 -176.12 3.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.343 -0.848 . . . . 0.0 110.309 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.2 -28.84 28.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.416 -0.802 . . . . 0.0 110.097 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.58 -47.49 75.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.356 -0.84 . . . . 0.0 109.552 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -63.85 -48.01 78.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.394 -0.816 . . . . 0.0 109.772 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 727' ' ' VAL . 12.2 tttt -53.77 -32.37 52.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.333 -0.854 . . . . 0.0 110.065 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.21 -36.24 79.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -0.827 . . . . 0.0 110.21 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 32.9 mt -59.52 -46.53 88.58 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.273 -0.892 . . . . 0.0 110.325 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 724' ' ' LYS . 8.5 p -70.79 -18.92 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.142 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.91 -43.74 69.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.214 -0.929 . . . . 0.0 108.824 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.59 103.52 10.48 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 122.281 1.039 . . . . 0.0 109.177 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.411 ' O ' ' CD2' ' A' ' 602' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.274 -2.712 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.365 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -83.82 2.77 36.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.366 -1.079 . . . . 0.0 110.696 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 139.38 -16.34 3.16 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -92.26 115.71 28.32 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.302 -1.117 . . . . 0.0 109.516 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.813 ' CE2' HD11 ' A' ' 702' ' ' LEU . 0.2 OUTLIER -106.49 -40.09 5.68 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.92 0.867 . . . . 0.0 109.545 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.979 HD22 HD12 ' A' ' 594' ' ' ILE . 9.7 tt -117.95 119.86 36.09 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.713 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 86.1 m -98.4 116.55 30.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.291 -0.881 . . . . 0.0 109.074 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.802 HD11 ' CD1' ' A' ' 625' ' ' ILE . 2.4 mt -90.78 112.16 23.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.415 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 2.4 mmtt -112.81 101.89 53.74 Favored Pre-proline 0 C--N 1.3 -1.548 0 C-N-CA 118.153 -1.419 . . . . 0.0 112.737 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 1.042 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.0 Cg_endo -79.55 144.97 18.14 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 N-CA-C 106.454 -2.172 . . . . 0.0 106.454 174.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.741 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.62 -173.54 0.28 Allowed Pre-proline 0 N--CA 1.494 1.74 0 C-N-CA 118.651 -1.22 . . . . 0.0 112.791 -176.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.741 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.2 Cg_endo -66.55 -28.3 45.4 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 124.113 1.586 . . . . 0.0 110.176 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.31 -28.4 66.76 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 46.7 p -95.43 153.57 17.63 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.584 ' H ' HD13 ' A' ' 690' ' ' ILE . 5.7 tp -57.07 -16.38 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.831 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.868 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.2 tp -113.98 117.73 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.219 -0.925 . . . . 0.0 110.231 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -110.95 80.82 1.34 Allowed 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.219 -1.551 . . . . 0.0 109.209 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 1.042 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 33.8 mm-40 -142.24 175.81 9.47 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.823 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.569 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.66 125.48 40.18 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.138 -0.976 . . . . 0.0 109.096 176.588 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 611' ' ' CYS . 61.5 mt -111.39 156.07 22.16 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.369 -0.832 . . . . 0.0 109.987 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -125.25 111.05 14.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.356 -0.84 . . . . 0.0 111.802 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.979 HD12 HD22 ' A' ' 578' ' ' LEU . 39.9 mt -82.31 110.61 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.51 ' O ' ' C ' ' A' ' 596' ' ' GLN . 21.2 mm100 -69.39 114.9 8.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.499 -0.751 . . . . 0.0 112.794 -177.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.51 ' C ' ' O ' ' A' ' 595' ' ' GLN . 0.0 OUTLIER 14.6 56.77 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 178.555 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 106.98 46.65 1.08 Allowed Glycine 0 N--CA 1.486 1.988 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.845 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.622 ' HB ' HG23 ' A' ' 594' ' ' ILE . 1.0 OUTLIER -79.4 104.66 7.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 177.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 2.8 t30 -140.41 137.9 18.27 Favored Pre-proline 0 C--N 1.28 -2.421 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.103 -178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.705 ' HB3' HD23 ' A' ' 726' ' ' LEU . 56.7 Cg_endo -90.01 160.18 34.22 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.009 -2.08 . . . . 0.0 109.581 -0.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 4.5 t80 -107.29 116.73 32.44 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.73 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 52.3 m-85 -91.23 145.77 24.39 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.207 -0.933 . . . . 0.0 110.817 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.699 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.2 mt -139.68 141.17 35.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.491 -0.755 . . . . 0.0 110.436 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 174.17 -167.12 39.44 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.431 -1.366 . . . . 0.0 111.362 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.447 ' HD2' ' HA ' ' A' ' 614' ' ' GLU . 6.7 mmm-85 -64.34 -40.61 96.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.919 -0.754 . . . . 0.0 110.834 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -84.23 127.81 34.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.396 -0.815 . . . . 0.0 111.446 -178.676 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.4 ' CG ' ' HD2' ' A' ' 612' ' ' LYS . 37.1 tt0 -57.67 -14.88 6.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -0.84 . . . . 0.0 109.854 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -44.23 -36.97 2.94 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.413 -0.804 . . . . 0.0 110.092 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.73 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 74.8 m -71.42 151.85 43.64 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.385 -0.822 . . . . 0.0 109.575 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.553 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -57.78 -14.5 5.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.432 -0.792 . . . . 0.0 110.508 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.699 ' SG ' HG23 ' A' ' 603' ' ' ILE . 7.0 t -120.4 143.66 48.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.546 -0.721 . . . . 0.0 109.692 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.59 ' O ' HG12 ' A' ' 588' ' ' ILE . 1.7 ttpm? -111.82 130.68 55.73 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.053 0.93 . . . . 0.0 112.769 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.651 HD11 ' CE1' ' A' ' 692' ' ' PHE . 4.8 mt -146.55 110.58 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.466 ' O ' HG12 ' A' ' 587' ' ' ILE . 1.2 mt-10 -93.64 102.34 14.51 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 117.73 -1.588 . . . . 0.0 109.306 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.726 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.1 m-20 -138.39 105.85 5.55 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.184 177.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 616' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 615' ' ' ASP . 1.7 t30 -35.9 -48.28 0.56 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.632 -0.668 . . . . 0.0 112.583 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -83.55 -17.44 41.79 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.969 -1.082 . . . . 0.0 111.963 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.641 HD22 HG22 ' A' ' 613' ' ' ILE . 0.6 OUTLIER -72.71 125.39 27.4 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.95 -1.094 . . . . 0.0 110.697 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -67.0 161.15 24.95 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.372 -0.83 . . . . 0.0 111.031 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.739 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -64.16 -45.56 87.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.243 -0.91 . . . . 0.0 109.223 179.35 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.59 ' HB ' HG23 ' A' ' 727' ' ' VAL . 12.4 m -94.86 2.3 9.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.386 -0.821 . . . . 0.0 109.336 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.9 t60 -29.09 -46.74 0.05 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.988 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.829 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -136.46 145.24 44.97 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 118.514 -1.274 . . . . 0.0 110.777 179.194 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 4.1 p90 -145.57 144.05 30.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.55 -0.719 . . . . 0.0 110.116 178.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.802 ' CD1' HD11 ' A' ' 580' ' ' LEU . 76.0 mt -103.31 120.4 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 3.7 t80 -114.46 155.1 27.0 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.618 0.723 . . . . 0.0 109.666 -178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 5.1 ttmt -118.01 137.45 52.87 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 121.639 0.733 . . . . 0.0 110.337 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.435 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -136.11 164.33 28.27 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.707 -0.62 . . . . 0.0 110.757 -179.121 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.0 tpt180 -77.52 117.26 18.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 108.677 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.51 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 5.6 t60 -58.57 124.55 20.05 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.591 0.71 . . . . 0.0 110.941 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -95.31 83.63 3.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.664 -0.648 . . . . 0.0 110.018 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.541 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.5 p -56.55 170.18 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.493 -0.754 . . . . 0.0 110.522 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.541 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -59.67 -168.89 0.32 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -59.17 133.56 56.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.308 -1.113 . . . . 0.0 110.238 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 74.4 p -95.55 40.32 1.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.376 -0.828 . . . . 0.0 110.405 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 17.3 mtt -89.87 48.17 1.55 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.382 -0.824 . . . . 0.0 109.873 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -172.89 -152.02 0.06 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.431 -0.793 . . . . 0.0 109.525 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -115.63 101.63 9.02 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.179 -0.95 . . . . 0.0 108.804 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 5.4 p -137.09 151.36 71.76 Favored Pre-proline 0 C--N 1.293 -1.868 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.087 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.569 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 49.6 Cg_endo -70.86 -154.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.705 1.371 . . . . 0.0 109.944 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 65.77 -62.86 0.23 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.781 -0.575 . . . . 0.0 110.77 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 642' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 640' ' ' PRO . 23.3 tt0 52.69 32.06 11.33 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.084 -1.01 . . . . 0.0 110.169 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.417 ' O ' ' HG ' ' A' ' 644' ' ' LEU . . . 69.38 119.18 0.03 OUTLIER Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 4.2 mt -139.55 -157.31 0.76 Allowed 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.724 ' O ' HD23 ' A' ' 702' ' ' LEU . 0.7 OUTLIER -115.04 124.53 51.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.877 -1.139 . . . . 0.0 111.476 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.754 ' CG ' HD11 ' A' ' 671' ' ' LEU . 12.6 t0 -108.18 156.67 19.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.524 -0.735 . . . . 0.0 109.871 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.588 HD13 ' CD1' ' A' ' 578' ' ' LEU . 14.6 pt -104.85 131.72 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.314 -0.866 . . . . 0.0 110.174 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.742 ' CH2' HD13 ' A' ' 671' ' ' LEU . 97.9 m95 -118.56 121.0 39.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.684 -0.635 . . . . 0.0 110.937 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.6 ' HB2' HD11 ' A' ' 672' ' ' LEU . 8.8 t80 -80.82 114.82 19.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 108.67 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.555 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 8.8 t -107.6 109.02 20.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.189 -0.944 . . . . 0.0 111.432 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.81 ' CE1' ' O ' ' A' ' 653' ' ' GLY . 8.0 t-80 -75.04 160.18 30.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.0 109.979 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -150.69 -32.4 0.17 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.394 -0.816 . . . . 0.0 112.868 -178.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.81 ' O ' ' CE1' ' A' ' 651' ' ' HIS . . . -79.38 130.35 9.8 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 117.897 -2.097 . . . . 0.0 109.976 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.405 ' C ' ' H ' ' A' ' 656' ' ' VAL . 14.5 m -36.01 -23.42 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 115.383 1.624 . . . . 0.0 115.383 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.52 ' C ' HG23 ' A' ' 656' ' ' VAL . 4.5 t-20 -54.97 -4.51 0.07 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.336 -1.478 . . . . 0.0 113.197 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 664' ' ' MET . 4.3 t 75.31 150.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 121.592 -0.692 . . . . 0.0 110.984 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.627 ' HB3' ' CD2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -111.66 151.9 28.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.577 -0.702 . . . . 0.0 110.347 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -138.39 126.47 22.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 109.863 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 1.018 HD13 HG22 ' A' ' 678' ' ' ILE . 19.4 tp -128.11 110.24 12.28 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.869 . . . . 0.0 110.161 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.67 -72.9 0.05 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.637 -0.664 . . . . 0.0 109.985 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 659' ' ' LEU . 4.9 m-80 -153.82 19.36 0.52 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.354 -0.841 . . . . 0.0 110.435 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.425 ' ND2' HG23 ' A' ' 716' ' ' VAL . 9.6 t-20 -116.95 116.92 28.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.031 -1.043 . . . . 0.0 110.501 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.97 141.6 32.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 109.579 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.652 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.8 OUTLIER -115.2 -169.17 1.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 110.681 -179.214 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.646 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.1 pt -120.3 -165.62 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.41 -0.806 . . . . 0.0 110.068 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -84.22 73.02 10.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.36 -0.838 . . . . 0.0 110.569 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 130.47 54.47 0.1 OUTLIER Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.646 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.0 OUTLIER -121.77 151.28 40.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -1.187 . . . . 0.0 110.106 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.773 ' HE2' HD11 ' A' ' 717' ' ' LEU . 7.2 tttt -109.04 139.69 43.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.486 -0.759 . . . . 0.0 109.411 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.948 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -144.36 146.59 32.64 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.299 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.754 HD11 ' CG ' ' A' ' 646' ' ' ASP . 12.7 tp -70.56 146.16 50.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.32 -0.862 . . . . 0.0 111.227 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.6 HD11 ' HB2' ' A' ' 649' ' ' TYR . 7.7 mt -118.93 102.15 8.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 110.585 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.412 ' NE2' ' HA3' ' A' ' 708' ' ' GLY . 71.9 mt-30 -84.53 160.61 20.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.458 -0.777 . . . . 0.0 109.204 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 706' ' ' GLY . 21.4 p-10 -52.25 149.31 5.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.008 -1.057 . . . . 0.0 110.289 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 63.75 50.14 63.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.441 ' HB3' HD22 ' A' ' 672' ' ' LEU . 0.2 OUTLIER -110.8 94.9 5.23 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.715 -0.874 . . . . 0.0 111.098 -178.648 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.891 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -94.64 106.83 18.83 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.414 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 1.018 HG22 HD13 ' A' ' 659' ' ' LEU . 17.6 pt -106.78 135.8 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.474 -0.766 . . . . 0.0 111.328 -178.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -98.52 109.57 22.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.369 -0.832 . . . . 0.0 109.146 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.829 HD13 ' SG ' ' A' ' 623' ' ' CYS . 89.7 mt -74.86 -42.19 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.39 -0.819 . . . . 0.0 110.537 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.635 HD12 ' HB2' ' A' ' 618' ' ' LEU . 3.1 mt -130.75 132.95 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.202 -0.936 . . . . 0.0 110.347 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -138.75 112.04 8.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.571 -0.706 . . . . 0.0 109.904 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -129.94 117.91 20.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 110.248 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -29.73 69.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.466 -0.771 . . . . 0.0 110.721 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -55.69 -43.36 76.33 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.365 -0.835 . . . . 0.0 111.031 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 686' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 688' ' ' PHE . 2.1 t30 -137.26 36.0 2.52 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.192 -0.942 . . . . 0.0 110.256 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.756 ' O ' HG23 ' A' ' 689' ' ' VAL . 0.8 OUTLIER 65.54 -67.82 0.13 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.77 -0.581 . . . . 0.0 109.856 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.509 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.1 OUTLIER 28.72 52.67 0.07 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.244 0.545 . . . . 0.0 111.346 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 687' ' ' LYS . 91.6 t -101.76 142.64 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 110.674 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.726 HD11 ' OD2' ' A' ' 615' ' ' ASP . 44.5 mm -120.0 165.32 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 179.79 121.37 0.72 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.052 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.891 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.8 m-85 -119.9 136.6 54.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.54 -0.977 . . . . 0.0 108.978 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.78 114.28 27.93 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.216 -0.927 . . . . 0.0 110.511 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -82.97 120.62 34.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.151 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -127.08 104.5 8.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.753 -0.592 . . . . 0.0 110.077 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.469 HD13 ' O ' ' A' ' 705' ' ' GLU . 65.4 mt -84.35 103.63 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.665 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -80.99 -42.97 20.34 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.9 OUTLIER -110.81 140.27 45.38 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.483 0.659 . . . . 0.0 110.271 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 12.1 p -114.9 96.13 5.56 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 35.7 m -117.94 121.67 41.28 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.208 0.528 . . . . 0.0 110.607 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.509 ' C ' HD22 ' A' ' 644' ' ' LEU . . . 52.41 45.5 58.65 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.813 HD11 ' CE2' ' A' ' 577' ' ' PHE . 3.7 mt -115.38 132.81 56.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.439 -1.036 . . . . 0.0 110.728 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.645 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 3.1 p90 -47.43 -24.71 0.87 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.568 0.699 . . . . 0.0 110.47 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.645 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER -170.8 155.0 4.53 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.093 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.738 ' OE2' HD23 ' A' ' 707' ' ' LEU . 11.7 pt-20 -51.15 -26.78 7.24 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.194 -0.941 . . . . 0.0 110.398 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 119.71 18.47 4.38 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.738 HD23 ' OE2' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -83.06 9.28 10.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.071 -1.252 . . . . 0.0 111.74 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.412 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 69.39 84.21 0.15 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.652 ' C ' HD23 ' A' ' 710' ' ' LEU . 0.2 OUTLIER -117.35 101.89 8.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.421 -1.046 . . . . 0.0 110.403 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.652 HD23 ' C ' ' A' ' 709' ' ' MET . 0.7 OUTLIER -175.87 153.47 1.37 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.02 -1.05 . . . . 0.0 110.499 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -42.08 97.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.359 -0.838 . . . . 0.0 109.663 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.65 149.04 47.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.454 -0.779 . . . . 0.0 109.559 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -110.4 95.32 5.5 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.172 -0.955 . . . . 0.0 109.697 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.731 ' NH1' HD21 ' A' ' 659' ' ' LEU . 1.3 mmm-85 38.32 84.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.893 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.444 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 35.5 m -108.31 151.13 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.455 -0.778 . . . . 0.0 109.583 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.45 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 87.5 t -98.44 127.47 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.266 -0.896 . . . . 0.0 110.758 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.773 HD11 ' HE2' ' A' ' 669' ' ' LYS . 0.5 OUTLIER -114.22 145.74 41.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.58 -0.7 . . . . 0.0 109.347 179.057 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.95 149.62 35.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.159 -0.963 . . . . 0.0 110.693 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 719' ' ' GLN . . . . . 0.408 ' HB2' ' CB ' ' A' ' 723' ' ' GLU . 9.1 pt20 -81.03 154.29 26.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.419 -0.801 . . . . 0.0 110.278 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 11.5 p -108.38 -176.61 3.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.331 -0.856 . . . . 0.0 110.677 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.51 -29.42 36.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.415 -0.803 . . . . 0.0 110.157 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 722' ' ' GLU . . . . . 0.461 ' O ' HD13 ' A' ' 726' ' ' LEU . 11.1 tp10 -60.72 -52.48 64.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.499 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.408 ' CB ' ' HB2' ' A' ' 719' ' ' GLN . 3.3 mp0 -63.89 -42.72 97.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 0.0 109.378 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.521 ' O ' HG12 ' A' ' 727' ' ' VAL . 1.4 mmtm -54.12 -32.21 54.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.341 -0.85 . . . . 0.0 109.552 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.26 -38.45 78.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.471 -0.768 . . . . 0.0 110.399 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.705 HD23 ' HB3' ' A' ' 600' ' ' PRO . 11.0 mp -55.75 -47.83 76.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.245 -0.909 . . . . 0.0 110.521 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.59 HG23 ' HB ' ' A' ' 621' ' ' VAL . 8.1 p -69.65 -22.22 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.226 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -51.44 65.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 108.912 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.84 104.98 11.87 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.171 0.986 . . . . 0.0 109.062 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 2.0 mt . . . . . 0 C--N 1.275 -2.657 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.444 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -83.18 -10.36 58.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.395 -1.062 . . . . 0.0 110.619 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 126.41 -30.68 4.21 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.405 ' CZ ' ' HG2' ' A' ' 593' ' ' GLU . 0.7 OUTLIER -92.59 114.39 26.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.325 -1.103 . . . . 0.0 109.661 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.504 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 6.7 t80 -98.09 -41.7 7.81 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.867 0.841 . . . . 0.0 109.678 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.846 HD23 HD12 ' A' ' 594' ' ' ILE . 48.5 tp -129.39 119.77 24.41 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.272 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 89.2 m -94.89 116.43 28.7 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.701 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 1.008 HD11 HD12 ' A' ' 625' ' ' ILE . 7.4 mt -89.91 111.34 22.36 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 583' ' ' LEU . 0.4 OUTLIER -114.08 102.77 55.09 Favored Pre-proline 0 C--N 1.298 -1.638 0 C-N-CA 118.116 -1.434 . . . . 0.0 112.463 -177.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 1.093 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.8 Cg_endo -79.63 143.97 17.26 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 N-CA-C 107.134 -1.91 . . . . 0.0 107.134 174.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 1.03 ' HB2' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -128.06 -173.98 0.34 Allowed Pre-proline 0 C--N 1.3 -1.585 0 C-N-CA 118.958 -1.097 . . . . 0.0 112.381 -177.239 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 1.03 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 35.3 Cg_endo -60.5 -33.43 93.88 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.819 1.431 . . . . 0.0 111.556 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 689' ' ' VAL . 4.3 m-20 -59.73 -23.99 63.65 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.734 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 19.1 t -95.73 151.45 19.36 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.804 HD13 ' HB2' ' A' ' 688' ' ' PHE . 7.8 tp -62.34 -17.09 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.026 -1.046 . . . . 0.0 109.647 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.957 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.2 tp -108.21 122.72 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.318 -0.864 . . . . 0.0 110.187 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 586' ' ' SER . 23.6 mp0 -110.07 79.8 1.25 Allowed 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.463 -1.398 . . . . 0.0 109.399 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 1.093 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 27.2 mt-10 -144.71 175.45 10.16 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.643 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.544 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.13 124.77 35.57 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.138 -0.976 . . . . 0.0 108.889 175.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.639 HD13 ' SG ' ' A' ' 611' ' ' CYS . 2.1 mt -109.53 155.73 21.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.918 . . . . 0.0 109.565 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.405 ' HG2' ' CZ ' ' A' ' 576' ' ' ARG . 3.1 mp0 -125.26 110.25 13.81 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.373 -0.829 . . . . 0.0 111.346 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.846 HD12 HD23 ' A' ' 578' ' ' LEU . 2.0 mt -81.61 109.21 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 597' ' ' GLY . 1.2 mp0 -56.15 165.07 1.08 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.446 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.504 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -63.17 70.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.54 -0.725 . . . . 0.0 110.065 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 137.79 21.83 0.48 Allowed Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.819 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.623 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -84.29 101.67 9.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 O-C-N 120.764 -1.433 . . . . 0.0 107.21 178.585 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 16.3 t-20 -145.46 132.57 10.1 Favored Pre-proline 0 C--N 1.283 -2.312 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.869 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.65 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 53.9 Cg_endo -91.71 163.5 27.77 Favored 'Cis proline' 0 C--N 1.311 -1.409 0 C-N-CA 123.31 -1.538 . . . . 0.0 109.045 -2.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.536 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 7.9 t80 -105.11 116.91 32.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.677 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 70.0 m-85 -86.34 146.15 26.6 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.416 -0.803 . . . . 0.0 111.406 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.686 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.9 mt -141.68 140.69 30.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.703 -0.623 . . . . 0.0 109.895 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.732 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 175.25 -161.41 30.59 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.298 -1.429 . . . . 0.0 111.436 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.408 ' CG ' ' O ' ' A' ' 615' ' ' ASP . 5.9 mmm-85 -69.7 -44.65 69.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.973 -0.722 . . . . 0.0 110.82 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.417 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -80.06 128.22 33.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.454 -0.779 . . . . 0.0 110.981 -178.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 1.6 pt-20 -58.54 -12.79 4.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.429 -0.794 . . . . 0.0 109.657 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 608' ' ' ASP . . . . . 0.452 ' OD2' HD13 ' A' ' 730' ' ' LEU . 15.7 t70 -45.25 -36.07 3.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.483 -0.761 . . . . 0.0 110.155 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.677 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 81.8 m -71.44 154.26 41.66 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 121.184 -0.947 . . . . 0.0 109.601 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.536 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 2.7 t-20 -58.98 -14.0 8.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.443 -0.785 . . . . 0.0 110.14 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.686 ' SG ' HG23 ' A' ' 603' ' ' ILE . 6.1 t -120.18 143.94 47.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.492 -0.755 . . . . 0.0 110.033 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.571 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -110.63 129.7 55.75 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 121.992 0.901 . . . . 0.0 112.562 -178.556 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.691 HD11 ' CE1' ' A' ' 692' ' ' PHE . 4.3 mt -146.82 111.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.49 ' O ' HG21 ' A' ' 587' ' ' ILE . 1.4 tt0 -93.05 102.76 15.1 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 117.69 -1.604 . . . . 0.0 109.095 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 3.2 m-20 -138.26 105.29 5.43 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.505 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -42.81 -41.43 3.24 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.412 -0.805 . . . . 0.0 111.881 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.97 -16.88 42.47 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.137 -0.977 . . . . 0.0 111.739 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.598 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.7 OUTLIER -80.75 134.75 35.87 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.121 -0.987 . . . . 0.0 111.319 -178.678 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.485 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.42 162.83 28.02 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.466 -0.771 . . . . 0.0 111.025 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.732 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 34.2 ttp180 -64.36 -46.77 81.98 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.348 -0.845 . . . . 0.0 109.738 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.569 ' HB ' HG23 ' A' ' 727' ' ' VAL . 13.8 m -94.67 2.43 9.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.209 -0.932 . . . . 0.0 109.059 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.764 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.4 t60 -28.59 -47.85 0.05 Allowed 'General case' 0 C--O 1.192 -1.954 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.751 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.845 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.21 145.16 43.32 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 118.311 -1.356 . . . . 0.0 111.166 179.049 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 6.5 p90 -145.86 150.4 36.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.573 -0.704 . . . . 0.0 110.339 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 1.008 HD12 HD11 ' A' ' 580' ' ' LEU . 19.0 mt -103.41 119.56 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 7.0 t80 -112.61 155.4 24.47 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.482 -0.761 . . . . 0.0 109.351 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 0.8 OUTLIER -119.61 136.06 54.54 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.852 0.834 . . . . 0.0 111.183 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.426 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -140.51 163.54 32.56 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 630' ' ' HIS . 0.0 OUTLIER -78.18 133.98 37.7 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.966 -1.084 . . . . 0.0 109.439 -179.492 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.517 ' O ' ' HD2' ' A' ' 629' ' ' ARG . 1.2 t60 -58.4 123.66 16.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.368 -0.832 . . . . 0.0 111.247 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -75.21 108.38 7.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.636 -0.665 . . . . 0.0 110.487 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.628 HG11 ' N ' ' A' ' 643' ' ' GLY . 7.1 p -109.17 168.27 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.392 -0.817 . . . . 0.0 110.087 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.516 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -110.98 -157.78 15.07 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -59.66 139.5 57.17 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.39 -1.065 . . . . 0.0 110.173 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.39 85.61 3.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.259 -0.901 . . . . 0.0 110.289 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.09 125.35 22.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.873 . . . . 0.0 109.649 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 64.53 -144.78 0.26 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.464 -0.772 . . . . 0.0 109.853 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -115.4 103.02 10.37 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.137 -0.977 . . . . 0.0 109.314 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 13.0 p -135.9 151.36 73.81 Favored Pre-proline 0 C--N 1.294 -1.838 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.737 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.28 -153.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.673 1.354 . . . . 0.0 110.094 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 54.48 20.69 2.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.56 -0.712 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.99 60.97 0.55 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.103 -0.998 . . . . 0.0 109.837 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.649 ' C ' HD12 ' A' ' 644' ' ' LEU . . . 62.26 117.71 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.76 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.9 mp -140.84 -146.9 0.2 Allowed 'General case' 0 C--N 1.29 -1.985 0 O-C-N 122.076 -0.661 . . . . 0.0 109.422 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.6 OUTLIER -108.63 124.96 51.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.067 -1.021 . . . . 0.0 110.728 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.736 ' OD2' HD21 ' A' ' 671' ' ' LEU . 17.5 t0 -121.36 135.51 55.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.355 -0.841 . . . . 0.0 110.509 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 25.4 pt -92.69 135.28 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.272 -0.893 . . . . 0.0 110.075 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.645 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.6 m95 -119.62 121.93 40.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.604 -0.685 . . . . 0.0 111.306 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.586 ' HB2' HD11 ' A' ' 672' ' ' LEU . 14.0 t80 -80.78 115.54 20.33 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 9.8 t -107.22 108.45 19.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 111.64 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.516 ' CD2' ' N ' ' A' ' 652' ' ' THR . 12.5 t60 -70.72 158.66 35.88 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.461 -0.774 . . . . 0.0 109.761 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.764 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -149.86 -29.58 0.23 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.43 -0.794 . . . . 0.0 112.441 -179.077 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.55 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.45 -167.59 31.86 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 117.642 -2.218 . . . . 0.0 109.17 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 27.6 m -95.62 -17.44 21.34 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.014 -1.286 . . . . 0.0 113.751 -176.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.516 ' C ' HG23 ' A' ' 656' ' ' VAL . 16.7 m120 -59.48 -4.01 0.54 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.775 -1.203 . . . . 0.0 112.683 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 664' ' ' MET . 3.4 t 71.52 148.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-O 121.494 0.664 . . . . 0.0 110.604 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.436 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -106.83 143.09 35.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.721 -0.612 . . . . 0.0 110.068 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.456 ' CE1' ' CG ' ' A' ' 663' ' ' ARG . 36.6 m-85 -136.0 126.74 27.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.211 -0.93 . . . . 0.0 110.701 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.581 ' HG ' HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -130.02 119.04 22.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.392 -0.817 . . . . 0.0 109.787 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 56.89 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.388 -0.82 . . . . 0.0 110.429 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 659' ' ' LEU . 3.6 t-20 -138.07 5.73 2.57 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.017 -1.052 . . . . 0.0 110.984 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -96.28 132.99 41.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.032 -1.043 . . . . 0.0 110.566 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.456 ' CG ' ' CE1' ' A' ' 658' ' ' TYR . 4.6 tmm_? -99.47 138.69 36.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.448 -0.783 . . . . 0.0 109.872 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.768 ' HG2' HG13 ' A' ' 716' ' ' VAL . 3.6 mtp -117.41 -165.99 1.14 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.229 -0.92 . . . . 0.0 110.716 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.588 HG13 HG23 ' A' ' 668' ' ' THR . 2.5 pt -141.86 -158.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.354 -0.842 . . . . 0.0 110.171 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -82.85 92.05 7.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.2 -0.938 . . . . 0.0 110.759 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 109.65 49.74 0.73 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.588 HG23 HG13 ' A' ' 665' ' ' ILE . 0.2 OUTLIER -118.52 148.39 42.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.06 -1.259 . . . . 0.0 109.943 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.45 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 7.6 tttt -108.5 138.88 44.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.441 -0.787 . . . . 0.0 109.088 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.51 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 5.2 t80 -144.25 147.19 33.25 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.104 -0.997 . . . . 0.0 112.032 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.736 HD21 ' OD2' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -69.76 147.49 50.41 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.554 -0.717 . . . . 0.0 111.583 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.663 HD23 ' OD2' ' A' ' 676' ' ' ASP . 7.8 mt -122.81 99.2 6.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.322 -0.861 . . . . 0.0 111.444 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 674' ' ' ASP . 94.2 mt-30 -84.65 141.26 30.75 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.672 ' OD1' HD12 ' A' ' 707' ' ' LEU . 0.3 OUTLIER -38.34 151.51 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.354 -0.842 . . . . 0.0 110.815 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 64.9 49.59 62.35 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 107.358 -2.297 . . . . 0.0 107.358 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.663 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.3 OUTLIER -115.81 92.43 3.9 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.871 -0.782 . . . . 0.0 110.774 -178.631 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.966 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.2 OUTLIER -93.93 106.98 18.93 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.189 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.581 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.2 pt -106.84 137.31 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.369 0.604 . . . . 0.0 111.404 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.409 ' CG ' ' HB2' ' A' ' 658' ' ' TYR . 2.9 ptmm? -97.17 110.44 22.99 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.488 -0.757 . . . . 0.0 109.418 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.845 HD13 ' SG ' ' A' ' 623' ' ' CYS . 68.5 mt -80.09 -22.65 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.373 -0.829 . . . . 0.0 110.692 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.514 HG22 ' HA ' ' A' ' 689' ' ' VAL . 0.4 OUTLIER -134.64 135.17 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.163 -0.961 . . . . 0.0 109.998 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -138.0 109.13 6.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.934 . . . . 0.0 110.562 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 686' ' ' ASN . 0.7 OUTLIER -130.16 118.23 21.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.281 -0.887 . . . . 0.0 109.666 179.19 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.95 -32.53 74.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.334 -0.854 . . . . 0.0 111.215 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -84.23 -43.71 14.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.092 -1.005 . . . . 0.0 111.504 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 686' ' ' ASN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 688' ' ' PHE . 88.4 m-20 -73.88 -19.83 60.59 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.137 -0.977 . . . . 0.0 110.798 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.53 22.09 4.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.168 -0.958 . . . . 0.0 110.46 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.804 ' HB2' HD13 ' A' ' 587' ' ' ILE . 0.7 OUTLIER -114.24 83.8 1.94 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.26 1.029 . . . . 0.0 109.472 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' A' ' 586' ' ' SER . 14.9 m -101.04 143.17 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.075 -1.016 . . . . 0.0 110.553 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.734 ' CD1' HG22 ' A' ' 587' ' ' ILE . 47.7 mm -85.19 165.13 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.554 -0.716 . . . . 0.0 109.975 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.455 ' N ' HG22 ' A' ' 690' ' ' ILE . . . -176.8 117.06 0.58 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.966 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.6 m-85 -121.46 137.26 54.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 109.945 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.96 113.95 25.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.282 -0.886 . . . . 0.0 109.98 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.769 HG22 HD11 ' A' ' 578' ' ' LEU . 0.5 OUTLIER -83.65 123.7 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.364 -0.835 . . . . 0.0 109.254 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.39 108.52 10.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.85 -0.531 . . . . 0.0 110.408 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.683 HD12 ' O ' ' A' ' 705' ' ' GLU . 81.0 mt -86.37 104.42 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.887 . . . . 0.0 109.826 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -77.4 -41.39 40.18 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.421 -0.8 . . . . 0.0 109.453 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.458 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 5.2 m-20 -110.22 140.97 43.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.479 -0.763 . . . . 0.0 110.735 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 15.7 p -115.88 96.27 5.51 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 82.5 m -108.7 114.71 28.74 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 121.752 -0.592 . . . . 0.0 110.738 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 49.46 36.37 23.58 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 704' ' ' ASN . 5.2 tp -98.41 141.18 31.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.613 -0.933 . . . . 0.0 110.195 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.76 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.6 p90 -51.75 -24.92 6.5 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.395 -0.816 . . . . 0.0 109.756 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.798 ' O ' HD23 ' A' ' 702' ' ' LEU . 0.8 OUTLIER -176.92 155.64 1.25 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.255 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.683 ' O ' HD12 ' A' ' 696' ' ' ILE . 11.1 pt-20 -51.41 -22.86 3.27 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.114 -0.991 . . . . 0.0 110.456 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 115.04 16.66 7.18 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.672 HD12 ' OD1' ' A' ' 674' ' ' ASP . 3.3 tp -85.17 8.76 17.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -1.204 . . . . 0.0 111.871 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.412 ' CA ' ' NE2' ' A' ' 673' ' ' GLN . . . 45.95 73.81 0.27 Allowed Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.906 ' HG2' HD23 ' A' ' 710' ' ' LEU . 0.0 OUTLIER -81.27 177.29 9.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.255 -1.144 . . . . 0.0 110.577 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.906 HD23 ' HG2' ' A' ' 709' ' ' MET . 0.3 OUTLIER 40.99 -159.41 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.416 0.627 . . . . 0.0 111.703 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -91.83 71.87 5.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.526 -0.734 . . . . 0.0 109.145 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.02 148.18 48.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.439 -0.788 . . . . 0.0 110.566 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -111.07 97.32 6.72 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.51 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -116.98 88.9 3.0 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.723 0.773 . . . . 0.0 109.356 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 36.0 m -105.25 168.7 2.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.666 -0.646 . . . . 0.0 109.63 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.768 HG13 ' HG2' ' A' ' 664' ' ' MET . 52.7 t -71.34 128.48 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.326 -0.859 . . . . 0.0 111.139 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.62 162.3 13.63 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -98.64 154.39 17.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.981 -1.074 . . . . 0.0 110.467 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 719' ' ' GLN . . . . . 0.428 ' HG3' ' HB3' ' A' ' 723' ' ' GLU . 0.4 OUTLIER -79.69 145.08 33.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.54 -0.725 . . . . 0.0 110.403 -179.69 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 34.3 p -121.07 -176.8 3.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 110.093 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.78 -32.21 63.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.292 -0.88 . . . . 0.0 110.448 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -64.49 -52.3 58.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.386 -0.822 . . . . 0.0 110.22 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.428 ' HB3' ' HG3' ' A' ' 719' ' ' GLN . 0.6 OUTLIER -64.42 -40.3 95.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.328 -0.857 . . . . 0.0 110.051 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.458 ' O ' HG12 ' A' ' 727' ' ' VAL . 18.3 ttpp -56.93 -35.11 68.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.311 -0.868 . . . . 0.0 109.945 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 725' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 728' ' ' LYS . 0.9 OUTLIER -67.7 -35.79 79.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.472 -0.768 . . . . 0.0 109.994 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.414 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 50.3 mt -57.06 -46.39 82.52 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.333 -0.854 . . . . 0.0 110.336 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.569 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.2 p -76.28 -24.33 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.613 -0.68 . . . . 0.0 110.914 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 728' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 725' ' ' ASP . 0.7 OUTLIER -53.32 -45.18 68.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.055 -1.028 . . . . 0.0 108.956 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -116.67 103.81 10.74 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 122.197 0.999 . . . . 0.0 109.057 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.452 HD13 ' OD2' ' A' ' 608' ' ' ASP . 2.2 mt . . . . . 0 C--N 1.274 -2.708 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.375 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.399 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -82.83 1.61 38.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.34 -1.094 . . . . 0.0 110.656 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 105.03 7.34 38.43 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -94.28 124.42 38.29 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.222 -1.164 . . . . 0.0 109.296 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.1 OUTLIER -120.96 -39.69 2.69 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.843 0.83 . . . . 0.0 109.415 -179.583 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.042 HD22 HD12 ' A' ' 594' ' ' ILE . 8.5 tt -120.31 119.52 33.38 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.326 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 71.2 m -99.44 118.89 37.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 109.52 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.658 HD11 HD12 ' A' ' 625' ' ' ILE . 5.8 mt -91.37 111.97 23.68 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.79 101.82 54.2 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 118.075 -1.45 . . . . 0.0 112.736 -177.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 1.047 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 44.2 Cg_endo -79.75 145.78 18.31 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 N-CA-C 106.784 -2.045 . . . . 0.0 106.784 174.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.73 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.33 -174.37 0.31 Allowed Pre-proline 0 N--CA 1.494 1.753 0 C-N-CA 118.81 -1.156 . . . . 0.0 112.763 -177.104 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.73 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.9 Cg_endo -66.79 -28.73 43.15 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 124.111 1.585 . . . . 0.0 110.319 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -59.4 -28.35 66.83 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 53.7 p -95.45 153.73 17.55 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.645 ' H ' HD13 ' A' ' 690' ' ' ILE . 3.8 tp -54.76 -16.98 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.333 -0.855 . . . . 0.0 109.944 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.86 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.6 tp -116.3 119.34 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.265 -0.897 . . . . 0.0 110.575 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.434 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 3.2 pm0 -112.39 80.73 1.37 Allowed 'General case' 0 N--CA 1.509 2.498 0 O-C-N 120.444 -1.41 . . . . 0.0 109.143 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 1.047 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 6.7 mm-40 -142.57 175.78 9.53 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.625 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.57 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.92 125.85 40.37 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.083 -1.011 . . . . 0.0 109.456 176.779 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 17.4 mt -111.17 156.02 22.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.405 -0.809 . . . . 0.0 109.649 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -125.23 111.12 14.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.378 -0.826 . . . . 0.0 111.836 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.042 HD12 HD22 ' A' ' 578' ' ' LEU . 45.9 mt -80.42 110.81 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.0 mt-30 -70.71 109.47 4.95 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.493 ' HA ' ' CD1' ' A' ' 577' ' ' PHE . 0.5 OUTLIER 20.43 53.89 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 178.333 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . 109.96 44.62 1.01 Allowed Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.603 -1.284 . . . . 0.0 111.03 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 598' ' ' VAL . 1.0 OUTLIER -79.63 103.85 7.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 177.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.445 ' CB ' ' HB3' ' A' ' 627' ' ' LYS . 0.2 OUTLIER -140.97 140.52 21.55 Favored Pre-proline 0 C--N 1.281 -2.371 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.639 -178.703 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.574 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.2 Cg_endo -88.79 160.82 40.67 Favored 'Cis proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.721 -2.199 . . . . 0.0 109.07 -0.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -106.56 116.82 32.58 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.706 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 58.1 m-85 -91.25 145.86 24.31 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.39 -0.818 . . . . 0.0 111.037 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.724 HD11 HG13 ' A' ' 625' ' ' ILE . 2.2 mt -140.02 141.05 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.33 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.713 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 175.33 -165.85 37.04 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.356 -1.402 . . . . 0.0 111.321 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 13.2 tpt180 -66.69 -38.81 87.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.956 -0.732 . . . . 0.0 110.777 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.471 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -84.22 126.8 33.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.398 -0.814 . . . . 0.0 110.748 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.422 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -59.3 -12.68 6.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 110.009 179.125 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.32 -36.97 6.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.882 . . . . 0.0 110.036 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.706 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 75.3 m -68.93 153.65 43.42 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 121.265 -0.897 . . . . 0.0 109.773 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.572 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 3.1 t-20 -58.63 -14.78 9.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.485 -0.76 . . . . 0.0 110.238 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.699 ' SG ' HG23 ' A' ' 603' ' ' ILE . 6.6 t -119.95 143.46 47.99 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.582 -0.699 . . . . 0.0 109.528 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.65 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -110.23 130.88 55.47 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 122.054 0.93 . . . . 0.0 112.856 -178.268 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.669 HD11 ' CE1' ' A' ' 692' ' ' PHE . 3.9 mt -147.15 110.39 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.436 ' O ' HG12 ' A' ' 587' ' ' ILE . 2.7 tt0 -92.31 102.98 15.48 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 117.666 -1.614 . . . . 0.0 109.277 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.857 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.0 OUTLIER -139.55 106.15 5.34 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.692 177.322 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -42.94 -43.68 4.25 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.485 -0.76 . . . . 0.0 111.962 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -83.53 -17.13 42.89 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.144 -0.973 . . . . 0.0 111.729 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.947 HD13 HD11 ' A' ' 681' ' ' ILE . 0.8 OUTLIER -78.01 134.65 37.77 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.07 -1.019 . . . . 0.0 110.694 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.479 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.1 m -73.37 161.14 30.79 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.337 -0.852 . . . . 0.0 110.915 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.713 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 43.6 mtm180 -64.2 -45.63 87.47 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.235 -0.916 . . . . 0.0 109.309 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.708 ' HB ' HG23 ' A' ' 727' ' ' VAL . 15.7 m -94.66 2.0 9.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.83 0.824 . . . . 0.0 109.402 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.6 t60 -28.28 -46.91 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.771 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.823 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -136.17 144.93 45.26 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.523 178.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 6.3 p90 -145.7 143.65 29.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.485 -0.759 . . . . 0.0 110.229 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.724 HG13 HD11 ' A' ' 603' ' ' ILE . 76.8 mt -103.43 117.66 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 8.3 t80 -110.95 155.0 23.32 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.853 0.835 . . . . 0.0 110.234 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.445 ' HB3' ' CB ' ' A' ' 599' ' ' ASN . 3.1 tppp? -118.96 137.13 53.71 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 121.372 0.606 . . . . 0.0 109.735 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.0 OUTLIER -133.88 163.82 28.65 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.566 -0.709 . . . . 0.0 111.038 -179.11 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.494 ' HD2' ' O ' ' A' ' 644' ' ' LEU . 2.5 tpt180 -77.66 116.2 18.02 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.366 -0.834 . . . . 0.0 108.929 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 703' ' ' PHE . 8.5 t60 -57.93 124.63 19.9 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.651 0.738 . . . . 0.0 110.649 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -60.11 124.3 19.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.683 -0.635 . . . . 0.0 110.537 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.556 HG22 ' N ' ' A' ' 633' ' ' GLY . 8.2 p -113.27 171.81 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.416 -0.803 . . . . 0.0 110.24 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.556 ' N ' HG22 ' A' ' 632' ' ' VAL . . . 68.24 150.66 0.27 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.16 35.62 17.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.336 -1.096 . . . . 0.0 110.455 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.0 83.46 1.76 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.45 -0.781 . . . . 0.0 110.085 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 636' ' ' MET . . . . . 0.424 ' O ' ' O ' ' A' ' 637' ' ' TYR . 13.4 mmt 53.48 -135.95 1.42 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.162 -0.961 . . . . 0.0 109.318 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 637' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 639' ' ' SER . 2.6 p90 -57.87 -160.31 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.413 -0.804 . . . . 0.0 109.743 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -115.58 101.63 9.04 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 120.773 -1.204 . . . . 0.0 109.691 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 639' ' ' SER . . . . . 0.43 ' HB3' ' CE1' ' A' ' 637' ' ' TYR . 4.4 p -137.81 145.44 48.43 Favored Pre-proline 0 C--N 1.293 -1.871 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.022 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.767 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 49.6 Cg_endo -70.05 -150.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.637 1.335 . . . . 0.0 109.319 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 82.47 -49.12 0.19 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.708 -0.62 . . . . 0.0 110.893 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -74.81 134.43 41.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.889 -1.132 . . . . 0.0 110.195 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 135.25 -3.04 3.98 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.662 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.6 mp -105.67 -154.45 0.51 Allowed 'General case' 0 C--N 1.283 -2.322 0 O-C-N 122.09 -0.653 . . . . 0.0 109.546 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 628' ' ' LYS . 41.6 m-20 -112.22 124.72 53.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.873 -1.142 . . . . 0.0 111.325 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.494 ' OD1' HD21 ' A' ' 671' ' ' LEU . 5.6 t0 -98.34 156.57 16.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.482 -0.761 . . . . 0.0 109.647 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.49 HD13 HD12 ' A' ' 578' ' ' LEU . 12.7 pt -106.25 130.18 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.278 -0.889 . . . . 0.0 110.38 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.729 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.6 m95 -117.84 124.38 48.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.841 -0.537 . . . . 0.0 111.194 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.716 ' HB2' HD11 ' A' ' 672' ' ' LEU . 7.1 t80 -83.91 114.47 21.7 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 17.4 t -109.71 106.1 15.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.061 -1.024 . . . . 0.0 112.112 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.549 ' CD2' ' N ' ' A' ' 652' ' ' THR . 14.4 t60 -67.54 162.55 23.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.454 -0.778 . . . . 0.0 109.854 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -154.47 -30.98 0.11 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.304 -0.872 . . . . 0.0 112.509 -179.244 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.557 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.62 -168.57 34.18 Favored Glycine 0 N--CA 1.497 2.712 0 C-N-CA 117.82 -2.133 . . . . 0.0 109.766 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 11.1 m -89.71 -18.78 25.74 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.088 -1.242 . . . . 0.0 114.217 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.692 ' O ' HG22 ' A' ' 656' ' ' VAL . 24.4 m120 -59.32 -3.03 0.36 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.605 -1.309 . . . . 0.0 112.728 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 62.52 142.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.549 -0.719 . . . . 0.0 110.164 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.482 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -96.95 151.8 19.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.589 -0.695 . . . . 0.0 110.554 -179.168 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.481 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 12.6 m-85 -138.02 125.46 21.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.363 -0.836 . . . . 0.0 110.175 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.761 HD21 ' CG1' ' A' ' 678' ' ' ILE . 1.7 mt -129.4 110.15 11.66 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.382 -0.824 . . . . 0.0 109.83 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 59.02 -80.67 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.428 -0.795 . . . . 0.0 110.37 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 659' ' ' LEU . 7.6 p-10 -144.64 13.73 1.54 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 110.94 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -100.16 116.74 32.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.017 -1.052 . . . . 0.0 110.225 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -81.46 136.14 35.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.348 -0.845 . . . . 0.0 109.676 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.789 ' CG ' HG21 ' A' ' 716' ' ' VAL . 1.6 mtp -119.07 -167.39 1.38 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 0.0 110.223 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.536 HG13 HG23 ' A' ' 668' ' ' THR . 11.2 pt -146.74 -162.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 652' ' ' THR . 28.5 tt0 -75.68 79.4 2.65 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.342 -0.849 . . . . 0.0 111.272 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.93 58.07 0.21 Allowed Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.833 -1.175 . . . . 0.0 110.678 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 1.2 p -123.9 145.58 49.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.994 -1.298 . . . . 0.0 110.074 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -108.52 136.94 47.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.398 -0.814 . . . . 0.0 109.205 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 671' ' ' LEU . 8.1 t80 -144.45 146.81 32.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.163 -0.96 . . . . 0.0 111.49 -178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.729 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.9 OUTLIER -72.17 145.88 47.77 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.413 -0.804 . . . . 0.0 111.628 -179.374 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.716 HD11 ' HB2' ' A' ' 649' ' ' TYR . 6.2 mt -115.55 112.94 22.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.228 -0.92 . . . . 0.0 111.318 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 15.3 mt-30 -84.53 -177.03 6.5 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 706' ' ' GLY . 0.0 OUTLIER -73.55 149.7 42.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.982 -1.074 . . . . 0.0 109.711 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 59.68 50.26 69.61 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.2 94.74 5.89 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.74 0.781 . . . . 0.0 110.643 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.912 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 5.9 tt0 -93.49 107.42 19.27 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.761 ' CG1' HD21 ' A' ' 659' ' ' LEU . 1.9 mp -104.15 137.15 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.642 -0.661 . . . . 0.0 111.88 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -99.58 109.89 22.37 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.823 HD13 ' SG ' ' A' ' 623' ' ' CYS . 74.9 mt -79.52 -19.89 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.352 -0.842 . . . . 0.0 111.076 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.947 HD11 HD13 ' A' ' 618' ' ' LEU . 8.4 mt -141.6 141.33 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.967 -1.083 . . . . 0.0 110.762 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -137.79 108.77 6.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.43 -0.794 . . . . 0.0 109.965 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.96 118.43 29.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.268 -0.895 . . . . 0.0 110.161 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -66.33 -46.87 75.36 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.364 -0.835 . . . . 0.0 110.963 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -84.93 -43.43 14.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.258 -0.901 . . . . 0.0 111.2 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 686' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -91.23 0.39 57.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.262 -0.899 . . . . 0.0 111.004 -179.353 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.626 ' O ' HG23 ' A' ' 689' ' ' VAL . 0.0 OUTLIER 65.49 -67.73 0.13 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.42 -0.8 . . . . 0.0 109.777 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.595 ' HD2' HG21 ' A' ' 681' ' ' ILE . 0.1 OUTLIER 24.52 61.0 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.369 0.604 . . . . 0.0 111.317 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 687' ' ' LYS . 59.8 t -101.97 142.46 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.422 -0.799 . . . . 0.0 110.718 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.857 HD11 ' OD2' ' A' ' 615' ' ' ASP . 40.4 mm -122.64 165.38 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -176.35 121.01 0.78 Allowed Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.912 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 10.6 m-85 -119.62 136.51 54.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.526 -0.985 . . . . 0.0 108.798 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -98.77 114.32 26.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 110.898 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 694' ' ' VAL . 1.2 t -84.78 114.0 24.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -122.37 104.34 9.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.733 -0.604 . . . . 0.0 109.826 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.548 ' CD1' ' HA3' ' A' ' 706' ' ' GLY . 83.3 mt -88.71 103.28 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.33 -0.856 . . . . 0.0 109.679 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.0 -41.75 22.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 0.0 108.927 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.7 OUTLIER -109.92 141.29 42.87 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.391 0.615 . . . . 0.0 109.629 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 16.3 p -113.29 95.8 5.56 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 40.7 m -129.65 134.62 47.78 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.87 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 57.72 29.35 61.28 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.596 ' O ' HD22 ' A' ' 644' ' ' LEU . 1.0 OUTLIER -113.83 128.07 56.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.503 -0.998 . . . . 0.0 110.24 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.662 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.5 p90 -50.44 -24.01 2.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.481 -0.762 . . . . 0.0 110.753 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.529 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.9 OUTLIER -157.93 171.37 20.38 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -178.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.528 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 16.6 pt-20 -51.33 -22.83 3.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.068 -1.02 . . . . 0.0 110.295 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.548 ' HA3' ' CD1' ' A' ' 696' ' ' ILE . . . 120.83 5.75 9.71 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.86 HD13 ' O ' ' A' ' 707' ' ' LEU . 0.8 OUTLIER -90.21 10.36 24.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.351 -1.088 . . . . 0.0 110.669 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.484 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 61.84 162.02 0.21 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.657 ' C ' HD23 ' A' ' 710' ' ' LEU . 0.0 OUTLIER -177.64 110.2 0.07 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.371 -1.076 . . . . 0.0 110.231 -179.746 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.834 HD12 ' HB2' ' A' ' 712' ' ' GLU . 0.7 OUTLIER -175.06 165.48 3.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.225 -0.922 . . . . 0.0 110.368 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.08 -44.05 95.06 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.351 -0.843 . . . . 0.0 109.895 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.834 ' HB2' HD12 ' A' ' 710' ' ' LEU . 9.6 mp0 -63.78 149.38 46.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.43 -0.794 . . . . 0.0 109.685 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.32 95.72 5.86 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.295 -0.878 . . . . 0.0 109.349 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.582 ' NH2' HD22 ' A' ' 659' ' ' LEU . 3.5 mmm-85 46.47 82.27 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.262 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 32.0 m -108.04 152.25 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.533 -0.729 . . . . 0.0 109.522 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.789 HG21 ' CG ' ' A' ' 664' ' ' MET . 14.6 p -104.21 133.29 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.725 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.0 mp -104.01 162.76 12.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.416 -0.803 . . . . 0.0 110.001 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -93.33 154.27 18.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.223 -0.923 . . . . 0.0 110.163 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -79.61 148.02 31.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.36 -0.838 . . . . 0.0 110.358 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 11.9 p -121.07 -176.37 3.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.381 -0.824 . . . . 0.0 110.359 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.49 -29.0 33.89 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.332 -0.855 . . . . 0.0 110.093 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.8 -51.32 65.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.461 -0.774 . . . . 0.0 109.745 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -64.06 -43.64 94.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.45 -0.781 . . . . 0.0 109.937 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.543 ' O ' HG12 ' A' ' 727' ' ' VAL . 16.1 tttt -56.41 -32.86 65.24 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.35 -0.843 . . . . 0.0 110.06 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -68.78 -36.31 78.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.387 -0.821 . . . . 0.0 110.364 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 37.8 mt -60.02 -46.32 89.9 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.362 -0.836 . . . . 0.0 110.439 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.708 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.1 p -69.15 -19.67 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.04 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.53 -50.8 69.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 108.877 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -116.85 105.29 12.2 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 122.132 0.968 . . . . 0.0 109.122 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.515 HD21 HG12 ' A' ' 621' ' ' VAL . 4.5 mt . . . . . 0 C--N 1.274 -2.68 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.472 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.97 -10.25 58.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.286 -1.126 . . . . 0.0 110.608 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -134.8 23.21 3.57 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.413 ' HD3' ' HG2' ' A' ' 593' ' ' GLU . 14.0 ttp-105 -92.04 114.1 26.55 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.265 -1.138 . . . . 0.0 109.202 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.681 ' CZ ' HD13 ' A' ' 702' ' ' LEU . 3.0 t80 -92.47 -43.52 9.14 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.913 0.863 . . . . 0.0 109.475 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.079 HD23 HD12 ' A' ' 594' ' ' ILE . 5.4 tp -125.1 119.7 29.36 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.628 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 36.2 m -96.75 118.66 33.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.53 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.788 HD11 HD12 ' A' ' 625' ' ' ILE . 3.3 mt -94.72 112.3 24.04 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.563 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -111.97 104.18 55.83 Favored Pre-proline 0 C--N 1.3 -1.563 0 C-N-CA 118.467 -1.293 . . . . 0.0 112.935 -177.328 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 1.086 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.7 Cg_endo -76.81 142.46 22.59 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 N-CA-C 105.72 -2.454 . . . . 0.0 105.72 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 1.027 ' HB2' ' HD2' ' A' ' 584' ' ' PRO . 0.1 OUTLIER -126.78 -175.28 0.41 Allowed Pre-proline 0 N--CA 1.499 1.982 0 C-N-CA 118.416 -1.314 . . . . 0.0 113.806 -176.052 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 1.027 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 37.7 Cg_endo -65.75 -33.43 44.17 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.961 1.506 . . . . 0.0 111.381 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.08 -30.34 68.01 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.598 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 84.2 p -97.59 153.77 17.97 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.687 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.2 OUTLIER -61.6 -11.06 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.935 . . . . 0.0 109.839 178.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.766 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 8.5 mm -98.54 116.95 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.351 -0.843 . . . . 0.0 109.779 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 586' ' ' SER . 17.8 mp0 -118.67 70.32 0.82 Allowed 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.491 -1.38 . . . . 0.0 109.932 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 1.086 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 18.0 mt-10 -144.31 175.44 10.09 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.014 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.496 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.61 125.57 36.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.995 -1.066 . . . . 0.0 109.04 176.371 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.673 HD13 ' HA ' ' A' ' 611' ' ' CYS . 46.5 mt -111.63 155.05 23.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 109.828 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.413 ' HG2' ' HD3' ' A' ' 576' ' ' ARG . 16.3 mp0 -126.27 110.59 13.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.835 . . . . 0.0 111.461 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.079 HD12 HD23 ' A' ' 578' ' ' LEU . 3.5 mt -77.94 109.52 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.06 -1.025 . . . . 0.0 108.32 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -53.61 161.22 1.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.451 -0.781 . . . . 0.0 109.766 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.506 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.3 OUTLIER -48.94 79.05 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.706 -0.621 . . . . 0.0 111.551 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 107.41 34.93 2.78 Favored Glycine 0 N--CA 1.486 1.995 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.844 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.722 ' HB ' HG23 ' A' ' 594' ' ' ILE . 1.0 OUTLIER -79.77 103.05 6.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.383 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.4 t30 -143.01 135.25 13.3 Favored Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.023 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.633 ' HB3' HD23 ' A' ' 726' ' ' LEU . 56.0 Cg_endo -91.08 161.9 29.67 Favored 'Cis proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.781 -1.758 . . . . 0.0 108.987 -1.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.516 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -106.62 116.2 31.52 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.628 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 63.6 m-85 -83.02 143.63 30.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 0.0 110.288 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.775 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.9 mt -142.93 142.08 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.563 -0.711 . . . . 0.0 110.224 -178.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.787 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 165.42 -161.2 34.67 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.339 -1.41 . . . . 0.0 111.4 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.461 ' N ' HD23 ' A' ' 618' ' ' LEU . 3.4 mmm-85 -63.74 -53.87 44.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.78 -0.835 . . . . 0.0 111.834 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.481 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -71.59 124.73 25.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 111.239 -178.592 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.485 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.1 OUTLIER -54.07 -17.67 2.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 0.0 109.813 178.894 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -45.18 -30.99 1.29 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 0.0 109.272 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 602' ' ' PHE . 1.7 m -68.6 133.81 49.05 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.516 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 1.9 t-20 -45.08 -26.93 0.51 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.318 -0.864 . . . . 0.0 109.759 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.775 ' HB3' HG23 ' A' ' 603' ' ' ILE . 13.0 t -106.23 143.61 34.1 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.485 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -108.91 125.15 51.71 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.253 1.025 . . . . 0.0 113.161 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.766 ' HA ' ' CD1' ' A' ' 588' ' ' ILE . 18.3 mt -143.13 108.31 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.431 ' HA ' ' HD2' ' A' ' 605' ' ' ARG . 3.8 mt-10 -97.77 104.41 16.43 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 118.302 -1.359 . . . . 0.0 109.25 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.705 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.0 OUTLIER -137.99 106.19 5.75 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.238 177.439 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -42.49 -39.48 2.27 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.485 -0.759 . . . . 0.0 111.678 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.67 -17.8 40.2 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.152 -0.968 . . . . 0.0 111.303 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.751 HD12 HD11 ' A' ' 681' ' ' ILE . 0.7 OUTLIER -79.3 140.45 37.56 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.177 -0.952 . . . . 0.0 110.562 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.427 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.82 161.02 29.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.372 -0.83 . . . . 0.0 110.718 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.787 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 9.8 ttp180 -63.6 -45.65 89.4 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.25 -0.906 . . . . 0.0 109.173 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.873 HG11 HG23 ' A' ' 727' ' ' VAL . 7.7 t -95.98 1.92 10.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.483 -0.761 . . . . 0.0 109.931 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.751 ' O ' ' N ' ' A' ' 652' ' ' THR . 9.2 t60 -27.49 -41.82 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.078 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.739 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.7 OUTLIER -136.76 145.0 44.07 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 118.228 -1.389 . . . . 0.0 110.861 179.195 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.551 ' CE2' ' CB ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -147.63 140.75 25.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.579 -0.7 . . . . 0.0 109.992 178.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.788 HD12 HD11 ' A' ' 580' ' ' LEU . 0.6 OUTLIER -103.21 136.88 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.231 -0.918 . . . . 0.0 109.327 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.544 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 7.6 t80 -128.97 155.83 44.75 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.503 -0.748 . . . . 0.0 109.636 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.677 ' HE2' HG23 ' A' ' 647' ' ' ILE . 1.2 tppp? -119.02 136.93 53.87 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.404 0.621 . . . . 0.0 110.622 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.433 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -140.32 163.82 31.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.627 -0.67 . . . . 0.0 110.709 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -78.39 128.61 33.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.377 -0.827 . . . . 0.0 109.411 -179.733 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.537 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.5 t60 -58.56 124.72 20.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.421 -0.799 . . . . 0.0 110.845 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -78.61 107.47 11.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.62 -0.675 . . . . 0.0 110.499 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.675 HG11 ' N ' ' A' ' 643' ' ' GLY . 9.1 p -122.1 172.37 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.445 -0.784 . . . . 0.0 110.491 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.565 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -87.41 -168.65 44.88 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -63.45 168.28 4.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.254 -1.144 . . . . 0.0 110.042 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.78 77.34 1.58 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.275 -0.89 . . . . 0.0 110.496 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 7.9 ptm -61.26 126.21 26.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 109.676 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 1.5 t80 63.15 -145.17 0.35 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.882 . . . . 0.0 109.87 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 638' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 638' ' ' GLU . 3.5 pt-20 -115.51 102.24 9.62 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.227 1.013 . . . . 0.0 109.393 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 62.7 p -136.78 151.33 72.25 Favored Pre-proline 0 C--N 1.294 -1.847 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.799 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.43 -154.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.661 1.348 . . . . 0.0 109.734 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 47.66 26.47 0.86 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.642 -0.661 . . . . 0.0 110.915 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -74.44 60.49 0.86 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.216 -0.927 . . . . 0.0 110.125 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.675 ' N ' HG11 ' A' ' 632' ' ' VAL . . . 62.04 116.11 0.01 OUTLIER Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.767 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.2 mp -141.52 -151.87 0.38 Allowed 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.8 OUTLIER -121.56 124.6 44.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.083 -1.01 . . . . 0.0 111.186 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.656 ' CG ' HD21 ' A' ' 671' ' ' LEU . 3.2 t0 -114.11 149.0 36.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.383 -0.823 . . . . 0.0 109.7 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.677 HG23 ' HE2' ' A' ' 627' ' ' LYS . 5.4 pt -94.76 136.81 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.211 -0.93 . . . . 0.0 110.194 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.601 ' CH2' HD12 ' A' ' 671' ' ' LEU . 95.7 m95 -119.39 121.37 39.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.653 -0.654 . . . . 0.0 110.525 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.94 ' HB2' HD11 ' A' ' 672' ' ' LEU . 5.2 t80 -80.53 117.95 21.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.138 -0.977 . . . . 0.0 108.6 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 668' ' ' THR . 4.3 m -107.84 102.57 11.77 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.422 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.667 ' HE1' ' O ' ' A' ' 653' ' ' GLY . 28.5 t-80 -64.47 163.58 13.1 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.29 -0.881 . . . . 0.0 109.503 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.751 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -151.9 -28.78 0.17 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.667 ' O ' ' HE1' ' A' ' 651' ' ' HIS . . . -79.16 -169.27 36.94 Favored Glycine 0 N--CA 1.496 2.665 0 O-C-N 119.204 -2.185 . . . . 0.0 109.856 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 12.6 m -94.06 -18.62 21.64 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.178 -1.189 . . . . 0.0 113.9 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.53 ' O ' HG12 ' A' ' 656' ' ' VAL . 29.8 m120 -61.86 -4.26 1.48 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.625 -1.297 . . . . 0.0 111.896 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 78.21 169.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 121.919 0.866 . . . . 0.0 110.607 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.582 ' HB3' ' CD2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -125.35 149.44 48.11 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.436 -179.222 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.416 ' CZ ' ' HG3' ' A' ' 663' ' ' ARG . 2.9 m-85 -138.58 126.7 22.71 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.313 -0.867 . . . . 0.0 110.657 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.825 HD23 ' CE2' ' A' ' 670' ' ' PHE . 24.8 tp -125.67 107.63 10.76 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.359 -0.838 . . . . 0.0 109.914 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 27.2 t30 64.73 -68.09 0.11 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.648 -0.658 . . . . 0.0 110.412 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.8 OUTLIER -158.86 24.68 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 110.164 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.31 132.87 56.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -0.937 . . . . 0.0 110.425 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 658' ' ' TYR . 5.4 ttt180 -95.12 130.14 41.94 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.467 -0.77 . . . . 0.0 110.28 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.692 ' HG2' HG13 ' A' ' 716' ' ' VAL . 2.4 mtp -110.05 -164.58 0.94 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.409 -0.807 . . . . 0.0 110.056 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.605 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.8 pt -140.21 -163.24 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 110.213 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -77.5 93.64 4.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.333 -0.854 . . . . 0.0 110.653 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.42 53.58 0.87 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.605 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.0 OUTLIER -118.24 147.74 43.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.183 -1.186 . . . . 0.0 109.911 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.422 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 2.7 tttm -108.38 139.5 43.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.538 -0.726 . . . . 0.0 109.53 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.825 ' CE2' HD23 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -144.47 142.87 30.57 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.093 -179.226 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.656 HD21 ' CG ' ' A' ' 646' ' ' ASP . 0.4 OUTLIER -69.87 147.01 50.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.519 -0.738 . . . . 0.0 110.753 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.94 HD11 ' HB2' ' A' ' 649' ' ' TYR . 26.1 mt -118.08 131.33 56.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.356 -0.84 . . . . 0.0 111.277 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.464 ' NE2' ' HA3' ' A' ' 708' ' ' GLY . 19.9 mt-30 -113.19 143.17 44.84 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.726 ' OD1' HD12 ' A' ' 707' ' ' LEU . 3.7 p-10 -41.03 144.91 0.24 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.184 -0.947 . . . . 0.0 110.748 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.48 49.39 44.92 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.687 ' OD2' HD11 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -109.7 97.43 6.97 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.788 0.804 . . . . 0.0 110.616 -178.846 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.706 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.82 107.01 18.95 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.757 HG22 HD13 ' A' ' 659' ' ' LEU . 35.3 pt -108.38 136.84 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.48 -0.763 . . . . 0.0 111.56 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.73 110.29 22.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.514 -0.741 . . . . 0.0 109.253 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.739 HD13 ' SG ' ' A' ' 623' ' ' CYS . 70.8 mt -76.74 -26.41 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.335 -0.853 . . . . 0.0 110.191 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.751 HD11 HD12 ' A' ' 618' ' ' LEU . 4.4 mt -143.29 133.84 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 109.961 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -137.61 114.61 10.73 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.359 -0.838 . . . . 0.0 110.329 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' A' ' 686' ' ' ASN . 0.2 OUTLIER -127.51 118.33 23.79 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.318 -0.864 . . . . 0.0 110.028 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -65.94 -42.76 89.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.393 -0.817 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -83.73 -43.34 15.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.332 -0.855 . . . . 0.0 110.844 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 686' ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 683' ' ' ASP . 1.9 t-20 -80.31 -12.05 59.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.283 -0.886 . . . . 0.0 110.663 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 57.16 18.77 4.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.13 -0.981 . . . . 0.0 110.5 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.404 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -77.52 76.21 4.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.161 179.213 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 681' ' ' ILE . 60.5 t -101.86 137.23 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.458 -0.776 . . . . 0.0 110.941 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.705 HD11 ' OD2' ' A' ' 615' ' ' ASP . 49.0 mm -118.73 164.43 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -178.02 124.94 0.96 Allowed Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.496 -1.335 . . . . 0.0 110.196 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.706 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 13.4 m-85 -120.43 137.76 54.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.591 -0.946 . . . . 0.0 109.132 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.4 113.95 26.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.157 -0.964 . . . . 0.0 109.985 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 694' ' ' VAL . 1.1 t -83.06 118.16 30.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.481 -0.762 . . . . 0.0 109.151 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -128.8 104.6 7.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.65 -0.657 . . . . 0.0 110.097 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.562 ' CG1' HD12 ' A' ' 578' ' ' LEU . 69.1 mt -81.86 104.69 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.46 -0.775 . . . . 0.0 109.832 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.48 -42.52 35.5 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.439 -0.788 . . . . 0.0 108.875 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.5 ' O ' ' CD1' ' A' ' 577' ' ' PHE . 3.9 m-20 -110.84 141.49 44.14 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.463 0.649 . . . . 0.0 110.68 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 9.0 p -114.04 96.2 5.69 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.8 m -94.65 100.03 12.05 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.261 0.553 . . . . 0.0 111.735 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 45.9 34.48 5.64 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.867 HD23 ' O ' ' A' ' 704' ' ' ASN . 1.1 tp -84.47 150.22 25.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -1.12 . . . . 0.0 110.043 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.767 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.6 p90 -51.49 -24.44 5.11 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.314 -0.866 . . . . 0.0 110.038 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.867 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.6 t30 -175.03 153.26 1.6 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.456 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 12.4 pt-20 -51.21 -24.95 4.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.23 -0.919 . . . . 0.0 110.45 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 116.91 19.08 5.36 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.726 HD12 ' OD1' ' A' ' 674' ' ' ASP . 3.8 tp -88.14 9.63 22.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -1.199 . . . . 0.0 111.643 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.464 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 61.97 49.16 78.21 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.694 ' HG3' HD23 ' A' ' 710' ' ' LEU . 0.3 OUTLIER -51.65 176.75 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.383 -1.069 . . . . 0.0 111.021 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.694 HD23 ' HG3' ' A' ' 709' ' ' MET . 0.4 OUTLIER 40.66 -157.68 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.384 0.612 . . . . 0.0 111.863 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -92.88 74.88 4.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.584 -0.697 . . . . 0.0 109.726 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.87 148.13 48.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.574 -0.704 . . . . 0.0 110.424 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -111.61 96.9 6.36 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.514 -0.741 . . . . 0.0 109.005 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.708 ' NH1' HD21 ' A' ' 659' ' ' LEU . 0.7 OUTLIER -70.91 70.33 0.49 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.54 0.686 . . . . 0.0 110.094 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 34.2 m -106.57 153.07 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.65 -0.656 . . . . 0.0 109.69 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.692 HG13 ' HG2' ' A' ' 664' ' ' MET . 84.1 t -85.06 133.32 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.22 -0.925 . . . . 0.0 110.916 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.6 mt -105.39 162.38 13.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.555 -0.716 . . . . 0.0 109.6 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -101.24 153.53 19.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.167 -0.958 . . . . 0.0 110.292 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -85.35 151.03 24.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.347 -0.846 . . . . 0.0 110.263 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 19.0 p -121.33 -176.66 3.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.329 -0.857 . . . . 0.0 110.47 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.68 -29.81 40.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.45 -0.781 . . . . 0.0 110.119 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 722' ' ' GLU . . . . . 0.434 ' O ' HD13 ' A' ' 726' ' ' LEU . 3.6 tt0 -63.49 -52.29 61.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.673 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.38 -38.18 90.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.427 -0.795 . . . . 0.0 109.496 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.477 ' O ' HG12 ' A' ' 727' ' ' VAL . 11.8 tttt -57.76 -32.27 67.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.421 -0.799 . . . . 0.0 109.833 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.69 -40.33 80.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.259 -0.901 . . . . 0.0 110.409 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.633 HD23 ' HB3' ' A' ' 600' ' ' PRO . 11.0 mp -55.91 -47.02 78.22 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.223 -0.923 . . . . 0.0 110.843 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.873 HG23 HG11 ' A' ' 621' ' ' VAL . 7.2 p -69.23 -18.05 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.486 -0.759 . . . . 0.0 110.232 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.37 -43.96 68.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 108.854 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -116.96 104.32 11.16 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 122.254 1.026 . . . . 0.0 109.221 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.413 ' O ' ' CD2' ' A' ' 602' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--N 1.275 -2.664 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.402 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -82.9 -10.4 58.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -1.115 . . . . 0.0 110.503 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 596' ' ' GLN . . . 84.1 27.39 37.34 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -93.31 118.03 30.78 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.204 -1.174 . . . . 0.0 109.239 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.6 ' CD2' ' O ' ' A' ' 698' ' ' ASP . 0.7 OUTLIER -110.01 -41.0 4.58 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.831 0.824 . . . . 0.0 109.832 -179.1 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.69 ' CD2' HD12 ' A' ' 594' ' ' ILE . 17.4 tp -121.17 127.68 51.76 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.448 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 94.1 m -111.38 117.97 34.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 1.051 HD11 HD12 ' A' ' 625' ' ' ILE . 6.1 mt -90.71 112.25 23.94 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.424 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 1.2 mmtt -113.54 101.05 53.24 Favored Pre-proline 0 C--N 1.303 -1.442 0 C-N-CA 118.02 -1.472 . . . . 0.0 112.611 -178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 1.115 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.5 Cg_endo -78.79 145.44 20.12 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 N-CA-C 106.232 -2.257 . . . . 0.0 106.232 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.765 HD13 ' OD2' ' A' ' 585' ' ' ASP . 0.0 OUTLIER -123.54 -176.76 0.46 Allowed Pre-proline 0 N--CA 1.498 1.931 0 C-N-CA 118.251 -1.38 . . . . 0.0 114.094 -175.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.726 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.6 Cg_endo -67.84 -34.0 25.3 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.825 1.683 . . . . 0.0 111.953 -178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.765 ' OD2' HD13 ' A' ' 583' ' ' LEU . 1.8 p30 -58.31 -29.69 66.08 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.772 -1.205 . . . . 0.0 107.931 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.503 ' HB3' ' N ' ' A' ' 691' ' ' GLY . 4.3 p -96.25 150.66 20.3 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.585 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.1 OUTLIER -55.64 -17.79 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 0.0 109.467 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.765 HD12 ' HA ' ' A' ' 613' ' ' ILE . 9.1 mm -100.03 114.87 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 3.6 pm0 -126.01 74.59 1.44 Allowed 'General case' 0 N--CA 1.51 2.569 0 O-C-N 120.581 -1.325 . . . . 0.0 110.423 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 1.115 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.2 mt-10 -143.31 175.9 9.55 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.506 -0.77 . . . . 0.0 108.993 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.525 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.3 127.04 42.01 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.761 -1.212 . . . . 0.0 109.476 176.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 611' ' ' CYS . 67.2 mt -111.32 156.21 21.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.419 -0.801 . . . . 0.0 109.628 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -124.46 110.77 14.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 111.423 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.69 HD12 ' CD2' ' A' ' 578' ' ' LEU . 31.3 mt -81.01 109.04 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.534 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -66.89 118.17 10.0 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.533 -0.729 . . . . 0.0 111.955 -177.801 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.593 ' HA ' ' HB3' ' A' ' 577' ' ' PHE . 6.8 tp-100 13.32 61.99 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 95.61 50.75 1.94 Allowed Glycine 0 N--CA 1.487 2.04 0 C-N-CA 119.931 -1.128 . . . . 0.0 110.585 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.6 OUTLIER -79.49 105.09 8.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.01 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.4 OUTLIER -140.26 142.0 28.22 Favored Pre-proline 0 C--N 1.28 -2.417 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.79 -178.462 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.482 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.5 Cg_endo -88.91 159.12 39.19 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.564 -2.265 . . . . 0.0 109.001 -0.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.556 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 5.1 t80 -106.53 116.24 31.58 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.811 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 39.6 m-85 -91.43 146.01 24.16 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 110.757 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.743 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.7 mt -139.91 141.08 34.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.48 -0.763 . . . . 0.0 110.618 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.741 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 173.24 -164.88 36.86 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.51 -1.329 . . . . 0.0 111.186 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.431 ' HD2' ' HA ' ' A' ' 614' ' ' GLU . 8.5 mmm-85 -66.66 -41.0 88.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.892 -0.769 . . . . 0.0 110.866 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.411 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -83.12 132.04 35.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -0.848 . . . . 0.0 111.218 -178.801 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.542 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.7 OUTLIER -61.24 -13.04 15.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.413 -0.804 . . . . 0.0 109.858 178.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.45 -37.4 5.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.3 -0.875 . . . . 0.0 109.858 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.811 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 64.4 m -71.23 148.79 46.9 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.403 -0.811 . . . . 0.0 109.613 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.555 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -56.0 -16.68 5.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.482 -0.761 . . . . 0.0 110.655 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.743 ' SG ' HG23 ' A' ' 603' ' ' ILE . 10.5 t -115.67 143.34 45.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.439 -0.788 . . . . 0.0 109.542 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.542 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -112.82 121.28 44.22 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.169 -0.957 . . . . 0.0 112.689 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.765 ' HA ' HD12 ' A' ' 588' ' ' ILE . 18.5 mt -141.73 108.25 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.431 ' HA ' ' HD2' ' A' ' 605' ' ' ARG . 3.8 tm-20 -90.64 103.89 16.53 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.625 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.489 ' HB2' ' HB3' ' A' ' 618' ' ' LEU . 1.5 m-20 -138.25 105.78 5.57 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.675 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -39.55 -52.34 2.17 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.755 -0.59 . . . . 0.0 112.256 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -75.12 -16.49 60.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.09 -1.006 . . . . 0.0 111.364 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.906 HD13 HD11 ' A' ' 681' ' ' ILE . 0.8 OUTLIER -80.0 132.67 36.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.215 -0.928 . . . . 0.0 111.134 -178.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.518 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -74.77 162.39 28.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.489 -0.757 . . . . 0.0 110.812 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.741 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.3 OUTLIER -64.19 -46.06 85.59 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.288 -0.883 . . . . 0.0 109.389 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.687 ' HB ' HG23 ' A' ' 727' ' ' VAL . 16.2 m -94.6 2.25 9.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.216 -0.927 . . . . 0.0 109.179 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.754 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.4 t60 -28.66 -47.44 0.05 Allowed 'General case' 0 C--O 1.192 -1.953 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.051 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.698 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.6 OUTLIER -137.44 145.12 42.75 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.398 -1.321 . . . . 0.0 111.02 179.046 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 3.6 p90 -145.95 144.81 30.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.589 -0.694 . . . . 0.0 110.212 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 1.051 HD12 HD11 ' A' ' 580' ' ' LEU . 11.3 mt -103.5 118.05 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.45 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 7.7 t80 -111.55 154.62 24.52 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.774 0.797 . . . . 0.0 109.819 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.446 ' HB3' ' CB ' ' A' ' 599' ' ' ASN . 3.7 ttmt -120.07 136.67 54.5 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 121.464 0.65 . . . . 0.0 110.31 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.45 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.82 163.72 28.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.617 -0.677 . . . . 0.0 110.343 -179.487 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.8 tpt180 -77.72 115.28 17.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.516 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 3.0 t60 -58.13 124.35 19.07 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.497 -0.752 . . . . 0.0 110.574 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -115.67 81.48 1.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.42 0.629 . . . . 0.0 110.466 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.54 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.3 p -61.46 171.76 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.457 -0.777 . . . . 0.0 109.875 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.54 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -53.12 176.09 0.2 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -53.26 142.03 22.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.223 -1.163 . . . . 0.0 110.35 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.07 60.74 1.47 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.291 -0.881 . . . . 0.0 110.297 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 636' ' ' MET . . . . . 0.41 ' O ' ' CB ' ' A' ' 637' ' ' TYR . 0.1 OUTLIER -61.97 125.94 25.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.749 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 637' ' ' TYR . . . . . 0.41 ' CB ' ' O ' ' A' ' 636' ' ' MET . 1.7 t80 65.79 -147.3 0.21 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.438 -0.789 . . . . 0.0 110.008 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -115.51 102.91 10.23 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.239 -0.913 . . . . 0.0 109.197 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 92.6 p -125.53 151.4 70.26 Favored Pre-proline 0 C--N 1.291 -1.943 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.994 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.613 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 47.6 Cg_endo -69.55 -151.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.741 1.39 . . . . 0.0 109.908 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 68.53 -61.3 0.41 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.618 -0.676 . . . . 0.0 110.676 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 52.49 -158.09 0.14 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.128 -0.982 . . . . 0.0 109.851 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.679 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -117.31 129.35 8.29 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.844 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.3 mp -141.44 -150.84 0.33 Allowed 'General case' 0 C--N 1.294 -1.84 0 O-C-N 122.072 -0.663 . . . . 0.0 109.297 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.4 m-20 -114.95 124.34 51.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.965 -1.084 . . . . 0.0 111.115 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.739 ' OD2' HD21 ' A' ' 671' ' ' LEU . 14.7 t0 -107.08 156.12 19.11 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.537 -0.727 . . . . 0.0 109.82 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 13.8 pt -110.7 131.45 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.635 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.4 m95 -119.11 121.95 40.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.654 -0.654 . . . . 0.0 111.369 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.81 ' HB2' HD11 ' A' ' 672' ' ' LEU . 8.7 t80 -80.95 114.84 20.1 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 668' ' ' THR . 7.5 t -107.12 110.3 22.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.207 -0.933 . . . . 0.0 111.731 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.633 ' HE1' ' O ' ' A' ' 653' ' ' GLY . 39.6 t-80 -72.66 162.67 29.19 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.476 -0.765 . . . . 0.0 109.833 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.754 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -155.11 -30.84 0.1 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.458 -0.776 . . . . 0.0 112.205 -179.114 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.633 ' O ' ' HE1' ' A' ' 651' ' ' HIS . . . -79.08 -165.23 29.11 Favored Glycine 0 N--CA 1.496 2.665 0 C-N-CA 117.966 -2.064 . . . . 0.0 109.739 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 14.5 m -93.55 -18.9 21.73 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.007 -1.29 . . . . 0.0 114.012 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.711 ' O ' HG22 ' A' ' 656' ' ' VAL . 17.4 m120 -59.81 -2.56 0.4 Allowed 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.746 -1.221 . . . . 0.0 112.727 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.711 HG22 ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 63.36 146.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 121.57 0.7 . . . . 0.0 110.305 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.486 ' CB ' ' CD2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -98.27 141.99 30.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.69 -0.631 . . . . 0.0 110.605 -178.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.459 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 11.1 m-85 -129.75 126.17 37.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 110.364 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.603 HD11 HD21 ' A' ' 672' ' ' LEU . 0.1 OUTLIER -132.6 114.89 14.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.356 -0.84 . . . . 0.0 110.047 179.594 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 56.54 -84.69 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.434 -0.791 . . . . 0.0 110.475 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.6 m120 -143.52 20.3 1.86 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.058 -1.026 . . . . 0.0 110.353 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -111.2 118.48 36.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.283 -0.886 . . . . 0.0 110.239 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -86.67 139.81 30.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 110.184 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.585 ' HG2' HG13 ' A' ' 716' ' ' VAL . 4.5 mtp -117.27 -167.29 1.29 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.866 . . . . 0.0 110.124 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.638 HG13 HG23 ' A' ' 668' ' ' THR . 1.5 pt -137.24 -158.49 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.253 -0.905 . . . . 0.0 110.426 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 652' ' ' THR . 17.5 tt0 -83.11 90.2 7.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.336 -0.853 . . . . 0.0 110.547 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.12 52.53 0.6 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.638 HG23 HG13 ' A' ' 665' ' ' ILE . 0.2 OUTLIER -119.8 148.89 42.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.145 -1.209 . . . . 0.0 110.177 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.458 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 9.5 tttt -108.59 139.02 43.95 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.524 ' CD1' HG22 ' A' ' 716' ' ' VAL . 13.4 t80 -142.54 146.38 34.58 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.154 -0.966 . . . . 0.0 111.615 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.739 HD21 ' OD2' ' A' ' 646' ' ' ASP . 0.4 OUTLIER -73.33 146.82 44.97 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.59 -0.694 . . . . 0.0 110.502 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.81 HD11 ' HB2' ' A' ' 649' ' ' TYR . 12.1 mt -119.39 115.35 23.93 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.559 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.457 ' CA ' ' O ' ' A' ' 706' ' ' GLY . 60.1 mt-30 -87.39 -177.41 5.92 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.812 ' OD1' HD22 ' A' ' 707' ' ' LEU . 21.8 p-10 -78.31 142.97 37.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 109.432 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.93 46.71 43.16 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 107.678 -2.169 . . . . 0.0 107.678 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.51 ' OD1' HD21 ' A' ' 659' ' ' LEU . 1.4 t0 -101.15 91.51 4.57 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.817 -0.813 . . . . 0.0 110.396 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.806 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -93.09 106.91 18.8 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.571 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.556 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.3 pt -114.17 137.8 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.7 -0.625 . . . . 0.0 111.55 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -95.68 112.76 24.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.553 -0.717 . . . . 0.0 109.418 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.698 HD13 ' SG ' ' A' ' 623' ' ' CYS . 64.5 mt -76.14 -20.9 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.927 . . . . 0.0 110.438 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.906 HD11 HD13 ' A' ' 618' ' ' LEU . 8.8 mt -141.55 133.66 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.075 -1.016 . . . . 0.0 110.721 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -137.86 108.86 6.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.48 -0.762 . . . . 0.0 109.943 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.406 ' CB ' ' HB2' ' A' ' 686' ' ' ASN . 45.3 m-20 -125.66 118.38 25.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 110.088 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -65.87 -38.64 89.32 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.461 -0.774 . . . . 0.0 110.983 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -84.04 -43.54 15.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.272 -0.892 . . . . 0.0 111.076 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 686' ' ' ASN . . . . . 0.406 ' HB2' ' CB ' ' A' ' 683' ' ' ASP . 50.9 m-80 -81.81 -12.35 58.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.129 -0.982 . . . . 0.0 110.69 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.471 ' O ' HG23 ' A' ' 689' ' ' VAL . 2.8 tttp 56.25 20.43 4.56 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.145 -0.972 . . . . 0.0 110.439 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.88 85.37 2.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.144 -0.972 . . . . 0.0 109.347 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 586' ' ' SER . 2.9 t -101.73 135.91 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.442 -0.786 . . . . 0.0 110.656 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.585 ' CD1' HG22 ' A' ' 587' ' ' ILE . 40.5 mm -123.44 163.63 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.503 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . -174.76 124.67 1.03 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.525 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.806 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.9 m-85 -120.44 138.01 54.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.559 -0.965 . . . . 0.0 108.736 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.5 114.59 28.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 110.976 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -80.96 112.97 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -116.3 104.66 11.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.495 -0.753 . . . . 0.0 110.456 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.412 HD12 ' HB3' ' A' ' 674' ' ' ASP . 78.8 mt -84.11 103.81 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -0.828 . . . . 0.0 109.517 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -81.94 -42.27 19.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 108.889 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.6 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.2 m-20 -110.55 142.29 42.55 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.401 0.62 . . . . 0.0 110.145 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 35.6 p -115.97 95.92 5.34 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 2.7 m -131.92 139.24 48.67 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.351 -0.539 . . . . 0.0 110.282 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.15 28.79 34.83 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.81 ' O ' HD22 ' A' ' 644' ' ' LEU . 0.2 OUTLIER -107.89 131.29 54.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.587 -0.949 . . . . 0.0 110.563 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.844 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.0 p90 -52.25 -23.7 6.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.42 -0.8 . . . . 0.0 109.806 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.585 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.9 OUTLIER -163.13 163.41 25.72 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.021 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.566 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 16.0 pt-20 -51.15 -27.8 9.5 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.115 -0.991 . . . . 0.0 110.174 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 123.55 13.41 4.26 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.812 HD22 ' OD1' ' A' ' 674' ' ' ASP . 0.2 OUTLIER -87.19 8.19 25.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.762 -1.434 . . . . 0.0 111.188 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 707' ' ' LEU . . . 37.42 97.7 0.01 OUTLIER Glycine 0 N--CA 1.502 3.067 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.455 ' HE3' ' HB2' ' A' ' 704' ' ' ASN . 0.0 OUTLIER -142.19 43.01 1.66 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.131 -1.217 . . . . 0.0 110.41 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.46 ' H ' HD23 ' A' ' 710' ' ' LEU . 0.5 OUTLIER -92.78 -168.21 1.9 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.392 -0.818 . . . . 0.0 110.449 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -59.78 -56.56 20.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.41 -0.806 . . . . 0.0 110.511 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -63.61 144.24 57.17 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.324 -0.86 . . . . 0.0 110.061 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -111.6 95.75 5.69 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.35 -0.844 . . . . 0.0 109.525 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.422 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 2.8 mmm-85 43.43 77.03 0.07 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.335 0.588 . . . . 0.0 111.345 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 32.6 m -107.73 153.07 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.412 -0.805 . . . . 0.0 109.433 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.585 HG13 ' HG2' ' A' ' 664' ' ' MET . 59.8 t -95.1 133.25 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 110.648 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.5 mt -104.83 162.26 13.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.488 -0.757 . . . . 0.0 109.765 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.78 153.43 19.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 110.246 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.85 122.29 26.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.4 -0.813 . . . . 0.0 110.249 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 27.8 p -95.92 -176.53 3.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.432 -0.792 . . . . 0.0 110.162 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.55 -28.99 34.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.293 -0.88 . . . . 0.0 110.188 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -69.01 -46.57 67.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.373 -0.829 . . . . 0.0 109.983 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.75 -50.26 69.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.383 -0.823 . . . . 0.0 110.043 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.46 ' O ' HG12 ' A' ' 727' ' ' VAL . 4.2 ttpt -53.71 -32.7 52.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.36 -0.837 . . . . 0.0 109.909 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 725' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 728' ' ' LYS . 28.7 t70 -66.18 -35.86 81.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.497 -0.752 . . . . 0.0 110.129 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 37.5 mt -61.16 -46.32 90.99 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.277 -0.89 . . . . 0.0 110.083 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.687 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.7 p -74.72 -24.26 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.601 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 728' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 725' ' ' ASP . 0.6 OUTLIER -53.94 -46.06 71.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.116 -0.99 . . . . 0.0 108.902 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -116.83 104.0 10.88 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.219 1.009 . . . . 0.0 109.011 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.599 HD21 ' SG ' ' A' ' 609' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--N 1.274 -2.701 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.336 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -82.88 -10.1 58.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -1.104 . . . . 0.0 110.534 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 144.02 62.59 0.02 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.419 ' HD2' ' CG ' ' A' ' 593' ' ' GLU . 41.0 ttp180 -91.16 116.7 29.02 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.347 -1.09 . . . . 0.0 109.319 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -102.92 -42.57 5.79 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 122.044 0.926 . . . . 0.0 109.286 -179.287 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.061 HD22 HD12 ' A' ' 594' ' ' ILE . 9.7 tt -120.47 131.67 54.85 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.611 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.415 ' N ' HD23 ' A' ' 578' ' ' LEU . 32.6 m -109.18 118.27 36.29 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.961 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.618 HD11 HD11 ' A' ' 594' ' ' ILE . 13.2 mt -93.17 112.28 24.17 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.454 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.3 OUTLIER -114.99 103.6 54.6 Favored Pre-proline 0 C--N 1.302 -1.488 0 C-N-CA 118.326 -1.35 . . . . 0.0 113.387 -176.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 1.079 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 45.6 Cg_endo -78.58 140.66 16.99 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 N-CA-C 105.045 -2.713 . . . . 0.0 105.045 174.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.762 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -121.55 -175.05 0.33 Allowed Pre-proline 0 N--CA 1.496 1.863 0 C-N-CA 118.044 -1.462 . . . . 0.0 113.779 -176.118 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.762 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.4 Cg_endo -66.11 -33.75 39.6 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 O-C-N 124.198 1.631 . . . . 0.0 111.969 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.74 -29.48 66.76 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.709 -1.196 . . . . 0.0 107.856 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.638 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 27.1 p -96.39 153.28 17.91 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.57 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.4 OUTLIER -59.92 -15.73 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.184 -0.948 . . . . 0.0 109.127 178.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.778 HD12 ' HA ' ' A' ' 613' ' ' ILE . 7.8 mm -95.03 115.83 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.468 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -121.74 70.23 0.95 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.55 -1.344 . . . . 0.0 109.372 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 1.079 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 33.8 tt0 -144.34 174.08 11.22 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.698 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.517 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.87 127.53 40.39 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.937 -1.102 . . . . 0.0 109.365 176.454 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.774 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.1 mp -111.5 153.78 25.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.183 -0.948 . . . . 0.0 110.073 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.419 ' CG ' ' HD2' ' A' ' 576' ' ' ARG . 4.2 mp0 -125.74 112.46 16.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.537 -0.727 . . . . 0.0 111.185 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.061 HD12 HD22 ' A' ' 578' ' ' LEU . 69.6 mt -78.88 109.52 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.087 -1.008 . . . . 0.0 108.71 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.589 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -63.49 100.31 0.25 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.59 -0.694 . . . . 0.0 110.948 -178.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.589 ' C ' ' O ' ' A' ' 595' ' ' GLN . 0.8 OUTLIER -0.21 75.9 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 179.422 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 128.84 10.04 3.3 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.365 -1.397 . . . . 0.0 110.973 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.652 ' HB ' HG23 ' A' ' 594' ' ' ILE . 1.5 t -82.77 100.67 6.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 O-C-N 120.6 -1.529 . . . . 0.0 107.632 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.2 OUTLIER -144.61 135.88 12.58 Favored Pre-proline 0 C--N 1.282 -2.36 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.69 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.522 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 53.3 Cg_endo -90.42 164.46 32.58 Favored 'Cis proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.78 -1.758 . . . . 0.0 108.918 -1.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.543 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 3.3 t80 -103.27 115.93 31.49 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.616 ' CG ' HD23 ' A' ' 730' ' ' LEU . 44.9 m-85 -81.38 143.6 32.05 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 110.342 -178.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.888 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.6 mt -142.88 142.12 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.667 -0.646 . . . . 0.0 110.291 -178.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.76 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 169.16 -161.46 35.07 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.778 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.403 ' HD2' ' HA ' ' A' ' 614' ' ' GLU . 9.7 tpt180 -72.61 -35.43 67.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.677 -0.896 . . . . 0.0 111.006 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -83.0 123.69 29.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.846 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.523 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 7.5 tt0 -53.23 -19.26 2.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.328 -0.857 . . . . 0.0 110.052 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -45.1 -31.11 1.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.367 -0.833 . . . . 0.0 109.043 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.3 m -69.76 131.44 44.53 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.543 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 2.0 t-20 -44.96 -27.89 0.6 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.34 -0.85 . . . . 0.0 110.027 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.888 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.0 t -107.27 143.52 35.39 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.523 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -110.46 128.01 55.4 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 119.102 -1.039 . . . . 0.0 112.963 -178.404 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.778 ' HA ' HD12 ' A' ' 588' ' ' ILE . 19.8 mt -142.19 107.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 605' ' ' ARG . 0.1 OUTLIER -89.12 103.18 15.82 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.108 -1.437 . . . . 0.0 108.651 179.32 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.702 ' OD1' HD11 ' A' ' 690' ' ' ILE . 1.1 m-20 -139.55 106.06 5.32 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.602 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -41.13 -57.0 2.19 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.545 -0.722 . . . . 0.0 112.253 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 617' ' ' ARG . . . . . 0.404 ' HD2' ' CD1' ' A' ' 681' ' ' ILE . 7.5 ptp180 -72.57 -16.85 61.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.169 -0.957 . . . . 0.0 111.975 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.594 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.8 OUTLIER -76.23 122.22 24.05 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.025 -1.047 . . . . 0.0 110.71 -179.187 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -58.54 159.86 6.04 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.466 -0.772 . . . . 0.0 110.942 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.76 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 14.3 mtt-85 -64.27 -45.2 89.13 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.354 -0.841 . . . . 0.0 109.493 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.5 HG11 HG22 ' A' ' 727' ' ' VAL . 11.8 t -95.4 1.7 10.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 121.93 0.871 . . . . 0.0 109.338 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.736 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.8 t60 -27.43 -46.69 0.03 OUTLIER 'General case' 0 C--O 1.195 -1.808 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.594 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.788 ' SG ' HD13 ' A' ' 680' ' ' ILE . 1.0 OUTLIER -137.92 146.18 42.97 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 117.953 -1.499 . . . . 0.0 112.06 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 2.4 p90 -145.92 145.67 30.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.701 -0.624 . . . . 0.0 109.819 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.683 HG13 HD11 ' A' ' 603' ' ' ILE . 88.2 mt -103.56 117.56 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 10.1 t80 -110.28 154.2 23.78 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.429 -0.794 . . . . 0.0 109.874 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 13.5 ttmt -120.33 136.84 54.56 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.55 0.69 . . . . 0.0 110.373 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.459 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.1 OUTLIER -134.66 164.22 28.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.702 -0.624 . . . . 0.0 109.892 -179.489 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -77.1 121.25 23.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.059 -1.026 . . . . 0.0 108.871 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.52 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 6.0 t60 -58.55 124.5 19.85 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.707 0.765 . . . . 0.0 111.05 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -77.68 104.43 8.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.706 -0.621 . . . . 0.0 110.095 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.656 HG22 ' H ' ' A' ' 633' ' ' GLY . 1.6 p -103.95 -167.53 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.333 -0.855 . . . . 0.0 110.019 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.656 ' H ' HG22 ' A' ' 632' ' ' VAL . . . -97.38 174.3 29.52 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.07 144.0 57.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.375 -1.074 . . . . 0.0 110.145 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 85.6 p -116.83 87.77 2.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 110.219 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 9.3 mmt -93.2 40.67 1.07 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.337 -0.852 . . . . 0.0 109.979 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -171.74 -147.68 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.536 -0.728 . . . . 0.0 109.234 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -115.23 99.97 7.8 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.167 -0.958 . . . . 0.0 108.925 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 29.8 p -138.87 151.19 67.83 Favored Pre-proline 0 C--N 1.294 -1.817 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.596 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -72.19 -157.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.583 1.307 . . . . 0.0 109.513 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.56 ' O ' HG21 ' A' ' 632' ' ' VAL . . . 38.52 31.84 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.993 -0.442 . . . . 0.0 111.658 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -72.13 61.3 0.44 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.015 -1.053 . . . . 0.0 110.198 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.608 ' C ' HD12 ' A' ' 644' ' ' LEU . . . 62.33 118.29 0.01 OUTLIER Glycine 0 N--CA 1.487 2.068 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.84 HD22 ' O ' ' A' ' 702' ' ' LEU . 5.0 mp -141.89 -153.65 0.47 Allowed 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.9 m-20 -112.2 124.17 51.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.044 -1.035 . . . . 0.0 111.367 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.682 ' OD2' HD21 ' A' ' 671' ' ' LEU . 21.1 t0 -105.1 156.46 18.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.555 -0.715 . . . . 0.0 109.584 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.534 HD13 ' CD1' ' A' ' 578' ' ' LEU . 18.5 pt -110.11 129.95 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.233 -0.917 . . . . 0.0 110.32 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.651 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.0 m95 -118.86 120.34 37.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.75 -0.594 . . . . 0.0 110.968 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.685 ' HB2' HD11 ' A' ' 672' ' ' LEU . 8.0 t80 -80.61 114.44 19.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.963 . . . . 0.0 108.474 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.0 OUTLIER -105.25 107.4 18.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.342 -0.849 . . . . 0.0 111.322 -178.678 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.515 ' CE1' ' C ' ' A' ' 656' ' ' VAL . 17.8 t60 -68.44 159.87 30.8 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.429 -0.794 . . . . 0.0 109.961 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.736 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -149.86 -31.02 0.22 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.437 -0.79 . . . . 0.0 112.879 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.542 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.57 -165.13 27.42 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 117.741 -2.171 . . . . 0.0 109.61 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 15.1 m -98.66 -17.65 18.48 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.976 -1.308 . . . . 0.0 113.552 -176.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.539 ' O ' HG12 ' A' ' 656' ' ' VAL . 18.0 m120 -59.73 -4.43 0.68 Allowed 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.786 -1.196 . . . . 0.0 112.328 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 77.7 166.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-O 121.939 0.876 . . . . 0.0 110.247 -179.539 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.457 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -125.61 141.41 52.04 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.474 -179.035 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -127.91 125.72 40.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.932 . . . . 0.0 110.715 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.694 HD22 ' CG2' ' A' ' 678' ' ' ILE . 0.1 OUTLIER -114.67 106.23 13.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.224 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 659' ' ' LEU . 17.2 m120 56.35 -79.25 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.548 -0.72 . . . . 0.0 110.295 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.539 ' N ' ' O ' ' A' ' 659' ' ' LEU . 21.4 t-20 -140.19 20.28 2.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 0.0 110.548 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -110.68 137.06 48.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.165 -0.959 . . . . 0.0 110.437 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.425 ' O ' HG21 ' A' ' 716' ' ' VAL . 8.0 tmm_? -93.76 141.39 28.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.397 -0.814 . . . . 0.0 110.005 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.626 ' O ' HG22 ' A' ' 656' ' ' VAL . 90.6 mtp -126.07 -168.19 1.82 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.355 -0.84 . . . . 0.0 110.056 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.588 HG13 HG23 ' A' ' 668' ' ' THR . 4.1 pt -144.09 -160.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.159 -0.963 . . . . 0.0 110.953 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -76.07 111.09 11.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.745 . . . . 0.0 110.748 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 86.12 48.87 4.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -114.19 146.1 40.81 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.051 -1.264 . . . . 0.0 109.863 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.429 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 10.8 tttt -108.24 138.91 43.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.561 -0.712 . . . . 0.0 109.488 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.529 ' CD2' HG22 ' A' ' 716' ' ' VAL . 2.8 t80 -144.64 146.25 32.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 111.329 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.682 HD21 ' OD2' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -72.55 147.01 46.35 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.468 -0.77 . . . . 0.0 110.89 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.766 HD23 ' OD2' ' A' ' 676' ' ' ASP . 10.6 mt -118.07 101.43 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.396 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -84.81 157.19 21.04 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.456 ' HB3' HD12 ' A' ' 696' ' ' ILE . 21.0 p-10 -52.69 148.37 7.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.933 -1.104 . . . . 0.0 109.925 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 67.95 48.52 53.81 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.766 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.3 OUTLIER -108.55 92.43 4.05 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.846 -0.796 . . . . 0.0 110.602 -178.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.894 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.0 OUTLIER -93.85 107.2 19.11 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.449 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.694 ' CG2' HD22 ' A' ' 659' ' ' LEU . 24.7 pt -111.85 138.07 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.667 -0.646 . . . . 0.0 111.537 -177.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -100.37 111.75 24.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.517 -0.74 . . . . 0.0 109.647 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.788 HD13 ' SG ' ' A' ' 623' ' ' CYS . 65.8 mt -80.01 -29.3 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 0.0 110.249 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.55 HG22 HG12 ' A' ' 690' ' ' ILE . 0.4 OUTLIER -128.61 133.59 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.25 -0.906 . . . . 0.0 109.817 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -138.17 111.75 8.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.467 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.68 117.63 25.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.89 . . . . 0.0 109.667 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -46.98 75.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.326 -0.859 . . . . 0.0 110.834 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -84.89 -43.21 14.3 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 110.776 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -71.51 -9.15 57.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.249 -0.907 . . . . 0.0 110.706 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.34 22.3 6.2 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.105 -0.997 . . . . 0.0 110.344 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -87.65 104.17 16.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 109.873 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 586' ' ' SER . 13.7 m -126.72 140.77 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.397 -0.814 . . . . 0.0 110.829 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.702 HD11 ' OD1' ' A' ' 615' ' ' ASP . 38.8 mm -117.47 163.6 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.485 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -173.28 123.05 0.96 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.894 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 11.3 m-85 -120.19 137.41 54.2 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.566 -0.961 . . . . 0.0 109.145 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -102.07 113.87 27.5 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.156 -0.965 . . . . 0.0 110.156 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -84.67 119.3 33.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.036 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -130.06 104.67 7.47 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.372 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.49 HD13 ' O ' ' A' ' 705' ' ' GLU . 46.3 mt -79.17 103.86 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -0.885 . . . . 0.0 109.6 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.92 -43.07 46.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.363 -0.836 . . . . 0.0 108.805 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 1.2 m-20 -110.53 141.54 43.54 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.442 0.639 . . . . 0.0 110.135 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 21.4 p -114.22 95.94 5.54 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 50.2 m -131.66 133.78 45.26 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.378 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.74 25.86 30.7 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.84 ' O ' HD22 ' A' ' 644' ' ' LEU . 4.8 tp -105.55 134.75 48.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.389 -1.065 . . . . 0.0 110.438 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.835 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.9 p90 -52.69 -23.69 7.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.521 -0.737 . . . . 0.0 110.403 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.609 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.9 OUTLIER -169.73 158.41 7.51 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -178.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.563 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 15.7 pt-20 -51.5 -26.33 8.16 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.179 -0.951 . . . . 0.0 110.589 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 122.76 12.72 4.87 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.442 ' N ' HD21 ' A' ' 704' ' ' ASN . 0.2 OUTLIER -83.64 9.9 10.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.996 -1.296 . . . . 0.0 111.19 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.477 ' C ' HD23 ' A' ' 710' ' ' LEU . . . 101.19 -94.6 1.27 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.416 ' HE2' ' HB3' ' A' ' 709' ' ' MET . 15.3 ttp 54.64 80.76 0.12 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.347 -1.09 . . . . 0.0 110.646 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.477 HD23 ' C ' ' A' ' 708' ' ' GLY . 0.8 OUTLIER -169.47 155.95 6.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.325 -0.859 . . . . 0.0 110.279 179.578 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.45 -51.84 52.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.283 -0.885 . . . . 0.0 110.191 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -63.73 149.0 47.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.268 -0.895 . . . . 0.0 109.885 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -110.47 95.29 5.48 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.145 -0.972 . . . . 0.0 109.52 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.415 ' HD2' ' HA ' ' A' ' 714' ' ' ARG . 12.7 mmm-85 40.07 77.13 0.06 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.385 0.612 . . . . 0.0 111.629 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.4 m -107.7 152.58 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.563 -0.711 . . . . 0.0 109.418 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.529 HG22 ' CD2' ' A' ' 670' ' ' PHE . 44.1 t -92.94 121.15 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.576 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.8 mp -91.44 162.49 14.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.437 -0.789 . . . . 0.0 109.55 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -98.05 153.65 18.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.103 -0.998 . . . . 0.0 110.665 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 719' ' ' GLN . . . . . 0.4 ' HG2' ' HB2' ' A' ' 723' ' ' GLU . 0.2 OUTLIER -89.47 142.61 27.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.488 -0.757 . . . . 0.0 109.963 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 37.6 p -121.18 -178.36 3.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.317 -0.865 . . . . 0.0 110.575 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.4 -36.3 66.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.459 -0.776 . . . . 0.0 110.244 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 722' ' ' GLU . . . . . 0.539 ' O ' HD23 ' A' ' 726' ' ' LEU . 6.2 tt0 -57.54 -52.16 66.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.381 -0.825 . . . . 0.0 109.963 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.709 ' O ' HG12 ' A' ' 727' ' ' VAL . 74.5 mm-40 -63.54 -46.21 87.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.34 -0.85 . . . . 0.0 109.771 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.475 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 10.1 tttt -62.64 -31.94 72.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.39 -0.819 . . . . 0.0 110.775 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.56 -50.48 71.17 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -0.934 . . . . 0.0 112.051 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 722' ' ' GLU . 0.4 OUTLIER -72.35 -36.55 68.82 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.825 -1.172 . . . . 0.0 111.269 -178.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 723' ' ' GLU . 8.3 p -79.4 -18.25 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.868 -1.145 . . . . 0.0 110.416 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -43.21 66.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.176 -0.953 . . . . 0.0 108.814 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.45 103.27 10.28 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 122.211 1.005 . . . . 0.0 109.034 178.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.616 HD23 ' CG ' ' A' ' 602' ' ' PHE . 1.5 mt . . . . . 0 C--N 1.273 -2.727 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.231 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.424 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -83.21 -10.09 58.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.393 -1.063 . . . . 0.0 110.633 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . -172.92 53.82 0.16 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.423 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.5 ttm105 -92.67 113.94 26.35 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.412 -1.052 . . . . 0.0 109.603 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.592 ' CE1' HD21 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -97.08 -43.24 7.49 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.89 0.852 . . . . 0.0 109.124 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.778 HD23 HD12 ' A' ' 594' ' ' ILE . 7.7 tp -126.68 139.74 52.93 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.188 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 87.2 m -121.83 119.52 31.88 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 8.6 mt -95.56 112.38 24.11 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.511 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.1 OUTLIER -110.72 103.46 54.5 Favored Pre-proline 0 C--N 1.301 -1.538 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.732 -177.547 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 1.054 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.3 Cg_endo -76.22 140.99 22.76 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 N-CA-C 105.737 -2.447 . . . . 0.0 105.737 174.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.769 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -127.48 -173.14 0.29 Allowed Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 118.187 -1.405 . . . . 0.0 113.338 -176.164 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.769 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 37.9 Cg_endo -64.68 -36.34 42.06 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 124.263 1.665 . . . . 0.0 111.116 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -58.52 -28.87 65.84 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.621 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 47.9 t -96.47 152.76 18.3 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.715 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.8 OUTLIER -64.56 -11.61 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.904 -1.123 . . . . 0.0 109.205 178.89 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.729 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 7.9 mm -97.21 117.05 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.484 -0.76 . . . . 0.0 109.401 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.621 ' NE2' ' O ' ' A' ' 586' ' ' SER . 21.1 mp0 -117.55 68.65 0.76 Allowed 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.462 -1.398 . . . . 0.0 109.743 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 1.054 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 2.6 mm-40 -143.35 175.78 9.66 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.607 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.549 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.97 125.42 35.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.071 -1.018 . . . . 0.0 109.585 176.606 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.732 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.6 mm? -106.8 151.15 25.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 108.963 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.423 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.2 mp0 -124.77 110.27 14.12 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.555 -0.716 . . . . 0.0 110.872 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.778 HD12 HD23 ' A' ' 578' ' ' LEU . 4.8 mt -83.78 109.19 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.181 -0.949 . . . . 0.0 109.156 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.617 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.2 OUTLIER -64.97 137.14 57.55 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.735 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.467 ' CA ' ' HB3' ' A' ' 577' ' ' PHE . 2.4 pt20 -44.45 84.37 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.507 -0.746 . . . . 0.0 110.782 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 137.67 3.85 1.99 Allowed Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.647 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -79.97 101.97 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 120.745 -1.444 . . . . 0.0 107.27 178.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 627' ' ' LYS . 49.0 t-20 -145.47 133.33 10.49 Favored Pre-proline 0 C--N 1.282 -2.367 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.85 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.629 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 51.1 Cg_endo -93.29 163.79 22.61 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 123.258 -1.559 . . . . 0.0 109.127 -2.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.627 ' HB3' ' CG2' ' A' ' 625' ' ' ILE . 3.9 t80 -104.96 116.03 31.28 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.669 ' HB3' HD23 ' A' ' 730' ' ' LEU . 34.8 m-85 -85.42 144.86 27.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.373 -0.829 . . . . 0.0 110.256 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.84 HG23 ' HB3' ' A' ' 611' ' ' CYS . 4.5 mt -140.52 142.34 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.512 -0.742 . . . . 0.0 110.201 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.834 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 164.96 -163.53 36.48 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.368 -1.396 . . . . 0.0 111.306 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 8.6 tpt180 -62.87 -55.81 22.86 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.78 -0.836 . . . . 0.0 111.772 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.476 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -72.18 126.9 30.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 111.492 -178.283 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.467 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -51.64 -19.25 1.46 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.072 178.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 608' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 607' ' ' GLU . 27.1 t0 -42.27 -32.16 0.47 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.484 -0.76 . . . . 0.0 109.01 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.6 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.3 m -69.86 129.59 39.95 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.616 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.1 m120 -44.55 -28.12 0.55 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.217 -0.927 . . . . 0.0 109.973 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.84 ' HB3' HG23 ' A' ' 603' ' ' ILE . 3.8 t -105.21 143.57 33.2 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.467 ' HD2' ' CB ' ' A' ' 607' ' ' GLU . 1.1 ttpm? -106.53 128.35 54.04 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.059 -1.057 . . . . 0.0 113.467 -178.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.832 HD12 HG22 ' A' ' 603' ' ' ILE . 24.2 mt -143.29 107.71 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.459 ' H ' ' CD1' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -97.86 104.73 16.78 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.238 -1.385 . . . . 0.0 109.306 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.649 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.3 m-20 -138.3 106.42 5.73 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.173 177.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 616' ' ' ASN . . . . . 0.454 ' HA ' ' NH1' ' A' ' 605' ' ' ARG . 1.4 m120 -41.12 -41.56 1.79 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.669 -0.644 . . . . 0.0 111.932 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.61 -21.61 32.49 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.093 -1.004 . . . . 0.0 111.272 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.834 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.6 OUTLIER -73.84 131.96 42.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.191 -0.943 . . . . 0.0 110.702 -179.531 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.454 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -68.09 158.39 33.12 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.356 -0.84 . . . . 0.0 110.725 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.781 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 15.2 ttp180 -62.24 -45.24 94.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.225 -0.922 . . . . 0.0 109.211 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.504 HG22 HD21 ' A' ' 730' ' ' LEU . 4.4 t -95.28 2.08 9.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.75 0.786 . . . . 0.0 109.593 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.75 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.0 t60 -29.63 -42.91 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.854 -178.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.752 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.9 OUTLIER -137.19 144.8 43.06 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 117.789 -1.564 . . . . 0.0 111.429 179.114 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.651 ' CE2' ' HB3' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -147.57 126.58 12.83 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.62 -0.675 . . . . 0.0 109.533 178.222 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.627 ' CG2' ' HB3' ' A' ' 601' ' ' PHE . 2.4 tt -104.08 118.16 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.362 -0.836 . . . . 0.0 108.869 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.651 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 17.5 p90 -122.83 155.2 37.08 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.758 0.789 . . . . 0.0 110.715 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 5.3 ttmt -99.55 136.68 39.13 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.939 0.876 . . . . 0.0 110.891 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.7 OUTLIER -131.11 163.09 28.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.648 -0.658 . . . . 0.0 109.934 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 6.6 tpt180 -78.0 115.06 17.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.041 -1.037 . . . . 0.0 109.257 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 703' ' ' PHE . 6.6 t60 -58.52 124.68 20.43 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.528 0.68 . . . . 0.0 110.866 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -85.94 86.82 7.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.727 -0.608 . . . . 0.0 109.974 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.597 HG13 ' N ' ' A' ' 633' ' ' GLY . 0.6 OUTLIER -78.74 -164.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.409 -0.807 . . . . 0.0 110.161 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.597 ' N ' HG13 ' A' ' 632' ' ' VAL . . . -72.47 174.64 44.7 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.47 156.31 16.44 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.37 -1.076 . . . . 0.0 110.16 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 59.6 p -106.65 43.46 1.15 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.0 110.306 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.13 40.01 1.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.359 -0.838 . . . . 0.0 109.714 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -169.0 -150.71 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.597 -0.689 . . . . 0.0 109.515 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -115.55 101.6 9.02 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.204 -0.935 . . . . 0.0 109.022 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.26 151.29 71.3 Favored Pre-proline 0 C--N 1.294 -1.815 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.986 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.504 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 49.9 Cg_endo -71.84 -156.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.614 1.323 . . . . 0.0 109.891 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.543 ' O ' HD11 ' A' ' 644' ' ' LEU . . . 63.01 -60.76 0.14 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.839 -0.538 . . . . 0.0 110.979 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 642' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 640' ' ' PRO . 30.2 mt-30 54.87 28.74 10.88 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.914 -1.116 . . . . 0.0 109.571 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 63.12 120.75 0.01 OUTLIER Glycine 0 N--CA 1.485 1.941 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.543 HD11 ' O ' ' A' ' 641' ' ' ALA . 1.1 mp -133.86 -150.61 0.41 Allowed 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 628' ' ' LYS . 0.3 OUTLIER -120.85 123.85 43.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.126 -0.984 . . . . 0.0 110.813 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.603 ' OD2' HD11 ' A' ' 671' ' ' LEU . 10.3 t0 -101.93 132.2 47.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.417 -0.802 . . . . 0.0 109.211 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.519 HD13 HD22 ' A' ' 578' ' ' LEU . 6.4 pt -80.97 129.3 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.114 -0.992 . . . . 0.0 109.972 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.804 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 87.8 m95 -116.15 122.56 45.43 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.526 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.909 ' HB2' HD11 ' A' ' 672' ' ' LEU . 6.8 t80 -82.05 113.12 19.71 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.1 OUTLIER -107.41 102.87 12.12 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.284 -0.967 . . . . 0.0 111.127 -178.513 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.504 ' CE1' ' C ' ' A' ' 656' ' ' VAL . 11.1 t60 -61.71 154.93 24.04 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.408 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.75 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -146.14 -25.22 0.44 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.857 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.624 ' N ' ' HA ' ' A' ' 622' ' ' HIS . . . -77.94 -171.12 36.94 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 117.992 -2.052 . . . . 0.0 109.119 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 27.1 m -95.56 -16.52 22.08 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.013 -1.287 . . . . 0.0 113.285 -176.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.569 ' O ' HG12 ' A' ' 656' ' ' VAL . 3.0 t-20 -62.33 -4.47 1.84 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.007 -1.058 . . . . 0.0 112.596 -178.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 78.62 166.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 CA-C-O 121.987 0.898 . . . . 0.0 110.464 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.443 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -124.99 152.13 44.61 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.435 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -138.34 126.91 23.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.252 -0.905 . . . . 0.0 110.437 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.927 HD21 ' NH1' ' A' ' 714' ' ' ARG . 43.5 tp -128.5 114.16 16.42 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 110.027 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 41.9 t30 56.43 -80.93 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.615 -0.678 . . . . 0.0 110.349 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 659' ' ' LEU . 46.1 p-10 -142.52 11.62 1.9 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.042 -1.037 . . . . 0.0 110.767 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -105.5 133.5 50.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.98 -1.075 . . . . 0.0 110.798 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -93.11 142.14 27.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.48 -0.762 . . . . 0.0 109.802 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.61 ' O ' HG22 ' A' ' 656' ' ' VAL . 4.4 mtp -121.03 -166.88 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -0.954 . . . . 0.0 110.617 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.635 ' CG1' HG23 ' A' ' 668' ' ' THR . 2.7 pt -141.27 -164.26 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.443 -0.786 . . . . 0.0 110.19 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -78.32 86.73 4.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.34 -0.85 . . . . 0.0 110.62 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.74 52.61 0.43 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.635 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.2 OUTLIER -119.32 147.19 44.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.226 -1.161 . . . . 0.0 110.009 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.477 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 1.7 tttt -108.76 148.13 30.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.739 . . . . 0.0 109.361 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.811 ' CD1' HD23 ' A' ' 659' ' ' LEU . 1.2 t80 -145.72 147.44 31.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.139 -0.975 . . . . 0.0 111.901 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.804 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.48 132.82 47.64 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.405 -0.809 . . . . 0.0 109.647 179.19 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.909 HD11 ' HB2' ' A' ' 649' ' ' TYR . 2.7 mt -113.22 104.91 12.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.022 -1.049 . . . . 0.0 111.106 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.508 ' NE2' HD12 ' A' ' 671' ' ' LEU . 53.5 mm-40 -90.79 -177.1 4.88 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.541 ' OD1' HD22 ' A' ' 707' ' ' LEU . 13.8 p-10 -76.28 144.11 40.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.12 . . . . 0.0 109.761 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.41 48.35 45.32 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.24 99.4 7.19 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.808 -0.819 . . . . 0.0 109.995 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.914 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.85 113.4 25.42 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.862 HG12 HD13 ' A' ' 659' ' ' LEU . 1.5 mp -104.82 137.43 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.582 -0.699 . . . . 0.0 111.594 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -99.25 117.14 33.05 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.752 HD13 ' SG ' ' A' ' 623' ' ' CYS . 79.9 mt -87.7 -27.92 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.221 -0.924 . . . . 0.0 111.145 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.596 HG13 HD12 ' A' ' 618' ' ' LEU . 1.5 mt -143.23 133.43 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 0.0 111.078 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 14.0 t90 -138.2 109.0 6.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.629 -0.669 . . . . 0.0 109.568 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.15 117.92 28.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.085 -1.009 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -66.63 -29.8 69.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.418 -0.801 . . . . 0.0 110.775 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -43.32 76.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.34 -0.85 . . . . 0.0 110.924 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 686' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 688' ' ' PHE . 10.9 t-20 -139.37 34.61 2.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.242 -0.912 . . . . 0.0 110.072 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.49 ' O ' ' C ' ' A' ' 688' ' ' PHE . 0.0 OUTLIER 66.26 -67.02 0.16 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.705 -0.622 . . . . 0.0 109.703 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.2 OUTLIER 30.76 56.85 0.22 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.34 0.591 . . . . 0.0 111.11 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 687' ' ' LYS . 41.6 t -101.67 141.52 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.43 -0.794 . . . . 0.0 110.714 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.715 ' CD1' HG22 ' A' ' 587' ' ' ILE . 47.9 mm -118.21 163.94 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.49 -0.756 . . . . 0.0 109.207 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.446 ' N ' ' OG ' ' A' ' 586' ' ' SER . . . -177.26 126.92 1.14 Allowed Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.19 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.914 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 12.9 m-85 -120.14 137.87 53.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.668 -0.901 . . . . 0.0 108.776 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.99 114.3 26.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.11 -0.994 . . . . 0.0 110.387 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.527 HG13 HD11 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -85.37 120.31 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.523 -0.736 . . . . 0.0 109.37 179.56 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -126.59 114.6 18.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.672 -0.642 . . . . 0.0 110.209 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.542 HG12 HD12 ' A' ' 578' ' ' LEU . 88.5 mt -92.1 104.55 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.353 -0.842 . . . . 0.0 110.19 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.45 -43.73 18.46 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.486 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 4.2 m-20 -110.58 143.59 40.75 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.346 0.593 . . . . 0.0 109.929 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 39.7 p -112.51 95.71 5.59 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 11.1 p -135.01 133.15 39.13 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.844 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 62.67 28.85 72.21 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.592 HD21 ' CE1' ' A' ' 577' ' ' PHE . 0.3 OUTLIER -111.4 129.85 55.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.426 -1.043 . . . . 0.0 110.099 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.537 ' CZ ' ' CG ' ' A' ' 704' ' ' ASN . 10.5 p90 -49.09 -24.58 1.67 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.434 -0.791 . . . . 0.0 110.403 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.537 ' CG ' ' CZ ' ' A' ' 703' ' ' PHE . 35.5 p-10 -139.85 -157.71 0.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.817 0.818 . . . . 0.0 110.347 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.466 ' HG3' ' N ' ' A' ' 706' ' ' GLY . 16.7 pt-20 -84.01 -32.38 24.95 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.466 ' N ' ' HG3' ' A' ' 705' ' ' GLU . . . 127.92 15.06 2.41 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.541 HD22 ' OD1' ' A' ' 674' ' ' ASP . 0.2 OUTLIER -104.94 9.58 34.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.123 -1.222 . . . . 0.0 111.32 -179.548 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 65.29 89.0 0.05 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -103.97 96.87 6.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.406 -1.055 . . . . 0.0 110.18 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.421 HD12 ' HB2' ' A' ' 712' ' ' GLU . 0.5 OUTLIER -171.65 161.93 6.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.302 -0.873 . . . . 0.0 110.307 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -81.01 -30.16 35.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.397 -0.814 . . . . 0.0 110.179 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.421 ' HB2' HD12 ' A' ' 710' ' ' LEU . 1.5 mt-10 -63.6 149.18 46.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.314 -0.866 . . . . 0.0 109.688 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -110.49 95.48 5.59 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.225 -0.922 . . . . 0.0 109.806 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.927 ' NH1' HD21 ' A' ' 659' ' ' LEU . 9.7 mmm180 38.15 90.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.383 0.611 . . . . 0.0 111.778 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 34.2 m -107.94 159.72 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.457 -0.777 . . . . 0.0 109.528 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.726 HG22 ' CD2' ' A' ' 670' ' ' PHE . 47.6 t -104.24 133.47 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.116 -0.99 . . . . 0.0 110.856 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.57 162.99 13.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.551 -0.718 . . . . 0.0 109.655 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -103.82 143.32 32.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.196 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -85.98 154.37 21.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.354 -0.841 . . . . 0.0 110.385 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 15.9 p -115.95 -176.63 2.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 0.0 110.426 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.58 -32.41 50.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.422 -0.799 . . . . 0.0 110.296 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -60.66 -52.25 65.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.337 -0.852 . . . . 0.0 109.772 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.76 ' HA ' HD21 ' A' ' 726' ' ' LEU . 5.6 mt-10 -64.68 -37.98 89.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.499 -0.751 . . . . 0.0 109.755 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -32.38 73.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.333 -0.854 . . . . 0.0 110.58 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.46 -50.91 49.02 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.245 -0.909 . . . . 0.0 111.766 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.76 HD21 ' HA ' ' A' ' 723' ' ' GLU . 0.6 OUTLIER -62.22 -42.22 99.11 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.949 -1.094 . . . . 0.0 110.935 -179.207 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 723' ' ' GLU . 7.2 p -76.67 -17.04 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.877 -1.14 . . . . 0.0 110.349 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -53.67 -43.32 68.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.202 -0.936 . . . . 0.0 108.856 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -116.52 103.78 10.76 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.249 1.024 . . . . 0.0 109.021 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.669 HD23 ' HB3' ' A' ' 602' ' ' PHE . 1.3 mt . . . . . 0 C--N 1.273 -2.743 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.362 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -91.92 6.14 47.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -1.123 . . . . 0.0 110.718 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . -150.51 54.45 0.48 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -93.05 114.46 27.0 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.371 -1.076 . . . . 0.0 109.512 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.654 ' HE1' HD22 ' A' ' 702' ' ' LEU . 0.8 OUTLIER -91.35 -40.92 11.19 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.76 0.79 . . . . 0.0 109.216 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.84 HD21 HG22 ' A' ' 694' ' ' VAL . 3.5 tt -135.63 142.76 45.26 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.597 0.713 . . . . 0.0 111.561 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 95.6 m -118.53 123.65 45.6 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.991 HD11 HD12 ' A' ' 625' ' ' ILE . 9.6 mt -93.16 112.41 24.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.448 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 2.9 mmtt -113.77 102.34 54.71 Favored Pre-proline 0 C--N 1.302 -1.497 0 C-N-CA 118.223 -1.391 . . . . 0.0 112.835 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 1.072 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.5 Cg_endo -81.15 141.1 12.76 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 N-CA-C 105.808 -2.42 . . . . 0.0 105.808 174.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.773 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -120.29 -174.86 0.31 Allowed Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 118.128 -1.429 . . . . 0.0 113.512 -176.891 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.773 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 37.7 Cg_endo -63.86 -36.23 51.67 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 124.269 1.668 . . . . 0.0 111.657 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.63 -27.32 64.62 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.429 ' OG ' ' HA ' ' A' ' 690' ' ' ILE . 33.0 t -96.04 148.48 22.62 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.541 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.741 HG21 ' O ' ' A' ' 614' ' ' GLU . 0.8 OUTLIER -56.68 -18.71 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.991 -1.068 . . . . 0.0 109.178 178.814 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.937 ' CD1' HD12 ' A' ' 690' ' ' ILE . 4.1 mp -94.72 116.38 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.478 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -120.67 67.2 0.85 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.545 -1.347 . . . . 0.0 108.864 -179.493 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 1.072 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 15.5 tp10 -145.0 175.14 10.45 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.243 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.529 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.19 124.24 38.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.085 -1.009 . . . . 0.0 109.447 176.626 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.752 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.1 mt -103.04 155.72 18.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.455 -0.778 . . . . 0.0 109.173 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -125.25 110.3 13.88 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.393 -0.817 . . . . 0.0 111.177 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.803 HD12 HD22 ' A' ' 578' ' ' LEU . 26.4 mt -80.08 108.31 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.4 OUTLIER -68.0 116.73 8.97 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.437 -0.79 . . . . 0.0 111.106 -178.29 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.686 ' HG3' HG21 ' A' ' 700' ' ' THR . 0.1 OUTLIER 38.57 32.41 0.05 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.255 0.55 . . . . 0.0 111.188 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.414 ' HA2' ' CG2' ' A' ' 594' ' ' ILE . . . 83.73 63.7 1.67 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 598' ' ' VAL . 9.8 p -79.47 105.15 8.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 O-C-N 121.039 -1.271 . . . . 0.0 107.583 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.443 ' CB ' ' HB3' ' A' ' 627' ' ' LYS . 3.9 p-10 -121.79 151.13 57.07 Favored Pre-proline 0 C--N 1.279 -2.466 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.649 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.482 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.7 Cg_endo -86.24 156.8 54.58 Favored 'Cis proline' 0 C--N 1.307 -1.618 0 C-N-CA 120.933 -2.528 . . . . 0.0 109.475 0.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.508 ' CD2' ' HB2' ' A' ' 611' ' ' CYS . 4.8 t80 -105.66 115.39 30.16 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.54 ' HB3' ' SG ' ' A' ' 609' ' ' CYS . 50.2 m-85 -86.14 143.68 27.89 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.431 -178.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.926 HG23 ' HB3' ' A' ' 611' ' ' CYS . 4.1 mt -140.68 141.75 31.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.894 -0.504 . . . . 0.0 110.013 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.963 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 165.42 -162.3 35.66 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.361 -1.399 . . . . 0.0 111.13 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 5.9 mmm-85 -61.26 -58.48 8.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.89 -0.771 . . . . 0.0 111.804 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.03 124.27 22.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 111.251 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.538 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 11.8 pt-20 -54.16 -16.98 2.35 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.922 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -44.88 -36.44 3.31 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.37 -0.831 . . . . 0.0 109.074 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.54 ' SG ' ' HB3' ' A' ' 602' ' ' PHE . 1.3 m -59.63 136.63 58.05 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.491 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 1.8 t-20 -47.42 -26.77 1.43 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.209 -0.932 . . . . 0.0 109.414 179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.926 ' HB3' HG23 ' A' ' 603' ' ' ILE . 3.0 t -109.48 143.02 39.66 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.538 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -103.1 126.62 50.36 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.497 -0.881 . . . . 0.0 112.447 -178.559 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.792 HG22 HD22 ' A' ' 618' ' ' LEU . 5.3 mt -143.19 109.64 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.741 ' O ' HG21 ' A' ' 587' ' ' ILE . 2.1 tp10 -97.26 103.04 14.94 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 117.99 -1.484 . . . . 0.0 108.357 178.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.534 ' HB2' ' HB3' ' A' ' 618' ' ' LEU . 4.3 m-20 -137.7 105.73 5.69 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.417 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -42.36 -51.66 4.81 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.599 -0.688 . . . . 0.0 112.181 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -74.77 -16.7 60.71 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.182 -0.949 . . . . 0.0 111.602 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.963 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.5 OUTLIER -80.23 143.58 33.62 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.155 -0.965 . . . . 0.0 111.071 -179.062 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.454 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -79.85 162.88 24.79 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.414 -0.803 . . . . 0.0 110.681 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.788 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.4 mpt_? -64.32 -46.76 82.11 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.145 -0.972 . . . . 0.0 109.936 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.557 ' HB ' HG23 ' A' ' 727' ' ' VAL . 5.2 m -95.75 2.14 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.235 -0.916 . . . . 0.0 109.42 178.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.725 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.2 t60 -25.28 -47.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.409 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.786 ' SG ' HD13 ' A' ' 680' ' ' ILE . 1.0 OUTLIER -136.82 146.41 45.63 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 118.206 -1.397 . . . . 0.0 111.497 179.523 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.555 ' HA ' HG13 ' A' ' 603' ' ' ILE . 3.6 p90 -145.82 146.58 31.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.622 -0.674 . . . . 0.0 110.073 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.991 HD12 HD11 ' A' ' 580' ' ' LEU . 19.8 mt -103.55 117.46 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.443 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 10.9 t80 -111.78 154.61 24.8 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 109.956 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.443 ' HB3' ' CB ' ' A' ' 599' ' ' ASN . 2.8 ttmt -120.3 136.6 54.63 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 121.556 0.694 . . . . 0.0 110.434 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.443 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.53 164.81 26.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.648 -0.658 . . . . 0.0 109.949 -179.589 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.1 OUTLIER -77.12 115.01 16.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 109.03 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.527 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.8 t-160 -63.33 124.88 22.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.585 -0.697 . . . . 0.0 110.998 -179.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 631' ' ' ALA . . . . . 0.711 ' O ' HG12 ' A' ' 632' ' ' VAL . . . -79.58 122.67 26.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.646 -0.659 . . . . 0.0 109.793 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.711 HG12 ' O ' ' A' ' 631' ' ' ALA . 1.6 p 44.8 -168.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.677 -0.639 . . . . 0.0 111.084 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.677 ' H ' HG22 ' A' ' 632' ' ' VAL . . . 131.75 -144.53 16.2 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -142.27 -173.24 3.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.306 -1.114 . . . . 0.0 110.229 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -169.38 135.29 1.59 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.328 -0.857 . . . . 0.0 110.51 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 636' ' ' MET . . . . . 0.424 ' O ' ' O ' ' A' ' 637' ' ' TYR . 0.8 OUTLIER 51.0 -134.76 1.55 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.248 -0.907 . . . . 0.0 110.158 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 637' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 636' ' ' MET . 0.1 OUTLIER -59.09 -154.34 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.496 -0.752 . . . . 0.0 109.741 179.522 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -78.9 98.02 6.22 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.775 -1.203 . . . . 0.0 108.108 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 10.0 p -139.44 152.52 69.25 Favored Pre-proline 0 C--N 1.289 -2.063 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.98 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.86 -150.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.584 1.307 . . . . 0.0 109.198 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.449 ' HB3' ' N ' ' A' ' 633' ' ' GLY . . . -163.41 105.81 0.99 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 109.623 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 642' ' ' GLN . . . . . 0.424 ' O ' ' O ' ' A' ' 643' ' ' GLY . 32.6 tt0 -77.82 48.9 0.73 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.376 -0.827 . . . . 0.0 110.839 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.582 ' C ' HD12 ' A' ' 644' ' ' LEU . . . 59.94 128.64 0.01 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.721 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.0 mp -140.39 -150.99 0.34 Allowed 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.828 -0.807 . . . . 0.0 109.141 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.3 OUTLIER -118.0 124.26 47.74 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.975 -1.078 . . . . 0.0 111.412 -179.426 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.475 ' OD2' HD11 ' A' ' 671' ' ' LEU . 28.7 t0 -111.18 155.65 22.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.443 -0.786 . . . . 0.0 109.92 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 21.8 pt -108.81 128.79 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.21 -0.931 . . . . 0.0 109.748 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.842 ' CH2' HD22 ' A' ' 671' ' ' LEU . 95.6 m95 -115.48 119.95 37.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.678 -0.639 . . . . 0.0 111.595 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.541 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 11.5 t80 -83.31 114.13 21.19 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.0 OUTLIER -108.86 103.28 12.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.154 -0.966 . . . . 0.0 111.353 -178.677 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.53 ' CD2' ' N ' ' A' ' 652' ' ' THR . 8.9 t60 -63.04 156.75 23.87 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.513 -0.742 . . . . 0.0 109.895 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.725 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -148.19 -29.11 0.31 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.395 -0.816 . . . . 0.0 112.875 -179.206 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.539 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.85 -163.66 25.15 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 117.864 -2.112 . . . . 0.0 109.473 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 19.3 m -99.3 -17.84 17.86 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.02 -1.282 . . . . 0.0 113.709 -176.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.551 ' C ' HG23 ' A' ' 656' ' ' VAL . 8.7 m120 -59.16 -3.77 0.43 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 120.667 -1.27 . . . . 0.0 112.492 -178.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.551 HG23 ' C ' ' A' ' 655' ' ' ASN . 2.9 t 71.52 147.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.626 -0.671 . . . . 0.0 110.207 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -102.74 141.64 35.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.517 -0.739 . . . . 0.0 111.145 -178.773 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.433 ' CE1' ' HG2' ' A' ' 663' ' ' ARG . 95.3 m-85 -129.46 126.61 39.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.552 -0.718 . . . . 0.0 109.724 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.772 HD23 ' CE1' ' A' ' 670' ' ' PHE . 31.3 tp -130.85 111.83 12.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.222 -0.924 . . . . 0.0 110.107 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 56.31 -82.2 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.565 -0.709 . . . . 0.0 110.167 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 659' ' ' LEU . 10.5 m120 -141.89 17.77 2.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 110.131 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.431 ' HB3' ' CE2' ' A' ' 670' ' ' PHE . 0.8 OUTLIER -109.45 127.12 54.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.494 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.433 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 0.0 OUTLIER -93.22 141.15 28.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.417 -0.802 . . . . 0.0 109.794 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.709 ' HG2' HG13 ' A' ' 716' ' ' VAL . 3.0 mtp -122.79 -167.65 1.62 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.372 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.606 HG13 HG23 ' A' ' 668' ' ' THR . 3.0 pt -139.82 -160.96 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.399 -0.813 . . . . 0.0 110.239 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -79.76 95.51 6.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.283 -0.886 . . . . 0.0 110.668 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 104.31 51.6 0.92 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.624 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -118.18 145.36 45.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.103 -1.233 . . . . 0.0 109.993 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.77 141.62 39.05 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.772 ' CE1' HD23 ' A' ' 659' ' ' LEU . 3.7 t80 -145.36 148.21 33.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.106 -0.996 . . . . 0.0 112.299 -177.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.842 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.53 130.91 44.24 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.443 -0.786 . . . . 0.0 109.893 179.514 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.541 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 4.3 mt -107.44 105.01 14.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.907 -1.121 . . . . 0.0 111.226 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.453 ' O ' HG11 ' A' ' 694' ' ' VAL . 85.9 mt-30 -87.51 165.36 15.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.476 -0.765 . . . . 0.0 109.052 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.885 ' OD1' HD12 ' A' ' 707' ' ' LEU . 14.4 p-10 -62.74 157.42 21.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.127 -0.983 . . . . 0.0 109.923 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 675' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 59.88 51.52 58.46 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 107.765 -2.134 . . . . 0.0 107.765 -178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.512 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.5 OUTLIER -114.09 96.34 5.76 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.786 -0.832 . . . . 0.0 110.868 -178.644 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.913 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.6 tt0 -94.46 107.98 19.93 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.739 HG22 HD13 ' A' ' 659' ' ' LEU . 35.5 pt -107.59 138.38 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.598 -0.689 . . . . 0.0 112.331 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -100.06 112.79 25.09 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.786 HD13 ' SG ' ' A' ' 623' ' ' CYS . 56.8 mt -81.63 -33.81 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.26 -0.9 . . . . 0.0 111.504 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.68 HG22 ' CG1' ' A' ' 690' ' ' ILE . 14.1 tt -133.85 136.15 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.938 -1.101 . . . . 0.0 110.213 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -137.59 116.48 12.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.316 -0.865 . . . . 0.0 110.462 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -127.94 117.6 22.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.84 -30.19 70.3 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.466 -0.771 . . . . 0.0 111.015 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -55.65 -43.45 76.28 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.301 -0.874 . . . . 0.0 110.872 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 686' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 688' ' ' PHE . 5.3 m120 -136.62 32.35 2.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 110.002 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 688' ' ' PHE . 5.8 mttm 64.21 -67.0 0.11 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.915 -0.49 . . . . 0.0 110.09 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.494 ' N ' ' O ' ' A' ' 686' ' ' ASN . 0.1 OUTLIER 33.42 55.48 0.5 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.3 0.571 . . . . 0.0 110.965 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 687' ' ' LYS . 34.4 m -101.3 142.19 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.414 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.937 HD12 ' CD1' ' A' ' 588' ' ' ILE . 31.2 mm -117.83 164.2 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.473 -0.767 . . . . 0.0 109.333 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.43 ' N ' HG22 ' A' ' 690' ' ' ILE . . . -170.96 124.71 1.14 Allowed Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.058 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.913 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 14.3 m-85 -119.19 137.25 53.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.625 -0.926 . . . . 0.0 108.654 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -101.13 113.95 27.46 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 110.753 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.84 HG22 HD21 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -83.84 121.51 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.778 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -129.26 105.81 8.4 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.623 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.603 HG12 HD12 ' A' ' 578' ' ' LEU . 82.1 mt -85.73 105.95 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.449 -0.782 . . . . 0.0 109.614 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.28 -44.13 13.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.428 -0.795 . . . . 0.0 108.889 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -111.26 142.35 43.59 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.401 0.62 . . . . 0.0 110.229 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.0 p -114.19 96.15 5.65 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.686 HG21 ' HG3' ' A' ' 596' ' ' GLN . 7.2 t -86.26 95.96 9.79 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.334 0.588 . . . . 0.0 111.216 -178.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 47.43 36.77 11.69 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.884 HD23 ' O ' ' A' ' 704' ' ' ASN . 1.7 tp -84.41 149.96 25.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.392 -1.063 . . . . 0.0 110.336 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.721 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.5 p90 -53.5 -23.2 9.67 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.384 -0.823 . . . . 0.0 109.939 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.884 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.8 t30 -172.12 154.96 3.54 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.516 ' O ' HD13 ' A' ' 696' ' ' ILE . 16.9 pt-20 -50.98 -26.64 6.27 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.18 -0.95 . . . . 0.0 110.226 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 120.86 15.54 4.78 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.885 HD12 ' OD1' ' A' ' 674' ' ' ASP . 1.5 tp -83.34 9.61 10.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.099 -1.236 . . . . 0.0 111.385 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 106.31 -103.31 2.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.544 ' C ' HD23 ' A' ' 710' ' ' LEU . 8.1 ttp 53.7 91.17 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.442 -1.034 . . . . 0.0 110.546 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.564 ' N ' HD23 ' A' ' 710' ' ' LEU . 1.0 OUTLIER -174.02 154.51 2.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.27 -0.894 . . . . 0.0 110.199 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -59.35 -57.71 11.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.273 -0.892 . . . . 0.0 109.834 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -63.86 149.35 47.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.514 -0.741 . . . . 0.0 109.642 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.17 95.62 5.7 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.149 -0.969 . . . . 0.0 109.274 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.447 ' HA ' ' HD2' ' A' ' 714' ' ' ARG . 5.2 mmm-85 43.59 72.8 0.17 Allowed 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.368 0.604 . . . . 0.0 111.354 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.77 151.75 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.475 -0.765 . . . . 0.0 109.279 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.709 HG13 ' HG2' ' A' ' 664' ' ' MET . 61.6 t -92.3 118.58 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 110.512 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.3 mp -90.22 161.8 15.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.546 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.12 153.99 17.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -0.93 . . . . 0.0 110.244 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 719' ' ' GLN . . . . . 0.407 ' HG3' ' CB ' ' A' ' 723' ' ' GLU . 33.0 tt0 -79.93 145.8 32.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.472 -0.768 . . . . 0.0 110.181 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 20.3 p -121.13 -176.89 3.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.309 -0.87 . . . . 0.0 110.362 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.7 67.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.376 -0.827 . . . . 0.0 110.456 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.32 -52.46 64.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.352 -0.842 . . . . 0.0 110.001 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.407 ' CB ' ' HG3' ' A' ' 719' ' ' GLN . 2.4 mp0 -66.8 -42.47 85.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -0.873 . . . . 0.0 109.929 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.563 ' O ' HG12 ' A' ' 727' ' ' VAL . 12.2 ttmm -56.69 -32.83 65.84 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.319 -0.863 . . . . 0.0 109.756 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.8 -36.21 77.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.399 -0.813 . . . . 0.0 110.09 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 33.4 mt -58.18 -46.63 85.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.404 -0.81 . . . . 0.0 110.446 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 724' ' ' LYS . 7.9 p -69.88 -19.57 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.065 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -54.44 -48.49 71.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -0.894 . . . . 0.0 108.79 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.81 104.98 11.88 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 122.229 1.014 . . . . 0.0 108.923 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.275 -2.657 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.377 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.78 -10.15 59.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.4 -1.059 . . . . 0.0 110.401 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 167.21 65.62 0.03 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.77 129.59 38.64 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.385 -1.068 . . . . 0.0 109.253 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.519 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 3.7 t80 -123.56 -41.47 2.27 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 122.074 0.94 . . . . 0.0 109.215 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.643 HD23 HD12 ' A' ' 594' ' ' ILE . 22.1 tp -123.83 140.76 52.67 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.285 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.434 ' H ' HD12 ' A' ' 578' ' ' LEU . 88.1 m -123.51 116.98 24.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.705 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.661 HD11 ' CD1' ' A' ' 625' ' ' ILE . 1.9 mm? -90.37 111.74 23.08 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.426 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 2.5 mmtt -112.89 101.26 52.91 Favored Pre-proline 0 C--N 1.299 -1.594 0 C-N-CA 117.987 -1.485 . . . . 0.0 112.657 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 1.104 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.1 Cg_endo -80.87 140.72 12.95 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 N-CA-C 105.428 -2.566 . . . . 0.0 105.428 174.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.737 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -118.86 -176.95 0.41 Allowed Pre-proline 0 N--CA 1.495 1.793 0 C-N-CA 118.177 -1.409 . . . . 0.0 113.567 -176.232 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.737 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.3 Cg_endo -66.56 -31.3 41.63 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 O-C-N 124.342 1.706 . . . . 0.0 111.83 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -59.0 -29.89 67.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.798 -1.189 . . . . 0.0 108.124 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.599 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 54.4 p -96.44 153.29 17.91 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.914 -0.491 . . . . 0.0 109.724 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.644 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.1 OUTLIER -57.0 -18.95 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.16 -0.963 . . . . 0.0 109.101 178.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.873 HD12 ' HA ' ' A' ' 613' ' ' ILE . 10.0 mm -95.96 115.38 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.51 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -124.47 71.37 1.14 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 120.601 -1.312 . . . . 0.0 110.099 -178.527 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 1.104 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 18.9 mt-10 -145.12 174.97 10.6 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.579 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.526 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.79 127.23 41.57 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.841 -1.162 . . . . 0.0 109.393 176.483 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.837 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.2 mp -111.39 155.73 22.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 109.747 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -124.96 110.41 14.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.481 -0.762 . . . . 0.0 111.406 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.643 HD12 HD23 ' A' ' 578' ' ' LEU . 3.0 mt -80.85 110.49 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.525 ' HB2' HG23 ' A' ' 598' ' ' VAL . 2.0 mp0 -51.48 172.83 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.634 -0.666 . . . . 0.0 110.052 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.519 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 5.6 mt-30 -64.36 66.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.476 -0.765 . . . . 0.0 110.555 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 128.72 30.65 0.69 Allowed Glycine 0 N--CA 1.486 2.01 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.806 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -81.34 102.81 7.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.486 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 11.8 t-20 -143.3 134.54 12.66 Favored Pre-proline 0 C--N 1.284 -2.265 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.89 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.646 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 55.9 Cg_endo -91.48 162.52 28.47 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.958 -1.684 . . . . 0.0 109.192 -1.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.547 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 3.8 t80 -106.25 116.35 31.79 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.646 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 73.0 m-85 -86.47 144.08 27.44 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.269 -0.894 . . . . 0.0 110.538 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.913 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.0 mt -141.64 141.46 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.73 -0.606 . . . . 0.0 110.148 -178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.838 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 163.94 -163.09 35.67 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.45 -1.357 . . . . 0.0 111.12 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.466 ' N ' HD23 ' A' ' 618' ' ' LEU . 1.1 mmm-85 -62.46 -53.11 59.73 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.832 -0.805 . . . . 0.0 111.491 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 3.1 p -68.22 121.14 15.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 111.04 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.533 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.6 mt-10 -54.2 -17.4 2.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.641 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -47.36 -30.23 3.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.426 -0.796 . . . . 0.0 109.032 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 602' ' ' PHE . 1.6 m -65.88 130.48 43.42 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.547 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 1.9 t-20 -43.97 -29.57 0.6 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.381 -0.824 . . . . 0.0 109.524 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.913 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.3 t -106.01 143.37 34.24 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.533 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -108.52 128.59 54.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.079 -1.013 . . . . 0.0 113.093 -178.144 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.873 ' HA ' HD12 ' A' ' 588' ' ' ILE . 8.8 mt -142.21 108.87 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -98.33 104.07 16.08 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.221 -1.392 . . . . 0.0 109.517 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.829 ' OD2' HD11 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -138.78 106.69 5.67 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.165 177.181 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -39.25 -43.79 1.17 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.65 -0.656 . . . . 0.0 112.123 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.01 -17.71 39.53 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.118 -0.988 . . . . 0.0 111.847 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.838 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.6 OUTLIER -75.47 131.37 40.09 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.103 -0.998 . . . . 0.0 110.882 -179.15 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 622' ' ' HIS . 10.0 t -65.34 159.08 24.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.335 -0.853 . . . . 0.0 110.837 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.766 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.9 mpp_? -64.76 -45.3 86.99 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.181 -0.949 . . . . 0.0 109.518 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 1.064 HG11 HG23 ' A' ' 727' ' ' VAL . 17.3 t -95.35 2.06 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 121.739 0.78 . . . . 0.0 109.721 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.734 ' O ' ' N ' ' A' ' 652' ' ' THR . 6.1 t60 -24.55 -46.82 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.542 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.824 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -138.19 146.1 42.29 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 118.283 -1.367 . . . . 0.0 112.038 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 1.9 p90 -146.13 144.25 29.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.454 -0.779 . . . . 0.0 109.981 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.661 ' CD1' HD11 ' A' ' 580' ' ' LEU . 26.8 mt -102.66 123.1 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.434 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 2.3 t80 -118.26 154.33 32.44 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.351 -0.843 . . . . 0.0 109.516 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 9.0 tttt -120.46 136.27 54.8 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.657 0.741 . . . . 0.0 110.786 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -126.35 163.66 22.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.715 -0.615 . . . . 0.0 109.676 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.474 ' C ' ' CD ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -78.67 123.1 26.79 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.157 -0.964 . . . . 0.0 108.894 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.3 t-160 -75.21 122.93 24.4 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.331 -0.856 . . . . 0.0 110.538 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -130.64 75.1 1.63 Allowed 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.512 0.672 . . . . 0.0 109.883 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.773 HG12 ' HA ' ' A' ' 642' ' ' GLN . 5.6 p -57.72 169.09 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.565 -0.71 . . . . 0.0 110.474 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.537 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -121.49 -159.46 10.7 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 24.6 tttt 52.28 64.62 1.78 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.24 -1.153 . . . . 0.0 110.362 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 89.4 p -129.67 108.94 10.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.312 -0.867 . . . . 0.0 110.43 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 9.3 mmt -105.85 37.67 2.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.346 -0.846 . . . . 0.0 109.926 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -171.67 -152.78 0.08 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.504 -0.747 . . . . 0.0 110.002 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -116.37 102.75 9.8 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.291 -0.881 . . . . 0.0 108.913 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 78.3 p -136.47 151.73 73.52 Favored Pre-proline 0 C--N 1.293 -1.863 0 O-C-N 121.881 -0.512 . . . . 0.0 110.139 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.6 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 46.1 Cg_endo -68.94 -151.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.756 1.398 . . . . 0.0 109.651 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 67.13 -61.05 0.35 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.607 -0.683 . . . . 0.0 110.553 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 642' ' ' GLN . . . . . 0.773 ' HA ' HG12 ' A' ' 632' ' ' VAL . 44.0 tt0 -62.83 83.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.368 -0.833 . . . . 0.0 110.548 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 133.03 5.94 2.94 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.958 -1.115 . . . . 0.0 111.046 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.602 ' HG ' ' HA ' ' A' ' 703' ' ' PHE . 3.4 mm? -82.17 -153.88 0.12 Allowed 'General case' 0 C--N 1.282 -2.363 0 O-C-N 121.948 -0.736 . . . . 0.0 109.792 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.9 m-20 -130.41 133.24 46.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.906 -1.122 . . . . 0.0 111.148 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.471 ' CG ' ' HE1' ' A' ' 648' ' ' TRP . 3.2 p30 -115.59 152.73 32.53 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.404 -0.81 . . . . 0.0 110.954 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 6.2 pt -111.2 130.89 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.264 -0.897 . . . . 0.0 109.868 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.62 ' CH2' HD12 ' A' ' 671' ' ' LEU . 94.2 m95 -119.04 140.06 50.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.611 -0.681 . . . . 0.0 110.89 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.949 ' CB ' HD11 ' A' ' 672' ' ' LEU . 4.3 t80 -97.97 114.34 26.43 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 24.8 t -104.22 102.32 12.03 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.23 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.744 ' CE1' ' O ' ' A' ' 653' ' ' GLY . 11.1 t-80 -67.59 164.68 18.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.443 -0.786 . . . . 0.0 109.543 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.734 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -155.28 -31.31 0.1 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.213 -0.93 . . . . 0.0 113.257 -178.83 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.744 ' O ' ' CE1' ' A' ' 651' ' ' HIS . . . -79.25 132.88 11.83 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 117.937 -2.077 . . . . 0.0 110.427 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.404 ' C ' ' H ' ' A' ' 656' ' ' VAL . 23.8 m -37.71 -24.46 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -177.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.533 ' O ' HG12 ' A' ' 656' ' ' VAL . 7.9 m120 -57.7 -4.72 0.3 Allowed 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.266 -1.521 . . . . 0.0 112.407 -178.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 76.77 168.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 CA-C-O 121.83 0.824 . . . . 0.0 110.256 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.698 ' HB3' ' CD2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -127.5 154.76 44.73 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.601 -179.01 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -137.92 126.36 23.37 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.163 -0.96 . . . . 0.0 110.83 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.789 HD23 ' CD2' ' A' ' 670' ' ' PHE . 22.2 tp -122.05 107.32 12.07 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.391 -0.818 . . . . 0.0 109.84 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.3 t30 63.2 -73.45 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.545 -0.722 . . . . 0.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 659' ' ' LEU . 37.1 m-20 -153.9 22.51 0.51 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.348 -0.845 . . . . 0.0 110.389 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.38 116.86 28.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.149 -0.969 . . . . 0.0 110.37 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -80.54 139.67 36.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.421 -0.8 . . . . 0.0 109.908 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.561 ' O ' HG22 ' A' ' 656' ' ' VAL . 37.7 mtp -118.2 -161.74 0.85 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.869 . . . . 0.0 110.094 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.538 ' CG1' HG23 ' A' ' 668' ' ' THR . 3.7 pt -133.02 -160.87 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 109.725 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -81.39 117.33 21.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.343 -0.848 . . . . 0.0 110.26 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 82.49 50.73 4.63 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.538 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.0 OUTLIER -115.27 146.34 41.58 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.109 -1.23 . . . . 0.0 110.111 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.442 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 2.7 ttpt -108.77 141.99 39.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.524 -0.735 . . . . 0.0 109.853 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.789 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -144.61 141.0 29.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 110.898 -179.067 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.62 HD12 ' CH2' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -70.05 146.35 51.05 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.285 -0.885 . . . . 0.0 110.682 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.949 HD11 ' CB ' ' A' ' 649' ' ' TYR . 3.9 mp -111.45 149.05 31.83 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.924 0.868 . . . . 0.0 111.632 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.669 ' HB3' HD12 ' A' ' 707' ' ' LEU . 15.3 mt-30 -127.0 136.59 52.45 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.805 ' OD2' HD13 ' A' ' 707' ' ' LEU . 0.0 OUTLIER -37.93 129.22 1.21 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.967 -1.083 . . . . 0.0 110.276 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 83.88 44.05 6.93 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.403 ' HB3' ' HB ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -100.97 90.48 4.19 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.948 -0.737 . . . . 0.0 110.463 -179.09 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.821 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.8 tt0 -94.21 107.74 19.65 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.653 HG22 ' HA ' ' A' ' 659' ' ' LEU . 41.5 pt -113.06 138.5 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.49 -0.757 . . . . 0.0 111.829 -178.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 15.9 mttp -94.47 110.53 22.32 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.824 HD13 ' SG ' ' A' ' 623' ' ' CYS . 69.9 mt -73.88 -30.95 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.348 -0.845 . . . . 0.0 110.801 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.693 ' CD1' HD12 ' A' ' 618' ' ' LEU . 6.0 mt -143.0 137.38 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.018 -1.051 . . . . 0.0 110.876 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 6.6 t90 -137.93 108.98 6.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.559 -0.713 . . . . 0.0 109.795 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 683' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 688' ' ' PHE . 1.2 t70 -114.34 118.12 32.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.096 -1.003 . . . . 0.0 110.598 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -66.52 -30.01 70.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.495 -0.753 . . . . 0.0 110.806 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -55.88 -43.71 77.44 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.397 -0.815 . . . . 0.0 111.078 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 686' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 688' ' ' PHE . 2.1 m-20 -141.26 34.96 1.69 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.92 . . . . 0.0 110.066 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.477 ' O ' ' C ' ' A' ' 688' ' ' PHE . 0.2 OUTLIER 66.54 -67.71 0.15 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.737 -0.602 . . . . 0.0 110.003 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.477 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.5 OUTLIER 33.69 59.92 0.52 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.684 -0.635 . . . . 0.0 110.7 179.718 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 586' ' ' SER . 34.2 m -102.06 142.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 111.352 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.829 HD11 ' OD2' ' A' ' 615' ' ' ASP . 43.1 mm -113.43 163.56 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -173.31 118.71 0.72 Allowed Glycine 0 N--CA 1.491 2.314 0 C-N-CA 118.948 -1.596 . . . . 0.0 110.618 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.87 ' CZ ' HG21 ' A' ' 588' ' ' ILE . 13.7 m-85 -120.5 138.02 54.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.613 -0.934 . . . . 0.0 108.784 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -108.64 114.52 28.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 0.0 110.763 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.523 HG22 HD11 ' A' ' 578' ' ' LEU . 1.2 t -76.52 119.68 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.382 -0.824 . . . . 0.0 108.924 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.71 104.61 7.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.672 -0.642 . . . . 0.0 110.023 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.484 ' CD1' ' HA3' ' A' ' 706' ' ' GLY . 62.5 mt -86.68 107.7 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 109.714 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -78.3 -41.14 34.69 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.405 -0.81 . . . . 0.0 109.077 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.438 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.3 m-20 -110.81 140.86 44.87 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.579 0.704 . . . . 0.0 110.682 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 14.5 p -115.16 96.0 5.47 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 22.2 m -113.58 129.64 56.52 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.853 -0.53 . . . . 0.0 110.797 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.513 ' C ' HD12 ' A' ' 644' ' ' LEU . . . 50.76 37.9 35.73 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 704' ' ' ASN . 5.0 tp -109.94 125.43 52.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.461 -1.023 . . . . 0.0 110.653 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.602 ' HA ' ' HG ' ' A' ' 644' ' ' LEU . 10.8 p90 -50.55 -27.4 6.63 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.901 0.858 . . . . 0.0 109.566 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 703' ' ' PHE . 6.6 t30 -148.25 170.33 18.12 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.456 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 12.8 pt-20 -52.73 -25.46 11.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 109.637 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 116.66 16.16 6.56 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.805 HD13 ' OD2' ' A' ' 674' ' ' ASP . 45.8 tp -103.37 10.55 37.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.56 -0.965 . . . . 0.0 110.955 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.533 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 53.41 98.17 0.01 OUTLIER Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.439 ' HG3' ' ND2' ' A' ' 704' ' ' ASN . 0.0 OUTLIER -139.38 36.2 2.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.409 -1.054 . . . . 0.0 110.419 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.7 HD11 ' OE2' ' A' ' 712' ' ' GLU . 0.5 OUTLIER -109.5 51.32 0.75 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.333 -0.854 . . . . 0.0 110.334 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 51.36 45.82 27.39 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.313 -0.867 . . . . 0.0 110.26 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.7 ' OE2' HD11 ' A' ' 710' ' ' LEU . 1.6 tt0 -102.97 148.65 25.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.426 -0.796 . . . . 0.0 110.452 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 713' ' ' GLN . . . . . 0.89 ' O ' HG13 ' A' ' 715' ' ' VAL . 0.3 OUTLIER -110.82 97.46 6.86 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.223 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.595 ' NH1' HD21 ' A' ' 659' ' ' LEU . 6.0 mmm-85 -29.58 79.47 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.849 0.833 . . . . 0.0 112.254 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.89 HG13 ' O ' ' A' ' 713' ' ' GLN . 11.2 m -106.96 151.76 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.486 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 60.4 t -86.2 133.15 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.85 . . . . 0.0 110.939 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.0 mt -103.65 162.15 13.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.54 -0.725 . . . . 0.0 109.552 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.01 154.15 18.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 110.259 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -79.94 134.19 36.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 0.0 110.168 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 63.1 p -106.18 -176.3 3.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.413 -0.804 . . . . 0.0 110.3 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.26 -28.86 29.78 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.282 -0.886 . . . . 0.0 110.018 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -65.93 -47.92 73.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.416 -0.802 . . . . 0.0 109.785 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -63.93 -47.86 78.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.417 -0.802 . . . . 0.0 109.956 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.48 ' O ' HG12 ' A' ' 727' ' ' VAL . 12.0 tttm -52.42 -33.71 45.1 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.422 -0.799 . . . . 0.0 109.85 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -69.16 -36.12 77.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.471 -0.768 . . . . 0.0 110.251 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 56.2 mt -56.25 -47.53 78.34 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.312 -0.867 . . . . 0.0 110.619 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 1.064 HG23 HG11 ' A' ' 621' ' ' VAL . 6.3 p -69.67 -17.67 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.154 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -54.27 -45.82 72.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 0.0 108.836 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.1 104.76 11.55 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.225 1.012 . . . . 0.0 109.209 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.414 ' OXT' ' CD2' ' A' ' 602' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.274 -2.714 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.365 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -82.9 0.34 44.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -1.123 . . . . 0.0 110.676 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . -110.15 40.0 2.7 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.418 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 2.6 ttm180 -92.61 114.0 26.44 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.377 -1.072 . . . . 0.0 109.686 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.512 ' HB3' ' CA ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -93.32 -44.09 8.47 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.809 0.814 . . . . 0.0 109.116 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.612 HD22 HD12 ' A' ' 594' ' ' ILE . 9.9 tt -125.48 142.2 51.63 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.275 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 579' ' ' THR . . . . . 0.421 ' N ' HD23 ' A' ' 578' ' ' LEU . 87.0 m -122.38 121.97 37.93 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.583 HD11 ' CD1' ' A' ' 625' ' ' ILE . 14.1 mt -95.15 112.5 24.2 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.49 103.66 55.57 Favored Pre-proline 0 C--N 1.302 -1.485 0 C-N-CA 118.464 -1.294 . . . . 0.0 113.21 -177.272 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 1.046 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 44.1 Cg_endo -78.5 137.24 14.54 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 N-CA-C 105.274 -2.625 . . . . 0.0 105.274 174.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.809 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -125.88 -171.9 0.24 Allowed Pre-proline 0 C--N 1.295 -1.786 0 C-N-CA 118.138 -1.425 . . . . 0.0 113.405 -176.104 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.809 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 36.7 Cg_endo -61.67 -35.4 80.57 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 124.129 1.594 . . . . 0.0 111.951 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.55 ' O ' HG23 ' A' ' 689' ' ' VAL . 45.3 m-20 -58.69 -29.75 66.86 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.494 ' OG ' ' HA ' ' A' ' 690' ' ' ILE . 24.6 t -96.54 148.09 23.18 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.563 ' CD1' HD11 ' A' ' 690' ' ' ILE . 1.4 pt -62.96 -18.21 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.244 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.711 HG13 HG12 ' A' ' 613' ' ' ILE . 4.3 mm -83.27 116.2 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.483 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -119.76 69.52 0.84 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.432 -1.417 . . . . 0.0 109.348 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 1.046 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 24.8 tt0 -144.61 174.35 11.04 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.637 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.526 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.2 125.01 36.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.971 -1.08 . . . . 0.0 109.011 176.342 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.778 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.1 mt -105.98 155.04 19.76 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.31 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.418 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.6 OUTLIER -125.48 110.54 14.02 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.478 -0.764 . . . . 0.0 111.287 -179.016 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.612 HD12 HD22 ' A' ' 578' ' ' LEU . 3.2 mt -84.16 109.27 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.157 -0.965 . . . . 0.0 109.007 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 597' ' ' GLY . 3.4 tp60 -64.74 140.41 58.86 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.512 ' CA ' ' HB3' ' A' ' 577' ' ' PHE . 12.0 pt20 -46.56 85.47 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.486 -0.759 . . . . 0.0 110.783 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 135.44 5.21 2.35 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.722 -1.227 . . . . 0.0 110.483 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -80.21 101.66 5.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 O-C-N 120.788 -1.419 . . . . 0.0 107.421 178.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 627' ' ' LYS . 21.6 t-20 -145.42 132.52 10.1 Favored Pre-proline 0 C--N 1.282 -2.352 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.065 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.542 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 50.8 Cg_endo -92.87 164.13 23.88 Favored 'Cis proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.38 -1.508 . . . . 0.0 108.747 -2.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.524 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.4 t80 -104.39 116.14 31.61 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.646 ' CG ' HD23 ' A' ' 730' ' ' LEU . 35.9 m-85 -82.96 143.91 30.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.435 -0.79 . . . . 0.0 110.616 -178.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.911 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.6 mt -141.99 141.57 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.659 -0.651 . . . . 0.0 109.952 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.85 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 163.8 -163.8 36.02 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.395 -1.383 . . . . 0.0 111.24 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.497 ' N ' HD23 ' A' ' 618' ' ' LEU . 4.8 mmm-85 -60.33 -57.7 11.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.921 -0.752 . . . . 0.0 111.862 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.45 125.07 25.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 111.209 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.46 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 4.3 pt-20 -54.08 -17.61 2.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.888 . . . . 0.0 109.735 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.49 -32.58 1.44 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.457 -0.777 . . . . 0.0 108.951 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.3 m -65.9 130.37 43.03 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.524 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -43.3 -29.42 0.41 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.333 -0.854 . . . . 0.0 109.893 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.911 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.9 t -104.73 143.11 33.55 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.46 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -107.91 126.48 52.73 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 122.279 1.038 . . . . 0.0 113.363 -178.077 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.711 HG12 HG13 ' A' ' 588' ' ' ILE . 22.9 mt -143.9 108.57 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 614' ' ' GLU . 1.5 pt-20 -96.0 104.2 16.13 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 118.197 -1.401 . . . . 0.0 108.718 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.548 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.3 m-20 -136.41 105.81 6.08 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.587 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 616' ' ' ASN . . . . . 0.402 ' OD1' ' CE2' ' A' ' 688' ' ' PHE . 16.2 p-10 -44.64 -40.41 5.83 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.657 -0.652 . . . . 0.0 111.734 -179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.4 -17.38 42.4 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.101 -0.999 . . . . 0.0 111.032 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.891 HD13 HD11 ' A' ' 681' ' ' ILE . 0.6 OUTLIER -81.03 139.25 35.86 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.305 -0.872 . . . . 0.0 110.555 -179.499 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.448 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.0 OUTLIER -73.95 158.87 33.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.392 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.735 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.2 mpt_? -63.31 -43.15 98.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.2 -0.938 . . . . 0.0 109.191 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.599 ' CG1' HG22 ' A' ' 727' ' ' VAL . 18.8 t -95.82 1.57 10.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.921 0.867 . . . . 0.0 109.693 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.747 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.2 t60 -28.1 -45.37 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.884 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.543 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.46 145.88 43.62 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 117.959 -1.496 . . . . 0.0 112.191 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.543 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 4.5 p90 -146.35 142.05 27.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.605 -0.685 . . . . 0.0 110.088 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.583 ' CD1' HD11 ' A' ' 580' ' ' LEU . 73.8 mt -102.99 117.61 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.431 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 4.1 t80 -112.86 155.46 24.63 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.769 0.795 . . . . 0.0 110.17 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.44 ' O ' ' ND2' ' A' ' 599' ' ' ASN . 21.9 ttmt -119.34 137.92 53.39 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 121.525 0.679 . . . . 0.0 110.487 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.0 OUTLIER -132.75 163.92 27.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.58 -0.7 . . . . 0.0 110.753 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.4 tpt85 -77.51 112.3 14.14 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.523 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.2 t60 -58.16 124.24 18.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.722 . . . . 0.0 110.887 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -111.04 92.66 4.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.736 -0.602 . . . . 0.0 109.956 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.527 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.4 p -53.33 169.69 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.497 -0.752 . . . . 0.0 110.355 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.527 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -64.28 83.29 0.06 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp 51.44 -175.24 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.313 -1.11 . . . . 0.0 110.544 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 78.5 p -164.37 69.31 0.17 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.268 -0.895 . . . . 0.0 110.383 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.91 36.93 1.25 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.284 -0.885 . . . . 0.0 110.017 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -168.96 -149.15 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.494 -0.753 . . . . 0.0 109.889 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -115.89 102.96 10.15 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.274 -0.891 . . . . 0.0 109.148 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 84.9 p -135.62 151.34 74.24 Favored Pre-proline 0 C--N 1.292 -1.896 0 O-C-N 121.933 -0.479 . . . . 0.0 110.05 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.57 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 48.6 Cg_endo -70.28 -153.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.666 1.351 . . . . 0.0 110.074 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 66.54 -60.06 0.34 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.769 -0.582 . . . . 0.0 110.785 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 57.41 -161.29 0.22 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.028 -1.045 . . . . 0.0 109.92 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.679 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -113.62 128.59 8.39 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.768 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.3 mp -142.09 -152.78 0.43 Allowed 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.2 OUTLIER -118.39 123.96 46.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.097 -1.002 . . . . 0.0 110.905 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.708 ' CG ' HD11 ' A' ' 671' ' ' LEU . 13.3 t0 -105.4 156.54 18.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.433 -0.792 . . . . 0.0 109.742 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 18.1 pt -106.65 129.37 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.342 -0.849 . . . . 0.0 110.423 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.763 ' CH2' HD13 ' A' ' 671' ' ' LEU . 97.9 m95 -116.63 121.12 40.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.718 -0.614 . . . . 0.0 110.791 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.65 ' HB2' HD11 ' A' ' 672' ' ' LEU . 13.9 t80 -80.61 116.13 20.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 108.469 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.543 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 13.8 t -109.0 107.01 17.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 0.0 111.767 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.708 ' HE1' ' O ' ' A' ' 653' ' ' GLY . 25.3 t-80 -70.51 161.67 30.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.568 -0.707 . . . . 0.0 109.812 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.747 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.94 -30.24 0.16 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.329 -0.857 . . . . 0.0 112.562 -179.191 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.708 ' O ' ' HE1' ' A' ' 651' ' ' HIS . . . -79.13 -167.71 33.93 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 117.853 -2.118 . . . . 0.0 109.901 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.6 m -89.6 -19.28 25.13 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.69 ' O ' HG22 ' A' ' 656' ' ' VAL . 18.6 m120 -59.75 -2.86 0.42 Allowed 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.686 -1.258 . . . . 0.0 112.924 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.69 HG22 ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 62.11 143.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.575 -0.703 . . . . 0.0 110.293 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.542 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -95.98 142.99 27.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.621 -0.675 . . . . 0.0 110.462 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.448 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 10.8 m-85 -129.03 126.13 38.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.923 . . . . 0.0 110.526 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.602 HD11 HG21 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -134.55 114.35 12.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.331 -0.856 . . . . 0.0 110.001 179.462 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.02 -85.79 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.439 -0.788 . . . . 0.0 110.494 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.6 p-10 -143.67 19.28 1.84 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.11 -0.994 . . . . 0.0 110.409 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 662' ' ' ASN . . . . . 0.59 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.4 OUTLIER -105.84 118.36 36.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.313 -0.867 . . . . 0.0 110.177 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.05 136.44 35.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.466 -0.772 . . . . 0.0 110.044 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.747 ' SD ' HG13 ' A' ' 716' ' ' VAL . 8.1 mmm -115.61 -168.2 1.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 0.0 109.997 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.639 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.1 pt -143.38 -165.81 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.22 -0.925 . . . . 0.0 110.494 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 652' ' ' THR . 17.2 tt0 -77.64 78.42 4.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.574 -0.704 . . . . 0.0 110.473 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.42 53.79 0.23 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.639 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.1 OUTLIER -122.24 148.15 45.33 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.056 -1.261 . . . . 0.0 109.928 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.44 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 2.8 tttt -108.4 138.75 44.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.524 -0.735 . . . . 0.0 109.574 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.464 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 0.7 OUTLIER -144.53 146.42 32.37 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.664 -178.697 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.763 HD13 ' CH2' ' A' ' 648' ' ' TRP . 13.5 tp -71.29 146.19 49.06 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.429 -0.794 . . . . 0.0 110.898 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 649' ' ' TYR . 9.0 mt -117.78 107.74 14.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.415 -0.803 . . . . 0.0 111.06 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.411 ' NE2' ' HA2' ' A' ' 708' ' ' GLY . 81.3 mt-30 -84.86 153.41 22.92 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.813 ' OD1' HD12 ' A' ' 707' ' ' LEU . 11.2 p-10 -50.42 141.97 11.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.072 -1.018 . . . . 0.0 109.947 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 71.87 45.97 39.98 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.5 ' OD2' HD21 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -106.94 90.49 3.32 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.855 -0.791 . . . . 0.0 110.198 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.825 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 5.3 tt0 -93.45 107.41 19.25 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.602 HG21 HD11 ' A' ' 659' ' ' LEU . 1.1 pt -111.44 137.77 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 121.446 0.641 . . . . 0.0 111.551 -177.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -95.13 110.83 22.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.486 -0.759 . . . . 0.0 109.258 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.543 HD13 ' SG ' ' A' ' 623' ' ' CYS . 57.0 mt -75.02 -23.92 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.232 -0.918 . . . . 0.0 110.517 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.891 HD11 HD13 ' A' ' 618' ' ' LEU . 7.1 mt -140.49 139.09 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.195 -0.941 . . . . 0.0 110.276 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -137.69 109.51 7.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.365 -0.834 . . . . 0.0 110.401 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.29 117.7 28.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.328 -0.858 . . . . 0.0 109.975 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -47.19 72.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.291 -0.881 . . . . 0.0 111.037 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -84.84 -43.56 14.04 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.259 -0.9 . . . . 0.0 110.849 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.63 -12.07 61.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.576 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm 52.14 25.36 3.22 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.242 -0.911 . . . . 0.0 110.314 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.448 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -93.06 79.43 4.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.374 -0.829 . . . . 0.0 109.764 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 585' ' ' ASP . 27.3 m -103.55 142.33 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.391 -0.818 . . . . 0.0 110.673 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.563 HD11 ' CD1' ' A' ' 587' ' ' ILE . 30.0 mm -116.6 164.34 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.456 -0.778 . . . . 0.0 109.03 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 690' ' ' ILE . . . -173.58 124.19 1.03 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.316 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.825 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 15.0 m-85 -120.2 138.6 53.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.647 -0.913 . . . . 0.0 108.857 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -103.3 114.01 27.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.057 -1.027 . . . . 0.0 110.582 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.595 HG21 HD13 ' A' ' 672' ' ' LEU . 1.0 OUTLIER -82.81 113.49 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -120.37 104.34 9.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.464 -0.772 . . . . 0.0 110.444 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 577' ' ' PHE . 87.6 mt -83.54 103.99 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 109.276 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -83.51 -45.29 13.75 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.482 -0.761 . . . . 0.0 109.211 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.423 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 4.8 m-20 -111.62 140.98 45.78 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.777 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 5.6 p -114.66 96.17 5.61 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 701' ' ' GLY . 70.3 m -78.65 -92.64 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.883 -0.511 . . . . 0.0 110.84 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 700' ' ' THR . . . -114.09 44.28 1.53 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.724 ' O ' HD22 ' A' ' 644' ' ' LEU . 1.6 tp -90.72 145.72 24.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.587 -0.949 . . . . 0.0 110.436 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.768 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.5 p90 -53.35 -23.04 8.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.531 -0.731 . . . . 0.0 110.636 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.577 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.3 t30 -169.73 156.88 6.64 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.549 ' OE2' HD22 ' A' ' 707' ' ' LEU . 16.4 pt-20 -51.12 -25.37 5.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.218 -0.926 . . . . 0.0 110.281 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 118.43 16.66 5.51 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.813 HD12 ' OD1' ' A' ' 674' ' ' ASP . 1.5 tp -82.63 9.32 9.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.088 -1.242 . . . . 0.0 111.616 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.411 ' HA2' ' NE2' ' A' ' 673' ' ' GLN . . . 114.6 -97.67 0.84 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.426 ' CE ' ' O ' ' A' ' 709' ' ' MET . 2.0 ttp 55.45 91.52 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.368 -1.078 . . . . 0.0 110.118 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 176.54 135.05 0.06 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.305 -0.872 . . . . 0.0 110.431 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -42.18 93.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.304 -0.872 . . . . 0.0 109.635 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -68.26 149.57 49.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.533 -0.729 . . . . 0.0 109.665 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 713' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 714' ' ' ARG . 1.4 tp-100 -107.18 95.33 5.64 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.193 -0.942 . . . . 0.0 109.518 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.464 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 4.1 mmm-85 35.05 80.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.945 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.412 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 27.7 m -107.89 151.77 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.447 -0.783 . . . . 0.0 109.431 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.747 HG13 ' SD ' ' A' ' 664' ' ' MET . 78.9 t -89.31 133.42 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.185 -0.947 . . . . 0.0 110.498 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.9 mp -107.77 162.35 14.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 109.954 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.97 147.5 26.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 110.273 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -80.02 152.82 29.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.31 -0.869 . . . . 0.0 110.301 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 75.6 p -121.08 -177.54 3.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.273 -0.892 . . . . 0.0 110.364 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.99 -35.72 67.1 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.422 -0.799 . . . . 0.0 110.146 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 722' ' ' GLU . . . . . 0.615 ' O ' HD23 ' A' ' 726' ' ' LEU . 0.7 OUTLIER -65.36 -44.93 86.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 0.0 110.022 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.49 ' HA ' HD21 ' A' ' 726' ' ' LEU . 7.1 mt-10 -63.02 -48.73 77.51 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.441 -0.787 . . . . 0.0 109.984 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.47 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 22.4 mtpp -63.04 -32.23 73.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.398 -0.813 . . . . 0.0 111.072 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -61.56 -50.81 71.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.247 -0.908 . . . . 0.0 112.46 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 722' ' ' GLU . 0.4 OUTLIER -68.43 -32.73 72.97 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.732 -1.23 . . . . 0.0 110.803 -179.062 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.599 HG22 ' CG1' ' A' ' 621' ' ' VAL . 12.6 p -83.87 -18.48 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.054 . . . . 0.0 110.073 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -53.34 -45.37 69.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 108.889 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.5 103.53 10.52 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.193 0.997 . . . . 0.0 109.021 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.646 HD23 ' CG ' ' A' ' 602' ' ' PHE . 1.6 mt . . . . . 0 C--N 1.273 -2.746 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.415 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -82.8 -9.21 59.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.334 -1.098 . . . . 0.0 110.475 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 127.64 -13.48 6.5 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -92.03 114.07 26.51 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.193 -1.18 . . . . 0.0 109.557 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.566 ' HB3' ' CA ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -91.02 -43.79 9.72 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.96 0.886 . . . . 0.0 108.898 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.909 HD22 HD12 ' A' ' 594' ' ' ILE . 9.0 tt -121.43 125.33 46.65 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.086 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 25.2 m -103.6 116.63 32.71 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.732 ' HG ' HD21 ' A' ' 578' ' ' LEU . 5.4 mt -91.49 112.25 24.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.578 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.1 OUTLIER -114.65 104.26 54.44 Favored Pre-proline 0 C--N 1.298 -1.645 0 C-N-CA 118.386 -1.326 . . . . 0.0 113.128 -177.268 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 1.085 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.4 Cg_endo -76.33 142.1 23.63 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 N-CA-C 105.221 -2.646 . . . . 0.0 105.221 174.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.765 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -125.97 -173.91 0.32 Allowed Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 117.916 -1.514 . . . . 0.0 113.87 -175.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.765 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.2 Cg_endo -66.41 -34.17 35.34 Favored 'Trans proline' 0 N--CA 1.487 1.142 0 O-C-N 124.169 1.615 . . . . 0.0 111.322 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.88 -30.63 67.91 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.636 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 88.9 p -97.74 153.49 18.23 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.544 HG22 ' CD1' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -62.41 -9.75 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.982 -1.074 . . . . 0.0 109.969 179.21 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.799 HD12 ' HA ' ' A' ' 613' ' ' ILE . 10.1 mm -97.85 116.36 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.274 -0.891 . . . . 0.0 109.626 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.61 ' NE2' ' O ' ' A' ' 586' ' ' SER . 16.3 mp0 -118.53 71.87 0.85 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.659 -1.276 . . . . 0.0 109.713 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 1.085 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 42.5 mt-10 -144.48 174.63 10.77 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.941 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.578 ' HB3' ' HG2' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.54 128.27 40.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.005 -1.06 . . . . 0.0 109.487 176.483 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.729 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.8 mm? -111.2 152.26 27.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.976 . . . . 0.0 109.343 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -124.7 110.77 14.79 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.517 -0.74 . . . . 0.0 110.578 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.909 HD12 HD22 ' A' ' 578' ' ' LEU . 40.6 mt -82.18 109.12 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.072 -1.018 . . . . 0.0 109.272 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.4 OUTLIER -62.46 110.38 1.66 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.423 -0.798 . . . . 0.0 108.963 179.454 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.566 ' CA ' ' HB3' ' A' ' 577' ' ' PHE . 10.1 pt20 -19.11 85.4 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 121.396 0.617 . . . . 0.0 112.03 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 124.98 10.27 4.82 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.366 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.697 HG12 HG23 ' A' ' 594' ' ' ILE . 0.9 OUTLIER -83.96 102.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-O 123.112 1.434 . . . . 0.0 107.57 178.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.2 OUTLIER -144.52 138.78 14.91 Favored Pre-proline 0 C--N 1.281 -2.384 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.808 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.582 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 51.9 Cg_endo -90.94 163.44 30.41 Favored 'Cis proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.564 -1.848 . . . . 0.0 108.817 -1.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.589 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 4.1 t80 -104.42 116.0 31.35 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.624 ' CG ' HD23 ' A' ' 730' ' ' LEU . 33.0 m-85 -83.82 144.17 29.45 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.478 -0.764 . . . . 0.0 110.303 -178.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.89 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.7 mt -142.19 142.12 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.653 -0.655 . . . . 0.0 110.036 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.764 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 168.43 -162.97 36.76 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.807 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 13.7 tpt180 -70.36 -42.4 71.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.768 -0.842 . . . . 0.0 110.863 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.83 123.34 26.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.742 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.446 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 14.3 tt0 -53.34 -17.77 2.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 110.247 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.47 -31.49 1.77 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.316 -0.865 . . . . 0.0 108.967 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.5 m -68.05 132.74 47.8 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.589 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.0 OUTLIER -46.77 -26.65 0.99 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.292 -0.88 . . . . 0.0 109.945 179.555 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.89 ' HB3' HG23 ' A' ' 603' ' ' ILE . 3.3 t -106.97 143.55 34.89 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.446 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -109.45 127.88 54.74 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 119.288 -0.965 . . . . 0.0 113.17 -178.363 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.799 ' HA ' HD12 ' A' ' 588' ' ' ILE . 29.3 mt -142.63 108.49 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.416 ' H ' HD12 ' A' ' 588' ' ' ILE . 4.5 tt0 -90.46 103.54 16.21 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 118.124 -1.43 . . . . 0.0 108.484 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 0.7 OUTLIER -139.15 106.11 5.43 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.692 178.163 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -43.68 -44.65 6.58 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.548 -0.72 . . . . 0.0 112.077 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.53 -17.33 42.2 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.168 -0.958 . . . . 0.0 111.855 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.598 HD11 HG21 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -76.46 122.31 24.35 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.037 -1.039 . . . . 0.0 110.506 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -57.84 158.99 5.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.306 -0.871 . . . . 0.0 110.927 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.764 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -64.09 -45.17 89.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.222 -0.924 . . . . 0.0 109.366 179.438 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.521 ' CG1' HG22 ' A' ' 727' ' ' VAL . 4.3 t -95.33 1.78 10.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.892 0.853 . . . . 0.0 109.347 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.733 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.4 t60 -28.37 -46.38 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.645 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.719 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.04 145.86 44.53 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 117.985 -1.486 . . . . 0.0 112.08 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.531 ' CZ ' ' CB ' ' A' ' 650' ' ' CYS . 9.7 p90 -145.91 139.63 26.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.791 -0.568 . . . . 0.0 109.554 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.708 ' CD1' HD11 ' A' ' 580' ' ' LEU . 82.7 mt -102.83 117.72 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.435 ' CE1' ' O ' ' A' ' 627' ' ' LYS . 6.6 t80 -109.97 154.75 22.7 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.734 0.778 . . . . 0.0 109.914 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.435 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 11.1 ttmt -118.47 136.12 53.98 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.573 0.702 . . . . 0.0 110.1 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.7 OUTLIER -129.75 163.54 25.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.659 -0.651 . . . . 0.0 110.238 -179.193 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.5 tpt180 -78.22 121.81 24.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.073 -1.017 . . . . 0.0 108.75 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.522 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 4.8 t60 -57.99 124.29 18.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.416 -0.803 . . . . 0.0 110.656 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -64.74 125.75 25.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.757 -0.589 . . . . 0.0 110.195 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.807 HG21 ' O ' ' A' ' 641' ' ' ALA . 0.8 OUTLIER -137.92 -163.52 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.372 -0.83 . . . . 0.0 109.958 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.598 ' N ' HG13 ' A' ' 632' ' ' VAL . . . -169.07 -158.58 13.13 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -61.42 105.93 0.58 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.348 -1.089 . . . . 0.0 110.076 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.77 161.69 27.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.338 -0.851 . . . . 0.0 110.715 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 636' ' ' MET . . . . . 0.431 ' O ' ' O ' ' A' ' 637' ' ' TYR . 41.3 mmm -65.68 -132.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.709 -0.62 . . . . 0.0 109.525 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 637' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 636' ' ' MET . 33.2 p90 -58.05 -155.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.41 -0.806 . . . . 0.0 110.094 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -78.45 100.96 7.07 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.836 -1.165 . . . . 0.0 108.549 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 639' ' ' SER . . . . . 0.414 ' HB3' ' CE1' ' A' ' 637' ' ' TYR . 22.6 p -136.71 151.95 73.53 Favored Pre-proline 0 C--N 1.286 -2.188 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.911 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.518 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 46.1 Cg_endo -68.25 -151.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.634 1.334 . . . . 0.0 109.74 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.807 ' O ' HG21 ' A' ' 632' ' ' VAL . . . 61.24 17.56 8.32 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.383 -0.823 . . . . 0.0 110.456 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -74.07 60.96 0.8 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.24 -0.913 . . . . 0.0 109.994 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.687 ' C ' HD12 ' A' ' 644' ' ' LEU . . . 63.05 114.07 0.01 OUTLIER Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.852 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.3 mp -141.29 -152.15 0.39 Allowed 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.8 m-20 -119.08 124.22 46.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.088 -1.007 . . . . 0.0 111.241 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.697 ' OD2' HD21 ' A' ' 671' ' ' LEU . 18.2 t0 -101.84 156.18 17.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.597 -0.689 . . . . 0.0 109.57 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.446 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 11.7 pt -109.87 128.84 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.187 -0.945 . . . . 0.0 110.3 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.619 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 97.0 m95 -117.8 123.16 45.28 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.137 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.744 ' HB2' HD11 ' A' ' 672' ' ' LEU . 8.9 t80 -81.11 117.01 21.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 668' ' ' THR . 89.0 m -109.14 103.3 12.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.972 . . . . 0.0 111.818 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.529 ' CD2' ' N ' ' A' ' 652' ' ' THR . 13.3 t60 -66.73 159.23 28.3 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.402 -0.811 . . . . 0.0 109.781 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.733 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -152.13 -28.85 0.17 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.38 -0.825 . . . . 0.0 113.008 -179.295 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.534 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.47 -167.91 32.51 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 117.678 -2.201 . . . . 0.0 109.535 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 26.2 m -93.35 -18.76 22.03 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.964 -1.315 . . . . 0.0 113.818 -176.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.507 ' C ' HG23 ' A' ' 656' ' ' VAL . 23.9 m120 -59.43 -4.27 0.57 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.669 -1.27 . . . . 0.0 112.359 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.507 HG23 ' C ' ' A' ' 655' ' ' ASN . 3.1 t 69.76 147.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.655 -0.653 . . . . 0.0 110.343 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.507 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -101.69 149.42 24.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.698 -0.626 . . . . 0.0 110.686 -179.012 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -136.83 126.37 25.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 110.441 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.961 ' CD2' HG22 ' A' ' 678' ' ' ILE . 1.0 OUTLIER -128.13 106.72 9.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.394 -0.816 . . . . 0.0 109.79 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.405 ' O ' ' ND2' ' A' ' 661' ' ' ASN . 10.3 t-20 63.52 -74.22 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.525 -0.735 . . . . 0.0 110.593 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 659' ' ' LEU . 25.0 m-80 -153.1 23.95 0.55 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.208 -0.933 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.67 120.99 43.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.304 -0.873 . . . . 0.0 110.238 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.65 131.07 34.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.412 -0.805 . . . . 0.0 110.002 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.445 ' O ' HG13 ' A' ' 656' ' ' VAL . 2.7 mtp -111.17 -165.25 0.97 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.413 -0.804 . . . . 0.0 110.424 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.66 ' CG1' HG23 ' A' ' 668' ' ' THR . 2.1 pt -137.44 -164.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.378 -0.826 . . . . 0.0 110.324 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -80.79 82.35 6.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.374 -0.829 . . . . 0.0 110.522 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 120.43 55.59 0.24 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.66 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.2 OUTLIER -121.97 147.05 46.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.192 -1.181 . . . . 0.0 109.986 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.486 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 2.8 tttm -108.61 140.21 42.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.61 -0.681 . . . . 0.0 109.188 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.56 ' CD2' HD12 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -144.31 142.89 30.71 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.101 -1.0 . . . . 0.0 111.418 -178.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.697 HD21 ' OD2' ' A' ' 646' ' ' ASP . 0.4 OUTLIER -69.96 146.72 50.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.428 -0.795 . . . . 0.0 110.47 179.673 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.744 HD11 ' HB2' ' A' ' 649' ' ' TYR . 12.2 mt -119.08 108.98 15.38 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.148 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.427 ' NE2' ' HA3' ' A' ' 708' ' ' GLY . 62.7 mt-30 -84.8 -176.98 6.46 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.844 ' OD1' HD12 ' A' ' 707' ' ' LEU . 16.6 p-10 -73.03 141.85 47.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.192 -0.942 . . . . 0.0 109.538 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.33 47.48 43.43 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 107.596 -2.201 . . . . 0.0 107.596 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.405 ' HB2' ' CG1' ' A' ' 694' ' ' VAL . 0.1 OUTLIER -103.28 91.81 4.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.956 -0.732 . . . . 0.0 110.302 -179.008 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.979 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 2.4 tt0 -93.61 108.33 20.06 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.961 HG22 ' CD2' ' A' ' 659' ' ' LEU . 11.8 pt -105.69 137.66 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.644 -0.66 . . . . 0.0 111.868 -177.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -99.92 110.5 22.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.563 -0.711 . . . . 0.0 109.341 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.719 HD13 ' SG ' ' A' ' 623' ' ' CYS . 66.3 mt -81.92 -34.01 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.297 -0.877 . . . . 0.0 110.586 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.585 HD12 ' HB2' ' A' ' 618' ' ' LEU . 0.1 OUTLIER -126.9 136.12 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.325 -0.859 . . . . 0.0 109.587 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -137.66 118.64 14.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.249 -0.907 . . . . 0.0 110.659 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.99 117.83 20.67 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.282 -0.886 . . . . 0.0 110.055 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -47.36 71.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.412 -0.805 . . . . 0.0 111.408 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -84.72 -43.49 14.24 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.213 -0.929 . . . . 0.0 111.079 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.6 -7.69 55.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.308 -0.87 . . . . 0.0 110.742 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.93 19.51 3.64 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.117 -0.989 . . . . 0.0 110.364 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.83 86.86 5.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.242 -0.911 . . . . 0.0 109.102 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 681' ' ' ILE . 9.3 p -116.61 141.83 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.41 -0.806 . . . . 0.0 110.572 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.636 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 42.9 mm -118.95 164.35 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.338 -0.851 . . . . 0.0 109.653 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.459 ' N ' ' CB ' ' A' ' 586' ' ' SER . . . -175.31 126.09 1.14 Allowed Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.979 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 10.1 m-85 -119.5 137.3 53.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.56 -0.965 . . . . 0.0 108.674 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 12.4 tptt -97.91 113.8 25.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.225 -0.922 . . . . 0.0 110.459 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -85.27 112.53 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.052 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.42 104.67 9.23 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.168 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.667 HD13 ' O ' ' A' ' 705' ' ' GLU . 57.3 mt -79.54 103.21 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.376 -0.827 . . . . 0.0 109.576 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.2 -45.25 20.25 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.457 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 3.4 m-20 -111.12 141.56 44.47 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.735 -0.603 . . . . 0.0 109.895 178.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 20.6 p -113.95 95.79 5.49 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.96 133.52 52.99 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.026 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.41 26.05 28.93 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.757 ' O ' HD22 ' A' ' 644' ' ' LEU . 0.2 OUTLIER -102.85 124.88 49.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.569 -0.96 . . . . 0.0 109.976 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.852 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.4 p90 -48.09 -24.56 1.14 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.384 -0.822 . . . . 0.0 110.197 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.691 ' ND2' ' HG2' ' A' ' 705' ' ' GLU . 0.6 OUTLIER -165.86 160.21 16.69 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.174 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.691 ' HG2' ' ND2' ' A' ' 704' ' ' ASN . 12.5 pt-20 -50.98 -27.48 7.79 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.09 -1.006 . . . . 0.0 109.993 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 123.66 12.59 4.5 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.844 HD12 ' OD1' ' A' ' 674' ' ' ASP . 3.5 tp -85.25 8.66 17.65 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.843 -1.386 . . . . 0.0 111.516 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.427 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 39.46 88.91 0.01 OUTLIER Glycine 0 N--CA 1.499 2.888 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.584 ' HE3' ' HB2' ' A' ' 704' ' ' ASN . 0.0 OUTLIER -111.03 51.86 0.76 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -1.166 . . . . 0.0 110.199 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.431 ' H ' HD23 ' A' ' 710' ' ' LEU . 0.5 OUTLIER -106.5 -165.75 1.12 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.36 -0.837 . . . . 0.0 110.707 -179.507 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -91.36 -41.76 10.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.43 -0.794 . . . . 0.0 110.998 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.426 ' HB2' ' CD1' ' A' ' 710' ' ' LEU . 10.9 mm-40 -63.24 148.52 47.93 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.116 -0.99 . . . . 0.0 109.793 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -110.87 95.6 5.65 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.316 -0.865 . . . . 0.0 109.72 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.51 ' NH1' HD13 ' A' ' 659' ' ' LEU . 0.0 OUTLIER 41.07 84.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.287 0.565 . . . . 0.0 111.626 179.239 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.451 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 31.4 m -107.83 150.85 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 109.509 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.436 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 61.6 t -97.52 133.07 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.215 -0.928 . . . . 0.0 110.643 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.3 mp -110.12 162.51 14.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.498 -0.751 . . . . 0.0 109.85 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.18 145.32 28.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.195 -0.941 . . . . 0.0 110.17 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -80.64 150.21 29.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.33 -0.856 . . . . 0.0 110.18 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 17.0 p -113.73 -176.7 2.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.322 -0.861 . . . . 0.0 110.397 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.92 -32.99 55.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.385 -0.822 . . . . 0.0 110.364 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 722' ' ' GLU . . . . . 0.588 ' O ' HD23 ' A' ' 726' ' ' LEU . 2.7 tt0 -66.59 -46.74 74.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.353 -0.842 . . . . 0.0 109.977 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.609 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.5 OUTLIER -62.78 -48.39 79.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.481 -0.762 . . . . 0.0 109.903 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.452 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 8.5 tttp -62.96 -31.61 72.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.447 -0.783 . . . . 0.0 110.468 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.48 -50.45 73.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.372 -0.83 . . . . 0.0 112.238 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.588 HD23 ' O ' ' A' ' 722' ' ' GLU . 0.3 OUTLIER -72.32 -36.32 68.83 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.921 -1.112 . . . . 0.0 111.415 -178.738 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.609 HG12 ' O ' ' A' ' 723' ' ' GLU . 7.2 p -81.31 -17.85 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.881 -1.137 . . . . 0.0 110.441 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -47.46 75.26 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.107 -0.996 . . . . 0.0 108.866 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.37 103.92 10.94 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.335 1.064 . . . . 0.0 109.01 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.624 HD23 ' CG ' ' A' ' 602' ' ' PHE . 1.8 mt . . . . . 0 C--N 1.273 -2.729 0 CA-C-O 117.984 -1.007 . . . . 0.0 110.366 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -85.88 5.88 30.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -1.11 . . . . 0.0 110.723 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 108.9 42.78 1.27 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -85.09 114.8 22.5 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.339 -1.095 . . . . 0.0 109.022 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.2 OUTLIER -102.65 -40.23 6.71 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.915 0.864 . . . . 0.0 109.502 -179.253 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 1.036 HD22 HD12 ' A' ' 594' ' ' ILE . 9.8 tt -116.7 124.5 49.84 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.246 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 25.5 m -108.58 116.88 32.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -0.852 . . . . 0.0 109.944 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.782 HD21 HG23 ' A' ' 694' ' ' VAL . 1.8 mt -95.71 112.83 24.46 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.497 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -109.62 104.58 55.67 Favored Pre-proline 0 C--N 1.299 -1.612 0 C-N-CA 118.496 -1.282 . . . . 0.0 113.071 -177.278 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 1.026 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 44.8 Cg_endo -76.09 142.02 24.24 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 N-CA-C 106.295 -2.233 . . . . 0.0 106.295 175.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 1.047 ' HB2' ' HD2' ' A' ' 584' ' ' PRO . 0.2 OUTLIER -127.59 -171.69 0.24 Allowed Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 120.991 -1.068 . . . . 0.0 112.743 -176.276 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 1.047 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 36.4 Cg_endo -61.86 -31.29 85.0 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.859 1.452 . . . . 0.0 110.631 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 585' ' ' ASP . . . . . 0.436 ' OD1' HD12 ' A' ' 583' ' ' LEU . 3.3 m-20 -59.34 -26.62 65.2 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.481 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 19.1 t -96.56 153.38 17.88 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.532 HD13 ' HA ' ' A' ' 615' ' ' ASP . 13.8 tt -62.94 -15.89 16.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.703 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.937 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.0 OUTLIER -109.72 120.95 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.415 -0.803 . . . . 0.0 110.533 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 586' ' ' SER . 24.9 mp0 -107.25 79.94 1.36 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.578 -1.326 . . . . 0.0 108.728 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 1.026 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.6 mm-40 -141.52 176.61 8.75 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.36 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.576 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.38 127.21 42.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.31 -0.869 . . . . 0.0 108.859 176.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.526 HD12 ' HB3' ' A' ' 580' ' ' LEU . 0.6 OUTLIER -104.0 148.87 25.71 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.149 -0.97 . . . . 0.0 110.147 -179.668 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -124.68 109.99 13.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.488 -0.757 . . . . 0.0 110.658 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 1.036 HD12 HD22 ' A' ' 578' ' ' LEU . 44.2 mt -86.0 112.47 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 108.493 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.525 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -67.07 104.98 1.54 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.678 -0.638 . . . . 0.0 112.522 -177.67 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.744 ' CD ' HG21 ' A' ' 700' ' ' THR . 0.0 OUTLIER 16.84 57.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 178.341 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 113.3 39.61 1.11 Allowed Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.592 -1.29 . . . . 0.0 111.197 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.644 HG12 ' O ' ' A' ' 598' ' ' VAL . 1.2 t -79.82 103.58 6.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.43 ' O ' ' OD1' ' A' ' 599' ' ' ASN . 0.3 OUTLIER -141.37 140.16 20.21 Favored Pre-proline 0 C--N 1.282 -2.339 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.499 -178.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.469 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.2 Cg_endo -88.61 161.06 41.71 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.728 -2.197 . . . . 0.0 108.88 -0.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.549 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.1 t80 -106.35 116.17 31.47 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.716 ' C ' ' HB2' ' A' ' 609' ' ' CYS . 32.1 m-85 -92.35 144.59 25.23 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.29 -0.881 . . . . 0.0 110.702 -178.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.834 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -135.68 142.47 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.644 -0.66 . . . . 0.0 110.079 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.649 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 170.82 -168.67 41.77 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.737 -1.221 . . . . 0.0 110.783 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 13.9 mmm-85 -70.0 -44.95 68.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.69 -0.888 . . . . 0.0 110.673 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.502 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -75.01 119.63 19.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 110.125 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 608' ' ' ASP . 12.8 pt-20 -48.53 -18.9 0.28 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.316 -0.865 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 608' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 607' ' ' GLU . 0.9 OUTLIER -42.48 -37.87 1.75 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.321 -0.862 . . . . 0.0 109.318 179.101 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.716 ' HB2' ' C ' ' A' ' 602' ' ' PHE . 23.0 p -68.73 128.21 35.82 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.549 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -43.66 -24.6 0.13 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.562 -0.711 . . . . 0.0 111.897 -178.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.834 ' HB3' HG23 ' A' ' 603' ' ' ILE . 9.0 t -108.57 142.64 38.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.351 -0.843 . . . . 0.0 109.593 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.515 ' C ' HD13 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -113.53 130.61 56.31 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.909 -1.119 . . . . 0.0 112.584 -178.785 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 613' ' ' ILE . 13.7 tt -145.09 109.26 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.451 ' O ' HD13 ' A' ' 587' ' ' ILE . 6.2 mm-40 -84.48 100.98 11.7 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 116.844 -1.942 . . . . 0.0 108.087 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.719 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 27.7 t0 -139.96 105.01 4.99 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.335 177.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.48 -67.96 0.18 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.506 -0.746 . . . . 0.0 112.746 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -16.58 25.62 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.174 -0.954 . . . . 0.0 111.839 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.719 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -72.84 124.32 25.16 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.077 -1.014 . . . . 0.0 111.02 -179.006 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.502 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -69.8 161.71 29.29 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.384 -0.823 . . . . 0.0 110.639 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.649 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 31.9 mtm105 -63.88 -45.17 90.58 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 122.087 0.946 . . . . 0.0 109.126 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.621 HG13 HD11 ' A' ' 730' ' ' LEU . 21.8 m -95.77 2.29 9.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 121.639 0.733 . . . . 0.0 109.422 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.755 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.3 t60 -29.86 -47.97 0.08 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.937 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.809 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -136.82 144.93 43.92 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 118.492 -1.283 . . . . 0.0 110.964 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.529 ' CZ ' ' CB ' ' A' ' 650' ' ' CYS . 8.4 p90 -145.87 141.44 27.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.506 -0.746 . . . . 0.0 110.053 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.6 HG13 HD11 ' A' ' 603' ' ' ILE . 71.5 mt -103.41 118.7 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 9.0 t80 -108.89 154.98 21.36 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.533 -0.729 . . . . 0.0 109.463 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.421 ' HB3' ' CB ' ' A' ' 599' ' ' ASN . 8.4 tttt -119.25 136.62 54.14 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.571 0.701 . . . . 0.0 110.379 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.453 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.23 163.97 29.15 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.749 -0.595 . . . . 0.0 110.421 -179.219 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.582 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.0 OUTLIER -77.78 124.97 28.64 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.564 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER -57.62 123.91 17.24 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.897 0.856 . . . . 0.0 111.312 -177.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -80.1 111.49 16.5 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.332 0.587 . . . . 0.0 110.633 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.55 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.3 p -116.7 170.52 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.396 -0.815 . . . . 0.0 110.166 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.55 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -94.24 -167.91 37.25 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.06 129.12 40.22 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.295 -1.121 . . . . 0.0 110.086 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.76 84.6 0.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.308 -0.87 . . . . 0.0 110.543 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 6.3 tpp -63.08 126.09 26.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.321 -0.862 . . . . 0.0 109.667 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.4 -144.5 0.4 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.954 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.14 102.22 9.7 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.162 -0.961 . . . . 0.0 109.15 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 27.9 p -136.91 151.74 72.81 Favored Pre-proline 0 C--N 1.293 -1.884 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.85 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.67 -153.1 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.614 1.323 . . . . 0.0 109.729 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 50.72 23.35 1.35 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.468 -0.77 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -74.34 61.73 0.92 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.132 -0.98 . . . . 0.0 110.153 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.642 ' C ' HD12 ' A' ' 644' ' ' LEU . . . 62.28 114.76 0.01 OUTLIER Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.719 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.1 mp -142.07 -151.16 0.35 Allowed 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.92 124.07 51.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.991 -1.068 . . . . 0.0 111.054 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -109.22 156.07 20.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.454 -0.779 . . . . 0.0 110.043 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.583 HD13 ' CD1' ' A' ' 578' ' ' LEU . 11.2 pt -111.06 128.92 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.271 -0.893 . . . . 0.0 109.633 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.977 ' CH2' HD22 ' A' ' 671' ' ' LEU . 99.0 m95 -114.29 120.09 39.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.724 -0.61 . . . . 0.0 111.539 -178.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.797 ' HB2' HD11 ' A' ' 672' ' ' LEU . 18.5 t80 -82.17 114.09 20.45 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.529 ' CB ' ' CZ ' ' A' ' 624' ' ' PHE . 62.2 m -109.54 102.27 11.14 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.145 -0.972 . . . . 0.0 111.399 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.613 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 12.1 t60 -69.0 160.39 31.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.461 -0.775 . . . . 0.0 109.918 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.755 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.37 -31.09 0.17 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.424 -0.797 . . . . 0.0 113.112 -178.888 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.613 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -78.53 134.91 14.77 Favored Glycine 0 N--CA 1.502 3.087 0 C-N-CA 117.801 -2.143 . . . . 0.0 110.253 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 26.7 m -34.45 -24.87 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -177.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.682 ' C ' HG13 ' A' ' 656' ' ' VAL . 10.0 m120 -59.23 -3.02 0.34 Allowed 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.346 -1.472 . . . . 0.0 113.123 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.682 HG13 ' C ' ' A' ' 655' ' ' ASN . 0.8 OUTLIER 62.14 145.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.509 -0.745 . . . . 0.0 110.259 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.55 ' OG ' ' HB2' ' A' ' 664' ' ' MET . 0.0 OUTLIER -93.98 151.36 19.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.555 -0.716 . . . . 0.0 110.495 -179.199 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.454 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 14.5 m-85 -135.1 125.78 27.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 109.929 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.614 ' CG ' HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -134.56 113.94 12.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.25 -0.907 . . . . 0.0 110.18 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 54.19 -88.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.482 -0.761 . . . . 0.0 110.773 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.3 m120 -136.71 18.25 3.07 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.066 -1.021 . . . . 0.0 110.509 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -111.85 116.77 31.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.924 . . . . 0.0 110.444 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -94.08 138.19 32.43 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.475 -0.765 . . . . 0.0 109.815 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.712 ' SD ' HG13 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -117.08 -159.44 0.73 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.893 . . . . 0.0 109.884 -179.722 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.662 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.7 pt -133.43 -171.69 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.246 -0.909 . . . . 0.0 110.372 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -74.27 70.06 1.62 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.351 -0.843 . . . . 0.0 110.452 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 133.13 55.77 0.08 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.662 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.0 OUTLIER -123.09 150.57 43.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.255 -1.144 . . . . 0.0 110.307 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.438 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 1.1 ttpm? -108.84 146.66 33.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.579 -0.701 . . . . 0.0 109.178 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.54 ' HD2' HD13 ' A' ' 659' ' ' LEU . 3.5 t80 -145.05 146.28 31.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 111.915 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.977 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.68 130.55 42.66 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.546 -0.721 . . . . 0.0 109.497 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.797 HD11 ' HB2' ' A' ' 649' ' ' TYR . 1.7 mt -104.61 118.75 37.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.081 -1.012 . . . . 0.0 111.26 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.495 ' NE2' ' HA2' ' A' ' 708' ' ' GLY . 78.4 mt-30 -106.94 138.99 42.06 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.784 ' OD1' HD12 ' A' ' 707' ' ' LEU . 6.2 p-10 -36.69 146.19 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.268 -0.895 . . . . 0.0 110.921 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 73.13 48.76 18.6 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.413 ' OD1' HD21 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -106.77 92.54 4.14 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.839 -0.8 . . . . 0.0 110.883 -178.738 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.25 106.49 18.45 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.023 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.614 HG22 ' CG ' ' A' ' 659' ' ' LEU . 5.0 pt -115.25 135.61 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.541 -0.724 . . . . 0.0 111.715 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.39 110.57 22.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.518 -0.739 . . . . 0.0 109.106 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.809 HD13 ' SG ' ' A' ' 623' ' ' CYS . 72.1 mt -72.4 -46.18 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.369 -0.832 . . . . 0.0 110.19 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.594 HD12 ' CG ' ' A' ' 615' ' ' ASP . 9.8 mt -126.81 133.59 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -0.845 . . . . 0.0 109.874 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -137.67 113.09 9.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 110.391 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -130.35 118.12 20.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.307 -0.87 . . . . 0.0 110.057 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -46.13 78.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.427 -0.796 . . . . 0.0 110.998 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.26 -43.02 82.91 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.31 -0.869 . . . . 0.0 110.75 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -90.47 -2.49 57.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.253 -0.904 . . . . 0.0 110.824 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.21 21.22 2.96 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.127 -0.983 . . . . 0.0 110.531 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.26 78.73 4.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.891 . . . . 0.0 109.084 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 586' ' ' SER . 39.5 t -101.69 131.47 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.557 -0.715 . . . . 0.0 110.682 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.647 ' CG2' HD11 ' A' ' 613' ' ' ILE . 49.7 mm -112.0 164.25 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.343 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 179.95 116.33 0.51 Allowed Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.417 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.916 ' CZ ' HG21 ' A' ' 588' ' ' ILE . 12.1 m-85 -119.5 137.32 53.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.251 -1.146 . . . . 0.0 108.484 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -107.98 114.75 28.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 111.209 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.782 HG23 HD21 ' A' ' 580' ' ' LEU . 0.8 OUTLIER -81.33 123.68 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.455 -0.778 . . . . 0.0 109.021 179.02 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -129.95 104.82 7.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.542 -0.724 . . . . 0.0 110.119 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 71.7 mt -84.35 103.95 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.366 -0.834 . . . . 0.0 109.851 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -81.78 -42.9 19.08 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.6 OUTLIER -110.7 140.29 45.21 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.682 -0.637 . . . . 0.0 110.249 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 6.6 p -114.7 96.09 5.56 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.744 HG21 ' CD ' ' A' ' 596' ' ' GLN . 4.6 p -97.07 105.42 17.56 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.298 0.57 . . . . 0.0 111.144 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 49.42 27.53 8.31 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.858 HD23 ' O ' ' A' ' 704' ' ' ASN . 0.5 OUTLIER -82.24 147.02 29.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.387 -1.066 . . . . 0.0 110.28 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.719 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.5 p90 -52.62 -23.55 6.73 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.43 -0.794 . . . . 0.0 110.292 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.858 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.6 t30 -175.9 155.14 1.59 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.456 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 16.1 pt-20 -51.43 -23.36 3.81 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.094 -1.004 . . . . 0.0 110.579 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 118.77 13.4 6.68 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.784 HD12 ' OD1' ' A' ' 674' ' ' ASP . 1.5 tp -83.96 9.97 10.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.193 -1.181 . . . . 0.0 111.345 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.495 ' HA2' ' NE2' ' A' ' 673' ' ' GLN . . . 94.95 -44.61 2.17 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.731 ' C ' HD23 ' A' ' 710' ' ' LEU . 1.1 ttm 62.75 149.77 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.384 -1.068 . . . . 0.0 110.515 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.731 HD23 ' C ' ' A' ' 709' ' ' MET . 0.7 OUTLIER 37.73 -155.66 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 CA-C-O 121.337 0.589 . . . . 0.0 111.769 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -94.14 72.22 3.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.515 -0.741 . . . . 0.0 109.46 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.32 148.27 48.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.497 -0.752 . . . . 0.0 110.694 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 713' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 715' ' ' VAL . 11.7 mt-30 -111.17 97.82 7.07 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.447 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 3.4 mmm-85 -64.68 68.11 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.434 0.635 . . . . 0.0 110.584 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.477 ' N ' ' O ' ' A' ' 713' ' ' GLN . 27.7 m -106.09 149.26 9.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.712 HG13 ' SD ' ' A' ' 664' ' ' MET . 89.3 t -78.63 133.12 30.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 111.041 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.35 162.2 13.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.519 -0.738 . . . . 0.0 109.782 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -100.11 152.95 19.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.943 . . . . 0.0 110.135 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -79.87 154.18 28.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.83 . . . . 0.0 110.263 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.6 p -120.29 -176.99 3.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.35 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.09 -28.95 56.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.318 -0.864 . . . . 0.0 110.241 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 722' ' ' GLU . . . . . 0.446 ' O ' HD13 ' A' ' 726' ' ' LEU . 0.0 OUTLIER -68.22 -52.51 33.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.49 -0.756 . . . . 0.0 110.077 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -63.44 -37.75 88.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.352 -0.843 . . . . 0.0 109.771 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.532 ' O ' HG12 ' A' ' 727' ' ' VAL . 13.1 tttm -58.44 -32.47 68.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.408 -0.807 . . . . 0.0 109.816 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.0 -39.21 79.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.459 -0.775 . . . . 0.0 110.341 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 722' ' ' GLU . 10.9 mp -55.75 -47.55 76.78 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.308 -0.87 . . . . 0.0 110.638 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 724' ' ' LYS . 8.8 p -69.98 -22.16 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.069 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -54.73 -50.37 68.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 109.048 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -116.53 103.46 10.44 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 122.241 1.02 . . . . 0.0 109.341 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.621 HD11 HG13 ' A' ' 621' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.273 -2.736 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.212 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -82.84 -10.03 59.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -1.08 . . . . 0.0 110.569 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 122.52 1.32 10.04 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -92.31 114.71 27.34 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.219 -1.165 . . . . 0.0 109.556 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.495 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 4.7 t80 -98.71 -42.77 7.07 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.953 0.882 . . . . 0.0 109.516 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.863 HD23 HD12 ' A' ' 594' ' ' ILE . 49.6 tp -123.3 120.35 32.83 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.606 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 85.5 m -101.17 116.81 33.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 1.045 HD11 HD12 ' A' ' 625' ' ' ILE . 4.3 mt -88.45 112.58 23.11 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 581' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.07 101.56 54.54 Favored Pre-proline 0 C--N 1.301 -1.505 0 C-N-CA 117.911 -1.516 . . . . 0.0 113.01 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 1.156 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.1 Cg_endo -82.13 145.18 13.68 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 N-CA-C 106.017 -2.34 . . . . 0.0 106.017 173.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.703 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.33 -178.73 0.66 Allowed Pre-proline 0 N--CA 1.498 1.971 0 C-N-CA 118.207 -1.397 . . . . 0.0 114.166 -176.373 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.703 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.1 Cg_endo -67.6 -28.54 37.73 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 124.322 1.696 . . . . 0.0 111.965 -178.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -58.6 -30.96 67.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.681 -1.262 . . . . 0.0 107.609 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.51 ' HB3' ' N ' ' A' ' 691' ' ' GLY . 3.3 p -97.88 153.85 18.04 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.457 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.4 OUTLIER -57.17 -16.09 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.97 -1.081 . . . . 0.0 109.437 179.255 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.856 HD12 ' HA ' ' A' ' 613' ' ' ILE . 9.9 mm -97.1 114.59 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.285 -0.884 . . . . 0.0 108.739 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 2.8 pm0 -126.75 73.96 1.44 Allowed 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.583 -1.323 . . . . 0.0 110.014 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 1.156 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 66.4 mm-40 -143.95 174.46 10.82 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.198 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.456 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.6 125.91 39.17 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.794 -1.191 . . . . 0.0 109.565 176.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.662 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.0 OUTLIER -109.34 155.43 21.21 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.284 -0.885 . . . . 0.0 109.626 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -125.02 109.99 13.63 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.363 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.863 HD12 HD23 ' A' ' 578' ' ' LEU . 4.4 mt -81.98 109.65 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.591 ' HB2' HG23 ' A' ' 598' ' ' VAL . 0.0 OUTLIER -53.01 174.47 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.504 -0.747 . . . . 0.0 109.952 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.495 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -62.0 65.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.47 -0.769 . . . . 0.0 110.854 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 125.62 34.16 0.67 Allowed Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.938 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 598' ' ' VAL . 1.2 t -79.62 103.17 6.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.4 t30 -143.18 134.68 12.82 Favored Pre-proline 0 C--N 1.283 -2.315 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.172 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.52 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 55.8 Cg_endo -91.47 161.35 28.16 Favored 'Cis proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.614 -1.828 . . . . 0.0 109.158 -1.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.487 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.8 t80 -107.08 116.65 32.3 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.745 ' C ' ' HB2' ' A' ' 609' ' ' CYS . 60.8 m-85 -89.63 144.98 25.57 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.375 -0.828 . . . . 0.0 110.786 -178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.831 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.2 mt -138.17 142.24 36.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.634 -0.666 . . . . 0.0 109.702 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 174.67 -161.24 30.84 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.415 -1.374 . . . . 0.0 111.111 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -76.26 -44.3 37.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.847 -0.796 . . . . 0.0 110.479 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.402 ' HB2' ' HG3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -80.5 123.27 27.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.277 -0.889 . . . . 0.0 110.413 -179.566 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 608' ' ' ASP . 10.1 pt-20 -48.18 -18.98 0.24 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.385 -0.822 . . . . 0.0 111.058 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 608' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 607' ' ' GLU . 2.2 t0 -40.76 -37.27 0.73 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.375 -0.828 . . . . 0.0 109.653 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.745 ' HB2' ' C ' ' A' ' 602' ' ' PHE . 18.0 p -73.43 133.6 43.76 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.487 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -44.58 -23.08 0.1 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.558 -0.713 . . . . 0.0 111.959 -178.691 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.831 ' HB3' HG23 ' A' ' 603' ' ' ILE . 10.7 t -110.08 143.63 39.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.316 -0.865 . . . . 0.0 109.743 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.7 125.61 52.09 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.003 -1.061 . . . . 0.0 113.122 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.856 ' HA ' HD12 ' A' ' 588' ' ' ILE . 10.7 mt -142.59 108.84 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -89.52 103.49 16.13 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 118.045 -1.462 . . . . 0.0 109.207 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.628 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 1.1 m-20 -139.37 106.45 5.46 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.348 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -43.15 -43.25 4.47 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.602 -0.686 . . . . 0.0 112.048 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -83.88 -17.52 40.57 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.017 -1.052 . . . . 0.0 111.905 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -77.27 133.96 38.68 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.056 -1.028 . . . . 0.0 110.834 -179.153 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.485 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.5 m -75.92 159.82 30.52 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.367 -0.833 . . . . 0.0 111.225 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.601 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 19.4 ttm105 -62.62 -44.48 96.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.361 -0.837 . . . . 0.0 109.219 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.756 ' HB ' HG23 ' A' ' 727' ' ' VAL . 27.4 m -94.65 1.81 9.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 121.761 0.791 . . . . 0.0 109.358 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.8 t60 -30.81 -48.22 0.11 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.718 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.827 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -136.5 144.89 44.56 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.579 -1.249 . . . . 0.0 110.826 178.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 650' ' ' CYS . 17.1 p90 -146.29 145.84 30.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.543 -0.723 . . . . 0.0 110.163 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 1.045 HD12 HD11 ' A' ' 580' ' ' LEU . 8.7 mt -103.2 122.37 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.432 ' HB2' ' HE2' ' A' ' 624' ' ' PHE . 3.5 t80 -117.63 154.9 30.79 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.543 -0.723 . . . . 0.0 109.462 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 10.1 tttt -119.72 136.19 54.53 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.77 0.795 . . . . 0.0 111.023 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.72 163.5 28.86 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.575 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -78.3 126.3 30.59 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.818 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -65.06 125.1 23.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.399 -0.813 . . . . 0.0 110.749 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -119.41 140.14 50.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.594 -0.691 . . . . 0.0 110.327 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.555 HG22 ' N ' ' A' ' 633' ' ' GLY . 14.6 p -118.39 174.09 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.366 -0.834 . . . . 0.0 110.172 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.555 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -108.9 113.79 3.85 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 10.4 tttt 56.17 102.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.39 -1.065 . . . . 0.0 110.584 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.33 95.19 9.56 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.364 -0.835 . . . . 0.0 110.105 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 4.5 ttm -63.4 125.08 22.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.38 -0.825 . . . . 0.0 109.968 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 1.5 t80 63.64 -144.8 0.32 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.363 -0.836 . . . . 0.0 110.26 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -113.26 102.8 10.69 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 122.013 0.911 . . . . 0.0 109.172 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 67.9 p -135.73 152.04 75.32 Favored Pre-proline 0 C--N 1.291 -1.95 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.695 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.95 -152.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.67 1.353 . . . . 0.0 109.856 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 52.85 22.43 2.36 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.371 -0.83 . . . . 0.0 110.636 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -105.61 57.83 0.67 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -0.898 . . . . 0.0 110.148 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 109.1 14.13 15.83 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.751 HD12 ' N ' ' A' ' 703' ' ' PHE . 3.0 mm? -65.87 -153.87 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.339 0 O-C-N 122.221 -0.576 . . . . 0.0 110.144 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.575 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 4.5 m-20 -130.19 132.53 46.06 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.035 -1.041 . . . . 0.0 111.306 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.588 ' OD1' HD21 ' A' ' 671' ' ' LEU . 2.2 t0 -127.26 143.24 51.28 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.229 -0.92 . . . . 0.0 110.538 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 12.7 pt -96.96 134.45 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.261 -0.9 . . . . 0.0 109.926 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.686 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.3 m95 -119.18 120.87 38.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.571 -0.706 . . . . 0.0 111.313 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.662 ' HB2' HD11 ' A' ' 672' ' ' LEU . 4.0 t80 -80.84 114.25 19.59 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 624' ' ' PHE . 38.5 m -108.57 108.62 19.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 111.117 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.791 ' CE1' ' O ' ' A' ' 653' ' ' GLY . 7.6 t-80 -74.21 161.7 29.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.572 -0.705 . . . . 0.0 110.362 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -151.11 -31.57 0.17 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.791 ' O ' ' CE1' ' A' ' 651' ' ' HIS . . . -79.41 130.89 10.18 Favored Glycine 0 N--CA 1.501 2.983 0 O-C-N 119.232 -2.167 . . . . 0.0 110.342 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 654' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 656' ' ' VAL . 11.4 m -36.54 -24.24 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -177.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.545 ' O ' HG12 ' A' ' 656' ' ' VAL . 4.1 t-20 -56.01 -4.74 0.13 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.325 -1.484 . . . . 0.0 112.775 -178.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 77.69 166.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 CA-C-O 122.043 0.925 . . . . 0.0 110.734 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.626 ' HB3' ' CD2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -126.84 150.9 48.99 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.045 -178.798 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -135.75 126.4 27.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.396 -0.815 . . . . 0.0 110.23 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.732 ' CD2' HG22 ' A' ' 678' ' ' ILE . 0.4 OUTLIER -127.36 108.95 11.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.305 -0.872 . . . . 0.0 109.679 179.487 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.9 m120 58.79 -81.34 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.426 -0.796 . . . . 0.0 110.195 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.9 OUTLIER -143.78 22.66 1.78 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.069 -1.019 . . . . 0.0 110.439 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -116.57 128.17 55.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.195 -0.941 . . . . 0.0 110.395 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -91.46 141.32 28.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.393 -0.817 . . . . 0.0 110.176 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.679 ' HG2' HG13 ' A' ' 716' ' ' VAL . 3.5 mtp -120.28 -172.96 2.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.401 -0.812 . . . . 0.0 110.208 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.567 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.1 pp -126.09 -169.94 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -0.87 . . . . 0.0 110.24 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -76.8 72.44 3.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.334 -0.854 . . . . 0.0 110.748 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 129.12 55.65 0.1 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.567 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.0 OUTLIER -122.17 151.76 40.64 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.281 -1.129 . . . . 0.0 110.296 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.597 ' HD3' HD13 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -108.85 139.03 44.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.264 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.657 ' CD1' HD13 ' A' ' 659' ' ' LEU . 8.5 t80 -143.56 146.36 33.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 111.268 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.686 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -73.88 146.98 43.66 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.614 -0.679 . . . . 0.0 110.778 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.761 HD13 HG21 ' A' ' 694' ' ' VAL . 10.2 mt -115.71 114.34 24.7 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.285 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.506 ' CG ' ' HA ' ' A' ' 707' ' ' LEU . 10.1 mt-30 -97.04 148.76 22.67 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.425 ' OD1' HD11 ' A' ' 707' ' ' LEU . 0.8 OUTLIER -51.0 135.19 25.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.044 -1.035 . . . . 0.0 110.087 -179.829 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 83.77 45.57 6.34 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 107.686 -2.166 . . . . 0.0 107.686 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.421 ' OD2' ' HA ' ' A' ' 672' ' ' LEU . 0.4 OUTLIER -109.85 93.5 4.53 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.802 -0.822 . . . . 0.0 110.444 -179.061 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.852 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 4.6 tt0 -93.35 107.47 19.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.732 HG22 ' CD2' ' A' ' 659' ' ' LEU . 4.1 pt -112.43 138.04 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.564 -0.71 . . . . 0.0 112.38 -176.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.22 113.58 26.76 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.827 HD13 ' SG ' ' A' ' 623' ' ' CYS . 85.0 mt -76.83 -30.66 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.172 -0.955 . . . . 0.0 110.51 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 618' ' ' LEU . 4.0 mt -138.64 134.93 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.269 -0.894 . . . . 0.0 110.047 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -137.38 108.84 6.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.539 -0.726 . . . . 0.0 110.104 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.59 118.39 33.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.32 -0.862 . . . . 0.0 110.221 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.04 -46.64 77.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.425 -0.797 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -84.6 -43.37 14.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.32 -0.863 . . . . 0.0 110.763 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -76.21 -10.09 59.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.333 -0.854 . . . . 0.0 110.662 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.76 20.2 4.95 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.111 -0.993 . . . . 0.0 110.433 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.407 ' CE2' ' HA ' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -82.3 75.15 9.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -0.885 . . . . 0.0 109.354 179.464 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 689' ' ' VAL . 10.8 p -103.16 131.65 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.387 -0.821 . . . . 0.0 111.054 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.566 HG23 HG12 ' A' ' 588' ' ' ILE . 36.3 mm -113.3 163.67 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.429 -0.795 . . . . 0.0 109.168 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.51 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . -167.79 120.29 0.89 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.198 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.852 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 7.7 m-85 -120.41 137.78 54.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.519 -0.989 . . . . 0.0 109.115 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -110.36 114.77 28.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.404 -0.81 . . . . 0.0 110.757 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.761 HG21 HD13 ' A' ' 672' ' ' LEU . 0.8 OUTLIER -75.67 119.97 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.478 -0.763 . . . . 0.0 109.084 179.227 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -129.68 103.95 7.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.438 -0.789 . . . . 0.0 110.143 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.551 ' CG1' HD13 ' A' ' 578' ' ' LEU . 60.0 mt -86.97 111.4 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -0.799 . . . . 0.0 109.734 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -81.28 -43.26 19.41 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.491 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.5 m-20 -111.65 140.56 46.18 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.555 0.693 . . . . 0.0 110.61 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 699' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 700' ' ' THR . 25.0 p -115.62 96.77 5.78 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 700' ' ' THR . . . . . 0.611 HG23 ' H ' ' A' ' 702' ' ' LEU . 9.0 t -60.0 -147.52 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.138 0.494 . . . . 0.0 110.248 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 644' ' ' LEU . . . -67.86 -1.17 16.79 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.611 ' H ' HG23 ' A' ' 700' ' ' THR . 0.0 OUTLIER -47.03 144.46 2.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.287 -1.125 . . . . 0.0 111.15 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.751 ' N ' HD12 ' A' ' 644' ' ' LEU . 50.7 p90 -53.53 -27.62 26.85 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.137 0.97 . . . . 0.0 108.803 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.507 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 10.7 t-20 -174.68 173.53 2.82 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.547 ' HB2' HD12 ' A' ' 696' ' ' ILE . 8.2 pt-20 -51.07 -40.93 59.48 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.098 -1.001 . . . . 0.0 110.191 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 149.83 37.92 0.04 OUTLIER Glycine 0 N--CA 1.498 2.796 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.971 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.506 ' HA ' ' CG ' ' A' ' 673' ' ' GLN . 6.6 mp -86.0 9.24 17.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.043 -1.269 . . . . 0.0 111.448 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.548 ' HA3' HD13 ' A' ' 671' ' ' LEU . . . 64.88 -79.23 0.06 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.414 ' N ' ' O ' ' A' ' 707' ' ' LEU . 69.2 mtm 54.53 60.51 3.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.432 -1.04 . . . . 0.0 110.419 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 712' ' ' GLU . 0.6 OUTLIER -132.03 -160.78 1.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.358 -0.839 . . . . 0.0 110.136 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -65.08 -26.97 68.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.338 -0.851 . . . . 0.0 110.325 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.484 ' HB2' HD11 ' A' ' 710' ' ' LEU . 1.8 mt-10 -97.6 146.87 24.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.354 -0.841 . . . . 0.0 110.265 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -111.71 96.16 5.92 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.283 -0.886 . . . . 0.0 109.381 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 15.9 mmm-85 48.85 67.04 0.93 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.286 0.565 . . . . 0.0 110.865 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.0 m -107.74 152.48 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.441 -0.787 . . . . 0.0 109.494 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.679 HG13 ' HG2' ' A' ' 664' ' ' MET . 57.7 t -89.4 121.5 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.16 -0.962 . . . . 0.0 110.543 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.597 HD13 ' HD3' ' A' ' 669' ' ' LYS . 3.1 mp -96.1 161.89 13.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.426 -0.796 . . . . 0.0 109.846 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.68 153.66 17.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.375 -0.828 . . . . 0.0 109.841 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -87.16 125.06 33.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.318 -0.864 . . . . 0.0 110.38 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 39.7 p -93.15 -176.31 4.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.376 -0.828 . . . . 0.0 110.124 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.44 -28.91 32.75 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.326 -0.859 . . . . 0.0 110.207 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.1 -52.17 63.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.377 -0.827 . . . . 0.0 109.858 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -48.65 75.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 0.0 109.975 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.505 ' O ' HG12 ' A' ' 727' ' ' VAL . 5.7 tttp -53.74 -32.17 51.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.386 -0.822 . . . . 0.0 110.123 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.28 -36.17 78.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.87 . . . . 0.0 110.242 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 42.1 mt -59.46 -46.33 89.09 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.346 -0.846 . . . . 0.0 110.245 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.756 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.1 p -71.77 -22.2 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.145 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.26 -47.69 68.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.895 . . . . 0.0 108.937 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -116.87 104.28 11.15 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.151 0.977 . . . . 0.0 109.235 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.274 -2.69 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.252 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -82.93 -9.99 59.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -1.074 . . . . 0.0 110.62 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 110.87 29.34 3.59 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.419 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.1 OUTLIER -92.56 114.38 26.92 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.337 -1.096 . . . . 0.0 109.515 179.614 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.495 ' HB3' ' HA ' ' A' ' 596' ' ' GLN . 3.4 t80 -106.29 -43.17 4.86 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.974 0.892 . . . . 0.0 109.46 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.738 HD23 HD12 ' A' ' 594' ' ' ILE . 31.4 tp -120.66 142.42 49.47 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.968 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 42.5 m -125.76 116.87 22.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.503 -0.748 . . . . 0.0 109.39 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.596 HD11 ' CD1' ' A' ' 625' ' ' ILE . 3.5 mt -95.13 112.08 23.83 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.416 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 1.6 mmtt -108.62 102.78 49.05 Favored Pre-proline 0 C--N 1.3 -1.586 0 C-N-CA 118.4 -1.32 . . . . 0.0 112.408 -177.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 1.052 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.8 Cg_endo -79.08 142.69 17.35 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 N-CA-C 106.547 -2.136 . . . . 0.0 106.547 175.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.794 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -128.05 -171.08 0.23 Allowed Pre-proline 0 C--N 1.297 -1.693 0 C-N-CA 118.501 -1.279 . . . . 0.0 112.79 -177.056 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.794 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 37.2 Cg_endo -63.58 -35.09 61.32 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 124.068 1.562 . . . . 0.0 110.815 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.99 -28.73 66.63 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.585 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 46.0 t -96.53 153.45 17.84 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.753 HG22 ' CD1' ' A' ' 690' ' ' ILE . 6.1 tp -63.53 -12.98 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.384 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.783 ' CG1' ' HA ' ' A' ' 613' ' ' ILE . 31.3 mm -100.97 120.29 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.369 -0.832 . . . . 0.0 109.838 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 589' ' ' GLN . . . . . 0.585 ' NE2' ' O ' ' A' ' 586' ' ' SER . 23.6 mp0 -115.98 68.27 0.72 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.55 -1.344 . . . . 0.0 109.307 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 1.052 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.5 mm-40 -143.97 176.85 8.98 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.593 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.524 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.19 125.77 41.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.194 -0.941 . . . . 0.0 108.859 176.576 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.732 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.9 mt -106.51 153.78 21.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.362 -0.836 . . . . 0.0 109.661 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.419 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 6.5 mp0 -125.99 110.12 13.22 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.308 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.738 HD12 HD23 ' A' ' 578' ' ' LEU . 1.7 mt -84.18 109.58 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.124 -0.985 . . . . 0.0 108.353 178.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' A' ' 597' ' ' GLY . 1.9 mp0 -51.66 172.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.655 -0.653 . . . . 0.0 109.869 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.495 ' HA ' ' HB3' ' A' ' 577' ' ' PHE . 4.2 mt-30 -66.55 65.31 0.05 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.477 -0.764 . . . . 0.0 110.086 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 135.09 27.19 0.48 Allowed Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.611 -1.28 . . . . 0.0 110.988 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -80.08 102.23 5.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.392 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 627' ' ' LYS . 14.2 t-20 -144.3 133.45 11.33 Favored Pre-proline 0 C--N 1.282 -2.341 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.367 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.676 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 55.2 Cg_endo -91.96 162.86 26.92 Favored 'Cis proline' 0 C--N 1.311 -1.442 0 C-N-CA 123.086 -1.631 . . . . 0.0 108.891 -2.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.565 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 5.5 t80 -105.97 116.42 31.91 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.676 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 73.8 m-85 -84.96 144.83 28.07 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.323 -0.861 . . . . 0.0 110.977 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.88 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.8 mt -142.19 141.62 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.724 -0.61 . . . . 0.0 110.291 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.834 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 167.88 -167.58 40.16 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.331 -1.414 . . . . 0.0 111.306 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 8.0 tpt180 -63.01 -36.34 83.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.889 -0.771 . . . . 0.0 111.774 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.22 121.62 28.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.043 -1.036 . . . . 0.0 111.246 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.559 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 7.0 tm-20 -53.11 -19.06 2.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 110.02 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.55 -30.24 2.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.347 -0.846 . . . . 0.0 109.292 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 602' ' ' PHE . 4.7 m -69.06 136.37 52.25 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.496 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -47.82 -25.09 1.16 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.276 -0.89 . . . . 0.0 110.056 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.88 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.0 t -110.52 143.32 41.06 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.589 ' O ' HG13 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -106.93 127.23 53.26 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.099 -1.001 . . . . 0.0 112.682 -178.694 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.868 HG22 HD22 ' A' ' 618' ' ' LEU . 2.3 mt -144.01 108.99 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.536 ' H ' HD11 ' A' ' 588' ' ' ILE . 3.1 tt0 -97.79 104.48 16.51 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.302 -1.359 . . . . 0.0 108.916 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.573 ' HA ' ' CZ ' ' A' ' 688' ' ' PHE . 6.1 m-20 -138.41 106.1 5.61 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.531 177.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -43.32 -42.3 4.44 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.671 -0.643 . . . . 0.0 111.953 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -83.09 -17.16 44.08 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.096 -1.002 . . . . 0.0 111.098 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.868 HD22 HG22 ' A' ' 613' ' ' ILE . 0.5 OUTLIER -79.74 140.4 36.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.25 -0.906 . . . . 0.0 110.677 -179.335 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.435 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.89 161.83 28.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.274 -0.891 . . . . 0.0 110.794 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.809 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -64.22 -45.24 89.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.337 -0.852 . . . . 0.0 109.534 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 1.021 HG11 HG23 ' A' ' 727' ' ' VAL . 11.5 t -95.76 2.22 9.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.383 -0.823 . . . . 0.0 109.405 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.8 t60 -26.05 -47.12 0.02 OUTLIER 'General case' 0 C--O 1.194 -1.831 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.46 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.804 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.69 146.09 43.38 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 118.049 -1.46 . . . . 0.0 111.955 179.528 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.55 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 2.0 p90 -145.3 148.91 33.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.6 -0.688 . . . . 0.0 109.984 177.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.596 ' CD1' HD11 ' A' ' 580' ' ' LEU . 13.8 mt -103.72 124.41 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 6.0 t80 -117.32 155.24 29.87 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.481 -0.762 . . . . 0.0 109.386 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.49 ' NZ ' HG23 ' A' ' 647' ' ' ILE . 4.3 tppt? -119.73 137.06 54.17 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.604 0.716 . . . . 0.0 110.896 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.417 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -139.09 163.07 33.39 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.719 -0.613 . . . . 0.0 109.641 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -78.5 121.24 24.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.974 -1.079 . . . . 0.0 109.314 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.522 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.0 t60 -63.26 123.82 19.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 111.07 -178.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -96.63 98.17 9.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.615 -0.678 . . . . 0.0 109.941 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 633' ' ' GLY . 6.3 p -57.34 168.29 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.41 -0.806 . . . . 0.0 110.323 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.507 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -75.2 89.63 0.8 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 51.3 -164.04 0.06 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.355 -1.085 . . . . 0.0 110.48 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 89.6 p -167.69 58.9 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.392 -0.817 . . . . 0.0 110.356 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 1.7 mtm -97.31 33.28 2.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.24 -0.912 . . . . 0.0 109.798 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -160.43 -154.94 0.4 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -115.61 101.85 9.23 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.062 -1.024 . . . . 0.0 108.975 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 77.8 p -136.98 151.43 72.11 Favored Pre-proline 0 C--N 1.294 -1.847 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.956 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 640' ' ' PRO . . . . . 0.589 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 48.5 Cg_endo -70.0 -152.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.664 1.349 . . . . 0.0 109.912 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 66.77 -65.37 0.21 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.693 -0.63 . . . . 0.0 110.413 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 642' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 640' ' ' PRO . 8.4 tt0 48.93 31.28 3.15 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.28 -0.887 . . . . 0.0 110.325 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.4 ' O ' ' HG ' ' A' ' 644' ' ' LEU . . . 70.01 120.6 0.04 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.588 ' CD1' ' HA ' ' A' ' 703' ' ' PHE . 2.9 mt -138.55 -150.72 0.35 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 122.185 -0.597 . . . . 0.0 109.393 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.533 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.0 OUTLIER -112.83 124.9 53.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.963 -1.085 . . . . 0.0 111.061 -179.592 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.722 ' OD1' HD21 ' A' ' 671' ' ' LEU . 37.6 t0 -112.72 143.63 43.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 0.0 110.188 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.49 HG23 ' NZ ' ' A' ' 627' ' ' LYS . 8.5 pt -99.39 132.36 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.259 -0.9 . . . . 0.0 109.663 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.624 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.2 m95 -118.12 142.95 46.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.527 -0.733 . . . . 0.0 110.918 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.92 ' CB ' HD11 ' A' ' 672' ' ' LEU . 27.0 t80 -103.24 114.81 29.39 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.5 OUTLIER -104.06 102.63 12.38 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.641 -178.531 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.526 ' CD2' ' N ' ' A' ' 652' ' ' THR . 8.7 t60 -64.2 156.63 28.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.345 -0.847 . . . . 0.0 109.294 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -149.55 -28.22 0.26 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.364 -0.835 . . . . 0.0 112.543 -179.122 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.587 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.51 -163.82 27.26 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 117.943 -2.075 . . . . 0.0 109.724 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 25.2 m -96.93 -17.99 19.76 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.961 -1.317 . . . . 0.0 113.921 -176.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.691 ' C ' HG13 ' A' ' 656' ' ' VAL . 20.3 m120 -59.6 -2.96 0.4 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.774 -1.204 . . . . 0.0 112.591 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.691 HG13 ' C ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 63.38 138.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-O 121.69 0.757 . . . . 0.0 110.161 -179.332 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.449 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -91.48 142.73 27.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.653 -0.655 . . . . 0.0 110.685 -178.905 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.466 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 6.1 m-85 -132.42 126.55 33.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.354 -0.841 . . . . 0.0 110.496 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.694 HD21 ' OD2' ' A' ' 676' ' ' ASP . 0.0 OUTLIER -130.97 115.38 16.42 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.366 -0.834 . . . . 0.0 109.955 179.515 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.08 -81.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.391 -0.818 . . . . 0.0 110.343 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.4 OUTLIER -148.36 26.87 0.94 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.0 110.157 179.865 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -111.21 133.52 53.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.234 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.421 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 6.5 tmm_? -98.71 126.66 44.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.372 -0.83 . . . . 0.0 110.102 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.534 ' HG2' HG13 ' A' ' 716' ' ' VAL . 4.4 mtp -108.06 -167.73 1.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 110.345 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.637 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.7 pt -138.43 -164.22 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.352 -0.842 . . . . 0.0 110.279 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 666' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 652' ' ' THR . 51.5 tt0 -79.81 82.27 5.93 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.49 -0.756 . . . . 0.0 110.505 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.07 52.19 0.24 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.637 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.3 OUTLIER -121.15 148.3 44.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.018 -1.284 . . . . 0.0 110.111 179.678 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.42 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.3 ttpm? -108.31 141.34 40.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.492 -0.755 . . . . 0.0 109.456 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.451 ' HB2' ' CE ' ' A' ' 664' ' ' MET . 0.5 OUTLIER -144.42 146.72 32.65 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.49 -178.828 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.722 HD21 ' OD1' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -71.31 147.17 48.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.511 -0.743 . . . . 0.0 111.197 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.92 HD11 ' CB ' ' A' ' 649' ' ' TYR . 3.0 mp -113.45 104.98 12.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.637 -0.664 . . . . 0.0 111.5 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.404 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 88.6 mt-30 -88.47 151.04 22.81 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.671 ' OD2' HD22 ' A' ' 707' ' ' LEU . 2.8 p30 -48.22 143.83 4.3 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.162 -0.961 . . . . 0.0 110.377 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.96 46.29 52.83 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 107.841 -2.104 . . . . 0.0 107.841 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.694 ' OD2' HD21 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -100.38 88.94 3.8 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.795 -0.826 . . . . 0.0 110.512 -179.14 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.788 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -93.41 107.08 18.98 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.397 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.627 HG21 HD11 ' A' ' 659' ' ' LEU . 1.8 pt -115.12 137.95 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.631 -0.668 . . . . 0.0 111.737 -176.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 679' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 7.2 mttp -96.89 111.23 23.52 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.804 HD13 ' SG ' ' A' ' 623' ' ' CYS . 73.1 mt -77.32 -11.76 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.299 -0.875 . . . . 0.0 110.64 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 688' ' ' PHE . 14.4 tt -143.2 133.87 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.074 -1.016 . . . . 0.0 110.158 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -138.11 111.69 8.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.149 -0.969 . . . . 0.0 110.738 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.3 117.15 19.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.233 -0.917 . . . . 0.0 109.86 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -46.93 72.71 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.361 -0.837 . . . . 0.0 110.954 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -66.94 -38.82 86.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.219 -0.925 . . . . 0.0 109.947 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 686' ' ' ASN . . . . . 0.58 ' O ' ' C ' ' A' ' 687' ' ' LYS . 1.5 m-80 -122.07 84.27 2.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.586 -0.696 . . . . 0.0 109.551 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 687' ' ' LYS . . . . . 0.58 ' C ' ' O ' ' A' ' 686' ' ' ASN . 23.4 mmtp -19.74 -82.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 122.054 -0.404 . . . . 0.0 111.335 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.573 ' CZ ' ' HA ' ' A' ' 615' ' ' ASP . 1.3 t80 33.8 73.41 0.07 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.504 -0.747 . . . . 0.0 110.099 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 586' ' ' SER . 58.6 t -112.21 143.14 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.459 -0.775 . . . . 0.0 111.49 -178.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.753 ' CD1' HG22 ' A' ' 587' ' ' ILE . 16.1 mm -103.46 164.65 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.443 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -177.12 115.8 0.52 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.001 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.788 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 12.8 m-85 -119.92 137.49 54.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -1.042 . . . . 0.0 109.138 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -101.5 114.75 29.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 110.593 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.653 HG22 HD11 ' A' ' 578' ' ' LEU . 1.2 t -82.43 121.48 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.578 -0.701 . . . . 0.0 109.169 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.12 104.83 7.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.711 -0.618 . . . . 0.0 110.172 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.451 HD13 ' O ' ' A' ' 705' ' ' GLU . 19.9 mt -80.91 104.43 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 0.0 109.935 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -72.78 -43.08 63.25 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.306 -0.872 . . . . 0.0 108.973 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.452 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 6.5 m-20 -110.68 140.75 44.76 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.618 0.723 . . . . 0.0 110.741 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 28.6 p -115.43 96.06 5.47 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 39.3 p -126.5 131.63 51.58 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.642 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 701' ' ' GLY . . . . . 0.426 ' C ' HD22 ' A' ' 644' ' ' LEU . . . 51.15 35.85 34.6 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 704' ' ' ASN . 5.3 tp -108.99 132.96 53.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.451 -1.029 . . . . 0.0 111.036 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.633 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 3.3 p90 -48.47 -25.02 1.47 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.644 0.735 . . . . 0.0 110.301 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.633 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.1 t30 -173.46 154.72 2.65 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.457 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 15.9 pt-20 -51.02 -26.06 5.61 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.095 -1.003 . . . . 0.0 110.475 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 118.92 18.22 4.78 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.671 HD22 ' OD2' ' A' ' 674' ' ' ASP . 0.1 OUTLIER -82.85 9.19 10.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.012 -1.287 . . . . 0.0 111.33 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 64.61 87.12 0.05 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.96 38.67 3.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.347 -1.09 . . . . 0.0 110.382 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.533 HD12 ' HB2' ' A' ' 712' ' ' GLU . 0.5 OUTLIER -103.92 166.81 10.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.364 -0.835 . . . . 0.0 110.158 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -58.93 -52.87 63.89 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.308 -0.87 . . . . 0.0 110.16 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.533 ' HB2' HD12 ' A' ' 710' ' ' LEU . 1.3 mt-10 -63.8 148.68 48.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.496 -0.752 . . . . 0.0 109.917 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -110.9 95.71 5.72 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.232 -0.917 . . . . 0.0 109.283 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.461 ' CZ ' HD23 ' A' ' 659' ' ' LEU . 0.1 OUTLIER 43.6 75.9 0.09 Allowed 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.269 0.557 . . . . 0.0 111.389 179.701 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.44 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 31.9 m -107.25 150.1 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 109.214 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.534 HG13 ' HG2' ' A' ' 664' ' ' MET . 85.1 t -95.45 133.16 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 110.729 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.2 mp -108.86 162.34 14.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.42 -0.8 . . . . 0.0 110.094 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.17 154.61 17.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.36 -0.838 . . . . 0.0 110.1 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.62 148.02 31.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.304 -0.872 . . . . 0.0 110.406 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 11.1 p -121.35 -176.2 3.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.379 -0.826 . . . . 0.0 110.384 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.44 -29.2 34.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.369 -0.832 . . . . 0.0 110.002 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -66.05 -45.45 81.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.421 -0.799 . . . . 0.0 109.523 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.95 -46.91 79.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.47 -0.769 . . . . 0.0 109.62 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.492 ' O ' HG12 ' A' ' 727' ' ' VAL . 9.1 tttt -53.53 -32.64 51.37 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.427 -0.795 . . . . 0.0 109.746 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.59 -35.94 78.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.527 -0.733 . . . . 0.0 110.33 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 34.4 mt -58.92 -46.84 86.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.274 -0.891 . . . . 0.0 110.305 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 1.021 HG23 HG11 ' A' ' 621' ' ' VAL . 7.5 p -70.8 -19.87 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.557 -0.715 . . . . 0.0 110.264 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.0 -43.51 66.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.265 -0.897 . . . . 0.0 108.956 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.94 103.52 10.37 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 122.222 1.01 . . . . 0.0 109.191 177.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.4 ' O ' ' CD2' ' A' ' 602' ' ' PHE . 1.2 mt . . . . . 0 C--N 1.273 -2.74 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.344 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.76 -1.336 . . . . 4.2000000000000002 109.76 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.36 -10.3 59.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -1.214 . . . . 3.9700000000000002 109.874 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 575' ' ' GLY . . . . . 0.637 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 132.53 -4.93 5.19 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 110.167 -1.173 . . . . 0.91000000000000003 110.167 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 576' ' ' ARG . . . . . 0.434 ' HD3' ' HB3' ' A' ' 593' ' ' GLU . 1.9 ttp180 -91.4 115.15 27.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.853 -1.38 . . . . 1.48 109.387 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 577' ' ' PHE . . . . . 0.608 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -115.5 -42.1 3.18 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.053 0.93 . . . . 1.03 109.241 -179.178 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.608 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 9.4 tt -120.45 128.79 53.49 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.872 -0.603 . . . . 1.1799999999999999 110.749 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 61.7 m -104.36 116.83 32.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 0.26000000000000001 109.704 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 580' ' ' LEU . . . . . 0.759 HD12 HG13 ' A' ' 594' ' ' ILE . 4.1 mt -92.11 112.6 24.6 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.843 -1.169 . . . . 0.89000000000000001 107.843 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 581' ' ' LYS . . . . . 0.441 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 1.0 OUTLIER -113.5 102.77 55.18 Favored Pre-proline 0 C--N 1.301 -1.502 0 C-N-CA 118.337 -1.345 . . . . 0.93000000000000005 112.565 -178.089 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 582' ' ' PRO . . . . . 1.06 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.7 Cg_endo -77.49 143.11 21.47 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 N-CA-C 105.83 -2.411 . . . . 0.25 105.83 174.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 583' ' ' LEU . . . . . 0.724 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.41 -177.53 0.52 Allowed Pre-proline 0 N--CA 1.497 1.909 0 C-N-CA 118.181 -1.408 . . . . 1.1000000000000001 113.848 -176.233 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 584' ' ' PRO . . . . . 0.724 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.6 Cg_endo -66.96 -34.83 28.24 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 124.253 1.659 . . . . 0.51000000000000001 111.75 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -58.25 -29.32 65.68 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.173 -1.417 . . . . 1.4199999999999999 107.173 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 586' ' ' SER . . . . . 0.532 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 3.0 t -95.92 150.8 20.04 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.396 -0.964 . . . . 1.1599999999999999 108.396 177.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 587' ' ' ILE . . . . . 0.67 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.5 OUTLIER -57.52 -15.98 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.994 -1.066 . . . . 1.29 109.428 179.457 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 588' ' ' ILE . . . . . 0.771 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 8.1 mm -98.49 114.67 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.388 -0.82 . . . . 1.6599999999999999 109.153 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -122.65 69.29 0.97 Allowed 'General case' 0 N--CA 1.507 2.395 0 O-C-N 120.711 -1.243 . . . . 1.29 109.512 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 590' ' ' GLU . . . . . 1.06 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 27.6 mt-10 -142.74 176.04 9.35 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.132 -0.94 . . . . 2.1299999999999999 109.004 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.551 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.73 123.67 35.92 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.791 -1.193 . . . . 0.22 109.926 177.382 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.547 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.8 mt -112.07 155.52 23.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.457 -0.777 . . . . 1.0800000000000001 109.37 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.434 ' HB3' ' HD3' ' A' ' 576' ' ' ARG . 10.5 mp0 -126.99 113.87 17.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 1.6699999999999999 111.501 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 594' ' ' ILE . . . . . 0.759 HG13 HD12 ' A' ' 580' ' ' LEU . 4.1 mt -72.13 109.36 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.98 -1.075 . . . . 0.46999999999999997 108.31 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 595' ' ' GLN . . . . . 0.637 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -61.52 107.95 0.88 Allowed 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.601 -0.687 . . . . 1.52 110.738 -178.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 596' ' ' GLN . . . . . 0.629 ' N ' ' O ' ' A' ' 575' ' ' GLY . 3.5 tt0 -11.52 87.29 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.298 0.571 . . . . 1.3400000000000001 112.253 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 597' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 105.87 22.1 8.2 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.668 -1.373 . . . . 1.0600000000000001 109.668 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 598' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 598' ' ' VAL . 1.2 t -82.28 103.59 9.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 107.074 -1.454 . . . . 0.53000000000000003 107.074 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 599' ' ' ASN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 627' ' ' LYS . 7.9 t30 -143.17 134.2 12.57 Favored Pre-proline 0 C--N 1.281 -2.403 0 CA-C-N 114.549 -1.205 . . . . 1.52 110.19 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 600' ' ' PRO . . . . . 0.668 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 54.9 Cg_endo -91.56 162.26 28.1 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.804 -1.748 . . . . 0.33000000000000002 109.334 -1.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 601' ' ' PHE . . . . . 0.625 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 5.1 t80 -106.28 117.21 33.45 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.363 -1.347 . . . . 0.28000000000000003 107.363 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 602' ' ' PHE . . . . . 0.681 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 56.3 m-85 -88.71 146.04 25.29 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.378 -0.826 . . . . 0.53000000000000003 110.939 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 603' ' ' ILE . . . . . 0.746 HD11 HG13 ' A' ' 625' ' ' ILE . 2.9 mt -141.76 139.72 31.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.965 -0.694 . . . . 0.28999999999999998 109.962 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.708 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 174.82 -166.81 38.74 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.505 -1.331 . . . . 0.22 110.977 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 605' ' ' ARG . . . . . 0.482 ' HD2' ' HA ' ' A' ' 614' ' ' GLU . 14.8 tpt180 -65.4 -38.83 91.14 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.858 -0.79 . . . . 1.5600000000000001 110.591 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 606' ' ' SER . . . . . 0.412 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 1.0 OUTLIER -81.04 122.32 27.16 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.323 -0.861 . . . . 0.75 110.862 -179.351 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.508 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.1 OUTLIER -57.73 -15.2 7.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 2.3900000000000001 109.79 178.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.09 -36.19 5.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.502 -0.749 . . . . 1.72 110.068 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 609' ' ' CYS . . . . . 0.681 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 73.6 m -67.41 152.71 45.21 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.552 -0.859 . . . . 0.98999999999999999 109.451 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 610' ' ' ASN . . . . . 0.566 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 1.5 t30 -57.06 -14.35 3.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.46 -0.775 . . . . 1.23 110.473 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 611' ' ' CYS . . . . . 0.711 ' HB3' HG23 ' A' ' 603' ' ' ILE . 8.7 t -120.08 144.21 47.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.398 -0.814 . . . . 0.34000000000000002 109.804 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 612' ' ' LYS . . . . . 0.508 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -110.46 120.06 41.21 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 122.158 0.98 . . . . 2.1699999999999999 113.29 -178.117 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 613' ' ' ILE . . . . . 0.771 ' HA ' ' CD1' ' A' ' 588' ' ' ILE . 14.1 mt -142.8 107.92 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 107.36 -1.348 . . . . 0.55000000000000004 107.36 176.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 614' ' ' GLU . . . . . 0.482 ' HA ' ' HD2' ' A' ' 605' ' ' ARG . 6.0 tt0 -92.45 104.4 16.73 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.98 1.371 . . . . 2.2799999999999998 109.664 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 615' ' ' ASP . . . . . 0.626 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.8 m-20 -138.4 106.06 5.61 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.074 -1.421 . . . . 1.3899999999999999 107.971 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -39.65 -44.27 1.48 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.617 -0.677 . . . . 1.8500000000000001 112.131 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.78 -17.32 41.52 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.093 -1.005 . . . . 2.9300000000000002 111.672 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.686 HD12 HD11 ' A' ' 681' ' ' ILE . 0.8 OUTLIER -78.04 119.28 21.24 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.019 -1.051 . . . . 0.40999999999999998 110.768 -179.137 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 619' ' ' SER . . . . . 0.476 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -59.18 159.86 7.04 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.4 -0.813 . . . . 0.91000000000000003 110.809 179.852 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 620' ' ' ARG . . . . . 0.708 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -63.91 -45.39 89.53 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.32 -0.862 . . . . 2.4199999999999999 109.183 179.521 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 621' ' ' VAL . . . . . 0.49 ' HB ' HG23 ' A' ' 727' ' ' VAL . 10.5 m -95.06 1.84 9.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.355 -0.84 . . . . 1.02 109.469 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 6.3 t60 -28.87 -46.79 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.622 -0.717 . . . . 0.22 110.875 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 623' ' ' CYS . . . . . 0.778 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.6 OUTLIER -136.45 145.77 45.58 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.45 -1.3 . . . . 0.19 110.777 178.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 624' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 3.1 p90 -144.72 149.58 35.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.458 -0.776 . . . . 0.53000000000000003 110.219 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 625' ' ' ILE . . . . . 0.746 HG13 HD11 ' A' ' 603' ' ' ILE . 69.2 mt -104.54 121.75 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.765 -0.828 . . . . 0.64000000000000001 108.765 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 626' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 4.5 t80 -115.27 153.96 29.95 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.52 -0.737 . . . . 0.92000000000000004 109.439 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 627' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 1.2 ttmt -120.12 137.08 54.35 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.578 0.704 . . . . 0.93999999999999995 110.501 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 628' ' ' LYS . . . . . 0.417 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.57 163.32 29.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.594 -0.691 . . . . 1.9399999999999999 110.321 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 629' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.5 OUTLIER -78.32 115.08 17.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.95 . . . . 2.1299999999999999 108.74 179.82 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 630' ' ' HIS . . . . . 0.538 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.9 t60 -58.7 124.52 20.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.505 -0.747 . . . . 0.69999999999999996 110.846 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -93.2 102.98 15.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.673 -0.642 . . . . 1.04 110.016 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 632' ' ' VAL . . . . . 0.542 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.3 p -61.23 170.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.395 -0.816 . . . . 1.9399999999999999 110.403 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 633' ' ' GLY . . . . . 0.542 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -91.72 58.69 2.93 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.89 -1.284 . . . . 2.8399999999999999 109.89 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 72.3 tttt 57.49 107.41 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.412 -1.052 . . . . 6.2199999999999998 110.646 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 79.6 p -90.91 94.49 9.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.91 . . . . 4.4400000000000004 110.142 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 2.8 mtt -90.8 44.35 1.19 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.25 -0.907 . . . . 7.3799999999999999 110.214 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.09 -151.87 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.826 -0.805 . . . . 7.6200000000000001 108.826 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -108.86 98.87 8.29 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.99 -1.069 . . . . 5.1600000000000001 108.311 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 25.0 p -139.57 152.04 67.82 Favored Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 115.799 -0.637 . . . . 2.8300000000000001 109.839 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.43 -152.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.554 1.291 . . . . 2.3799999999999999 108.988 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 641' ' ' ALA . . . . . 0.491 ' HA ' HD13 ' A' ' 644' ' ' LEU . . . 50.03 24.81 1.47 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.417 -0.802 . . . . 1.9099999999999999 110.997 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -68.8 64.62 0.12 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.274 -0.891 . . . . 3.6000000000000001 110.152 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 643' ' ' GLY . . . . . 0.626 ' C ' HD12 ' A' ' 644' ' ' LEU . . . 62.4 110.44 0.01 OUTLIER Glycine 0 N--CA 1.487 2.061 0 N-CA-C 110.244 -1.142 . . . . 0.93999999999999995 110.244 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 644' ' ' LEU . . . . . 0.751 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.0 mp -139.53 -153.77 0.48 Allowed 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.97 -0.752 . . . . 1.23 108.97 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 645' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 13.2 m-20 -112.54 123.97 51.48 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.974 -1.079 . . . . 1.54 111.276 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 646' ' ' ASP . . . . . 0.535 ' OD2' HD21 ' A' ' 671' ' ' LEU . 26.5 t70 -109.57 146.8 34.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.513 -0.742 . . . . 1.2 109.665 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 647' ' ' ILE . . . . . 0.554 HD13 ' CD1' ' A' ' 578' ' ' LEU . 12.5 pt -102.49 130.66 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.279 -0.888 . . . . 0.28999999999999998 110.039 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 648' ' ' TRP . . . . . 0.616 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 91.3 m95 -118.58 119.71 35.31 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.092 -0.643 . . . . 0.32000000000000001 110.754 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.853 ' HB2' HD11 ' A' ' 672' ' ' LEU . 3.8 t80 -80.93 114.69 19.98 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.366 -0.975 . . . . 0.33000000000000002 108.366 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 650' ' ' CYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.1 OUTLIER -106.35 114.29 28.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.909 . . . . 1.1200000000000001 111.564 -178.608 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.706 ' HE1' ' O ' ' A' ' 653' ' ' GLY . 29.0 t-80 -74.04 159.92 32.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.451 -0.781 . . . . 0.23999999999999999 109.975 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -149.96 -30.59 0.22 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.403 -0.81 . . . . 0.31 112.968 -179.158 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 653' ' ' GLY . . . . . 0.706 ' O ' ' HE1' ' A' ' 651' ' ' HIS . . . -78.03 -167.73 30.93 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 117.579 -2.248 . . . . 0.71999999999999997 109.416 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 24.3 m -94.94 -17.85 21.62 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.968 -1.313 . . . . 0.54000000000000004 113.91 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 655' ' ' ASN . . . . . 0.535 ' O ' HG12 ' A' ' 656' ' ' VAL . 30.5 m120 -60.85 -4.29 0.96 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.774 -1.204 . . . . 1.79 112.398 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 75.45 166.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-O 121.95 0.881 . . . . 1.46 110.648 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 657' ' ' SER . . . . . 0.539 ' CB ' ' CD2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -123.73 145.51 48.96 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.162 -0.615 . . . . 0.28999999999999998 110.585 -178.921 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.434 ' CE1' ' CG ' ' A' ' 663' ' ' ARG . 15.7 m-85 -135.64 126.32 27.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.272 -0.893 . . . . 1.22 110.615 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.64 HD22 ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -128.2 109.85 11.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.273 -0.892 . . . . 1.28 109.927 179.231 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.77 -80.34 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.484 -0.76 . . . . 1.73 110.358 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 661' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.6 OUTLIER -146.13 25.21 1.27 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.25 -0.906 . . . . 2.1899999999999999 110.307 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.03 117.95 30.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.284 -0.885 . . . . 1.45 110.285 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 663' ' ' ARG . . . . . 0.434 ' CG ' ' CE1' ' A' ' 658' ' ' TYR . 3.0 tmm_? -84.39 141.06 31.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 2.4300000000000002 110.098 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 664' ' ' MET . . . . . 0.597 ' O ' HG22 ' A' ' 656' ' ' VAL . 3.5 mtp -118.89 -166.12 1.21 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.279 -0.888 . . . . 0.63 110.294 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 665' ' ' ILE . . . . . 0.624 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.4 pt -138.34 -160.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.225 -0.922 . . . . 0.5 110.365 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -81.65 90.43 6.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.398 -0.814 . . . . 0.75 110.564 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.07 50.43 0.68 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.021 -1.232 . . . . 0.28000000000000003 110.021 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 668' ' ' THR . . . . . 0.624 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.1 OUTLIER -117.61 149.43 40.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.113 -1.227 . . . . 0.29999999999999999 110.13 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.454 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 10.8 tttt -108.39 141.01 40.87 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.985 -0.746 . . . . 0.67000000000000004 108.985 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 670' ' ' PHE . . . . . 0.64 ' CD2' HD22 ' A' ' 659' ' ' LEU . 13.5 t80 -143.96 146.29 32.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.148 -0.97 . . . . 1.03 111.665 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 671' ' ' LEU . . . . . 0.616 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -73.08 147.26 45.14 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.626 -0.671 . . . . 1.3100000000000001 110.621 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 672' ' ' LEU . . . . . 0.853 HD11 ' HB2' ' A' ' 649' ' ' TYR . 12.8 mt -118.56 112.83 20.39 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.672 -0.811 . . . . 0.84999999999999998 111.306 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 673' ' ' GLN . . . . . 0.496 ' O ' HG11 ' A' ' 694' ' ' VAL . 75.2 mt-30 -90.25 -177.43 5.12 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.044 -0.725 . . . . 1.1599999999999999 109.044 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 674' ' ' ASP . . . . . 0.582 ' OD1' HD12 ' A' ' 707' ' ' LEU . 14.9 p-10 -76.26 142.83 41.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.138 -0.976 . . . . 1.21 109.691 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.34 47.2 59.48 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 107.788 -2.125 . . . . 0.29999999999999999 107.788 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 676' ' ' ASP . . . . . 0.61 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.5 OUTLIER -100.45 91.93 4.92 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.748 -0.854 . . . . 1.3300000000000001 110.491 -179.117 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.919 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.3 tt0 -93.16 107.42 19.23 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.76 -1.2 . . . . 1.79 107.76 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 678' ' ' ILE . . . . . 0.563 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.4 pt -111.73 137.74 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.419 0.628 . . . . 0.98999999999999999 111.667 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -98.95 111.01 23.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.515 -0.741 . . . . 2.4399999999999999 109.4 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 680' ' ' ILE . . . . . 0.778 HD13 ' SG ' ' A' ' 623' ' ' CYS . 72.8 mt -75.35 -24.11 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.23000000000000001 110.352 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 681' ' ' ILE . . . . . 0.686 HD11 HD12 ' A' ' 618' ' ' LEU . 3.6 mt -143.02 136.15 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -0.942 . . . . 1.3400000000000001 110.394 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -137.49 108.91 6.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.435 -0.79 . . . . 1.0700000000000001 110.109 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.36 118.36 29.27 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.265 -0.897 . . . . 1.4299999999999999 110.221 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -65.99 -46.35 78.31 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.423 -0.798 . . . . 2.21 110.887 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -80.4 -43.31 21.25 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.252 -0.905 . . . . 2.0499999999999998 110.68 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.74 -13.8 58.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.306 -0.871 . . . . 2.4100000000000001 110.471 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 57.23 18.95 4.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.221 -0.925 . . . . 2.6600000000000001 110.56 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 688' ' ' PHE . . . . . 0.414 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -74.66 77.98 2.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 1.3100000000000001 109.034 179.252 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 689' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 586' ' ' SER . 43.5 t -101.63 136.15 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.82 . . . . 1.3899999999999999 110.881 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 690' ' ' ILE . . . . . 0.67 ' CD1' HG22 ' A' ' 587' ' ' ILE . 47.1 mm -117.5 163.26 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.738 -0.838 . . . . 0.81000000000000005 108.738 178.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 691' ' ' GLY . . . . . 0.532 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -172.98 125.39 1.14 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.511 -1.328 . . . . 0.25 109.932 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 692' ' ' PHE . . . . . 0.919 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 6.9 m-85 -120.63 137.71 54.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.603 -0.939 . . . . 0.25 109.484 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -100.67 113.71 26.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.13 -0.981 . . . . 2.2400000000000002 110.031 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 694' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 694' ' ' VAL . 1.2 t -85.45 115.03 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.365 -0.835 . . . . 0.28000000000000003 108.884 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -122.55 103.92 9.02 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.136 -0.626 . . . . 1.6599999999999999 109.923 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 696' ' ' ILE . . . . . 0.483 HD13 ' O ' ' A' ' 705' ' ' GLU . 74.0 mt -77.23 103.95 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.4 -0.812 . . . . 0.37 109.113 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.21 -43.51 28.26 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.355 -0.841 . . . . 1.1399999999999999 108.808 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 698' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 8.0 m-20 -111.33 141.81 44.38 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.543 0.687 . . . . 1.1899999999999999 110.612 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 27.1 p -115.27 96.1 5.5 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.164 -1.421 . . . . 0.52000000000000002 107.164 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 6.7 m -127.43 132.63 50.04 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.305 0.574 . . . . 1.6000000000000001 111.077 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 50.4 25.99 9.19 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.135 -1.186 . . . . 1.3100000000000001 110.135 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 702' ' ' LEU . . . . . 0.739 ' O ' HD22 ' A' ' 644' ' ' LEU . 0.9 OUTLIER -102.23 134.87 44.81 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.283 -1.128 . . . . 1.22 110.239 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 703' ' ' PHE . . . . . 0.751 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.4 p90 -49.47 -24.28 1.96 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.627 -0.67 . . . . 0.76000000000000001 110.673 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 704' ' ' ASN . . . . . 0.643 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER -169.63 157.75 7.27 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.531 -0.731 . . . . 0.98999999999999999 109.031 -178.638 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.554 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 15.4 pt-20 -51.48 -26.5 8.37 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.201 -0.937 . . . . 1.5800000000000001 110.458 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 706' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 120.95 15.72 4.68 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.433 -1.467 . . . . 1.0900000000000001 109.433 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 707' ' ' LEU . . . . . 0.582 HD12 ' OD1' ' A' ' 674' ' ' ASP . 1.6 tp -82.73 9.16 10.26 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.005 -1.291 . . . . 1.72 111.622 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 708' ' ' GLY . . . . . 0.631 ' C ' HD23 ' A' ' 710' ' ' LEU . . . 66.61 43.56 91.82 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.866 -0.894 . . . . 2.0499999999999998 110.866 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 709' ' ' MET . . . . . 0.448 ' HG2' ' CG ' ' A' ' 704' ' ' ASN . 0.0 OUTLIER -83.29 101.62 11.4 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.05 -1.264 . . . . 1.8999999999999999 110.073 179.299 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 710' ' ' LEU . . . . . 0.631 HD23 ' C ' ' A' ' 708' ' ' GLY . 0.5 OUTLIER -172.78 -170.11 0.64 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.064 -1.022 . . . . 3.1699999999999999 110.347 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -90.9 -45.65 8.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.342 -0.849 . . . . 3.8300000000000001 110.412 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 712' ' ' GLU . . . . . 0.412 ' HB2' HD12 ' A' ' 710' ' ' LEU . 1.6 mt-10 -63.61 143.81 57.52 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.254 -0.904 . . . . 3.46 110.031 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -111.68 95.51 5.54 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.217 -0.927 . . . . 3.6299999999999999 109.73 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 714' ' ' ARG . . . . . 0.41 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 0.8 OUTLIER 39.91 83.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.238 0.542 . . . . 1.3799999999999999 111.691 179.346 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.86 153.1 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.553 -0.717 . . . . 0.63 109.522 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 716' ' ' VAL . . . . . 0.59 HG13 ' HG2' ' A' ' 664' ' ' MET . 48.1 t -96.52 133.33 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.121 -0.987 . . . . 0.58999999999999997 110.581 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 717' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 717' ' ' LEU . 4.9 mp -109.5 162.66 14.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.478 -0.764 . . . . 0.81999999999999995 109.94 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -99.16 149.05 23.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.971 . . . . 2.4300000000000002 110.045 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.92 150.13 30.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.829 . . . . 1.98 110.248 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 21.8 p -116.42 -176.48 2.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.55000000000000004 110.277 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.58 -28.96 35.07 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.337 -0.852 . . . . 0.57999999999999996 110.163 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.63 -47.88 71.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.385 -0.822 . . . . 2.3300000000000001 109.779 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 723' ' ' GLU . . . . . 0.583 ' OE1' HD12 ' A' ' 726' ' ' LEU . 12.3 mm-40 -64.21 -48.61 75.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.417 -0.802 . . . . 1.95 110.056 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 724' ' ' LYS . . . . . 0.49 ' O ' HG12 ' A' ' 727' ' ' VAL . 5.5 tttp -52.61 -33.19 45.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.389 -0.819 . . . . 2.3399999999999999 109.795 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 725' ' ' ASP . . . . . 0.406 ' HA ' ' HB2' ' A' ' 728' ' ' LYS . 3.6 t0 -68.39 -35.91 78.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.528 -0.732 . . . . 1.6000000000000001 109.911 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 726' ' ' LEU . . . . . 0.583 HD12 ' OE1' ' A' ' 723' ' ' GLU . 42.7 mt -55.95 -46.54 78.54 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.395 -0.816 . . . . 1.1000000000000001 110.018 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 727' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 724' ' ' LYS . 7.7 p -76.01 -21.01 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.606 -0.683 . . . . 1.1899999999999999 110.351 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 728' ' ' LYS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 725' ' ' ASP . 17.3 tttt -52.9 -43.09 65.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.238 -0.914 . . . . 2.5499999999999998 108.857 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -116.8 103.67 10.56 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.292 1.044 . . . . 2.5 109.138 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 730' ' ' LEU . . . . . 0.411 HD23 ' CG ' ' A' ' 602' ' ' PHE . 4.3 mt . . . . . 0 C--N 1.274 -2.687 0 CA-C-O 118.017 -0.992 . . . . 1.25 110.38 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.546 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 0.5 OUTLIER -150.92 -40.8 0.12 Allowed 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.045 0.926 . . . . 0.0 108.795 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.646 ' CD2' HD12 ' A' ' 594' ' ' ILE . 16.1 tp -130.69 119.59 22.63 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.335 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 88.7 m -102.66 118.3 36.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.141 -0.974 . . . . 0.0 109.434 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.636 HD11 HD12 ' A' ' 625' ' ' ILE . 15.3 mt -91.16 112.02 23.74 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.431 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -114.24 101.56 54.18 Favored Pre-proline 0 C--N 1.302 -1.473 0 C-N-CA 118.131 -1.428 . . . . 0.0 112.843 -177.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 1.131 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.2 Cg_endo -79.6 144.24 17.51 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 N-CA-C 105.788 -2.428 . . . . 0.0 105.788 174.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.709 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -123.48 -178.3 0.64 Allowed Pre-proline 0 N--CA 1.498 1.927 0 C-N-CA 118.214 -1.394 . . . . 0.0 114.082 -175.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.709 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.5 Cg_endo -67.6 -31.81 32.39 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 124.272 1.67 . . . . 0.0 111.375 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.79 -30.72 67.8 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.558 ' OG ' HD12 ' A' ' 583' ' ' LEU . 4.0 p -97.43 153.41 18.13 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.652 HD12 ' O ' ' A' ' 614' ' ' GLU . 4.7 pt -56.69 -17.15 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 109.637 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.759 HD12 ' HA ' ' A' ' 613' ' ' ILE . 7.0 mm -99.61 114.96 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.318 -0.864 . . . . 0.0 108.7 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.487 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -126.12 73.0 1.33 Allowed 'General case' 0 N--CA 1.508 2.443 0 O-C-N 120.653 -1.28 . . . . 0.0 110.587 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 1.131 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 49.6 mt-10 -143.04 174.7 10.45 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.521 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.32 126.34 40.59 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.589 -1.319 . . . . 0.0 109.752 176.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.825 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.1 mt -110.7 156.0 21.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 0.0 109.28 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -125.2 110.04 13.59 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.427 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.646 HD12 ' CD2' ' A' ' 578' ' ' LEU . 29.3 mt -80.28 108.39 13.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.406 ' O ' ' C ' ' A' ' 596' ' ' GLN . 3.8 mt-30 -70.99 120.67 16.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.507 -0.746 . . . . 0.0 111.261 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.546 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 11.6 mm-40 37.77 33.72 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.409 0.624 . . . . 0.0 111.035 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . 80.15 65.07 1.78 Allowed Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.654 ' O ' HG13 ' A' ' 598' ' ' VAL . 10.9 p -79.69 105.07 8.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.42 ' CB ' ' HB3' ' A' ' 627' ' ' LYS . 3.8 p-10 -121.72 150.9 56.43 Favored Pre-proline 0 C--N 1.28 -2.454 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.694 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.476 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.6 Cg_endo -86.68 157.46 51.63 Favored 'Cis proline' 0 C--N 1.308 -1.602 0 C-N-CA 121.075 -2.469 . . . . 0.0 109.511 0.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.481 ' CD2' ' HB2' ' A' ' 611' ' ' CYS . 3.0 t80 -106.25 116.11 31.37 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.561 ' HB3' ' SG ' ' A' ' 609' ' ' CYS . 60.6 m-85 -87.89 144.33 26.63 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.311 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.948 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.8 mt -141.02 142.12 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.742 -0.599 . . . . 0.0 110.602 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.784 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 170.37 -159.05 31.27 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.912 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 14.1 tpt180 -71.37 -47.24 57.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.819 -0.812 . . . . 0.0 110.957 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.88 126.97 31.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 110.808 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.554 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.2 OUTLIER -56.76 -15.54 4.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.832 . . . . 0.0 110.439 179.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -45.73 -35.94 4.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.251 -0.906 . . . . 0.0 109.125 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 602' ' ' PHE . 1.3 m -62.78 136.65 57.97 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.475 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -49.86 -25.51 3.22 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.307 -0.87 . . . . 0.0 109.628 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.948 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.1 t -109.03 143.57 38.16 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -110.48 128.55 55.67 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 122.198 0.999 . . . . 0.0 113.101 -178.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.759 ' HA ' HD12 ' A' ' 588' ' ' ILE . 13.0 mt -142.39 108.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.652 ' O ' HD12 ' A' ' 587' ' ' ILE . 1.4 tt0 -89.68 102.46 15.15 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 117.838 -1.545 . . . . 0.0 107.796 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.823 ' HB3' ' CB ' ' A' ' 618' ' ' LEU . 9.9 t0 -139.93 106.39 5.31 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.57 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -38.67 -65.86 0.32 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.579 -0.701 . . . . 0.0 112.747 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.72 -16.51 64.29 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.117 -0.99 . . . . 0.0 112.455 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.823 ' CB ' ' HB3' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -73.19 129.44 38.05 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.0 -1.062 . . . . 0.0 110.87 -179.035 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.405 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -66.8 160.89 24.94 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.287 -0.883 . . . . 0.0 110.818 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.784 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.7 mtt180 -64.43 -46.94 81.03 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.294 -0.879 . . . . 0.0 109.474 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.499 ' HB ' HG23 ' A' ' 727' ' ' VAL . 9.3 m -95.37 2.58 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.402 -0.811 . . . . 0.0 109.577 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.6 t60 -25.41 -45.94 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.263 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.84 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.7 OUTLIER -136.49 145.68 45.41 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.453 -1.299 . . . . 0.0 111.283 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 2.1 p90 -145.52 144.15 30.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.544 -0.723 . . . . 0.0 110.09 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.636 HD12 HD11 ' A' ' 580' ' ' LEU . 12.3 mt -103.28 121.42 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 9.4 t80 -114.52 154.87 27.48 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.397 -0.814 . . . . 0.0 109.861 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.432 ' HE2' HG23 ' A' ' 647' ' ' ILE . 5.2 ttmt -120.17 136.84 54.48 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.49 0.662 . . . . 0.0 110.583 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.469 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -138.93 163.57 31.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.628 -0.67 . . . . 0.0 110.357 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.0 OUTLIER -78.11 127.64 32.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.241 -0.912 . . . . 0.0 108.728 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.529 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.6 t60 . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 110.769 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.774 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.3 mp . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 24.4 m-20 -119.24 124.76 47.52 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.007 -1.058 . . . . 0.0 111.386 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.459 ' OD2' HD21 ' A' ' 671' ' ' LEU . 7.9 t0 -112.87 155.93 23.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.481 -0.762 . . . . 0.0 110.027 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.503 HD13 HD22 ' A' ' 578' ' ' LEU . 13.2 pt -107.08 134.71 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.252 -0.905 . . . . 0.0 109.943 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.71 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.4 m95 -119.05 124.01 45.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.649 -0.657 . . . . 0.0 111.233 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.623 ' HB2' HD11 ' A' ' 672' ' ' LEU . 12.5 t80 -83.37 114.95 21.79 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 8.2 t -108.67 109.17 20.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.051 -1.031 . . . . 0.0 111.423 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.599 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 9.4 t60 -75.28 160.72 30.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.43 -0.794 . . . . 0.0 110.057 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -152.52 -29.72 0.15 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.355 -0.841 . . . . 0.0 113.187 -178.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.599 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -79.28 135.48 15.48 Favored Glycine 0 N--CA 1.502 3.047 0 C-N-CA 117.866 -2.111 . . . . 0.0 110.212 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.8 m -36.87 -24.56 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.7 ' C ' HG13 ' A' ' 656' ' ' VAL . 2.4 t-20 -59.12 -2.22 0.25 Allowed 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.471 -1.393 . . . . 0.0 113.179 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.7 HG13 ' C ' ' A' ' 655' ' ' ASN . 0.9 OUTLIER 63.92 146.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.453 -0.779 . . . . 0.0 110.702 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.551 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -97.7 153.38 18.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.76 -0.587 . . . . 0.0 110.246 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.474 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 10.2 m-85 -138.45 125.4 21.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.324 -0.86 . . . . 0.0 110.057 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.662 HD11 HG21 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -134.52 121.16 20.61 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.318 -0.864 . . . . 0.0 109.908 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 6.5 m120 55.16 -86.29 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.479 -0.763 . . . . 0.0 110.437 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 659' ' ' LEU . 5.8 t30 -143.32 14.05 1.81 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.096 -1.003 . . . . 0.0 110.602 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -102.29 118.16 36.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.135 -0.978 . . . . 0.0 110.383 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.453 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 0.0 OUTLIER -85.04 139.01 32.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.366 -0.834 . . . . 0.0 110.004 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.468 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 3.5 mtp -120.25 -179.54 3.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 0.0 110.616 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.547 ' CG1' HG23 ' A' ' 668' ' ' THR . 7.0 pt -120.18 -161.0 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.41 -0.806 . . . . 0.0 110.093 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -84.96 72.03 10.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.345 -0.847 . . . . 0.0 110.748 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 134.2 59.54 0.07 OUTLIER Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.547 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.6 OUTLIER -124.31 149.89 46.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.155 -1.203 . . . . 0.0 110.318 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.492 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 11.9 tttt -108.79 133.67 52.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.493 -0.754 . . . . 0.0 109.016 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.527 ' CD1' HG22 ' A' ' 716' ' ' VAL . 11.9 t80 -138.01 146.42 43.06 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.485 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.71 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.9 OUTLIER -72.69 144.66 47.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.461 -0.774 . . . . 0.0 110.267 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 649' ' ' TYR . 1.3 mt -111.71 104.56 12.92 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.676 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -84.62 161.28 20.2 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -56.85 143.94 35.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.119 . . . . 0.0 109.569 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.67 47.27 50.01 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.664 -2.174 . . . . 0.0 107.664 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.416 ' HB2' ' CG1' ' A' ' 694' ' ' VAL . 0.1 OUTLIER -103.31 89.91 3.54 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.836 -0.803 . . . . 0.0 110.473 -179.108 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.933 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 7.1 tt0 -93.29 106.85 18.76 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.662 HG21 HD11 ' A' ' 659' ' ' LEU . 3.3 pt -111.1 137.32 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.346 0.593 . . . . 0.0 111.473 -177.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.415 ' HG2' ' HB2' ' A' ' 658' ' ' TYR . 0.0 OUTLIER -99.29 109.96 22.53 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.525 -0.734 . . . . 0.0 109.091 178.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.84 HD13 ' SG ' ' A' ' 623' ' ' CYS . 89.9 mt -74.35 -29.51 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.404 -0.81 . . . . 0.0 110.26 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.605 HG13 HD12 ' A' ' 618' ' ' LEU . 3.0 mt -143.0 133.26 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 109.851 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -138.42 111.79 8.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.572 -0.705 . . . . 0.0 110.108 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -129.12 117.54 21.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -66.69 -33.28 75.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.437 -0.789 . . . . 0.0 110.726 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -55.98 -43.52 77.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.395 -0.816 . . . . 0.0 111.08 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.05 12.14 11.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 110.706 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.31 23.69 2.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.159 -0.963 . . . . 0.0 110.41 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.55 ' CE2' ' HA ' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -72.81 74.39 1.13 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 0.0 109.53 179.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 681' ' ' ILE . 14.6 p -105.56 136.96 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.43 -0.794 . . . . 0.0 110.895 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.562 HG12 ' CG1' ' A' ' 587' ' ' ILE . 18.2 mt -108.38 163.77 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.347 -0.846 . . . . 0.0 108.928 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.449 ' N ' ' CB ' ' A' ' 586' ' ' SER . . . -170.84 123.62 1.06 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.933 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 11.4 m-85 -120.16 137.34 54.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.53 -0.982 . . . . 0.0 109.589 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 21.2 tptt -100.52 114.21 27.65 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 110.515 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.592 HG22 HD11 ' A' ' 578' ' ' LEU . 1.2 t -85.62 118.78 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.373 -0.829 . . . . 0.0 109.001 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -130.08 104.75 7.51 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.925 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 577' ' ' PHE . 10.9 mt -85.49 104.4 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 110.037 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -77.27 -43.15 34.37 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.54 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -111.02 140.94 45.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.712 -0.618 . . . . 0.0 110.316 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.406 ' O ' ' OG1' ' A' ' 699' ' ' THR . 2.0 p -114.94 96.45 5.71 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.423 HG21 ' CD ' ' A' ' 596' ' ' GLN . 4.6 p -81.93 92.94 6.82 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.507 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 47.6 42.97 20.96 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.614 ' O ' HD22 ' A' ' 644' ' ' LEU . 2.0 tp -85.79 148.78 25.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.45 -1.029 . . . . 0.0 110.337 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.774 ' HA ' HD13 ' A' ' 644' ' ' LEU . 5.1 p90 -49.47 -25.48 2.65 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.505 -0.747 . . . . 0.0 110.288 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.563 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.6 t30 . . . . . 0 C--N 1.301 -1.507 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.412 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 7.7 mmm-85 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.274 0.559 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.6 m -107.71 152.58 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.844 . . . . 0.0 109.406 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 670' ' ' PHE . 49.6 t -96.24 133.37 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 110.735 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.43 162.14 14.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.514 -0.742 . . . . 0.0 109.56 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -97.37 149.49 22.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 0.0 110.511 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -80.94 129.07 34.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.434 -0.791 . . . . 0.0 110.015 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.2 p -103.42 -176.39 3.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.393 -0.817 . . . . 0.0 110.19 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.31 -28.79 30.23 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.397 -0.814 . . . . 0.0 110.113 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.11 -51.69 62.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.849 . . . . 0.0 109.897 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -64.02 -47.58 79.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.997 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.532 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.0 OUTLIER -53.61 -32.73 52.36 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.322 -0.861 . . . . 0.0 110.076 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.45 -36.15 78.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.414 -0.804 . . . . 0.0 110.101 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 38.6 mt -58.55 -46.59 86.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.365 -0.834 . . . . 0.0 110.296 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 724' ' ' LYS . 7.8 p -71.42 -20.75 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.225 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -53.41 -45.31 69.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.24 -0.913 . . . . 0.0 108.81 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.8 104.44 11.34 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.218 1.009 . . . . 0.0 109.006 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.415 ' OXT' ' CD2' ' A' ' 602' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--N 1.274 -2.692 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.281 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.572 0.701 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.516 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 8.5 t80 -95.83 -43.28 7.93 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.92 0.867 . . . . 0.0 109.392 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.806 HD11 HD13 ' A' ' 647' ' ' ILE . 0.5 OUTLIER -126.97 136.98 53.0 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.043 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 88.4 m -113.43 117.26 31.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.14 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.598 HD12 HG13 ' A' ' 594' ' ' ILE . 2.6 mt -92.69 112.11 23.95 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.448 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 2.1 mmtt -112.81 102.18 54.18 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 118.255 -1.378 . . . . 0.0 113.24 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 1.08 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 45.0 Cg_endo -79.58 142.01 16.0 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 N-CA-C 105.32 -2.608 . . . . 0.0 105.32 173.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.746 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -119.16 -176.2 0.37 Allowed Pre-proline 0 N--CA 1.496 1.847 0 C-N-CA 118.16 -1.416 . . . . 0.0 113.896 -175.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.746 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.1 Cg_endo -66.82 -32.41 36.76 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 124.274 1.671 . . . . 0.0 112.033 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -59.08 -29.68 67.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.785 -1.197 . . . . 0.0 108.525 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.666 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 66.7 p -96.5 150.24 20.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.857 -0.527 . . . . 0.0 109.833 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.445 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -54.76 -20.31 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.146 -0.971 . . . . 0.0 109.028 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.865 HD12 ' HA ' ' A' ' 613' ' ' ILE . 9.2 mm -93.65 115.06 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.506 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -125.46 72.31 1.26 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 109.865 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 1.08 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 58.3 mm-40 -145.15 175.85 9.95 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.623 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.548 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.47 126.02 39.65 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.986 -1.071 . . . . 0.0 109.052 176.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.749 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.2 mp -109.79 154.08 23.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 0.0 109.745 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -125.53 110.05 13.41 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.502 -0.749 . . . . 0.0 110.989 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.598 HG13 HD12 ' A' ' 580' ' ' LEU . 1.9 mt -80.91 109.86 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.151 -0.968 . . . . 0.0 108.675 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.512 ' HB2' HG23 ' A' ' 598' ' ' VAL . 0.0 OUTLIER -53.06 165.89 0.27 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.672 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.516 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 5.2 mt-30 -65.1 68.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.421 -0.799 . . . . 0.0 109.87 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 138.57 21.87 0.43 Allowed Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.567 -1.302 . . . . 0.0 110.789 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -85.92 101.53 10.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 O-C-N 120.732 -1.452 . . . . 0.0 107.176 178.449 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 13.8 t-20 -144.99 134.05 11.17 Favored Pre-proline 0 C--N 1.284 -2.266 0 CA-C-N 114.777 -1.102 . . . . 0.0 110.21 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.571 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 51.0 Cg_endo -91.99 164.01 26.78 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 123.222 -1.574 . . . . 0.0 108.784 -2.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.504 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 4.1 t80 -104.48 116.11 31.53 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.668 ' HB3' HD23 ' A' ' 730' ' ' LEU . 36.4 m-85 -83.16 144.2 29.98 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.541 -0.724 . . . . 0.0 110.436 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.875 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.3 mt -142.67 141.77 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.66 -0.65 . . . . 0.0 110.045 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.797 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 168.75 -160.97 34.63 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.925 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 14.5 tpt180 -71.13 -43.52 67.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.713 -0.875 . . . . 0.0 111.189 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.466 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -78.3 126.51 30.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 110.872 -179.227 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.445 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.9 tt0 -54.04 -18.33 3.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.141 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.06 -31.32 0.9 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.255 -0.903 . . . . 0.0 109.142 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.5 m -69.89 130.77 43.15 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.504 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -44.83 -28.59 0.66 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.267 -0.895 . . . . 0.0 109.904 179.514 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.875 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.4 t -105.19 143.49 33.29 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.445 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.1 OUTLIER -109.19 128.19 54.83 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.286 -0.966 . . . . 0.0 112.859 -178.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.865 ' HA ' HD12 ' A' ' 588' ' ' ILE . 12.1 mt -141.79 108.06 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -91.73 103.79 16.32 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.228 -1.389 . . . . 0.0 108.396 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 2.6 m-20 -138.81 106.02 5.49 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.363 -1.289 . . . . 0.0 108.839 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -45.69 -42.17 11.31 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.546 -0.721 . . . . 0.0 111.948 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 27.2 mtm-85 -83.12 -17.14 44.11 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.074 -1.016 . . . . 0.0 111.269 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.797 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.8 OUTLIER -77.85 140.54 39.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.271 -0.893 . . . . 0.0 110.826 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.45 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.84 161.45 28.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.322 -0.861 . . . . 0.0 110.694 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.755 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 13.3 ttp180 -64.09 -45.79 87.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.328 -0.858 . . . . 0.0 109.255 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.586 HG11 HG22 ' A' ' 727' ' ' VAL . 2.8 t -95.52 2.07 9.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.84 0.829 . . . . 0.0 109.475 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.2 t60 -27.18 -46.69 0.03 OUTLIER 'General case' 0 C--O 1.196 -1.762 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.549 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.79 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.59 145.69 43.12 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 118.025 -1.47 . . . . 0.0 111.857 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.531 ' CZ ' ' HB2' ' A' ' 650' ' ' CYS . 13.1 p90 -146.68 142.64 28.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.595 -0.691 . . . . 0.0 109.9 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.538 HG13 HD11 ' A' ' 603' ' ' ILE . 60.3 mt -102.61 117.97 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.424 ' HB2' ' HE1' ' A' ' 624' ' ' PHE . 8.6 t80 -114.53 154.72 27.76 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.767 0.794 . . . . 0.0 110.017 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 5.4 ttmt -120.18 137.48 54.16 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.597 0.713 . . . . 0.0 110.737 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.413 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.44 163.94 29.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.516 -0.74 . . . . 0.0 110.092 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.6 OUTLIER -77.25 117.79 19.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.158 -0.964 . . . . 0.0 108.704 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.526 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.7 t60 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 121.647 0.737 . . . . 0.0 110.701 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 702' ' ' LEU . 5.1 mp . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.2 m-20 -110.02 124.22 51.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.007 -1.058 . . . . 0.0 110.908 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.698 ' OD2' HD21 ' A' ' 671' ' ' LEU . 24.0 t0 -110.02 151.11 27.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.425 -0.797 . . . . 0.0 109.944 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.806 HD13 HD11 ' A' ' 578' ' ' LEU . 11.1 pt -105.66 132.0 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.338 -0.851 . . . . 0.0 109.898 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.636 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.7 m95 -119.03 119.25 33.72 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.87 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.789 ' HB2' HD11 ' A' ' 672' ' ' LEU . 1.1 t80 -80.96 114.08 19.6 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 668' ' ' THR . 62.9 m -108.37 108.66 19.72 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.506 -0.877 . . . . 0.0 111.206 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.558 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 17.8 t60 -73.24 169.16 17.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.499 -0.75 . . . . 0.0 109.992 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -159.58 -29.87 0.06 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.292 -0.88 . . . . 0.0 113.118 -178.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.558 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -79.7 140.43 22.55 Favored Glycine 0 N--CA 1.502 3.035 0 O-C-N 119.453 -2.029 . . . . 0.0 110.406 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 22.7 m -47.1 -22.2 0.33 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.732 ' CG ' HG23 ' A' ' 681' ' ' ILE . 1.0 OUTLIER -58.51 -4.27 0.38 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.601 -1.312 . . . . 0.0 112.444 -178.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.765 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 79.52 167.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 CA-C-O 121.878 0.847 . . . . 0.0 110.814 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.526 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -128.93 151.13 50.0 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.612 -179.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -138.48 126.59 22.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.174 -0.954 . . . . 0.0 110.946 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.912 HD23 ' CD2' ' A' ' 670' ' ' PHE . 14.7 tp -124.49 107.35 10.98 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.256 -0.903 . . . . 0.0 109.576 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 63.2 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.51 -0.743 . . . . 0.0 110.042 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 659' ' ' LEU . 3.2 m-20 -154.5 23.91 0.47 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 110.172 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.46 116.94 29.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.176 -0.953 . . . . 0.0 110.373 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.76 139.08 43.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 110.001 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.765 ' O ' HG22 ' A' ' 656' ' ' VAL . 47.2 mtp -122.6 157.84 31.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.345 -0.847 . . . . 0.0 110.234 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.479 ' CG1' HG23 ' A' ' 668' ' ' THR . 16.2 pt -98.8 -157.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.0 109.829 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -86.12 119.63 26.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.288 -0.883 . . . . 0.0 110.43 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 81.03 52.83 4.15 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -114.85 148.49 38.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.991 -1.299 . . . . 0.0 110.274 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.464 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -109.04 138.68 45.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.566 -0.709 . . . . 0.0 109.345 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.912 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -144.59 145.21 31.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 111.288 -178.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.698 HD21 ' OD2' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -70.15 147.69 49.59 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.433 -0.792 . . . . 0.0 110.604 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.789 HD11 ' HB2' ' A' ' 649' ' ' TYR . 10.7 mt -118.02 114.67 23.49 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.413 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -95.1 147.91 22.93 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.474 ' HB3' HD12 ' A' ' 696' ' ' ILE . 23.1 p-10 -46.3 143.02 2.64 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.133 -0.98 . . . . 0.0 110.532 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.66 47.33 41.58 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 107.611 -2.196 . . . . 0.0 107.611 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.521 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.4 OUTLIER -109.52 93.87 4.73 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.885 -0.774 . . . . 0.0 110.07 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.904 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.1 tm-20 -93.86 107.58 19.45 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.766 HG22 HD13 ' A' ' 659' ' ' LEU . 28.2 pt -107.43 137.91 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.602 -0.686 . . . . 0.0 111.811 -178.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -98.76 110.81 23.35 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.79 HD13 ' SG ' ' A' ' 623' ' ' CYS . 72.4 mt -75.01 -19.86 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.886 . . . . 0.0 110.839 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.739 HD11 HD13 ' A' ' 618' ' ' LEU . 8.4 mt -142.9 136.47 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.16 -0.962 . . . . 0.0 110.52 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -137.65 108.96 6.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.455 -0.778 . . . . 0.0 109.899 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . 0.424 ' HB3' ' HB2' ' A' ' 686' ' ' ASN . 0.3 OUTLIER -120.96 117.68 27.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -45.13 78.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.459 -0.776 . . . . 0.0 111.115 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.64 -43.63 15.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.241 -0.912 . . . . 0.0 111.361 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 683' ' ' ASP . 97.5 m-20 -83.19 -8.67 59.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.136 -0.978 . . . . 0.0 110.601 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.5 tptt 56.25 19.66 4.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.225 -0.922 . . . . 0.0 110.778 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.43 78.76 1.03 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.175 -0.953 . . . . 0.0 109.144 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 586' ' ' SER . 41.0 t -101.79 141.32 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.381 -0.824 . . . . 0.0 110.912 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.666 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 41.6 mm -126.32 163.94 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.423 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . -172.48 124.98 1.12 Allowed Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.367 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.904 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.5 m-85 -120.23 138.06 53.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.59 -0.947 . . . . 0.0 108.828 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -105.1 117.95 35.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.841 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -87.12 122.28 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.542 -0.724 . . . . 0.0 109.241 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -130.24 104.54 7.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.516 -0.74 . . . . 0.0 110.289 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 674' ' ' ASP . 71.8 mt -76.51 104.35 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 109.571 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.11 -42.85 59.43 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.609 -0.836 . . . . 0.0 108.889 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.8 OUTLIER -111.01 141.3 44.67 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.698 0.761 . . . . 0.0 110.747 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 44.5 p -115.38 96.06 5.47 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 7.2 t -136.16 136.31 39.92 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.262 0.554 . . . . 0.0 110.587 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.04 26.52 27.76 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.83 ' O ' HD22 ' A' ' 644' ' ' LEU . 4.1 tp -105.26 138.19 41.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.358 -1.084 . . . . 0.0 110.469 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.828 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.0 p90 -53.83 -23.75 13.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.404 -0.81 . . . . 0.0 110.045 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.593 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.1 t30 . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.799 ' NH1' HD21 ' A' ' 659' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.821 0 CA-C-O 121.257 0.551 . . . . 0.0 111.782 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.424 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 31.5 m -107.78 151.01 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.431 -0.793 . . . . 0.0 109.382 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.538 HG13 ' HG2' ' A' ' 664' ' ' MET . 65.0 t -93.12 117.8 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 0.0 110.489 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.438 HD13 ' HD3' ' A' ' 669' ' ' LYS . 4.8 mp -89.88 162.51 15.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.38 -0.825 . . . . 0.0 109.734 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.98 146.24 28.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.215 -0.928 . . . . 0.0 110.167 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -79.88 137.38 36.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.223 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.8 p -110.16 -176.79 3.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.416 -0.802 . . . . 0.0 110.353 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.61 -28.92 35.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.432 -0.792 . . . . 0.0 110.153 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . 0.509 ' O ' HD23 ' A' ' 726' ' ' LEU . 3.9 tp10 -66.21 -50.16 64.79 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.448 -0.782 . . . . 0.0 110.043 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.704 ' O ' HG12 ' A' ' 727' ' ' VAL . 14.6 mt-10 -63.71 -47.68 80.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.36 -0.838 . . . . 0.0 110.123 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.467 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 3.0 tmmm? -62.46 -31.9 72.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.471 -0.768 . . . . 0.0 110.946 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.07 -50.74 69.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.217 -0.927 . . . . 0.0 112.041 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 722' ' ' GLU . 0.7 OUTLIER -72.72 -35.93 67.67 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.907 -1.121 . . . . 0.0 111.516 -178.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.704 HG12 ' O ' ' A' ' 723' ' ' GLU . 9.3 p -79.08 -15.18 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.828 -1.17 . . . . 0.0 110.37 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -41.98 69.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.944 . . . . 0.0 108.685 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.44 103.32 10.32 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 122.253 1.025 . . . . 0.0 108.963 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.668 HD23 ' HB3' ' A' ' 602' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.272 -2.78 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.269 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.412 ' HD3' ' HG2' ' A' ' 593' ' ' GLU . 32.2 ttp-105 . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 121.591 0.71 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.593 ' CZ ' HD13 ' A' ' 702' ' ' LEU . 9.8 t80 -111.6 -40.23 4.39 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 122.061 0.934 . . . . 0.0 109.288 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.003 HD11 HD13 ' A' ' 647' ' ' ILE . 0.9 OUTLIER -124.5 119.69 29.86 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.787 -179.126 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 62.3 m -99.15 115.45 29.09 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.989 -1.069 . . . . 0.0 109.005 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.491 HD21 HD12 ' A' ' 594' ' ' ILE . 1.6 mm? -89.98 111.76 22.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.408 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 1.1 mmtt -112.04 101.49 51.86 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 118.026 -1.47 . . . . 0.0 112.478 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 1.05 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.9 Cg_endo -80.17 144.58 16.67 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 N-CA-C 106.45 -2.173 . . . . 0.0 106.45 174.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.741 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -121.56 -174.31 0.3 Allowed Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.765 -176.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.741 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.1 Cg_endo -66.09 -31.17 46.2 Favored 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 124.289 1.679 . . . . 0.0 110.086 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.734 ' O ' HG23 ' A' ' 689' ' ' VAL . 70.2 m-20 -59.13 -25.28 63.73 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 13.4 t -95.19 150.58 20.06 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 614' ' ' GLU . 5.3 tp -55.58 -21.47 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.289 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.876 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.6 tp -110.17 117.92 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.522 -0.736 . . . . 0.0 109.903 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.58 79.89 1.25 Allowed 'General case' 0 N--CA 1.508 2.429 0 O-C-N 120.359 -1.463 . . . . 0.0 108.938 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 1.05 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.6 mt-10 -143.02 175.55 9.77 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.787 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.566 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.66 125.56 40.35 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.097 -1.002 . . . . 0.0 109.127 176.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 611' ' ' CYS . 65.9 mt -110.17 156.08 21.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 109.592 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.412 ' HG2' ' HD3' ' A' ' 576' ' ' ARG . 7.7 mp0 -124.85 110.56 14.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.856 . . . . 0.0 111.683 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.723 HG23 HG12 ' A' ' 598' ' ' VAL . 21.1 mt -82.33 110.38 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 597' ' ' GLY . 2.3 mt-30 -53.98 179.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.213 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.572 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -58.03 69.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.455 -0.778 . . . . 0.0 111.138 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 106.07 43.84 1.46 Allowed Glycine 0 N--CA 1.485 1.915 0 C-N-CA 119.699 -1.239 . . . . 0.0 110.591 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.723 HG12 HG23 ' A' ' 594' ' ' ILE . 0.5 OUTLIER -79.05 104.57 7.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 2.9 t30 -141.53 138.27 17.25 Favored Pre-proline 0 C--N 1.28 -2.442 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.004 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.637 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.1 Cg_endo -90.54 161.1 31.99 Favored 'Cis proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.273 -1.97 . . . . 0.0 109.38 -1.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.558 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 5.3 t80 -107.28 116.6 32.22 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.697 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 60.7 m-85 -90.08 145.93 24.7 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 111.047 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.704 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.4 mt -140.5 141.02 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.554 -0.716 . . . . 0.0 110.239 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.69 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 178.1 -161.14 27.86 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.867 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.424 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 15.0 tpt180 -75.71 -32.45 60.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.754 -0.85 . . . . 0.0 110.087 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.438 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -86.3 127.46 34.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.417 -0.802 . . . . 0.0 110.623 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.535 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.5 tm-20 -59.41 -13.73 9.57 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.972 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -46.44 -36.19 6.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.426 -0.796 . . . . 0.0 110.24 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.697 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 62.2 m -71.26 152.7 43.04 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.558 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.1 m120 -59.17 -13.63 7.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.415 -0.803 . . . . 0.0 110.48 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.704 ' SG ' HG23 ' A' ' 603' ' ' ILE . 6.9 t -120.43 144.22 48.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.433 -0.792 . . . . 0.0 109.942 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.613 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -113.37 130.95 56.16 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 122.032 0.92 . . . . 0.0 112.901 -178.43 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.655 HD11 ' CE1' ' A' ' 692' ' ' PHE . 7.9 mt -146.63 109.96 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.465 ' O ' HG12 ' A' ' 587' ' ' ILE . 3.3 mm-40 -85.58 102.44 13.54 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 117.806 -1.558 . . . . 0.0 108.547 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.592 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 4.3 m-20 -139.05 106.13 5.46 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.728 178.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -45.4 -44.51 12.06 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.42 -0.8 . . . . 0.0 111.925 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.86 -16.75 43.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.126 -0.984 . . . . 0.0 112.023 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.922 HD13 HD11 ' A' ' 681' ' ' ILE . 1.3 tp -76.55 130.35 37.77 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.95 -1.093 . . . . 0.0 110.898 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.511 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.2 m -68.81 161.2 29.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.43 -0.794 . . . . 0.0 110.467 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.69 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -63.61 -45.75 88.89 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.189 -0.944 . . . . 0.0 109.204 179.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.592 HG12 HD21 ' A' ' 730' ' ' LEU . 16.4 m -94.8 2.12 9.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 121.386 -0.821 . . . . 0.0 109.481 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.776 ' CE1' HD12 ' A' ' 618' ' ' LEU . 3.8 t60 -28.47 -48.27 0.06 Allowed 'General case' 0 C--O 1.192 -1.946 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.946 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.846 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.13 145.5 43.91 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.375 -1.33 . . . . 0.0 110.901 179.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.591 ' HA ' HG13 ' A' ' 603' ' ' ILE . 24.2 p90 -146.37 151.18 37.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.493 -0.754 . . . . 0.0 110.419 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.598 HG13 HD11 ' A' ' 603' ' ' ILE . 15.7 mt -103.13 120.95 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 8.0 t80 -116.45 154.23 30.7 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.39 -0.818 . . . . 0.0 109.828 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.519 ' HE2' HG23 ' A' ' 647' ' ' ILE . 8.3 ttmt -120.22 136.98 54.46 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.444 0.64 . . . . 0.0 110.368 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.03 163.97 28.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.64 -0.663 . . . . 0.0 110.389 -179.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -77.6 115.65 17.53 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.507 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.2 t60 . . . . . 0 N--CA 1.488 1.461 0 O-C-N 121.542 -0.724 . . . . 0.0 110.561 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.782 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.1 mp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.46 124.63 51.61 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.846 -1.159 . . . . 0.0 111.386 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.531 ' OD2' HD21 ' A' ' 671' ' ' LEU . 24.0 t0 -113.5 156.4 23.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.386 -0.821 . . . . 0.0 110.129 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 1.003 HD13 HD11 ' A' ' 578' ' ' LEU . 11.2 pt -109.67 129.85 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.26 -0.9 . . . . 0.0 110.142 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.652 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 91.6 m95 -119.86 128.53 53.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.621 -0.675 . . . . 0.0 111.199 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.865 ' HB2' HD11 ' A' ' 672' ' ' LEU . 9.3 t80 -88.17 114.87 25.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 668' ' ' THR . 14.4 m -108.01 106.03 16.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 111.781 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.524 ' CD2' ' N ' ' A' ' 652' ' ' THR . 13.1 t60 -65.95 159.07 26.51 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.482 -0.761 . . . . 0.0 109.975 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.74 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.03 -28.79 0.2 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.471 -0.768 . . . . 0.0 112.84 -179.228 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.525 ' HA3' ' CG ' ' A' ' 622' ' ' HIS . . . -79.26 -163.89 26.79 Favored Glycine 0 N--CA 1.496 2.688 0 O-C-N 119.337 -2.102 . . . . 0.0 109.885 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 21.3 m -94.08 -19.12 21.12 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.096 -1.238 . . . . 0.0 114.095 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.717 ' HB3' HG23 ' A' ' 681' ' ' ILE . 24.7 m120 -61.01 -2.83 0.65 Allowed 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.597 -1.315 . . . . 0.0 112.629 -178.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.698 HG13 ' C ' ' A' ' 655' ' ' ASN . 0.8 OUTLIER 62.68 145.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.58 -0.7 . . . . 0.0 109.847 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -95.09 151.29 19.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.601 -0.687 . . . . 0.0 111.071 -178.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.464 ' CZ ' ' CG2' ' A' ' 656' ' ' VAL . 37.5 m-85 -134.45 126.22 29.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.595 -0.691 . . . . 0.0 109.569 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.928 HD13 HG12 ' A' ' 678' ' ' ILE . 53.8 tp -130.93 111.89 12.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.198 -0.939 . . . . 0.0 110.098 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.83 -79.43 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.594 -0.691 . . . . 0.0 110.027 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 659' ' ' LEU . 25.5 p30 -148.74 23.92 0.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 110.128 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.74 119.68 39.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 110.253 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -84.97 134.92 34.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.889 . . . . 0.0 110.045 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.466 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 2.8 mtp -116.3 -166.2 1.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.647 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.5 ' CG1' HG23 ' A' ' 668' ' ' THR . 7.9 pt -139.94 -154.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.447 -0.783 . . . . 0.0 110.291 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 652' ' ' THR . 44.2 tt0 -86.31 91.71 8.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.376 -0.828 . . . . 0.0 110.699 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.5 54.62 0.54 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.6 OUTLIER -119.07 145.53 45.83 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.06 -1.259 . . . . 0.0 110.001 179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.411 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 15.5 tttt -108.34 138.72 44.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.454 -0.779 . . . . 0.0 109.247 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.765 ' CE2' HD23 ' A' ' 659' ' ' LEU . 0.5 OUTLIER -144.62 142.88 30.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.027 -1.045 . . . . 0.0 111.518 -178.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.652 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -70.89 147.5 48.74 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.524 -0.735 . . . . 0.0 110.773 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.865 HD11 ' HB2' ' A' ' 649' ' ' TYR . 14.6 mt -120.3 114.67 22.21 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.386 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' ' 676' ' ' ASP . 17.2 mt-30 -84.5 -177.16 6.54 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.403 ' HB3' HD12 ' A' ' 696' ' ' ILE . 2.2 p30 -78.24 139.06 38.92 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.778 -1.201 . . . . 0.0 109.315 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 73.25 47.9 21.37 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.451 -2.259 . . . . 0.0 107.451 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.868 ' OD1' HD11 ' A' ' 659' ' ' LEU . 2.1 t0 -105.55 97.77 7.56 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.847 -0.796 . . . . 0.0 110.337 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.895 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.47 107.03 18.93 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.928 HG12 HD13 ' A' ' 659' ' ' LEU . 1.5 mp -105.01 138.01 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.531 -0.731 . . . . 0.0 111.57 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -100.39 114.58 28.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.747 -0.596 . . . . 0.0 109.639 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.846 HD13 ' SG ' ' A' ' 623' ' ' CYS . 76.7 mt -79.35 -24.09 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.926 . . . . 0.0 110.933 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.922 HD11 HD13 ' A' ' 618' ' ' LEU . 7.2 mt -141.57 141.15 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.148 -0.97 . . . . 0.0 110.389 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -138.09 109.59 6.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.89 . . . . 0.0 110.11 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 686' ' ' ASN . 1.0 OUTLIER -125.44 118.04 24.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.331 -0.856 . . . . 0.0 110.005 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -46.85 76.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.306 -0.871 . . . . 0.0 110.963 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -84.65 -43.47 14.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.345 -0.847 . . . . 0.0 110.939 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . 0.4 ' CB ' ' HB3' ' A' ' 683' ' ' ASP . 0.6 OUTLIER -72.33 -11.1 60.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.249 -0.907 . . . . 0.0 110.556 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.1 mttt 52.46 24.86 3.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.17 -0.956 . . . . 0.0 110.388 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.88 73.76 7.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.434 -0.792 . . . . 0.0 109.896 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 585' ' ' ASP . 34.8 m -101.92 135.87 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 110.322 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.522 HG12 ' HB ' ' A' ' 681' ' ' ILE . 19.3 mm -114.05 164.44 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.535 -0.728 . . . . 0.0 109.505 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -174.43 123.33 0.95 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.527 -1.32 . . . . 0.0 110.446 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.895 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.3 m-85 -120.04 137.74 53.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.534 -0.98 . . . . 0.0 108.581 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -102.56 114.54 28.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.871 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 694' ' ' VAL . 1.0 OUTLIER -81.31 113.24 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.03 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -121.56 104.3 9.54 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.695 -0.628 . . . . 0.0 109.914 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.433 HG12 ' HG ' ' A' ' 578' ' ' LEU . 63.1 mt -79.13 104.58 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 109.51 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.88 -42.76 48.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.328 -0.857 . . . . 0.0 108.826 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 577' ' ' PHE . 1.2 m-20 -110.84 142.45 42.84 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.397 0.618 . . . . 0.0 110.336 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 42.9 p -114.18 95.78 5.47 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.44 -133.57 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.027 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.761 ' O ' HD23 ' A' ' 644' ' ' LEU . . . -93.49 35.04 4.29 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.593 HD13 ' CZ ' ' A' ' 577' ' ' PHE . 1.0 OUTLIER -60.77 149.98 33.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.617 -0.931 . . . . 0.0 110.172 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.782 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.1 p90 -49.63 -24.56 2.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.362 -0.836 . . . . 0.0 110.402 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.532 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.497 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 121.381 0.61 . . . . 0.0 112.225 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.408 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 34.9 m -107.59 151.59 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.453 -0.779 . . . . 0.0 109.454 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.466 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 86.6 t -97.04 122.77 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 110.564 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.5 mp -93.8 162.16 14.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.52 -0.737 . . . . 0.0 109.822 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.33 151.09 21.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.875 . . . . 0.0 110.068 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -80.31 142.83 34.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.807 . . . . 0.0 110.343 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 12.8 p -117.16 -176.27 2.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.399 -0.813 . . . . 0.0 110.143 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.53 -28.8 33.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.355 -0.84 . . . . 0.0 110.224 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -68.15 -47.65 67.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.0 109.984 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.8 -48.05 78.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -0.796 . . . . 0.0 110.023 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 727' ' ' VAL . 94.7 mttt -54.03 -32.49 54.55 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.364 -0.835 . . . . 0.0 110.069 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -68.11 -36.38 79.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.487 -0.758 . . . . 0.0 110.383 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 37.8 mt -59.8 -46.55 88.85 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.262 -0.899 . . . . 0.0 110.195 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.571 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.5 p -72.34 -19.46 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.087 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -53.5 -44.73 69.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.865 . . . . 0.0 108.904 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.54 103.48 10.45 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 122.215 1.007 . . . . 0.0 109.262 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.592 HD21 HG12 ' A' ' 621' ' ' VAL . 3.5 mt . . . . . 0 C--N 1.274 -2.696 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.518 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 121.613 0.72 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.563 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 9.8 t80 -124.8 -39.69 2.25 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 122.063 0.935 . . . . 0.0 109.427 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.723 HD11 HD13 ' A' ' 647' ' ' ILE . 0.4 OUTLIER -131.6 120.23 22.56 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.26 -178.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 4.4 m -93.95 120.19 33.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.0 109.093 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 1.058 HD11 HD12 ' A' ' 625' ' ' ILE . 4.6 mt -87.05 112.38 21.81 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.526 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -111.1 100.48 47.06 Favored Pre-proline 0 C--N 1.301 -1.505 0 C-N-CA 118.197 -1.401 . . . . 0.0 112.989 -176.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 1.09 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 55.6 Cg_endo -87.88 141.23 5.25 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 N-CA-C 106.342 -2.214 . . . . 0.0 106.342 174.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.75 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -120.52 -173.71 0.27 Allowed Pre-proline 0 C--N 1.294 -1.815 0 C-N-CA 118.57 -1.252 . . . . 0.0 112.575 -177.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.75 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.2 Cg_endo -66.42 -30.71 43.86 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 O-C-N 124.212 1.638 . . . . 0.0 110.279 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -59.2 -24.45 63.12 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 17.6 t -95.35 153.32 17.74 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 614' ' ' GLU . 4.9 tp -57.42 -19.69 11.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.178 -0.951 . . . . 0.0 109.298 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.841 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.5 tp -113.17 118.08 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 110.117 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -111.24 81.65 1.47 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.483 -1.386 . . . . 0.0 108.634 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 1.09 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.5 mt-10 -143.11 175.68 9.68 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.883 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.526 ' HB3' ' CD ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.62 122.88 36.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.018 -1.051 . . . . 0.0 109.17 176.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.66 155.05 20.59 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -125.69 110.26 13.56 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.433 -0.792 . . . . 0.0 111.304 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.506 HG23 ' HB ' ' A' ' 598' ' ' VAL . 9.9 mt -81.37 109.56 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.7 OUTLIER -53.14 168.97 0.12 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.609 -0.837 . . . . 0.0 109.054 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.563 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 6.0 mt-30 -61.58 70.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.391 -0.818 . . . . 0.0 110.432 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 124.69 30.44 0.97 Allowed Glycine 0 N--CA 1.487 2.044 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.78 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 598' ' ' VAL . 1.2 t -79.9 102.73 6.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.8 t30 -143.95 135.5 12.8 Favored Pre-proline 0 C--N 1.282 -2.358 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.885 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.655 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.1 Cg_endo -90.91 162.12 30.45 Favored 'Cis proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.747 -1.772 . . . . 0.0 109.15 -1.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.536 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 6.3 t80 -106.41 116.69 32.36 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.735 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 58.3 m-85 -88.62 146.24 25.22 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.406 -0.808 . . . . 0.0 111.182 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.72 HD11 HG13 ' A' ' 625' ' ' ILE . 2.4 mt -140.85 140.48 33.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.648 -0.657 . . . . 0.0 110.18 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.683 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 177.18 -162.63 30.86 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.924 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.412 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 14.2 tpt180 -74.0 -35.06 64.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.794 -0.827 . . . . 0.0 110.248 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.406 ' CB ' ' HD3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -85.16 127.37 34.24 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.394 -0.817 . . . . 0.0 110.585 -179.606 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 42.8 tt0 -58.75 -12.89 4.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.291 -0.881 . . . . 0.0 109.993 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.18 -36.86 4.05 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.421 -0.8 . . . . 0.0 110.079 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.735 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 79.6 m -71.68 154.48 41.34 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.284 -0.885 . . . . 0.0 109.926 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.521 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -61.53 -12.06 13.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.511 -0.743 . . . . 0.0 110.396 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.719 ' SG ' HG23 ' A' ' 603' ' ' ILE . 6.9 t -119.84 143.74 47.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.531 -0.731 . . . . 0.0 109.559 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.622 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -113.32 130.22 56.32 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.055 0.931 . . . . 0.0 112.993 -178.237 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.606 HD11 ' CE1' ' A' ' 692' ' ' PHE . 7.3 mt -146.57 109.75 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 177.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.46 ' O ' HG12 ' A' ' 587' ' ' ILE . 2.2 mt-10 -85.68 102.47 13.63 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 117.704 -1.598 . . . . 0.0 108.538 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.622 ' CG ' HD12 ' A' ' 681' ' ' ILE . 4.9 m-20 -139.42 106.08 5.36 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.869 178.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . 0.41 ' OD1' ' CZ ' ' A' ' 688' ' ' PHE . 29.5 p-10 -47.45 -41.33 20.17 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.453 -0.779 . . . . 0.0 111.648 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -84.19 -16.99 41.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.089 -1.007 . . . . 0.0 111.8 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.866 HD13 HD11 ' A' ' 681' ' ' ILE . 1.3 tp -78.27 130.84 36.7 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.082 -1.012 . . . . 0.0 110.816 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.497 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 2.2 t -70.75 159.4 34.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.362 -0.836 . . . . 0.0 110.53 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.683 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 35.7 ttp180 -61.55 -45.66 93.21 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.26 -0.9 . . . . 0.0 109.344 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.595 ' HB ' HG23 ' A' ' 727' ' ' VAL . 15.8 m -94.74 1.95 9.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.389 -0.82 . . . . 0.0 109.613 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.9 t60 -28.1 -48.18 0.05 OUTLIER 'General case' 0 C--O 1.192 -1.962 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.833 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.816 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.7 OUTLIER -137.03 145.58 44.22 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.406 -1.318 . . . . 0.0 110.753 178.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.527 ' CZ ' ' CB ' ' A' ' 650' ' ' CYS . 12.4 p90 -145.3 148.75 33.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.532 -0.73 . . . . 0.0 110.306 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 1.058 HD12 HD11 ' A' ' 580' ' ' LEU . 24.5 mt -103.9 121.1 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 7.5 t80 -114.95 154.44 28.75 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.694 0.759 . . . . 0.0 109.484 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 0.2 OUTLIER -120.01 137.09 54.29 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.548 0.689 . . . . 0.0 110.587 -179.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -137.62 163.6 30.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.712 -0.617 . . . . 0.0 110.152 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.0 OUTLIER -77.93 115.48 17.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.188 -0.945 . . . . 0.0 108.889 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.507 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.4 t60 . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.536 -0.728 . . . . 0.0 110.615 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.812 HD22 ' O ' ' A' ' 702' ' ' LEU . 5.1 mp . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.19 124.4 50.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.859 -1.151 . . . . 0.0 111.08 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -110.26 150.56 28.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.443 -0.785 . . . . 0.0 109.847 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.723 HD13 HD11 ' A' ' 578' ' ' LEU . 11.3 pt -106.56 131.66 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.304 -0.873 . . . . 0.0 109.85 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.777 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 95.2 m95 -119.47 123.05 43.11 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.649 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.643 ' HB2' HD11 ' A' ' 672' ' ' LEU . 9.7 t80 -88.83 114.35 25.36 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 668' ' ' THR . 1.0 OUTLIER -108.12 102.66 11.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.078 -1.014 . . . . 0.0 111.697 -178.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.496 ' CD2' ' N ' ' A' ' 652' ' ' THR . 13.1 t60 -62.07 157.46 18.89 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.471 -0.768 . . . . 0.0 109.77 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -149.14 -29.75 0.26 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.469 -0.769 . . . . 0.0 112.702 -179.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.539 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.68 -164.05 25.42 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 117.72 -2.181 . . . . 0.0 109.498 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 25.0 m -97.65 -18.22 19.02 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.858 -1.378 . . . . 0.0 113.821 -176.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.594 ' HB3' HG23 ' A' ' 681' ' ' ILE . 22.8 m120 -58.35 -4.25 0.36 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.681 -1.262 . . . . 0.0 112.497 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.525 HG23 ' C ' ' A' ' 655' ' ' ASN . 3.1 t 70.21 148.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.609 -0.682 . . . . 0.0 110.169 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.434 ' CB ' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -105.82 143.82 33.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.508 -0.745 . . . . 0.0 110.741 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.445 ' CE1' ' HG2' ' A' ' 663' ' ' ARG . 74.7 m-85 -135.22 126.2 27.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.43 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.562 ' HG ' HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -124.11 114.32 19.53 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.373 -0.829 . . . . 0.0 109.789 179.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 659' ' ' LEU . 14.0 t-20 59.27 -78.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.549 -0.72 . . . . 0.0 110.499 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 659' ' ' LEU . 10.7 t30 -147.86 27.27 0.98 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.077 -1.014 . . . . 0.0 110.33 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.453 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.2 OUTLIER -113.71 139.36 49.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 0.0 110.269 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.445 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 8.5 tmm_? -103.52 129.48 50.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.339 -0.85 . . . . 0.0 110.107 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.557 ' HG2' HG13 ' A' ' 716' ' ' VAL . 4.3 mtp -112.1 -165.7 1.01 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 110.325 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.646 HG13 HG23 ' A' ' 668' ' ' THR . 1.6 pt -141.54 -158.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.375 -0.828 . . . . 0.0 110.091 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -82.06 93.24 6.96 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.286 -0.884 . . . . 0.0 110.524 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 106.84 53.21 0.71 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.646 HG23 HG13 ' A' ' 665' ' ' ILE . 0.2 OUTLIER -120.51 147.62 44.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.11 -1.23 . . . . 0.0 110.078 179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -108.32 144.04 36.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 0.0 109.196 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.48 ' CE1' ' O ' ' A' ' 715' ' ' VAL . 0.6 OUTLIER -144.65 147.11 32.69 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.508 -178.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.777 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.68 131.5 45.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.465 -0.772 . . . . 0.0 109.705 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.643 HD11 ' HB2' ' A' ' 649' ' ' TYR . 6.3 mt -104.61 97.68 7.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 111.173 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -84.86 146.64 27.2 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.415 ' HB3' HD12 ' A' ' 696' ' ' ILE . 20.0 p-10 -46.11 151.78 0.46 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.222 -0.924 . . . . 0.0 110.612 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 65.36 49.11 62.82 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.589 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.6 OUTLIER -107.04 92.52 4.11 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.763 -0.845 . . . . 0.0 110.611 -178.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.829 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -92.93 106.91 18.8 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.171 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.562 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.0 OUTLIER -116.56 137.78 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.6 -0.687 . . . . 0.0 111.865 -176.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.45 111.54 23.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.586 -0.696 . . . . 0.0 109.675 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.816 HD13 ' SG ' ' A' ' 623' ' ' CYS . 81.0 mt -74.08 -19.57 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.302 -0.874 . . . . 0.0 110.465 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.866 HD11 HD13 ' A' ' 618' ' ' LEU . 12.7 mt -141.81 137.67 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.028 -1.045 . . . . 0.0 110.286 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -137.43 110.41 7.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.131 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -129.25 118.38 22.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.784 . . . . 0.0 109.844 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.6 -44.84 85.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.375 -0.828 . . . . 0.0 110.884 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -84.11 -43.42 15.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.324 -0.86 . . . . 0.0 110.924 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -17.69 60.57 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.263 -0.898 . . . . 0.0 110.456 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.6 tttt 60.53 14.66 5.03 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.193 -0.942 . . . . 0.0 110.887 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.41 ' CZ ' ' OD1' ' A' ' 616' ' ' ASN . 0.3 OUTLIER -72.06 78.69 0.93 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.039 -1.038 . . . . 0.0 108.975 179.189 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 586' ' ' SER . 96.3 t -101.59 130.98 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.496 -0.752 . . . . 0.0 110.706 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.521 HG12 ' HB ' ' A' ' 681' ' ' ILE . 18.0 mm -114.94 164.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -173.27 116.13 0.59 Allowed Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.446 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.829 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.4 m-85 -119.7 137.13 54.11 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 581' ' ' LYS . 5.8 ttmm -110.77 114.14 27.26 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 110.305 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.636 HG22 ' CD2' ' A' ' 578' ' ' LEU . 0.5 OUTLIER -75.49 126.85 36.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.758 -0.777 . . . . 0.0 108.95 179.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.67 104.41 7.41 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.192 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.508 HG12 ' HG ' ' A' ' 578' ' ' LEU . 83.6 mt -79.47 103.6 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 109.559 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.27 -41.01 58.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.387 -0.821 . . . . 0.0 108.844 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 698' ' ' ASP . 1.3 m-20 -110.34 140.2 44.76 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.678 0.751 . . . . 0.0 110.655 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 36.0 p -115.98 96.17 5.46 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 30.2 m -133.09 133.18 42.63 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.814 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 50.32 30.11 17.66 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.812 ' O ' HD22 ' A' ' 644' ' ' LEU . 7.2 tp -103.91 138.92 39.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.545 -0.974 . . . . 0.0 110.717 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.805 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.6 p90 -53.28 -23.87 10.1 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.418 -0.801 . . . . 0.0 109.988 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.601 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.2 t30 . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.434 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.349 0.595 . . . . 0.0 111.869 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.48 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 26.9 m -107.58 150.01 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.481 -0.762 . . . . 0.0 109.069 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.557 HG13 ' HG2' ' A' ' 664' ' ' MET . 58.3 t -96.73 133.12 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.186 -0.946 . . . . 0.0 111.109 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.8 mp -105.08 162.64 13.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.656 -0.653 . . . . 0.0 109.598 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.35 145.37 28.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.17 -0.956 . . . . 0.0 110.291 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.82 152.09 29.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.355 -0.841 . . . . 0.0 110.259 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 38.6 p -121.14 -176.25 3.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.42 -0.8 . . . . 0.0 110.359 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.36 -29.08 32.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.361 -0.837 . . . . 0.0 110.105 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -51.0 68.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.353 -0.842 . . . . 0.0 109.579 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -64.65 -45.25 87.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.463 -0.773 . . . . 0.0 109.734 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.528 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.4 OUTLIER -54.71 -32.73 59.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.344 -0.848 . . . . 0.0 109.837 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -36.11 78.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.399 -0.813 . . . . 0.0 110.227 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 34.1 mt -58.76 -46.16 88.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.298 -0.877 . . . . 0.0 110.228 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.595 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.2 p -71.76 -20.34 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.546 -0.721 . . . . 0.0 110.087 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.78 -45.84 70.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 108.845 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.71 104.26 11.18 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.206 1.003 . . . . 0.0 109.025 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--N 1.274 -2.71 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.432 -179.933 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 121.584 0.707 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.575 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 0.9 OUTLIER -113.85 -41.62 3.54 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 122.052 0.93 . . . . 0.0 109.36 -179.316 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.707 ' CD2' HD12 ' A' ' 594' ' ' ILE . 14.2 tp -126.1 119.87 28.7 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.529 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 55.9 m -96.88 117.3 30.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.759 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.901 HD11 HD12 ' A' ' 625' ' ' ILE . 7.6 mt -91.98 112.18 24.01 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.534 ' O ' ' CD1' ' A' ' 583' ' ' LEU . 0.7 OUTLIER -116.07 104.58 52.15 Favored Pre-proline 0 C--N 1.299 -1.617 0 C-N-CA 118.379 -1.328 . . . . 0.0 113.289 -177.066 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 1.127 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 40.8 Cg_endo -77.86 145.04 22.24 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 N-CA-C 105.968 -2.358 . . . . 0.0 105.968 174.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.974 HD13 ' N ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -122.14 176.73 1.86 Allowed Pre-proline 0 N--CA 1.496 1.826 0 C-N-CA 118.197 -1.401 . . . . 0.0 113.599 -176.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.683 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 37.8 Cg_endo -66.36 -35.42 31.36 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.905 1.737 . . . . 0.0 111.848 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 689' ' ' VAL . 2.3 m-20 -58.43 -26.38 63.23 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.61 ' HB3' HD22 ' A' ' 583' ' ' LEU . 1.9 t -95.57 151.84 18.97 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.062 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.75 HG21 ' OD1' ' A' ' 615' ' ' ASP . 7.5 mm -57.35 -18.63 9.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 108.993 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.698 HD12 ' HA ' ' A' ' 613' ' ' ILE . 3.1 mm -99.67 115.55 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.472 -0.768 . . . . 0.0 109.218 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.86 71.42 1.04 Allowed 'General case' 0 N--CA 1.509 2.512 0 O-C-N 120.672 -1.268 . . . . 0.0 109.888 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 1.127 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 45.3 mt-10 -143.75 175.37 10.04 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.354 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.498 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.25 126.66 39.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.79 -1.194 . . . . 0.0 109.978 176.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.831 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.1 mt -111.41 156.17 22.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.329 -0.857 . . . . 0.0 109.391 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -125.19 110.6 14.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 111.835 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.707 HD12 ' CD2' ' A' ' 578' ' ' LEU . 24.8 mt -81.29 110.9 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 597' ' ' GLY . 2.3 mt-30 -54.67 179.25 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.979 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.575 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -59.08 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.505 -0.747 . . . . 0.0 111.217 -179.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 115.15 41.71 0.81 Allowed Glycine 0 N--CA 1.485 1.962 0 C-N-CA 119.496 -1.335 . . . . 0.0 111.019 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.691 ' HB ' HG23 ' A' ' 594' ' ' ILE . 1.2 t -79.01 103.75 6.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 627' ' ' LYS . 5.2 t30 -141.4 136.41 15.67 Favored Pre-proline 0 C--N 1.283 -2.314 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.258 -178.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.545 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.4 Cg_endo -90.44 161.28 32.53 Favored 'Cis proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.41 -1.913 . . . . 0.0 109.366 -1.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.548 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 2.9 t80 -107.03 116.26 31.62 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.557 ' HB3' ' SG ' ' A' ' 609' ' ' CYS . 58.8 m-85 -87.48 143.74 27.07 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 110.162 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.834 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.6 mt -140.56 142.16 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.782 -0.574 . . . . 0.0 110.345 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.785 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 166.14 -165.22 38.04 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.617 -1.278 . . . . 0.0 111.131 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 10.1 tpt180 -60.67 -55.55 31.97 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.854 -0.791 . . . . 0.0 111.879 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.43 126.15 28.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 111.499 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.44 ' HB2' ' HD2' ' A' ' 612' ' ' LYS . 42.3 tt0 -52.67 -19.05 2.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.418 -0.801 . . . . 0.0 110.046 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 607' ' ' GLU . 0.9 OUTLIER -42.36 -35.39 1.0 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.399 -0.813 . . . . 0.0 109.092 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 602' ' ' PHE . 1.3 m -64.92 133.76 52.52 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.548 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -45.72 -28.16 0.97 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.389 -0.82 . . . . 0.0 109.544 179.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.834 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.4 t -107.6 143.53 35.92 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.463 ' O ' ' CG2' ' A' ' 588' ' ' ILE . 0.3 OUTLIER -107.7 129.0 55.06 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.078 -1.014 . . . . 0.0 113.178 -178.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.772 ' CG2' HD13 ' A' ' 690' ' ' ILE . 13.5 mt -143.5 109.5 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.5 ' H ' HD12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -97.8 103.6 15.55 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 117.865 -1.534 . . . . 0.0 109.535 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.769 ' OD2' HD13 ' A' ' 681' ' ' ILE . 0.2 OUTLIER -139.38 106.93 5.57 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.965 177.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -41.33 -41.65 2.0 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.611 -0.681 . . . . 0.0 111.993 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -83.84 -17.69 40.08 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.064 -1.023 . . . . 0.0 111.502 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.728 HD22 HG22 ' A' ' 613' ' ' ILE . 0.6 OUTLIER -80.16 130.4 35.21 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.212 -0.93 . . . . 0.0 110.691 -179.189 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.415 ' CB ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -66.78 160.84 24.99 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.254 -0.904 . . . . 0.0 111.169 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.785 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -64.74 -47.04 79.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.233 -0.917 . . . . 0.0 109.746 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.476 ' O ' ' C ' ' A' ' 622' ' ' HIS . 3.7 m -95.32 2.4 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.247 -0.908 . . . . 0.0 109.316 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.735 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.8 t60 -25.36 -46.43 0.02 OUTLIER 'General case' 0 C--O 1.193 -1.897 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.267 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.806 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -136.92 146.33 45.34 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 118.32 -1.352 . . . . 0.0 111.336 179.121 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.546 ' HA ' HG13 ' A' ' 603' ' ' ILE . 14.7 p90 -145.86 143.77 29.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.563 -0.71 . . . . 0.0 109.997 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.901 HD12 HD11 ' A' ' 580' ' ' LEU . 10.7 mt -102.85 118.2 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 5.0 t80 -113.39 155.07 25.89 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.572 0.701 . . . . 0.0 109.544 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 5.6 ttmt -119.67 137.16 54.07 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.617 0.723 . . . . 0.0 110.773 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.49 164.16 28.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.741 -0.6 . . . . 0.0 110.167 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.3 tpt180 -77.75 118.97 20.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.128 -0.983 . . . . 0.0 109.043 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.532 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.7 t60 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.566 -0.709 . . . . 0.0 110.719 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.826 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.0 mp . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.7 m-20 -108.1 124.38 50.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.98 -1.075 . . . . 0.0 111.264 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 628' ' ' LYS . 29.5 t70 -110.11 141.05 43.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.452 -0.78 . . . . 0.0 109.803 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 22.6 pt -95.97 132.44 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.243 -0.911 . . . . 0.0 110.105 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.879 ' CH2' HD22 ' A' ' 671' ' ' LEU . 95.5 m95 -119.07 122.12 41.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.616 -0.678 . . . . 0.0 111.179 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.688 ' HB2' HD11 ' A' ' 672' ' ' LEU . 11.9 t80 -85.21 115.69 23.13 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 624' ' ' PHE . 22.5 m -108.11 102.9 12.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.186 -0.946 . . . . 0.0 111.582 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' A' ' 652' ' ' THR . 12.2 t60 -63.89 159.28 20.09 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.442 -0.786 . . . . 0.0 109.93 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.735 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.44 -29.55 0.18 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.435 -0.791 . . . . 0.0 112.757 -179.196 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.573 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.29 -165.59 30.28 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 117.857 -2.116 . . . . 0.0 109.937 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 26.0 m -93.6 -18.87 21.72 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.064 -1.256 . . . . 0.0 114.025 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.722 ' OD1' HD12 ' A' ' 681' ' ' ILE . 19.4 m120 -60.04 -2.56 0.44 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.663 -1.273 . . . . 0.0 112.564 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.684 HG13 ' C ' ' A' ' 655' ' ' ASN . 0.8 OUTLIER 63.11 142.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 121.583 0.706 . . . . 0.0 110.173 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.507 ' OG ' ' HB2' ' A' ' 664' ' ' MET . 0.0 OUTLIER -94.52 150.49 20.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.691 -0.631 . . . . 0.0 110.729 -179.034 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.483 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 20.2 m-85 -135.05 126.4 28.38 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.332 -0.855 . . . . 0.0 110.437 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.728 HD21 ' OD2' ' A' ' 676' ' ' ASP . 0.0 OUTLIER -134.2 120.8 20.5 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.21 -0.931 . . . . 0.0 109.926 179.251 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 56.3 -85.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.569 -0.707 . . . . 0.0 110.521 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 659' ' ' LEU . 55.6 t30 -148.17 25.46 1.0 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.221 -0.924 . . . . 0.0 110.247 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -119.34 117.52 28.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 0.0 110.447 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.415 ' CG ' ' CE1' ' A' ' 658' ' ' TYR . 2.7 tmm_? -87.24 138.33 31.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.374 -0.829 . . . . 0.0 109.983 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.732 ' SD ' HG13 ' A' ' 716' ' ' VAL . 0.3 OUTLIER -112.83 -152.68 0.51 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.278 -0.889 . . . . 0.0 109.969 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.502 HG13 HG23 ' A' ' 668' ' ' THR . 1.1 pp -143.4 -165.96 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.241 -0.912 . . . . 0.0 110.706 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 652' ' ' THR . 50.3 tt0 -76.58 83.99 3.25 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.483 -0.761 . . . . 0.0 110.412 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 117.88 53.15 0.31 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -122.92 149.17 44.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.098 -1.236 . . . . 0.0 110.08 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 717' ' ' LEU . 3.8 tttt -108.64 146.34 33.54 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.502 -0.749 . . . . 0.0 109.472 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.553 ' CD2' HD22 ' A' ' 659' ' ' LEU . 9.7 t80 -145.17 147.82 32.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.12 -0.988 . . . . 0.0 112.404 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.879 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.12 131.8 45.56 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.599 -0.688 . . . . 0.0 109.535 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.742 HD23 ' OD2' ' A' ' 676' ' ' ASP . 7.2 mt -105.88 104.95 14.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.049 -1.032 . . . . 0.0 111.227 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -91.73 146.75 23.52 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.558 -0.714 . . . . 0.0 109.127 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -43.94 147.84 0.45 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.139 -0.975 . . . . 0.0 110.397 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 66.31 48.1 66.46 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 107.587 -2.205 . . . . 0.0 107.587 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.742 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.3 OUTLIER -110.27 90.15 3.23 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.798 -0.825 . . . . 0.0 110.787 -178.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.966 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 3.2 tt0 -93.46 107.03 18.94 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.658 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.8 pt -105.49 136.87 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.861 -0.524 . . . . 0.0 110.972 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 25.2 mttt -95.31 110.32 22.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.569 -0.707 . . . . 0.0 109.637 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.806 HD13 ' SG ' ' A' ' 623' ' ' CYS . 63.4 mt -76.72 -22.77 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 110.074 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.769 HD13 ' OD2' ' A' ' 615' ' ' ASP . 15.0 tt -143.39 137.92 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.241 -0.912 . . . . 0.0 110.284 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -138.07 112.78 8.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.203 -0.936 . . . . 0.0 110.701 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.93 117.19 28.15 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.233 -0.917 . . . . 0.0 109.753 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -67.57 -47.6 69.3 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.423 -0.798 . . . . 0.0 111.475 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.23 -43.47 13.74 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.307 -0.871 . . . . 0.0 111.225 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.01 -7.07 51.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.211 -0.93 . . . . 0.0 110.914 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.95 24.15 3.24 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.152 -0.968 . . . . 0.0 110.038 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.03 95.98 10.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.44 -0.787 . . . . 0.0 109.681 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 586' ' ' SER . 31.5 m -125.79 142.36 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 111.059 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.772 HD13 ' CG2' ' A' ' 613' ' ' ILE . 12.2 mt -123.81 164.06 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -175.38 142.94 6.42 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.439 -1.362 . . . . 0.0 110.376 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.966 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 17.0 m-85 -129.14 137.6 51.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.503 -0.998 . . . . 0.0 109.865 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -98.45 113.66 25.74 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.219 -0.925 . . . . 0.0 109.682 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.641 HG22 HD11 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -82.66 121.48 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.361 -0.837 . . . . 0.0 109.074 179.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.05 104.62 7.44 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.581 -0.699 . . . . 0.0 110.237 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 60.2 mt -81.12 104.17 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.325 -0.86 . . . . 0.0 109.552 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -75.57 -42.1 53.02 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.377 -0.827 . . . . 0.0 108.996 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.462 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.1 m-20 -110.66 141.3 44.09 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.637 0.732 . . . . 0.0 110.521 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 21.9 p -114.99 96.04 5.5 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 16.1 p -128.12 131.99 48.97 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.235 0.54 . . . . 0.0 110.707 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 51.86 32.37 33.56 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.823 ' O ' HD22 ' A' ' 644' ' ' LEU . 4.1 tp -108.09 138.37 44.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.45 -1.029 . . . . 0.0 110.717 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.826 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.1 p90 -54.92 -24.03 21.67 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.71 . . . . 0.0 109.921 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.588 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.2 t30 . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.447 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.355 0.598 . . . . 0.0 111.616 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 715' ' ' VAL . 35.4 m -107.69 153.33 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.465 -0.772 . . . . 0.0 109.3 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.732 HG13 ' SD ' ' A' ' 664' ' ' MET . 58.1 t -98.39 133.11 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.935 . . . . 0.0 110.797 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 669' ' ' LYS . 4.0 mp -102.44 156.63 17.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.509 -0.744 . . . . 0.0 109.569 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.13 154.11 17.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.192 -0.942 . . . . 0.0 110.489 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -87.27 146.2 26.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.389 -0.82 . . . . 0.0 110.345 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 10.5 p -121.21 -176.12 3.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.343 -0.848 . . . . 0.0 110.309 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.2 -28.84 28.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.416 -0.802 . . . . 0.0 110.097 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.58 -47.49 75.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.356 -0.84 . . . . 0.0 109.552 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -63.85 -48.01 78.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.394 -0.816 . . . . 0.0 109.772 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 727' ' ' VAL . 12.2 tttt -53.77 -32.37 52.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.333 -0.854 . . . . 0.0 110.065 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.21 -36.24 79.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -0.827 . . . . 0.0 110.21 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 32.9 mt -59.52 -46.53 88.58 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.273 -0.892 . . . . 0.0 110.325 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 724' ' ' LYS . 8.5 p -70.79 -18.92 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.142 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.91 -43.74 69.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.214 -0.929 . . . . 0.0 108.824 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.59 103.52 10.48 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 122.281 1.039 . . . . 0.0 109.177 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.411 ' O ' ' CD2' ' A' ' 602' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.274 -2.712 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.365 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 121.44 0.638 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.813 ' CE2' HD11 ' A' ' 702' ' ' LEU . 0.2 OUTLIER -106.49 -40.09 5.68 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.92 0.867 . . . . 0.0 109.545 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.979 HD22 HD12 ' A' ' 594' ' ' ILE . 9.7 tt -117.95 119.86 36.09 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.713 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 86.1 m -98.4 116.55 30.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.291 -0.881 . . . . 0.0 109.074 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.802 HD11 ' CD1' ' A' ' 625' ' ' ILE . 2.4 mt -90.78 112.16 23.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.415 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 2.4 mmtt -112.81 101.89 53.74 Favored Pre-proline 0 C--N 1.3 -1.548 0 C-N-CA 118.153 -1.419 . . . . 0.0 112.737 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 1.042 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.0 Cg_endo -79.55 144.97 18.14 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 N-CA-C 106.454 -2.172 . . . . 0.0 106.454 174.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.741 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.62 -173.54 0.28 Allowed Pre-proline 0 N--CA 1.494 1.74 0 C-N-CA 118.651 -1.22 . . . . 0.0 112.791 -176.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.741 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.2 Cg_endo -66.55 -28.3 45.4 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 124.113 1.586 . . . . 0.0 110.176 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.31 -28.4 66.76 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 46.7 p -95.43 153.57 17.63 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.584 ' H ' HD13 ' A' ' 690' ' ' ILE . 5.7 tp -57.07 -16.38 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.831 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.868 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.2 tp -113.98 117.73 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.219 -0.925 . . . . 0.0 110.231 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.95 80.82 1.34 Allowed 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.219 -1.551 . . . . 0.0 109.209 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 1.042 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 33.8 mm-40 -142.24 175.81 9.47 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.823 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.569 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.66 125.48 40.18 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.138 -0.976 . . . . 0.0 109.096 176.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 611' ' ' CYS . 61.5 mt -111.39 156.07 22.16 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.369 -0.832 . . . . 0.0 109.987 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -125.25 111.05 14.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.356 -0.84 . . . . 0.0 111.802 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.979 HD12 HD22 ' A' ' 578' ' ' LEU . 39.9 mt -82.31 110.61 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.51 ' O ' ' C ' ' A' ' 596' ' ' GLN . 21.2 mm100 -69.39 114.9 8.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.499 -0.751 . . . . 0.0 112.794 -177.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.51 ' C ' ' O ' ' A' ' 595' ' ' GLN . 0.0 OUTLIER 14.6 56.77 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 178.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 106.98 46.65 1.08 Allowed Glycine 0 N--CA 1.486 1.988 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.845 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.622 ' HB ' HG23 ' A' ' 594' ' ' ILE . 1.0 OUTLIER -79.4 104.66 7.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 177.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 2.8 t30 -140.41 137.9 18.27 Favored Pre-proline 0 C--N 1.28 -2.421 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.103 -178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.705 ' HB3' HD23 ' A' ' 726' ' ' LEU . 56.7 Cg_endo -90.01 160.18 34.22 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.009 -2.08 . . . . 0.0 109.581 -0.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 4.5 t80 -107.29 116.73 32.44 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.73 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 52.3 m-85 -91.23 145.77 24.39 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.207 -0.933 . . . . 0.0 110.817 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.699 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.2 mt -139.68 141.17 35.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.491 -0.755 . . . . 0.0 110.436 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 174.17 -167.12 39.44 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.431 -1.366 . . . . 0.0 111.362 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.447 ' HD2' ' HA ' ' A' ' 614' ' ' GLU . 6.7 mmm-85 -64.34 -40.61 96.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.919 -0.754 . . . . 0.0 110.834 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -84.23 127.81 34.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.396 -0.815 . . . . 0.0 111.446 -178.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.4 ' CG ' ' HD2' ' A' ' 612' ' ' LYS . 37.1 tt0 -57.67 -14.88 6.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -0.84 . . . . 0.0 109.854 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -44.23 -36.97 2.94 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.413 -0.804 . . . . 0.0 110.092 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.73 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 74.8 m -71.42 151.85 43.64 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.385 -0.822 . . . . 0.0 109.575 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.553 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -57.78 -14.5 5.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.432 -0.792 . . . . 0.0 110.508 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.699 ' SG ' HG23 ' A' ' 603' ' ' ILE . 7.0 t -120.4 143.66 48.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.546 -0.721 . . . . 0.0 109.692 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.59 ' O ' HG12 ' A' ' 588' ' ' ILE . 1.7 ttpm? -111.82 130.68 55.73 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.053 0.93 . . . . 0.0 112.769 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.651 HD11 ' CE1' ' A' ' 692' ' ' PHE . 4.8 mt -146.55 110.58 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.466 ' O ' HG12 ' A' ' 587' ' ' ILE . 1.2 mt-10 -93.64 102.34 14.51 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 117.73 -1.588 . . . . 0.0 109.306 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.726 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.1 m-20 -138.39 105.85 5.55 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.184 177.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 615' ' ' ASP . 1.7 t30 -35.9 -48.28 0.56 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.632 -0.668 . . . . 0.0 112.583 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -83.55 -17.44 41.79 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.969 -1.082 . . . . 0.0 111.963 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.641 HD22 HG22 ' A' ' 613' ' ' ILE . 0.6 OUTLIER -72.71 125.39 27.4 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.95 -1.094 . . . . 0.0 110.697 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -67.0 161.15 24.95 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.372 -0.83 . . . . 0.0 111.031 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.739 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -64.16 -45.56 87.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.243 -0.91 . . . . 0.0 109.223 179.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.59 ' HB ' HG23 ' A' ' 727' ' ' VAL . 12.4 m -94.86 2.3 9.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.386 -0.821 . . . . 0.0 109.336 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.9 t60 -29.09 -46.74 0.05 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.988 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.829 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -136.46 145.24 44.97 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 118.514 -1.274 . . . . 0.0 110.777 179.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 4.1 p90 -145.57 144.05 30.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.55 -0.719 . . . . 0.0 110.116 178.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.802 ' CD1' HD11 ' A' ' 580' ' ' LEU . 76.0 mt -103.31 120.4 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 3.7 t80 -114.46 155.1 27.0 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.618 0.723 . . . . 0.0 109.666 -178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 5.1 ttmt -118.01 137.45 52.87 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 121.639 0.733 . . . . 0.0 110.337 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.435 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -136.11 164.33 28.27 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.707 -0.62 . . . . 0.0 110.757 -179.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.0 tpt180 -77.52 117.26 18.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 108.677 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.51 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 5.6 t60 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.591 0.71 . . . . 0.0 110.941 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 4.2 mt . . . . . 0 N--CA 1.486 1.325 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.724 ' O ' HD23 ' A' ' 702' ' ' LEU . 0.7 OUTLIER -115.04 124.53 51.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.877 -1.139 . . . . 0.0 111.476 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.754 ' CG ' HD11 ' A' ' 671' ' ' LEU . 12.6 t0 -108.18 156.67 19.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.524 -0.735 . . . . 0.0 109.871 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.588 HD13 ' CD1' ' A' ' 578' ' ' LEU . 14.6 pt -104.85 131.72 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.314 -0.866 . . . . 0.0 110.174 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.742 ' CH2' HD13 ' A' ' 671' ' ' LEU . 97.9 m95 -118.56 121.0 39.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.684 -0.635 . . . . 0.0 110.937 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.6 ' HB2' HD11 ' A' ' 672' ' ' LEU . 8.8 t80 -80.82 114.82 19.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 108.67 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.555 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 8.8 t -107.6 109.02 20.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.189 -0.944 . . . . 0.0 111.432 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.605 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 10.5 t60 -75.04 160.18 30.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.0 109.979 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -150.69 -32.4 0.17 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.394 -0.816 . . . . 0.0 112.868 -178.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.605 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -79.38 130.35 9.8 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 117.897 -2.097 . . . . 0.0 109.976 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . 0.405 ' C ' ' H ' ' A' ' 656' ' ' VAL . 14.5 m -36.01 -23.42 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 115.383 1.624 . . . . 0.0 115.383 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.52 ' C ' HG23 ' A' ' 656' ' ' VAL . 4.5 t-20 -54.97 -4.51 0.07 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.336 -1.478 . . . . 0.0 113.197 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 664' ' ' MET . 4.3 t 75.31 150.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 121.592 -0.692 . . . . 0.0 110.984 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.572 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -111.66 151.9 28.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.577 -0.702 . . . . 0.0 110.347 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -138.39 126.47 22.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 109.863 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 1.018 HD13 HG22 ' A' ' 678' ' ' ILE . 19.4 tp -128.11 110.24 12.28 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.869 . . . . 0.0 110.161 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.67 -72.9 0.05 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.637 -0.664 . . . . 0.0 109.985 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 659' ' ' LEU . 4.9 m-80 -153.82 19.36 0.52 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.354 -0.841 . . . . 0.0 110.435 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.425 ' ND2' HG23 ' A' ' 716' ' ' VAL . 9.6 t-20 -116.95 116.92 28.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.031 -1.043 . . . . 0.0 110.501 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.97 141.6 32.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 109.579 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.652 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.8 OUTLIER -115.2 -169.17 1.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 110.681 -179.214 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.646 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.1 pt -120.3 -165.62 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.41 -0.806 . . . . 0.0 110.068 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -84.22 73.02 10.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.36 -0.838 . . . . 0.0 110.569 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 130.47 54.47 0.1 OUTLIER Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.646 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.0 OUTLIER -121.77 151.28 40.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -1.187 . . . . 0.0 110.106 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.773 ' HE2' HD11 ' A' ' 717' ' ' LEU . 7.2 tttt -109.04 139.69 43.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.486 -0.759 . . . . 0.0 109.411 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.948 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -144.36 146.59 32.64 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.299 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.754 HD11 ' CG ' ' A' ' 646' ' ' ASP . 12.7 tp -70.56 146.16 50.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.32 -0.862 . . . . 0.0 111.227 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.6 HD11 ' HB2' ' A' ' 649' ' ' TYR . 7.7 mt -118.93 102.15 8.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 110.585 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -84.53 160.61 20.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.458 -0.777 . . . . 0.0 109.204 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.446 ' HB3' HD12 ' A' ' 696' ' ' ILE . 21.4 p-10 -52.25 149.31 5.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.008 -1.057 . . . . 0.0 110.289 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 63.75 50.14 63.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.441 ' HB3' HD22 ' A' ' 672' ' ' LEU . 0.2 OUTLIER -110.8 94.9 5.23 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.715 -0.874 . . . . 0.0 111.098 -178.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.891 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -94.64 106.83 18.83 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.414 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 1.018 HG22 HD13 ' A' ' 659' ' ' LEU . 17.6 pt -106.78 135.8 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.474 -0.766 . . . . 0.0 111.328 -178.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -98.52 109.57 22.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.369 -0.832 . . . . 0.0 109.146 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.829 HD13 ' SG ' ' A' ' 623' ' ' CYS . 89.7 mt -74.86 -42.19 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.39 -0.819 . . . . 0.0 110.537 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.635 HD12 ' HB2' ' A' ' 618' ' ' LEU . 3.1 mt -130.75 132.95 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.202 -0.936 . . . . 0.0 110.347 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -138.75 112.04 8.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.571 -0.706 . . . . 0.0 109.904 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -129.94 117.91 20.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 110.248 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -29.73 69.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.466 -0.771 . . . . 0.0 110.721 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -55.69 -43.36 76.33 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.365 -0.835 . . . . 0.0 111.031 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 688' ' ' PHE . 2.1 t30 -137.26 36.0 2.52 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.192 -0.942 . . . . 0.0 110.256 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . 0.756 ' O ' HG23 ' A' ' 689' ' ' VAL . 0.8 OUTLIER 65.54 -67.82 0.13 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.77 -0.581 . . . . 0.0 109.856 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.509 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.1 OUTLIER 28.72 52.67 0.07 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.244 0.545 . . . . 0.0 111.346 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 687' ' ' LYS . 91.6 t -101.76 142.64 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 110.674 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.726 HD11 ' OD2' ' A' ' 615' ' ' ASP . 44.5 mm -120.0 165.32 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 179.79 121.37 0.72 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.052 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.891 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.8 m-85 -119.9 136.6 54.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.54 -0.977 . . . . 0.0 108.978 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.78 114.28 27.93 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.216 -0.927 . . . . 0.0 110.511 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -82.97 120.62 34.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.151 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -127.08 104.5 8.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.753 -0.592 . . . . 0.0 110.077 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 674' ' ' ASP . 65.4 mt -84.35 103.63 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.665 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -80.99 -42.97 20.34 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.9 OUTLIER -110.81 140.27 45.38 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.483 0.659 . . . . 0.0 110.271 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 12.1 p -114.9 96.13 5.56 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 35.7 m -117.94 121.67 41.28 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.208 0.528 . . . . 0.0 110.607 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.509 ' C ' HD22 ' A' ' 644' ' ' LEU . . . 52.41 45.5 58.65 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.813 HD11 ' CE2' ' A' ' 577' ' ' PHE . 3.7 mt -115.38 132.81 56.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.439 -1.036 . . . . 0.0 110.728 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.645 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 3.1 p90 -47.43 -24.71 0.87 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.568 0.699 . . . . 0.0 110.47 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.645 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.731 ' NH1' HD21 ' A' ' 659' ' ' LEU . 1.3 mmm-85 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.259 0.552 . . . . 0.0 111.893 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.444 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 35.5 m -108.31 151.13 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.455 -0.778 . . . . 0.0 109.583 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.45 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 87.5 t -98.44 127.47 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.266 -0.896 . . . . 0.0 110.758 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.773 HD11 ' HE2' ' A' ' 669' ' ' LYS . 0.5 OUTLIER -114.22 145.74 41.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.58 -0.7 . . . . 0.0 109.347 179.057 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.95 149.62 35.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.159 -0.963 . . . . 0.0 110.693 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . 0.408 ' HB2' ' CB ' ' A' ' 723' ' ' GLU . 9.1 pt20 -81.03 154.29 26.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.419 -0.801 . . . . 0.0 110.278 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 11.5 p -108.38 -176.61 3.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.331 -0.856 . . . . 0.0 110.677 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.51 -29.42 36.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.415 -0.803 . . . . 0.0 110.157 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . 0.461 ' O ' HD13 ' A' ' 726' ' ' LEU . 11.1 tp10 -60.72 -52.48 64.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.499 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.408 ' CB ' ' HB2' ' A' ' 719' ' ' GLN . 3.3 mp0 -63.89 -42.72 97.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 0.0 109.378 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.521 ' O ' HG12 ' A' ' 727' ' ' VAL . 1.4 mmtm -54.12 -32.21 54.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.341 -0.85 . . . . 0.0 109.552 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.26 -38.45 78.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.471 -0.768 . . . . 0.0 110.399 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.705 HD23 ' HB3' ' A' ' 600' ' ' PRO . 11.0 mp -55.75 -47.83 76.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.245 -0.909 . . . . 0.0 110.521 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.59 HG23 ' HB ' ' A' ' 621' ' ' VAL . 8.1 p -69.65 -22.22 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.226 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -51.44 65.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 108.912 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.84 104.98 11.87 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.171 0.986 . . . . 0.0 109.062 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 2.0 mt . . . . . 0 C--N 1.275 -2.657 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.444 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.405 ' CZ ' ' HG2' ' A' ' 593' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.599 0.714 . . . . 0.0 109.661 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.504 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 6.7 t80 -98.09 -41.7 7.81 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.867 0.841 . . . . 0.0 109.678 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.846 HD23 HD12 ' A' ' 594' ' ' ILE . 48.5 tp -129.39 119.77 24.41 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.272 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 89.2 m -94.89 116.43 28.7 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.701 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 1.008 HD11 HD12 ' A' ' 625' ' ' ILE . 7.4 mt -89.91 111.34 22.36 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 583' ' ' LEU . 0.4 OUTLIER -114.08 102.77 55.09 Favored Pre-proline 0 C--N 1.298 -1.638 0 C-N-CA 118.116 -1.434 . . . . 0.0 112.463 -177.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 1.093 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.8 Cg_endo -79.63 143.97 17.26 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 N-CA-C 107.134 -1.91 . . . . 0.0 107.134 174.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 1.03 ' HB2' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -128.06 -173.98 0.34 Allowed Pre-proline 0 C--N 1.3 -1.585 0 C-N-CA 118.958 -1.097 . . . . 0.0 112.381 -177.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 1.03 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 35.3 Cg_endo -60.5 -33.43 93.88 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.819 1.431 . . . . 0.0 111.556 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 689' ' ' VAL . 4.3 m-20 -59.73 -23.99 63.65 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.734 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 19.1 t -95.73 151.45 19.36 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.804 HD13 ' HB2' ' A' ' 688' ' ' PHE . 7.8 tp -62.34 -17.09 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.026 -1.046 . . . . 0.0 109.647 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.957 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.2 tp -108.21 122.72 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.318 -0.864 . . . . 0.0 110.187 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 586' ' ' SER . 23.6 mp0 -110.07 79.8 1.25 Allowed 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.463 -1.398 . . . . 0.0 109.399 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 1.093 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 27.2 mt-10 -144.71 175.45 10.16 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.643 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.544 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.13 124.77 35.57 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.138 -0.976 . . . . 0.0 108.889 175.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.639 HD13 ' SG ' ' A' ' 611' ' ' CYS . 2.1 mt -109.53 155.73 21.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.918 . . . . 0.0 109.565 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.405 ' HG2' ' CZ ' ' A' ' 576' ' ' ARG . 3.1 mp0 -125.26 110.25 13.81 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.373 -0.829 . . . . 0.0 111.346 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.846 HD12 HD23 ' A' ' 578' ' ' LEU . 2.0 mt -81.61 109.21 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.2 OUTLIER -56.15 165.07 1.08 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.446 -179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.504 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -63.17 70.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.54 -0.725 . . . . 0.0 110.065 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 137.79 21.83 0.48 Allowed Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.819 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.623 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -84.29 101.67 9.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 O-C-N 120.764 -1.433 . . . . 0.0 107.21 178.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 16.3 t-20 -145.46 132.57 10.1 Favored Pre-proline 0 C--N 1.283 -2.312 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.869 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.65 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 53.9 Cg_endo -91.71 163.5 27.77 Favored 'Cis proline' 0 C--N 1.311 -1.409 0 C-N-CA 123.31 -1.538 . . . . 0.0 109.045 -2.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.536 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 7.9 t80 -105.11 116.91 32.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.677 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 70.0 m-85 -86.34 146.15 26.6 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.416 -0.803 . . . . 0.0 111.406 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.686 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.9 mt -141.68 140.69 30.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.703 -0.623 . . . . 0.0 109.895 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.732 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 175.25 -161.41 30.59 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.298 -1.429 . . . . 0.0 111.436 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.408 ' CG ' ' O ' ' A' ' 615' ' ' ASP . 5.9 mmm-85 -69.7 -44.65 69.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.973 -0.722 . . . . 0.0 110.82 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.417 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -80.06 128.22 33.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.454 -0.779 . . . . 0.0 110.981 -178.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 1.6 pt-20 -58.54 -12.79 4.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.429 -0.794 . . . . 0.0 109.657 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . 0.452 ' OD2' HD13 ' A' ' 730' ' ' LEU . 15.7 t70 -45.25 -36.07 3.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.483 -0.761 . . . . 0.0 110.155 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.677 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 81.8 m -71.44 154.26 41.66 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 121.184 -0.947 . . . . 0.0 109.601 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.536 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -58.98 -14.0 8.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.443 -0.785 . . . . 0.0 110.14 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.686 ' SG ' HG23 ' A' ' 603' ' ' ILE . 6.1 t -120.18 143.94 47.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.492 -0.755 . . . . 0.0 110.033 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.571 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -110.63 129.7 55.75 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 121.992 0.901 . . . . 0.0 112.562 -178.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.691 HD11 ' CE1' ' A' ' 692' ' ' PHE . 4.3 mt -146.82 111.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.49 ' O ' HG21 ' A' ' 587' ' ' ILE . 1.4 tt0 -93.05 102.76 15.1 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 117.69 -1.604 . . . . 0.0 109.095 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 3.2 m-20 -138.26 105.29 5.43 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.505 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -42.81 -41.43 3.24 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.412 -0.805 . . . . 0.0 111.881 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.97 -16.88 42.47 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.137 -0.977 . . . . 0.0 111.739 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.598 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.7 OUTLIER -80.75 134.75 35.87 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.121 -0.987 . . . . 0.0 111.319 -178.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.485 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.42 162.83 28.02 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.466 -0.771 . . . . 0.0 111.025 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.732 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 34.2 ttp180 -64.36 -46.77 81.98 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.348 -0.845 . . . . 0.0 109.738 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.569 ' HB ' HG23 ' A' ' 727' ' ' VAL . 13.8 m -94.67 2.43 9.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.209 -0.932 . . . . 0.0 109.059 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.764 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.4 t60 -28.59 -47.85 0.05 Allowed 'General case' 0 C--O 1.192 -1.954 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.751 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.845 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.21 145.16 43.32 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 118.311 -1.356 . . . . 0.0 111.166 179.049 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 6.5 p90 -145.86 150.4 36.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.573 -0.704 . . . . 0.0 110.339 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 1.008 HD12 HD11 ' A' ' 580' ' ' LEU . 19.0 mt -103.41 119.56 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 7.0 t80 -112.61 155.4 24.47 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.482 -0.761 . . . . 0.0 109.351 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 0.8 OUTLIER -119.61 136.06 54.54 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.852 0.834 . . . . 0.0 111.183 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.426 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -140.51 163.54 32.56 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 630' ' ' HIS . 0.0 OUTLIER -78.18 133.98 37.7 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.966 -1.084 . . . . 0.0 109.439 -179.492 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.517 ' O ' ' HD2' ' A' ' 629' ' ' ARG . 1.2 t60 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.368 -0.832 . . . . 0.0 111.247 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.76 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.9 mp . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.6 OUTLIER -108.63 124.96 51.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.067 -1.021 . . . . 0.0 110.728 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.736 ' OD2' HD21 ' A' ' 671' ' ' LEU . 17.5 t0 -121.36 135.51 55.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.355 -0.841 . . . . 0.0 110.509 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 25.4 pt -92.69 135.28 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.272 -0.893 . . . . 0.0 110.075 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.645 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.6 m95 -119.62 121.93 40.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.604 -0.685 . . . . 0.0 111.306 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.586 ' HB2' HD11 ' A' ' 672' ' ' LEU . 14.0 t80 -80.78 115.54 20.33 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 9.8 t -107.22 108.45 19.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 111.64 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.516 ' CD2' ' N ' ' A' ' 652' ' ' THR . 12.5 t60 -70.72 158.66 35.88 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.461 -0.774 . . . . 0.0 109.761 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.764 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -149.86 -29.58 0.23 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.43 -0.794 . . . . 0.0 112.441 -179.077 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.55 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.45 -167.59 31.86 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 117.642 -2.218 . . . . 0.0 109.17 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 27.6 m -95.62 -17.44 21.34 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.014 -1.286 . . . . 0.0 113.751 -176.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.516 ' C ' HG23 ' A' ' 656' ' ' VAL . 16.7 m120 -59.48 -4.01 0.54 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.775 -1.203 . . . . 0.0 112.683 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 664' ' ' MET . 3.4 t 71.52 148.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-O 121.494 0.664 . . . . 0.0 110.604 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.436 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -106.83 143.09 35.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.721 -0.612 . . . . 0.0 110.068 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.456 ' CE1' ' CG ' ' A' ' 663' ' ' ARG . 36.6 m-85 -136.0 126.74 27.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.211 -0.93 . . . . 0.0 110.701 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.581 ' HG ' HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -130.02 119.04 22.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.392 -0.817 . . . . 0.0 109.787 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 56.89 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.388 -0.82 . . . . 0.0 110.429 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 659' ' ' LEU . 3.6 t-20 -138.07 5.73 2.57 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.017 -1.052 . . . . 0.0 110.984 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -96.28 132.99 41.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.032 -1.043 . . . . 0.0 110.566 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.456 ' CG ' ' CE1' ' A' ' 658' ' ' TYR . 4.6 tmm_? -99.47 138.69 36.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.448 -0.783 . . . . 0.0 109.872 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.768 ' HG2' HG13 ' A' ' 716' ' ' VAL . 3.6 mtp -117.41 -165.99 1.14 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.229 -0.92 . . . . 0.0 110.716 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.588 HG13 HG23 ' A' ' 668' ' ' THR . 2.5 pt -141.86 -158.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.354 -0.842 . . . . 0.0 110.171 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -82.85 92.05 7.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.2 -0.938 . . . . 0.0 110.759 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 109.65 49.74 0.73 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.588 HG23 HG13 ' A' ' 665' ' ' ILE . 0.2 OUTLIER -118.52 148.39 42.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.06 -1.259 . . . . 0.0 109.943 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.45 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 7.6 tttt -108.5 138.88 44.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.441 -0.787 . . . . 0.0 109.088 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.51 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 5.2 t80 -144.25 147.19 33.25 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.104 -0.997 . . . . 0.0 112.032 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.736 HD21 ' OD2' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -69.76 147.49 50.41 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.554 -0.717 . . . . 0.0 111.583 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.663 HD23 ' OD2' ' A' ' 676' ' ' ASP . 7.8 mt -122.81 99.2 6.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.322 -0.861 . . . . 0.0 111.444 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 674' ' ' ASP . 94.2 mt-30 -84.65 141.26 30.75 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 673' ' ' GLN . 0.3 OUTLIER -38.34 151.51 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.354 -0.842 . . . . 0.0 110.815 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 64.9 49.59 62.35 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 107.358 -2.297 . . . . 0.0 107.358 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.663 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.3 OUTLIER -115.81 92.43 3.9 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.871 -0.782 . . . . 0.0 110.774 -178.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.966 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.2 OUTLIER -93.93 106.98 18.93 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.581 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.2 pt -106.84 137.31 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.369 0.604 . . . . 0.0 111.404 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.409 ' CG ' ' HB2' ' A' ' 658' ' ' TYR . 2.9 ptmm? -97.17 110.44 22.99 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.488 -0.757 . . . . 0.0 109.418 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.845 HD13 ' SG ' ' A' ' 623' ' ' CYS . 68.5 mt -80.09 -22.65 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.373 -0.829 . . . . 0.0 110.692 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.514 HG22 ' HA ' ' A' ' 689' ' ' VAL . 0.4 OUTLIER -134.64 135.17 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.163 -0.961 . . . . 0.0 109.998 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -138.0 109.13 6.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.934 . . . . 0.0 110.562 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 686' ' ' ASN . 0.7 OUTLIER -130.16 118.23 21.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.281 -0.887 . . . . 0.0 109.666 179.19 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.95 -32.53 74.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.334 -0.854 . . . . 0.0 111.215 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -84.23 -43.71 14.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.092 -1.005 . . . . 0.0 111.504 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 688' ' ' PHE . 88.4 m-20 -73.88 -19.83 60.59 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.137 -0.977 . . . . 0.0 110.798 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.53 22.09 4.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.168 -0.958 . . . . 0.0 110.46 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.804 ' HB2' HD13 ' A' ' 587' ' ' ILE . 0.7 OUTLIER -114.24 83.8 1.94 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.26 1.029 . . . . 0.0 109.472 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' A' ' 586' ' ' SER . 14.9 m -101.04 143.17 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.075 -1.016 . . . . 0.0 110.553 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.734 ' CD1' HG22 ' A' ' 587' ' ' ILE . 47.7 mm -85.19 165.13 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.554 -0.716 . . . . 0.0 109.975 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.455 ' N ' HG22 ' A' ' 690' ' ' ILE . . . -176.8 117.06 0.58 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.966 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.6 m-85 -121.46 137.26 54.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 109.945 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.96 113.95 25.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.282 -0.886 . . . . 0.0 109.98 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.769 HG22 HD11 ' A' ' 578' ' ' LEU . 0.5 OUTLIER -83.65 123.7 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.364 -0.835 . . . . 0.0 109.254 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.39 108.52 10.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.85 -0.531 . . . . 0.0 110.408 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 81.0 mt -86.37 104.42 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.887 . . . . 0.0 109.826 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -77.4 -41.39 40.18 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.421 -0.8 . . . . 0.0 109.453 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.458 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 5.2 m-20 -110.22 140.97 43.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.479 -0.763 . . . . 0.0 110.735 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 15.7 p -115.88 96.27 5.51 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 82.5 m -108.7 114.71 28.74 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 121.752 -0.592 . . . . 0.0 110.738 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 49.46 36.37 23.58 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 704' ' ' ASN . 5.2 tp -98.41 141.18 31.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.613 -0.933 . . . . 0.0 110.195 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.76 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.6 p90 -51.75 -24.92 6.5 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.395 -0.816 . . . . 0.0 109.756 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.798 ' O ' HD23 ' A' ' 702' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.51 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 121.723 0.773 . . . . 0.0 109.356 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 36.0 m -105.25 168.7 2.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.666 -0.646 . . . . 0.0 109.63 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.768 HG13 ' HG2' ' A' ' 664' ' ' MET . 52.7 t -71.34 128.48 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.326 -0.859 . . . . 0.0 111.139 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.62 162.3 13.63 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -98.64 154.39 17.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.981 -1.074 . . . . 0.0 110.467 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . 0.428 ' HG3' ' HB3' ' A' ' 723' ' ' GLU . 0.4 OUTLIER -79.69 145.08 33.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.54 -0.725 . . . . 0.0 110.403 -179.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 34.3 p -121.07 -176.8 3.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 110.093 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.78 -32.21 63.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.292 -0.88 . . . . 0.0 110.448 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -64.49 -52.3 58.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.386 -0.822 . . . . 0.0 110.22 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.428 ' HB3' ' HG3' ' A' ' 719' ' ' GLN . 0.6 OUTLIER -64.42 -40.3 95.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.328 -0.857 . . . . 0.0 110.051 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.458 ' O ' HG12 ' A' ' 727' ' ' VAL . 18.3 ttpp -56.93 -35.11 68.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.311 -0.868 . . . . 0.0 109.945 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 728' ' ' LYS . 0.9 OUTLIER -67.7 -35.79 79.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.472 -0.768 . . . . 0.0 109.994 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.414 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 50.3 mt -57.06 -46.39 82.52 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.333 -0.854 . . . . 0.0 110.336 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.569 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.2 p -76.28 -24.33 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.613 -0.68 . . . . 0.0 110.914 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 725' ' ' ASP . 0.7 OUTLIER -53.32 -45.18 68.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.055 -1.028 . . . . 0.0 108.956 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -116.67 103.81 10.74 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 122.197 0.999 . . . . 0.0 109.057 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.452 HD13 ' OD2' ' A' ' 608' ' ' ASP . 2.2 mt . . . . . 0 C--N 1.274 -2.708 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.375 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.1 OUTLIER -120.96 -39.69 2.69 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.843 0.83 . . . . 0.0 109.415 -179.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.042 HD22 HD12 ' A' ' 594' ' ' ILE . 8.5 tt -120.31 119.52 33.38 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.326 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 71.2 m -99.44 118.89 37.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 109.52 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.658 HD11 HD12 ' A' ' 625' ' ' ILE . 5.8 mt -91.37 111.97 23.68 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.79 101.82 54.2 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 118.075 -1.45 . . . . 0.0 112.736 -177.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 1.047 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 44.2 Cg_endo -79.75 145.78 18.31 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 N-CA-C 106.784 -2.045 . . . . 0.0 106.784 174.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.73 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.33 -174.37 0.31 Allowed Pre-proline 0 N--CA 1.494 1.753 0 C-N-CA 118.81 -1.156 . . . . 0.0 112.763 -177.104 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.73 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.9 Cg_endo -66.79 -28.73 43.15 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 124.111 1.585 . . . . 0.0 110.319 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -59.4 -28.35 66.83 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 53.7 p -95.45 153.73 17.55 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.645 ' H ' HD13 ' A' ' 690' ' ' ILE . 3.8 tp -54.76 -16.98 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.333 -0.855 . . . . 0.0 109.944 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.86 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.6 tp -116.3 119.34 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.265 -0.897 . . . . 0.0 110.575 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.434 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -112.39 80.73 1.37 Allowed 'General case' 0 N--CA 1.509 2.498 0 O-C-N 120.444 -1.41 . . . . 0.0 109.143 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 1.047 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 6.7 mm-40 -142.57 175.78 9.53 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.625 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.57 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.92 125.85 40.37 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.083 -1.011 . . . . 0.0 109.456 176.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 17.4 mt -111.17 156.02 22.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.405 -0.809 . . . . 0.0 109.649 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -125.23 111.12 14.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.378 -0.826 . . . . 0.0 111.836 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.042 HD12 HD22 ' A' ' 578' ' ' LEU . 45.9 mt -80.42 110.81 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.491 ' O ' ' C ' ' A' ' 596' ' ' GLN . 2.0 mt-30 -70.71 109.47 4.95 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.493 ' HA ' ' CD1' ' A' ' 577' ' ' PHE . 0.5 OUTLIER 20.43 53.89 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 178.333 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . 109.96 44.62 1.01 Allowed Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.603 -1.284 . . . . 0.0 111.03 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 598' ' ' VAL . 1.0 OUTLIER -79.63 103.85 7.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 177.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.445 ' CB ' ' HB3' ' A' ' 627' ' ' LYS . 0.2 OUTLIER -140.97 140.52 21.55 Favored Pre-proline 0 C--N 1.281 -2.371 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.639 -178.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.574 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.2 Cg_endo -88.79 160.82 40.67 Favored 'Cis proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.721 -2.199 . . . . 0.0 109.07 -0.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -106.56 116.82 32.58 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.706 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 58.1 m-85 -91.25 145.86 24.31 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.39 -0.818 . . . . 0.0 111.037 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.724 HD11 HG13 ' A' ' 625' ' ' ILE . 2.2 mt -140.02 141.05 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.33 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.713 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 175.33 -165.85 37.04 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.356 -1.402 . . . . 0.0 111.321 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 13.2 tpt180 -66.69 -38.81 87.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.956 -0.732 . . . . 0.0 110.777 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.471 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -84.22 126.8 33.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.398 -0.814 . . . . 0.0 110.748 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.422 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -59.3 -12.68 6.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 110.009 179.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.32 -36.97 6.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.882 . . . . 0.0 110.036 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.706 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 75.3 m -68.93 153.65 43.42 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 121.265 -0.897 . . . . 0.0 109.773 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.572 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -58.63 -14.78 9.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.485 -0.76 . . . . 0.0 110.238 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.699 ' SG ' HG23 ' A' ' 603' ' ' ILE . 6.6 t -119.95 143.46 47.99 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.582 -0.699 . . . . 0.0 109.528 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.65 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -110.23 130.88 55.47 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 122.054 0.93 . . . . 0.0 112.856 -178.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.669 HD11 ' CE1' ' A' ' 692' ' ' PHE . 3.9 mt -147.15 110.39 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.436 ' O ' HG12 ' A' ' 587' ' ' ILE . 2.7 tt0 -92.31 102.98 15.48 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 117.666 -1.614 . . . . 0.0 109.277 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.857 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.0 OUTLIER -139.55 106.15 5.34 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.692 177.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -42.94 -43.68 4.25 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.485 -0.76 . . . . 0.0 111.962 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -83.53 -17.13 42.89 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.144 -0.973 . . . . 0.0 111.729 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.947 HD13 HD11 ' A' ' 681' ' ' ILE . 0.8 OUTLIER -78.01 134.65 37.77 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.07 -1.019 . . . . 0.0 110.694 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.479 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.1 m -73.37 161.14 30.79 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.337 -0.852 . . . . 0.0 110.915 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.713 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 43.6 mtm180 -64.2 -45.63 87.47 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.235 -0.916 . . . . 0.0 109.309 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.708 ' HB ' HG23 ' A' ' 727' ' ' VAL . 15.7 m -94.66 2.0 9.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.83 0.824 . . . . 0.0 109.402 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.6 t60 -28.28 -46.91 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.771 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.823 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -136.17 144.93 45.26 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.523 178.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 6.3 p90 -145.7 143.65 29.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.485 -0.759 . . . . 0.0 110.229 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.724 HG13 HD11 ' A' ' 603' ' ' ILE . 76.8 mt -103.43 117.66 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 8.3 t80 -110.95 155.0 23.32 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.853 0.835 . . . . 0.0 110.234 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.445 ' HB3' ' CB ' ' A' ' 599' ' ' ASN . 3.1 tppp? -118.96 137.13 53.71 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 121.372 0.606 . . . . 0.0 109.735 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.0 OUTLIER -133.88 163.82 28.65 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.566 -0.709 . . . . 0.0 111.038 -179.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.494 ' HD2' ' O ' ' A' ' 644' ' ' LEU . 2.5 tpt180 -77.66 116.2 18.02 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.366 -0.834 . . . . 0.0 108.929 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 703' ' ' PHE . 8.5 t60 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.651 0.738 . . . . 0.0 110.649 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.662 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.6 mp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 628' ' ' LYS . 41.6 m-20 -112.22 124.72 53.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.873 -1.142 . . . . 0.0 111.325 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.494 ' OD1' HD21 ' A' ' 671' ' ' LEU . 5.6 t0 -98.34 156.57 16.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.482 -0.761 . . . . 0.0 109.647 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.49 HD13 HD12 ' A' ' 578' ' ' LEU . 12.7 pt -106.25 130.18 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.278 -0.889 . . . . 0.0 110.38 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.729 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.6 m95 -117.84 124.38 48.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.841 -0.537 . . . . 0.0 111.194 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.716 ' HB2' HD11 ' A' ' 672' ' ' LEU . 7.1 t80 -83.91 114.47 21.7 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 17.4 t -109.71 106.1 15.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.061 -1.024 . . . . 0.0 112.112 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.549 ' CD2' ' N ' ' A' ' 652' ' ' THR . 14.4 t60 -67.54 162.55 23.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.454 -0.778 . . . . 0.0 109.854 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -154.47 -30.98 0.11 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.304 -0.872 . . . . 0.0 112.509 -179.244 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.557 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.62 -168.57 34.18 Favored Glycine 0 N--CA 1.497 2.712 0 C-N-CA 117.82 -2.133 . . . . 0.0 109.766 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 11.1 m -89.71 -18.78 25.74 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.088 -1.242 . . . . 0.0 114.217 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.692 ' O ' HG22 ' A' ' 656' ' ' VAL . 24.4 m120 -59.32 -3.03 0.36 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.605 -1.309 . . . . 0.0 112.728 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 62.52 142.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.549 -0.719 . . . . 0.0 110.164 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.482 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -96.95 151.8 19.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.589 -0.695 . . . . 0.0 110.554 -179.168 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.481 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 12.6 m-85 -138.02 125.46 21.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.363 -0.836 . . . . 0.0 110.175 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.761 HD21 ' CG1' ' A' ' 678' ' ' ILE . 1.7 mt -129.4 110.15 11.66 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.382 -0.824 . . . . 0.0 109.83 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 59.02 -80.67 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.428 -0.795 . . . . 0.0 110.37 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 659' ' ' LEU . 7.6 p-10 -144.64 13.73 1.54 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 110.94 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -100.16 116.74 32.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.017 -1.052 . . . . 0.0 110.225 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -81.46 136.14 35.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.348 -0.845 . . . . 0.0 109.676 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.789 ' CG ' HG21 ' A' ' 716' ' ' VAL . 1.6 mtp -119.07 -167.39 1.38 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 0.0 110.223 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.536 HG13 HG23 ' A' ' 668' ' ' THR . 11.2 pt -146.74 -162.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 652' ' ' THR . 31.9 tt0 -75.68 79.4 2.65 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.342 -0.849 . . . . 0.0 111.272 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.93 58.07 0.21 Allowed Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.833 -1.175 . . . . 0.0 110.678 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 1.2 p -123.9 145.58 49.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.994 -1.298 . . . . 0.0 110.074 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -108.52 136.94 47.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.398 -0.814 . . . . 0.0 109.205 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 671' ' ' LEU . 8.1 t80 -144.45 146.81 32.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.163 -0.96 . . . . 0.0 111.49 -178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.729 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.9 OUTLIER -72.17 145.88 47.77 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.413 -0.804 . . . . 0.0 111.628 -179.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.716 HD11 ' HB2' ' A' ' 649' ' ' TYR . 6.2 mt -115.55 112.94 22.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.228 -0.92 . . . . 0.0 111.318 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . 0.498 ' O ' HG11 ' A' ' 694' ' ' VAL . 15.3 mt-30 -84.53 -177.03 6.5 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.55 149.7 42.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.982 -1.074 . . . . 0.0 109.711 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 59.68 50.26 69.61 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.2 94.74 5.89 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.74 0.781 . . . . 0.0 110.643 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.912 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 5.9 tt0 -93.49 107.42 19.27 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.761 ' CG1' HD21 ' A' ' 659' ' ' LEU . 1.9 mp -104.15 137.15 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.642 -0.661 . . . . 0.0 111.88 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -99.58 109.89 22.37 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.823 HD13 ' SG ' ' A' ' 623' ' ' CYS . 74.9 mt -79.52 -19.89 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.352 -0.842 . . . . 0.0 111.076 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.947 HD11 HD13 ' A' ' 618' ' ' LEU . 8.4 mt -141.6 141.33 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.967 -1.083 . . . . 0.0 110.762 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -137.79 108.77 6.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.43 -0.794 . . . . 0.0 109.965 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.96 118.43 29.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.268 -0.895 . . . . 0.0 110.161 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -66.33 -46.87 75.36 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.364 -0.835 . . . . 0.0 110.963 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -84.93 -43.43 14.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.258 -0.901 . . . . 0.0 111.2 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -91.23 0.39 57.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.262 -0.899 . . . . 0.0 111.004 -179.353 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . 0.626 ' O ' HG23 ' A' ' 689' ' ' VAL . 0.0 OUTLIER 65.49 -67.73 0.13 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.42 -0.8 . . . . 0.0 109.777 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.595 ' HD2' HG21 ' A' ' 681' ' ' ILE . 0.1 OUTLIER 24.52 61.0 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.369 0.604 . . . . 0.0 111.317 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 687' ' ' LYS . 59.8 t -101.97 142.46 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.422 -0.799 . . . . 0.0 110.718 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.857 HD11 ' OD2' ' A' ' 615' ' ' ASP . 40.4 mm -122.64 165.38 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -176.35 121.01 0.78 Allowed Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.912 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 10.6 m-85 -119.62 136.51 54.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.526 -0.985 . . . . 0.0 108.798 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -98.77 114.32 26.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 110.898 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 694' ' ' VAL . 1.2 t -84.78 114.0 24.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -122.37 104.34 9.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.733 -0.604 . . . . 0.0 109.826 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 83.3 mt -88.71 103.28 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.33 -0.856 . . . . 0.0 109.679 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.0 -41.75 22.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 0.0 108.927 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.7 OUTLIER -109.92 141.29 42.87 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.391 0.615 . . . . 0.0 109.629 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 16.3 p -113.29 95.8 5.56 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 40.7 m -129.65 134.62 47.78 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.87 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 57.72 29.35 61.28 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.596 ' O ' HD22 ' A' ' 644' ' ' LEU . 1.0 OUTLIER -113.83 128.07 56.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.503 -0.998 . . . . 0.0 110.24 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.662 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.5 p90 -50.44 -24.01 2.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.481 -0.762 . . . . 0.0 110.753 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.529 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.582 ' NH2' HD22 ' A' ' 659' ' ' LEU . 3.5 mmm-85 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.223 0.535 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 32.0 m -108.04 152.25 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.533 -0.729 . . . . 0.0 109.522 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.789 HG21 ' CG ' ' A' ' 664' ' ' MET . 14.6 p -104.21 133.29 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.725 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.0 mp -104.01 162.76 12.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.416 -0.803 . . . . 0.0 110.001 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -93.33 154.27 18.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.223 -0.923 . . . . 0.0 110.163 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -79.61 148.02 31.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.36 -0.838 . . . . 0.0 110.358 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 11.9 p -121.07 -176.37 3.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.381 -0.824 . . . . 0.0 110.359 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.49 -29.0 33.89 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.332 -0.855 . . . . 0.0 110.093 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.8 -51.32 65.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.461 -0.774 . . . . 0.0 109.745 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -64.06 -43.64 94.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.45 -0.781 . . . . 0.0 109.937 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.543 ' O ' HG12 ' A' ' 727' ' ' VAL . 16.1 tttt -56.41 -32.86 65.24 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.35 -0.843 . . . . 0.0 110.06 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -68.78 -36.31 78.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.387 -0.821 . . . . 0.0 110.364 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 37.8 mt -60.02 -46.32 89.9 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.362 -0.836 . . . . 0.0 110.439 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.708 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.1 p -69.15 -19.67 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.04 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.53 -50.8 69.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 108.877 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -116.85 105.29 12.2 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 122.132 0.968 . . . . 0.0 109.122 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.515 HD21 HG12 ' A' ' 621' ' ' VAL . 4.5 mt . . . . . 0 C--N 1.274 -2.68 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.472 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.413 ' HD3' ' HG2' ' A' ' 593' ' ' GLU . 14.0 ttp-105 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 121.707 0.765 . . . . 0.0 109.202 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.681 ' CZ ' HD13 ' A' ' 702' ' ' LEU . 3.0 t80 -92.47 -43.52 9.14 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.913 0.863 . . . . 0.0 109.475 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.079 HD23 HD12 ' A' ' 594' ' ' ILE . 5.4 tp -125.1 119.7 29.36 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.628 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 36.2 m -96.75 118.66 33.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.53 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.788 HD11 HD12 ' A' ' 625' ' ' ILE . 3.3 mt -94.72 112.3 24.04 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.563 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -111.97 104.18 55.83 Favored Pre-proline 0 C--N 1.3 -1.563 0 C-N-CA 118.467 -1.293 . . . . 0.0 112.935 -177.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 1.086 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.7 Cg_endo -76.81 142.46 22.59 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 N-CA-C 105.72 -2.454 . . . . 0.0 105.72 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 1.027 ' HB2' ' HD2' ' A' ' 584' ' ' PRO . 0.1 OUTLIER -126.78 -175.28 0.41 Allowed Pre-proline 0 N--CA 1.499 1.982 0 C-N-CA 118.416 -1.314 . . . . 0.0 113.806 -176.052 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 1.027 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 37.7 Cg_endo -65.75 -33.43 44.17 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.961 1.506 . . . . 0.0 111.381 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.08 -30.34 68.01 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.598 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 84.2 p -97.59 153.77 17.97 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.687 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.2 OUTLIER -61.6 -11.06 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.935 . . . . 0.0 109.839 178.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.766 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 8.5 mm -98.54 116.95 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.351 -0.843 . . . . 0.0 109.779 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 586' ' ' SER . 17.8 mp0 -118.67 70.32 0.82 Allowed 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.491 -1.38 . . . . 0.0 109.932 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 1.086 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 18.0 mt-10 -144.31 175.44 10.09 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.014 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.496 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.61 125.57 36.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.995 -1.066 . . . . 0.0 109.04 176.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.673 HD13 ' HA ' ' A' ' 611' ' ' CYS . 46.5 mt -111.63 155.05 23.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 109.828 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.413 ' HG2' ' HD3' ' A' ' 576' ' ' ARG . 16.3 mp0 -126.27 110.59 13.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.835 . . . . 0.0 111.461 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.079 HD12 HD23 ' A' ' 578' ' ' LEU . 3.5 mt -77.94 109.52 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.06 -1.025 . . . . 0.0 108.32 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -53.61 161.22 1.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.451 -0.781 . . . . 0.0 109.766 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.506 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.3 OUTLIER -48.94 79.05 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.706 -0.621 . . . . 0.0 111.551 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 107.41 34.93 2.78 Favored Glycine 0 N--CA 1.486 1.995 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.844 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.722 ' HB ' HG23 ' A' ' 594' ' ' ILE . 1.0 OUTLIER -79.77 103.05 6.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.4 t30 -143.01 135.25 13.3 Favored Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.023 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.633 ' HB3' HD23 ' A' ' 726' ' ' LEU . 56.0 Cg_endo -91.08 161.9 29.67 Favored 'Cis proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.781 -1.758 . . . . 0.0 108.987 -1.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.516 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -106.62 116.2 31.52 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.628 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 63.6 m-85 -83.02 143.63 30.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 0.0 110.288 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.775 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.9 mt -142.93 142.08 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.563 -0.711 . . . . 0.0 110.224 -178.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.787 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 165.42 -161.2 34.67 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.339 -1.41 . . . . 0.0 111.4 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.461 ' N ' HD23 ' A' ' 618' ' ' LEU . 3.4 mmm-85 -63.74 -53.87 44.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.78 -0.835 . . . . 0.0 111.834 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.481 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -71.59 124.73 25.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 111.239 -178.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.485 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.1 OUTLIER -54.07 -17.67 2.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 0.0 109.813 178.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -45.18 -30.99 1.29 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 0.0 109.272 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 602' ' ' PHE . 1.7 m -68.6 133.81 49.05 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.516 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -45.08 -26.93 0.51 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.318 -0.864 . . . . 0.0 109.759 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.775 ' HB3' HG23 ' A' ' 603' ' ' ILE . 13.0 t -106.23 143.61 34.1 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.485 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -108.91 125.15 51.71 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.253 1.025 . . . . 0.0 113.161 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.766 ' HA ' ' CD1' ' A' ' 588' ' ' ILE . 18.3 mt -143.13 108.31 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.431 ' HA ' ' HD2' ' A' ' 605' ' ' ARG . 3.8 mt-10 -97.77 104.41 16.43 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 118.302 -1.359 . . . . 0.0 109.25 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.705 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.0 OUTLIER -137.99 106.19 5.75 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.238 177.439 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -42.49 -39.48 2.27 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.485 -0.759 . . . . 0.0 111.678 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.67 -17.8 40.2 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.152 -0.968 . . . . 0.0 111.303 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.751 HD12 HD11 ' A' ' 681' ' ' ILE . 0.7 OUTLIER -79.3 140.45 37.56 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.177 -0.952 . . . . 0.0 110.562 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.427 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.82 161.02 29.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.372 -0.83 . . . . 0.0 110.718 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.787 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 9.8 ttp180 -63.6 -45.65 89.4 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.25 -0.906 . . . . 0.0 109.173 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.873 HG11 HG23 ' A' ' 727' ' ' VAL . 7.7 t -95.98 1.92 10.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.483 -0.761 . . . . 0.0 109.931 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.751 ' O ' ' N ' ' A' ' 652' ' ' THR . 9.2 t60 -27.49 -41.82 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.078 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.739 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.7 OUTLIER -136.76 145.0 44.07 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 118.228 -1.389 . . . . 0.0 110.861 179.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.551 ' CE2' ' CB ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -147.63 140.75 25.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.579 -0.7 . . . . 0.0 109.992 178.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.788 HD12 HD11 ' A' ' 580' ' ' LEU . 0.6 OUTLIER -103.21 136.88 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.231 -0.918 . . . . 0.0 109.327 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.544 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 7.6 t80 -128.97 155.83 44.75 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.503 -0.748 . . . . 0.0 109.636 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.677 ' HE2' HG23 ' A' ' 647' ' ' ILE . 1.2 tppp? -119.02 136.93 53.87 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.404 0.621 . . . . 0.0 110.622 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.433 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -140.32 163.82 31.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.627 -0.67 . . . . 0.0 110.709 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -78.39 128.61 33.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.377 -0.827 . . . . 0.0 109.411 -179.733 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.537 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.5 t60 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.421 -0.799 . . . . 0.0 110.845 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.767 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.2 mp . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.8 OUTLIER -121.56 124.6 44.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.083 -1.01 . . . . 0.0 111.186 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.656 ' CG ' HD21 ' A' ' 671' ' ' LEU . 3.2 t0 -114.11 149.0 36.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.383 -0.823 . . . . 0.0 109.7 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.677 HG23 ' HE2' ' A' ' 627' ' ' LYS . 5.4 pt -94.76 136.81 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.211 -0.93 . . . . 0.0 110.194 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.601 ' CH2' HD12 ' A' ' 671' ' ' LEU . 95.7 m95 -119.39 121.37 39.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.653 -0.654 . . . . 0.0 110.525 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.94 ' HB2' HD11 ' A' ' 672' ' ' LEU . 5.2 t80 -80.53 117.95 21.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.138 -0.977 . . . . 0.0 108.6 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 668' ' ' THR . 4.3 m -107.84 102.57 11.77 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.422 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.501 ' CD2' ' N ' ' A' ' 652' ' ' THR . 27.0 t60 -64.47 163.58 13.1 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.29 -0.881 . . . . 0.0 109.503 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.751 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -151.9 -28.78 0.17 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.615 ' N ' ' HA ' ' A' ' 622' ' ' HIS . . . -79.16 -169.27 36.94 Favored Glycine 0 N--CA 1.496 2.665 0 O-C-N 119.204 -2.185 . . . . 0.0 109.856 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 12.6 m -94.06 -18.62 21.64 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.178 -1.189 . . . . 0.0 113.9 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.53 ' O ' HG12 ' A' ' 656' ' ' VAL . 29.8 m120 -61.86 -4.26 1.48 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.625 -1.297 . . . . 0.0 111.896 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 78.21 169.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 121.919 0.866 . . . . 0.0 110.607 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.477 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -125.35 149.44 48.11 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.436 -179.222 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.416 ' CZ ' ' HG3' ' A' ' 663' ' ' ARG . 2.9 m-85 -138.58 126.7 22.71 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.313 -0.867 . . . . 0.0 110.657 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.825 HD23 ' CE2' ' A' ' 670' ' ' PHE . 24.8 tp -125.67 107.63 10.76 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.359 -0.838 . . . . 0.0 109.914 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 27.2 t30 64.73 -68.09 0.11 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.648 -0.658 . . . . 0.0 110.412 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.8 OUTLIER -158.86 24.68 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 110.164 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.31 132.87 56.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -0.937 . . . . 0.0 110.425 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 658' ' ' TYR . 5.4 ttt180 -95.12 130.14 41.94 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.467 -0.77 . . . . 0.0 110.28 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.692 ' HG2' HG13 ' A' ' 716' ' ' VAL . 2.4 mtp -110.05 -164.58 0.94 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.409 -0.807 . . . . 0.0 110.056 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.605 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.8 pt -140.21 -163.24 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 110.213 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -77.5 93.64 4.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.333 -0.854 . . . . 0.0 110.653 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.42 53.58 0.87 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.605 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.0 OUTLIER -118.24 147.74 43.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.183 -1.186 . . . . 0.0 109.911 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.422 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 2.7 tttm -108.38 139.5 43.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.538 -0.726 . . . . 0.0 109.53 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.825 ' CE2' HD23 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -144.47 142.87 30.57 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.093 -179.226 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.656 HD21 ' CG ' ' A' ' 646' ' ' ASP . 0.4 OUTLIER -69.87 147.01 50.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.519 -0.738 . . . . 0.0 110.753 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.94 HD11 ' HB2' ' A' ' 649' ' ' TYR . 26.1 mt -118.08 131.33 56.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.356 -0.84 . . . . 0.0 111.277 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . 0.409 ' O ' ' C ' ' A' ' 674' ' ' ASP . 61.6 mt-30 -113.19 143.17 44.84 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 673' ' ' GLN . 3.7 p-10 -41.03 144.91 0.24 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.184 -0.947 . . . . 0.0 110.748 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.48 49.39 44.92 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.687 ' OD2' HD11 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -109.7 97.43 6.97 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.788 0.804 . . . . 0.0 110.616 -178.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.706 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.82 107.01 18.95 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.757 HG22 HD13 ' A' ' 659' ' ' LEU . 35.3 pt -108.38 136.84 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.48 -0.763 . . . . 0.0 111.56 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.73 110.29 22.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.514 -0.741 . . . . 0.0 109.253 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.739 HD13 ' SG ' ' A' ' 623' ' ' CYS . 70.8 mt -76.74 -26.41 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.335 -0.853 . . . . 0.0 110.191 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.751 HD11 HD12 ' A' ' 618' ' ' LEU . 4.4 mt -143.29 133.84 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 109.961 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -137.61 114.61 10.73 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.359 -0.838 . . . . 0.0 110.329 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' A' ' 686' ' ' ASN . 0.2 OUTLIER -127.51 118.33 23.79 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.318 -0.864 . . . . 0.0 110.028 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -65.94 -42.76 89.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.393 -0.817 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -83.73 -43.34 15.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.332 -0.855 . . . . 0.0 110.844 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 683' ' ' ASP . 1.9 t-20 -80.31 -12.05 59.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.283 -0.886 . . . . 0.0 110.663 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 57.16 18.77 4.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.13 -0.981 . . . . 0.0 110.5 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.404 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -77.52 76.21 4.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.161 179.213 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 681' ' ' ILE . 60.5 t -101.86 137.23 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.458 -0.776 . . . . 0.0 110.941 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.705 HD11 ' OD2' ' A' ' 615' ' ' ASP . 49.0 mm -118.73 164.43 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -178.02 124.94 0.96 Allowed Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.496 -1.335 . . . . 0.0 110.196 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.706 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 13.4 m-85 -120.43 137.76 54.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.591 -0.946 . . . . 0.0 109.132 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.4 113.95 26.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.157 -0.964 . . . . 0.0 109.985 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 694' ' ' VAL . 1.1 t -83.06 118.16 30.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.481 -0.762 . . . . 0.0 109.151 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -128.8 104.6 7.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.65 -0.657 . . . . 0.0 110.097 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.562 ' CG1' HD12 ' A' ' 578' ' ' LEU . 69.1 mt -81.86 104.69 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.46 -0.775 . . . . 0.0 109.832 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.48 -42.52 35.5 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.439 -0.788 . . . . 0.0 108.875 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.5 ' O ' ' CD1' ' A' ' 577' ' ' PHE . 3.9 m-20 -110.84 141.49 44.14 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.463 0.649 . . . . 0.0 110.68 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 9.0 p -114.04 96.2 5.69 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.8 m -94.65 100.03 12.05 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.261 0.553 . . . . 0.0 111.735 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 45.9 34.48 5.64 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.867 HD23 ' O ' ' A' ' 704' ' ' ASN . 1.1 tp -84.47 150.22 25.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -1.12 . . . . 0.0 110.043 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.767 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.6 p90 -51.49 -24.44 5.11 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.314 -0.866 . . . . 0.0 110.038 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.867 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.6 t30 . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.708 ' NH1' HD21 ' A' ' 659' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 121.54 0.686 . . . . 0.0 110.094 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 34.2 m -106.57 153.07 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.65 -0.656 . . . . 0.0 109.69 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.692 HG13 ' HG2' ' A' ' 664' ' ' MET . 84.1 t -85.06 133.32 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.22 -0.925 . . . . 0.0 110.916 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.6 mt -105.39 162.38 13.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.555 -0.716 . . . . 0.0 109.6 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -101.24 153.53 19.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.167 -0.958 . . . . 0.0 110.292 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -85.35 151.03 24.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.347 -0.846 . . . . 0.0 110.263 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 19.0 p -121.33 -176.66 3.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.329 -0.857 . . . . 0.0 110.47 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.68 -29.81 40.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.45 -0.781 . . . . 0.0 110.119 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . 0.434 ' O ' HD13 ' A' ' 726' ' ' LEU . 3.6 tt0 -63.49 -52.29 61.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.673 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.38 -38.18 90.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.427 -0.795 . . . . 0.0 109.496 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.477 ' O ' HG12 ' A' ' 727' ' ' VAL . 11.8 tttt -57.76 -32.27 67.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.421 -0.799 . . . . 0.0 109.833 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.69 -40.33 80.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.259 -0.901 . . . . 0.0 110.409 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.633 HD23 ' HB3' ' A' ' 600' ' ' PRO . 11.0 mp -55.91 -47.02 78.22 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.223 -0.923 . . . . 0.0 110.843 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.873 HG23 HG11 ' A' ' 621' ' ' VAL . 7.2 p -69.23 -18.05 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.486 -0.759 . . . . 0.0 110.232 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.37 -43.96 68.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 108.854 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -116.96 104.32 11.16 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 122.254 1.026 . . . . 0.0 109.221 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.413 ' O ' ' CD2' ' A' ' 602' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--N 1.275 -2.664 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.402 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.6 ' CD2' ' O ' ' A' ' 698' ' ' ASP . 0.7 OUTLIER -110.01 -41.0 4.58 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.831 0.824 . . . . 0.0 109.832 -179.1 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.69 ' CD2' HD12 ' A' ' 594' ' ' ILE . 17.4 tp -121.17 127.68 51.76 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.448 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 94.1 m -111.38 117.97 34.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 1.051 HD11 HD12 ' A' ' 625' ' ' ILE . 6.1 mt -90.71 112.25 23.94 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.424 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 1.2 mmtt -113.54 101.05 53.24 Favored Pre-proline 0 C--N 1.303 -1.442 0 C-N-CA 118.02 -1.472 . . . . 0.0 112.611 -178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 1.115 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.5 Cg_endo -78.79 145.44 20.12 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 N-CA-C 106.232 -2.257 . . . . 0.0 106.232 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.765 HD13 ' OD2' ' A' ' 585' ' ' ASP . 0.0 OUTLIER -123.54 -176.76 0.46 Allowed Pre-proline 0 N--CA 1.498 1.931 0 C-N-CA 118.251 -1.38 . . . . 0.0 114.094 -175.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.726 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.6 Cg_endo -67.84 -34.0 25.3 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.825 1.683 . . . . 0.0 111.953 -178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.765 ' OD2' HD13 ' A' ' 583' ' ' LEU . 1.8 p30 -58.31 -29.69 66.08 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.772 -1.205 . . . . 0.0 107.931 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.503 ' HB3' ' N ' ' A' ' 691' ' ' GLY . 4.3 p -96.25 150.66 20.3 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.585 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.1 OUTLIER -55.64 -17.79 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 0.0 109.467 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.765 HD12 ' HA ' ' A' ' 613' ' ' ILE . 9.1 mm -100.03 114.87 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -126.01 74.59 1.44 Allowed 'General case' 0 N--CA 1.51 2.569 0 O-C-N 120.581 -1.325 . . . . 0.0 110.423 -179.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 1.115 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.2 mt-10 -143.31 175.9 9.55 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.506 -0.77 . . . . 0.0 108.993 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.525 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.3 127.04 42.01 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.761 -1.212 . . . . 0.0 109.476 176.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 611' ' ' CYS . 67.2 mt -111.32 156.21 21.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.419 -0.801 . . . . 0.0 109.628 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -124.46 110.77 14.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 111.423 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.69 HD12 ' CD2' ' A' ' 578' ' ' LEU . 31.3 mt -81.01 109.04 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.534 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -66.89 118.17 10.0 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.533 -0.729 . . . . 0.0 111.955 -177.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.593 ' HA ' ' HB3' ' A' ' 577' ' ' PHE . 6.8 tp-100 13.32 61.99 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 95.61 50.75 1.94 Allowed Glycine 0 N--CA 1.487 2.04 0 C-N-CA 119.931 -1.128 . . . . 0.0 110.585 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.6 OUTLIER -79.49 105.09 8.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.01 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.4 OUTLIER -140.26 142.0 28.22 Favored Pre-proline 0 C--N 1.28 -2.417 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.79 -178.462 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.482 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.5 Cg_endo -88.91 159.12 39.19 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.564 -2.265 . . . . 0.0 109.001 -0.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.556 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 5.1 t80 -106.53 116.24 31.58 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.811 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 39.6 m-85 -91.43 146.01 24.16 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 110.757 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.743 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.7 mt -139.91 141.08 34.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.48 -0.763 . . . . 0.0 110.618 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.741 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 173.24 -164.88 36.86 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.51 -1.329 . . . . 0.0 111.186 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.431 ' HD2' ' HA ' ' A' ' 614' ' ' GLU . 8.5 mmm-85 -66.66 -41.0 88.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.892 -0.769 . . . . 0.0 110.866 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.411 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -83.12 132.04 35.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -0.848 . . . . 0.0 111.218 -178.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.542 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.7 OUTLIER -61.24 -13.04 15.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.413 -0.804 . . . . 0.0 109.858 178.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.45 -37.4 5.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.3 -0.875 . . . . 0.0 109.858 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.811 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 64.4 m -71.23 148.79 46.9 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.403 -0.811 . . . . 0.0 109.613 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.555 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -56.0 -16.68 5.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.482 -0.761 . . . . 0.0 110.655 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.743 ' SG ' HG23 ' A' ' 603' ' ' ILE . 10.5 t -115.67 143.34 45.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.439 -0.788 . . . . 0.0 109.542 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.542 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -112.82 121.28 44.22 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.169 -0.957 . . . . 0.0 112.689 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.765 ' HA ' HD12 ' A' ' 588' ' ' ILE . 18.5 mt -141.73 108.25 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.431 ' HA ' ' HD2' ' A' ' 605' ' ' ARG . 3.8 tm-20 -90.64 103.89 16.53 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.625 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.489 ' HB2' ' HB3' ' A' ' 618' ' ' LEU . 1.5 m-20 -138.25 105.78 5.57 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.675 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -39.55 -52.34 2.17 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.755 -0.59 . . . . 0.0 112.256 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -75.12 -16.49 60.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.09 -1.006 . . . . 0.0 111.364 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.906 HD13 HD11 ' A' ' 681' ' ' ILE . 0.8 OUTLIER -80.0 132.67 36.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.215 -0.928 . . . . 0.0 111.134 -178.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.518 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -74.77 162.39 28.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.489 -0.757 . . . . 0.0 110.812 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.741 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.3 OUTLIER -64.19 -46.06 85.59 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.288 -0.883 . . . . 0.0 109.389 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.687 ' HB ' HG23 ' A' ' 727' ' ' VAL . 16.2 m -94.6 2.25 9.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.216 -0.927 . . . . 0.0 109.179 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.754 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.4 t60 -28.66 -47.44 0.05 Allowed 'General case' 0 C--O 1.192 -1.953 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.051 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.698 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.6 OUTLIER -137.44 145.12 42.75 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.398 -1.321 . . . . 0.0 111.02 179.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 3.6 p90 -145.95 144.81 30.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.589 -0.694 . . . . 0.0 110.212 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 1.051 HD12 HD11 ' A' ' 580' ' ' LEU . 11.3 mt -103.5 118.05 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.45 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 7.7 t80 -111.55 154.62 24.52 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.774 0.797 . . . . 0.0 109.819 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.446 ' HB3' ' CB ' ' A' ' 599' ' ' ASN . 3.7 ttmt -120.07 136.67 54.5 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 121.464 0.65 . . . . 0.0 110.31 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.45 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.82 163.72 28.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.617 -0.677 . . . . 0.0 110.343 -179.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.8 tpt180 -77.72 115.28 17.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.516 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 3.0 t60 . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.497 -0.752 . . . . 0.0 110.574 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.844 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.3 mp . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.4 m-20 -114.95 124.34 51.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.965 -1.084 . . . . 0.0 111.115 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.739 ' OD2' HD21 ' A' ' 671' ' ' LEU . 14.7 t0 -107.08 156.12 19.11 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.537 -0.727 . . . . 0.0 109.82 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 13.8 pt -110.7 131.45 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.635 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.4 m95 -119.11 121.95 40.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.654 -0.654 . . . . 0.0 111.369 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.81 ' HB2' HD11 ' A' ' 672' ' ' LEU . 8.7 t80 -80.95 114.84 20.1 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 668' ' ' THR . 7.5 t -107.12 110.3 22.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.207 -0.933 . . . . 0.0 111.731 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.518 ' CD2' ' N ' ' A' ' 652' ' ' THR . 18.5 t60 -72.66 162.67 29.19 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.476 -0.765 . . . . 0.0 109.833 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.754 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -155.11 -30.84 0.1 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.458 -0.776 . . . . 0.0 112.205 -179.114 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.547 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.08 -165.23 29.11 Favored Glycine 0 N--CA 1.496 2.665 0 C-N-CA 117.966 -2.064 . . . . 0.0 109.739 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 14.5 m -93.55 -18.9 21.73 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.007 -1.29 . . . . 0.0 114.012 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.711 ' O ' HG22 ' A' ' 656' ' ' VAL . 86.6 m-20 -59.81 -2.56 0.4 Allowed 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.746 -1.221 . . . . 0.0 112.727 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.711 HG22 ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 63.36 146.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 121.57 0.7 . . . . 0.0 110.305 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.463 ' CB ' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -98.27 141.99 30.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.69 -0.631 . . . . 0.0 110.605 -178.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.459 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 11.1 m-85 -129.75 126.17 37.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 110.364 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.603 HD11 HD21 ' A' ' 672' ' ' LEU . 0.1 OUTLIER -132.6 114.89 14.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.356 -0.84 . . . . 0.0 110.047 179.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 56.54 -84.69 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.434 -0.791 . . . . 0.0 110.475 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.6 m120 -143.52 20.3 1.86 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.058 -1.026 . . . . 0.0 110.353 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -111.2 118.48 36.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.283 -0.886 . . . . 0.0 110.239 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -86.67 139.81 30.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 110.184 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.585 ' HG2' HG13 ' A' ' 716' ' ' VAL . 4.5 mtp -117.27 -167.29 1.29 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.866 . . . . 0.0 110.124 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.638 HG13 HG23 ' A' ' 668' ' ' THR . 1.5 pt -137.24 -158.49 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.253 -0.905 . . . . 0.0 110.426 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 652' ' ' THR . 17.5 tt0 -83.11 90.2 7.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.336 -0.853 . . . . 0.0 110.547 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.12 52.53 0.6 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.638 HG23 HG13 ' A' ' 665' ' ' ILE . 0.2 OUTLIER -119.8 148.89 42.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.145 -1.209 . . . . 0.0 110.177 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.458 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 9.5 tttt -108.59 139.02 43.95 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.524 ' CD1' HG22 ' A' ' 716' ' ' VAL . 13.4 t80 -142.54 146.38 34.58 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.154 -0.966 . . . . 0.0 111.615 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.739 HD21 ' OD2' ' A' ' 646' ' ' ASP . 0.4 OUTLIER -73.33 146.82 44.97 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.59 -0.694 . . . . 0.0 110.502 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.81 HD11 ' HB2' ' A' ' 649' ' ' TYR . 12.1 mt -119.39 115.35 23.93 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.559 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -87.39 -177.41 5.92 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.412 ' HB3' HD12 ' A' ' 696' ' ' ILE . 21.8 p-10 -78.31 142.97 37.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 109.432 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.93 46.71 43.16 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 107.678 -2.169 . . . . 0.0 107.678 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.51 ' OD1' HD21 ' A' ' 659' ' ' LEU . 1.4 t0 -101.15 91.51 4.57 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.817 -0.813 . . . . 0.0 110.396 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.806 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -93.09 106.91 18.8 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.556 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.3 pt -114.17 137.8 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.7 -0.625 . . . . 0.0 111.55 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -95.68 112.76 24.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.553 -0.717 . . . . 0.0 109.418 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.698 HD13 ' SG ' ' A' ' 623' ' ' CYS . 64.5 mt -76.14 -20.9 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.927 . . . . 0.0 110.438 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.906 HD11 HD13 ' A' ' 618' ' ' LEU . 8.8 mt -141.55 133.66 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.075 -1.016 . . . . 0.0 110.721 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -137.86 108.86 6.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.48 -0.762 . . . . 0.0 109.943 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . 0.406 ' CB ' ' HB2' ' A' ' 686' ' ' ASN . 45.3 m-20 -125.66 118.38 25.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 110.088 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -65.87 -38.64 89.32 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.461 -0.774 . . . . 0.0 110.983 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -84.04 -43.54 15.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.272 -0.892 . . . . 0.0 111.076 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . 0.406 ' HB2' ' CB ' ' A' ' 683' ' ' ASP . 50.9 m-80 -81.81 -12.35 58.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.129 -0.982 . . . . 0.0 110.69 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . 0.471 ' O ' HG23 ' A' ' 689' ' ' VAL . 2.8 tttp 56.25 20.43 4.56 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.145 -0.972 . . . . 0.0 110.439 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.88 85.37 2.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.144 -0.972 . . . . 0.0 109.347 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 586' ' ' SER . 2.9 t -101.73 135.91 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.442 -0.786 . . . . 0.0 110.656 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.585 ' CD1' HG22 ' A' ' 587' ' ' ILE . 40.5 mm -123.44 163.63 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.503 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . -174.76 124.67 1.03 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.525 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.806 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.9 m-85 -120.44 138.01 54.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.559 -0.965 . . . . 0.0 108.736 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.5 114.59 28.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 110.976 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -80.96 112.97 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -116.3 104.66 11.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.495 -0.753 . . . . 0.0 110.456 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.412 HD12 ' HB3' ' A' ' 674' ' ' ASP . 78.8 mt -84.11 103.81 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -0.828 . . . . 0.0 109.517 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -81.94 -42.27 19.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 108.889 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.6 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.2 m-20 -110.55 142.29 42.55 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.401 0.62 . . . . 0.0 110.145 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 35.6 p -115.97 95.92 5.34 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 2.7 m -131.92 139.24 48.67 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.351 -0.539 . . . . 0.0 110.282 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.15 28.79 34.83 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.81 ' O ' HD22 ' A' ' 644' ' ' LEU . 0.2 OUTLIER -107.89 131.29 54.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.587 -0.949 . . . . 0.0 110.563 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.844 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.0 p90 -52.25 -23.7 6.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.42 -0.8 . . . . 0.0 109.806 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.585 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.422 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 2.8 mmm-85 . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.335 0.588 . . . . 0.0 111.345 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 32.6 m -107.73 153.07 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.412 -0.805 . . . . 0.0 109.433 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.585 HG13 ' HG2' ' A' ' 664' ' ' MET . 59.8 t -95.1 133.25 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 110.648 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.5 mt -104.83 162.26 13.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.488 -0.757 . . . . 0.0 109.765 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.78 153.43 19.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 110.246 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.85 122.29 26.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.4 -0.813 . . . . 0.0 110.249 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 27.8 p -95.92 -176.53 3.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.432 -0.792 . . . . 0.0 110.162 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.55 -28.99 34.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.293 -0.88 . . . . 0.0 110.188 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -69.01 -46.57 67.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.373 -0.829 . . . . 0.0 109.983 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.75 -50.26 69.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.383 -0.823 . . . . 0.0 110.043 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.46 ' O ' HG12 ' A' ' 727' ' ' VAL . 4.2 ttpt -53.71 -32.7 52.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.36 -0.837 . . . . 0.0 109.909 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 728' ' ' LYS . 28.7 t70 -66.18 -35.86 81.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.497 -0.752 . . . . 0.0 110.129 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 37.5 mt -61.16 -46.32 90.99 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.277 -0.89 . . . . 0.0 110.083 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.687 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.7 p -74.72 -24.26 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.601 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 725' ' ' ASP . 0.6 OUTLIER -53.94 -46.06 71.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.116 -0.99 . . . . 0.0 108.902 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -116.83 104.0 10.88 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.219 1.009 . . . . 0.0 109.011 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.599 HD21 ' SG ' ' A' ' 609' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--N 1.274 -2.701 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.336 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.419 ' HD2' ' CG ' ' A' ' 593' ' ' GLU . 41.0 ttp180 . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 121.688 0.756 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -102.92 -42.57 5.79 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 122.044 0.926 . . . . 0.0 109.286 -179.287 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.061 HD22 HD12 ' A' ' 594' ' ' ILE . 9.7 tt -120.47 131.67 54.85 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.611 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.415 ' N ' HD23 ' A' ' 578' ' ' LEU . 32.6 m -109.18 118.27 36.29 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.961 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.618 HD11 HD11 ' A' ' 594' ' ' ILE . 13.2 mt -93.17 112.28 24.17 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.454 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.3 OUTLIER -114.99 103.6 54.6 Favored Pre-proline 0 C--N 1.302 -1.488 0 C-N-CA 118.326 -1.35 . . . . 0.0 113.387 -176.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 1.079 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 45.6 Cg_endo -78.58 140.66 16.99 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 N-CA-C 105.045 -2.713 . . . . 0.0 105.045 174.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.762 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -121.55 -175.05 0.33 Allowed Pre-proline 0 N--CA 1.496 1.863 0 C-N-CA 118.044 -1.462 . . . . 0.0 113.779 -176.118 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.762 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.4 Cg_endo -66.11 -33.75 39.6 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 O-C-N 124.198 1.631 . . . . 0.0 111.969 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.74 -29.48 66.76 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.709 -1.196 . . . . 0.0 107.856 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.638 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 27.1 p -96.39 153.28 17.91 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.57 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.4 OUTLIER -59.92 -15.73 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.184 -0.948 . . . . 0.0 109.127 178.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.778 HD12 ' HA ' ' A' ' 613' ' ' ILE . 7.8 mm -95.03 115.83 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.468 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -121.74 70.23 0.95 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.55 -1.344 . . . . 0.0 109.372 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 1.079 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 33.8 tt0 -144.34 174.08 11.22 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.698 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.517 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.87 127.53 40.39 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.937 -1.102 . . . . 0.0 109.365 176.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.774 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.1 mp -111.5 153.78 25.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.183 -0.948 . . . . 0.0 110.073 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.419 ' CG ' ' HD2' ' A' ' 576' ' ' ARG . 4.2 mp0 -125.74 112.46 16.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.537 -0.727 . . . . 0.0 111.185 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.061 HD12 HD22 ' A' ' 578' ' ' LEU . 69.6 mt -78.88 109.52 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.087 -1.008 . . . . 0.0 108.71 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.589 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -63.49 100.31 0.25 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.59 -0.694 . . . . 0.0 110.948 -178.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.589 ' C ' ' O ' ' A' ' 595' ' ' GLN . 0.8 OUTLIER -0.21 75.9 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 179.422 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 128.84 10.04 3.3 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.365 -1.397 . . . . 0.0 110.973 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.652 ' HB ' HG23 ' A' ' 594' ' ' ILE . 1.5 t -82.77 100.67 6.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 O-C-N 120.6 -1.529 . . . . 0.0 107.632 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.2 OUTLIER -144.61 135.88 12.58 Favored Pre-proline 0 C--N 1.282 -2.36 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.69 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.522 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 53.3 Cg_endo -90.42 164.46 32.58 Favored 'Cis proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.78 -1.758 . . . . 0.0 108.918 -1.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.543 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 3.3 t80 -103.27 115.93 31.49 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.616 ' CG ' HD23 ' A' ' 730' ' ' LEU . 44.9 m-85 -81.38 143.6 32.05 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 110.342 -178.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.888 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.6 mt -142.88 142.12 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.667 -0.646 . . . . 0.0 110.291 -178.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.76 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 169.16 -161.46 35.07 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.778 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.403 ' HD2' ' HA ' ' A' ' 614' ' ' GLU . 9.7 tpt180 -72.61 -35.43 67.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.677 -0.896 . . . . 0.0 111.006 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -83.0 123.69 29.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.846 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.523 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 7.5 tt0 -53.23 -19.26 2.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.328 -0.857 . . . . 0.0 110.052 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -45.1 -31.11 1.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.367 -0.833 . . . . 0.0 109.043 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.3 m -69.76 131.44 44.53 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.543 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -44.96 -27.89 0.6 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.34 -0.85 . . . . 0.0 110.027 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.888 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.0 t -107.27 143.52 35.39 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.523 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -110.46 128.01 55.4 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 119.102 -1.039 . . . . 0.0 112.963 -178.404 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.778 ' HA ' HD12 ' A' ' 588' ' ' ILE . 19.8 mt -142.19 107.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 605' ' ' ARG . 0.1 OUTLIER -89.12 103.18 15.82 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.108 -1.437 . . . . 0.0 108.651 179.32 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.702 ' OD1' HD11 ' A' ' 690' ' ' ILE . 1.1 m-20 -139.55 106.06 5.32 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.602 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -41.13 -57.0 2.19 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.545 -0.722 . . . . 0.0 112.253 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . 0.404 ' HD2' ' CD1' ' A' ' 681' ' ' ILE . 7.5 ptp180 -72.57 -16.85 61.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.169 -0.957 . . . . 0.0 111.975 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.594 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.8 OUTLIER -76.23 122.22 24.05 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.025 -1.047 . . . . 0.0 110.71 -179.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -58.54 159.86 6.04 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.466 -0.772 . . . . 0.0 110.942 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.76 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 14.3 mtt-85 -64.27 -45.2 89.13 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.354 -0.841 . . . . 0.0 109.493 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.5 HG11 HG22 ' A' ' 727' ' ' VAL . 11.8 t -95.4 1.7 10.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 121.93 0.871 . . . . 0.0 109.338 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.736 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.8 t60 -27.43 -46.69 0.03 OUTLIER 'General case' 0 C--O 1.195 -1.808 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.594 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.788 ' SG ' HD13 ' A' ' 680' ' ' ILE . 1.0 OUTLIER -137.92 146.18 42.97 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 117.953 -1.499 . . . . 0.0 112.06 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 2.4 p90 -145.92 145.67 30.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.701 -0.624 . . . . 0.0 109.819 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.683 HG13 HD11 ' A' ' 603' ' ' ILE . 88.2 mt -103.56 117.56 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 10.1 t80 -110.28 154.2 23.78 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.429 -0.794 . . . . 0.0 109.874 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 13.5 ttmt -120.33 136.84 54.56 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.55 0.69 . . . . 0.0 110.373 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.459 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.1 OUTLIER -134.66 164.22 28.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.702 -0.624 . . . . 0.0 109.892 -179.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -77.1 121.25 23.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.059 -1.026 . . . . 0.0 108.871 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.52 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 6.0 t60 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.707 0.765 . . . . 0.0 111.05 -178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.84 HD22 ' O ' ' A' ' 702' ' ' LEU . 5.0 mp . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.9 m-20 -112.2 124.17 51.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.044 -1.035 . . . . 0.0 111.367 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.682 ' OD2' HD21 ' A' ' 671' ' ' LEU . 21.1 t0 -105.1 156.46 18.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.555 -0.715 . . . . 0.0 109.584 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.534 HD13 ' CD1' ' A' ' 578' ' ' LEU . 18.5 pt -110.11 129.95 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.233 -0.917 . . . . 0.0 110.32 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.651 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.0 m95 -118.86 120.34 37.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.75 -0.594 . . . . 0.0 110.968 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.685 ' HB2' HD11 ' A' ' 672' ' ' LEU . 8.0 t80 -80.61 114.44 19.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.963 . . . . 0.0 108.474 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.0 OUTLIER -105.25 107.4 18.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.342 -0.849 . . . . 0.0 111.322 -178.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.515 ' CE1' ' C ' ' A' ' 656' ' ' VAL . 17.8 t60 -68.44 159.87 30.8 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.429 -0.794 . . . . 0.0 109.961 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.736 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -149.86 -31.02 0.22 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.437 -0.79 . . . . 0.0 112.879 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.542 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.57 -165.13 27.42 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 117.741 -2.171 . . . . 0.0 109.61 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 15.1 m -98.66 -17.65 18.48 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.976 -1.308 . . . . 0.0 113.552 -176.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.539 ' O ' HG12 ' A' ' 656' ' ' VAL . 18.0 m120 -59.73 -4.43 0.68 Allowed 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.786 -1.196 . . . . 0.0 112.328 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 77.7 166.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-O 121.939 0.876 . . . . 0.0 110.247 -179.539 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.457 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -125.61 141.41 52.04 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.474 -179.035 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -127.91 125.72 40.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.932 . . . . 0.0 110.715 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.694 HD22 ' CG2' ' A' ' 678' ' ' ILE . 0.1 OUTLIER -114.67 106.23 13.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.224 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 659' ' ' LEU . 17.2 m120 56.35 -79.25 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.548 -0.72 . . . . 0.0 110.295 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.539 ' N ' ' O ' ' A' ' 659' ' ' LEU . 21.4 t-20 -140.19 20.28 2.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 0.0 110.548 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -110.68 137.06 48.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.165 -0.959 . . . . 0.0 110.437 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.425 ' O ' HG21 ' A' ' 716' ' ' VAL . 8.0 tmm_? -93.76 141.39 28.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.397 -0.814 . . . . 0.0 110.005 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.626 ' O ' HG22 ' A' ' 656' ' ' VAL . 90.6 mtp -126.07 -168.19 1.82 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.355 -0.84 . . . . 0.0 110.056 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.588 HG13 HG23 ' A' ' 668' ' ' THR . 4.1 pt -144.09 -160.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.159 -0.963 . . . . 0.0 110.953 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -76.07 111.09 11.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.745 . . . . 0.0 110.748 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 86.12 48.87 4.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -114.19 146.1 40.81 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.051 -1.264 . . . . 0.0 109.863 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.429 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 10.8 tttt -108.24 138.91 43.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.561 -0.712 . . . . 0.0 109.488 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.529 ' CD2' HG22 ' A' ' 716' ' ' VAL . 2.8 t80 -144.64 146.25 32.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 111.329 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.682 HD21 ' OD2' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -72.55 147.01 46.35 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.468 -0.77 . . . . 0.0 110.89 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.766 HD23 ' OD2' ' A' ' 676' ' ' ASP . 10.6 mt -118.07 101.43 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.396 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -84.81 157.19 21.04 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.456 ' HB3' HD12 ' A' ' 696' ' ' ILE . 21.0 p-10 -52.69 148.37 7.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.933 -1.104 . . . . 0.0 109.925 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 67.95 48.52 53.81 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.766 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.3 OUTLIER -108.55 92.43 4.05 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.846 -0.796 . . . . 0.0 110.602 -178.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.894 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.0 OUTLIER -93.85 107.2 19.11 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.449 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.694 ' CG2' HD22 ' A' ' 659' ' ' LEU . 24.7 pt -111.85 138.07 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.667 -0.646 . . . . 0.0 111.537 -177.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -100.37 111.75 24.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.517 -0.74 . . . . 0.0 109.647 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.788 HD13 ' SG ' ' A' ' 623' ' ' CYS . 65.8 mt -80.01 -29.3 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 0.0 110.249 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.55 HG22 HG12 ' A' ' 690' ' ' ILE . 0.4 OUTLIER -128.61 133.59 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.25 -0.906 . . . . 0.0 109.817 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -138.17 111.75 8.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.467 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.68 117.63 25.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.89 . . . . 0.0 109.667 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -46.98 75.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.326 -0.859 . . . . 0.0 110.834 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -84.89 -43.21 14.3 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 110.776 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -71.51 -9.15 57.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.249 -0.907 . . . . 0.0 110.706 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.34 22.3 6.2 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.105 -0.997 . . . . 0.0 110.344 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -87.65 104.17 16.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 109.873 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 586' ' ' SER . 13.7 m -126.72 140.77 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.397 -0.814 . . . . 0.0 110.829 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.702 HD11 ' OD1' ' A' ' 615' ' ' ASP . 38.8 mm -117.47 163.6 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.485 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -173.28 123.05 0.96 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.894 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 11.3 m-85 -120.19 137.41 54.2 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.566 -0.961 . . . . 0.0 109.145 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -102.07 113.87 27.5 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.156 -0.965 . . . . 0.0 110.156 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -84.67 119.3 33.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -130.06 104.67 7.47 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.372 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 674' ' ' ASP . 46.3 mt -79.17 103.86 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -0.885 . . . . 0.0 109.6 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.92 -43.07 46.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.363 -0.836 . . . . 0.0 108.805 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 1.2 m-20 -110.53 141.54 43.54 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.442 0.639 . . . . 0.0 110.135 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 21.4 p -114.22 95.94 5.54 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 50.2 m -131.66 133.78 45.26 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.378 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.74 25.86 30.7 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.84 ' O ' HD22 ' A' ' 644' ' ' LEU . 4.8 tp -105.55 134.75 48.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.389 -1.065 . . . . 0.0 110.438 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.835 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.9 p90 -52.69 -23.69 7.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.521 -0.737 . . . . 0.0 110.403 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.609 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -178.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.415 ' HD2' ' HA ' ' A' ' 714' ' ' ARG . 12.7 mmm-85 . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.385 0.612 . . . . 0.0 111.629 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.4 m -107.7 152.58 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.563 -0.711 . . . . 0.0 109.418 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.529 HG22 ' CD2' ' A' ' 670' ' ' PHE . 44.1 t -92.94 121.15 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.576 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.8 mp -91.44 162.49 14.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.437 -0.789 . . . . 0.0 109.55 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -98.05 153.65 18.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.103 -0.998 . . . . 0.0 110.665 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . 0.4 ' HG2' ' HB2' ' A' ' 723' ' ' GLU . 0.2 OUTLIER -89.47 142.61 27.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.488 -0.757 . . . . 0.0 109.963 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 37.6 p -121.18 -178.36 3.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.317 -0.865 . . . . 0.0 110.575 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.4 -36.3 66.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.459 -0.776 . . . . 0.0 110.244 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . 0.539 ' O ' HD23 ' A' ' 726' ' ' LEU . 6.2 tt0 -57.54 -52.16 66.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.381 -0.825 . . . . 0.0 109.963 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.709 ' O ' HG12 ' A' ' 727' ' ' VAL . 74.5 mm-40 -63.54 -46.21 87.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.34 -0.85 . . . . 0.0 109.771 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.475 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 10.1 tttt -62.64 -31.94 72.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.39 -0.819 . . . . 0.0 110.775 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.56 -50.48 71.17 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -0.934 . . . . 0.0 112.051 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 722' ' ' GLU . 0.4 OUTLIER -72.35 -36.55 68.82 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.825 -1.172 . . . . 0.0 111.269 -178.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 723' ' ' GLU . 8.3 p -79.4 -18.25 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.868 -1.145 . . . . 0.0 110.416 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -43.21 66.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.176 -0.953 . . . . 0.0 108.814 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.45 103.27 10.28 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 122.211 1.005 . . . . 0.0 109.034 178.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.616 HD23 ' CG ' ' A' ' 602' ' ' PHE . 1.5 mt . . . . . 0 C--N 1.273 -2.727 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.231 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.423 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.5 ttm105 . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 121.575 0.702 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.592 ' CE1' HD21 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -97.08 -43.24 7.49 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.89 0.852 . . . . 0.0 109.124 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.778 HD23 HD12 ' A' ' 594' ' ' ILE . 7.7 tp -126.68 139.74 52.93 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.188 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 87.2 m -121.83 119.52 31.88 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 8.6 mt -95.56 112.38 24.11 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.511 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.1 OUTLIER -110.72 103.46 54.5 Favored Pre-proline 0 C--N 1.301 -1.538 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.732 -177.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 1.054 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.3 Cg_endo -76.22 140.99 22.76 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 N-CA-C 105.737 -2.447 . . . . 0.0 105.737 174.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.769 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -127.48 -173.14 0.29 Allowed Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 118.187 -1.405 . . . . 0.0 113.338 -176.164 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.769 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 37.9 Cg_endo -64.68 -36.34 42.06 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 124.263 1.665 . . . . 0.0 111.116 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -58.52 -28.87 65.84 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.621 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 47.9 t -96.47 152.76 18.3 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.715 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.8 OUTLIER -64.56 -11.61 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.904 -1.123 . . . . 0.0 109.205 178.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.729 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 7.9 mm -97.21 117.05 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.484 -0.76 . . . . 0.0 109.401 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.621 ' NE2' ' O ' ' A' ' 586' ' ' SER . 21.1 mp0 -117.55 68.65 0.76 Allowed 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.462 -1.398 . . . . 0.0 109.743 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 1.054 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 2.6 mm-40 -143.35 175.78 9.66 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.607 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.549 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.97 125.42 35.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.071 -1.018 . . . . 0.0 109.585 176.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.732 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.6 mm? -106.8 151.15 25.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 108.963 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.423 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.2 mp0 -124.77 110.27 14.12 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.555 -0.716 . . . . 0.0 110.872 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.778 HD12 HD23 ' A' ' 578' ' ' LEU . 4.8 mt -83.78 109.19 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.181 -0.949 . . . . 0.0 109.156 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.617 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.2 OUTLIER -64.97 137.14 57.55 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.467 ' CA ' ' HB3' ' A' ' 577' ' ' PHE . 2.4 pt20 -44.45 84.37 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.507 -0.746 . . . . 0.0 110.782 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 137.67 3.85 1.99 Allowed Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.647 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -79.97 101.97 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 120.745 -1.444 . . . . 0.0 107.27 178.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 627' ' ' LYS . 49.0 t-20 -145.47 133.33 10.49 Favored Pre-proline 0 C--N 1.282 -2.367 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.85 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.629 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 51.1 Cg_endo -93.29 163.79 22.61 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 123.258 -1.559 . . . . 0.0 109.127 -2.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.627 ' HB3' ' CG2' ' A' ' 625' ' ' ILE . 3.9 t80 -104.96 116.03 31.28 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.669 ' HB3' HD23 ' A' ' 730' ' ' LEU . 34.8 m-85 -85.42 144.86 27.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.373 -0.829 . . . . 0.0 110.256 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.84 HG23 ' HB3' ' A' ' 611' ' ' CYS . 4.5 mt -140.52 142.34 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.512 -0.742 . . . . 0.0 110.201 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.834 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 164.96 -163.53 36.48 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.368 -1.396 . . . . 0.0 111.306 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 8.6 tpt180 -62.87 -55.81 22.86 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.78 -0.836 . . . . 0.0 111.772 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.476 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -72.18 126.9 30.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 111.492 -178.283 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.467 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -51.64 -19.25 1.46 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.072 178.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 607' ' ' GLU . 27.1 t0 -42.27 -32.16 0.47 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.484 -0.76 . . . . 0.0 109.01 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.6 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.3 m -69.86 129.59 39.95 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.616 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.1 m120 -44.55 -28.12 0.55 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.217 -0.927 . . . . 0.0 109.973 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.84 ' HB3' HG23 ' A' ' 603' ' ' ILE . 3.8 t -105.21 143.57 33.2 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.467 ' HD2' ' CB ' ' A' ' 607' ' ' GLU . 1.1 ttpm? -106.53 128.35 54.04 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.059 -1.057 . . . . 0.0 113.467 -178.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.832 HD12 HG22 ' A' ' 603' ' ' ILE . 24.2 mt -143.29 107.71 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.459 ' H ' ' CD1' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -97.86 104.73 16.78 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.238 -1.385 . . . . 0.0 109.306 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.649 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.3 m-20 -138.3 106.42 5.73 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.173 177.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . 0.454 ' HA ' ' NH1' ' A' ' 605' ' ' ARG . 1.4 m120 -41.12 -41.56 1.79 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.669 -0.644 . . . . 0.0 111.932 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.61 -21.61 32.49 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.093 -1.004 . . . . 0.0 111.272 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.834 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.6 OUTLIER -73.84 131.96 42.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.191 -0.943 . . . . 0.0 110.702 -179.531 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.454 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -68.09 158.39 33.12 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.356 -0.84 . . . . 0.0 110.725 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.781 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 15.2 ttp180 -62.24 -45.24 94.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.225 -0.922 . . . . 0.0 109.211 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.504 HG22 HD21 ' A' ' 730' ' ' LEU . 4.4 t -95.28 2.08 9.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.75 0.786 . . . . 0.0 109.593 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.75 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.0 t60 -29.63 -42.91 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.854 -178.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.752 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.9 OUTLIER -137.19 144.8 43.06 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 117.789 -1.564 . . . . 0.0 111.429 179.114 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.651 ' CE2' ' HB3' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -147.57 126.58 12.83 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.62 -0.675 . . . . 0.0 109.533 178.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.627 ' CG2' ' HB3' ' A' ' 601' ' ' PHE . 2.4 tt -104.08 118.16 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.362 -0.836 . . . . 0.0 108.869 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.651 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 17.5 p90 -122.83 155.2 37.08 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.758 0.789 . . . . 0.0 110.715 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 5.3 ttmt -99.55 136.68 39.13 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.939 0.876 . . . . 0.0 110.891 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.7 OUTLIER -131.11 163.09 28.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.648 -0.658 . . . . 0.0 109.934 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 6.6 tpt180 -78.0 115.06 17.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.041 -1.037 . . . . 0.0 109.257 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 703' ' ' PHE . 6.6 t60 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.528 0.68 . . . . 0.0 110.866 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 1.1 mp . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 628' ' ' LYS . 0.3 OUTLIER -120.85 123.85 43.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.126 -0.984 . . . . 0.0 110.813 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.603 ' OD2' HD11 ' A' ' 671' ' ' LEU . 10.3 t0 -101.93 132.2 47.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.417 -0.802 . . . . 0.0 109.211 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.519 HD13 HD22 ' A' ' 578' ' ' LEU . 6.4 pt -80.97 129.3 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.114 -0.992 . . . . 0.0 109.972 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.804 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 87.8 m95 -116.15 122.56 45.43 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.526 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.909 ' HB2' HD11 ' A' ' 672' ' ' LEU . 6.8 t80 -82.05 113.12 19.71 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.1 OUTLIER -107.41 102.87 12.12 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.284 -0.967 . . . . 0.0 111.127 -178.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.504 ' CE1' ' C ' ' A' ' 656' ' ' VAL . 11.1 t60 -61.71 154.93 24.04 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.408 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.75 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -146.14 -25.22 0.44 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.624 ' N ' ' HA ' ' A' ' 622' ' ' HIS . . . -77.94 -171.12 36.94 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 117.992 -2.052 . . . . 0.0 109.119 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 27.1 m -95.56 -16.52 22.08 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.013 -1.287 . . . . 0.0 113.285 -176.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.569 ' O ' HG12 ' A' ' 656' ' ' VAL . 3.0 t-20 -62.33 -4.47 1.84 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.007 -1.058 . . . . 0.0 112.596 -178.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 78.62 166.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 CA-C-O 121.987 0.898 . . . . 0.0 110.464 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.443 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -124.99 152.13 44.61 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.435 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -138.34 126.91 23.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.252 -0.905 . . . . 0.0 110.437 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.927 HD21 ' NH1' ' A' ' 714' ' ' ARG . 43.5 tp -128.5 114.16 16.42 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 110.027 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 41.9 t30 56.43 -80.93 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.615 -0.678 . . . . 0.0 110.349 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 659' ' ' LEU . 46.1 p-10 -142.52 11.62 1.9 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.042 -1.037 . . . . 0.0 110.767 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -105.5 133.5 50.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.98 -1.075 . . . . 0.0 110.798 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -93.11 142.14 27.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.48 -0.762 . . . . 0.0 109.802 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.61 ' O ' HG22 ' A' ' 656' ' ' VAL . 4.4 mtp -121.03 -166.88 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -0.954 . . . . 0.0 110.617 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.635 ' CG1' HG23 ' A' ' 668' ' ' THR . 2.7 pt -141.27 -164.26 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.443 -0.786 . . . . 0.0 110.19 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -78.32 86.73 4.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.34 -0.85 . . . . 0.0 110.62 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.74 52.61 0.43 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.635 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.2 OUTLIER -119.32 147.19 44.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.226 -1.161 . . . . 0.0 110.009 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.477 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 1.7 tttt -108.76 148.13 30.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.739 . . . . 0.0 109.361 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.811 ' CD1' HD23 ' A' ' 659' ' ' LEU . 1.2 t80 -145.72 147.44 31.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.139 -0.975 . . . . 0.0 111.901 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.804 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.48 132.82 47.64 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.405 -0.809 . . . . 0.0 109.647 179.19 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.909 HD11 ' HB2' ' A' ' 649' ' ' TYR . 2.7 mt -113.22 104.91 12.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.022 -1.049 . . . . 0.0 111.106 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . 0.508 ' NE2' HD12 ' A' ' 671' ' ' LEU . 53.5 mm-40 -90.79 -177.1 4.88 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.474 ' HB3' HD12 ' A' ' 696' ' ' ILE . 13.8 p-10 -76.28 144.11 40.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.12 . . . . 0.0 109.761 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.41 48.35 45.32 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.24 99.4 7.19 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.808 -0.819 . . . . 0.0 109.995 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.914 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.85 113.4 25.42 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.862 HG12 HD13 ' A' ' 659' ' ' LEU . 1.5 mp -104.82 137.43 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.582 -0.699 . . . . 0.0 111.594 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -99.25 117.14 33.05 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.752 HD13 ' SG ' ' A' ' 623' ' ' CYS . 79.9 mt -87.7 -27.92 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.221 -0.924 . . . . 0.0 111.145 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.596 HG13 HD12 ' A' ' 618' ' ' LEU . 1.5 mt -143.23 133.43 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 0.0 111.078 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 14.0 t90 -138.2 109.0 6.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.629 -0.669 . . . . 0.0 109.568 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.15 117.92 28.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.085 -1.009 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -66.63 -29.8 69.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.418 -0.801 . . . . 0.0 110.775 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -43.32 76.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.34 -0.85 . . . . 0.0 110.924 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 688' ' ' PHE . 10.9 t-20 -139.37 34.61 2.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.242 -0.912 . . . . 0.0 110.072 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . 0.49 ' O ' ' C ' ' A' ' 688' ' ' PHE . 0.0 OUTLIER 66.26 -67.02 0.16 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.705 -0.622 . . . . 0.0 109.703 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.2 OUTLIER 30.76 56.85 0.22 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.34 0.591 . . . . 0.0 111.11 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 687' ' ' LYS . 41.6 t -101.67 141.52 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.43 -0.794 . . . . 0.0 110.714 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.715 ' CD1' HG22 ' A' ' 587' ' ' ILE . 47.9 mm -118.21 163.94 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.49 -0.756 . . . . 0.0 109.207 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.446 ' N ' ' OG ' ' A' ' 586' ' ' SER . . . -177.26 126.92 1.14 Allowed Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.19 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.914 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 12.9 m-85 -120.14 137.87 53.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.668 -0.901 . . . . 0.0 108.776 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.99 114.3 26.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.11 -0.994 . . . . 0.0 110.387 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.527 HG13 HD11 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -85.37 120.31 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.523 -0.736 . . . . 0.0 109.37 179.56 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -126.59 114.6 18.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.672 -0.642 . . . . 0.0 110.209 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.542 HG12 HD12 ' A' ' 578' ' ' LEU . 88.5 mt -92.1 104.55 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.353 -0.842 . . . . 0.0 110.19 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.45 -43.73 18.46 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.486 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 4.2 m-20 -110.58 143.59 40.75 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.346 0.593 . . . . 0.0 109.929 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 39.7 p -112.51 95.71 5.59 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 11.1 p -135.01 133.15 39.13 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.844 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 62.67 28.85 72.21 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.592 HD21 ' CE1' ' A' ' 577' ' ' PHE . 0.3 OUTLIER -111.4 129.85 55.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.426 -1.043 . . . . 0.0 110.099 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.537 ' CZ ' ' CG ' ' A' ' 704' ' ' ASN . 10.5 p90 -49.09 -24.58 1.67 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.434 -0.791 . . . . 0.0 110.403 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.537 ' CG ' ' CZ ' ' A' ' 703' ' ' PHE . 35.5 p-10 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.817 0.818 . . . . 0.0 110.347 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.927 ' NH1' HD21 ' A' ' 659' ' ' LEU . 9.7 mmm180 . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.383 0.611 . . . . 0.0 111.778 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 34.2 m -107.94 159.72 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.457 -0.777 . . . . 0.0 109.528 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.726 HG22 ' CD2' ' A' ' 670' ' ' PHE . 47.6 t -104.24 133.47 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.116 -0.99 . . . . 0.0 110.856 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.57 162.99 13.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.551 -0.718 . . . . 0.0 109.655 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -103.82 143.32 32.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.196 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -85.98 154.37 21.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.354 -0.841 . . . . 0.0 110.385 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 15.9 p -115.95 -176.63 2.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 0.0 110.426 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.58 -32.41 50.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.422 -0.799 . . . . 0.0 110.296 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -60.66 -52.25 65.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.337 -0.852 . . . . 0.0 109.772 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.76 ' HA ' HD21 ' A' ' 726' ' ' LEU . 5.6 mt-10 -64.68 -37.98 89.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.499 -0.751 . . . . 0.0 109.755 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -32.38 73.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.333 -0.854 . . . . 0.0 110.58 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.46 -50.91 49.02 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.245 -0.909 . . . . 0.0 111.766 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.76 HD21 ' HA ' ' A' ' 723' ' ' GLU . 0.6 OUTLIER -62.22 -42.22 99.11 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.949 -1.094 . . . . 0.0 110.935 -179.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 723' ' ' GLU . 7.2 p -76.67 -17.04 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.877 -1.14 . . . . 0.0 110.349 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -53.67 -43.32 68.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.202 -0.936 . . . . 0.0 108.856 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -116.52 103.78 10.76 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.249 1.024 . . . . 0.0 109.021 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.669 HD23 ' HB3' ' A' ' 602' ' ' PHE . 1.3 mt . . . . . 0 C--N 1.273 -2.743 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.362 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 121.499 0.666 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.654 ' HE1' HD22 ' A' ' 702' ' ' LEU . 0.8 OUTLIER -91.35 -40.92 11.19 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.76 0.79 . . . . 0.0 109.216 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.84 HD21 HG22 ' A' ' 694' ' ' VAL . 3.5 tt -135.63 142.76 45.26 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.597 0.713 . . . . 0.0 111.561 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 95.6 m -118.53 123.65 45.6 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.991 HD11 HD12 ' A' ' 625' ' ' ILE . 9.6 mt -93.16 112.41 24.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.448 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 2.9 mmtt -113.77 102.34 54.71 Favored Pre-proline 0 C--N 1.302 -1.497 0 C-N-CA 118.223 -1.391 . . . . 0.0 112.835 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 1.072 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.5 Cg_endo -81.15 141.1 12.76 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 N-CA-C 105.808 -2.42 . . . . 0.0 105.808 174.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.773 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -120.29 -174.86 0.31 Allowed Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 118.128 -1.429 . . . . 0.0 113.512 -176.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.773 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 37.7 Cg_endo -63.86 -36.23 51.67 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 124.269 1.668 . . . . 0.0 111.657 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.63 -27.32 64.62 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.429 ' OG ' ' HA ' ' A' ' 690' ' ' ILE . 33.0 t -96.04 148.48 22.62 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.541 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.741 HG21 ' O ' ' A' ' 614' ' ' GLU . 0.8 OUTLIER -56.68 -18.71 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.991 -1.068 . . . . 0.0 109.178 178.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.937 ' CD1' HD12 ' A' ' 690' ' ' ILE . 4.1 mp -94.72 116.38 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.478 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -120.67 67.2 0.85 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.545 -1.347 . . . . 0.0 108.864 -179.493 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 1.072 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 15.5 tp10 -145.0 175.14 10.45 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.243 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.529 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.19 124.24 38.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.085 -1.009 . . . . 0.0 109.447 176.626 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.752 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.1 mt -103.04 155.72 18.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.455 -0.778 . . . . 0.0 109.173 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -125.25 110.3 13.88 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.393 -0.817 . . . . 0.0 111.177 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.803 HD12 HD22 ' A' ' 578' ' ' LEU . 26.4 mt -80.08 108.31 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.4 OUTLIER -68.0 116.73 8.97 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.437 -0.79 . . . . 0.0 111.106 -178.29 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.686 ' HG3' HG21 ' A' ' 700' ' ' THR . 0.1 OUTLIER 38.57 32.41 0.05 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.255 0.55 . . . . 0.0 111.188 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.414 ' HA2' ' CG2' ' A' ' 594' ' ' ILE . . . 83.73 63.7 1.67 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 598' ' ' VAL . 9.8 p -79.47 105.15 8.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 O-C-N 121.039 -1.271 . . . . 0.0 107.583 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.443 ' CB ' ' HB3' ' A' ' 627' ' ' LYS . 3.9 p-10 -121.79 151.13 57.07 Favored Pre-proline 0 C--N 1.279 -2.466 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.649 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.482 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.7 Cg_endo -86.24 156.8 54.58 Favored 'Cis proline' 0 C--N 1.307 -1.618 0 C-N-CA 120.933 -2.528 . . . . 0.0 109.475 0.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.508 ' CD2' ' HB2' ' A' ' 611' ' ' CYS . 4.8 t80 -105.66 115.39 30.16 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.54 ' HB3' ' SG ' ' A' ' 609' ' ' CYS . 50.2 m-85 -86.14 143.68 27.89 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.431 -178.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.926 HG23 ' HB3' ' A' ' 611' ' ' CYS . 4.1 mt -140.68 141.75 31.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.894 -0.504 . . . . 0.0 110.013 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.963 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 165.42 -162.3 35.66 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.361 -1.399 . . . . 0.0 111.13 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 5.9 mmm-85 -61.26 -58.48 8.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.89 -0.771 . . . . 0.0 111.804 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.03 124.27 22.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 111.251 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.538 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 11.8 pt-20 -54.16 -16.98 2.35 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.922 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -44.88 -36.44 3.31 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.37 -0.831 . . . . 0.0 109.074 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.54 ' SG ' ' HB3' ' A' ' 602' ' ' PHE . 1.3 m -59.63 136.63 58.05 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.491 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -47.42 -26.77 1.43 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.209 -0.932 . . . . 0.0 109.414 179.165 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.926 ' HB3' HG23 ' A' ' 603' ' ' ILE . 3.0 t -109.48 143.02 39.66 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.538 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -103.1 126.62 50.36 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.497 -0.881 . . . . 0.0 112.447 -178.559 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.792 HG22 HD22 ' A' ' 618' ' ' LEU . 5.3 mt -143.19 109.64 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.741 ' O ' HG21 ' A' ' 587' ' ' ILE . 2.1 tp10 -97.26 103.04 14.94 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 117.99 -1.484 . . . . 0.0 108.357 178.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.534 ' HB2' ' HB3' ' A' ' 618' ' ' LEU . 4.3 m-20 -137.7 105.73 5.69 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.417 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -42.36 -51.66 4.81 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.599 -0.688 . . . . 0.0 112.181 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -74.77 -16.7 60.71 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.182 -0.949 . . . . 0.0 111.602 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.963 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.5 OUTLIER -80.23 143.58 33.62 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.155 -0.965 . . . . 0.0 111.071 -179.062 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.454 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -79.85 162.88 24.79 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.414 -0.803 . . . . 0.0 110.681 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.788 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.4 mpt_? -64.32 -46.76 82.11 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.145 -0.972 . . . . 0.0 109.936 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.557 ' HB ' HG23 ' A' ' 727' ' ' VAL . 5.2 m -95.75 2.14 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.235 -0.916 . . . . 0.0 109.42 178.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.725 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.2 t60 -25.28 -47.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.409 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.786 ' SG ' HD13 ' A' ' 680' ' ' ILE . 1.0 OUTLIER -136.82 146.41 45.63 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 118.206 -1.397 . . . . 0.0 111.497 179.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.555 ' HA ' HG13 ' A' ' 603' ' ' ILE . 3.6 p90 -145.82 146.58 31.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.622 -0.674 . . . . 0.0 110.073 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.991 HD12 HD11 ' A' ' 580' ' ' LEU . 19.8 mt -103.55 117.46 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.443 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 10.9 t80 -111.78 154.61 24.8 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 109.956 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.443 ' HB3' ' CB ' ' A' ' 599' ' ' ASN . 2.8 ttmt -120.3 136.6 54.63 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 121.556 0.694 . . . . 0.0 110.434 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.443 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.53 164.81 26.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.648 -0.658 . . . . 0.0 109.949 -179.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.1 OUTLIER -77.12 115.01 16.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 109.03 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.527 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.8 t-160 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.585 -0.697 . . . . 0.0 110.998 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.721 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.0 mp . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.3 OUTLIER -118.0 124.26 47.74 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.975 -1.078 . . . . 0.0 111.412 -179.426 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.475 ' OD2' HD11 ' A' ' 671' ' ' LEU . 28.7 t0 -111.18 155.65 22.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.443 -0.786 . . . . 0.0 109.92 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 21.8 pt -108.81 128.79 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.21 -0.931 . . . . 0.0 109.748 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.842 ' CH2' HD22 ' A' ' 671' ' ' LEU . 95.6 m95 -115.48 119.95 37.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.678 -0.639 . . . . 0.0 111.595 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.541 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 11.5 t80 -83.31 114.13 21.19 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.0 OUTLIER -108.86 103.28 12.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.154 -0.966 . . . . 0.0 111.353 -178.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.53 ' CD2' ' N ' ' A' ' 652' ' ' THR . 8.9 t60 -63.04 156.75 23.87 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.513 -0.742 . . . . 0.0 109.895 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.725 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -148.19 -29.11 0.31 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.395 -0.816 . . . . 0.0 112.875 -179.206 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.539 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.85 -163.66 25.15 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 117.864 -2.112 . . . . 0.0 109.473 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 19.3 m -99.3 -17.84 17.86 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.02 -1.282 . . . . 0.0 113.709 -176.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.551 ' C ' HG23 ' A' ' 656' ' ' VAL . 8.7 m120 -59.16 -3.77 0.43 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 120.667 -1.27 . . . . 0.0 112.492 -178.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.551 HG23 ' C ' ' A' ' 655' ' ' ASN . 2.9 t 71.52 147.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.626 -0.671 . . . . 0.0 110.207 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -102.74 141.64 35.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.517 -0.739 . . . . 0.0 111.145 -178.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.433 ' CE1' ' HG2' ' A' ' 663' ' ' ARG . 95.3 m-85 -129.46 126.61 39.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.552 -0.718 . . . . 0.0 109.724 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.772 HD23 ' CE1' ' A' ' 670' ' ' PHE . 31.3 tp -130.85 111.83 12.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.222 -0.924 . . . . 0.0 110.107 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 56.31 -82.2 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.565 -0.709 . . . . 0.0 110.167 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 659' ' ' LEU . 17.1 m-80 -141.89 17.77 2.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 110.131 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.431 ' HB3' ' CE2' ' A' ' 670' ' ' PHE . 0.8 OUTLIER -109.45 127.12 54.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.494 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.433 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 0.0 OUTLIER -93.22 141.15 28.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.417 -0.802 . . . . 0.0 109.794 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.709 ' HG2' HG13 ' A' ' 716' ' ' VAL . 3.0 mtp -122.79 -167.65 1.62 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.372 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.606 HG13 HG23 ' A' ' 668' ' ' THR . 3.0 pt -139.82 -160.96 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.399 -0.813 . . . . 0.0 110.239 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -79.76 95.51 6.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.283 -0.886 . . . . 0.0 110.668 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 104.31 51.6 0.92 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.624 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -118.18 145.36 45.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.103 -1.233 . . . . 0.0 109.993 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.77 141.62 39.05 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.772 ' CE1' HD23 ' A' ' 659' ' ' LEU . 3.7 t80 -145.36 148.21 33.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.106 -0.996 . . . . 0.0 112.299 -177.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.842 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.53 130.91 44.24 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.443 -0.786 . . . . 0.0 109.893 179.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.541 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 4.3 mt -107.44 105.01 14.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.907 -1.121 . . . . 0.0 111.226 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . 0.453 ' O ' HG11 ' A' ' 694' ' ' VAL . 85.9 mt-30 -87.51 165.36 15.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.476 -0.765 . . . . 0.0 109.052 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.506 ' HB3' HD12 ' A' ' 696' ' ' ILE . 14.4 p-10 -62.74 157.42 21.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.127 -0.983 . . . . 0.0 109.923 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 59.88 51.52 58.46 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 107.765 -2.134 . . . . 0.0 107.765 -178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.512 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.5 OUTLIER -114.09 96.34 5.76 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.786 -0.832 . . . . 0.0 110.868 -178.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.913 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.6 tt0 -94.46 107.98 19.93 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.739 HG22 HD13 ' A' ' 659' ' ' LEU . 35.5 pt -107.59 138.38 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.598 -0.689 . . . . 0.0 112.331 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -100.06 112.79 25.09 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.786 HD13 ' SG ' ' A' ' 623' ' ' CYS . 56.8 mt -81.63 -33.81 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.26 -0.9 . . . . 0.0 111.504 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.68 HG22 ' CG1' ' A' ' 690' ' ' ILE . 14.1 tt -133.85 136.15 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.938 -1.101 . . . . 0.0 110.213 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -137.59 116.48 12.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.316 -0.865 . . . . 0.0 110.462 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -127.94 117.6 22.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.84 -30.19 70.3 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.466 -0.771 . . . . 0.0 111.015 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -55.65 -43.45 76.28 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.301 -0.874 . . . . 0.0 110.872 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 688' ' ' PHE . 6.9 m-80 -136.62 32.35 2.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 110.002 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 688' ' ' PHE . 5.8 mttm 64.21 -67.0 0.11 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.915 -0.49 . . . . 0.0 110.09 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.494 ' N ' ' O ' ' A' ' 686' ' ' ASN . 0.1 OUTLIER 33.42 55.48 0.5 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.3 0.571 . . . . 0.0 110.965 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 687' ' ' LYS . 34.4 m -101.3 142.19 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.414 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.937 HD12 ' CD1' ' A' ' 588' ' ' ILE . 31.2 mm -117.83 164.2 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.473 -0.767 . . . . 0.0 109.333 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.43 ' N ' HG22 ' A' ' 690' ' ' ILE . . . -170.96 124.71 1.14 Allowed Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.058 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.913 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 14.3 m-85 -119.19 137.25 53.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.625 -0.926 . . . . 0.0 108.654 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -101.13 113.95 27.46 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 110.753 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.84 HG22 HD21 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -83.84 121.51 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -129.26 105.81 8.4 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.623 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.603 HG12 HD12 ' A' ' 578' ' ' LEU . 82.1 mt -85.73 105.95 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.449 -0.782 . . . . 0.0 109.614 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.28 -44.13 13.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.428 -0.795 . . . . 0.0 108.889 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -111.26 142.35 43.59 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.401 0.62 . . . . 0.0 110.229 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.0 p -114.19 96.15 5.65 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.686 HG21 ' HG3' ' A' ' 596' ' ' GLN . 7.2 t -86.26 95.96 9.79 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.334 0.588 . . . . 0.0 111.216 -178.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 47.43 36.77 11.69 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.884 HD23 ' O ' ' A' ' 704' ' ' ASN . 1.7 tp -84.41 149.96 25.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.392 -1.063 . . . . 0.0 110.336 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.721 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.5 p90 -53.5 -23.2 9.67 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.384 -0.823 . . . . 0.0 109.939 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.884 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.8 t30 . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.447 ' HA ' ' HD2' ' A' ' 714' ' ' ARG . 5.2 mmm-85 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.368 0.604 . . . . 0.0 111.354 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.77 151.75 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.475 -0.765 . . . . 0.0 109.279 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.709 HG13 ' HG2' ' A' ' 664' ' ' MET . 61.6 t -92.3 118.58 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 110.512 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.3 mp -90.22 161.8 15.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.546 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.12 153.99 17.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -0.93 . . . . 0.0 110.244 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . 0.407 ' HG3' ' CB ' ' A' ' 723' ' ' GLU . 33.0 tt0 -79.93 145.8 32.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.472 -0.768 . . . . 0.0 110.181 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 20.3 p -121.13 -176.89 3.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.309 -0.87 . . . . 0.0 110.362 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.7 67.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.376 -0.827 . . . . 0.0 110.456 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.32 -52.46 64.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.352 -0.842 . . . . 0.0 110.001 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.407 ' CB ' ' HG3' ' A' ' 719' ' ' GLN . 2.4 mp0 -66.8 -42.47 85.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -0.873 . . . . 0.0 109.929 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.563 ' O ' HG12 ' A' ' 727' ' ' VAL . 12.2 ttmm -56.69 -32.83 65.84 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.319 -0.863 . . . . 0.0 109.756 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.8 -36.21 77.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.399 -0.813 . . . . 0.0 110.09 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 33.4 mt -58.18 -46.63 85.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.404 -0.81 . . . . 0.0 110.446 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 724' ' ' LYS . 7.9 p -69.88 -19.57 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.065 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -54.44 -48.49 71.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -0.894 . . . . 0.0 108.79 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.81 104.98 11.88 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 122.229 1.014 . . . . 0.0 108.923 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.275 -2.657 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.377 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.483 1.206 0 CA-C-O 121.62 0.724 . . . . 0.0 109.253 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.519 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 3.7 t80 -123.56 -41.47 2.27 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 122.074 0.94 . . . . 0.0 109.215 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.643 HD23 HD12 ' A' ' 594' ' ' ILE . 22.1 tp -123.83 140.76 52.67 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.285 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.434 ' H ' HD12 ' A' ' 578' ' ' LEU . 88.1 m -123.51 116.98 24.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.705 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.661 HD11 ' CD1' ' A' ' 625' ' ' ILE . 1.9 mm? -90.37 111.74 23.08 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.426 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 2.5 mmtt -112.89 101.26 52.91 Favored Pre-proline 0 C--N 1.299 -1.594 0 C-N-CA 117.987 -1.485 . . . . 0.0 112.657 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 1.104 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.1 Cg_endo -80.87 140.72 12.95 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 N-CA-C 105.428 -2.566 . . . . 0.0 105.428 174.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.737 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -118.86 -176.95 0.41 Allowed Pre-proline 0 N--CA 1.495 1.793 0 C-N-CA 118.177 -1.409 . . . . 0.0 113.567 -176.232 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.737 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.3 Cg_endo -66.56 -31.3 41.63 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 O-C-N 124.342 1.706 . . . . 0.0 111.83 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -59.0 -29.89 67.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.798 -1.189 . . . . 0.0 108.124 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.599 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 54.4 p -96.44 153.29 17.91 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.914 -0.491 . . . . 0.0 109.724 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.644 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.1 OUTLIER -57.0 -18.95 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.16 -0.963 . . . . 0.0 109.101 178.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.873 HD12 ' HA ' ' A' ' 613' ' ' ILE . 10.0 mm -95.96 115.38 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.51 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -124.47 71.37 1.14 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 120.601 -1.312 . . . . 0.0 110.099 -178.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 1.104 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 18.9 mt-10 -145.12 174.97 10.6 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.579 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.526 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.79 127.23 41.57 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.841 -1.162 . . . . 0.0 109.393 176.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.837 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.2 mp -111.39 155.73 22.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 109.747 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -124.96 110.41 14.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.481 -0.762 . . . . 0.0 111.406 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.643 HD12 HD23 ' A' ' 578' ' ' LEU . 3.0 mt -80.85 110.49 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.525 ' HB2' HG23 ' A' ' 598' ' ' VAL . 0.7 OUTLIER -51.48 172.83 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.634 -0.666 . . . . 0.0 110.052 -179.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.519 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 5.6 mt-30 -64.36 66.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.476 -0.765 . . . . 0.0 110.555 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 128.72 30.65 0.69 Allowed Glycine 0 N--CA 1.486 2.01 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.806 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -81.34 102.81 7.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 11.8 t-20 -143.3 134.54 12.66 Favored Pre-proline 0 C--N 1.284 -2.265 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.89 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.646 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 55.9 Cg_endo -91.48 162.52 28.47 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.958 -1.684 . . . . 0.0 109.192 -1.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.547 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 3.8 t80 -106.25 116.35 31.79 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.646 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 73.0 m-85 -86.47 144.08 27.44 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.269 -0.894 . . . . 0.0 110.538 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.913 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.0 mt -141.64 141.46 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.73 -0.606 . . . . 0.0 110.148 -178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.838 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 163.94 -163.09 35.67 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.45 -1.357 . . . . 0.0 111.12 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.466 ' N ' HD23 ' A' ' 618' ' ' LEU . 1.1 mmm-85 -62.46 -53.11 59.73 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.832 -0.805 . . . . 0.0 111.491 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 3.1 p -68.22 121.14 15.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 111.04 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.533 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.6 mt-10 -54.2 -17.4 2.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.641 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -47.36 -30.23 3.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.426 -0.796 . . . . 0.0 109.032 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 602' ' ' PHE . 1.6 m -65.88 130.48 43.42 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.547 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -43.97 -29.57 0.6 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.381 -0.824 . . . . 0.0 109.524 179.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.913 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.3 t -106.01 143.37 34.24 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.533 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -108.52 128.59 54.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.079 -1.013 . . . . 0.0 113.093 -178.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.873 ' HA ' HD12 ' A' ' 588' ' ' ILE . 8.8 mt -142.21 108.87 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -98.33 104.07 16.08 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.221 -1.392 . . . . 0.0 109.517 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.829 ' OD2' HD11 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -138.78 106.69 5.67 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.165 177.181 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -39.25 -43.79 1.17 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.65 -0.656 . . . . 0.0 112.123 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.01 -17.71 39.53 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.118 -0.988 . . . . 0.0 111.847 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.838 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.6 OUTLIER -75.47 131.37 40.09 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.103 -0.998 . . . . 0.0 110.882 -179.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 622' ' ' HIS . 10.0 t -65.34 159.08 24.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.335 -0.853 . . . . 0.0 110.837 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.766 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.9 mpp_? -64.76 -45.3 86.99 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.181 -0.949 . . . . 0.0 109.518 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 1.064 HG11 HG23 ' A' ' 727' ' ' VAL . 17.3 t -95.35 2.06 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 121.739 0.78 . . . . 0.0 109.721 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.734 ' O ' ' N ' ' A' ' 652' ' ' THR . 6.1 t60 -24.55 -46.82 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.542 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.824 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -138.19 146.1 42.29 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 118.283 -1.367 . . . . 0.0 112.038 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 1.9 p90 -146.13 144.25 29.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.454 -0.779 . . . . 0.0 109.981 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.661 ' CD1' HD11 ' A' ' 580' ' ' LEU . 26.8 mt -102.66 123.1 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.434 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 2.3 t80 -118.26 154.33 32.44 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.351 -0.843 . . . . 0.0 109.516 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 9.0 tttt -120.46 136.27 54.8 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.657 0.741 . . . . 0.0 110.786 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -126.35 163.66 22.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.715 -0.615 . . . . 0.0 109.676 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.474 ' C ' ' CD ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -78.67 123.1 26.79 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.157 -0.964 . . . . 0.0 108.894 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.3 t-160 . . . . . 0 N--CA 1.486 1.328 0 O-C-N 121.331 -0.856 . . . . 0.0 110.538 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.602 ' HG ' ' HA ' ' A' ' 703' ' ' PHE . 3.4 mm? . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.9 m-20 -130.41 133.24 46.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.906 -1.122 . . . . 0.0 111.148 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.471 ' CG ' ' HE1' ' A' ' 648' ' ' TRP . 3.2 p30 -115.59 152.73 32.53 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.404 -0.81 . . . . 0.0 110.954 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 6.2 pt -111.2 130.89 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.264 -0.897 . . . . 0.0 109.868 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.62 ' CH2' HD12 ' A' ' 671' ' ' LEU . 94.2 m95 -119.04 140.06 50.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.611 -0.681 . . . . 0.0 110.89 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.949 ' CB ' HD11 ' A' ' 672' ' ' LEU . 4.3 t80 -97.97 114.34 26.43 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 24.8 t -104.22 102.32 12.03 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.23 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.544 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 24.9 t60 -67.59 164.68 18.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.443 -0.786 . . . . 0.0 109.543 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.734 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -155.28 -31.31 0.1 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.213 -0.93 . . . . 0.0 113.257 -178.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.564 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.25 132.88 11.83 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 117.937 -2.077 . . . . 0.0 110.427 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . 0.404 ' C ' ' H ' ' A' ' 656' ' ' VAL . 23.8 m -37.71 -24.46 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -177.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.533 ' O ' HG12 ' A' ' 656' ' ' VAL . 7.9 m120 -57.7 -4.72 0.3 Allowed 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.266 -1.521 . . . . 0.0 112.407 -178.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 76.77 168.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 CA-C-O 121.83 0.824 . . . . 0.0 110.256 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.498 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -127.5 154.76 44.73 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.601 -179.01 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -137.92 126.36 23.37 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.163 -0.96 . . . . 0.0 110.83 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.789 HD23 ' CD2' ' A' ' 670' ' ' PHE . 22.2 tp -122.05 107.32 12.07 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.391 -0.818 . . . . 0.0 109.84 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.3 t30 63.2 -73.45 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.545 -0.722 . . . . 0.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 659' ' ' LEU . 37.1 m-20 -153.9 22.51 0.51 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.348 -0.845 . . . . 0.0 110.389 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.38 116.86 28.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.149 -0.969 . . . . 0.0 110.37 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -80.54 139.67 36.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.421 -0.8 . . . . 0.0 109.908 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.561 ' O ' HG22 ' A' ' 656' ' ' VAL . 37.7 mtp -118.2 -161.74 0.85 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.869 . . . . 0.0 110.094 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.538 ' CG1' HG23 ' A' ' 668' ' ' THR . 3.7 pt -133.02 -160.87 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 109.725 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -81.39 117.33 21.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.343 -0.848 . . . . 0.0 110.26 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 82.49 50.73 4.63 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.538 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.0 OUTLIER -115.27 146.34 41.58 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.109 -1.23 . . . . 0.0 110.111 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.442 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 2.7 ttpt -108.77 141.99 39.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.524 -0.735 . . . . 0.0 109.853 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.789 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -144.61 141.0 29.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 110.898 -179.067 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.62 HD12 ' CH2' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -70.05 146.35 51.05 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.285 -0.885 . . . . 0.0 110.682 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.949 HD11 ' CB ' ' A' ' 649' ' ' TYR . 3.9 mp -111.45 149.05 31.83 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.924 0.868 . . . . 0.0 111.632 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . 0.467 ' O ' ' C ' ' A' ' 674' ' ' ASP . 15.3 mt-30 -127.0 136.59 52.45 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 673' ' ' GLN . 0.0 OUTLIER -37.93 129.22 1.21 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.967 -1.083 . . . . 0.0 110.276 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 83.88 44.05 6.93 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.403 ' HB3' ' HB ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -100.97 90.48 4.19 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.948 -0.737 . . . . 0.0 110.463 -179.09 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.821 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.8 tt0 -94.21 107.74 19.65 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.653 HG22 ' HA ' ' A' ' 659' ' ' LEU . 41.5 pt -113.06 138.5 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.49 -0.757 . . . . 0.0 111.829 -178.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 15.9 mttp -94.47 110.53 22.32 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.824 HD13 ' SG ' ' A' ' 623' ' ' CYS . 69.9 mt -73.88 -30.95 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.348 -0.845 . . . . 0.0 110.801 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.693 ' CD1' HD12 ' A' ' 618' ' ' LEU . 6.0 mt -143.0 137.38 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.018 -1.051 . . . . 0.0 110.876 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 6.6 t90 -137.93 108.98 6.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.559 -0.713 . . . . 0.0 109.795 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 688' ' ' PHE . 1.2 t70 -114.34 118.12 32.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.096 -1.003 . . . . 0.0 110.598 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -66.52 -30.01 70.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.495 -0.753 . . . . 0.0 110.806 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -55.88 -43.71 77.44 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.397 -0.815 . . . . 0.0 111.078 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 688' ' ' PHE . 2.1 m-20 -141.26 34.96 1.69 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.92 . . . . 0.0 110.066 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . 0.477 ' O ' ' C ' ' A' ' 688' ' ' PHE . 0.2 OUTLIER 66.54 -67.71 0.15 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.737 -0.602 . . . . 0.0 110.003 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.477 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.5 OUTLIER 33.69 59.92 0.52 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.684 -0.635 . . . . 0.0 110.7 179.718 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 586' ' ' SER . 34.2 m -102.06 142.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 111.352 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.829 HD11 ' OD2' ' A' ' 615' ' ' ASP . 43.1 mm -113.43 163.56 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -173.31 118.71 0.72 Allowed Glycine 0 N--CA 1.491 2.314 0 C-N-CA 118.948 -1.596 . . . . 0.0 110.618 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.87 ' CZ ' HG21 ' A' ' 588' ' ' ILE . 13.7 m-85 -120.5 138.02 54.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.613 -0.934 . . . . 0.0 108.784 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -108.64 114.52 28.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 0.0 110.763 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.523 HG22 HD11 ' A' ' 578' ' ' LEU . 1.2 t -76.52 119.68 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.382 -0.824 . . . . 0.0 108.924 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.71 104.61 7.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.672 -0.642 . . . . 0.0 110.023 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 62.5 mt -86.68 107.7 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 109.714 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -78.3 -41.14 34.69 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.405 -0.81 . . . . 0.0 109.077 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.438 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.3 m-20 -110.81 140.86 44.87 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.579 0.704 . . . . 0.0 110.682 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 14.5 p -115.16 96.0 5.47 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 22.2 m -113.58 129.64 56.52 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.853 -0.53 . . . . 0.0 110.797 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.513 ' C ' HD12 ' A' ' 644' ' ' LEU . . . 50.76 37.9 35.73 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 704' ' ' ASN . 5.0 tp -109.94 125.43 52.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.461 -1.023 . . . . 0.0 110.653 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.602 ' HA ' ' HG ' ' A' ' 644' ' ' LEU . 10.8 p90 -50.55 -27.4 6.63 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.901 0.858 . . . . 0.0 109.566 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 703' ' ' PHE . 6.6 t30 . . . . . 0 C--N 1.303 -1.423 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.595 ' NH1' HD21 ' A' ' 659' ' ' LEU . 6.0 mmm-85 . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.849 0.833 . . . . 0.0 112.254 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 11.2 m -106.96 151.76 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.486 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 60.4 t -86.2 133.15 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.85 . . . . 0.0 110.939 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.0 mt -103.65 162.15 13.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.54 -0.725 . . . . 0.0 109.552 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.01 154.15 18.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 110.259 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -79.94 134.19 36.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 0.0 110.168 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 63.1 p -106.18 -176.3 3.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.413 -0.804 . . . . 0.0 110.3 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.26 -28.86 29.78 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.282 -0.886 . . . . 0.0 110.018 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -65.93 -47.92 73.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.416 -0.802 . . . . 0.0 109.785 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -63.93 -47.86 78.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.417 -0.802 . . . . 0.0 109.956 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.48 ' O ' HG12 ' A' ' 727' ' ' VAL . 12.0 tttm -52.42 -33.71 45.1 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.422 -0.799 . . . . 0.0 109.85 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -69.16 -36.12 77.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.471 -0.768 . . . . 0.0 110.251 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 56.2 mt -56.25 -47.53 78.34 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.312 -0.867 . . . . 0.0 110.619 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 1.064 HG23 HG11 ' A' ' 621' ' ' VAL . 6.3 p -69.67 -17.67 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.154 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -54.27 -45.82 72.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 0.0 108.836 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.1 104.76 11.55 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.225 1.012 . . . . 0.0 109.209 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.414 ' OXT' ' CD2' ' A' ' 602' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.274 -2.714 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.365 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.418 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 2.6 ttm180 . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 121.612 0.72 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.512 ' HB3' ' CA ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -93.32 -44.09 8.47 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.809 0.814 . . . . 0.0 109.116 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.612 HD22 HD12 ' A' ' 594' ' ' ILE . 9.9 tt -125.48 142.2 51.63 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.275 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . 0.421 ' N ' HD23 ' A' ' 578' ' ' LEU . 87.0 m -122.38 121.97 37.93 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.583 HD11 ' CD1' ' A' ' 625' ' ' ILE . 14.1 mt -95.15 112.5 24.2 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.49 103.66 55.57 Favored Pre-proline 0 C--N 1.302 -1.485 0 C-N-CA 118.464 -1.294 . . . . 0.0 113.21 -177.272 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 1.046 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 44.1 Cg_endo -78.5 137.24 14.54 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 N-CA-C 105.274 -2.625 . . . . 0.0 105.274 174.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.809 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -125.88 -171.9 0.24 Allowed Pre-proline 0 C--N 1.295 -1.786 0 C-N-CA 118.138 -1.425 . . . . 0.0 113.405 -176.104 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.809 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 36.7 Cg_endo -61.67 -35.4 80.57 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 124.129 1.594 . . . . 0.0 111.951 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.55 ' O ' HG23 ' A' ' 689' ' ' VAL . 45.3 m-20 -58.69 -29.75 66.86 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.494 ' OG ' ' HA ' ' A' ' 690' ' ' ILE . 24.6 t -96.54 148.09 23.18 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.563 ' CD1' HD11 ' A' ' 690' ' ' ILE . 1.4 pt -62.96 -18.21 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.244 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.711 HG13 HG12 ' A' ' 613' ' ' ILE . 4.3 mm -83.27 116.2 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.483 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -119.76 69.52 0.84 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.432 -1.417 . . . . 0.0 109.348 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 1.046 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 24.8 tt0 -144.61 174.35 11.04 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.637 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.526 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.2 125.01 36.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.971 -1.08 . . . . 0.0 109.011 176.342 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.778 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.1 mt -105.98 155.04 19.76 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.31 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.418 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.6 OUTLIER -125.48 110.54 14.02 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.478 -0.764 . . . . 0.0 111.287 -179.016 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.612 HD12 HD22 ' A' ' 578' ' ' LEU . 3.2 mt -84.16 109.27 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.157 -0.965 . . . . 0.0 109.007 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.2 OUTLIER -64.74 140.41 58.86 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.048 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.512 ' CA ' ' HB3' ' A' ' 577' ' ' PHE . 2.2 pt20 -46.56 85.47 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.486 -0.759 . . . . 0.0 110.783 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 135.44 5.21 2.35 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.722 -1.227 . . . . 0.0 110.483 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -80.21 101.66 5.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 O-C-N 120.788 -1.419 . . . . 0.0 107.421 178.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 627' ' ' LYS . 21.6 t-20 -145.42 132.52 10.1 Favored Pre-proline 0 C--N 1.282 -2.352 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.065 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.542 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 50.8 Cg_endo -92.87 164.13 23.88 Favored 'Cis proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.38 -1.508 . . . . 0.0 108.747 -2.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.524 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.4 t80 -104.39 116.14 31.61 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.646 ' CG ' HD23 ' A' ' 730' ' ' LEU . 35.9 m-85 -82.96 143.91 30.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.435 -0.79 . . . . 0.0 110.616 -178.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.911 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.6 mt -141.99 141.57 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.659 -0.651 . . . . 0.0 109.952 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.85 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 163.8 -163.8 36.02 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.395 -1.383 . . . . 0.0 111.24 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.497 ' N ' HD23 ' A' ' 618' ' ' LEU . 4.8 mmm-85 -60.33 -57.7 11.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.921 -0.752 . . . . 0.0 111.862 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.45 125.07 25.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 111.209 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.46 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 4.3 pt-20 -54.08 -17.61 2.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.888 . . . . 0.0 109.735 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.49 -32.58 1.44 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.457 -0.777 . . . . 0.0 108.951 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.3 m -65.9 130.37 43.03 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.524 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -43.3 -29.42 0.41 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.333 -0.854 . . . . 0.0 109.893 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.911 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.9 t -104.73 143.11 33.55 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.46 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -107.91 126.48 52.73 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 122.279 1.038 . . . . 0.0 113.363 -178.077 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.711 HG12 HG13 ' A' ' 588' ' ' ILE . 22.9 mt -143.9 108.57 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 614' ' ' GLU . 1.5 pt-20 -96.0 104.2 16.13 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 118.197 -1.401 . . . . 0.0 108.718 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.548 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.3 m-20 -136.41 105.81 6.08 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.587 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . 0.402 ' OD1' ' CE2' ' A' ' 688' ' ' PHE . 16.2 p-10 -44.64 -40.41 5.83 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.657 -0.652 . . . . 0.0 111.734 -179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.4 -17.38 42.4 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.101 -0.999 . . . . 0.0 111.032 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.891 HD13 HD11 ' A' ' 681' ' ' ILE . 0.6 OUTLIER -81.03 139.25 35.86 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.305 -0.872 . . . . 0.0 110.555 -179.499 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.448 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.0 OUTLIER -73.95 158.87 33.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.392 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.735 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.2 mpt_? -63.31 -43.15 98.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.2 -0.938 . . . . 0.0 109.191 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.599 ' CG1' HG22 ' A' ' 727' ' ' VAL . 18.8 t -95.82 1.57 10.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.921 0.867 . . . . 0.0 109.693 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.747 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.2 t60 -28.1 -45.37 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.884 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.543 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.46 145.88 43.62 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 117.959 -1.496 . . . . 0.0 112.191 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.543 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 4.5 p90 -146.35 142.05 27.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.605 -0.685 . . . . 0.0 110.088 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.583 ' CD1' HD11 ' A' ' 580' ' ' LEU . 73.8 mt -102.99 117.61 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.431 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 4.1 t80 -112.86 155.46 24.63 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.769 0.795 . . . . 0.0 110.17 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.44 ' O ' ' ND2' ' A' ' 599' ' ' ASN . 21.9 ttmt -119.34 137.92 53.39 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 121.525 0.679 . . . . 0.0 110.487 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.0 OUTLIER -132.75 163.92 27.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.58 -0.7 . . . . 0.0 110.753 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.4 tpt85 -77.51 112.3 14.14 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.523 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.2 t60 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.722 . . . . 0.0 110.887 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.768 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.3 mp . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.2 OUTLIER -118.39 123.96 46.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.097 -1.002 . . . . 0.0 110.905 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.708 ' CG ' HD11 ' A' ' 671' ' ' LEU . 13.3 t0 -105.4 156.54 18.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.433 -0.792 . . . . 0.0 109.742 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 18.1 pt -106.65 129.37 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.342 -0.849 . . . . 0.0 110.423 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.763 ' CH2' HD13 ' A' ' 671' ' ' LEU . 97.9 m95 -116.63 121.12 40.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.718 -0.614 . . . . 0.0 110.791 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.65 ' HB2' HD11 ' A' ' 672' ' ' LEU . 13.9 t80 -80.61 116.13 20.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 108.469 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.543 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 13.8 t -109.0 107.01 17.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 0.0 111.767 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.542 ' CB ' ' OG ' ' A' ' 657' ' ' SER . 11.9 t60 -70.51 161.67 30.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.568 -0.707 . . . . 0.0 109.812 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.747 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.94 -30.24 0.16 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.329 -0.857 . . . . 0.0 112.562 -179.191 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.59 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.13 -167.71 33.93 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 117.853 -2.118 . . . . 0.0 109.901 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.6 m -89.6 -19.28 25.13 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.69 ' O ' HG22 ' A' ' 656' ' ' VAL . 89.7 m-20 -59.75 -2.86 0.42 Allowed 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.686 -1.258 . . . . 0.0 112.924 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.69 HG22 ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 62.11 143.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.575 -0.703 . . . . 0.0 110.293 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.542 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -95.98 142.99 27.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.621 -0.675 . . . . 0.0 110.462 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.448 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 10.8 m-85 -129.03 126.13 38.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.923 . . . . 0.0 110.526 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.602 HD11 HG21 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -134.55 114.35 12.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.331 -0.856 . . . . 0.0 110.001 179.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.02 -85.79 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.439 -0.788 . . . . 0.0 110.494 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.6 p-10 -143.67 19.28 1.84 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.11 -0.994 . . . . 0.0 110.409 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . 0.59 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.4 OUTLIER -105.84 118.36 36.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.313 -0.867 . . . . 0.0 110.177 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.05 136.44 35.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.466 -0.772 . . . . 0.0 110.044 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.747 ' SD ' HG13 ' A' ' 716' ' ' VAL . 8.1 mmm -115.61 -168.2 1.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 0.0 109.997 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.639 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.1 pt -143.38 -165.81 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.22 -0.925 . . . . 0.0 110.494 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 652' ' ' THR . 17.2 tt0 -77.64 78.42 4.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.574 -0.704 . . . . 0.0 110.473 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.42 53.79 0.23 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.639 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.1 OUTLIER -122.24 148.15 45.33 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.056 -1.261 . . . . 0.0 109.928 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.44 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 2.8 tttt -108.4 138.75 44.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.524 -0.735 . . . . 0.0 109.574 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.464 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 0.7 OUTLIER -144.53 146.42 32.37 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.664 -178.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.763 HD13 ' CH2' ' A' ' 648' ' ' TRP . 13.5 tp -71.29 146.19 49.06 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.429 -0.794 . . . . 0.0 110.898 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 649' ' ' TYR . 9.0 mt -117.78 107.74 14.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.415 -0.803 . . . . 0.0 111.06 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -84.86 153.41 22.92 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -50.42 141.97 11.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.072 -1.018 . . . . 0.0 109.947 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 71.87 45.97 39.98 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.5 ' OD2' HD21 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -106.94 90.49 3.32 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.855 -0.791 . . . . 0.0 110.198 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.825 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 5.3 tt0 -93.45 107.41 19.25 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.602 HG21 HD11 ' A' ' 659' ' ' LEU . 1.1 pt -111.44 137.77 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 121.446 0.641 . . . . 0.0 111.551 -177.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -95.13 110.83 22.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.486 -0.759 . . . . 0.0 109.258 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.543 HD13 ' SG ' ' A' ' 623' ' ' CYS . 57.0 mt -75.02 -23.92 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.232 -0.918 . . . . 0.0 110.517 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.891 HD11 HD13 ' A' ' 618' ' ' LEU . 7.1 mt -140.49 139.09 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.195 -0.941 . . . . 0.0 110.276 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -137.69 109.51 7.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.365 -0.834 . . . . 0.0 110.401 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.29 117.7 28.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.328 -0.858 . . . . 0.0 109.975 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -47.19 72.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.291 -0.881 . . . . 0.0 111.037 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -84.84 -43.56 14.04 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.259 -0.9 . . . . 0.0 110.849 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.63 -12.07 61.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.576 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm 52.14 25.36 3.22 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.242 -0.911 . . . . 0.0 110.314 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.448 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -93.06 79.43 4.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.374 -0.829 . . . . 0.0 109.764 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 585' ' ' ASP . 27.3 m -103.55 142.33 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.391 -0.818 . . . . 0.0 110.673 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.563 HD11 ' CD1' ' A' ' 587' ' ' ILE . 30.0 mm -116.6 164.34 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.456 -0.778 . . . . 0.0 109.03 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 690' ' ' ILE . . . -173.58 124.19 1.03 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.316 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.825 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 15.0 m-85 -120.2 138.6 53.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.647 -0.913 . . . . 0.0 108.857 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -103.3 114.01 27.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.057 -1.027 . . . . 0.0 110.582 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.595 HG21 HD13 ' A' ' 672' ' ' LEU . 1.0 OUTLIER -82.81 113.49 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -120.37 104.34 9.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.464 -0.772 . . . . 0.0 110.444 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 577' ' ' PHE . 87.6 mt -83.54 103.99 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 109.276 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -83.51 -45.29 13.75 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.482 -0.761 . . . . 0.0 109.211 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.423 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 4.8 m-20 -111.62 140.98 45.78 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.777 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 5.6 p -114.66 96.17 5.61 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 701' ' ' GLY . 70.3 m -78.65 -92.64 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.883 -0.511 . . . . 0.0 110.84 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 700' ' ' THR . . . -114.09 44.28 1.53 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.724 ' O ' HD22 ' A' ' 644' ' ' LEU . 1.6 tp -90.72 145.72 24.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.587 -0.949 . . . . 0.0 110.436 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.768 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.5 p90 -53.35 -23.04 8.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.531 -0.731 . . . . 0.0 110.636 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.577 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.3 t30 . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.464 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 4.1 mmm-85 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.36 0.6 . . . . 0.0 111.945 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.412 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 27.7 m -107.89 151.77 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.447 -0.783 . . . . 0.0 109.431 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.747 HG13 ' SD ' ' A' ' 664' ' ' MET . 78.9 t -89.31 133.42 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.185 -0.947 . . . . 0.0 110.498 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.9 mp -107.77 162.35 14.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 109.954 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.97 147.5 26.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 110.273 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -80.02 152.82 29.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.31 -0.869 . . . . 0.0 110.301 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 75.6 p -121.08 -177.54 3.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.273 -0.892 . . . . 0.0 110.364 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.99 -35.72 67.1 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.422 -0.799 . . . . 0.0 110.146 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . 0.615 ' O ' HD23 ' A' ' 726' ' ' LEU . 0.7 OUTLIER -65.36 -44.93 86.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 0.0 110.022 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.49 ' HA ' HD21 ' A' ' 726' ' ' LEU . 7.1 mt-10 -63.02 -48.73 77.51 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.441 -0.787 . . . . 0.0 109.984 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.47 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 22.4 mtpp -63.04 -32.23 73.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.398 -0.813 . . . . 0.0 111.072 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -61.56 -50.81 71.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.247 -0.908 . . . . 0.0 112.46 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 722' ' ' GLU . 0.4 OUTLIER -68.43 -32.73 72.97 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.732 -1.23 . . . . 0.0 110.803 -179.062 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.599 HG22 ' CG1' ' A' ' 621' ' ' VAL . 12.6 p -83.87 -18.48 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.054 . . . . 0.0 110.073 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -53.34 -45.37 69.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 108.889 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.5 103.53 10.52 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.193 0.997 . . . . 0.0 109.021 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.646 HD23 ' CG ' ' A' ' 602' ' ' PHE . 1.6 mt . . . . . 0 C--N 1.273 -2.746 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.415 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 121.687 0.756 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.566 ' HB3' ' CA ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -91.02 -43.79 9.72 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.96 0.886 . . . . 0.0 108.898 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.909 HD22 HD12 ' A' ' 594' ' ' ILE . 9.0 tt -121.43 125.33 46.65 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.086 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 25.2 m -103.6 116.63 32.71 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.732 ' HG ' HD21 ' A' ' 578' ' ' LEU . 5.4 mt -91.49 112.25 24.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.578 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.1 OUTLIER -114.65 104.26 54.44 Favored Pre-proline 0 C--N 1.298 -1.645 0 C-N-CA 118.386 -1.326 . . . . 0.0 113.128 -177.268 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 1.085 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.4 Cg_endo -76.33 142.1 23.63 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 N-CA-C 105.221 -2.646 . . . . 0.0 105.221 174.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.765 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -125.97 -173.91 0.32 Allowed Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 117.916 -1.514 . . . . 0.0 113.87 -175.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.765 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.2 Cg_endo -66.41 -34.17 35.34 Favored 'Trans proline' 0 N--CA 1.487 1.142 0 O-C-N 124.169 1.615 . . . . 0.0 111.322 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.88 -30.63 67.91 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.636 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 88.9 p -97.74 153.49 18.23 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.544 HG22 ' CD1' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -62.41 -9.75 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.982 -1.074 . . . . 0.0 109.969 179.21 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.799 HD12 ' HA ' ' A' ' 613' ' ' ILE . 10.1 mm -97.85 116.36 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.274 -0.891 . . . . 0.0 109.626 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.61 ' NE2' ' O ' ' A' ' 586' ' ' SER . 16.3 mp0 -118.53 71.87 0.85 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.659 -1.276 . . . . 0.0 109.713 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 1.085 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 42.5 mt-10 -144.48 174.63 10.77 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.941 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.578 ' HB3' ' HG2' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.54 128.27 40.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.005 -1.06 . . . . 0.0 109.487 176.483 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.729 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.8 mm? -111.2 152.26 27.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.976 . . . . 0.0 109.343 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -124.7 110.77 14.79 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.517 -0.74 . . . . 0.0 110.578 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.909 HD12 HD22 ' A' ' 578' ' ' LEU . 40.6 mt -82.18 109.12 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.072 -1.018 . . . . 0.0 109.272 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -62.46 110.38 1.66 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.423 -0.798 . . . . 0.0 108.963 179.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.566 ' CA ' ' HB3' ' A' ' 577' ' ' PHE . 1.9 pt20 -19.11 85.4 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 121.396 0.617 . . . . 0.0 112.03 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 124.98 10.27 4.82 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.366 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.697 HG12 HG23 ' A' ' 594' ' ' ILE . 0.9 OUTLIER -83.96 102.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-O 123.112 1.434 . . . . 0.0 107.57 178.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.2 OUTLIER -144.52 138.78 14.91 Favored Pre-proline 0 C--N 1.281 -2.384 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.808 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.582 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 51.9 Cg_endo -90.94 163.44 30.41 Favored 'Cis proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.564 -1.848 . . . . 0.0 108.817 -1.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.589 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 4.1 t80 -104.42 116.0 31.35 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.624 ' CG ' HD23 ' A' ' 730' ' ' LEU . 33.0 m-85 -83.82 144.17 29.45 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.478 -0.764 . . . . 0.0 110.303 -178.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.89 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.7 mt -142.19 142.12 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.653 -0.655 . . . . 0.0 110.036 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.764 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 168.43 -162.97 36.76 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.807 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 13.7 tpt180 -70.36 -42.4 71.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.768 -0.842 . . . . 0.0 110.863 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.83 123.34 26.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.742 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.446 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 14.3 tt0 -53.34 -17.77 2.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 110.247 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.47 -31.49 1.77 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.316 -0.865 . . . . 0.0 108.967 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.5 m -68.05 132.74 47.8 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.589 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.0 OUTLIER -46.77 -26.65 0.99 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.292 -0.88 . . . . 0.0 109.945 179.555 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.89 ' HB3' HG23 ' A' ' 603' ' ' ILE . 3.3 t -106.97 143.55 34.89 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.446 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -109.45 127.88 54.74 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 119.288 -0.965 . . . . 0.0 113.17 -178.363 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.799 ' HA ' HD12 ' A' ' 588' ' ' ILE . 29.3 mt -142.63 108.49 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.416 ' H ' HD12 ' A' ' 588' ' ' ILE . 4.5 tt0 -90.46 103.54 16.21 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 118.124 -1.43 . . . . 0.0 108.484 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 0.7 OUTLIER -139.15 106.11 5.43 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.692 178.163 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -43.68 -44.65 6.58 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.548 -0.72 . . . . 0.0 112.077 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.53 -17.33 42.2 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.168 -0.958 . . . . 0.0 111.855 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.598 HD11 HG21 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -76.46 122.31 24.35 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.037 -1.039 . . . . 0.0 110.506 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -57.84 158.99 5.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.306 -0.871 . . . . 0.0 110.927 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.764 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -64.09 -45.17 89.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.222 -0.924 . . . . 0.0 109.366 179.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.521 ' CG1' HG22 ' A' ' 727' ' ' VAL . 4.3 t -95.33 1.78 10.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.892 0.853 . . . . 0.0 109.347 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.733 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.4 t60 -28.37 -46.38 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.645 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.719 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.04 145.86 44.53 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 117.985 -1.486 . . . . 0.0 112.08 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.531 ' CZ ' ' CB ' ' A' ' 650' ' ' CYS . 9.7 p90 -145.91 139.63 26.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.791 -0.568 . . . . 0.0 109.554 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.708 ' CD1' HD11 ' A' ' 580' ' ' LEU . 82.7 mt -102.83 117.72 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.435 ' CE1' ' O ' ' A' ' 627' ' ' LYS . 6.6 t80 -109.97 154.75 22.7 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.734 0.778 . . . . 0.0 109.914 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.435 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 11.1 ttmt -118.47 136.12 53.98 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.573 0.702 . . . . 0.0 110.1 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.7 OUTLIER -129.75 163.54 25.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.659 -0.651 . . . . 0.0 110.238 -179.193 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.5 tpt180 -78.22 121.81 24.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.073 -1.017 . . . . 0.0 108.75 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.522 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 4.8 t60 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.416 -0.803 . . . . 0.0 110.656 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.852 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.3 mp . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.8 m-20 -119.08 124.22 46.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.088 -1.007 . . . . 0.0 111.241 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.697 ' OD2' HD21 ' A' ' 671' ' ' LEU . 18.2 t0 -101.84 156.18 17.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.597 -0.689 . . . . 0.0 109.57 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.446 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 11.7 pt -109.87 128.84 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.187 -0.945 . . . . 0.0 110.3 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.619 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 97.0 m95 -117.8 123.16 45.28 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.137 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.744 ' HB2' HD11 ' A' ' 672' ' ' LEU . 8.9 t80 -81.11 117.01 21.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 668' ' ' THR . 89.0 m -109.14 103.3 12.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.972 . . . . 0.0 111.818 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.529 ' CD2' ' N ' ' A' ' 652' ' ' THR . 13.3 t60 -66.73 159.23 28.3 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.402 -0.811 . . . . 0.0 109.781 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.733 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -152.13 -28.85 0.17 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.38 -0.825 . . . . 0.0 113.008 -179.295 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.534 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.47 -167.91 32.51 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 117.678 -2.201 . . . . 0.0 109.535 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 26.2 m -93.35 -18.76 22.03 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.964 -1.315 . . . . 0.0 113.818 -176.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.507 ' C ' HG23 ' A' ' 656' ' ' VAL . 23.9 m120 -59.43 -4.27 0.57 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.669 -1.27 . . . . 0.0 112.359 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.507 HG23 ' C ' ' A' ' 655' ' ' ASN . 3.1 t 69.76 147.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.655 -0.653 . . . . 0.0 110.343 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.507 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -101.69 149.42 24.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.698 -0.626 . . . . 0.0 110.686 -179.012 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -136.83 126.37 25.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 110.441 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.961 ' CD2' HG22 ' A' ' 678' ' ' ILE . 1.0 OUTLIER -128.13 106.72 9.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.394 -0.816 . . . . 0.0 109.79 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.0 t30 63.52 -74.22 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.525 -0.735 . . . . 0.0 110.593 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 659' ' ' LEU . 10.7 m120 -153.1 23.95 0.55 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.208 -0.933 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.67 120.99 43.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.304 -0.873 . . . . 0.0 110.238 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.65 131.07 34.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.412 -0.805 . . . . 0.0 110.002 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.445 ' O ' HG13 ' A' ' 656' ' ' VAL . 2.7 mtp -111.17 -165.25 0.97 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.413 -0.804 . . . . 0.0 110.424 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.66 ' CG1' HG23 ' A' ' 668' ' ' THR . 2.1 pt -137.44 -164.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.378 -0.826 . . . . 0.0 110.324 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -80.79 82.35 6.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.374 -0.829 . . . . 0.0 110.522 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 120.43 55.59 0.24 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.66 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.2 OUTLIER -121.97 147.05 46.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.192 -1.181 . . . . 0.0 109.986 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.486 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 2.8 tttm -108.61 140.21 42.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.61 -0.681 . . . . 0.0 109.188 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.56 ' CD2' HD12 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -144.31 142.89 30.71 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.101 -1.0 . . . . 0.0 111.418 -178.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.697 HD21 ' OD2' ' A' ' 646' ' ' ASP . 0.4 OUTLIER -69.96 146.72 50.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.428 -0.795 . . . . 0.0 110.47 179.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.744 HD11 ' HB2' ' A' ' 649' ' ' TYR . 12.2 mt -119.08 108.98 15.38 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.148 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -84.8 -176.98 6.46 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -73.03 141.85 47.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.192 -0.942 . . . . 0.0 109.538 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.33 47.48 43.43 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 107.596 -2.201 . . . . 0.0 107.596 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.405 ' HB2' ' CG1' ' A' ' 694' ' ' VAL . 0.1 OUTLIER -103.28 91.81 4.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.956 -0.732 . . . . 0.0 110.302 -179.008 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.979 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 2.4 tt0 -93.61 108.33 20.06 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.961 HG22 ' CD2' ' A' ' 659' ' ' LEU . 11.8 pt -105.69 137.66 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.644 -0.66 . . . . 0.0 111.868 -177.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -99.92 110.5 22.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.563 -0.711 . . . . 0.0 109.341 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.719 HD13 ' SG ' ' A' ' 623' ' ' CYS . 66.3 mt -81.92 -34.01 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.297 -0.877 . . . . 0.0 110.586 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.585 HD12 ' HB2' ' A' ' 618' ' ' LEU . 0.1 OUTLIER -126.9 136.12 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.325 -0.859 . . . . 0.0 109.587 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -137.66 118.64 14.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.249 -0.907 . . . . 0.0 110.659 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.99 117.83 20.67 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.282 -0.886 . . . . 0.0 110.055 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -47.36 71.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.412 -0.805 . . . . 0.0 111.408 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -84.72 -43.49 14.24 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.213 -0.929 . . . . 0.0 111.079 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.6 -7.69 55.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.308 -0.87 . . . . 0.0 110.742 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.93 19.51 3.64 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.117 -0.989 . . . . 0.0 110.364 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.83 86.86 5.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.242 -0.911 . . . . 0.0 109.102 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 681' ' ' ILE . 9.3 p -116.61 141.83 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.41 -0.806 . . . . 0.0 110.572 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.636 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 42.9 mm -118.95 164.35 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.338 -0.851 . . . . 0.0 109.653 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.459 ' N ' ' CB ' ' A' ' 586' ' ' SER . . . -175.31 126.09 1.14 Allowed Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.979 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 10.1 m-85 -119.5 137.3 53.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.56 -0.965 . . . . 0.0 108.674 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 12.4 tptt -97.91 113.8 25.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.225 -0.922 . . . . 0.0 110.459 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -85.27 112.53 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.052 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.42 104.67 9.23 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.168 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 577' ' ' PHE . 57.3 mt -79.54 103.21 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.376 -0.827 . . . . 0.0 109.576 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.2 -45.25 20.25 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.457 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 3.4 m-20 -111.12 141.56 44.47 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.735 -0.603 . . . . 0.0 109.895 178.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 20.6 p -113.95 95.79 5.49 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.96 133.52 52.99 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.026 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.41 26.05 28.93 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.757 ' O ' HD22 ' A' ' 644' ' ' LEU . 0.2 OUTLIER -102.85 124.88 49.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.569 -0.96 . . . . 0.0 109.976 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.852 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.4 p90 -48.09 -24.56 1.14 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.384 -0.822 . . . . 0.0 110.197 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.643 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.9 OUTLIER . . . . . 0 C--N 1.303 -1.442 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.51 ' NH1' HD13 ' A' ' 659' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.287 0.565 . . . . 0.0 111.626 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.451 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 31.4 m -107.83 150.85 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 109.509 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.436 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 61.6 t -97.52 133.07 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.215 -0.928 . . . . 0.0 110.643 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.3 mp -110.12 162.51 14.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.498 -0.751 . . . . 0.0 109.85 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.18 145.32 28.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.195 -0.941 . . . . 0.0 110.17 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -80.64 150.21 29.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.33 -0.856 . . . . 0.0 110.18 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 17.0 p -113.73 -176.7 2.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.322 -0.861 . . . . 0.0 110.397 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.92 -32.99 55.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.385 -0.822 . . . . 0.0 110.364 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . 0.588 ' O ' HD23 ' A' ' 726' ' ' LEU . 2.7 tt0 -66.59 -46.74 74.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.353 -0.842 . . . . 0.0 109.977 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.609 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.5 OUTLIER -62.78 -48.39 79.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.481 -0.762 . . . . 0.0 109.903 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.452 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 8.5 tttp -62.96 -31.61 72.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.447 -0.783 . . . . 0.0 110.468 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.48 -50.45 73.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.372 -0.83 . . . . 0.0 112.238 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.588 HD23 ' O ' ' A' ' 722' ' ' GLU . 0.3 OUTLIER -72.32 -36.32 68.83 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.921 -1.112 . . . . 0.0 111.415 -178.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.609 HG12 ' O ' ' A' ' 723' ' ' GLU . 7.2 p -81.31 -17.85 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.881 -1.137 . . . . 0.0 110.441 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -47.46 75.26 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.107 -0.996 . . . . 0.0 108.866 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.37 103.92 10.94 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.335 1.064 . . . . 0.0 109.01 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.624 HD23 ' CG ' ' A' ' 602' ' ' PHE . 1.8 mt . . . . . 0 C--N 1.273 -2.729 0 CA-C-O 117.984 -1.007 . . . . 0.0 110.366 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.2 OUTLIER -102.65 -40.23 6.71 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.915 0.864 . . . . 0.0 109.502 -179.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 1.036 HD22 HD12 ' A' ' 594' ' ' ILE . 9.8 tt -116.7 124.5 49.84 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.246 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 25.5 m -108.58 116.88 32.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -0.852 . . . . 0.0 109.944 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.782 HD21 HG23 ' A' ' 694' ' ' VAL . 1.8 mt -95.71 112.83 24.46 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.497 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -109.62 104.58 55.67 Favored Pre-proline 0 C--N 1.299 -1.612 0 C-N-CA 118.496 -1.282 . . . . 0.0 113.071 -177.278 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 1.026 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 44.8 Cg_endo -76.09 142.02 24.24 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 N-CA-C 106.295 -2.233 . . . . 0.0 106.295 175.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 1.047 ' HB2' ' HD2' ' A' ' 584' ' ' PRO . 0.2 OUTLIER -127.59 -171.69 0.24 Allowed Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 120.991 -1.068 . . . . 0.0 112.743 -176.276 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 1.047 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 36.4 Cg_endo -61.86 -31.29 85.0 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.859 1.452 . . . . 0.0 110.631 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . 0.436 ' OD1' HD12 ' A' ' 583' ' ' LEU . 3.3 m-20 -59.34 -26.62 65.2 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.481 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 19.1 t -96.56 153.38 17.88 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.532 HD13 ' HA ' ' A' ' 615' ' ' ASP . 13.8 tt -62.94 -15.89 16.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.703 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.937 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.0 OUTLIER -109.72 120.95 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.415 -0.803 . . . . 0.0 110.533 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 586' ' ' SER . 24.9 mp0 -107.25 79.94 1.36 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.578 -1.326 . . . . 0.0 108.728 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 1.026 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.6 mm-40 -141.52 176.61 8.75 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.36 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.576 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.38 127.21 42.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.31 -0.869 . . . . 0.0 108.859 176.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.526 HD12 ' HB3' ' A' ' 580' ' ' LEU . 0.6 OUTLIER -104.0 148.87 25.71 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.149 -0.97 . . . . 0.0 110.147 -179.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -124.68 109.99 13.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.488 -0.757 . . . . 0.0 110.658 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 1.036 HD12 HD22 ' A' ' 578' ' ' LEU . 44.2 mt -86.0 112.47 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 108.493 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.525 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -67.07 104.98 1.54 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.678 -0.638 . . . . 0.0 112.522 -177.67 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.744 ' CD ' HG21 ' A' ' 700' ' ' THR . 0.0 OUTLIER 16.84 57.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 178.341 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 113.3 39.61 1.11 Allowed Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.592 -1.29 . . . . 0.0 111.197 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.644 HG12 ' O ' ' A' ' 598' ' ' VAL . 1.2 t -79.82 103.58 6.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.43 ' O ' ' OD1' ' A' ' 599' ' ' ASN . 0.3 OUTLIER -141.37 140.16 20.21 Favored Pre-proline 0 C--N 1.282 -2.339 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.499 -178.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.469 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.2 Cg_endo -88.61 161.06 41.71 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.728 -2.197 . . . . 0.0 108.88 -0.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.549 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.1 t80 -106.35 116.17 31.47 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.716 ' C ' ' HB2' ' A' ' 609' ' ' CYS . 32.1 m-85 -92.35 144.59 25.23 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.29 -0.881 . . . . 0.0 110.702 -178.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.834 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -135.68 142.47 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.644 -0.66 . . . . 0.0 110.079 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.649 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 170.82 -168.67 41.77 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.737 -1.221 . . . . 0.0 110.783 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 13.9 mmm-85 -70.0 -44.95 68.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.69 -0.888 . . . . 0.0 110.673 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.502 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -75.01 119.63 19.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 110.125 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 608' ' ' ASP . 12.8 pt-20 -48.53 -18.9 0.28 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.316 -0.865 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 607' ' ' GLU . 0.9 OUTLIER -42.48 -37.87 1.75 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.321 -0.862 . . . . 0.0 109.318 179.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.716 ' HB2' ' C ' ' A' ' 602' ' ' PHE . 23.0 p -68.73 128.21 35.82 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.549 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -43.66 -24.6 0.13 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.562 -0.711 . . . . 0.0 111.897 -178.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.834 ' HB3' HG23 ' A' ' 603' ' ' ILE . 9.0 t -108.57 142.64 38.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.351 -0.843 . . . . 0.0 109.593 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.515 ' C ' HD13 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -113.53 130.61 56.31 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.909 -1.119 . . . . 0.0 112.584 -178.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 613' ' ' ILE . 13.7 tt -145.09 109.26 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.451 ' O ' HD13 ' A' ' 587' ' ' ILE . 6.2 mm-40 -84.48 100.98 11.7 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 116.844 -1.942 . . . . 0.0 108.087 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.719 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 27.7 t0 -139.96 105.01 4.99 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.335 177.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.48 -67.96 0.18 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.506 -0.746 . . . . 0.0 112.746 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -16.58 25.62 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.174 -0.954 . . . . 0.0 111.839 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.719 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -72.84 124.32 25.16 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.077 -1.014 . . . . 0.0 111.02 -179.006 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.502 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -69.8 161.71 29.29 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.384 -0.823 . . . . 0.0 110.639 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.649 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 31.9 mtm105 -63.88 -45.17 90.58 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 122.087 0.946 . . . . 0.0 109.126 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.621 HG13 HD11 ' A' ' 730' ' ' LEU . 21.8 m -95.77 2.29 9.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 121.639 0.733 . . . . 0.0 109.422 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.755 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.3 t60 -29.86 -47.97 0.08 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.937 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.809 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -136.82 144.93 43.92 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 118.492 -1.283 . . . . 0.0 110.964 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.529 ' CZ ' ' CB ' ' A' ' 650' ' ' CYS . 8.4 p90 -145.87 141.44 27.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.506 -0.746 . . . . 0.0 110.053 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.6 HG13 HD11 ' A' ' 603' ' ' ILE . 71.5 mt -103.41 118.7 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 9.0 t80 -108.89 154.98 21.36 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.533 -0.729 . . . . 0.0 109.463 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.421 ' HB3' ' CB ' ' A' ' 599' ' ' ASN . 8.4 tttt -119.25 136.62 54.14 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.571 0.701 . . . . 0.0 110.379 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.453 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.23 163.97 29.15 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.749 -0.595 . . . . 0.0 110.421 -179.219 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.582 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.0 OUTLIER -77.78 124.97 28.64 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.564 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.897 0.856 . . . . 0.0 111.312 -177.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.719 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.1 mp . . . . . 0 N--CA 1.486 1.344 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.92 124.07 51.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.991 -1.068 . . . . 0.0 111.054 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -109.22 156.07 20.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.454 -0.779 . . . . 0.0 110.043 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.583 HD13 ' CD1' ' A' ' 578' ' ' LEU . 11.2 pt -111.06 128.92 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.271 -0.893 . . . . 0.0 109.633 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.977 ' CH2' HD22 ' A' ' 671' ' ' LEU . 99.0 m95 -114.29 120.09 39.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.724 -0.61 . . . . 0.0 111.539 -178.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.797 ' HB2' HD11 ' A' ' 672' ' ' LEU . 18.5 t80 -82.17 114.09 20.45 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.529 ' CB ' ' CZ ' ' A' ' 624' ' ' PHE . 62.2 m -109.54 102.27 11.14 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.145 -0.972 . . . . 0.0 111.399 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.613 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 12.1 t60 -69.0 160.39 31.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.461 -0.775 . . . . 0.0 109.918 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.755 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.37 -31.09 0.17 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.424 -0.797 . . . . 0.0 113.112 -178.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.613 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -78.53 134.91 14.77 Favored Glycine 0 N--CA 1.502 3.087 0 C-N-CA 117.801 -2.143 . . . . 0.0 110.253 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 26.7 m -34.45 -24.87 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -177.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.682 ' C ' HG13 ' A' ' 656' ' ' VAL . 10.0 m120 -59.23 -3.02 0.34 Allowed 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.346 -1.472 . . . . 0.0 113.123 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.682 HG13 ' C ' ' A' ' 655' ' ' ASN . 0.8 OUTLIER 62.14 145.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.509 -0.745 . . . . 0.0 110.259 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.55 ' OG ' ' HB2' ' A' ' 664' ' ' MET . 0.0 OUTLIER -93.98 151.36 19.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.555 -0.716 . . . . 0.0 110.495 -179.199 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.454 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 14.5 m-85 -135.1 125.78 27.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 109.929 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.614 ' CG ' HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -134.56 113.94 12.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.25 -0.907 . . . . 0.0 110.18 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 54.19 -88.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.482 -0.761 . . . . 0.0 110.773 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.3 m120 -136.71 18.25 3.07 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.066 -1.021 . . . . 0.0 110.509 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -111.85 116.77 31.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.924 . . . . 0.0 110.444 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -94.08 138.19 32.43 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.475 -0.765 . . . . 0.0 109.815 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.712 ' SD ' HG13 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -117.08 -159.44 0.73 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.893 . . . . 0.0 109.884 -179.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.662 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.7 pt -133.43 -171.69 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.246 -0.909 . . . . 0.0 110.372 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -74.27 70.06 1.62 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.351 -0.843 . . . . 0.0 110.452 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 133.13 55.77 0.08 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.662 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.0 OUTLIER -123.09 150.57 43.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.255 -1.144 . . . . 0.0 110.307 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.438 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 1.1 ttpm? -108.84 146.66 33.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.579 -0.701 . . . . 0.0 109.178 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.54 ' HD2' HD13 ' A' ' 659' ' ' LEU . 3.5 t80 -145.05 146.28 31.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 111.915 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.977 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.68 130.55 42.66 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.546 -0.721 . . . . 0.0 109.497 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.797 HD11 ' HB2' ' A' ' 649' ' ' TYR . 1.7 mt -104.61 118.75 37.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.081 -1.012 . . . . 0.0 111.26 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 674' ' ' ASP . 78.4 mt-30 -106.94 138.99 42.06 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 673' ' ' GLN . 6.2 p-10 -36.69 146.19 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.268 -0.895 . . . . 0.0 110.921 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 73.13 48.76 18.6 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.413 ' OD1' HD21 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -106.77 92.54 4.14 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.839 -0.8 . . . . 0.0 110.883 -178.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.25 106.49 18.45 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.023 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.614 HG22 ' CG ' ' A' ' 659' ' ' LEU . 5.0 pt -115.25 135.61 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.541 -0.724 . . . . 0.0 111.715 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.39 110.57 22.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.518 -0.739 . . . . 0.0 109.106 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.809 HD13 ' SG ' ' A' ' 623' ' ' CYS . 72.1 mt -72.4 -46.18 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.369 -0.832 . . . . 0.0 110.19 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.594 HD12 ' CG ' ' A' ' 615' ' ' ASP . 9.8 mt -126.81 133.59 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -0.845 . . . . 0.0 109.874 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -137.67 113.09 9.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 110.391 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -130.35 118.12 20.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.307 -0.87 . . . . 0.0 110.057 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -46.13 78.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.427 -0.796 . . . . 0.0 110.998 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.26 -43.02 82.91 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.31 -0.869 . . . . 0.0 110.75 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -90.47 -2.49 57.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.253 -0.904 . . . . 0.0 110.824 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.21 21.22 2.96 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.127 -0.983 . . . . 0.0 110.531 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.26 78.73 4.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.891 . . . . 0.0 109.084 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 586' ' ' SER . 39.5 t -101.69 131.47 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.557 -0.715 . . . . 0.0 110.682 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.647 ' CG2' HD11 ' A' ' 613' ' ' ILE . 49.7 mm -112.0 164.25 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.343 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 179.95 116.33 0.51 Allowed Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.417 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.916 ' CZ ' HG21 ' A' ' 588' ' ' ILE . 12.1 m-85 -119.5 137.32 53.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.251 -1.146 . . . . 0.0 108.484 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -107.98 114.75 28.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 111.209 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.782 HG23 HD21 ' A' ' 580' ' ' LEU . 0.8 OUTLIER -81.33 123.68 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.455 -0.778 . . . . 0.0 109.021 179.02 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -129.95 104.82 7.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.542 -0.724 . . . . 0.0 110.119 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 71.7 mt -84.35 103.95 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.366 -0.834 . . . . 0.0 109.851 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -81.78 -42.9 19.08 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.6 OUTLIER -110.7 140.29 45.21 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.682 -0.637 . . . . 0.0 110.249 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 6.6 p -114.7 96.09 5.56 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.744 HG21 ' CD ' ' A' ' 596' ' ' GLN . 4.6 p -97.07 105.42 17.56 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.298 0.57 . . . . 0.0 111.144 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 49.42 27.53 8.31 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.858 HD23 ' O ' ' A' ' 704' ' ' ASN . 0.5 OUTLIER -82.24 147.02 29.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.387 -1.066 . . . . 0.0 110.28 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.719 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.5 p90 -52.62 -23.55 6.73 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.43 -0.794 . . . . 0.0 110.292 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.858 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.6 t30 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.447 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 3.4 mmm-85 . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 121.434 0.635 . . . . 0.0 110.584 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 27.7 m -106.09 149.26 9.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.712 HG13 ' SD ' ' A' ' 664' ' ' MET . 89.3 t -78.63 133.12 30.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 111.041 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.35 162.2 13.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.519 -0.738 . . . . 0.0 109.782 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -100.11 152.95 19.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.943 . . . . 0.0 110.135 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -79.87 154.18 28.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.83 . . . . 0.0 110.263 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.6 p -120.29 -176.99 3.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.35 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.09 -28.95 56.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.318 -0.864 . . . . 0.0 110.241 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . 0.446 ' O ' HD13 ' A' ' 726' ' ' LEU . 0.0 OUTLIER -68.22 -52.51 33.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.49 -0.756 . . . . 0.0 110.077 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -63.44 -37.75 88.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.352 -0.843 . . . . 0.0 109.771 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.532 ' O ' HG12 ' A' ' 727' ' ' VAL . 13.1 tttm -58.44 -32.47 68.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.408 -0.807 . . . . 0.0 109.816 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.0 -39.21 79.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.459 -0.775 . . . . 0.0 110.341 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 722' ' ' GLU . 10.9 mp -55.75 -47.55 76.78 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.308 -0.87 . . . . 0.0 110.638 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 724' ' ' LYS . 8.8 p -69.98 -22.16 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.069 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -54.73 -50.37 68.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 109.048 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -116.53 103.46 10.44 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 122.241 1.02 . . . . 0.0 109.341 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.621 HD11 HG13 ' A' ' 621' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.273 -2.736 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.212 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 121.653 0.74 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.495 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 4.7 t80 -98.71 -42.77 7.07 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.953 0.882 . . . . 0.0 109.516 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.863 HD23 HD12 ' A' ' 594' ' ' ILE . 49.6 tp -123.3 120.35 32.83 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.606 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 85.5 m -101.17 116.81 33.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 1.045 HD11 HD12 ' A' ' 625' ' ' ILE . 4.3 mt -88.45 112.58 23.11 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.07 101.56 54.54 Favored Pre-proline 0 C--N 1.301 -1.505 0 C-N-CA 117.911 -1.516 . . . . 0.0 113.01 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 1.156 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.1 Cg_endo -82.13 145.18 13.68 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 N-CA-C 106.017 -2.34 . . . . 0.0 106.017 173.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.703 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.33 -178.73 0.66 Allowed Pre-proline 0 N--CA 1.498 1.971 0 C-N-CA 118.207 -1.397 . . . . 0.0 114.166 -176.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.703 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.1 Cg_endo -67.6 -28.54 37.73 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 124.322 1.696 . . . . 0.0 111.965 -178.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -58.6 -30.96 67.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.681 -1.262 . . . . 0.0 107.609 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.51 ' HB3' ' N ' ' A' ' 691' ' ' GLY . 3.3 p -97.88 153.85 18.04 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.457 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.4 OUTLIER -57.17 -16.09 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.97 -1.081 . . . . 0.0 109.437 179.255 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.856 HD12 ' HA ' ' A' ' 613' ' ' ILE . 9.9 mm -97.1 114.59 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.285 -0.884 . . . . 0.0 108.739 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -126.75 73.96 1.44 Allowed 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.583 -1.323 . . . . 0.0 110.014 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 1.156 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 66.4 mm-40 -143.95 174.46 10.82 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.198 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.456 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.6 125.91 39.17 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.794 -1.191 . . . . 0.0 109.565 176.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.662 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.0 OUTLIER -109.34 155.43 21.21 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.284 -0.885 . . . . 0.0 109.626 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -125.02 109.99 13.63 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.363 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.863 HD12 HD23 ' A' ' 578' ' ' LEU . 4.4 mt -81.98 109.65 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.591 ' HB2' HG23 ' A' ' 598' ' ' VAL . 0.0 OUTLIER -53.01 174.47 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.504 -0.747 . . . . 0.0 109.952 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.495 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -62.0 65.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.47 -0.769 . . . . 0.0 110.854 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 125.62 34.16 0.67 Allowed Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.938 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 598' ' ' VAL . 1.2 t -79.62 103.17 6.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.4 t30 -143.18 134.68 12.82 Favored Pre-proline 0 C--N 1.283 -2.315 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.172 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.52 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 55.8 Cg_endo -91.47 161.35 28.16 Favored 'Cis proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.614 -1.828 . . . . 0.0 109.158 -1.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.487 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.8 t80 -107.08 116.65 32.3 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.745 ' C ' ' HB2' ' A' ' 609' ' ' CYS . 60.8 m-85 -89.63 144.98 25.57 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.375 -0.828 . . . . 0.0 110.786 -178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.831 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.2 mt -138.17 142.24 36.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.634 -0.666 . . . . 0.0 109.702 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 174.67 -161.24 30.84 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.415 -1.374 . . . . 0.0 111.111 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -76.26 -44.3 37.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.847 -0.796 . . . . 0.0 110.479 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.402 ' HB2' ' HG3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -80.5 123.27 27.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.277 -0.889 . . . . 0.0 110.413 -179.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 608' ' ' ASP . 10.1 pt-20 -48.18 -18.98 0.24 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.385 -0.822 . . . . 0.0 111.058 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 607' ' ' GLU . 2.2 t0 -40.76 -37.27 0.73 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.375 -0.828 . . . . 0.0 109.653 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.745 ' HB2' ' C ' ' A' ' 602' ' ' PHE . 18.0 p -73.43 133.6 43.76 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.487 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -44.58 -23.08 0.1 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.558 -0.713 . . . . 0.0 111.959 -178.691 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.831 ' HB3' HG23 ' A' ' 603' ' ' ILE . 10.7 t -110.08 143.63 39.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.316 -0.865 . . . . 0.0 109.743 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.7 125.61 52.09 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.003 -1.061 . . . . 0.0 113.122 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.856 ' HA ' HD12 ' A' ' 588' ' ' ILE . 10.7 mt -142.59 108.84 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -89.52 103.49 16.13 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 118.045 -1.462 . . . . 0.0 109.207 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.628 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 1.1 m-20 -139.37 106.45 5.46 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.348 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -43.15 -43.25 4.47 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.602 -0.686 . . . . 0.0 112.048 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -83.88 -17.52 40.57 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.017 -1.052 . . . . 0.0 111.905 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -77.27 133.96 38.68 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.056 -1.028 . . . . 0.0 110.834 -179.153 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.485 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.5 m -75.92 159.82 30.52 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.367 -0.833 . . . . 0.0 111.225 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.601 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 19.4 ttm105 -62.62 -44.48 96.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.361 -0.837 . . . . 0.0 109.219 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.756 ' HB ' HG23 ' A' ' 727' ' ' VAL . 27.4 m -94.65 1.81 9.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 121.761 0.791 . . . . 0.0 109.358 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.8 t60 -30.81 -48.22 0.11 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.718 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.827 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -136.5 144.89 44.56 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.579 -1.249 . . . . 0.0 110.826 178.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 650' ' ' CYS . 17.1 p90 -146.29 145.84 30.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.543 -0.723 . . . . 0.0 110.163 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 1.045 HD12 HD11 ' A' ' 580' ' ' LEU . 8.7 mt -103.2 122.37 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.432 ' HB2' ' HE2' ' A' ' 624' ' ' PHE . 3.5 t80 -117.63 154.9 30.79 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.543 -0.723 . . . . 0.0 109.462 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 10.1 tttt -119.72 136.19 54.53 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.77 0.795 . . . . 0.0 111.023 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.72 163.5 28.86 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.575 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -78.3 126.3 30.59 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.818 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 7.0 t60 . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.399 -0.813 . . . . 0.0 110.749 -179.039 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.751 HD12 ' N ' ' A' ' 703' ' ' PHE . 3.0 mm? . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.575 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 4.5 m-20 -130.19 132.53 46.06 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.035 -1.041 . . . . 0.0 111.306 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.588 ' OD1' HD21 ' A' ' 671' ' ' LEU . 2.2 t0 -127.26 143.24 51.28 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.229 -0.92 . . . . 0.0 110.538 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 12.7 pt -96.96 134.45 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.261 -0.9 . . . . 0.0 109.926 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.686 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.3 m95 -119.18 120.87 38.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.571 -0.706 . . . . 0.0 111.313 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.662 ' HB2' HD11 ' A' ' 672' ' ' LEU . 4.0 t80 -80.84 114.25 19.59 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 624' ' ' PHE . 38.5 m -108.57 108.62 19.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 111.117 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.587 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 12.1 t60 -74.21 161.7 29.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.572 -0.705 . . . . 0.0 110.362 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -151.11 -31.57 0.17 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.587 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -79.41 130.89 10.18 Favored Glycine 0 N--CA 1.501 2.983 0 O-C-N 119.232 -2.167 . . . . 0.0 110.342 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 656' ' ' VAL . 11.4 m -36.54 -24.24 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -177.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.545 ' O ' HG12 ' A' ' 656' ' ' VAL . 4.1 t-20 -56.01 -4.74 0.13 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.325 -1.484 . . . . 0.0 112.775 -178.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 77.69 166.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 CA-C-O 122.043 0.925 . . . . 0.0 110.734 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.479 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -126.84 150.9 48.99 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.045 -178.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -135.75 126.4 27.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.396 -0.815 . . . . 0.0 110.23 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.732 ' CD2' HG22 ' A' ' 678' ' ' ILE . 0.4 OUTLIER -127.36 108.95 11.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.305 -0.872 . . . . 0.0 109.679 179.487 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.9 m120 58.79 -81.34 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.426 -0.796 . . . . 0.0 110.195 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.9 OUTLIER -143.78 22.66 1.78 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.069 -1.019 . . . . 0.0 110.439 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -116.57 128.17 55.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.195 -0.941 . . . . 0.0 110.395 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -91.46 141.32 28.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.393 -0.817 . . . . 0.0 110.176 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.679 ' HG2' HG13 ' A' ' 716' ' ' VAL . 3.5 mtp -120.28 -172.96 2.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.401 -0.812 . . . . 0.0 110.208 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.567 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.1 pp -126.09 -169.94 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -0.87 . . . . 0.0 110.24 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -76.8 72.44 3.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.334 -0.854 . . . . 0.0 110.748 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 129.12 55.65 0.1 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.567 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.0 OUTLIER -122.17 151.76 40.64 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.281 -1.129 . . . . 0.0 110.296 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.597 ' HD3' HD13 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -108.85 139.03 44.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.264 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.657 ' CD1' HD13 ' A' ' 659' ' ' LEU . 8.5 t80 -143.56 146.36 33.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 111.268 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.686 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -73.88 146.98 43.66 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.614 -0.679 . . . . 0.0 110.778 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.761 HD13 HG21 ' A' ' 694' ' ' VAL . 10.2 mt -115.71 114.34 24.7 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.285 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -97.04 148.76 22.67 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.0 135.19 25.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.044 -1.035 . . . . 0.0 110.087 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 83.77 45.57 6.34 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 107.686 -2.166 . . . . 0.0 107.686 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.421 ' OD2' ' HA ' ' A' ' 672' ' ' LEU . 0.4 OUTLIER -109.85 93.5 4.53 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.802 -0.822 . . . . 0.0 110.444 -179.061 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.852 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 4.6 tt0 -93.35 107.47 19.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.732 HG22 ' CD2' ' A' ' 659' ' ' LEU . 4.1 pt -112.43 138.04 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.564 -0.71 . . . . 0.0 112.38 -176.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.22 113.58 26.76 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.827 HD13 ' SG ' ' A' ' 623' ' ' CYS . 85.0 mt -76.83 -30.66 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.172 -0.955 . . . . 0.0 110.51 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 618' ' ' LEU . 4.0 mt -138.64 134.93 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.269 -0.894 . . . . 0.0 110.047 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -137.38 108.84 6.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.539 -0.726 . . . . 0.0 110.104 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.59 118.39 33.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.32 -0.862 . . . . 0.0 110.221 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.04 -46.64 77.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.425 -0.797 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -84.6 -43.37 14.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.32 -0.863 . . . . 0.0 110.763 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -76.21 -10.09 59.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.333 -0.854 . . . . 0.0 110.662 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.76 20.2 4.95 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.111 -0.993 . . . . 0.0 110.433 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.407 ' CE2' ' HA ' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -82.3 75.15 9.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -0.885 . . . . 0.0 109.354 179.464 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 689' ' ' VAL . 10.8 p -103.16 131.65 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.387 -0.821 . . . . 0.0 111.054 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.566 HG23 HG12 ' A' ' 588' ' ' ILE . 36.3 mm -113.3 163.67 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.429 -0.795 . . . . 0.0 109.168 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.51 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . -167.79 120.29 0.89 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.198 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.852 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 7.7 m-85 -120.41 137.78 54.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.519 -0.989 . . . . 0.0 109.115 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -110.36 114.77 28.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.404 -0.81 . . . . 0.0 110.757 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.761 HG21 HD13 ' A' ' 672' ' ' LEU . 0.8 OUTLIER -75.67 119.97 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.478 -0.763 . . . . 0.0 109.084 179.227 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -129.68 103.95 7.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.438 -0.789 . . . . 0.0 110.143 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.551 ' CG1' HD13 ' A' ' 578' ' ' LEU . 60.0 mt -86.97 111.4 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -0.799 . . . . 0.0 109.734 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -81.28 -43.26 19.41 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.491 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.5 m-20 -111.65 140.56 46.18 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.555 0.693 . . . . 0.0 110.61 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 700' ' ' THR . 25.0 p -115.62 96.77 5.78 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . 0.611 HG23 ' H ' ' A' ' 702' ' ' LEU . 9.0 t -60.0 -147.52 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.138 0.494 . . . . 0.0 110.248 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 644' ' ' LEU . . . -67.86 -1.17 16.79 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.611 ' H ' HG23 ' A' ' 700' ' ' THR . 0.0 OUTLIER -47.03 144.46 2.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.287 -1.125 . . . . 0.0 111.15 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.751 ' N ' HD12 ' A' ' 644' ' ' LEU . 50.7 p90 -53.53 -27.62 26.85 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.137 0.97 . . . . 0.0 108.803 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.507 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 24.4 t30 . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 15.9 mmm-85 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.286 0.565 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.0 m -107.74 152.48 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.441 -0.787 . . . . 0.0 109.494 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.679 HG13 ' HG2' ' A' ' 664' ' ' MET . 57.7 t -89.4 121.5 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.16 -0.962 . . . . 0.0 110.543 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.597 HD13 ' HD3' ' A' ' 669' ' ' LYS . 3.1 mp -96.1 161.89 13.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.426 -0.796 . . . . 0.0 109.846 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.68 153.66 17.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.375 -0.828 . . . . 0.0 109.841 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -87.16 125.06 33.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.318 -0.864 . . . . 0.0 110.38 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 39.7 p -93.15 -176.31 4.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.376 -0.828 . . . . 0.0 110.124 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.44 -28.91 32.75 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.326 -0.859 . . . . 0.0 110.207 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.1 -52.17 63.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.377 -0.827 . . . . 0.0 109.858 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -48.65 75.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 0.0 109.975 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.505 ' O ' HG12 ' A' ' 727' ' ' VAL . 5.7 tttp -53.74 -32.17 51.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.386 -0.822 . . . . 0.0 110.123 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.28 -36.17 78.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.87 . . . . 0.0 110.242 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 42.1 mt -59.46 -46.33 89.09 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.346 -0.846 . . . . 0.0 110.245 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.756 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.1 p -71.77 -22.2 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.145 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.26 -47.69 68.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.895 . . . . 0.0 108.937 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -116.87 104.28 11.15 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.151 0.977 . . . . 0.0 109.235 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.274 -2.69 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.252 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.419 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 121.692 0.758 . . . . 0.0 109.515 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.495 ' HB3' ' HA ' ' A' ' 596' ' ' GLN . 3.4 t80 -106.29 -43.17 4.86 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.974 0.892 . . . . 0.0 109.46 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.738 HD23 HD12 ' A' ' 594' ' ' ILE . 31.4 tp -120.66 142.42 49.47 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.968 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 42.5 m -125.76 116.87 22.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.503 -0.748 . . . . 0.0 109.39 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.596 HD11 ' CD1' ' A' ' 625' ' ' ILE . 3.5 mt -95.13 112.08 23.83 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.416 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 1.6 mmtt -108.62 102.78 49.05 Favored Pre-proline 0 C--N 1.3 -1.586 0 C-N-CA 118.4 -1.32 . . . . 0.0 112.408 -177.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 1.052 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.8 Cg_endo -79.08 142.69 17.35 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 N-CA-C 106.547 -2.136 . . . . 0.0 106.547 175.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.794 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -128.05 -171.08 0.23 Allowed Pre-proline 0 C--N 1.297 -1.693 0 C-N-CA 118.501 -1.279 . . . . 0.0 112.79 -177.056 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.794 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 37.2 Cg_endo -63.58 -35.09 61.32 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 124.068 1.562 . . . . 0.0 110.815 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.99 -28.73 66.63 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.585 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 46.0 t -96.53 153.45 17.84 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.753 HG22 ' CD1' ' A' ' 690' ' ' ILE . 6.1 tp -63.53 -12.98 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.384 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.783 ' CG1' ' HA ' ' A' ' 613' ' ' ILE . 31.3 mm -100.97 120.29 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.369 -0.832 . . . . 0.0 109.838 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . 0.585 ' NE2' ' O ' ' A' ' 586' ' ' SER . 23.6 mp0 -115.98 68.27 0.72 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.55 -1.344 . . . . 0.0 109.307 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 1.052 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.5 mm-40 -143.97 176.85 8.98 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.593 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.524 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.19 125.77 41.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.194 -0.941 . . . . 0.0 108.859 176.576 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.732 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.9 mt -106.51 153.78 21.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.362 -0.836 . . . . 0.0 109.661 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.419 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 6.5 mp0 -125.99 110.12 13.22 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.308 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.738 HD12 HD23 ' A' ' 578' ' ' LEU . 1.7 mt -84.18 109.58 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.124 -0.985 . . . . 0.0 108.353 178.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.8 OUTLIER -51.66 172.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.655 -0.653 . . . . 0.0 109.869 -179.622 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.495 ' HA ' ' HB3' ' A' ' 577' ' ' PHE . 4.2 mt-30 -66.55 65.31 0.05 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.477 -0.764 . . . . 0.0 110.086 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 135.09 27.19 0.48 Allowed Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.611 -1.28 . . . . 0.0 110.988 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -80.08 102.23 5.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 627' ' ' LYS . 14.2 t-20 -144.3 133.45 11.33 Favored Pre-proline 0 C--N 1.282 -2.341 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.367 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.676 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 55.2 Cg_endo -91.96 162.86 26.92 Favored 'Cis proline' 0 C--N 1.311 -1.442 0 C-N-CA 123.086 -1.631 . . . . 0.0 108.891 -2.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.565 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 5.5 t80 -105.97 116.42 31.91 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.676 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 73.8 m-85 -84.96 144.83 28.07 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.323 -0.861 . . . . 0.0 110.977 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.88 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.8 mt -142.19 141.62 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.724 -0.61 . . . . 0.0 110.291 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.834 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 167.88 -167.58 40.16 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.331 -1.414 . . . . 0.0 111.306 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 8.0 tpt180 -63.01 -36.34 83.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.889 -0.771 . . . . 0.0 111.774 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.22 121.62 28.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.043 -1.036 . . . . 0.0 111.246 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.559 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 7.0 tm-20 -53.11 -19.06 2.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 110.02 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.55 -30.24 2.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.347 -0.846 . . . . 0.0 109.292 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 602' ' ' PHE . 4.7 m -69.06 136.37 52.25 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.496 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -47.82 -25.09 1.16 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.276 -0.89 . . . . 0.0 110.056 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.88 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.0 t -110.52 143.32 41.06 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.589 ' O ' HG13 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -106.93 127.23 53.26 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.099 -1.001 . . . . 0.0 112.682 -178.694 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.868 HG22 HD22 ' A' ' 618' ' ' LEU . 2.3 mt -144.01 108.99 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.536 ' H ' HD11 ' A' ' 588' ' ' ILE . 3.1 tt0 -97.79 104.48 16.51 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.302 -1.359 . . . . 0.0 108.916 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.573 ' HA ' ' CZ ' ' A' ' 688' ' ' PHE . 6.1 m-20 -138.41 106.1 5.61 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.531 177.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -43.32 -42.3 4.44 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.671 -0.643 . . . . 0.0 111.953 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -83.09 -17.16 44.08 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.096 -1.002 . . . . 0.0 111.098 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.868 HD22 HG22 ' A' ' 613' ' ' ILE . 0.5 OUTLIER -79.74 140.4 36.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.25 -0.906 . . . . 0.0 110.677 -179.335 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.435 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.89 161.83 28.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.274 -0.891 . . . . 0.0 110.794 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.809 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -64.22 -45.24 89.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.337 -0.852 . . . . 0.0 109.534 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 1.021 HG11 HG23 ' A' ' 727' ' ' VAL . 11.5 t -95.76 2.22 9.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.383 -0.823 . . . . 0.0 109.405 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.8 t60 -26.05 -47.12 0.02 OUTLIER 'General case' 0 C--O 1.194 -1.831 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.46 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.804 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.69 146.09 43.38 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 118.049 -1.46 . . . . 0.0 111.955 179.528 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.55 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 2.0 p90 -145.3 148.91 33.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.6 -0.688 . . . . 0.0 109.984 177.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.596 ' CD1' HD11 ' A' ' 580' ' ' LEU . 13.8 mt -103.72 124.41 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 6.0 t80 -117.32 155.24 29.87 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.481 -0.762 . . . . 0.0 109.386 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.49 ' NZ ' HG23 ' A' ' 647' ' ' ILE . 4.3 tppt? -119.73 137.06 54.17 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.604 0.716 . . . . 0.0 110.896 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.417 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -139.09 163.07 33.39 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.719 -0.613 . . . . 0.0 109.641 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -78.5 121.24 24.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.974 -1.079 . . . . 0.0 109.314 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.522 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.0 t60 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 111.07 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.588 ' CD1' ' HA ' ' A' ' 703' ' ' PHE . 2.9 mt . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.533 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.0 OUTLIER -112.83 124.9 53.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.963 -1.085 . . . . 0.0 111.061 -179.592 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.722 ' OD1' HD21 ' A' ' 671' ' ' LEU . 37.6 t0 -112.72 143.63 43.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 0.0 110.188 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.49 HG23 ' NZ ' ' A' ' 627' ' ' LYS . 8.5 pt -99.39 132.36 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.259 -0.9 . . . . 0.0 109.663 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.624 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.2 m95 -118.12 142.95 46.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.527 -0.733 . . . . 0.0 110.918 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.92 ' CB ' HD11 ' A' ' 672' ' ' LEU . 27.0 t80 -103.24 114.81 29.39 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.5 OUTLIER -104.06 102.63 12.38 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.641 -178.531 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.526 ' CD2' ' N ' ' A' ' 652' ' ' THR . 8.7 t60 -64.2 156.63 28.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.345 -0.847 . . . . 0.0 109.294 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -149.55 -28.22 0.26 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.364 -0.835 . . . . 0.0 112.543 -179.122 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.587 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.51 -163.82 27.26 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 117.943 -2.075 . . . . 0.0 109.724 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 25.2 m -96.93 -17.99 19.76 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.961 -1.317 . . . . 0.0 113.921 -176.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.691 ' C ' HG13 ' A' ' 656' ' ' VAL . 20.3 m120 -59.6 -2.96 0.4 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.774 -1.204 . . . . 0.0 112.591 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.691 HG13 ' C ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 63.38 138.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-O 121.69 0.757 . . . . 0.0 110.161 -179.332 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.449 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -91.48 142.73 27.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.653 -0.655 . . . . 0.0 110.685 -178.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.466 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 6.1 m-85 -132.42 126.55 33.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.354 -0.841 . . . . 0.0 110.496 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.694 HD21 ' OD2' ' A' ' 676' ' ' ASP . 0.0 OUTLIER -130.97 115.38 16.42 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.366 -0.834 . . . . 0.0 109.955 179.515 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.08 -81.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.391 -0.818 . . . . 0.0 110.343 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.7 OUTLIER -148.36 26.87 0.94 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.0 110.157 179.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -111.21 133.52 53.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.234 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.421 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 6.5 tmm_? -98.71 126.66 44.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.372 -0.83 . . . . 0.0 110.102 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.534 ' HG2' HG13 ' A' ' 716' ' ' VAL . 4.4 mtp -108.06 -167.73 1.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 110.345 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.637 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.7 pt -138.43 -164.22 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.352 -0.842 . . . . 0.0 110.279 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 652' ' ' THR . 51.5 tt0 -79.81 82.27 5.93 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.49 -0.756 . . . . 0.0 110.505 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.07 52.19 0.24 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.637 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.3 OUTLIER -121.15 148.3 44.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.018 -1.284 . . . . 0.0 110.111 179.678 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.42 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.3 ttpm? -108.31 141.34 40.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.492 -0.755 . . . . 0.0 109.456 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.451 ' HB2' ' CE ' ' A' ' 664' ' ' MET . 0.5 OUTLIER -144.42 146.72 32.65 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.49 -178.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.722 HD21 ' OD1' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -71.31 147.17 48.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.511 -0.743 . . . . 0.0 111.197 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.92 HD11 ' CB ' ' A' ' 649' ' ' TYR . 3.0 mp -113.45 104.98 12.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.637 -0.664 . . . . 0.0 111.5 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -88.47 151.04 22.81 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . 0.405 ' HB3' HD12 ' A' ' 696' ' ' ILE . 2.8 p30 -48.22 143.83 4.3 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.162 -0.961 . . . . 0.0 110.377 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.96 46.29 52.83 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 107.841 -2.104 . . . . 0.0 107.841 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.694 ' OD2' HD21 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -100.38 88.94 3.8 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.795 -0.826 . . . . 0.0 110.512 -179.14 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.788 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -93.41 107.08 18.98 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.627 HG21 HD11 ' A' ' 659' ' ' LEU . 1.8 pt -115.12 137.95 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.631 -0.668 . . . . 0.0 111.737 -176.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 7.2 mttp -96.89 111.23 23.52 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.804 HD13 ' SG ' ' A' ' 623' ' ' CYS . 73.1 mt -77.32 -11.76 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.299 -0.875 . . . . 0.0 110.64 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 688' ' ' PHE . 14.4 tt -143.2 133.87 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.074 -1.016 . . . . 0.0 110.158 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -138.11 111.69 8.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.149 -0.969 . . . . 0.0 110.738 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.3 117.15 19.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.233 -0.917 . . . . 0.0 109.86 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -46.93 72.71 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.361 -0.837 . . . . 0.0 110.954 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -66.94 -38.82 86.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.219 -0.925 . . . . 0.0 109.947 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . 0.58 ' O ' ' C ' ' A' ' 687' ' ' LYS . 1.5 m-80 -122.07 84.27 2.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.586 -0.696 . . . . 0.0 109.551 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . 0.58 ' C ' ' O ' ' A' ' 686' ' ' ASN . 23.4 mmtp -19.74 -82.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 122.054 -0.404 . . . . 0.0 111.335 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.573 ' CZ ' ' HA ' ' A' ' 615' ' ' ASP . 1.3 t80 33.8 73.41 0.07 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.504 -0.747 . . . . 0.0 110.099 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 586' ' ' SER . 58.6 t -112.21 143.14 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.459 -0.775 . . . . 0.0 111.49 -178.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.753 ' CD1' HG22 ' A' ' 587' ' ' ILE . 16.1 mm -103.46 164.65 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.443 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -177.12 115.8 0.52 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.001 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.788 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 12.8 m-85 -119.92 137.49 54.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -1.042 . . . . 0.0 109.138 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -101.5 114.75 29.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 110.593 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.653 HG22 HD11 ' A' ' 578' ' ' LEU . 1.2 t -82.43 121.48 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.578 -0.701 . . . . 0.0 109.169 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.12 104.83 7.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.711 -0.618 . . . . 0.0 110.172 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . 0.405 HD12 ' HB3' ' A' ' 674' ' ' ASP . 19.9 mt -80.91 104.43 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 0.0 109.935 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -72.78 -43.08 63.25 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.306 -0.872 . . . . 0.0 108.973 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.452 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 6.5 m-20 -110.68 140.75 44.76 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.618 0.723 . . . . 0.0 110.741 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 28.6 p -115.43 96.06 5.47 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 39.3 p -126.5 131.63 51.58 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.642 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . 0.426 ' C ' HD22 ' A' ' 644' ' ' LEU . . . 51.15 35.85 34.6 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 704' ' ' ASN . 5.3 tp -108.99 132.96 53.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.451 -1.029 . . . . 0.0 111.036 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.633 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 3.3 p90 -48.47 -25.02 1.47 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.644 0.735 . . . . 0.0 110.301 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.633 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.1 t30 . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.461 ' CZ ' HD23 ' A' ' 659' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.269 0.557 . . . . 0.0 111.389 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.44 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 31.9 m -107.25 150.1 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 109.214 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.534 HG13 ' HG2' ' A' ' 664' ' ' MET . 85.1 t -95.45 133.16 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 110.729 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.2 mp -108.86 162.34 14.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.42 -0.8 . . . . 0.0 110.094 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.17 154.61 17.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.36 -0.838 . . . . 0.0 110.1 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.62 148.02 31.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.304 -0.872 . . . . 0.0 110.406 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 11.1 p -121.35 -176.2 3.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.379 -0.826 . . . . 0.0 110.384 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.44 -29.2 34.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.369 -0.832 . . . . 0.0 110.002 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -66.05 -45.45 81.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.421 -0.799 . . . . 0.0 109.523 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.95 -46.91 79.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.47 -0.769 . . . . 0.0 109.62 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.492 ' O ' HG12 ' A' ' 727' ' ' VAL . 9.1 tttt -53.53 -32.64 51.37 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.427 -0.795 . . . . 0.0 109.746 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.59 -35.94 78.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.527 -0.733 . . . . 0.0 110.33 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 34.4 mt -58.92 -46.84 86.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.274 -0.891 . . . . 0.0 110.305 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 1.021 HG23 HG11 ' A' ' 621' ' ' VAL . 7.5 p -70.8 -19.87 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.557 -0.715 . . . . 0.0 110.264 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.0 -43.51 66.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.265 -0.897 . . . . 0.0 108.956 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.94 103.52 10.37 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 122.222 1.01 . . . . 0.0 109.191 177.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.4 ' O ' ' CD2' ' A' ' 602' ' ' PHE . 1.2 mt . . . . . 0 C--N 1.273 -2.74 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.344 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 576' ' ' ARG . . . . . 0.434 ' HD3' ' HB3' ' A' ' 593' ' ' GLU . 1.9 ttp180 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.751 0.786 . . . . 1.48 109.387 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 577' ' ' PHE . . . . . 0.608 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -115.5 -42.1 3.18 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.053 0.93 . . . . 1.03 109.241 -179.178 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.608 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 9.4 tt -120.45 128.79 53.49 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.872 -0.603 . . . . 1.1799999999999999 110.749 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 61.7 m -104.36 116.83 32.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 0.26000000000000001 109.704 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 580' ' ' LEU . . . . . 0.759 HD12 HG13 ' A' ' 594' ' ' ILE . 4.1 mt -92.11 112.6 24.6 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.843 -1.169 . . . . 0.89000000000000001 107.843 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 581' ' ' LYS . . . . . 0.441 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 1.0 OUTLIER -113.5 102.77 55.18 Favored Pre-proline 0 C--N 1.301 -1.502 0 C-N-CA 118.337 -1.345 . . . . 0.93000000000000005 112.565 -178.089 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 582' ' ' PRO . . . . . 1.06 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.7 Cg_endo -77.49 143.11 21.47 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 N-CA-C 105.83 -2.411 . . . . 0.25 105.83 174.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 583' ' ' LEU . . . . . 0.724 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.41 -177.53 0.52 Allowed Pre-proline 0 N--CA 1.497 1.909 0 C-N-CA 118.181 -1.408 . . . . 1.1000000000000001 113.848 -176.233 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 584' ' ' PRO . . . . . 0.724 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.6 Cg_endo -66.96 -34.83 28.24 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 124.253 1.659 . . . . 0.51000000000000001 111.75 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -58.25 -29.32 65.68 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.173 -1.417 . . . . 1.4199999999999999 107.173 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 586' ' ' SER . . . . . 0.532 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 3.0 t -95.92 150.8 20.04 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.396 -0.964 . . . . 1.1599999999999999 108.396 177.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 587' ' ' ILE . . . . . 0.67 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.5 OUTLIER -57.52 -15.98 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.994 -1.066 . . . . 1.29 109.428 179.457 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 588' ' ' ILE . . . . . 0.771 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 8.1 mm -98.49 114.67 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.388 -0.82 . . . . 1.6599999999999999 109.153 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.65 69.29 0.97 Allowed 'General case' 0 N--CA 1.507 2.395 0 O-C-N 120.711 -1.243 . . . . 1.29 109.512 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . 1.06 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 27.6 mt-10 -142.74 176.04 9.35 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.132 -0.94 . . . . 2.1299999999999999 109.004 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.551 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.73 123.67 35.92 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.791 -1.193 . . . . 0.22 109.926 177.382 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.547 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.8 mt -112.07 155.52 23.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.457 -0.777 . . . . 1.0800000000000001 109.37 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.434 ' HB3' ' HD3' ' A' ' 576' ' ' ARG . 10.5 mp0 -126.99 113.87 17.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 1.6699999999999999 111.501 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 594' ' ' ILE . . . . . 0.759 HG13 HD12 ' A' ' 580' ' ' LEU . 4.1 mt -72.13 109.36 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.98 -1.075 . . . . 0.46999999999999997 108.31 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 595' ' ' GLN . . . . . 0.557 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -61.52 107.95 0.88 Allowed 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.601 -0.687 . . . . 1.52 110.738 -178.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 596' ' ' GLN . . . . . 0.557 ' C ' ' O ' ' A' ' 595' ' ' GLN . 3.5 tt0 -11.52 87.29 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.298 0.571 . . . . 1.3400000000000001 112.253 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 597' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 105.87 22.1 8.2 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.668 -1.373 . . . . 1.0600000000000001 109.668 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 598' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 598' ' ' VAL . 1.2 t -82.28 103.59 9.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 107.074 -1.454 . . . . 0.53000000000000003 107.074 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 599' ' ' ASN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 627' ' ' LYS . 7.9 t30 -143.17 134.2 12.57 Favored Pre-proline 0 C--N 1.281 -2.403 0 CA-C-N 114.549 -1.205 . . . . 1.52 110.19 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 600' ' ' PRO . . . . . 0.668 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 54.9 Cg_endo -91.56 162.26 28.1 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.804 -1.748 . . . . 0.33000000000000002 109.334 -1.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 601' ' ' PHE . . . . . 0.625 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 5.1 t80 -106.28 117.21 33.45 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.363 -1.347 . . . . 0.28000000000000003 107.363 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 602' ' ' PHE . . . . . 0.681 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 56.3 m-85 -88.71 146.04 25.29 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.378 -0.826 . . . . 0.53000000000000003 110.939 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 603' ' ' ILE . . . . . 0.746 HD11 HG13 ' A' ' 625' ' ' ILE . 2.9 mt -141.76 139.72 31.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.965 -0.694 . . . . 0.28999999999999998 109.962 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 604' ' ' GLY . . . . . 0.708 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 174.82 -166.81 38.74 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.505 -1.331 . . . . 0.22 110.977 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 605' ' ' ARG . . . . . 0.482 ' HD2' ' HA ' ' A' ' 614' ' ' GLU . 14.8 tpt180 -65.4 -38.83 91.14 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.858 -0.79 . . . . 1.5600000000000001 110.591 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 606' ' ' SER . . . . . 0.412 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 1.0 OUTLIER -81.04 122.32 27.16 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.323 -0.861 . . . . 0.75 110.862 -179.351 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 607' ' ' GLU . . . . . 0.508 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.1 OUTLIER -57.73 -15.2 7.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 2.3900000000000001 109.79 178.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.09 -36.19 5.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.502 -0.749 . . . . 1.72 110.068 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 609' ' ' CYS . . . . . 0.681 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 73.6 m -67.41 152.71 45.21 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.552 -0.859 . . . . 0.98999999999999999 109.451 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 610' ' ' ASN . . . . . 0.566 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.2 OUTLIER -57.06 -14.35 3.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.46 -0.775 . . . . 1.23 110.473 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 611' ' ' CYS . . . . . 0.711 ' HB3' HG23 ' A' ' 603' ' ' ILE . 8.7 t -120.08 144.21 47.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.398 -0.814 . . . . 0.34000000000000002 109.804 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 612' ' ' LYS . . . . . 0.508 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -110.46 120.06 41.21 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 122.158 0.98 . . . . 2.1699999999999999 113.29 -178.117 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 613' ' ' ILE . . . . . 0.771 ' HA ' ' CD1' ' A' ' 588' ' ' ILE . 14.1 mt -142.8 107.92 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 107.36 -1.348 . . . . 0.55000000000000004 107.36 176.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 614' ' ' GLU . . . . . 0.482 ' HA ' ' HD2' ' A' ' 605' ' ' ARG . 6.0 tt0 -92.45 104.4 16.73 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.98 1.371 . . . . 2.2799999999999998 109.664 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 615' ' ' ASP . . . . . 0.626 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.8 m-20 -138.4 106.06 5.61 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.074 -1.421 . . . . 1.3899999999999999 107.971 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -39.65 -44.27 1.48 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.617 -0.677 . . . . 1.8500000000000001 112.131 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.78 -17.32 41.52 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.093 -1.005 . . . . 2.9300000000000002 111.672 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.686 HD12 HD11 ' A' ' 681' ' ' ILE . 0.8 OUTLIER -78.04 119.28 21.24 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.019 -1.051 . . . . 0.40999999999999998 110.768 -179.137 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 619' ' ' SER . . . . . 0.476 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -59.18 159.86 7.04 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.4 -0.813 . . . . 0.91000000000000003 110.809 179.852 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 620' ' ' ARG . . . . . 0.708 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -63.91 -45.39 89.53 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.32 -0.862 . . . . 2.4199999999999999 109.183 179.521 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 621' ' ' VAL . . . . . 0.49 ' HB ' HG23 ' A' ' 727' ' ' VAL . 10.5 m -95.06 1.84 9.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.355 -0.84 . . . . 1.02 109.469 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 6.3 t60 -28.87 -46.79 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.622 -0.717 . . . . 0.22 110.875 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 623' ' ' CYS . . . . . 0.778 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.6 OUTLIER -136.45 145.77 45.58 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.45 -1.3 . . . . 0.19 110.777 178.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 624' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 3.1 p90 -144.72 149.58 35.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.458 -0.776 . . . . 0.53000000000000003 110.219 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 625' ' ' ILE . . . . . 0.746 HG13 HD11 ' A' ' 603' ' ' ILE . 69.2 mt -104.54 121.75 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.765 -0.828 . . . . 0.64000000000000001 108.765 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 626' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 4.5 t80 -115.27 153.96 29.95 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.52 -0.737 . . . . 0.92000000000000004 109.439 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 627' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 1.2 ttmt -120.12 137.08 54.35 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.578 0.704 . . . . 0.93999999999999995 110.501 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 628' ' ' LYS . . . . . 0.417 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.57 163.32 29.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.594 -0.691 . . . . 1.9399999999999999 110.321 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 629' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.5 OUTLIER -78.32 115.08 17.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.95 . . . . 2.1299999999999999 108.74 179.82 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 630' ' ' HIS . . . . . 0.538 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.9 t60 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.505 -0.747 . . . . 0.69999999999999996 110.846 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 644' ' ' LEU . . . . . 0.751 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.0 mp . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 108.97 -0.752 . . . . 1.23 108.97 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 645' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 13.2 m-20 -112.54 123.97 51.48 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.974 -1.079 . . . . 1.54 111.276 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 646' ' ' ASP . . . . . 0.535 ' OD2' HD21 ' A' ' 671' ' ' LEU . 26.5 t70 -109.57 146.8 34.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.513 -0.742 . . . . 1.2 109.665 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 647' ' ' ILE . . . . . 0.554 HD13 ' CD1' ' A' ' 578' ' ' LEU . 12.5 pt -102.49 130.66 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.279 -0.888 . . . . 0.28999999999999998 110.039 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 648' ' ' TRP . . . . . 0.616 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 91.3 m95 -118.58 119.71 35.31 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.092 -0.643 . . . . 0.32000000000000001 110.754 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.853 ' HB2' HD11 ' A' ' 672' ' ' LEU . 3.8 t80 -80.93 114.69 19.98 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.366 -0.975 . . . . 0.33000000000000002 108.366 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 650' ' ' CYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.1 OUTLIER -106.35 114.29 28.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.909 . . . . 1.1200000000000001 111.564 -178.608 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.527 ' CE1' ' C ' ' A' ' 656' ' ' VAL . 17.2 t60 -74.04 159.92 32.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.451 -0.781 . . . . 0.23999999999999999 109.975 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -149.96 -30.59 0.22 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.403 -0.81 . . . . 0.31 112.968 -179.158 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 653' ' ' GLY . . . . . 0.566 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.03 -167.73 30.93 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 117.579 -2.248 . . . . 0.71999999999999997 109.416 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 24.3 m -94.94 -17.85 21.62 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.968 -1.313 . . . . 0.54000000000000004 113.91 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 655' ' ' ASN . . . . . 0.535 ' O ' HG12 ' A' ' 656' ' ' VAL . 30.5 m120 -60.85 -4.29 0.96 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.774 -1.204 . . . . 1.79 112.398 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 75.45 166.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-O 121.95 0.881 . . . . 1.46 110.648 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 657' ' ' SER . . . . . 0.42 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -123.73 145.51 48.96 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.162 -0.615 . . . . 0.28999999999999998 110.585 -178.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.434 ' CE1' ' CG ' ' A' ' 663' ' ' ARG . 15.7 m-85 -135.64 126.32 27.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.272 -0.893 . . . . 1.22 110.615 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.64 HD22 ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -128.2 109.85 11.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.273 -0.892 . . . . 1.28 109.927 179.231 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.77 -80.34 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.484 -0.76 . . . . 1.73 110.358 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 661' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.4 m-20 -146.13 25.21 1.27 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.25 -0.906 . . . . 2.1899999999999999 110.307 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.03 117.95 30.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.284 -0.885 . . . . 1.45 110.285 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 663' ' ' ARG . . . . . 0.434 ' CG ' ' CE1' ' A' ' 658' ' ' TYR . 3.0 tmm_? -84.39 141.06 31.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 2.4300000000000002 110.098 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 664' ' ' MET . . . . . 0.597 ' O ' HG22 ' A' ' 656' ' ' VAL . 3.5 mtp -118.89 -166.12 1.21 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.279 -0.888 . . . . 0.63 110.294 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 665' ' ' ILE . . . . . 0.624 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.4 pt -138.34 -160.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.225 -0.922 . . . . 0.5 110.365 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -81.65 90.43 6.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.398 -0.814 . . . . 0.75 110.564 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.07 50.43 0.68 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.021 -1.232 . . . . 0.28000000000000003 110.021 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 668' ' ' THR . . . . . 0.624 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.1 OUTLIER -117.61 149.43 40.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.113 -1.227 . . . . 0.29999999999999999 110.13 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.454 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 10.8 tttt -108.39 141.01 40.87 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.985 -0.746 . . . . 0.67000000000000004 108.985 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 670' ' ' PHE . . . . . 0.64 ' CD2' HD22 ' A' ' 659' ' ' LEU . 13.5 t80 -143.96 146.29 32.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.148 -0.97 . . . . 1.03 111.665 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 671' ' ' LEU . . . . . 0.616 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -73.08 147.26 45.14 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.626 -0.671 . . . . 1.3100000000000001 110.621 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 672' ' ' LEU . . . . . 0.853 HD11 ' HB2' ' A' ' 649' ' ' TYR . 12.8 mt -118.56 112.83 20.39 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.672 -0.811 . . . . 0.84999999999999998 111.306 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 673' ' ' GLN . . . . . 0.496 ' O ' HG11 ' A' ' 694' ' ' VAL . 75.2 mt-30 -90.25 -177.43 5.12 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.044 -0.725 . . . . 1.1599999999999999 109.044 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 674' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -76.26 142.83 41.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.138 -0.976 . . . . 1.21 109.691 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.34 47.2 59.48 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 107.788 -2.125 . . . . 0.29999999999999999 107.788 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 676' ' ' ASP . . . . . 0.61 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.5 OUTLIER -100.45 91.93 4.92 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.748 -0.854 . . . . 1.3300000000000001 110.491 -179.117 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.919 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.3 tt0 -93.16 107.42 19.23 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.76 -1.2 . . . . 1.79 107.76 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 678' ' ' ILE . . . . . 0.563 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.4 pt -111.73 137.74 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.419 0.628 . . . . 0.98999999999999999 111.667 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -98.95 111.01 23.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.515 -0.741 . . . . 2.4399999999999999 109.4 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 680' ' ' ILE . . . . . 0.778 HD13 ' SG ' ' A' ' 623' ' ' CYS . 72.8 mt -75.35 -24.11 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.23000000000000001 110.352 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 681' ' ' ILE . . . . . 0.686 HD11 HD12 ' A' ' 618' ' ' LEU . 3.6 mt -143.02 136.15 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -0.942 . . . . 1.3400000000000001 110.394 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -137.49 108.91 6.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.435 -0.79 . . . . 1.0700000000000001 110.109 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.36 118.36 29.27 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.265 -0.897 . . . . 1.4299999999999999 110.221 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -65.99 -46.35 78.31 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.423 -0.798 . . . . 2.21 110.887 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -80.4 -43.31 21.25 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.252 -0.905 . . . . 2.0499999999999998 110.68 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.74 -13.8 58.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.306 -0.871 . . . . 2.4100000000000001 110.471 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 57.23 18.95 4.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.221 -0.925 . . . . 2.6600000000000001 110.56 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 688' ' ' PHE . . . . . 0.414 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -74.66 77.98 2.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 1.3100000000000001 109.034 179.252 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 689' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 586' ' ' SER . 43.5 t -101.63 136.15 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.82 . . . . 1.3899999999999999 110.881 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 690' ' ' ILE . . . . . 0.67 ' CD1' HG22 ' A' ' 587' ' ' ILE . 47.1 mm -117.5 163.26 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.738 -0.838 . . . . 0.81000000000000005 108.738 178.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 691' ' ' GLY . . . . . 0.532 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -172.98 125.39 1.14 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.511 -1.328 . . . . 0.25 109.932 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 692' ' ' PHE . . . . . 0.919 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 6.9 m-85 -120.63 137.71 54.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.603 -0.939 . . . . 0.25 109.484 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -100.67 113.71 26.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.13 -0.981 . . . . 2.2400000000000002 110.031 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 694' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 694' ' ' VAL . 1.2 t -85.45 115.03 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.365 -0.835 . . . . 0.28000000000000003 108.884 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -122.55 103.92 9.02 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.136 -0.626 . . . . 1.6599999999999999 109.923 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 74.0 mt -77.23 103.95 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.4 -0.812 . . . . 0.37 109.113 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.21 -43.51 28.26 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.355 -0.841 . . . . 1.1399999999999999 108.808 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 698' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 8.0 m-20 -111.33 141.81 44.38 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.543 0.687 . . . . 1.1899999999999999 110.612 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 27.1 p -115.27 96.1 5.5 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.164 -1.421 . . . . 0.52000000000000002 107.164 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 6.7 m -127.43 132.63 50.04 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.305 0.574 . . . . 1.6000000000000001 111.077 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 50.4 25.99 9.19 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.135 -1.186 . . . . 1.3100000000000001 110.135 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 702' ' ' LEU . . . . . 0.739 ' O ' HD22 ' A' ' 644' ' ' LEU . 0.9 OUTLIER -102.23 134.87 44.81 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.283 -1.128 . . . . 1.22 110.239 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 703' ' ' PHE . . . . . 0.751 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.4 p90 -49.47 -24.28 1.96 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.627 -0.67 . . . . 0.76000000000000001 110.673 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 704' ' ' ASN . . . . . 0.643 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 O-C-N 121.531 -0.731 . . . . 0.98999999999999999 109.031 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 714' ' ' ARG . . . . . 0.41 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.238 0.542 . . . . 1.3799999999999999 111.691 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.86 153.1 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.553 -0.717 . . . . 0.63 109.522 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 716' ' ' VAL . . . . . 0.59 HG13 ' HG2' ' A' ' 664' ' ' MET . 48.1 t -96.52 133.33 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.121 -0.987 . . . . 0.58999999999999997 110.581 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 717' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 717' ' ' LEU . 4.9 mp -109.5 162.66 14.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.478 -0.764 . . . . 0.81999999999999995 109.94 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -99.16 149.05 23.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.971 . . . . 2.4300000000000002 110.045 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.92 150.13 30.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.829 . . . . 1.98 110.248 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 21.8 p -116.42 -176.48 2.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.55000000000000004 110.277 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.58 -28.96 35.07 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.337 -0.852 . . . . 0.57999999999999996 110.163 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.63 -47.88 71.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.385 -0.822 . . . . 2.3300000000000001 109.779 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 723' ' ' GLU . . . . . 0.583 ' OE1' HD12 ' A' ' 726' ' ' LEU . 12.3 mm-40 -64.21 -48.61 75.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.417 -0.802 . . . . 1.95 110.056 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 724' ' ' LYS . . . . . 0.49 ' O ' HG12 ' A' ' 727' ' ' VAL . 5.5 tttp -52.61 -33.19 45.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.389 -0.819 . . . . 2.3399999999999999 109.795 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 725' ' ' ASP . . . . . 0.406 ' HA ' ' HB2' ' A' ' 728' ' ' LYS . 3.6 t0 -68.39 -35.91 78.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.528 -0.732 . . . . 1.6000000000000001 109.911 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 726' ' ' LEU . . . . . 0.583 HD12 ' OE1' ' A' ' 723' ' ' GLU . 42.7 mt -55.95 -46.54 78.54 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.395 -0.816 . . . . 1.1000000000000001 110.018 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 727' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 724' ' ' LYS . 7.7 p -76.01 -21.01 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.606 -0.683 . . . . 1.1899999999999999 110.351 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 728' ' ' LYS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 725' ' ' ASP . 17.3 tttt -52.9 -43.09 65.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.238 -0.914 . . . . 2.5499999999999998 108.857 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -116.8 103.67 10.56 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.292 1.044 . . . . 2.5 109.138 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 730' ' ' LEU . . . . . 0.411 HD23 ' CG ' ' A' ' 602' ' ' PHE . 4.3 mt . . . . . 0 C--N 1.274 -2.687 0 CA-C-O 118.017 -0.992 . . . . 1.25 110.38 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.412 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -82.84 -10.51 58.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.368 -1.077 . . . . 0.0 110.622 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 165.2 38.64 0.02 OUTLIER Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.49 151.82 19.06 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.317 -1.108 . . . . 0.0 109.102 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.546 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 0.5 OUTLIER -150.92 -40.8 0.12 Allowed 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.045 0.926 . . . . 0.0 108.795 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.646 ' CD2' HD12 ' A' ' 594' ' ' ILE . 16.1 tp -130.69 119.59 22.63 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.335 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 88.7 m -102.66 118.3 36.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.141 -0.974 . . . . 0.0 109.434 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.636 HD11 HD12 ' A' ' 625' ' ' ILE . 15.3 mt -91.16 112.02 23.74 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.431 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -114.24 101.56 54.18 Favored Pre-proline 0 C--N 1.302 -1.473 0 C-N-CA 118.131 -1.428 . . . . 0.0 112.843 -177.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 1.131 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.2 Cg_endo -79.6 144.24 17.51 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 N-CA-C 105.788 -2.428 . . . . 0.0 105.788 174.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.709 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -123.48 -178.3 0.64 Allowed Pre-proline 0 N--CA 1.498 1.927 0 C-N-CA 118.214 -1.394 . . . . 0.0 114.082 -175.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.709 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.5 Cg_endo -67.6 -31.81 32.39 Favored 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 124.272 1.67 . . . . 0.0 111.375 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.79 -30.72 67.8 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.558 ' OG ' HD12 ' A' ' 583' ' ' LEU . 4.0 p -97.43 153.41 18.13 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.652 HD12 ' O ' ' A' ' 614' ' ' GLU . 4.7 pt -56.69 -17.15 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 109.637 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.759 HD12 ' HA ' ' A' ' 613' ' ' ILE . 7.0 mm -99.61 114.96 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.318 -0.864 . . . . 0.0 108.7 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.487 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -126.12 73.0 1.33 Allowed 'General case' 0 N--CA 1.508 2.443 0 O-C-N 120.653 -1.28 . . . . 0.0 110.587 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 1.131 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 49.6 mt-10 -143.04 174.7 10.45 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.521 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.32 126.34 40.59 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.589 -1.319 . . . . 0.0 109.752 176.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.825 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.1 mt -110.7 156.0 21.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 0.0 109.28 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -125.2 110.04 13.59 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.427 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.646 HD12 ' CD2' ' A' ' 578' ' ' LEU . 29.3 mt -80.28 108.39 13.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 3.8 mt-30 -70.99 120.67 16.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.507 -0.746 . . . . 0.0 111.261 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.546 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 11.6 mm-40 37.77 33.72 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.409 0.624 . . . . 0.0 111.035 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . 80.15 65.07 1.78 Allowed Glycine 0 N--CA 1.487 2.053 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.654 ' O ' HG13 ' A' ' 598' ' ' VAL . 10.9 p -79.69 105.07 8.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.42 ' CB ' ' HB3' ' A' ' 627' ' ' LYS . 3.8 p-10 -121.72 150.9 56.43 Favored Pre-proline 0 C--N 1.28 -2.454 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.694 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.476 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.6 Cg_endo -86.68 157.46 51.63 Favored 'Cis proline' 0 C--N 1.308 -1.602 0 C-N-CA 121.075 -2.469 . . . . 0.0 109.511 0.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.481 ' CD2' ' HB2' ' A' ' 611' ' ' CYS . 3.0 t80 -106.25 116.11 31.37 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.561 ' HB3' ' SG ' ' A' ' 609' ' ' CYS . 60.6 m-85 -87.89 144.33 26.63 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.311 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.948 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.8 mt -141.02 142.12 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.742 -0.599 . . . . 0.0 110.602 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.784 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 170.37 -159.05 31.27 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.912 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 14.1 tpt180 -71.37 -47.24 57.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.819 -0.812 . . . . 0.0 110.957 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.88 126.97 31.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 110.808 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.554 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.2 OUTLIER -56.76 -15.54 4.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -0.832 . . . . 0.0 110.439 179.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -45.73 -35.94 4.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.251 -0.906 . . . . 0.0 109.125 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 602' ' ' PHE . 1.3 m -62.78 136.65 57.97 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.475 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -49.86 -25.51 3.22 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.307 -0.87 . . . . 0.0 109.628 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.948 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.1 t -109.03 143.57 38.16 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -110.48 128.55 55.67 Favored 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 122.198 0.999 . . . . 0.0 113.101 -178.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.759 ' HA ' HD12 ' A' ' 588' ' ' ILE . 13.0 mt -142.39 108.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.652 ' O ' HD12 ' A' ' 587' ' ' ILE . 1.4 tt0 -89.68 102.46 15.15 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 117.838 -1.545 . . . . 0.0 107.796 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.823 ' HB3' ' CB ' ' A' ' 618' ' ' LEU . 9.9 t0 -139.93 106.39 5.31 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.57 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -38.67 -65.86 0.32 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.579 -0.701 . . . . 0.0 112.747 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.72 -16.51 64.29 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.117 -0.99 . . . . 0.0 112.455 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.823 ' CB ' ' HB3' ' A' ' 615' ' ' ASP . 0.7 OUTLIER -73.19 129.44 38.05 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.0 -1.062 . . . . 0.0 110.87 -179.035 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.405 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -66.8 160.89 24.94 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.287 -0.883 . . . . 0.0 110.818 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.784 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.7 mtt180 -64.43 -46.94 81.03 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.294 -0.879 . . . . 0.0 109.474 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.499 ' HB ' HG23 ' A' ' 727' ' ' VAL . 9.3 m -95.37 2.58 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.402 -0.811 . . . . 0.0 109.577 178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.6 t60 -25.41 -45.94 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.263 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.84 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.7 OUTLIER -136.49 145.68 45.41 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 118.453 -1.299 . . . . 0.0 111.283 179.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 2.1 p90 -145.52 144.15 30.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.544 -0.723 . . . . 0.0 110.09 177.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.636 HD12 HD11 ' A' ' 580' ' ' LEU . 12.3 mt -103.28 121.42 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 9.4 t80 -114.52 154.87 27.48 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.397 -0.814 . . . . 0.0 109.861 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.432 ' HE2' HG23 ' A' ' 647' ' ' ILE . 5.2 ttmt -120.17 136.84 54.48 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.49 0.662 . . . . 0.0 110.583 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.469 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -138.93 163.57 31.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.628 -0.67 . . . . 0.0 110.357 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.0 OUTLIER -78.11 127.64 32.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.241 -0.912 . . . . 0.0 108.728 179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.529 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.6 t60 -57.79 124.07 17.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 110.769 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -79.85 113.92 18.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.793 -0.567 . . . . 0.0 110.47 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.552 HG22 ' N ' ' A' ' 633' ' ' GLY . 14.6 p -123.82 174.64 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.431 -0.793 . . . . 0.0 110.321 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.552 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -99.3 -169.17 30.42 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.56 137.91 58.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.273 -1.134 . . . . 0.0 109.979 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.93 84.77 1.25 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.386 -0.821 . . . . 0.0 110.703 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 26.8 mtt -63.21 126.24 26.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.416 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.61 -145.67 0.38 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.414 -0.804 . . . . 0.0 109.603 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -115.33 101.29 8.79 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.114 -0.991 . . . . 0.0 109.147 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 91.8 p -137.61 151.38 70.76 Favored Pre-proline 0 C--N 1.293 -1.853 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.905 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.64 -151.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.588 1.31 . . . . 0.0 109.6 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 52.73 24.92 3.45 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.38 -0.825 . . . . 0.0 110.821 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -73.17 60.31 0.57 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.191 -0.943 . . . . 0.0 110.175 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.702 ' C ' HD12 ' A' ' 644' ' ' LEU . . . 62.48 114.63 0.01 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.774 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.3 mp -141.99 -152.71 0.42 Allowed 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 24.4 m-20 -119.24 124.76 47.52 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.007 -1.058 . . . . 0.0 111.386 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.459 ' OD2' HD21 ' A' ' 671' ' ' LEU . 7.9 t0 -112.87 155.93 23.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.481 -0.762 . . . . 0.0 110.027 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.503 HD13 HD22 ' A' ' 578' ' ' LEU . 13.2 pt -107.08 134.71 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.252 -0.905 . . . . 0.0 109.943 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.71 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.4 m95 -119.05 124.01 45.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.649 -0.657 . . . . 0.0 111.233 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.623 ' HB2' HD11 ' A' ' 672' ' ' LEU . 12.5 t80 -83.37 114.95 21.79 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 8.2 t -108.67 109.17 20.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.051 -1.031 . . . . 0.0 111.423 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.599 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 9.4 t60 -75.28 160.72 30.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.43 -0.794 . . . . 0.0 110.057 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -152.52 -29.72 0.15 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.355 -0.841 . . . . 0.0 113.187 -178.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.599 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -79.28 135.48 15.48 Favored Glycine 0 N--CA 1.502 3.047 0 C-N-CA 117.866 -2.111 . . . . 0.0 110.212 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.8 m -36.87 -24.56 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.7 ' C ' HG13 ' A' ' 656' ' ' VAL . 2.4 t-20 -59.12 -2.22 0.25 Allowed 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.471 -1.393 . . . . 0.0 113.179 -178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.7 HG13 ' C ' ' A' ' 655' ' ' ASN . 0.9 OUTLIER 63.92 146.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.453 -0.779 . . . . 0.0 110.702 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.551 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -97.7 153.38 18.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.76 -0.587 . . . . 0.0 110.246 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.474 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 10.2 m-85 -138.45 125.4 21.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.324 -0.86 . . . . 0.0 110.057 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.662 HD11 HG21 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -134.52 121.16 20.61 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.318 -0.864 . . . . 0.0 109.908 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 6.5 m120 55.16 -86.29 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.479 -0.763 . . . . 0.0 110.437 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 659' ' ' LEU . 5.8 t30 -143.32 14.05 1.81 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.096 -1.003 . . . . 0.0 110.602 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -102.29 118.16 36.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.135 -0.978 . . . . 0.0 110.383 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.453 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 0.0 OUTLIER -85.04 139.01 32.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.366 -0.834 . . . . 0.0 110.004 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.468 ' CE ' ' HB2' ' A' ' 670' ' ' PHE . 3.5 mtp -120.25 -179.54 3.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 0.0 110.616 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.547 ' CG1' HG23 ' A' ' 668' ' ' THR . 7.0 pt -120.18 -161.0 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.41 -0.806 . . . . 0.0 110.093 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -84.96 72.03 10.86 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.345 -0.847 . . . . 0.0 110.748 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 134.2 59.54 0.07 OUTLIER Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.547 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.6 OUTLIER -124.31 149.89 46.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.155 -1.203 . . . . 0.0 110.318 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.492 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 11.9 tttt -108.79 133.67 52.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.493 -0.754 . . . . 0.0 109.016 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.527 ' CD1' HG22 ' A' ' 716' ' ' VAL . 11.9 t80 -138.01 146.42 43.06 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.485 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.71 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.9 OUTLIER -72.69 144.66 47.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.461 -0.774 . . . . 0.0 110.267 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 649' ' ' TYR . 1.3 mt -111.71 104.56 12.92 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.676 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.549 ' NE2' ' HA3' ' A' ' 708' ' ' GLY . 17.1 mt-30 -84.62 161.28 20.2 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.8 ' OD2' HD12 ' A' ' 707' ' ' LEU . 8.2 p-10 -56.85 143.94 35.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.119 . . . . 0.0 109.569 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.67 47.27 50.01 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 107.664 -2.174 . . . . 0.0 107.664 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.416 ' HB2' ' CG1' ' A' ' 694' ' ' VAL . 0.1 OUTLIER -103.31 89.91 3.54 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.836 -0.803 . . . . 0.0 110.473 -179.108 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.933 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 7.1 tt0 -93.29 106.85 18.76 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.662 HG21 HD11 ' A' ' 659' ' ' LEU . 3.3 pt -111.1 137.32 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.346 0.593 . . . . 0.0 111.473 -177.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.415 ' HG2' ' HB2' ' A' ' 658' ' ' TYR . 0.0 OUTLIER -99.29 109.96 22.53 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.525 -0.734 . . . . 0.0 109.091 178.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.84 HD13 ' SG ' ' A' ' 623' ' ' CYS . 89.9 mt -74.35 -29.51 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.404 -0.81 . . . . 0.0 110.26 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.605 HG13 HD12 ' A' ' 618' ' ' LEU . 3.0 mt -143.0 133.26 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 109.851 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -138.42 111.79 8.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.572 -0.705 . . . . 0.0 110.108 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -129.12 117.54 21.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.238 -0.914 . . . . 0.0 110.189 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -66.69 -33.28 75.28 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.437 -0.789 . . . . 0.0 110.726 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -55.98 -43.52 77.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.395 -0.816 . . . . 0.0 111.08 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.05 12.14 11.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.164 -0.96 . . . . 0.0 110.706 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.31 23.69 2.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.159 -0.963 . . . . 0.0 110.41 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.55 ' CE2' ' HA ' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -72.81 74.39 1.13 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 0.0 109.53 179.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 681' ' ' ILE . 14.6 p -105.56 136.96 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.43 -0.794 . . . . 0.0 110.895 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.562 HG12 ' CG1' ' A' ' 587' ' ' ILE . 18.2 mt -108.38 163.77 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.347 -0.846 . . . . 0.0 108.928 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.449 ' N ' ' CB ' ' A' ' 586' ' ' SER . . . -170.84 123.62 1.06 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.933 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 11.4 m-85 -120.16 137.34 54.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.53 -0.982 . . . . 0.0 109.589 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 21.2 tptt -100.52 114.21 27.65 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 110.515 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.592 HG22 HD11 ' A' ' 578' ' ' LEU . 1.2 t -85.62 118.78 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.373 -0.829 . . . . 0.0 109.001 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -130.08 104.75 7.51 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.925 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.784 HD13 ' HA3' ' A' ' 706' ' ' GLY . 10.9 mt -85.49 104.4 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 110.037 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -77.27 -43.15 34.37 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.54 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -111.02 140.94 45.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.712 -0.618 . . . . 0.0 110.316 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.406 ' O ' ' OG1' ' A' ' 699' ' ' THR . 2.0 p -114.94 96.45 5.71 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.423 HG21 ' CD ' ' A' ' 596' ' ' GLN . 4.6 p -81.93 92.94 6.82 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.507 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 47.6 42.97 20.96 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.614 ' O ' HD22 ' A' ' 644' ' ' LEU . 2.0 tp -85.79 148.78 25.67 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.45 -1.029 . . . . 0.0 110.337 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.774 ' HA ' HD13 ' A' ' 644' ' ' LEU . 5.1 p90 -49.47 -25.48 2.65 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.505 -0.747 . . . . 0.0 110.288 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.563 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.6 t30 -157.88 168.94 25.76 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.468 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 13.5 pt-20 -51.29 -23.47 3.6 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.09 -1.006 . . . . 0.0 110.073 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.784 ' HA3' HD13 ' A' ' 696' ' ' ILE . . . 121.71 6.52 8.57 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.034 -1.627 . . . . 0.0 109.034 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.8 HD12 ' OD2' ' A' ' 674' ' ' ASP . 0.3 OUTLIER -89.59 10.01 24.62 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.447 -1.031 . . . . 0.0 111.157 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.549 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 49.73 100.85 0.01 OUTLIER Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.84 40.44 2.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -1.184 . . . . 0.0 110.391 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.512 ' H ' HD23 ' A' ' 710' ' ' LEU . 0.5 OUTLIER -91.49 -173.31 3.53 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.296 -0.878 . . . . 0.0 110.338 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -57.47 -53.51 57.34 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.341 -0.849 . . . . 0.0 110.933 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.463 ' HB2' HD11 ' A' ' 710' ' ' LEU . 40.3 mt-10 -63.41 141.68 58.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.21 -0.931 . . . . 0.0 110.146 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -111.48 95.92 5.8 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.349 -0.844 . . . . 0.0 109.454 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.412 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 7.7 mmm-85 46.88 70.98 0.35 Allowed 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.274 0.559 . . . . 0.0 111.225 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.6 m -107.71 152.58 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.844 . . . . 0.0 109.406 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 670' ' ' PHE . 49.6 t -96.24 133.37 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 0.0 110.735 -179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.43 162.14 14.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.514 -0.742 . . . . 0.0 109.56 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -97.37 149.49 22.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 0.0 110.511 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -80.94 129.07 34.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.434 -0.791 . . . . 0.0 110.015 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 3.2 p -103.42 -176.39 3.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.393 -0.817 . . . . 0.0 110.19 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.31 -28.79 30.23 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.397 -0.814 . . . . 0.0 110.113 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.11 -51.69 62.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.341 -0.849 . . . . 0.0 109.897 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -64.02 -47.58 79.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.997 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.532 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.0 OUTLIER -53.61 -32.73 52.36 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.322 -0.861 . . . . 0.0 110.076 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.45 -36.15 78.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.414 -0.804 . . . . 0.0 110.101 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 38.6 mt -58.55 -46.59 86.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.365 -0.834 . . . . 0.0 110.296 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 724' ' ' LYS . 7.8 p -71.42 -20.75 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.944 -0.702 . . . . 0.0 110.225 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -53.41 -45.31 69.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.24 -0.913 . . . . 0.0 108.81 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.8 104.44 11.34 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 122.218 1.009 . . . . 0.0 109.006 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.415 ' OXT' ' CD2' ' A' ' 602' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--N 1.274 -2.692 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.281 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -82.7 -10.21 59.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -1.098 . . . . 0.0 110.529 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 126.16 -19.07 6.48 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -92.77 114.36 26.89 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.213 -1.169 . . . . 0.0 109.54 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.516 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 8.5 t80 -95.83 -43.28 7.93 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.92 0.867 . . . . 0.0 109.392 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.806 HD11 HD13 ' A' ' 647' ' ' ILE . 0.5 OUTLIER -126.97 136.98 53.0 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.043 -178.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 88.4 m -113.43 117.26 31.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.14 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.598 HD12 HG13 ' A' ' 594' ' ' ILE . 2.6 mt -92.69 112.11 23.95 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.448 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 2.1 mmtt -112.81 102.18 54.18 Favored Pre-proline 0 C--N 1.301 -1.517 0 C-N-CA 118.255 -1.378 . . . . 0.0 113.24 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 1.08 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 45.0 Cg_endo -79.58 142.01 16.0 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 N-CA-C 105.32 -2.608 . . . . 0.0 105.32 173.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.746 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -119.16 -176.2 0.37 Allowed Pre-proline 0 N--CA 1.496 1.847 0 C-N-CA 118.16 -1.416 . . . . 0.0 113.896 -175.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.746 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.1 Cg_endo -66.82 -32.41 36.76 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 124.274 1.671 . . . . 0.0 112.033 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -59.08 -29.68 67.51 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.785 -1.197 . . . . 0.0 108.525 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.666 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 66.7 p -96.5 150.24 20.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.857 -0.527 . . . . 0.0 109.833 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.445 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.0 OUTLIER -54.76 -20.31 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.146 -0.971 . . . . 0.0 109.028 178.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.865 HD12 ' HA ' ' A' ' 613' ' ' ILE . 9.2 mm -93.65 115.06 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.506 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -125.46 72.31 1.26 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.604 -1.31 . . . . 0.0 109.865 -178.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 1.08 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 58.3 mm-40 -145.15 175.85 9.95 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.623 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.548 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.47 126.02 39.65 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.986 -1.071 . . . . 0.0 109.052 176.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.749 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.2 mp -109.79 154.08 23.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 0.0 109.745 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 17.7 mp0 -125.53 110.05 13.41 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.502 -0.749 . . . . 0.0 110.989 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.598 HG13 HD12 ' A' ' 580' ' ' LEU . 1.9 mt -80.91 109.86 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.151 -0.968 . . . . 0.0 108.675 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.512 ' HB2' HG23 ' A' ' 598' ' ' VAL . 0.0 OUTLIER -53.06 165.89 0.27 Allowed 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.672 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.516 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 5.2 mt-30 -65.1 68.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.421 -0.799 . . . . 0.0 109.87 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 138.57 21.87 0.43 Allowed Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.567 -1.302 . . . . 0.0 110.789 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -85.92 101.53 10.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 O-C-N 120.732 -1.452 . . . . 0.0 107.176 178.449 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 13.8 t-20 -144.99 134.05 11.17 Favored Pre-proline 0 C--N 1.284 -2.266 0 CA-C-N 114.777 -1.102 . . . . 0.0 110.21 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.571 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 51.0 Cg_endo -91.99 164.01 26.78 Favored 'Cis proline' 0 C--N 1.31 -1.459 0 C-N-CA 123.222 -1.574 . . . . 0.0 108.784 -2.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.504 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 4.1 t80 -104.48 116.11 31.53 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.668 ' HB3' HD23 ' A' ' 730' ' ' LEU . 36.4 m-85 -83.16 144.2 29.98 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.541 -0.724 . . . . 0.0 110.436 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.875 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.3 mt -142.67 141.77 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.66 -0.65 . . . . 0.0 110.045 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.797 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 168.75 -160.97 34.63 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.925 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 14.5 tpt180 -71.13 -43.52 67.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.713 -0.875 . . . . 0.0 111.189 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.466 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -78.3 126.51 30.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.926 . . . . 0.0 110.872 -179.227 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.445 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.9 tt0 -54.04 -18.33 3.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.141 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.06 -31.32 0.9 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.255 -0.903 . . . . 0.0 109.142 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.5 m -69.89 130.77 43.15 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.504 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -44.83 -28.59 0.66 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.267 -0.895 . . . . 0.0 109.904 179.514 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.875 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.4 t -105.19 143.49 33.29 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.445 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.1 OUTLIER -109.19 128.19 54.83 Favored 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 119.286 -0.966 . . . . 0.0 112.859 -178.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.865 ' HA ' HD12 ' A' ' 588' ' ' ILE . 12.1 mt -141.79 108.06 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -91.73 103.79 16.32 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.228 -1.389 . . . . 0.0 108.396 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 2.6 m-20 -138.81 106.02 5.49 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.363 -1.289 . . . . 0.0 108.839 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -45.69 -42.17 11.31 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.546 -0.721 . . . . 0.0 111.948 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 27.2 mtm-85 -83.12 -17.14 44.11 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.074 -1.016 . . . . 0.0 111.269 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.797 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.8 OUTLIER -77.85 140.54 39.37 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.271 -0.893 . . . . 0.0 110.826 -179.331 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.45 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.84 161.45 28.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.322 -0.861 . . . . 0.0 110.694 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.755 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 13.3 ttp180 -64.09 -45.79 87.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.328 -0.858 . . . . 0.0 109.255 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.586 HG11 HG22 ' A' ' 727' ' ' VAL . 2.8 t -95.52 2.07 9.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.84 0.829 . . . . 0.0 109.475 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.2 t60 -27.18 -46.69 0.03 OUTLIER 'General case' 0 C--O 1.196 -1.762 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.549 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.79 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.59 145.69 43.12 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 118.025 -1.47 . . . . 0.0 111.857 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.531 ' CZ ' ' HB2' ' A' ' 650' ' ' CYS . 13.1 p90 -146.68 142.64 28.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.595 -0.691 . . . . 0.0 109.9 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.538 HG13 HD11 ' A' ' 603' ' ' ILE . 60.3 mt -102.61 117.97 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.424 ' HB2' ' HE1' ' A' ' 624' ' ' PHE . 8.6 t80 -114.53 154.72 27.76 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.767 0.794 . . . . 0.0 110.017 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 5.4 ttmt -120.18 137.48 54.16 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.597 0.713 . . . . 0.0 110.737 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.413 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.44 163.94 29.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.516 -0.74 . . . . 0.0 110.092 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.6 OUTLIER -77.25 117.79 19.12 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.158 -0.964 . . . . 0.0 108.704 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.526 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.7 t60 -58.23 124.47 19.56 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.647 0.737 . . . . 0.0 110.701 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -114.01 112.91 24.03 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.765 -0.584 . . . . 0.0 110.259 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 633' ' ' GLY . 57.7 t -86.92 167.56 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.417 -0.802 . . . . 0.0 110.178 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.484 ' N ' HG12 ' A' ' 632' ' ' VAL . . . -59.38 174.1 3.9 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 3.4 tptm -55.53 129.61 39.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.294 -1.121 . . . . 0.0 110.232 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 85.6 p -105.99 93.36 4.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 110.608 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.6 36.79 1.45 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.348 -0.845 . . . . 0.0 109.722 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -163.24 -151.65 0.19 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.538 -0.726 . . . . 0.0 109.911 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -116.07 102.97 10.1 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.195 -0.941 . . . . 0.0 109.036 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 48.5 p -134.72 150.44 73.48 Favored Pre-proline 0 C--N 1.293 -1.85 0 O-C-N 121.883 -0.511 . . . . 0.0 110.191 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.602 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 50.0 Cg_endo -70.36 -151.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.77 1.405 . . . . 0.0 110.012 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 68.21 -61.58 0.39 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.651 -0.656 . . . . 0.0 110.669 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 640' ' ' PRO . 84.3 mt-30 52.05 -159.76 0.11 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.118 -0.989 . . . . 0.0 109.93 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.668 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -114.79 130.59 9.29 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 702' ' ' LEU . 5.1 mp -142.58 -151.35 0.35 Allowed 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.959 -0.73 . . . . 0.0 109.326 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.2 m-20 -110.02 124.22 51.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.007 -1.058 . . . . 0.0 110.908 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.698 ' OD2' HD21 ' A' ' 671' ' ' LEU . 24.0 t0 -110.02 151.11 27.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.425 -0.797 . . . . 0.0 109.944 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.806 HD13 HD11 ' A' ' 578' ' ' LEU . 11.1 pt -105.66 132.0 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.338 -0.851 . . . . 0.0 109.898 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.636 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.7 m95 -119.03 119.25 33.72 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.87 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.789 ' HB2' HD11 ' A' ' 672' ' ' LEU . 1.1 t80 -80.96 114.08 19.6 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 668' ' ' THR . 62.9 m -108.37 108.66 19.72 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.506 -0.877 . . . . 0.0 111.206 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.558 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 17.8 t60 -73.24 169.16 17.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.499 -0.75 . . . . 0.0 109.992 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -159.58 -29.87 0.06 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.292 -0.88 . . . . 0.0 113.118 -178.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.558 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -79.7 140.43 22.55 Favored Glycine 0 N--CA 1.502 3.035 0 O-C-N 119.453 -2.029 . . . . 0.0 110.406 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 22.7 m -47.1 -22.2 0.33 Allowed 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.732 ' CG ' HG23 ' A' ' 681' ' ' ILE . 1.0 OUTLIER -58.51 -4.27 0.38 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.601 -1.312 . . . . 0.0 112.444 -178.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.765 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 79.52 167.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 CA-C-O 121.878 0.847 . . . . 0.0 110.814 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.526 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -128.93 151.13 50.0 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.612 -179.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -138.48 126.59 22.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.174 -0.954 . . . . 0.0 110.946 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.912 HD23 ' CD2' ' A' ' 670' ' ' PHE . 14.7 tp -124.49 107.35 10.98 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.256 -0.903 . . . . 0.0 109.576 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 63.2 -73.8 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.51 -0.743 . . . . 0.0 110.042 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 659' ' ' LEU . 3.2 m-20 -154.5 23.91 0.47 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 110.172 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.46 116.94 29.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.176 -0.953 . . . . 0.0 110.373 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.76 139.08 43.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 110.001 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.765 ' O ' HG22 ' A' ' 656' ' ' VAL . 47.2 mtp -122.6 157.84 31.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.345 -0.847 . . . . 0.0 110.234 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.479 ' CG1' HG23 ' A' ' 668' ' ' THR . 16.2 pt -98.8 -157.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 0.0 109.829 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -86.12 119.63 26.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.288 -0.883 . . . . 0.0 110.43 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 81.03 52.83 4.15 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -114.85 148.49 38.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.991 -1.299 . . . . 0.0 110.274 179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.464 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -109.04 138.68 45.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.566 -0.709 . . . . 0.0 109.345 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.912 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -144.59 145.21 31.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 111.288 -178.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.698 HD21 ' OD2' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -70.15 147.69 49.59 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.433 -0.792 . . . . 0.0 110.604 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.789 HD11 ' HB2' ' A' ' 649' ' ' TYR . 10.7 mt -118.02 114.67 23.49 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.413 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.422 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 87.4 mt-30 -95.1 147.91 22.93 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.474 ' HB3' HD12 ' A' ' 696' ' ' ILE . 23.1 p-10 -46.3 143.02 2.64 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.133 -0.98 . . . . 0.0 110.532 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.66 47.33 41.58 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 107.611 -2.196 . . . . 0.0 107.611 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.521 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.4 OUTLIER -109.52 93.87 4.73 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.885 -0.774 . . . . 0.0 110.07 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.904 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.1 tm-20 -93.86 107.58 19.45 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.766 HG22 HD13 ' A' ' 659' ' ' LEU . 28.2 pt -107.43 137.91 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.602 -0.686 . . . . 0.0 111.811 -178.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -98.76 110.81 23.35 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.79 HD13 ' SG ' ' A' ' 623' ' ' CYS . 72.4 mt -75.01 -19.86 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.886 . . . . 0.0 110.839 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.739 HD11 HD13 ' A' ' 618' ' ' LEU . 8.4 mt -142.9 136.47 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.16 -0.962 . . . . 0.0 110.52 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -137.65 108.96 6.86 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.455 -0.778 . . . . 0.0 109.899 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.424 ' HB3' ' HB2' ' A' ' 686' ' ' ASN . 0.3 OUTLIER -120.96 117.68 27.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.207 -0.933 . . . . 0.0 110.345 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -45.13 78.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.459 -0.776 . . . . 0.0 111.115 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.64 -43.63 15.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.241 -0.912 . . . . 0.0 111.361 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 683' ' ' ASP . 97.5 m-20 -83.19 -8.67 59.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.136 -0.978 . . . . 0.0 110.601 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.5 tptt 56.25 19.66 4.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.225 -0.922 . . . . 0.0 110.778 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.43 78.76 1.03 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.175 -0.953 . . . . 0.0 109.144 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 586' ' ' SER . 41.0 t -101.79 141.32 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.381 -0.824 . . . . 0.0 110.912 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.666 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 41.6 mm -126.32 163.94 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.423 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . -172.48 124.98 1.12 Allowed Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.367 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.904 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.5 m-85 -120.23 138.06 53.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.59 -0.947 . . . . 0.0 108.828 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -105.1 117.95 35.3 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.161 -0.962 . . . . 0.0 110.841 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -87.12 122.28 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.542 -0.724 . . . . 0.0 109.241 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -130.24 104.54 7.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.516 -0.74 . . . . 0.0 110.289 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 674' ' ' ASP . 71.8 mt -76.51 104.35 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.306 -0.871 . . . . 0.0 109.571 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.11 -42.85 59.43 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.609 -0.836 . . . . 0.0 108.889 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.8 OUTLIER -111.01 141.3 44.67 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.698 0.761 . . . . 0.0 110.747 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 44.5 p -115.38 96.06 5.47 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 7.2 t -136.16 136.31 39.92 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 121.262 0.554 . . . . 0.0 110.587 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.04 26.52 27.76 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.83 ' O ' HD22 ' A' ' 644' ' ' LEU . 4.1 tp -105.26 138.19 41.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.358 -1.084 . . . . 0.0 110.469 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.828 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.0 p90 -53.83 -23.75 13.39 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.404 -0.81 . . . . 0.0 110.045 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.593 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.1 t30 -170.76 157.26 5.5 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.527 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 16.4 pt-20 -50.92 -26.98 6.59 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.25 -0.906 . . . . 0.0 110.575 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 122.57 15.05 4.15 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.431 ' N ' HD21 ' A' ' 704' ' ' ASN . 0.2 OUTLIER -82.76 9.07 10.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.025 -1.279 . . . . 0.0 111.264 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.645 ' C ' HD23 ' A' ' 710' ' ' LEU . . . 91.34 -79.16 1.33 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.581 ' HG3' ' O ' ' A' ' 708' ' ' GLY . 0.9 OUTLIER 26.59 66.84 0.06 Allowed 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.94 -0.741 . . . . 0.0 112.158 -179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.645 HD23 ' C ' ' A' ' 708' ' ' GLY . 0.6 OUTLIER -140.8 159.96 41.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 110.243 179.593 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -60.04 -54.46 45.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.315 -0.866 . . . . 0.0 110.198 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.72 149.05 47.57 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.366 -0.834 . . . . 0.0 109.903 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . 0.402 ' O ' ' C ' ' A' ' 714' ' ' ARG . 2.6 tt0 -110.59 95.33 5.49 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.212 -0.93 . . . . 0.0 109.316 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.799 ' NH1' HD21 ' A' ' 659' ' ' LEU . 0.0 OUTLIER 36.06 76.1 0.05 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.782 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.424 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 31.5 m -107.78 151.01 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.431 -0.793 . . . . 0.0 109.382 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.538 HG13 ' HG2' ' A' ' 664' ' ' MET . 65.0 t -93.12 117.8 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -0.935 . . . . 0.0 110.489 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.438 HD13 ' HD3' ' A' ' 669' ' ' LYS . 4.8 mp -89.88 162.51 15.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.38 -0.825 . . . . 0.0 109.734 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.98 146.24 28.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.215 -0.928 . . . . 0.0 110.167 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -79.88 137.38 36.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 110.223 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 30.8 p -110.16 -176.79 3.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.416 -0.802 . . . . 0.0 110.353 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.61 -28.92 35.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.432 -0.792 . . . . 0.0 110.153 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . 0.509 ' O ' HD23 ' A' ' 726' ' ' LEU . 3.9 tp10 -66.21 -50.16 64.79 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.448 -0.782 . . . . 0.0 110.043 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.704 ' O ' HG12 ' A' ' 727' ' ' VAL . 14.6 mt-10 -63.71 -47.68 80.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.36 -0.838 . . . . 0.0 110.123 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.467 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 3.0 tmmm? -62.46 -31.9 72.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.471 -0.768 . . . . 0.0 110.946 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.07 -50.74 69.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.217 -0.927 . . . . 0.0 112.041 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 722' ' ' GLU . 0.7 OUTLIER -72.72 -35.93 67.67 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.907 -1.121 . . . . 0.0 111.516 -178.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.704 HG12 ' O ' ' A' ' 723' ' ' GLU . 9.3 p -79.08 -15.18 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.828 -1.17 . . . . 0.0 110.37 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -41.98 69.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.944 . . . . 0.0 108.685 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.44 103.32 10.32 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 122.253 1.025 . . . . 0.0 108.963 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.668 HD23 ' HB3' ' A' ' 602' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.272 -2.78 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.269 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.24 -10.14 58.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.345 -1.091 . . . . 0.0 110.601 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 166.76 66.27 0.03 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.412 ' HD3' ' HG2' ' A' ' 593' ' ' GLU . 32.2 ttp-105 -92.68 123.61 36.09 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.5 -1.0 . . . . 0.0 109.484 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.593 ' CZ ' HD13 ' A' ' 702' ' ' LEU . 9.8 t80 -111.6 -40.23 4.39 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 122.061 0.934 . . . . 0.0 109.288 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.003 HD11 HD13 ' A' ' 647' ' ' ILE . 0.9 OUTLIER -124.5 119.69 29.86 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.787 -179.126 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 62.3 m -99.15 115.45 29.09 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.989 -1.069 . . . . 0.0 109.005 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.491 HD21 HD12 ' A' ' 594' ' ' ILE . 1.6 mm? -89.98 111.76 22.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.408 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 1.1 mmtt -112.04 101.49 51.86 Favored Pre-proline 0 C--N 1.3 -1.562 0 C-N-CA 118.026 -1.47 . . . . 0.0 112.478 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 1.05 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.9 Cg_endo -80.17 144.58 16.67 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 N-CA-C 106.45 -2.173 . . . . 0.0 106.45 174.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.741 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -121.56 -174.31 0.3 Allowed Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 118.707 -1.197 . . . . 0.0 112.765 -176.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.741 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.1 Cg_endo -66.09 -31.17 46.2 Favored 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 124.289 1.679 . . . . 0.0 110.086 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.734 ' O ' HG23 ' A' ' 689' ' ' VAL . 70.2 m-20 -59.13 -25.28 63.73 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 13.4 t -95.19 150.58 20.06 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.465 HG12 ' O ' ' A' ' 614' ' ' GLU . 5.3 tp -55.58 -21.47 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.289 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.876 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.6 tp -110.17 117.92 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.522 -0.736 . . . . 0.0 109.903 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.58 79.89 1.25 Allowed 'General case' 0 N--CA 1.508 2.429 0 O-C-N 120.359 -1.463 . . . . 0.0 108.938 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 1.05 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.6 mt-10 -143.02 175.55 9.77 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.787 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.566 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.66 125.56 40.35 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.097 -1.002 . . . . 0.0 109.127 176.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 611' ' ' CYS . 65.9 mt -110.17 156.08 21.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 109.592 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.412 ' HG2' ' HD3' ' A' ' 576' ' ' ARG . 7.7 mp0 -124.85 110.56 14.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.856 . . . . 0.0 111.683 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.723 HG23 HG12 ' A' ' 598' ' ' VAL . 21.1 mt -82.33 110.38 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.593 ' O ' ' N ' ' A' ' 597' ' ' GLY . 2.3 mt-30 -53.98 179.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.213 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.572 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -58.03 69.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.455 -0.778 . . . . 0.0 111.138 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 106.07 43.84 1.46 Allowed Glycine 0 N--CA 1.485 1.915 0 C-N-CA 119.699 -1.239 . . . . 0.0 110.591 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.723 HG12 HG23 ' A' ' 594' ' ' ILE . 0.5 OUTLIER -79.05 104.57 7.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 178.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 2.9 t30 -141.53 138.27 17.25 Favored Pre-proline 0 C--N 1.28 -2.442 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.004 -178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.637 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.1 Cg_endo -90.54 161.1 31.99 Favored 'Cis proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.273 -1.97 . . . . 0.0 109.38 -1.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.558 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 5.3 t80 -107.28 116.6 32.22 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.697 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 60.7 m-85 -90.08 145.93 24.7 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 111.047 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.704 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.4 mt -140.5 141.02 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.554 -0.716 . . . . 0.0 110.239 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.69 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 178.1 -161.14 27.86 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.867 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.424 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 15.0 tpt180 -75.71 -32.45 60.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.754 -0.85 . . . . 0.0 110.087 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.438 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -86.3 127.46 34.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.417 -0.802 . . . . 0.0 110.623 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.535 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.5 tm-20 -59.41 -13.73 9.57 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.972 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -46.44 -36.19 6.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.426 -0.796 . . . . 0.0 110.24 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.697 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 62.2 m -71.26 152.7 43.04 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.558 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.1 m120 -59.17 -13.63 7.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.415 -0.803 . . . . 0.0 110.48 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.704 ' SG ' HG23 ' A' ' 603' ' ' ILE . 6.9 t -120.43 144.22 48.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.433 -0.792 . . . . 0.0 109.942 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.613 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -113.37 130.95 56.16 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 122.032 0.92 . . . . 0.0 112.901 -178.43 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.655 HD11 ' CE1' ' A' ' 692' ' ' PHE . 7.9 mt -146.63 109.96 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.465 ' O ' HG12 ' A' ' 587' ' ' ILE . 3.3 mm-40 -85.58 102.44 13.54 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 117.806 -1.558 . . . . 0.0 108.547 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.592 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 4.3 m-20 -139.05 106.13 5.46 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.728 178.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -45.4 -44.51 12.06 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.42 -0.8 . . . . 0.0 111.925 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.86 -16.75 43.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.126 -0.984 . . . . 0.0 112.023 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.922 HD13 HD11 ' A' ' 681' ' ' ILE . 1.3 tp -76.55 130.35 37.77 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.95 -1.093 . . . . 0.0 110.898 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.511 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.2 m -68.81 161.2 29.04 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.43 -0.794 . . . . 0.0 110.467 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.69 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -63.61 -45.75 88.89 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.189 -0.944 . . . . 0.0 109.204 179.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.592 HG12 HD21 ' A' ' 730' ' ' LEU . 16.4 m -94.8 2.12 9.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 O-C-N 121.386 -0.821 . . . . 0.0 109.481 178.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.776 ' CE1' HD12 ' A' ' 618' ' ' LEU . 3.8 t60 -28.47 -48.27 0.06 Allowed 'General case' 0 C--O 1.192 -1.946 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.946 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.846 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.13 145.5 43.91 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 118.375 -1.33 . . . . 0.0 110.901 179.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.591 ' HA ' HG13 ' A' ' 603' ' ' ILE . 24.2 p90 -146.37 151.18 37.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.493 -0.754 . . . . 0.0 110.419 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.598 HG13 HD11 ' A' ' 603' ' ' ILE . 15.7 mt -103.13 120.95 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 8.0 t80 -116.45 154.23 30.7 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.39 -0.818 . . . . 0.0 109.828 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.519 ' HE2' HG23 ' A' ' 647' ' ' ILE . 8.3 ttmt -120.22 136.98 54.46 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.444 0.64 . . . . 0.0 110.368 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.03 163.97 28.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.64 -0.663 . . . . 0.0 110.389 -179.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -77.6 115.65 17.53 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.507 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.2 t60 -58.04 124.46 19.42 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.542 -0.724 . . . . 0.0 110.561 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -125.16 103.81 8.18 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.386 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.54 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.5 p -73.15 170.98 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.561 -0.712 . . . . 0.0 110.089 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.54 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -60.25 -165.25 0.2 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.54 133.36 55.18 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.287 -1.125 . . . . 0.0 110.279 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.87 63.48 3.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.312 -0.867 . . . . 0.0 110.358 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -58.65 125.93 25.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 109.705 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 64.61 -145.35 0.26 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.428 -0.795 . . . . 0.0 109.901 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -115.44 103.05 10.39 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.08 -1.013 . . . . 0.0 109.16 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 5.2 p -120.78 151.33 54.4 Favored Pre-proline 0 C--N 1.292 -1.899 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.029 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.621 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 48.7 Cg_endo -69.72 -151.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.732 1.385 . . . . 0.0 110.088 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 68.88 -62.02 0.4 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.662 -0.649 . . . . 0.0 110.642 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.97 -155.35 0.16 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.073 -1.017 . . . . 0.0 110.183 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.648 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -119.95 129.72 8.09 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.782 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.1 mp -142.77 -146.23 0.18 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 122.088 -0.654 . . . . 0.0 109.363 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.46 124.63 51.61 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.846 -1.159 . . . . 0.0 111.386 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.531 ' OD2' HD21 ' A' ' 671' ' ' LEU . 24.0 t0 -113.5 156.4 23.64 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.386 -0.821 . . . . 0.0 110.129 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 1.003 HD13 HD11 ' A' ' 578' ' ' LEU . 11.2 pt -109.67 129.85 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.26 -0.9 . . . . 0.0 110.142 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.652 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 91.6 m95 -119.86 128.53 53.75 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.621 -0.675 . . . . 0.0 111.199 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.865 ' HB2' HD11 ' A' ' 672' ' ' LEU . 9.3 t80 -88.17 114.87 25.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 177.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 668' ' ' THR . 14.4 m -108.01 106.03 16.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 111.781 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.524 ' CD2' ' N ' ' A' ' 652' ' ' THR . 13.1 t60 -65.95 159.07 26.51 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.482 -0.761 . . . . 0.0 109.975 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.74 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.03 -28.79 0.2 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.471 -0.768 . . . . 0.0 112.84 -179.228 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.525 ' HA3' ' CG ' ' A' ' 622' ' ' HIS . . . -79.26 -163.89 26.79 Favored Glycine 0 N--CA 1.496 2.688 0 O-C-N 119.337 -2.102 . . . . 0.0 109.885 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 21.3 m -94.08 -19.12 21.12 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.096 -1.238 . . . . 0.0 114.095 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.717 ' HB3' HG23 ' A' ' 681' ' ' ILE . 24.7 m120 -61.01 -2.83 0.65 Allowed 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.597 -1.315 . . . . 0.0 112.629 -178.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.698 HG13 ' C ' ' A' ' 655' ' ' ASN . 0.8 OUTLIER 62.68 145.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.58 -0.7 . . . . 0.0 109.847 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -95.09 151.29 19.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.601 -0.687 . . . . 0.0 111.071 -178.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.464 ' CZ ' ' CG2' ' A' ' 656' ' ' VAL . 37.5 m-85 -134.45 126.22 29.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.595 -0.691 . . . . 0.0 109.569 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.928 HD13 HG12 ' A' ' 678' ' ' ILE . 53.8 tp -130.93 111.89 12.47 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.198 -0.939 . . . . 0.0 110.098 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.83 -79.43 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.594 -0.691 . . . . 0.0 110.027 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 659' ' ' LEU . 25.5 p30 -148.74 23.92 0.98 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 110.128 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -111.74 119.68 39.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.241 -0.912 . . . . 0.0 110.253 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -84.97 134.92 34.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.889 . . . . 0.0 110.045 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.466 ' HG2' ' CG1' ' A' ' 716' ' ' VAL . 2.8 mtp -116.3 -166.2 1.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.647 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.5 ' CG1' HG23 ' A' ' 668' ' ' THR . 7.9 pt -139.94 -154.95 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.447 -0.783 . . . . 0.0 110.291 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 652' ' ' THR . 44.2 tt0 -86.31 91.71 8.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.376 -0.828 . . . . 0.0 110.699 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.5 54.62 0.54 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.6 OUTLIER -119.07 145.53 45.83 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.06 -1.259 . . . . 0.0 110.001 179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.411 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 15.5 tttt -108.34 138.72 44.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.454 -0.779 . . . . 0.0 109.247 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.765 ' CE2' HD23 ' A' ' 659' ' ' LEU . 0.5 OUTLIER -144.62 142.88 30.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.027 -1.045 . . . . 0.0 111.518 -178.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.652 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -70.89 147.5 48.74 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.524 -0.735 . . . . 0.0 110.773 179.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.865 HD11 ' HB2' ' A' ' 649' ' ' TYR . 14.6 mt -120.3 114.67 22.21 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.386 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 17.2 mt-30 -84.5 -177.16 6.54 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 706' ' ' GLY . 2.2 p30 -78.24 139.06 38.92 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.778 -1.201 . . . . 0.0 109.315 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 73.25 47.9 21.37 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.451 -2.259 . . . . 0.0 107.451 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.868 ' OD1' HD11 ' A' ' 659' ' ' LEU . 2.1 t0 -105.55 97.77 7.56 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.847 -0.796 . . . . 0.0 110.337 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.895 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.47 107.03 18.93 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.928 HG12 HD13 ' A' ' 659' ' ' LEU . 1.5 mp -105.01 138.01 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.531 -0.731 . . . . 0.0 111.57 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -100.39 114.58 28.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.747 -0.596 . . . . 0.0 109.639 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.846 HD13 ' SG ' ' A' ' 623' ' ' CYS . 76.7 mt -79.35 -24.09 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.926 . . . . 0.0 110.933 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.922 HD11 HD13 ' A' ' 618' ' ' LEU . 7.2 mt -141.57 141.15 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.148 -0.97 . . . . 0.0 110.389 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -138.09 109.59 6.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.89 . . . . 0.0 110.11 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 686' ' ' ASN . 1.0 OUTLIER -125.44 118.04 24.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.331 -0.856 . . . . 0.0 110.005 179.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -46.85 76.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.306 -0.871 . . . . 0.0 110.963 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -84.65 -43.47 14.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.345 -0.847 . . . . 0.0 110.939 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . 0.4 ' CB ' ' HB3' ' A' ' 683' ' ' ASP . 0.6 OUTLIER -72.33 -11.1 60.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.249 -0.907 . . . . 0.0 110.556 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 4.1 mttt 52.46 24.86 3.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.17 -0.956 . . . . 0.0 110.388 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.88 73.76 7.43 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.434 -0.792 . . . . 0.0 109.896 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 585' ' ' ASP . 34.8 m -101.92 135.87 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 110.322 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.522 HG12 ' HB ' ' A' ' 681' ' ' ILE . 19.3 mm -114.05 164.44 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.535 -0.728 . . . . 0.0 109.505 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -174.43 123.33 0.95 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.527 -1.32 . . . . 0.0 110.446 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.895 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.3 m-85 -120.04 137.74 53.93 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.534 -0.98 . . . . 0.0 108.581 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -102.56 114.54 28.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.871 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 694' ' ' VAL . 1.0 OUTLIER -81.31 113.24 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.03 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -121.56 104.3 9.54 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.695 -0.628 . . . . 0.0 109.914 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.528 ' CD1' ' HA3' ' A' ' 706' ' ' GLY . 63.1 mt -79.13 104.58 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 109.51 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.88 -42.76 48.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.328 -0.857 . . . . 0.0 108.826 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.523 ' O ' ' CD1' ' A' ' 577' ' ' PHE . 1.2 m-20 -110.84 142.45 42.84 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.397 0.618 . . . . 0.0 110.336 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 42.9 p -114.18 95.78 5.47 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.44 -133.57 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.027 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.761 ' O ' HD23 ' A' ' 644' ' ' LEU . . . -93.49 35.04 4.29 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.593 HD13 ' CZ ' ' A' ' 577' ' ' PHE . 1.0 OUTLIER -60.77 149.98 33.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.617 -0.931 . . . . 0.0 110.172 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.782 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.1 p90 -49.63 -24.56 2.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.362 -0.836 . . . . 0.0 110.402 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.532 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER -158.06 170.8 21.48 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.228 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.466 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 16.3 pt-20 -51.19 -23.6 3.5 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.961 -1.087 . . . . 0.0 110.309 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 123.77 4.55 7.98 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.435 HD13 ' OD2' ' A' ' 674' ' ' ASP . 24.8 tp -89.9 11.66 19.7 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.325 -1.103 . . . . 0.0 110.941 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.502 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 77.81 -137.99 20.86 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 6.7 ptp -161.1 -174.46 4.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -1.079 . . . . 0.0 110.031 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.404 ' HA ' HD13 ' A' ' 710' ' ' LEU . 0.8 OUTLIER -112.53 34.35 4.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.27 -0.894 . . . . 0.0 110.674 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.77 -41.48 5.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.447 -0.783 . . . . 0.0 109.268 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -114.09 149.11 36.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.653 -0.655 . . . . 0.0 109.331 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . 0.509 ' O ' ' C ' ' A' ' 714' ' ' ARG . 2.1 mt-30 -109.86 95.52 5.65 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.21 -0.931 . . . . 0.0 109.481 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.509 ' C ' ' O ' ' A' ' 713' ' ' GLN . 0.1 OUTLIER 22.04 82.62 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.225 179.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.408 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 34.9 m -107.59 151.59 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.453 -0.779 . . . . 0.0 109.454 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.466 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 86.6 t -97.04 122.77 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 110.564 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.5 mp -93.8 162.16 14.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.52 -0.737 . . . . 0.0 109.822 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.33 151.09 21.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.875 . . . . 0.0 110.068 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -80.31 142.83 34.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.807 . . . . 0.0 110.343 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 12.8 p -117.16 -176.27 2.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.399 -0.813 . . . . 0.0 110.143 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.53 -28.8 33.34 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.355 -0.84 . . . . 0.0 110.224 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -68.15 -47.65 67.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.0 109.984 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.8 -48.05 78.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -0.796 . . . . 0.0 110.023 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.473 ' O ' HG12 ' A' ' 727' ' ' VAL . 94.7 mttt -54.03 -32.49 54.55 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.364 -0.835 . . . . 0.0 110.069 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -68.11 -36.38 79.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.487 -0.758 . . . . 0.0 110.383 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 37.8 mt -59.8 -46.55 88.85 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.262 -0.899 . . . . 0.0 110.195 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.571 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.5 p -72.34 -19.46 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.087 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -53.5 -44.73 69.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.315 -0.865 . . . . 0.0 108.904 179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.54 103.48 10.45 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 122.215 1.007 . . . . 0.0 109.262 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.592 HD21 HG12 ' A' ' 621' ' ' VAL . 3.5 mt . . . . . 0 C--N 1.274 -2.696 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.518 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -84.14 -10.19 57.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.406 -1.055 . . . . 0.0 110.687 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 67.19 37.02 90.93 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -93.55 135.33 34.92 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.407 -1.055 . . . . 0.0 109.261 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.563 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 9.8 t80 -124.8 -39.69 2.25 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 122.063 0.935 . . . . 0.0 109.427 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.723 HD11 HD13 ' A' ' 647' ' ' ILE . 0.4 OUTLIER -131.6 120.23 22.56 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.26 -178.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 4.4 m -93.95 120.19 33.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.0 109.093 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 1.058 HD11 HD12 ' A' ' 625' ' ' ILE . 4.6 mt -87.05 112.38 21.81 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.526 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -111.1 100.48 47.06 Favored Pre-proline 0 C--N 1.301 -1.505 0 C-N-CA 118.197 -1.401 . . . . 0.0 112.989 -176.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 1.09 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 55.6 Cg_endo -87.88 141.23 5.25 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 N-CA-C 106.342 -2.214 . . . . 0.0 106.342 174.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.75 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -120.52 -173.71 0.27 Allowed Pre-proline 0 C--N 1.294 -1.815 0 C-N-CA 118.57 -1.252 . . . . 0.0 112.575 -177.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.75 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.2 Cg_endo -66.42 -30.71 43.86 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 O-C-N 124.212 1.638 . . . . 0.0 110.279 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -59.2 -24.45 63.12 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 17.6 t -95.35 153.32 17.74 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 614' ' ' GLU . 4.9 tp -57.42 -19.69 11.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.178 -0.951 . . . . 0.0 109.298 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.841 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.5 tp -113.17 118.08 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.866 . . . . 0.0 110.117 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -111.24 81.65 1.47 Allowed 'General case' 0 N--CA 1.507 2.39 0 O-C-N 120.483 -1.386 . . . . 0.0 108.634 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 1.09 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.5 mt-10 -143.11 175.68 9.68 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.883 -178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.526 ' HB3' ' CD ' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -126.62 122.88 36.29 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.018 -1.051 . . . . 0.0 109.17 176.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.66 155.05 20.59 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.46 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -125.69 110.26 13.56 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.433 -0.792 . . . . 0.0 111.304 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.506 HG23 ' HB ' ' A' ' 598' ' ' VAL . 9.9 mt -81.37 109.56 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.7 OUTLIER -53.14 168.97 0.12 Allowed 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.609 -0.837 . . . . 0.0 109.054 179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.563 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 6.0 mt-30 -61.58 70.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.391 -0.818 . . . . 0.0 110.432 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 124.69 30.44 0.97 Allowed Glycine 0 N--CA 1.487 2.044 0 C-N-CA 119.622 -1.275 . . . . 0.0 110.78 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 598' ' ' VAL . 1.2 t -79.9 102.73 6.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.8 t30 -143.95 135.5 12.8 Favored Pre-proline 0 C--N 1.282 -2.358 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.885 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.655 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.1 Cg_endo -90.91 162.12 30.45 Favored 'Cis proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.747 -1.772 . . . . 0.0 109.15 -1.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.536 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 6.3 t80 -106.41 116.69 32.36 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.735 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 58.3 m-85 -88.62 146.24 25.22 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.406 -0.808 . . . . 0.0 111.182 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.72 HD11 HG13 ' A' ' 625' ' ' ILE . 2.4 mt -140.85 140.48 33.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.648 -0.657 . . . . 0.0 110.18 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.683 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 177.18 -162.63 30.86 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.924 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.412 ' HD3' ' C ' ' A' ' 615' ' ' ASP . 14.2 tpt180 -74.0 -35.06 64.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.794 -0.827 . . . . 0.0 110.248 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.406 ' CB ' ' HD3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -85.16 127.37 34.24 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.394 -0.817 . . . . 0.0 110.585 -179.606 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 42.8 tt0 -58.75 -12.89 4.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.291 -0.881 . . . . 0.0 109.993 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.18 -36.86 4.05 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.421 -0.8 . . . . 0.0 110.079 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.735 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 79.6 m -71.68 154.48 41.34 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.284 -0.885 . . . . 0.0 109.926 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.521 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -61.53 -12.06 13.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.511 -0.743 . . . . 0.0 110.396 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.719 ' SG ' HG23 ' A' ' 603' ' ' ILE . 6.9 t -119.84 143.74 47.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.531 -0.731 . . . . 0.0 109.559 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.622 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -113.32 130.22 56.32 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 122.055 0.931 . . . . 0.0 112.993 -178.237 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.606 HD11 ' CE1' ' A' ' 692' ' ' PHE . 7.3 mt -146.57 109.75 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 177.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.46 ' O ' HG12 ' A' ' 587' ' ' ILE . 2.2 mt-10 -85.68 102.47 13.63 Favored 'General case' 0 C--N 1.293 -1.888 0 C-N-CA 117.704 -1.598 . . . . 0.0 108.538 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.622 ' CG ' HD12 ' A' ' 681' ' ' ILE . 4.9 m-20 -139.42 106.08 5.36 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.869 178.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . 0.41 ' OD1' ' CZ ' ' A' ' 688' ' ' PHE . 29.5 p-10 -47.45 -41.33 20.17 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.453 -0.779 . . . . 0.0 111.648 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -84.19 -16.99 41.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.089 -1.007 . . . . 0.0 111.8 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.866 HD13 HD11 ' A' ' 681' ' ' ILE . 1.3 tp -78.27 130.84 36.7 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.082 -1.012 . . . . 0.0 110.816 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.497 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 2.2 t -70.75 159.4 34.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.362 -0.836 . . . . 0.0 110.53 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.683 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 35.7 ttp180 -61.55 -45.66 93.21 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.26 -0.9 . . . . 0.0 109.344 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.595 ' HB ' HG23 ' A' ' 727' ' ' VAL . 15.8 m -94.74 1.95 9.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 121.389 -0.82 . . . . 0.0 109.613 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.9 t60 -28.1 -48.18 0.05 OUTLIER 'General case' 0 C--O 1.192 -1.962 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.833 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.816 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.7 OUTLIER -137.03 145.58 44.22 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.406 -1.318 . . . . 0.0 110.753 178.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.527 ' CZ ' ' CB ' ' A' ' 650' ' ' CYS . 12.4 p90 -145.3 148.75 33.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.532 -0.73 . . . . 0.0 110.306 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 1.058 HD12 HD11 ' A' ' 580' ' ' LEU . 24.5 mt -103.9 121.1 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.423 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 7.5 t80 -114.95 154.44 28.75 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.694 0.759 . . . . 0.0 109.484 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 0.2 OUTLIER -120.01 137.09 54.29 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.548 0.689 . . . . 0.0 110.587 -179.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -137.62 163.6 30.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.712 -0.617 . . . . 0.0 110.152 -179.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.0 OUTLIER -77.93 115.48 17.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.188 -0.945 . . . . 0.0 108.889 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.507 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.4 t60 -58.62 124.77 20.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.536 -0.728 . . . . 0.0 110.615 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -111.64 111.72 22.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.678 -0.639 . . . . 0.0 110.325 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.545 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.7 p -69.72 169.78 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.341 -0.849 . . . . 0.0 109.945 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.545 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -126.11 155.68 19.36 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt 52.07 62.5 2.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.383 -1.069 . . . . 0.0 110.466 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 89.3 p -103.25 46.93 0.9 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 0.0 110.236 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 38.3 mtt -92.49 43.31 1.13 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.426 -0.796 . . . . 0.0 109.894 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -172.21 -147.77 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.49 -0.757 . . . . 0.0 109.751 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -115.41 102.34 9.74 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.177 -0.952 . . . . 0.0 108.8 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 59.8 p -136.4 151.49 73.19 Favored Pre-proline 0 C--N 1.292 -1.911 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.193 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.597 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 48.6 Cg_endo -69.4 -151.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.691 1.364 . . . . 0.0 110.013 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 68.35 -62.8 0.36 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.617 -0.677 . . . . 0.0 110.481 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.92 -154.48 0.15 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.211 -0.931 . . . . 0.0 110.051 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.656 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -120.03 125.91 6.48 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.812 HD22 ' O ' ' A' ' 702' ' ' LEU . 5.1 mp -142.41 -148.22 0.23 Allowed 'General case' 0 C--N 1.293 -1.865 0 O-C-N 122.046 -0.679 . . . . 0.0 109.207 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.19 124.4 50.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.859 -1.151 . . . . 0.0 111.08 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -110.26 150.56 28.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.443 -0.785 . . . . 0.0 109.847 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.723 HD13 HD11 ' A' ' 578' ' ' LEU . 11.3 pt -106.56 131.66 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.304 -0.873 . . . . 0.0 109.85 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.777 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 95.2 m95 -119.47 123.05 43.11 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.649 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.643 ' HB2' HD11 ' A' ' 672' ' ' LEU . 9.7 t80 -88.83 114.35 25.36 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 668' ' ' THR . 1.0 OUTLIER -108.12 102.66 11.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.078 -1.014 . . . . 0.0 111.697 -178.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.496 ' CD2' ' N ' ' A' ' 652' ' ' THR . 13.1 t60 -62.07 157.46 18.89 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.471 -0.768 . . . . 0.0 109.77 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -149.14 -29.75 0.26 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.469 -0.769 . . . . 0.0 112.702 -179.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.539 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.68 -164.05 25.42 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 117.72 -2.181 . . . . 0.0 109.498 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 25.0 m -97.65 -18.22 19.02 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.858 -1.378 . . . . 0.0 113.821 -176.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.594 ' HB3' HG23 ' A' ' 681' ' ' ILE . 22.8 m120 -58.35 -4.25 0.36 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.681 -1.262 . . . . 0.0 112.497 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.525 HG23 ' C ' ' A' ' 655' ' ' ASN . 3.1 t 70.21 148.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.609 -0.682 . . . . 0.0 110.169 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.434 ' CB ' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -105.82 143.82 33.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.508 -0.745 . . . . 0.0 110.741 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.445 ' CE1' ' HG2' ' A' ' 663' ' ' ARG . 74.7 m-85 -135.22 126.2 27.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.43 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.562 ' HG ' HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -124.11 114.32 19.53 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.373 -0.829 . . . . 0.0 109.789 179.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 659' ' ' LEU . 14.0 t-20 59.27 -78.21 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.549 -0.72 . . . . 0.0 110.499 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 659' ' ' LEU . 10.7 t30 -147.86 27.27 0.98 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.077 -1.014 . . . . 0.0 110.33 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.453 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.2 OUTLIER -113.71 139.36 49.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.317 -0.864 . . . . 0.0 110.269 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.445 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 8.5 tmm_? -103.52 129.48 50.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.339 -0.85 . . . . 0.0 110.107 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.557 ' HG2' HG13 ' A' ' 716' ' ' VAL . 4.3 mtp -112.1 -165.7 1.01 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.326 -0.859 . . . . 0.0 110.325 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.646 HG13 HG23 ' A' ' 668' ' ' THR . 1.6 pt -141.54 -158.66 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.375 -0.828 . . . . 0.0 110.091 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -82.06 93.24 6.96 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.286 -0.884 . . . . 0.0 110.524 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 106.84 53.21 0.71 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.646 HG23 HG13 ' A' ' 665' ' ' ILE . 0.2 OUTLIER -120.51 147.62 44.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.11 -1.23 . . . . 0.0 110.078 179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -108.32 144.04 36.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 0.0 109.196 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.48 ' CE1' ' O ' ' A' ' 715' ' ' VAL . 0.6 OUTLIER -144.65 147.11 32.69 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.508 -178.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.777 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.68 131.5 45.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.465 -0.772 . . . . 0.0 109.705 179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.643 HD11 ' HB2' ' A' ' 649' ' ' TYR . 6.3 mt -104.61 97.68 7.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.14 -0.975 . . . . 0.0 111.173 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.406 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 87.9 mt-30 -84.86 146.64 27.2 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 706' ' ' GLY . 20.0 p-10 -46.11 151.78 0.46 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.222 -0.924 . . . . 0.0 110.612 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 65.36 49.11 62.82 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.589 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.6 OUTLIER -107.04 92.52 4.11 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.763 -0.845 . . . . 0.0 110.611 -178.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.829 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -92.93 106.91 18.8 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.171 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.562 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.0 OUTLIER -116.56 137.78 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.6 -0.687 . . . . 0.0 111.865 -176.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -98.45 111.54 23.86 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.586 -0.696 . . . . 0.0 109.675 178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.816 HD13 ' SG ' ' A' ' 623' ' ' CYS . 81.0 mt -74.08 -19.57 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.302 -0.874 . . . . 0.0 110.465 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.866 HD11 HD13 ' A' ' 618' ' ' LEU . 12.7 mt -141.81 137.67 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.028 -1.045 . . . . 0.0 110.286 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -137.43 110.41 7.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.327 -0.858 . . . . 0.0 110.131 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -129.25 118.38 22.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.784 . . . . 0.0 109.844 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -65.6 -44.84 85.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.375 -0.828 . . . . 0.0 110.884 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -84.11 -43.42 15.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.324 -0.86 . . . . 0.0 110.924 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.82 -17.69 60.57 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.263 -0.898 . . . . 0.0 110.456 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 3.6 tttt 60.53 14.66 5.03 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.193 -0.942 . . . . 0.0 110.887 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.41 ' CZ ' ' OD1' ' A' ' 616' ' ' ASN . 0.3 OUTLIER -72.06 78.69 0.93 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.039 -1.038 . . . . 0.0 108.975 179.189 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 586' ' ' SER . 96.3 t -101.59 130.98 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.496 -0.752 . . . . 0.0 110.706 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.521 HG12 ' HB ' ' A' ' 681' ' ' ILE . 18.0 mm -114.94 164.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . . . . . . . . . . . -173.27 116.13 0.59 Allowed Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.446 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.829 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.4 m-85 -119.7 137.13 54.11 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 581' ' ' LYS . 5.8 ttmm -110.77 114.14 27.26 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 110.305 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.636 HG22 ' CD2' ' A' ' 578' ' ' LEU . 0.5 OUTLIER -75.49 126.85 36.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.758 -0.777 . . . . 0.0 108.95 179.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.67 104.41 7.41 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.192 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.508 HG12 ' HG ' ' A' ' 578' ' ' LEU . 83.6 mt -79.47 103.6 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 109.559 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.27 -41.01 58.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.387 -0.821 . . . . 0.0 108.844 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 1.3 m-20 -110.34 140.2 44.76 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.678 0.751 . . . . 0.0 110.655 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 36.0 p -115.98 96.17 5.46 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 30.2 m -133.09 133.18 42.63 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.814 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 50.32 30.11 17.66 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.812 ' O ' HD22 ' A' ' 644' ' ' LEU . 7.2 tp -103.91 138.92 39.79 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.545 -0.974 . . . . 0.0 110.717 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.805 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.6 p90 -53.28 -23.87 10.1 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.418 -0.801 . . . . 0.0 109.988 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.601 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.2 t30 -174.52 155.05 2.18 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.477 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 14.6 pt-20 -51.24 -25.14 5.15 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.18 -0.95 . . . . 0.0 110.825 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 124.32 13.12 4.01 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.45 ' N ' HD21 ' A' ' 704' ' ' ASN . 0.4 OUTLIER -82.64 9.19 10.01 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.001 -1.293 . . . . 0.0 111.502 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.607 ' O ' ' HG3' ' A' ' 709' ' ' MET . . . 96.71 -63.74 1.08 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.607 ' HG3' ' O ' ' A' ' 708' ' ' GLY . 0.8 OUTLIER 40.65 39.39 0.75 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.743 -0.857 . . . . 0.0 111.714 -179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.16 136.11 43.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.172 -0.955 . . . . 0.0 110.623 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -57.4 -35.48 70.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.42 -0.8 . . . . 0.0 110.006 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.585 ' OE1' HG11 ' A' ' 715' ' ' VAL . 17.4 mm-40 -63.83 149.15 47.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.447 -0.783 . . . . 0.0 109.73 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -110.31 95.34 5.51 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.248 -0.907 . . . . 0.0 109.471 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.434 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 0.5 OUTLIER 39.23 82.97 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.349 0.595 . . . . 0.0 111.869 179.401 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.585 HG11 ' OE1' ' A' ' 712' ' ' GLU . 26.9 m -107.58 150.01 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.481 -0.762 . . . . 0.0 109.069 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.557 HG13 ' HG2' ' A' ' 664' ' ' MET . 58.3 t -96.73 133.12 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.186 -0.946 . . . . 0.0 111.109 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.8 mp -105.08 162.64 13.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.656 -0.653 . . . . 0.0 109.598 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.35 145.37 28.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.17 -0.956 . . . . 0.0 110.291 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.82 152.09 29.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.355 -0.841 . . . . 0.0 110.259 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 38.6 p -121.14 -176.25 3.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.42 -0.8 . . . . 0.0 110.359 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.36 -29.08 32.44 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.361 -0.837 . . . . 0.0 110.105 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -51.0 68.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.353 -0.842 . . . . 0.0 109.579 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -64.65 -45.25 87.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.463 -0.773 . . . . 0.0 109.734 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.528 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.4 OUTLIER -54.71 -32.73 59.98 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.344 -0.848 . . . . 0.0 109.837 179.571 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -36.11 78.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.399 -0.813 . . . . 0.0 110.227 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 34.1 mt -58.76 -46.16 88.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.298 -0.877 . . . . 0.0 110.228 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.595 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.2 p -71.76 -20.34 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.546 -0.721 . . . . 0.0 110.087 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.78 -45.84 70.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.215 -0.928 . . . . 0.0 108.845 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.71 104.26 11.18 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.206 1.003 . . . . 0.0 109.025 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--N 1.274 -2.71 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.432 -179.933 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.55 -10.28 58.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.342 -1.093 . . . . 0.0 110.626 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 78.96 12.42 84.16 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -92.77 126.25 37.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.291 -1.123 . . . . 0.0 109.284 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.575 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 0.9 OUTLIER -113.85 -41.62 3.54 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 122.052 0.93 . . . . 0.0 109.36 -179.316 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.707 ' CD2' HD12 ' A' ' 594' ' ' ILE . 14.2 tp -126.1 119.87 28.7 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.529 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 55.9 m -96.88 117.3 30.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.186 -0.946 . . . . 0.0 109.759 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.901 HD11 HD12 ' A' ' 625' ' ' ILE . 7.6 mt -91.98 112.18 24.01 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.534 ' O ' ' CD1' ' A' ' 583' ' ' LEU . 0.7 OUTLIER -116.07 104.58 52.15 Favored Pre-proline 0 C--N 1.299 -1.617 0 C-N-CA 118.379 -1.328 . . . . 0.0 113.289 -177.066 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 1.127 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 40.8 Cg_endo -77.86 145.04 22.24 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 N-CA-C 105.968 -2.358 . . . . 0.0 105.968 174.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.974 HD13 ' N ' ' A' ' 583' ' ' LEU . 0.0 OUTLIER -122.14 176.73 1.86 Allowed Pre-proline 0 N--CA 1.496 1.826 0 C-N-CA 118.197 -1.401 . . . . 0.0 113.599 -176.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.683 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 37.8 Cg_endo -66.36 -35.42 31.36 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.905 1.737 . . . . 0.0 111.848 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 689' ' ' VAL . 2.3 m-20 -58.43 -26.38 63.23 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.61 ' HB3' HD22 ' A' ' 583' ' ' LEU . 1.9 t -95.57 151.84 18.97 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.062 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.75 HG21 ' OD1' ' A' ' 615' ' ' ASP . 7.5 mm -57.35 -18.63 9.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 108.993 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.698 HD12 ' HA ' ' A' ' 613' ' ' ILE . 3.1 mm -99.67 115.55 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.472 -0.768 . . . . 0.0 109.218 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.86 71.42 1.04 Allowed 'General case' 0 N--CA 1.509 2.512 0 O-C-N 120.672 -1.268 . . . . 0.0 109.888 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 1.127 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 45.3 mt-10 -143.75 175.37 10.04 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.354 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.498 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.25 126.66 39.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.79 -1.194 . . . . 0.0 109.978 176.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.831 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.1 mt -111.41 156.17 22.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.329 -0.857 . . . . 0.0 109.391 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -125.19 110.6 14.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 0.0 111.835 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.707 HD12 ' CD2' ' A' ' 578' ' ' LEU . 24.8 mt -81.29 110.9 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 597' ' ' GLY . 2.3 mt-30 -54.67 179.25 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.979 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.575 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -59.08 65.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.505 -0.747 . . . . 0.0 111.217 -179.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 115.15 41.71 0.81 Allowed Glycine 0 N--CA 1.485 1.962 0 C-N-CA 119.496 -1.335 . . . . 0.0 111.019 178.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.691 ' HB ' HG23 ' A' ' 594' ' ' ILE . 1.2 t -79.01 103.75 6.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 627' ' ' LYS . 5.2 t30 -141.4 136.41 15.67 Favored Pre-proline 0 C--N 1.283 -2.314 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.258 -178.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.545 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.4 Cg_endo -90.44 161.28 32.53 Favored 'Cis proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.41 -1.913 . . . . 0.0 109.366 -1.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.548 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 2.9 t80 -107.03 116.26 31.62 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.557 ' HB3' ' SG ' ' A' ' 609' ' ' CYS . 58.8 m-85 -87.48 143.74 27.07 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 110.162 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.834 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.6 mt -140.56 142.16 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.782 -0.574 . . . . 0.0 110.345 -177.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.785 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 166.14 -165.22 38.04 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.617 -1.278 . . . . 0.0 111.131 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 10.1 tpt180 -60.67 -55.55 31.97 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.854 -0.791 . . . . 0.0 111.879 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.43 126.15 28.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 111.499 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.44 ' HB2' ' HD2' ' A' ' 612' ' ' LYS . 42.3 tt0 -52.67 -19.05 2.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.418 -0.801 . . . . 0.0 110.046 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 607' ' ' GLU . 0.9 OUTLIER -42.36 -35.39 1.0 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.399 -0.813 . . . . 0.0 109.092 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 602' ' ' PHE . 1.3 m -64.92 133.76 52.52 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.548 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -45.72 -28.16 0.97 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.389 -0.82 . . . . 0.0 109.544 179.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.834 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.4 t -107.6 143.53 35.92 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.463 ' O ' ' CG2' ' A' ' 588' ' ' ILE . 0.3 OUTLIER -107.7 129.0 55.06 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.078 -1.014 . . . . 0.0 113.178 -178.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.772 ' CG2' HD13 ' A' ' 690' ' ' ILE . 13.5 mt -143.5 109.5 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.5 ' H ' HD12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -97.8 103.6 15.55 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 117.865 -1.534 . . . . 0.0 109.535 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.769 ' OD2' HD13 ' A' ' 681' ' ' ILE . 0.2 OUTLIER -139.38 106.93 5.57 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.965 177.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -41.33 -41.65 2.0 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.611 -0.681 . . . . 0.0 111.993 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -83.84 -17.69 40.08 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.064 -1.023 . . . . 0.0 111.502 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.728 HD22 HG22 ' A' ' 613' ' ' ILE . 0.6 OUTLIER -80.16 130.4 35.21 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.212 -0.93 . . . . 0.0 110.691 -179.189 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.415 ' CB ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -66.78 160.84 24.99 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.254 -0.904 . . . . 0.0 111.169 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.785 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -64.74 -47.04 79.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.233 -0.917 . . . . 0.0 109.746 179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.476 ' O ' ' C ' ' A' ' 622' ' ' HIS . 3.7 m -95.32 2.4 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.247 -0.908 . . . . 0.0 109.316 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.735 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.8 t60 -25.36 -46.43 0.02 OUTLIER 'General case' 0 C--O 1.193 -1.897 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.267 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.806 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -136.92 146.33 45.34 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 118.32 -1.352 . . . . 0.0 111.336 179.121 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.546 ' HA ' HG13 ' A' ' 603' ' ' ILE . 14.7 p90 -145.86 143.77 29.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.563 -0.71 . . . . 0.0 109.997 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.901 HD12 HD11 ' A' ' 580' ' ' LEU . 10.7 mt -102.85 118.2 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.431 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 5.0 t80 -113.39 155.07 25.89 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.572 0.701 . . . . 0.0 109.544 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 5.6 ttmt -119.67 137.16 54.07 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.617 0.723 . . . . 0.0 110.773 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.431 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.49 164.16 28.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.741 -0.6 . . . . 0.0 110.167 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.3 tpt180 -77.75 118.97 20.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.128 -0.983 . . . . 0.0 109.043 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.532 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.7 t60 -58.43 124.45 19.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.566 -0.709 . . . . 0.0 110.719 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -98.35 125.35 43.45 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.689 -0.632 . . . . 0.0 110.279 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 52.3 t -83.63 161.8 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.315 -0.866 . . . . 0.0 110.223 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . . . . . . . . . . . -79.9 -165.22 30.99 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.91 88.98 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.33 -1.1 . . . . 0.0 110.205 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 637' ' ' TYR . 9.4 p -101.58 83.68 2.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.308 -0.87 . . . . 0.0 110.451 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -95.8 36.81 1.25 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.341 -0.85 . . . . 0.0 109.821 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 635' ' ' SER . 3.3 p90 -148.59 -153.11 0.47 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.586 -0.696 . . . . 0.0 109.506 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -115.21 102.83 10.26 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.109 -0.994 . . . . 0.0 109.134 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 75.8 p -136.24 152.15 74.68 Favored Pre-proline 0 C--N 1.293 -1.882 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.014 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.608 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 44.9 Cg_endo -67.91 -150.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.803 1.422 . . . . 0.0 109.821 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 68.21 -62.74 0.35 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.626 -0.671 . . . . 0.0 110.326 -179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.75 -162.57 0.06 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.243 -0.911 . . . . 0.0 110.313 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.647 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -111.99 129.89 9.33 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.826 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.0 mp -143.91 -150.59 0.32 Allowed 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.7 m-20 -108.1 124.38 50.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.98 -1.075 . . . . 0.0 111.264 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 628' ' ' LYS . 29.5 t70 -110.11 141.05 43.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.452 -0.78 . . . . 0.0 109.803 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 22.6 pt -95.97 132.44 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.243 -0.911 . . . . 0.0 110.105 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.879 ' CH2' HD22 ' A' ' 671' ' ' LEU . 95.5 m95 -119.07 122.12 41.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.616 -0.678 . . . . 0.0 111.179 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.688 ' HB2' HD11 ' A' ' 672' ' ' LEU . 11.9 t80 -85.21 115.69 23.13 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 624' ' ' PHE . 22.5 m -108.11 102.9 12.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.186 -0.946 . . . . 0.0 111.582 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.534 ' CD2' ' N ' ' A' ' 652' ' ' THR . 12.2 t60 -63.89 159.28 20.09 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.442 -0.786 . . . . 0.0 109.93 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.735 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.44 -29.55 0.18 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.435 -0.791 . . . . 0.0 112.757 -179.196 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.573 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.29 -165.59 30.28 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 117.857 -2.116 . . . . 0.0 109.937 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 26.0 m -93.6 -18.87 21.72 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.064 -1.256 . . . . 0.0 114.025 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.722 ' OD1' HD12 ' A' ' 681' ' ' ILE . 19.4 m120 -60.04 -2.56 0.44 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.663 -1.273 . . . . 0.0 112.564 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.684 HG13 ' C ' ' A' ' 655' ' ' ASN . 0.8 OUTLIER 63.11 142.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-O 121.583 0.706 . . . . 0.0 110.173 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.507 ' OG ' ' HB2' ' A' ' 664' ' ' MET . 0.0 OUTLIER -94.52 150.49 20.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.691 -0.631 . . . . 0.0 110.729 -179.034 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.483 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 20.2 m-85 -135.05 126.4 28.38 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.332 -0.855 . . . . 0.0 110.437 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.728 HD21 ' OD2' ' A' ' 676' ' ' ASP . 0.0 OUTLIER -134.2 120.8 20.5 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.21 -0.931 . . . . 0.0 109.926 179.251 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 56.3 -85.15 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.569 -0.707 . . . . 0.0 110.521 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 659' ' ' LEU . 55.6 t30 -148.17 25.46 1.0 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.221 -0.924 . . . . 0.0 110.247 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -119.34 117.52 28.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 0.0 110.447 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.415 ' CG ' ' CE1' ' A' ' 658' ' ' TYR . 2.7 tmm_? -87.24 138.33 31.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.374 -0.829 . . . . 0.0 109.983 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.732 ' SD ' HG13 ' A' ' 716' ' ' VAL . 0.3 OUTLIER -112.83 -152.68 0.51 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.278 -0.889 . . . . 0.0 109.969 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.502 HG13 HG23 ' A' ' 668' ' ' THR . 1.1 pp -143.4 -165.96 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.241 -0.912 . . . . 0.0 110.706 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 652' ' ' THR . 50.3 tt0 -76.58 83.99 3.25 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.483 -0.761 . . . . 0.0 110.412 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 117.88 53.15 0.31 Allowed Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -122.92 149.17 44.6 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.098 -1.236 . . . . 0.0 110.08 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 717' ' ' LEU . 3.8 tttt -108.64 146.34 33.54 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.502 -0.749 . . . . 0.0 109.472 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.553 ' CD2' HD22 ' A' ' 659' ' ' LEU . 9.7 t80 -145.17 147.82 32.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.12 -0.988 . . . . 0.0 112.404 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.879 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.12 131.8 45.56 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.599 -0.688 . . . . 0.0 109.535 179.382 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.742 HD23 ' OD2' ' A' ' 676' ' ' ASP . 7.2 mt -105.88 104.95 14.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.049 -1.032 . . . . 0.0 111.227 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 87.6 mt-30 -91.73 146.75 23.52 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.558 -0.714 . . . . 0.0 109.127 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.699 ' OD1' HD12 ' A' ' 707' ' ' LEU . 8.7 p-10 -43.94 147.84 0.45 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.139 -0.975 . . . . 0.0 110.397 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 66.31 48.1 66.46 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 107.587 -2.205 . . . . 0.0 107.587 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.742 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.3 OUTLIER -110.27 90.15 3.23 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.798 -0.825 . . . . 0.0 110.787 -178.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.966 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 3.2 tt0 -93.46 107.03 18.94 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.658 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.8 pt -105.49 136.87 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.861 -0.524 . . . . 0.0 110.972 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 25.2 mttt -95.31 110.32 22.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.569 -0.707 . . . . 0.0 109.637 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.806 HD13 ' SG ' ' A' ' 623' ' ' CYS . 63.4 mt -76.72 -22.77 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.183 -0.948 . . . . 0.0 110.074 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.769 HD13 ' OD2' ' A' ' 615' ' ' ASP . 15.0 tt -143.39 137.92 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.241 -0.912 . . . . 0.0 110.284 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -138.07 112.78 8.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.203 -0.936 . . . . 0.0 110.701 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.93 117.19 28.15 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.233 -0.917 . . . . 0.0 109.753 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -67.57 -47.6 69.3 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.423 -0.798 . . . . 0.0 111.475 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.23 -43.47 13.74 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.307 -0.871 . . . . 0.0 111.225 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.01 -7.07 51.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.211 -0.93 . . . . 0.0 110.914 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.95 24.15 3.24 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.152 -0.968 . . . . 0.0 110.038 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -90.03 95.98 10.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.44 -0.787 . . . . 0.0 109.681 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 586' ' ' SER . 31.5 m -125.79 142.36 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 111.059 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.772 HD13 ' CG2' ' A' ' 613' ' ' ILE . 12.2 mt -123.81 164.06 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -175.38 142.94 6.42 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.439 -1.362 . . . . 0.0 110.376 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.966 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 17.0 m-85 -129.14 137.6 51.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.503 -0.998 . . . . 0.0 109.865 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -98.45 113.66 25.74 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.219 -0.925 . . . . 0.0 109.682 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.641 HG22 HD11 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -82.66 121.48 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.361 -0.837 . . . . 0.0 109.074 179.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.05 104.62 7.44 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.581 -0.699 . . . . 0.0 110.237 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . . . . . . . . . 60.2 mt -81.12 104.17 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.325 -0.86 . . . . 0.0 109.552 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -75.57 -42.1 53.02 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.377 -0.827 . . . . 0.0 108.996 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.462 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.1 m-20 -110.66 141.3 44.09 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.637 0.732 . . . . 0.0 110.521 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 21.9 p -114.99 96.04 5.5 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 16.1 p -128.12 131.99 48.97 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.235 0.54 . . . . 0.0 110.707 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 51.86 32.37 33.56 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.823 ' O ' HD22 ' A' ' 644' ' ' LEU . 4.1 tp -108.09 138.37 44.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.45 -1.029 . . . . 0.0 110.717 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.826 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.1 p90 -54.92 -24.03 21.67 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.563 -0.71 . . . . 0.0 109.921 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.588 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.2 t30 -172.37 157.01 3.95 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.603 ' OE1' HD13 ' A' ' 707' ' ' LEU . 13.0 pt-20 -51.11 -24.36 3.95 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.11 -0.994 . . . . 0.0 110.546 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 118.66 15.74 5.73 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.699 HD12 ' OD1' ' A' ' 674' ' ' ASP . 1.1 tp -82.76 9.13 10.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.03 -1.277 . . . . 0.0 111.431 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.551 ' O ' ' HG3' ' A' ' 709' ' ' MET . . . 92.08 -76.92 1.31 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.551 ' HG3' ' O ' ' A' ' 708' ' ' GLY . 0.5 OUTLIER 25.22 88.75 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.914 -0.757 . . . . 0.0 112.079 -179.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.408 ' N ' HD23 ' A' ' 710' ' ' LEU . 1.0 OUTLIER -163.59 178.89 7.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 0.0 110.362 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -80.57 -54.16 5.91 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.367 -0.833 . . . . 0.0 109.688 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.81 149.03 47.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.456 -0.778 . . . . 0.0 109.826 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.59 95.51 5.61 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.237 -0.915 . . . . 0.0 109.393 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.447 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 0.3 OUTLIER 40.11 76.7 0.06 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.355 0.598 . . . . 0.0 111.616 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 715' ' ' VAL . 35.4 m -107.69 153.33 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.465 -0.772 . . . . 0.0 109.3 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.732 HG13 ' SD ' ' A' ' 664' ' ' MET . 58.1 t -98.39 133.11 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.935 . . . . 0.0 110.797 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 669' ' ' LYS . 4.0 mp -102.44 156.63 17.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.509 -0.744 . . . . 0.0 109.569 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.13 154.11 17.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.192 -0.942 . . . . 0.0 110.489 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -87.27 146.2 26.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.389 -0.82 . . . . 0.0 110.345 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 10.5 p -121.21 -176.12 3.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.343 -0.848 . . . . 0.0 110.309 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.2 -28.84 28.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.416 -0.802 . . . . 0.0 110.097 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.58 -47.49 75.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.356 -0.84 . . . . 0.0 109.552 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -63.85 -48.01 78.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.394 -0.816 . . . . 0.0 109.772 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.547 ' O ' HG12 ' A' ' 727' ' ' VAL . 12.2 tttt -53.77 -32.37 52.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.333 -0.854 . . . . 0.0 110.065 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.21 -36.24 79.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.377 -0.827 . . . . 0.0 110.21 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 32.9 mt -59.52 -46.53 88.58 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.273 -0.892 . . . . 0.0 110.325 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 724' ' ' LYS . 8.5 p -70.79 -18.92 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.142 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.91 -43.74 69.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.214 -0.929 . . . . 0.0 108.824 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.59 103.52 10.48 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 122.281 1.039 . . . . 0.0 109.177 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.411 ' O ' ' CD2' ' A' ' 602' ' ' PHE . 0.4 OUTLIER . . . . . 0 C--N 1.274 -2.712 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.365 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -83.82 2.77 36.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.366 -1.079 . . . . 0.0 110.696 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 139.38 -16.34 3.16 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -92.26 115.71 28.32 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.302 -1.117 . . . . 0.0 109.516 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.813 ' CE2' HD11 ' A' ' 702' ' ' LEU . 0.2 OUTLIER -106.49 -40.09 5.68 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.92 0.867 . . . . 0.0 109.545 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.979 HD22 HD12 ' A' ' 594' ' ' ILE . 9.7 tt -117.95 119.86 36.09 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.713 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 86.1 m -98.4 116.55 30.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.291 -0.881 . . . . 0.0 109.074 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.802 HD11 ' CD1' ' A' ' 625' ' ' ILE . 2.4 mt -90.78 112.16 23.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.415 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 2.4 mmtt -112.81 101.89 53.74 Favored Pre-proline 0 C--N 1.3 -1.548 0 C-N-CA 118.153 -1.419 . . . . 0.0 112.737 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 1.042 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.0 Cg_endo -79.55 144.97 18.14 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 N-CA-C 106.454 -2.172 . . . . 0.0 106.454 174.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.741 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.62 -173.54 0.28 Allowed Pre-proline 0 N--CA 1.494 1.74 0 C-N-CA 118.651 -1.22 . . . . 0.0 112.791 -176.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.741 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.2 Cg_endo -66.55 -28.3 45.4 Favored 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 124.113 1.586 . . . . 0.0 110.176 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.31 -28.4 66.76 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 46.7 p -95.43 153.57 17.63 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.584 ' H ' HD13 ' A' ' 690' ' ' ILE . 5.7 tp -57.07 -16.38 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 119.344 -0.942 . . . . 0.0 109.831 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.868 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.2 tp -113.98 117.73 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.219 -0.925 . . . . 0.0 110.231 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.95 80.82 1.34 Allowed 'General case' 0 N--CA 1.508 2.46 0 O-C-N 120.219 -1.551 . . . . 0.0 109.209 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 1.042 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 33.8 mm-40 -142.24 175.81 9.47 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.823 -178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.569 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.66 125.48 40.18 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.138 -0.976 . . . . 0.0 109.096 176.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 611' ' ' CYS . 61.5 mt -111.39 156.07 22.16 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.369 -0.832 . . . . 0.0 109.987 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -125.25 111.05 14.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.356 -0.84 . . . . 0.0 111.802 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.979 HD12 HD22 ' A' ' 578' ' ' LEU . 39.9 mt -82.31 110.61 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.51 ' O ' ' C ' ' A' ' 596' ' ' GLN . 21.2 mm100 -69.39 114.9 8.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.499 -0.751 . . . . 0.0 112.794 -177.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.51 ' C ' ' O ' ' A' ' 595' ' ' GLN . 0.0 OUTLIER 14.6 56.77 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 178.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 106.98 46.65 1.08 Allowed Glycine 0 N--CA 1.486 1.988 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.845 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.622 ' HB ' HG23 ' A' ' 594' ' ' ILE . 1.0 OUTLIER -79.4 104.66 7.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 177.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 2.8 t30 -140.41 137.9 18.27 Favored Pre-proline 0 C--N 1.28 -2.421 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.103 -178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.705 ' HB3' HD23 ' A' ' 726' ' ' LEU . 56.7 Cg_endo -90.01 160.18 34.22 Favored 'Cis proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.009 -2.08 . . . . 0.0 109.581 -0.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 4.5 t80 -107.29 116.73 32.44 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.73 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 52.3 m-85 -91.23 145.77 24.39 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.207 -0.933 . . . . 0.0 110.817 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.699 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.2 mt -139.68 141.17 35.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.491 -0.755 . . . . 0.0 110.436 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.739 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 174.17 -167.12 39.44 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.431 -1.366 . . . . 0.0 111.362 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.447 ' HD2' ' HA ' ' A' ' 614' ' ' GLU . 6.7 mmm-85 -64.34 -40.61 96.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.919 -0.754 . . . . 0.0 110.834 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -84.23 127.81 34.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.396 -0.815 . . . . 0.0 111.446 -178.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.4 ' CG ' ' HD2' ' A' ' 612' ' ' LYS . 37.1 tt0 -57.67 -14.88 6.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.356 -0.84 . . . . 0.0 109.854 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -44.23 -36.97 2.94 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.413 -0.804 . . . . 0.0 110.092 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.73 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 74.8 m -71.42 151.85 43.64 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.385 -0.822 . . . . 0.0 109.575 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.553 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -57.78 -14.5 5.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.432 -0.792 . . . . 0.0 110.508 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.699 ' SG ' HG23 ' A' ' 603' ' ' ILE . 7.0 t -120.4 143.66 48.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.546 -0.721 . . . . 0.0 109.692 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.59 ' O ' HG12 ' A' ' 588' ' ' ILE . 1.7 ttpm? -111.82 130.68 55.73 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 122.053 0.93 . . . . 0.0 112.769 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.651 HD11 ' CE1' ' A' ' 692' ' ' PHE . 4.8 mt -146.55 110.58 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.466 ' O ' HG12 ' A' ' 587' ' ' ILE . 1.2 mt-10 -93.64 102.34 14.51 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 117.73 -1.588 . . . . 0.0 109.306 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.726 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.1 m-20 -138.39 105.85 5.55 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.184 177.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 615' ' ' ASP . 1.7 t30 -35.9 -48.28 0.56 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.632 -0.668 . . . . 0.0 112.583 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -83.55 -17.44 41.79 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.969 -1.082 . . . . 0.0 111.963 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.641 HD22 HG22 ' A' ' 613' ' ' ILE . 0.6 OUTLIER -72.71 125.39 27.4 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.95 -1.094 . . . . 0.0 110.697 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -67.0 161.15 24.95 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.372 -0.83 . . . . 0.0 111.031 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.739 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -64.16 -45.56 87.92 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.243 -0.91 . . . . 0.0 109.223 179.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.59 ' HB ' HG23 ' A' ' 727' ' ' VAL . 12.4 m -94.86 2.3 9.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 O-C-N 121.386 -0.821 . . . . 0.0 109.336 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.9 t60 -29.09 -46.74 0.05 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.988 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.829 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -136.46 145.24 44.97 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 118.514 -1.274 . . . . 0.0 110.777 179.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 4.1 p90 -145.57 144.05 30.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.55 -0.719 . . . . 0.0 110.116 178.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.802 ' CD1' HD11 ' A' ' 580' ' ' LEU . 76.0 mt -103.31 120.4 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.435 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 3.7 t80 -114.46 155.1 27.0 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.618 0.723 . . . . 0.0 109.666 -178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 5.1 ttmt -118.01 137.45 52.87 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 121.639 0.733 . . . . 0.0 110.337 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.435 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.1 OUTLIER -136.11 164.33 28.27 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.707 -0.62 . . . . 0.0 110.757 -179.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 2.0 tpt180 -77.52 117.26 18.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.295 -0.878 . . . . 0.0 108.677 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.51 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 5.6 t60 -58.57 124.55 20.05 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.591 0.71 . . . . 0.0 110.941 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -95.31 83.63 3.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.664 -0.648 . . . . 0.0 110.018 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.541 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.5 p -56.55 170.18 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.493 -0.754 . . . . 0.0 110.522 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.541 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -59.67 -168.89 0.32 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -59.17 133.56 56.2 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.308 -1.113 . . . . 0.0 110.238 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 74.4 p -95.55 40.32 1.11 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.376 -0.828 . . . . 0.0 110.405 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 17.3 mtt -89.87 48.17 1.55 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.382 -0.824 . . . . 0.0 109.873 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -172.89 -152.02 0.06 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.431 -0.793 . . . . 0.0 109.525 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -115.63 101.63 9.02 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.179 -0.95 . . . . 0.0 108.804 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 5.4 p -137.09 151.36 71.76 Favored Pre-proline 0 C--N 1.293 -1.868 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.087 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.569 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 49.6 Cg_endo -70.86 -154.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.705 1.371 . . . . 0.0 109.944 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 65.77 -62.86 0.23 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.781 -0.575 . . . . 0.0 110.77 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 640' ' ' PRO . 23.3 tt0 52.69 32.06 11.33 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.084 -1.01 . . . . 0.0 110.169 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.417 ' O ' ' HG ' ' A' ' 644' ' ' LEU . . . 69.38 119.18 0.03 OUTLIER Glycine 0 N--CA 1.487 2.036 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 629' ' ' ARG . 4.2 mt -139.55 -157.31 0.76 Allowed 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.724 ' O ' HD23 ' A' ' 702' ' ' LEU . 0.7 OUTLIER -115.04 124.53 51.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.877 -1.139 . . . . 0.0 111.476 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.754 ' CG ' HD11 ' A' ' 671' ' ' LEU . 12.6 t0 -108.18 156.67 19.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.524 -0.735 . . . . 0.0 109.871 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.588 HD13 ' CD1' ' A' ' 578' ' ' LEU . 14.6 pt -104.85 131.72 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.314 -0.866 . . . . 0.0 110.174 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.742 ' CH2' HD13 ' A' ' 671' ' ' LEU . 97.9 m95 -118.56 121.0 39.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.684 -0.635 . . . . 0.0 110.937 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.6 ' HB2' HD11 ' A' ' 672' ' ' LEU . 8.8 t80 -80.82 114.82 19.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 108.67 178.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.555 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 8.8 t -107.6 109.02 20.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.189 -0.944 . . . . 0.0 111.432 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.605 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 10.5 t60 -75.04 160.18 30.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.0 109.979 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -150.69 -32.4 0.17 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.394 -0.816 . . . . 0.0 112.868 -178.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.605 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -79.38 130.35 9.8 Favored Glycine 0 N--CA 1.501 2.967 0 C-N-CA 117.897 -2.097 . . . . 0.0 109.976 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.405 ' C ' ' H ' ' A' ' 656' ' ' VAL . 14.5 m -36.01 -23.42 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 115.383 1.624 . . . . 0.0 115.383 -177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.52 ' C ' HG23 ' A' ' 656' ' ' VAL . 4.5 t-20 -54.97 -4.51 0.07 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.336 -1.478 . . . . 0.0 113.197 -178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.652 HG13 ' O ' ' A' ' 664' ' ' MET . 4.3 t 75.31 150.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.413 0 O-C-N 121.592 -0.692 . . . . 0.0 110.984 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.572 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -111.66 151.9 28.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.577 -0.702 . . . . 0.0 110.347 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -138.39 126.47 22.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.287 -0.883 . . . . 0.0 109.863 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 1.018 HD13 HG22 ' A' ' 678' ' ' ILE . 19.4 tp -128.11 110.24 12.28 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.869 . . . . 0.0 110.161 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.67 -72.9 0.05 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.637 -0.664 . . . . 0.0 109.985 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 659' ' ' LEU . 4.9 m-80 -153.82 19.36 0.52 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.354 -0.841 . . . . 0.0 110.435 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.425 ' ND2' HG23 ' A' ' 716' ' ' VAL . 9.6 t-20 -116.95 116.92 28.32 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.031 -1.043 . . . . 0.0 110.501 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.97 141.6 32.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 109.579 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.652 ' O ' HG13 ' A' ' 656' ' ' VAL . 0.8 OUTLIER -115.2 -169.17 1.51 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 110.681 -179.214 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.646 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.1 pt -120.3 -165.62 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.41 -0.806 . . . . 0.0 110.068 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -84.22 73.02 10.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.36 -0.838 . . . . 0.0 110.569 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 130.47 54.47 0.1 OUTLIER Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.646 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.0 OUTLIER -121.77 151.28 40.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -1.187 . . . . 0.0 110.106 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.773 ' HE2' HD11 ' A' ' 717' ' ' LEU . 7.2 tttt -109.04 139.69 43.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.486 -0.759 . . . . 0.0 109.411 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.948 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -144.36 146.59 32.64 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.299 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.754 HD11 ' CG ' ' A' ' 646' ' ' ASP . 12.7 tp -70.56 146.16 50.32 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.32 -0.862 . . . . 0.0 111.227 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.6 HD11 ' HB2' ' A' ' 649' ' ' TYR . 7.7 mt -118.93 102.15 8.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 110.585 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.412 ' NE2' ' HA3' ' A' ' 708' ' ' GLY . 71.9 mt-30 -84.53 160.61 20.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.458 -0.777 . . . . 0.0 109.204 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 706' ' ' GLY . 21.4 p-10 -52.25 149.31 5.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.008 -1.057 . . . . 0.0 110.289 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 63.75 50.14 63.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 107.827 -2.109 . . . . 0.0 107.827 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.441 ' HB3' HD22 ' A' ' 672' ' ' LEU . 0.2 OUTLIER -110.8 94.9 5.23 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.715 -0.874 . . . . 0.0 111.098 -178.648 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.891 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -94.64 106.83 18.83 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.414 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 1.018 HG22 HD13 ' A' ' 659' ' ' LEU . 17.6 pt -106.78 135.8 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.474 -0.766 . . . . 0.0 111.328 -178.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -98.52 109.57 22.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.369 -0.832 . . . . 0.0 109.146 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.829 HD13 ' SG ' ' A' ' 623' ' ' CYS . 89.7 mt -74.86 -42.19 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.39 -0.819 . . . . 0.0 110.537 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.635 HD12 ' HB2' ' A' ' 618' ' ' LEU . 3.1 mt -130.75 132.95 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.202 -0.936 . . . . 0.0 110.347 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -138.75 112.04 8.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.571 -0.706 . . . . 0.0 109.904 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -129.94 117.91 20.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -0.905 . . . . 0.0 110.248 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -29.73 69.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.466 -0.771 . . . . 0.0 110.721 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -55.69 -43.36 76.33 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.365 -0.835 . . . . 0.0 111.031 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 688' ' ' PHE . 2.1 t30 -137.26 36.0 2.52 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.192 -0.942 . . . . 0.0 110.256 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.756 ' O ' HG23 ' A' ' 689' ' ' VAL . 0.8 OUTLIER 65.54 -67.82 0.13 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.77 -0.581 . . . . 0.0 109.856 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.509 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.1 OUTLIER 28.72 52.67 0.07 Allowed 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.244 0.545 . . . . 0.0 111.346 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 687' ' ' LYS . 91.6 t -101.76 142.64 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.392 -0.818 . . . . 0.0 110.674 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.726 HD11 ' OD2' ' A' ' 615' ' ' ASP . 44.5 mm -120.0 165.32 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 179.79 121.37 0.72 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.052 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.891 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.8 m-85 -119.9 136.6 54.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.54 -0.977 . . . . 0.0 108.978 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.78 114.28 27.93 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.216 -0.927 . . . . 0.0 110.511 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -82.97 120.62 34.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.151 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -127.08 104.5 8.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.753 -0.592 . . . . 0.0 110.077 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.469 HD13 ' O ' ' A' ' 705' ' ' GLU . 65.4 mt -84.35 103.63 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.665 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -80.99 -42.97 20.34 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.9 OUTLIER -110.81 140.27 45.38 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.483 0.659 . . . . 0.0 110.271 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 12.1 p -114.9 96.13 5.56 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 35.7 m -117.94 121.67 41.28 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.208 0.528 . . . . 0.0 110.607 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.509 ' C ' HD22 ' A' ' 644' ' ' LEU . . . 52.41 45.5 58.65 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.813 HD11 ' CE2' ' A' ' 577' ' ' PHE . 3.7 mt -115.38 132.81 56.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.439 -1.036 . . . . 0.0 110.728 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.645 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 3.1 p90 -47.43 -24.71 0.87 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.568 0.699 . . . . 0.0 110.47 179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.645 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER -170.8 155.0 4.53 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.093 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.738 ' OE2' HD23 ' A' ' 707' ' ' LEU . 11.7 pt-20 -51.15 -26.78 7.24 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.194 -0.941 . . . . 0.0 110.398 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 119.71 18.47 4.38 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.738 HD23 ' OE2' ' A' ' 705' ' ' GLU . 0.1 OUTLIER -83.06 9.28 10.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.071 -1.252 . . . . 0.0 111.74 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.412 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 69.39 84.21 0.15 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.652 ' C ' HD23 ' A' ' 710' ' ' LEU . 0.2 OUTLIER -117.35 101.89 8.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.421 -1.046 . . . . 0.0 110.403 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.652 HD23 ' C ' ' A' ' 709' ' ' MET . 0.7 OUTLIER -175.87 153.47 1.37 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.02 -1.05 . . . . 0.0 110.499 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -42.08 97.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.359 -0.838 . . . . 0.0 109.663 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.65 149.04 47.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.454 -0.779 . . . . 0.0 109.559 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -110.4 95.32 5.5 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.172 -0.955 . . . . 0.0 109.697 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.731 ' NH1' HD21 ' A' ' 659' ' ' LEU . 1.3 mmm-85 38.32 84.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.893 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.444 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 35.5 m -108.31 151.13 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.455 -0.778 . . . . 0.0 109.583 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.45 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 87.5 t -98.44 127.47 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.266 -0.896 . . . . 0.0 110.758 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.773 HD11 ' HE2' ' A' ' 669' ' ' LYS . 0.5 OUTLIER -114.22 145.74 41.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.58 -0.7 . . . . 0.0 109.347 179.057 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.95 149.62 35.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.159 -0.963 . . . . 0.0 110.693 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . 0.408 ' HB2' ' CB ' ' A' ' 723' ' ' GLU . 9.1 pt20 -81.03 154.29 26.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.419 -0.801 . . . . 0.0 110.278 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 11.5 p -108.38 -176.61 3.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.331 -0.856 . . . . 0.0 110.677 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.51 -29.42 36.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.415 -0.803 . . . . 0.0 110.157 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . 0.461 ' O ' HD13 ' A' ' 726' ' ' LEU . 11.1 tp10 -60.72 -52.48 64.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.369 -0.832 . . . . 0.0 109.499 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.408 ' CB ' ' HB2' ' A' ' 719' ' ' GLN . 3.3 mp0 -63.89 -42.72 97.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 0.0 109.378 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.521 ' O ' HG12 ' A' ' 727' ' ' VAL . 1.4 mmtm -54.12 -32.21 54.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.341 -0.85 . . . . 0.0 109.552 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.26 -38.45 78.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.471 -0.768 . . . . 0.0 110.399 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.705 HD23 ' HB3' ' A' ' 600' ' ' PRO . 11.0 mp -55.75 -47.83 76.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.245 -0.909 . . . . 0.0 110.521 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.59 HG23 ' HB ' ' A' ' 621' ' ' VAL . 8.1 p -69.65 -22.22 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.226 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -51.44 65.06 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 108.912 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.84 104.98 11.87 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.171 0.986 . . . . 0.0 109.062 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 2.0 mt . . . . . 0 C--N 1.275 -2.657 0 CA-C-O 117.969 -1.015 . . . . 0.0 110.444 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -83.18 -10.36 58.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.395 -1.062 . . . . 0.0 110.619 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 126.41 -30.68 4.21 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.405 ' CZ ' ' HG2' ' A' ' 593' ' ' GLU . 0.7 OUTLIER -92.59 114.39 26.93 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.325 -1.103 . . . . 0.0 109.661 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.504 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 6.7 t80 -98.09 -41.7 7.81 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.867 0.841 . . . . 0.0 109.678 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.846 HD23 HD12 ' A' ' 594' ' ' ILE . 48.5 tp -129.39 119.77 24.41 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.272 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 89.2 m -94.89 116.43 28.7 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.431 -0.908 . . . . 0.0 108.701 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 1.008 HD11 HD12 ' A' ' 625' ' ' ILE . 7.4 mt -89.91 111.34 22.36 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.522 ' O ' ' CD1' ' A' ' 583' ' ' LEU . 0.4 OUTLIER -114.08 102.77 55.09 Favored Pre-proline 0 C--N 1.298 -1.638 0 C-N-CA 118.116 -1.434 . . . . 0.0 112.463 -177.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 1.093 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.8 Cg_endo -79.63 143.97 17.26 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 N-CA-C 107.134 -1.91 . . . . 0.0 107.134 174.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 1.03 ' HB2' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -128.06 -173.98 0.34 Allowed Pre-proline 0 C--N 1.3 -1.585 0 C-N-CA 118.958 -1.097 . . . . 0.0 112.381 -177.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 1.03 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 35.3 Cg_endo -60.5 -33.43 93.88 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.819 1.431 . . . . 0.0 111.556 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 689' ' ' VAL . 4.3 m-20 -59.73 -23.99 63.65 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.734 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 19.1 t -95.73 151.45 19.36 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.804 HD13 ' HB2' ' A' ' 688' ' ' PHE . 7.8 tp -62.34 -17.09 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.026 -1.046 . . . . 0.0 109.647 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.957 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.2 tp -108.21 122.72 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.318 -0.864 . . . . 0.0 110.187 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 586' ' ' SER . 23.6 mp0 -110.07 79.8 1.25 Allowed 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.463 -1.398 . . . . 0.0 109.399 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 1.093 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 27.2 mt-10 -144.71 175.45 10.16 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.643 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.544 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.13 124.77 35.57 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.138 -0.976 . . . . 0.0 108.889 175.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.639 HD13 ' SG ' ' A' ' 611' ' ' CYS . 2.1 mt -109.53 155.73 21.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.232 -0.918 . . . . 0.0 109.565 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.405 ' HG2' ' CZ ' ' A' ' 576' ' ' ARG . 3.1 mp0 -125.26 110.25 13.81 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.373 -0.829 . . . . 0.0 111.346 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.846 HD12 HD23 ' A' ' 578' ' ' LEU . 2.0 mt -81.61 109.21 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.539 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.2 OUTLIER -56.15 165.07 1.08 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.446 -179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.504 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.0 OUTLIER -63.17 70.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.54 -0.725 . . . . 0.0 110.065 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 137.79 21.83 0.48 Allowed Glycine 0 N--CA 1.487 2.089 0 C-N-CA 119.579 -1.296 . . . . 0.0 110.819 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.623 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -84.29 101.67 9.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 O-C-N 120.764 -1.433 . . . . 0.0 107.21 178.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.429 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 16.3 t-20 -145.46 132.57 10.1 Favored Pre-proline 0 C--N 1.283 -2.312 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.869 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.65 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 53.9 Cg_endo -91.71 163.5 27.77 Favored 'Cis proline' 0 C--N 1.311 -1.409 0 C-N-CA 123.31 -1.538 . . . . 0.0 109.045 -2.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.536 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 7.9 t80 -105.11 116.91 32.75 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.677 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 70.0 m-85 -86.34 146.15 26.6 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.416 -0.803 . . . . 0.0 111.406 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.686 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.9 mt -141.68 140.69 30.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.703 -0.623 . . . . 0.0 109.895 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.732 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 175.25 -161.41 30.59 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.298 -1.429 . . . . 0.0 111.436 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.408 ' CG ' ' O ' ' A' ' 615' ' ' ASP . 5.9 mmm-85 -69.7 -44.65 69.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.973 -0.722 . . . . 0.0 110.82 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.417 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -80.06 128.22 33.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.454 -0.779 . . . . 0.0 110.981 -178.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 1.6 pt-20 -58.54 -12.79 4.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.429 -0.794 . . . . 0.0 109.657 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . 0.452 ' OD2' HD13 ' A' ' 730' ' ' LEU . 15.7 t70 -45.25 -36.07 3.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.483 -0.761 . . . . 0.0 110.155 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.677 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 81.8 m -71.44 154.26 41.66 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 121.184 -0.947 . . . . 0.0 109.601 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.536 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -58.98 -14.0 8.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.443 -0.785 . . . . 0.0 110.14 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.686 ' SG ' HG23 ' A' ' 603' ' ' ILE . 6.1 t -120.18 143.94 47.96 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.492 -0.755 . . . . 0.0 110.033 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.571 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -110.63 129.7 55.75 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 121.992 0.901 . . . . 0.0 112.562 -178.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.691 HD11 ' CE1' ' A' ' 692' ' ' PHE . 4.3 mt -146.82 111.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.49 ' O ' HG21 ' A' ' 587' ' ' ILE . 1.4 tt0 -93.05 102.76 15.1 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 117.69 -1.604 . . . . 0.0 109.095 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 3.2 m-20 -138.26 105.29 5.43 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 114.403 -1.271 . . . . 0.0 108.505 177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -42.81 -41.43 3.24 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.412 -0.805 . . . . 0.0 111.881 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.97 -16.88 42.47 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.137 -0.977 . . . . 0.0 111.739 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.598 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.7 OUTLIER -80.75 134.75 35.87 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.121 -0.987 . . . . 0.0 111.319 -178.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.485 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.42 162.83 28.02 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.466 -0.771 . . . . 0.0 111.025 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.732 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 34.2 ttp180 -64.36 -46.77 81.98 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.348 -0.845 . . . . 0.0 109.738 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.569 ' HB ' HG23 ' A' ' 727' ' ' VAL . 13.8 m -94.67 2.43 9.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.209 -0.932 . . . . 0.0 109.059 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.764 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.4 t60 -28.59 -47.85 0.05 Allowed 'General case' 0 C--O 1.192 -1.954 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.751 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.845 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.21 145.16 43.32 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 118.311 -1.356 . . . . 0.0 111.166 179.049 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 6.5 p90 -145.86 150.4 36.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.573 -0.704 . . . . 0.0 110.339 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 1.008 HD12 HD11 ' A' ' 580' ' ' LEU . 19.0 mt -103.41 119.56 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 7.0 t80 -112.61 155.4 24.47 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.482 -0.761 . . . . 0.0 109.351 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 0.8 OUTLIER -119.61 136.06 54.54 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.852 0.834 . . . . 0.0 111.183 -179.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.426 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -140.51 163.54 32.56 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 630' ' ' HIS . 0.0 OUTLIER -78.18 133.98 37.7 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.966 -1.084 . . . . 0.0 109.439 -179.492 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.517 ' O ' ' HD2' ' A' ' 629' ' ' ARG . 1.2 t60 -58.4 123.66 16.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.368 -0.832 . . . . 0.0 111.247 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -75.21 108.38 7.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.636 -0.665 . . . . 0.0 110.487 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.628 HG11 ' N ' ' A' ' 643' ' ' GLY . 7.1 p -109.17 168.27 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.392 -0.817 . . . . 0.0 110.087 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.516 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -110.98 -157.78 15.07 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -59.66 139.5 57.17 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.39 -1.065 . . . . 0.0 110.173 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.39 85.61 3.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.259 -0.901 . . . . 0.0 110.289 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.09 125.35 22.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.873 . . . . 0.0 109.649 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 64.53 -144.78 0.26 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.464 -0.772 . . . . 0.0 109.853 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -115.4 103.02 10.37 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.137 -0.977 . . . . 0.0 109.314 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 13.0 p -135.9 151.36 73.81 Favored Pre-proline 0 C--N 1.294 -1.838 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.737 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.28 -153.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.673 1.354 . . . . 0.0 110.094 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 54.48 20.69 2.92 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.56 -0.712 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.99 60.97 0.55 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.103 -0.998 . . . . 0.0 109.837 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.649 ' C ' HD12 ' A' ' 644' ' ' LEU . . . 62.26 117.71 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.76 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.9 mp -140.84 -146.9 0.2 Allowed 'General case' 0 C--N 1.29 -1.985 0 O-C-N 122.076 -0.661 . . . . 0.0 109.422 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.6 OUTLIER -108.63 124.96 51.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.067 -1.021 . . . . 0.0 110.728 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.736 ' OD2' HD21 ' A' ' 671' ' ' LEU . 17.5 t0 -121.36 135.51 55.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.355 -0.841 . . . . 0.0 110.509 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 25.4 pt -92.69 135.28 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.272 -0.893 . . . . 0.0 110.075 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.645 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.6 m95 -119.62 121.93 40.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.604 -0.685 . . . . 0.0 111.306 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.586 ' HB2' HD11 ' A' ' 672' ' ' LEU . 14.0 t80 -80.78 115.54 20.33 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 9.8 t -107.22 108.45 19.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 111.64 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.516 ' CD2' ' N ' ' A' ' 652' ' ' THR . 12.5 t60 -70.72 158.66 35.88 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.461 -0.774 . . . . 0.0 109.761 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.764 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -149.86 -29.58 0.23 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.43 -0.794 . . . . 0.0 112.441 -179.077 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.55 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.45 -167.59 31.86 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 117.642 -2.218 . . . . 0.0 109.17 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 27.6 m -95.62 -17.44 21.34 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.014 -1.286 . . . . 0.0 113.751 -176.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.516 ' C ' HG23 ' A' ' 656' ' ' VAL . 16.7 m120 -59.48 -4.01 0.54 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 120.775 -1.203 . . . . 0.0 112.683 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.517 HG13 ' O ' ' A' ' 664' ' ' MET . 3.4 t 71.52 148.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-O 121.494 0.664 . . . . 0.0 110.604 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.436 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -106.83 143.09 35.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.721 -0.612 . . . . 0.0 110.068 -179.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.456 ' CE1' ' CG ' ' A' ' 663' ' ' ARG . 36.6 m-85 -136.0 126.74 27.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.211 -0.93 . . . . 0.0 110.701 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.581 ' HG ' HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -130.02 119.04 22.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.392 -0.817 . . . . 0.0 109.787 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 56.89 -86.74 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.388 -0.82 . . . . 0.0 110.429 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 659' ' ' LEU . 3.6 t-20 -138.07 5.73 2.57 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.017 -1.052 . . . . 0.0 110.984 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -96.28 132.99 41.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.032 -1.043 . . . . 0.0 110.566 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.456 ' CG ' ' CE1' ' A' ' 658' ' ' TYR . 4.6 tmm_? -99.47 138.69 36.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.448 -0.783 . . . . 0.0 109.872 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.768 ' HG2' HG13 ' A' ' 716' ' ' VAL . 3.6 mtp -117.41 -165.99 1.14 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.229 -0.92 . . . . 0.0 110.716 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.588 HG13 HG23 ' A' ' 668' ' ' THR . 2.5 pt -141.86 -158.7 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.354 -0.842 . . . . 0.0 110.171 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -82.85 92.05 7.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.2 -0.938 . . . . 0.0 110.759 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 109.65 49.74 0.73 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.588 HG23 HG13 ' A' ' 665' ' ' ILE . 0.2 OUTLIER -118.52 148.39 42.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.06 -1.259 . . . . 0.0 109.943 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.45 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 7.6 tttt -108.5 138.88 44.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.441 -0.787 . . . . 0.0 109.088 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.51 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 5.2 t80 -144.25 147.19 33.25 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.104 -0.997 . . . . 0.0 112.032 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.736 HD21 ' OD2' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -69.76 147.49 50.41 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.554 -0.717 . . . . 0.0 111.583 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.663 HD23 ' OD2' ' A' ' 676' ' ' ASP . 7.8 mt -122.81 99.2 6.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.322 -0.861 . . . . 0.0 111.444 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 674' ' ' ASP . 94.2 mt-30 -84.65 141.26 30.75 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.672 ' OD1' HD12 ' A' ' 707' ' ' LEU . 0.3 OUTLIER -38.34 151.51 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.354 -0.842 . . . . 0.0 110.815 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 64.9 49.59 62.35 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 107.358 -2.297 . . . . 0.0 107.358 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.663 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.3 OUTLIER -115.81 92.43 3.9 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.871 -0.782 . . . . 0.0 110.774 -178.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.966 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.2 OUTLIER -93.93 106.98 18.93 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.581 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.2 pt -106.84 137.31 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.369 0.604 . . . . 0.0 111.404 -177.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.409 ' CG ' ' HB2' ' A' ' 658' ' ' TYR . 2.9 ptmm? -97.17 110.44 22.99 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.488 -0.757 . . . . 0.0 109.418 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.845 HD13 ' SG ' ' A' ' 623' ' ' CYS . 68.5 mt -80.09 -22.65 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.373 -0.829 . . . . 0.0 110.692 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.514 HG22 ' HA ' ' A' ' 689' ' ' VAL . 0.4 OUTLIER -134.64 135.17 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.163 -0.961 . . . . 0.0 109.998 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -138.0 109.13 6.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.934 . . . . 0.0 110.562 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 686' ' ' ASN . 0.7 OUTLIER -130.16 118.23 21.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.281 -0.887 . . . . 0.0 109.666 179.19 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.95 -32.53 74.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.334 -0.854 . . . . 0.0 111.215 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -84.23 -43.71 14.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.092 -1.005 . . . . 0.0 111.504 -178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 688' ' ' PHE . 88.4 m-20 -73.88 -19.83 60.59 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.137 -0.977 . . . . 0.0 110.798 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.53 22.09 4.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.168 -0.958 . . . . 0.0 110.46 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.804 ' HB2' HD13 ' A' ' 587' ' ' ILE . 0.7 OUTLIER -114.24 83.8 1.94 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.26 1.029 . . . . 0.0 109.472 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' A' ' 586' ' ' SER . 14.9 m -101.04 143.17 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.075 -1.016 . . . . 0.0 110.553 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.734 ' CD1' HG22 ' A' ' 587' ' ' ILE . 47.7 mm -85.19 165.13 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.554 -0.716 . . . . 0.0 109.975 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.455 ' N ' HG22 ' A' ' 690' ' ' ILE . . . -176.8 117.06 0.58 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.966 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.6 m-85 -121.46 137.26 54.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.172 -1.193 . . . . 0.0 109.945 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.96 113.95 25.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.282 -0.886 . . . . 0.0 109.98 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.769 HG22 HD11 ' A' ' 578' ' ' LEU . 0.5 OUTLIER -83.65 123.7 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.364 -0.835 . . . . 0.0 109.254 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.39 108.52 10.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.85 -0.531 . . . . 0.0 110.408 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.683 HD12 ' O ' ' A' ' 705' ' ' GLU . 81.0 mt -86.37 104.42 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.887 . . . . 0.0 109.826 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -77.4 -41.39 40.18 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.421 -0.8 . . . . 0.0 109.453 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.458 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 5.2 m-20 -110.22 140.97 43.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.479 -0.763 . . . . 0.0 110.735 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 15.7 p -115.88 96.27 5.51 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 82.5 m -108.7 114.71 28.74 Favored 'General case' 0 C--N 1.291 -1.96 0 O-C-N 121.752 -0.592 . . . . 0.0 110.738 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 49.46 36.37 23.58 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 704' ' ' ASN . 5.2 tp -98.41 141.18 31.61 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.613 -0.933 . . . . 0.0 110.195 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.76 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.6 p90 -51.75 -24.92 6.5 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.395 -0.816 . . . . 0.0 109.756 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.798 ' O ' HD23 ' A' ' 702' ' ' LEU . 0.8 OUTLIER -176.92 155.64 1.25 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.255 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.683 ' O ' HD12 ' A' ' 696' ' ' ILE . 11.1 pt-20 -51.41 -22.86 3.27 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.114 -0.991 . . . . 0.0 110.456 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 115.04 16.66 7.18 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.672 HD12 ' OD1' ' A' ' 674' ' ' ASP . 3.3 tp -85.17 8.76 17.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -1.204 . . . . 0.0 111.871 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.412 ' CA ' ' NE2' ' A' ' 673' ' ' GLN . . . 45.95 73.81 0.27 Allowed Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.906 ' HG2' HD23 ' A' ' 710' ' ' LEU . 0.0 OUTLIER -81.27 177.29 9.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.255 -1.144 . . . . 0.0 110.577 -179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.906 HD23 ' HG2' ' A' ' 709' ' ' MET . 0.3 OUTLIER 40.99 -159.41 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.416 0.627 . . . . 0.0 111.703 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -91.83 71.87 5.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.526 -0.734 . . . . 0.0 109.145 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.02 148.18 48.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.439 -0.788 . . . . 0.0 110.566 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -111.07 97.32 6.72 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.51 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 0.0 OUTLIER -116.98 88.9 3.0 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-O 121.723 0.773 . . . . 0.0 109.356 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 36.0 m -105.25 168.7 2.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.666 -0.646 . . . . 0.0 109.63 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.768 HG13 ' HG2' ' A' ' 664' ' ' MET . 52.7 t -71.34 128.48 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.326 -0.859 . . . . 0.0 111.139 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.62 162.3 13.63 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -98.64 154.39 17.98 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.981 -1.074 . . . . 0.0 110.467 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . 0.428 ' HG3' ' HB3' ' A' ' 723' ' ' GLU . 0.4 OUTLIER -79.69 145.08 33.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.54 -0.725 . . . . 0.0 110.403 -179.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 34.3 p -121.07 -176.8 3.35 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 110.093 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.78 -32.21 63.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.292 -0.88 . . . . 0.0 110.448 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -64.49 -52.3 58.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.386 -0.822 . . . . 0.0 110.22 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.428 ' HB3' ' HG3' ' A' ' 719' ' ' GLN . 0.6 OUTLIER -64.42 -40.3 95.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.328 -0.857 . . . . 0.0 110.051 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.458 ' O ' HG12 ' A' ' 727' ' ' VAL . 18.3 ttpp -56.93 -35.11 68.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.311 -0.868 . . . . 0.0 109.945 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 728' ' ' LYS . 0.9 OUTLIER -67.7 -35.79 79.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.472 -0.768 . . . . 0.0 109.994 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.414 ' HB3' ' HG3' ' A' ' 600' ' ' PRO . 50.3 mt -57.06 -46.39 82.52 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.333 -0.854 . . . . 0.0 110.336 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.569 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.2 p -76.28 -24.33 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.613 -0.68 . . . . 0.0 110.914 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 725' ' ' ASP . 0.7 OUTLIER -53.32 -45.18 68.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.055 -1.028 . . . . 0.0 108.956 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -116.67 103.81 10.74 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 122.197 0.999 . . . . 0.0 109.057 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.452 HD13 ' OD2' ' A' ' 608' ' ' ASP . 2.2 mt . . . . . 0 C--N 1.274 -2.708 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.375 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.399 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -82.83 1.61 38.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.34 -1.094 . . . . 0.0 110.656 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 105.03 7.34 38.43 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -94.28 124.42 38.29 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.222 -1.164 . . . . 0.0 109.296 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.1 OUTLIER -120.96 -39.69 2.69 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.843 0.83 . . . . 0.0 109.415 -179.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.042 HD22 HD12 ' A' ' 594' ' ' ILE . 8.5 tt -120.31 119.52 33.38 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.326 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 71.2 m -99.44 118.89 37.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 109.52 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.658 HD11 HD12 ' A' ' 625' ' ' ILE . 5.8 mt -91.37 111.97 23.68 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -113.79 101.82 54.2 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 118.075 -1.45 . . . . 0.0 112.736 -177.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 1.047 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 44.2 Cg_endo -79.75 145.78 18.31 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 N-CA-C 106.784 -2.045 . . . . 0.0 106.784 174.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.73 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.33 -174.37 0.31 Allowed Pre-proline 0 N--CA 1.494 1.753 0 C-N-CA 118.81 -1.156 . . . . 0.0 112.763 -177.104 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.73 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.9 Cg_endo -66.79 -28.73 43.15 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 O-C-N 124.111 1.585 . . . . 0.0 110.319 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -59.4 -28.35 66.83 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 689' ' ' VAL . 53.7 p -95.45 153.73 17.55 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.645 ' H ' HD13 ' A' ' 690' ' ' ILE . 3.8 tp -54.76 -16.98 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.333 -0.855 . . . . 0.0 109.944 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.86 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.6 tp -116.3 119.34 61.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.265 -0.897 . . . . 0.0 110.575 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.434 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -112.39 80.73 1.37 Allowed 'General case' 0 N--CA 1.509 2.498 0 O-C-N 120.444 -1.41 . . . . 0.0 109.143 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 1.047 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 6.7 mm-40 -142.57 175.78 9.53 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.625 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.57 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.92 125.85 40.37 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.083 -1.011 . . . . 0.0 109.456 176.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 17.4 mt -111.17 156.02 22.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.405 -0.809 . . . . 0.0 109.649 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -125.23 111.12 14.88 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.378 -0.826 . . . . 0.0 111.836 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.042 HD12 HD22 ' A' ' 578' ' ' LEU . 45.9 mt -80.42 110.81 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 2.0 mt-30 -70.71 109.47 4.95 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.493 ' HA ' ' CD1' ' A' ' 577' ' ' PHE . 0.5 OUTLIER 20.43 53.89 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 178.333 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . . . . . . . . . . . 109.96 44.62 1.01 Allowed Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.603 -1.284 . . . . 0.0 111.03 178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.636 HG12 ' O ' ' A' ' 598' ' ' VAL . 1.0 OUTLIER -79.63 103.85 7.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 177.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.445 ' CB ' ' HB3' ' A' ' 627' ' ' LYS . 0.2 OUTLIER -140.97 140.52 21.55 Favored Pre-proline 0 C--N 1.281 -2.371 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.639 -178.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.574 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.2 Cg_endo -88.79 160.82 40.67 Favored 'Cis proline' 0 C--N 1.309 -1.523 0 C-N-CA 121.721 -2.199 . . . . 0.0 109.07 -0.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -106.56 116.82 32.58 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.706 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 58.1 m-85 -91.25 145.86 24.31 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.39 -0.818 . . . . 0.0 111.037 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.724 HD11 HG13 ' A' ' 625' ' ' ILE . 2.2 mt -140.02 141.05 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.33 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.713 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 175.33 -165.85 37.04 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.356 -1.402 . . . . 0.0 111.321 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 13.2 tpt180 -66.69 -38.81 87.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.956 -0.732 . . . . 0.0 110.777 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.471 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -84.22 126.8 33.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.398 -0.814 . . . . 0.0 110.748 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.422 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -59.3 -12.68 6.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 110.009 179.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.32 -36.97 6.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.882 . . . . 0.0 110.036 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.706 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 75.3 m -68.93 153.65 43.42 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 121.265 -0.897 . . . . 0.0 109.773 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.572 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -58.63 -14.78 9.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.485 -0.76 . . . . 0.0 110.238 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.699 ' SG ' HG23 ' A' ' 603' ' ' ILE . 6.6 t -119.95 143.46 47.99 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.582 -0.699 . . . . 0.0 109.528 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.65 ' O ' HG12 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -110.23 130.88 55.47 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-O 122.054 0.93 . . . . 0.0 112.856 -178.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.669 HD11 ' CE1' ' A' ' 692' ' ' PHE . 3.9 mt -147.15 110.39 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.436 ' O ' HG12 ' A' ' 587' ' ' ILE . 2.7 tt0 -92.31 102.98 15.48 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 117.666 -1.614 . . . . 0.0 109.277 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.857 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.0 OUTLIER -139.55 106.15 5.34 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 114.39 -1.277 . . . . 0.0 108.692 177.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -42.94 -43.68 4.25 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.485 -0.76 . . . . 0.0 111.962 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -83.53 -17.13 42.89 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.144 -0.973 . . . . 0.0 111.729 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.947 HD13 HD11 ' A' ' 681' ' ' ILE . 0.8 OUTLIER -78.01 134.65 37.77 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.07 -1.019 . . . . 0.0 110.694 -179.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.479 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.1 m -73.37 161.14 30.79 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.337 -0.852 . . . . 0.0 110.915 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.713 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 43.6 mtm180 -64.2 -45.63 87.47 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.235 -0.916 . . . . 0.0 109.309 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.708 ' HB ' HG23 ' A' ' 727' ' ' VAL . 15.7 m -94.66 2.0 9.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-O 121.83 0.824 . . . . 0.0 109.402 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.6 t60 -28.28 -46.91 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.771 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.823 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -136.17 144.93 45.26 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.523 178.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 6.3 p90 -145.7 143.65 29.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.485 -0.759 . . . . 0.0 110.229 178.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.724 HG13 HD11 ' A' ' 603' ' ' ILE . 76.8 mt -103.43 117.66 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 8.3 t80 -110.95 155.0 23.32 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.853 0.835 . . . . 0.0 110.234 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.445 ' HB3' ' CB ' ' A' ' 599' ' ' ASN . 3.1 tppp? -118.96 137.13 53.71 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 121.372 0.606 . . . . 0.0 109.735 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.0 OUTLIER -133.88 163.82 28.65 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.566 -0.709 . . . . 0.0 111.038 -179.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.494 ' HD2' ' O ' ' A' ' 644' ' ' LEU . 2.5 tpt180 -77.66 116.2 18.02 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.366 -0.834 . . . . 0.0 108.929 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 703' ' ' PHE . 8.5 t60 -57.93 124.63 19.9 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.651 0.738 . . . . 0.0 110.649 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -60.11 124.3 19.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.683 -0.635 . . . . 0.0 110.537 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.556 HG22 ' N ' ' A' ' 633' ' ' GLY . 8.2 p -113.27 171.81 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.416 -0.803 . . . . 0.0 110.24 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.556 ' N ' HG22 ' A' ' 632' ' ' VAL . . . 68.24 150.66 0.27 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.16 35.62 17.08 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.336 -1.096 . . . . 0.0 110.455 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.0 83.46 1.76 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.45 -0.781 . . . . 0.0 110.085 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . 0.424 ' O ' ' O ' ' A' ' 637' ' ' TYR . 13.4 mmt 53.48 -135.95 1.42 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.162 -0.961 . . . . 0.0 109.318 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 639' ' ' SER . 2.6 p90 -57.87 -160.31 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.413 -0.804 . . . . 0.0 109.743 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -115.58 101.63 9.04 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 120.773 -1.204 . . . . 0.0 109.691 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . 0.43 ' HB3' ' CE1' ' A' ' 637' ' ' TYR . 4.4 p -137.81 145.44 48.43 Favored Pre-proline 0 C--N 1.293 -1.871 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.022 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.767 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 49.6 Cg_endo -70.05 -150.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.637 1.335 . . . . 0.0 109.319 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 82.47 -49.12 0.19 Allowed 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.708 -0.62 . . . . 0.0 110.893 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -74.81 134.43 41.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.889 -1.132 . . . . 0.0 110.195 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 135.25 -3.04 3.98 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.662 HD13 ' HA ' ' A' ' 703' ' ' PHE . 4.6 mp -105.67 -154.45 0.51 Allowed 'General case' 0 C--N 1.283 -2.322 0 O-C-N 122.09 -0.653 . . . . 0.0 109.546 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 628' ' ' LYS . 41.6 m-20 -112.22 124.72 53.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.873 -1.142 . . . . 0.0 111.325 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.494 ' OD1' HD21 ' A' ' 671' ' ' LEU . 5.6 t0 -98.34 156.57 16.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.482 -0.761 . . . . 0.0 109.647 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.49 HD13 HD12 ' A' ' 578' ' ' LEU . 12.7 pt -106.25 130.18 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.278 -0.889 . . . . 0.0 110.38 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.729 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.6 m95 -117.84 124.38 48.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.841 -0.537 . . . . 0.0 111.194 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.716 ' HB2' HD11 ' A' ' 672' ' ' LEU . 7.1 t80 -83.91 114.47 21.7 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 17.4 t -109.71 106.1 15.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.061 -1.024 . . . . 0.0 112.112 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.549 ' CD2' ' N ' ' A' ' 652' ' ' THR . 14.4 t60 -67.54 162.55 23.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.454 -0.778 . . . . 0.0 109.854 178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -154.47 -30.98 0.11 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.304 -0.872 . . . . 0.0 112.509 -179.244 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.557 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.62 -168.57 34.18 Favored Glycine 0 N--CA 1.497 2.712 0 C-N-CA 117.82 -2.133 . . . . 0.0 109.766 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 11.1 m -89.71 -18.78 25.74 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.088 -1.242 . . . . 0.0 114.217 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.692 ' O ' HG22 ' A' ' 656' ' ' VAL . 24.4 m120 -59.32 -3.03 0.36 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.605 -1.309 . . . . 0.0 112.728 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.692 HG22 ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 62.52 142.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.549 -0.719 . . . . 0.0 110.164 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.482 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -96.95 151.8 19.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.589 -0.695 . . . . 0.0 110.554 -179.168 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.481 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 12.6 m-85 -138.02 125.46 21.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.363 -0.836 . . . . 0.0 110.175 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.761 HD21 ' CG1' ' A' ' 678' ' ' ILE . 1.7 mt -129.4 110.15 11.66 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.382 -0.824 . . . . 0.0 109.83 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 59.02 -80.67 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.428 -0.795 . . . . 0.0 110.37 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.47 ' N ' ' O ' ' A' ' 659' ' ' LEU . 7.6 p-10 -144.64 13.73 1.54 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.126 -0.984 . . . . 0.0 110.94 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -100.16 116.74 32.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.017 -1.052 . . . . 0.0 110.225 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -81.46 136.14 35.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.348 -0.845 . . . . 0.0 109.676 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.789 ' CG ' HG21 ' A' ' 716' ' ' VAL . 1.6 mtp -119.07 -167.39 1.38 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 0.0 110.223 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.536 HG13 HG23 ' A' ' 668' ' ' THR . 11.2 pt -146.74 -162.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.342 -0.849 . . . . 0.0 110.121 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 652' ' ' THR . 31.9 tt0 -75.68 79.4 2.65 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.342 -0.849 . . . . 0.0 111.272 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.93 58.07 0.21 Allowed Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.833 -1.175 . . . . 0.0 110.678 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 1.2 p -123.9 145.58 49.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.994 -1.298 . . . . 0.0 110.074 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -108.52 136.94 47.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.398 -0.814 . . . . 0.0 109.205 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 671' ' ' LEU . 8.1 t80 -144.45 146.81 32.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.163 -0.96 . . . . 0.0 111.49 -178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.729 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.9 OUTLIER -72.17 145.88 47.77 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.413 -0.804 . . . . 0.0 111.628 -179.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.716 HD11 ' HB2' ' A' ' 649' ' ' TYR . 6.2 mt -115.55 112.94 22.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.228 -0.92 . . . . 0.0 111.318 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 706' ' ' GLY . 15.3 mt-30 -84.53 -177.03 6.5 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 706' ' ' GLY . 0.0 OUTLIER -73.55 149.7 42.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.982 -1.074 . . . . 0.0 109.711 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 59.68 50.26 69.61 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.2 94.74 5.89 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.74 0.781 . . . . 0.0 110.643 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.912 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 5.9 tt0 -93.49 107.42 19.27 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.761 ' CG1' HD21 ' A' ' 659' ' ' LEU . 1.9 mp -104.15 137.15 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.642 -0.661 . . . . 0.0 111.88 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -99.58 109.89 22.37 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.823 HD13 ' SG ' ' A' ' 623' ' ' CYS . 74.9 mt -79.52 -19.89 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.352 -0.842 . . . . 0.0 111.076 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.947 HD11 HD13 ' A' ' 618' ' ' LEU . 8.4 mt -141.6 141.33 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.967 -1.083 . . . . 0.0 110.762 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.4 t90 -137.79 108.77 6.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.43 -0.794 . . . . 0.0 109.965 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.96 118.43 29.85 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.268 -0.895 . . . . 0.0 110.161 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -66.33 -46.87 75.36 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.364 -0.835 . . . . 0.0 110.963 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -84.93 -43.43 14.06 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.258 -0.901 . . . . 0.0 111.2 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 688' ' ' PHE . 0.3 OUTLIER -91.23 0.39 57.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.262 -0.899 . . . . 0.0 111.004 -179.353 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.626 ' O ' HG23 ' A' ' 689' ' ' VAL . 0.0 OUTLIER 65.49 -67.73 0.13 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.42 -0.8 . . . . 0.0 109.777 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.595 ' HD2' HG21 ' A' ' 681' ' ' ILE . 0.1 OUTLIER 24.52 61.0 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.369 0.604 . . . . 0.0 111.317 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 687' ' ' LYS . 59.8 t -101.97 142.46 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.422 -0.799 . . . . 0.0 110.718 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.857 HD11 ' OD2' ' A' ' 615' ' ' ASP . 40.4 mm -122.64 165.38 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -176.35 121.01 0.78 Allowed Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.912 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 10.6 m-85 -119.62 136.51 54.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.526 -0.985 . . . . 0.0 108.798 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -98.77 114.32 26.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 110.898 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 694' ' ' VAL . 1.2 t -84.78 114.0 24.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -122.37 104.34 9.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.733 -0.604 . . . . 0.0 109.826 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.548 ' CD1' ' HA3' ' A' ' 706' ' ' GLY . 83.3 mt -88.71 103.28 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.33 -0.856 . . . . 0.0 109.679 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.0 -41.75 22.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.816 . . . . 0.0 108.927 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.7 OUTLIER -109.92 141.29 42.87 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.391 0.615 . . . . 0.0 109.629 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 16.3 p -113.29 95.8 5.56 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 40.7 m -129.65 134.62 47.78 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.87 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 57.72 29.35 61.28 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.596 ' O ' HD22 ' A' ' 644' ' ' LEU . 1.0 OUTLIER -113.83 128.07 56.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.503 -0.998 . . . . 0.0 110.24 -179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.662 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.5 p90 -50.44 -24.01 2.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.481 -0.762 . . . . 0.0 110.753 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.529 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.9 OUTLIER -157.93 171.37 20.38 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -178.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.528 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 16.6 pt-20 -51.33 -22.83 3.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.068 -1.02 . . . . 0.0 110.295 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.548 ' HA3' ' CD1' ' A' ' 696' ' ' ILE . . . 120.83 5.75 9.71 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.86 HD13 ' O ' ' A' ' 707' ' ' LEU . 0.8 OUTLIER -90.21 10.36 24.9 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.351 -1.088 . . . . 0.0 110.669 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.484 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 61.84 162.02 0.21 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.657 ' C ' HD23 ' A' ' 710' ' ' LEU . 0.0 OUTLIER -177.64 110.2 0.07 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.371 -1.076 . . . . 0.0 110.231 -179.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.834 HD12 ' HB2' ' A' ' 712' ' ' GLU . 0.7 OUTLIER -175.06 165.48 3.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.225 -0.922 . . . . 0.0 110.368 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.08 -44.05 95.06 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.351 -0.843 . . . . 0.0 109.895 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.834 ' HB2' HD12 ' A' ' 710' ' ' LEU . 9.6 mp0 -63.78 149.38 46.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.43 -0.794 . . . . 0.0 109.685 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.32 95.72 5.86 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.295 -0.878 . . . . 0.0 109.349 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.582 ' NH2' HD22 ' A' ' 659' ' ' LEU . 3.5 mmm-85 46.47 82.27 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.262 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 32.0 m -108.04 152.25 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.533 -0.729 . . . . 0.0 109.522 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.789 HG21 ' CG ' ' A' ' 664' ' ' MET . 14.6 p -104.21 133.29 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.725 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.0 mp -104.01 162.76 12.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.416 -0.803 . . . . 0.0 110.001 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -93.33 154.27 18.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.223 -0.923 . . . . 0.0 110.163 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -79.61 148.02 31.85 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.36 -0.838 . . . . 0.0 110.358 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 11.9 p -121.07 -176.37 3.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.381 -0.824 . . . . 0.0 110.359 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.49 -29.0 33.89 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.332 -0.855 . . . . 0.0 110.093 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.8 -51.32 65.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.461 -0.774 . . . . 0.0 109.745 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -64.06 -43.64 94.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.45 -0.781 . . . . 0.0 109.937 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.543 ' O ' HG12 ' A' ' 727' ' ' VAL . 16.1 tttt -56.41 -32.86 65.24 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.35 -0.843 . . . . 0.0 110.06 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -68.78 -36.31 78.13 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.387 -0.821 . . . . 0.0 110.364 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 37.8 mt -60.02 -46.32 89.9 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.362 -0.836 . . . . 0.0 110.439 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.708 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.1 p -69.15 -19.67 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.04 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.53 -50.8 69.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 108.877 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -116.85 105.29 12.2 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 122.132 0.968 . . . . 0.0 109.122 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.515 HD21 HG12 ' A' ' 621' ' ' VAL . 4.5 mt . . . . . 0 C--N 1.274 -2.68 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.472 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.97 -10.25 58.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.286 -1.126 . . . . 0.0 110.608 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . -134.8 23.21 3.57 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.413 ' HD3' ' HG2' ' A' ' 593' ' ' GLU . 14.0 ttp-105 -92.04 114.1 26.55 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.265 -1.138 . . . . 0.0 109.202 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.681 ' CZ ' HD13 ' A' ' 702' ' ' LEU . 3.0 t80 -92.47 -43.52 9.14 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.913 0.863 . . . . 0.0 109.475 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.079 HD23 HD12 ' A' ' 594' ' ' ILE . 5.4 tp -125.1 119.7 29.36 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.628 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 36.2 m -96.75 118.66 33.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -0.903 . . . . 0.0 109.53 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.788 HD11 HD12 ' A' ' 625' ' ' ILE . 3.3 mt -94.72 112.3 24.04 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.563 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -111.97 104.18 55.83 Favored Pre-proline 0 C--N 1.3 -1.563 0 C-N-CA 118.467 -1.293 . . . . 0.0 112.935 -177.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 1.086 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.7 Cg_endo -76.81 142.46 22.59 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 N-CA-C 105.72 -2.454 . . . . 0.0 105.72 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 1.027 ' HB2' ' HD2' ' A' ' 584' ' ' PRO . 0.1 OUTLIER -126.78 -175.28 0.41 Allowed Pre-proline 0 N--CA 1.499 1.982 0 C-N-CA 118.416 -1.314 . . . . 0.0 113.806 -176.052 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 1.027 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 37.7 Cg_endo -65.75 -33.43 44.17 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 O-C-N 123.961 1.506 . . . . 0.0 111.381 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.08 -30.34 68.01 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.598 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 84.2 p -97.59 153.77 17.97 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.687 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.2 OUTLIER -61.6 -11.06 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.205 -0.935 . . . . 0.0 109.839 178.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.766 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 8.5 mm -98.54 116.95 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.351 -0.843 . . . . 0.0 109.779 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.598 ' NE2' ' O ' ' A' ' 586' ' ' SER . 17.8 mp0 -118.67 70.32 0.82 Allowed 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.491 -1.38 . . . . 0.0 109.932 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 1.086 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 18.0 mt-10 -144.31 175.44 10.09 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.014 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.496 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.61 125.57 36.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.995 -1.066 . . . . 0.0 109.04 176.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.673 HD13 ' HA ' ' A' ' 611' ' ' CYS . 46.5 mt -111.63 155.05 23.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 109.828 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.413 ' HG2' ' HD3' ' A' ' 576' ' ' ARG . 16.3 mp0 -126.27 110.59 13.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.835 . . . . 0.0 111.461 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.079 HD12 HD23 ' A' ' 578' ' ' LEU . 3.5 mt -77.94 109.52 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.06 -1.025 . . . . 0.0 108.32 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.0 OUTLIER -53.61 161.22 1.1 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.451 -0.781 . . . . 0.0 109.766 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.506 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.3 OUTLIER -48.94 79.05 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.706 -0.621 . . . . 0.0 111.551 -179.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 107.41 34.93 2.78 Favored Glycine 0 N--CA 1.486 1.995 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.844 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.722 ' HB ' HG23 ' A' ' 594' ' ' ILE . 1.0 OUTLIER -79.77 103.05 6.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 178.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 6.4 t30 -143.01 135.25 13.3 Favored Pre-proline 0 C--N 1.283 -2.302 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.023 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.633 ' HB3' HD23 ' A' ' 726' ' ' LEU . 56.0 Cg_endo -91.08 161.9 29.67 Favored 'Cis proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.781 -1.758 . . . . 0.0 108.987 -1.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.516 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.0 t80 -106.62 116.2 31.52 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.628 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 63.6 m-85 -83.02 143.63 30.49 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 0.0 110.288 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.775 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.9 mt -142.93 142.08 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.563 -0.711 . . . . 0.0 110.224 -178.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.787 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 165.42 -161.2 34.67 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.339 -1.41 . . . . 0.0 111.4 178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.461 ' N ' HD23 ' A' ' 618' ' ' LEU . 3.4 mmm-85 -63.74 -53.87 44.35 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.78 -0.835 . . . . 0.0 111.834 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.481 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -71.59 124.73 25.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.147 -0.971 . . . . 0.0 111.239 -178.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.485 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.1 OUTLIER -54.07 -17.67 2.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.288 -0.883 . . . . 0.0 109.813 178.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -45.18 -30.99 1.29 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.411 -0.806 . . . . 0.0 109.272 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 602' ' ' PHE . 1.7 m -68.6 133.81 49.05 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.516 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -45.08 -26.93 0.51 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.318 -0.864 . . . . 0.0 109.759 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.775 ' HB3' HG23 ' A' ' 603' ' ' ILE . 13.0 t -106.23 143.61 34.1 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.485 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -108.91 125.15 51.71 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.253 1.025 . . . . 0.0 113.161 -178.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.766 ' HA ' ' CD1' ' A' ' 588' ' ' ILE . 18.3 mt -143.13 108.31 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.431 ' HA ' ' HD2' ' A' ' 605' ' ' ARG . 3.8 mt-10 -97.77 104.41 16.43 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 118.302 -1.359 . . . . 0.0 109.25 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.705 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.0 OUTLIER -137.99 106.19 5.75 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 114.287 -1.324 . . . . 0.0 108.238 177.439 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -42.49 -39.48 2.27 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.485 -0.759 . . . . 0.0 111.678 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.67 -17.8 40.2 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.152 -0.968 . . . . 0.0 111.303 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.751 HD12 HD11 ' A' ' 681' ' ' ILE . 0.7 OUTLIER -79.3 140.45 37.56 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.177 -0.952 . . . . 0.0 110.562 -179.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.427 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.82 161.02 29.36 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.372 -0.83 . . . . 0.0 110.718 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.787 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 9.8 ttp180 -63.6 -45.65 89.4 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.25 -0.906 . . . . 0.0 109.173 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.873 HG11 HG23 ' A' ' 727' ' ' VAL . 7.7 t -95.98 1.92 10.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.483 -0.761 . . . . 0.0 109.931 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.751 ' O ' ' N ' ' A' ' 652' ' ' THR . 9.2 t60 -27.49 -41.82 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.078 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.739 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.7 OUTLIER -136.76 145.0 44.07 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 118.228 -1.389 . . . . 0.0 110.861 179.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.551 ' CE2' ' CB ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -147.63 140.75 25.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.579 -0.7 . . . . 0.0 109.992 178.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.788 HD12 HD11 ' A' ' 580' ' ' LEU . 0.6 OUTLIER -103.21 136.88 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.231 -0.918 . . . . 0.0 109.327 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.544 ' HB2' ' CE1' ' A' ' 624' ' ' PHE . 7.6 t80 -128.97 155.83 44.75 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.503 -0.748 . . . . 0.0 109.636 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.677 ' HE2' HG23 ' A' ' 647' ' ' ILE . 1.2 tppp? -119.02 136.93 53.87 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.404 0.621 . . . . 0.0 110.622 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.433 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -140.32 163.82 31.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.627 -0.67 . . . . 0.0 110.709 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.55 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.1 OUTLIER -78.39 128.61 33.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.377 -0.827 . . . . 0.0 109.411 -179.733 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.537 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.5 t60 -58.56 124.72 20.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.421 -0.799 . . . . 0.0 110.845 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -78.61 107.47 11.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.62 -0.675 . . . . 0.0 110.499 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.675 HG11 ' N ' ' A' ' 643' ' ' GLY . 9.1 p -122.1 172.37 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.445 -0.784 . . . . 0.0 110.491 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.565 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -87.41 -168.65 44.88 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -63.45 168.28 4.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.254 -1.144 . . . . 0.0 110.042 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.78 77.34 1.58 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.275 -0.89 . . . . 0.0 110.496 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 7.9 ptm -61.26 126.21 26.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.269 -0.894 . . . . 0.0 109.676 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 1.5 t80 63.15 -145.17 0.35 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.29 -0.882 . . . . 0.0 109.87 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 638' ' ' GLU . 3.5 pt-20 -115.51 102.24 9.62 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 122.227 1.013 . . . . 0.0 109.393 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 62.7 p -136.78 151.33 72.25 Favored Pre-proline 0 C--N 1.294 -1.847 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.799 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.43 -154.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.661 1.348 . . . . 0.0 109.734 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 47.66 26.47 0.86 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.642 -0.661 . . . . 0.0 110.915 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -74.44 60.49 0.86 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.216 -0.927 . . . . 0.0 110.125 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.675 ' N ' HG11 ' A' ' 632' ' ' VAL . . . 62.04 116.11 0.01 OUTLIER Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.767 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.2 mp -141.52 -151.87 0.38 Allowed 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.8 OUTLIER -121.56 124.6 44.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.083 -1.01 . . . . 0.0 111.186 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.656 ' CG ' HD21 ' A' ' 671' ' ' LEU . 3.2 t0 -114.11 149.0 36.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.383 -0.823 . . . . 0.0 109.7 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.677 HG23 ' HE2' ' A' ' 627' ' ' LYS . 5.4 pt -94.76 136.81 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.211 -0.93 . . . . 0.0 110.194 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.601 ' CH2' HD12 ' A' ' 671' ' ' LEU . 95.7 m95 -119.39 121.37 39.37 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.653 -0.654 . . . . 0.0 110.525 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.94 ' HB2' HD11 ' A' ' 672' ' ' LEU . 5.2 t80 -80.53 117.95 21.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.138 -0.977 . . . . 0.0 108.6 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 668' ' ' THR . 4.3 m -107.84 102.57 11.77 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.422 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.501 ' CD2' ' N ' ' A' ' 652' ' ' THR . 27.0 t60 -64.47 163.58 13.1 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.29 -0.881 . . . . 0.0 109.503 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.751 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -151.9 -28.78 0.17 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -178.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.615 ' N ' ' HA ' ' A' ' 622' ' ' HIS . . . -79.16 -169.27 36.94 Favored Glycine 0 N--CA 1.496 2.665 0 O-C-N 119.204 -2.185 . . . . 0.0 109.856 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 12.6 m -94.06 -18.62 21.64 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.178 -1.189 . . . . 0.0 113.9 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.53 ' O ' HG12 ' A' ' 656' ' ' VAL . 29.8 m120 -61.86 -4.26 1.48 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 120.625 -1.297 . . . . 0.0 111.896 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 78.21 169.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 121.919 0.866 . . . . 0.0 110.607 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.477 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -125.35 149.44 48.11 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.436 -179.222 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.416 ' CZ ' ' HG3' ' A' ' 663' ' ' ARG . 2.9 m-85 -138.58 126.7 22.71 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.313 -0.867 . . . . 0.0 110.657 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.825 HD23 ' CE2' ' A' ' 670' ' ' PHE . 24.8 tp -125.67 107.63 10.76 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.359 -0.838 . . . . 0.0 109.914 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 27.2 t30 64.73 -68.09 0.11 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.648 -0.658 . . . . 0.0 110.412 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.8 OUTLIER -158.86 24.68 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 110.164 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.31 132.87 56.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -0.937 . . . . 0.0 110.425 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 658' ' ' TYR . 5.4 ttt180 -95.12 130.14 41.94 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.467 -0.77 . . . . 0.0 110.28 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.692 ' HG2' HG13 ' A' ' 716' ' ' VAL . 2.4 mtp -110.05 -164.58 0.94 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.409 -0.807 . . . . 0.0 110.056 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.605 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.8 pt -140.21 -163.24 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 110.213 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -77.5 93.64 4.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.333 -0.854 . . . . 0.0 110.653 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 103.42 53.58 0.87 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.605 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.0 OUTLIER -118.24 147.74 43.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.183 -1.186 . . . . 0.0 109.911 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.422 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 2.7 tttm -108.38 139.5 43.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.538 -0.726 . . . . 0.0 109.53 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.825 ' CE2' HD23 ' A' ' 659' ' ' LEU . 0.6 OUTLIER -144.47 142.87 30.57 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.093 -179.226 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.656 HD21 ' CG ' ' A' ' 646' ' ' ASP . 0.4 OUTLIER -69.87 147.01 50.84 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.519 -0.738 . . . . 0.0 110.753 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.94 HD11 ' HB2' ' A' ' 649' ' ' TYR . 26.1 mt -118.08 131.33 56.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.356 -0.84 . . . . 0.0 111.277 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.455 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 61.6 mt-30 -113.19 143.17 44.84 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.726 ' OD1' HD12 ' A' ' 707' ' ' LEU . 3.7 p-10 -41.03 144.91 0.24 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.184 -0.947 . . . . 0.0 110.748 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.48 49.39 44.92 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.687 ' OD2' HD11 ' A' ' 659' ' ' LEU . 0.1 OUTLIER -109.7 97.43 6.97 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.788 0.804 . . . . 0.0 110.616 -178.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.706 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.82 107.01 18.95 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.757 HG22 HD13 ' A' ' 659' ' ' LEU . 35.3 pt -108.38 136.84 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.48 -0.763 . . . . 0.0 111.56 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.73 110.29 22.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.514 -0.741 . . . . 0.0 109.253 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.739 HD13 ' SG ' ' A' ' 623' ' ' CYS . 70.8 mt -76.74 -26.41 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.335 -0.853 . . . . 0.0 110.191 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.751 HD11 HD12 ' A' ' 618' ' ' LEU . 4.4 mt -143.29 133.84 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.831 . . . . 0.0 109.961 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -137.61 114.61 10.73 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.359 -0.838 . . . . 0.0 110.329 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' A' ' 686' ' ' ASN . 0.2 OUTLIER -127.51 118.33 23.79 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.318 -0.864 . . . . 0.0 110.028 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -65.94 -42.76 89.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.393 -0.817 . . . . 0.0 110.857 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -83.73 -43.34 15.6 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.332 -0.855 . . . . 0.0 110.844 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 683' ' ' ASP . 1.9 t-20 -80.31 -12.05 59.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.283 -0.886 . . . . 0.0 110.663 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 57.16 18.77 4.35 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.13 -0.981 . . . . 0.0 110.5 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.404 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -77.52 76.21 4.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.161 179.213 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 681' ' ' ILE . 60.5 t -101.86 137.23 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.458 -0.776 . . . . 0.0 110.941 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.705 HD11 ' OD2' ' A' ' 615' ' ' ASP . 49.0 mm -118.73 164.43 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . -178.02 124.94 0.96 Allowed Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.496 -1.335 . . . . 0.0 110.196 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.706 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 13.4 m-85 -120.43 137.76 54.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.591 -0.946 . . . . 0.0 109.132 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.4 113.95 26.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.157 -0.964 . . . . 0.0 109.985 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 694' ' ' VAL . 1.1 t -83.06 118.16 30.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.481 -0.762 . . . . 0.0 109.151 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -128.8 104.6 7.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.65 -0.657 . . . . 0.0 110.097 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.562 ' CG1' HD12 ' A' ' 578' ' ' LEU . 69.1 mt -81.86 104.69 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.46 -0.775 . . . . 0.0 109.832 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.48 -42.52 35.5 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.439 -0.788 . . . . 0.0 108.875 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.5 ' O ' ' CD1' ' A' ' 577' ' ' PHE . 3.9 m-20 -110.84 141.49 44.14 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.463 0.649 . . . . 0.0 110.68 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 9.0 p -114.04 96.2 5.69 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 5.8 m -94.65 100.03 12.05 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.261 0.553 . . . . 0.0 111.735 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 45.9 34.48 5.64 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.867 HD23 ' O ' ' A' ' 704' ' ' ASN . 1.1 tp -84.47 150.22 25.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -1.12 . . . . 0.0 110.043 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.767 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.6 p90 -51.49 -24.44 5.11 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.314 -0.866 . . . . 0.0 110.038 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.867 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.6 t30 -175.03 153.26 1.6 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.456 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 12.4 pt-20 -51.21 -24.95 4.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.23 -0.919 . . . . 0.0 110.45 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 116.91 19.08 5.36 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.291 -1.523 . . . . 0.0 109.291 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.726 HD12 ' OD1' ' A' ' 674' ' ' ASP . 3.8 tp -88.14 9.63 22.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -1.199 . . . . 0.0 111.643 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.419 ' CA ' ' NE2' ' A' ' 673' ' ' GLN . . . 61.97 49.16 78.21 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.694 ' HG3' HD23 ' A' ' 710' ' ' LEU . 0.3 OUTLIER -51.65 176.75 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.383 -1.069 . . . . 0.0 111.021 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.694 HD23 ' HG3' ' A' ' 709' ' ' MET . 0.4 OUTLIER 40.66 -157.68 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.384 0.612 . . . . 0.0 111.863 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -92.88 74.88 4.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.584 -0.697 . . . . 0.0 109.726 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.87 148.13 48.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.574 -0.704 . . . . 0.0 110.424 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -111.61 96.9 6.36 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.514 -0.741 . . . . 0.0 109.005 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.708 ' NH1' HD21 ' A' ' 659' ' ' LEU . 0.7 OUTLIER -70.91 70.33 0.49 Allowed 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.54 0.686 . . . . 0.0 110.094 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 34.2 m -106.57 153.07 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.65 -0.656 . . . . 0.0 109.69 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.692 HG13 ' HG2' ' A' ' 664' ' ' MET . 84.1 t -85.06 133.32 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.22 -0.925 . . . . 0.0 110.916 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 1.6 mt -105.39 162.38 13.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.555 -0.716 . . . . 0.0 109.6 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -101.24 153.53 19.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.167 -0.958 . . . . 0.0 110.292 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -85.35 151.03 24.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.347 -0.846 . . . . 0.0 110.263 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 19.0 p -121.33 -176.66 3.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.329 -0.857 . . . . 0.0 110.47 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.68 -29.81 40.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.45 -0.781 . . . . 0.0 110.119 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . 0.434 ' O ' HD13 ' A' ' 726' ' ' LEU . 3.6 tt0 -63.49 -52.29 61.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.673 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.38 -38.18 90.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.427 -0.795 . . . . 0.0 109.496 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.477 ' O ' HG12 ' A' ' 727' ' ' VAL . 11.8 tttt -57.76 -32.27 67.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.421 -0.799 . . . . 0.0 109.833 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.69 -40.33 80.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.259 -0.901 . . . . 0.0 110.409 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.633 HD23 ' HB3' ' A' ' 600' ' ' PRO . 11.0 mp -55.91 -47.02 78.22 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.223 -0.923 . . . . 0.0 110.843 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.873 HG23 HG11 ' A' ' 621' ' ' VAL . 7.2 p -69.23 -18.05 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.486 -0.759 . . . . 0.0 110.232 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.37 -43.96 68.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.249 -0.907 . . . . 0.0 108.854 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -116.96 104.32 11.16 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 122.254 1.026 . . . . 0.0 109.221 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.413 ' O ' ' CD2' ' A' ' 602' ' ' PHE . 0.5 OUTLIER . . . . . 0 C--N 1.275 -2.664 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.402 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -82.9 -10.4 58.84 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -1.115 . . . . 0.0 110.503 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 596' ' ' GLN . . . 84.1 27.39 37.34 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -93.31 118.03 30.78 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.204 -1.174 . . . . 0.0 109.239 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.6 ' CD2' ' O ' ' A' ' 698' ' ' ASP . 0.7 OUTLIER -110.01 -41.0 4.58 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.831 0.824 . . . . 0.0 109.832 -179.1 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.69 ' CD2' HD12 ' A' ' 594' ' ' ILE . 17.4 tp -121.17 127.68 51.76 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.448 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 94.1 m -111.38 117.97 34.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 1.051 HD11 HD12 ' A' ' 625' ' ' ILE . 6.1 mt -90.71 112.25 23.94 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.424 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 1.2 mmtt -113.54 101.05 53.24 Favored Pre-proline 0 C--N 1.303 -1.442 0 C-N-CA 118.02 -1.472 . . . . 0.0 112.611 -178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 1.115 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.5 Cg_endo -78.79 145.44 20.12 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 N-CA-C 106.232 -2.257 . . . . 0.0 106.232 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.765 HD13 ' OD2' ' A' ' 585' ' ' ASP . 0.0 OUTLIER -123.54 -176.76 0.46 Allowed Pre-proline 0 N--CA 1.498 1.931 0 C-N-CA 118.251 -1.38 . . . . 0.0 114.094 -175.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.726 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.6 Cg_endo -67.84 -34.0 25.3 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 121.825 1.683 . . . . 0.0 111.953 -178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.765 ' OD2' HD13 ' A' ' 583' ' ' LEU . 1.8 p30 -58.31 -29.69 66.08 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.772 -1.205 . . . . 0.0 107.931 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.503 ' HB3' ' N ' ' A' ' 691' ' ' GLY . 4.3 p -96.25 150.66 20.3 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.585 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.1 OUTLIER -55.64 -17.79 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.122 -0.986 . . . . 0.0 109.467 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.765 HD12 ' HA ' ' A' ' 613' ' ' ILE . 9.1 mm -100.03 114.87 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -126.01 74.59 1.44 Allowed 'General case' 0 N--CA 1.51 2.569 0 O-C-N 120.581 -1.325 . . . . 0.0 110.423 -179.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 1.115 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 1.2 mt-10 -143.31 175.9 9.55 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.506 -0.77 . . . . 0.0 108.993 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.525 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.3 127.04 42.01 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.761 -1.212 . . . . 0.0 109.476 176.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 611' ' ' CYS . 67.2 mt -111.32 156.21 21.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.419 -0.801 . . . . 0.0 109.628 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -124.46 110.77 14.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 111.423 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.69 HD12 ' CD2' ' A' ' 578' ' ' LEU . 31.3 mt -81.01 109.04 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.534 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -66.89 118.17 10.0 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.533 -0.729 . . . . 0.0 111.955 -177.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.593 ' HA ' ' HB3' ' A' ' 577' ' ' PHE . 6.8 tp-100 13.32 61.99 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 95.61 50.75 1.94 Allowed Glycine 0 N--CA 1.487 2.04 0 C-N-CA 119.931 -1.128 . . . . 0.0 110.585 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.6 OUTLIER -79.49 105.09 8.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.01 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.4 OUTLIER -140.26 142.0 28.22 Favored Pre-proline 0 C--N 1.28 -2.417 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.79 -178.462 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.482 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.5 Cg_endo -88.91 159.12 39.19 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 121.564 -2.265 . . . . 0.0 109.001 -0.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.556 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 5.1 t80 -106.53 116.24 31.58 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.811 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 39.6 m-85 -91.43 146.01 24.16 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 110.757 -177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.743 HG23 ' SG ' ' A' ' 611' ' ' CYS . 2.7 mt -139.91 141.08 34.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.48 -0.763 . . . . 0.0 110.618 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.741 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 173.24 -164.88 36.86 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.51 -1.329 . . . . 0.0 111.186 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.431 ' HD2' ' HA ' ' A' ' 614' ' ' GLU . 8.5 mmm-85 -66.66 -41.0 88.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.892 -0.769 . . . . 0.0 110.866 -179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.411 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -83.12 132.04 35.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.343 -0.848 . . . . 0.0 111.218 -178.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.542 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.7 OUTLIER -61.24 -13.04 15.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.413 -0.804 . . . . 0.0 109.858 178.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.45 -37.4 5.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.3 -0.875 . . . . 0.0 109.858 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.811 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 64.4 m -71.23 148.79 46.9 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.403 -0.811 . . . . 0.0 109.613 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.555 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.7 OUTLIER -56.0 -16.68 5.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.482 -0.761 . . . . 0.0 110.655 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.743 ' SG ' HG23 ' A' ' 603' ' ' ILE . 10.5 t -115.67 143.34 45.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.439 -0.788 . . . . 0.0 109.542 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.542 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -112.82 121.28 44.22 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.169 -0.957 . . . . 0.0 112.689 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.765 ' HA ' HD12 ' A' ' 588' ' ' ILE . 18.5 mt -141.73 108.25 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.431 ' HA ' ' HD2' ' A' ' 605' ' ' ARG . 3.8 tm-20 -90.64 103.89 16.53 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.625 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.489 ' HB2' ' HB3' ' A' ' 618' ' ' LEU . 1.5 m-20 -138.25 105.78 5.57 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.675 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -39.55 -52.34 2.17 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.755 -0.59 . . . . 0.0 112.256 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -75.12 -16.49 60.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.09 -1.006 . . . . 0.0 111.364 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.906 HD13 HD11 ' A' ' 681' ' ' ILE . 0.8 OUTLIER -80.0 132.67 36.06 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.215 -0.928 . . . . 0.0 111.134 -178.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.518 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -74.77 162.39 28.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.489 -0.757 . . . . 0.0 110.812 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.741 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.3 OUTLIER -64.19 -46.06 85.59 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.288 -0.883 . . . . 0.0 109.389 179.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.687 ' HB ' HG23 ' A' ' 727' ' ' VAL . 16.2 m -94.6 2.25 9.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.216 -0.927 . . . . 0.0 109.179 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.754 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.4 t60 -28.66 -47.44 0.05 Allowed 'General case' 0 C--O 1.192 -1.953 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.051 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.698 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.6 OUTLIER -137.44 145.12 42.75 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.398 -1.321 . . . . 0.0 111.02 179.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 3.6 p90 -145.95 144.81 30.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.589 -0.694 . . . . 0.0 110.212 177.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 1.051 HD12 HD11 ' A' ' 580' ' ' LEU . 11.3 mt -103.5 118.05 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.45 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 7.7 t80 -111.55 154.62 24.52 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.774 0.797 . . . . 0.0 109.819 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.446 ' HB3' ' CB ' ' A' ' 599' ' ' ASN . 3.7 ttmt -120.07 136.67 54.5 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-O 121.464 0.65 . . . . 0.0 110.31 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.45 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -133.82 163.72 28.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.617 -0.677 . . . . 0.0 110.343 -179.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.8 tpt180 -77.72 115.28 17.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.516 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 3.0 t60 -58.13 124.35 19.07 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.497 -0.752 . . . . 0.0 110.574 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -115.67 81.48 1.6 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.42 0.629 . . . . 0.0 110.466 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.54 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.3 p -61.46 171.76 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.457 -0.777 . . . . 0.0 109.875 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.54 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -53.12 176.09 0.2 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -53.26 142.03 22.17 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.223 -1.163 . . . . 0.0 110.35 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.07 60.74 1.47 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.291 -0.881 . . . . 0.0 110.297 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . 0.41 ' O ' ' CB ' ' A' ' 637' ' ' TYR . 0.1 OUTLIER -61.97 125.94 25.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.749 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . 0.41 ' CB ' ' O ' ' A' ' 636' ' ' MET . 1.7 t80 65.79 -147.3 0.21 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.438 -0.789 . . . . 0.0 110.008 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -115.51 102.91 10.23 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.239 -0.913 . . . . 0.0 109.197 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 92.6 p -125.53 151.4 70.26 Favored Pre-proline 0 C--N 1.291 -1.943 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.994 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.613 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 47.6 Cg_endo -69.55 -151.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.741 1.39 . . . . 0.0 109.908 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 68.53 -61.3 0.41 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.618 -0.676 . . . . 0.0 110.676 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 52.49 -158.09 0.14 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.128 -0.982 . . . . 0.0 109.851 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.679 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -117.31 129.35 8.29 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.844 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.3 mp -141.44 -150.84 0.33 Allowed 'General case' 0 C--N 1.294 -1.84 0 O-C-N 122.072 -0.663 . . . . 0.0 109.297 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.4 m-20 -114.95 124.34 51.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.965 -1.084 . . . . 0.0 111.115 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.739 ' OD2' HD21 ' A' ' 671' ' ' LEU . 14.7 t0 -107.08 156.12 19.11 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.537 -0.727 . . . . 0.0 109.82 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 13.8 pt -110.7 131.45 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.281 -0.887 . . . . 0.0 110.114 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.635 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.4 m95 -119.11 121.95 40.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.654 -0.654 . . . . 0.0 111.369 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.81 ' HB2' HD11 ' A' ' 672' ' ' LEU . 8.7 t80 -80.95 114.84 20.1 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 668' ' ' THR . 7.5 t -107.12 110.3 22.35 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.207 -0.933 . . . . 0.0 111.731 -178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.518 ' CD2' ' N ' ' A' ' 652' ' ' THR . 18.5 t60 -72.66 162.67 29.19 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.476 -0.765 . . . . 0.0 109.833 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.754 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -155.11 -30.84 0.1 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.458 -0.776 . . . . 0.0 112.205 -179.114 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.547 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.08 -165.23 29.11 Favored Glycine 0 N--CA 1.496 2.665 0 C-N-CA 117.966 -2.064 . . . . 0.0 109.739 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 14.5 m -93.55 -18.9 21.73 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.007 -1.29 . . . . 0.0 114.012 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.711 ' O ' HG22 ' A' ' 656' ' ' VAL . 86.6 m-20 -59.81 -2.56 0.4 Allowed 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.746 -1.221 . . . . 0.0 112.727 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.711 HG22 ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 63.36 146.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 121.57 0.7 . . . . 0.0 110.305 -179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.463 ' CB ' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -98.27 141.99 30.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.69 -0.631 . . . . 0.0 110.605 -178.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.459 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 11.1 m-85 -129.75 126.17 37.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 110.364 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.603 HD11 HD21 ' A' ' 672' ' ' LEU . 0.1 OUTLIER -132.6 114.89 14.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.356 -0.84 . . . . 0.0 110.047 179.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 56.54 -84.69 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.434 -0.791 . . . . 0.0 110.475 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.6 m120 -143.52 20.3 1.86 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.058 -1.026 . . . . 0.0 110.353 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -111.2 118.48 36.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.283 -0.886 . . . . 0.0 110.239 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -86.67 139.81 30.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.386 -0.821 . . . . 0.0 110.184 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.585 ' HG2' HG13 ' A' ' 716' ' ' VAL . 4.5 mtp -117.27 -167.29 1.29 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.866 . . . . 0.0 110.124 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.638 HG13 HG23 ' A' ' 668' ' ' THR . 1.5 pt -137.24 -158.49 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.253 -0.905 . . . . 0.0 110.426 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 652' ' ' THR . 17.5 tt0 -83.11 90.2 7.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.336 -0.853 . . . . 0.0 110.547 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.12 52.53 0.6 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.638 HG23 HG13 ' A' ' 665' ' ' ILE . 0.2 OUTLIER -119.8 148.89 42.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.145 -1.209 . . . . 0.0 110.177 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.458 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 9.5 tttt -108.59 139.02 43.95 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.524 ' CD1' HG22 ' A' ' 716' ' ' VAL . 13.4 t80 -142.54 146.38 34.58 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.154 -0.966 . . . . 0.0 111.615 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.739 HD21 ' OD2' ' A' ' 646' ' ' ASP . 0.4 OUTLIER -73.33 146.82 44.97 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.59 -0.694 . . . . 0.0 110.502 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.81 HD11 ' HB2' ' A' ' 649' ' ' TYR . 12.1 mt -119.39 115.35 23.93 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.559 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.457 ' CA ' ' O ' ' A' ' 706' ' ' GLY . 60.1 mt-30 -87.39 -177.41 5.92 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.812 ' OD1' HD22 ' A' ' 707' ' ' LEU . 21.8 p-10 -78.31 142.97 37.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 109.432 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.93 46.71 43.16 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 107.678 -2.169 . . . . 0.0 107.678 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.51 ' OD1' HD21 ' A' ' 659' ' ' LEU . 1.4 t0 -101.15 91.51 4.57 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.817 -0.813 . . . . 0.0 110.396 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.806 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -93.09 106.91 18.8 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.556 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.3 pt -114.17 137.8 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.7 -0.625 . . . . 0.0 111.55 -176.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -95.68 112.76 24.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.553 -0.717 . . . . 0.0 109.418 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.698 HD13 ' SG ' ' A' ' 623' ' ' CYS . 64.5 mt -76.14 -20.9 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.218 -0.927 . . . . 0.0 110.438 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.906 HD11 HD13 ' A' ' 618' ' ' LEU . 8.8 mt -141.55 133.66 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.075 -1.016 . . . . 0.0 110.721 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -137.86 108.86 6.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.48 -0.762 . . . . 0.0 109.943 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.406 ' CB ' ' HB2' ' A' ' 686' ' ' ASN . 45.3 m-20 -125.66 118.38 25.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.883 . . . . 0.0 110.088 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -65.87 -38.64 89.32 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.461 -0.774 . . . . 0.0 110.983 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -84.04 -43.54 15.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.272 -0.892 . . . . 0.0 111.076 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . 0.406 ' HB2' ' CB ' ' A' ' 683' ' ' ASP . 50.9 m-80 -81.81 -12.35 58.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.129 -0.982 . . . . 0.0 110.69 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.471 ' O ' HG23 ' A' ' 689' ' ' VAL . 2.8 tttp 56.25 20.43 4.56 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.145 -0.972 . . . . 0.0 110.439 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.88 85.37 2.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.144 -0.972 . . . . 0.0 109.347 179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 586' ' ' SER . 2.9 t -101.73 135.91 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.442 -0.786 . . . . 0.0 110.656 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.585 ' CD1' HG22 ' A' ' 587' ' ' ILE . 40.5 mm -123.44 163.63 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.503 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . -174.76 124.67 1.03 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.525 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.806 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 9.9 m-85 -120.44 138.01 54.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.559 -0.965 . . . . 0.0 108.736 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.5 114.59 28.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 110.976 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -80.96 112.97 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -116.3 104.66 11.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.495 -0.753 . . . . 0.0 110.456 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.412 HD12 ' HB3' ' A' ' 674' ' ' ASP . 78.8 mt -84.11 103.81 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.376 -0.828 . . . . 0.0 109.517 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -81.94 -42.27 19.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 108.889 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.6 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.2 m-20 -110.55 142.29 42.55 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.401 0.62 . . . . 0.0 110.145 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 35.6 p -115.97 95.92 5.34 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 2.7 m -131.92 139.24 48.67 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.351 -0.539 . . . . 0.0 110.282 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.15 28.79 34.83 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.81 ' O ' HD22 ' A' ' 644' ' ' LEU . 0.2 OUTLIER -107.89 131.29 54.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.587 -0.949 . . . . 0.0 110.563 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.844 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.0 p90 -52.25 -23.7 6.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.42 -0.8 . . . . 0.0 109.806 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.585 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.9 OUTLIER -163.13 163.41 25.72 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.021 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.566 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 16.0 pt-20 -51.15 -27.8 9.5 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.115 -0.991 . . . . 0.0 110.174 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 123.55 13.41 4.26 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.812 HD22 ' OD1' ' A' ' 674' ' ' ASP . 0.2 OUTLIER -87.19 8.19 25.03 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.762 -1.434 . . . . 0.0 111.188 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 707' ' ' LEU . . . 37.42 97.7 0.01 OUTLIER Glycine 0 N--CA 1.502 3.067 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.455 ' HE3' ' HB2' ' A' ' 704' ' ' ASN . 0.0 OUTLIER -142.19 43.01 1.66 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.131 -1.217 . . . . 0.0 110.41 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.46 ' H ' HD23 ' A' ' 710' ' ' LEU . 0.5 OUTLIER -92.78 -168.21 1.9 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.392 -0.818 . . . . 0.0 110.449 -179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -59.78 -56.56 20.27 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.41 -0.806 . . . . 0.0 110.511 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -63.61 144.24 57.17 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.324 -0.86 . . . . 0.0 110.061 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -111.6 95.75 5.69 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.35 -0.844 . . . . 0.0 109.525 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.422 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 2.8 mmm-85 43.43 77.03 0.07 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.335 0.588 . . . . 0.0 111.345 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 32.6 m -107.73 153.07 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.412 -0.805 . . . . 0.0 109.433 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.585 HG13 ' HG2' ' A' ' 664' ' ' MET . 59.8 t -95.1 133.25 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 110.648 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.5 mt -104.83 162.26 13.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.488 -0.757 . . . . 0.0 109.765 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.78 153.43 19.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 110.246 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.85 122.29 26.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.4 -0.813 . . . . 0.0 110.249 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 27.8 p -95.92 -176.53 3.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.432 -0.792 . . . . 0.0 110.162 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.55 -28.99 34.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.293 -0.88 . . . . 0.0 110.188 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -69.01 -46.57 67.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.373 -0.829 . . . . 0.0 109.983 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.75 -50.26 69.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.383 -0.823 . . . . 0.0 110.043 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.46 ' O ' HG12 ' A' ' 727' ' ' VAL . 4.2 ttpt -53.71 -32.7 52.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.36 -0.837 . . . . 0.0 109.909 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 728' ' ' LYS . 28.7 t70 -66.18 -35.86 81.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.497 -0.752 . . . . 0.0 110.129 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 37.5 mt -61.16 -46.32 90.99 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.277 -0.89 . . . . 0.0 110.083 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.687 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.7 p -74.72 -24.26 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.601 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 725' ' ' ASP . 0.6 OUTLIER -53.94 -46.06 71.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.116 -0.99 . . . . 0.0 108.902 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -116.83 104.0 10.88 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.219 1.009 . . . . 0.0 109.011 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.599 HD21 ' SG ' ' A' ' 609' ' ' CYS . 0.5 OUTLIER . . . . . 0 C--N 1.274 -2.701 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.336 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -82.88 -10.1 58.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -1.104 . . . . 0.0 110.534 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 144.02 62.59 0.02 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.419 ' HD2' ' CG ' ' A' ' 593' ' ' GLU . 41.0 ttp180 -91.16 116.7 29.02 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.347 -1.09 . . . . 0.0 109.319 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.541 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -102.92 -42.57 5.79 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 122.044 0.926 . . . . 0.0 109.286 -179.287 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.061 HD22 HD12 ' A' ' 594' ' ' ILE . 9.7 tt -120.47 131.67 54.85 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.611 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.415 ' N ' HD23 ' A' ' 578' ' ' LEU . 32.6 m -109.18 118.27 36.29 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.961 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.618 HD11 HD11 ' A' ' 594' ' ' ILE . 13.2 mt -93.17 112.28 24.17 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.454 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.3 OUTLIER -114.99 103.6 54.6 Favored Pre-proline 0 C--N 1.302 -1.488 0 C-N-CA 118.326 -1.35 . . . . 0.0 113.387 -176.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 1.079 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 45.6 Cg_endo -78.58 140.66 16.99 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 N-CA-C 105.045 -2.713 . . . . 0.0 105.045 174.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.762 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -121.55 -175.05 0.33 Allowed Pre-proline 0 N--CA 1.496 1.863 0 C-N-CA 118.044 -1.462 . . . . 0.0 113.779 -176.118 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.762 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.4 Cg_endo -66.11 -33.75 39.6 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 O-C-N 124.198 1.631 . . . . 0.0 111.969 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -58.74 -29.48 66.76 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.709 -1.196 . . . . 0.0 107.856 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.638 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 27.1 p -96.39 153.28 17.91 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.57 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.4 OUTLIER -59.92 -15.73 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.184 -0.948 . . . . 0.0 109.127 178.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.778 HD12 ' HA ' ' A' ' 613' ' ' ILE . 7.8 mm -95.03 115.83 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.468 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -121.74 70.23 0.95 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.55 -1.344 . . . . 0.0 109.372 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 1.079 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 33.8 tt0 -144.34 174.08 11.22 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.698 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.517 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.87 127.53 40.39 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.937 -1.102 . . . . 0.0 109.365 176.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.774 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.1 mp -111.5 153.78 25.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.183 -0.948 . . . . 0.0 110.073 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.419 ' CG ' ' HD2' ' A' ' 576' ' ' ARG . 4.2 mp0 -125.74 112.46 16.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.537 -0.727 . . . . 0.0 111.185 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.061 HD12 HD22 ' A' ' 578' ' ' LEU . 69.6 mt -78.88 109.52 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.087 -1.008 . . . . 0.0 108.71 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.589 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -63.49 100.31 0.25 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.59 -0.694 . . . . 0.0 110.948 -178.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.589 ' C ' ' O ' ' A' ' 595' ' ' GLN . 0.8 OUTLIER -0.21 75.9 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 179.422 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 128.84 10.04 3.3 Favored Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.365 -1.397 . . . . 0.0 110.973 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.652 ' HB ' HG23 ' A' ' 594' ' ' ILE . 1.5 t -82.77 100.67 6.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 O-C-N 120.6 -1.529 . . . . 0.0 107.632 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.2 OUTLIER -144.61 135.88 12.58 Favored Pre-proline 0 C--N 1.282 -2.36 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.69 179.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.522 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 53.3 Cg_endo -90.42 164.46 32.58 Favored 'Cis proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.78 -1.758 . . . . 0.0 108.918 -1.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.543 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 3.3 t80 -103.27 115.93 31.49 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.616 ' CG ' HD23 ' A' ' 730' ' ' LEU . 44.9 m-85 -81.38 143.6 32.05 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 110.342 -178.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.888 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.6 mt -142.88 142.12 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.667 -0.646 . . . . 0.0 110.291 -178.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.76 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 169.16 -161.46 35.07 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.778 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.403 ' HD2' ' HA ' ' A' ' 614' ' ' GLU . 9.7 tpt180 -72.61 -35.43 67.86 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.677 -0.896 . . . . 0.0 111.006 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 620' ' ' ARG . 0.4 OUTLIER -83.0 123.69 29.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.846 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.523 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 7.5 tt0 -53.23 -19.26 2.96 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.328 -0.857 . . . . 0.0 110.052 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -45.1 -31.11 1.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.367 -0.833 . . . . 0.0 109.043 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.505 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.3 m -69.76 131.44 44.53 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.543 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -44.96 -27.89 0.6 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.34 -0.85 . . . . 0.0 110.027 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.888 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.0 t -107.27 143.52 35.39 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.523 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -110.46 128.01 55.4 Favored 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 119.102 -1.039 . . . . 0.0 112.963 -178.404 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.778 ' HA ' HD12 ' A' ' 588' ' ' ILE . 19.8 mt -142.19 107.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.403 ' HA ' ' HD2' ' A' ' 605' ' ' ARG . 0.1 OUTLIER -89.12 103.18 15.82 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.108 -1.437 . . . . 0.0 108.651 179.32 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.702 ' OD1' HD11 ' A' ' 690' ' ' ILE . 1.1 m-20 -139.55 106.06 5.32 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.602 178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -41.13 -57.0 2.19 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.545 -0.722 . . . . 0.0 112.253 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . 0.404 ' HD2' ' CD1' ' A' ' 681' ' ' ILE . 7.5 ptp180 -72.57 -16.85 61.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.169 -0.957 . . . . 0.0 111.975 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.594 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.8 OUTLIER -76.23 122.22 24.05 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.025 -1.047 . . . . 0.0 110.71 -179.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -58.54 159.86 6.04 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.466 -0.772 . . . . 0.0 110.942 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.76 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 14.3 mtt-85 -64.27 -45.2 89.13 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.354 -0.841 . . . . 0.0 109.493 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.5 HG11 HG22 ' A' ' 727' ' ' VAL . 11.8 t -95.4 1.7 10.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 121.93 0.871 . . . . 0.0 109.338 178.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.736 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.8 t60 -27.43 -46.69 0.03 OUTLIER 'General case' 0 C--O 1.195 -1.808 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.594 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.788 ' SG ' HD13 ' A' ' 680' ' ' ILE . 1.0 OUTLIER -137.92 146.18 42.97 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 117.953 -1.499 . . . . 0.0 112.06 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.555 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 2.4 p90 -145.92 145.67 30.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.701 -0.624 . . . . 0.0 109.819 177.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.683 HG13 HD11 ' A' ' 603' ' ' ILE . 88.2 mt -103.56 117.56 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 10.1 t80 -110.28 154.2 23.78 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.429 -0.794 . . . . 0.0 109.874 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 13.5 ttmt -120.33 136.84 54.56 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.55 0.69 . . . . 0.0 110.373 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.459 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.1 OUTLIER -134.66 164.22 28.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.702 -0.624 . . . . 0.0 109.892 -179.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.3 OUTLIER -77.1 121.25 23.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.059 -1.026 . . . . 0.0 108.871 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.52 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 6.0 t60 -58.55 124.5 19.85 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.707 0.765 . . . . 0.0 111.05 -178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -77.68 104.43 8.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.706 -0.621 . . . . 0.0 110.095 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.656 HG22 ' H ' ' A' ' 633' ' ' GLY . 1.6 p -103.95 -167.53 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.333 -0.855 . . . . 0.0 110.019 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.656 ' H ' HG22 ' A' ' 632' ' ' VAL . . . -97.38 174.3 29.52 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.07 144.0 57.44 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.375 -1.074 . . . . 0.0 110.145 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 85.6 p -116.83 87.77 2.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 110.219 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 9.3 mmt -93.2 40.67 1.07 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.337 -0.852 . . . . 0.0 109.979 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -171.74 -147.68 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.536 -0.728 . . . . 0.0 109.234 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -115.23 99.97 7.8 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.167 -0.958 . . . . 0.0 108.925 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 29.8 p -138.87 151.19 67.83 Favored Pre-proline 0 C--N 1.294 -1.817 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.596 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -72.19 -157.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.583 1.307 . . . . 0.0 109.513 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.56 ' O ' HG21 ' A' ' 632' ' ' VAL . . . 38.52 31.84 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.993 -0.442 . . . . 0.0 111.658 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -72.13 61.3 0.44 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.015 -1.053 . . . . 0.0 110.198 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.608 ' C ' HD12 ' A' ' 644' ' ' LEU . . . 62.33 118.29 0.01 OUTLIER Glycine 0 N--CA 1.487 2.068 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.84 HD22 ' O ' ' A' ' 702' ' ' LEU . 5.0 mp -141.89 -153.65 0.47 Allowed 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.9 m-20 -112.2 124.17 51.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.044 -1.035 . . . . 0.0 111.367 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.682 ' OD2' HD21 ' A' ' 671' ' ' LEU . 21.1 t0 -105.1 156.46 18.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.555 -0.715 . . . . 0.0 109.584 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.534 HD13 ' CD1' ' A' ' 578' ' ' LEU . 18.5 pt -110.11 129.95 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.233 -0.917 . . . . 0.0 110.32 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.651 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 96.0 m95 -118.86 120.34 37.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.75 -0.594 . . . . 0.0 110.968 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.685 ' HB2' HD11 ' A' ' 672' ' ' LEU . 8.0 t80 -80.61 114.44 19.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.963 . . . . 0.0 108.474 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.0 OUTLIER -105.25 107.4 18.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.342 -0.849 . . . . 0.0 111.322 -178.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.515 ' CE1' ' C ' ' A' ' 656' ' ' VAL . 17.8 t60 -68.44 159.87 30.8 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.429 -0.794 . . . . 0.0 109.961 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.736 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -149.86 -31.02 0.22 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.437 -0.79 . . . . 0.0 112.879 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.542 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.57 -165.13 27.42 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 117.741 -2.171 . . . . 0.0 109.61 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 15.1 m -98.66 -17.65 18.48 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.976 -1.308 . . . . 0.0 113.552 -176.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.539 ' O ' HG12 ' A' ' 656' ' ' VAL . 18.0 m120 -59.73 -4.43 0.68 Allowed 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.786 -1.196 . . . . 0.0 112.328 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 77.7 166.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-O 121.939 0.876 . . . . 0.0 110.247 -179.539 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.457 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -125.61 141.41 52.04 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.474 -179.035 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -127.91 125.72 40.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.932 . . . . 0.0 110.715 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.694 HD22 ' CG2' ' A' ' 678' ' ' ILE . 0.1 OUTLIER -114.67 106.23 13.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.224 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 659' ' ' LEU . 17.2 m120 56.35 -79.25 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.548 -0.72 . . . . 0.0 110.295 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.539 ' N ' ' O ' ' A' ' 659' ' ' LEU . 21.4 t-20 -140.19 20.28 2.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.183 -0.948 . . . . 0.0 110.548 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -110.68 137.06 48.84 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.165 -0.959 . . . . 0.0 110.437 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.425 ' O ' HG21 ' A' ' 716' ' ' VAL . 8.0 tmm_? -93.76 141.39 28.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.397 -0.814 . . . . 0.0 110.005 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.626 ' O ' HG22 ' A' ' 656' ' ' VAL . 90.6 mtp -126.07 -168.19 1.82 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.355 -0.84 . . . . 0.0 110.056 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.588 HG13 HG23 ' A' ' 668' ' ' THR . 4.1 pt -144.09 -160.57 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.159 -0.963 . . . . 0.0 110.953 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -76.07 111.09 11.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.507 -0.745 . . . . 0.0 110.748 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 86.12 48.87 4.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.0 OUTLIER -114.19 146.1 40.81 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.051 -1.264 . . . . 0.0 109.863 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.429 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 10.8 tttt -108.24 138.91 43.72 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.561 -0.712 . . . . 0.0 109.488 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.529 ' CD2' HG22 ' A' ' 716' ' ' VAL . 2.8 t80 -144.64 146.25 32.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 111.329 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.682 HD21 ' OD2' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -72.55 147.01 46.35 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.468 -0.77 . . . . 0.0 110.89 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.766 HD23 ' OD2' ' A' ' 676' ' ' ASP . 10.6 mt -118.07 101.43 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.396 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -84.81 157.19 21.04 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.456 ' HB3' HD12 ' A' ' 696' ' ' ILE . 21.0 p-10 -52.69 148.37 7.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.933 -1.104 . . . . 0.0 109.925 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 67.95 48.52 53.81 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.766 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.3 OUTLIER -108.55 92.43 4.05 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.846 -0.796 . . . . 0.0 110.602 -178.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.894 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.0 OUTLIER -93.85 107.2 19.11 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.449 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.694 ' CG2' HD22 ' A' ' 659' ' ' LEU . 24.7 pt -111.85 138.07 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.667 -0.646 . . . . 0.0 111.537 -177.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -100.37 111.75 24.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.517 -0.74 . . . . 0.0 109.647 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.788 HD13 ' SG ' ' A' ' 623' ' ' CYS . 65.8 mt -80.01 -29.3 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 0.0 110.249 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.55 HG22 HG12 ' A' ' 690' ' ' ILE . 0.4 OUTLIER -128.61 133.59 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.25 -0.906 . . . . 0.0 109.817 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -138.17 111.75 8.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 0.0 110.467 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.68 117.63 25.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.275 -0.89 . . . . 0.0 109.667 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -46.98 75.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.326 -0.859 . . . . 0.0 110.834 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -84.89 -43.21 14.3 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.377 -0.827 . . . . 0.0 110.776 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -71.51 -9.15 57.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.249 -0.907 . . . . 0.0 110.706 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.34 22.3 6.2 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.105 -0.997 . . . . 0.0 110.344 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -87.65 104.17 16.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.234 -0.916 . . . . 0.0 109.873 179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 586' ' ' SER . 13.7 m -126.72 140.77 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.397 -0.814 . . . . 0.0 110.829 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.702 HD11 ' OD1' ' A' ' 615' ' ' ASP . 38.8 mm -117.47 163.6 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.485 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -173.28 123.05 0.96 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.894 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 11.3 m-85 -120.19 137.41 54.2 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.566 -0.961 . . . . 0.0 109.145 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -102.07 113.87 27.5 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.156 -0.965 . . . . 0.0 110.156 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -84.67 119.3 33.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -130.06 104.67 7.47 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.372 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.49 HD13 ' O ' ' A' ' 705' ' ' GLU . 46.3 mt -79.17 103.86 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -0.885 . . . . 0.0 109.6 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.92 -43.07 46.82 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.363 -0.836 . . . . 0.0 108.805 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 1.2 m-20 -110.53 141.54 43.54 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.442 0.639 . . . . 0.0 110.135 179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 21.4 p -114.22 95.94 5.54 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 50.2 m -131.66 133.78 45.26 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.378 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.74 25.86 30.7 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.84 ' O ' HD22 ' A' ' 644' ' ' LEU . 4.8 tp -105.55 134.75 48.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.389 -1.065 . . . . 0.0 110.438 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.835 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.9 p90 -52.69 -23.69 7.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.521 -0.737 . . . . 0.0 110.403 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.609 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 0.9 OUTLIER -169.73 158.41 7.51 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -178.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.563 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 15.7 pt-20 -51.5 -26.33 8.16 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.179 -0.951 . . . . 0.0 110.589 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 122.76 12.72 4.87 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.442 ' N ' HD21 ' A' ' 704' ' ' ASN . 0.2 OUTLIER -83.64 9.9 10.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.996 -1.296 . . . . 0.0 111.19 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.477 ' C ' HD23 ' A' ' 710' ' ' LEU . . . 101.19 -94.6 1.27 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.416 ' HE2' ' HB3' ' A' ' 709' ' ' MET . 15.3 ttp 54.64 80.76 0.12 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.347 -1.09 . . . . 0.0 110.646 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.477 HD23 ' C ' ' A' ' 708' ' ' GLY . 0.8 OUTLIER -169.47 155.95 6.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.325 -0.859 . . . . 0.0 110.279 179.578 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.45 -51.84 52.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.283 -0.885 . . . . 0.0 110.191 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -63.73 149.0 47.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.268 -0.895 . . . . 0.0 109.885 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -110.47 95.29 5.48 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.145 -0.972 . . . . 0.0 109.52 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.415 ' HD2' ' HA ' ' A' ' 714' ' ' ARG . 12.7 mmm-85 40.07 77.13 0.06 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.385 0.612 . . . . 0.0 111.629 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.4 m -107.7 152.58 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.563 -0.711 . . . . 0.0 109.418 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.529 HG22 ' CD2' ' A' ' 670' ' ' PHE . 44.1 t -92.94 121.15 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 110.576 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.8 mp -91.44 162.49 14.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.437 -0.789 . . . . 0.0 109.55 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -98.05 153.65 18.26 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.103 -0.998 . . . . 0.0 110.665 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . 0.4 ' HG2' ' HB2' ' A' ' 723' ' ' GLU . 0.2 OUTLIER -89.47 142.61 27.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.488 -0.757 . . . . 0.0 109.963 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 37.6 p -121.18 -178.36 3.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.317 -0.865 . . . . 0.0 110.575 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.4 -36.3 66.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.459 -0.776 . . . . 0.0 110.244 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . 0.539 ' O ' HD23 ' A' ' 726' ' ' LEU . 6.2 tt0 -57.54 -52.16 66.55 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.381 -0.825 . . . . 0.0 109.963 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.709 ' O ' HG12 ' A' ' 727' ' ' VAL . 74.5 mm-40 -63.54 -46.21 87.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.34 -0.85 . . . . 0.0 109.771 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.475 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 10.1 tttt -62.64 -31.94 72.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.39 -0.819 . . . . 0.0 110.775 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.56 -50.48 71.17 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -0.934 . . . . 0.0 112.051 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 722' ' ' GLU . 0.4 OUTLIER -72.35 -36.55 68.82 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.825 -1.172 . . . . 0.0 111.269 -178.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.709 HG12 ' O ' ' A' ' 723' ' ' GLU . 8.3 p -79.4 -18.25 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.868 -1.145 . . . . 0.0 110.416 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -43.21 66.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.176 -0.953 . . . . 0.0 108.814 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -116.45 103.27 10.28 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 122.211 1.005 . . . . 0.0 109.034 178.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.616 HD23 ' CG ' ' A' ' 602' ' ' PHE . 1.5 mt . . . . . 0 C--N 1.273 -2.727 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.231 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.424 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -83.21 -10.09 58.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.393 -1.063 . . . . 0.0 110.633 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . -172.92 53.82 0.16 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.423 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 4.5 ttm105 -92.67 113.94 26.35 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.412 -1.052 . . . . 0.0 109.603 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.592 ' CE1' HD21 ' A' ' 702' ' ' LEU . 0.0 OUTLIER -97.08 -43.24 7.49 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.89 0.852 . . . . 0.0 109.124 -179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.778 HD23 HD12 ' A' ' 594' ' ' ILE . 7.7 tp -126.68 139.74 52.93 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.188 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 87.2 m -121.83 119.52 31.88 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . . . . . . . . . 8.6 mt -95.56 112.38 24.11 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.511 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.1 OUTLIER -110.72 103.46 54.5 Favored Pre-proline 0 C--N 1.301 -1.538 0 C-N-CA 118.587 -1.245 . . . . 0.0 112.732 -177.547 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 1.054 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 42.3 Cg_endo -76.22 140.99 22.76 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 N-CA-C 105.737 -2.447 . . . . 0.0 105.737 174.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.769 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -127.48 -173.14 0.29 Allowed Pre-proline 0 N--CA 1.494 1.739 0 C-N-CA 118.187 -1.405 . . . . 0.0 113.338 -176.164 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.769 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 37.9 Cg_endo -64.68 -36.34 42.06 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 O-C-N 124.263 1.665 . . . . 0.0 111.116 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -58.52 -28.87 65.84 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.621 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 47.9 t -96.47 152.76 18.3 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.715 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.8 OUTLIER -64.56 -11.61 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.904 -1.123 . . . . 0.0 109.205 178.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.729 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 7.9 mm -97.21 117.05 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.484 -0.76 . . . . 0.0 109.401 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.621 ' NE2' ' O ' ' A' ' 586' ' ' SER . 21.1 mp0 -117.55 68.65 0.76 Allowed 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.462 -1.398 . . . . 0.0 109.743 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 1.054 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 2.6 mm-40 -143.35 175.78 9.66 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.607 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.549 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.97 125.42 35.39 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.071 -1.018 . . . . 0.0 109.585 176.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.732 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.6 mm? -106.8 151.15 25.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 108.963 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.423 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 1.2 mp0 -124.77 110.27 14.12 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.555 -0.716 . . . . 0.0 110.872 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.778 HD12 HD23 ' A' ' 578' ' ' LEU . 4.8 mt -83.78 109.19 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.181 -0.949 . . . . 0.0 109.156 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.617 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.2 OUTLIER -64.97 137.14 57.55 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.467 ' CA ' ' HB3' ' A' ' 577' ' ' PHE . 2.4 pt20 -44.45 84.37 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.507 -0.746 . . . . 0.0 110.782 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 137.67 3.85 1.99 Allowed Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.647 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -79.97 101.97 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 120.745 -1.444 . . . . 0.0 107.27 178.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 627' ' ' LYS . 49.0 t-20 -145.47 133.33 10.49 Favored Pre-proline 0 C--N 1.282 -2.367 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.85 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.629 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 51.1 Cg_endo -93.29 163.79 22.61 Favored 'Cis proline' 0 C--N 1.312 -1.348 0 C-N-CA 123.258 -1.559 . . . . 0.0 109.127 -2.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.627 ' HB3' ' CG2' ' A' ' 625' ' ' ILE . 3.9 t80 -104.96 116.03 31.28 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.669 ' HB3' HD23 ' A' ' 730' ' ' LEU . 34.8 m-85 -85.42 144.86 27.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.373 -0.829 . . . . 0.0 110.256 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.84 HG23 ' HB3' ' A' ' 611' ' ' CYS . 4.5 mt -140.52 142.34 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.512 -0.742 . . . . 0.0 110.201 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.834 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 164.96 -163.53 36.48 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.368 -1.396 . . . . 0.0 111.306 179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 8.6 tpt180 -62.87 -55.81 22.86 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.78 -0.836 . . . . 0.0 111.772 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.476 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -72.18 126.9 30.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 111.492 -178.283 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.467 ' CB ' ' HD2' ' A' ' 612' ' ' LYS . 0.0 OUTLIER -51.64 -19.25 1.46 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -0.831 . . . . 0.0 110.072 178.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 607' ' ' GLU . 27.1 t0 -42.27 -32.16 0.47 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.484 -0.76 . . . . 0.0 109.01 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.6 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.3 m -69.86 129.59 39.95 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.616 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.1 m120 -44.55 -28.12 0.55 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.217 -0.927 . . . . 0.0 109.973 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.84 ' HB3' HG23 ' A' ' 603' ' ' ILE . 3.8 t -105.21 143.57 33.2 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.467 ' HD2' ' CB ' ' A' ' 607' ' ' GLU . 1.1 ttpm? -106.53 128.35 54.04 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.059 -1.057 . . . . 0.0 113.467 -178.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.832 HD12 HG22 ' A' ' 603' ' ' ILE . 24.2 mt -143.29 107.71 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.459 ' H ' ' CD1' ' A' ' 588' ' ' ILE . 0.0 OUTLIER -97.86 104.73 16.78 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 118.238 -1.385 . . . . 0.0 109.306 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.649 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.3 m-20 -138.3 106.42 5.73 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.173 177.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . 0.454 ' HA ' ' NH1' ' A' ' 605' ' ' ARG . 1.4 m120 -41.12 -41.56 1.79 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.669 -0.644 . . . . 0.0 111.932 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.61 -21.61 32.49 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.093 -1.004 . . . . 0.0 111.272 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.834 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.6 OUTLIER -73.84 131.96 42.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.191 -0.943 . . . . 0.0 110.702 -179.531 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.454 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -68.09 158.39 33.12 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.356 -0.84 . . . . 0.0 110.725 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.781 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 15.2 ttp180 -62.24 -45.24 94.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.225 -0.922 . . . . 0.0 109.211 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.504 HG22 HD21 ' A' ' 730' ' ' LEU . 4.4 t -95.28 2.08 9.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.75 0.786 . . . . 0.0 109.593 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.75 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.0 t60 -29.63 -42.91 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.854 -178.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.752 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.9 OUTLIER -137.19 144.8 43.06 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 117.789 -1.564 . . . . 0.0 111.429 179.114 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.651 ' CE2' ' HB3' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -147.57 126.58 12.83 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.62 -0.675 . . . . 0.0 109.533 178.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.627 ' CG2' ' HB3' ' A' ' 601' ' ' PHE . 2.4 tt -104.08 118.16 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.362 -0.836 . . . . 0.0 108.869 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.651 ' HB3' ' CE2' ' A' ' 624' ' ' PHE . 17.5 p90 -122.83 155.2 37.08 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.758 0.789 . . . . 0.0 110.715 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 5.3 ttmt -99.55 136.68 39.13 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.939 0.876 . . . . 0.0 110.891 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.7 OUTLIER -131.11 163.09 28.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.648 -0.658 . . . . 0.0 109.934 -179.437 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 6.6 tpt180 -78.0 115.06 17.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.041 -1.037 . . . . 0.0 109.257 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 703' ' ' PHE . 6.6 t60 -58.52 124.68 20.43 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.528 0.68 . . . . 0.0 110.866 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -85.94 86.82 7.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.727 -0.608 . . . . 0.0 109.974 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.597 HG13 ' N ' ' A' ' 633' ' ' GLY . 0.6 OUTLIER -78.74 -164.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.409 -0.807 . . . . 0.0 110.161 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.597 ' N ' HG13 ' A' ' 632' ' ' VAL . . . -72.47 174.64 44.7 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.47 156.31 16.44 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.37 -1.076 . . . . 0.0 110.16 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 59.6 p -106.65 43.46 1.15 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.0 110.306 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.13 40.01 1.08 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.359 -0.838 . . . . 0.0 109.714 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -169.0 -150.71 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.597 -0.689 . . . . 0.0 109.515 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -115.55 101.6 9.02 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.204 -0.935 . . . . 0.0 109.022 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.26 151.29 71.3 Favored Pre-proline 0 C--N 1.294 -1.815 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.986 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.504 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 49.9 Cg_endo -71.84 -156.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.614 1.323 . . . . 0.0 109.891 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.543 ' O ' HD11 ' A' ' 644' ' ' LEU . . . 63.01 -60.76 0.14 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.839 -0.538 . . . . 0.0 110.979 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 640' ' ' PRO . 30.2 mt-30 54.87 28.74 10.88 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.914 -1.116 . . . . 0.0 109.571 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 63.12 120.75 0.01 OUTLIER Glycine 0 N--CA 1.485 1.941 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.543 HD11 ' O ' ' A' ' 641' ' ' ALA . 1.1 mp -133.86 -150.61 0.41 Allowed 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 628' ' ' LYS . 0.3 OUTLIER -120.85 123.85 43.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.126 -0.984 . . . . 0.0 110.813 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.603 ' OD2' HD11 ' A' ' 671' ' ' LEU . 10.3 t0 -101.93 132.2 47.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.417 -0.802 . . . . 0.0 109.211 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.519 HD13 HD22 ' A' ' 578' ' ' LEU . 6.4 pt -80.97 129.3 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.114 -0.992 . . . . 0.0 109.972 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.804 ' CZ3' HD22 ' A' ' 671' ' ' LEU . 87.8 m95 -116.15 122.56 45.43 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.526 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.909 ' HB2' HD11 ' A' ' 672' ' ' LEU . 6.8 t80 -82.05 113.12 19.71 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.1 OUTLIER -107.41 102.87 12.12 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.284 -0.967 . . . . 0.0 111.127 -178.513 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.504 ' CE1' ' C ' ' A' ' 656' ' ' VAL . 11.1 t60 -61.71 154.93 24.04 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.408 179.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.75 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -146.14 -25.22 0.44 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.624 ' N ' ' HA ' ' A' ' 622' ' ' HIS . . . -77.94 -171.12 36.94 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 117.992 -2.052 . . . . 0.0 109.119 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 27.1 m -95.56 -16.52 22.08 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.013 -1.287 . . . . 0.0 113.285 -176.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.569 ' O ' HG12 ' A' ' 656' ' ' VAL . 3.0 t-20 -62.33 -4.47 1.84 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.007 -1.058 . . . . 0.0 112.596 -178.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 78.62 166.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 CA-C-O 121.987 0.898 . . . . 0.0 110.464 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.443 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -124.99 152.13 44.61 Favored 'General case' 0 C--N 1.292 -1.916 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.435 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -138.34 126.91 23.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.252 -0.905 . . . . 0.0 110.437 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.927 HD21 ' NH1' ' A' ' 714' ' ' ARG . 43.5 tp -128.5 114.16 16.42 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 110.027 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 41.9 t30 56.43 -80.93 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.615 -0.678 . . . . 0.0 110.349 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.505 ' N ' ' O ' ' A' ' 659' ' ' LEU . 46.1 p-10 -142.52 11.62 1.9 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.042 -1.037 . . . . 0.0 110.767 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 32.7 m120 -105.5 133.5 50.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.98 -1.075 . . . . 0.0 110.798 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -93.11 142.14 27.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.48 -0.762 . . . . 0.0 109.802 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.61 ' O ' HG22 ' A' ' 656' ' ' VAL . 4.4 mtp -121.03 -166.88 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -0.954 . . . . 0.0 110.617 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.635 ' CG1' HG23 ' A' ' 668' ' ' THR . 2.7 pt -141.27 -164.26 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.443 -0.786 . . . . 0.0 110.19 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -78.32 86.73 4.39 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.34 -0.85 . . . . 0.0 110.62 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 114.74 52.61 0.43 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.635 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.2 OUTLIER -119.32 147.19 44.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.226 -1.161 . . . . 0.0 110.009 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.477 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 1.7 tttt -108.76 148.13 30.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.517 -0.739 . . . . 0.0 109.361 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.811 ' CD1' HD23 ' A' ' 659' ' ' LEU . 1.2 t80 -145.72 147.44 31.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.139 -0.975 . . . . 0.0 111.901 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.804 HD22 ' CZ3' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.48 132.82 47.64 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.405 -0.809 . . . . 0.0 109.647 179.19 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.909 HD11 ' HB2' ' A' ' 649' ' ' TYR . 2.7 mt -113.22 104.91 12.81 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.022 -1.049 . . . . 0.0 111.106 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.508 ' NE2' HD12 ' A' ' 671' ' ' LEU . 53.5 mm-40 -90.79 -177.1 4.88 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.541 ' OD1' HD22 ' A' ' 707' ' ' LEU . 13.8 p-10 -76.28 144.11 40.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.12 . . . . 0.0 109.761 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.41 48.35 45.32 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 107.83 -2.108 . . . . 0.0 107.83 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -116.24 99.4 7.19 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.808 -0.819 . . . . 0.0 109.995 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.914 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.85 113.4 25.42 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.862 HG12 HD13 ' A' ' 659' ' ' LEU . 1.5 mp -104.82 137.43 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.582 -0.699 . . . . 0.0 111.594 -177.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -99.25 117.14 33.05 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.752 HD13 ' SG ' ' A' ' 623' ' ' CYS . 79.9 mt -87.7 -27.92 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.221 -0.924 . . . . 0.0 111.145 -179.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.596 HG13 HD12 ' A' ' 618' ' ' LEU . 1.5 mt -143.23 133.43 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 0.0 111.078 -179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 14.0 t90 -138.2 109.0 6.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.629 -0.669 . . . . 0.0 109.568 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.15 117.92 28.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.085 -1.009 . . . . 0.0 110.699 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -66.63 -29.8 69.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.418 -0.801 . . . . 0.0 110.775 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -43.32 76.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.34 -0.85 . . . . 0.0 110.924 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 688' ' ' PHE . 10.9 t-20 -139.37 34.61 2.07 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.242 -0.912 . . . . 0.0 110.072 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.49 ' O ' ' C ' ' A' ' 688' ' ' PHE . 0.0 OUTLIER 66.26 -67.02 0.16 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.705 -0.622 . . . . 0.0 109.703 -179.616 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.2 OUTLIER 30.76 56.85 0.22 Allowed 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.34 0.591 . . . . 0.0 111.11 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 687' ' ' LYS . 41.6 t -101.67 141.52 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.43 -0.794 . . . . 0.0 110.714 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.715 ' CD1' HG22 ' A' ' 587' ' ' ILE . 47.9 mm -118.21 163.94 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.49 -0.756 . . . . 0.0 109.207 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.446 ' N ' ' OG ' ' A' ' 586' ' ' SER . . . -177.26 126.92 1.14 Allowed Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.19 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.914 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 12.9 m-85 -120.14 137.87 53.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.668 -0.901 . . . . 0.0 108.776 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.99 114.3 26.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.11 -0.994 . . . . 0.0 110.387 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.527 HG13 HD11 ' A' ' 578' ' ' LEU . 0.9 OUTLIER -85.37 120.31 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.523 -0.736 . . . . 0.0 109.37 179.56 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -126.59 114.6 18.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.672 -0.642 . . . . 0.0 110.209 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.542 HG12 HD12 ' A' ' 578' ' ' LEU . 88.5 mt -92.1 104.55 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.353 -0.842 . . . . 0.0 110.19 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.45 -43.73 18.46 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.486 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 4.2 m-20 -110.58 143.59 40.75 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.346 0.593 . . . . 0.0 109.929 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 39.7 p -112.51 95.71 5.59 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 11.1 p -135.01 133.15 39.13 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.844 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 62.67 28.85 72.21 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.592 HD21 ' CE1' ' A' ' 577' ' ' PHE . 0.3 OUTLIER -111.4 129.85 55.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.426 -1.043 . . . . 0.0 110.099 -179.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.537 ' CZ ' ' CG ' ' A' ' 704' ' ' ASN . 10.5 p90 -49.09 -24.58 1.67 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.434 -0.791 . . . . 0.0 110.403 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.537 ' CG ' ' CZ ' ' A' ' 703' ' ' PHE . 35.5 p-10 -139.85 -157.71 0.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.817 0.818 . . . . 0.0 110.347 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.466 ' HG3' ' N ' ' A' ' 706' ' ' GLY . 16.7 pt-20 -84.01 -32.38 24.95 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.466 ' N ' ' HG3' ' A' ' 705' ' ' GLU . . . 127.92 15.06 2.41 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.541 HD22 ' OD1' ' A' ' 674' ' ' ASP . 0.2 OUTLIER -104.94 9.58 34.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.123 -1.222 . . . . 0.0 111.32 -179.548 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 65.29 89.0 0.05 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -103.97 96.87 6.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.406 -1.055 . . . . 0.0 110.18 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.421 HD12 ' HB2' ' A' ' 712' ' ' GLU . 0.5 OUTLIER -171.65 161.93 6.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.302 -0.873 . . . . 0.0 110.307 -179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -81.01 -30.16 35.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.397 -0.814 . . . . 0.0 110.179 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.421 ' HB2' HD12 ' A' ' 710' ' ' LEU . 1.5 mt-10 -63.6 149.18 46.98 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.314 -0.866 . . . . 0.0 109.688 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -110.49 95.48 5.59 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.225 -0.922 . . . . 0.0 109.806 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.927 ' NH1' HD21 ' A' ' 659' ' ' LEU . 9.7 mmm180 38.15 90.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.383 0.611 . . . . 0.0 111.778 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 34.2 m -107.94 159.72 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.457 -0.777 . . . . 0.0 109.528 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.726 HG22 ' CD2' ' A' ' 670' ' ' PHE . 47.6 t -104.24 133.47 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.116 -0.99 . . . . 0.0 110.856 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.57 162.99 13.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.551 -0.718 . . . . 0.0 109.655 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -103.82 143.32 32.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.196 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -85.98 154.37 21.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.354 -0.841 . . . . 0.0 110.385 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 15.9 p -115.95 -176.63 2.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 0.0 110.426 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.58 -32.41 50.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.422 -0.799 . . . . 0.0 110.296 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -60.66 -52.25 65.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.337 -0.852 . . . . 0.0 109.772 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.76 ' HA ' HD21 ' A' ' 726' ' ' LEU . 5.6 mt-10 -64.68 -37.98 89.42 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.499 -0.751 . . . . 0.0 109.755 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.09 -32.38 73.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.333 -0.854 . . . . 0.0 110.58 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.46 -50.91 49.02 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.245 -0.909 . . . . 0.0 111.766 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.76 HD21 ' HA ' ' A' ' 723' ' ' GLU . 0.6 OUTLIER -62.22 -42.22 99.11 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.949 -1.094 . . . . 0.0 110.935 -179.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 723' ' ' GLU . 7.2 p -76.67 -17.04 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.877 -1.14 . . . . 0.0 110.349 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -53.67 -43.32 68.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.202 -0.936 . . . . 0.0 108.856 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -116.52 103.78 10.76 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.249 1.024 . . . . 0.0 109.021 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.669 HD23 ' HB3' ' A' ' 602' ' ' PHE . 1.3 mt . . . . . 0 C--N 1.273 -2.743 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.362 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -91.92 6.14 47.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -1.123 . . . . 0.0 110.718 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . -150.51 54.45 0.48 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -93.05 114.46 27.0 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.371 -1.076 . . . . 0.0 109.512 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.654 ' HE1' HD22 ' A' ' 702' ' ' LEU . 0.8 OUTLIER -91.35 -40.92 11.19 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.76 0.79 . . . . 0.0 109.216 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.84 HD21 HG22 ' A' ' 694' ' ' VAL . 3.5 tt -135.63 142.76 45.26 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.597 0.713 . . . . 0.0 111.561 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 95.6 m -118.53 123.65 45.6 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.991 HD11 HD12 ' A' ' 625' ' ' ILE . 9.6 mt -93.16 112.41 24.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.448 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 2.9 mmtt -113.77 102.34 54.71 Favored Pre-proline 0 C--N 1.302 -1.497 0 C-N-CA 118.223 -1.391 . . . . 0.0 112.835 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 1.072 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.5 Cg_endo -81.15 141.1 12.76 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 N-CA-C 105.808 -2.42 . . . . 0.0 105.808 174.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.773 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -120.29 -174.86 0.31 Allowed Pre-proline 0 N--CA 1.495 1.802 0 C-N-CA 118.128 -1.429 . . . . 0.0 113.512 -176.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.773 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 37.7 Cg_endo -63.86 -36.23 51.67 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 124.269 1.668 . . . . 0.0 111.657 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.63 -27.32 64.62 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.429 ' OG ' ' HA ' ' A' ' 690' ' ' ILE . 33.0 t -96.04 148.48 22.62 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.541 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.741 HG21 ' O ' ' A' ' 614' ' ' GLU . 0.8 OUTLIER -56.68 -18.71 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.991 -1.068 . . . . 0.0 109.178 178.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.937 ' CD1' HD12 ' A' ' 690' ' ' ILE . 4.1 mp -94.72 116.38 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.478 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -120.67 67.2 0.85 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.545 -1.347 . . . . 0.0 108.864 -179.493 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 1.072 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 15.5 tp10 -145.0 175.14 10.45 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.217 -0.902 . . . . 0.0 109.243 -178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.529 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.19 124.24 38.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.085 -1.009 . . . . 0.0 109.447 176.626 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.752 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.1 mt -103.04 155.72 18.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.455 -0.778 . . . . 0.0 109.173 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -125.25 110.3 13.88 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.393 -0.817 . . . . 0.0 111.177 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.803 HD12 HD22 ' A' ' 578' ' ' LEU . 26.4 mt -80.08 108.31 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.4 OUTLIER -68.0 116.73 8.97 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.437 -0.79 . . . . 0.0 111.106 -178.29 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.686 ' HG3' HG21 ' A' ' 700' ' ' THR . 0.1 OUTLIER 38.57 32.41 0.05 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.255 0.55 . . . . 0.0 111.188 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.414 ' HA2' ' CG2' ' A' ' 594' ' ' ILE . . . 83.73 63.7 1.67 Allowed Glycine 0 N--CA 1.486 1.983 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 598' ' ' VAL . 9.8 p -79.47 105.15 8.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 O-C-N 121.039 -1.271 . . . . 0.0 107.583 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.443 ' CB ' ' HB3' ' A' ' 627' ' ' LYS . 3.9 p-10 -121.79 151.13 57.07 Favored Pre-proline 0 C--N 1.279 -2.466 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.649 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.482 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.7 Cg_endo -86.24 156.8 54.58 Favored 'Cis proline' 0 C--N 1.307 -1.618 0 C-N-CA 120.933 -2.528 . . . . 0.0 109.475 0.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.508 ' CD2' ' HB2' ' A' ' 611' ' ' CYS . 4.8 t80 -105.66 115.39 30.16 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.54 ' HB3' ' SG ' ' A' ' 609' ' ' CYS . 50.2 m-85 -86.14 143.68 27.89 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.431 -178.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.926 HG23 ' HB3' ' A' ' 611' ' ' CYS . 4.1 mt -140.68 141.75 31.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.894 -0.504 . . . . 0.0 110.013 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.963 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 165.42 -162.3 35.66 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.361 -1.399 . . . . 0.0 111.13 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.464 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 5.9 mmm-85 -61.26 -58.48 8.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.89 -0.771 . . . . 0.0 111.804 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.03 124.27 22.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 111.251 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.538 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 11.8 pt-20 -54.16 -16.98 2.35 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.922 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -44.88 -36.44 3.31 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.37 -0.831 . . . . 0.0 109.074 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.54 ' SG ' ' HB3' ' A' ' 602' ' ' PHE . 1.3 m -59.63 136.63 58.05 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.491 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -47.42 -26.77 1.43 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.209 -0.932 . . . . 0.0 109.414 179.165 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.926 ' HB3' HG23 ' A' ' 603' ' ' ILE . 3.0 t -109.48 143.02 39.66 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.538 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -103.1 126.62 50.36 Favored 'General case' 0 N--CA 1.505 2.298 0 C-N-CA 119.497 -0.881 . . . . 0.0 112.447 -178.559 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.792 HG22 HD22 ' A' ' 618' ' ' LEU . 5.3 mt -143.19 109.64 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.741 ' O ' HG21 ' A' ' 587' ' ' ILE . 2.1 tp10 -97.26 103.04 14.94 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 117.99 -1.484 . . . . 0.0 108.357 178.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.534 ' HB2' ' HB3' ' A' ' 618' ' ' LEU . 4.3 m-20 -137.7 105.73 5.69 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.417 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -42.36 -51.66 4.81 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.599 -0.688 . . . . 0.0 112.181 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -74.77 -16.7 60.71 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.182 -0.949 . . . . 0.0 111.602 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.963 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.5 OUTLIER -80.23 143.58 33.62 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.155 -0.965 . . . . 0.0 111.071 -179.062 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.454 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -79.85 162.88 24.79 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.414 -0.803 . . . . 0.0 110.681 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.788 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.4 mpt_? -64.32 -46.76 82.11 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.145 -0.972 . . . . 0.0 109.936 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.557 ' HB ' HG23 ' A' ' 727' ' ' VAL . 5.2 m -95.75 2.14 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.235 -0.916 . . . . 0.0 109.42 178.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.725 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.2 t60 -25.28 -47.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.409 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.786 ' SG ' HD13 ' A' ' 680' ' ' ILE . 1.0 OUTLIER -136.82 146.41 45.63 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 118.206 -1.397 . . . . 0.0 111.497 179.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.555 ' HA ' HG13 ' A' ' 603' ' ' ILE . 3.6 p90 -145.82 146.58 31.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.622 -0.674 . . . . 0.0 110.073 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.991 HD12 HD11 ' A' ' 580' ' ' LEU . 19.8 mt -103.55 117.46 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.443 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 10.9 t80 -111.78 154.61 24.8 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 109.956 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.443 ' HB3' ' CB ' ' A' ' 599' ' ' ASN . 2.8 ttmt -120.3 136.6 54.63 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 121.556 0.694 . . . . 0.0 110.434 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.443 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -135.53 164.81 26.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.648 -0.658 . . . . 0.0 109.949 -179.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.1 OUTLIER -77.12 115.01 16.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 109.03 -179.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.527 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.8 t-160 -63.33 124.88 22.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.585 -0.697 . . . . 0.0 110.998 -179.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . 0.711 ' O ' HG12 ' A' ' 632' ' ' VAL . . . -79.58 122.67 26.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.646 -0.659 . . . . 0.0 109.793 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.711 HG12 ' O ' ' A' ' 631' ' ' ALA . 1.6 p 44.8 -168.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.677 -0.639 . . . . 0.0 111.084 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.677 ' H ' HG22 ' A' ' 632' ' ' VAL . . . 131.75 -144.53 16.2 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -142.27 -173.24 3.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.306 -1.114 . . . . 0.0 110.229 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -169.38 135.29 1.59 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.328 -0.857 . . . . 0.0 110.51 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . 0.424 ' O ' ' O ' ' A' ' 637' ' ' TYR . 0.8 OUTLIER 51.0 -134.76 1.55 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.248 -0.907 . . . . 0.0 110.158 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 636' ' ' MET . 0.1 OUTLIER -59.09 -154.34 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.496 -0.752 . . . . 0.0 109.741 179.522 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -78.9 98.02 6.22 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.775 -1.203 . . . . 0.0 108.108 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 10.0 p -139.44 152.52 69.25 Favored Pre-proline 0 C--N 1.289 -2.063 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.98 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.86 -150.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.659 0 O-C-N 123.584 1.307 . . . . 0.0 109.198 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.449 ' HB3' ' N ' ' A' ' 633' ' ' GLY . . . -163.41 105.81 0.99 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 109.623 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . 0.424 ' O ' ' O ' ' A' ' 643' ' ' GLY . 32.6 tt0 -77.82 48.9 0.73 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.376 -0.827 . . . . 0.0 110.839 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.582 ' C ' HD12 ' A' ' 644' ' ' LEU . . . 59.94 128.64 0.01 OUTLIER Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.721 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.0 mp -140.39 -150.99 0.34 Allowed 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.828 -0.807 . . . . 0.0 109.141 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.3 OUTLIER -118.0 124.26 47.74 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.975 -1.078 . . . . 0.0 111.412 -179.426 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.475 ' OD2' HD11 ' A' ' 671' ' ' LEU . 28.7 t0 -111.18 155.65 22.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.443 -0.786 . . . . 0.0 109.92 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 21.8 pt -108.81 128.79 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.21 -0.931 . . . . 0.0 109.748 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.842 ' CH2' HD22 ' A' ' 671' ' ' LEU . 95.6 m95 -115.48 119.95 37.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.678 -0.639 . . . . 0.0 111.595 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.541 ' HB2' ' CD1' ' A' ' 672' ' ' LEU . 11.5 t80 -83.31 114.13 21.19 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.0 OUTLIER -108.86 103.28 12.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.154 -0.966 . . . . 0.0 111.353 -178.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.53 ' CD2' ' N ' ' A' ' 652' ' ' THR . 8.9 t60 -63.04 156.75 23.87 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.513 -0.742 . . . . 0.0 109.895 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.725 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -148.19 -29.11 0.31 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.395 -0.816 . . . . 0.0 112.875 -179.206 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.539 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.85 -163.66 25.15 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 117.864 -2.112 . . . . 0.0 109.473 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 19.3 m -99.3 -17.84 17.86 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.02 -1.282 . . . . 0.0 113.709 -176.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.551 ' C ' HG23 ' A' ' 656' ' ' VAL . 8.7 m120 -59.16 -3.77 0.43 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 120.667 -1.27 . . . . 0.0 112.492 -178.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.551 HG23 ' C ' ' A' ' 655' ' ' ASN . 2.9 t 71.52 147.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.626 -0.671 . . . . 0.0 110.207 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -102.74 141.64 35.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.517 -0.739 . . . . 0.0 111.145 -178.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.433 ' CE1' ' HG2' ' A' ' 663' ' ' ARG . 95.3 m-85 -129.46 126.61 39.11 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.552 -0.718 . . . . 0.0 109.724 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.772 HD23 ' CE1' ' A' ' 670' ' ' PHE . 31.3 tp -130.85 111.83 12.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.222 -0.924 . . . . 0.0 110.107 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 56.31 -82.2 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.565 -0.709 . . . . 0.0 110.167 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 659' ' ' LEU . 17.1 m-80 -141.89 17.77 2.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 110.131 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.431 ' HB3' ' CE2' ' A' ' 670' ' ' PHE . 0.8 OUTLIER -109.45 127.12 54.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.178 -0.951 . . . . 0.0 110.494 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.433 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 0.0 OUTLIER -93.22 141.15 28.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.417 -0.802 . . . . 0.0 109.794 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.709 ' HG2' HG13 ' A' ' 716' ' ' VAL . 3.0 mtp -122.79 -167.65 1.62 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.372 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.606 HG13 HG23 ' A' ' 668' ' ' THR . 3.0 pt -139.82 -160.96 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.399 -0.813 . . . . 0.0 110.239 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -79.76 95.51 6.01 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.283 -0.886 . . . . 0.0 110.668 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 104.31 51.6 0.92 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.624 ' O ' ' HA ' ' A' ' 650' ' ' CYS . 0.1 OUTLIER -118.18 145.36 45.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.103 -1.233 . . . . 0.0 109.993 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.77 141.62 39.05 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.772 ' CE1' HD23 ' A' ' 659' ' ' LEU . 3.7 t80 -145.36 148.21 33.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.106 -0.996 . . . . 0.0 112.299 -177.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.842 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -68.53 130.91 44.24 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.443 -0.786 . . . . 0.0 109.893 179.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.541 ' CD1' ' HB2' ' A' ' 649' ' ' TYR . 4.3 mt -107.44 105.01 14.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.907 -1.121 . . . . 0.0 111.226 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.453 ' O ' HG11 ' A' ' 694' ' ' VAL . 85.9 mt-30 -87.51 165.36 15.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.476 -0.765 . . . . 0.0 109.052 178.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.885 ' OD1' HD12 ' A' ' 707' ' ' LEU . 14.4 p-10 -62.74 157.42 21.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.127 -0.983 . . . . 0.0 109.923 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 694' ' ' VAL . . . 59.88 51.52 58.46 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 107.765 -2.134 . . . . 0.0 107.765 -178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.512 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.5 OUTLIER -114.09 96.34 5.76 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.786 -0.832 . . . . 0.0 110.868 -178.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.913 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.6 tt0 -94.46 107.98 19.93 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.739 HG22 HD13 ' A' ' 659' ' ' LEU . 35.5 pt -107.59 138.38 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.598 -0.689 . . . . 0.0 112.331 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -100.06 112.79 25.09 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.786 HD13 ' SG ' ' A' ' 623' ' ' CYS . 56.8 mt -81.63 -33.81 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.26 -0.9 . . . . 0.0 111.504 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.68 HG22 ' CG1' ' A' ' 690' ' ' ILE . 14.1 tt -133.85 136.15 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 120.938 -1.101 . . . . 0.0 110.213 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -137.59 116.48 12.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.316 -0.865 . . . . 0.0 110.462 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -127.94 117.6 22.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.84 -30.19 70.3 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.466 -0.771 . . . . 0.0 111.015 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -55.65 -43.45 76.28 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.301 -0.874 . . . . 0.0 110.872 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 688' ' ' PHE . 6.9 m-80 -136.62 32.35 2.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 110.002 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 688' ' ' PHE . 5.8 mttm 64.21 -67.0 0.11 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.915 -0.49 . . . . 0.0 110.09 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.494 ' N ' ' O ' ' A' ' 686' ' ' ASN . 0.1 OUTLIER 33.42 55.48 0.5 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.3 0.571 . . . . 0.0 110.965 179.664 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 687' ' ' LYS . 34.4 m -101.3 142.19 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 110.414 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.937 HD12 ' CD1' ' A' ' 588' ' ' ILE . 31.2 mm -117.83 164.2 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.473 -0.767 . . . . 0.0 109.333 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.43 ' N ' HG22 ' A' ' 690' ' ' ILE . . . -170.96 124.71 1.14 Allowed Glycine 0 N--CA 1.486 1.987 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.058 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.913 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 14.3 m-85 -119.19 137.25 53.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.625 -0.926 . . . . 0.0 108.654 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -101.13 113.95 27.46 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 110.753 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.84 HG22 HD21 ' A' ' 578' ' ' LEU . 0.8 OUTLIER -83.84 121.51 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -129.26 105.81 8.4 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.623 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.603 HG12 HD12 ' A' ' 578' ' ' LEU . 82.1 mt -85.73 105.95 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.449 -0.782 . . . . 0.0 109.614 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.28 -44.13 13.13 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.428 -0.795 . . . . 0.0 108.889 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -111.26 142.35 43.59 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.401 0.62 . . . . 0.0 110.229 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 2.0 p -114.19 96.15 5.65 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.686 HG21 ' HG3' ' A' ' 596' ' ' GLN . 7.2 t -86.26 95.96 9.79 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 121.334 0.588 . . . . 0.0 111.216 -178.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 47.43 36.77 11.69 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.884 HD23 ' O ' ' A' ' 704' ' ' ASN . 1.7 tp -84.41 149.96 25.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.392 -1.063 . . . . 0.0 110.336 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.721 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.5 p90 -53.5 -23.2 9.67 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.384 -0.823 . . . . 0.0 109.939 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.884 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.8 t30 -172.12 154.96 3.54 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.516 ' O ' HD13 ' A' ' 696' ' ' ILE . 16.9 pt-20 -50.98 -26.64 6.27 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.18 -0.95 . . . . 0.0 110.226 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 120.86 15.54 4.78 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.885 HD12 ' OD1' ' A' ' 674' ' ' ASP . 1.5 tp -83.34 9.61 10.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.099 -1.236 . . . . 0.0 111.385 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 106.31 -103.31 2.05 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.544 ' C ' HD23 ' A' ' 710' ' ' LEU . 8.1 ttp 53.7 91.17 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.442 -1.034 . . . . 0.0 110.546 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.564 ' N ' HD23 ' A' ' 710' ' ' LEU . 1.0 OUTLIER -174.02 154.51 2.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.27 -0.894 . . . . 0.0 110.199 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -59.35 -57.71 11.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.273 -0.892 . . . . 0.0 109.834 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -63.86 149.35 47.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.514 -0.741 . . . . 0.0 109.642 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.17 95.62 5.7 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.149 -0.969 . . . . 0.0 109.274 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.447 ' HA ' ' HD2' ' A' ' 714' ' ' ARG . 5.2 mmm-85 43.59 72.8 0.17 Allowed 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.368 0.604 . . . . 0.0 111.354 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 30.9 m -107.77 151.75 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.475 -0.765 . . . . 0.0 109.279 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.709 HG13 ' HG2' ' A' ' 664' ' ' MET . 61.6 t -92.3 118.58 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 110.512 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.3 mp -90.22 161.8 15.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.546 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.12 153.99 17.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.212 -0.93 . . . . 0.0 110.244 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . 0.407 ' HG3' ' CB ' ' A' ' 723' ' ' GLU . 33.0 tt0 -79.93 145.8 32.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.472 -0.768 . . . . 0.0 110.181 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 20.3 p -121.13 -176.89 3.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.309 -0.87 . . . . 0.0 110.362 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -57.93 -31.7 67.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.376 -0.827 . . . . 0.0 110.456 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.32 -52.46 64.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.352 -0.842 . . . . 0.0 110.001 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.407 ' CB ' ' HG3' ' A' ' 719' ' ' GLN . 2.4 mp0 -66.8 -42.47 85.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -0.873 . . . . 0.0 109.929 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.563 ' O ' HG12 ' A' ' 727' ' ' VAL . 12.2 ttmm -56.69 -32.83 65.84 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.319 -0.863 . . . . 0.0 109.756 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.8 -36.21 77.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.399 -0.813 . . . . 0.0 110.09 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 33.4 mt -58.18 -46.63 85.41 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.404 -0.81 . . . . 0.0 110.446 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 724' ' ' LYS . 7.9 p -69.88 -19.57 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.065 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -54.44 -48.49 71.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -0.894 . . . . 0.0 108.79 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.81 104.98 11.88 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 122.229 1.014 . . . . 0.0 108.923 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.275 -2.657 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.377 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.78 -10.15 59.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.4 -1.059 . . . . 0.0 110.401 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 167.21 65.62 0.03 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.77 129.59 38.64 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.385 -1.068 . . . . 0.0 109.253 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.519 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 3.7 t80 -123.56 -41.47 2.27 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 122.074 0.94 . . . . 0.0 109.215 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.643 HD23 HD12 ' A' ' 594' ' ' ILE . 22.1 tp -123.83 140.76 52.67 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.285 -178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.434 ' H ' HD12 ' A' ' 578' ' ' LEU . 88.1 m -123.51 116.98 24.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.705 179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.661 HD11 ' CD1' ' A' ' 625' ' ' ILE . 1.9 mm? -90.37 111.74 23.08 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.426 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 2.5 mmtt -112.89 101.26 52.91 Favored Pre-proline 0 C--N 1.299 -1.594 0 C-N-CA 117.987 -1.485 . . . . 0.0 112.657 -177.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 1.104 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 47.1 Cg_endo -80.87 140.72 12.95 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 N-CA-C 105.428 -2.566 . . . . 0.0 105.428 174.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.737 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -118.86 -176.95 0.41 Allowed Pre-proline 0 N--CA 1.495 1.793 0 C-N-CA 118.177 -1.409 . . . . 0.0 113.567 -176.232 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.737 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.3 Cg_endo -66.56 -31.3 41.63 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 O-C-N 124.342 1.706 . . . . 0.0 111.83 -178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -59.0 -29.89 67.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.798 -1.189 . . . . 0.0 108.124 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.599 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 54.4 p -96.44 153.29 17.91 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.914 -0.491 . . . . 0.0 109.724 178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.644 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.1 OUTLIER -57.0 -18.95 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.16 -0.963 . . . . 0.0 109.101 178.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.873 HD12 ' HA ' ' A' ' 613' ' ' ILE . 10.0 mm -95.96 115.38 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.51 ' CD ' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -124.47 71.37 1.14 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 120.601 -1.312 . . . . 0.0 110.099 -178.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 1.104 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 18.9 mt-10 -145.12 174.97 10.6 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.579 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.526 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.79 127.23 41.57 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.841 -1.162 . . . . 0.0 109.393 176.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.837 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.2 mp -111.39 155.73 22.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 109.747 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -124.96 110.41 14.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.481 -0.762 . . . . 0.0 111.406 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.643 HD12 HD23 ' A' ' 578' ' ' LEU . 3.0 mt -80.85 110.49 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.525 ' HB2' HG23 ' A' ' 598' ' ' VAL . 0.7 OUTLIER -51.48 172.83 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.634 -0.666 . . . . 0.0 110.052 -179.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.519 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 5.6 mt-30 -64.36 66.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.476 -0.765 . . . . 0.0 110.555 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 128.72 30.65 0.69 Allowed Glycine 0 N--CA 1.486 2.01 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.806 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.641 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -81.34 102.81 7.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.486 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 11.8 t-20 -143.3 134.54 12.66 Favored Pre-proline 0 C--N 1.284 -2.265 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.89 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.646 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 55.9 Cg_endo -91.48 162.52 28.47 Favored 'Cis proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.958 -1.684 . . . . 0.0 109.192 -1.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.547 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 3.8 t80 -106.25 116.35 31.79 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.646 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 73.0 m-85 -86.47 144.08 27.44 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.269 -0.894 . . . . 0.0 110.538 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.913 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.0 mt -141.64 141.46 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.73 -0.606 . . . . 0.0 110.148 -178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.838 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 163.94 -163.09 35.67 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 119.45 -1.357 . . . . 0.0 111.12 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.466 ' N ' HD23 ' A' ' 618' ' ' LEU . 1.1 mmm-85 -62.46 -53.11 59.73 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.832 -0.805 . . . . 0.0 111.491 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 3.1 p -68.22 121.14 15.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 111.04 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.533 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 2.6 mt-10 -54.2 -17.4 2.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.879 . . . . 0.0 109.641 178.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -47.36 -30.23 3.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.426 -0.796 . . . . 0.0 109.032 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 602' ' ' PHE . 1.6 m -65.88 130.48 43.42 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.547 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.1 OUTLIER -43.97 -29.57 0.6 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.381 -0.824 . . . . 0.0 109.524 179.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.913 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.3 t -106.01 143.37 34.24 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.533 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -108.52 128.59 54.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.079 -1.013 . . . . 0.0 113.093 -178.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.873 ' HA ' HD12 ' A' ' 588' ' ' ILE . 8.8 mt -142.21 108.87 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -98.33 104.07 16.08 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 118.221 -1.392 . . . . 0.0 109.517 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.829 ' OD2' HD11 ' A' ' 690' ' ' ILE . 0.2 OUTLIER -138.78 106.69 5.67 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.165 177.181 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -39.25 -43.79 1.17 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.65 -0.656 . . . . 0.0 112.123 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.01 -17.71 39.53 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.118 -0.988 . . . . 0.0 111.847 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.838 HD21 ' HA2' ' A' ' 604' ' ' GLY . 0.6 OUTLIER -75.47 131.37 40.09 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.103 -0.998 . . . . 0.0 110.882 -179.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 622' ' ' HIS . 10.0 t -65.34 159.08 24.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.335 -0.853 . . . . 0.0 110.837 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.766 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.9 mpp_? -64.76 -45.3 86.99 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.181 -0.949 . . . . 0.0 109.518 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 1.064 HG11 HG23 ' A' ' 727' ' ' VAL . 17.3 t -95.35 2.06 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 121.739 0.78 . . . . 0.0 109.721 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.734 ' O ' ' N ' ' A' ' 652' ' ' THR . 6.1 t60 -24.55 -46.82 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.542 -178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.824 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -138.19 146.1 42.29 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 118.283 -1.367 . . . . 0.0 112.038 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 1.9 p90 -146.13 144.25 29.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.454 -0.779 . . . . 0.0 109.981 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.661 ' CD1' HD11 ' A' ' 580' ' ' LEU . 26.8 mt -102.66 123.1 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.434 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 2.3 t80 -118.26 154.33 32.44 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.351 -0.843 . . . . 0.0 109.516 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 9.0 tttt -120.46 136.27 54.8 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.657 0.741 . . . . 0.0 110.786 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -126.35 163.66 22.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.715 -0.615 . . . . 0.0 109.676 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.474 ' C ' ' CD ' ' A' ' 629' ' ' ARG . 0.0 OUTLIER -78.67 123.1 26.79 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.157 -0.964 . . . . 0.0 108.894 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' A' ' 644' ' ' LEU . 2.3 t-160 -75.21 122.93 24.4 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.331 -0.856 . . . . 0.0 110.538 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -130.64 75.1 1.63 Allowed 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.512 0.672 . . . . 0.0 109.883 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.773 HG12 ' HA ' ' A' ' 642' ' ' GLN . 5.6 p -57.72 169.09 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.565 -0.71 . . . . 0.0 110.474 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.537 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -121.49 -159.46 10.7 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 24.6 tttt 52.28 64.62 1.78 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.24 -1.153 . . . . 0.0 110.362 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 89.4 p -129.67 108.94 10.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.312 -0.867 . . . . 0.0 110.43 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 9.3 mmt -105.85 37.67 2.19 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.346 -0.846 . . . . 0.0 109.926 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -171.67 -152.78 0.08 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.504 -0.747 . . . . 0.0 110.002 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -116.37 102.75 9.8 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.291 -0.881 . . . . 0.0 108.913 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 78.3 p -136.47 151.73 73.52 Favored Pre-proline 0 C--N 1.293 -1.863 0 O-C-N 121.881 -0.512 . . . . 0.0 110.139 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.6 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 46.1 Cg_endo -68.94 -151.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.756 1.398 . . . . 0.0 109.651 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 67.13 -61.05 0.35 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.607 -0.683 . . . . 0.0 110.553 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . 0.773 ' HA ' HG12 ' A' ' 632' ' ' VAL . 44.0 tt0 -62.83 83.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.368 -0.833 . . . . 0.0 110.548 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 133.03 5.94 2.94 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.958 -1.115 . . . . 0.0 111.046 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.602 ' HG ' ' HA ' ' A' ' 703' ' ' PHE . 3.4 mm? -82.17 -153.88 0.12 Allowed 'General case' 0 C--N 1.282 -2.363 0 O-C-N 121.948 -0.736 . . . . 0.0 109.792 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.9 m-20 -130.41 133.24 46.21 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.906 -1.122 . . . . 0.0 111.148 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.471 ' CG ' ' HE1' ' A' ' 648' ' ' TRP . 3.2 p30 -115.59 152.73 32.53 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.404 -0.81 . . . . 0.0 110.954 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 6.2 pt -111.2 130.89 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.264 -0.897 . . . . 0.0 109.868 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.62 ' CH2' HD12 ' A' ' 671' ' ' LEU . 94.2 m95 -119.04 140.06 50.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.611 -0.681 . . . . 0.0 110.89 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.949 ' CB ' HD11 ' A' ' 672' ' ' LEU . 4.3 t80 -97.97 114.34 26.43 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 24.8 t -104.22 102.32 12.03 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.23 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.544 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 24.9 t60 -67.59 164.68 18.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.443 -0.786 . . . . 0.0 109.543 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.734 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -155.28 -31.31 0.1 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.213 -0.93 . . . . 0.0 113.257 -178.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.564 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.25 132.88 11.83 Favored Glycine 0 N--CA 1.501 2.995 0 C-N-CA 117.937 -2.077 . . . . 0.0 110.427 -178.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.404 ' C ' ' H ' ' A' ' 656' ' ' VAL . 23.8 m -37.71 -24.46 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -177.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.533 ' O ' HG12 ' A' ' 656' ' ' VAL . 7.9 m120 -57.7 -4.72 0.3 Allowed 'General case' 0 N--CA 1.504 2.241 0 O-C-N 120.266 -1.521 . . . . 0.0 112.407 -178.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 76.77 168.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 CA-C-O 121.83 0.824 . . . . 0.0 110.256 -179.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.498 ' HB3' ' ND1' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -127.5 154.76 44.73 Favored 'General case' 0 C--N 1.292 -1.923 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.601 -179.01 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -137.92 126.36 23.37 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.163 -0.96 . . . . 0.0 110.83 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.789 HD23 ' CD2' ' A' ' 670' ' ' PHE . 22.2 tp -122.05 107.32 12.07 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.391 -0.818 . . . . 0.0 109.84 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.3 t30 63.2 -73.45 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.545 -0.722 . . . . 0.0 110.174 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 659' ' ' LEU . 37.1 m-20 -153.9 22.51 0.51 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.348 -0.845 . . . . 0.0 110.389 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.38 116.86 28.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.149 -0.969 . . . . 0.0 110.37 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -80.54 139.67 36.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.421 -0.8 . . . . 0.0 109.908 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.561 ' O ' HG22 ' A' ' 656' ' ' VAL . 37.7 mtp -118.2 -161.74 0.85 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.869 . . . . 0.0 110.094 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.538 ' CG1' HG23 ' A' ' 668' ' ' THR . 3.7 pt -133.02 -160.87 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 0.0 109.725 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -81.39 117.33 21.76 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.343 -0.848 . . . . 0.0 110.26 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 82.49 50.73 4.63 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.538 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.0 OUTLIER -115.27 146.34 41.58 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.109 -1.23 . . . . 0.0 110.111 179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.442 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 2.7 ttpt -108.77 141.99 39.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.524 -0.735 . . . . 0.0 109.853 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.789 ' CD2' HD23 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -144.61 141.0 29.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.293 -0.879 . . . . 0.0 110.898 -179.067 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.62 HD12 ' CH2' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -70.05 146.35 51.05 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.285 -0.885 . . . . 0.0 110.682 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.949 HD11 ' CB ' ' A' ' 649' ' ' TYR . 3.9 mp -111.45 149.05 31.83 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.924 0.868 . . . . 0.0 111.632 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.669 ' HB3' HD12 ' A' ' 707' ' ' LEU . 15.3 mt-30 -127.0 136.59 52.45 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.805 ' OD2' HD13 ' A' ' 707' ' ' LEU . 0.0 OUTLIER -37.93 129.22 1.21 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.967 -1.083 . . . . 0.0 110.276 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 83.88 44.05 6.93 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.403 ' HB3' ' HB ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -100.97 90.48 4.19 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.948 -0.737 . . . . 0.0 110.463 -179.09 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.821 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.8 tt0 -94.21 107.74 19.65 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.653 HG22 ' HA ' ' A' ' 659' ' ' LEU . 41.5 pt -113.06 138.5 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.49 -0.757 . . . . 0.0 111.829 -178.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 15.9 mttp -94.47 110.53 22.32 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.824 HD13 ' SG ' ' A' ' 623' ' ' CYS . 69.9 mt -73.88 -30.95 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.348 -0.845 . . . . 0.0 110.801 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.693 ' CD1' HD12 ' A' ' 618' ' ' LEU . 6.0 mt -143.0 137.38 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.018 -1.051 . . . . 0.0 110.876 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 6.6 t90 -137.93 108.98 6.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.559 -0.713 . . . . 0.0 109.795 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 688' ' ' PHE . 1.2 t70 -114.34 118.12 32.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.096 -1.003 . . . . 0.0 110.598 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -66.52 -30.01 70.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.495 -0.753 . . . . 0.0 110.806 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -55.88 -43.71 77.44 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.397 -0.815 . . . . 0.0 111.078 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 688' ' ' PHE . 2.1 m-20 -141.26 34.96 1.69 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.229 -0.92 . . . . 0.0 110.066 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.477 ' O ' ' C ' ' A' ' 688' ' ' PHE . 0.2 OUTLIER 66.54 -67.71 0.15 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.737 -0.602 . . . . 0.0 110.003 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.477 ' C ' ' O ' ' A' ' 687' ' ' LYS . 0.5 OUTLIER 33.69 59.92 0.52 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.684 -0.635 . . . . 0.0 110.7 179.718 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 586' ' ' SER . 34.2 m -102.06 142.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.341 -0.849 . . . . 0.0 111.352 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.829 HD11 ' OD2' ' A' ' 615' ' ' ASP . 43.1 mm -113.43 163.56 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 582' ' ' PRO . . . -173.31 118.71 0.72 Allowed Glycine 0 N--CA 1.491 2.314 0 C-N-CA 118.948 -1.596 . . . . 0.0 110.618 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.87 ' CZ ' HG21 ' A' ' 588' ' ' ILE . 13.7 m-85 -120.5 138.02 54.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.613 -0.934 . . . . 0.0 108.784 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -108.64 114.52 28.4 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.128 -0.982 . . . . 0.0 110.763 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.523 HG22 HD11 ' A' ' 578' ' ' LEU . 1.2 t -76.52 119.68 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.382 -0.824 . . . . 0.0 108.924 179.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.71 104.61 7.94 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.672 -0.642 . . . . 0.0 110.023 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.484 ' CD1' ' HA3' ' A' ' 706' ' ' GLY . 62.5 mt -86.68 107.7 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.356 -0.84 . . . . 0.0 109.714 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -78.3 -41.14 34.69 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.405 -0.81 . . . . 0.0 109.077 179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.438 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.3 m-20 -110.81 140.86 44.87 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.579 0.704 . . . . 0.0 110.682 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 14.5 p -115.16 96.0 5.47 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 22.2 m -113.58 129.64 56.52 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.853 -0.53 . . . . 0.0 110.797 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.513 ' C ' HD12 ' A' ' 644' ' ' LEU . . . 50.76 37.9 35.73 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 704' ' ' ASN . 5.0 tp -109.94 125.43 52.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.461 -1.023 . . . . 0.0 110.653 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.602 ' HA ' ' HG ' ' A' ' 644' ' ' LEU . 10.8 p90 -50.55 -27.4 6.63 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.901 0.858 . . . . 0.0 109.566 179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.573 ' HB3' ' CZ ' ' A' ' 703' ' ' PHE . 6.6 t30 -148.25 170.33 18.12 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.456 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 12.8 pt-20 -52.73 -25.46 11.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 109.637 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.631 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 116.66 16.16 6.56 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.805 HD13 ' OD2' ' A' ' 674' ' ' ASP . 45.8 tp -103.37 10.55 37.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.56 -0.965 . . . . 0.0 110.955 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.533 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 53.41 98.17 0.01 OUTLIER Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.439 ' HG3' ' ND2' ' A' ' 704' ' ' ASN . 0.0 OUTLIER -139.38 36.2 2.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.409 -1.054 . . . . 0.0 110.419 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.7 HD11 ' OE2' ' A' ' 712' ' ' GLU . 0.5 OUTLIER -109.5 51.32 0.75 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.333 -0.854 . . . . 0.0 110.334 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 51.36 45.82 27.39 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.313 -0.867 . . . . 0.0 110.26 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.7 ' OE2' HD11 ' A' ' 710' ' ' LEU . 1.6 tt0 -102.97 148.65 25.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.426 -0.796 . . . . 0.0 110.452 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . 0.89 ' O ' HG13 ' A' ' 715' ' ' VAL . 0.3 OUTLIER -110.82 97.46 6.86 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.223 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.595 ' NH1' HD21 ' A' ' 659' ' ' LEU . 6.0 mmm-85 -29.58 79.47 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.849 0.833 . . . . 0.0 112.254 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.89 HG13 ' O ' ' A' ' 713' ' ' GLN . 11.2 m -106.96 151.76 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.486 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 60.4 t -86.2 133.15 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.341 -0.85 . . . . 0.0 110.939 -179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 3.0 mt -103.65 162.15 13.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.54 -0.725 . . . . 0.0 109.552 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.01 154.15 18.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 110.259 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -79.94 134.19 36.25 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 0.0 110.168 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 63.1 p -106.18 -176.3 3.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.413 -0.804 . . . . 0.0 110.3 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.26 -28.86 29.78 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.282 -0.886 . . . . 0.0 110.018 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 7.1 tm-20 -65.93 -47.92 73.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.416 -0.802 . . . . 0.0 109.785 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -63.93 -47.86 78.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.417 -0.802 . . . . 0.0 109.956 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.48 ' O ' HG12 ' A' ' 727' ' ' VAL . 12.0 tttm -52.42 -33.71 45.1 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.422 -0.799 . . . . 0.0 109.85 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -69.16 -36.12 77.05 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.471 -0.768 . . . . 0.0 110.251 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 56.2 mt -56.25 -47.53 78.34 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.312 -0.867 . . . . 0.0 110.619 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 1.064 HG23 HG11 ' A' ' 621' ' ' VAL . 6.3 p -69.67 -17.67 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.154 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -54.27 -45.82 72.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 0.0 108.836 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.1 104.76 11.55 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.225 1.012 . . . . 0.0 109.209 178.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.414 ' OXT' ' CD2' ' A' ' 602' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.274 -2.714 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.365 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -82.9 0.34 44.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -1.123 . . . . 0.0 110.676 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . -110.15 40.0 2.7 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.418 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 2.6 ttm180 -92.61 114.0 26.44 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.377 -1.072 . . . . 0.0 109.686 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.512 ' HB3' ' CA ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -93.32 -44.09 8.47 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.809 0.814 . . . . 0.0 109.116 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.612 HD22 HD12 ' A' ' 594' ' ' ILE . 9.9 tt -125.48 142.2 51.63 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.275 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . 0.421 ' N ' HD23 ' A' ' 578' ' ' LEU . 87.0 m -122.38 121.97 37.93 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.583 HD11 ' CD1' ' A' ' 625' ' ' ILE . 14.1 mt -95.15 112.5 24.2 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.0 OUTLIER -112.49 103.66 55.57 Favored Pre-proline 0 C--N 1.302 -1.485 0 C-N-CA 118.464 -1.294 . . . . 0.0 113.21 -177.272 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 1.046 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 44.1 Cg_endo -78.5 137.24 14.54 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 N-CA-C 105.274 -2.625 . . . . 0.0 105.274 174.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.809 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -125.88 -171.9 0.24 Allowed Pre-proline 0 C--N 1.295 -1.786 0 C-N-CA 118.138 -1.425 . . . . 0.0 113.405 -176.104 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.809 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 36.7 Cg_endo -61.67 -35.4 80.57 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 O-C-N 124.129 1.594 . . . . 0.0 111.951 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.55 ' O ' HG23 ' A' ' 689' ' ' VAL . 45.3 m-20 -58.69 -29.75 66.86 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.494 ' OG ' ' HA ' ' A' ' 690' ' ' ILE . 24.6 t -96.54 148.09 23.18 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.563 ' CD1' HD11 ' A' ' 690' ' ' ILE . 1.4 pt -62.96 -18.21 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 118.456 -1.298 . . . . 0.0 108.244 178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.711 HG13 HG12 ' A' ' 613' ' ' ILE . 4.3 mm -83.27 116.2 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.483 ' NE2' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -119.76 69.52 0.84 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.432 -1.417 . . . . 0.0 109.348 -179.129 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 1.046 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 24.8 tt0 -144.61 174.35 11.04 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.637 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.526 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -129.2 125.01 36.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.971 -1.08 . . . . 0.0 109.011 176.342 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.778 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.1 mt -105.98 155.04 19.76 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.31 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.418 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 0.6 OUTLIER -125.48 110.54 14.02 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.478 -0.764 . . . . 0.0 111.287 -179.016 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.612 HD12 HD22 ' A' ' 578' ' ' LEU . 3.2 mt -84.16 109.27 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.157 -0.965 . . . . 0.0 109.007 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.2 OUTLIER -64.74 140.41 58.86 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.048 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.512 ' CA ' ' HB3' ' A' ' 577' ' ' PHE . 2.2 pt20 -46.56 85.47 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.486 -0.759 . . . . 0.0 110.783 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 135.44 5.21 2.35 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.722 -1.227 . . . . 0.0 110.483 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -80.21 101.66 5.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 O-C-N 120.788 -1.419 . . . . 0.0 107.421 178.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 627' ' ' LYS . 21.6 t-20 -145.42 132.52 10.1 Favored Pre-proline 0 C--N 1.282 -2.352 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.065 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.542 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 50.8 Cg_endo -92.87 164.13 23.88 Favored 'Cis proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.38 -1.508 . . . . 0.0 108.747 -2.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.524 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.4 t80 -104.39 116.14 31.61 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.646 ' CG ' HD23 ' A' ' 730' ' ' LEU . 35.9 m-85 -82.96 143.91 30.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.435 -0.79 . . . . 0.0 110.616 -178.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.911 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.6 mt -141.99 141.57 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.659 -0.651 . . . . 0.0 109.952 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.85 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 163.8 -163.8 36.02 Favored Glycine 0 N--CA 1.489 2.186 0 C-N-CA 119.395 -1.383 . . . . 0.0 111.24 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.497 ' N ' HD23 ' A' ' 618' ' ' LEU . 4.8 mmm-85 -60.33 -57.7 11.64 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.921 -0.752 . . . . 0.0 111.862 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.45 125.07 25.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 111.209 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.46 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 4.3 pt-20 -54.08 -17.61 2.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.888 . . . . 0.0 109.735 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.49 -32.58 1.44 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.457 -0.777 . . . . 0.0 108.951 178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.582 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.3 m -65.9 130.37 43.03 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.524 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -43.3 -29.42 0.41 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.333 -0.854 . . . . 0.0 109.893 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.911 ' HB3' HG23 ' A' ' 603' ' ' ILE . 2.9 t -104.73 143.11 33.55 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.46 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -107.91 126.48 52.73 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-O 122.279 1.038 . . . . 0.0 113.363 -178.077 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.711 HG12 HG13 ' A' ' 588' ' ' ILE . 22.9 mt -143.9 108.57 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' ' 614' ' ' GLU . 1.5 pt-20 -96.0 104.2 16.13 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 118.197 -1.401 . . . . 0.0 108.718 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.548 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.3 m-20 -136.41 105.81 6.08 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.587 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . 0.402 ' OD1' ' CE2' ' A' ' 688' ' ' PHE . 16.2 p-10 -44.64 -40.41 5.83 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.657 -0.652 . . . . 0.0 111.734 -179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.4 -17.38 42.4 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.101 -0.999 . . . . 0.0 111.032 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.891 HD13 HD11 ' A' ' 681' ' ' ILE . 0.6 OUTLIER -81.03 139.25 35.86 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.305 -0.872 . . . . 0.0 110.555 -179.499 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.448 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.0 OUTLIER -73.95 158.87 33.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.273 -0.892 . . . . 0.0 110.392 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.735 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 1.2 mpt_? -63.31 -43.15 98.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.2 -0.938 . . . . 0.0 109.191 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.599 ' CG1' HG22 ' A' ' 727' ' ' VAL . 18.8 t -95.82 1.57 10.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 121.921 0.867 . . . . 0.0 109.693 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.747 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.2 t60 -28.1 -45.37 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.884 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.543 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.46 145.88 43.62 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 117.959 -1.496 . . . . 0.0 112.191 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.543 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 4.5 p90 -146.35 142.05 27.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.605 -0.685 . . . . 0.0 110.088 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.583 ' CD1' HD11 ' A' ' 580' ' ' LEU . 73.8 mt -102.99 117.61 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.431 ' CE2' ' HG3' ' A' ' 628' ' ' LYS . 4.1 t80 -112.86 155.46 24.63 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.769 0.795 . . . . 0.0 110.17 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.44 ' O ' ' ND2' ' A' ' 599' ' ' ASN . 21.9 ttmt -119.34 137.92 53.39 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 121.525 0.679 . . . . 0.0 110.487 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.477 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.0 OUTLIER -132.75 163.92 27.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.58 -0.7 . . . . 0.0 110.753 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.568 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.4 tpt85 -77.51 112.3 14.14 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.523 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.2 t60 -58.16 124.24 18.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.722 . . . . 0.0 110.887 -178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -111.04 92.66 4.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.736 -0.602 . . . . 0.0 109.956 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.527 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.4 p -53.33 169.69 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.497 -0.752 . . . . 0.0 110.355 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.527 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -64.28 83.29 0.06 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp 51.44 -175.24 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.313 -1.11 . . . . 0.0 110.544 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 78.5 p -164.37 69.31 0.17 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.268 -0.895 . . . . 0.0 110.383 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.91 36.93 1.25 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.284 -0.885 . . . . 0.0 110.017 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -168.96 -149.15 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.494 -0.753 . . . . 0.0 109.889 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -115.89 102.96 10.15 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.274 -0.891 . . . . 0.0 109.148 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 84.9 p -135.62 151.34 74.24 Favored Pre-proline 0 C--N 1.292 -1.896 0 O-C-N 121.933 -0.479 . . . . 0.0 110.05 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.57 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 48.6 Cg_endo -70.28 -153.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.666 1.351 . . . . 0.0 110.074 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 66.54 -60.06 0.34 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.769 -0.582 . . . . 0.0 110.785 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 57.41 -161.29 0.22 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.028 -1.045 . . . . 0.0 109.92 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.679 ' C ' HD12 ' A' ' 644' ' ' LEU . . . -113.62 128.59 8.39 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.768 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.3 mp -142.09 -152.78 0.43 Allowed 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 0.2 OUTLIER -118.39 123.96 46.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.097 -1.002 . . . . 0.0 110.905 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.708 ' CG ' HD11 ' A' ' 671' ' ' LEU . 13.3 t0 -105.4 156.54 18.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.433 -0.792 . . . . 0.0 109.742 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 18.1 pt -106.65 129.37 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.342 -0.849 . . . . 0.0 110.423 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.763 ' CH2' HD13 ' A' ' 671' ' ' LEU . 97.9 m95 -116.63 121.12 40.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.718 -0.614 . . . . 0.0 110.791 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.65 ' HB2' HD11 ' A' ' 672' ' ' LEU . 13.9 t80 -80.61 116.13 20.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.188 -0.945 . . . . 0.0 108.469 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.543 ' HB3' ' CZ ' ' A' ' 624' ' ' PHE . 13.8 t -109.0 107.01 17.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 0.0 111.767 -178.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.542 ' CB ' ' OG ' ' A' ' 657' ' ' SER . 11.9 t60 -70.51 161.67 30.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.568 -0.707 . . . . 0.0 109.812 178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.747 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.94 -30.24 0.16 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.329 -0.857 . . . . 0.0 112.562 -179.191 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.59 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.13 -167.71 33.93 Favored Glycine 0 N--CA 1.496 2.697 0 C-N-CA 117.853 -2.118 . . . . 0.0 109.901 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 5.6 m -89.6 -19.28 25.13 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.69 ' O ' HG22 ' A' ' 656' ' ' VAL . 89.7 m-20 -59.75 -2.86 0.42 Allowed 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.686 -1.258 . . . . 0.0 112.924 -178.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.69 HG22 ' O ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 62.11 143.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.575 -0.703 . . . . 0.0 110.293 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.542 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -95.98 142.99 27.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.621 -0.675 . . . . 0.0 110.462 -179.092 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.448 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 10.8 m-85 -129.03 126.13 38.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.923 . . . . 0.0 110.526 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.602 HD11 HG21 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -134.55 114.35 12.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.331 -0.856 . . . . 0.0 110.001 179.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.02 -85.79 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.439 -0.788 . . . . 0.0 110.494 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.6 p-10 -143.67 19.28 1.84 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.11 -0.994 . . . . 0.0 110.409 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . 0.59 ' OD1' HG23 ' A' ' 716' ' ' VAL . 0.4 OUTLIER -105.84 118.36 36.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.313 -0.867 . . . . 0.0 110.177 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.05 136.44 35.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.466 -0.772 . . . . 0.0 110.044 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.747 ' SD ' HG13 ' A' ' 716' ' ' VAL . 8.1 mmm -115.61 -168.2 1.37 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 0.0 109.997 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.639 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.1 pt -143.38 -165.81 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.22 -0.925 . . . . 0.0 110.494 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 652' ' ' THR . 17.2 tt0 -77.64 78.42 4.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.574 -0.704 . . . . 0.0 110.473 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.42 53.79 0.23 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.639 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.1 OUTLIER -122.24 148.15 45.33 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.056 -1.261 . . . . 0.0 109.928 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.44 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 2.8 tttt -108.4 138.75 44.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.524 -0.735 . . . . 0.0 109.574 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.464 ' CE1' ' HD2' ' A' ' 714' ' ' ARG . 0.7 OUTLIER -144.53 146.42 32.37 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.664 -178.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.763 HD13 ' CH2' ' A' ' 648' ' ' TRP . 13.5 tp -71.29 146.19 49.06 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.429 -0.794 . . . . 0.0 110.898 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 649' ' ' TYR . 9.0 mt -117.78 107.74 14.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.415 -0.803 . . . . 0.0 111.06 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.411 ' NE2' ' HA2' ' A' ' 708' ' ' GLY . 81.3 mt-30 -84.86 153.41 22.92 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.813 ' OD1' HD12 ' A' ' 707' ' ' LEU . 11.2 p-10 -50.42 141.97 11.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.072 -1.018 . . . . 0.0 109.947 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 71.87 45.97 39.98 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.5 ' OD2' HD21 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -106.94 90.49 3.32 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.855 -0.791 . . . . 0.0 110.198 -179.313 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.825 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 5.3 tt0 -93.45 107.41 19.25 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.602 HG21 HD11 ' A' ' 659' ' ' LEU . 1.1 pt -111.44 137.77 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 121.446 0.641 . . . . 0.0 111.551 -177.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -95.13 110.83 22.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.486 -0.759 . . . . 0.0 109.258 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.543 HD13 ' SG ' ' A' ' 623' ' ' CYS . 57.0 mt -75.02 -23.92 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.232 -0.918 . . . . 0.0 110.517 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.891 HD11 HD13 ' A' ' 618' ' ' LEU . 7.1 mt -140.49 139.09 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.195 -0.941 . . . . 0.0 110.276 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -137.69 109.51 7.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.365 -0.834 . . . . 0.0 110.401 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.29 117.7 28.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.328 -0.858 . . . . 0.0 109.975 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.81 -47.19 72.83 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.291 -0.881 . . . . 0.0 111.037 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -84.84 -43.56 14.04 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.259 -0.9 . . . . 0.0 110.849 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.63 -12.07 61.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 110.576 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm 52.14 25.36 3.22 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.242 -0.911 . . . . 0.0 110.314 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.448 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.0 OUTLIER -93.06 79.43 4.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.374 -0.829 . . . . 0.0 109.764 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 585' ' ' ASP . 27.3 m -103.55 142.33 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.391 -0.818 . . . . 0.0 110.673 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.563 HD11 ' CD1' ' A' ' 587' ' ' ILE . 30.0 mm -116.6 164.34 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.456 -0.778 . . . . 0.0 109.03 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 690' ' ' ILE . . . -173.58 124.19 1.03 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.316 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.825 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 15.0 m-85 -120.2 138.6 53.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.647 -0.913 . . . . 0.0 108.857 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 7.0 tptt -103.3 114.01 27.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.057 -1.027 . . . . 0.0 110.582 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.595 HG21 HD13 ' A' ' 672' ' ' LEU . 1.0 OUTLIER -82.81 113.49 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 178.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -120.37 104.34 9.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.464 -0.772 . . . . 0.0 110.444 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 577' ' ' PHE . 87.6 mt -83.54 103.99 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 109.276 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -83.51 -45.29 13.75 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.482 -0.761 . . . . 0.0 109.211 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.423 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 4.8 m-20 -111.62 140.98 45.78 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.777 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 5.6 p -114.66 96.17 5.61 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 177.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 701' ' ' GLY . 70.3 m -78.65 -92.64 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.883 -0.511 . . . . 0.0 110.84 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 700' ' ' THR . . . -114.09 44.28 1.53 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.724 ' O ' HD22 ' A' ' 644' ' ' LEU . 1.6 tp -90.72 145.72 24.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.587 -0.949 . . . . 0.0 110.436 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.768 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.5 p90 -53.35 -23.04 8.42 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.531 -0.731 . . . . 0.0 110.636 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.577 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.3 t30 -169.73 156.88 6.64 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.549 ' OE2' HD22 ' A' ' 707' ' ' LEU . 16.4 pt-20 -51.12 -25.37 5.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.218 -0.926 . . . . 0.0 110.281 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 118.43 16.66 5.51 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.813 HD12 ' OD1' ' A' ' 674' ' ' ASP . 1.5 tp -82.63 9.32 9.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.088 -1.242 . . . . 0.0 111.616 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.411 ' HA2' ' NE2' ' A' ' 673' ' ' GLN . . . 114.6 -97.67 0.84 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.426 ' CE ' ' O ' ' A' ' 709' ' ' MET . 2.0 ttp 55.45 91.52 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.368 -1.078 . . . . 0.0 110.118 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 176.54 135.05 0.06 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.305 -0.872 . . . . 0.0 110.431 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.04 -42.18 93.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.304 -0.872 . . . . 0.0 109.635 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -68.26 149.57 49.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.533 -0.729 . . . . 0.0 109.665 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 714' ' ' ARG . 1.4 tp-100 -107.18 95.33 5.64 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.193 -0.942 . . . . 0.0 109.518 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.464 ' HD2' ' CE1' ' A' ' 670' ' ' PHE . 4.1 mmm-85 35.05 80.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.945 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.412 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 27.7 m -107.89 151.77 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.447 -0.783 . . . . 0.0 109.431 178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.747 HG13 ' SD ' ' A' ' 664' ' ' MET . 78.9 t -89.31 133.42 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.185 -0.947 . . . . 0.0 110.498 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.9 mp -107.77 162.35 14.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.483 -0.761 . . . . 0.0 109.954 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.97 147.5 26.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.239 -0.913 . . . . 0.0 110.273 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -80.02 152.82 29.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.31 -0.869 . . . . 0.0 110.301 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 75.6 p -121.08 -177.54 3.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.273 -0.892 . . . . 0.0 110.364 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.99 -35.72 67.1 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.422 -0.799 . . . . 0.0 110.146 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . 0.615 ' O ' HD23 ' A' ' 726' ' ' LEU . 0.7 OUTLIER -65.36 -44.93 86.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 0.0 110.022 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.49 ' HA ' HD21 ' A' ' 726' ' ' LEU . 7.1 mt-10 -63.02 -48.73 77.51 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.441 -0.787 . . . . 0.0 109.984 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.47 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 22.4 mtpp -63.04 -32.23 73.55 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.398 -0.813 . . . . 0.0 111.072 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -61.56 -50.81 71.13 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.247 -0.908 . . . . 0.0 112.46 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.615 HD23 ' O ' ' A' ' 722' ' ' GLU . 0.4 OUTLIER -68.43 -32.73 72.97 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.732 -1.23 . . . . 0.0 110.803 -179.062 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.599 HG22 ' CG1' ' A' ' 621' ' ' VAL . 12.6 p -83.87 -18.48 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.054 . . . . 0.0 110.073 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -53.34 -45.37 69.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 108.889 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.5 103.53 10.52 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 122.193 0.997 . . . . 0.0 109.021 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.646 HD23 ' CG ' ' A' ' 602' ' ' PHE . 1.6 mt . . . . . 0 C--N 1.273 -2.746 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.415 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -82.8 -9.21 59.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.334 -1.098 . . . . 0.0 110.475 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 127.64 -13.48 6.5 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -92.03 114.07 26.51 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.193 -1.18 . . . . 0.0 109.557 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.566 ' HB3' ' CA ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -91.02 -43.79 9.72 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.96 0.886 . . . . 0.0 108.898 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.909 HD22 HD12 ' A' ' 594' ' ' ILE . 9.0 tt -121.43 125.33 46.65 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.086 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 25.2 m -103.6 116.63 32.71 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.732 ' HG ' HD21 ' A' ' 578' ' ' LEU . 5.4 mt -91.49 112.25 24.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.578 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 0.1 OUTLIER -114.65 104.26 54.44 Favored Pre-proline 0 C--N 1.298 -1.645 0 C-N-CA 118.386 -1.326 . . . . 0.0 113.128 -177.268 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 1.085 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 41.4 Cg_endo -76.33 142.1 23.63 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 N-CA-C 105.221 -2.646 . . . . 0.0 105.221 174.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.765 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -125.97 -173.91 0.32 Allowed Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 117.916 -1.514 . . . . 0.0 113.87 -175.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.765 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.2 Cg_endo -66.41 -34.17 35.34 Favored 'Trans proline' 0 N--CA 1.487 1.142 0 O-C-N 124.169 1.615 . . . . 0.0 111.322 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.88 -30.63 67.91 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.636 ' HB2' ' HA ' ' A' ' 690' ' ' ILE . 88.9 p -97.74 153.49 18.23 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.544 HG22 ' CD1' ' A' ' 690' ' ' ILE . 1.0 OUTLIER -62.41 -9.75 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.982 -1.074 . . . . 0.0 109.969 179.21 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.799 HD12 ' HA ' ' A' ' 613' ' ' ILE . 10.1 mm -97.85 116.36 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.274 -0.891 . . . . 0.0 109.626 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.61 ' NE2' ' O ' ' A' ' 586' ' ' SER . 16.3 mp0 -118.53 71.87 0.85 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.659 -1.276 . . . . 0.0 109.713 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 1.085 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 42.5 mt-10 -144.48 174.63 10.77 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.941 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.578 ' HB3' ' HG2' ' A' ' 581' ' ' LYS . 0.0 OUTLIER -130.54 128.27 40.8 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.005 -1.06 . . . . 0.0 109.487 176.483 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.729 HD22 ' N ' ' A' ' 592' ' ' LEU . 1.8 mm? -111.2 152.26 27.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.976 . . . . 0.0 109.343 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -124.7 110.77 14.79 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.517 -0.74 . . . . 0.0 110.578 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.909 HD12 HD22 ' A' ' 578' ' ' LEU . 40.6 mt -82.18 109.12 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.072 -1.018 . . . . 0.0 109.272 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.551 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -62.46 110.38 1.66 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.423 -0.798 . . . . 0.0 108.963 179.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.566 ' CA ' ' HB3' ' A' ' 577' ' ' PHE . 1.9 pt20 -19.11 85.4 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 121.396 0.617 . . . . 0.0 112.03 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 124.98 10.27 4.82 Favored Glycine 0 N--CA 1.486 1.991 0 C-N-CA 119.767 -1.206 . . . . 0.0 110.366 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.697 HG12 HG23 ' A' ' 594' ' ' ILE . 0.9 OUTLIER -83.96 102.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-O 123.112 1.434 . . . . 0.0 107.57 178.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 0.2 OUTLIER -144.52 138.78 14.91 Favored Pre-proline 0 C--N 1.281 -2.384 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.808 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.582 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 51.9 Cg_endo -90.94 163.44 30.41 Favored 'Cis proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.564 -1.848 . . . . 0.0 108.817 -1.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.589 ' CE1' ' HB3' ' A' ' 610' ' ' ASN . 4.1 t80 -104.42 116.0 31.35 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.624 ' CG ' HD23 ' A' ' 730' ' ' LEU . 33.0 m-85 -83.82 144.17 29.45 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.478 -0.764 . . . . 0.0 110.303 -178.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.89 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.7 mt -142.19 142.12 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.653 -0.655 . . . . 0.0 110.036 -178.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.764 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 168.43 -162.97 36.76 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.807 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 13.7 tpt180 -70.36 -42.4 71.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.768 -0.842 . . . . 0.0 110.863 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.83 123.34 26.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.742 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.446 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 14.3 tt0 -53.34 -17.77 2.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 110.247 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.47 -31.49 1.77 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.316 -0.865 . . . . 0.0 108.967 178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.552 ' HA ' ' HB2' ' A' ' 602' ' ' PHE . 1.5 m -68.05 132.74 47.8 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.589 ' HB3' ' CE1' ' A' ' 601' ' ' PHE . 1.0 OUTLIER -46.77 -26.65 0.99 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.292 -0.88 . . . . 0.0 109.945 179.555 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.89 ' HB3' HG23 ' A' ' 603' ' ' ILE . 3.3 t -106.97 143.55 34.89 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.446 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -109.45 127.88 54.74 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 119.288 -0.965 . . . . 0.0 113.17 -178.363 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.799 ' HA ' HD12 ' A' ' 588' ' ' ILE . 29.3 mt -142.63 108.49 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.416 ' H ' HD12 ' A' ' 588' ' ' ILE . 4.5 tt0 -90.46 103.54 16.21 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 118.124 -1.43 . . . . 0.0 108.484 179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 0.7 OUTLIER -139.15 106.11 5.43 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 114.374 -1.285 . . . . 0.0 108.692 178.163 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -43.68 -44.65 6.58 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.548 -0.72 . . . . 0.0 112.077 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.53 -17.33 42.2 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.168 -0.958 . . . . 0.0 111.855 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.598 HD11 HG21 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -76.46 122.31 24.35 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.037 -1.039 . . . . 0.0 110.506 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -57.84 158.99 5.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.306 -0.871 . . . . 0.0 110.927 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.764 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -64.09 -45.17 89.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.222 -0.924 . . . . 0.0 109.366 179.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.521 ' CG1' HG22 ' A' ' 727' ' ' VAL . 4.3 t -95.33 1.78 10.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-O 121.892 0.853 . . . . 0.0 109.347 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.733 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.4 t60 -28.37 -46.38 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.645 -178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.719 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.04 145.86 44.53 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 117.985 -1.486 . . . . 0.0 112.08 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.531 ' CZ ' ' CB ' ' A' ' 650' ' ' CYS . 9.7 p90 -145.91 139.63 26.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.791 -0.568 . . . . 0.0 109.554 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.708 ' CD1' HD11 ' A' ' 580' ' ' LEU . 82.7 mt -102.83 117.72 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.435 ' CE1' ' O ' ' A' ' 627' ' ' LYS . 6.6 t80 -109.97 154.75 22.7 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.734 0.778 . . . . 0.0 109.914 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.435 ' O ' ' CE1' ' A' ' 626' ' ' PHE . 11.1 ttmt -118.47 136.12 53.98 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-O 121.573 0.702 . . . . 0.0 110.1 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 646' ' ' ASP . 0.7 OUTLIER -129.75 163.54 25.96 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.659 -0.651 . . . . 0.0 110.238 -179.193 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 1.5 tpt180 -78.22 121.81 24.87 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.073 -1.017 . . . . 0.0 108.75 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.522 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 4.8 t60 -57.99 124.29 18.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.416 -0.803 . . . . 0.0 110.656 -179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -64.74 125.75 25.76 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.757 -0.589 . . . . 0.0 110.195 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.807 HG21 ' O ' ' A' ' 641' ' ' ALA . 0.8 OUTLIER -137.92 -163.52 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.372 -0.83 . . . . 0.0 109.958 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.598 ' N ' HG13 ' A' ' 632' ' ' VAL . . . -169.07 -158.58 13.13 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -61.42 105.93 0.58 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.348 -1.089 . . . . 0.0 110.076 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.77 161.69 27.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.338 -0.851 . . . . 0.0 110.715 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . 0.431 ' O ' ' O ' ' A' ' 637' ' ' TYR . 41.3 mmm -65.68 -132.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.709 -0.62 . . . . 0.0 109.525 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 636' ' ' MET . 33.2 p90 -58.05 -155.19 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.41 -0.806 . . . . 0.0 110.094 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -78.45 100.96 7.07 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 120.836 -1.165 . . . . 0.0 108.549 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . 0.414 ' HB3' ' CE1' ' A' ' 637' ' ' TYR . 22.6 p -136.71 151.95 73.53 Favored Pre-proline 0 C--N 1.286 -2.188 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.911 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.518 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 46.1 Cg_endo -68.25 -151.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.634 1.334 . . . . 0.0 109.74 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.807 ' O ' HG21 ' A' ' 632' ' ' VAL . . . 61.24 17.56 8.32 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.383 -0.823 . . . . 0.0 110.456 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -74.07 60.96 0.8 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.24 -0.913 . . . . 0.0 109.994 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.687 ' C ' HD12 ' A' ' 644' ' ' LEU . . . 63.05 114.07 0.01 OUTLIER Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.852 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.3 mp -141.29 -152.15 0.39 Allowed 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 5.8 m-20 -119.08 124.22 46.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.088 -1.007 . . . . 0.0 111.241 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.697 ' OD2' HD21 ' A' ' 671' ' ' LEU . 18.2 t0 -101.84 156.18 17.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.597 -0.689 . . . . 0.0 109.57 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.446 ' CD1' ' CD1' ' A' ' 578' ' ' LEU . 11.7 pt -109.87 128.84 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.187 -0.945 . . . . 0.0 110.3 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.619 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 97.0 m95 -117.8 123.16 45.28 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.137 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.744 ' HB2' HD11 ' A' ' 672' ' ' LEU . 8.9 t80 -81.11 117.01 21.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 668' ' ' THR . 89.0 m -109.14 103.3 12.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.972 . . . . 0.0 111.818 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.529 ' CD2' ' N ' ' A' ' 652' ' ' THR . 13.3 t60 -66.73 159.23 28.3 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.402 -0.811 . . . . 0.0 109.781 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.733 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -152.13 -28.85 0.17 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.38 -0.825 . . . . 0.0 113.008 -179.295 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.534 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.47 -167.91 32.51 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 117.678 -2.201 . . . . 0.0 109.535 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 26.2 m -93.35 -18.76 22.03 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.964 -1.315 . . . . 0.0 113.818 -176.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.507 ' C ' HG23 ' A' ' 656' ' ' VAL . 23.9 m120 -59.43 -4.27 0.57 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.669 -1.27 . . . . 0.0 112.359 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.507 HG23 ' C ' ' A' ' 655' ' ' ASN . 3.1 t 69.76 147.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.655 -0.653 . . . . 0.0 110.343 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.507 ' HB3' ' HB2' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -101.69 149.42 24.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.698 -0.626 . . . . 0.0 110.686 -179.012 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -136.83 126.37 25.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 110.441 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.961 ' CD2' HG22 ' A' ' 678' ' ' ILE . 1.0 OUTLIER -128.13 106.72 9.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.394 -0.816 . . . . 0.0 109.79 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.0 t30 63.52 -74.22 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.525 -0.735 . . . . 0.0 110.593 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 659' ' ' LEU . 10.7 m120 -153.1 23.95 0.55 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.208 -0.933 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.67 120.99 43.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.304 -0.873 . . . . 0.0 110.238 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.65 131.07 34.41 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.412 -0.805 . . . . 0.0 110.002 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.445 ' O ' HG13 ' A' ' 656' ' ' VAL . 2.7 mtp -111.17 -165.25 0.97 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.413 -0.804 . . . . 0.0 110.424 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.66 ' CG1' HG23 ' A' ' 668' ' ' THR . 2.1 pt -137.44 -164.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.378 -0.826 . . . . 0.0 110.324 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -80.79 82.35 6.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.374 -0.829 . . . . 0.0 110.522 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 120.43 55.59 0.24 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.66 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.2 OUTLIER -121.97 147.05 46.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.192 -1.181 . . . . 0.0 109.986 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.486 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 2.8 tttm -108.61 140.21 42.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.61 -0.681 . . . . 0.0 109.188 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.56 ' CD2' HD12 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -144.31 142.89 30.71 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.101 -1.0 . . . . 0.0 111.418 -178.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.697 HD21 ' OD2' ' A' ' 646' ' ' ASP . 0.4 OUTLIER -69.96 146.72 50.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.428 -0.795 . . . . 0.0 110.47 179.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.744 HD11 ' HB2' ' A' ' 649' ' ' TYR . 12.2 mt -119.08 108.98 15.38 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.148 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.427 ' NE2' ' HA3' ' A' ' 708' ' ' GLY . 62.7 mt-30 -84.8 -176.98 6.46 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.844 ' OD1' HD12 ' A' ' 707' ' ' LEU . 16.6 p-10 -73.03 141.85 47.68 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.192 -0.942 . . . . 0.0 109.538 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 70.33 47.48 43.43 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 107.596 -2.201 . . . . 0.0 107.596 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.405 ' HB2' ' CG1' ' A' ' 694' ' ' VAL . 0.1 OUTLIER -103.28 91.81 4.24 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.956 -0.732 . . . . 0.0 110.302 -179.008 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.979 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 2.4 tt0 -93.61 108.33 20.06 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.961 HG22 ' CD2' ' A' ' 659' ' ' LEU . 11.8 pt -105.69 137.66 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.644 -0.66 . . . . 0.0 111.868 -177.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -99.92 110.5 22.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.563 -0.711 . . . . 0.0 109.341 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.719 HD13 ' SG ' ' A' ' 623' ' ' CYS . 66.3 mt -81.92 -34.01 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.297 -0.877 . . . . 0.0 110.586 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.585 HD12 ' HB2' ' A' ' 618' ' ' LEU . 0.1 OUTLIER -126.9 136.12 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.325 -0.859 . . . . 0.0 109.587 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.6 t90 -137.66 118.64 14.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.249 -0.907 . . . . 0.0 110.659 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.99 117.83 20.67 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.282 -0.886 . . . . 0.0 110.055 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -47.36 71.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.412 -0.805 . . . . 0.0 111.408 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -84.72 -43.49 14.24 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.213 -0.929 . . . . 0.0 111.079 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.6 -7.69 55.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.308 -0.87 . . . . 0.0 110.742 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.93 19.51 3.64 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.117 -0.989 . . . . 0.0 110.364 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.83 86.86 5.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.242 -0.911 . . . . 0.0 109.102 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 681' ' ' ILE . 9.3 p -116.61 141.83 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.41 -0.806 . . . . 0.0 110.572 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.636 ' HA ' ' HB2' ' A' ' 586' ' ' SER . 42.9 mm -118.95 164.35 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.338 -0.851 . . . . 0.0 109.653 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.459 ' N ' ' CB ' ' A' ' 586' ' ' SER . . . -175.31 126.09 1.14 Allowed Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.979 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 10.1 m-85 -119.5 137.3 53.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.56 -0.965 . . . . 0.0 108.674 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 12.4 tptt -97.91 113.8 25.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.225 -0.922 . . . . 0.0 110.459 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 694' ' ' VAL . 0.9 OUTLIER -85.27 112.53 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.052 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.42 104.67 9.23 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.168 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.667 HD13 ' O ' ' A' ' 705' ' ' GLU . 57.3 mt -79.54 103.21 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.376 -0.827 . . . . 0.0 109.576 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.2 -45.25 20.25 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.457 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 3.4 m-20 -111.12 141.56 44.47 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.735 -0.603 . . . . 0.0 109.895 178.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 20.6 p -113.95 95.79 5.49 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.96 133.52 52.99 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.026 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 53.41 26.05 28.93 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.757 ' O ' HD22 ' A' ' 644' ' ' LEU . 0.2 OUTLIER -102.85 124.88 49.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.569 -0.96 . . . . 0.0 109.976 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.852 ' HA ' HD13 ' A' ' 644' ' ' LEU . 4.4 p90 -48.09 -24.56 1.14 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.384 -0.822 . . . . 0.0 110.197 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.671 ' HB2' ' HE3' ' A' ' 709' ' ' MET . 0.9 OUTLIER -165.86 160.21 16.69 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.174 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.667 ' O ' HD13 ' A' ' 696' ' ' ILE . 12.5 pt-20 -50.98 -27.48 7.79 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.09 -1.006 . . . . 0.0 109.993 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 123.66 12.59 4.5 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.844 HD12 ' OD1' ' A' ' 674' ' ' ASP . 3.5 tp -85.25 8.66 17.65 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.843 -1.386 . . . . 0.0 111.516 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.427 ' HA3' ' NE2' ' A' ' 673' ' ' GLN . . . 39.46 88.91 0.01 OUTLIER Glycine 0 N--CA 1.499 2.888 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.671 ' HE3' ' HB2' ' A' ' 704' ' ' ASN . 0.0 OUTLIER -111.03 51.86 0.76 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -1.166 . . . . 0.0 110.199 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.431 ' H ' HD23 ' A' ' 710' ' ' LEU . 0.5 OUTLIER -106.5 -165.75 1.12 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.36 -0.837 . . . . 0.0 110.707 -179.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -91.36 -41.76 10.72 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.43 -0.794 . . . . 0.0 110.998 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.426 ' HB2' ' CD1' ' A' ' 710' ' ' LEU . 10.9 mm-40 -63.24 148.52 47.93 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.116 -0.99 . . . . 0.0 109.793 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -110.87 95.6 5.65 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.316 -0.865 . . . . 0.0 109.72 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.51 ' NH1' HD13 ' A' ' 659' ' ' LEU . 0.0 OUTLIER 41.07 84.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.287 0.565 . . . . 0.0 111.626 179.239 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.451 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 31.4 m -107.83 150.85 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 109.509 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.436 ' CG1' ' HG2' ' A' ' 664' ' ' MET . 61.6 t -97.52 133.07 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.215 -0.928 . . . . 0.0 110.643 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 2.3 mp -110.12 162.51 14.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.498 -0.751 . . . . 0.0 109.85 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.18 145.32 28.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.195 -0.941 . . . . 0.0 110.17 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -80.64 150.21 29.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.33 -0.856 . . . . 0.0 110.18 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 17.0 p -113.73 -176.7 2.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.322 -0.861 . . . . 0.0 110.397 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.92 -32.99 55.43 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.385 -0.822 . . . . 0.0 110.364 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . 0.588 ' O ' HD23 ' A' ' 726' ' ' LEU . 2.7 tt0 -66.59 -46.74 74.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.353 -0.842 . . . . 0.0 109.977 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.609 ' O ' HG12 ' A' ' 727' ' ' VAL . 0.5 OUTLIER -62.78 -48.39 79.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.481 -0.762 . . . . 0.0 109.903 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.452 ' HA ' ' CG1' ' A' ' 727' ' ' VAL . 8.5 tttp -62.96 -31.61 72.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.447 -0.783 . . . . 0.0 110.468 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.48 -50.45 73.86 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.372 -0.83 . . . . 0.0 112.238 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.588 HD23 ' O ' ' A' ' 722' ' ' GLU . 0.3 OUTLIER -72.32 -36.32 68.83 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.921 -1.112 . . . . 0.0 111.415 -178.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.609 HG12 ' O ' ' A' ' 723' ' ' GLU . 7.2 p -81.31 -17.85 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.881 -1.137 . . . . 0.0 110.441 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.21 -47.46 75.26 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.107 -0.996 . . . . 0.0 108.866 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.37 103.92 10.94 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.335 1.064 . . . . 0.0 109.01 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.624 HD23 ' CG ' ' A' ' 602' ' ' PHE . 1.8 mt . . . . . 0 C--N 1.273 -2.729 0 CA-C-O 117.984 -1.007 . . . . 0.0 110.366 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -85.88 5.88 30.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -1.11 . . . . 0.0 110.723 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 108.9 42.78 1.27 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -85.09 114.8 22.5 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.339 -1.095 . . . . 0.0 109.022 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 578' ' ' LEU . 0.2 OUTLIER -102.65 -40.23 6.71 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.915 0.864 . . . . 0.0 109.502 -179.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 1.036 HD22 HD12 ' A' ' 594' ' ' ILE . 9.8 tt -116.7 124.5 49.84 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.246 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 25.5 m -108.58 116.88 32.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.336 -0.852 . . . . 0.0 109.944 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.782 HD21 HG23 ' A' ' 694' ' ' VAL . 1.8 mt -95.71 112.83 24.46 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.497 ' O ' HD23 ' A' ' 583' ' ' LEU . 0.1 OUTLIER -109.62 104.58 55.67 Favored Pre-proline 0 C--N 1.299 -1.612 0 C-N-CA 118.496 -1.282 . . . . 0.0 113.071 -177.278 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 1.026 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 44.8 Cg_endo -76.09 142.02 24.24 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 N-CA-C 106.295 -2.233 . . . . 0.0 106.295 175.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 1.047 ' HB2' ' HD2' ' A' ' 584' ' ' PRO . 0.2 OUTLIER -127.59 -171.69 0.24 Allowed Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 120.991 -1.068 . . . . 0.0 112.743 -176.276 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 1.047 ' HD2' ' HB2' ' A' ' 583' ' ' LEU . 36.4 Cg_endo -61.86 -31.29 85.0 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.859 1.452 . . . . 0.0 110.631 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . 0.436 ' OD1' HD12 ' A' ' 583' ' ' LEU . 3.3 m-20 -59.34 -26.62 65.2 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 177.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.481 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 19.1 t -96.56 153.38 17.88 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.532 HD13 ' HA ' ' A' ' 615' ' ' ASP . 13.8 tt -62.94 -15.89 16.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.703 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.937 HG23 ' HB2' ' A' ' 582' ' ' PRO . 1.0 OUTLIER -109.72 120.95 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.415 -0.803 . . . . 0.0 110.533 179.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.481 ' NE2' ' O ' ' A' ' 586' ' ' SER . 24.9 mp0 -107.25 79.94 1.36 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.578 -1.326 . . . . 0.0 108.728 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 1.026 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.6 mm-40 -141.52 176.61 8.75 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.36 -178.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.576 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.38 127.21 42.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.31 -0.869 . . . . 0.0 108.859 176.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.526 HD12 ' HB3' ' A' ' 580' ' ' LEU . 0.6 OUTLIER -104.0 148.87 25.71 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.149 -0.97 . . . . 0.0 110.147 -179.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -124.68 109.99 13.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.488 -0.757 . . . . 0.0 110.658 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 1.036 HD12 HD22 ' A' ' 578' ' ' LEU . 44.2 mt -86.0 112.47 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 108.493 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.525 ' O ' ' C ' ' A' ' 596' ' ' GLN . 0.0 OUTLIER -67.07 104.98 1.54 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.678 -0.638 . . . . 0.0 112.522 -177.67 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.744 ' CD ' HG21 ' A' ' 700' ' ' THR . 0.0 OUTLIER 16.84 57.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 178.341 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 113.3 39.61 1.11 Allowed Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.592 -1.29 . . . . 0.0 111.197 178.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.644 HG12 ' O ' ' A' ' 598' ' ' VAL . 1.2 t -79.82 103.58 6.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.43 ' O ' ' OD1' ' A' ' 599' ' ' ASN . 0.3 OUTLIER -141.37 140.16 20.21 Favored Pre-proline 0 C--N 1.282 -2.339 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.499 -178.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.469 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 56.2 Cg_endo -88.61 161.06 41.71 Favored 'Cis proline' 0 C--N 1.31 -1.457 0 C-N-CA 121.728 -2.197 . . . . 0.0 108.88 -0.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.549 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.1 t80 -106.35 116.17 31.47 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.716 ' C ' ' HB2' ' A' ' 609' ' ' CYS . 32.1 m-85 -92.35 144.59 25.23 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.29 -0.881 . . . . 0.0 110.702 -178.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.834 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.2 mt -135.68 142.47 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.644 -0.66 . . . . 0.0 110.079 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.649 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 170.82 -168.67 41.77 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.737 -1.221 . . . . 0.0 110.783 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 13.9 mmm-85 -70.0 -44.95 68.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.69 -0.888 . . . . 0.0 110.673 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.502 ' HB2' ' CG ' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -75.01 119.63 19.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 110.125 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 608' ' ' ASP . 12.8 pt-20 -48.53 -18.9 0.28 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.316 -0.865 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 607' ' ' GLU . 0.9 OUTLIER -42.48 -37.87 1.75 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.321 -0.862 . . . . 0.0 109.318 179.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.716 ' HB2' ' C ' ' A' ' 602' ' ' PHE . 23.0 p -68.73 128.21 35.82 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.549 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -43.66 -24.6 0.13 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.562 -0.711 . . . . 0.0 111.897 -178.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.834 ' HB3' HG23 ' A' ' 603' ' ' ILE . 9.0 t -108.57 142.64 38.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.351 -0.843 . . . . 0.0 109.593 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.515 ' C ' HD13 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -113.53 130.61 56.31 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.909 -1.119 . . . . 0.0 112.584 -178.785 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 613' ' ' ILE . 13.7 tt -145.09 109.26 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.451 ' O ' HD13 ' A' ' 587' ' ' ILE . 6.2 mm-40 -84.48 100.98 11.7 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 116.844 -1.942 . . . . 0.0 108.087 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.719 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 27.7 t0 -139.96 105.01 4.99 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 114.329 -1.305 . . . . 0.0 108.335 177.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -38.48 -67.96 0.18 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.506 -0.746 . . . . 0.0 112.746 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -16.58 25.62 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.174 -0.954 . . . . 0.0 111.839 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.719 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.3 OUTLIER -72.84 124.32 25.16 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.077 -1.014 . . . . 0.0 111.02 -179.006 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.502 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -69.8 161.71 29.29 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.384 -0.823 . . . . 0.0 110.639 179.558 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.649 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 31.9 mtm105 -63.88 -45.17 90.58 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 122.087 0.946 . . . . 0.0 109.126 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.621 HG13 HD11 ' A' ' 730' ' ' LEU . 21.8 m -95.77 2.29 9.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 CA-C-O 121.639 0.733 . . . . 0.0 109.422 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.755 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.3 t60 -29.86 -47.97 0.08 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.937 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.809 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -136.82 144.93 43.92 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 118.492 -1.283 . . . . 0.0 110.964 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.529 ' CZ ' ' CB ' ' A' ' 650' ' ' CYS . 8.4 p90 -145.87 141.44 27.84 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.506 -0.746 . . . . 0.0 110.053 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.6 HG13 HD11 ' A' ' 603' ' ' ILE . 71.5 mt -103.41 118.7 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 9.0 t80 -108.89 154.98 21.36 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.533 -0.729 . . . . 0.0 109.463 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.421 ' HB3' ' CB ' ' A' ' 599' ' ' ASN . 8.4 tttt -119.25 136.62 54.14 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.571 0.701 . . . . 0.0 110.379 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.453 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -136.23 163.97 29.15 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.749 -0.595 . . . . 0.0 110.421 -179.219 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.582 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.0 OUTLIER -77.78 124.97 28.64 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.564 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER -57.62 123.91 17.24 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.897 0.856 . . . . 0.0 111.312 -177.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -80.1 111.49 16.5 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.332 0.587 . . . . 0.0 110.633 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.55 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.3 p -116.7 170.52 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.396 -0.815 . . . . 0.0 110.166 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.55 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -94.24 -167.91 37.25 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.06 129.12 40.22 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.295 -1.121 . . . . 0.0 110.086 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.76 84.6 0.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.308 -0.87 . . . . 0.0 110.543 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 6.3 tpp -63.08 126.09 26.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.321 -0.862 . . . . 0.0 109.667 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.4 -144.5 0.4 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 0.0 109.954 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.14 102.22 9.7 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.162 -0.961 . . . . 0.0 109.15 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 27.9 p -136.91 151.74 72.81 Favored Pre-proline 0 C--N 1.293 -1.884 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.85 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.67 -153.1 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.614 1.323 . . . . 0.0 109.729 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 50.72 23.35 1.35 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.468 -0.77 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -74.34 61.73 0.92 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.132 -0.98 . . . . 0.0 110.153 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.642 ' C ' HD12 ' A' ' 644' ' ' LEU . . . 62.28 114.76 0.01 OUTLIER Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.719 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.1 mp -142.07 -151.16 0.35 Allowed 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.92 124.07 51.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.991 -1.068 . . . . 0.0 111.054 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -109.22 156.07 20.34 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.454 -0.779 . . . . 0.0 110.043 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.583 HD13 ' CD1' ' A' ' 578' ' ' LEU . 11.2 pt -111.06 128.92 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.271 -0.893 . . . . 0.0 109.633 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.977 ' CH2' HD22 ' A' ' 671' ' ' LEU . 99.0 m95 -114.29 120.09 39.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.724 -0.61 . . . . 0.0 111.539 -178.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.797 ' HB2' HD11 ' A' ' 672' ' ' LEU . 18.5 t80 -82.17 114.09 20.45 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.529 ' CB ' ' CZ ' ' A' ' 624' ' ' PHE . 62.2 m -109.54 102.27 11.14 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.145 -0.972 . . . . 0.0 111.399 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.613 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 12.1 t60 -69.0 160.39 31.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.461 -0.775 . . . . 0.0 109.918 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.755 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.1 OUTLIER -151.37 -31.09 0.17 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.424 -0.797 . . . . 0.0 113.112 -178.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.613 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -78.53 134.91 14.77 Favored Glycine 0 N--CA 1.502 3.087 0 C-N-CA 117.801 -2.143 . . . . 0.0 110.253 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 26.7 m -34.45 -24.87 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -177.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.682 ' C ' HG13 ' A' ' 656' ' ' VAL . 10.0 m120 -59.23 -3.02 0.34 Allowed 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.346 -1.472 . . . . 0.0 113.123 -178.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.682 HG13 ' C ' ' A' ' 655' ' ' ASN . 0.8 OUTLIER 62.14 145.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.509 -0.745 . . . . 0.0 110.259 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.55 ' OG ' ' HB2' ' A' ' 664' ' ' MET . 0.0 OUTLIER -93.98 151.36 19.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.555 -0.716 . . . . 0.0 110.495 -179.199 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.454 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 14.5 m-85 -135.1 125.78 27.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.25 -0.906 . . . . 0.0 109.929 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.614 ' CG ' HG22 ' A' ' 678' ' ' ILE . 0.1 OUTLIER -134.56 113.94 12.29 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.25 -0.907 . . . . 0.0 110.18 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 54.19 -88.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.482 -0.761 . . . . 0.0 110.773 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.3 m120 -136.71 18.25 3.07 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.066 -1.021 . . . . 0.0 110.509 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -111.85 116.77 31.21 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.222 -0.924 . . . . 0.0 110.444 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -94.08 138.19 32.43 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.475 -0.765 . . . . 0.0 109.815 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.712 ' SD ' HG13 ' A' ' 716' ' ' VAL . 0.0 OUTLIER -117.08 -159.44 0.73 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -0.893 . . . . 0.0 109.884 -179.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.662 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.7 pt -133.43 -171.69 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.246 -0.909 . . . . 0.0 110.372 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -74.27 70.06 1.62 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.351 -0.843 . . . . 0.0 110.452 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 133.13 55.77 0.08 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.662 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.0 OUTLIER -123.09 150.57 43.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.255 -1.144 . . . . 0.0 110.307 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.438 ' HG3' ' HB3' ' A' ' 648' ' ' TRP . 1.1 ttpm? -108.84 146.66 33.31 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.579 -0.701 . . . . 0.0 109.178 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.54 ' HD2' HD13 ' A' ' 659' ' ' LEU . 3.5 t80 -145.05 146.28 31.81 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 111.915 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.977 HD22 ' CH2' ' A' ' 648' ' ' TRP . 0.0 OUTLIER -69.68 130.55 42.66 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.546 -0.721 . . . . 0.0 109.497 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.797 HD11 ' HB2' ' A' ' 649' ' ' TYR . 1.7 mt -104.61 118.75 37.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.081 -1.012 . . . . 0.0 111.26 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.495 ' NE2' ' HA2' ' A' ' 708' ' ' GLY . 78.4 mt-30 -106.94 138.99 42.06 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.784 ' OD1' HD12 ' A' ' 707' ' ' LEU . 6.2 p-10 -36.69 146.19 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.268 -0.895 . . . . 0.0 110.921 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 73.13 48.76 18.6 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.413 ' OD1' HD21 ' A' ' 659' ' ' LEU . 0.4 OUTLIER -106.77 92.54 4.14 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.839 -0.8 . . . . 0.0 110.883 -178.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.679 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.0 OUTLIER -93.25 106.49 18.45 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.023 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.614 HG22 ' CG ' ' A' ' 659' ' ' LEU . 5.0 pt -115.25 135.61 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.541 -0.724 . . . . 0.0 111.715 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.39 110.57 22.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.518 -0.739 . . . . 0.0 109.106 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.809 HD13 ' SG ' ' A' ' 623' ' ' CYS . 72.1 mt -72.4 -46.18 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.369 -0.832 . . . . 0.0 110.19 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.594 HD12 ' CG ' ' A' ' 615' ' ' ASP . 9.8 mt -126.81 133.59 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.349 -0.845 . . . . 0.0 109.874 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -137.67 113.09 9.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 110.391 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -130.35 118.12 20.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.307 -0.87 . . . . 0.0 110.057 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -46.13 78.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.427 -0.796 . . . . 0.0 110.998 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -67.26 -43.02 82.91 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.31 -0.869 . . . . 0.0 110.75 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -90.47 -2.49 57.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.253 -0.904 . . . . 0.0 110.824 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.21 21.22 2.96 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.127 -0.983 . . . . 0.0 110.531 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.26 78.73 4.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.891 . . . . 0.0 109.084 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 586' ' ' SER . 39.5 t -101.69 131.47 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.557 -0.715 . . . . 0.0 110.682 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.647 ' CG2' HD11 ' A' ' 613' ' ' ILE . 49.7 mm -112.0 164.25 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.53 -0.731 . . . . 0.0 109.343 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 678' ' ' ILE . . . 179.95 116.33 0.51 Allowed Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.48 -1.343 . . . . 0.0 110.417 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.916 ' CZ ' HG21 ' A' ' 588' ' ' ILE . 12.1 m-85 -119.5 137.32 53.88 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.251 -1.146 . . . . 0.0 108.484 178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -107.98 114.75 28.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 111.209 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.782 HG23 HD21 ' A' ' 580' ' ' LEU . 0.8 OUTLIER -81.33 123.68 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.455 -0.778 . . . . 0.0 109.021 179.02 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -129.95 104.82 7.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.542 -0.724 . . . . 0.0 110.119 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.458 ' HA ' ' HA ' ' A' ' 578' ' ' LEU . 71.7 mt -84.35 103.95 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.366 -0.834 . . . . 0.0 109.851 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -81.78 -42.9 19.08 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 698' ' ' ASP . 0.6 OUTLIER -110.7 140.29 45.21 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.682 -0.637 . . . . 0.0 110.249 179.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 6.6 p -114.7 96.09 5.56 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.744 HG21 ' CD ' ' A' ' 596' ' ' GLN . 4.6 p -97.07 105.42 17.56 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.298 0.57 . . . . 0.0 111.144 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 49.42 27.53 8.31 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.858 HD23 ' O ' ' A' ' 704' ' ' ASN . 0.5 OUTLIER -82.24 147.02 29.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.387 -1.066 . . . . 0.0 110.28 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.719 ' HA ' HD13 ' A' ' 644' ' ' LEU . 2.5 p90 -52.62 -23.55 6.73 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.43 -0.794 . . . . 0.0 110.292 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.858 ' O ' HD23 ' A' ' 702' ' ' LEU . 1.6 t30 -175.9 155.14 1.59 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.456 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 16.1 pt-20 -51.43 -23.36 3.81 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.094 -1.004 . . . . 0.0 110.579 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 118.77 13.4 6.68 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.784 HD12 ' OD1' ' A' ' 674' ' ' ASP . 1.5 tp -83.96 9.97 10.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.193 -1.181 . . . . 0.0 111.345 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.495 ' HA2' ' NE2' ' A' ' 673' ' ' GLN . . . 94.95 -44.61 2.17 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.731 ' C ' HD23 ' A' ' 710' ' ' LEU . 1.1 ttm 62.75 149.77 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.384 -1.068 . . . . 0.0 110.515 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.731 HD23 ' C ' ' A' ' 709' ' ' MET . 0.7 OUTLIER 37.73 -155.66 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 CA-C-O 121.337 0.589 . . . . 0.0 111.769 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -94.14 72.22 3.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.515 -0.741 . . . . 0.0 109.46 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.32 148.27 48.78 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.497 -0.752 . . . . 0.0 110.694 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 715' ' ' VAL . 11.7 mt-30 -111.17 97.82 7.07 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.447 ' HD2' ' CZ ' ' A' ' 670' ' ' PHE . 3.4 mmm-85 -64.68 68.11 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.434 0.635 . . . . 0.0 110.584 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.477 ' N ' ' O ' ' A' ' 713' ' ' GLN . 27.7 m -106.09 149.26 9.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.712 HG13 ' SD ' ' A' ' 664' ' ' MET . 89.3 t -78.63 133.12 30.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 111.041 -178.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.35 162.2 13.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.519 -0.738 . . . . 0.0 109.782 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -100.11 152.95 19.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.943 . . . . 0.0 110.135 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -79.87 154.18 28.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.83 . . . . 0.0 110.263 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 29.6 p -120.29 -176.99 3.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.35 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -55.09 -28.95 56.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.318 -0.864 . . . . 0.0 110.241 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . 0.446 ' O ' HD13 ' A' ' 726' ' ' LEU . 0.0 OUTLIER -68.22 -52.51 33.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.49 -0.756 . . . . 0.0 110.077 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -63.44 -37.75 88.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.352 -0.843 . . . . 0.0 109.771 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.532 ' O ' HG12 ' A' ' 727' ' ' VAL . 13.1 tttm -58.44 -32.47 68.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.408 -0.807 . . . . 0.0 109.816 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.0 -39.21 79.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.459 -0.775 . . . . 0.0 110.341 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 722' ' ' GLU . 10.9 mp -55.75 -47.55 76.78 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.308 -0.87 . . . . 0.0 110.638 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 724' ' ' LYS . 8.8 p -69.98 -22.16 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.069 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -54.73 -50.37 68.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.257 -0.902 . . . . 0.0 109.048 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -116.53 103.46 10.44 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 122.241 1.02 . . . . 0.0 109.341 178.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.621 HD11 HG13 ' A' ' 621' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.273 -2.736 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.212 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -82.84 -10.03 59.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -1.08 . . . . 0.0 110.569 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 122.52 1.32 10.04 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -92.31 114.71 27.34 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.219 -1.165 . . . . 0.0 109.556 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.495 ' CB ' ' HA ' ' A' ' 596' ' ' GLN . 4.7 t80 -98.71 -42.77 7.07 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.953 0.882 . . . . 0.0 109.516 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.863 HD23 HD12 ' A' ' 594' ' ' ILE . 49.6 tp -123.3 120.35 32.83 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.606 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 85.5 m -101.17 116.81 33.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 1.045 HD11 HD12 ' A' ' 625' ' ' ILE . 4.3 mt -88.45 112.58 23.11 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.07 101.56 54.54 Favored Pre-proline 0 C--N 1.301 -1.505 0 C-N-CA 117.911 -1.516 . . . . 0.0 113.01 -177.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 1.156 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.1 Cg_endo -82.13 145.18 13.68 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 N-CA-C 106.017 -2.34 . . . . 0.0 106.017 173.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.703 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.33 -178.73 0.66 Allowed Pre-proline 0 N--CA 1.498 1.971 0 C-N-CA 118.207 -1.397 . . . . 0.0 114.166 -176.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.703 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 39.1 Cg_endo -67.6 -28.54 37.73 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 124.322 1.696 . . . . 0.0 111.965 -178.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -58.6 -30.96 67.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.681 -1.262 . . . . 0.0 107.609 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.51 ' HB3' ' N ' ' A' ' 691' ' ' GLY . 3.3 p -97.88 153.85 18.04 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.457 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.4 OUTLIER -57.17 -16.09 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.97 -1.081 . . . . 0.0 109.437 179.255 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.856 HD12 ' HA ' ' A' ' 613' ' ' ILE . 9.9 mm -97.1 114.59 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.285 -0.884 . . . . 0.0 108.739 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -126.75 73.96 1.44 Allowed 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.583 -1.323 . . . . 0.0 110.014 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 1.156 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 66.4 mm-40 -143.95 174.46 10.82 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.198 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.456 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -128.6 125.91 39.17 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.794 -1.191 . . . . 0.0 109.565 176.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.662 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.0 OUTLIER -109.34 155.43 21.21 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.284 -0.885 . . . . 0.0 109.626 179.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -125.02 109.99 13.63 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.363 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.863 HD12 HD23 ' A' ' 578' ' ' LEU . 4.4 mt -81.98 109.65 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.591 ' HB2' HG23 ' A' ' 598' ' ' VAL . 0.0 OUTLIER -53.01 174.47 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.504 -0.747 . . . . 0.0 109.952 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.495 ' HA ' ' CB ' ' A' ' 577' ' ' PHE . 0.4 OUTLIER -62.0 65.47 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.47 -0.769 . . . . 0.0 110.854 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 125.62 34.16 0.67 Allowed Glycine 0 N--CA 1.486 2.028 0 C-N-CA 119.507 -1.33 . . . . 0.0 110.938 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.643 HG12 ' O ' ' A' ' 598' ' ' VAL . 1.2 t -79.62 103.17 6.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 600' ' ' PRO . 10.4 t30 -143.18 134.68 12.82 Favored Pre-proline 0 C--N 1.283 -2.315 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.172 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.52 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 55.8 Cg_endo -91.47 161.35 28.16 Favored 'Cis proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.614 -1.828 . . . . 0.0 109.158 -1.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.487 ' CD1' ' HB3' ' A' ' 610' ' ' ASN . 5.8 t80 -107.08 116.65 32.3 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.745 ' C ' ' HB2' ' A' ' 609' ' ' CYS . 60.8 m-85 -89.63 144.98 25.57 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.375 -0.828 . . . . 0.0 110.786 -178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.831 HG23 ' HB3' ' A' ' 611' ' ' CYS . 3.2 mt -138.17 142.24 36.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.634 -0.666 . . . . 0.0 109.702 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 174.67 -161.24 30.84 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.415 -1.374 . . . . 0.0 111.111 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -76.26 -44.3 37.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.847 -0.796 . . . . 0.0 110.479 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.402 ' HB2' ' HG3' ' A' ' 620' ' ' ARG . 0.5 OUTLIER -80.5 123.27 27.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.277 -0.889 . . . . 0.0 110.413 -179.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 608' ' ' ASP . 10.1 pt-20 -48.18 -18.98 0.24 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.385 -0.822 . . . . 0.0 111.058 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 607' ' ' GLU . 2.2 t0 -40.76 -37.27 0.73 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.375 -0.828 . . . . 0.0 109.653 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.745 ' HB2' ' C ' ' A' ' 602' ' ' PHE . 18.0 p -73.43 133.6 43.76 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.487 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -44.58 -23.08 0.1 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.558 -0.713 . . . . 0.0 111.959 -178.691 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.831 ' HB3' HG23 ' A' ' 603' ' ' ILE . 10.7 t -110.08 143.63 39.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.316 -0.865 . . . . 0.0 109.743 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.7 125.61 52.09 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.003 -1.061 . . . . 0.0 113.122 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.856 ' HA ' HD12 ' A' ' 588' ' ' ILE . 10.7 mt -142.59 108.84 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -89.52 103.49 16.13 Favored 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 118.045 -1.462 . . . . 0.0 109.207 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.628 ' HB3' ' HB2' ' A' ' 618' ' ' LEU . 1.1 m-20 -139.37 106.45 5.46 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.348 177.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -43.15 -43.25 4.47 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.602 -0.686 . . . . 0.0 112.048 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -83.88 -17.52 40.57 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.017 -1.052 . . . . 0.0 111.905 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 615' ' ' ASP . 0.6 OUTLIER -77.27 133.96 38.68 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.056 -1.028 . . . . 0.0 110.834 -179.153 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.485 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 1.5 m -75.92 159.82 30.52 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.367 -0.833 . . . . 0.0 111.225 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.601 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 19.4 ttm105 -62.62 -44.48 96.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.361 -0.837 . . . . 0.0 109.219 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.756 ' HB ' HG23 ' A' ' 727' ' ' VAL . 27.4 m -94.65 1.81 9.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 121.761 0.791 . . . . 0.0 109.358 178.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 5.8 t60 -30.81 -48.22 0.11 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.718 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.827 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.5 OUTLIER -136.5 144.89 44.56 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.579 -1.249 . . . . 0.0 110.826 178.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 650' ' ' CYS . 17.1 p90 -146.29 145.84 30.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.543 -0.723 . . . . 0.0 110.163 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 1.045 HD12 HD11 ' A' ' 580' ' ' LEU . 8.7 mt -103.2 122.37 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.432 ' HB2' ' HE2' ' A' ' 624' ' ' PHE . 3.5 t80 -117.63 154.9 30.79 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.543 -0.723 . . . . 0.0 109.462 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 647' ' ' ILE . 10.1 tttt -119.72 136.19 54.53 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.77 0.795 . . . . 0.0 111.023 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.72 163.5 28.86 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.575 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -78.3 126.3 30.59 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.818 -179.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -65.06 125.1 23.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.399 -0.813 . . . . 0.0 110.749 -179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -119.41 140.14 50.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.594 -0.691 . . . . 0.0 110.327 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.555 HG22 ' N ' ' A' ' 633' ' ' GLY . 14.6 p -118.39 174.09 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.366 -0.834 . . . . 0.0 110.172 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.555 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -108.9 113.79 3.85 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 10.4 tttt 56.17 102.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.39 -1.065 . . . . 0.0 110.584 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.33 95.19 9.56 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.364 -0.835 . . . . 0.0 110.105 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 4.5 ttm -63.4 125.08 22.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.38 -0.825 . . . . 0.0 109.968 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 1.5 t80 63.64 -144.8 0.32 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.363 -0.836 . . . . 0.0 110.26 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -113.26 102.8 10.69 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 122.013 0.911 . . . . 0.0 109.172 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 67.9 p -135.73 152.04 75.32 Favored Pre-proline 0 C--N 1.291 -1.95 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.695 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.95 -152.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 O-C-N 123.67 1.353 . . . . 0.0 109.856 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . . . . . . . . . . . 52.85 22.43 2.36 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.371 -0.83 . . . . 0.0 110.636 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -105.61 57.83 0.67 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.264 -0.898 . . . . 0.0 110.148 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . . . . . . . . . . . 109.1 14.13 15.83 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.751 HD12 ' N ' ' A' ' 703' ' ' PHE . 3.0 mm? -65.87 -153.87 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.339 0 O-C-N 122.221 -0.576 . . . . 0.0 110.144 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.575 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 4.5 m-20 -130.19 132.53 46.06 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.035 -1.041 . . . . 0.0 111.306 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.588 ' OD1' HD21 ' A' ' 671' ' ' LEU . 2.2 t0 -127.26 143.24 51.28 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.229 -0.92 . . . . 0.0 110.538 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 627' ' ' LYS . 12.7 pt -96.96 134.45 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.261 -0.9 . . . . 0.0 109.926 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.686 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.3 m95 -119.18 120.87 38.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.571 -0.706 . . . . 0.0 111.313 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.662 ' HB2' HD11 ' A' ' 672' ' ' LEU . 4.0 t80 -80.84 114.25 19.59 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 624' ' ' PHE . 38.5 m -108.57 108.62 19.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 111.117 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.587 ' NE2' ' O ' ' A' ' 653' ' ' GLY . 12.1 t60 -74.21 161.7 29.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.572 -0.705 . . . . 0.0 110.362 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -151.11 -31.57 0.17 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.587 ' O ' ' NE2' ' A' ' 651' ' ' HIS . . . -79.41 130.89 10.18 Favored Glycine 0 N--CA 1.501 2.983 0 O-C-N 119.232 -2.167 . . . . 0.0 110.342 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 656' ' ' VAL . 11.4 m -36.54 -24.24 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -177.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.545 ' O ' HG12 ' A' ' 656' ' ' VAL . 4.1 t-20 -56.01 -4.74 0.13 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.325 -1.484 . . . . 0.0 112.775 -178.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 77.69 166.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 CA-C-O 122.043 0.925 . . . . 0.0 110.734 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.479 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -126.84 150.9 48.99 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 120.213 -0.595 . . . . 0.0 111.045 -178.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -135.75 126.4 27.15 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.396 -0.815 . . . . 0.0 110.23 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.732 ' CD2' HG22 ' A' ' 678' ' ' ILE . 0.4 OUTLIER -127.36 108.95 11.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.305 -0.872 . . . . 0.0 109.679 179.487 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.9 m120 58.79 -81.34 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.426 -0.796 . . . . 0.0 110.195 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.9 OUTLIER -143.78 22.66 1.78 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.069 -1.019 . . . . 0.0 110.439 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -116.57 128.17 55.17 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.195 -0.941 . . . . 0.0 110.395 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -91.46 141.32 28.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.393 -0.817 . . . . 0.0 110.176 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.679 ' HG2' HG13 ' A' ' 716' ' ' VAL . 3.5 mtp -120.28 -172.96 2.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.401 -0.812 . . . . 0.0 110.208 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.567 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.1 pp -126.09 -169.94 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.309 -0.87 . . . . 0.0 110.24 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -76.8 72.44 3.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.334 -0.854 . . . . 0.0 110.748 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 129.12 55.65 0.1 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.567 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.0 OUTLIER -122.17 151.76 40.64 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.281 -1.129 . . . . 0.0 110.296 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.597 ' HD3' HD13 ' A' ' 717' ' ' LEU . 0.0 OUTLIER -108.85 139.03 44.24 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.61 -0.681 . . . . 0.0 109.264 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.657 ' CD1' HD13 ' A' ' 659' ' ' LEU . 8.5 t80 -143.56 146.36 33.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 111.268 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.686 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.4 OUTLIER -73.88 146.98 43.66 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.614 -0.679 . . . . 0.0 110.778 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.761 HD13 HG21 ' A' ' 694' ' ' VAL . 10.2 mt -115.71 114.34 24.7 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.285 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.506 ' CG ' ' HA ' ' A' ' 707' ' ' LEU . 10.1 mt-30 -97.04 148.76 22.67 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.425 ' OD1' HD11 ' A' ' 707' ' ' LEU . 0.8 OUTLIER -51.0 135.19 25.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.044 -1.035 . . . . 0.0 110.087 -179.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 83.77 45.57 6.34 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 107.686 -2.166 . . . . 0.0 107.686 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.421 ' OD2' ' HA ' ' A' ' 672' ' ' LEU . 0.4 OUTLIER -109.85 93.5 4.53 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.802 -0.822 . . . . 0.0 110.444 -179.061 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.852 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 4.6 tt0 -93.35 107.47 19.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.732 HG22 ' CD2' ' A' ' 659' ' ' LEU . 4.1 pt -112.43 138.04 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.564 -0.71 . . . . 0.0 112.38 -176.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.22 113.58 26.76 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.827 HD13 ' SG ' ' A' ' 623' ' ' CYS . 85.0 mt -76.83 -30.66 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.172 -0.955 . . . . 0.0 110.51 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 618' ' ' LEU . 4.0 mt -138.64 134.93 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.269 -0.894 . . . . 0.0 110.047 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -137.38 108.84 6.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.539 -0.726 . . . . 0.0 110.104 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.59 118.39 33.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.32 -0.862 . . . . 0.0 110.221 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.04 -46.64 77.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.425 -0.797 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -84.6 -43.37 14.51 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.32 -0.863 . . . . 0.0 110.763 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -76.21 -10.09 59.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.333 -0.854 . . . . 0.0 110.662 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.76 20.2 4.95 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.111 -0.993 . . . . 0.0 110.433 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.407 ' CE2' ' HA ' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -82.3 75.15 9.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.285 -0.885 . . . . 0.0 109.354 179.464 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 689' ' ' VAL . 10.8 p -103.16 131.65 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.387 -0.821 . . . . 0.0 111.054 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.566 HG23 HG12 ' A' ' 588' ' ' ILE . 36.3 mm -113.3 163.67 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.429 -0.795 . . . . 0.0 109.168 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.51 ' N ' ' HB3' ' A' ' 586' ' ' SER . . . -167.79 120.29 0.89 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.198 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.852 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 7.7 m-85 -120.41 137.78 54.13 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.519 -0.989 . . . . 0.0 109.115 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -110.36 114.77 28.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.404 -0.81 . . . . 0.0 110.757 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.761 HG21 HD13 ' A' ' 672' ' ' LEU . 0.8 OUTLIER -75.67 119.97 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.478 -0.763 . . . . 0.0 109.084 179.227 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -129.68 103.95 7.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.438 -0.789 . . . . 0.0 110.143 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.551 ' CG1' HD13 ' A' ' 578' ' ' LEU . 60.0 mt -86.97 111.4 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -0.799 . . . . 0.0 109.734 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -81.28 -43.26 19.41 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.491 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 1.5 m-20 -111.65 140.56 46.18 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.555 0.693 . . . . 0.0 110.61 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . 0.407 ' O ' ' O ' ' A' ' 700' ' ' THR . 25.0 p -115.62 96.77 5.78 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . 0.611 HG23 ' H ' ' A' ' 702' ' ' LEU . 9.0 t -60.0 -147.52 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.138 0.494 . . . . 0.0 110.248 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.606 ' O ' ' CD1' ' A' ' 644' ' ' LEU . . . -67.86 -1.17 16.79 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.611 ' H ' HG23 ' A' ' 700' ' ' THR . 0.0 OUTLIER -47.03 144.46 2.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.287 -1.125 . . . . 0.0 111.15 -179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.751 ' N ' HD12 ' A' ' 644' ' ' LEU . 50.7 p90 -53.53 -27.62 26.85 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.137 0.97 . . . . 0.0 108.803 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.566 HD22 ' H ' ' A' ' 707' ' ' LEU . 24.4 t30 -174.68 173.53 2.82 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.547 ' HB2' HD12 ' A' ' 696' ' ' ILE . 8.2 pt-20 -51.07 -40.93 59.48 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.098 -1.001 . . . . 0.0 110.191 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 673' ' ' GLN . . . 149.83 37.92 0.04 OUTLIER Glycine 0 N--CA 1.498 2.796 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.971 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.566 ' H ' HD22 ' A' ' 704' ' ' ASN . 6.6 mp -86.0 9.24 17.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.043 -1.269 . . . . 0.0 111.448 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.548 ' HA3' HD13 ' A' ' 671' ' ' LEU . . . 64.88 -79.23 0.06 OUTLIER Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.414 ' N ' ' O ' ' A' ' 707' ' ' LEU . 69.2 mtm 54.53 60.51 3.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.432 -1.04 . . . . 0.0 110.419 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 712' ' ' GLU . 0.6 OUTLIER -132.03 -160.78 1.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.358 -0.839 . . . . 0.0 110.136 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -65.08 -26.97 68.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.338 -0.851 . . . . 0.0 110.325 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.484 ' HB2' HD11 ' A' ' 710' ' ' LEU . 1.8 mt-10 -97.6 146.87 24.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.354 -0.841 . . . . 0.0 110.265 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -111.71 96.16 5.92 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.283 -0.886 . . . . 0.0 109.381 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . . . . . . . . . 15.9 mmm-85 48.85 67.04 0.93 Allowed 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.286 0.565 . . . . 0.0 110.865 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.0 m -107.74 152.48 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.441 -0.787 . . . . 0.0 109.494 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.679 HG13 ' HG2' ' A' ' 664' ' ' MET . 57.7 t -89.4 121.5 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.16 -0.962 . . . . 0.0 110.543 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.597 HD13 ' HD3' ' A' ' 669' ' ' LYS . 3.1 mp -96.1 161.89 13.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.426 -0.796 . . . . 0.0 109.846 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.68 153.66 17.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.375 -0.828 . . . . 0.0 109.841 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -87.16 125.06 33.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.318 -0.864 . . . . 0.0 110.38 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 39.7 p -93.15 -176.31 4.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.376 -0.828 . . . . 0.0 110.124 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.44 -28.91 32.75 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.326 -0.859 . . . . 0.0 110.207 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.1 -52.17 63.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.377 -0.827 . . . . 0.0 109.858 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.15 -48.65 75.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 0.0 109.975 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.505 ' O ' HG12 ' A' ' 727' ' ' VAL . 5.7 tttp -53.74 -32.17 51.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.386 -0.822 . . . . 0.0 110.123 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.28 -36.17 78.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.87 . . . . 0.0 110.242 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 42.1 mt -59.46 -46.33 89.09 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.346 -0.846 . . . . 0.0 110.245 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.756 HG23 ' HB ' ' A' ' 621' ' ' VAL . 7.1 p -71.77 -22.2 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.145 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.26 -47.69 68.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.895 . . . . 0.0 108.937 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -116.87 104.28 11.15 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.151 0.977 . . . . 0.0 109.235 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.274 -2.69 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.252 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -82.93 -9.99 59.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.374 -1.074 . . . . 0.0 110.62 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 110.87 29.34 3.59 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.419 ' CG ' ' HB3' ' A' ' 593' ' ' GLU . 0.1 OUTLIER -92.56 114.38 26.92 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.337 -1.096 . . . . 0.0 109.515 179.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.495 ' HB3' ' HA ' ' A' ' 596' ' ' GLN . 3.4 t80 -106.29 -43.17 4.86 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.974 0.892 . . . . 0.0 109.46 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.738 HD23 HD12 ' A' ' 594' ' ' ILE . 31.4 tp -120.66 142.42 49.47 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.968 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 42.5 m -125.76 116.87 22.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.503 -0.748 . . . . 0.0 109.39 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.596 HD11 ' CD1' ' A' ' 625' ' ' ILE . 3.5 mt -95.13 112.08 23.83 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.416 ' CD ' ' HB3' ' A' ' 591' ' ' SER . 1.6 mmtt -108.62 102.78 49.05 Favored Pre-proline 0 C--N 1.3 -1.586 0 C-N-CA 118.4 -1.32 . . . . 0.0 112.408 -177.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 1.052 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 49.8 Cg_endo -79.08 142.69 17.35 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 N-CA-C 106.547 -2.136 . . . . 0.0 106.547 175.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.794 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -128.05 -171.08 0.23 Allowed Pre-proline 0 C--N 1.297 -1.693 0 C-N-CA 118.501 -1.279 . . . . 0.0 112.79 -177.056 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.794 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 37.2 Cg_endo -63.58 -35.09 61.32 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 124.068 1.562 . . . . 0.0 110.815 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.99 -28.73 66.63 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.585 ' O ' ' NE2' ' A' ' 589' ' ' GLN . 46.0 t -96.53 153.45 17.84 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.753 HG22 ' CD1' ' A' ' 690' ' ' ILE . 6.1 tp -63.53 -12.98 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.384 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.783 ' CG1' ' HA ' ' A' ' 613' ' ' ILE . 31.3 mm -100.97 120.29 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.369 -0.832 . . . . 0.0 109.838 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . 0.585 ' NE2' ' O ' ' A' ' 586' ' ' SER . 23.6 mp0 -115.98 68.27 0.72 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 120.55 -1.344 . . . . 0.0 109.307 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 1.052 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 5.5 mm-40 -143.97 176.85 8.98 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.593 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.524 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.19 125.77 41.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.194 -0.941 . . . . 0.0 108.859 176.576 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.732 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.9 mt -106.51 153.78 21.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.362 -0.836 . . . . 0.0 109.661 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.419 ' HB3' ' CG ' ' A' ' 576' ' ' ARG . 6.5 mp0 -125.99 110.12 13.22 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.308 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.738 HD12 HD23 ' A' ' 578' ' ' LEU . 1.7 mt -84.18 109.58 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.124 -0.985 . . . . 0.0 108.353 178.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.491 ' O ' ' N ' ' A' ' 597' ' ' GLY . 0.8 OUTLIER -51.66 172.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.655 -0.653 . . . . 0.0 109.869 -179.622 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.495 ' HA ' ' HB3' ' A' ' 577' ' ' PHE . 4.2 mt-30 -66.55 65.31 0.05 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.477 -0.764 . . . . 0.0 110.086 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 135.09 27.19 0.48 Allowed Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.611 -1.28 . . . . 0.0 110.988 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 598' ' ' VAL . 0.9 OUTLIER -80.08 102.23 5.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 627' ' ' LYS . 14.2 t-20 -144.3 133.45 11.33 Favored Pre-proline 0 C--N 1.282 -2.341 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.367 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.676 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 55.2 Cg_endo -91.96 162.86 26.92 Favored 'Cis proline' 0 C--N 1.311 -1.442 0 C-N-CA 123.086 -1.631 . . . . 0.0 108.891 -2.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.565 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 5.5 t80 -105.97 116.42 31.91 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.676 ' CZ ' ' HG2' ' A' ' 600' ' ' PRO . 73.8 m-85 -84.96 144.83 28.07 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.323 -0.861 . . . . 0.0 110.977 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.88 HG23 ' HB3' ' A' ' 611' ' ' CYS . 2.8 mt -142.19 141.62 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.724 -0.61 . . . . 0.0 110.291 -179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.834 ' HA2' HD21 ' A' ' 618' ' ' LEU . . . 167.88 -167.58 40.16 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.331 -1.414 . . . . 0.0 111.306 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 613' ' ' ILE . 8.0 tpt180 -63.01 -36.34 83.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.889 -0.771 . . . . 0.0 111.774 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.22 121.62 28.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.043 -1.036 . . . . 0.0 111.246 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.559 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 7.0 tm-20 -53.11 -19.06 2.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 110.02 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.55 -30.24 2.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.347 -0.846 . . . . 0.0 109.292 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 602' ' ' PHE . 4.7 m -69.06 136.37 52.25 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.496 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.6 OUTLIER -47.82 -25.09 1.16 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.276 -0.89 . . . . 0.0 110.056 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.88 ' HB3' HG23 ' A' ' 603' ' ' ILE . 4.0 t -110.52 143.32 41.06 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.589 ' O ' HG13 ' A' ' 588' ' ' ILE . 0.0 OUTLIER -106.93 127.23 53.26 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.099 -1.001 . . . . 0.0 112.682 -178.694 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.868 HG22 HD22 ' A' ' 618' ' ' LEU . 2.3 mt -144.01 108.99 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.536 ' H ' HD11 ' A' ' 588' ' ' ILE . 3.1 tt0 -97.79 104.48 16.51 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.302 -1.359 . . . . 0.0 108.916 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.573 ' HA ' ' CZ ' ' A' ' 688' ' ' PHE . 6.1 m-20 -138.41 106.1 5.61 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.531 177.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -43.32 -42.3 4.44 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.671 -0.643 . . . . 0.0 111.953 -178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -83.09 -17.16 44.08 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.096 -1.002 . . . . 0.0 111.098 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.868 HD22 HG22 ' A' ' 613' ' ' ILE . 0.5 OUTLIER -79.74 140.4 36.96 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.25 -0.906 . . . . 0.0 110.677 -179.335 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.435 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.4 OUTLIER -75.89 161.83 28.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.274 -0.891 . . . . 0.0 110.794 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.809 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.1 OUTLIER -64.22 -45.24 89.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.337 -0.852 . . . . 0.0 109.534 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 1.021 HG11 HG23 ' A' ' 727' ' ' VAL . 11.5 t -95.76 2.22 9.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.383 -0.823 . . . . 0.0 109.405 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.744 ' O ' ' N ' ' A' ' 652' ' ' THR . 4.8 t60 -26.05 -47.12 0.02 OUTLIER 'General case' 0 C--O 1.194 -1.831 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.46 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.804 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.8 OUTLIER -137.69 146.09 43.38 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 118.049 -1.46 . . . . 0.0 111.955 179.528 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.55 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 2.0 p90 -145.3 148.91 33.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.6 -0.688 . . . . 0.0 109.984 177.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.596 ' CD1' HD11 ' A' ' 580' ' ' LEU . 13.8 mt -103.72 124.41 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 6.0 t80 -117.32 155.24 29.87 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.481 -0.762 . . . . 0.0 109.386 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.49 ' NZ ' HG23 ' A' ' 647' ' ' ILE . 4.3 tppt? -119.73 137.06 54.17 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.604 0.716 . . . . 0.0 110.896 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.417 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -139.09 163.07 33.39 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.719 -0.613 . . . . 0.0 109.641 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 645' ' ' ASP . 0.0 OUTLIER -78.5 121.24 24.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.974 -1.079 . . . . 0.0 109.314 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.522 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 2.0 t60 -63.26 123.82 19.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 111.07 -178.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -96.63 98.17 9.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.615 -0.678 . . . . 0.0 109.941 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 633' ' ' GLY . 6.3 p -57.34 168.29 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.41 -0.806 . . . . 0.0 110.323 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.507 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -75.2 89.63 0.8 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 51.3 -164.04 0.06 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.355 -1.085 . . . . 0.0 110.48 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 89.6 p -167.69 58.9 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.392 -0.817 . . . . 0.0 110.356 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 1.7 mtm -97.31 33.28 2.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.24 -0.912 . . . . 0.0 109.798 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -160.43 -154.94 0.4 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -115.61 101.85 9.23 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.062 -1.024 . . . . 0.0 108.975 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 77.8 p -136.98 151.43 72.11 Favored Pre-proline 0 C--N 1.294 -1.847 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.956 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . 0.589 ' O ' ' HB3' ' A' ' 641' ' ' ALA . 48.5 Cg_endo -70.0 -152.6 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.664 1.349 . . . . 0.0 109.912 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 640' ' ' PRO . . . 66.77 -65.37 0.21 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.693 -0.63 . . . . 0.0 110.413 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 640' ' ' PRO . 8.4 tt0 48.93 31.28 3.15 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.28 -0.887 . . . . 0.0 110.325 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.4 ' O ' ' HG ' ' A' ' 644' ' ' LEU . . . 70.01 120.6 0.04 OUTLIER Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.588 ' CD1' ' HA ' ' A' ' 703' ' ' PHE . 2.9 mt -138.55 -150.72 0.35 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 122.185 -0.597 . . . . 0.0 109.393 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.533 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 1.0 OUTLIER -112.83 124.9 53.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.963 -1.085 . . . . 0.0 111.061 -179.592 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.722 ' OD1' HD21 ' A' ' 671' ' ' LEU . 37.6 t0 -112.72 143.63 43.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.39 -0.819 . . . . 0.0 110.188 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.49 HG23 ' NZ ' ' A' ' 627' ' ' LYS . 8.5 pt -99.39 132.36 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.259 -0.9 . . . . 0.0 109.663 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.624 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 95.2 m95 -118.12 142.95 46.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.527 -0.733 . . . . 0.0 110.918 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.92 ' CB ' HD11 ' A' ' 672' ' ' LEU . 27.0 t80 -103.24 114.81 29.39 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.5 OUTLIER -104.06 102.63 12.38 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.641 -178.531 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.526 ' CD2' ' N ' ' A' ' 652' ' ' THR . 8.7 t60 -64.2 156.63 28.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.345 -0.847 . . . . 0.0 109.294 178.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.744 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.0 OUTLIER -149.55 -28.22 0.26 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.364 -0.835 . . . . 0.0 112.543 -179.122 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.587 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -79.51 -163.82 27.26 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 117.943 -2.075 . . . . 0.0 109.724 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 25.2 m -96.93 -17.99 19.76 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.961 -1.317 . . . . 0.0 113.921 -176.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.691 ' C ' HG13 ' A' ' 656' ' ' VAL . 20.3 m120 -59.6 -2.96 0.4 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.774 -1.204 . . . . 0.0 112.591 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.691 HG13 ' C ' ' A' ' 655' ' ' ASN . 0.7 OUTLIER 63.38 138.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-O 121.69 0.757 . . . . 0.0 110.161 -179.332 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.449 ' OG ' ' CB ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -91.48 142.73 27.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.653 -0.655 . . . . 0.0 110.685 -178.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.466 ' CE2' ' CG2' ' A' ' 656' ' ' VAL . 6.1 m-85 -132.42 126.55 33.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.354 -0.841 . . . . 0.0 110.496 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.694 HD21 ' OD2' ' A' ' 676' ' ' ASP . 0.0 OUTLIER -130.97 115.38 16.42 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.366 -0.834 . . . . 0.0 109.955 179.515 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.08 -81.97 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.391 -0.818 . . . . 0.0 110.343 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 659' ' ' LEU . 0.7 OUTLIER -148.36 26.87 0.94 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.0 110.157 179.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -111.21 133.52 53.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 110.234 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.421 ' HG2' ' CE1' ' A' ' 658' ' ' TYR . 6.5 tmm_? -98.71 126.66 44.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.372 -0.83 . . . . 0.0 110.102 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.534 ' HG2' HG13 ' A' ' 716' ' ' VAL . 4.4 mtp -108.06 -167.73 1.28 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 110.345 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.637 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.7 pt -138.43 -164.22 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.352 -0.842 . . . . 0.0 110.279 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 652' ' ' THR . 51.5 tt0 -79.81 82.27 5.93 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.49 -0.756 . . . . 0.0 110.505 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 121.07 52.19 0.24 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.637 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.3 OUTLIER -121.15 148.3 44.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.018 -1.284 . . . . 0.0 110.111 179.678 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.42 ' CG ' ' HB3' ' A' ' 648' ' ' TRP . 1.3 ttpm? -108.31 141.34 40.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.492 -0.755 . . . . 0.0 109.456 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.451 ' HB2' ' CE ' ' A' ' 664' ' ' MET . 0.5 OUTLIER -144.42 146.72 32.65 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.49 -178.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.722 HD21 ' OD1' ' A' ' 646' ' ' ASP . 0.3 OUTLIER -71.31 147.17 48.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.511 -0.743 . . . . 0.0 111.197 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.92 HD11 ' CB ' ' A' ' 649' ' ' TYR . 3.0 mp -113.45 104.98 12.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.637 -0.664 . . . . 0.0 111.5 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.404 ' HB3' ' O ' ' A' ' 706' ' ' GLY . 88.6 mt-30 -88.47 151.04 22.81 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.671 ' OD2' HD22 ' A' ' 707' ' ' LEU . 2.8 p30 -48.22 143.83 4.3 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.162 -0.961 . . . . 0.0 110.377 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 69.96 46.29 52.83 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 107.841 -2.104 . . . . 0.0 107.841 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.694 ' OD2' HD21 ' A' ' 659' ' ' LEU . 0.2 OUTLIER -100.38 88.94 3.8 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.795 -0.826 . . . . 0.0 110.512 -179.14 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.788 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 0.3 OUTLIER -93.41 107.08 18.98 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.627 HG21 HD11 ' A' ' 659' ' ' LEU . 1.8 pt -115.12 137.95 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.631 -0.668 . . . . 0.0 111.737 -176.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 690' ' ' ILE . 7.2 mttp -96.89 111.23 23.52 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.804 HD13 ' SG ' ' A' ' 623' ' ' CYS . 73.1 mt -77.32 -11.76 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.299 -0.875 . . . . 0.0 110.64 -179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 688' ' ' PHE . 14.4 tt -143.2 133.87 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.074 -1.016 . . . . 0.0 110.158 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -138.11 111.69 8.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.149 -0.969 . . . . 0.0 110.738 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.3 117.15 19.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.233 -0.917 . . . . 0.0 109.86 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -46.93 72.71 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.361 -0.837 . . . . 0.0 110.954 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -66.94 -38.82 86.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.219 -0.925 . . . . 0.0 109.947 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . 0.58 ' O ' ' C ' ' A' ' 687' ' ' LYS . 1.5 m-80 -122.07 84.27 2.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.586 -0.696 . . . . 0.0 109.551 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . 0.58 ' C ' ' O ' ' A' ' 686' ' ' ASN . 23.4 mmtp -19.74 -82.55 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 122.054 -0.404 . . . . 0.0 111.335 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.573 ' CZ ' ' HA ' ' A' ' 615' ' ' ASP . 1.3 t80 33.8 73.41 0.07 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.504 -0.747 . . . . 0.0 110.099 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 586' ' ' SER . 58.6 t -112.21 143.14 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.459 -0.775 . . . . 0.0 111.49 -178.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.753 ' CD1' HG22 ' A' ' 587' ' ' ILE . 16.1 mm -103.46 164.65 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.443 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -177.12 115.8 0.52 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.001 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.788 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 12.8 m-85 -119.92 137.49 54.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -1.042 . . . . 0.0 109.138 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -101.5 114.75 29.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 110.593 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.653 HG22 HD11 ' A' ' 578' ' ' LEU . 1.2 t -82.43 121.48 35.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.578 -0.701 . . . . 0.0 109.169 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.12 104.83 7.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.711 -0.618 . . . . 0.0 110.172 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.451 HD13 ' O ' ' A' ' 705' ' ' GLU . 19.9 mt -80.91 104.43 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 0.0 109.935 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -72.78 -43.08 63.25 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.306 -0.872 . . . . 0.0 108.973 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.452 ' O ' ' CD2' ' A' ' 577' ' ' PHE . 6.5 m-20 -110.68 140.75 44.76 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.618 0.723 . . . . 0.0 110.741 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 28.6 p -115.43 96.06 5.47 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 39.3 p -126.5 131.63 51.58 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.642 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . 0.426 ' C ' HD22 ' A' ' 644' ' ' LEU . . . 51.15 35.85 34.6 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 704' ' ' ASN . 5.3 tp -108.99 132.96 53.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.451 -1.029 . . . . 0.0 111.036 -179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.633 ' CE2' ' HB3' ' A' ' 704' ' ' ASN . 3.3 p90 -48.47 -25.02 1.47 Allowed 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.644 0.735 . . . . 0.0 110.301 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.633 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.1 t30 -173.46 154.72 2.65 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.457 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 15.9 pt-20 -51.02 -26.06 5.61 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.095 -1.003 . . . . 0.0 110.475 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 118.92 18.22 4.78 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.671 HD22 ' OD2' ' A' ' 674' ' ' ASP . 0.1 OUTLIER -82.85 9.19 10.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.012 -1.287 . . . . 0.0 111.33 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . . . . . . . . . . . 64.61 87.12 0.05 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.96 38.67 3.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.347 -1.09 . . . . 0.0 110.382 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.533 HD12 ' HB2' ' A' ' 712' ' ' GLU . 0.5 OUTLIER -103.92 166.81 10.18 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.364 -0.835 . . . . 0.0 110.158 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -58.93 -52.87 63.89 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.308 -0.87 . . . . 0.0 110.16 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.533 ' HB2' HD12 ' A' ' 710' ' ' LEU . 1.3 mt-10 -63.8 148.68 48.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.496 -0.752 . . . . 0.0 109.917 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -110.9 95.71 5.72 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.232 -0.917 . . . . 0.0 109.283 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.461 ' CZ ' HD23 ' A' ' 659' ' ' LEU . 0.1 OUTLIER 43.6 75.9 0.09 Allowed 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.269 0.557 . . . . 0.0 111.389 179.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.44 ' O ' ' CE1' ' A' ' 670' ' ' PHE . 31.9 m -107.25 150.1 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 109.214 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.534 HG13 ' HG2' ' A' ' 664' ' ' MET . 85.1 t -95.45 133.16 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 110.729 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . . . . . . . . . 4.2 mp -108.86 162.34 14.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.42 -0.8 . . . . 0.0 110.094 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.17 154.61 17.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.36 -0.838 . . . . 0.0 110.1 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.62 148.02 31.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.304 -0.872 . . . . 0.0 110.406 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 11.1 p -121.35 -176.2 3.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.379 -0.826 . . . . 0.0 110.384 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.44 -29.2 34.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.369 -0.832 . . . . 0.0 110.002 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -66.05 -45.45 81.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.421 -0.799 . . . . 0.0 109.523 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -64.95 -46.91 79.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.47 -0.769 . . . . 0.0 109.62 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.492 ' O ' HG12 ' A' ' 727' ' ' VAL . 9.1 tttt -53.53 -32.64 51.37 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.427 -0.795 . . . . 0.0 109.746 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.59 -35.94 78.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.527 -0.733 . . . . 0.0 110.33 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . . . . . . . . . 34.4 mt -58.92 -46.84 86.96 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.274 -0.891 . . . . 0.0 110.305 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 1.021 HG23 HG11 ' A' ' 621' ' ' VAL . 7.5 p -70.8 -19.87 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.557 -0.715 . . . . 0.0 110.264 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.0 -43.51 66.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.265 -0.897 . . . . 0.0 108.956 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.94 103.52 10.37 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 122.222 1.01 . . . . 0.0 109.191 177.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.4 ' O ' ' CD2' ' A' ' 602' ' ' PHE . 1.2 mt . . . . . 0 C--N 1.273 -2.74 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.344 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 573' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.76 -1.336 . . . . 4.2000000000000002 109.76 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 574' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.36 -10.3 59.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -1.214 . . . . 3.9700000000000002 109.874 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . 0.637 ' O ' ' HA ' ' A' ' 595' ' ' GLN . . . 132.53 -4.93 5.19 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 110.167 -1.173 . . . . 0.91000000000000003 110.167 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 576' ' ' ARG . . . . . 0.434 ' HD3' ' HB3' ' A' ' 593' ' ' GLU . 1.9 ttp180 -91.4 115.15 27.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.853 -1.38 . . . . 1.48 109.387 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 577' ' ' PHE . . . . . 0.608 ' CE2' ' HB2' ' A' ' 578' ' ' LEU . 0.0 OUTLIER -115.5 -42.1 3.18 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.053 0.93 . . . . 1.03 109.241 -179.178 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.608 ' HB2' ' CE2' ' A' ' 577' ' ' PHE . 9.4 tt -120.45 128.79 53.49 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.872 -0.603 . . . . 1.1799999999999999 110.749 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 579' ' ' THR . . . . . . . . . . . . . 61.7 m -104.36 116.83 32.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 0.26000000000000001 109.704 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 580' ' ' LEU . . . . . 0.759 HD12 HG13 ' A' ' 594' ' ' ILE . 4.1 mt -92.11 112.6 24.6 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.843 -1.169 . . . . 0.89000000000000001 107.843 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 581' ' ' LYS . . . . . 0.441 ' HG2' ' HB3' ' A' ' 591' ' ' SER . 1.0 OUTLIER -113.5 102.77 55.18 Favored Pre-proline 0 C--N 1.301 -1.502 0 C-N-CA 118.337 -1.345 . . . . 0.93000000000000005 112.565 -178.089 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 582' ' ' PRO . . . . . 1.06 ' HD2' ' O ' ' A' ' 590' ' ' GLU . 43.7 Cg_endo -77.49 143.11 21.47 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 N-CA-C 105.83 -2.411 . . . . 0.25 105.83 174.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 583' ' ' LEU . . . . . 0.724 ' CB ' ' HD2' ' A' ' 584' ' ' PRO . 0.0 OUTLIER -122.41 -177.53 0.52 Allowed Pre-proline 0 N--CA 1.497 1.909 0 C-N-CA 118.181 -1.408 . . . . 1.1000000000000001 113.848 -176.233 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 584' ' ' PRO . . . . . 0.724 ' HD2' ' CB ' ' A' ' 583' ' ' LEU . 38.6 Cg_endo -66.96 -34.83 28.24 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 124.253 1.659 . . . . 0.51000000000000001 111.75 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 585' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -58.25 -29.32 65.68 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.173 -1.417 . . . . 1.4199999999999999 107.173 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 586' ' ' SER . . . . . 0.532 ' HB2' ' N ' ' A' ' 691' ' ' GLY . 3.0 t -95.92 150.8 20.04 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.396 -0.964 . . . . 1.1599999999999999 108.396 177.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 587' ' ' ILE . . . . . 0.67 HG22 ' CD1' ' A' ' 690' ' ' ILE . 0.5 OUTLIER -57.52 -15.98 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.994 -1.066 . . . . 1.29 109.428 179.457 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 588' ' ' ILE . . . . . 0.771 ' CD1' ' HA ' ' A' ' 613' ' ' ILE . 8.1 mm -98.49 114.67 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.388 -0.82 . . . . 1.6599999999999999 109.153 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 589' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.65 69.29 0.97 Allowed 'General case' 0 N--CA 1.507 2.395 0 O-C-N 120.711 -1.243 . . . . 1.29 109.512 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . 1.06 ' O ' ' HD2' ' A' ' 582' ' ' PRO . 27.6 mt-10 -142.74 176.04 9.35 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.132 -0.94 . . . . 2.1299999999999999 109.004 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.551 ' HA ' ' HD2' ' A' ' 582' ' ' PRO . 0.0 OUTLIER -127.73 123.67 35.92 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.791 -1.193 . . . . 0.22 109.926 177.382 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.547 HD13 ' SG ' ' A' ' 611' ' ' CYS . 1.8 mt -112.07 155.52 23.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.457 -0.777 . . . . 1.0800000000000001 109.37 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.434 ' HB3' ' HD3' ' A' ' 576' ' ' ARG . 10.5 mp0 -126.99 113.87 17.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -0.868 . . . . 1.6699999999999999 111.501 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 594' ' ' ILE . . . . . 0.759 HG13 HD12 ' A' ' 580' ' ' LEU . 4.1 mt -72.13 109.36 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.98 -1.075 . . . . 0.46999999999999997 108.31 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 595' ' ' GLN . . . . . 0.637 ' HA ' ' O ' ' A' ' 575' ' ' GLY . 0.0 OUTLIER -61.52 107.95 0.88 Allowed 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.601 -0.687 . . . . 1.52 110.738 -178.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 596' ' ' GLN . . . . . 0.629 ' N ' ' O ' ' A' ' 575' ' ' GLY . 3.5 tt0 -11.52 87.29 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.298 0.571 . . . . 1.3400000000000001 112.253 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 597' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 595' ' ' GLN . . . 105.87 22.1 8.2 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.668 -1.373 . . . . 1.0600000000000001 109.668 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 598' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 598' ' ' VAL . 1.2 t -82.28 103.59 9.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 107.074 -1.454 . . . . 0.53000000000000003 107.074 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 599' ' ' ASN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 627' ' ' LYS . 7.9 t30 -143.17 134.2 12.57 Favored Pre-proline 0 C--N 1.281 -2.403 0 CA-C-N 114.549 -1.205 . . . . 1.52 110.19 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 600' ' ' PRO . . . . . 0.668 ' HG2' ' CZ ' ' A' ' 602' ' ' PHE . 54.9 Cg_endo -91.56 162.26 28.1 Favored 'Cis proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.804 -1.748 . . . . 0.33000000000000002 109.334 -1.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 601' ' ' PHE . . . . . 0.625 ' HB3' ' HB ' ' A' ' 625' ' ' ILE . 5.1 t80 -106.28 117.21 33.45 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.363 -1.347 . . . . 0.28000000000000003 107.363 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 602' ' ' PHE . . . . . 0.681 ' C ' ' HB3' ' A' ' 609' ' ' CYS . 56.3 m-85 -88.71 146.04 25.29 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.378 -0.826 . . . . 0.53000000000000003 110.939 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 603' ' ' ILE . . . . . 0.746 HD11 HG13 ' A' ' 625' ' ' ILE . 2.9 mt -141.76 139.72 31.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.965 -0.694 . . . . 0.28999999999999998 109.962 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.708 ' HA3' ' O ' ' A' ' 620' ' ' ARG . . . 174.82 -166.81 38.74 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.505 -1.331 . . . . 0.22 110.977 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 605' ' ' ARG . . . . . 0.482 ' HD2' ' HA ' ' A' ' 614' ' ' GLU . 14.8 tpt180 -65.4 -38.83 91.14 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.858 -0.79 . . . . 1.5600000000000001 110.591 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 606' ' ' SER . . . . . 0.412 ' HB2' ' HG2' ' A' ' 620' ' ' ARG . 1.0 OUTLIER -81.04 122.32 27.16 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.323 -0.861 . . . . 0.75 110.862 -179.351 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.508 ' HA ' ' HG2' ' A' ' 612' ' ' LYS . 0.1 OUTLIER -57.73 -15.2 7.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 2.3900000000000001 109.79 178.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 608' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.09 -36.19 5.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.502 -0.749 . . . . 1.72 110.068 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 609' ' ' CYS . . . . . 0.681 ' HB3' ' C ' ' A' ' 602' ' ' PHE . 73.6 m -67.41 152.71 45.21 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.552 -0.859 . . . . 0.98999999999999999 109.451 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 610' ' ' ASN . . . . . 0.566 ' HB3' ' CD1' ' A' ' 601' ' ' PHE . 0.2 OUTLIER -57.06 -14.35 3.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.46 -0.775 . . . . 1.23 110.473 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 611' ' ' CYS . . . . . 0.711 ' HB3' HG23 ' A' ' 603' ' ' ILE . 8.7 t -120.08 144.21 47.72 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.398 -0.814 . . . . 0.34000000000000002 109.804 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 612' ' ' LYS . . . . . 0.508 ' HG2' ' HA ' ' A' ' 607' ' ' GLU . 0.0 OUTLIER -110.46 120.06 41.21 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 122.158 0.98 . . . . 2.1699999999999999 113.29 -178.117 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 613' ' ' ILE . . . . . 0.771 ' HA ' ' CD1' ' A' ' 588' ' ' ILE . 14.1 mt -142.8 107.92 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 107.36 -1.348 . . . . 0.55000000000000004 107.36 176.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 614' ' ' GLU . . . . . 0.482 ' HA ' ' HD2' ' A' ' 605' ' ' ARG . 6.0 tt0 -92.45 104.4 16.73 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.98 1.371 . . . . 2.2799999999999998 109.664 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 615' ' ' ASP . . . . . 0.626 ' OD2' HD11 ' A' ' 690' ' ' ILE . 1.8 m-20 -138.4 106.06 5.61 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.074 -1.421 . . . . 1.3899999999999999 107.971 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -39.65 -44.27 1.48 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.617 -0.677 . . . . 1.8500000000000001 112.131 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 617' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.78 -17.32 41.52 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.093 -1.005 . . . . 2.9300000000000002 111.672 -179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.686 HD12 HD11 ' A' ' 681' ' ' ILE . 0.8 OUTLIER -78.04 119.28 21.24 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.019 -1.051 . . . . 0.40999999999999998 110.768 -179.137 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 619' ' ' SER . . . . . 0.476 ' N ' ' HB2' ' A' ' 622' ' ' HIS . 0.3 OUTLIER -59.18 159.86 7.04 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.4 -0.813 . . . . 0.91000000000000003 110.809 179.852 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 620' ' ' ARG . . . . . 0.708 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 0.0 OUTLIER -63.91 -45.39 89.53 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.32 -0.862 . . . . 2.4199999999999999 109.183 179.521 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 621' ' ' VAL . . . . . 0.49 ' HB ' HG23 ' A' ' 727' ' ' VAL . 10.5 m -95.06 1.84 9.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 121.355 -0.84 . . . . 1.02 109.469 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 622' ' ' HIS . . . . . 0.749 ' O ' ' N ' ' A' ' 652' ' ' THR . 6.3 t60 -28.87 -46.79 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-N 115.622 -0.717 . . . . 0.22 110.875 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . 0.778 ' SG ' HD13 ' A' ' 680' ' ' ILE . 0.6 OUTLIER -136.45 145.77 45.58 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.45 -1.3 . . . . 0.19 110.777 178.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 624' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 650' ' ' CYS . 3.1 p90 -144.72 149.58 35.82 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.458 -0.776 . . . . 0.53000000000000003 110.219 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 625' ' ' ILE . . . . . 0.746 HG13 HD11 ' A' ' 603' ' ' ILE . 69.2 mt -104.54 121.75 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.765 -0.828 . . . . 0.64000000000000001 108.765 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 626' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 628' ' ' LYS . 4.5 t80 -115.27 153.96 29.95 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.52 -0.737 . . . . 0.92000000000000004 109.439 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 627' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 599' ' ' ASN . 1.2 ttmt -120.12 137.08 54.35 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.578 0.704 . . . . 0.93999999999999995 110.501 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . 0.417 ' HB2' ' CE2' ' A' ' 626' ' ' PHE . 0.0 OUTLIER -134.57 163.32 29.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.594 -0.691 . . . . 1.9399999999999999 110.321 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 629' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 644' ' ' LEU . 0.5 OUTLIER -78.32 115.08 17.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.95 . . . . 2.1299999999999999 108.74 179.82 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 630' ' ' HIS . . . . . 0.538 ' CE1' ' CD2' ' A' ' 703' ' ' PHE . 1.9 t60 -58.7 124.52 20.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.505 -0.747 . . . . 0.69999999999999996 110.846 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -93.2 102.98 15.28 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.673 -0.642 . . . . 1.04 110.016 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . 0.542 HG22 ' N ' ' A' ' 633' ' ' GLY . 7.3 p -61.23 170.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.395 -0.816 . . . . 1.9399999999999999 110.403 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 633' ' ' GLY . . . . . 0.542 ' N ' HG22 ' A' ' 632' ' ' VAL . . . -91.72 58.69 2.93 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.89 -1.284 . . . . 2.8399999999999999 109.89 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 634' ' ' LYS . . . . . . . . . . . . . 72.3 tttt 57.49 107.41 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.412 -1.052 . . . . 6.2199999999999998 110.646 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 635' ' ' SER . . . . . . . . . . . . . 79.6 p -90.91 94.49 9.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.245 -0.91 . . . . 4.4400000000000004 110.142 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 636' ' ' MET . . . . . . . . . . . . . 2.8 mtt -90.8 44.35 1.19 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.25 -0.907 . . . . 7.3799999999999999 110.214 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 637' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.09 -151.87 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.826 -0.805 . . . . 7.6200000000000001 108.826 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -108.86 98.87 8.29 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.99 -1.069 . . . . 5.1600000000000001 108.311 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 639' ' ' SER . . . . . . . . . . . . . 25.0 p -139.57 152.04 67.82 Favored Pre-proline 0 C--N 1.291 -1.961 0 CA-C-N 115.799 -0.637 . . . . 2.8300000000000001 109.839 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 640' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.43 -152.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.554 1.291 . . . . 2.3799999999999999 108.988 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 641' ' ' ALA . . . . . 0.491 ' HA ' HD13 ' A' ' 644' ' ' LEU . . . 50.03 24.81 1.47 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.417 -0.802 . . . . 1.9099999999999999 110.997 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 642' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -68.8 64.62 0.12 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.274 -0.891 . . . . 3.6000000000000001 110.152 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 643' ' ' GLY . . . . . 0.626 ' C ' HD12 ' A' ' 644' ' ' LEU . . . 62.4 110.44 0.01 OUTLIER Glycine 0 N--CA 1.487 2.061 0 N-CA-C 110.244 -1.142 . . . . 0.93999999999999995 110.244 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 644' ' ' LEU . . . . . 0.751 HD13 ' HA ' ' A' ' 703' ' ' PHE . 5.0 mp -139.53 -153.77 0.48 Allowed 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.97 -0.752 . . . . 1.23 108.97 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 645' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 629' ' ' ARG . 13.2 m-20 -112.54 123.97 51.48 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.974 -1.079 . . . . 1.54 111.276 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 646' ' ' ASP . . . . . 0.535 ' OD2' HD21 ' A' ' 671' ' ' LEU . 26.5 t70 -109.57 146.8 34.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.513 -0.742 . . . . 1.2 109.665 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 647' ' ' ILE . . . . . 0.554 HD13 ' CD1' ' A' ' 578' ' ' LEU . 12.5 pt -102.49 130.66 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.279 -0.888 . . . . 0.28999999999999998 110.039 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 648' ' ' TRP . . . . . 0.616 ' CZ3' ' HG ' ' A' ' 671' ' ' LEU . 91.3 m95 -118.58 119.71 35.31 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.092 -0.643 . . . . 0.32000000000000001 110.754 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.853 ' HB2' HD11 ' A' ' 672' ' ' LEU . 3.8 t80 -80.93 114.69 19.98 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.366 -0.975 . . . . 0.33000000000000002 108.366 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 650' ' ' CYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 668' ' ' THR . 0.1 OUTLIER -106.35 114.29 28.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.909 . . . . 1.1200000000000001 111.564 -178.608 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.527 ' CE1' ' C ' ' A' ' 656' ' ' VAL . 17.2 t60 -74.04 159.92 32.0 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.451 -0.781 . . . . 0.23999999999999999 109.975 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 652' ' ' THR . . . . . 0.749 ' N ' ' O ' ' A' ' 622' ' ' HIS . 0.2 OUTLIER -149.96 -30.59 0.22 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.403 -0.81 . . . . 0.31 112.968 -179.158 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 653' ' ' GLY . . . . . 0.566 ' HA3' ' ND1' ' A' ' 622' ' ' HIS . . . -78.03 -167.73 30.93 Favored Glycine 0 N--CA 1.494 2.546 0 C-N-CA 117.579 -2.248 . . . . 0.71999999999999997 109.416 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 654' ' ' THR . . . . . . . . . . . . . 24.3 m -94.94 -17.85 21.62 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.968 -1.313 . . . . 0.54000000000000004 113.91 -176.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 655' ' ' ASN . . . . . 0.535 ' O ' HG12 ' A' ' 656' ' ' VAL . 30.5 m120 -60.85 -4.29 0.96 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.774 -1.204 . . . . 1.79 112.398 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 664' ' ' MET . 0.4 OUTLIER 75.45 166.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-O 121.95 0.881 . . . . 1.46 110.648 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 657' ' ' SER . . . . . 0.42 ' OG ' ' CG ' ' A' ' 651' ' ' HIS . 0.0 OUTLIER -123.73 145.51 48.96 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.162 -0.615 . . . . 0.28999999999999998 110.585 -178.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.434 ' CE1' ' CG ' ' A' ' 663' ' ' ARG . 15.7 m-85 -135.64 126.32 27.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.272 -0.893 . . . . 1.22 110.615 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.64 HD22 ' CD2' ' A' ' 670' ' ' PHE . 0.2 OUTLIER -128.2 109.85 11.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.273 -0.892 . . . . 1.28 109.927 179.231 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.77 -80.34 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.484 -0.76 . . . . 1.73 110.358 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 661' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 659' ' ' LEU . 1.4 m-20 -146.13 25.21 1.27 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.25 -0.906 . . . . 2.1899999999999999 110.307 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 662' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.03 117.95 30.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.284 -0.885 . . . . 1.45 110.285 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 663' ' ' ARG . . . . . 0.434 ' CG ' ' CE1' ' A' ' 658' ' ' TYR . 3.0 tmm_? -84.39 141.06 31.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 2.4300000000000002 110.098 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 664' ' ' MET . . . . . 0.597 ' O ' HG22 ' A' ' 656' ' ' VAL . 3.5 mtp -118.89 -166.12 1.21 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.279 -0.888 . . . . 0.63 110.294 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 665' ' ' ILE . . . . . 0.624 ' CG1' HG23 ' A' ' 668' ' ' THR . 1.4 pt -138.34 -160.67 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.225 -0.922 . . . . 0.5 110.365 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 666' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -81.65 90.43 6.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.398 -0.814 . . . . 0.75 110.564 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . 110.07 50.43 0.68 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.021 -1.232 . . . . 0.28000000000000003 110.021 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 668' ' ' THR . . . . . 0.624 HG23 ' CG1' ' A' ' 665' ' ' ILE . 0.1 OUTLIER -117.61 149.43 40.69 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.113 -1.227 . . . . 0.29999999999999999 110.13 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.454 ' HE3' ' CG ' ' A' ' 648' ' ' TRP . 10.8 tttt -108.39 141.01 40.87 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.985 -0.746 . . . . 0.67000000000000004 108.985 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . 0.64 ' CD2' HD22 ' A' ' 659' ' ' LEU . 13.5 t80 -143.96 146.29 32.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.148 -0.97 . . . . 1.03 111.665 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 671' ' ' LEU . . . . . 0.616 ' HG ' ' CZ3' ' A' ' 648' ' ' TRP . 0.3 OUTLIER -73.08 147.26 45.14 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.626 -0.671 . . . . 1.3100000000000001 110.621 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 672' ' ' LEU . . . . . 0.853 HD11 ' HB2' ' A' ' 649' ' ' TYR . 12.8 mt -118.56 112.83 20.39 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.672 -0.811 . . . . 0.84999999999999998 111.306 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 673' ' ' GLN . . . . . 0.496 ' O ' HG11 ' A' ' 694' ' ' VAL . 75.2 mt-30 -90.25 -177.43 5.12 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.044 -0.725 . . . . 1.1599999999999999 109.044 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 674' ' ' ASP . . . . . 0.582 ' OD1' HD12 ' A' ' 707' ' ' LEU . 14.9 p-10 -76.26 142.83 41.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.138 -0.976 . . . . 1.21 109.691 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 675' ' ' GLY . . . . . . . . . . . . . . . 68.34 47.2 59.48 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 107.788 -2.125 . . . . 0.29999999999999999 107.788 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 676' ' ' ASP . . . . . 0.61 ' OD2' HD23 ' A' ' 672' ' ' LEU . 0.5 OUTLIER -100.45 91.93 4.92 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.748 -0.854 . . . . 1.3300000000000001 110.491 -179.117 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.919 ' HA ' ' O ' ' A' ' 692' ' ' PHE . 1.3 tt0 -93.16 107.42 19.23 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.76 -1.2 . . . . 1.79 107.76 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 678' ' ' ILE . . . . . 0.563 HG22 ' HG ' ' A' ' 659' ' ' LEU . 1.4 pt -111.73 137.74 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.419 0.628 . . . . 0.98999999999999999 111.667 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 679' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -98.95 111.01 23.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.515 -0.741 . . . . 2.4399999999999999 109.4 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 680' ' ' ILE . . . . . 0.778 HD13 ' SG ' ' A' ' 623' ' ' CYS . 72.8 mt -75.35 -24.11 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.23000000000000001 110.352 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 681' ' ' ILE . . . . . 0.686 HD11 HD12 ' A' ' 618' ' ' LEU . 3.6 mt -143.02 136.15 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -0.942 . . . . 1.3400000000000001 110.394 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 682' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -137.49 108.91 6.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.435 -0.79 . . . . 1.0700000000000001 110.109 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 683' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -121.36 118.36 29.27 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.265 -0.897 . . . . 1.4299999999999999 110.221 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -65.99 -46.35 78.31 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.423 -0.798 . . . . 2.21 110.887 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 685' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -80.4 -43.31 21.25 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.252 -0.905 . . . . 2.0499999999999998 110.68 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 686' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.74 -13.8 58.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.306 -0.871 . . . . 2.4100000000000001 110.471 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 687' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 57.23 18.95 4.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.221 -0.925 . . . . 2.6600000000000001 110.56 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 688' ' ' PHE . . . . . 0.414 ' CE2' ' OD1' ' A' ' 615' ' ' ASP . 0.1 OUTLIER -74.66 77.98 2.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 1.3100000000000001 109.034 179.252 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 689' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 586' ' ' SER . 43.5 t -101.63 136.15 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.387 -0.82 . . . . 1.3899999999999999 110.881 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 690' ' ' ILE . . . . . 0.67 ' CD1' HG22 ' A' ' 587' ' ' ILE . 47.1 mm -117.5 163.26 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.738 -0.838 . . . . 0.81000000000000005 108.738 178.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 691' ' ' GLY . . . . . 0.532 ' N ' ' HB2' ' A' ' 586' ' ' SER . . . -172.98 125.39 1.14 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.511 -1.328 . . . . 0.25 109.932 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 692' ' ' PHE . . . . . 0.919 ' O ' ' HA ' ' A' ' 677' ' ' GLU . 6.9 m-85 -120.63 137.71 54.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.603 -0.939 . . . . 0.25 109.484 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 693' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -100.67 113.71 26.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.13 -0.981 . . . . 2.2400000000000002 110.031 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 694' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 694' ' ' VAL . 1.2 t -85.45 115.03 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.365 -0.835 . . . . 0.28000000000000003 108.884 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 695' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -122.55 103.92 9.02 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.136 -0.626 . . . . 1.6599999999999999 109.923 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 696' ' ' ILE . . . . . 0.483 HD13 ' O ' ' A' ' 705' ' ' GLU . 74.0 mt -77.23 103.95 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.4 -0.812 . . . . 0.37 109.113 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 697' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.21 -43.51 28.26 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.355 -0.841 . . . . 1.1399999999999999 108.808 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 698' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 577' ' ' PHE . 8.0 m-20 -111.33 141.81 44.38 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.543 0.687 . . . . 1.1899999999999999 110.612 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 699' ' ' THR . . . . . . . . . . . . . 27.1 p -115.27 96.1 5.5 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.164 -1.421 . . . . 0.52000000000000002 107.164 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 700' ' ' THR . . . . . . . . . . . . . 6.7 m -127.43 132.63 50.04 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.305 0.574 . . . . 1.6000000000000001 111.077 -178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 701' ' ' GLY . . . . . . . . . . . . . . . 50.4 25.99 9.19 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 110.135 -1.186 . . . . 1.3100000000000001 110.135 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 702' ' ' LEU . . . . . 0.739 ' O ' HD22 ' A' ' 644' ' ' LEU . 0.9 OUTLIER -102.23 134.87 44.81 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.283 -1.128 . . . . 1.22 110.239 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 703' ' ' PHE . . . . . 0.751 ' HA ' HD13 ' A' ' 644' ' ' LEU . 3.4 p90 -49.47 -24.28 1.96 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.627 -0.67 . . . . 0.76000000000000001 110.673 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 704' ' ' ASN . . . . . 0.643 ' HB3' ' CE2' ' A' ' 703' ' ' PHE . 1.0 OUTLIER -169.63 157.75 7.27 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.531 -0.731 . . . . 0.98999999999999999 109.031 -178.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.554 ' HG2' ' OD1' ' A' ' 704' ' ' ASN . 15.4 pt-20 -51.48 -26.5 8.37 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.201 -0.937 . . . . 1.5800000000000001 110.458 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 706' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 674' ' ' ASP . . . 120.95 15.72 4.68 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.433 -1.467 . . . . 1.0900000000000001 109.433 -179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 707' ' ' LEU . . . . . 0.582 HD12 ' OD1' ' A' ' 674' ' ' ASP . 1.6 tp -82.73 9.16 10.26 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.005 -1.291 . . . . 1.72 111.622 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 708' ' ' GLY . . . . . 0.631 ' C ' HD23 ' A' ' 710' ' ' LEU . . . 66.61 43.56 91.82 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.866 -0.894 . . . . 2.0499999999999998 110.866 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 709' ' ' MET . . . . . 0.448 ' HG2' ' CG ' ' A' ' 704' ' ' ASN . 0.0 OUTLIER -83.29 101.62 11.4 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.05 -1.264 . . . . 1.8999999999999999 110.073 179.299 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 710' ' ' LEU . . . . . 0.631 HD23 ' C ' ' A' ' 708' ' ' GLY . 0.5 OUTLIER -172.78 -170.11 0.64 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.064 -1.022 . . . . 3.1699999999999999 110.347 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 711' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -90.9 -45.65 8.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.342 -0.849 . . . . 3.8300000000000001 110.412 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 712' ' ' GLU . . . . . 0.412 ' HB2' HD12 ' A' ' 710' ' ' LEU . 1.6 mt-10 -63.61 143.81 57.52 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.254 -0.904 . . . . 3.46 110.031 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 713' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -111.68 95.51 5.54 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.217 -0.927 . . . . 3.6299999999999999 109.73 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 714' ' ' ARG . . . . . 0.41 ' HD2' ' CE2' ' A' ' 670' ' ' PHE . 0.8 OUTLIER 39.91 83.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.238 0.542 . . . . 1.3799999999999999 111.691 179.346 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . . . . . . . . . 35.6 m -111.86 153.1 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.553 -0.717 . . . . 0.63 109.522 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 716' ' ' VAL . . . . . 0.59 HG13 ' HG2' ' A' ' 664' ' ' MET . 48.1 t -96.52 133.33 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.121 -0.987 . . . . 0.58999999999999997 110.581 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 717' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 717' ' ' LEU . 4.9 mp -109.5 162.66 14.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.478 -0.764 . . . . 0.81999999999999995 109.94 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -99.16 149.05 23.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.971 . . . . 2.4300000000000002 110.045 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 719' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.92 150.13 30.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.829 . . . . 1.98 110.248 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 720' ' ' THR . . . . . . . . . . . . . 21.8 p -116.42 -176.48 2.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.55000000000000004 110.277 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 721' ' ' ALA . . . . . . . . . . . . . . . -53.58 -28.96 35.07 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.337 -0.852 . . . . 0.57999999999999996 110.163 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 722' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.63 -47.88 71.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.385 -0.822 . . . . 2.3300000000000001 109.779 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 723' ' ' GLU . . . . . 0.583 ' OE1' HD12 ' A' ' 726' ' ' LEU . 12.3 mm-40 -64.21 -48.61 75.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.417 -0.802 . . . . 1.95 110.056 179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 724' ' ' LYS . . . . . 0.49 ' O ' HG12 ' A' ' 727' ' ' VAL . 5.5 tttp -52.61 -33.19 45.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.389 -0.819 . . . . 2.3399999999999999 109.795 179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 725' ' ' ASP . . . . . 0.406 ' HA ' ' HB2' ' A' ' 728' ' ' LYS . 3.6 t0 -68.39 -35.91 78.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.528 -0.732 . . . . 1.6000000000000001 109.911 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 726' ' ' LEU . . . . . 0.583 HD12 ' OE1' ' A' ' 723' ' ' GLU . 42.7 mt -55.95 -46.54 78.54 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.395 -0.816 . . . . 1.1000000000000001 110.018 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 727' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 724' ' ' LYS . 7.7 p -76.01 -21.01 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.606 -0.683 . . . . 1.1899999999999999 110.351 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 728' ' ' LYS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 725' ' ' ASP . 17.3 tttt -52.9 -43.09 65.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.238 -0.914 . . . . 2.5499999999999998 108.857 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 729' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -116.8 103.67 10.56 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 122.292 1.044 . . . . 2.5 109.138 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 730' ' ' LEU . . . . . 0.411 HD23 ' CG ' ' A' ' 602' ' ' PHE . 4.3 mt . . . . . 0 C--N 1.274 -2.687 0 CA-C-O 118.017 -0.992 . . . . 1.25 110.38 179.938 . . . . . . . . 1 1 . 1 stop_ save_